,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1351416,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,100131755,ARMCX4,https://ctdbase.org/detail.go?type=gene&acc=100131755,,,100131755.0,ARMCX4,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ARMCX4 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
1,1351417,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,100131755,ARMCX4,https://ctdbase.org/detail.go?type=gene&acc=100131755,,,100131755.0,ARMCX4,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of ARMCX4 mRNA,,,PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/27760801,27760801,,
2,1351418,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,10095,ARPC1B,https://ctdbase.org/detail.go?type=gene&acc=10095,,,10095.0,ARPC1B,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of ARPC1B mRNA,,,PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/27760801,27760801,,
3,1351419,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,10094,ARPC3,https://ctdbase.org/detail.go?type=gene&acc=10094,,,10094.0,ARPC3,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of ARPC3 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
4,1351420,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,10776,ARPP19,https://ctdbase.org/detail.go?type=gene&acc=10776,,,10776.0,ARPP19,10090.0,Mus musculus (house mouse),Titanium dioxide affects the expression of ARPP19 mRNA,,,PMID:17656681,https://www.ncbi.nlm.nih.gov/pubmed/17656681,17656681,,
5,1351421,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,407,ARR3,https://ctdbase.org/detail.go?type=gene&acc=407,,,407.0,ARR3,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ARR3 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
6,1351422,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,409,ARRB2,https://ctdbase.org/detail.go?type=gene&acc=409,,,409.0,ARRB2,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ARRB2 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
7,1351432,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,23105,FSTL4,https://ctdbase.org/detail.go?type=gene&acc=23105,,,23105.0,FSTL4,10116.0,Rattus norvegicus (Norway rat),Titanium dioxide results in increased expression of FSTL4 mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
8,1351433,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,2495,FTH1,https://ctdbase.org/detail.go?type=gene&acc=2495,,,2495.0,FTH1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of FTH1 mRNA,,,PMID:23557971|PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/23557971|https://www.ncbi.nlm.nih.gov/pubmed/27760801,23557971|27760801,,
9,1351434,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,71996,FTHL17A,https://ctdbase.org/detail.go?type=gene&acc=71996,,,71996.0,Fthl17a,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of FTHL17A mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
10,1351435,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,94033,FTMT,https://ctdbase.org/detail.go?type=gene&acc=94033,,,94033.0,FTMT,9606.0,Homo sapiens (human),Titanium dioxide results in increased expression of FTMT mRNA,,,PMID:34973136,https://www.ncbi.nlm.nih.gov/pubmed/34973136,34973136,,
11,1351436,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,100150934,FUK,https://ctdbase.org/detail.go?type=gene&acc=100150934,,,100150934.0,fuk,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of FUK mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
12,1351833,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,14380,G6PD2,https://ctdbase.org/detail.go?type=gene&acc=14380,,,14380.0,G6pd2,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of G6PD2 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
13,1352164,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,481,ATP1B1,https://ctdbase.org/detail.go?type=gene&acc=481,,,481.0,ATP1B1,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ATP1B1 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
14,1352165,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,481,ATP1B1,https://ctdbase.org/detail.go?type=gene&acc=481,,,481.0,ATP1B1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of ATP1B1 mRNA,,,PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/27760801,27760801,,
15,1352166,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,483,ATP1B3,https://ctdbase.org/detail.go?type=gene&acc=483,,,483.0,ATP1B3,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of ATP1B3 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
16,1352167,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,91419,ATP23,https://ctdbase.org/detail.go?type=gene&acc=91419,,,91419.0,ATP23,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of ATP23 mRNA,,,PMID:23409001,https://www.ncbi.nlm.nih.gov/pubmed/23409001,23409001,,
17,1352168,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,487,ATP2A1,https://ctdbase.org/detail.go?type=gene&acc=487,,,487.0,ATP2A1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of ATP2A1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
18,1352169,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,487,ATP2A1,https://ctdbase.org/detail.go?type=gene&acc=487,,,487.0,ATP2A1,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ATP2A1 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
19,1352334,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,117248,GALNT15,https://ctdbase.org/detail.go?type=gene&acc=117248,,,117248.0,GALNT15,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GALNT15 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
20,1352335,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,117248,GALNT15,https://ctdbase.org/detail.go?type=gene&acc=117248,,,117248.0,GALNT15,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of GALNT15 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
21,1352336,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,57452,GALNT16,https://ctdbase.org/detail.go?type=gene&acc=57452,,,57452.0,GALNT16,10090.0,Mus musculus (house mouse),Titanium dioxide affects the expression of GALNT16 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
22,1352337,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,57452,GALNT16,https://ctdbase.org/detail.go?type=gene&acc=57452,,,57452.0,GALNT16,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GALNT16 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
23,1352338,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,374378,GALNT18,https://ctdbase.org/detail.go?type=gene&acc=374378,,,374378.0,GALNT18,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GALNT18 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
24,1352339,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,374378,GALNT18,https://ctdbase.org/detail.go?type=gene&acc=374378,,,374378.0,GALNT18,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of GALNT18 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
25,1352340,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,2590,GALNT2,https://ctdbase.org/detail.go?type=gene&acc=2590,,,2590.0,GALNT2,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GALNT2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
26,1352341,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,2591,GALNT3,https://ctdbase.org/detail.go?type=gene&acc=2591,,,2591.0,GALNT3,10090.0,Mus musculus (house mouse),Titanium dioxide affects the expression of GALNT3 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
27,1352342,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,8693,GALNT4,https://ctdbase.org/detail.go?type=gene&acc=8693,,,8693.0,GALNT4,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of GALNT4 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
28,1352663,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,5205,ATP8B1,https://ctdbase.org/detail.go?type=gene&acc=5205,,,5205.0,ATP8B1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of ATP8B1 mRNA,,,PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/27760801,27760801,,
29,1352664,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,57198,ATP8B2,https://ctdbase.org/detail.go?type=gene&acc=57198,,,57198.0,ATP8B2,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of ATP8B2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
30,1352665,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,57198,ATP8B2,https://ctdbase.org/detail.go?type=gene&acc=57198,,,57198.0,ATP8B2,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ATP8B2 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
31,1352666,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,10079,ATP9A,https://ctdbase.org/detail.go?type=gene&acc=10079,,,10079.0,ATP9A,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ATP9A mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
32,1352667,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,8455,ATRN,https://ctdbase.org/detail.go?type=gene&acc=8455,,,8455.0,ATRN,9606.0,Homo sapiens (human),Titanium dioxide results in decreased methylation of ATRN gene,,,PMID:34973136,https://www.ncbi.nlm.nih.gov/pubmed/34973136,34973136,,
33,1352668,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,26033,ATRNL1,https://ctdbase.org/detail.go?type=gene&acc=26033,,,26033.0,ATRNL1,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ATRNL1 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
34,1352669,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,26033,ATRNL1,https://ctdbase.org/detail.go?type=gene&acc=26033,,,26033.0,ATRNL1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of ATRNL1 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
35,1352670,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,6790,AURKA,https://ctdbase.org/detail.go?type=gene&acc=6790,,,6790.0,AURKA,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of AURKA mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
36,1352671,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,9212,AURKB,https://ctdbase.org/detail.go?type=gene&acc=9212,,,9212.0,AURKB,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of AURKB mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
37,1352976,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,2662,GDF10,https://ctdbase.org/detail.go?type=gene&acc=2662,,,2662.0,GDF10,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of GDF10 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
38,1354173,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,8553,BHLHE40,https://ctdbase.org/detail.go?type=gene&acc=8553,,,8553.0,BHLHE40,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of BHLHE40 mRNA,,,PMID:23409001|PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/23409001|https://www.ncbi.nlm.nih.gov/pubmed/27760801,23409001|27760801,,
39,1354174,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,79365,BHLHE41,https://ctdbase.org/detail.go?type=gene&acc=79365,,,79365.0,BHLHE41,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of BHLHE41 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
40,1354175,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,79365,BHLHE41,https://ctdbase.org/detail.go?type=gene&acc=79365,,,79365.0,BHLHE41,10116.0,Rattus norvegicus (Norway rat),Titanium dioxide results in increased expression of BHLHE41 mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
41,1354176,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,635,BHMT,https://ctdbase.org/detail.go?type=gene&acc=635,,,635.0,BHMT,10090.0,Mus musculus (house mouse),Resveratrol promotes the reaction [titanium dioxide results in increased expression of BHMT mrna]|titanium dioxide results in increased expression of BHMT mRNA,,,PMID:31298478,https://www.ncbi.nlm.nih.gov/pubmed/31298478,31298478,,
42,1354177,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,80114,BICC1,https://ctdbase.org/detail.go?type=gene&acc=80114,,,80114.0,BICC1,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of BICC1 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
43,1354178,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,80114,BICC1,https://ctdbase.org/detail.go?type=gene&acc=80114,,,80114.0,BICC1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of BICC1 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
44,1354179,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,23299,BICD2,https://ctdbase.org/detail.go?type=gene&acc=23299,,,23299.0,BICD2,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of BICD2 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
45,1354180,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,23299,BICD2,https://ctdbase.org/detail.go?type=gene&acc=23299,,,23299.0,BICD2,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of BICD2 mRNA,,,PMID:23409001,https://www.ncbi.nlm.nih.gov/pubmed/23409001,23409001,,
46,1354788,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,92747,BPIFB1,https://ctdbase.org/detail.go?type=gene&acc=92747,,,92747.0,BPIFB1,10116.0,Rattus norvegicus (Norway rat),Titanium dioxide results in increased expression of BPIFB1 mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
47,1354789,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,128859,BPIFB6,https://ctdbase.org/detail.go?type=gene&acc=128859,,,128859.0,BPIFB6,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of BPIFB6 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
48,1354790,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,8315,BRAP,https://ctdbase.org/detail.go?type=gene&acc=8315,,,8315.0,BRAP,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of BRAP mrna]|titanium dioxide results in decreased expression of BRAP mRNA,,,PMID:31298478,https://www.ncbi.nlm.nih.gov/pubmed/31298478,31298478,,
49,1354791,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,8315,BRAP,https://ctdbase.org/detail.go?type=gene&acc=8315,,,8315.0,BRAP,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of BRAP mRNA,,,PMID:23409001,https://www.ncbi.nlm.nih.gov/pubmed/23409001,23409001,,
50,1354792,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,79184,BRCC3,https://ctdbase.org/detail.go?type=gene&acc=79184,,,79184.0,BRCC3,9606.0,Homo sapiens (human),Titanium dioxide results in increased expression of BRCC3 mRNA,,,PMID:34973136,https://www.ncbi.nlm.nih.gov/pubmed/34973136,34973136,,
51,1354793,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,140707,BRI3BP,https://ctdbase.org/detail.go?type=gene&acc=140707,,,140707.0,BRI3BP,10116.0,Rattus norvegicus (Norway rat),Titanium dioxide results in increased expression of BRI3BP mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
52,1354794,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,55299,BRIX1,https://ctdbase.org/detail.go?type=gene&acc=55299,,,55299.0,BRIX1,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of BRIX1 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
53,1354795,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,25855,BRMS1,https://ctdbase.org/detail.go?type=gene&acc=25855,,,25855.0,BRMS1,10090.0,Mus musculus (house mouse),Titanium dioxide affects the expression of BRMS1 mRNA,,,PMID:17656681,https://www.ncbi.nlm.nih.gov/pubmed/17656681,17656681,,
54,1354964,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,1880,GPR183,https://ctdbase.org/detail.go?type=gene&acc=1880,,,1880.0,GPR183,10116.0,Rattus norvegicus (Norway rat),Titanium dioxide results in increased expression of GPR183 mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
55,1354965,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,2843,GPR20,https://ctdbase.org/detail.go?type=gene&acc=2843,,,2843.0,GPR20,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GPR20 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
56,1354966,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,2850,GPR27,https://ctdbase.org/detail.go?type=gene&acc=2850,,,2850.0,GPR27,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of GPR27 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
57,1355144,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,10438,C1D,https://ctdbase.org/detail.go?type=gene&acc=10438,,,10438.0,C1D,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of C1D mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
58,1355145,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,56913,C1GALT1,https://ctdbase.org/detail.go?type=gene&acc=56913,,,56913.0,C1GALT1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of C1GALT1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
59,1355146,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,29071,C1GALT1C1,https://ctdbase.org/detail.go?type=gene&acc=29071,,,29071.0,C1GALT1C1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of C1GALT1C1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
60,1355147,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,79169,C1ORF35,https://ctdbase.org/detail.go?type=gene&acc=79169,,,79169.0,C1orf35,9606.0,Homo sapiens (human),Titanium dioxide results in decreased expression of C1ORF35 mRNA,,,PMID:34973136,https://www.ncbi.nlm.nih.gov/pubmed/34973136,34973136,,
61,1355148,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,712,C1QA,https://ctdbase.org/detail.go?type=gene&acc=712,,,712.0,C1QA,10090.0,Mus musculus (house mouse),Titanium dioxide affects the expression of C1QA mRNA,,,PMID:17656681,https://www.ncbi.nlm.nih.gov/pubmed/17656681,17656681,,
62,1355149,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,712,C1QA,https://ctdbase.org/detail.go?type=gene&acc=712,,,712.0,C1QA,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of C1QA mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
63,1355150,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,712,C1QA,https://ctdbase.org/detail.go?type=gene&acc=712,,,712.0,C1QA,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of C1QA mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
64,1355637,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,735,C9,https://ctdbase.org/detail.go?type=gene&acc=735,,,735.0,C9,10116.0,Rattus norvegicus (Norway rat),Titanium dioxide results in increased expression of C9 mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
65,1355638,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,760,CA2,https://ctdbase.org/detail.go?type=gene&acc=760,,,760.0,CA2,9606.0,Homo sapiens (human),Titanium dioxide results in increased expression of CA2 protein,,,PMID:30910687,https://www.ncbi.nlm.nih.gov/pubmed/30910687,30910687,,
66,1355639,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,51719,CAB39,https://ctdbase.org/detail.go?type=gene&acc=51719,,,51719.0,CAB39,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of CAB39 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
67,1355640,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,23523,CABIN1,https://ctdbase.org/detail.go?type=gene&acc=23523,,,23523.0,CABIN1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of CABIN1 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
68,1355641,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,56344,CABP5,https://ctdbase.org/detail.go?type=gene&acc=56344,,,56344.0,CABP5,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of CABP5 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
69,1355642,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,26256,CABYR,https://ctdbase.org/detail.go?type=gene&acc=26256,,,26256.0,CABYR,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of CABYR mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
70,1355774,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,783,CACNB2,https://ctdbase.org/detail.go?type=gene&acc=783,,,783.0,CACNB2,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of CACNB2 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
71,1355956,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,2934,GSN,https://ctdbase.org/detail.go?type=gene&acc=2934,,,2934.0,GSN,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GSN mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
72,1355957,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,2934,GSN,https://ctdbase.org/detail.go?type=gene&acc=2934,,,2934.0,GSN,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of GSN mRNA,,,PMID:23557971|PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/23557971|https://www.ncbi.nlm.nih.gov/pubmed/27760801,23557971|27760801,,
73,1356630,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,57513,CASKIN2,https://ctdbase.org/detail.go?type=gene&acc=57513,,,57513.0,CASKIN2,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of CASKIN2 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
74,1356631,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,9606.0,Homo sapiens (human),Titanium dioxide results in increased activity of CASP1 protein|dehydroxymethylepoxyquinomicin inhibits the reaction [titanium dioxide results in increased activity of CASP1 protein],,,PMID:30320338,https://www.ncbi.nlm.nih.gov/pubmed/30320338,30320338,,
75,1356632,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of CASP1 mRNA,,,PMID:23409001|PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23409001|https://www.ncbi.nlm.nih.gov/pubmed/23557971,23409001|23557971,,
76,1356633,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,100506742,CASP12,https://ctdbase.org/detail.go?type=gene&acc=100506742,,,100506742.0,CASP12,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of CASP12 mRNA,,,PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/27760801,27760801,,
77,1356820,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,8335,H2AC4,https://ctdbase.org/detail.go?type=gene&acc=8335,,,8335.0,H2AC4,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of H2AC4 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
78,1356821,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,100042922,H2AL1A,https://ctdbase.org/detail.go?type=gene&acc=100042922,,,100042922.0,H2al1a,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of H2AL1A mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
79,1356822,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,547160,H2AL1E,https://ctdbase.org/detail.go?type=gene&acc=547160,,,547160.0,H2al1e,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of H2AL1E mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
80,1356823,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of H2AX mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
81,1356824,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3015,H2AZ1,https://ctdbase.org/detail.go?type=gene&acc=3015,,,3015.0,H2AZ1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of H2AZ1 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
82,1356825,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,128312,H2BC26,https://ctdbase.org/detail.go?type=gene&acc=128312,,,128312.0,H2BC26,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of H2BC26 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
83,1356826,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,8347,H2BC4,https://ctdbase.org/detail.go?type=gene&acc=8347,,,8347.0,H2BC4,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of H2BC4 mRNA,,,PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/27760801,27760801,,
84,1357001,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,845,CASQ2,https://ctdbase.org/detail.go?type=gene&acc=845,,,845.0,CASQ2,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of CASQ2 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
85,1357002,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,57091,CASS4,https://ctdbase.org/detail.go?type=gene&acc=57091,,,57091.0,CASS4,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of CASS4 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
86,1357003,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,57091,CASS4,https://ctdbase.org/detail.go?type=gene&acc=57091,,,57091.0,CASS4,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of CASS4 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
87,1357004,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,54897,CASZ1,https://ctdbase.org/detail.go?type=gene&acc=54897,,,54897.0,CASZ1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of CASZ1 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
88,1357005,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),[titanium dioxide co-treated with cadmium chloride] results in decreased activity of CAT protein,,,PMID:21671166,https://www.ncbi.nlm.nih.gov/pubmed/21671166,21671166,,
89,1357006,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),Titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of lead] which results in decreased activity of CAT protein],,,PMID:30738203,https://www.ncbi.nlm.nih.gov/pubmed/30738203,30738203,,
90,1357007,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),Titanium dioxide results in decreased activity of CAT protein,,,PMID:22210200|PMID:23111874,https://www.ncbi.nlm.nih.gov/pubmed/22210200|https://www.ncbi.nlm.nih.gov/pubmed/23111874,22210200|23111874,,
91,1357008,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased activity of CAT protein|chlorophyllin inhibits the reaction [titanium dioxide results in increased activity of CAT protein],,,PMID:25129858,https://www.ncbi.nlm.nih.gov/pubmed/25129858,25129858,,
92,1357009,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of CAT mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
93,1357986,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,886,CCKAR,https://ctdbase.org/detail.go?type=gene&acc=886,,,886.0,CCKAR,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of CCKAR mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
94,1357987,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,887,CCKBR,https://ctdbase.org/detail.go?type=gene&acc=887,,,887.0,CCKBR,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of CCKBR mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
95,1357988,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,6346,CCL1,https://ctdbase.org/detail.go?type=gene&acc=6346,,,6346.0,CCL1,9606.0,Homo sapiens (human),Titanium dioxide affects the expression of CCL1 mRNA,,,PMID:19695317,https://www.ncbi.nlm.nih.gov/pubmed/19695317,19695317,,
96,1357989,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,6346,CCL1,https://ctdbase.org/detail.go?type=gene&acc=6346,,,6346.0,CCL1,9606.0,Homo sapiens (human),Titanium dioxide results in increased secretion of CCL1 protein,,,PMID:20005940,https://www.ncbi.nlm.nih.gov/pubmed/20005940,20005940,,
97,1357990,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,6346,CCL1,https://ctdbase.org/detail.go?type=gene&acc=6346,,,6346.0,CCL1,10116.0,Rattus norvegicus (Norway rat),Titanium dioxide results in increased expression of CCL1 mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
98,1357991,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,6356,CCL11,https://ctdbase.org/detail.go?type=gene&acc=6356,,,6356.0,CCL11,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of CCL11 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
99,1357992,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,6356,CCL11,https://ctdbase.org/detail.go?type=gene&acc=6356,,,6356.0,CCL11,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of CCL11 mRNA,,,PMID:21259345,https://www.ncbi.nlm.nih.gov/pubmed/21259345,21259345,,
100,1357993,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,6356,CCL11,https://ctdbase.org/detail.go?type=gene&acc=6356,,,6356.0,CCL11,10116.0,Rattus norvegicus (Norway rat),Titanium dioxide results in decreased expression of CCL11 mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
101,1357994,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,20293,CCL12,https://ctdbase.org/detail.go?type=gene&acc=20293,,,20293.0,Ccl12,10090.0,Mus musculus (house mouse),Titanium dioxide affects the expression of CCL12 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
102,1358428,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),Titanium dioxide results in increased expression of HIF1A protein|acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of HIF1A protein]|pimagedine inhibits the reaction [titanium dioxide results in increased expression of HIF1A protein],,,PMID:25406100,https://www.ncbi.nlm.nih.gov/pubmed/25406100,25406100,,
103,1358429,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of HIF1A protein,,,PMID:25406100|PMID:28646487,https://www.ncbi.nlm.nih.gov/pubmed/25406100|https://www.ncbi.nlm.nih.gov/pubmed/28646487,25406100|28646487,,
104,1358910,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of HMOX1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
105,1358911,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of HMOX1 mRNA,,,PMID:23557971|PMID:27760801|PMID:31769605,https://www.ncbi.nlm.nih.gov/pubmed/23557971|https://www.ncbi.nlm.nih.gov/pubmed/27760801|https://www.ncbi.nlm.nih.gov/pubmed/31769605,23557971|27760801|31769605,,
106,1358912,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of HMOX1 protein,,,PMID:25406100,https://www.ncbi.nlm.nih.gov/pubmed/25406100,25406100,,
107,1358913,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3163,HMOX2,https://ctdbase.org/detail.go?type=gene&acc=3163,,,3163.0,HMOX2,9606.0,Homo sapiens (human),Titanium dioxide results in increased expression of HMOX2 mRNA,,,PMID:19695317,https://www.ncbi.nlm.nih.gov/pubmed/19695317,19695317,,
108,1358914,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,6927,HNF1A,https://ctdbase.org/detail.go?type=gene&acc=6927,,,6927.0,HNF1A,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of HNF1A mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
109,1358915,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,6928,HNF1B,https://ctdbase.org/detail.go?type=gene&acc=6928,,,6928.0,HNF1B,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of HNF1B mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
110,1358916,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3172,HNF4A,https://ctdbase.org/detail.go?type=gene&acc=3172,,,3172.0,HNF4A,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of HNF4A mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
111,1358917,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3174,HNF4G,https://ctdbase.org/detail.go?type=gene&acc=3174,,,3174.0,HNF4G,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of HNF4G mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
112,1358918,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,220988,HNRNPA3,https://ctdbase.org/detail.go?type=gene&acc=220988,,,220988.0,HNRNPA3,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of HNRNPA3 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
113,1358919,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3183,HNRNPC,https://ctdbase.org/detail.go?type=gene&acc=3183,,,3183.0,HNRNPC,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of HNRNPC mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
114,1359428,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,57126,CD177,https://ctdbase.org/detail.go?type=gene&acc=57126,,,57126.0,CD177,10116.0,Rattus norvegicus (Norway rat),Titanium dioxide results in increased expression of CD177 mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
115,1359429,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,140497,CD300C2,https://ctdbase.org/detail.go?type=gene&acc=140497,,,140497.0,Cd300c2,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of CD300C2 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
116,1359430,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,4064,CD180,https://ctdbase.org/detail.go?type=gene&acc=4064,,,4064.0,CD180,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of CD180 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
117,1359431,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,930,CD19,https://ctdbase.org/detail.go?type=gene&acc=930,,,930.0,CD19,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of CD19 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
118,1359432,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,12479,CD1D1,https://ctdbase.org/detail.go?type=gene&acc=12479,,,12479.0,Cd1d1,10090.0,Mus musculus (house mouse),Titanium dioxide affects the expression of CD1D1 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
119,1359433,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,12479,CD1D1,https://ctdbase.org/detail.go?type=gene&acc=12479,,,12479.0,Cd1d1,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of CD1D1 mRNA,,,PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/27760801,27760801,,
120,1359434,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,914,CD2,https://ctdbase.org/detail.go?type=gene&acc=914,,,914.0,CD2,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of CD2 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
121,1359435,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,4345,CD200,https://ctdbase.org/detail.go?type=gene&acc=4345,,,4345.0,CD200,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of CD200 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
122,1359634,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,51478,HSD17B7,https://ctdbase.org/detail.go?type=gene&acc=51478,,,51478.0,HSD17B7,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of HSD17B7 mRNA,,,PMID:23557971|PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/23557971|https://www.ncbi.nlm.nih.gov/pubmed/27760801,23557971|27760801,,
123,1359635,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,15495,HSD3B4,https://ctdbase.org/detail.go?type=gene&acc=15495,,,15495.0,Hsd3b4,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of HSD3B4 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
124,1359636,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,15495,HSD3B4,https://ctdbase.org/detail.go?type=gene&acc=15495,,,15495.0,Hsd3b4,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of HSD3B4 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
125,1359637,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,15496,HSD3B5,https://ctdbase.org/detail.go?type=gene&acc=15496,,,15496.0,Hsd3b5,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of HSD3B5 mrna]|titanium dioxide results in decreased expression of HSD3B5 mRNA,,,PMID:31298478,https://www.ncbi.nlm.nih.gov/pubmed/31298478,31298478,,
126,1359638,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,83693,HSDL1,https://ctdbase.org/detail.go?type=gene&acc=83693,,,83693.0,HSDL1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of HSDL1 mRNA,,,PMID:23409001,https://www.ncbi.nlm.nih.gov/pubmed/23409001,23409001,,
127,1359639,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3320,HSP90AA1,https://ctdbase.org/detail.go?type=gene&acc=3320,,,3320.0,HSP90AA1,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of HSP90AA1 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
128,1359640,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3320,HSP90AA1,https://ctdbase.org/detail.go?type=gene&acc=3320,,,3320.0,HSP90AA1,10116.0,Rattus norvegicus (Norway rat),Titanium dioxide results in decreased expression of HSP90AA1 mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
129,1360243,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,10525,HYOU1,https://ctdbase.org/detail.go?type=gene&acc=10525,,,10525.0,HYOU1,9606.0,Homo sapiens (human),Titanium dioxide results in decreased methylation of HYOU1 promoter,,,PMID:34973136,https://www.ncbi.nlm.nih.gov/pubmed/34973136,34973136,,
130,1360244,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,10525,HYOU1,https://ctdbase.org/detail.go?type=gene&acc=10525,,,10525.0,HYOU1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of HYOU1 mRNA,,,PMID:23409001|PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23409001|https://www.ncbi.nlm.nih.gov/pubmed/23557971,23409001|23557971,,
131,1360245,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3375,IAPP,https://ctdbase.org/detail.go?type=gene&acc=3375,,,3375.0,IAPP,10116.0,Rattus norvegicus (Norway rat),Titanium dioxide results in increased expression of IAPP mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
132,1360246,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3381,IBSP,https://ctdbase.org/detail.go?type=gene&acc=3381,,,3381.0,IBSP,9606.0,Homo sapiens (human),Titanium dioxide results in increased expression of IBSP mRNA,,,PMID:19464052,https://www.ncbi.nlm.nih.gov/pubmed/19464052,19464052,,
133,1360247,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,25998,IBTK,https://ctdbase.org/detail.go?type=gene&acc=25998,,,25998.0,IBTK,9606.0,Homo sapiens (human),Titanium dioxide affects the expression of IBTK mRNA,,,PMID:24023007,https://www.ncbi.nlm.nih.gov/pubmed/24023007,24023007,,
134,1360248,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Curcumin inhibits the reaction [titanium dioxide results in increased expression of ICAM1 protein],,,PMID:29244817,https://www.ncbi.nlm.nih.gov/pubmed/29244817,29244817,,
135,1360249,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Titanium dioxide results in increased expression of ICAM1 mRNA,,,PMID:34633093,https://www.ncbi.nlm.nih.gov/pubmed/34633093,34633093,,
136,1360250,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Titanium dioxide results in increased expression of ICAM1 protein,,,PMID:22352400|PMID:29244817,https://www.ncbi.nlm.nih.gov/pubmed/22352400|https://www.ncbi.nlm.nih.gov/pubmed/29244817,22352400|29244817,,
137,1360251,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Titanium dioxide results in increased secretion of ICAM1 protein,,,PMID:20005940,https://www.ncbi.nlm.nih.gov/pubmed/20005940,20005940,,
138,1360368,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10090.0,Mus musculus (house mouse),Titanium dioxide affects the expression of ICAM1 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
139,1360369,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of ICAM1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
140,1360370,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ICAM1 protein,,,PMID:36528116,https://www.ncbi.nlm.nih.gov/pubmed/36528116,36528116,,
141,1360371,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of ICAM1 mRNA,,,PMID:23409001|PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/23409001|https://www.ncbi.nlm.nih.gov/pubmed/27760801,23409001|27760801,,
142,1360372,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of ICAM1 protein,,,PMID:30626778,https://www.ncbi.nlm.nih.gov/pubmed/30626778,30626778,,
143,1360373,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3384,ICAM2,https://ctdbase.org/detail.go?type=gene&acc=3384,,,3384.0,ICAM2,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ICAM2 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
144,1360374,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3386,ICAM4,https://ctdbase.org/detail.go?type=gene&acc=3386,,,3386.0,ICAM4,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of ICAM4 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
145,1360737,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,15950,IFI203,https://ctdbase.org/detail.go?type=gene&acc=15950,,,15950.0,Ifi203,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of IFI203 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
146,1360738,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,15951,IFI204,https://ctdbase.org/detail.go?type=gene&acc=15951,,,15951.0,Ifi204,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of IFI204 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
147,1360739,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,15951,IFI204,https://ctdbase.org/detail.go?type=gene&acc=15951,,,15951.0,Ifi204,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of IFI204 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
148,1360740,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,226695,IFI205,https://ctdbase.org/detail.go?type=gene&acc=226695,,,226695.0,Ifi205,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of IFI205 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
149,1360741,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,226695,IFI205,https://ctdbase.org/detail.go?type=gene&acc=226695,,,226695.0,Ifi205,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of IFI205 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
150,1360742,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,100033459,IFI208,https://ctdbase.org/detail.go?type=gene&acc=100033459,,,100033459.0,Ifi208,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of IFI208 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
151,1360743,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,381308,IFI211,https://ctdbase.org/detail.go?type=gene&acc=381308,,,381308.0,Ifi211,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of IFI211 mRNA,,,PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/27760801,27760801,,
152,1360744,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3429,IFI27,https://ctdbase.org/detail.go?type=gene&acc=3429,,,3429.0,IFI27,10090.0,Mus musculus (house mouse),Titanium dioxide affects the expression of IFI27 mRNA,,,PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/27760801,27760801,,
153,1360745,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3429,IFI27,https://ctdbase.org/detail.go?type=gene&acc=3429,,,3429.0,IFI27,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of IFI27 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
154,1362072,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of IKBKB protein,,,PMID:28646487,https://www.ncbi.nlm.nih.gov/pubmed/28646487,28646487,,
155,1362073,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,10320,IKZF1,https://ctdbase.org/detail.go?type=gene&acc=10320,,,10320.0,IKZF1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of IKZF1 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
156,1362074,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,22806,IKZF3,https://ctdbase.org/detail.go?type=gene&acc=22806,,,22806.0,IKZF3,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of IKZF3 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
157,1362075,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,9606.0,Homo sapiens (human),Titanium dioxide affects the expression of IL10 mRNA,,,PMID:19695317,https://www.ncbi.nlm.nih.gov/pubmed/19695317,19695317,,
158,1362076,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,9606.0,Homo sapiens (human),Titanium dioxide results in increased expression of IL10 mRNA,,,PMID:22342292,https://www.ncbi.nlm.nih.gov/pubmed/22342292,22342292,,
159,1362077,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of IL10 protein,,,PMID:19464567|PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/19464567|https://www.ncbi.nlm.nih.gov/pubmed/23557971,19464567|23557971,,
160,1362078,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3587,IL10RA,https://ctdbase.org/detail.go?type=gene&acc=3587,,,3587.0,IL10RA,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of IL10RA mRNA,,,PMID:27760801|PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/27760801|https://www.ncbi.nlm.nih.gov/pubmed/29264374,27760801|29264374,,
161,1362537,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Titanium dioxide results in increased secretion of IL1B protein,,,PMID:22939914,https://www.ncbi.nlm.nih.gov/pubmed/22939914,22939914,,
162,1362538,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,84639,IL1F10,https://ctdbase.org/detail.go?type=gene&acc=84639,,,84639.0,IL1F10,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of IL1F10 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
163,1362539,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3554,IL1R1,https://ctdbase.org/detail.go?type=gene&acc=3554,,,3554.0,IL1R1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of IL1R1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
164,1362540,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,7850,IL1R2,https://ctdbase.org/detail.go?type=gene&acc=7850,,,7850.0,IL1R2,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of IL1R2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
165,1362541,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,7850,IL1R2,https://ctdbase.org/detail.go?type=gene&acc=7850,,,7850.0,IL1R2,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of IL1R2 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
166,1363405,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3619,INCENP,https://ctdbase.org/detail.go?type=gene&acc=3619,,,3619.0,INCENP,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of INCENP mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
167,1363406,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3623,INHA,https://ctdbase.org/detail.go?type=gene&acc=3623,,,3623.0,INHA,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of INHA mrna|titanium dioxide results in decreased expression of INHA protein,,,PMID:23565150,https://www.ncbi.nlm.nih.gov/pubmed/23565150,23565150,,
168,1363407,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3624,INHBA,https://ctdbase.org/detail.go?type=gene&acc=3624,,,3624.0,INHBA,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of INHBA mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
169,1363408,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3624,INHBA,https://ctdbase.org/detail.go?type=gene&acc=3624,,,3624.0,INHBA,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of INHBA mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
170,1363409,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3625,INHBB,https://ctdbase.org/detail.go?type=gene&acc=3625,,,3625.0,INHBB,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of INHBB mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
171,1363410,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3625,INHBB,https://ctdbase.org/detail.go?type=gene&acc=3625,,,3625.0,INHBB,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of INHBB mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
172,1363411,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,11185,INMT,https://ctdbase.org/detail.go?type=gene&acc=11185,,,11185.0,INMT,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of INMT mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
173,1364702,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3705,ITPK1,https://ctdbase.org/detail.go?type=gene&acc=3705,,,3705.0,ITPK1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of ITPK1 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
174,1364703,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3706,ITPKA,https://ctdbase.org/detail.go?type=gene&acc=3706,,,3706.0,ITPKA,10090.0,Mus musculus (house mouse),Titanium dioxide affects the expression of ITPKA mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
175,1364704,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3706,ITPKA,https://ctdbase.org/detail.go?type=gene&acc=3706,,,3706.0,ITPKA,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of ITPKA mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
176,1364705,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3706,ITPKA,https://ctdbase.org/detail.go?type=gene&acc=3706,,,3706.0,ITPKA,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of ITPKA mRNA,,,PMID:23409001,https://www.ncbi.nlm.nih.gov/pubmed/23409001,23409001,,
177,1364706,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3707,ITPKB,https://ctdbase.org/detail.go?type=gene&acc=3707,,,3707.0,ITPKB,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of ITPKB mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
178,1364707,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3710,ITPR3,https://ctdbase.org/detail.go?type=gene&acc=3710,,,3710.0,ITPR3,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of ITPR3 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
179,1364708,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,223075,ITPRID1,https://ctdbase.org/detail.go?type=gene&acc=223075,,,223075.0,ITPRID1,10090.0,Mus musculus (house mouse),Titanium dioxide affects the expression of ITPRID1 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
180,1365051,26399,Toxin and Toxin Target Database (T3DB),ZINC dichromate,T3D0716,Zinc dichromate,http://www.t3db.ca/toxins/T3D0716,BE0000923,Mitogen-activated protein kinase 1,http://www.t3db.ca/biodb/bio_entities/BE0000923,P28482,Mitogen-activated protein kinase 1,5594.0,MAPK1,9606.0,Homo sapiens (human),Chromium has been shown to induce carcinogenesis by overstimulating cellular regulatory pathways and increasing peroxide levels by activating certain mitogen-activated protein kinases. (A34),,,PMID:8616849,https://www.ncbi.nlm.nih.gov/pubmed/8616849,8616849,,
181,1365052,26399,Toxin and Toxin Target Database (T3DB),ZINC dichromate,T3D0716,Zinc dichromate,http://www.t3db.ca/toxins/T3D0716,BE0001062,Mitogen-activated protein kinase 3,http://www.t3db.ca/biodb/bio_entities/BE0001062,P27361,Mitogen-activated protein kinase 3 ,5595.0,MAPK3,9606.0,Homo sapiens (human),Chromium has been shown to induce carcinogenesis by overstimulating cellular regulatory pathways and increasing peroxide levels by activating certain mitogen-activated protein kinases. (A34),,,PMID:8616849,https://www.ncbi.nlm.nih.gov/pubmed/8616849,8616849,,
182,1365053,26399,Toxin and Toxin Target Database (T3DB),ZINC dichromate,T3D0716,Zinc dichromate,http://www.t3db.ca/toxins/T3D0716,BE0002390,Superoxide dismutase [Cu-Zn],http://www.t3db.ca/biodb/bio_entities/BE0002390,P00441,Superoxide dismutase [Cu-Zn],6647.0,SOD1,9606.0,Homo sapiens (human),"Unbalanced levels of copper and zinc binding to cu,zn-superoxide dismutase has been linked to amyotrophic lateral sclerosis (ALS). (A49)",,,PMID:19021549,https://www.ncbi.nlm.nih.gov/pubmed/19021549,19021549,,
183,1365054,26436,BindingDB,Felbinac ethyl,442805,Felbinac ethyl,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=442805,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),200,DOI:10.1101/2020.12.16.422677,https://doi.org/10.1101/2020.12.16.422677,,10.1101/2020.12.16.422677,
184,1365055,26436,BindingDB,Felbinac ethyl,442805,Felbinac ethyl,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=442805,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),80,DOI:10.1101/2020.12.16.422677,https://doi.org/10.1101/2020.12.16.422677,,10.1101/2020.12.16.422677,
185,1365056,26627,Toxin and Toxin Target Database (T3DB),Lithium chromate,T3D0715,Lithium chromate,http://www.t3db.ca/toxins/T3D0715,BE0002365,Histone deacetylase 1,http://www.t3db.ca/biodb/bio_entities/BE0002365,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),"Chromium can cause transcriptional repression by cross-linking histone deacetylase 1-DNA methyltransferase 1 complexes to CYP1A1 promoter chromatin, inhibiting histone modification. (A35)",,,PMID:17682057,https://www.ncbi.nlm.nih.gov/pubmed/17682057,17682057,,
186,1361748,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,2534,FYN,https://ctdbase.org/detail.go?type=gene&acc=2534,,,2534.0,FYN,9606.0,Homo sapiens (human),FYN protein promotes the reaction [chromium hexavalent ion results in increased expression of IRF7 mrna]|fyn protein promotes the reaction [chromium hexavalent ion results in increased phosphorylation of STAT1 protein]|[chromium hexavalent ion results in increased activity of FYN protein] which results in increased activity of STAT1 protein,,,PMID:19994902,https://www.ncbi.nlm.nih.gov/pubmed/19994902,19994902,,
187,1361749,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,8322,FZD4,https://ctdbase.org/detail.go?type=gene&acc=8322,,,8322.0,FZD4,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of FZD4 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
188,1361750,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,8325,FZD8,https://ctdbase.org/detail.go?type=gene&acc=8325,,,8325.0,FZD8,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of FZD8 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
189,1361751,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,8326,FZD9,https://ctdbase.org/detail.go?type=gene&acc=8326,,,8326.0,FZD9,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of FZD9 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
190,1361752,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,2538,G6PC1,https://ctdbase.org/detail.go?type=gene&acc=2538,,,2538.0,G6PC1,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of G6PC1 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
191,1361753,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,9548.0,Macaca radiata (bonnet macaque),Chromium hexavalent ion results in decreased activity of G6PD protein,,,PMID:15980013,https://www.ncbi.nlm.nih.gov/pubmed/15980013,15980013,,
192,1361884,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,2633,GBP1,https://ctdbase.org/detail.go?type=gene&acc=2633,,,2633.0,GBP1,9606.0,Homo sapiens (human),Chromium hexavalent ion results in decreased expression of GBP1 mRNA,,,PMID:30690063,https://www.ncbi.nlm.nih.gov/pubmed/30690063,30690063,,
193,1362235,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,51738,GHRL,https://ctdbase.org/detail.go?type=gene&acc=51738,,,51738.0,GHRL,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of GHRL mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
194,1362236,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,83408,GIMAP3,https://ctdbase.org/detail.go?type=gene&acc=83408,,,83408.0,Gimap3,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of GIMAP3 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
195,1362237,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,474344,GIMAP6,https://ctdbase.org/detail.go?type=gene&acc=474344,,,474344.0,GIMAP6,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of GIMAP6 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
196,1362238,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,2710,GK,https://ctdbase.org/detail.go?type=gene&acc=2710,,,2710.0,GK,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of GK mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
197,1362239,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,2720,GLB1,https://ctdbase.org/detail.go?type=gene&acc=2720,,,2720.0,GLB1,10116.0,Rattus norvegicus (Norway rat),[potassium dichromate results in increased abundance of chromium hexavalent ion] which results in increased activity of GLB1 protein|s-allylcysteine inhibits the reaction [[potassium dichromate results in increased abundance of chromium hexavalent ion] which results in increased activity of GLB1 protein],,,PMID:28988497,https://www.ncbi.nlm.nih.gov/pubmed/28988497,28988497,,
198,1362240,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,2735,GLI1,https://ctdbase.org/detail.go?type=gene&acc=2735,,,2735.0,GLI1,10090.0,Mus musculus (house mouse),SHH protein affects the reaction [[potassium dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of GLI1 mrna]|[potassium dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of GLI1 mRNA,,,PMID:31756458,https://www.ncbi.nlm.nih.gov/pubmed/31756458,31756458,,
199,1362241,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,2736,GLI2,https://ctdbase.org/detail.go?type=gene&acc=2736,,,2736.0,GLI2,10090.0,Mus musculus (house mouse),SHH protein affects the reaction [[potassium dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of GLI2 mrna]|[potassium dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of GLI2 protein|shh protein affects the reaction [[potassium dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of GLI2 protein]|[potassium dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of GLI2 mRNA,,,PMID:31756458,https://www.ncbi.nlm.nih.gov/pubmed/31756458,31756458,,
200,1362242,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,2737,GLI3,https://ctdbase.org/detail.go?type=gene&acc=2737,,,2737.0,GLI3,9606.0,Homo sapiens (human),Chromium hexavalent ion results in decreased expression of GLI3 mRNA,,,PMID:30690063,https://www.ncbi.nlm.nih.gov/pubmed/30690063,30690063,,
201,1362967,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116.0,Rattus norvegicus (Norway rat),S-allylcysteine inhibits the reaction [[potassium dichromate results in increased abundance of chromium hexavalent ion] which results in decreased activity of GSR protein]|[potassium dichromate results in increased abundance of chromium hexavalent ion] which results in decreased activity of GSR protein,,,PMID:28988497,https://www.ncbi.nlm.nih.gov/pubmed/28988497,28988497,,
202,1362968,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606.0,Homo sapiens (human),GSR protein results in increased reduction of chromium hexavalent ion,,,PMID:10905508|PMID:1375053,https://www.ncbi.nlm.nih.gov/pubmed/10905508|https://www.ncbi.nlm.nih.gov/pubmed/1375053,10905508|1375053,,
203,1362969,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,2940,GSTA3,https://ctdbase.org/detail.go?type=gene&acc=2940,,,2940.0,GSTA3,8265.0,Pseudopleuronectes americanus (winter flounder),Chromium hexavalent ion results in decreased expression of GSTA3 mRNA,,,PMID:15003702,https://www.ncbi.nlm.nih.gov/pubmed/15003702,15003702,,
204,1365229,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558.0,IL2,9606.0,Homo sapiens (human),Chromium hexavalent ion results in increased expression of IL2 protein,,,PMID:19051261,https://www.ncbi.nlm.nih.gov/pubmed/19051261,19051261,,
205,1365230,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,3560,IL2RB,https://ctdbase.org/detail.go?type=gene&acc=3560,,,3560.0,IL2RB,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of IL2RB mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
206,1365231,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,90865,IL33,https://ctdbase.org/detail.go?type=gene&acc=90865,,,90865.0,IL33,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of IL33 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
207,1365232,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,9606.0,Homo sapiens (human),Chromium hexavalent ion results in increased expression of IL4 protein,,,PMID:19051261,https://www.ncbi.nlm.nih.gov/pubmed/19051261,19051261,,
208,1365233,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Chromium hexavalent ion results in decreased expression of IL6 mRNA,,,PMID:30690063,https://www.ncbi.nlm.nih.gov/pubmed/30690063,30690063,,
209,1365234,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Chromium hexavalent ion results in increased expression of IL6 mRNA,,,PMID:17078813|PMID:31152816,https://www.ncbi.nlm.nih.gov/pubmed/17078813|https://www.ncbi.nlm.nih.gov/pubmed/31152816,17078813|31152816,,
210,1365235,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Chromium hexavalent ion results in increased expression of IL6 protein,,,PMID:19051261|PMID:27323401,https://www.ncbi.nlm.nih.gov/pubmed/19051261|https://www.ncbi.nlm.nih.gov/pubmed/27323401,19051261|27323401,,
211,1365236,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Luteolin inhibits the reaction [chromium hexavalent ion results in increased secretion of IL6 protein]|chromium hexavalent ion results in increased secretion of IL6 protein,,,PMID:25448439,https://www.ncbi.nlm.nih.gov/pubmed/25448439,25448439,,
212,1365237,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),LCK protein affects the reaction [chromium hexavalent ion results in increased expression of IL6 mrna],,,PMID:17078813,https://www.ncbi.nlm.nih.gov/pubmed/17078813,17078813,,
213,1365359,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,64423,INF2,https://ctdbase.org/detail.go?type=gene&acc=64423,,,64423.0,INF2,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of INF2 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
214,1365360,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,3624,INHBA,https://ctdbase.org/detail.go?type=gene&acc=3624,,,3624.0,INHBA,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of INHBA mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
215,1365361,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,3625,INHBB,https://ctdbase.org/detail.go?type=gene&acc=3625,,,3625.0,INHBB,10116.0,Rattus norvegicus (Norway rat),Chromium hexavalent ion results in decreased expression of INHBB mrna|chromium hexavalent ion results in decreased expression of INHBB protein,,,PMID:32679048,https://www.ncbi.nlm.nih.gov/pubmed/32679048,32679048,,
216,1365482,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,10527,IPO7,https://ctdbase.org/detail.go?type=gene&acc=10527,,,10527.0,IPO7,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of IPO7 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
217,1365483,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,64768,IPPK,https://ctdbase.org/detail.go?type=gene&acc=64768,,,64768.0,IPPK,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of IPPK mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
218,1365484,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,10788,IQGAP2,https://ctdbase.org/detail.go?type=gene&acc=10788,,,10788.0,IQGAP2,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of IQGAP2 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
219,1365598,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,3659,IRF1,https://ctdbase.org/detail.go?type=gene&acc=3659,,,3659.0,IRF1,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of IRF1 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
220,1365599,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,3665,IRF7,https://ctdbase.org/detail.go?type=gene&acc=3665,,,3665.0,IRF7,9606.0,Homo sapiens (human),FYN protein promotes the reaction [chromium hexavalent ion results in increased expression of IRF7 mrna]|chromium hexavalent ion results in increased expression of IRF7 mrna|stat1 protein affects the reaction [chromium hexavalent ion results in increased expression of IRF7 mrna]|ag 1879 inhibits the reaction [chromium hexavalent ion results in increased expression of IRF7 mrna],,,PMID:19994902,https://www.ncbi.nlm.nih.gov/pubmed/19994902,19994902,,
221,1351710,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,6840,SVIL,https://ctdbase.org/detail.go?type=gene&acc=6840,,,6840.0,SVIL,10116.0,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of SVIL mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
222,1351711,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,6840,SVIL,https://ctdbase.org/detail.go?type=gene&acc=6840,,,6840.0,SVIL,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of SVIL mRNA,,,PMID:23555832,https://www.ncbi.nlm.nih.gov/pubmed/23555832,23555832,,
223,1351712,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,6840,SVIL,https://ctdbase.org/detail.go?type=gene&acc=6840,,,6840.0,SVIL,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of SVIL gene,,,PMID:31682807,https://www.ncbi.nlm.nih.gov/pubmed/31682807,31682807,,
224,1351834,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,55530,SVOP,https://ctdbase.org/detail.go?type=gene&acc=55530,,,55530.0,SVOP,10116.0,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of SVOP mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
225,1351835,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,256126,SYCE2,https://ctdbase.org/detail.go?type=gene&acc=256126,,,256126.0,SYCE2,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of SYCE2 mRNA,,,PMID:23555832,https://www.ncbi.nlm.nih.gov/pubmed/23555832,23555832,,
226,1351836,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,6853,SYN1,https://ctdbase.org/detail.go?type=gene&acc=6853,,,6853.0,SYN1,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of SYN1 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
227,1351837,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,6854,SYN2,https://ctdbase.org/detail.go?type=gene&acc=6854,,,6854.0,SYN2,10116.0,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of SYN2 mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
228,1351838,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,8224,SYN3,https://ctdbase.org/detail.go?type=gene&acc=8224,,,8224.0,SYN3,10116.0,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of SYN3 mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
229,1351839,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,10492,SYNCRIP,https://ctdbase.org/detail.go?type=gene&acc=10492,,,10492.0,SYNCRIP,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of SYNCRIP mRNA,,,PMID:22570695,https://www.ncbi.nlm.nih.gov/pubmed/22570695,22570695,,
230,1351840,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,23345,SYNE1,https://ctdbase.org/detail.go?type=gene&acc=23345,,,23345.0,SYNE1,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of SYNE1 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
231,1351841,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,8831,SYNGAP1,https://ctdbase.org/detail.go?type=gene&acc=8831,,,8831.0,SYNGAP1,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in increased expression of SYNGAP1 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
232,1351842,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,9145,SYNGR1,https://ctdbase.org/detail.go?type=gene&acc=9145,,,9145.0,SYNGR1,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of SYNGR1 mRNA,,,PMID:22570695,https://www.ncbi.nlm.nih.gov/pubmed/22570695,22570695,,
233,1353317,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7010,TEK,https://ctdbase.org/detail.go?type=gene&acc=7010,,,7010.0,TEK,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TEK mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
234,1353318,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,100134934,TEN1,https://ctdbase.org/detail.go?type=gene&acc=100134934,,,100134934.0,TEN1,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TEN1 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
235,1353319,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,100134934,TEN1,https://ctdbase.org/detail.go?type=gene&acc=100134934,,,100134934.0,TEN1,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TEN1 mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
236,1353320,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,57451,TENM2,https://ctdbase.org/detail.go?type=gene&acc=57451,,,57451.0,TENM2,10116.0,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of TENM2 mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
237,1353321,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,26011,TENM4,https://ctdbase.org/detail.go?type=gene&acc=26011,,,26011.0,TENM4,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased methylation of TENM4 gene,,,PMID:31079544,https://www.ncbi.nlm.nih.gov/pubmed/31079544,31079544,,
238,1353322,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,26011,TENM4,https://ctdbase.org/detail.go?type=gene&acc=26011,,,26011.0,TENM4,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TENM4 mRNA,,,PMID:23555832,https://www.ncbi.nlm.nih.gov/pubmed/23555832,23555832,,
239,1353323,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,11044,TENT4A,https://ctdbase.org/detail.go?type=gene&acc=11044,,,11044.0,TENT4A,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TENT4A mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
240,1354472,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,79816,TLE6,https://ctdbase.org/detail.go?type=gene&acc=79816,,,79816.0,TLE6,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TLE6 mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
241,1354473,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,9874,TLK1,https://ctdbase.org/detail.go?type=gene&acc=9874,,,9874.0,TLK1,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of TLK1 gene,,,PMID:31682807,https://www.ncbi.nlm.nih.gov/pubmed/31682807,31682807,,
242,1354474,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7092,TLL1,https://ctdbase.org/detail.go?type=gene&acc=7092,,,7092.0,TLL1,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of TLL1 gene,,,PMID:31682807,https://www.ncbi.nlm.nih.gov/pubmed/31682807,31682807,,
243,1354475,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7093,TLL2,https://ctdbase.org/detail.go?type=gene&acc=7093,,,7093.0,TLL2,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased methylation of TLL2 gene,,,PMID:31682807,https://www.ncbi.nlm.nih.gov/pubmed/31682807,31682807,,
244,1354476,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7096,TLR1,https://ctdbase.org/detail.go?type=gene&acc=7096,,,7096.0,TLR1,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TLR1 mRNA,,,PMID:18629315,https://www.ncbi.nlm.nih.gov/pubmed/18629315,18629315,,
245,1354477,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,279572,TLR13,https://ctdbase.org/detail.go?type=gene&acc=279572,,,279572.0,Tlr13,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of TLR13 gene,,,PMID:31079544,https://www.ncbi.nlm.nih.gov/pubmed/31079544,31079544,,
246,1354478,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7097,TLR2,https://ctdbase.org/detail.go?type=gene&acc=7097,,,7097.0,TLR2,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TLR2 mRNA,,,PMID:18629315,https://www.ncbi.nlm.nih.gov/pubmed/18629315,18629315,,
247,1354479,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7098,TLR3,https://ctdbase.org/detail.go?type=gene&acc=7098,,,7098.0,TLR3,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TLR3 mRNA,,,PMID:18629315,https://www.ncbi.nlm.nih.gov/pubmed/18629315,18629315,,
248,1354956,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,65084,TMEM135,https://ctdbase.org/detail.go?type=gene&acc=65084,,,65084.0,TMEM135,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TMEM135 mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
249,1354957,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,55281,TMEM140,https://ctdbase.org/detail.go?type=gene&acc=55281,,,55281.0,TMEM140,10116.0,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of TMEM140 mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
250,1354958,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,55281,TMEM140,https://ctdbase.org/detail.go?type=gene&acc=55281,,,55281.0,TMEM140,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TMEM140 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
251,1354959,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,10430,TMEM147,https://ctdbase.org/detail.go?type=gene&acc=10430,,,10430.0,TMEM147,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TMEM147 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
252,1354960,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,10430,TMEM147,https://ctdbase.org/detail.go?type=gene&acc=10430,,,10430.0,TMEM147,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TMEM147 mRNA,,,PMID:22570695,https://www.ncbi.nlm.nih.gov/pubmed/22570695,22570695,,
253,1354961,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,441027,TMEM150C,https://ctdbase.org/detail.go?type=gene&acc=441027,,,441027.0,TMEM150C,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TMEM150C mRNA,,,PMID:22570695,https://www.ncbi.nlm.nih.gov/pubmed/22570695,22570695,,
254,1354962,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,54958,TMEM160,https://ctdbase.org/detail.go?type=gene&acc=54958,,,54958.0,TMEM160,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TMEM160 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
255,1354963,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,54929,TMEM161A,https://ctdbase.org/detail.go?type=gene&acc=54929,,,54929.0,TMEM161A,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TMEM161A mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
256,1355948,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7136,TNNI2,https://ctdbase.org/detail.go?type=gene&acc=7136,,,7136.0,TNNI2,10116.0,Rattus norvegicus (Norway rat),[genistein co-treated with vinclozolin] results in increased expression of TNNI2 mrna|vinclozolin results in increased expression of TNNI2 mRNA,,,PMID:23160963,https://www.ncbi.nlm.nih.gov/pubmed/23160963,23160963,,
257,1355949,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7136,TNNI2,https://ctdbase.org/detail.go?type=gene&acc=7136,,,7136.0,TNNI2,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TNNI2 mRNA,,,PMID:20566332,https://www.ncbi.nlm.nih.gov/pubmed/20566332,20566332,,
258,1355950,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,51086,TNNI3K,https://ctdbase.org/detail.go?type=gene&acc=51086,,,51086.0,TNNI3K,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TNNI3K mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
259,1355951,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,553694,TNNI4B.3,https://ctdbase.org/detail.go?type=gene&acc=553694,,,553694.0,tnni4b.3,7955.0,Danio rerio (zebrafish),Vinclozolin results in decreased expression of TNNI4B.3 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
260,1355952,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7139,TNNT2,https://ctdbase.org/detail.go?type=gene&acc=7139,,,7139.0,TNNT2,10116.0,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of TNNT2 mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
261,1355953,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7139,TNNT2,https://ctdbase.org/detail.go?type=gene&acc=7139,,,7139.0,TNNT2,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TNNT2 mRNA,,,PMID:20566332,https://www.ncbi.nlm.nih.gov/pubmed/20566332,20566332,,
262,1355954,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,100003572,TNNT3B,https://ctdbase.org/detail.go?type=gene&acc=100003572,,,100003572.0,tnnt3b,7955.0,Danio rerio (zebrafish),Vinclozolin results in increased expression of TNNT3B mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
263,1355955,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7141,TNP1,https://ctdbase.org/detail.go?type=gene&acc=7141,,,7141.0,TNP1,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TNP1 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
264,1356439,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7159,TP53BP2,https://ctdbase.org/detail.go?type=gene&acc=7159,,,7159.0,TP53BP2,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of TP53BP2 gene|vinclozolin results in decreased methylation of TP53BP2 gene,,,PMID:31079544,https://www.ncbi.nlm.nih.gov/pubmed/31079544,31079544,,
265,1356440,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,94241,TP53INP1,https://ctdbase.org/detail.go?type=gene&acc=94241,,,94241.0,TP53INP1,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TP53INP1 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
266,1356441,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7162,TPBG,https://ctdbase.org/detail.go?type=gene&acc=7162,,,7162.0,TPBG,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TPBG mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
267,1356442,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7164,TPD52L1,https://ctdbase.org/detail.go?type=gene&acc=7164,,,7164.0,TPD52L1,7955.0,Danio rerio (zebrafish),Vinclozolin results in decreased expression of TPD52L1 mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
268,1356443,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,25941,TPGS2,https://ctdbase.org/detail.go?type=gene&acc=25941,,,25941.0,TPGS2,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TPGS2 mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
269,1356444,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7168,TPM1,https://ctdbase.org/detail.go?type=gene&acc=7168,,,7168.0,TPM1,10116.0,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of TPM1 mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
270,1356817,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,373,TRIM23,https://ctdbase.org/detail.go?type=gene&acc=373,,,373.0,TRIM23,10116.0,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of TRIM23 mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
271,1356818,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,8805,TRIM24,https://ctdbase.org/detail.go?type=gene&acc=8805,,,8805.0,TRIM24,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TRIM24 mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
272,1356819,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7706,TRIM25,https://ctdbase.org/detail.go?type=gene&acc=7706,,,7706.0,TRIM25,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TRIM25 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
273,1357313,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,9819,TSC22D2,https://ctdbase.org/detail.go?type=gene&acc=9819,,,9819.0,TSC22D2,7955.0,Danio rerio (zebrafish),Vinclozolin results in decreased expression of TSC22D2 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
274,1357314,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,9819,TSC22D2,https://ctdbase.org/detail.go?type=gene&acc=9819,,,9819.0,TSC22D2,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TSC22D2 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
275,1357810,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,79739,TTLL7,https://ctdbase.org/detail.go?type=gene&acc=79739,,,79739.0,TTLL7,10116.0,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of TTLL7 mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
276,1357811,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,164395,TTLL9,https://ctdbase.org/detail.go?type=gene&acc=164395,,,164395.0,TTLL9,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of TTLL9 gene,,,PMID:31079544,https://www.ncbi.nlm.nih.gov/pubmed/31079544,31079544,,
277,1357812,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,79183,TTPAL,https://ctdbase.org/detail.go?type=gene&acc=79183,,,79183.0,TTPAL,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TTPAL mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
278,1357813,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,57348,TTYH1,https://ctdbase.org/detail.go?type=gene&acc=57348,,,57348.0,TTYH1,10116.0,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of TTYH1 mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
279,1357814,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,94015,TTYH2,https://ctdbase.org/detail.go?type=gene&acc=94015,,,94015.0,TTYH2,7955.0,Danio rerio (zebrafish),Vinclozolin results in increased expression of TTYH2 mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
280,1357815,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,80727,TTYH3,https://ctdbase.org/detail.go?type=gene&acc=80727,,,80727.0,TTYH3,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TTYH3 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
281,1357816,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,7846,TUBA1A,https://ctdbase.org/detail.go?type=gene&acc=7846,,,7846.0,TUBA1A,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of TUBA1A mRNA,,,PMID:15686871,https://www.ncbi.nlm.nih.gov/pubmed/15686871,15686871,,
282,1357817,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,84790,TUBA1C,https://ctdbase.org/detail.go?type=gene&acc=84790,,,84790.0,TUBA1C,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of TUBA1C mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
283,1357818,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,445164,TUBA8L3,https://ctdbase.org/detail.go?type=gene&acc=445164,,,445164.0,tuba8l3,7955.0,Danio rerio (zebrafish),Vinclozolin results in decreased expression of TUBA8L3 mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
284,1359252,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,10090,UST,https://ctdbase.org/detail.go?type=gene&acc=10090,,,10090.0,UST,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of UST gene,,,PMID:31079544,https://www.ncbi.nlm.nih.gov/pubmed/31079544,31079544,,
285,1359253,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,51118,UTP11,https://ctdbase.org/detail.go?type=gene&acc=51118,,,51118.0,UTP11,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of UTP11 mRNA,,,PMID:22615374|PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/22615374|https://www.ncbi.nlm.nih.gov/pubmed/23869203,22615374|23869203,,
286,1359254,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,84135,UTP15,https://ctdbase.org/detail.go?type=gene&acc=84135,,,84135.0,UTP15,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of UTP15 gene,,,PMID:31682807,https://www.ncbi.nlm.nih.gov/pubmed/31682807,31682807,,
287,1359255,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,51096,UTP18,https://ctdbase.org/detail.go?type=gene&acc=51096,,,51096.0,UTP18,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of UTP18 mRNA,,,PMID:22615374,https://www.ncbi.nlm.nih.gov/pubmed/22615374,22615374,,
288,1359256,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,84294,UTP23,https://ctdbase.org/detail.go?type=gene&acc=84294,,,84294.0,UTP23,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of UTP23 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
289,1359257,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,57050,UTP3,https://ctdbase.org/detail.go?type=gene&acc=57050,,,57050.0,UTP3,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of UTP3 mRNA,,,PMID:22615374|PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/22615374|https://www.ncbi.nlm.nih.gov/pubmed/23034163,22615374|23034163,,
290,1359258,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,84916,UTP4,https://ctdbase.org/detail.go?type=gene&acc=84916,,,84916.0,UTP4,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of UTP4 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
291,1360101,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,738,VPS51,https://ctdbase.org/detail.go?type=gene&acc=738,,,738.0,VPS51,7955.0,Danio rerio (zebrafish),Vinclozolin results in decreased expression of VPS51 mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
292,1360102,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,55275,VPS53,https://ctdbase.org/detail.go?type=gene&acc=55275,,,55275.0,VPS53,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of VPS53 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
293,1360103,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,55275,VPS53,https://ctdbase.org/detail.go?type=gene&acc=55275,,,55275.0,VPS53,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased expression of VPS53 mRNA,,,PMID:23869203,https://www.ncbi.nlm.nih.gov/pubmed/23869203,23869203,,
294,1360104,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,55275,VPS53,https://ctdbase.org/detail.go?type=gene&acc=55275,,,55275.0,VPS53,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in increased methylation of VPS53 gene,,,PMID:31682807,https://www.ncbi.nlm.nih.gov/pubmed/31682807,31682807,,
295,1360105,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,6944,VPS72,https://ctdbase.org/detail.go?type=gene&acc=6944,,,6944.0,VPS72,10116.0,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of VPS72 mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
296,1352661,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,5718,PSMD12,https://ctdbase.org/detail.go?type=gene&acc=5718,,,5718.0,PSMD12,9823.0,Sus scrofa (pig),Deoxynivalenol results in increased expression of PSMD12 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
297,1352662,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,10213,PSMD14,https://ctdbase.org/detail.go?type=gene&acc=10213,,,10213.0,PSMD14,9823.0,Sus scrofa (pig),Deoxynivalenol results in increased expression of PSMD14 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
298,1354181,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,9771,RAPGEF5,https://ctdbase.org/detail.go?type=gene&acc=9771,,,9771.0,RAPGEF5,9823.0,Sus scrofa (pig),Deoxynivalenol results in decreased expression of RAPGEF5 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
299,1354182,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,51195,RAPGEFL1,https://ctdbase.org/detail.go?type=gene&acc=51195,,,51195.0,RAPGEFL1,9823.0,Sus scrofa (pig),Deoxynivalenol results in decreased expression of RAPGEFL1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
300,1354316,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,5929,RBBP5,https://ctdbase.org/detail.go?type=gene&acc=5929,,,5929.0,RBBP5,9606.0,Homo sapiens (human),Deoxynivalenol results in increased expression of RBBP5 mRNA,,,PMID:19438726,https://www.ncbi.nlm.nih.gov/pubmed/19438726,19438726,,
301,1354317,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,5930,RBBP6,https://ctdbase.org/detail.go?type=gene&acc=5930,,,5930.0,RBBP6,9606.0,Homo sapiens (human),Deoxynivalenol results in increased expression of RBBP6 mRNA,,,PMID:31863870,https://www.ncbi.nlm.nih.gov/pubmed/31863870,31863870,,
302,1354318,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,401466,RBIS,https://ctdbase.org/detail.go?type=gene&acc=401466,,,401466.0,RBIS,9823.0,Sus scrofa (pig),Deoxynivalenol results in increased expression of RBIS mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
303,1351713,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Permethrin results in decreased expression of IL6 mRNA,,,PMID:29477483,https://www.ncbi.nlm.nih.gov/pubmed/29477483,29477483,,
304,1351714,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Permethrin results in increased expression of IL6 protein,,,PMID:32911180|PMID:34224971,https://www.ncbi.nlm.nih.gov/pubmed/32911180|https://www.ncbi.nlm.nih.gov/pubmed/34224971,32911180|34224971,,
305,1351715,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),[pyridostigmine bromide co-treated with DEET co-treated with permethrin] results in increased expression of IL6 mrna|[pyridostigmine bromide co-treated with DEET co-treated with permethrin] results in increased expression of and results in increased secretion of IL6 protein,,,PMID:28659758,https://www.ncbi.nlm.nih.gov/pubmed/28659758,28659758,,
306,1351716,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,16194,IL6RA,https://ctdbase.org/detail.go?type=gene&acc=16194,,,16194.0,Il6ra,10090.0,Mus musculus (house mouse),Permethrin results in decreased expression of IL6RA mRNA,,,PMID:30629241,https://www.ncbi.nlm.nih.gov/pubmed/30629241,30629241,,
307,1352479,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,11202,KLK8,https://ctdbase.org/detail.go?type=gene&acc=11202,,,11202.0,KLK8,9606.0,Homo sapiens (human),Permethrin results in increased expression of KLK8 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
308,1352480,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,3820,KLRB1,https://ctdbase.org/detail.go?type=gene&acc=3820,,,3820.0,KLRB1,10116.0,Rattus norvegicus (Norway rat),[permethrin co-treated with DEET] results in decreased methylation of KLRB1 gene,,,PMID:33148267,https://www.ncbi.nlm.nih.gov/pubmed/33148267,33148267,,
309,1352481,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,80782,KLRB1B,https://ctdbase.org/detail.go?type=gene&acc=80782,,,80782.0,Klrb1b,10116.0,Rattus norvegicus (Norway rat),[permethrin co-treated with DEET] results in increased methylation of KLRB1B gene,,,PMID:33148267,https://www.ncbi.nlm.nih.gov/pubmed/33148267,33148267,,
310,1352482,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,4297,KMT2A,https://ctdbase.org/detail.go?type=gene&acc=4297,,,4297.0,KMT2A,9606.0,Homo sapiens (human),Permethrin results in increased mutagenesis of KMT2A gene,,,PMID:12937054|PMID:28624474,https://www.ncbi.nlm.nih.gov/pubmed/12937054|https://www.ncbi.nlm.nih.gov/pubmed/28624474,12937054|28624474,,
311,1352483,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,54474,KRT20,https://ctdbase.org/detail.go?type=gene&acc=54474,,,54474.0,KRT20,10116.0,Rattus norvegicus (Norway rat),[permethrin co-treated with DEET] results in decreased methylation of KRT20 gene,,,PMID:33148267,https://www.ncbi.nlm.nih.gov/pubmed/33148267,33148267,,
312,1352484,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,125115,KRT40,https://ctdbase.org/detail.go?type=gene&acc=125115,,,125115.0,KRT40,9606.0,Homo sapiens (human),Permethrin results in decreased expression of KRT40 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
313,1352485,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,388818,KRTAP26-1,https://ctdbase.org/detail.go?type=gene&acc=388818,,,388818.0,KRTAP26-1,9606.0,Homo sapiens (human),Permethrin results in decreased expression of KRTAP26-1 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
314,1352486,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,643812,KRTAP27-1,https://ctdbase.org/detail.go?type=gene&acc=643812,,,643812.0,KRTAP27-1,9606.0,Homo sapiens (human),Permethrin results in increased expression of KRTAP27-1 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
315,1352487,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,8844,KSR1,https://ctdbase.org/detail.go?type=gene&acc=8844,,,8844.0,KSR1,10116.0,Rattus norvegicus (Norway rat),[permethrin co-treated with DEET] results in decreased methylation of KSR1 gene,,,PMID:33148267,https://www.ncbi.nlm.nih.gov/pubmed/33148267,33148267,,
316,1352488,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,283455,KSR2,https://ctdbase.org/detail.go?type=gene&acc=283455,,,283455.0,KSR2,10116.0,Rattus norvegicus (Norway rat),[permethrin co-treated with DEET] affects the methylation of KSR2 gene,,,PMID:33148267,https://www.ncbi.nlm.nih.gov/pubmed/33148267,33148267,,
317,1352977,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,283143,LINC00900,https://ctdbase.org/detail.go?type=gene&acc=283143,,,283143.0,LINC00900,9606.0,Homo sapiens (human),Permethrin results in increased expression of LINC00900 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
318,1352978,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,100130581,LINC00910,https://ctdbase.org/detail.go?type=gene&acc=100130581,,,100130581.0,LINC00910,9606.0,Homo sapiens (human),Permethrin results in increased expression of LINC00910 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
319,1352979,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,728342,LINC00992,https://ctdbase.org/detail.go?type=gene&acc=728342,,,728342.0,LINC00992,9606.0,Homo sapiens (human),Permethrin results in decreased expression of LINC00992 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
320,1352980,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,285547,LINC01097,https://ctdbase.org/detail.go?type=gene&acc=285547,,,285547.0,LINC01097,9606.0,Homo sapiens (human),Permethrin results in increased expression of LINC01097 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
321,1352981,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,150568,LINC01102,https://ctdbase.org/detail.go?type=gene&acc=150568,,,150568.0,LINC01102,9606.0,Homo sapiens (human),Permethrin results in decreased expression of LINC01102 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
322,1352982,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,101927433,LINC01255,https://ctdbase.org/detail.go?type=gene&acc=101927433,,,101927433.0,LINC01255,9606.0,Homo sapiens (human),Permethrin results in decreased expression of LINC01255 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
323,1352983,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,387978,LINC01551,https://ctdbase.org/detail.go?type=gene&acc=387978,,,387978.0,LINC01551,9606.0,Homo sapiens (human),Permethrin results in decreased expression of LINC01551 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
324,1352984,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,439927,LINC01555,https://ctdbase.org/detail.go?type=gene&acc=439927,,,439927.0,LINC01555,9606.0,Homo sapiens (human),Permethrin results in decreased expression of LINC01555 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
325,1352985,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,285043,LINC01936,https://ctdbase.org/detail.go?type=gene&acc=285043,,,285043.0,LINC01936,9606.0,Homo sapiens (human),Permethrin results in decreased expression of LINC01936 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
326,1352986,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,340113,LINC02120,https://ctdbase.org/detail.go?type=gene&acc=340113,,,340113.0,LINC02120,9606.0,Homo sapiens (human),Permethrin results in increased expression of LINC02120 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
327,1353477,40326,Comparative Toxicogenomics Database (CTD),Permethrin,D026023,Permethrin,https://ctdbase.org/detail.go?type=chem&acc=D026023,5596,MAPK4,https://ctdbase.org/detail.go?type=gene&acc=5596,,,5596.0,MAPK4,9606.0,Homo sapiens (human),Permethrin results in decreased expression of MAPK4 mRNA,,,PMID:37047231,https://www.ncbi.nlm.nih.gov/pubmed/37047231,37047231,,
328,1351413,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,8785,MATN4,https://ctdbase.org/detail.go?type=gene&acc=8785,,,8785.0,MATN4,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of MATN4 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
329,1351414,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,9782,MATR3,https://ctdbase.org/detail.go?type=gene&acc=9782,,,9782.0,MATR3,10090.0,Mus musculus (house mouse),Decamethrin affects the expression of MATR3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
330,1351415,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4149,MAX,https://ctdbase.org/detail.go?type=gene&acc=4149,,,4149.0,MAX,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of MAX mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
331,1352170,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4190,MDH1,https://ctdbase.org/detail.go?type=gene&acc=4190,,,4190.0,MDH1,10090.0,Mus musculus (house mouse),Decamethrin affects the expression of MDH1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
332,1352171,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4191,MDH2,https://ctdbase.org/detail.go?type=gene&acc=4191,,,4191.0,MDH2,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of MDH2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
333,1352172,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4192,MDK,https://ctdbase.org/detail.go?type=gene&acc=4192,,,4192.0,MDK,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of MDK mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
334,1353818,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4323,MMP14,https://ctdbase.org/detail.go?type=gene&acc=4323,,,4323.0,MMP14,10090.0,Mus musculus (house mouse),Decamethrin affects the expression of MMP14 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
335,1353819,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4324,MMP15,https://ctdbase.org/detail.go?type=gene&acc=4324,,,4324.0,MMP15,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of MMP15 mRNA,,,PMID:34520793|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/34520793|https://www.ncbi.nlm.nih.gov/pubmed/37019170,34520793|37019170,,
336,1354319,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,730094,MOSMO,https://ctdbase.org/detail.go?type=gene&acc=730094,,,730094.0,MOSMO,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of MOSMO mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
337,1354320,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,56180,MOSPD1,https://ctdbase.org/detail.go?type=gene&acc=56180,,,56180.0,MOSPD1,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of MOSPD1 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
338,1354321,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,64598,MOSPD3,https://ctdbase.org/detail.go?type=gene&acc=64598,,,64598.0,MOSPD3,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of MOSPD3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
339,1354322,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4343,MOV10,https://ctdbase.org/detail.go?type=gene&acc=4343,,,4343.0,MOV10,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of MOV10 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
340,1354323,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,26002,MOXD1,https://ctdbase.org/detail.go?type=gene&acc=26002,,,26002.0,MOXD1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of MOXD1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
341,1354324,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,51660,MPC1,https://ctdbase.org/detail.go?type=gene&acc=51660,,,51660.0,MPC1,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of MPC1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
342,1354325,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,8777,MPDZ,https://ctdbase.org/detail.go?type=gene&acc=8777,,,8777.0,MPDZ,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of MPDZ mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
343,1354326,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,54737,MPHOSPH8,https://ctdbase.org/detail.go?type=gene&acc=54737,,,54737.0,MPHOSPH8,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of MPHOSPH8 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
344,1355303,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,51734,MSRB1,https://ctdbase.org/detail.go?type=gene&acc=51734,,,51734.0,MSRB1,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of MSRB1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
345,1355304,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,22921,MSRB2,https://ctdbase.org/detail.go?type=gene&acc=22921,,,22921.0,MSRB2,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of MSRB2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
346,1355305,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,253827,MSRB3,https://ctdbase.org/detail.go?type=gene&acc=253827,,,253827.0,MSRB3,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of MSRB3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
347,1356275,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4632,MYL1,https://ctdbase.org/detail.go?type=gene&acc=4632,,,4632.0,MYL1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of MYL1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
348,1357141,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,222236,NAPEPLD,https://ctdbase.org/detail.go?type=gene&acc=222236,,,222236.0,NAPEPLD,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of NAPEPLD mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
349,1357142,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,8774,NAPG,https://ctdbase.org/detail.go?type=gene&acc=8774,,,8774.0,NAPG,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NAPG mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
350,1358125,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,64168,NECAB1,https://ctdbase.org/detail.go?type=gene&acc=64168,,,64168.0,NECAB1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of NECAB1 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
351,1358126,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,64168,NECAB1,https://ctdbase.org/detail.go?type=gene&acc=64168,,,64168.0,NECAB1,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NECAB1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
352,1358127,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,54550,NECAB2,https://ctdbase.org/detail.go?type=gene&acc=54550,,,54550.0,NECAB2,10090.0,Mus musculus (house mouse),Decamethrin affects the expression of NECAB2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
353,1358128,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,25977,NECAP1,https://ctdbase.org/detail.go?type=gene&acc=25977,,,25977.0,NECAP1,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NECAP1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
354,1358129,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,55707,NECAP2,https://ctdbase.org/detail.go?type=gene&acc=55707,,,55707.0,NECAP2,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NECAP2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
355,1358130,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,5818,NECTIN1,https://ctdbase.org/detail.go?type=gene&acc=5818,,,5818.0,NECTIN1,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NECTIN1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
356,1358131,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,5819,NECTIN2,https://ctdbase.org/detail.go?type=gene&acc=5819,,,5819.0,NECTIN2,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NECTIN2 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
357,1358132,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,25945,NECTIN3,https://ctdbase.org/detail.go?type=gene&acc=25945,,,25945.0,NECTIN3,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of NECTIN3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
358,1358133,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,81607,NECTIN4,https://ctdbase.org/detail.go?type=gene&acc=81607,,,81607.0,NECTIN4,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NECTIN4 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
359,1359086,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,58157,NGB,https://ctdbase.org/detail.go?type=gene&acc=58157,,,58157.0,NGB,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NGB mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
360,1359087,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,25983,NGDN,https://ctdbase.org/detail.go?type=gene&acc=25983,,,25983.0,NGDN,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of NGDN mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
361,1359088,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,25791,NGEF,https://ctdbase.org/detail.go?type=gene&acc=25791,,,25791.0,NGEF,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NGEF mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
362,1359089,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4803,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803.0,NGF,10090.0,Mus musculus (house mouse),NGF protein inhibits the reaction [decamethrin results in decreased phosphorylation of AKT1 protein]|salubrinal inhibits the reaction [decamethrin results in decreased expression of NGF protein]|decamethrin results in decreased expression of NGF protein|decamethrin results in decreased expression of NGF mRNA,,,PMID:31841155,https://www.ncbi.nlm.nih.gov/pubmed/31841155,31841155,,
363,1359090,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4803,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803.0,NGF,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NGF mRNA,,,PMID:35715053,https://www.ncbi.nlm.nih.gov/pubmed/35715053,35715053,,
364,1359091,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4803,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803.0,NGF,10116.0,Rattus norvegicus (Norway rat),Decamethrin inhibits the reaction [NGF protein results in increased expression of CAMK2B mrna]|decamethrin inhibits the reaction [NGF protein results in increased expression of TUBB3 mrna],,,PMID:28385489,https://www.ncbi.nlm.nih.gov/pubmed/28385489,28385489,,
365,1359092,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4804,NGFR,https://ctdbase.org/detail.go?type=gene&acc=4804,,,4804.0,NGFR,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of NGFR mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
366,1359093,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,51335,NGRN,https://ctdbase.org/detail.go?type=gene&acc=51335,,,51335.0,NGRN,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NGRN mRNA,,,PMID:34520793|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/34520793|https://www.ncbi.nlm.nih.gov/pubmed/37019170,34520793|37019170,,
367,1359094,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,9351,NHERF2,https://ctdbase.org/detail.go?type=gene&acc=9351,,,9351.0,NHERF2,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NHERF2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
368,1359796,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,9397,NMT2,https://ctdbase.org/detail.go?type=gene&acc=9397,,,9397.0,NMT2,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NMT2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
369,1360524,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4852,NPY,https://ctdbase.org/detail.go?type=gene&acc=4852,,,4852.0,NPY,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NPY mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
370,1360525,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4886,NPY1R,https://ctdbase.org/detail.go?type=gene&acc=4886,,,4886.0,NPY1R,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NPY1R mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
371,1360526,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4887,NPY2R,https://ctdbase.org/detail.go?type=gene&acc=4887,,,4887.0,NPY2R,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NPY2R mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
372,1360527,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4889,NPY5R,https://ctdbase.org/detail.go?type=gene&acc=4889,,,4889.0,NPY5R,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NPY5R mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
373,1360528,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,93934.0,Coturnix japonica (Japanese quail),Decamethrin results in decreased expression of NQO1 mRNA,,,PMID:34216712,https://www.ncbi.nlm.nih.gov/pubmed/34216712,34216712,,
374,1360529,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of NQO1 mRNA,,,PMID:23401056,https://www.ncbi.nlm.nih.gov/pubmed/23401056,23401056,,
375,1360530,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of NQO1 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
376,1360531,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] affects the expression of NQO1 mRNA,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
377,1360532,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of NQO1 mRNA,,,PMID:33396045,https://www.ncbi.nlm.nih.gov/pubmed/33396045,33396045,,
378,1362677,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3175,ONECUT1,https://ctdbase.org/detail.go?type=gene&acc=3175,,,3175.0,ONECUT1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of ONECUT1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
379,1362678,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,9480,ONECUT2,https://ctdbase.org/detail.go?type=gene&acc=9480,,,9480.0,ONECUT2,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of ONECUT2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
380,1362679,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,390874,ONECUT3,https://ctdbase.org/detail.go?type=gene&acc=390874,,,390874.0,ONECUT3,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of ONECUT3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
381,1362680,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,219990,OOSP2,https://ctdbase.org/detail.go?type=gene&acc=219990,,,219990.0,OOSP2,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of OOSP2 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
382,1362681,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,80207,OPA3,https://ctdbase.org/detail.go?type=gene&acc=80207,,,80207.0,OPA3,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of OPA3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
383,1362682,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,93377,OPALIN,https://ctdbase.org/detail.go?type=gene&acc=93377,,,93377.0,OPALIN,10116.0,Rattus norvegicus (Norway rat),Decamethrin results in decreased expression of OPALIN mRNA,,,PMID:19017407,https://www.ncbi.nlm.nih.gov/pubmed/19017407,19017407,,
384,1363538,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,93129,ORAI3,https://ctdbase.org/detail.go?type=gene&acc=93129,,,93129.0,ORAI3,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of ORAI3 mRNA,,,PMID:34520793|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/34520793|https://www.ncbi.nlm.nih.gov/pubmed/37019170,34520793|37019170,,
385,1363539,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4998,ORC1,https://ctdbase.org/detail.go?type=gene&acc=4998,,,4998.0,ORC1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of ORC1 mRNA,,,PMID:34520793|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/34520793|https://www.ncbi.nlm.nih.gov/pubmed/37019170,34520793|37019170,,
386,1363540,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,4999,ORC2,https://ctdbase.org/detail.go?type=gene&acc=4999,,,4999.0,ORC2,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of ORC2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
387,1363541,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,23595,ORC3,https://ctdbase.org/detail.go?type=gene&acc=23595,,,23595.0,ORC3,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of ORC3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
388,1364137,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,5031,P2RY6,https://ctdbase.org/detail.go?type=gene&acc=5031,,,5031.0,P2RY6,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of P2RY6 mRNA,,,PMID:34520793|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/34520793|https://www.ncbi.nlm.nih.gov/pubmed/37019170,34520793|37019170,,
389,1364138,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,64175,P3H1,https://ctdbase.org/detail.go?type=gene&acc=64175,,,64175.0,P3H1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of P3H1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
390,1364139,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,10536,P3H3,https://ctdbase.org/detail.go?type=gene&acc=10536,,,10536.0,P3H3,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of P3H3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
391,1364140,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,5033,P4HA1,https://ctdbase.org/detail.go?type=gene&acc=5033,,,5033.0,P4HA1,10090.0,Mus musculus (house mouse),Decamethrin affects the expression of P4HA1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
392,1364141,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,8974,P4HA2,https://ctdbase.org/detail.go?type=gene&acc=8974,,,8974.0,P4HA2,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of P4HA2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
393,1364260,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,29943,PADI1,https://ctdbase.org/detail.go?type=gene&acc=29943,,,29943.0,PADI1,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of PADI1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
394,1364261,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,54623,PAF1,https://ctdbase.org/detail.go?type=gene&acc=54623,,,54623.0,PAF1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of PAF1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
395,1364262,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,54623,PAF1,https://ctdbase.org/detail.go?type=gene&acc=54623,,,54623.0,PAF1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of PAF1 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
396,1429377,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,26575,RGS17,https://ctdbase.org/detail.go?type=gene&acc=26575,,,26575.0,RGS17,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of RGS17 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
397,1429378,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,5998,RGS3,https://ctdbase.org/detail.go?type=gene&acc=5998,,,5998.0,RGS3,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RGS3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
398,1429379,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,5999,RGS4,https://ctdbase.org/detail.go?type=gene&acc=5999,,,5999.0,RGS4,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RGS4 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
399,1429380,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,5999,RGS4,https://ctdbase.org/detail.go?type=gene&acc=5999,,,5999.0,RGS4,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of RGS4 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
400,1431124,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6117,RPA1,https://ctdbase.org/detail.go?type=gene&acc=6117,,,6117.0,RPA1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPA1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
401,1431125,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6118,RPA2,https://ctdbase.org/detail.go?type=gene&acc=6118,,,6118.0,RPA2,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPA2 mRNA,,,PMID:34520793|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/34520793|https://www.ncbi.nlm.nih.gov/pubmed/37019170,34520793|37019170,,
402,1431126,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6119,RPA3,https://ctdbase.org/detail.go?type=gene&acc=6119,,,6119.0,RPA3,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPA3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
403,1431127,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,26015,RPAP1,https://ctdbase.org/detail.go?type=gene&acc=26015,,,26015.0,RPAP1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPAP1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
404,1431128,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,79871,RPAP2,https://ctdbase.org/detail.go?type=gene&acc=79871,,,79871.0,RPAP2,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPAP2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
405,1431129,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,79657,RPAP3,https://ctdbase.org/detail.go?type=gene&acc=79657,,,79657.0,RPAP3,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPAP3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
406,1431130,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6120,RPE,https://ctdbase.org/detail.go?type=gene&acc=6120,,,6120.0,RPE,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPE mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
407,1431131,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,80135,RPF1,https://ctdbase.org/detail.go?type=gene&acc=80135,,,80135.0,RPF1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPF1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
408,1431132,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,84154,RPF2,https://ctdbase.org/detail.go?type=gene&acc=84154,,,84154.0,RPF2,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPF2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
409,1431549,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6222,RPS18,https://ctdbase.org/detail.go?type=gene&acc=6222,,,6222.0,RPS18,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPS18 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
410,1431550,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6223,RPS19,https://ctdbase.org/detail.go?type=gene&acc=6223,,,6223.0,RPS19,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPS19 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
411,1431551,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6223,RPS19,https://ctdbase.org/detail.go?type=gene&acc=6223,,,6223.0,RPS19,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of RPS19 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
412,1431664,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6193,RPS5,https://ctdbase.org/detail.go?type=gene&acc=6193,,,6193.0,RPS5,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of RPS5 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
413,1431665,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194.0,RPS6,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPS6 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
414,1431666,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,9252,RPS6KA5,https://ctdbase.org/detail.go?type=gene&acc=9252,,,9252.0,RPS6KA5,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of RPS6KA5 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
415,1431667,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,27330,RPS6KA6,https://ctdbase.org/detail.go?type=gene&acc=27330,,,27330.0,RPS6KA6,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPS6KA6 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
416,1431668,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,26750,RPS6KC1,https://ctdbase.org/detail.go?type=gene&acc=26750,,,26750.0,RPS6KC1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPS6KC1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
417,1431669,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,83694,RPS6KL1,https://ctdbase.org/detail.go?type=gene&acc=83694,,,83694.0,RPS6KL1,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of RPS6KL1 mRNA,,,PMID:34520793|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/34520793|https://www.ncbi.nlm.nih.gov/pubmed/37019170,34520793|37019170,,
418,1431670,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6202,RPS8,https://ctdbase.org/detail.go?type=gene&acc=6202,,,6202.0,RPS8,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPS8 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
419,1431671,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6203,RPS9,https://ctdbase.org/detail.go?type=gene&acc=6203,,,6203.0,RPS9,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPS9 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
420,1431672,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3921,RPSA,https://ctdbase.org/detail.go?type=gene&acc=3921,,,3921.0,RPSA,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of RPSA mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
421,1354618,40973,Comparative Toxicogenomics Database (CTD),Desogestrel,D017135,Desogestrel,https://ctdbase.org/detail.go?type=chem&acc=D017135,6847,SYCP1,https://ctdbase.org/detail.go?type=gene&acc=6847,,,6847.0,SYCP1,9606.0,Homo sapiens (human),[cetrorelix co-treated with testosterone enanthate co-treated with desogestrel] results in decreased expression of SYCP1 mRNA,,,PMID:18160741,https://www.ncbi.nlm.nih.gov/pubmed/18160741,18160741,,
422,1354619,40973,Comparative Toxicogenomics Database (CTD),Desogestrel,D017135,Desogestrel,https://ctdbase.org/detail.go?type=chem&acc=D017135,6875,TAF4B,https://ctdbase.org/detail.go?type=gene&acc=6875,,,6875.0,TAF4B,9606.0,Homo sapiens (human),[cetrorelix co-treated with testosterone enanthate co-treated with desogestrel] results in decreased expression of TAF4B mRNA,,,PMID:18160741,https://www.ncbi.nlm.nih.gov/pubmed/18160741,18160741,,
423,1354620,40973,Comparative Toxicogenomics Database (CTD),Desogestrel,D017135,Desogestrel,https://ctdbase.org/detail.go?type=chem&acc=D017135,400629,TEX19,https://ctdbase.org/detail.go?type=gene&acc=400629,,,400629.0,TEX19,9606.0,Homo sapiens (human),[cetrorelix co-treated with testosterone enanthate co-treated with desogestrel] results in decreased expression of TEX19 mRNA,,,PMID:18160741,https://www.ncbi.nlm.nih.gov/pubmed/18160741,18160741,,
424,1354621,40973,Comparative Toxicogenomics Database (CTD),Desogestrel,D017135,Desogestrel,https://ctdbase.org/detail.go?type=chem&acc=D017135,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606.0,Homo sapiens (human),Simvastatin promotes the reaction [[ethinyl estradiol co-treated with desogestrel] results in decreased expression of VCAM1 protein]|[ethinyl estradiol co-treated with desogestrel] results in decreased expression of VCAM1 protein,,,PMID:17105841,https://www.ncbi.nlm.nih.gov/pubmed/17105841,17105841,,
425,1354622,41114,Comparative Toxicogenomics Database (CTD),Nicardipine Hydrochloride,D009529,Nicardipine,https://ctdbase.org/detail.go?type=chem&acc=D009529,10499,NCOA2,https://ctdbase.org/detail.go?type=gene&acc=10499,,,10499.0,NCOA2,9606.0,Homo sapiens (human),Nicardipine inhibits the reaction [chenodeoxycholic acid promotes the reaction [NCOA2 protein modified form binds to NR1H4 protein]],,,PMID:27773686,https://www.ncbi.nlm.nih.gov/pubmed/27773686,27773686,,
426,1354623,41114,Comparative Toxicogenomics Database (CTD),Nicardipine Hydrochloride,D009529,Nicardipine,https://ctdbase.org/detail.go?type=chem&acc=D009529,4747,NEFL,https://ctdbase.org/detail.go?type=gene&acc=4747,,,4747.0,NEFL,10116.0,Rattus norvegicus (Norway rat),Nicardipine inhibits the reaction [rotenone results in decreased expression of NEFL mrna],,,PMID:31969611,https://www.ncbi.nlm.nih.gov/pubmed/31969611,31969611,,
427,1432384,41376,IUPHAR/BPS Guide to PHARMACOLOGY,Impromidine,1226,impromidine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1226,264,H3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=264,Q9Y5N1,Histamine H3 receptor,11255.0,HRH3,9606.0,Homo sapiens (human),Partial agonist,pKi,7.2,PMID:11179434,https://www.ncbi.nlm.nih.gov/pubmed/11179434,11179434,,
428,1432385,41684,Drug Gene Interaction database (DGIdb),Nitazoxanide,,NITAZOXANIDE,https://www.dgidb.org/drugs/rxcui:31819,,SMN1,https://www.dgidb.org/genes/hgnc:11117,,,6606.0,SMN1,9606.0,Homo sapiens (human),,,,,,,,
429,1432386,41774,BindingDB,Precose,23406,"(3R,4R,5S,6R)-5-{[(2R,3R,4R,5S,6R)-5-{[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-2,3,4-triol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23406,2394,Alpha-amylase 1A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2394,P0DUB6,Alpha-amylase 1A ,277.0,AMY1B,9606.0,Homo sapiens (human),,IC50 (nM),996,PMID:18507367|DOI:10.1021/jm800115x,https://www.ncbi.nlm.nih.gov/pubmed/18507367|https://doi.org/10.1021/jm800115x,18507367,10.1021/jm800115x,
430,1355643,41781,Drug Gene Interaction database (DGIdb),Torsemide,,TORSEMIDE,https://www.dgidb.org/drugs/rxcui:38413,,SLC12A3,https://www.dgidb.org/genes/hgnc:10912,,,6559.0,SLC12A3,9606.0,Homo sapiens (human),,,,,,,,
431,1355644,41781,Drug Gene Interaction database (DGIdb),Torsemide,,TORSEMIDE,https://www.dgidb.org/drugs/rxcui:38413,,ACE,https://www.dgidb.org/genes/hgnc:2707,,,1636.0,ACE,9606.0,Homo sapiens (human),,,,,,,,
432,1432387,41867,Drug Gene Interaction database (DGIdb),Epirubicin,,EPIRUBICIN,https://www.dgidb.org/drugs/rxcui:3995,,CHD1,https://www.dgidb.org/genes/hgnc:1915,,,1105.0,CHD1,9606.0,Homo sapiens (human),,,,,,,,
433,1355471,42113,Drug Gene Interaction database (DGIdb),Desflurane,,DESFLURANE,https://www.dgidb.org/drugs/rxcui:27340,,GABRB2,https://www.dgidb.org/genes/hgnc:4082,,,2561.0,GABRB2,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
434,1355472,42113,Drug Gene Interaction database (DGIdb),Desflurane,,DESFLURANE,https://www.dgidb.org/drugs/rxcui:27340,,GABRG3,https://www.dgidb.org/genes/hgnc:4088,,,2567.0,GABRG3,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
435,1355473,42113,Drug Gene Interaction database (DGIdb),Desflurane,,DESFLURANE,https://www.dgidb.org/drugs/rxcui:27340,,GLRB,https://www.dgidb.org/genes/hgnc:4329,,,2743.0,GLRB,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
436,1355474,42113,Drug Gene Interaction database (DGIdb),Desflurane,,DESFLURANE,https://www.dgidb.org/drugs/rxcui:27340,,GLRA1,https://www.dgidb.org/genes/hgnc:4326,,,2741.0,GLRA1,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
437,1355475,42113,Drug Gene Interaction database (DGIdb),Desflurane,,DESFLURANE,https://www.dgidb.org/drugs/rxcui:27340,,KCNK3,https://www.dgidb.org/genes/hgnc:6278,,,3777.0,KCNK3,9606.0,Homo sapiens (human),Potentiator,,,,,,,
438,1355476,42113,DrugBank,Desflurane,DB01189,Desflurane,https://www.drugbank.ca/drugs/DB01189,BE0004797,Gamma-aminobutyric acid receptor subunit alpha-1,https://www.drugbank.ca/bio_entities/BE0004797,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),Positive allosteric modulator,,,PMID:11752090|PMID:18384456,https://www.ncbi.nlm.nih.gov/pubmed/11752090|https://www.ncbi.nlm.nih.gov/pubmed/18384456,11752090|18384456,,
439,1355477,42113,DrugBank,Desflurane,DB01189,Desflurane,https://www.drugbank.ca/drugs/DB01189,BE0004797,Gamma-aminobutyric acid receptor subunit alpha-2,https://www.drugbank.ca/bio_entities/BE0004797,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,2555.0,GABRA2,9606.0,Homo sapiens (human),Positive allosteric modulator,,,PMID:11752090|PMID:18384456,https://www.ncbi.nlm.nih.gov/pubmed/11752090|https://www.ncbi.nlm.nih.gov/pubmed/18384456,11752090|18384456,,
440,1355478,42113,DrugBank,Desflurane,DB01189,Desflurane,https://www.drugbank.ca/drugs/DB01189,BE0004797,Gamma-aminobutyric acid receptor subunit alpha-3,https://www.drugbank.ca/bio_entities/BE0004797,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,2556.0,GABRA3,9606.0,Homo sapiens (human),Positive allosteric modulator,,,PMID:11752090|PMID:18384456,https://www.ncbi.nlm.nih.gov/pubmed/11752090|https://www.ncbi.nlm.nih.gov/pubmed/18384456,11752090|18384456,,
441,1355479,42113,DrugBank,Desflurane,DB01189,Desflurane,https://www.drugbank.ca/drugs/DB01189,BE0004797,Gamma-aminobutyric acid receptor subunit alpha-4,https://www.drugbank.ca/bio_entities/BE0004797,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,2557.0,GABRA4,9606.0,Homo sapiens (human),Positive allosteric modulator,,,PMID:11752090|PMID:18384456,https://www.ncbi.nlm.nih.gov/pubmed/11752090|https://www.ncbi.nlm.nih.gov/pubmed/18384456,11752090|18384456,,
442,1432388,42113,Drug Gene Interaction database (DGIdb),Desflurane,,DESFLURANE,https://www.dgidb.org/drugs/rxcui:27340,,KCNK10,https://www.dgidb.org/genes/hgnc:6273,,,54207.0,KCNK10,9606.0,Homo sapiens (human),Potentiator,,,,,,,
443,1355775,42540,Comparative Toxicogenomics Database (CTD),"1,2,3,6,7,8-Hexachlorodibenzo-P-dioxin",C046838,"1,2,3,6,7,8-hexachlorodibenzodioxin",https://ctdbase.org/detail.go?type=chem&acc=C046838,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606.0,Homo sapiens (human),"1,2,3,6,7,8-hexachlorodibenzodioxin inhibits the reaction [metribolone results in increased activity of AR protein]",,,PMID:18324785,https://www.ncbi.nlm.nih.gov/pubmed/18324785,18324785,,
444,1355776,42540,Comparative Toxicogenomics Database (CTD),"1,2,3,6,7,8-Hexachlorodibenzo-P-dioxin",C046838,"1,2,3,6,7,8-hexachlorodibenzodioxin",https://ctdbase.org/detail.go?type=chem&acc=C046838,140634,CYP1A,https://ctdbase.org/detail.go?type=gene&acc=140634,,,140634.0,cyp1a,7955.0,Danio rerio (zebrafish),"1,2,3,6,7,8-hexachlorodibenzodioxin results in increased expression of CYP1A mRNA",,,PMID:11337868,https://www.ncbi.nlm.nih.gov/pubmed/11337868,11337868,,
445,1355777,42540,Comparative Toxicogenomics Database (CTD),"1,2,3,6,7,8-Hexachlorodibenzo-P-dioxin",C046838,"1,2,3,6,7,8-hexachlorodibenzodioxin",https://ctdbase.org/detail.go?type=chem&acc=C046838,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),"1,2,3,6,7,8-hexachlorodibenzodioxin results in increased expression of CYP1A1 mRNA",,,PMID:20819910|PMID:25654323,https://www.ncbi.nlm.nih.gov/pubmed/20819910|https://www.ncbi.nlm.nih.gov/pubmed/25654323,20819910|25654323,,
446,1355778,42540,Comparative Toxicogenomics Database (CTD),"1,2,3,6,7,8-Hexachlorodibenzo-P-dioxin",C046838,"1,2,3,6,7,8-hexachlorodibenzodioxin",https://ctdbase.org/detail.go?type=chem&acc=C046838,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),"1,2,3,6,7,8-hexachlorodibenzodioxin results in increased expression of CYP1A1 protein",,,PMID:25654323,https://www.ncbi.nlm.nih.gov/pubmed/25654323,25654323,,
447,1355779,42540,Comparative Toxicogenomics Database (CTD),"1,2,3,6,7,8-Hexachlorodibenzo-P-dioxin",C046838,"1,2,3,6,7,8-hexachlorodibenzodioxin",https://ctdbase.org/detail.go?type=chem&acc=C046838,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090.0,Mus musculus (house mouse),"AHR protein promotes the reaction [1,2,3,6,7,8-hexachlorodibenzodioxin results in increased expression of CYP1A1 mrna]|1,2,3,6,7,8-hexachlorodibenzodioxin results in increased expression of CYP1A1 mRNA",,,PMID:11046109,https://www.ncbi.nlm.nih.gov/pubmed/11046109,11046109,,
448,1355780,42540,Comparative Toxicogenomics Database (CTD),"1,2,3,6,7,8-Hexachlorodibenzo-P-dioxin",C046838,"1,2,3,6,7,8-hexachlorodibenzodioxin",https://ctdbase.org/detail.go?type=chem&acc=C046838,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10116.0,Rattus norvegicus (Norway rat),"1,2,3,6,7,8-hexachlorodibenzodioxin results in increased expression of CYP1A1 mRNA",,,PMID:25654323|PMID:29738842,https://www.ncbi.nlm.nih.gov/pubmed/25654323|https://www.ncbi.nlm.nih.gov/pubmed/29738842,25654323|29738842,,
449,1355781,42540,Comparative Toxicogenomics Database (CTD),"1,2,3,6,7,8-Hexachlorodibenzo-P-dioxin",C046838,"1,2,3,6,7,8-hexachlorodibenzodioxin",https://ctdbase.org/detail.go?type=chem&acc=C046838,104045292,CYP1A4,https://ctdbase.org/detail.go?type=gene&acc=104045292,,,104045292.0,,9209.0,Phalacrocorax carbo (great cormorant),"1,2,3,6,7,8-hexachlorodibenzodioxin results in increased expression of CYP1A4 mRNA",,,PMID:16679348,https://www.ncbi.nlm.nih.gov/pubmed/16679348,16679348,,
450,1355782,42540,Comparative Toxicogenomics Database (CTD),"1,2,3,6,7,8-Hexachlorodibenzo-P-dioxin",C046838,"1,2,3,6,7,8-hexachlorodibenzodioxin",https://ctdbase.org/detail.go?type=chem&acc=C046838,664714,CYP1A5,https://ctdbase.org/detail.go?type=gene&acc=664714,,,664714.0,,9209.0,Phalacrocorax carbo (great cormorant),"1,2,3,6,7,8-hexachlorodibenzodioxin results in increased expression of CYP1A5 mRNA",,,PMID:16679348,https://www.ncbi.nlm.nih.gov/pubmed/16679348,16679348,,
451,1355783,42540,Comparative Toxicogenomics Database (CTD),"1,2,3,6,7,8-Hexachlorodibenzo-P-dioxin",C046838,"1,2,3,6,7,8-hexachlorodibenzodioxin",https://ctdbase.org/detail.go?type=chem&acc=C046838,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,10116.0,Rattus norvegicus (Norway rat),"1,2,3,6,7,8-hexachlorodibenzodioxin results in increased expression of CYP1B1 mRNA",,,PMID:25654323|PMID:29738842,https://www.ncbi.nlm.nih.gov/pubmed/25654323|https://www.ncbi.nlm.nih.gov/pubmed/29738842,25654323|29738842,,
452,1361196,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,770,CA11,https://ctdbase.org/detail.go?type=gene&acc=770,,,770.0,CA11,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of CA11 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
453,1361197,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,801,CALM1,https://ctdbase.org/detail.go?type=gene&acc=801,,,801.0,CALM1,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of CALM1 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
454,1361198,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,808,CALM3,https://ctdbase.org/detail.go?type=gene&acc=808,,,808.0,CALM3,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of CALM3 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
455,1361199,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,23271,CAMSAP2,https://ctdbase.org/detail.go?type=gene&acc=23271,,,23271.0,CAMSAP2,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of CAMSAP2 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
456,1361200,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,4076,CAPRIN1,https://ctdbase.org/detail.go?type=gene&acc=4076,,,4076.0,CAPRIN1,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of CAPRIN1 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
457,1361201,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,8573,CASK,https://ctdbase.org/detail.go?type=gene&acc=8573,,,8573.0,CASK,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of CASK mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
458,1361426,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,4267,CD99,https://ctdbase.org/detail.go?type=gene&acc=4267,,,4267.0,CD99,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of CD99 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
459,1361427,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,998,CDC42,https://ctdbase.org/detail.go?type=gene&acc=998,,,998.0,CDC42,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of CDC42 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
460,1361428,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,80205,CHD9,https://ctdbase.org/detail.go?type=gene&acc=80205,,,80205.0,CHD9,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of CHD9 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
461,1361429,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,1113,CHGA,https://ctdbase.org/detail.go?type=gene&acc=1113,,,1113.0,CHGA,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of CHGA mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
462,1361430,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,1116,CHI3L1,https://ctdbase.org/detail.go?type=gene&acc=1116,,,1116.0,CHI3L1,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of CHI3L1 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
463,1361431,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,1153,CIRBP,https://ctdbase.org/detail.go?type=gene&acc=1153,,,1153.0,CIRBP,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of CIRBP mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
464,1361432,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,23122,CLASP2,https://ctdbase.org/detail.go?type=gene&acc=23122,,,23122.0,CLASP2,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of CLASP2 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
465,1361433,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,1186,CLCN7,https://ctdbase.org/detail.go?type=gene&acc=1186,,,1186.0,CLCN7,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of CLCN7 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
466,1362386,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,3107,HLA-C,https://ctdbase.org/detail.go?type=gene&acc=3107,,,3107.0,HLA-C,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of HLA-C mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
467,1363118,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,80097,MZT2B,https://ctdbase.org/detail.go?type=gene&acc=80097,,,80097.0,MZT2B,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of MZT2B mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
468,1363246,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,4915,NTRK2,https://ctdbase.org/detail.go?type=gene&acc=4915,,,4915.0,NTRK2,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of NTRK2 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
469,1363846,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,5900,RALGDS,https://ctdbase.org/detail.go?type=gene&acc=5900,,,5900.0,RALGDS,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of RALGDS mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
470,1363847,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,10048,RANBP9,https://ctdbase.org/detail.go?type=gene&acc=10048,,,10048.0,RANBP9,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of RANBP9 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
471,1363848,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,9693,RAPGEF2,https://ctdbase.org/detail.go?type=gene&acc=9693,,,9693.0,RAPGEF2,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of RAPGEF2 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
472,1363849,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,23543,RBFOX2,https://ctdbase.org/detail.go?type=gene&acc=23543,,,23543.0,RBFOX2,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of RBFOX2 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
473,1363850,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,9584,RBM39,https://ctdbase.org/detail.go?type=gene&acc=9584,,,9584.0,RBM39,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of RBM39 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
474,1363851,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,6004,RGS16,https://ctdbase.org/detail.go?type=gene&acc=6004,,,6004.0,RGS16,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of RGS16 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
475,1363852,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,23433,RHOQ,https://ctdbase.org/detail.go?type=gene&acc=23433,,,23433.0,RHOQ,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of RHOQ mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
476,1363853,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,8635,RNASET2,https://ctdbase.org/detail.go?type=gene&acc=8635,,,8635.0,RNASET2,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of RNASET2 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
477,1363854,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,22895,RPH3A,https://ctdbase.org/detail.go?type=gene&acc=22895,,,22895.0,RPH3A,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of RPH3A mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
478,1363986,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,6167,RPL37,https://ctdbase.org/detail.go?type=gene&acc=6167,,,6167.0,RPL37,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of RPL37 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
479,1363987,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,6168,RPL37A,https://ctdbase.org/detail.go?type=gene&acc=6168,,,6168.0,RPL37A,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of RPL37A mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
480,1363988,43264,Comparative Toxicogenomics Database (CTD),"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",https://ctdbase.org/detail.go?type=chem&acc=C030370,6132,RPL8,https://ctdbase.org/detail.go?type=gene&acc=6132,,,6132.0,RPL8,9541.0,Macaca fascicularis (crab-eating macaque),"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of RPL8 mRNA",,,PMID:20206263,https://www.ncbi.nlm.nih.gov/pubmed/20206263,20206263,,
481,1359425,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,4292,MLH1,https://ctdbase.org/detail.go?type=gene&acc=4292,,,4292.0,MLH1,9606.0,Homo sapiens (human),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MLH1 mRNA,,,PMID:32326378,https://www.ncbi.nlm.nih.gov/pubmed/32326378,32326378,,
482,1359426,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of MMP9 mrna|4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MMP9 mRNA,,,PMID:21167638,https://www.ncbi.nlm.nih.gov/pubmed/21167638,21167638,,
483,1359427,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,64975,MRPL41,https://ctdbase.org/detail.go?type=gene&acc=64975,,,64975.0,MRPL41,9606.0,Homo sapiens (human),[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with benzo(a)pyrene] results in increased expression of MRPL41 mrna|catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with benzo(a)pyrene] results in increased expression of MRPL41 mrna],,,PMID:21882252,https://www.ncbi.nlm.nih.gov/pubmed/21882252,21882252,,
484,1359788,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,672,BRCA1,https://ctdbase.org/detail.go?type=gene&acc=672,,,672.0,BRCA1,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of BRCA1 mrna|4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BRCA1 mRNA,,,PMID:21167638,https://www.ncbi.nlm.nih.gov/pubmed/21167638,21167638,,
485,1359789,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,7832,BTG2,https://ctdbase.org/detail.go?type=gene&acc=7832,,,7832.0,BTG2,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BTG2 mRNA,,,PMID:14600272|PMID:15890375|PMID:22484513|PMID:23052194,https://www.ncbi.nlm.nih.gov/pubmed/14600272|https://www.ncbi.nlm.nih.gov/pubmed/15890375|https://www.ncbi.nlm.nih.gov/pubmed/22484513|https://www.ncbi.nlm.nih.gov/pubmed/23052194,14600272|15890375|22484513|23052194,,
486,1359790,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,10950,BTG3,https://ctdbase.org/detail.go?type=gene&acc=10950,,,10950.0,BTG3,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BTG3 mRNA,,,PMID:22484513|PMID:23052194,https://www.ncbi.nlm.nih.gov/pubmed/22484513|https://www.ncbi.nlm.nih.gov/pubmed/23052194,22484513|23052194,,
487,1359791,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,10090.0,Mus musculus (house mouse),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CASP8 mRNA,,,PMID:21167638,https://www.ncbi.nlm.nih.gov/pubmed/21167638,21167638,,
488,1359792,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,873,CBR1,https://ctdbase.org/detail.go?type=gene&acc=873,,,873.0,CBR1,9606.0,Homo sapiens (human),CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone|rutin inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]|quercetin inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]|vitamin K 3 inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]|ethacrynic acid inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone],,,PMID:11306090,https://www.ncbi.nlm.nih.gov/pubmed/11306090,11306090,,
489,1359793,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,873,CBR1,https://ctdbase.org/detail.go?type=gene&acc=873,,,873.0,CBR1,9606.0,Homo sapiens (human),CBR1 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,,,PMID:28257955,https://www.ncbi.nlm.nih.gov/pubmed/28257955,28257955,,
490,1359794,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CCL2 protein,,,PMID:15762874,https://www.ncbi.nlm.nih.gov/pubmed/15762874,15762874,,
491,1359795,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CCNB1 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
492,1360522,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,22943,DKK1,https://ctdbase.org/detail.go?type=gene&acc=22943,,,22943.0,DKK1,9606.0,Homo sapiens (human),Benzamides analog inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DKK1 mrna]|4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DKK1 mrna|acetylcysteine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DKK1 mrna]|wortmannin inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DKK1 mrna]|diphenyleneiodonium inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DKK1 mrna],,,PMID:28321046,https://www.ncbi.nlm.nih.gov/pubmed/28321046,28321046,,
493,1360523,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,1755,DMBT1,https://ctdbase.org/detail.go?type=gene&acc=1755,,,1755.0,DMBT1,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DMBT1 mRNA,,,PMID:23052194,https://www.ncbi.nlm.nih.gov/pubmed/23052194,23052194,,
494,1361587,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,2180,ACSL1,https://ctdbase.org/detail.go?type=gene&acc=2180,,,2180.0,ACSL1,9606.0,Homo sapiens (human),[benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of ACSL1 mRNA,,,PMID:20146248,https://www.ncbi.nlm.nih.gov/pubmed/20146248,20146248,,
495,1361588,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,10554,AGPAT1,https://ctdbase.org/detail.go?type=gene&acc=10554,,,10554.0,AGPAT1,9606.0,Homo sapiens (human),[benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of AGPAT1 mRNA,,,PMID:20146248,https://www.ncbi.nlm.nih.gov/pubmed/20146248,20146248,,
496,1361589,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,199,AIF1,https://ctdbase.org/detail.go?type=gene&acc=199,,,199.0,AIF1,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of AIF1 mRNA,,,PMID:14600272,https://www.ncbi.nlm.nih.gov/pubmed/14600272,14600272,,
497,1361590,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,57016,AKR1B10,https://ctdbase.org/detail.go?type=gene&acc=57016,,,57016.0,AKR1B10,9606.0,Homo sapiens (human),Testosterone inhibits the reaction [AKR1B10 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]|estradiol inhibits the reaction [AKR1B10 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]|ethinyl estradiol inhibits the reaction [AKR1B10 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]|drospirenone inhibits the reaction [AKR1B10 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]|akr1b10 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone|progesterone inhibits the reaction [AKR1B10 protein results in increased reduction of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone],,,PMID:28257955,https://www.ncbi.nlm.nih.gov/pubmed/28257955,28257955,,
498,1361591,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606.0,Homo sapiens (human),AKR1C1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,,,PMID:11306090,https://www.ncbi.nlm.nih.gov/pubmed/11306090,11306090,,
499,1362079,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,4864,NPC1,https://ctdbase.org/detail.go?type=gene&acc=4864,,,4864.0,NPC1,9606.0,Homo sapiens (human),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NPC1 mRNA,,,PMID:19038236,https://www.ncbi.nlm.nih.gov/pubmed/19038236,19038236,,
500,1362080,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,4869,NPM1,https://ctdbase.org/detail.go?type=gene&acc=4869,,,4869.0,NPM1,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NPM1 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
501,1362081,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NQO1 mRNA,,,PMID:14600272|PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/14600272|https://www.ncbi.nlm.nih.gov/pubmed/15890375,14600272|15890375,,
502,1362542,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,5685,PSMA4,https://ctdbase.org/detail.go?type=gene&acc=5685,,,5685.0,PSMA4,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMA4 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
503,1362543,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,5686,PSMA5,https://ctdbase.org/detail.go?type=gene&acc=5686,,,5686.0,PSMA5,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PSMA5 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
504,1362544,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,5688,PSMA7,https://ctdbase.org/detail.go?type=gene&acc=5688,,,5688.0,PSMA7,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMA7 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
505,1362545,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,5689,PSMB1,https://ctdbase.org/detail.go?type=gene&acc=5689,,,5689.0,PSMB1,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMB1 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
506,1362546,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,5691,PSMB3,https://ctdbase.org/detail.go?type=gene&acc=5691,,,5691.0,PSMB3,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMB3 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
507,1362675,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,7803,PTP4A1,https://ctdbase.org/detail.go?type=gene&acc=7803,,,7803.0,PTP4A1,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PTP4A1 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
508,1362676,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,13924,PTPRV,https://ctdbase.org/detail.go?type=gene&acc=13924,,,13924.0,Ptprv,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PTPRV mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
509,1363412,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,64093,SMOC1,https://ctdbase.org/detail.go?type=gene&acc=64093,,,64093.0,SMOC1,9606.0,Homo sapiens (human),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of SMOC1 mRNA,,,PMID:19038236,https://www.ncbi.nlm.nih.gov/pubmed/19038236,19038236,,
510,1363413,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,6591,SNAI2,https://ctdbase.org/detail.go?type=gene&acc=6591,,,6591.0,SNAI2,9606.0,Homo sapiens (human),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of SNAI2 protein,,,PMID:30236600,https://www.ncbi.nlm.nih.gov/pubmed/30236600,30236600,,
511,1363414,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,8435,SOAT2,https://ctdbase.org/detail.go?type=gene&acc=8435,,,8435.0,SOAT2,9606.0,Homo sapiens (human),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SOAT2 mRNA,,,PMID:19038236,https://www.ncbi.nlm.nih.gov/pubmed/19038236,19038236,,
512,1363531,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,6897,TARS1,https://ctdbase.org/detail.go?type=gene&acc=6897,,,6897.0,TARS1,9606.0,Homo sapiens (human),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TARS1 mRNA,,,PMID:19038236,https://www.ncbi.nlm.nih.gov/pubmed/19038236,19038236,,
513,1363532,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,6898,TAT,https://ctdbase.org/detail.go?type=gene&acc=6898,,,6898.0,TAT,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TAT mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
514,1363533,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,9238,TBRG4,https://ctdbase.org/detail.go?type=gene&acc=9238,,,9238.0,TBRG4,9606.0,Homo sapiens (human),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of TBRG4 mRNA,,,PMID:19038236,https://www.ncbi.nlm.nih.gov/pubmed/19038236,19038236,,
515,1363534,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,26515,TIMM10B,https://ctdbase.org/detail.go?type=gene&acc=26515,,,26515.0,TIMM10B,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TIMM10B mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
516,1363535,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TIMP1 mRNA,,,PMID:14600272|PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/14600272|https://www.ncbi.nlm.nih.gov/pubmed/15890375,14600272|15890375,,
517,1363536,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,9168,TMSB10,https://ctdbase.org/detail.go?type=gene&acc=9168,,,9168.0,TMSB10,10116.0,Rattus norvegicus (Norway rat),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TMSB10 mRNA,,,PMID:14600272,https://www.ncbi.nlm.nih.gov/pubmed/14600272,14600272,,
518,1363537,47289,Comparative Toxicogenomics Database (CTD),4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,https://ctdbase.org/detail.go?type=chem&acc=C016583,7128,TNFAIP3,https://ctdbase.org/detail.go?type=gene&acc=7128,,,7128.0,TNFAIP3,9606.0,Homo sapiens (human),4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TNFAIP3 mRNA,,,PMID:21873647,https://www.ncbi.nlm.nih.gov/pubmed/21873647,21873647,,
519,1364133,47326,Comparative Toxicogenomics Database (CTD),Fenpropathrin,C044267,fenpropathrin,https://ctdbase.org/detail.go?type=chem&acc=C044267,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10116.0,Rattus norvegicus (Norway rat),Fenpropathrin results in increased expression of CYP1A1 mRNA,,,PMID:32949931,https://www.ncbi.nlm.nih.gov/pubmed/32949931,32949931,,
520,1364134,47326,Comparative Toxicogenomics Database (CTD),Fenpropathrin,C044267,fenpropathrin,https://ctdbase.org/detail.go?type=chem&acc=C044267,41503,GSTD1,https://ctdbase.org/detail.go?type=gene&acc=41503,,,41503.0,GstD1,121845.0,Diaphorina citri (Asian citrus psyllid),Fenpropathrin results in increased expression of GSTD1 mrna|gstd1 mRNA results in decreased susceptibility to fenpropathrin,,,PMID:28971568,https://www.ncbi.nlm.nih.gov/pubmed/28971568,28971568,,
521,1364135,47326,Comparative Toxicogenomics Database (CTD),Fenpropathrin,C044267,fenpropathrin,https://ctdbase.org/detail.go?type=chem&acc=C044267,37107,GSTE2,https://ctdbase.org/detail.go?type=gene&acc=37107,,,37107.0,GstE2,121845.0,Diaphorina citri (Asian citrus psyllid),GSTE2 mRNA results in decreased susceptibility to fenpropathrin,,,PMID:28971568,https://www.ncbi.nlm.nih.gov/pubmed/28971568,28971568,,
522,1364136,47326,Comparative Toxicogenomics Database (CTD),Fenpropathrin,C044267,fenpropathrin,https://ctdbase.org/detail.go?type=chem&acc=C044267,101898332,PARA-LIKE,https://ctdbase.org/detail.go?type=gene&acc=101898332,,,101898332.0,,7159.0,Aedes aegypti (yellow fever mosquito),PARA-LIKE protein affects the susceptibility to fenpropathrin,,,PMID:29064635,https://www.ncbi.nlm.nih.gov/pubmed/29064635,29064635,,
523,1430228,51263,Toxin and Toxin Target Database (T3DB),Alfentanil,T3D2894,Alfentanil,http://www.t3db.ca/toxins/T3D2894,BE0002362,Cytochrome P450 3A5,http://www.t3db.ca/biodb/bio_entities/BE0002362,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606.0,Homo sapiens (human),"Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. as the effector system is adenylate cyclase and camp located at the inner surface of the plasma membrane, opioids decrease intracellular camp by inhibiting adenylate cyclase. subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. alfentanil's analgesic activity is, most likely, due to its conversion to morphine. opioids close N-type voltage-operated calcium channels (OP2-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (OP3 and OP1 receptor agonist). this results in hyperpolarization and reduced neuronal excitability.",,,PMID:15557344|PMID:15731592|PMID:17554244,https://www.ncbi.nlm.nih.gov/pubmed/15557344|https://www.ncbi.nlm.nih.gov/pubmed/15731592|https://www.ncbi.nlm.nih.gov/pubmed/17554244,15557344|15731592|17554244,,
524,1430331,52919,Drug Gene Interaction database (DGIdb),Haloperidol Decanoate,,HALOPERIDOL DECANOATE,https://www.dgidb.org/drugs/rxcui:26420,,ARID5B,https://www.dgidb.org/genes/hgnc:17362,,,84159.0,ARID5B,9606.0,Homo sapiens (human),,,,,,,,
525,1430332,52919,Drug Gene Interaction database (DGIdb),Haloperidol Decanoate,,HALOPERIDOL DECANOATE,https://www.dgidb.org/drugs/rxcui:26420,,GRIN1,https://www.dgidb.org/genes/hgnc:4584,,,2902.0,GRIN1,9606.0,Homo sapiens (human),,,,,,,,
526,1430333,52919,Drug Gene Interaction database (DGIdb),Haloperidol Decanoate,,HALOPERIDOL DECANOATE,https://www.dgidb.org/drugs/rxcui:26420,,AKAP13,https://www.dgidb.org/genes/hgnc:371,,,11214.0,AKAP13,9606.0,Homo sapiens (human),,,,,,,,
527,1430334,52919,Drug Gene Interaction database (DGIdb),Haloperidol Decanoate,,HALOPERIDOL DECANOATE,https://www.dgidb.org/drugs/rxcui:26420,,KCNH2,https://www.dgidb.org/genes/hgnc:6251,,,3757.0,KCNH2,9606.0,Homo sapiens (human),,,,,,,,
528,1430335,52919,Drug Gene Interaction database (DGIdb),Haloperidol Decanoate,,HALOPERIDOL DECANOATE,https://www.dgidb.org/drugs/rxcui:26420,,CYP3A43,https://www.dgidb.org/genes/hgnc:17450,,,64816.0,CYP3A43,9606.0,Homo sapiens (human),,,,,,,,
529,1430336,52919,Drug Gene Interaction database (DGIdb),Haloperidol Decanoate,,HALOPERIDOL DECANOATE,https://www.dgidb.org/drugs/rxcui:26420,,DRD2,https://www.dgidb.org/genes/hgnc:3023,,,1813.0,DRD2,9606.0,Homo sapiens (human),Inverse agonist,,,,,,,
530,1430337,52919,Drug Gene Interaction database (DGIdb),Haloperidol Decanoate,,HALOPERIDOL DECANOATE,https://www.dgidb.org/drugs/rxcui:26420,,COMT,https://www.dgidb.org/genes/hgnc:2228,,,1312.0,COMT,9606.0,Homo sapiens (human),,,,,,,,
531,1430338,52919,Drug Gene Interaction database (DGIdb),Haloperidol Decanoate,,HALOPERIDOL DECANOATE,https://www.dgidb.org/drugs/rxcui:26420,,ABCB5,https://www.dgidb.org/genes/hgnc:46,,,340273.0,ABCB5,9606.0,Homo sapiens (human),,,,,,,,
532,1430339,52919,Drug Gene Interaction database (DGIdb),Haloperidol Decanoate,,HALOPERIDOL DECANOATE,https://www.dgidb.org/drugs/rxcui:26420,,MTOR,https://www.dgidb.org/genes/hgnc:3942,,,2475.0,MTOR,9606.0,Homo sapiens (human),,,,,,,,
533,1430340,53001,IUPHAR/BPS Guide to PHARMACOLOGY,Dazoxiben,5175,dazoxiben,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5175,1353,CYP5A1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1353,P24557,Thromboxane-A synthase ,6916.0,TBXAS1,9606.0,Homo sapiens (human),Inhibition,pIC50,8.5,PMID:6795753,https://www.ncbi.nlm.nih.gov/pubmed/6795753,6795753,,
534,1430341,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606.0,Homo sapiens (human),Lovastatin results in increased expression of ABCA1 mrna|lovastatin results in decreased expression of ABCA1 mRNA,,,PMID:19260826,https://www.ncbi.nlm.nih.gov/pubmed/19260826,19260826,,
535,1430448,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10090.0,Mus musculus (house mouse),[dietary fats co-treated with lovastatin] affects the expression of ABCA1 mRNA,,,PMID:29852127,https://www.ncbi.nlm.nih.gov/pubmed/29852127,29852127,,
536,1430449,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),ABCB1 protein results in increased transport of lovastatin analog|abcb1 protein results in increased transport of lovastatin|lovastatin analog inhibits the reaction [ABCB1 protein results in increased transport of calcein am]|lovastatin analog results in decreased activity of ABCB1 protein,,,PMID:15616150,https://www.ncbi.nlm.nih.gov/pubmed/15616150,15616150,,
537,1430450,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606.0,Homo sapiens (human),Lovastatin inhibits the reaction [ABCB11 protein results in increased transport of taurocholic acid],,,PMID:24014644,https://www.ncbi.nlm.nih.gov/pubmed/24014644,24014644,,
538,1430451,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606.0,Homo sapiens (human),Lovastatin results in decreased activity of ABCB11 protein,,,PMID:23956101|PMID:24014644,https://www.ncbi.nlm.nih.gov/pubmed/23956101|https://www.ncbi.nlm.nih.gov/pubmed/24014644,23956101|24014644,,
539,1430452,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,10090.0,Mus musculus (house mouse),Doxorubicin inhibits the reaction [lovastatin results in increased expression of ABCC1 mrna],,,PMID:22712078,https://www.ncbi.nlm.nih.gov/pubmed/22712078,22712078,,
540,1430453,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,10090.0,Mus musculus (house mouse),[lovastatin results in decreased activity of ABCC1 protein] which results in increased susceptibility to antimony sodium gluconate|lovastatin results in decreased activity of ABCC1 protein,,,PMID:18056276,https://www.ncbi.nlm.nih.gov/pubmed/18056276,18056276,,
541,1430454,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),Lovastatin results in decreased phosphorylation of AKT1 protein,,,PMID:20578043,https://www.ncbi.nlm.nih.gov/pubmed/20578043,20578043,,
542,1430455,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606.0,Homo sapiens (human),"Lovastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]|abcc2 protein binds to and results in increased uptake of lovastatin analog",,,PMID:23562342,https://www.ncbi.nlm.nih.gov/pubmed/23562342,23562342,,
543,1430456,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606.0,Homo sapiens (human),Lovastatin analog results in decreased activity of ABCC2 protein|lovastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM],,,PMID:15616150,https://www.ncbi.nlm.nih.gov/pubmed/15616150,15616150,,
544,1430457,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10116.0,Rattus norvegicus (Norway rat),Lovastatin results in increased expression of ABCC2 mrna|lovastatin promotes the reaction [cisplatin results in decreased expression of ABCC2 mrna],,,PMID:26739623,https://www.ncbi.nlm.nih.gov/pubmed/26739623,26739623,,
545,1430561,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,64240,ABCG5,https://ctdbase.org/detail.go?type=gene&acc=64240,,,64240.0,ABCG5,10090.0,Mus musculus (house mouse),[dietary fats co-treated with lovastatin] affects the expression of ABCG5 mRNA,,,PMID:29852127,https://www.ncbi.nlm.nih.gov/pubmed/29852127,29852127,,
546,1430562,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,64240,ABCG5,https://ctdbase.org/detail.go?type=gene&acc=64240,,,64240.0,ABCG5,10090.0,Mus musculus (house mouse),Lovastatin affects the expression of ABCG5 mRNA,,,PMID:27208389,https://www.ncbi.nlm.nih.gov/pubmed/27208389,27208389,,
547,1430563,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,64241,ABCG8,https://ctdbase.org/detail.go?type=gene&acc=64241,,,64241.0,ABCG8,10090.0,Mus musculus (house mouse),Lovastatin affects the expression of ABCG8 mRNA,,,PMID:27208389,https://www.ncbi.nlm.nih.gov/pubmed/27208389,27208389,,
548,1430564,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,10090.0,Mus musculus (house mouse),[dietary fats co-treated with lovastatin] affects the expression of ACACA mRNA,,,PMID:29852127,https://www.ncbi.nlm.nih.gov/pubmed/29852127,29852127,,
549,1430565,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,51,ACOX1,https://ctdbase.org/detail.go?type=gene&acc=51,,,51.0,ACOX1,10090.0,Mus musculus (house mouse),[dietary fats co-treated with lovastatin] affects the expression of ACOX1 mRNA,,,PMID:29852127,https://www.ncbi.nlm.nih.gov/pubmed/29852127,29852127,,
550,1430566,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,55902,ACSS2,https://ctdbase.org/detail.go?type=gene&acc=55902,,,55902.0,ACSS2,10090.0,Mus musculus (house mouse),[dietary fats co-treated with lovastatin] affects the expression of ACSS2 mRNA,,,PMID:29852127,https://www.ncbi.nlm.nih.gov/pubmed/29852127,29852127,,
551,1430670,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,287,ANK2,https://ctdbase.org/detail.go?type=gene&acc=287,,,287.0,ANK2,9606.0,Homo sapiens (human),ANK2 SNP results in decreased susceptibility to lovastatin,,,PMID:21483694,https://www.ncbi.nlm.nih.gov/pubmed/21483694,21483694,,
552,1430671,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,307,ANXA4,https://ctdbase.org/detail.go?type=gene&acc=307,,,307.0,ANXA4,10090.0,Mus musculus (house mouse),Lovastatin results in decreased expression of ANXA4 mRNA,,,PMID:20493250,https://www.ncbi.nlm.nih.gov/pubmed/20493250,20493250,,
553,1430672,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,308,ANXA5,https://ctdbase.org/detail.go?type=gene&acc=308,,,308.0,ANXA5,10090.0,Mus musculus (house mouse),Lovastatin results in decreased expression of ANXA5 mRNA,,,PMID:20493250,https://www.ncbi.nlm.nih.gov/pubmed/20493250,20493250,,
554,1432259,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116.0,Rattus norvegicus (Norway rat),Lovastatin results in increased phosphorylation of GSK3B protein,,,PMID:19741129,https://www.ncbi.nlm.nih.gov/pubmed/19741129,19741129,,
555,1433522,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,4942,OAT,https://ctdbase.org/detail.go?type=gene&acc=4942,,,4942.0,OAT,10090.0,Mus musculus (house mouse),Lovastatin results in decreased expression of OAT mRNA,,,PMID:20493250,https://www.ncbi.nlm.nih.gov/pubmed/20493250,20493250,,
556,1433523,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,5008,OSM,https://ctdbase.org/detail.go?type=gene&acc=5008,,,5008.0,OSM,9606.0,Homo sapiens (human),OSM protein promotes the reaction [lovastatin results in increased expression of LDLR mrna],,,PMID:12524230,https://www.ncbi.nlm.nih.gov/pubmed/12524230,12524230,,
557,1434212,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606.0,Homo sapiens (human),Lovastatin inhibits the reaction [guanidine promotes the reaction [SOD1 protein mutant form binds to SOD1 protein mutant form]],,,PMID:27556028,https://www.ncbi.nlm.nih.gov/pubmed/27556028,27556028,,
558,1434213,53232,Comparative Toxicogenomics Database (CTD),Lovastatin,D008148,Lovastatin,https://ctdbase.org/detail.go?type=chem&acc=D008148,6663,SOX10,https://ctdbase.org/detail.go?type=gene&acc=6663,,,6663.0,SOX10,10116.0,Rattus norvegicus (Norway rat),PTEN protein affects the reaction [lovastatin results in increased expression of SOX10 mrna]|geranylgeranyl pyrophosphate inhibits the reaction [lovastatin results in increased expression of SOX10 mrna]|pparg protein affects the reaction [lovastatin results in increased expression of SOX10 mrna]|lovastatin results in increased expression of SOX10 mRNA,,,PMID:20578043,https://www.ncbi.nlm.nih.gov/pubmed/20578043,20578043,,
559,1434793,54454,Drug Gene Interaction database (DGIdb),Simvastatin,,SIMVASTATIN,https://www.dgidb.org/drugs/rxcui:36567,,KRAS,https://www.dgidb.org/genes/hgnc:6407,,,3845.0,KRAS,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
560,1434794,54454,Drug Gene Interaction database (DGIdb),Simvastatin,,SIMVASTATIN,https://www.dgidb.org/drugs/rxcui:36567,,PRDM16,https://www.dgidb.org/genes/hgnc:14000,,,63976.0,PRDM16,9606.0,Homo sapiens (human),,,,,,,,
561,1434795,54454,Drug Gene Interaction database (DGIdb),Simvastatin,,SIMVASTATIN,https://www.dgidb.org/drugs/rxcui:36567,,CACNA1S,https://www.dgidb.org/genes/hgnc:1397,,,779.0,CACNA1S,9606.0,Homo sapiens (human),,,,,,,,
562,1434796,54454,Drug Gene Interaction database (DGIdb),Simvastatin,,SIMVASTATIN,https://www.dgidb.org/drugs/rxcui:36567,,ABCA1,https://www.dgidb.org/genes/hgnc:29,,,19.0,ABCA1,9606.0,Homo sapiens (human),,,,,,,,
563,1434797,54454,Drug Gene Interaction database (DGIdb),Simvastatin,,SIMVASTATIN,https://www.dgidb.org/drugs/rxcui:36567,,HMGCR,https://www.dgidb.org/genes/hgnc:5006,,,3156.0,HMGCR,9606.0,Homo sapiens (human),,,,,,,,
564,1434798,54454,Drug Gene Interaction database (DGIdb),Simvastatin,,SIMVASTATIN,https://www.dgidb.org/drugs/rxcui:36567,,CYP2C19,https://www.dgidb.org/genes/hgnc:2621,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,,,,,
565,1434799,54454,Drug Gene Interaction database (DGIdb),Simvastatin,,SIMVASTATIN,https://www.dgidb.org/drugs/rxcui:36567,,UGT1A3,https://www.dgidb.org/genes/hgnc:12535,,,54659.0,UGT1A3,9606.0,Homo sapiens (human),,,,,,,,
566,1434800,54562,Drug Gene Interaction database (DGIdb),Quinpirole,,QUINPIROLE,https://www.dgidb.org/drugs/ncit:C152128,,DRD3,https://www.dgidb.org/genes/hgnc:3024,,,1814.0,DRD3,9606.0,Homo sapiens (human),,,,,,,,
567,1434801,54687,IUPHAR/BPS Guide to PHARMACOLOGY,Pravastatin,2953,pravastatin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2953,1220,OATP1B1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1220,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Binding,,5.7,,,,,
568,1434802,54738,Comparative Toxicogenomics Database (CTD),Imazapyr,C076656,imazapyr,https://ctdbase.org/detail.go?type=chem&acc=C076656,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971.0,NR1H4,9606.0,Homo sapiens (human),Imazapyr binds to and results in decreased activity of NR1H4 protein,,,PMID:21251949,https://www.ncbi.nlm.nih.gov/pubmed/21251949,21251949,,
569,1357662,60602,Drug Gene Interaction database (DGIdb),S(+)-Niguldipine hydrochloride,,NIGULDIPINE,https://www.dgidb.org/drugs/ncit:C84018,,CYP2C19,https://www.dgidb.org/genes/hgnc:2621,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,,,,,
570,1357663,60602,Drug Gene Interaction database (DGIdb),S(+)-Niguldipine hydrochloride,,NIGULDIPINE,https://www.dgidb.org/drugs/ncit:C84018,,TP53,https://www.dgidb.org/genes/hgnc:11998,,,7157.0,TP53,9606.0,Homo sapiens (human),,,,,,,,
571,1357664,60652,Drug Gene Interaction database (DGIdb),Liarozole,,LIAROZOLE,https://www.dgidb.org/drugs/ncit:C1433,,CYP26A1,https://www.dgidb.org/genes/hgnc:2603,,,1592.0,CYP26A1,9606.0,Homo sapiens (human),,,,,,,,
572,1357665,60748,Drug Gene Interaction database (DGIdb),Pivanex,,PIVALOYLOXYMETHYLBUTYRATE,https://www.dgidb.org/drugs/ncit:C1344,,HDAC2,https://www.dgidb.org/genes/hgnc:4853,,,3066.0,HDAC2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
573,1357666,60750,Drug Gene Interaction database (DGIdb),Gemcitabine,,GEMCITABINE,https://www.dgidb.org/drugs/rxcui:12574,,PIK3CA,https://www.dgidb.org/genes/hgnc:8975,,,5290.0,PIK3CA,9606.0,Homo sapiens (human),,,,,,,,
574,1357667,60750,Drug Gene Interaction database (DGIdb),Gemcitabine,,GEMCITABINE,https://www.dgidb.org/drugs/rxcui:12574,,BRAF,https://www.dgidb.org/genes/hgnc:1097,,,673.0,BRAF,9606.0,Homo sapiens (human),,,,,,,,
575,1357668,60773,DrugBank,,DB00577,Valaciclovir,https://www.drugbank.ca/drugs/DB00577,BE0000458,Thymidine kinase,https://www.drugbank.ca/bio_entities/BE0000458,Q9QNF7,Thymidine kinase,,,10298.0,Human alphaherpesvirus 1 (Herpes simplex virus type 1),Substrate,,,PMID:16982796,https://www.ncbi.nlm.nih.gov/pubmed/16982796,16982796,,
576,1357669,60773,DrugBank,,DB00577,Valaciclovir,https://www.drugbank.ca/drugs/DB00577,BE0000308,DNA polymerase catalytic subunit,https://www.drugbank.ca/bio_entities/BE0000308,P04293,DNA polymerase catalytic subunit,2703462.0,UL30,10299.0,Human alphaherpesvirus 1 strain 17,Inhibitor,,,PMID:16033961|PMID:9892653,https://www.ncbi.nlm.nih.gov/pubmed/16033961|https://www.ncbi.nlm.nih.gov/pubmed/9892653,16033961|9892653,,
577,1436652,60854,Drug Gene Interaction database (DGIdb),Ziprasidone,,ZIPRASIDONE,https://www.dgidb.org/drugs/rxcui:115698,,EIF2AK4,https://www.dgidb.org/genes/hgnc:19687,,,440275.0,EIF2AK4,9606.0,Homo sapiens (human),,,,,,,,
578,1436653,60854,Drug Gene Interaction database (DGIdb),Ziprasidone,,ZIPRASIDONE,https://www.dgidb.org/drugs/rxcui:115698,,CDH4,https://www.dgidb.org/genes/hgnc:1763,,,1002.0,CDH4,9606.0,Homo sapiens (human),,,,,,,,
579,1436654,60854,Drug Gene Interaction database (DGIdb),Ziprasidone,,ZIPRASIDONE,https://www.dgidb.org/drugs/rxcui:115698,,DRD2,https://www.dgidb.org/genes/hgnc:3023,,,1813.0,DRD2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
580,1436655,60854,Drug Gene Interaction database (DGIdb),Ziprasidone,,ZIPRASIDONE,https://www.dgidb.org/drugs/rxcui:115698,,DRD2,https://www.dgidb.org/genes/hgnc:3023,,,1813.0,DRD2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
581,1436656,60857,IUPHAR/BPS Guide to PHARMACOLOGY,Zolmitriptan,60,zolmitriptan,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=60,1,5-HT1A receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1,P08908,5-hydroxytryptamine receptor 1A,3350.0,HTR1A,9606.0,Homo sapiens (human),Full agonist,pKi,6.6,PMID:10193663,https://www.ncbi.nlm.nih.gov/pubmed/10193663,10193663,,
582,1436657,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606.0,Homo sapiens (human),Adefovir dipivoxil affects the activity of AHR protein,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
583,1436658,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646.0,AKR1C2,9606.0,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of AKR1C2 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
584,1436659,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,5832,ALDH18A1,https://ctdbase.org/detail.go?type=gene&acc=5832,,,5832.0,ALDH18A1,9606.0,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of ALDH18A1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
585,1436660,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,220,ALDH1A3,https://ctdbase.org/detail.go?type=gene&acc=220,,,220.0,ALDH1A3,9606.0,Homo sapiens (human),Adefovir dipivoxil results in increased expression of ALDH1A3 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
586,1437767,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,11309,SLCO2B1,https://ctdbase.org/detail.go?type=gene&acc=11309,,,11309.0,SLCO2B1,9606.0,Homo sapiens (human),Adefovir dipivoxil results in increased expression of SLCO2B1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
587,1437768,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,60682,SMAP1,https://ctdbase.org/detail.go?type=gene&acc=60682,,,60682.0,SMAP1,9606.0,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of SMAP1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
588,1437769,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,55959,SULF2,https://ctdbase.org/detail.go?type=gene&acc=55959,,,55959.0,SULF2,9606.0,Homo sapiens (human),Adefovir dipivoxil results in increased expression of SULF2 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
589,1437770,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,7067,THRA,https://ctdbase.org/detail.go?type=gene&acc=7067,,,7067.0,THRA,9606.0,Homo sapiens (human),Adefovir dipivoxil binds to and results in decreased activity of THRA protein,,,PMID:25752796,https://www.ncbi.nlm.nih.gov/pubmed/25752796,25752796,,
590,1437771,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,57103,TIGAR,https://ctdbase.org/detail.go?type=gene&acc=57103,,,57103.0,TIGAR,9606.0,Homo sapiens (human),Adefovir dipivoxil results in increased expression of TIGAR mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
591,1437772,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,25976,TIPARP,https://ctdbase.org/detail.go?type=gene&acc=25976,,,25976.0,TIPARP,9606.0,Homo sapiens (human),Adefovir dipivoxil results in increased expression of TIPARP mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
592,1437773,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,9606.0,Homo sapiens (human),Adefovir dipivoxil results in increased expression of TNFRSF10B mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
593,1437774,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,8744,TNFSF9,https://ctdbase.org/detail.go?type=gene&acc=8744,,,8744.0,TNFSF9,9606.0,Homo sapiens (human),Adefovir dipivoxil results in increased expression of TNFSF9 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
594,1358276,60947,Drug Gene Interaction database (DGIdb),Tirofiban,,TIROFIBAN,https://www.dgidb.org/drugs/rxcui:73137,,FGA,https://www.dgidb.org/genes/hgnc:3661,,,2243.0,FGA,9606.0,Homo sapiens (human),,,,,,,,
595,1358277,60953,Drug Gene Interaction database (DGIdb),Capecitabine,,CAPECITABINE,https://www.dgidb.org/drugs/rxcui:194000,,BRAF,https://www.dgidb.org/genes/hgnc:1097,,,673.0,BRAF,9606.0,Homo sapiens (human),,,,,,,,
596,1434346,60953,Comparative Toxicogenomics Database (CTD),Capecitabine,D000069287,Capecitabine,https://ctdbase.org/detail.go?type=chem&acc=D000069287,28401,IGHV4-4,https://ctdbase.org/detail.go?type=gene&acc=28401,,,28401.0,IGHV4-4,9606.0,Homo sapiens (human),Capecitabine results in decreased expression of IGHV4-4 mRNA,,,PMID:36183961,https://www.ncbi.nlm.nih.gov/pubmed/36183961,36183961,,
597,1358278,60961,DrugBank,Adenosine,DB00640,Adenosine,https://www.drugbank.ca/drugs/DB00640,BE0000013,Adenosine receptor A1,https://www.drugbank.ca/bio_entities/BE0000013,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),Agonist,,,PMID:20370662|PMID:20370661|PMID:17321471|PMID:20136829|PMID:17438146|PMID:17442976,https://www.ncbi.nlm.nih.gov/pubmed/20370662|https://www.ncbi.nlm.nih.gov/pubmed/20370661|https://www.ncbi.nlm.nih.gov/pubmed/17321471|https://www.ncbi.nlm.nih.gov/pubmed/20136829|https://www.ncbi.nlm.nih.gov/pubmed/17438146|https://www.ncbi.nlm.nih.gov/pubmed/17442976,20370662|20370661|17321471|20136829|17438146|17442976,,
598,1358279,60961,DrugBank,Adenosine,DB00640,Adenosine,https://www.drugbank.ca/drugs/DB00640,BE0000924,Adenosine receptor A2a,https://www.drugbank.ca/bio_entities/BE0000924,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),Agonist,,,PMID:20370662|PMID:20370661|PMID:17321471|PMID:16339914|PMID:19749080|PMID:20136829|PMID:17438146|PMID:17442976,https://www.ncbi.nlm.nih.gov/pubmed/20370662|https://www.ncbi.nlm.nih.gov/pubmed/20370661|https://www.ncbi.nlm.nih.gov/pubmed/17321471|https://www.ncbi.nlm.nih.gov/pubmed/16339914|https://www.ncbi.nlm.nih.gov/pubmed/19749080|https://www.ncbi.nlm.nih.gov/pubmed/20136829|https://www.ncbi.nlm.nih.gov/pubmed/17438146|https://www.ncbi.nlm.nih.gov/pubmed/17442976,20370662|20370661|17321471|16339914|19749080|20136829|17438146|17442976,,
599,1358280,60961,DrugBank,Adenosine,DB00640,Adenosine,https://www.drugbank.ca/drugs/DB00640,BE0000241,Adenosine receptor A2b,https://www.drugbank.ca/bio_entities/BE0000241,P29275,Adenosine receptor A2b,136.0,ADORA2B,9606.0,Homo sapiens (human),Agonist,,,PMID:20370662|PMID:20370661|PMID:17321471|PMID:16339914|PMID:20136829|PMID:17438146|PMID:17442976,https://www.ncbi.nlm.nih.gov/pubmed/20370662|https://www.ncbi.nlm.nih.gov/pubmed/20370661|https://www.ncbi.nlm.nih.gov/pubmed/17321471|https://www.ncbi.nlm.nih.gov/pubmed/16339914|https://www.ncbi.nlm.nih.gov/pubmed/20136829|https://www.ncbi.nlm.nih.gov/pubmed/17438146|https://www.ncbi.nlm.nih.gov/pubmed/17442976,20370662|20370661|17321471|16339914|20136829|17438146|17442976,,
600,1438383,60961,Comparative Toxicogenomics Database (CTD),Adenosine,D000241,Adenosine,https://ctdbase.org/detail.go?type=chem&acc=D000241,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),"Adenosine inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of TNF protein]|zm 241385 inhibits the reaction [adenosine inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of TNF protein]]|adenosine inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of TNF mrna]|5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine inhibits the reaction [adenosine inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of TNF protein]]",,,PMID:21538184,https://www.ncbi.nlm.nih.gov/pubmed/21538184,21538184,,
601,1438384,60961,Comparative Toxicogenomics Database (CTD),Adenosine,D000241,Adenosine,https://ctdbase.org/detail.go?type=chem&acc=D000241,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),[adenosine co-treated with homocysteine co-treated with TNF protein] results in increased cleavage of RIPK1 protein|[adenosine co-treated with homocysteine] affects the reaction [TNF protein affects the localization of RELA protein modified form]|[adenosine co-treated with homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 mrna]|[adenosine co-treated with homocysteine] inhibits the reaction [TNF protein results in increased expression of CXCL8 mrna]|[adenosine co-treated with homocysteine] results in increased susceptibility to TNF protein|[adenosine co-treated with homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein]|[adenosine co-treated with homocysteine] affects the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]|[adenosine co-treated with homocysteine] affects the reaction [TNF protein results in increased phosphorylation of RELA protein]|[adenosine co-treated with homocysteine] inhibits the reaction [TNF protein results in increased expression of NFKBIA mrna],,,PMID:24224954,https://www.ncbi.nlm.nih.gov/pubmed/24224954,24224954,,
602,1440175,62210,Comparative Toxicogenomics Database (CTD),Flumetralin,C000617134,flumetralin,https://ctdbase.org/detail.go?type=chem&acc=C000617134,317733,ESR2B,https://ctdbase.org/detail.go?type=gene&acc=317733,,,317733.0,esr2b,7955.0,Danio rerio (zebrafish),Flumetralin binds to and results in increased activity of ESR2B protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
603,1440176,62210,Comparative Toxicogenomics Database (CTD),Flumetralin,C000617134,flumetralin,https://ctdbase.org/detail.go?type=chem&acc=C000617134,100174814,ESR2.L,https://ctdbase.org/detail.go?type=gene&acc=100174814,,,100174814.0,esr2.L,8355.0,Xenopus laevis (African clawed frog),Flumetralin binds to and results in increased activity of ESR2.L protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
604,1359963,63009,Comparative Toxicogenomics Database (CTD),Sertraline Hydrochloride,D020280,Sertraline,https://ctdbase.org/detail.go?type=chem&acc=D020280,1392,CRH,https://ctdbase.org/detail.go?type=gene&acc=1392,,,1392.0,CRH,10090.0,Mus musculus (house mouse),[cannabidiol co-treated with sertraline] results in decreased expression of CRH mRNA,,,PMID:34262461,https://www.ncbi.nlm.nih.gov/pubmed/34262461,34262461,,
605,1359964,63009,Comparative Toxicogenomics Database (CTD),Sertraline Hydrochloride,D020280,Sertraline,https://ctdbase.org/detail.go?type=chem&acc=D020280,1409,CRYAA,https://ctdbase.org/detail.go?type=gene&acc=1409,,,1409.0,CRYAA,9606.0,Homo sapiens (human),Sertraline results in increased expression of CRYAA mRNA,,,PMID:24865413,https://www.ncbi.nlm.nih.gov/pubmed/24865413,24865413,,
606,1359965,63009,Comparative Toxicogenomics Database (CTD),Sertraline Hydrochloride,D020280,Sertraline,https://ctdbase.org/detail.go?type=chem&acc=D020280,8454,CUL1,https://ctdbase.org/detail.go?type=gene&acc=8454,,,8454.0,CUL1,9606.0,Homo sapiens (human),Sertraline results in decreased expression of CUL1 mRNA,,,PMID:24865413,https://www.ncbi.nlm.nih.gov/pubmed/24865413,24865413,,
607,1359966,63009,Comparative Toxicogenomics Database (CTD),Sertraline Hydrochloride,D020280,Sertraline,https://ctdbase.org/detail.go?type=chem&acc=D020280,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116.0,Rattus norvegicus (Norway rat),Sertraline results in decreased expression of CYP11A1 mRNA,,,PMID:29850907,https://www.ncbi.nlm.nih.gov/pubmed/29850907,29850907,,
608,1359967,63009,Comparative Toxicogenomics Database (CTD),Sertraline Hydrochloride,D020280,Sertraline,https://ctdbase.org/detail.go?type=chem&acc=D020280,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586.0,CYP17A1,10116.0,Rattus norvegicus (Norway rat),Sertraline results in decreased expression of CYP17A1 mRNA,,,PMID:29850907,https://www.ncbi.nlm.nih.gov/pubmed/29850907,29850907,,
609,1361053,63009,Comparative Toxicogenomics Database (CTD),Sertraline Hydrochloride,D020280,Sertraline,https://ctdbase.org/detail.go?type=chem&acc=D020280,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Sertraline results in decreased expression of PTGS2 mrna|sertraline results in decreased expression of PTGS2 protein,,,PMID:17499975,https://www.ncbi.nlm.nih.gov/pubmed/17499975,17499975,,
610,1361054,63009,Comparative Toxicogenomics Database (CTD),Sertraline Hydrochloride,D020280,Sertraline,https://ctdbase.org/detail.go?type=chem&acc=D020280,9978,RBX1,https://ctdbase.org/detail.go?type=gene&acc=9978,,,9978.0,RBX1,9606.0,Homo sapiens (human),Sertraline results in decreased expression of RBX1 mRNA,,,PMID:24865413,https://www.ncbi.nlm.nih.gov/pubmed/24865413,24865413,,
611,1361055,63009,Comparative Toxicogenomics Database (CTD),Sertraline Hydrochloride,D020280,Sertraline,https://ctdbase.org/detail.go?type=chem&acc=D020280,5971,RELB,https://ctdbase.org/detail.go?type=gene&acc=5971,,,5971.0,RELB,9606.0,Homo sapiens (human),Sertraline results in increased expression of RELB mRNA,,,PMID:24865413,https://www.ncbi.nlm.nih.gov/pubmed/24865413,24865413,,
612,1361056,63009,Comparative Toxicogenomics Database (CTD),Sertraline Hydrochloride,D020280,Sertraline,https://ctdbase.org/detail.go?type=chem&acc=D020280,7844,RNF103,https://ctdbase.org/detail.go?type=gene&acc=7844,,,7844.0,RNF103,10116.0,Rattus norvegicus (Norway rat),Sertraline results in increased expression of RNF103 mRNA,,,PMID:11071867,https://www.ncbi.nlm.nih.gov/pubmed/11071867,11071867,,
613,1361057,63009,Comparative Toxicogenomics Database (CTD),Sertraline Hydrochloride,D020280,Sertraline,https://ctdbase.org/detail.go?type=chem&acc=D020280,6197,RPS6KA3,https://ctdbase.org/detail.go?type=gene&acc=6197,,,6197.0,RPS6KA3,9606.0,Homo sapiens (human),Sertraline results in decreased expression of RPS6KA3 mRNA,,,PMID:24865413,https://www.ncbi.nlm.nih.gov/pubmed/24865413,24865413,,
614,1361058,63009,Comparative Toxicogenomics Database (CTD),Sertraline Hydrochloride,D020280,Sertraline,https://ctdbase.org/detail.go?type=chem&acc=D020280,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198.0,RPS6KB1,9606.0,Homo sapiens (human),Sertraline results in decreased phosphorylation of RPS6KB1 protein|vdac1 protein affects the reaction [sertraline results in decreased phosphorylation of RPS6KB1 protein],,,PMID:33124469,https://www.ncbi.nlm.nih.gov/pubmed/33124469,33124469,,
615,1351437,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,2829,XCR1,https://ctdbase.org/detail.go?type=gene&acc=2829,,,2829.0,XCR1,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of XCR1 mRNA",,,PMID:32119087,https://www.ncbi.nlm.nih.gov/pubmed/32119087,32119087,,
616,1351438,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,10090.0,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of XDH mRNA",,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
617,1351439,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,10116.0,Rattus norvegicus (Norway rat),"AHR gene mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of XDH mrna]|3,4,5,3',4'-pentachlorobiphenyl results in increased expression of XDH mRNA",,,PMID:34256052,https://www.ncbi.nlm.nih.gov/pubmed/34256052,34256052,,
618,1351440,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,108179076,XKR6A,https://ctdbase.org/detail.go?type=gene&acc=108179076,,,108179076.0,xkr6a,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of XKR6A mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
619,1351441,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,7507,XPA,https://ctdbase.org/detail.go?type=gene&acc=7507,,,7507.0,XPA,9606.0,Homo sapiens (human),"[3,4,5,3',4'-pentachlorobiphenyl co-treated with benzo(a)pyrene] results in decreased expression of XPA protein|3,4,5,3',4'-pentachlorobiphenyl results in increased expression of XPA protein",,,PMID:19553035,https://www.ncbi.nlm.nih.gov/pubmed/19553035,19553035,,
620,1352823,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,243085,UGT2B35,https://ctdbase.org/detail.go?type=gene&acc=243085,,,243085.0,Ugt2b35,10090.0,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of UGT2B35 mRNA",,,PMID:19144771,https://www.ncbi.nlm.nih.gov/pubmed/19144771,19144771,,
621,1352824,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,29128,UHRF1,https://ctdbase.org/detail.go?type=gene&acc=29128,,,29128.0,UHRF1,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of UHRF1 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
622,1352825,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,90249,UNC5A,https://ctdbase.org/detail.go?type=gene&acc=90249,,,90249.0,UNC5A,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of UNC5A mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
623,1352826,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,285175,UNC80,https://ctdbase.org/detail.go?type=gene&acc=285175,,,285175.0,UNC80,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of UNC80 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
624,1364420,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,116988,AGAP3,https://ctdbase.org/detail.go?type=gene&acc=116988,,,116988.0,AGAP3,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of AGAP3 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
625,1364421,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,185,AGTR1,https://ctdbase.org/detail.go?type=gene&acc=185,,,185.0,AGTR1,9606.0,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of AGTR1 mRNA",,,PMID:14962509,https://www.ncbi.nlm.nih.gov/pubmed/14962509,14962509,,
626,1364422,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,27245,AHDC1,https://ctdbase.org/detail.go?type=gene&acc=27245,,,27245.0,AHDC1,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of AHDC1 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
627,1364423,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,54806,AHI1,https://ctdbase.org/detail.go?type=gene&acc=54806,,,54806.0,AHI1,10116.0,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of AHI1 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
628,1364424,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,79026,AHNAK,https://ctdbase.org/detail.go?type=gene&acc=79026,,,79026.0,AHNAK,7955.0,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of AHNAK mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
629,1364886,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10116.0,Rattus norvegicus (Norway rat),"AHR affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PCK1 mrna]",,,PMID:26396156,https://www.ncbi.nlm.nih.gov/pubmed/26396156,26396156,,
630,1353314,63106,Toxin and Toxin Target Database (T3DB),"2,2',4,6'-Tetrachlorobiphenyl",T3D0440,"2,2',4,6'-Tetrachlorobiphenyl",http://www.t3db.ca/toxins/T3D0440,BE0004289,Uteroglobin,http://www.t3db.ca/biodb/bio_entities/BE0004289,P11684,Uteroglobin,7356.0,SCGB1A1,9606.0,Homo sapiens (human),Pcbs will bioaccumulate by binding to receptor proteins such as uteroglobin. (A30),,,PMID:11205532,https://www.ncbi.nlm.nih.gov/pubmed/11205532,11205532,,
631,1353315,63108,Toxin and Toxin Target Database (T3DB),"2,2',3,6-Tetrachlorobiphenyl",T3D0434,"2,2',3,6-Tetrachlorobiphenyl",http://www.t3db.ca/toxins/T3D0434,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
632,1353316,63108,Toxin and Toxin Target Database (T3DB),"2,2',3,6-Tetrachlorobiphenyl",T3D0434,"2,2',3,6-Tetrachlorobiphenyl",http://www.t3db.ca/toxins/T3D0434,BE0000792,Estrogen receptor beta,http://www.t3db.ca/biodb/bio_entities/BE0000792,Q92731,Estrogen receptor beta,2100.0,ESR2,9606.0,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
633,1436816,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0001371,Cyclomaltodextrin glucanotransferase,https://www.drugbank.ca/bio_entities/BE0001371,P05618,Cyclomaltodextrin glucanotransferase,,,1410.0,Bacillus sp. 1011,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
634,1436817,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0001539,Endoglucanase G,https://www.drugbank.ca/bio_entities/BE0001539,P37700,Endoglucanase G,,,394503.0,Ruminiclostridium cellulolyticum H10,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
635,1437077,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0001698,Maltodextrin phosphorylase,https://www.drugbank.ca/bio_entities/BE0001698,P00490,Maltodextrin phosphorylase,75202260.0,,83333.0,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
636,1437078,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0001772,Shiga-like toxin 1 subunit B,https://www.drugbank.ca/bio_entities/BE0001772,P69178,Shiga-like toxin 1 subunit B,,,12371.0,Phage h30,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
637,1437079,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0004512,Neurocan core protein,https://www.drugbank.ca/bio_entities/BE0004512,O14594,Neurocan core protein,1463.0,NCAN,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
638,1437080,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0001654,Beta-glucanase,https://www.drugbank.ca/bio_entities/BE0001654,P23904,Beta-glucanase,,,44252.0,Paenibacillus macerans,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
639,1437195,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0001996,Maltose-binding periplasmic protein,https://www.drugbank.ca/bio_entities/BE0001996,P0AEX9,Maltose/maltodextrin-binding periplasmic protein,948538.0,malE,83333.0,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
640,1437196,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0002006,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,https://www.drugbank.ca/bio_entities/BE0002006,P0AEK4,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,83576489.0,,83333.0,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
641,1437197,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0002017,Endoglucanase A,https://www.drugbank.ca/bio_entities/BE0002017,P0C2S2,Endoglucanase A,,,1515.0,Acetivibrio thermocellus,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
642,1437198,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0002059,"Cellulose 1,4-beta-cellobiosidase (reducing end) CelS",https://www.drugbank.ca/bio_entities/BE0002059,P0C2S5,"Cellulose 1,4-beta-cellobiosidase (reducing end) CelS",,,1515.0,Acetivibrio thermocellus,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
643,1437199,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0002058,D-galactose-binding periplasmic protein,https://www.drugbank.ca/bio_entities/BE0002058,P0AEE5,D-galactose-binding periplasmic protein,83580249.0,,83333.0,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
644,1437200,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0002078,Aspartate ammonia-lyase,https://www.drugbank.ca/bio_entities/BE0002078,P0AC38,Aspartate ammonia-lyase,948658.0,aspA,83333.0,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
645,1437201,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0002735,Glucokinase,https://www.drugbank.ca/bio_entities/BE0002735,P0A6V8,Glucokinase,75202543.0,,83333.0,Escherichia coli K-12,,,,,,,,
646,1437202,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0002737,BH0236 protein,https://www.drugbank.ca/bio_entities/BE0002737,Q9KG76,"Glucan endo-1,3-beta-D-glucosidase",,,272558.0,Alkalihalobacillus halodurans C-125,,,,,,,,
647,1437203,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0002739,"Endo-1,4-beta-xylanase A",https://www.drugbank.ca/bio_entities/BE0002739,Q8GJ44,"Endo-1,4-beta-xylanase A",,,1510.0,Thermoclostridium stercorarium,,,,,,,,
648,1437326,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0004492,Keratin-associated protein 5-2,https://www.drugbank.ca/bio_entities/BE0004492,Q701N4,Keratin-associated protein 5-2,440021.0,KRTAP5-2,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
649,1437327,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0004592,Sialoadhesin,https://www.drugbank.ca/bio_entities/BE0004592,Q9BZZ2,Sialoadhesin,6614.0,SIGLEC1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
650,1437328,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0003243,Neopullulanase,https://www.drugbank.ca/bio_entities/BE0003243,P38940,Neopullulanase,,,1422.0,Geobacillus stearothermophilus,,,,,,,,
651,1437329,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0003244,"Endo-1,4-beta-xylanase A",https://www.drugbank.ca/bio_entities/BE0003244,Q60037,"Endo-1,4-beta-xylanase A",,,243274.0,Thermotoga maritima MSB8,,,,,,,,
652,1437330,64689,DrugBank,beta-D-glucopyranose,DB02379,Beta-D-Glucose,https://www.drugbank.ca/drugs/DB02379,BE0003245,Maltoporin,https://www.drugbank.ca/bio_entities/BE0003245,P26466,Maltoporin,1255757.0,lamB,99287.0,Salmonella enterica subsp. enterica serovar Typhimurium str. LT2,,,,,,,,
653,1439286,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,100499526,MIR3472,https://ctdbase.org/detail.go?type=gene&acc=100499526,,,100499526.0,Mir3472,10090.0,Mus musculus (house mouse),Ginkgo biloba extract results in decreased expression of MIR3472 mRNA,,,PMID:32306082,https://www.ncbi.nlm.nih.gov/pubmed/32306082,32306082,,
654,1439287,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,723855,MIR376A,https://ctdbase.org/detail.go?type=gene&acc=723855,,,723855.0,Mir376a,10090.0,Mus musculus (house mouse),Ginkgo biloba extract results in increased expression of MIR376A mRNA,,,PMID:32306082,https://www.ncbi.nlm.nih.gov/pubmed/32306082,32306082,,
655,1439288,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,574435,MIR376B,https://ctdbase.org/detail.go?type=gene&acc=574435,,,574435.0,MIR376B,10090.0,Mus musculus (house mouse),Ginkgo biloba extract results in increased expression of MIR376B mRNA,,,PMID:32306082,https://www.ncbi.nlm.nih.gov/pubmed/32306082,32306082,,
656,1439656,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,100039089,MUP13,https://ctdbase.org/detail.go?type=gene&acc=100039089,,,100039089.0,Mup13,10090.0,Mus musculus (house mouse),Ginkgo biloba extract results in decreased expression of MUP13 mrna|ginkgo biloba extract results in increased methylation of MUP13 promoter,,,PMID:31278416,https://www.ncbi.nlm.nih.gov/pubmed/31278416,31278416,,
657,1439657,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,100189605,MUP19,https://ctdbase.org/detail.go?type=gene&acc=100189605,,,100189605.0,Mup19,10090.0,Mus musculus (house mouse),Ginkgo biloba extract results in increased methylation of MUP19 promoter|ginkgo biloba extract results in decreased expression of MUP19 mRNA,,,PMID:31278416,https://www.ncbi.nlm.nih.gov/pubmed/31278416,31278416,,
658,1439658,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,17841,MUP2,https://ctdbase.org/detail.go?type=gene&acc=17841,,,17841.0,Mup2,10090.0,Mus musculus (house mouse),Ginkgo biloba extract results in decreased expression of MUP2 mRNA,,,PMID:31278416,https://www.ncbi.nlm.nih.gov/pubmed/31278416,31278416,,
659,1439659,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,17842,MUP3,https://ctdbase.org/detail.go?type=gene&acc=17842,,,17842.0,Mup3,10090.0,Mus musculus (house mouse),Ginkgo biloba extract results in decreased expression of MUP3 mRNA,,,PMID:31278416,https://www.ncbi.nlm.nih.gov/pubmed/31278416,31278416,,
660,1439772,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,4734,NEDD4,https://ctdbase.org/detail.go?type=gene&acc=4734,,,4734.0,NEDD4,10090.0,Mus musculus (house mouse),Ginkgo biloba extract results in increased methylation of NEDD4 promoter,,,PMID:31278416,https://www.ncbi.nlm.nih.gov/pubmed/31278416,31278416,,
661,1439773,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10090.0,Mus musculus (house mouse),Ginkgo biloba extract inhibits the reaction [lipopolysaccharides results in increased localization of NFKB1 protein]|ginkgo biloba extract inhibits the reaction [lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]|ginkgo biloba extract inhibits the reaction [lipopolysaccharides results in increased activity of [NFKB1 protein binds to NFKB1 protein]],,,PMID:11543732,https://www.ncbi.nlm.nih.gov/pubmed/11543732,11543732,,
662,1354470,64971,Comparative Toxicogenomics Database (CTD),Betulinic Acid,D000094062,Betulinic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000094062,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),Betulinic acid analog results in decreased expression of CCND1 protein,,,PMID:28254521,https://www.ncbi.nlm.nih.gov/pubmed/28254521,28254521,,
663,1354471,64971,Comparative Toxicogenomics Database (CTD),Betulinic Acid,D000094062,Betulinic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000094062,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),[betulinic acid co-treated with oxygen deficiency] results in decreased expression of CCND1 protein|betulinic acid results in decreased expression of CCND1 protein,,,PMID:33181113,https://www.ncbi.nlm.nih.gov/pubmed/33181113,33181113,,
664,1441412,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7318,UBA7,https://ctdbase.org/detail.go?type=gene&acc=7318,,,7318.0,UBA7,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of UBA7 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
665,1441413,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,283991,UBALD2,https://ctdbase.org/detail.go?type=gene&acc=283991,,,283991.0,UBALD2,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of UBALD2 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
666,1441414,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,51619,UBE2D4,https://ctdbase.org/detail.go?type=gene&acc=51619,,,51619.0,UBE2D4,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of UBE2D4 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
667,1441415,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,9246,UBE2L6,https://ctdbase.org/detail.go?type=gene&acc=9246,,,9246.0,UBE2L6,9606.0,Homo sapiens (human),Epigallocatechin gallate results in decreased expression of UBE2L6 mRNA,,,PMID:32512070,https://www.ncbi.nlm.nih.gov/pubmed/32512070,32512070,,
668,1441416,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,92912,UBE2Q2,https://ctdbase.org/detail.go?type=gene&acc=92912,,,92912.0,UBE2Q2,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of UBE2Q2 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
669,1441417,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,65264,UBE2Z,https://ctdbase.org/detail.go?type=gene&acc=65264,,,65264.0,UBE2Z,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of UBE2Z mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
670,1443288,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,25888,ZNF473,https://ctdbase.org/detail.go?type=gene&acc=25888,,,25888.0,ZNF473,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of ZNF473 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
671,1443289,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,220992,ZNF485,https://ctdbase.org/detail.go?type=gene&acc=220992,,,220992.0,ZNF485,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of ZNF485 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
672,1444658,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,692085,SNORD45C,https://ctdbase.org/detail.go?type=gene&acc=692085,,,692085.0,SNORD45C,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD45C mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
673,1444659,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,26800,SNORD49A,https://ctdbase.org/detail.go?type=gene&acc=26800,,,26800.0,SNORD49A,9606.0,Homo sapiens (human),Epigallocatechin gallate results in decreased expression of SNORD49A mrna|[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD49A mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
674,1444660,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,692087,SNORD49B,https://ctdbase.org/detail.go?type=gene&acc=692087,,,692087.0,SNORD49B,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD49B mrna|epigallocatechin gallate results in decreased expression of SNORD49B mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
675,1444661,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,26773,SNORD4A,https://ctdbase.org/detail.go?type=gene&acc=26773,,,26773.0,SNORD4A,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD4A mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
676,1444662,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,26772,SNORD4B,https://ctdbase.org/detail.go?type=gene&acc=26772,,,26772.0,SNORD4B,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD4B mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
677,1444663,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,26799,SNORD50A,https://ctdbase.org/detail.go?type=gene&acc=26799,,,26799.0,SNORD50A,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD50A mrna|epigallocatechin gallate results in decreased expression of SNORD50A mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
678,1444664,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,692088,SNORD50B,https://ctdbase.org/detail.go?type=gene&acc=692088,,,692088.0,SNORD50B,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD50B mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
679,1444665,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,26798,SNORD51,https://ctdbase.org/detail.go?type=gene&acc=26798,,,26798.0,SNORD51,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD51 mrna|epigallocatechin gallate results in decreased expression of SNORD51 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
680,1444666,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,26796,SNORD53,https://ctdbase.org/detail.go?type=gene&acc=26796,,,26796.0,SNORD53,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD53 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
681,1445155,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116.0,Rattus norvegicus (Norway rat),[1-methyl-4-phenylpyridinium co-treated with epigallocatechin gallate] results in increased expression of SOD1 mRNA,,,PMID:22742579,https://www.ncbi.nlm.nih.gov/pubmed/22742579,22742579,,
682,1445156,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116.0,Rattus norvegicus (Norway rat),Epigallocatechin gallate inhibits the reaction [acrylamide results in decreased activity of SOD1 protein],,,PMID:28056603,https://www.ncbi.nlm.nih.gov/pubmed/28056603,28056603,,
683,1445872,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,57559,STAMBPL1,https://ctdbase.org/detail.go?type=gene&acc=57559,,,57559.0,STAMBPL1,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of STAMBPL1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
684,1445873,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,90627,STARD13,https://ctdbase.org/detail.go?type=gene&acc=90627,,,90627.0,STARD13,9606.0,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of STARD13 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
685,1445874,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,9606.0,Homo sapiens (human),Epigallocatechin gallate results in decreased expression of STAT1 mRNA,,,PMID:32512070,https://www.ncbi.nlm.nih.gov/pubmed/32512070,32512070,,
686,1357659,65126,Comparative Toxicogenomics Database (CTD),Carnosic acid,C018381,salvin,https://ctdbase.org/detail.go?type=chem&acc=C018381,2962,GTF2F1,https://ctdbase.org/detail.go?type=gene&acc=2962,,,2962.0,GTF2F1,10090.0,Mus musculus (house mouse),Salvin results in decreased expression of GTF2F1 protein,,,PMID:35926579,https://www.ncbi.nlm.nih.gov/pubmed/35926579,35926579,,
687,1357660,65126,Comparative Toxicogenomics Database (CTD),Carnosic acid,C018381,salvin,https://ctdbase.org/detail.go?type=chem&acc=C018381,3158,HMGCS2,https://ctdbase.org/detail.go?type=gene&acc=3158,,,3158.0,HMGCS2,10090.0,Mus musculus (house mouse),Salvin results in decreased expression of HMGCS2 protein,,,PMID:35926579,https://www.ncbi.nlm.nih.gov/pubmed/35926579,35926579,,
688,1357661,65126,Comparative Toxicogenomics Database (CTD),Carnosic acid,C018381,salvin,https://ctdbase.org/detail.go?type=chem&acc=C018381,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Salvin results in increased expression of HMOX1 protein|nfe2l2 protein promotes the reaction [salvin results in increased expression of HMOX1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin results in increased expression of HMOX1 protein],,,PMID:26686574,https://www.ncbi.nlm.nih.gov/pubmed/26686574,26686574,,
689,1441729,66011,Comparative Toxicogenomics Database (CTD),4-Nitrobenzyl bromide,C027563,4-nitrobenzyl bromide,https://ctdbase.org/detail.go?type=chem&acc=C027563,3310,HSPA6,https://ctdbase.org/detail.go?type=gene&acc=3310,,,3310.0,HSPA6,9606.0,Homo sapiens (human),4-nitrobenzyl bromide results in increased expression of HSPA6 mRNA,,,PMID:23999411,https://www.ncbi.nlm.nih.gov/pubmed/23999411,23999411,,
690,1441730,66011,Comparative Toxicogenomics Database (CTD),4-Nitrobenzyl bromide,C027563,4-nitrobenzyl bromide,https://ctdbase.org/detail.go?type=chem&acc=C027563,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606.0,IL18,9606.0,Homo sapiens (human),4-nitrobenzyl bromide results in increased expression of IL18 protein,,,PMID:23063874,https://www.ncbi.nlm.nih.gov/pubmed/23063874,23063874,,
691,1441731,66011,Comparative Toxicogenomics Database (CTD),4-Nitrobenzyl bromide,C027563,4-nitrobenzyl bromide,https://ctdbase.org/detail.go?type=chem&acc=C027563,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9606.0,Homo sapiens (human),4-nitrobenzyl bromide results in increased expression of IL1A mRNA,,,PMID:33715048,https://www.ncbi.nlm.nih.gov/pubmed/33715048,33715048,,
692,1359957,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,55324,ABCF3,https://ctdbase.org/detail.go?type=gene&acc=55324,,,55324.0,ABCF3,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ABCF3 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
693,1359958,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,55347,ABHD10,https://ctdbase.org/detail.go?type=gene&acc=55347,,,55347.0,ABHD10,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ABHD10 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
694,1359959,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,116236,ABHD15,https://ctdbase.org/detail.go?type=gene&acc=116236,,,116236.0,ABHD15,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ABHD15 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
695,1359960,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,51099,ABHD5,https://ctdbase.org/detail.go?type=gene&acc=51099,,,51099.0,ABHD5,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ABHD5 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
696,1359961,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,30,ACAA1,https://ctdbase.org/detail.go?type=gene&acc=30,,,30.0,ACAA1,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ACAA1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
697,1359962,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,10449,ACAA2,https://ctdbase.org/detail.go?type=gene&acc=10449,,,10449.0,ACAA2,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ACAA2 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
698,1361048,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,301,ANXA1,https://ctdbase.org/detail.go?type=gene&acc=301,,,301.0,ANXA1,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ANXA1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
699,1361049,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,311,ANXA11,https://ctdbase.org/detail.go?type=gene&acc=311,,,311.0,ANXA11,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ANXA11 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
700,1361050,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,302,ANXA2,https://ctdbase.org/detail.go?type=gene&acc=302,,,302.0,ANXA2,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ANXA2 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
701,1361051,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,307,ANXA4,https://ctdbase.org/detail.go?type=gene&acc=307,,,307.0,ANXA4,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ANXA4 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
702,1361052,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,309,ANXA6,https://ctdbase.org/detail.go?type=gene&acc=309,,,309.0,ANXA6,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ANXA6 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
703,1361885,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,515,ATP5PB,https://ctdbase.org/detail.go?type=gene&acc=515,,,515.0,ATP5PB,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ATP5PB protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
704,1361886,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,539,ATP5PO,https://ctdbase.org/detail.go?type=gene&acc=539,,,539.0,ATP5PO,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ATP5PO protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
705,1361887,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,527,ATP6V0C,https://ctdbase.org/detail.go?type=gene&acc=527,,,527.0,ATP6V0C,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ATP6V0C protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
706,1361888,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,9114,ATP6V0D1,https://ctdbase.org/detail.go?type=gene&acc=9114,,,9114.0,ATP6V0D1,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ATP6V0D1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
707,1361889,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,523,ATP6V1A,https://ctdbase.org/detail.go?type=gene&acc=523,,,523.0,ATP6V1A,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ATP6V1A protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
708,1361890,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,529,ATP6V1E1,https://ctdbase.org/detail.go?type=gene&acc=529,,,529.0,ATP6V1E1,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ATP6V1E1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
709,1361891,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,6311,ATXN2,https://ctdbase.org/detail.go?type=gene&acc=6311,,,6311.0,ATXN2,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of ATXN2 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
710,1361892,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,567,B2M,https://ctdbase.org/detail.go?type=gene&acc=567,,,567.0,B2M,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of B2M protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
711,1361893,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,29086,BABAM1,https://ctdbase.org/detail.go?type=gene&acc=29086,,,29086.0,BABAM1,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of BABAM1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
712,1362243,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,8913,CACNA1G,https://ctdbase.org/detail.go?type=gene&acc=8913,,,8913.0,CACNA1G,7955.0,Danio rerio (zebrafish),"[bisphenol A co-treated with bisphenol B co-treated with bisphenol F co-treated with 4,4'-hexafluorisopropylidene diphenol] results in decreased expression of CACNA1G mRNA",,,PMID:37418940,https://www.ncbi.nlm.nih.gov/pubmed/37418940,37418940,,
713,1362244,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,781,CACNA2D1,https://ctdbase.org/detail.go?type=gene&acc=781,,,781.0,CACNA2D1,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of CACNA2D1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
714,1362245,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,27101,CACYBP,https://ctdbase.org/detail.go?type=gene&acc=27101,,,27101.0,CACYBP,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of CACYBP protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
715,1362970,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10116.0,Rattus norvegicus (Norway rat),Bisphenol B results in increased expression of CDK2 mrna|bisphenol B results in increased expression of CDK2 protein,,,PMID:33940105,https://www.ncbi.nlm.nih.gov/pubmed/33940105,33940105,,
716,1362971,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,10116.0,Rattus norvegicus (Norway rat),Bisphenol B results in increased expression of CDK4 protein|bisphenol B results in increased expression of CDK4 mRNA,,,PMID:33940105,https://www.ncbi.nlm.nih.gov/pubmed/33940105,33940105,,
717,1362972,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,80279,CDK5RAP3,https://ctdbase.org/detail.go?type=gene&acc=80279,,,80279.0,CDK5RAP3,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of CDK5RAP3 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
718,1362973,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1031,CDKN2C,https://ctdbase.org/detail.go?type=gene&acc=1031,,,1031.0,CDKN2C,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of CDKN2C protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
719,1362974,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,55573,CDV3,https://ctdbase.org/detail.go?type=gene&acc=55573,,,55573.0,CDV3,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of CDV3 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
720,1362975,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,9606.0,Homo sapiens (human),Bisphenol B results in decreased expression of CEBPA mRNA,,,PMID:32387340,https://www.ncbi.nlm.nih.gov/pubmed/32387340,32387340,,
721,1362976,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,9606.0,Homo sapiens (human),Bisphenol B results in decreased expression of CEBPB mRNA,,,PMID:32387340,https://www.ncbi.nlm.nih.gov/pubmed/32387340,32387340,,
722,1363699,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1382,CRABP2,https://ctdbase.org/detail.go?type=gene&acc=1382,,,1382.0,CRABP2,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of CRABP2 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
723,1363700,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1384,CRAT,https://ctdbase.org/detail.go?type=gene&acc=1384,,,1384.0,CRAT,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of CRAT protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
724,1363701,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10116.0,Rattus norvegicus (Norway rat),Bisphenol B results in increased acetylation of CREB1 protein,,,PMID:31332466,https://www.ncbi.nlm.nih.gov/pubmed/31332466,31332466,,
725,1363702,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1399,CRKL,https://ctdbase.org/detail.go?type=gene&acc=1399,,,1399.0,CRKL,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of CRKL protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
726,1363703,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1429,CRYZ,https://ctdbase.org/detail.go?type=gene&acc=1429,,,1429.0,CRYZ,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of CRYZ protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
727,1363704,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1431,CS,https://ctdbase.org/detail.go?type=gene&acc=1431,,,1431.0,CS,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of CS protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
728,1363705,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,51380,CSAD,https://ctdbase.org/detail.go?type=gene&acc=51380,,,51380.0,CSAD,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of CSAD protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
729,1363706,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1434,CSE1L,https://ctdbase.org/detail.go?type=gene&acc=1434,,,1434.0,CSE1L,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of CSE1L protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
730,1363707,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1457,CSNK2A1,https://ctdbase.org/detail.go?type=gene&acc=1457,,,1457.0,CSNK2A1,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of CSNK2A1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
731,1364415,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,51635,DHRS7,https://ctdbase.org/detail.go?type=gene&acc=51635,,,51635.0,DHRS7,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of DHRS7 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
732,1364416,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,25979,DHRS7B,https://ctdbase.org/detail.go?type=gene&acc=25979,,,25979.0,DHRS7B,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of DHRS7B protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
733,1364417,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1665,DHX15,https://ctdbase.org/detail.go?type=gene&acc=1665,,,1665.0,DHX15,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of DHX15 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
734,1364418,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,56616,DIABLO,https://ctdbase.org/detail.go?type=gene&acc=56616,,,56616.0,DIABLO,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of DIABLO protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
735,1364419,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1733,DIO1,https://ctdbase.org/detail.go?type=gene&acc=1733,,,1733.0,DIO1,10116.0,Rattus norvegicus (Norway rat),Bisphenol B results in increased expression of DIO1 mRNA,,,PMID:28167136,https://www.ncbi.nlm.nih.gov/pubmed/28167136,28167136,,
736,1364887,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1915,EEF1A1,https://ctdbase.org/detail.go?type=gene&acc=1915,,,1915.0,EEF1A1,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of EEF1A1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
737,1364888,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,100526837,EEF1E1-BLOC1S5,https://ctdbase.org/detail.go?type=gene&acc=100526837,,,100526837.0,EEF1E1-BLOC1S5,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of EEF1E1-BLOC1S5 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
738,1364889,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1938,EEF2,https://ctdbase.org/detail.go?type=gene&acc=1938,,,1938.0,EEF2,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of EEF2 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
739,1364890,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,399665,EEIG1,https://ctdbase.org/detail.go?type=gene&acc=399665,,,399665.0,EEIG1,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of EEIG1 mRNA,,,PMID:32387340,https://www.ncbi.nlm.nih.gov/pubmed/32387340,32387340,,
740,1364891,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,9343,EFTUD2,https://ctdbase.org/detail.go?type=gene&acc=9343,,,9343.0,EFTUD2,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of EFTUD2 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
741,1364892,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,23301,EHBP1,https://ctdbase.org/detail.go?type=gene&acc=23301,,,23301.0,EHBP1,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of EHBP1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
742,1364893,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,10938,EHD1,https://ctdbase.org/detail.go?type=gene&acc=10938,,,10938.0,EHD1,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of EHD1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
743,1364894,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,30846,EHD2,https://ctdbase.org/detail.go?type=gene&acc=30846,,,30846.0,EHD2,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of EHD2 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
744,1364895,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,1964,EIF1AX,https://ctdbase.org/detail.go?type=gene&acc=1964,,,1964.0,EIF1AX,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of EIF1AX protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
745,1364896,66166,Comparative Toxicogenomics Database (CTD),Bisphenol B,C492482,bisphenol B,https://ctdbase.org/detail.go?type=chem&acc=C492482,83939,EIF2A,https://ctdbase.org/detail.go?type=gene&acc=83939,,,83939.0,EIF2A,9606.0,Homo sapiens (human),Bisphenol B results in increased expression of EIF2A protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
746,1353130,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,23158,TBC1D9,https://ctdbase.org/detail.go?type=gene&acc=23158,,,23158.0,TBC1D9,10090.0,Mus musculus (house mouse),Perfluorohexanesulfonic acid results in decreased expression of TBC1D9 mRNA,,,PMID:37995155,https://www.ncbi.nlm.nih.gov/pubmed/37995155,37995155,,
747,1353131,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,6905,TBCE,https://ctdbase.org/detail.go?type=gene&acc=6905,,,6905.0,TBCE,10090.0,Mus musculus (house mouse),Perfluorohexanesulfonic acid results in increased expression of TBCE mRNA,,,PMID:37995155,https://www.ncbi.nlm.nih.gov/pubmed/37995155,37995155,,
748,1353132,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,100039542,TBX3OS1,https://ctdbase.org/detail.go?type=gene&acc=100039542,,,100039542.0,Tbx3os1,10090.0,Mus musculus (house mouse),Perfluorohexanesulfonic acid results in decreased expression of TBX3OS1 mRNA,,,PMID:37995155,https://www.ncbi.nlm.nih.gov/pubmed/37995155,37995155,,
749,1353133,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,9747,TCAF1,https://ctdbase.org/detail.go?type=gene&acc=9747,,,9747.0,TCAF1,10090.0,Mus musculus (house mouse),Perfluorohexanesulfonic acid results in increased expression of TCAF1 mRNA,,,PMID:37995155,https://www.ncbi.nlm.nih.gov/pubmed/37995155,37995155,,
750,1353134,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,6920,TCEA3,https://ctdbase.org/detail.go?type=gene&acc=6920,,,6920.0,TCEA3,9606.0,Homo sapiens (human),Perfluorohexanesulfonic acid results in decreased expression of TCEA3 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
751,1353135,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,90843,TCEAL8,https://ctdbase.org/detail.go?type=gene&acc=90843,,,90843.0,TCEAL8,10090.0,Mus musculus (house mouse),Perfluorohexanesulfonic acid results in increased expression of TCEAL8 mRNA,,,PMID:37995155,https://www.ncbi.nlm.nih.gov/pubmed/37995155,37995155,,
752,1353136,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,10915,TCERG1,https://ctdbase.org/detail.go?type=gene&acc=10915,,,10915.0,TCERG1,10090.0,Mus musculus (house mouse),Perfluorohexanesulfonic acid results in decreased expression of TCERG1 mRNA,,,PMID:37995155,https://www.ncbi.nlm.nih.gov/pubmed/37995155,37995155,,
753,1353137,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,6941,TCF19,https://ctdbase.org/detail.go?type=gene&acc=6941,,,6941.0,TCF19,10090.0,Mus musculus (house mouse),Perfluorohexanesulfonic acid results in increased expression of TCF19 mRNA,,,PMID:37995155,https://www.ncbi.nlm.nih.gov/pubmed/37995155,37995155,,
754,1353640,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,9967,THRAP3,https://ctdbase.org/detail.go?type=gene&acc=9967,,,9967.0,THRAP3,10090.0,Mus musculus (house mouse),Perfluorohexanesulfonic acid results in decreased expression of THRAP3 mRNA,,,PMID:37995155,https://www.ncbi.nlm.nih.gov/pubmed/37995155,37995155,,
755,1353641,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,221981,THSD7A,https://ctdbase.org/detail.go?type=gene&acc=221981,,,221981.0,THSD7A,10090.0,Mus musculus (house mouse),Perfluorohexanesulfonic acid results in increased expression of THSD7A mRNA,,,PMID:37995155,https://www.ncbi.nlm.nih.gov/pubmed/37995155,37995155,,
756,1353642,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,7074,TIAM1,https://ctdbase.org/detail.go?type=gene&acc=7074,,,7074.0,TIAM1,10090.0,Mus musculus (house mouse),Perfluorohexanesulfonic acid results in decreased expression of TIAM1 mRNA,,,PMID:37995155,https://www.ncbi.nlm.nih.gov/pubmed/37995155,37995155,,
757,1357486,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,57335,ZNF286A,https://ctdbase.org/detail.go?type=gene&acc=57335,,,57335.0,ZNF286A,9606.0,Homo sapiens (human),Perfluorohexanesulfonic acid results in decreased expression of ZNF286A mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
758,1357487,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,26152,ZNF337,https://ctdbase.org/detail.go?type=gene&acc=26152,,,26152.0,ZNF337,9606.0,Homo sapiens (human),Perfluorohexanesulfonic acid results in decreased expression of ZNF337 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
759,1357488,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,70005,ZNF41-PS,https://ctdbase.org/detail.go?type=gene&acc=70005,,,70005.0,Znf41-ps,10090.0,Mus musculus (house mouse),Perfluorohexanesulfonic acid results in decreased expression of ZNF41-PS mRNA,,,PMID:37995155,https://www.ncbi.nlm.nih.gov/pubmed/37995155,37995155,,
760,1357489,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,374900,ZNF568,https://ctdbase.org/detail.go?type=gene&acc=374900,,,374900.0,ZNF568,9913.0,Bos taurus (cattle),Perfluorohexanesulfonic acid results in decreased expression of ZNF568 mRNA,,,PMID:35219833,https://www.ncbi.nlm.nih.gov/pubmed/35219833,35219833,,
761,1357490,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,23060,ZNF609,https://ctdbase.org/detail.go?type=gene&acc=23060,,,23060.0,ZNF609,9606.0,Homo sapiens (human),Perfluorohexanesulfonic acid results in decreased expression of ZNF609 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
762,1357491,67734,Comparative Toxicogenomics Database (CTD),Perfluorohexanesulfonic acid,C471071,perfluorohexanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C471071,80110,ZNF614,https://ctdbase.org/detail.go?type=gene&acc=80110,,,80110.0,ZNF614,9606.0,Homo sapiens (human),Perfluorohexanesulfonic acid results in decreased expression of ZNF614 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
763,1360252,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,273,AMPH,https://ctdbase.org/detail.go?type=gene&acc=273,,,273.0,AMPH,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of AMPH mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
764,1360253,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,29882,ANAPC2,https://ctdbase.org/detail.go?type=gene&acc=29882,,,29882.0,ANAPC2,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in decreased expression of ANAPC2 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
765,1360872,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,219681,ARMC3,https://ctdbase.org/detail.go?type=gene&acc=219681,,,219681.0,ARMC3,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of ARMC3 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
766,1360873,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,10776,ARPP19,https://ctdbase.org/detail.go?type=gene&acc=10776,,,10776.0,ARPP19,10090.0,Mus musculus (house mouse),Perfluoro-n-nonanoic acid results in increased expression of ARPP19 mRNA,,,PMID:28558994,https://www.ncbi.nlm.nih.gov/pubmed/28558994,28558994,,
767,1451083,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,30449,SERPINH1B,https://ctdbase.org/detail.go?type=gene&acc=30449,,,30449.0,serpinh1b,8049.0,Gadus morhua (Atlantic cod),Perfluoro-n-nonanoic acid results in increased expression of SERPINH1B mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
768,1451084,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,83667,SESN2,https://ctdbase.org/detail.go?type=gene&acc=83667,,,83667.0,SESN2,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of SESN2 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
769,1451085,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,143686,SESN3,https://ctdbase.org/detail.go?type=gene&acc=143686,,,143686.0,SESN3,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SESN3 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
770,1451086,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,26040,SETBP1,https://ctdbase.org/detail.go?type=gene&acc=26040,,,26040.0,SETBP1,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of SETBP1 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
771,1451257,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,26040,SETBP1,https://ctdbase.org/detail.go?type=gene&acc=26040,,,26040.0,SETBP1,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SETBP1 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
772,1451258,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,9814,SFI1,https://ctdbase.org/detail.go?type=gene&acc=9814,,,9814.0,SFI1,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SFI1 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
773,1364698,68245,Comparative Toxicogenomics Database (CTD),Delphinidin,C017185,delphinidin,https://ctdbase.org/detail.go?type=chem&acc=C017185,7153,TOP2A,https://ctdbase.org/detail.go?type=gene&acc=7153,,,7153.0,TOP2A,9606.0,Homo sapiens (human),Delphinidin results in decreased susceptibility to [etoposide affects the activity of TOP2A protein]|delphinidin results in decreased susceptibility to [doxorubicin affects the activity of TOP2A protein]|delphinidin results in decreased activity of TOP2A protein,,,PMID:19182879,https://www.ncbi.nlm.nih.gov/pubmed/19182879,19182879,,
774,1364699,68245,Comparative Toxicogenomics Database (CTD),Delphinidin,C017185,delphinidin,https://ctdbase.org/detail.go?type=chem&acc=C017185,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),Delphinidin inhibits the reaction [[PDGFA protein co-treated with PDGFB protein] results in increased secretion of VEGFA protein],,,PMID:16921400,https://www.ncbi.nlm.nih.gov/pubmed/16921400,16921400,,
775,1364700,68245,Comparative Toxicogenomics Database (CTD),Delphinidin,C017185,delphinidin,https://ctdbase.org/detail.go?type=chem&acc=C017185,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10090.0,Mus musculus (house mouse),Delphinidin inhibits the reaction [carbon tetrachloride results in increased expression of ACTA2 protein],,,PMID:20371262,https://www.ncbi.nlm.nih.gov/pubmed/20371262,20371262,,
776,1364701,68245,Comparative Toxicogenomics Database (CTD),Delphinidin,C017185,delphinidin,https://ctdbase.org/detail.go?type=chem&acc=C017185,405,ARNT,https://ctdbase.org/detail.go?type=gene&acc=405,,,405.0,ARNT,9606.0,Homo sapiens (human),Delphinidin inhibits the reaction [hydrogen peroxide results in increased expression of ARNT protein],,,PMID:18603805,https://www.ncbi.nlm.nih.gov/pubmed/18603805,18603805,,
777,1365046,68245,Comparative Toxicogenomics Database (CTD),Delphinidin,C017185,delphinidin,https://ctdbase.org/detail.go?type=chem&acc=C017185,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,9606.0,Homo sapiens (human),Delphinidin results in decreased expression of CDH2 protein,,,PMID:29451351,https://www.ncbi.nlm.nih.gov/pubmed/29451351,29451351,,
778,1365047,68245,Comparative Toxicogenomics Database (CTD),Delphinidin,C017185,delphinidin,https://ctdbase.org/detail.go?type=chem&acc=C017185,1149,CIDEA,https://ctdbase.org/detail.go?type=gene&acc=1149,,,1149.0,CIDEA,9606.0,Homo sapiens (human),Delphinidin results in increased expression of CIDEA mRNA,,,PMID:19182879,https://www.ncbi.nlm.nih.gov/pubmed/19182879,19182879,,
779,1365048,68245,Comparative Toxicogenomics Database (CTD),Delphinidin,C017185,delphinidin,https://ctdbase.org/detail.go?type=chem&acc=C017185,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606.0,Homo sapiens (human),Delphinidin results in increased expression of CYCS protein,,,PMID:33955636,https://www.ncbi.nlm.nih.gov/pubmed/33955636,33955636,,
780,1365049,68245,Comparative Toxicogenomics Database (CTD),Delphinidin,C017185,delphinidin,https://ctdbase.org/detail.go?type=chem&acc=C017185,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Delphinidin results in decreased activity of CYP1A1 protein,,,PMID:23419638,https://www.ncbi.nlm.nih.gov/pubmed/23419638,23419638,,
781,1365050,68245,Comparative Toxicogenomics Database (CTD),Delphinidin,C017185,delphinidin,https://ctdbase.org/detail.go?type=chem&acc=C017185,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),Delphinidin results in decreased phosphorylation of EGFR protein,,,PMID:18618485,https://www.ncbi.nlm.nih.gov/pubmed/18618485,18618485,,
782,1430051,71329,Comparative Toxicogenomics Database (CTD),Dofetilide,C063533,dofetilide,https://ctdbase.org/detail.go?type=chem&acc=C063533,3757,KCNH2,https://ctdbase.org/detail.go?type=gene&acc=3757,,,3757.0,KCNH2,9606.0,Homo sapiens (human),Potassium inhibits the reaction [dofetilide results in decreased activity of KCNH2 protein],,,PMID:16960444,https://www.ncbi.nlm.nih.gov/pubmed/16960444,16960444,,
783,1430582,71360,DrugBank,Iloperidone,DB04946,Iloperidone,https://www.drugbank.ca/drugs/DB04946,BE0003533,Cytochrome P450 2E1,https://www.drugbank.ca/bio_entities/BE0003533,P05181,Cytochrome P450 2E1,1571.0,CYP2E1,9606.0,Homo sapiens (human),Substrate,,,PMID:9732390,https://www.ncbi.nlm.nih.gov/pubmed/9732390,9732390,,
784,1430583,71360,DrugBank,Iloperidone,DB04946,Iloperidone,https://www.drugbank.ca/drugs/DB04946,BE0002363,Cytochrome P450 2D6,https://www.drugbank.ca/bio_entities/BE0002363,P10635,Cytochrome P450 2D6,1565.0,CYP2D6,9606.0,Homo sapiens (human),Substrate,,,PMID:9732390|PMID:21034370,https://www.ncbi.nlm.nih.gov/pubmed/9732390|https://www.ncbi.nlm.nih.gov/pubmed/21034370,9732390|21034370,,
785,1373986,71398,Comparative Toxicogenomics Database (CTD),Masoprocol,D009637,Masoprocol,https://ctdbase.org/detail.go?type=chem&acc=D009637,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Masoprocol results in decreased phosphorylation of MAPK3 protein,,,PMID:19503098,https://www.ncbi.nlm.nih.gov/pubmed/19503098,19503098,,
786,1430584,71398,DrugBank,Masoprocol,DB00179,Masoprocol,https://www.drugbank.ca/drugs/DB00179,BE0000248,Arachidonate 5-lipoxygenase,https://www.drugbank.ca/bio_entities/BE0000248,P09917,Polyunsaturated fatty acid 5-lipoxygenase,240.0,ALOX5,9606.0,Homo sapiens (human),Inhibitor,,,PMID:11277534|PMID:11318430|PMID:15098224|PMID:15379894|PMID:15694390|PMID:11752352|PMID:20567598,https://www.ncbi.nlm.nih.gov/pubmed/11277534|https://www.ncbi.nlm.nih.gov/pubmed/11318430|https://www.ncbi.nlm.nih.gov/pubmed/15098224|https://www.ncbi.nlm.nih.gov/pubmed/15379894|https://www.ncbi.nlm.nih.gov/pubmed/15694390|https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/20567598,11277534|11318430|15098224|15379894|15694390|11752352|20567598,,
787,1430585,71398,DrugBank,Masoprocol,DB00179,Masoprocol,https://www.drugbank.ca/drugs/DB00179,BE0000685,Sex hormone-binding globulin,https://www.drugbank.ca/bio_entities/BE0000685,P04278,Sex hormone-binding globulin,6462.0,SHBG,9606.0,Homo sapiens (human),,,,PMID:25349334,https://www.ncbi.nlm.nih.gov/pubmed/25349334,25349334,,
788,1430586,71398,DrugBank,Masoprocol,DB00179,Masoprocol,https://www.drugbank.ca/drugs/DB00179,BE0004624,Transient receptor potential cation channel subfamily M member 7,https://www.drugbank.ca/bio_entities/BE0004624,Q96QT4,Transient receptor potential cation channel subfamily M member 7,54822.0,TRPM7,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20567598,https://www.ncbi.nlm.nih.gov/pubmed/20567598,20567598,,
789,1352333,72301,Comparative Toxicogenomics Database (CTD),Tetrahydropalmatine,C014215,tetrahydropalmatine,https://ctdbase.org/detail.go?type=chem&acc=C014215,2879,GPX4,https://ctdbase.org/detail.go?type=gene&acc=2879,,,2879.0,GPX4,9606.0,Homo sapiens (human),Tetrahydropalmatine results in decreased expression of GPX4 protein,,,PMID:20109541,https://www.ncbi.nlm.nih.gov/pubmed/20109541,20109541,,
790,1431395,72344,Comparative Toxicogenomics Database (CTD),Nobiletin,C008661,nobiletin,https://ctdbase.org/detail.go?type=chem&acc=C008661,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10116.0,Rattus norvegicus (Norway rat),[paeonol co-treated with icariin co-treated with nobiletin co-treated with ginsenosides co-treated with astragaloside A] affects the secretion of TIMP1 protein,,,PMID:32344236,https://www.ncbi.nlm.nih.gov/pubmed/32344236,32344236,,
791,1444001,73641,Comparative Toxicogenomics Database (CTD),Arjunolic acid,C061640,arjunolic acid,https://ctdbase.org/detail.go?type=chem&acc=C061640,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Arjunolic acid inhibits the reaction [streptozocin results in increased activity of CASP3 protein],,,PMID:19133311|PMID:19682444|PMID:20053369,https://www.ncbi.nlm.nih.gov/pubmed/19133311|https://www.ncbi.nlm.nih.gov/pubmed/19682444|https://www.ncbi.nlm.nih.gov/pubmed/20053369,19133311|19682444|20053369,,
792,1444002,73641,Comparative Toxicogenomics Database (CTD),Arjunolic acid,C061640,arjunolic acid,https://ctdbase.org/detail.go?type=chem&acc=C061640,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,10090.0,Mus musculus (house mouse),Arjunolic acid inhibits the reaction [cadmium chloride results in increased expression of CASP8 protein],,,PMID:21420465,https://www.ncbi.nlm.nih.gov/pubmed/21420465,21420465,,
793,1444003,73641,Comparative Toxicogenomics Database (CTD),Arjunolic acid,C061640,arjunolic acid,https://ctdbase.org/detail.go?type=chem&acc=C061640,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,10090.0,Mus musculus (house mouse),Arjunolic acid inhibits the reaction [cadmium chloride results in increased activity of CASP9 protein],,,PMID:21420465,https://www.ncbi.nlm.nih.gov/pubmed/21420465,21420465,,
794,1451709,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,13095,CYP2C29,https://ctdbase.org/detail.go?type=gene&acc=13095,,,13095.0,Cyp2c29,10090.0,Mus musculus (house mouse),Prochloraz results in increased expression of CYP2C29 protein,,,PMID:33150952,https://www.ncbi.nlm.nih.gov/pubmed/33150952,33150952,,
795,1451710,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,72082,CYP2C55,https://ctdbase.org/detail.go?type=gene&acc=72082,,,72082.0,Cyp2c55,10090.0,Mus musculus (house mouse),Prochloraz results in increased expression of CYP2C55 protein,,,PMID:33150952,https://www.ncbi.nlm.nih.gov/pubmed/33150952,33150952,,
796,1451711,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,13101,CYP2D10,https://ctdbase.org/detail.go?type=gene&acc=13101,,,13101.0,Cyp2d10,10090.0,Mus musculus (house mouse),Prochloraz results in increased expression of CYP2D10 protein,,,PMID:33150952,https://www.ncbi.nlm.nih.gov/pubmed/33150952,33150952,,
797,1451712,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),Prochloraz results in decreased expression of CYP2D6 mRNA,,,PMID:20035023,https://www.ncbi.nlm.nih.gov/pubmed/20035023,20035023,,
798,1451713,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,13105,CYP2D9,https://ctdbase.org/detail.go?type=gene&acc=13105,,,13105.0,Cyp2d9,10090.0,Mus musculus (house mouse),Prochloraz results in increased expression of CYP2D9 protein,,,PMID:33150952,https://www.ncbi.nlm.nih.gov/pubmed/33150952,33150952,,
799,1451714,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606.0,Homo sapiens (human),Prochloraz results in decreased expression of CYP2E1 mRNA,,,PMID:20035023,https://www.ncbi.nlm.nih.gov/pubmed/20035023,20035023,,
800,1451715,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1573,CYP2J2,https://ctdbase.org/detail.go?type=gene&acc=1573,,,1573.0,CYP2J2,9606.0,Homo sapiens (human),Prochloraz results in decreased expression of CYP2J2 mRNA,,,PMID:20035023,https://www.ncbi.nlm.nih.gov/pubmed/20035023,20035023,,
801,1452187,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,22839,DLGAP4,https://ctdbase.org/detail.go?type=gene&acc=22839,,,22839.0,DLGAP4,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in increased expression of DLGAP4 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
802,1452188,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,8448,DOC2A,https://ctdbase.org/detail.go?type=gene&acc=8448,,,8448.0,DOC2A,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in increased expression of DOC2A mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
803,1452189,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,57628,DPP10,https://ctdbase.org/detail.go?type=gene&acc=57628,,,57628.0,DPP10,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in decreased expression of DPP10 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
804,1452190,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1804,DPP6,https://ctdbase.org/detail.go?type=gene&acc=1804,,,1804.0,DPP6,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in increased expression of DPP6 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
805,1452191,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1806,DPYD,https://ctdbase.org/detail.go?type=gene&acc=1806,,,1806.0,DPYD,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in decreased expression of DPYD mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
806,1452192,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1780,DYNC1I1,https://ctdbase.org/detail.go?type=gene&acc=1780,,,1780.0,DYNC1I1,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of DYNC1I1 mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
807,1452193,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in decreased expression of EGF mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
808,1452194,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in decreased expression of EGFR mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
809,1452329,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1962,EHHADH,https://ctdbase.org/detail.go?type=gene&acc=1962,,,1962.0,EHHADH,10116.0,Rattus norvegicus (Norway rat),[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EHHADH mRNA,,,PMID:29038839,https://www.ncbi.nlm.nih.gov/pubmed/29038839,29038839,,
810,1452330,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,9451,EIF2AK3,https://ctdbase.org/detail.go?type=gene&acc=9451,,,9451.0,EIF2AK3,10116.0,Rattus norvegicus (Norway rat),[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EIF2AK3 mRNA,,,PMID:29038839,https://www.ncbi.nlm.nih.gov/pubmed/29038839,29038839,,
811,1452331,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,8666,EIF3G,https://ctdbase.org/detail.go?type=gene&acc=8666,,,8666.0,EIF3G,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of EIF3G mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
812,1452332,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,406725,ELOVL1B,https://ctdbase.org/detail.go?type=gene&acc=406725,,,406725.0,elovl1b,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of ELOVL1B mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
813,1452333,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,55068,ENOX1,https://ctdbase.org/detail.go?type=gene&acc=55068,,,55068.0,ENOX1,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of ENOX1 mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
814,1452334,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,22875,ENPP4,https://ctdbase.org/detail.go?type=gene&acc=22875,,,22875.0,ENPP4,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of ENPP4 mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
815,1353487,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,13121,CYP51,https://ctdbase.org/detail.go?type=gene&acc=13121,,,13121.0,Cyp51,10090.0,Mus musculus (house mouse),Flusilazole results in increased expression of CYP51 mRNA,,,PMID:21192963|PMID:29337257|PMID:34737147,https://www.ncbi.nlm.nih.gov/pubmed/21192963|https://www.ncbi.nlm.nih.gov/pubmed/29337257|https://www.ncbi.nlm.nih.gov/pubmed/34737147,21192963|29337257|34737147,,
816,1353988,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,553306,EVI5B,https://ctdbase.org/detail.go?type=gene&acc=553306,,,553306.0,evi5b,7955.0,Danio rerio (zebrafish),Flusilazole results in decreased expression of EVI5B mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
817,1353989,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,2128,EVX1,https://ctdbase.org/detail.go?type=gene&acc=2128,,,2128.0,EVX1,10090.0,Mus musculus (house mouse),Flusilazole affects the expression of EVX1 mRNA,,,PMID:22634333,https://www.ncbi.nlm.nih.gov/pubmed/22634333,22634333,,
818,1353990,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,9002,F2RL3,https://ctdbase.org/detail.go?type=gene&acc=9002,,,9002.0,F2RL3,10116.0,Rattus norvegicus (Norway rat),Flusilazole results in decreased expression of F2RL3 mRNA,,,PMID:28263823,https://www.ncbi.nlm.nih.gov/pubmed/28263823,28263823,,
819,1353991,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,171481,FABP10A,https://ctdbase.org/detail.go?type=gene&acc=171481,,,171481.0,fabp10a,7955.0,Danio rerio (zebrafish),Flusilazole affects the expression of FABP10A mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
820,1353992,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,2169,FABP2,https://ctdbase.org/detail.go?type=gene&acc=2169,,,2169.0,FABP2,7955.0,Danio rerio (zebrafish),Flusilazole affects the expression of FABP2 mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
821,1353993,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,58128,FABP7A,https://ctdbase.org/detail.go?type=gene&acc=58128,,,58128.0,fabp7a,7955.0,Danio rerio (zebrafish),Flusilazole affects the expression of FABP7A mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
822,1353994,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,9415,FADS2,https://ctdbase.org/detail.go?type=gene&acc=9415,,,9415.0,FADS2,7955.0,Danio rerio (zebrafish),Flusilazole affects the expression of FADS2 mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
823,1353995,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,3995,FADS3,https://ctdbase.org/detail.go?type=gene&acc=3995,,,3995.0,FADS3,10116.0,Rattus norvegicus (Norway rat),Flusilazole results in increased expression of FADS3 mRNA,,,PMID:22664269,https://www.ncbi.nlm.nih.gov/pubmed/22664269,22664269,,
824,1354624,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,792391,HNF1BA,https://ctdbase.org/detail.go?type=gene&acc=792391,,,792391.0,hnf1ba,7955.0,Danio rerio (zebrafish),Flusilazole results in increased expression of HNF1BA mrna|flusilazole results in decreased expression of HNF1BA mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
825,1354625,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,3198,HOXA1,https://ctdbase.org/detail.go?type=gene&acc=3198,,,3198.0,HOXA1,10090.0,Mus musculus (house mouse),Flusilazole affects the expression of HOXA1 mRNA,,,PMID:21195148,https://www.ncbi.nlm.nih.gov/pubmed/21195148,21195148,,
826,1354626,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,3198,HOXA1,https://ctdbase.org/detail.go?type=gene&acc=3198,,,3198.0,HOXA1,10090.0,Mus musculus (house mouse),Flusilazole results in increased expression of HOXA1 mRNA,,,PMID:21192963,https://www.ncbi.nlm.nih.gov/pubmed/21192963,21192963,,
827,1354627,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,3198,HOXA1,https://ctdbase.org/detail.go?type=gene&acc=3198,,,3198.0,HOXA1,10116.0,Rattus norvegicus (Norway rat),Flusilazole results in increased expression of HOXA1 mRNA,,,PMID:28263823,https://www.ncbi.nlm.nih.gov/pubmed/28263823,28263823,,
828,1354628,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,58049,HOXA3A,https://ctdbase.org/detail.go?type=gene&acc=58049,,,58049.0,hoxa3a,7955.0,Danio rerio (zebrafish),Flusilazole results in increased expression of HOXA3A mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
829,1430673,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2882,GPX7,https://ctdbase.org/detail.go?type=gene&acc=2882,,,2882.0,GPX7,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GPX7 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
830,1430674,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,493869,GPX8,https://ctdbase.org/detail.go?type=gene&acc=493869,,,493869.0,GPX8,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GPX8 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
831,1430675,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2885,GRB2,https://ctdbase.org/detail.go?type=gene&acc=2885,,,2885.0,GRB2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GRB2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
832,1430676,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,406308,GRB2B,https://ctdbase.org/detail.go?type=gene&acc=406308,,,406308.0,grb2b,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of GRB2B mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
833,1430677,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GREB1 mRNA",,,PMID:24349450|PMID:29389661|PMID:31388671,https://www.ncbi.nlm.nih.gov/pubmed/24349450|https://www.ncbi.nlm.nih.gov/pubmed/29389661|https://www.ncbi.nlm.nih.gov/pubmed/31388671,24349450|29389661|31388671,,
834,1430678,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),"Fulvestrant inhibits the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of GREB1 mrna]",,,PMID:29389661,https://www.ncbi.nlm.nih.gov/pubmed/29389661,29389661,,
835,1430679,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,26585,GREM1,https://ctdbase.org/detail.go?type=gene&acc=26585,,,26585.0,GREM1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GREM1 mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
836,1431267,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2931,GSK3A,https://ctdbase.org/detail.go?type=gene&acc=2931,,,2931.0,GSK3A,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of GSK3A mRNA",,,PMID:31121516,https://www.ncbi.nlm.nih.gov/pubmed/31121516,31121516,,
837,1431268,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2934,GSN,https://ctdbase.org/detail.go?type=gene&acc=2934,,,2934.0,GSN,9606.0,Homo sapiens (human),"[4,4'-hexafluorisopropylidene diphenol binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to GSN protein modified form]",,,PMID:28751236,https://www.ncbi.nlm.nih.gov/pubmed/28751236,28751236,,
838,1431269,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2934,GSN,https://ctdbase.org/detail.go?type=gene&acc=2934,,,2934.0,GSN,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GSN protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
839,1431270,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GSR protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
840,1431271,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,373156,GSTK1,https://ctdbase.org/detail.go?type=gene&acc=373156,,,373156.0,GSTK1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GSTK1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
841,1431272,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GSTM1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
842,1431273,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GSTM2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
843,1432708,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,402830,EHMT1B,https://ctdbase.org/detail.go?type=gene&acc=402830,,,402830.0,ehmt1b,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of EHMT1B mRNA",,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
844,1432709,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1964,EIF1AX,https://ctdbase.org/detail.go?type=gene&acc=1964,,,1964.0,EIF1AX,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of EIF1AX protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
845,1432710,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,83939,EIF2A,https://ctdbase.org/detail.go?type=gene&acc=83939,,,83939.0,EIF2A,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of EIF2A protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
846,1432711,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1967,EIF2B1,https://ctdbase.org/detail.go?type=gene&acc=1967,,,1967.0,EIF2B1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of EIF2B1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
847,1432712,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,8892,EIF2B2,https://ctdbase.org/detail.go?type=gene&acc=8892,,,8892.0,EIF2B2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of EIF2B2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
848,1432713,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,8890,EIF2B4,https://ctdbase.org/detail.go?type=gene&acc=8890,,,8890.0,EIF2B4,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of EIF2B4 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
849,1432714,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,8893,EIF2B5,https://ctdbase.org/detail.go?type=gene&acc=8893,,,8893.0,EIF2B5,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of EIF2B5 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
850,1434066,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090.0,Mus musculus (house mouse),"NCOA2 protein promotes the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of ESR2 protein]|ncoa1 protein promotes the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of ESR2 protein]|esr2 protein alternative form inhibits the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of ESR2 protein]|4,4'-hexafluorisopropylidene diphenol results in increased expression of ESR2 protein|ncoa3 protein promotes the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of ESR2 protein]|4,4'-hexafluorisopropylidene diphenol results in increased expression of ESR2 protein alternative form",,,PMID:27634370,https://www.ncbi.nlm.nih.gov/pubmed/27634370,27634370,,
851,1434067,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,317734,ESR2A,https://ctdbase.org/detail.go?type=gene&acc=317734,,,317734.0,esr2a,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol binds to and results in increased activity of ESR2A protein",,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
852,1435454,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2548,GAA,https://ctdbase.org/detail.go?type=gene&acc=2548,,,2548.0,GAA,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GAA protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
853,1435455,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9031.0,Gallus gallus (chicken),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of GADD45A mRNA",,,PMID:33465250,https://www.ncbi.nlm.nih.gov/pubmed/33465250,33465250,,
854,1435456,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606.0,Homo sapiens (human),"[4,4'-hexafluorisopropylidene diphenol co-treated with cylindrospermopsin] results in increased expression of GADD45A mrna|4,4'-hexafluorisopropylidene diphenol results in increased expression of GADD45A mRNA",,,PMID:32244372,https://www.ncbi.nlm.nih.gov/pubmed/32244372,32244372,,
855,1435457,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GADD45A",,,PMID:31207516,https://www.ncbi.nlm.nih.gov/pubmed/31207516,31207516,,
856,1435458,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,431763,GADD45AB,https://ctdbase.org/detail.go?type=gene&acc=431763,,,431763.0,gadd45ab,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of GADD45AB mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
857,1435459,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,406304,GADD45BA,https://ctdbase.org/detail.go?type=gene&acc=406304,,,406304.0,gadd45ba,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of GADD45BA mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
858,1435460,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,497646,GADD45BB,https://ctdbase.org/detail.go?type=gene&acc=497646,,,497646.0,gadd45bb,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of GADD45BB mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
859,1435461,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,406507,GADD45GB.1,https://ctdbase.org/detail.go?type=gene&acc=406507,,,406507.0,gadd45gb.1,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of GADD45GB.1 mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
860,1435462,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2584,GALK1,https://ctdbase.org/detail.go?type=gene&acc=2584,,,2584.0,GALK1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GALK1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
861,1435463,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2588,GALNS,https://ctdbase.org/detail.go?type=gene&acc=2588,,,2588.0,GALNS,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GALNS protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
862,1435577,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2590,GALNT2,https://ctdbase.org/detail.go?type=gene&acc=2590,,,2590.0,GALNT2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GALNT2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
863,1435578,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,11226,GALNT6,https://ctdbase.org/detail.go?type=gene&acc=11226,,,11226.0,GALNT6,10090.0,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of GALNT6 mRNA",,,PMID:37611474,https://www.ncbi.nlm.nih.gov/pubmed/37611474,37611474,,
864,1435579,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,8139,GAN,https://ctdbase.org/detail.go?type=gene&acc=8139,,,8139.0,GAN,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GAN mRNA",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
865,1435580,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,23193,GANAB,https://ctdbase.org/detail.go?type=gene&acc=23193,,,23193.0,GANAB,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GANAB protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
866,1435581,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2596,GAP43,https://ctdbase.org/detail.go?type=gene&acc=2596,,,2596.0,GAP43,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GAP43 mrna|curcumin inhibits the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of GAP43 mrna]",,,PMID:37423901,https://www.ncbi.nlm.nih.gov/pubmed/37423901,37423901,,
867,1435582,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GAPDH mRNA",,,PMID:35598417,https://www.ncbi.nlm.nih.gov/pubmed/35598417,35598417,,
868,1435583,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GAPDH protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
869,1435584,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,26330,GAPDHS,https://ctdbase.org/detail.go?type=gene&acc=26330,,,26330.0,GAPDHS,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GAPDHS mRNA",,,PMID:35598417,https://www.ncbi.nlm.nih.gov/pubmed/35598417,35598417,,
870,1435585,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,26130,GAPVD1,https://ctdbase.org/detail.go?type=gene&acc=26130,,,26130.0,GAPVD1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GAPVD1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
871,1435586,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,54433,GAR1,https://ctdbase.org/detail.go?type=gene&acc=54433,,,54433.0,GAR1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GAR1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
872,1436312,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2803,GOLGA4,https://ctdbase.org/detail.go?type=gene&acc=2803,,,2803.0,GOLGA4,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GOLGA4 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
873,1436313,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2804,GOLGB1,https://ctdbase.org/detail.go?type=gene&acc=2804,,,2804.0,GOLGB1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GOLGB1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
874,1436314,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,26003,GORASP2,https://ctdbase.org/detail.go?type=gene&acc=26003,,,26003.0,GORASP2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GORASP2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
875,1436315,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,9570,GOSR2,https://ctdbase.org/detail.go?type=gene&acc=9570,,,9570.0,GOSR2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GOSR2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
876,1436316,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2805,GOT1,https://ctdbase.org/detail.go?type=gene&acc=2805,,,2805.0,GOT1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GOT1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
877,1436317,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2806,GOT2,https://ctdbase.org/detail.go?type=gene&acc=2806,,,2806.0,GOT2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GOT2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
878,1436318,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,57678,GPAM,https://ctdbase.org/detail.go?type=gene&acc=57678,,,57678.0,GPAM,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of GPAM protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
879,1436960,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,100034580,CACNG6A,https://ctdbase.org/detail.go?type=gene&acc=100034580,,,100034580.0,cacng6a,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CACNG6A mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
880,1436961,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,100003220,CACNG6B,https://ctdbase.org/detail.go?type=gene&acc=100003220,,,100003220.0,cacng6b,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CACNG6B mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
881,1436962,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,100034540,CACNG7A,https://ctdbase.org/detail.go?type=gene&acc=100034540,,,100034540.0,cacng7a,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CACNG7A mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
882,1436963,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,790,CAD,https://ctdbase.org/detail.go?type=gene&acc=790,,,790.0,CAD,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CAD protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
883,1436964,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,794,CALB2,https://ctdbase.org/detail.go?type=gene&acc=794,,,794.0,CALB2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CALB2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
884,1436965,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,800,CALD1,https://ctdbase.org/detail.go?type=gene&acc=800,,,800.0,CALD1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CALD1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
885,1436966,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,801,CALM1,https://ctdbase.org/detail.go?type=gene&acc=801,,,801.0,CALM1,10090.0,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol affects the expression of CALM1 mRNA",,,PMID:31981723,https://www.ncbi.nlm.nih.gov/pubmed/31981723,31981723,,
886,1437081,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,805,CALM2,https://ctdbase.org/detail.go?type=gene&acc=805,,,805.0,CALM2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CALM2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
887,1437082,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,811,CALR,https://ctdbase.org/detail.go?type=gene&acc=811,,,811.0,CALR,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CALR protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
888,1437083,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,813,CALU,https://ctdbase.org/detail.go?type=gene&acc=813,,,813.0,CALU,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CALU protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
889,1437084,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,8536,CAMK1,https://ctdbase.org/detail.go?type=gene&acc=8536,,,8536.0,CAMK1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CAMK1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
890,1437085,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,100144566,CAMK1DA,https://ctdbase.org/detail.go?type=gene&acc=100144566,,,100144566.0,camk1da,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CAMK1DA mRNA",,,PMID:37556959,https://www.ncbi.nlm.nih.gov/pubmed/37556959,37556959,,
891,1437204,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10487,CAP1,https://ctdbase.org/detail.go?type=gene&acc=10487,,,10487.0,CAP1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CAP1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
892,1437331,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,833,CARS1,https://ctdbase.org/detail.go?type=gene&acc=833,,,833.0,CARS1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CARS1 mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
893,1437332,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,833,CARS1,https://ctdbase.org/detail.go?type=gene&acc=833,,,833.0,CARS1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CARS1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
894,1437333,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,561021,CASP22,https://ctdbase.org/detail.go?type=gene&acc=561021,,,561021.0,casp22,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CASP22 mRNA",,,PMID:37556959,https://www.ncbi.nlm.nih.gov/pubmed/37556959,37556959,,
895,1437334,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,140621,CASP3A,https://ctdbase.org/detail.go?type=gene&acc=140621,,,140621.0,casp3a,7955.0,Danio rerio (zebrafish),"Curcumin inhibits the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of CASP3A mrna]|4,4'-hexafluorisopropylidene diphenol results in increased expression of CASP3A mRNA",,,PMID:37423901,https://www.ncbi.nlm.nih.gov/pubmed/37423901,37423901,,
896,1437335,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,566604,CASP3B,https://ctdbase.org/detail.go?type=gene&acc=566604,,,566604.0,casp3b,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CASP3B mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
897,1437462,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),"[4,4'-hexafluorisopropylidene diphenol co-treated with cylindrospermopsin] results in decreased expression of CAT mRNA",,,PMID:32244372,https://www.ncbi.nlm.nih.gov/pubmed/32244372,32244372,,
898,1437463,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CAT protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
899,1437464,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,30732.0,Oryzias melastigma (Indian medaka),"4,4'-hexafluorisopropylidene diphenol results in decreased activity of CAT protein",,,PMID:35690219,https://www.ncbi.nlm.nih.gov/pubmed/35690219,35690219,,
900,1437465,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,30732.0,Oryzias melastigma (Indian medaka),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CAT mRNA",,,PMID:36116629,https://www.ncbi.nlm.nih.gov/pubmed/36116629,36116629,,
901,1437466,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CAT protein|4,4'-hexafluorisopropylidene diphenol results in decreased expression of CAT mRNA",,,PMID:35605789,https://www.ncbi.nlm.nih.gov/pubmed/35605789,35605789,,
902,1437467,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,857,CAV1,https://ctdbase.org/detail.go?type=gene&acc=857,,,857.0,CAV1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CAV1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
903,1437468,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,858,CAV2,https://ctdbase.org/detail.go?type=gene&acc=858,,,858.0,CAV2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CAV2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
904,1437937,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10576,CCT2,https://ctdbase.org/detail.go?type=gene&acc=10576,,,10576.0,CCT2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CCT2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
905,1437938,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7203,CCT3,https://ctdbase.org/detail.go?type=gene&acc=7203,,,7203.0,CCT3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CCT3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
906,1437939,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10575,CCT4,https://ctdbase.org/detail.go?type=gene&acc=10575,,,10575.0,CCT4,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CCT4 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
907,1437940,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,22948,CCT5,https://ctdbase.org/detail.go?type=gene&acc=22948,,,22948.0,CCT5,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CCT5 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
908,1438516,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1149,CIDEA,https://ctdbase.org/detail.go?type=gene&acc=1149,,,1149.0,CIDEA,9606.0,Homo sapiens (human),"[INS protein co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with rosiglitazone co-treated with 4,4'-hexafluorisopropylidene diphenol] results in increased expression of CIDEA mRNA",,,PMID:31596606,https://www.ncbi.nlm.nih.gov/pubmed/31596606,31596606,,
909,1438517,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,493856,CISD2,https://ctdbase.org/detail.go?type=gene&acc=493856,,,493856.0,CISD2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CISD2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
910,1438750,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,23277,CLUH,https://ctdbase.org/detail.go?type=gene&acc=23277,,,23277.0,CLUH,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CLUH protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
911,1438751,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,134147,CMBL,https://ctdbase.org/detail.go?type=gene&acc=134147,,,134147.0,CMBL,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CMBL protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
912,1438752,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1240,CMKLR1,https://ctdbase.org/detail.go?type=gene&acc=1240,,,1240.0,CMKLR1,10090.0,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CMKLR1 mRNA",,,PMID:37611474,https://www.ncbi.nlm.nih.gov/pubmed/37611474,37611474,,
913,1438753,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,51727,CMPK1,https://ctdbase.org/detail.go?type=gene&acc=51727,,,51727.0,CMPK1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CMPK1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
914,1438754,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,55748,CNDP2,https://ctdbase.org/detail.go?type=gene&acc=55748,,,55748.0,CNDP2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CNDP2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
915,1438755,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1265,CNN2,https://ctdbase.org/detail.go?type=gene&acc=1265,,,1265.0,CNN2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CNN2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
916,1438756,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1266,CNN3,https://ctdbase.org/detail.go?type=gene&acc=1266,,,1266.0,CNN3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CNN3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
917,1438757,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,23019,CNOT1,https://ctdbase.org/detail.go?type=gene&acc=23019,,,23019.0,CNOT1,9606.0,Homo sapiens (human),"[4,4'-hexafluorisopropylidene diphenol binds to and affects the folding of AR protein] affects the reaction [AR protein modified form binds to CNOT1 protein modified form]",,,PMID:28751236,https://www.ncbi.nlm.nih.gov/pubmed/28751236,28751236,,
918,1441587,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,23317,DNAJC13,https://ctdbase.org/detail.go?type=gene&acc=23317,,,23317.0,DNAJC13,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of DNAJC13 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
919,1441588,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5611,DNAJC3,https://ctdbase.org/detail.go?type=gene&acc=5611,,,5611.0,DNAJC3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of DNAJC3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
920,1441589,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,84277,DNAJC30,https://ctdbase.org/detail.go?type=gene&acc=84277,,,84277.0,DNAJC30,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of DNAJC30 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
921,1441590,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,22826,DNAJC8,https://ctdbase.org/detail.go?type=gene&acc=22826,,,22826.0,DNAJC8,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of DNAJC8 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
922,1442302,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of EGFR mRNA",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
923,1442303,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of EGFR protein|pyrrolidine dithiocarbamic acid affects the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of EGFR protein]",,,PMID:38003411,https://www.ncbi.nlm.nih.gov/pubmed/38003411,38003411,,
924,1442304,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,378478,EGFRA,https://ctdbase.org/detail.go?type=gene&acc=378478,,,378478.0,egfra,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of EGFRA mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
925,1442688,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10550,ARL6IP5,https://ctdbase.org/detail.go?type=gene&acc=10550,,,10550.0,ARL6IP5,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ARL6IP5 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
926,1442689,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,55207,ARL8B,https://ctdbase.org/detail.go?type=gene&acc=55207,,,55207.0,ARL8B,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ARL8B protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
927,1442690,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,79624,ARMT1,https://ctdbase.org/detail.go?type=gene&acc=79624,,,79624.0,ARMT1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ARMT1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
928,1442691,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10095,ARPC1B,https://ctdbase.org/detail.go?type=gene&acc=10095,,,10095.0,ARPC1B,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ARPC1B protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
929,1442692,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10109,ARPC2,https://ctdbase.org/detail.go?type=gene&acc=10109,,,10109.0,ARPC2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ARPC2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
930,1442693,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10094,ARPC3,https://ctdbase.org/detail.go?type=gene&acc=10094,,,10094.0,ARPC3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ARPC3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
931,1442694,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10092,ARPC5,https://ctdbase.org/detail.go?type=gene&acc=10092,,,10092.0,ARPC5,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ARPC5 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
932,1442821,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,408,ARRB1,https://ctdbase.org/detail.go?type=gene&acc=408,,,408.0,ARRB1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ARRB1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
933,1442822,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,408,ARRB1,https://ctdbase.org/detail.go?type=gene&acc=408,,,408.0,ARRB1,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ARRB1 mRNA",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
934,1443970,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,47,ACLY,https://ctdbase.org/detail.go?type=gene&acc=47,,,47.0,ACLY,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ACLY protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
935,1443971,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,48,ACO1,https://ctdbase.org/detail.go?type=gene&acc=48,,,48.0,ACO1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ACO1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
936,1443972,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,50,ACO2,https://ctdbase.org/detail.go?type=gene&acc=50,,,50.0,ACO2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ACO2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
937,1466203,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,559229,VTG6,https://ctdbase.org/detail.go?type=gene&acc=559229,,,559229.0,vtg6,8090.0,Oryzias latipes (Japanese medaka),"4,4'-hexafluorisopropylidene diphenol results in increased expression of VTG6 mRNA",,,PMID:26086576,https://www.ncbi.nlm.nih.gov/pubmed/26086576,26086576,,
938,1466204,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10490,VTI1B,https://ctdbase.org/detail.go?type=gene&acc=10490,,,10490.0,VTI1B,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of VTI1B protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
939,1466205,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7448,VTN,https://ctdbase.org/detail.go?type=gene&acc=7448,,,7448.0,VTN,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of VTN protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
940,1466206,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,340706,VWA2,https://ctdbase.org/detail.go?type=gene&acc=340706,,,340706.0,VWA2,10090.0,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of VWA2 mRNA",,,PMID:34850234,https://www.ncbi.nlm.nih.gov/pubmed/34850234,34850234,,
941,1466554,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,9589,WTAP,https://ctdbase.org/detail.go?type=gene&acc=9589,,,9589.0,WTAP,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of WTAP protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
942,1466555,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7494,XBP1,https://ctdbase.org/detail.go?type=gene&acc=7494,,,7494.0,XBP1,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of XBP1 mRNA",,,PMID:35598417,https://www.ncbi.nlm.nih.gov/pubmed/35598417,35598417,,
943,1466556,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7511,XPNPEP1,https://ctdbase.org/detail.go?type=gene&acc=7511,,,7511.0,XPNPEP1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of XPNPEP1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
944,1466557,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7514,XPO1,https://ctdbase.org/detail.go?type=gene&acc=7514,,,7514.0,XPO1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of XPO1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
945,1466558,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,23039,XPO7,https://ctdbase.org/detail.go?type=gene&acc=23039,,,23039.0,XPO7,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of XPO7 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
946,1466559,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,11260,XPOT,https://ctdbase.org/detail.go?type=gene&acc=11260,,,11260.0,XPOT,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of XPOT protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
947,1466727,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5467,PPARD,https://ctdbase.org/detail.go?type=gene&acc=5467,,,5467.0,PPARD,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased activity of PPARD protein",,,PMID:34627044,https://www.ncbi.nlm.nih.gov/pubmed/34627044,34627044,,
948,1466728,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,2547,XRCC6,https://ctdbase.org/detail.go?type=gene&acc=2547,,,2547.0,XRCC6,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of XRCC6 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
949,1466729,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,22803,XRN2,https://ctdbase.org/detail.go?type=gene&acc=22803,,,22803.0,XRN2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of XRN2 mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
950,1466730,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10413,YAP1,https://ctdbase.org/detail.go?type=gene&acc=10413,,,10413.0,YAP1,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of YAP1 mRNA",,,PMID:37556959,https://www.ncbi.nlm.nih.gov/pubmed/37556959,37556959,,
951,1466731,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10413,YAP1,https://ctdbase.org/detail.go?type=gene&acc=10413,,,10413.0,YAP1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of YAP1 mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
952,1466732,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,8565,YARS1,https://ctdbase.org/detail.go?type=gene&acc=8565,,,8565.0,YARS1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of YARS1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
953,1466733,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,51067,YARS2,https://ctdbase.org/detail.go?type=gene&acc=51067,,,51067.0,YARS2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of YARS2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
954,1466734,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4904,YBX1,https://ctdbase.org/detail.go?type=gene&acc=4904,,,4904.0,YBX1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of YBX1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
955,1352489,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of NQO1 mRNA,,,PMID:18692542,https://www.ncbi.nlm.nih.gov/pubmed/18692542,18692542,,
956,1352817,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,22746,ZFP85,https://ctdbase.org/detail.go?type=gene&acc=22746,,,22746.0,Zfp85,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of ZFP85 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
957,1352818,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,319748,ZFP865,https://ctdbase.org/detail.go?type=gene&acc=319748,,,319748.0,Zfp865,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of ZFP865 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
958,1352819,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,330788,ZFP866,https://ctdbase.org/detail.go?type=gene&acc=330788,,,330788.0,Zfp866,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of ZFP866 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
959,1352820,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,66869,ZFP869,https://ctdbase.org/detail.go?type=gene&acc=66869,,,66869.0,Zfp869,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of ZFP869 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
960,1352821,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,170763,ZFP87,https://ctdbase.org/detail.go?type=gene&acc=170763,,,170763.0,Zfp87,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of ZFP87 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
961,1352822,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,208292,ZFP871,https://ctdbase.org/detail.go?type=gene&acc=208292,,,208292.0,Zfp871,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of ZFP871 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
962,1353478,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51471,NAT8B,https://ctdbase.org/detail.go?type=gene&acc=51471,,,51471.0,NAT8B,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of NAT8B mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
963,1353479,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,66116,NAT8F1,https://ctdbase.org/detail.go?type=gene&acc=66116,,,66116.0,Nat8f1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of NAT8F1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of NAT8F1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
964,1353480,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,93673,NAT8F2,https://ctdbase.org/detail.go?type=gene&acc=93673,,,93673.0,Nat8f2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of NAT8F2 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of NAT8F2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
965,1353481,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,75541,NAT8F4,https://ctdbase.org/detail.go?type=gene&acc=75541,,,75541.0,Nat8f4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of NAT8F4 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of NAT8F4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
966,1353482,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,69049,NAT8F5,https://ctdbase.org/detail.go?type=gene&acc=69049,,,69049.0,Nat8f5,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of NAT8F5 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
967,1353483,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,100043497,NAT8F7,https://ctdbase.org/detail.go?type=gene&acc=100043497,,,100043497.0,Nat8f7,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of NAT8F7 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
968,1353484,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,339983,NAT8L,https://ctdbase.org/detail.go?type=gene&acc=339983,,,339983.0,NAT8L,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of NAT8L mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
969,1353485,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,89796,NAV1,https://ctdbase.org/detail.go?type=gene&acc=89796,,,89796.0,NAV1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of NAV1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
970,1353486,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,89797,NAV2,https://ctdbase.org/detail.go?type=gene&acc=89797,,,89797.0,NAV2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of NAV2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
971,1353632,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9075,CLDN2,https://ctdbase.org/detail.go?type=gene&acc=9075,,,9075.0,CLDN2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CLDN2 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of CLDN2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
972,1353633,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1364,CLDN4,https://ctdbase.org/detail.go?type=gene&acc=1364,,,1364.0,CLDN4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of CLDN4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
973,1353634,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,406559,CLDN5A,https://ctdbase.org/detail.go?type=gene&acc=406559,,,406559.0,cldn5a,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of CLDN5A mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
974,1353635,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9073,CLDN8,https://ctdbase.org/detail.go?type=gene&acc=9073,,,9073.0,CLDN8,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of CLDN8 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
975,1353636,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,26063,DECR2,https://ctdbase.org/detail.go?type=gene&acc=26063,,,26063.0,DECR2,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of DECR2 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
976,1353637,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,56650,CLDND1,https://ctdbase.org/detail.go?type=gene&acc=56650,,,56650.0,CLDND1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CLDND1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
977,1353638,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,160364,CLEC12A,https://ctdbase.org/detail.go?type=gene&acc=160364,,,160364.0,CLEC12A,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CLEC12A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
978,1353639,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23274,CLEC16A,https://ctdbase.org/detail.go?type=gene&acc=23274,,,23274.0,CLEC16A,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of CLEC16A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
979,1353820,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,196441,ZFC3H1,https://ctdbase.org/detail.go?type=gene&acc=196441,,,196441.0,ZFC3H1,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of ZFC3H1 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
980,1353821,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,196441,ZFC3H1,https://ctdbase.org/detail.go?type=gene&acc=196441,,,196441.0,ZFC3H1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of ZFC3H1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
981,1353822,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,85446,ZFHX2,https://ctdbase.org/detail.go?type=gene&acc=85446,,,85446.0,ZFHX2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of ZFHX2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
982,1353823,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,79776,ZFHX4,https://ctdbase.org/detail.go?type=gene&acc=79776,,,79776.0,ZFHX4,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of ZFHX4 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
983,1353824,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,79776,ZFHX4,https://ctdbase.org/detail.go?type=gene&acc=79776,,,79776.0,ZFHX4,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of ZFHX4 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
984,1353825,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,22651,ZFP125,https://ctdbase.org/detail.go?type=gene&acc=22651,,,22651.0,Zfp125,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of ZFP125 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of ZFP125 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
985,1353826,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,57677,ZFP14,https://ctdbase.org/detail.go?type=gene&acc=57677,,,57677.0,ZFP14,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of ZFP14 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
986,1353827,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,26465,ZFP146,https://ctdbase.org/detail.go?type=gene&acc=26465,,,26465.0,Zfp146,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of ZFP146 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of ZFP146 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of ZFP146 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
987,1353828,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,210135,ZFP180,https://ctdbase.org/detail.go?type=gene&acc=210135,,,210135.0,Zfp180,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of ZFP180 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
988,1353996,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,57727,NCOA5,https://ctdbase.org/detail.go?type=gene&acc=57727,,,57727.0,NCOA5,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of NCOA5 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of NCOA5 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
989,1353997,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9611,NCOR1,https://ctdbase.org/detail.go?type=gene&acc=9611,,,9611.0,NCOR1,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of NCOR1 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
990,1353998,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9611,NCOR1,https://ctdbase.org/detail.go?type=gene&acc=9611,,,9611.0,NCOR1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of NCOR1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
991,1355306,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,147166,TRIM16L,https://ctdbase.org/detail.go?type=gene&acc=147166,,,147166.0,TRIM16L,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of TRIM16L mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
992,1355307,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23321,TRIM2,https://ctdbase.org/detail.go?type=gene&acc=23321,,,23321.0,TRIM2,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of TRIM2 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
993,1355308,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8805,TRIM24,https://ctdbase.org/detail.go?type=gene&acc=8805,,,8805.0,TRIM24,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of TRIM24 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
994,1355309,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7706,TRIM25,https://ctdbase.org/detail.go?type=gene&acc=7706,,,7706.0,TRIM25,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of TRIM25 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
995,1355310,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10155,TRIM28,https://ctdbase.org/detail.go?type=gene&acc=10155,,,10155.0,TRIM28,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of TRIM28 protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
996,1355311,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23650,TRIM29,https://ctdbase.org/detail.go?type=gene&acc=23650,,,23650.0,TRIM29,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of TRIM29 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
997,1355480,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7082,TJP1,https://ctdbase.org/detail.go?type=gene&acc=7082,,,7082.0,TJP1,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of TJP1 protein,,,PMID:28439067|PMID:28973641,https://www.ncbi.nlm.nih.gov/pubmed/28439067|https://www.ncbi.nlm.nih.gov/pubmed/28973641,28439067|28973641,,
998,1355481,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7083,TK1,https://ctdbase.org/detail.go?type=gene&acc=7083,,,7083.0,TK1,7955.0,Danio rerio (zebrafish),Perfluorooctane sulfonic acid results in increased expression of TK1 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
999,1356099,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55374,TMCO6,https://ctdbase.org/detail.go?type=gene&acc=55374,,,55374.0,TMCO6,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of TMCO6 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1000,1356100,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10972,TMED10,https://ctdbase.org/detail.go?type=gene&acc=10972,,,10972.0,TMED10,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of TMED10 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1001,1356101,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23423,TMED3,https://ctdbase.org/detail.go?type=gene&acc=23423,,,23423.0,TMED3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of TMED3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1002,1356102,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,222068,TMED4,https://ctdbase.org/detail.go?type=gene&acc=222068,,,222068.0,TMED4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of TMED4 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of TMED4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1003,1356103,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,50999,TMED5,https://ctdbase.org/detail.go?type=gene&acc=50999,,,50999.0,TMED5,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of TMED5 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1004,1356104,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51014,TMED7,https://ctdbase.org/detail.go?type=gene&acc=51014,,,51014.0,TMED7,9913.0,Bos taurus (cattle),Perfluorooctane sulfonic acid results in decreased expression of TMED7 mrna|perfluorooctane sulfonic acid results in decreased methylation of TMED7 intron,,,PMID:34762985,https://www.ncbi.nlm.nih.gov/pubmed/34762985,34762985,,
1005,1356105,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51014,TMED7,https://ctdbase.org/detail.go?type=gene&acc=51014,,,51014.0,TMED7,8049.0,Gadus morhua (Atlantic cod),"Perfluorooctane sulfonic acid results in increased expression of TMED7 mrna|[hydrocarbons, chlorinated co-treated with pentabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in increased expression of TMED7 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1006,1356106,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55273,TMEM100,https://ctdbase.org/detail.go?type=gene&acc=55273,,,55273.0,TMEM100,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of TMEM100 mrna|[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of TMEM100 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1007,1356107,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,284114,TMEM102,https://ctdbase.org/detail.go?type=gene&acc=284114,,,284114.0,TMEM102,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of TMEM102 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1008,1356434,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7106,TSPAN4,https://ctdbase.org/detail.go?type=gene&acc=7106,,,7106.0,TSPAN4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of TSPAN4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1009,1356435,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7102,TSPAN7,https://ctdbase.org/detail.go?type=gene&acc=7102,,,7102.0,TSPAN7,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of TSPAN7 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1010,1356436,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7103,TSPAN8,https://ctdbase.org/detail.go?type=gene&acc=7103,,,7103.0,TSPAN8,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of TSPAN8 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1011,1356437,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,706,TSPO,https://ctdbase.org/detail.go?type=gene&acc=706,,,706.0,TSPO,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of TSPO mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of TSPO mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1012,1356438,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,706,TSPO,https://ctdbase.org/detail.go?type=gene&acc=706,,,706.0,TSPO,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of TSPO mRNA,,,PMID:20136073,https://www.ncbi.nlm.nih.gov/pubmed/20136073,20136073,,
1013,1356623,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4664,NAB1,https://ctdbase.org/detail.go?type=gene&acc=4664,,,4664.0,NAB1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of NAB1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1014,1356624,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23531,MMD,https://ctdbase.org/detail.go?type=gene&acc=23531,,,23531.0,MMD,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of MMD mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1015,1356625,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,221938,MMD2,https://ctdbase.org/detail.go?type=gene&acc=221938,,,221938.0,MMD2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of MMD2 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of MMD2 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of MMD2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1016,1356626,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4311,MME,https://ctdbase.org/detail.go?type=gene&acc=4311,,,4311.0,MME,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of MME mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1017,1356627,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4311,MME,https://ctdbase.org/detail.go?type=gene&acc=4311,,,4311.0,MME,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of MME mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1018,1356628,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4320,MMP11,https://ctdbase.org/detail.go?type=gene&acc=4320,,,4320.0,MMP11,8355.0,Xenopus laevis (African clawed frog),Perfluorooctane sulfonic acid results in increased expression of MMP11 mRNA,,,PMID:24819616,https://www.ncbi.nlm.nih.gov/pubmed/24819616,24819616,,
1019,1356629,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4321,MMP12,https://ctdbase.org/detail.go?type=gene&acc=4321,,,4321.0,MMP12,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of MMP12 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1020,1356999,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4340,MOG,https://ctdbase.org/detail.go?type=gene&acc=4340,,,4340.0,MOG,9031.0,Gallus gallus (chicken),Perfluorooctane sulfonic acid results in decreased expression of MOG mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
1021,1357000,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,116255,MOGAT1,https://ctdbase.org/detail.go?type=gene&acc=116255,,,116255.0,MOGAT1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of MOGAT1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of MOGAT1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of MOGAT1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1022,1357304,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51030,TVP23B,https://ctdbase.org/detail.go?type=gene&acc=51030,,,51030.0,TVP23B,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of TVP23B mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1023,1357305,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51030,TVP23B,https://ctdbase.org/detail.go?type=gene&acc=51030,,,51030.0,TVP23B,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of TVP23B mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1024,1357306,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51030,TVP23B,https://ctdbase.org/detail.go?type=gene&acc=51030,,,51030.0,TVP23B,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of TVP23B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1025,1357307,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5756,TWF1,https://ctdbase.org/detail.go?type=gene&acc=5756,,,5756.0,TWF1,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of TWF1 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1026,1357308,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,325677,TWF1A,https://ctdbase.org/detail.go?type=gene&acc=325677,,,325677.0,twf1a,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of TWF1A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1027,1357309,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,117581,TWIST2,https://ctdbase.org/detail.go?type=gene&acc=117581,,,117581.0,TWIST2,9913.0,Bos taurus (cattle),Perfluorooctane sulfonic acid results in decreased expression of TWIST2 mrna|perfluorooctane sulfonic acid results in decreased methylation of TWIST2 promoter,,,PMID:34762985,https://www.ncbi.nlm.nih.gov/pubmed/34762985,34762985,,
1028,1357310,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,57045,TWSG1,https://ctdbase.org/detail.go?type=gene&acc=57045,,,57045.0,TWSG1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of TWSG1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1029,1357311,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,200081,TXLNA,https://ctdbase.org/detail.go?type=gene&acc=200081,,,200081.0,TXLNA,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of TXLNA mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of TXLNA mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1030,1357312,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55787,TXLNG,https://ctdbase.org/detail.go?type=gene&acc=55787,,,55787.0,TXLNG,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of TXLNG mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1031,1357492,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10198,MPHOSPH9,https://ctdbase.org/detail.go?type=gene&acc=10198,,,10198.0,MPHOSPH9,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of MPHOSPH9 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1032,1357493,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84954,MPND,https://ctdbase.org/detail.go?type=gene&acc=84954,,,84954.0,MPND,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of MPND mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1033,1357494,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4354,MPP1,https://ctdbase.org/detail.go?type=gene&acc=4354,,,4354.0,MPP1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of MPP1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of MPP1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1034,1357495,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4354,MPP1,https://ctdbase.org/detail.go?type=gene&acc=4354,,,4354.0,MPP1,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of MPP1 mRNA,,,PMID:28558994,https://www.ncbi.nlm.nih.gov/pubmed/28558994,28558994,,
1035,1357496,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4355,MPP2,https://ctdbase.org/detail.go?type=gene&acc=4355,,,4355.0,MPP2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of MPP2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1036,1357809,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7318,UBA7,https://ctdbase.org/detail.go?type=gene&acc=7318,,,7318.0,UBA7,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of UBA7 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1037,1357985,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,64978,MRPL38,https://ctdbase.org/detail.go?type=gene&acc=64978,,,64978.0,MRPL38,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of MRPL38 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1038,1358281,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7512,XPNPEP2,https://ctdbase.org/detail.go?type=gene&acc=7512,,,7512.0,XPNPEP2,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of XPNPEP2 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1039,1358282,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7512,XPNPEP2,https://ctdbase.org/detail.go?type=gene&acc=7512,,,7512.0,XPNPEP2,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of XPNPEP2 mRNA,,,PMID:18692542,https://www.ncbi.nlm.nih.gov/pubmed/18692542,18692542,,
1040,1358283,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7514,XPO1,https://ctdbase.org/detail.go?type=gene&acc=7514,,,7514.0,XPO1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of XPO1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1041,1358284,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,558395,XPO1A,https://ctdbase.org/detail.go?type=gene&acc=558395,,,558395.0,xpo1a,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of XPO1A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1042,1358421,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6855,SYP,https://ctdbase.org/detail.go?type=gene&acc=6855,,,6855.0,SYP,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid affects the expression of SYP mRNA,,,PMID:20136073,https://www.ncbi.nlm.nih.gov/pubmed/20136073,20136073,,
1043,1358422,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6855,SYP,https://ctdbase.org/detail.go?type=gene&acc=6855,,,6855.0,SYP,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid affects the expression of SYP protein,,,PMID:20937303,https://www.ncbi.nlm.nih.gov/pubmed/20937303,20937303,,
1044,1358423,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6856,SYPL1,https://ctdbase.org/detail.go?type=gene&acc=6856,,,6856.0,SYPL1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of SYPL1 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1045,1358424,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,393640,SYPL2A,https://ctdbase.org/detail.go?type=gene&acc=393640,,,393640.0,sypl2a,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of SYPL2A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1046,1358425,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,799482,SYPL2B,https://ctdbase.org/detail.go?type=gene&acc=799482,,,799482.0,sypl2b,8049.0,Gadus morhua (Atlantic cod),"Perfluorooctane sulfonic acid results in increased expression of SYPL2B mrna|[hydrocarbons, chlorinated co-treated with pentabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in increased expression of SYPL2B mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1047,1358426,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,90196,SYS1,https://ctdbase.org/detail.go?type=gene&acc=90196,,,90196.0,SYS1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of SYS1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1048,1358427,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,90196,SYS1,https://ctdbase.org/detail.go?type=gene&acc=90196,,,90196.0,SYS1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of SYS1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of SYS1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1049,1358576,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51338,MS4A4A,https://ctdbase.org/detail.go?type=gene&acc=51338,,,51338.0,MS4A4A,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of MS4A4A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1050,1358577,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,64380,MS4A4C,https://ctdbase.org/detail.go?type=gene&acc=64380,,,64380.0,Ms4a4c,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of MS4A4C mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1051,1358578,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,69774,MS4A6B,https://ctdbase.org/detail.go?type=gene&acc=69774,,,69774.0,Ms4a6b,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of MS4A6B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1052,1358579,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,68774,MS4A6D,https://ctdbase.org/detail.go?type=gene&acc=68774,,,68774.0,Ms4a6d,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of MS4A6D mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1053,1358580,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4437,MSH3,https://ctdbase.org/detail.go?type=gene&acc=4437,,,4437.0,MSH3,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of MSH3 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1054,1358581,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4439,MSH5,https://ctdbase.org/detail.go?type=gene&acc=4439,,,4439.0,MSH5,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of MSH5 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1055,1358582,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2956,MSH6,https://ctdbase.org/detail.go?type=gene&acc=2956,,,2956.0,MSH6,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of MSH6 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1056,1358758,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,79789,CLMN,https://ctdbase.org/detail.go?type=gene&acc=79789,,,79789.0,CLMN,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CLMN mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1057,1358759,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,100330877,CLMPB,https://ctdbase.org/detail.go?type=gene&acc=100330877,,,100330877.0,clmpb,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of CLMPB mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1058,1358760,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,54982,CLN6,https://ctdbase.org/detail.go?type=gene&acc=54982,,,54982.0,CLN6,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of CLN6 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of CLN6 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CLN6 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1059,1358761,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2055,CLN8,https://ctdbase.org/detail.go?type=gene&acc=2055,,,2055.0,CLN8,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of CLN8 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1060,1358762,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2055,CLN8,https://ctdbase.org/detail.go?type=gene&acc=2055,,,2055.0,CLN8,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of CLN8 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CLN8 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1061,1358763,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1207,CLNS1A,https://ctdbase.org/detail.go?type=gene&acc=1207,,,1207.0,CLNS1A,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of CLNS1A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1062,1358764,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51646,YPEL5,https://ctdbase.org/detail.go?type=gene&acc=51646,,,51646.0,YPEL5,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of YPEL5 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1063,1358765,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,337571,YRK,https://ctdbase.org/detail.go?type=gene&acc=337571,,,337571.0,yrk,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of YRK mrna|perfluorooctane sulfonic acid results in increased expression of YRK mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1064,1358766,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,91746,YTHDC1,https://ctdbase.org/detail.go?type=gene&acc=91746,,,91746.0,YTHDC1,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of YTHDC1 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1065,1358767,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,91746,YTHDC1,https://ctdbase.org/detail.go?type=gene&acc=91746,,,91746.0,YTHDC1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of YTHDC1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1066,1358909,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6890,TAP1,https://ctdbase.org/detail.go?type=gene&acc=6890,,,6890.0,TAP1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of TAP1 mRNA,,,PMID:33138996|PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/33138996|https://www.ncbi.nlm.nih.gov/pubmed/37528559,33138996|37528559,,
1067,1359259,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,26000,TBC1D10B,https://ctdbase.org/detail.go?type=gene&acc=26000,,,26000.0,TBC1D10B,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of TBC1D10B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1068,1359260,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,374403,TBC1D10C,https://ctdbase.org/detail.go?type=gene&acc=374403,,,374403.0,TBC1D10C,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of TBC1D10C mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1069,1359261,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,54662,TBC1D13,https://ctdbase.org/detail.go?type=gene&acc=54662,,,54662.0,TBC1D13,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of TBC1D13 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1070,1359262,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,54662,TBC1D13,https://ctdbase.org/detail.go?type=gene&acc=54662,,,54662.0,TBC1D13,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of TBC1D13 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1071,1359630,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,123036,TC2N,https://ctdbase.org/detail.go?type=gene&acc=123036,,,123036.0,TC2N,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of TC2N mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of TC2N mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1072,1359631,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6917,TCEA1,https://ctdbase.org/detail.go?type=gene&acc=6917,,,6917.0,TCEA1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of TCEA1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1073,1359632,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6919,TCEA2,https://ctdbase.org/detail.go?type=gene&acc=6919,,,6919.0,TCEA2,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of TCEA2 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1074,1359633,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6919,TCEA2,https://ctdbase.org/detail.go?type=gene&acc=6919,,,6919.0,TCEA2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of TCEA2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1075,1359786,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,56034,PDGFC,https://ctdbase.org/detail.go?type=gene&acc=56034,,,56034.0,PDGFC,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of PDGFC mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
1076,1359787,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,80310,PDGFD,https://ctdbase.org/detail.go?type=gene&acc=80310,,,80310.0,PDGFD,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PDGFD mrna|[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of PDGFD mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1077,1360095,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51075,TMX2,https://ctdbase.org/detail.go?type=gene&acc=51075,,,51075.0,TMX2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of TMX2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1078,1360096,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,415203,TMX2B,https://ctdbase.org/detail.go?type=gene&acc=415203,,,415203.0,tmx2b,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of TMX2B mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1079,1360097,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,56255,TMX4,https://ctdbase.org/detail.go?type=gene&acc=56255,,,56255.0,TMX4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of TMX4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1080,1360098,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3371,TNC,https://ctdbase.org/detail.go?type=gene&acc=3371,,,3371.0,TNC,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of TNC mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1081,1360099,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),[perfluorooctane sulfonic acid co-treated with lipopolysaccharides] results in decreased expression of TNF protein|mifepristone inhibits the reaction [[perfluorooctane sulfonic acid co-treated with lipopolysaccharides] results in decreased expression of TNF protein],,,PMID:36113621,https://www.ncbi.nlm.nih.gov/pubmed/36113621,36113621,,
1082,1360100,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid inhibits the reaction [lipopolysaccharides results in increased secretion of TNF protein]|perfluorooctane sulfonic acid inhibits the reaction [lipopolysaccharides results in increased expression of TNF mrna],,,PMID:21075133,https://www.ncbi.nlm.nih.gov/pubmed/21075133,21075133,,
1083,1360364,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55603,TENT5A,https://ctdbase.org/detail.go?type=gene&acc=55603,,,55603.0,TENT5A,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of TENT5A mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1084,1360365,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55603,TENT5A,https://ctdbase.org/detail.go?type=gene&acc=55603,,,55603.0,TENT5A,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of TENT5A mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of TENT5A mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of TENT5A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1085,1360366,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,115572,TENT5B,https://ctdbase.org/detail.go?type=gene&acc=115572,,,115572.0,TENT5B,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of TENT5B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1086,1360367,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,54855,TENT5C,https://ctdbase.org/detail.go?type=gene&acc=54855,,,54855.0,TENT5C,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of TENT5C mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of TENT5C mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1087,1360735,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7031,TFF1,https://ctdbase.org/detail.go?type=gene&acc=7031,,,7031.0,TFF1,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid promotes the reaction [estradiol results in increased expression of TFF1 mrna],,,PMID:26234195,https://www.ncbi.nlm.nih.gov/pubmed/26234195,26234195,,
1088,1360736,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7033,TFF3,https://ctdbase.org/detail.go?type=gene&acc=7033,,,7033.0,TFF3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of TFF3 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of TFF3 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of TFF3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1089,1361202,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7050,TGIF1,https://ctdbase.org/detail.go?type=gene&acc=7050,,,7050.0,TGIF1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of TGIF1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1090,1361203,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,60436,TGIF2,https://ctdbase.org/detail.go?type=gene&acc=60436,,,60436.0,TGIF2,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of TGIF2 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1091,1361204,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7051,TGM1,https://ctdbase.org/detail.go?type=gene&acc=7051,,,7051.0,TGM1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of TGM1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1092,1361434,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,80255,SLC35F5,https://ctdbase.org/detail.go?type=gene&acc=80255,,,80255.0,SLC35F5,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of SLC35F5 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of SLC35F5 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of SLC35F5 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1093,1361435,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,54978,SLC35F6,https://ctdbase.org/detail.go?type=gene&acc=54978,,,54978.0,SLC35F6,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of SLC35F6 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1094,1362377,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,22239,UGT8A,https://ctdbase.org/detail.go?type=gene&acc=22239,,,22239.0,Ugt8a,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of UGT8A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1095,1362378,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,127933,UHMK1,https://ctdbase.org/detail.go?type=gene&acc=127933,,,127933.0,UHMK1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of UHMK1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1096,1362379,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,115426,UHRF2,https://ctdbase.org/detail.go?type=gene&acc=115426,,,115426.0,UHRF2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of UHRF2 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of UHRF2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1097,1362380,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8408,ULK1,https://ctdbase.org/detail.go?type=gene&acc=8408,,,8408.0,ULK1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of ULK1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of ULK1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1098,1362381,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9706,ULK2,https://ctdbase.org/detail.go?type=gene&acc=9706,,,9706.0,ULK2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of ULK2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1099,1362382,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,25989,ULK3,https://ctdbase.org/detail.go?type=gene&acc=25989,,,25989.0,ULK3,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of ULK3 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1100,1362383,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,25989,ULK3,https://ctdbase.org/detail.go?type=gene&acc=25989,,,25989.0,ULK3,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of ULK3 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1101,1362384,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,729852,UMAD1,https://ctdbase.org/detail.go?type=gene&acc=729852,,,729852.0,UMAD1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of UMAD1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1102,1362385,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,89766,UMODL1,https://ctdbase.org/detail.go?type=gene&acc=89766,,,89766.0,UMODL1,9913.0,Bos taurus (cattle),Perfluorooctane sulfonic acid affects the expression of UMODL1 mrna|perfluorooctane sulfonic acid affects the methylation of UMODL1 gene,,,PMID:34762985,https://www.ncbi.nlm.nih.gov/pubmed/34762985,34762985,,
1103,1363109,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10600,USP16,https://ctdbase.org/detail.go?type=gene&acc=10600,,,10600.0,USP16,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of USP16 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1104,1363110,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,11274,USP18,https://ctdbase.org/detail.go?type=gene&acc=11274,,,11274.0,USP18,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of USP18 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of USP18 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of USP18 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1105,1363111,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9099,USP2,https://ctdbase.org/detail.go?type=gene&acc=9099,,,9099.0,USP2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of USP2 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of USP2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1106,1363112,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10868,USP20,https://ctdbase.org/detail.go?type=gene&acc=10868,,,10868.0,USP20,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of USP20 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1107,1363113,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23358,USP24,https://ctdbase.org/detail.go?type=gene&acc=23358,,,23358.0,USP24,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of USP24 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1108,1363114,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,29761,USP25,https://ctdbase.org/detail.go?type=gene&acc=29761,,,29761.0,USP25,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of USP25 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1109,1363115,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,29761,USP25,https://ctdbase.org/detail.go?type=gene&acc=29761,,,29761.0,USP25,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of USP25 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1110,1363116,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,57602,USP36,https://ctdbase.org/detail.go?type=gene&acc=57602,,,57602.0,USP36,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of USP36 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of USP36 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1111,1363117,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84640,USP38,https://ctdbase.org/detail.go?type=gene&acc=84640,,,84640.0,USP38,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of USP38 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1112,1363237,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7375,USP4,https://ctdbase.org/detail.go?type=gene&acc=7375,,,7375.0,USP4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of USP4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1113,1363238,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84132,USP42,https://ctdbase.org/detail.go?type=gene&acc=84132,,,84132.0,USP42,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of USP42 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1114,1363239,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,124739,USP43,https://ctdbase.org/detail.go?type=gene&acc=124739,,,124739.0,USP43,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of USP43 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1115,1363240,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,85015,USP45,https://ctdbase.org/detail.go?type=gene&acc=85015,,,85015.0,USP45,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of USP45 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1116,1363241,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55031,USP47,https://ctdbase.org/detail.go?type=gene&acc=55031,,,55031.0,USP47,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of USP47 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1117,1363242,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84196,USP48,https://ctdbase.org/detail.go?type=gene&acc=84196,,,84196.0,USP48,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of USP48 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1118,1363243,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8078,USP5,https://ctdbase.org/detail.go?type=gene&acc=8078,,,8078.0,USP5,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of USP5 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1119,1363244,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,373509,USP50,https://ctdbase.org/detail.go?type=gene&acc=373509,,,373509.0,USP50,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of USP50 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1120,1363245,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,54532,USP53,https://ctdbase.org/detail.go?type=gene&acc=54532,,,54532.0,USP53,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of USP53 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1121,1363845,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7423,VEGFB,https://ctdbase.org/detail.go?type=gene&acc=7423,,,7423.0,VEGFB,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of VEGFB mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of VEGFB mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of VEGFB mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1122,1363989,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6606,SMN1,https://ctdbase.org/detail.go?type=gene&acc=6606,,,6606.0,SMN1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of SMN1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1123,1363990,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6608,SMO,https://ctdbase.org/detail.go?type=gene&acc=6608,,,6608.0,SMO,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of SMO mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1124,1363991,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,64093,SMOC1,https://ctdbase.org/detail.go?type=gene&acc=64093,,,64093.0,SMOC1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of SMOC1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1125,1363992,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,64094,SMOC2,https://ctdbase.org/detail.go?type=gene&acc=64094,,,64094.0,SMOC2,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of SMOC2 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1126,1363993,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,64094,SMOC2,https://ctdbase.org/detail.go?type=gene&acc=64094,,,64094.0,SMOC2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of SMOC2 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of SMOC2 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of SMOC2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1127,1363994,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,54498,SMOX,https://ctdbase.org/detail.go?type=gene&acc=54498,,,54498.0,SMOX,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of SMOX mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1128,1363995,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6610,SMPD2,https://ctdbase.org/detail.go?type=gene&acc=6610,,,6610.0,SMPD2,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of SMPD2 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1129,1363996,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6610,SMPD2,https://ctdbase.org/detail.go?type=gene&acc=6610,,,6610.0,SMPD2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of SMPD2 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of SMPD2 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of SMPD2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1130,1364547,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,559475,VTG1,https://ctdbase.org/detail.go?type=gene&acc=559475,,,559475.0,vtg1,7955.0,Danio rerio (zebrafish),Perfluorooctane sulfonic acid affects the expression of VTG1 mRNA,,,PMID:31437491,https://www.ncbi.nlm.nih.gov/pubmed/31437491,31437491,,
1131,1364548,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,559475,VTG1,https://ctdbase.org/detail.go?type=gene&acc=559475,,,559475.0,vtg1,8022.0,Oncorhynchus mykiss (rainbow trout),Perfluorooctane sulfonic acid results in increased expression of VTG1 mRNA,,,PMID:21984479,https://www.ncbi.nlm.nih.gov/pubmed/21984479,21984479,,
1132,1364549,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,143187,VTI1A,https://ctdbase.org/detail.go?type=gene&acc=143187,,,143187.0,VTI1A,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of VTI1A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1133,1364550,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10490,VTI1B,https://ctdbase.org/detail.go?type=gene&acc=10490,,,10490.0,VTI1B,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of VTI1B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1134,1364551,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7448,VTN,https://ctdbase.org/detail.go?type=gene&acc=7448,,,7448.0,VTN,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of VTN mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of VTN mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1135,1364552,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,4013,VWA5A,https://ctdbase.org/detail.go?type=gene&acc=4013,,,4013.0,VWA5A,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of VWA5A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1136,1430219,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8708,B3GALT1,https://ctdbase.org/detail.go?type=gene&acc=8708,,,8708.0,B3GALT1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of B3GALT1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1137,1430220,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,100288842,B3GALT9,https://ctdbase.org/detail.go?type=gene&acc=100288842,,,100288842.0,B3GALT9,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of B3GALT9 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1138,1430221,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,27087,B3GAT1,https://ctdbase.org/detail.go?type=gene&acc=27087,,,27087.0,B3GAT1,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of B3GAT1 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1139,1430222,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,26229,B3GAT3,https://ctdbase.org/detail.go?type=gene&acc=26229,,,26229.0,B3GAT3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of B3GAT3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1140,1430223,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,145173,B3GLCT,https://ctdbase.org/detail.go?type=gene&acc=145173,,,145173.0,B3GLCT,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of B3GLCT mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1141,1430224,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10678,B3GNT2,https://ctdbase.org/detail.go?type=gene&acc=10678,,,10678.0,B3GNT2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of B3GNT2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1142,1430225,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10331,B3GNT3,https://ctdbase.org/detail.go?type=gene&acc=10331,,,10331.0,B3GNT3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of B3GNT3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1143,1430226,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84002,B3GNT5,https://ctdbase.org/detail.go?type=gene&acc=84002,,,84002.0,B3GNT5,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of B3GNT5 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1144,1430227,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,374907,B3GNT8,https://ctdbase.org/detail.go?type=gene&acc=374907,,,374907.0,B3GNT8,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of B3GNT8 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1145,1430447,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9532,BAG2,https://ctdbase.org/detail.go?type=gene&acc=9532,,,9532.0,BAG2,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of BAG2 mrna|[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of BAG2 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1146,1430556,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,387261,BAIAP2L1A,https://ctdbase.org/detail.go?type=gene&acc=387261,,,387261.0,baiap2l1a,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of BAIAP2L1A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1147,1430557,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8938,BAIAP3,https://ctdbase.org/detail.go?type=gene&acc=8938,,,8938.0,BAIAP3,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of BAIAP3 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1148,1430558,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid promotes the reaction [BAX protein binds to BAK1 protein],,,PMID:34006824,https://www.ncbi.nlm.nih.gov/pubmed/34006824,34006824,,
1149,1430559,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of BAK1 mRNA,,,PMID:32790152,https://www.ncbi.nlm.nih.gov/pubmed/32790152,32790152,,
1150,1430560,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of BAK1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of BAK1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of BAK1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1151,1430767,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of BAX protein,,,PMID:26844784|PMID:34006824|PMID:36988283,https://www.ncbi.nlm.nih.gov/pubmed/26844784|https://www.ncbi.nlm.nih.gov/pubmed/34006824|https://www.ncbi.nlm.nih.gov/pubmed/36988283,26844784|34006824|36988283,,
1152,1430768,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of BAX mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1153,1430769,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of BAX mRNA,,,PMID:23562911,https://www.ncbi.nlm.nih.gov/pubmed/23562911,23562911,,
1154,1430770,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of BAX mRNA,,,PMID:21115943|PMID:23562911|PMID:36988283,https://www.ncbi.nlm.nih.gov/pubmed/21115943|https://www.ncbi.nlm.nih.gov/pubmed/23562911|https://www.ncbi.nlm.nih.gov/pubmed/36988283,21115943|23562911|36988283,,
1155,1430771,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of BAX protein,,,PMID:34303733|PMID:36988283,https://www.ncbi.nlm.nih.gov/pubmed/34303733|https://www.ncbi.nlm.nih.gov/pubmed/36988283,34303733|36988283,,
1156,1430979,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10286,BCAS2,https://ctdbase.org/detail.go?type=gene&acc=10286,,,10286.0,BCAS2,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of BCAS2 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1157,1430980,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10286,BCAS2,https://ctdbase.org/detail.go?type=gene&acc=10286,,,10286.0,BCAS2,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of BCAS2 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1158,1430981,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,586,BCAT1,https://ctdbase.org/detail.go?type=gene&acc=586,,,586.0,BCAT1,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of BCAT1 protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
1159,1430982,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,587,BCAT2,https://ctdbase.org/detail.go?type=gene&acc=587,,,587.0,BCAT2,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of BCAT2 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1160,1430983,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,587,BCAT2,https://ctdbase.org/detail.go?type=gene&acc=587,,,587.0,BCAT2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of BCAT2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1161,1431804,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9044,BTAF1,https://ctdbase.org/detail.go?type=gene&acc=9044,,,9044.0,BTAF1,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of BTAF1 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1162,1431805,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,560466,BTBD10A,https://ctdbase.org/detail.go?type=gene&acc=560466,,,560466.0,btbd10a,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of BTBD10A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1163,1431806,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,90135,BTBD6,https://ctdbase.org/detail.go?type=gene&acc=90135,,,90135.0,BTBD6,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of BTBD6 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1164,1431807,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,284697,BTBD8,https://ctdbase.org/detail.go?type=gene&acc=284697,,,284697.0,BTBD8,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of BTBD8 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1165,1431808,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,685,BTC,https://ctdbase.org/detail.go?type=gene&acc=685,,,685.0,BTC,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of BTC mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of BTC mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1166,1431809,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,686,BTD,https://ctdbase.org/detail.go?type=gene&acc=686,,,686.0,BTD,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of BTD mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1167,1431810,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,689,BTF3,https://ctdbase.org/detail.go?type=gene&acc=689,,,689.0,BTF3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of BTF3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1168,1431811,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,694,BTG1,https://ctdbase.org/detail.go?type=gene&acc=694,,,694.0,BTG1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of BTG1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1169,1431812,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,7832,BTG2,https://ctdbase.org/detail.go?type=gene&acc=7832,,,7832.0,BTG2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of BTG2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1170,1431813,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10950,BTG3,https://ctdbase.org/detail.go?type=gene&acc=10950,,,10950.0,BTG3,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of BTG3 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1171,1432551,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,562475,C7A,https://ctdbase.org/detail.go?type=gene&acc=562475,,,562475.0,c7a,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of C7A mrna|perfluorooctane sulfonic acid results in increased expression of C7A mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1172,1432552,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,570832,C7B,https://ctdbase.org/detail.go?type=gene&acc=570832,,,570832.0,c7b,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of C7B mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1173,1432553,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,731,C8A,https://ctdbase.org/detail.go?type=gene&acc=731,,,731.0,C8A,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of C8A mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
1174,1433239,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,822,CAPG,https://ctdbase.org/detail.go?type=gene&acc=822,,,822.0,CAPG,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CAPG mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1175,1433240,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,336597,CAPGB,https://ctdbase.org/detail.go?type=gene&acc=336597,,,336597.0,capgb,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of CAPGB mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1176,1433241,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,823,CAPN1,https://ctdbase.org/detail.go?type=gene&acc=823,,,823.0,CAPN1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CAPN1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1177,1433366,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,826,CAPNS1,https://ctdbase.org/detail.go?type=gene&acc=826,,,826.0,CAPNS1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CAPNS1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of CAPNS1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of CAPNS1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1178,1435005,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,729438,CASTOR2,https://ctdbase.org/detail.go?type=gene&acc=729438,,,729438.0,CASTOR2,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of CASTOR2 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1179,1435006,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,7955.0,Danio rerio (zebrafish),Perfluorooctane sulfonic acid results in increased activity of CAT protein,,,PMID:20200220,https://www.ncbi.nlm.nih.gov/pubmed/20200220,20200220,,
1180,1435007,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),CAT protein inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of MIR155 mrna],,,PMID:26844784,https://www.ncbi.nlm.nih.gov/pubmed/26844784,26844784,,
1181,1435008,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased activity of CAT protein,,,PMID:19468714,https://www.ncbi.nlm.nih.gov/pubmed/19468714,19468714,,
1182,1435009,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of CAT mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
1183,1435010,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of CAT mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1184,1435011,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,29158.0,Mytilus galloprovincialis (Mediterranean mussel),Perfluorooctane sulfonic acid results in increased activity of CAT protein,,,PMID:27626137,https://www.ncbi.nlm.nih.gov/pubmed/27626137,27626137,,
1185,1435012,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased activity of CAT protein,,,PMID:27825932,https://www.ncbi.nlm.nih.gov/pubmed/27825932,27825932,,
1186,1435131,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,857,CAV1,https://ctdbase.org/detail.go?type=gene&acc=857,,,857.0,CAV1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CAV1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of CAV1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of CAV1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1187,1435132,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,858,CAV2,https://ctdbase.org/detail.go?type=gene&acc=858,,,858.0,CAV2,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of CAV2 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1188,1435854,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,339829,CCDC39,https://ctdbase.org/detail.go?type=gene&acc=339829,,,339829.0,CCDC39,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of CCDC39 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1189,1435855,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,560952,CCDC3A,https://ctdbase.org/detail.go?type=gene&acc=560952,,,560952.0,ccdc3a,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of CCDC3A mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1190,1435856,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,124808,CCDC43,https://ctdbase.org/detail.go?type=gene&acc=124808,,,124808.0,CCDC43,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of CCDC43 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1191,1435857,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,80323,CCDC68,https://ctdbase.org/detail.go?type=gene&acc=80323,,,80323.0,CCDC68,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of CCDC68 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1192,1435858,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,26112,CCDC69,https://ctdbase.org/detail.go?type=gene&acc=26112,,,26112.0,CCDC69,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of CCDC69 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1193,1436492,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,283638,CEP170B,https://ctdbase.org/detail.go?type=gene&acc=283638,,,283638.0,CEP170B,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of CEP170B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1194,1436493,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55125,CEP192,https://ctdbase.org/detail.go?type=gene&acc=55125,,,55125.0,CEP192,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in decreased expression of CEP192 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1195,1436494,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55125,CEP192,https://ctdbase.org/detail.go?type=gene&acc=55125,,,55125.0,CEP192,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CEP192 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1196,1436495,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,80184,CEP290,https://ctdbase.org/detail.go?type=gene&acc=80184,,,80184.0,CEP290,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of CEP290 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1197,1436496,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,80184,CEP290,https://ctdbase.org/detail.go?type=gene&acc=80184,,,80184.0,CEP290,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of CEP290 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1198,1438110,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,933,CD22,https://ctdbase.org/detail.go?type=gene&acc=933,,,933.0,CD22,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of CD22 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1199,1438111,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,100133941,CD24,https://ctdbase.org/detail.go?type=gene&acc=100133941,,,100133941.0,CD24,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of CD24 mRNA,,,PMID:18692542,https://www.ncbi.nlm.nih.gov/pubmed/18692542,18692542,,
1200,1438112,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,12484,CD24A,https://ctdbase.org/detail.go?type=gene&acc=12484,,,12484.0,Cd24a,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of CD24A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1201,1438113,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,80381,CD276,https://ctdbase.org/detail.go?type=gene&acc=80381,,,80381.0,CD276,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of CD276 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CD276 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1202,1438114,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23607,CD2AP,https://ctdbase.org/detail.go?type=gene&acc=23607,,,23607.0,CD2AP,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of CD2AP mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1203,1438115,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,140497,CD300C2,https://ctdbase.org/detail.go?type=gene&acc=140497,,,140497.0,Cd300c2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CD300C2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1204,1438116,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,100131439,CD300LD,https://ctdbase.org/detail.go?type=gene&acc=100131439,,,100131439.0,CD300LD,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CD300LD mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1205,1438117,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,146894,CD300LG,https://ctdbase.org/detail.go?type=gene&acc=146894,,,146894.0,CD300LG,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of CD300LG mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1206,1438118,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9936,CD302,https://ctdbase.org/detail.go?type=gene&acc=9936,,,9936.0,CD302,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of CD302 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1207,1438238,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in increased expression of CD36 mRNA,,,PMID:18692542|PMID:21723365,https://www.ncbi.nlm.nih.gov/pubmed/18692542|https://www.ncbi.nlm.nih.gov/pubmed/21723365,18692542|21723365,,
1208,1439912,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,100505876,CEBPZOS,https://ctdbase.org/detail.go?type=gene&acc=100505876,,,100505876.0,CEBPZOS,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of CEBPZOS mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1209,1439913,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,27443,CECR2,https://ctdbase.org/detail.go?type=gene&acc=27443,,,27443.0,CECR2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CECR2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1210,1439914,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1990,CELA1,https://ctdbase.org/detail.go?type=gene&acc=1990,,,1990.0,CELA1,8049.0,Gadus morhua (Atlantic cod),"Perfluorooctane sulfonic acid results in increased expression of CELA1 mrna|[hydrocarbons, chlorinated co-treated with pentabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in increased expression of CELA1 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1211,1439915,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1990,CELA1,https://ctdbase.org/detail.go?type=gene&acc=1990,,,1990.0,CELA1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of CELA1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CELA1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1212,1439916,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1990,CELA1,https://ctdbase.org/detail.go?type=gene&acc=1990,,,1990.0,CELA1,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in increased expression of CELA1 mRNA,,,PMID:18692542,https://www.ncbi.nlm.nih.gov/pubmed/18692542,18692542,,
1213,1439917,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,63036,CELA2A,https://ctdbase.org/detail.go?type=gene&acc=63036,,,63036.0,CELA2A,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of CELA2A mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
1214,1444484,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5162,PDHB,https://ctdbase.org/detail.go?type=gene&acc=5162,,,5162.0,PDHB,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of PDHB mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1215,1444485,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2923,PDIA3,https://ctdbase.org/detail.go?type=gene&acc=2923,,,2923.0,PDIA3,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of PDIA3 mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
1216,1444486,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2923,PDIA3,https://ctdbase.org/detail.go?type=gene&acc=2923,,,2923.0,PDIA3,8030.0,Salmo salar (Atlantic salmon),Perfluorooctane sulfonic acid results in increased expression of PDIA3 mRNA,,,PMID:19747560,https://www.ncbi.nlm.nih.gov/pubmed/19747560,19747560,,
1217,1444487,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10130,PDIA6,https://ctdbase.org/detail.go?type=gene&acc=10130,,,10130.0,PDIA6,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PDIA6 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1218,1444488,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10130,PDIA6,https://ctdbase.org/detail.go?type=gene&acc=10130,,,10130.0,PDIA6,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PDIA6 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of PDIA6 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1219,1444981,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5178,PEG3,https://ctdbase.org/detail.go?type=gene&acc=5178,,,5178.0,PEG3,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of PEG3 mRNA,,,PMID:28558994,https://www.ncbi.nlm.nih.gov/pubmed/28558994,28558994,,
1220,1444982,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,558420,PELI1B,https://ctdbase.org/detail.go?type=gene&acc=558420,,,558420.0,peli1b,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PELI1B mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1221,1444983,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,57161,PELI2,https://ctdbase.org/detail.go?type=gene&acc=57161,,,57161.0,PELI2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PELI2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1222,1444984,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,53918,PELO,https://ctdbase.org/detail.go?type=gene&acc=53918,,,53918.0,PELO,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PELO mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1223,1445471,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8504,PEX3,https://ctdbase.org/detail.go?type=gene&acc=8504,,,8504.0,PEX3,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of PEX3 mRNA,,,PMID:19429403|PMID:20936131,https://www.ncbi.nlm.nih.gov/pubmed/19429403|https://www.ncbi.nlm.nih.gov/pubmed/20936131,19429403|20936131,,
1224,1445472,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5830,PEX5,https://ctdbase.org/detail.go?type=gene&acc=5830,,,5830.0,PEX5,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PEX5 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1225,1450303,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5527,PPP2R5C,https://ctdbase.org/detail.go?type=gene&acc=5527,,,5527.0,PPP2R5C,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PPP2R5C mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PPP2R5C mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PPP2R5C mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1226,1450304,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5529,PPP2R5E,https://ctdbase.org/detail.go?type=gene&acc=5529,,,5529.0,PPP2R5E,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of PPP2R5E mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PPP2R5E mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1227,1450305,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5530,PPP3CA,https://ctdbase.org/detail.go?type=gene&acc=5530,,,5530.0,PPP3CA,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in increased expression of PPP3CA mRNA,,,PMID:20136073,https://www.ncbi.nlm.nih.gov/pubmed/20136073,20136073,,
1228,1450306,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5533,PPP3CC,https://ctdbase.org/detail.go?type=gene&acc=5533,,,5533.0,PPP3CC,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PPP3CC mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1229,1450307,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5534,PPP3R1,https://ctdbase.org/detail.go?type=gene&acc=5534,,,5534.0,PPP3R1,10116.0,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in increased expression of PPP3R1 mRNA,,,PMID:20136073,https://www.ncbi.nlm.nih.gov/pubmed/20136073,20136073,,
1230,1450638,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PPARGC1A mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of PPARGC1A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1231,1450639,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of PPARGC1A mRNA,,,PMID:20936131|PMID:21705711,https://www.ncbi.nlm.nih.gov/pubmed/20936131|https://www.ncbi.nlm.nih.gov/pubmed/21705711,20936131|21705711,,
1232,1450640,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of PPARGC1A protein,,,PMID:28288859|PMID:32861759,https://www.ncbi.nlm.nih.gov/pubmed/28288859|https://www.ncbi.nlm.nih.gov/pubmed/32861759,28288859|32861759,,
1233,1450641,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,133522,PPARGC1B,https://ctdbase.org/detail.go?type=gene&acc=133522,,,133522.0,PPARGC1B,8049.0,Gadus morhua (Atlantic cod),[petroleum analog co-treated with aroclor 1242 co-treated with chlorodiphenyl (54% chlorine) co-treated with aroclor 1260 co-treated with polychlorinated biphenyls co-treated with pentabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in decreased expression of PPARGC1B mRNA,,,PMID:23266412,https://www.ncbi.nlm.nih.gov/pubmed/23266412,23266412,,
1234,1450642,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5471,PPAT,https://ctdbase.org/detail.go?type=gene&acc=5471,,,5471.0,PPAT,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PPAT mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1235,1450643,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,60490,PPCDC,https://ctdbase.org/detail.go?type=gene&acc=60490,,,60490.0,PPCDC,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PPCDC mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1236,1450644,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,79717,PPCS,https://ctdbase.org/detail.go?type=gene&acc=79717,,,79717.0,PPCS,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PPCS mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PPCS mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1237,1451567,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,26051,PPP1R16B,https://ctdbase.org/detail.go?type=gene&acc=26051,,,26051.0,PPP1R16B,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of PPP1R16B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1238,1451568,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5502,PPP1R1A,https://ctdbase.org/detail.go?type=gene&acc=5502,,,5502.0,PPP1R1A,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of PPP1R1A mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
1239,1482916,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8411,EEA1,https://ctdbase.org/detail.go?type=gene&acc=8411,,,8411.0,EEA1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of EEA1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1240,1482917,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8411,EEA1,https://ctdbase.org/detail.go?type=gene&acc=8411,,,8411.0,EEA1,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of EEA1 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1241,1485593,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10436,EMG1,https://ctdbase.org/detail.go?type=gene&acc=10436,,,10436.0,EMG1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of EMG1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1242,1485594,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,751598,EMILIN1B,https://ctdbase.org/detail.go?type=gene&acc=751598,,,751598.0,emilin1b,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of EMILIN1B mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1243,1485595,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84034,EMILIN2,https://ctdbase.org/detail.go?type=gene&acc=84034,,,84034.0,EMILIN2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of EMILIN2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1244,1485596,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2009,EML1,https://ctdbase.org/detail.go?type=gene&acc=2009,,,2009.0,EML1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of EML1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1245,1485597,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2009,EML1,https://ctdbase.org/detail.go?type=gene&acc=2009,,,2009.0,EML1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of EML1 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1246,1485598,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,24139,EML2,https://ctdbase.org/detail.go?type=gene&acc=24139,,,24139.0,EML2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of EML2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1247,1485599,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,256364,EML3,https://ctdbase.org/detail.go?type=gene&acc=256364,,,256364.0,EML3,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of EML3 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1248,1485600,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,256364,EML3,https://ctdbase.org/detail.go?type=gene&acc=256364,,,256364.0,EML3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of EML3 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of EML3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1249,1485601,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,27436,EML4,https://ctdbase.org/detail.go?type=gene&acc=27436,,,27436.0,EML4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of EML4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1250,1485602,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2012,EMP1,https://ctdbase.org/detail.go?type=gene&acc=2012,,,2012.0,EMP1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of EMP1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of EMP1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1251,1440028,75834,Comparative Toxicogenomics Database (CTD),4-Nitrophenyl butyrate,C033592,4-nitrophenyl butyrate,https://ctdbase.org/detail.go?type=chem&acc=C033592,1066,CES1,https://ctdbase.org/detail.go?type=gene&acc=1066,,,1066.0,CES1,9606.0,Homo sapiens (human),CES1 protein binds to and results in increased hydrolysis of 4-nitrophenyl butyrate,,,PMID:16282638,https://www.ncbi.nlm.nih.gov/pubmed/16282638,16282638,,
1252,1488628,76223,Toxin and Toxin Target Database (T3DB),Silver trifluoromethanesulfonate,T3D1620,Silver trifluoromethanesulfonate,http://www.t3db.ca/toxins/T3D1620,BE0005031,Sodium/potassium-transporting ATPase subunit alpha-4,http://www.t3db.ca/biodb/bio_entities/BE0005031,Q13733,Sodium/potassium-transporting ATPase subunit alpha-4,480.0,ATP1A4,9606.0,Homo sapiens (human),"The silver ion is known to inhibit NA+,K+-atpase activity, disrupting intracellular ion concentrations. (A243)",,,PMID:15748748,https://www.ncbi.nlm.nih.gov/pubmed/15748748,15748748,,
1253,1488629,76223,Toxin and Toxin Target Database (T3DB),Silver trifluoromethanesulfonate,T3D1620,Silver trifluoromethanesulfonate,http://www.t3db.ca/toxins/T3D1620,BE0004994,Sodium/potassium-transporting ATPase subunit beta-1,http://www.t3db.ca/biodb/bio_entities/BE0004994,P05026,Sodium/potassium-transporting ATPase subunit beta-1,481.0,ATP1B1,9606.0,Homo sapiens (human),"The silver ion is known to inhibit NA+,K+-atpase activity, disrupting intracellular ion concentrations. (A243)",,,PMID:15748748,https://www.ncbi.nlm.nih.gov/pubmed/15748748,15748748,,
1254,1360874,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,2297,FOXD1,https://ctdbase.org/detail.go?type=gene&acc=2297,,,2297.0,FOXD1,10090.0,Mus musculus (house mouse),Fluorene-9-bisphenol results in increased expression of FOXD1 mRNA,,,PMID:33989918,https://www.ncbi.nlm.nih.gov/pubmed/33989918,33989918,,
1255,1360875,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,27086,FOXP1,https://ctdbase.org/detail.go?type=gene&acc=27086,,,27086.0,FOXP1,10090.0,Mus musculus (house mouse),Fluorene-9-bisphenol results in increased expression of FOXP1 mRNA,,,PMID:33989918,https://www.ncbi.nlm.nih.gov/pubmed/33989918,33989918,,
1256,1360876,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,7955.0,Danio rerio (zebrafish),Fluorene-9-bisphenol results in increased expression of FSHB mRNA,,,PMID:36801538,https://www.ncbi.nlm.nih.gov/pubmed/36801538,36801538,,
1257,1360877,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,2492,FSHR,https://ctdbase.org/detail.go?type=gene&acc=2492,,,2492.0,FSHR,10116.0,Rattus norvegicus (Norway rat),Fluorene-9-bisphenol results in increased expression of FSHR protein|fluorene-9-bisphenol results in increased expression of FSHR mRNA,,,PMID:35764126,https://www.ncbi.nlm.nih.gov/pubmed/35764126,35764126,,
1258,1360878,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,2524,FUT2,https://ctdbase.org/detail.go?type=gene&acc=2524,,,2524.0,FUT2,10090.0,Mus musculus (house mouse),Fluorene-9-bisphenol results in increased expression of FUT2 mRNA,,,PMID:33989918,https://www.ncbi.nlm.nih.gov/pubmed/33989918,33989918,,
1259,1360879,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10090.0,Mus musculus (house mouse),Fluorene-9-bisphenol results in increased activity of GPT protein,,,PMID:33989918,https://www.ncbi.nlm.nih.gov/pubmed/33989918,33989918,,
1260,1360880,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,352926,GPX1A,https://ctdbase.org/detail.go?type=gene&acc=352926,,,352926.0,gpx1a,7955.0,Danio rerio (zebrafish),Fluorene-9-bisphenol results in increased expression of GPX1A mRNA,,,PMID:31048237,https://www.ncbi.nlm.nih.gov/pubmed/31048237,31048237,,
1261,1360881,76716,Comparative Toxicogenomics Database (CTD),"9,9-Bis(4-hydroxyphenyl)fluorene",C000655605,fluorene-9-bisphenol,https://ctdbase.org/detail.go?type=chem&acc=C000655605,2878,GPX3,https://ctdbase.org/detail.go?type=gene&acc=2878,,,2878.0,GPX3,10090.0,Mus musculus (house mouse),Fluorene-9-bisphenol results in increased expression of GPX3 mRNA,,,PMID:31082581,https://www.ncbi.nlm.nih.gov/pubmed/31082581,31082581,,
1262,1361583,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10090.0,Mus musculus (house mouse),Rosiglitazone results in increased expression of PPARGC1A mRNA,,,PMID:15520860|PMID:16513826|PMID:22087241|PMID:28853159|PMID:29910772|PMID:30027469,https://www.ncbi.nlm.nih.gov/pubmed/15520860|https://www.ncbi.nlm.nih.gov/pubmed/16513826|https://www.ncbi.nlm.nih.gov/pubmed/22087241|https://www.ncbi.nlm.nih.gov/pubmed/28853159|https://www.ncbi.nlm.nih.gov/pubmed/29910772|https://www.ncbi.nlm.nih.gov/pubmed/30027469,15520860|16513826|22087241|28853159|29910772|30027469,,
1263,1361584,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of PPARGC1A mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1264,1361585,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,9940.0,Ovis aries (sheep),Rosiglitazone results in increased expression of PPARGC1A mRNA,,,PMID:19520784,https://www.ncbi.nlm.nih.gov/pubmed/19520784,19520784,,
1265,1361586,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone inhibits the reaction [fructose results in increased expression of PPARGC1A protein],,,PMID:19196556,https://www.ncbi.nlm.nih.gov/pubmed/19196556,19196556,,
1266,1362824,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5791,PTPRE,https://ctdbase.org/detail.go?type=gene&acc=5791,,,5791.0,PTPRE,9606.0,Homo sapiens (human),Rosiglitazone results in increased expression of PTPRE mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
1267,1362825,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5795,PTPRJ,https://ctdbase.org/detail.go?type=gene&acc=5795,,,5795.0,PTPRJ,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of PTPRJ mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1268,1362826,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,29108,PYCARD,https://ctdbase.org/detail.go?type=gene&acc=29108,,,29108.0,PYCARD,10090.0,Mus musculus (house mouse),NFE2L2 protein affects the reaction [rosiglitazone results in decreased expression of PYCARD mrna]|rosiglitazone results in decreased expression of PYCARD mrna|[nfe2l2 protein affects the susceptibility to rosiglitazone] which affects the expression of PYCARD mRNA,,,PMID:33137425,https://www.ncbi.nlm.nih.gov/pubmed/33137425,33137425,,
1269,1362827,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5836,PYGL,https://ctdbase.org/detail.go?type=gene&acc=5836,,,5836.0,PYGL,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of PYGL mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
1270,1365362,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,27244,SESN1,https://ctdbase.org/detail.go?type=gene&acc=27244,,,27244.0,SESN1,10090.0,Mus musculus (house mouse),2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of SESN1 mrna]|rosiglitazone results in increased expression of SESN1 mRNA,,,PMID:19226370,https://www.ncbi.nlm.nih.gov/pubmed/19226370,19226370,,
1271,1365363,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,143686,SESN3,https://ctdbase.org/detail.go?type=gene&acc=143686,,,143686.0,SESN3,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of SESN3 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1272,1365364,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,26040,SETBP1,https://ctdbase.org/detail.go?type=gene&acc=26040,,,26040.0,SETBP1,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of SETBP1 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1273,1365365,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,57713,SFMBT2,https://ctdbase.org/detail.go?type=gene&acc=57713,,,57713.0,SFMBT2,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of SFMBT2 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1274,1365366,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,6422,SFRP1,https://ctdbase.org/detail.go?type=gene&acc=6422,,,6422.0,SFRP1,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of SFRP1 mRNA,,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
1275,1365367,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,6423,SFRP2,https://ctdbase.org/detail.go?type=gene&acc=6423,,,6423.0,SFRP2,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of SFRP2 mRNA,,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
1276,1365368,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,6424,SFRP4,https://ctdbase.org/detail.go?type=gene&acc=6424,,,6424.0,SFRP4,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in increased expression of SFRP4 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1277,1365369,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,6439,SFTPB,https://ctdbase.org/detail.go?type=gene&acc=6439,,,6439.0,SFTPB,10090.0,Mus musculus (house mouse),Rosiglitazone inhibits the reaction [ozone results in decreased expression of SFTPB protein],,,PMID:37202362,https://www.ncbi.nlm.nih.gov/pubmed/37202362,37202362,,
1278,1365485,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,81855,SFXN3,https://ctdbase.org/detail.go?type=gene&acc=81855,,,81855.0,SFXN3,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of SFXN3 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1279,1365486,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,6444,SGCD,https://ctdbase.org/detail.go?type=gene&acc=6444,,,6444.0,SGCD,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of SGCD mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1280,1365487,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,6446,SGK1,https://ctdbase.org/detail.go?type=gene&acc=6446,,,6446.0,SGK1,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SGK1 mRNA,,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
1281,1365488,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,10110,SGK2,https://ctdbase.org/detail.go?type=gene&acc=10110,,,10110.0,SGK2,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of SGK2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1282,1365489,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,9467,SH3BP5,https://ctdbase.org/detail.go?type=gene&acc=9467,,,9467.0,SH3BP5,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of SH3BP5 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1283,1365490,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,54436,SH3TC1,https://ctdbase.org/detail.go?type=gene&acc=54436,,,54436.0,SH3TC1,9606.0,Homo sapiens (human),Rosiglitazone results in increased expression of SH3TC1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
1284,1365491,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,56961,SHD,https://ctdbase.org/detail.go?type=gene&acc=56961,,,56961.0,SHD,9606.0,Homo sapiens (human),Rosiglitazone results in decreased expression of SHD mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
1285,1365492,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,57477,SHROOM4,https://ctdbase.org/detail.go?type=gene&acc=57477,,,57477.0,SHROOM4,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of SHROOM4 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1286,1466056,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,51,ACOX1,https://ctdbase.org/detail.go?type=gene&acc=51,,,51.0,ACOX1,10090.0,Mus musculus (house mouse),Rosiglitazone results in increased expression of ACOX1 mRNA,,,PMID:17245590|PMID:22173916|PMID:23322813|PMID:29910772,https://www.ncbi.nlm.nih.gov/pubmed/17245590|https://www.ncbi.nlm.nih.gov/pubmed/22173916|https://www.ncbi.nlm.nih.gov/pubmed/23322813|https://www.ncbi.nlm.nih.gov/pubmed/29910772,17245590|22173916|23322813|29910772,,
1287,1466057,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,51,ACOX1,https://ctdbase.org/detail.go?type=gene&acc=51,,,51.0,ACOX1,10090.0,Mus musculus (house mouse),Rosiglitazone results in increased expression of ACOX1 protein,,,PMID:22173916,https://www.ncbi.nlm.nih.gov/pubmed/22173916,22173916,,
1288,1466058,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,51,ACOX1,https://ctdbase.org/detail.go?type=gene&acc=51,,,51.0,ACOX1,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of ACOX1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1289,1466059,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,53,ACP2,https://ctdbase.org/detail.go?type=gene&acc=53,,,53.0,ACP2,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ACP2 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1290,1466060,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,55,ACP3,https://ctdbase.org/detail.go?type=gene&acc=55,,,55.0,ACP3,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of ACP3 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1291,1466061,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,2180,ACSL1,https://ctdbase.org/detail.go?type=gene&acc=2180,,,2180.0,ACSL1,10090.0,Mus musculus (house mouse),EGF protein inhibits the reaction [[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACSL1 mrna]|tetrachlorodibenzodioxin inhibits the reaction [[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACSL1 mrna]|[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACSL1 mRNA,,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
1292,1466318,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,3716,JAK1,https://ctdbase.org/detail.go?type=gene&acc=3716,,,3716.0,JAK1,9606.0,Homo sapiens (human),Rosiglitazone inhibits the reaction [IFNG protein results in increased phosphorylation of JAK1 protein],,,PMID:12584205,https://www.ncbi.nlm.nih.gov/pubmed/12584205,12584205,,
1293,1466319,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,3717,JAK2,https://ctdbase.org/detail.go?type=gene&acc=3717,,,3717.0,JAK2,9606.0,Homo sapiens (human),Rosiglitazone inhibits the reaction [IFNG protein results in increased phosphorylation of JAK2 protein],,,PMID:12584205,https://www.ncbi.nlm.nih.gov/pubmed/12584205,12584205,,
1294,1466320,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,58494,JAM2,https://ctdbase.org/detail.go?type=gene&acc=58494,,,58494.0,JAM2,10090.0,Mus musculus (house mouse),Rosiglitazone results in increased expression of JAM2 mRNA,,,PMID:24848799,https://www.ncbi.nlm.nih.gov/pubmed/24848799,24848799,,
1295,1466321,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10090.0,Mus musculus (house mouse),Rosiglitazone inhibits the reaction [ceruletide results in increased expression of JUN mrna],,,PMID:17463185,https://www.ncbi.nlm.nih.gov/pubmed/17463185,17463185,,
1296,1466322,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,3726,JUNB,https://ctdbase.org/detail.go?type=gene&acc=3726,,,3726.0,JUNB,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of JUNB mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1297,1466323,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,84056,KATNAL1,https://ctdbase.org/detail.go?type=gene&acc=84056,,,84056.0,KATNAL1,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of KATNAL1 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1298,1466324,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,3764,KCNJ8,https://ctdbase.org/detail.go?type=gene&acc=3764,,,3764.0,KCNJ8,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of KCNJ8 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1299,1466325,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,3776,KCNK2,https://ctdbase.org/detail.go?type=gene&acc=3776,,,3776.0,KCNK2,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of KCNK2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1300,1482108,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,10154,PLXNC1,https://ctdbase.org/detail.go?type=gene&acc=10154,,,10154.0,PLXNC1,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of PLXNC1 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1301,1482109,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,56937,PMEPA1,https://ctdbase.org/detail.go?type=gene&acc=56937,,,56937.0,PMEPA1,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of PMEPA1 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1302,1482110,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,56937,PMEPA1,https://ctdbase.org/detail.go?type=gene&acc=56937,,,56937.0,PMEPA1,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of PMEPA1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
1303,1482111,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5376,PMP22,https://ctdbase.org/detail.go?type=gene&acc=5376,,,5376.0,PMP22,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of PMP22 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
1304,1482112,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5406,PNLIP,https://ctdbase.org/detail.go?type=gene&acc=5406,,,5406.0,PNLIP,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of PNLIP mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1305,1482113,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,57104,PNPLA2,https://ctdbase.org/detail.go?type=gene&acc=57104,,,57104.0,PNPLA2,10090.0,Mus musculus (house mouse),"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone results in increased expression of PNPLA2 mrna]|cycloheximide inhibits the reaction [rosiglitazone results in increased expression of PNPLA2 protein]|rosiglitazone results in increased expression of PNPLA2 protein",,,PMID:18643838,https://www.ncbi.nlm.nih.gov/pubmed/18643838,18643838,,
1306,1482114,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,57104,PNPLA2,https://ctdbase.org/detail.go?type=gene&acc=57104,,,57104.0,PNPLA2,10090.0,Mus musculus (house mouse),[NFE2L2 protein affects the susceptibility to rosiglitazone] which affects the expression of PNPLA2 mRNA alternative form|nfe2l2 protein affects the reaction [rosiglitazone results in decreased expression of PNPLA2 mrna]|rosiglitazone results in decreased expression of PNPLA2 mRNA,,,PMID:33137425,https://www.ncbi.nlm.nih.gov/pubmed/33137425,33137425,,
1307,1482115,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,57104,PNPLA2,https://ctdbase.org/detail.go?type=gene&acc=57104,,,57104.0,PNPLA2,10090.0,Mus musculus (house mouse),Rosiglitazone affects the expression of PNPLA2 mRNA,,,PMID:22013433,https://www.ncbi.nlm.nih.gov/pubmed/22013433,22013433,,
1308,1482116,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,57104,PNPLA2,https://ctdbase.org/detail.go?type=gene&acc=57104,,,57104.0,PNPLA2,10090.0,Mus musculus (house mouse),Rosiglitazone inhibits the reaction [[dietary fats co-treated with dietary sugars] results in decreased expression of PNPLA2 mrna],,,PMID:28611668,https://www.ncbi.nlm.nih.gov/pubmed/28611668,28611668,,
1309,1484859,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Triphenyl bismuth inhibits the reaction [rosiglitazone binds to PPARG protein]|triphenylarsine inhibits the reaction [rosiglitazone binds to PPARG protein],,,PMID:27725436,https://www.ncbi.nlm.nih.gov/pubmed/27725436,27725436,,
1310,1487065,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,401409,RAB19,https://ctdbase.org/detail.go?type=gene&acc=401409,,,401409.0,RAB19,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of RAB19 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
1311,1487066,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Rosiglitazone binds to PPARG protein,,,PMID:10813377|PMID:19632256|PMID:20860658|PMID:21525782|PMID:24796862,https://www.ncbi.nlm.nih.gov/pubmed/10813377|https://www.ncbi.nlm.nih.gov/pubmed/19632256|https://www.ncbi.nlm.nih.gov/pubmed/20860658|https://www.ncbi.nlm.nih.gov/pubmed/21525782|https://www.ncbi.nlm.nih.gov/pubmed/24796862,10813377|19632256|20860658|21525782|24796862,,
1312,1487067,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Rosiglitazone binds to [PPARG protein binds to RXRA protein],,,PMID:10882139,https://www.ncbi.nlm.nih.gov/pubmed/10882139,10882139,,
1313,1487068,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),[rosiglitazone binds to PPARG protein] which binds to RXRA protein,,,PMID:15715931,https://www.ncbi.nlm.nih.gov/pubmed/15715931,15715931,,
1314,1487069,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Rosiglitazone inhibits the reaction [AGT protein results in decreased expression of PPARG mrna]|rosiglitazone inhibits the reaction [AGT protein results in decreased expression of PPARG protein]|tlr4 mRNA affects the reaction [rosiglitazone inhibits the reaction [AGT protein results in increased expression of PPARG protein]],,,PMID:19451898,https://www.ncbi.nlm.nih.gov/pubmed/19451898,19451898,,
1315,1487070,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Rosiglitazone promotes the reaction [NCOA6 protein binds to PPARG protein]|rosiglitazone promotes the reaction [PPARGC1A protein binds to PPARG protein],,,PMID:30920877,https://www.ncbi.nlm.nih.gov/pubmed/30920877,30920877,,
1316,1487071,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Rosiglitazone results in increased activity of PPARG protein,,,PMID:10799317|PMID:11416043|PMID:16775433|PMID:16819505|PMID:16982809|PMID:19277604|PMID:19666838|PMID:19951259|PMID:21347706|PMID:21484566|PMID:21720023,https://www.ncbi.nlm.nih.gov/pubmed/10799317|https://www.ncbi.nlm.nih.gov/pubmed/11416043|https://www.ncbi.nlm.nih.gov/pubmed/16775433|https://www.ncbi.nlm.nih.gov/pubmed/16819505|https://www.ncbi.nlm.nih.gov/pubmed/16982809|https://www.ncbi.nlm.nih.gov/pubmed/19277604|https://www.ncbi.nlm.nih.gov/pubmed/19666838|https://www.ncbi.nlm.nih.gov/pubmed/19951259|https://www.ncbi.nlm.nih.gov/pubmed/21347706|https://www.ncbi.nlm.nih.gov/pubmed/21484566|https://www.ncbi.nlm.nih.gov/pubmed/21720023,10799317|11416043|16775433|16819505|16982809|19277604|19666838|19951259|21347706|21484566|21720023,,
1317,1487072,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Rosiglitazone results in increased activity of [RXRA protein binds to PPARG protein],,,PMID:11752099,https://www.ncbi.nlm.nih.gov/pubmed/11752099,11752099,,
1318,1487073,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Rosiglitazone results in increased expression of PPARG,,,PMID:17614770,https://www.ncbi.nlm.nih.gov/pubmed/17614770,17614770,,
1319,1491653,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,5608,MAP2K6,https://ctdbase.org/detail.go?type=gene&acc=5608,,,5608.0,MAP2K6,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in decreased expression of MAP2K6 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1320,1491654,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090.0,Mus musculus (house mouse),"2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased phosphorylation of MAPK1 protein]|4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased phosphorylation of MAPK1 protein",,,PMID:33771661,https://www.ncbi.nlm.nih.gov/pubmed/33771661,33771661,,
1321,1491655,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),"2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased phosphorylation of MAPK3 protein]|4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased phosphorylation of MAPK3 protein",,,PMID:33771661,https://www.ncbi.nlm.nih.gov/pubmed/33771661,33771661,,
1322,1493600,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,6152,RPL24,https://ctdbase.org/detail.go?type=gene&acc=6152,,,6152.0,RPL24,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RPL24 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1323,1493601,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,6154,RPL26,https://ctdbase.org/detail.go?type=gene&acc=6154,,,6154.0,RPL26,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RPL26 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1324,1493602,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,6155,RPL27,https://ctdbase.org/detail.go?type=gene&acc=6155,,,6155.0,RPL27,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RPL27 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1325,1493603,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,6157,RPL27A,https://ctdbase.org/detail.go?type=gene&acc=6157,,,6157.0,RPL27A,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RPL27A protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1326,1494096,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,6185,RPN2,https://ctdbase.org/detail.go?type=gene&acc=6185,,,6185.0,RPN2,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RPN2 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1327,1494097,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,6204,RPS10,https://ctdbase.org/detail.go?type=gene&acc=6204,,,6204.0,RPS10,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RPS10 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1328,1495804,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,100333114,TLN2B,https://ctdbase.org/detail.go?type=gene&acc=100333114,,,100333114.0,tln2b,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of TLN2B protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1329,1495805,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,7108,TM7SF2,https://ctdbase.org/detail.go?type=gene&acc=7108,,,7108.0,TM7SF2,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of TM7SF2 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1330,1495806,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,56889,TM9SF3,https://ctdbase.org/detail.go?type=gene&acc=56889,,,56889.0,TM9SF3,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of TM9SF3 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1331,1495807,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,10972,TMED10,https://ctdbase.org/detail.go?type=gene&acc=10972,,,10972.0,TMED10,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of TMED10 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1332,1495808,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,10959,TMED2,https://ctdbase.org/detail.go?type=gene&acc=10959,,,10959.0,TMED2,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of TMED2 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1333,1495809,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,54732,TMED9,https://ctdbase.org/detail.go?type=gene&acc=54732,,,54732.0,TMED9,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of TMED9 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1334,1495810,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,153339,TMEM167A,https://ctdbase.org/detail.go?type=gene&acc=153339,,,153339.0,TMEM167A,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of TMEM167A protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1335,1495811,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,54867,TMEM214,https://ctdbase.org/detail.go?type=gene&acc=54867,,,54867.0,TMEM214,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of TMEM214 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1336,1496443,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,6059,ABCE1,https://ctdbase.org/detail.go?type=gene&acc=6059,,,6059.0,ABCE1,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of ABCE1 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1337,1496444,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,7920,ABHD16A,https://ctdbase.org/detail.go?type=gene&acc=7920,,,7920.0,ABHD16A,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of ABHD16A protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1338,1496445,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,414149,ACBD7,https://ctdbase.org/detail.go?type=gene&acc=414149,,,414149.0,ACBD7,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of ACBD7 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1339,1496446,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,555308,ACSL1A,https://ctdbase.org/detail.go?type=gene&acc=555308,,,555308.0,acsl1a,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in decreased expression of ACSL1A protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1340,1496447,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,100332846,ACSL2,https://ctdbase.org/detail.go?type=gene&acc=100332846,,,100332846.0,acsl2,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in decreased expression of ACSL2 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1341,1496448,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,95,ACY1,https://ctdbase.org/detail.go?type=gene&acc=95,,,95.0,ACY1,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of ACY1 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1342,1496449,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,137872,ADHFE1,https://ctdbase.org/detail.go?type=gene&acc=137872,,,137872.0,ADHFE1,28743.0,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in decreased expression of ADHFE1 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
1343,1497659,83720,Toxin and Toxin Target Database (T3DB),Nickel sulfamate,T3D0699,Nickel sulfamate,http://www.t3db.ca/toxins/T3D0699,BE0005170,Histone H2B type F-S,http://www.t3db.ca/biodb/bio_entities/BE0005170,P57053,Histone H2B type F-S,102724334.0,LOC102724334,9606.0,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
1344,1497660,83720,Toxin and Toxin Target Database (T3DB),Nickel sulfamate,T3D0699,Nickel sulfamate,http://www.t3db.ca/toxins/T3D0699,BE0005173,Histone H2B type W-T,http://www.t3db.ca/biodb/bio_entities/BE0005173,Q7Z2G1,Histone H2B type W-T,158983.0,H2BW1,9606.0,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
1345,1497661,83720,Toxin and Toxin Target Database (T3DB),Nickel sulfamate,T3D0699,Nickel sulfamate,http://www.t3db.ca/toxins/T3D0699,BE0005095,Histone H3-like centromeric protein A,http://www.t3db.ca/biodb/bio_entities/BE0005095,P49450,Histone H3-like centromeric protein A,1058.0,CENPA,9606.0,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
1346,1489756,83887,Comparative Toxicogenomics Database (CTD),D-Aspartic acid,D026603,D-Aspartic Acid,https://ctdbase.org/detail.go?type=chem&acc=D026603,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,10090.0,Mus musculus (house mouse),D-aspartic acid results in increased expression of CYP19A1 mrna|d-aspartic acid results in increased expression of CYP19A1 protein,,,PMID:26189884,https://www.ncbi.nlm.nih.gov/pubmed/26189884,26189884,,
1347,1489757,83887,Comparative Toxicogenomics Database (CTD),D-Aspartic acid,D026603,D-Aspartic Acid,https://ctdbase.org/detail.go?type=chem&acc=D026603,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,10116.0,Rattus norvegicus (Norway rat),D-aspartic acid results in decreased expression of CYP19A1 protein,,,PMID:24439162,https://www.ncbi.nlm.nih.gov/pubmed/24439162,24439162,,
1348,1489758,83887,Comparative Toxicogenomics Database (CTD),D-Aspartic acid,D026603,D-Aspartic Acid,https://ctdbase.org/detail.go?type=chem&acc=D026603,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,10116.0,Rattus norvegicus (Norway rat),D-aspartic acid results in increased expression of CYP19A1 mRNA,,,PMID:26044185,https://www.ncbi.nlm.nih.gov/pubmed/26044185,26044185,,
1349,1489759,83887,Comparative Toxicogenomics Database (CTD),D-Aspartic acid,D026603,D-Aspartic Acid,https://ctdbase.org/detail.go?type=chem&acc=D026603,8528,DDO,https://ctdbase.org/detail.go?type=gene&acc=8528,,,8528.0,DDO,10090.0,Mus musculus (house mouse),DDO protein affects the abundance of D-aspartic acid,,,PMID:16516413|PMID:16525061|PMID:16725213|PMID:18842900|PMID:26961959,https://www.ncbi.nlm.nih.gov/pubmed/16516413|https://www.ncbi.nlm.nih.gov/pubmed/16525061|https://www.ncbi.nlm.nih.gov/pubmed/16725213|https://www.ncbi.nlm.nih.gov/pubmed/18842900|https://www.ncbi.nlm.nih.gov/pubmed/26961959,16516413|16525061|16725213|18842900|26961959,,
1350,1489760,83887,Comparative Toxicogenomics Database (CTD),D-Aspartic acid,D026603,D-Aspartic Acid,https://ctdbase.org/detail.go?type=chem&acc=D026603,8528,DDO,https://ctdbase.org/detail.go?type=gene&acc=8528,,,8528.0,DDO,10090.0,Mus musculus (house mouse),DDO protein results in increased metabolism of D-aspartic acid,,,PMID:32185508,https://www.ncbi.nlm.nih.gov/pubmed/32185508,32185508,,
1351,1489761,83887,Comparative Toxicogenomics Database (CTD),D-Aspartic acid,D026603,D-Aspartic Acid,https://ctdbase.org/detail.go?type=chem&acc=D026603,8528,DDO,https://ctdbase.org/detail.go?type=gene&acc=8528,,,8528.0,DDO,10116.0,Rattus norvegicus (Norway rat),DDO protein results in increased degradation of D-aspartic acid,,,PMID:32376478,https://www.ncbi.nlm.nih.gov/pubmed/32376478,32376478,,
1352,1489762,83887,Comparative Toxicogenomics Database (CTD),D-Aspartic acid,D026603,D-Aspartic Acid,https://ctdbase.org/detail.go?type=chem&acc=D026603,183530,DDO-1,https://ctdbase.org/detail.go?type=gene&acc=183530,,,183530.0,ddo-1,6239.0,Caenorhabditis elegans,DDO-1 protein results in increased degradation of D-aspartic acid,,,PMID:32376478,https://www.ncbi.nlm.nih.gov/pubmed/32376478,32376478,,
1353,1442157,84029,DrugBank,Clarithromycin,DB01211,Clarithromycin,https://www.drugbank.ca/drugs/DB01211,BE0001004,Solute carrier organic anion transporter family member 1B1,https://www.drugbank.ca/bio_entities/BE0001004,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,10599.0,SLCO1B1,9606.0,Homo sapiens (human),,,,PMID:23571415,https://www.ncbi.nlm.nih.gov/pubmed/23571415,23571415,,
1354,1442158,84029,DrugBank,Clarithromycin,DB01211,Clarithromycin,https://www.drugbank.ca/drugs/DB01211,BE0003659,Solute carrier organic anion transporter family member 1B3,https://www.drugbank.ca/bio_entities/BE0003659,Q9NPD5,Solute carrier organic anion transporter family member 1B3,28234.0,SLCO1B3,9606.0,Homo sapiens (human),,,,PMID:23571415,https://www.ncbi.nlm.nih.gov/pubmed/23571415,23571415,,
1355,1442159,84029,DrugBank,Clarithromycin,DB01211,Clarithromycin,https://www.drugbank.ca/drugs/DB01211,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:19909895|PMID:11452245|PMID:24035278|PMID:23514827|PMID:15762770,https://www.ncbi.nlm.nih.gov/pubmed/19909895|https://www.ncbi.nlm.nih.gov/pubmed/11452245|https://www.ncbi.nlm.nih.gov/pubmed/24035278|https://www.ncbi.nlm.nih.gov/pubmed/23514827|https://www.ncbi.nlm.nih.gov/pubmed/15762770,19909895|11452245|24035278|23514827|15762770,,
1356,1442160,84029,DrugBank,Clarithromycin,DB01211,Clarithromycin,https://www.drugbank.ca/drugs/DB01211,BE0002362,Cytochrome P450 3A5,https://www.drugbank.ca/bio_entities/BE0002362,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,,,,,
1357,1491121,86298,Toxin and Toxin Target Database (T3DB),Dimethomorph,T3D4495,Dimethomorph,http://www.t3db.ca/toxins/T3D4495,BE0001196,Tumor necrosis factor receptor superfamily member 5,http://www.t3db.ca/biodb/bio_entities/BE0001196,P25942,Tumor necrosis factor receptor superfamily member 5,958.0,CD40,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1358,1491122,86298,Toxin and Toxin Target Database (T3DB),Dimethomorph,T3D4495,Dimethomorph,http://www.t3db.ca/toxins/T3D4495,BE0000717,Urokinase plasminogen activator surface receptor,http://www.t3db.ca/biodb/bio_entities/BE0000717,Q03405,Urokinase plasminogen activator surface receptor,5329.0,PLAUR,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1359,1492916,90570,Toxin and Toxin Target Database (T3DB),Vanadium nitride (VN),T3D1626,Vanadium nitride,http://www.t3db.ca/toxins/T3D1626,BE0005227,Protein tyrosine phosphatase type IVA 3,http://www.t3db.ca/biodb/bio_entities/BE0005227,O75365,Protein tyrosine phosphatase type IVA 3,11156.0,PTP4A3,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
1360,1492917,90570,Toxin and Toxin Target Database (T3DB),Vanadium nitride (VN),T3D1626,Vanadium nitride,http://www.t3db.ca/toxins/T3D1626,BE0005243,Receptor-type tyrosine-protein phosphatase F,http://www.t3db.ca/biodb/bio_entities/BE0005243,P10586,Receptor-type tyrosine-protein phosphatase F,5792.0,PTPRF,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
1361,1492918,90570,Toxin and Toxin Target Database (T3DB),Vanadium nitride (VN),T3D1626,Vanadium nitride,http://www.t3db.ca/toxins/T3D1626,BE0005245,Receptor-type tyrosine-protein phosphatase H,http://www.t3db.ca/biodb/bio_entities/BE0005245,Q9HD43,Receptor-type tyrosine-protein phosphatase H,5794.0,PTPRH,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
1362,1492919,90570,Toxin and Toxin Target Database (T3DB),Vanadium nitride (VN),T3D1626,Vanadium nitride,http://www.t3db.ca/toxins/T3D1626,BE0005241,Receptor-type tyrosine-protein phosphatase N2,http://www.t3db.ca/biodb/bio_entities/BE0005241,Q92932,Receptor-type tyrosine-protein phosphatase N2,5799.0,PTPRN2,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
1363,1492920,90570,Toxin and Toxin Target Database (T3DB),Vanadium nitride (VN),T3D1626,Vanadium nitride,http://www.t3db.ca/toxins/T3D1626,BE0005250,Receptor-type tyrosine-protein phosphatase O,http://www.t3db.ca/biodb/bio_entities/BE0005250,Q16827,Receptor-type tyrosine-protein phosphatase O,5800.0,PTPRO,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
1364,1492921,90570,Toxin and Toxin Target Database (T3DB),Vanadium nitride (VN),T3D1626,Vanadium nitride,http://www.t3db.ca/toxins/T3D1626,BE0005251,Receptor-type tyrosine-protein phosphatase R,http://www.t3db.ca/biodb/bio_entities/BE0005251,Q15256,Receptor-type tyrosine-protein phosphatase R,5801.0,PTPRR,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
1365,1492922,90570,Toxin and Toxin Target Database (T3DB),Vanadium nitride (VN),T3D1626,Vanadium nitride,http://www.t3db.ca/toxins/T3D1626,BE0003567,Receptor-type tyrosine-protein phosphatase S,http://www.t3db.ca/biodb/bio_entities/BE0003567,Q13332,Receptor-type tyrosine-protein phosphatase S,5802.0,PTPRS,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
1366,1492923,90570,Toxin and Toxin Target Database (T3DB),Vanadium nitride (VN),T3D1626,Vanadium nitride,http://www.t3db.ca/toxins/T3D1626,BE0005252,Receptor-type tyrosine-protein phosphatase T,http://www.t3db.ca/biodb/bio_entities/BE0005252,O14522,Receptor-type tyrosine-protein phosphatase T,11122.0,PTPRT,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
1367,1450931,91631,Toxin and Toxin Target Database (T3DB),"2,3,3',4,5,5'-Hexachlorobiphenyl",T3D0548,"2,3,3',4,5,5'-Hexachlorobiphenyl",http://www.t3db.ca/toxins/T3D0548,BE0002151,Aromatic-L-amino-acid decarboxylase,http://www.t3db.ca/biodb/bio_entities/BE0002151,P20711,Aromatic-L-amino-acid decarboxylase,1644.0,DDC,9606.0,Homo sapiens (human),PCB inhibition of aromatic-L-amino-acid decarboxylase is believed to cause decreased dopamine synthesis. (L4),,,,,,,
1368,1450932,91631,Toxin and Toxin Target Database (T3DB),"2,3,3',4,5,5'-Hexachlorobiphenyl",T3D0548,"2,3,3',4,5,5'-Hexachlorobiphenyl",http://www.t3db.ca/toxins/T3D0548,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606.0,Homo sapiens (human),"Dioxin-like pcbs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic phase I and phase II enzymes, especially of the cytochrome P450 family. (A4)",,,PMID:2992927,https://www.ncbi.nlm.nih.gov/pubmed/2992927,2992927,,
1369,1450933,91631,Toxin and Toxin Target Database (T3DB),"2,3,3',4,5,5'-Hexachlorobiphenyl",T3D0548,"2,3,3',4,5,5'-Hexachlorobiphenyl",http://www.t3db.ca/toxins/T3D0548,BE0000614,Tyrosine 3-monooxygenase,http://www.t3db.ca/biodb/bio_entities/BE0000614,P07101,Tyrosine 3-monooxygenase,7054.0,TH,9606.0,Homo sapiens (human),PCB inhibition of tyrosine 3-monooxygenase is believed to cause decreased dopamine synthesis. (L4),,,,,,,
1370,1452016,91704,Toxin and Toxin Target Database (T3DB),"2,3,3',4,5'-Pentachlorobiphenyl",T3D0497,"2,3,3',4,5'-Pentachlorobiphenyl",http://www.t3db.ca/toxins/T3D0497,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606.0,Homo sapiens (human),"Dioxin-like pcbs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic phase I and phase II enzymes, especially of the cytochrome P450 family. (A4)",,,PMID:2992927,https://www.ncbi.nlm.nih.gov/pubmed/2992927,2992927,,
1371,1452017,91704,Toxin and Toxin Target Database (T3DB),"2,3,3',4,5'-Pentachlorobiphenyl",T3D0497,"2,3,3',4,5'-Pentachlorobiphenyl",http://www.t3db.ca/toxins/T3D0497,BE0000614,Tyrosine 3-monooxygenase,http://www.t3db.ca/biodb/bio_entities/BE0000614,P07101,Tyrosine 3-monooxygenase,7054.0,TH,9606.0,Homo sapiens (human),PCB inhibition of tyrosine 3-monooxygenase is believed to cause decreased dopamine synthesis. (L4),,,,,,,
1372,1452018,91704,Toxin and Toxin Target Database (T3DB),"2,3,3',4,5'-Pentachlorobiphenyl",T3D0497,"2,3,3',4,5'-Pentachlorobiphenyl",http://www.t3db.ca/toxins/T3D0497,BE0004289,Uteroglobin,http://www.t3db.ca/biodb/bio_entities/BE0004289,P11684,Uteroglobin,7356.0,SCGB1A1,9606.0,Homo sapiens (human),Pcbs will bioaccumulate by binding to receptor proteins such as uteroglobin. (A30),,,PMID:11205532,https://www.ncbi.nlm.nih.gov/pubmed/11205532,11205532,,
1373,1452019,91719,Toxin and Toxin Target Database (T3DB),"2,3,3',5,6-Pentachlorobiphenyl",T3D0501,"2,3,3',5,6-Pentachlorobiphenyl",http://www.t3db.ca/toxins/T3D0501,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
1374,1480729,91731,Toxin and Toxin Target Database (T3DB),Fluazinam,T3D3842,Fluazinam,http://www.t3db.ca/toxins/T3D3842,BE0004734,Interleukin-1 alpha,http://www.t3db.ca/biodb/bio_entities/BE0004734,P01583,Interleukin-1 alpha,3552.0,IL1A,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1375,1480730,91731,Toxin and Toxin Target Database (T3DB),Fluazinam,T3D3842,Fluazinam,http://www.t3db.ca/toxins/T3D3842,BE0001160,Macrophage colony-stimulating factor 1,http://www.t3db.ca/biodb/bio_entities/BE0001160,P09603,Macrophage colony-stimulating factor 1,1435.0,CSF1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1376,1480731,91731,Toxin and Toxin Target Database (T3DB),Fluazinam,T3D3842,Fluazinam,http://www.t3db.ca/toxins/T3D3842,BE0000058,Matrix metalloproteinase-9,http://www.t3db.ca/biodb/bio_entities/BE0000058,P14780,Matrix metalloproteinase-9,4318.0,MMP9,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1377,1480732,91731,Toxin and Toxin Target Database (T3DB),Fluazinam,T3D3842,Fluazinam,http://www.t3db.ca/toxins/T3D3842,BE0001151,Thrombomodulin,http://www.t3db.ca/biodb/bio_entities/BE0001151,P07204,Thrombomodulin,7056.0,THBD,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1378,1480733,91731,Toxin and Toxin Target Database (T3DB),Fluazinam,T3D3842,Fluazinam,http://www.t3db.ca/toxins/T3D3842,BE0000886,Bile salt sulfotransferase,http://www.t3db.ca/biodb/bio_entities/BE0000886,Q06520,Sulfotransferase 2A1,6822.0,SULT2A1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1379,1480734,91731,Toxin and Toxin Target Database (T3DB),Fluazinam,T3D3842,Fluazinam,http://www.t3db.ca/toxins/T3D3842,BE0000132,Androgen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000132,P10275,Androgen receptor,367.0,AR,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1380,1480735,91739,Toxin and Toxin Target Database (T3DB),Quinclorac,T3D3918,Quinclorac,http://www.t3db.ca/toxins/T3D3918,BE0001047,C-C motif chemokine 2,http://www.t3db.ca/biodb/bio_entities/BE0001047,P13500,C-C motif chemokine 2,6347.0,CCL2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1381,1480736,91751,Toxin and Toxin Target Database (T3DB),Prosulfuron,T3D3912,Prosulfuron,http://www.t3db.ca/toxins/T3D3912,BE0003549,Cytochrome P450 2B6,http://www.t3db.ca/biodb/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1382,1481530,92253,Toxin and Toxin Target Database (T3DB),Levobupivacaine,T3D2955,Levobupivacaine,http://www.t3db.ca/toxins/T3D2955,BE0000177,Sodium channel protein type 10 subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0000177,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,6336.0,SCN10A,9606.0,Homo sapiens (human),"Local anesthetics such as levobupivacaine block the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. in general, the progression of anesthesia is related to the diameter, myelination and conduction velocity of affected nerve fibers.",,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
1383,1481531,92283,Comparative Toxicogenomics Database (CTD),Glucurolactone,C004940,glucuronolactone,https://ctdbase.org/detail.go?type=chem&acc=C004940,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,9606.0,Homo sapiens (human),Glucuronolactone results in increased expression of PPARGC1A mRNA,,,PMID:23056435,https://www.ncbi.nlm.nih.gov/pubmed/23056435,23056435,,
1384,1495941,92629,Comparative Toxicogenomics Database (CTD),1-Tert-butoxy-2-propanol,C487282,propylene glycol mono-t-butyl ether,https://ctdbase.org/detail.go?type=chem&acc=C487282,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,10090.0,Mus musculus (house mouse),Propylene glycol mono-t-butyl ether results in increased activity of NR1I3 protein,,,PMID:30203046,https://www.ncbi.nlm.nih.gov/pubmed/30203046,30203046,,
1385,1495942,92629,Comparative Toxicogenomics Database (CTD),1-Tert-butoxy-2-propanol,C487282,propylene glycol mono-t-butyl ether,https://ctdbase.org/detail.go?type=chem&acc=C487282,6777,STAT5B,https://ctdbase.org/detail.go?type=gene&acc=6777,,,6777.0,STAT5B,10090.0,Mus musculus (house mouse),Propylene glycol mono-t-butyl ether affects the activity of STAT5B protein,,,PMID:30114225,https://www.ncbi.nlm.nih.gov/pubmed/30114225,30114225,,
1386,1481532,92716,BindingDB,Laudanosoline,50291683,"1-(3,4-Dihydroxy-benzyl)-2-methyl-1,2,3,4-tetrahydro-isoquinoline-6,7-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50291683,5759,"Polymerase acidic protein [1-204,T86I,G186S]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5759,P13166,Polymerase acidic protein,,,387207.0,Influenza A virus (A/duck/Hokkaido/8/1980(H3N8)),,IC50 (nM),2e+3,PMID:23978130|DOI:10.1021/cb400400j,https://www.ncbi.nlm.nih.gov/pubmed/23978130|https://doi.org/10.1021/cb400400j,23978130,10.1021/cb400400j,
1387,1481533,92716,BindingDB,Laudanosoline,50291683,"1-(3,4-Dihydroxy-benzyl)-2-methyl-1,2,3,4-tetrahydro-isoquinoline-6,7-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50291683,5759,"Polymerase acidic protein [1-204,T86I,G186S]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5759,P13166,Polymerase acidic protein,,,387207.0,Influenza A virus (A/duck/Hokkaido/8/1980(H3N8)),,IC50 (nM),2e+3,PMID:23978130|DOI:10.1021/cb400400j,https://www.ncbi.nlm.nih.gov/pubmed/23978130|https://doi.org/10.1021/cb400400j,23978130,10.1021/cb400400j,
1388,1495943,92745,DrugBank,"5beta-Pregnane-3,20-dione",DB07557,"3,20-Pregnanedione",https://www.drugbank.ca/drugs/DB07557,BE0003728,Nuclear receptor coactivator 1,https://www.drugbank.ca/bio_entities/BE0003728,Q15788,Nuclear receptor coactivator 1,8648.0,NCOA1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1389,1495944,92745,DrugBank,"5beta-Pregnane-3,20-dione",DB07557,"3,20-Pregnanedione",https://www.drugbank.ca/drugs/DB07557,BE0000412,Retinoic acid receptor RXR-alpha,https://www.drugbank.ca/bio_entities/BE0000412,P19793,Retinoic acid receptor RXR-alpha,6256.0,RXRA,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1390,1495945,92745,DrugBank,"5beta-Pregnane-3,20-dione",DB07557,"3,20-Pregnanedione",https://www.drugbank.ca/drugs/DB07557,BE0003848,Nuclear receptor subfamily 1 group I member 3,https://www.drugbank.ca/bio_entities/BE0003848,Q14994,Nuclear receptor subfamily 1 group I member 3 ,9970.0,NR1I3,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1391,1495946,92745,DrugBank,"5beta-Pregnane-3,20-dione",DB07557,"3,20-Pregnanedione",https://www.drugbank.ca/drugs/DB07557,BE0003610,3-oxo-5-beta-steroid 4-dehydrogenase,https://www.drugbank.ca/bio_entities/BE0003610,P51857,Aldo-keto reductase family 1 member D1,6718.0,AKR1D1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1392,1495947,92786,Therapeutic Target Database (TTD),Brexanolone,D00VZZ,Allopregnanolone,https://idrblab.net/ttd/data/drug/details/D00VZZ,T27376,GABA(A) receptor delta (GABRD),https://idrblab.net/ttd/data/target/details/T27376,O14764,Gamma-aminobutyric acid receptor subunit delta,2563.0,GABRD,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1393,1483820,94952,BindingDB,"2,5-Difluorophenol",26191,"2,5-difluorophenol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26191,1233,Carbonic anhydrase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1233,Q16790,Carbonic anhydrase 9,768.0,CA9,9606.0,Homo sapiens (human),,Ki (nM),68700,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
1394,1483821,94952,BindingDB,"2,5-Difluorophenol",26191,"2,5-difluorophenol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26191,1364,Carbonic anhydrase 13,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1364,Q9D6N1,Carbonic anhydrase 13,71934.0,Car13,10090.0,Mus musculus (house mouse),,Ki (nM),69500,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
1395,1352005,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,7936,NELFE,https://ctdbase.org/detail.go?type=gene&acc=7936,,,7936.0,NELFE,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NELFE protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1396,1352006,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,10763,NES,https://ctdbase.org/detail.go?type=gene&acc=10763,,,10763.0,NES,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of NES mRNA",,,PMID:31326446,https://www.ncbi.nlm.nih.gov/pubmed/31326446,31326446,,
1397,1352007,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,4763,NF1,https://ctdbase.org/detail.go?type=gene&acc=4763,,,4763.0,NF1,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NF1 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1398,1352008,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,4772,NFATC1,https://ctdbase.org/detail.go?type=gene&acc=4772,,,4772.0,NFATC1,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of NFATC1 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1399,1352009,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,4779,NFE2L1,https://ctdbase.org/detail.go?type=gene&acc=4779,,,4779.0,NFE2L1,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of NFE2L1 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1400,1352010,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of NFE2L2 mRNA",,,PMID:31173147,https://www.ncbi.nlm.nih.gov/pubmed/31173147,31173147,,
1401,1352011,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,4781,NFIB,https://ctdbase.org/detail.go?type=gene&acc=4781,,,4781.0,NFIB,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NFIB mRNA",,,PMID:21394737,https://www.ncbi.nlm.nih.gov/pubmed/21394737,21394737,,
1402,1352012,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,4783,NFIL3,https://ctdbase.org/detail.go?type=gene&acc=4783,,,4783.0,NFIL3,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of NFIL3 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1403,1352013,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,4783,NFIL3,https://ctdbase.org/detail.go?type=gene&acc=4783,,,4783.0,NFIL3,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of NFIL3 mRNA",,,PMID:19095052,https://www.ncbi.nlm.nih.gov/pubmed/19095052,19095052,,
1404,1352014,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,4783,NFIL3,https://ctdbase.org/detail.go?type=gene&acc=4783,,,4783.0,NFIL3,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of NFIL3 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1405,1353138,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of NQO1 mRNA",,,PMID:32679240,https://www.ncbi.nlm.nih.gov/pubmed/32679240,32679240,,
1406,1353139,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,190,NR0B1,https://ctdbase.org/detail.go?type=gene&acc=190,,,190.0,NR0B1,10116.0,Rattus norvegicus (Norway rat),"Dietary fats promotes the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of NR0B1 protein]|2,2',4,4'-tetrabromodiphenyl ether results in increased expression of NR0B1 protein",,,PMID:28300557,https://www.ncbi.nlm.nih.gov/pubmed/28300557,28300557,,
1407,1353140,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,8431,NR0B2,https://ctdbase.org/detail.go?type=gene&acc=8431,,,8431.0,NR0B2,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of NR0B2 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1408,1354785,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5901,RAN,https://ctdbase.org/detail.go?type=gene&acc=5901,,,5901.0,RAN,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of RAN mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1409,1354786,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5902,RANBP1,https://ctdbase.org/detail.go?type=gene&acc=5902,,,5902.0,RANBP1,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of RANBP1 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1410,1354787,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,54884,RETSAT,https://ctdbase.org/detail.go?type=gene&acc=54884,,,54884.0,RETSAT,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of RETSAT mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1411,1355140,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,6009,RHEB,https://ctdbase.org/detail.go?type=gene&acc=6009,,,6009.0,RHEB,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RHEB protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1412,1355141,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of RHOA mRNA",,,PMID:20056577,https://www.ncbi.nlm.nih.gov/pubmed/20056577,20056577,,
1413,1355142,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,100006041,RHOAB,https://ctdbase.org/detail.go?type=gene&acc=100006041,,,100006041.0,rhoab,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of RHOAB mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1414,1355143,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,389,RHOC,https://ctdbase.org/detail.go?type=gene&acc=389,,,389.0,RHOC,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RHOC protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1415,1356266,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5771,PTPN2,https://ctdbase.org/detail.go?type=gene&acc=5771,,,5771.0,PTPN2,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of PTPN2 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1416,1356267,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,25930,PTPN23,https://ctdbase.org/detail.go?type=gene&acc=25930,,,25930.0,PTPN23,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PTPN23 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1417,1356268,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5777,PTPN6,https://ctdbase.org/detail.go?type=gene&acc=5777,,,5777.0,PTPN6,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PTPN6 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1418,1356269,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5787,PTPRB,https://ctdbase.org/detail.go?type=gene&acc=5787,,,5787.0,PTPRB,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of PTPRB mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1419,1356270,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5789,PTPRD,https://ctdbase.org/detail.go?type=gene&acc=5789,,,5789.0,PTPRD,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PTPRD mRNA",,,PMID:21394737,https://www.ncbi.nlm.nih.gov/pubmed/21394737,21394737,,
1420,1356271,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5792,PTPRF,https://ctdbase.org/detail.go?type=gene&acc=5792,,,5792.0,PTPRF,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PTPRF protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1421,1356272,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5795,PTPRJ,https://ctdbase.org/detail.go?type=gene&acc=5795,,,5795.0,PTPRJ,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PTPRJ mRNA",,,PMID:31826744,https://www.ncbi.nlm.nih.gov/pubmed/31826744,31826744,,
1422,1356273,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5799,PTPRN2,https://ctdbase.org/detail.go?type=gene&acc=5799,,,5799.0,PTPRN2,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PTPRN2 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1423,1356274,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,374462,PTPRQ,https://ctdbase.org/detail.go?type=gene&acc=374462,,,374462.0,PTPRQ,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PTPRQ mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1424,1357132,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,171568,POLR3H,https://ctdbase.org/detail.go?type=gene&acc=171568,,,171568.0,POLR3H,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of POLR3H mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1425,1357133,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,51728,POLR3K,https://ctdbase.org/detail.go?type=gene&acc=51728,,,51728.0,POLR3K,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of POLR3K mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1426,1357134,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,51728,POLR3K,https://ctdbase.org/detail.go?type=gene&acc=51728,,,51728.0,POLR3K,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of POLR3K mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1427,1357135,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443.0,POMC,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of POMC mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1428,1357136,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443.0,POMC,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of POMC mRNA",,,PMID:21394737,https://www.ncbi.nlm.nih.gov/pubmed/21394737,21394737,,
1429,1357137,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,353221,POMCA,https://ctdbase.org/detail.go?type=gene&acc=353221,,,353221.0,pomca,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of POMCA mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1430,1357138,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,100034412,POMCB,https://ctdbase.org/detail.go?type=gene&acc=100034412,,,100034412.0,pomcb,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of POMCB mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1431,1357139,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,84197,POMK,https://ctdbase.org/detail.go?type=gene&acc=84197,,,84197.0,POMK,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of POMK mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1432,1357140,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,10775,POP4,https://ctdbase.org/detail.go?type=gene&acc=10775,,,10775.0,POP4,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of POP4 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1433,1358124,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,4736,RPL10A,https://ctdbase.org/detail.go?type=gene&acc=4736,,,4736.0,RPL10A,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of RPL10A mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1434,1359084,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,6218,RPS17,https://ctdbase.org/detail.go?type=gene&acc=6218,,,6218.0,RPS17,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RPS17 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1435,1359085,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,6218,RPS17,https://ctdbase.org/detail.go?type=gene&acc=6218,,,6218.0,RPS17,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of RPS17 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1436,1361744,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5713,PSMD7,https://ctdbase.org/detail.go?type=gene&acc=5713,,,5713.0,PSMD7,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of PSMD7 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1437,1361745,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5714,PSMD8,https://ctdbase.org/detail.go?type=gene&acc=5714,,,5714.0,PSMD8,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PSMD8 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1438,1361746,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5714,PSMD8,https://ctdbase.org/detail.go?type=gene&acc=5714,,,5714.0,PSMD8,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of PSMD8 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1439,1361747,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5720,PSME1,https://ctdbase.org/detail.go?type=gene&acc=5720,,,5720.0,PSME1,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PSME1 mRNA",,,PMID:21394737,https://www.ncbi.nlm.nih.gov/pubmed/21394737,21394737,,
1440,1364263,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5202,PFDN2,https://ctdbase.org/detail.go?type=gene&acc=5202,,,5202.0,PFDN2,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of PFDN2 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1441,1364264,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5203,PFDN4,https://ctdbase.org/detail.go?type=gene&acc=5203,,,5203.0,PFDN4,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of PFDN4 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1442,1364265,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,10471,PFDN6,https://ctdbase.org/detail.go?type=gene&acc=10471,,,10471.0,PFDN6,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of PFDN6 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1443,1364266,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5209,PFKFB3,https://ctdbase.org/detail.go?type=gene&acc=5209,,,5209.0,PFKFB3,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PFKFB3 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1444,1364267,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,386663,PFKFB4B,https://ctdbase.org/detail.go?type=gene&acc=386663,,,386663.0,pfkfb4b,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PFKFB4B mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1445,1364268,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5211,PFKL,https://ctdbase.org/detail.go?type=gene&acc=5211,,,5211.0,PFKL,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PFKL mRNA",,,PMID:21394737,https://www.ncbi.nlm.nih.gov/pubmed/21394737,21394737,,
1446,1364269,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5213,PFKM,https://ctdbase.org/detail.go?type=gene&acc=5213,,,5213.0,PFKM,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PFKM protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1447,1364270,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5213,PFKM,https://ctdbase.org/detail.go?type=gene&acc=5213,,,5213.0,PFKM,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of PFKM mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1448,1365227,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,23646,PLD3,https://ctdbase.org/detail.go?type=gene&acc=23646,,,23646.0,PLD3,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PLD3 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1449,1365228,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,26499,PLEK2,https://ctdbase.org/detail.go?type=gene&acc=26499,,,26499.0,PLEK2,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PLEK2 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1450,1484359,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,553537,CYP2AA11,https://ctdbase.org/detail.go?type=gene&acc=553537,,,553537.0,cyp2aa11,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CYP2AA11 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1451,1484360,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,450060,CYP2AA8,https://ctdbase.org/detail.go?type=gene&acc=450060,,,450060.0,cyp2aa8,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CYP2AA8 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1452,1484361,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,790957,CYP2AA9,https://ctdbase.org/detail.go?type=gene&acc=790957,,,790957.0,cyp2aa9,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CYP2AA9 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1453,1484362,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,259306,CYP2AD2,https://ctdbase.org/detail.go?type=gene&acc=259306,,,259306.0,cyp2ad2,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CYP2AD2 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1454,1484363,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,24300,CYP2B1,https://ctdbase.org/detail.go?type=gene&acc=24300,,,24300.0,Cyp2b1,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CYP2B1 mRNA",,,PMID:16107549|PMID:20566336|PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/16107549|https://www.ncbi.nlm.nih.gov/pubmed/20566336|https://www.ncbi.nlm.nih.gov/pubmed/27291303,16107549|20566336|27291303,,
1455,1484364,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,24300,CYP2B1,https://ctdbase.org/detail.go?type=gene&acc=24300,,,24300.0,Cyp2b1,10116.0,Rattus norvegicus (Norway rat),"CYP2B1 protein results in increased oxidation of 2,2',4,4'-tetrabromodiphenyl ether|[cyp2b1 protein results in increased oxidation of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether metabolite",,,PMID:21673328,https://www.ncbi.nlm.nih.gov/pubmed/21673328,21673328,,
1456,1484365,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,13088,CYP2B10,https://ctdbase.org/detail.go?type=gene&acc=13088,,,13088.0,Cyp2b10,10090.0,Mus musculus (house mouse),"Dietary fats inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CYP2B10 mrna]|2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [dietary fats results in increased expression of CYP2B10 mrna]",,,PMID:29523931,https://www.ncbi.nlm.nih.gov/pubmed/29523931,29523931,,
1457,1484696,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1555,CYP2B6,https://ctdbase.org/detail.go?type=gene&acc=1555,,,1555.0,CYP2B6,9606.0,Homo sapiens (human),"CYP2B6 protein results in increased chemical synthesis of 2,2',4,4'-tetrabromodiphenyl ether analog",,,PMID:23249762,https://www.ncbi.nlm.nih.gov/pubmed/23249762,23249762,,
1458,1484697,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1555,CYP2B6,https://ctdbase.org/detail.go?type=gene&acc=1555,,,1555.0,CYP2B6,9606.0,Homo sapiens (human),"CYP2B6 protein results in increased metabolism of 2,2',4,4'-tetrabromodiphenyl ether",,,PMID:23249762|PMID:23537005,https://www.ncbi.nlm.nih.gov/pubmed/23249762|https://www.ncbi.nlm.nih.gov/pubmed/23537005,23249762|23537005,,
1459,1484698,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,100328933,CYP2C,https://ctdbase.org/detail.go?type=gene&acc=100328933,,,100328933.0,CYP2C,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CYP2C mRNA",,,PMID:20056577,https://www.ncbi.nlm.nih.gov/pubmed/20056577,20056577,,
1460,1484699,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,29277,CYP2C11,https://ctdbase.org/detail.go?type=gene&acc=29277,,,29277.0,Cyp2c11,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CYP2C11 mRNA",,,PMID:31826744,https://www.ncbi.nlm.nih.gov/pubmed/31826744,31826744,,
1461,1484700,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,403107,CYP2C33,https://ctdbase.org/detail.go?type=gene&acc=403107,,,403107.0,CYP2C33,8049.0,Gadus morhua (Atlantic cod),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CYP2C33 mRNA",,,PMID:19167021,https://www.ncbi.nlm.nih.gov/pubmed/19167021,19167021,,
1462,1484701,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,293989,CYP2C6V1,https://ctdbase.org/detail.go?type=gene&acc=293989,,,293989.0,Cyp2c6v1,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CYP2C6V1 mRNA",,,PMID:31826744,https://www.ncbi.nlm.nih.gov/pubmed/31826744,31826744,,
1463,1484702,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,29298,CYP2C7,https://ctdbase.org/detail.go?type=gene&acc=29298,,,29298.0,Cyp2c7,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of CYP2C7 mRNA",,,PMID:20056577,https://www.ncbi.nlm.nih.gov/pubmed/20056577,20056577,,
1464,1488266,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CDK4 mrna|2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CDK4 protein",,,PMID:26988655,https://www.ncbi.nlm.nih.gov/pubmed/26988655,26988655,,
1465,1488267,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of CDK4 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1466,1488268,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,80279,CDK5RAP3,https://ctdbase.org/detail.go?type=gene&acc=80279,,,80279.0,CDK5RAP3,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CDK5RAP3 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1467,1488269,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1021,CDK6,https://ctdbase.org/detail.go?type=gene&acc=1021,,,1021.0,CDK6,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CDK6 mRNA",,,PMID:26988655,https://www.ncbi.nlm.nih.gov/pubmed/26988655,26988655,,
1468,1488270,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1022,CDK7,https://ctdbase.org/detail.go?type=gene&acc=1022,,,1022.0,CDK7,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CDK7 mrna|2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CDK7 protein",,,PMID:26988655,https://www.ncbi.nlm.nih.gov/pubmed/26988655,26988655,,
1469,1488271,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1025,CDK9,https://ctdbase.org/detail.go?type=gene&acc=1025,,,1025.0,CDK9,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CDK9 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1470,1488272,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CDKN1A mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1471,1488273,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CDKN1A mRNA",,,PMID:26988655,https://www.ncbi.nlm.nih.gov/pubmed/26988655,26988655,,
1472,1488457,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,81620,CDT1,https://ctdbase.org/detail.go?type=gene&acc=81620,,,81620.0,CDT1,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CDT1 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1473,1488630,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1044,CDX1,https://ctdbase.org/detail.go?type=gene&acc=1044,,,1044.0,CDX1,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CDX1 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1474,1488631,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,9425,CDYL,https://ctdbase.org/detail.go?type=gene&acc=9425,,,9425.0,CDYL,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CDYL protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1475,1488632,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CEBPA mRNA",,,PMID:24559133,https://www.ncbi.nlm.nih.gov/pubmed/24559133,24559133,,
1476,1488633,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CEBPB mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1477,1488634,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of CEBPB mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1478,1488635,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CEBPB mRNA",,,PMID:24559133,https://www.ncbi.nlm.nih.gov/pubmed/24559133,24559133,,
1479,1488636,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1052,CEBPD,https://ctdbase.org/detail.go?type=gene&acc=1052,,,1052.0,CEBPD,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CEBPD mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1480,1488637,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1052,CEBPD,https://ctdbase.org/detail.go?type=gene&acc=1052,,,1052.0,CEBPD,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of CEBPD mRNA",,,PMID:19095052,https://www.ncbi.nlm.nih.gov/pubmed/19095052,19095052,,
1481,1490409,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,436612,CLDN7A,https://ctdbase.org/detail.go?type=gene&acc=436612,,,436612.0,cldn7a,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CLDN7A mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1482,1490410,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,60635,CLDN7B,https://ctdbase.org/detail.go?type=gene&acc=60635,,,60635.0,cldn7b,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CLDN7B mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1483,1490411,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,81581,CLDNB,https://ctdbase.org/detail.go?type=gene&acc=81581,,,81581.0,cldnb,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CLDNB mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1484,1490412,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,81584,CLDNE,https://ctdbase.org/detail.go?type=gene&acc=81584,,,81584.0,cldne,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CLDNE mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1485,1490413,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,81585,CLDNF,https://ctdbase.org/detail.go?type=gene&acc=81585,,,81585.0,cldnf,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CLDNF mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1486,1490414,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,10462,CLEC10A,https://ctdbase.org/detail.go?type=gene&acc=10462,,,10462.0,CLEC10A,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CLEC10A mRNA",,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
1487,1490995,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,134147,CMBL,https://ctdbase.org/detail.go?type=gene&acc=134147,,,134147.0,CMBL,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CMBL mRNA",,,PMID:31826744,https://www.ncbi.nlm.nih.gov/pubmed/31826744,31826744,,
1488,1490996,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1240,CMKLR1,https://ctdbase.org/detail.go?type=gene&acc=1240,,,1240.0,CMKLR1,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CMKLR1 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1489,1490997,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,51727,CMPK1,https://ctdbase.org/detail.go?type=gene&acc=51727,,,51727.0,CMPK1,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CMPK1 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1490,1492714,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1387,CREBBP,https://ctdbase.org/detail.go?type=gene&acc=1387,,,1387.0,CREBBP,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CREBBP mRNA",,,PMID:31826744,https://www.ncbi.nlm.nih.gov/pubmed/31826744,31826744,,
1491,1493248,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,55057,CRYBG2,https://ctdbase.org/detail.go?type=gene&acc=55057,,,55057.0,CRYBG2,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CRYBG2 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1492,1493249,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,493631,CRYGM3,https://ctdbase.org/detail.go?type=gene&acc=493631,,,493631.0,crygm3,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CRYGM3 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1493,1493250,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,474328,CRYGM5,https://ctdbase.org/detail.go?type=gene&acc=474328,,,474328.0,crygm5,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CRYGM5 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1494,1493251,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,553967,CRYGM7,https://ctdbase.org/detail.go?type=gene&acc=553967,,,553967.0,crygm7,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CRYGM7 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1495,1493252,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1431,CS,https://ctdbase.org/detail.go?type=gene&acc=1431,,,1431.0,CS,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CS protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1496,1493253,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1436,CSF1R,https://ctdbase.org/detail.go?type=gene&acc=1436,,,1436.0,CSF1R,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of CSF1R mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1497,1493254,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [lipopolysaccharides results in increased secretion of CSF2 protein]",,,PMID:19211157,https://www.ncbi.nlm.nih.gov/pubmed/19211157,19211157,,
1498,1496100,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1735,DIO3,https://ctdbase.org/detail.go?type=gene&acc=1735,,,1735.0,DIO3,9606.0,Homo sapiens (human),"[environmental pollutants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased methylation of DIO3 promoter",,,PMID:31272017,https://www.ncbi.nlm.nih.gov/pubmed/31272017,31272017,,
1499,1496101,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,798872,DIO3B,https://ctdbase.org/detail.go?type=gene&acc=798872,,,798872.0,dio3b,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DIO3B mRNA",,,PMID:30763833,https://www.ncbi.nlm.nih.gov/pubmed/30763833,30763833,,
1500,1496102,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,57609,DIP2B,https://ctdbase.org/detail.go?type=gene&acc=57609,,,57609.0,DIP2B,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DIP2B protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1501,1496103,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,388650,DIPK1A,https://ctdbase.org/detail.go?type=gene&acc=388650,,,388650.0,DIPK1A,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of DIPK1A mRNA",,,PMID:19095052,https://www.ncbi.nlm.nih.gov/pubmed/19095052,19095052,,
1502,1496104,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,22894,DIS3,https://ctdbase.org/detail.go?type=gene&acc=22894,,,22894.0,DIS3,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DIS3 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1503,1496105,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,22894,DIS3,https://ctdbase.org/detail.go?type=gene&acc=22894,,,22894.0,DIS3,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of DIS3 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1504,1496106,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,22943,DKK1,https://ctdbase.org/detail.go?type=gene&acc=22943,,,22943.0,DKK1,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of DKK1 mRNA",,,PMID:19095052,https://www.ncbi.nlm.nih.gov/pubmed/19095052,19095052,,
1505,1496107,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,9229,DLGAP1,https://ctdbase.org/detail.go?type=gene&acc=9229,,,9229.0,DLGAP1,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DLGAP1 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1506,1496721,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,414061,DNAJB3,https://ctdbase.org/detail.go?type=gene&acc=414061,,,414061.0,DNAJB3,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DNAJB3 mRNA",,,PMID:31826744,https://www.ncbi.nlm.nih.gov/pubmed/31826744,31826744,,
1507,1496722,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,393275,DNAJB6B,https://ctdbase.org/detail.go?type=gene&acc=393275,,,393275.0,dnajb6b,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DNAJB6B mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1508,1496723,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,4189,DNAJB9,https://ctdbase.org/detail.go?type=gene&acc=4189,,,4189.0,DNAJB9,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of DNAJB9 mRNA",,,PMID:19095052,https://www.ncbi.nlm.nih.gov/pubmed/19095052,19095052,,
1509,1496724,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,4189,DNAJB9,https://ctdbase.org/detail.go?type=gene&acc=4189,,,4189.0,DNAJB9,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of DNAJB9 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1510,1496725,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,4189,DNAJB9,https://ctdbase.org/detail.go?type=gene&acc=4189,,,4189.0,DNAJB9,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNAJB9 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1511,1496726,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,54431,DNAJC10,https://ctdbase.org/detail.go?type=gene&acc=54431,,,54431.0,DNAJC10,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNAJC10 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1512,1496727,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,55735,DNAJC11,https://ctdbase.org/detail.go?type=gene&acc=55735,,,55735.0,DNAJC11,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNAJC11 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1513,1496728,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,23317,DNAJC13,https://ctdbase.org/detail.go?type=gene&acc=23317,,,23317.0,DNAJC13,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNAJC13 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1514,1497054,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [[estradiol co-treated with phosphoadenosine phosphosulfate] results in increased activity of SULT1A1 protein]",,,PMID:16601080,https://www.ncbi.nlm.nih.gov/pubmed/16601080,16601080,,
1515,1497055,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,445329,SULT1A4,https://ctdbase.org/detail.go?type=gene&acc=445329,,,445329.0,SULT1A4,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SULT1A4 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1516,1497056,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,27284,SULT1B1,https://ctdbase.org/detail.go?type=gene&acc=27284,,,27284.0,SULT1B1,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of SULT1B1 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1517,1497057,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,27284,SULT1B1,https://ctdbase.org/detail.go?type=gene&acc=27284,,,27284.0,SULT1B1,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SULT1B1 mRNA",,,PMID:20056577,https://www.ncbi.nlm.nih.gov/pubmed/20056577,20056577,,
1518,1497058,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,442038,SULT1C3,https://ctdbase.org/detail.go?type=gene&acc=442038,,,442038.0,SULT1C3,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SULT1C3 mRNA",,,PMID:20056577,https://www.ncbi.nlm.nih.gov/pubmed/20056577,20056577,,
1519,1497059,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,6783,SULT1E1,https://ctdbase.org/detail.go?type=gene&acc=6783,,,6783.0,SULT1E1,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [SULT1E1 protein results in increased metabolism of estradiol]",,,PMID:18161906,https://www.ncbi.nlm.nih.gov/pubmed/18161906,18161906,,
1520,1497060,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,6783,SULT1E1,https://ctdbase.org/detail.go?type=gene&acc=6783,,,6783.0,SULT1E1,9606.0,Homo sapiens (human),"[2,2',4,4'-tetrabromodiphenyl ether metabolite co-treated with adenosine 3'-phosphate-5'-phosphate] binds to SULT1E1 protein|2,2',4,4'-tetrabromodiphenyl ether metabolite results in decreased activity of SULT1E1 protein",,,PMID:23959441,https://www.ncbi.nlm.nih.gov/pubmed/23959441,23959441,,
1521,1497208,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,619193,SULT1ST5,https://ctdbase.org/detail.go?type=gene&acc=619193,,,619193.0,sult1st5,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SULT1ST5 mRNA",,,PMID:25544063,https://www.ncbi.nlm.nih.gov/pubmed/25544063,25544063,,
1522,1497209,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,629219,SULT2A6,https://ctdbase.org/detail.go?type=gene&acc=629219,,,629219.0,Sult2a6,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SULT2A6 mRNA",,,PMID:32679240,https://www.ncbi.nlm.nih.gov/pubmed/32679240,32679240,,
1523,1497210,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,6820,SULT2B1,https://ctdbase.org/detail.go?type=gene&acc=6820,,,6820.0,SULT2B1,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SULT2B1 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1524,1497211,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,338214,SULT2ST1,https://ctdbase.org/detail.go?type=gene&acc=338214,,,338214.0,sult2st1,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SULT2ST1 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1525,1497212,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,330440,SULT6B2,https://ctdbase.org/detail.go?type=gene&acc=330440,,,330440.0,Sult6b2,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SULT6B2 mRNA",,,PMID:31826744,https://www.ncbi.nlm.nih.gov/pubmed/31826744,31826744,,
1526,1497213,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,25870,SUMF2,https://ctdbase.org/detail.go?type=gene&acc=25870,,,25870.0,SUMF2,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SUMF2 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1527,1497214,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,25870,SUMF2,https://ctdbase.org/detail.go?type=gene&acc=25870,,,25870.0,SUMF2,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of SUMF2 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
1528,1497215,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,25870,SUMF2,https://ctdbase.org/detail.go?type=gene&acc=25870,,,25870.0,SUMF2,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SUMF2 mRNA",,,PMID:31826744,https://www.ncbi.nlm.nih.gov/pubmed/31826744,31826744,,
1529,1497216,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,11198,SUPT16H,https://ctdbase.org/detail.go?type=gene&acc=11198,,,11198.0,SUPT16H,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SUPT16H protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1530,1498259,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1870,E2F2,https://ctdbase.org/detail.go?type=gene&acc=1870,,,1870.0,E2F2,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of E2F2 protein|2,2',4,4'-tetrabromodiphenyl ether results in increased expression of E2F2 mRNA",,,PMID:26988655,https://www.ncbi.nlm.nih.gov/pubmed/26988655,26988655,,
1531,1498541,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,55775,TDP1,https://ctdbase.org/detail.go?type=gene&acc=55775,,,55775.0,TDP1,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TDP1 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1532,1498542,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,499018,TECRL2,https://ctdbase.org/detail.go?type=gene&acc=499018,,,499018.0,Tecrl2,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TECRL2 mRNA",,,PMID:20056577,https://www.ncbi.nlm.nih.gov/pubmed/20056577,20056577,,
1533,1498543,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,6975,TECTB,https://ctdbase.org/detail.go?type=gene&acc=6975,,,6975.0,TECTB,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TECTB mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1534,1498544,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,79736,TEFM,https://ctdbase.org/detail.go?type=gene&acc=79736,,,79736.0,TEFM,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TEFM mRNA",,,PMID:31826744,https://www.ncbi.nlm.nih.gov/pubmed/31826744,31826744,,
1535,1498545,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,150483,TEKT4,https://ctdbase.org/detail.go?type=gene&acc=150483,,,150483.0,TEKT4,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TEKT4 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1536,1499028,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of UGT1A1 mRNA",,,PMID:17964624,https://www.ncbi.nlm.nih.gov/pubmed/17964624,17964624,,
1537,1499029,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of UGT1A1 mRNA",,,PMID:20056577,https://www.ncbi.nlm.nih.gov/pubmed/20056577,20056577,,
1538,1499030,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of UGT1A1 protein",,,PMID:32679240,https://www.ncbi.nlm.nih.gov/pubmed/32679240,32679240,,
1539,1499031,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,54577,UGT1A7,https://ctdbase.org/detail.go?type=gene&acc=54577,,,54577.0,UGT1A7,10090.0,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of UGT1A7 mRNA",,,PMID:17964624,https://www.ncbi.nlm.nih.gov/pubmed/17964624,17964624,,
1540,1499032,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,406731,UGT1AB,https://ctdbase.org/detail.go?type=gene&acc=406731,,,406731.0,ugt1ab,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of UGT1AB mRNA",,,PMID:25544063,https://www.ncbi.nlm.nih.gov/pubmed/25544063,25544063,,
1541,1513133,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,114461,TNFRSFA,https://ctdbase.org/detail.go?type=gene&acc=114461,,,114461.0,tnfrsfa,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TNFRSFA mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1542,1513134,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,7955.0,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TNFSF10 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
1543,1514430,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,7706,TRIM25,https://ctdbase.org/detail.go?type=gene&acc=7706,,,7706.0,TRIM25,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TRIM25 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1544,1514431,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,23650,TRIM29,https://ctdbase.org/detail.go?type=gene&acc=23650,,,23650.0,TRIM29,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TRIM29 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
1545,1514432,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,51592,TRIM33,https://ctdbase.org/detail.go?type=gene&acc=51592,,,51592.0,TRIM33,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TRIM33 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1546,1514583,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,54482,TRMT13,https://ctdbase.org/detail.go?type=gene&acc=54482,,,54482.0,TRMT13,10116.0,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TRMT13 mRNA",,,PMID:21394737,https://www.ncbi.nlm.nih.gov/pubmed/21394737,21394737,,
1547,1514584,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,81627,TRMT1L,https://ctdbase.org/detail.go?type=gene&acc=81627,,,81627.0,TRMT1L,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TRMT1L protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1548,1514585,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,115708,TRMT61A,https://ctdbase.org/detail.go?type=gene&acc=115708,,,115708.0,TRMT61A,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TRMT61A protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1549,1443455,98531,Toxin and Toxin Target Database (T3DB),(mu-(Carbonato(2-)-O:O'))dihydroxydicobalt,T3D1389,Cobalt(II) carbonate hydroxide (1:1),http://www.t3db.ca/toxins/T3D1389,BE0000322,Carbonic anhydrase 2,http://www.t3db.ca/biodb/bio_entities/BE0000322,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),"Cobalt inhibits carbonic anhydrases.(a38, A98)",,,PMID:18237030|PMID:12164389,https://www.ncbi.nlm.nih.gov/pubmed/18237030|https://www.ncbi.nlm.nih.gov/pubmed/12164389,18237030|12164389,,
1550,1443456,98531,Toxin and Toxin Target Database (T3DB),(mu-(Carbonato(2-)-O:O'))dihydroxydicobalt,T3D1389,Cobalt(II) carbonate hydroxide (1:1),http://www.t3db.ca/toxins/T3D1389,BE0000535,Carbonic anhydrase 4,http://www.t3db.ca/biodb/bio_entities/BE0000535,P22748,Carbonic anhydrase 4,762.0,CA4,9606.0,Homo sapiens (human),"Cobalt inhibits carbonic anhydrases.(a38, A98)",,,PMID:18237030|PMID:12164389,https://www.ncbi.nlm.nih.gov/pubmed/18237030|https://www.ncbi.nlm.nih.gov/pubmed/12164389,18237030|12164389,,
1551,1484366,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,10149,ADGRG2,https://ctdbase.org/detail.go?type=gene&acc=10149,,,10149.0,ADGRG2,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of ADGRG2 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1552,1484367,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,57016,AKR1B10,https://ctdbase.org/detail.go?type=gene&acc=57016,,,57016.0,AKR1B10,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of AKR1B10 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1553,1484368,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,11997,AKR1B7,https://ctdbase.org/detail.go?type=gene&acc=11997,,,11997.0,Akr1b7,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of AKR1B7 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1554,1484546,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,360,AQP3,https://ctdbase.org/detail.go?type=gene&acc=360,,,360.0,AQP3,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of AQP3 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1555,1484547,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,364,AQP7,https://ctdbase.org/detail.go?type=gene&acc=364,,,364.0,AQP7,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of AQP7 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1556,1484548,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,57221,ARFGEF3,https://ctdbase.org/detail.go?type=gene&acc=57221,,,57221.0,ARFGEF3,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of ARFGEF3 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1557,1484549,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,57561,ARRDC3,https://ctdbase.org/detail.go?type=gene&acc=57561,,,57561.0,ARRDC3,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of ARRDC3 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1558,1486177,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,2731,GLDC,https://ctdbase.org/detail.go?type=gene&acc=2731,,,2731.0,GLDC,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of GLDC mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1559,1486178,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,9630,GNA14,https://ctdbase.org/detail.go?type=gene&acc=9630,,,9630.0,GNA14,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of GNA14 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1560,1486179,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,2770,GNAI1,https://ctdbase.org/detail.go?type=gene&acc=2770,,,2770.0,GNAI1,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of GNAI1 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1561,1486180,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,27232,GNMT,https://ctdbase.org/detail.go?type=gene&acc=27232,,,27232.0,GNMT,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of GNMT mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1562,1486181,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,2805,GOT1,https://ctdbase.org/detail.go?type=gene&acc=2805,,,2805.0,GOT1,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of GOT1 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1563,1486182,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,2822,GPLD1,https://ctdbase.org/detail.go?type=gene&acc=2822,,,2822.0,GPLD1,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of GPLD1 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1564,1486183,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,10116.0,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of GPX2 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
1565,1444310,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of BBC3 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1566,1444311,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of BCL2L1 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1567,1444312,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,6046,BRD2,https://ctdbase.org/detail.go?type=gene&acc=6046,,,6046.0,BRD2,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of BRD2 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1568,1444313,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,83990,BRIP1,https://ctdbase.org/detail.go?type=gene&acc=83990,,,83990.0,BRIP1,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of BRIP1 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1569,1444805,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,1962,EHHADH,https://ctdbase.org/detail.go?type=gene&acc=1962,,,1962.0,EHHADH,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of EHHADH mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1570,1444806,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,54898,ELOVL2,https://ctdbase.org/detail.go?type=gene&acc=54898,,,54898.0,ELOVL2,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of ELOVL2 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1571,1444807,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,1969,EPHA2,https://ctdbase.org/detail.go?type=gene&acc=1969,,,1969.0,EPHA2,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of EPHA2 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1572,1444808,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,2150,F2RL1,https://ctdbase.org/detail.go?type=gene&acc=2150,,,2150.0,F2RL1,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of F2RL1 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1573,1444809,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of FABP1 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1574,1444810,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of FAS mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1575,1445685,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of MDM2 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1576,1445686,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,51085,MLXIPL,https://ctdbase.org/detail.go?type=gene&acc=51085,,,51085.0,MLXIPL,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of MLXIPL mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1577,1445687,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,4320,MMP11,https://ctdbase.org/detail.go?type=gene&acc=4320,,,4320.0,MMP11,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of MMP11 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1578,1445688,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,56180,MOSPD1,https://ctdbase.org/detail.go?type=gene&acc=56180,,,56180.0,MOSPD1,9606.0,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of MOSPD1 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
1579,1490234,101771,Therapeutic Target Database (TTD),Tetrahydrodeoxycorticosterone,D03PBN,tetrahydrodeoxycorticosterone,https://idrblab.net/ttd/data/drug/details/D03PBN,T28722,GABA(A) receptor gamma-3 (GABRG3),https://idrblab.net/ttd/data/target/details/T28722,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,2567.0,GABRG3,9606.0,Homo sapiens (human),Modulator (allosteric modulator),,,,,,,
1580,1490235,101771,Therapeutic Target Database (TTD),Tetrahydrodeoxycorticosterone,D03PBN,tetrahydrodeoxycorticosterone,https://idrblab.net/ttd/data/drug/details/D03PBN,T26368,GABA(A) receptor alpha-5 (GABRA5),https://idrblab.net/ttd/data/target/details/T26368,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,2558.0,GABRA5,9606.0,Homo sapiens (human),Modulator (allosteric modulator),,,,,,,
1581,1490236,101771,Comparative Toxicogenomics Database (CTD),Tetrahydrodeoxycorticosterone,C009413,tetrahydrodeoxycorticosterone,https://ctdbase.org/detail.go?type=chem&acc=C009413,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606.0,Homo sapiens (human),AKR1C1 protein affects the oxidation of tetrahydrodeoxycorticosterone,,,PMID:12604236,https://www.ncbi.nlm.nih.gov/pubmed/12604236,12604236,,
1582,1490237,101771,Comparative Toxicogenomics Database (CTD),Tetrahydrodeoxycorticosterone,C009413,tetrahydrodeoxycorticosterone,https://ctdbase.org/detail.go?type=chem&acc=C009413,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646.0,AKR1C2,9606.0,Homo sapiens (human),AKR1C2 protein affects the oxidation of tetrahydrodeoxycorticosterone,,,PMID:12604236,https://www.ncbi.nlm.nih.gov/pubmed/12604236,12604236,,
1583,1490238,101771,Comparative Toxicogenomics Database (CTD),Tetrahydrodeoxycorticosterone,C009413,tetrahydrodeoxycorticosterone,https://ctdbase.org/detail.go?type=chem&acc=C009413,1109,AKR1C4,https://ctdbase.org/detail.go?type=gene&acc=1109,,,1109.0,AKR1C4,9606.0,Homo sapiens (human),AKR1C4 protein affects the oxidation of tetrahydrodeoxycorticosterone,,,PMID:12604236,https://www.ncbi.nlm.nih.gov/pubmed/12604236,12604236,,
1584,1490239,101771,Comparative Toxicogenomics Database (CTD),Tetrahydrodeoxycorticosterone,C009413,tetrahydrodeoxycorticosterone,https://ctdbase.org/detail.go?type=chem&acc=C009413,2563,GABRD,https://ctdbase.org/detail.go?type=gene&acc=2563,,,2563.0,GABRD,10116.0,Rattus norvegicus (Norway rat),Tetrahydrodeoxycorticosterone results in decreased expression of GABRD protein,,,PMID:16914187,https://www.ncbi.nlm.nih.gov/pubmed/16914187,16914187,,
1585,1490240,102028,BindingDB,5alpha-Androstan-3-one,217387,"Steroid scaffold, 12",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=217387,9153,Ghrelin O-acyltransferase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9153,Q96T53,Ghrelin O-acyltransferase,619373.0,MBOAT4,9606.0,Homo sapiens (human),,IC50 (nM),>4.00e+5,PMID:28134508|DOI:10.1021/acs.biochem.6b01008,https://www.ncbi.nlm.nih.gov/pubmed/28134508|https://doi.org/10.1021/acs.biochem.6b01008,28134508,10.1021/acs.biochem.6b01008,
1586,1490241,102614,Therapeutic Target Database (TTD),"2,3-Bis(4-hydroxyphenyl)propionitrile",D05EOW,diarylpropionitril,https://idrblab.net/ttd/data/drug/details/D05EOW,T80896,Estrogen receptor beta (ESR2),https://idrblab.net/ttd/data/target/details/T80896,Q92731,Estrogen receptor beta,2100.0,ESR2,9606.0,Homo sapiens (human),Agonist,,,,,,,
1587,1490242,102678,Drug Gene Interaction database (DGIdb),Alexidine dihydrochloride,,ALEXIDINE DIHYDROCHLORIDE,https://www.dgidb.org/drugs/chembl:CHEMBL554041,,TP53,https://www.dgidb.org/genes/hgnc:11998,,,7157.0,TP53,9606.0,Homo sapiens (human),,,,,,,,
1588,1490243,104735,Comparative Toxicogenomics Database (CTD),4-Methoxy-N-methylbenzeneethanamine,D003189,p-Methoxy-N-methylphenethylamine,https://ctdbase.org/detail.go?type=chem&acc=D003189,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),P-methoxy-N-methylphenethylamine results in increased secretion of CCL2 protein,,,PMID:34826398,https://www.ncbi.nlm.nih.gov/pubmed/34826398,34826398,,
1589,1490415,104735,Comparative Toxicogenomics Database (CTD),4-Methoxy-N-methylbenzeneethanamine,D003189,p-Methoxy-N-methylphenethylamine,https://ctdbase.org/detail.go?type=chem&acc=D003189,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),P-methoxy-N-methylphenethylamine results in increased secretion of CXCL8 protein,,,PMID:34826398,https://www.ncbi.nlm.nih.gov/pubmed/34826398,34826398,,
1590,1490416,104735,Comparative Toxicogenomics Database (CTD),4-Methoxy-N-methylbenzeneethanamine,D003189,p-Methoxy-N-methylphenethylamine,https://ctdbase.org/detail.go?type=chem&acc=D003189,2990,GUSB,https://ctdbase.org/detail.go?type=gene&acc=2990,,,2990.0,GUSB,10116.0,Rattus norvegicus (Norway rat),P-methoxy-N-methylphenethylamine results in increased secretion of GUSB protein,,,PMID:9545557,https://www.ncbi.nlm.nih.gov/pubmed/9545557,9545557,,
1591,1490417,104735,Comparative Toxicogenomics Database (CTD),4-Methoxy-N-methylbenzeneethanamine,D003189,p-Methoxy-N-methylphenethylamine,https://ctdbase.org/detail.go?type=chem&acc=D003189,3073,HEXA,https://ctdbase.org/detail.go?type=gene&acc=3073,,,3073.0,HEXA,9606.0,Homo sapiens (human),P-methoxy-N-methylphenethylamine results in increased secretion of HEXA protein|apigenin inhibits the reaction [p-methoxy-N-methylphenethylamine results in increased secretion of HEXA protein],,,PMID:36350155,https://www.ncbi.nlm.nih.gov/pubmed/36350155,36350155,,
1592,1490418,104735,Comparative Toxicogenomics Database (CTD),4-Methoxy-N-methylbenzeneethanamine,D003189,p-Methoxy-N-methylphenethylamine,https://ctdbase.org/detail.go?type=chem&acc=D003189,3074,HEXB,https://ctdbase.org/detail.go?type=gene&acc=3074,,,3074.0,HEXB,9606.0,Homo sapiens (human),P-methoxy-N-methylphenethylamine results in increased secretion of HEXB protein,,,PMID:34774977,https://www.ncbi.nlm.nih.gov/pubmed/34774977,34774977,,
1593,1490419,104735,Comparative Toxicogenomics Database (CTD),4-Methoxy-N-methylbenzeneethanamine,D003189,p-Methoxy-N-methylphenethylamine,https://ctdbase.org/detail.go?type=chem&acc=D003189,3350,HTR1A,https://ctdbase.org/detail.go?type=gene&acc=3350,,,3350.0,HTR1A,10116.0,Rattus norvegicus (Norway rat),P-methoxy-N-methylphenethylamine results in increased activity of HTR1A protein,,,PMID:16415902,https://www.ncbi.nlm.nih.gov/pubmed/16415902,16415902,,
1594,1512090,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,9712,USP6NL,https://ctdbase.org/detail.go?type=gene&acc=9712,,,9712.0,USP6NL,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of USP6NL gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1595,1512091,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,7874,USP7,https://ctdbase.org/detail.go?type=gene&acc=7874,,,7874.0,USP7,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of USP7 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1596,1512092,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,55813,UTP6,https://ctdbase.org/detail.go?type=gene&acc=55813,,,55813.0,UTP6,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of UTP6 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1597,1512093,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,257313,UTS2B,https://ctdbase.org/detail.go?type=gene&acc=257313,,,257313.0,UTS2B,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of UTS2B gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1598,1512094,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,80146,UXS1,https://ctdbase.org/detail.go?type=gene&acc=80146,,,80146.0,UXS1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of UXS1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1599,1512095,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,6844,VAMP2,https://ctdbase.org/detail.go?type=gene&acc=6844,,,6844.0,VAMP2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of VAMP2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1600,1512096,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,10791,VAMP5,https://ctdbase.org/detail.go?type=gene&acc=10791,,,10791.0,VAMP5,9606.0,Homo sapiens (human),[bisphenol F co-treated with fulvestrant] results in increased methylation of VAMP5 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1601,1512097,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,81839,VANGL1,https://ctdbase.org/detail.go?type=gene&acc=81839,,,81839.0,VANGL1,9606.0,Homo sapiens (human),[bisphenol F co-treated with fulvestrant] results in decreased methylation of VANGL1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1602,1512997,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,54621,VSIG10,https://ctdbase.org/detail.go?type=gene&acc=54621,,,54621.0,VSIG10,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of VSIG10 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1603,1512998,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,23584,VSIG2,https://ctdbase.org/detail.go?type=gene&acc=23584,,,23584.0,VSIG2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of VSIG2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1604,1518728,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5064,PALM,https://ctdbase.org/detail.go?type=gene&acc=5064,,,5064.0,PALM,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of PALM gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1605,1518729,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,445815,PALM2AKAP2,https://ctdbase.org/detail.go?type=gene&acc=445815,,,445815.0,PALM2AKAP2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of PALM2AKAP2 gene|[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in increased methylation of PALM2AKAP2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1606,1518730,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,342979,PALM3,https://ctdbase.org/detail.go?type=gene&acc=342979,,,342979.0,PALM3,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of PALM3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1607,1518731,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,25891,PAMR1,https://ctdbase.org/detail.go?type=gene&acc=25891,,,25891.0,PAMR1,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of PAMR1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1608,1518732,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,9924,PAN2,https://ctdbase.org/detail.go?type=gene&acc=9924,,,9924.0,PAN2,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of PAN2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1609,1518733,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,100506421,PANTR1,https://ctdbase.org/detail.go?type=gene&acc=100506421,,,100506421.0,PANTR1,9606.0,Homo sapiens (human),[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in decreased methylation of PANTR1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1610,1521228,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [zearalenol results in increased expression of PGR protein]|fulvestrant inhibits the reaction [zearalenone results in increased expression of PGR protein],,,PMID:21803136,https://www.ncbi.nlm.nih.gov/pubmed/21803136,21803136,,
1611,1521229,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606.0,Homo sapiens (human),Fulvestrant results in decreased expression of PGR mRNA,,,PMID:11867264|PMID:15072547|PMID:20206645|PMID:20543978|PMID:26865669|PMID:31646340,https://www.ncbi.nlm.nih.gov/pubmed/11867264|https://www.ncbi.nlm.nih.gov/pubmed/15072547|https://www.ncbi.nlm.nih.gov/pubmed/20206645|https://www.ncbi.nlm.nih.gov/pubmed/20543978|https://www.ncbi.nlm.nih.gov/pubmed/26865669|https://www.ncbi.nlm.nih.gov/pubmed/31646340,11867264|15072547|20206645|20543978|26865669|31646340,,
1612,1521230,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606.0,Homo sapiens (human),Fulvestrant results in decreased expression of PGR protein,,,PMID:20179196,https://www.ncbi.nlm.nih.gov/pubmed/20179196,20179196,,
1613,1521231,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,10090.0,Mus musculus (house mouse),Estradiol promotes the reaction [fulvestrant results in decreased expression of PGR mrna]|fulvestrant results in decreased expression of PGR mrna|bisphenol A promotes the reaction [fulvestrant results in decreased expression of PGR mrna]|fulvestrant promotes the reaction [estradiol results in decreased expression of PGR mrna],,,PMID:30061528,https://www.ncbi.nlm.nih.gov/pubmed/30061528,30061528,,
1614,1521232,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,10090.0,Mus musculus (house mouse),Fulvestrant affects the reaction [chlordecone results in increased expression of PGR mrna],,,PMID:9607801,https://www.ncbi.nlm.nih.gov/pubmed/9607801,9607801,,
1615,1521233,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,10090.0,Mus musculus (house mouse),Fulvestrant inhibits the reaction [estradiol results in increased expression of PGR mrna],,,PMID:37657410,https://www.ncbi.nlm.nih.gov/pubmed/37657410,37657410,,
1616,1521234,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,10116.0,Rattus norvegicus (Norway rat),Fulvestrant inhibits the reaction [biochanin A results in increased expression of PGR mrna]|fulvestrant inhibits the reaction [8-prenylnaringenin results in increased expression of PGR mrna]|[fulvestrant co-treated with coumestrol] results in decreased expression of PGR mRNA,,,PMID:34848279,https://www.ncbi.nlm.nih.gov/pubmed/34848279,34848279,,
1617,1523519,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,94026,POM121L2,https://ctdbase.org/detail.go?type=gene&acc=94026,,,94026.0,POM121L2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of POM121L2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1618,1525748,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5746,PTH2R,https://ctdbase.org/detail.go?type=gene&acc=5746,,,5746.0,PTH2R,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of PTH2R gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1619,1525749,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5747,PTK2,https://ctdbase.org/detail.go?type=gene&acc=5747,,,5747.0,PTK2,9606.0,Homo sapiens (human),[bisphenol F co-treated with fulvestrant] results in decreased methylation of PTK2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1620,1525750,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5747,PTK2,https://ctdbase.org/detail.go?type=gene&acc=5747,,,5747.0,PTK2,9606.0,Homo sapiens (human),Fulvestrant results in increased degradation of PTK2 protein,,,PMID:24440569,https://www.ncbi.nlm.nih.gov/pubmed/24440569,24440569,,
1621,1525751,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5753,PTK6,https://ctdbase.org/detail.go?type=gene&acc=5753,,,5753.0,PTK6,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of PTK6 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1622,1527464,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,3516,RBPJ,https://ctdbase.org/detail.go?type=gene&acc=3516,,,3516.0,RBPJ,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of RBPJ gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1623,1527465,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,11030,RBPMS,https://ctdbase.org/detail.go?type=gene&acc=11030,,,11030.0,RBPMS,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RBPMS gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1624,1527466,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,10231,RCAN2,https://ctdbase.org/detail.go?type=gene&acc=10231,,,10231.0,RCAN2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RCAN2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1625,1527467,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1102,RCBTB2,https://ctdbase.org/detail.go?type=gene&acc=1102,,,1102.0,RCBTB2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RCBTB2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1626,1527468,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,10171,RCL1,https://ctdbase.org/detail.go?type=gene&acc=10171,,,10171.0,RCL1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RCL1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1627,1527469,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,10171,RCL1,https://ctdbase.org/detail.go?type=gene&acc=10171,,,10171.0,RCL1,9606.0,Homo sapiens (human),Fulvestrant results in decreased expression of RCL1 mRNA,,,PMID:26865669,https://www.ncbi.nlm.nih.gov/pubmed/26865669,26865669,,
1628,1528789,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,54476,RNF216,https://ctdbase.org/detail.go?type=gene&acc=54476,,,54476.0,RNF216,9606.0,Homo sapiens (human),[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in decreased methylation of RNF216 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1629,1528790,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,154214,RNF217,https://ctdbase.org/detail.go?type=gene&acc=154214,,,154214.0,RNF217,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] affects the methylation of RNF217 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1630,1528791,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,55182,RNF220,https://ctdbase.org/detail.go?type=gene&acc=55182,,,55182.0,RNF220,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of RNF220 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1631,1528792,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,80352,RNF39,https://ctdbase.org/detail.go?type=gene&acc=80352,,,80352.0,RNF39,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RNF39 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1632,1528793,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,6047,RNF4,https://ctdbase.org/detail.go?type=gene&acc=6047,,,6047.0,RNF4,10090.0,Mus musculus (house mouse),Fulvestrant inhibits the reaction [diethylstilbestrol results in increased expression of RNF4 mrna],,,PMID:14749358,https://www.ncbi.nlm.nih.gov/pubmed/14749358,14749358,,
1633,1528794,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,22838,RNF44,https://ctdbase.org/detail.go?type=gene&acc=22838,,,22838.0,RNF44,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of RNF44 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1634,1528795,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,6049,RNF6,https://ctdbase.org/detail.go?type=gene&acc=6049,,,6049.0,RNF6,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RNF6 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1635,1528796,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,9025,RNF8,https://ctdbase.org/detail.go?type=gene&acc=9025,,,9025.0,RNF8,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RNF8 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1636,1528797,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,55328,RNLS,https://ctdbase.org/detail.go?type=gene&acc=55328,,,55328.0,RNLS,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RNLS gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1637,1528798,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,6051,RNPEP,https://ctdbase.org/detail.go?type=gene&acc=6051,,,6051.0,RNPEP,9606.0,Homo sapiens (human),[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in decreased methylation of RNPEP gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1638,1528942,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,4550,RNR2,https://ctdbase.org/detail.go?type=gene&acc=4550,,,4550.0,RNR2,9606.0,Homo sapiens (human),Fulvestrant promotes the reaction [SIN3B protein binds to RNR2 promoter]|rb1 mutant form inhibits the reaction [fulvestrant promotes the reaction [SIN3B protein binds to RNR2 promoter]]|fulvestrant promotes the reaction [RB1 protein binds to RNR2 promoter],,,PMID:21367843,https://www.ncbi.nlm.nih.gov/pubmed/21367843,21367843,,
1639,1528943,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,6091,ROBO1,https://ctdbase.org/detail.go?type=gene&acc=6091,,,6091.0,ROBO1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of ROBO1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1640,1528944,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,6092,ROBO2,https://ctdbase.org/detail.go?type=gene&acc=6092,,,6092.0,ROBO2,9606.0,Homo sapiens (human),Fulvestrant results in decreased methylation of ROBO2 gene|[bisphenol F co-treated with fulvestrant] affects the methylation of ROBO2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1641,1528945,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,54538,ROBO4,https://ctdbase.org/detail.go?type=gene&acc=54538,,,54538.0,ROBO4,9606.0,Homo sapiens (human),[bisphenol F co-treated with fulvestrant] results in decreased methylation of ROBO4 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1642,1528946,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,9475,ROCK2,https://ctdbase.org/detail.go?type=gene&acc=9475,,,9475.0,ROCK2,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of ROCK2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1643,1528947,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,4919,ROR1,https://ctdbase.org/detail.go?type=gene&acc=4919,,,4919.0,ROR1,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of ROR1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1644,1528948,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,6095,RORA,https://ctdbase.org/detail.go?type=gene&acc=6095,,,6095.0,RORA,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] affects the methylation of RORA gene|fulvestrant results in increased methylation of RORA gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1645,1528949,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,6096,RORB,https://ctdbase.org/detail.go?type=gene&acc=6096,,,6096.0,RORB,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RORB gene|[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in increased methylation of RORB gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1646,1528950,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,6101,RP1,https://ctdbase.org/detail.go?type=gene&acc=6101,,,6101.0,RP1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RP1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1647,1517371,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,780,DDR1,https://ctdbase.org/detail.go?type=gene&acc=780,,,780.0,DDR1,10114.0,Rattus,Butyrates results in increased expression of DDR1 mRNA,,,PMID:14674679,https://www.ncbi.nlm.nih.gov/pubmed/14674679,14674679,,
1648,1517372,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719.0,DHFR,9606.0,Homo sapiens (human),Butyrates results in decreased expression of DHFR mRNA,,,PMID:20072153,https://www.ncbi.nlm.nih.gov/pubmed/20072153,20072153,,
1649,1517373,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,56616,DIABLO,https://ctdbase.org/detail.go?type=gene&acc=56616,,,56616.0,DIABLO,9606.0,Homo sapiens (human),[bortezomib co-treated with butyrates] affects the localization of DIABLO protein,,,PMID:12893773,https://www.ncbi.nlm.nih.gov/pubmed/12893773,12893773,,
1650,1517374,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,151871,DPPA2,https://ctdbase.org/detail.go?type=gene&acc=151871,,,151871.0,DPPA2,9606.0,Homo sapiens (human),Butyrates results in increased expression of DPPA2 protein,,,PMID:20201064,https://www.ncbi.nlm.nih.gov/pubmed/20201064,20201064,,
1651,1519417,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,5602,MAPK10,https://ctdbase.org/detail.go?type=gene&acc=5602,,,5602.0,MAPK10,9606.0,Homo sapiens (human),[bortezomib co-treated with butyrates] results in increased phosphorylation of and results in increased activity of MAPK10 protein|acetylcysteine inhibits the reaction [[bortezomib co-treated with butyrates] results in increased phosphorylation of and results in increased activity of MAPK10 protein]|[[bortezomib co-treated with butyrates] results in increased abundance of reactive oxygen species] which results in increased phosphorylation of and results in increased activity of MAPK10 protein,,,PMID:15173093,https://www.ncbi.nlm.nih.gov/pubmed/15173093,15173093,,
1652,1519418,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,9606.0,Homo sapiens (human),[bortezomib co-treated with butyrates] results in increased phosphorylation of MAPK14 protein,,,PMID:12893773,https://www.ncbi.nlm.nih.gov/pubmed/12893773,12893773,,
1653,1519419,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,10114.0,Rattus,Butyrates results in increased phosphorylation of and results in increased activity of MAPK14 protein,,,PMID:15978324,https://www.ncbi.nlm.nih.gov/pubmed/15978324,15978324,,
1654,1519420,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),[bortezomib co-treated with butyrates] results in decreased expression of MAPK3 protein|butyrates results in decreased expression of MAPK3 protein,,,PMID:12893773,https://www.ncbi.nlm.nih.gov/pubmed/12893773,12893773,,
1655,1519421,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Butyrates results in decreased phosphorylation of MAPK3 protein,,,PMID:20346929,https://www.ncbi.nlm.nih.gov/pubmed/20346929,20346929,,
1656,1519422,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),[perifosine co-treated with butyrates] results in decreased activity of MAPK3 protein,,,PMID:15781658,https://www.ncbi.nlm.nih.gov/pubmed/15781658,15781658,,
1657,1519423,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10114.0,Rattus,Butyrates results in decreased phosphorylation of and results in decreased activity of MAPK3 protein,,,PMID:15978324,https://www.ncbi.nlm.nih.gov/pubmed/15978324,15978324,,
1658,1519424,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,5596,MAPK4,https://ctdbase.org/detail.go?type=gene&acc=5596,,,5596.0,MAPK4,10114.0,Rattus,Butyrates results in decreased expression of MAPK4 mRNA,,,PMID:14674679,https://www.ncbi.nlm.nih.gov/pubmed/14674679,14674679,,
1659,1519425,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,79923,NANOG,https://ctdbase.org/detail.go?type=gene&acc=79923,,,79923.0,NANOG,9606.0,Homo sapiens (human),Butyrates results in increased expression of NANOG protein,,,PMID:20201064,https://www.ncbi.nlm.nih.gov/pubmed/20201064,20201064,,
1660,1492243,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),Bosentan results in increased expression of CYP2C9,,,PMID:16550733,https://www.ncbi.nlm.nih.gov/pubmed/16550733,16550733,,
1661,1492244,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Bosentan results in increased expression of CYP3A4 mRNA,,,PMID:18332078|PMID:29761207,https://www.ncbi.nlm.nih.gov/pubmed/18332078|https://www.ncbi.nlm.nih.gov/pubmed/29761207,18332078|29761207,,
1662,1492245,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Bosentan results in increased expression of CYP3A4,,,PMID:16550733,https://www.ncbi.nlm.nih.gov/pubmed/16550733,16550733,,
1663,1492246,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,64816,CYP3A43,https://ctdbase.org/detail.go?type=gene&acc=64816,,,64816.0,CYP3A43,9606.0,Homo sapiens (human),Bosentan affects the expression of CYP3A43 mRNA,,,PMID:29761207,https://www.ncbi.nlm.nih.gov/pubmed/29761207,29761207,,
1664,1492247,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,1551,CYP3A7,https://ctdbase.org/detail.go?type=gene&acc=1551,,,1551.0,CYP3A7,9606.0,Homo sapiens (human),Bosentan affects the expression of CYP3A7 mRNA,,,PMID:29761207,https://www.ncbi.nlm.nih.gov/pubmed/29761207,29761207,,
1665,1492248,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,9606.0,Homo sapiens (human),Bosentan results in decreased expression of CYP7A1 mRNA,,,PMID:29761207,https://www.ncbi.nlm.nih.gov/pubmed/29761207,29761207,,
1666,1492249,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,9201,DCLK1,https://ctdbase.org/detail.go?type=gene&acc=9201,,,9201.0,DCLK1,9606.0,Homo sapiens (human),Bosentan affects the expression of DCLK1 mRNA,,,PMID:29761207,https://www.ncbi.nlm.nih.gov/pubmed/29761207,29761207,,
1667,1492715,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,1910,EDNRB,https://ctdbase.org/detail.go?type=gene&acc=1910,,,1910.0,EDNRB,9606.0,Homo sapiens (human),Bosentan binds to and results in decreased activity of EDNRB protein,,,PMID:10796056|PMID:11922906|PMID:15093706|PMID:16335785|PMID:16700825|PMID:16741059|PMID:17234519|PMID:20967148|PMID:22483689|PMID:7828305|PMID:8572876|PMID:8587695|PMID:8604712|PMID:8794820|PMID:9052893,https://www.ncbi.nlm.nih.gov/pubmed/10796056|https://www.ncbi.nlm.nih.gov/pubmed/11922906|https://www.ncbi.nlm.nih.gov/pubmed/15093706|https://www.ncbi.nlm.nih.gov/pubmed/16335785|https://www.ncbi.nlm.nih.gov/pubmed/16700825|https://www.ncbi.nlm.nih.gov/pubmed/16741059|https://www.ncbi.nlm.nih.gov/pubmed/17234519|https://www.ncbi.nlm.nih.gov/pubmed/20967148|https://www.ncbi.nlm.nih.gov/pubmed/22483689|https://www.ncbi.nlm.nih.gov/pubmed/7828305|https://www.ncbi.nlm.nih.gov/pubmed/8572876|https://www.ncbi.nlm.nih.gov/pubmed/8587695|https://www.ncbi.nlm.nih.gov/pubmed/8604712|https://www.ncbi.nlm.nih.gov/pubmed/8794820|https://www.ncbi.nlm.nih.gov/pubmed/9052893,10796056|11922906|15093706|16335785|16700825|16741059|17234519|20967148|22483689|7828305|8572876|8587695|8604712|8794820|9052893,,
1668,1492716,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,9606.0,Homo sapiens (human),Bosentan results in decreased expression of FABP1 protein|bosentan results in decreased expression of FABP1 mRNA,,,PMID:29761207,https://www.ncbi.nlm.nih.gov/pubmed/29761207,29761207,,
1669,1492717,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,9606.0,Homo sapiens (human),Bosentan inhibits the reaction [glucose results in increased expression of FN1 protein]|bosentan inhibits the reaction [glucose results in increased expression of FN1 mrna],,,PMID:12388107,https://www.ncbi.nlm.nih.gov/pubmed/12388107,12388107,,
1670,1492718,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,50486,G0S2,https://ctdbase.org/detail.go?type=gene&acc=50486,,,50486.0,G0S2,9606.0,Homo sapiens (human),Bosentan affects the expression of G0S2 mRNA,,,PMID:29761207,https://www.ncbi.nlm.nih.gov/pubmed/29761207,29761207,,
1671,1492719,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,2538,G6PC1,https://ctdbase.org/detail.go?type=gene&acc=2538,,,2538.0,G6PC1,9606.0,Homo sapiens (human),Bosentan affects the expression of G6PC1 mRNA,,,PMID:29761207,https://www.ncbi.nlm.nih.gov/pubmed/29761207,29761207,,
1672,1492720,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,2626,GATA4,https://ctdbase.org/detail.go?type=gene&acc=2626,,,2626.0,GATA4,10090.0,Mus musculus (house mouse),Bosentan inhibits the reaction [doxorubicin results in decreased expression of GATA4 mrna]|bosentan inhibits the reaction [doxorubicin results in decreased expression of GATA4 protein],,,PMID:17974986,https://www.ncbi.nlm.nih.gov/pubmed/17974986,17974986,,
1673,1492721,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,2626,GATA4,https://ctdbase.org/detail.go?type=gene&acc=2626,,,2626.0,GATA4,10116.0,Rattus norvegicus (Norway rat),Bosentan affects the activity of GATA4 protein,,,PMID:21084678,https://www.ncbi.nlm.nih.gov/pubmed/21084678,21084678,,
1674,1492722,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606.0,Homo sapiens (human),Bosentan results in increased expression of GCLC mRNA,,,PMID:29761207,https://www.ncbi.nlm.nih.gov/pubmed/29761207,29761207,,
1675,1492723,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Bosentan inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased activity of GPT protein],,,PMID:33026618,https://www.ncbi.nlm.nih.gov/pubmed/33026618,33026618,,
1676,1493255,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9606.0,Homo sapiens (human),Bosentan results in decreased expression of NR1H3 mRNA,,,PMID:29761207,https://www.ncbi.nlm.nih.gov/pubmed/29761207,29761207,,
1677,1493256,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971.0,NR1H4,9606.0,Homo sapiens (human),Bosentan results in decreased expression of NR1H4 mRNA,,,PMID:29761207,https://www.ncbi.nlm.nih.gov/pubmed/29761207,29761207,,
1678,1493257,104865,Comparative Toxicogenomics Database (CTD),Bosentan,D000077300,Bosentan,https://ctdbase.org/detail.go?type=chem&acc=D000077300,5106,PCK2,https://ctdbase.org/detail.go?type=gene&acc=5106,,,5106.0,PCK2,9606.0,Homo sapiens (human),Bosentan results in decreased expression of PCK2 mRNA,,,PMID:29761207,https://www.ncbi.nlm.nih.gov/pubmed/29761207,29761207,,
1679,1485176,104926,Toxin and Toxin Target Database (T3DB),Cyfluthrin,T3D1031,Cyfluthrin,http://www.t3db.ca/toxins/T3D1031,BE0003541,UDP-glucuronosyltransferase 1-1,http://www.t3db.ca/biodb/bio_entities/BE0003541,P22309,UDP-glucuronosyltransferase 1A1 ,54658.0,UGT1A1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1680,1485177,104926,Toxin and Toxin Target Database (T3DB),Cyfluthrin,T3D1031,Cyfluthrin,http://www.t3db.ca/toxins/T3D1031,BE0003536,Cytochrome P450 2C19,http://www.t3db.ca/biodb/bio_entities/BE0003536,P33261,Cytochrome P450 2C19,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1681,1494767,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,10090.0,Mus musculus (house mouse),Trimethylarsine oxide results in increased expression of CYP1B1 mrna|trimethylarsine oxide promotes the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1B1 mrna],,,PMID:26042454|PMID:26144063,https://www.ncbi.nlm.nih.gov/pubmed/26042454|https://www.ncbi.nlm.nih.gov/pubmed/26144063,26042454|26144063,,
1682,1494768,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,10090.0,Mus musculus (house mouse),Trimethylarsine oxide promotes the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1B1 protein],,,PMID:26144063,https://www.ncbi.nlm.nih.gov/pubmed/26144063,26144063,,
1683,1494769,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,24300,CYP2B1,https://ctdbase.org/detail.go?type=gene&acc=24300,,,24300.0,Cyp2b1,10116.0,Rattus norvegicus (Norway rat),[trimethylarsine oxide co-treated with diethylnitrosamine] results in increased expression of CYP2B1 mrna|[trimethylarsine oxide co-treated with diethylnitrosamine] results in increased expression of CYP2B1 protein,,,PMID:12115560,https://www.ncbi.nlm.nih.gov/pubmed/12115560,12115560,,
1684,1494770,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,24300,CYP2B1,https://ctdbase.org/detail.go?type=gene&acc=24300,,,24300.0,Cyp2b1,10116.0,Rattus norvegicus (Norway rat),Trimethylarsine oxide results in increased expression of CYP2B1 mRNA,,,PMID:17481689,https://www.ncbi.nlm.nih.gov/pubmed/17481689,17481689,,
1685,1494771,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,361523,CYP2B2,https://ctdbase.org/detail.go?type=gene&acc=361523,,,361523.0,Cyp2b2,10116.0,Rattus norvegicus (Norway rat),[trimethylarsine oxide co-treated with diethylnitrosamine] results in increased expression of CYP2B2 mRNA,,,PMID:12115560,https://www.ncbi.nlm.nih.gov/pubmed/12115560,12115560,,
1686,1495536,104930,Toxin and Toxin Target Database (T3DB),Trimethylarsine oxide,T3D0318,Trimethylarsine oxide,http://www.t3db.ca/toxins/T3D0318,BE0001275,Tubulin alpha-1B chain,http://www.t3db.ca/biodb/bio_entities/BE0001275,P68363,Tubulin alpha-1B chain,10376.0,TUBA1B,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
1687,1495537,104930,Toxin and Toxin Target Database (T3DB),Trimethylarsine oxide,T3D0318,Trimethylarsine oxide,http://www.t3db.ca/toxins/T3D0318,BE0001388,Tubulin alpha-1C chain,http://www.t3db.ca/biodb/bio_entities/BE0001388,Q9BQE3,Tubulin alpha-1C chain,84790.0,TUBA1C,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
1688,1511763,104977,Comparative Toxicogenomics Database (CTD),1-Pyrenemethanol,C065833,1-hydroxymethylpyrene,https://ctdbase.org/detail.go?type=chem&acc=C065833,6819,SULT1C2,https://ctdbase.org/detail.go?type=gene&acc=6819,,,6819.0,SULT1C2,9606.0,Homo sapiens (human),[SULT1C2 protein co-treated with PAPSS1 protein] results in increased activity of 1-hydroxymethylpyrene,,,PMID:24802129,https://www.ncbi.nlm.nih.gov/pubmed/24802129,24802129,,
1689,1511764,104977,Comparative Toxicogenomics Database (CTD),1-Pyrenemethanol,C065833,1-hydroxymethylpyrene,https://ctdbase.org/detail.go?type=chem&acc=C065833,53315,SULT1D1,https://ctdbase.org/detail.go?type=gene&acc=53315,,,53315.0,Sult1d1,9606.0,Homo sapiens (human),SULT1D1 protein results in increased sulfation of 1-hydroxymethylpyrene|[sult1d1 protein co-treated with PAPSS1 protein] results in increased activity of 1-hydroxymethylpyrene,,,PMID:24802129,https://www.ncbi.nlm.nih.gov/pubmed/24802129,24802129,,
1690,1511765,104977,Comparative Toxicogenomics Database (CTD),1-Pyrenemethanol,C065833,1-hydroxymethylpyrene,https://ctdbase.org/detail.go?type=chem&acc=C065833,6783,SULT1E1,https://ctdbase.org/detail.go?type=gene&acc=6783,,,6783.0,SULT1E1,9606.0,Homo sapiens (human),SULT1E1 protein results in increased activity of 1-hydroxymethylpyrene|[sult1e1 protein co-treated with PAPSS1 protein] results in increased activity of 1-hydroxymethylpyrene,,,PMID:24802129,https://www.ncbi.nlm.nih.gov/pubmed/24802129,24802129,,
1691,1511766,104977,Comparative Toxicogenomics Database (CTD),1-Pyrenemethanol,C065833,1-hydroxymethylpyrene,https://ctdbase.org/detail.go?type=chem&acc=C065833,6822,SULT2A1,https://ctdbase.org/detail.go?type=gene&acc=6822,,,6822.0,SULT2A1,9606.0,Homo sapiens (human),[SULT2A1 protein co-treated with PAPSS1 protein] results in increased activity of 1-hydroxymethylpyrene,,,PMID:24802129,https://www.ncbi.nlm.nih.gov/pubmed/24802129,24802129,,
1692,1511767,104977,Comparative Toxicogenomics Database (CTD),1-Pyrenemethanol,C065833,1-hydroxymethylpyrene,https://ctdbase.org/detail.go?type=chem&acc=C065833,100043194,SULT2A2,https://ctdbase.org/detail.go?type=gene&acc=100043194,,,100043194.0,Sult2a2,9606.0,Homo sapiens (human),[SULT2A2 protein co-treated with PAPSS1 protein] results in increased activity of 1-hydroxymethylpyrene,,,PMID:24802129,https://www.ncbi.nlm.nih.gov/pubmed/24802129,24802129,,
1693,1511768,104977,Comparative Toxicogenomics Database (CTD),1-Pyrenemethanol,C065833,1-hydroxymethylpyrene,https://ctdbase.org/detail.go?type=chem&acc=C065833,57429,SULT5A1,https://ctdbase.org/detail.go?type=gene&acc=57429,,,57429.0,Sult5a1,9606.0,Homo sapiens (human),[SULT5A1 protein co-treated with PAPSS1 protein] results in increased activity of 1-hydroxymethylpyrene,,,PMID:24802129,https://www.ncbi.nlm.nih.gov/pubmed/24802129,24802129,,
1694,1511769,105010,Toxin and Toxin Target Database (T3DB),Methoxyfenozide,T3D3880,Methoxyfenozide,http://www.t3db.ca/toxins/T3D3880,BE0002638,Cytochrome P450 3A4,http://www.t3db.ca/biodb/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1695,1511770,105010,Toxin and Toxin Target Database (T3DB),Methoxyfenozide,T3D3880,Methoxyfenozide,http://www.t3db.ca/toxins/T3D3880,BE0000956,Nuclear receptor subfamily 1 group I member 2,http://www.t3db.ca/biodb/bio_entities/BE0000956,O75469,Nuclear receptor subfamily 1 group I member 2,8856.0,NR1I2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1696,1513135,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),Astragaloside A inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which results in increased phosphorylation of NFKBIA protein]|[iron-dextran complex results in increased abundance of iron] which results in increased phosphorylation of NFKBIA protein|deferiprone inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which results in increased phosphorylation of NFKBIA protein],,,PMID:33285147,https://www.ncbi.nlm.nih.gov/pubmed/33285147,33285147,,
1697,1513136,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),Iron-dextran complex results in increased expression of NOS2 protein,,,PMID:28700905,https://www.ncbi.nlm.nih.gov/pubmed/28700905,28700905,,
1698,1513137,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,9606.0,Homo sapiens (human),Iron-dextran complex results in decreased phosphorylation of NOS3 protein|arginine inhibits the reaction [iron-dextran complex results in decreased phosphorylation of NOS3 protein]|ddah2 promotes the reaction [tetramethylpyrazine inhibits the reaction [iron-dextran complex results in decreased phosphorylation of NOS3 protein]]|tetramethylpyrazine inhibits the reaction [iron-dextran complex results in decreased phosphorylation of NOS3 protein],,,PMID:32135237,https://www.ncbi.nlm.nih.gov/pubmed/32135237,32135237,,
1699,1513138,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116.0,Rattus norvegicus (Norway rat),Iron-dextran complex results in increased expression of and results in increased phosphorylation of NOS3 protein,,,PMID:29990562,https://www.ncbi.nlm.nih.gov/pubmed/29990562,29990562,,
1700,1513139,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,4953,ODC1,https://ctdbase.org/detail.go?type=gene&acc=4953,,,4953.0,ODC1,10090.0,Mus musculus (house mouse),Iron-dextran complex promotes the reaction [cumene hydroperoxide results in increased activity of ODC1 protein]|iron-dextran complex results in increased activity of ODC1 protein|iron-dextran complex promotes the reaction [hydrogen peroxide results in increased activity of ODC1 protein]|iron-dextran complex promotes the reaction [mezerein results in increased activity of ODC1 protein]|iron-dextran complex promotes the reaction [benzoyl peroxide results in increased activity of ODC1 protein]|iron-dextran complex promotes the reaction [tetradecanoylphorbol acetate results in increased activity of ODC1 protein],,,PMID:12065085,https://www.ncbi.nlm.nih.gov/pubmed/12065085,12065085,,
1701,1513140,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10116.0,Rattus norvegicus (Norway rat),[taxifolin co-treated with [iron-dextran complex results in increased abundance of iron]] results in increased expression of PCNA protein,,,PMID:32828744,https://www.ncbi.nlm.nih.gov/pubmed/32828744,32828744,,
1702,1513141,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,5290,PIK3CA,https://ctdbase.org/detail.go?type=gene&acc=5290,,,5290.0,PIK3CA,10116.0,Rattus norvegicus (Norway rat),Ergothioneine inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which results in decreased expression of PIK3CA protein]|[iron-dextran complex results in increased abundance of iron] which results in decreased expression of PIK3CA protein,,,PMID:33580994,https://www.ncbi.nlm.nih.gov/pubmed/33580994,33580994,,
1703,1513142,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,5290,PIK3CA,https://ctdbase.org/detail.go?type=gene&acc=5290,,,5290.0,PIK3CA,10116.0,Rattus norvegicus (Norway rat),Taxifolin inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which results in decreased phosphorylation of PIK3CA protein]|[iron-dextran complex results in increased abundance of iron] which results in decreased phosphorylation of PIK3CA protein,,,PMID:32828744,https://www.ncbi.nlm.nih.gov/pubmed/32828744,32828744,,
1704,1513297,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,10036.0,Mesocricetus auratus (golden hamster),Iron-dextran complex inhibits the reaction [cholesterol results in increased expression of PPARA mrna],,,PMID:22570273,https://www.ncbi.nlm.nih.gov/pubmed/22570273,22570273,,
1705,1513298,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116.0,Rattus norvegicus (Norway rat),Bergenin inhibits the reaction [iron-dextran complex results in decreased expression of PPARG protein]|iron-dextran complex results in decreased expression of PPARG protein,,,PMID:36207002,https://www.ncbi.nlm.nih.gov/pubmed/36207002,36207002,,
1706,1513299,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Bergenin inhibits the reaction [iron-dextran complex results in increased expression of PTGS2 protein]|iron-dextran complex results in increased expression of PTGS2 protein,,,PMID:36207002,https://www.ncbi.nlm.nih.gov/pubmed/36207002,36207002,,
1707,1513300,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Astragaloside A inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which affects the localization of RELA protein]|u 0126 inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which affects the localization of RELA protein]|sb 203580 inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which affects the localization of RELA protein]|deferiprone inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which affects the localization of RELA protein]|[iron-dextran complex results in increased abundance of iron] which affects the localization of RELA protein,,,PMID:33285147,https://www.ncbi.nlm.nih.gov/pubmed/33285147,33285147,,
1708,1513301,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Iron-dextran complex affects the localization of and results in increased expression of RELA protein|bergenin inhibits the reaction [iron-dextran complex affects the localization of and results in increased expression of RELA protein],,,PMID:36207002,https://www.ncbi.nlm.nih.gov/pubmed/36207002,36207002,,
1709,1513302,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),[iron-dextran complex results in increased abundance of iron] which affects the localization of RELA protein|ergothioneine inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which affects the localization of RELA protein],,,PMID:33580994,https://www.ncbi.nlm.nih.gov/pubmed/33580994,33580994,,
1710,1513303,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,6010,RHO,https://ctdbase.org/detail.go?type=gene&acc=6010,,,6010.0,RHO,10090.0,Mus musculus (house mouse),[iron-dextran complex results in increased abundance of iron] which results in decreased expression of RHO mrna|astragaloside A inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which results in decreased expression of RHO mrna],,,PMID:33285147,https://www.ncbi.nlm.nih.gov/pubmed/33285147,33285147,,
1711,1513654,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Bergenin inhibits the reaction [iron-dextran complex results in increased expression of TNF protein]|iron-dextran complex results in increased expression of TNF protein,,,PMID:36207002,https://www.ncbi.nlm.nih.gov/pubmed/36207002,36207002,,
1712,1513655,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Ergothioneine inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which results in increased expression of TNF protein],,,PMID:33580994,https://www.ncbi.nlm.nih.gov/pubmed/33580994,33580994,,
1713,1513656,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),[iron-dextran complex results in increased abundance of iron] which results in increased expression of TNF protein,,,PMID:32828744|PMID:33580994,https://www.ncbi.nlm.nih.gov/pubmed/32828744|https://www.ncbi.nlm.nih.gov/pubmed/33580994,32828744|33580994,,
1714,1513657,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Taxifolin inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which results in increased expression of TNF protein],,,PMID:32828744,https://www.ncbi.nlm.nih.gov/pubmed/32828744,32828744,,
1715,1513658,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,4982,TNFRSF11B,https://ctdbase.org/detail.go?type=gene&acc=4982,,,4982.0,TNFRSF11B,10116.0,Rattus norvegicus (Norway rat),Iron-dextran complex results in decreased expression of TNFRSF11B mRNA,,,PMID:29122540,https://www.ncbi.nlm.nih.gov/pubmed/29122540,29122540,,
1716,1513659,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600.0,TNFSF11,10116.0,Rattus norvegicus (Norway rat),Iron-dextran complex results in increased expression of TNFSF11 mRNA,,,PMID:29122540,https://www.ncbi.nlm.nih.gov/pubmed/29122540,29122540,,
1717,1513660,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,10090.0,Mus musculus (house mouse),[iron-dextran complex results in increased abundance of iron] which results in increased expression of TXNIP mrna|[iron-dextran complex results in increased abundance of iron] which results in increased expression of TXNIP protein,,,PMID:33393188,https://www.ncbi.nlm.nih.gov/pubmed/33393188,33393188,,
1718,1513661,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,7296,TXNRD1,https://ctdbase.org/detail.go?type=gene&acc=7296,,,7296.0,TXNRD1,10090.0,Mus musculus (house mouse),[iron-dextran complex results in increased abundance of iron] which results in increased expression of TXNRD1 protein|[iron-dextran complex results in increased abundance of iron] which results in decreased expression of TXNRD1 mRNA,,,PMID:33393188,https://www.ncbi.nlm.nih.gov/pubmed/33393188,33393188,,
1719,1513662,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,7389,UROD,https://ctdbase.org/detail.go?type=gene&acc=7389,,,7389.0,UROD,10090.0,Mus musculus (house mouse),Iron-dextran complex promotes the reaction [tetrachlorodibenzodioxin results in decreased activity of UROD protein],,,PMID:9443932,https://www.ncbi.nlm.nih.gov/pubmed/9443932,9443932,,
1720,1513972,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,10090.0,Mus musculus (house mouse),[ADIPOQ protein results in increased expression of BCL2L1 protein] inhibits the reaction [iron-dextran complex results in increased activity of CASP3 protein]|[pirinixic acid results in increased expression of BCL2L1 protein] inhibits the reaction [iron-dextran complex results in increased activity of CASP3 protein]|bilirubin promotes the reaction [iron-dextran complex results in increased expression of BCL2L1 protein]|iron-dextran complex results in increased expression of BCL2L1 protein,,,PMID:20709802,https://www.ncbi.nlm.nih.gov/pubmed/20709802,20709802,,
1721,1513973,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,10116.0,Rattus norvegicus (Norway rat),Iron-dextran complex results in decreased expression of BGLAP mRNA,,,PMID:29122540,https://www.ncbi.nlm.nih.gov/pubmed/29122540,29122540,,
1722,1513974,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,775,CACNA1C,https://ctdbase.org/detail.go?type=gene&acc=775,,,775.0,CACNA1C,9606.0,Homo sapiens (human),[iron-dextran complex results in increased abundance of iron] which results in increased expression of CACNA1C protein|astragaloside A inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which results in increased expression of CACNA1C protein]|deferiprone inhibits the reaction [[iron-dextran complex results in increased abundance of iron] which results in increased expression of CACNA1C protein],,,PMID:33285147,https://www.ncbi.nlm.nih.gov/pubmed/33285147,33285147,,
1723,1513975,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,775,CACNA1C,https://ctdbase.org/detail.go?type=gene&acc=775,,,775.0,CACNA1C,10090.0,Mus musculus (house mouse),Diltiazem inhibits the reaction [iron-dextran complex affects the expression of CACNA1C protein]|nimodipine inhibits the reaction [iron-dextran complex affects the expression of CACNA1C protein]|iron-dextran complex affects the expression of CACNA1C protein|verapamil inhibits the reaction [iron-dextran complex affects the expression of CACNA1C protein],,,PMID:27095094,https://www.ncbi.nlm.nih.gov/pubmed/27095094,27095094,,
1724,1513976,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9913.0,Bos taurus (cattle),[iron-dextran complex co-treated with dihydroxyfumarate] results in increased activity of CASP3 protein|propranolol inhibits the reaction [[iron-dextran complex co-treated with dihydroxyfumarate] results in increased activity of CASP3 protein],,,PMID:16456084,https://www.ncbi.nlm.nih.gov/pubmed/16456084,16456084,,
1725,1513977,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Iron-dextran complex results in increased activity of CAT protein,,,PMID:24120471,https://www.ncbi.nlm.nih.gov/pubmed/24120471,24120471,,
1726,1513978,105075,Comparative Toxicogenomics Database (CTD),Conferon,D007505,Iron-Dextran Complex,https://ctdbase.org/detail.go?type=chem&acc=D007505,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Iron-dextran complex results in increased expression of CAT protein,,,PMID:28700905,https://www.ncbi.nlm.nih.gov/pubmed/28700905,28700905,,
1727,1498260,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9084,Kappa-type opioid receptor [M226A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9084,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
1728,1498261,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9085,Kappa-type opioid receptor [K227A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9085,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
1729,1498262,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9086,Kappa-type opioid receptor [H291A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9086,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
1730,1498263,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9087,Kappa-type opioid receptor [H291F],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9087,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
1731,1498264,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9088,Kappa-type opioid receptor [I294A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9088,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
1732,1498265,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9089,Kappa-type opioid receptor [E297A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9089,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
1733,1498266,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9090,Kappa-type opioid receptor [Y312A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9090,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
1734,1523108,105135,Toxin and Toxin Target Database (T3DB),BREVETOXIN PbTx-1,T3D2645,Brevetoxin,http://www.t3db.ca/toxins/T3D2645,BE0002083,Sodium channel protein type 4 subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0002083,P35499,Sodium channel protein type 4 subunit alpha,6329.0,SCN4A,9606.0,Homo sapiens (human),"Brevetoxins are neurotoxins that bind to voltage-gated sodium channels in nerve cells, leading to disruption of normal neurological processes. (L1112)",,,,,,,
1735,1523109,105135,Toxin and Toxin Target Database (T3DB),BREVETOXIN PbTx-1,T3D2645,Brevetoxin,http://www.t3db.ca/toxins/T3D2645,BE0000197,Sodium channel protein type 5 subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0000197,Q14524,Sodium channel protein type 5 subunit alpha,6331.0,SCN5A,9606.0,Homo sapiens (human),"Brevetoxins are neurotoxins that bind to voltage-gated sodium channels in nerve cells, leading to disruption of normal neurological processes. (L1112)",,,,,,,
1736,1523110,105135,Toxin and Toxin Target Database (T3DB),BREVETOXIN PbTx-1,T3D2645,Brevetoxin,http://www.t3db.ca/toxins/T3D2645,BE0004900,Sodium channel protein type 7 subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0004900,Q01118,Sodium channel protein type 7 subunit alpha,6332.0,SCN7A,9606.0,Homo sapiens (human),"Brevetoxins are neurotoxins that bind to voltage-gated sodium channels in nerve cells, leading to disruption of normal neurological processes. (L1112)",,,,,,,
1737,1523111,105135,Toxin and Toxin Target Database (T3DB),BREVETOXIN PbTx-1,T3D2645,Brevetoxin,http://www.t3db.ca/toxins/T3D2645,BE0002084,Sodium channel protein type 8 subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0002084,Q9UQD0,Sodium channel protein type 8 subunit alpha,6334.0,SCN8A,9606.0,Homo sapiens (human),"Brevetoxins are neurotoxins that bind to voltage-gated sodium channels in nerve cells, leading to disruption of normal neurological processes. (L1112)",,,,,,,
1738,1449937,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,85376,RIMBP3,https://ctdbase.org/detail.go?type=gene&acc=85376,,,85376.0,RIMBP3,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in increased expression of RIMBP3 mrna]|glucose results in increased expression of RIMBP3 mRNA,,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
1739,1450308,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6161,RPL32,https://ctdbase.org/detail.go?type=gene&acc=6161,,,6161.0,RPL32,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPL32 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1740,1450309,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6164,RPL34,https://ctdbase.org/detail.go?type=gene&acc=6164,,,6164.0,RPL34,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPL34 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1741,1450310,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,11224,RPL35,https://ctdbase.org/detail.go?type=gene&acc=11224,,,11224.0,RPL35,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of RPL35 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1742,1450311,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6165,RPL35A,https://ctdbase.org/detail.go?type=gene&acc=6165,,,6165.0,RPL35A,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPL35A mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1743,1450645,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6195,RPS6KA1,https://ctdbase.org/detail.go?type=gene&acc=6195,,,6195.0,RPS6KA1,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of RPS6KA1 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1744,1450646,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,9252,RPS6KA5,https://ctdbase.org/detail.go?type=gene&acc=9252,,,9252.0,RPS6KA5,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPS6KA5 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1745,1450647,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198.0,RPS6KB1,9544.0,Macaca mulatta (Rhesus monkey),RPS6KB1 protein affects the reaction [sirolimus inhibits the reaction [glucose results in increased secretion of INS1 protein]],,,PMID:26563389,https://www.ncbi.nlm.nih.gov/pubmed/26563389,26563389,,
1746,1450648,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198.0,RPS6KB1,10090.0,Mus musculus (house mouse),Glucose results in increased phosphorylation of RPS6KB1 protein|hu 308 inhibits the reaction [glucose results in increased phosphorylation of RPS6KB1 protein],,,PMID:30459625,https://www.ncbi.nlm.nih.gov/pubmed/30459625,30459625,,
1747,1450780,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,23076,RRP1B,https://ctdbase.org/detail.go?type=gene&acc=23076,,,23076.0,RRP1B,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RRP1B mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1748,1450781,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,54665,RSBN1,https://ctdbase.org/detail.go?type=gene&acc=54665,,,54665.0,RSBN1,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RSBN1 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1749,1450782,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,10313,RTN3,https://ctdbase.org/detail.go?type=gene&acc=10313,,,10313.0,RTN3,10116.0,Rattus norvegicus (Norway rat),Glucose results in increased expression of RTN3 protein|metformin inhibits the reaction [glucose results in increased expression of RTN3 protein]|chlorogenic acid inhibits the reaction [glucose results in increased expression of RTN3 protein],,,PMID:34801538,https://www.ncbi.nlm.nih.gov/pubmed/34801538,34801538,,
1750,1450783,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,349667,RTN4RL2,https://ctdbase.org/detail.go?type=gene&acc=349667,,,349667.0,RTN4RL2,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of RTN4RL2 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1751,1450784,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,64108,RTP4,https://ctdbase.org/detail.go?type=gene&acc=64108,,,64108.0,RTP4,10090.0,Mus musculus (house mouse),Glucose results in increased expression of RTP4 mrna|fucoxanthin inhibits the reaction [glucose results in increased expression of RTP4 mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
1752,1450785,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,64108,RTP4,https://ctdbase.org/detail.go?type=gene&acc=64108,,,64108.0,RTP4,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of RTP4 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1753,1450786,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,80183,RUBCNL,https://ctdbase.org/detail.go?type=gene&acc=80183,,,80183.0,RUBCNL,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of RUBCNL mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1754,1450787,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,53637,S1PR5,https://ctdbase.org/detail.go?type=gene&acc=53637,,,53637.0,S1PR5,10116.0,Rattus norvegicus (Norway rat),Glucose results in increased expression of S1PR5 mRNA,,,PMID:22406263,https://www.ncbi.nlm.nih.gov/pubmed/22406263,22406263,,
1755,1452467,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),Glucose results in decreased expression of SERPINE1 mRNA,,,PMID:31655124,https://www.ncbi.nlm.nih.gov/pubmed/31655124,31655124,,
1756,1452468,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),Indomethacin inhibits the reaction [glucose results in increased secretion of SERPINE1 protein]|glucose results in increased secretion of SERPINE1 protein,,,PMID:16320596,https://www.ncbi.nlm.nih.gov/pubmed/16320596,16320596,,
1757,1452469,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,10116.0,Rattus norvegicus (Norway rat),Glucose results in increased expression of SERPINE1 mrna|bisindolylmaleimide I inhibits the reaction [glucose results in increased expression of SERPINE1 mrna]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [glucose results in increased expression of SERPINE1 mrna],,,PMID:12409145,https://www.ncbi.nlm.nih.gov/pubmed/12409145,12409145,,
1758,1452470,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,10116.0,Rattus norvegicus (Norway rat),Enalapril inhibits the reaction [[aldosterone co-treated with glucose] results in increased expression of SERPINE1 mrna]|eplerenone inhibits the reaction [[aldosterone co-treated with glucose] results in increased expression of SERPINE1 protein]|[aldosterone co-treated with glucose] results in increased expression of SERPINE1 protein|[eplerenone co-treated with enalapril] inhibits the reaction [[aldosterone co-treated with glucose] results in increased expression of SERPINE1 protein]|[eplerenone co-treated with enalapril] inhibits the reaction [[aldosterone co-treated with glucose] results in increased expression of SERPINE1 mrna]|[aldosterone co-treated with glucose] results in increased expression of SERPINE1 mrna|enalapril inhibits the reaction [[aldosterone co-treated with glucose] results in increased expression of SERPINE1 protein]|eplerenone inhibits the reaction [[aldosterone co-treated with glucose] results in increased expression of SERPINE1 mrna],,,PMID:18682491,https://www.ncbi.nlm.nih.gov/pubmed/18682491,18682491,,
1759,1452471,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5270,SERPINE2,https://ctdbase.org/detail.go?type=gene&acc=5270,,,5270.0,SERPINE2,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of SERPINE2 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1760,1452472,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5176,SERPINF1,https://ctdbase.org/detail.go?type=gene&acc=5176,,,5176.0,SERPINF1,9606.0,Homo sapiens (human),Glucose deficiency results in decreased secretion of SERPINF1 protein,,,PMID:24802182,https://www.ncbi.nlm.nih.gov/pubmed/24802182,24802182,,
1761,1465899,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Melatonin inhibits the reaction [[glucose co-treated with deferoxamine] results in increased expression of TP53 mrna]|[glucose co-treated with deferoxamine] results in increased expression of TP53 mRNA,,,PMID:33962019,https://www.ncbi.nlm.nih.gov/pubmed/33962019,33962019,,
1762,1485592,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,27083,XLR4B,https://ctdbase.org/detail.go?type=gene&acc=27083,,,27083.0,Xlr4b,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of XLR4B mrna|[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of XLR4B mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1763,1510674,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A promotes the reaction [glucose results in increased secretion of INS1 protein],,,PMID:27836638,https://www.ncbi.nlm.nih.gov/pubmed/27836638,27836638,,
1764,1510675,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116.0,Rattus norvegicus (Norway rat),BL 11282 analog promotes the reaction [glucose results in increased secretion of INS1 protein],,,PMID:17339113|PMID:17723306,https://www.ncbi.nlm.nih.gov/pubmed/17339113|https://www.ncbi.nlm.nih.gov/pubmed/17723306,17339113|17723306,,
1765,1510676,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),"3-pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester inhibits the reaction [dimethylarsinous acid inhibits the reaction [glucose results in increased secretion of INS1 protein]]|methylarsonite inhibits the reaction [3-pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester promotes the reaction [glucose results in increased secretion of INS1 protein]]|arsenite inhibits the reaction [glucose results in increased secretion of INS1 protein]|arsenite inhibits the reaction [3-pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester promotes the reaction [glucose results in increased secretion of INS1 protein]]|3-pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester promotes the reaction [glucose results in increased secretion of INS1 protein]|dimethylarsinous acid inhibits the reaction [glucose results in increased secretion of INS1 protein]|tolbutamide inhibits the reaction [arsenite inhibits the reaction [glucose results in increased secretion of INS1 protein]]|tolbutamide inhibits the reaction [methylarsonite inhibits the reaction [glucose results in increased secretion of INS1 protein]]|tolbutamide inhibits the reaction [dimethylarsinous acid inhibits the reaction [glucose results in increased secretion of INS1 protein]]|3-pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester inhibits the reaction [methylarsonite inhibits the reaction [glucose results in increased secretion of INS1 protein]]|tolbutamide promotes the reaction [glucose results in increased secretion of INS1 protein]|3-pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester inhibits the reaction [arsenite inhibits the reaction [glucose results in increased secretion of INS1 protein]]|methylarsonite inhibits the reaction [glucose results in increased secretion of INS1 protein]|dimethylarsinous acid inhibits the reaction [3-pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester promotes the reaction [glucose results in increased secretion of INS1 protein]]",,,PMID:31332465,https://www.ncbi.nlm.nih.gov/pubmed/31332465,31332465,,
1766,1510677,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),DX600 peptide promotes the reaction [glucose results in increased secretion of INS1 protein]|7-ala-angiotensin (1-7) promotes the reaction [glucose results in increased secretion of INS1 protein]|mme protein affects the reaction [angiotensin I (1-7) promotes the reaction [glucose results in increased secretion of INS1 protein]]|dx600 peptide inhibits the reaction [angiotensin I (1-7) promotes the reaction [glucose results in increased secretion of INS1 protein]]|[mme protein results in increased cleavage of angiotensin I (1-7)] affects the reaction [glucose results in increased secretion of INS1 protein]|angiotensin I (1-7) promotes the reaction [glucose results in increased secretion of INS1 protein],,,PMID:28559246,https://www.ncbi.nlm.nih.gov/pubmed/28559246,28559246,,
1767,1510678,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),"Ferrostatin-1 inhibits the reaction [acrolein inhibits the reaction [glucose results in increased secretion of INS1 protein]]|resveratrol inhibits the reaction [acrolein inhibits the reaction [glucose results in increased secretion of INS1 protein]]|acrolein inhibits the reaction [glucose results in increased secretion of INS1 protein]|7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [acrolein inhibits the reaction [glucose results in increased secretion of INS1 protein]]|rosiglitazone inhibits the reaction [acrolein inhibits the reaction [glucose results in increased secretion of INS1 protein]]",,,PMID:34813903,https://www.ncbi.nlm.nih.gov/pubmed/34813903,34813903,,
1768,1510679,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),"7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [arsenic trioxide inhibits the reaction [glucose results in increased secretion of INS1 protein]]|arsenic trioxide inhibits the reaction [glucose results in increased secretion of INS1 protein]",,,PMID:29111283,https://www.ncbi.nlm.nih.gov/pubmed/29111283,29111283,,
1769,1514150,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0001004,Solute carrier organic anion transporter family member 1B1,http://www.t3db.ca/biodb/bio_entities/BE0001004,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,10599.0,SLCO1B1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1770,1514151,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0003536,Cytochrome P450 2C19,http://www.t3db.ca/biodb/bio_entities/BE0003536,P33261,Cytochrome P450 2C19,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1771,1514152,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0002638,Cytochrome P450 3A4,http://www.t3db.ca/biodb/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1772,1514153,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0002433,Cytochrome P450 1A2,http://www.t3db.ca/biodb/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1773,1514154,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0000956,Nuclear receptor subfamily 1 group I member 2,http://www.t3db.ca/biodb/bio_entities/BE0000956,O75469,Nuclear receptor subfamily 1 group I member 2,8856.0,NR1I2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1774,1514155,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0003549,Cytochrome P450 2B6,http://www.t3db.ca/biodb/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1775,1514156,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0003541,UDP-glucuronosyltransferase 1-1,http://www.t3db.ca/biodb/bio_entities/BE0003541,P22309,UDP-glucuronosyltransferase 1A1 ,54658.0,UGT1A1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1776,1514157,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0005459,ADP-ribosyl cyclase 1,http://www.t3db.ca/biodb/bio_entities/BE0005459,P28907,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,952.0,CD38,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1777,1514300,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0000240,Plasminogen activator inhibitor 1,http://www.t3db.ca/biodb/bio_entities/BE0000240,P05121,Plasminogen activator inhibitor 1,5054.0,SERPINE1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1778,1514301,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0000984,Transforming growth factor beta-1,http://www.t3db.ca/biodb/bio_entities/BE0000984,P01137,Transforming growth factor beta-1 proprotein,7040.0,TGFB1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1779,1514302,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0000717,Urokinase plasminogen activator surface receptor,http://www.t3db.ca/biodb/bio_entities/BE0000717,Q03405,Urokinase plasminogen activator surface receptor,5329.0,PLAUR,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1780,1514303,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0005528,"POU domain, class 2, transcription factor 1",http://www.t3db.ca/biodb/bio_entities/BE0005528,P14859,"POU domain, class 2, transcription factor 1",5451.0,POU2F1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1781,1514304,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0001777,Bile acid receptor,http://www.t3db.ca/biodb/bio_entities/BE0001777,Q96RI1,Bile acid receptor,9971.0,NR1H4,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1782,1514305,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0003543,Cytochrome P450 1A1,http://www.t3db.ca/biodb/bio_entities/BE0003543,P04798,Cytochrome P450 1A1,1543.0,CYP1A1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1783,1524296,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,5199,CFP,https://ctdbase.org/detail.go?type=gene&acc=5199,,,5199.0,CFP,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in increased expression of CFP mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
1784,1524297,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,22856,CHSY1,https://ctdbase.org/detail.go?type=gene&acc=22856,,,22856.0,CHSY1,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in decreased expression of CHSY1 mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
1785,1524298,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,339145,CIBAR2,https://ctdbase.org/detail.go?type=gene&acc=339145,,,339145.0,CIBAR2,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in increased expression of CIBAR2 mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
1786,1524299,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,23155,CLCC1,https://ctdbase.org/detail.go?type=gene&acc=23155,,,23155.0,CLCC1,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in increased expression of CLCC1 mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
1787,1525377,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,3350,HTR1A,https://ctdbase.org/detail.go?type=gene&acc=3350,,,3350.0,HTR1A,10116.0,Rattus norvegicus (Norway rat),HU 211 results in increased expression of HTR1A mrna|hu 211 results in increased activity of HTR1A protein,,,PMID:20438810,https://www.ncbi.nlm.nih.gov/pubmed/20438810,20438810,,
1788,1525378,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,3356,HTR2A,https://ctdbase.org/detail.go?type=gene&acc=3356,,,3356.0,HTR2A,10090.0,Mus musculus (house mouse),HU 211 inhibits the reaction [ketanserin binds to HTR2A protein]|hu 211 results in decreased expression of HTR2A protein,,,PMID:20600638,https://www.ncbi.nlm.nih.gov/pubmed/20600638,20600638,,
1789,1525379,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,25998,IBTK,https://ctdbase.org/detail.go?type=gene&acc=25998,,,25998.0,IBTK,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in decreased expression of IBTK mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
1790,1525380,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,317698,IFNT2,https://ctdbase.org/detail.go?type=gene&acc=317698,,,317698.0,IFNT2,9913.0,Bos taurus (cattle),HU 211 results in increased expression of IFNT2 mRNA,,,PMID:27798282,https://www.ncbi.nlm.nih.gov/pubmed/27798282,27798282,,
1791,1525381,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,10261,IGSF6,https://ctdbase.org/detail.go?type=gene&acc=10261,,,10261.0,IGSF6,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in increased expression of IGSF6 mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
1792,1525382,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,10090.0,Mus musculus (house mouse),"HU 211 promotes the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of IL10 protein]",,,PMID:32385136,https://www.ncbi.nlm.nih.gov/pubmed/32385136,32385136,,
1793,1525383,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,3605,IL17A,https://ctdbase.org/detail.go?type=gene&acc=3605,,,3605.0,IL17A,10090.0,Mus musculus (house mouse),HU 211 inhibits the reaction [dextran sulfate results in increased expression of IL17A protein]|tlr4 protein affects the reaction [HU 211 inhibits the reaction [dextran sulfate results in increased expression of IL17A protein]],,,PMID:27995407,https://www.ncbi.nlm.nih.gov/pubmed/27995407,27995407,,
1794,1525384,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),HU 211 inhibits the reaction [dextran sulfate results in increased expression of IL1B protein]|tlr4 protein affects the reaction [HU 211 inhibits the reaction [dextran sulfate results in increased expression of IL1B protein]],,,PMID:27995407,https://www.ncbi.nlm.nih.gov/pubmed/27995407,27995407,,
1795,1527594,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,57282,SLC4A10,https://ctdbase.org/detail.go?type=gene&acc=57282,,,57282.0,SLC4A10,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in decreased expression of SLC4A10 mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
1796,1527595,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,6602,SMARCD1,https://ctdbase.org/detail.go?type=gene&acc=6602,,,6602.0,SMARCD1,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in decreased expression of SMARCD1 mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
1797,1527596,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,54861,SNRK,https://ctdbase.org/detail.go?type=gene&acc=54861,,,54861.0,SNRK,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in decreased expression of SNRK mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
1798,1527597,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,10090.0,Mus musculus (house mouse),[HU 211 co-treated with hydroxychloroquine] results in increased expression of SQSTM1 protein|[hu 211 co-treated with aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein|hu 211 results in increased expression of SQSTM1 protein,,,PMID:32773031,https://www.ncbi.nlm.nih.gov/pubmed/32773031,32773031,,
1799,1527598,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,10090.0,Mus musculus (house mouse),HU 211 results in increased phosphorylation of SRC protein|pertussis toxin inhibits the reaction [HU 211 results in increased phosphorylation of SRC protein]|rimonabant inhibits the reaction [HU 211 results in increased phosphorylation of SRC protein]|rala affects the reaction [HU 211 results in increased phosphorylation of SRC protein],,,PMID:16046413,https://www.ncbi.nlm.nih.gov/pubmed/16046413,16046413,,
1800,1516113,107867,IUPHAR/BPS Guide to PHARMACOLOGY,Otenzepad,309,otenzepad,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=309,16,M4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=16,P08485,Muscarinic acetylcholine receptor M4,25111.0,Chrm4,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,6.5,PMID:1325587,https://www.ncbi.nlm.nih.gov/pubmed/1325587,1325587,,
1801,1516114,107867,IUPHAR/BPS Guide to PHARMACOLOGY,Otenzepad,309,otenzepad,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=309,16,M4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=16,P08173,Muscarinic acetylcholine receptor M4,1132.0,CHRM4,9606.0,Homo sapiens (human),Antagonist,pKd,7,PMID:8759038,https://www.ncbi.nlm.nih.gov/pubmed/8759038,8759038,,
1802,1516115,107867,IUPHAR/BPS Guide to PHARMACOLOGY,Otenzepad,309,otenzepad,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=309,15,M3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=15,P08483,Muscarinic acetylcholine receptor M3,24260.0,Chrm3,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,6,PMID:1325587,https://www.ncbi.nlm.nih.gov/pubmed/1325587,1325587,,
1803,1516116,107867,IUPHAR/BPS Guide to PHARMACOLOGY,Otenzepad,309,otenzepad,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=309,15,M3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=15,P20309,Muscarinic acetylcholine receptor M3,1131.0,CHRM3,9606.0,Homo sapiens (human),Antagonist,pKi,6.1,PMID:2704370,https://www.ncbi.nlm.nih.gov/pubmed/2704370,2704370,,
1804,1516117,107867,IUPHAR/BPS Guide to PHARMACOLOGY,Otenzepad,309,otenzepad,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=309,14,M2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=14,P08172,Muscarinic acetylcholine receptor M2,1129.0,CHRM2,9606.0,Homo sapiens (human),Antagonist,pKi,6.7 - 7.2,PMID:2704370|PMID:9454790,https://www.ncbi.nlm.nih.gov/pubmed/2704370|https://www.ncbi.nlm.nih.gov/pubmed/9454790,2704370|9454790,,
1805,1516118,107867,IUPHAR/BPS Guide to PHARMACOLOGY,Otenzepad,309,otenzepad,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=309,14,M2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=14,P10980,Muscarinic acetylcholine receptor M2,81645.0,Chrm2,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,4.6 - 7.3,PMID:2846274|PMID:1325587|PMID:9454790,https://www.ncbi.nlm.nih.gov/pubmed/2846274|https://www.ncbi.nlm.nih.gov/pubmed/1325587|https://www.ncbi.nlm.nih.gov/pubmed/9454790,2846274|1325587|9454790,,
1806,1451853,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,283592,FAM181A-AS1,https://ctdbase.org/detail.go?type=gene&acc=283592,,,283592.0,FAM181A-AS1,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of FAM181A-AS1 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1807,1451854,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,54540,FAM193B,https://ctdbase.org/detail.go?type=gene&acc=54540,,,54540.0,FAM193B,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of FAM193B mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1808,1451855,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,645528,FAM238A,https://ctdbase.org/detail.go?type=gene&acc=645528,,,645528.0,FAM238A,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of FAM238A mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1809,1451856,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,163933,FAM43B,https://ctdbase.org/detail.go?type=gene&acc=163933,,,163933.0,FAM43B,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of FAM43B mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1810,1451857,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,728833,FAM72D,https://ctdbase.org/detail.go?type=gene&acc=728833,,,728833.0,FAM72D,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of FAM72D mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1811,1451858,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,286077,FAM83H,https://ctdbase.org/detail.go?type=gene&acc=286077,,,286077.0,FAM83H,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of FAM83H mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1812,1451859,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,146330,FBXL16,https://ctdbase.org/detail.go?type=gene&acc=146330,,,146330.0,FBXL16,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of FBXL16 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1813,1451860,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,126433,FBXO27,https://ctdbase.org/detail.go?type=gene&acc=126433,,,126433.0,FBXO27,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of FBXO27 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1814,1451861,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,23219,FBXO28,https://ctdbase.org/detail.go?type=gene&acc=23219,,,23219.0,FBXO28,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of FBXO28 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1815,1451862,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,8547,FCN3,https://ctdbase.org/detail.go?type=gene&acc=8547,,,8547.0,FCN3,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of FCN3 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
1816,1516119,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C017674,procyanidin,https://ctdbase.org/detail.go?type=chem&acc=C017674,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Procyanidin results in decreased phosphorylation of CDK1 protein,,,PMID:15827326,https://www.ncbi.nlm.nih.gov/pubmed/15827326,15827326,,
1817,1516120,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C017674,procyanidin,https://ctdbase.org/detail.go?type=chem&acc=C017674,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308.0,FOXO1,9606.0,Homo sapiens (human),Procyanidin results in decreased phosphorylation of FOXO1 protein,,,PMID:15827326,https://www.ncbi.nlm.nih.gov/pubmed/15827326,15827326,,
1818,1516121,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C017674,procyanidin,https://ctdbase.org/detail.go?type=chem&acc=C017674,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9606.0,Homo sapiens (human),Procyanidin results in decreased phosphorylation of and results in decreased expression of RB1 protein,,,PMID:15827326,https://www.ncbi.nlm.nih.gov/pubmed/15827326,15827326,,
1819,1516122,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C017674,procyanidin,https://ctdbase.org/detail.go?type=chem&acc=C017674,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Procyanidin results in decreased phosphorylation of TP53 protein,,,PMID:15827326,https://www.ncbi.nlm.nih.gov/pubmed/15827326,15827326,,
1820,1430579,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,51077,FCF1,https://ctdbase.org/detail.go?type=gene&acc=51077,,,51077.0,FCF1,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of FCF1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1821,1430580,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,2213,FCGR2B,https://ctdbase.org/detail.go?type=gene&acc=2213,,,2213.0,FCGR2B,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of FCGR2B mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1822,1430581,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,14131,FCGR3,https://ctdbase.org/detail.go?type=gene&acc=14131,,,14131.0,Fcgr3,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of FCGR3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1823,1431814,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of GCLC mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1824,1487819,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,3983,ABLIM1,https://ctdbase.org/detail.go?type=gene&acc=3983,,,3983.0,ABLIM1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ABLIM1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1825,1487820,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,58527,ABRACL,https://ctdbase.org/detail.go?type=gene&acc=58527,,,58527.0,ABRACL,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of ABRACL mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1826,1487821,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,113868,ACAA1A,https://ctdbase.org/detail.go?type=gene&acc=113868,,,113868.0,Acaa1a,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ACAA1A mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1827,1487822,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,235674,ACAA1B,https://ctdbase.org/detail.go?type=gene&acc=235674,,,235674.0,Acaa1b,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ACAA1B mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1828,1487823,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,10449,ACAA2,https://ctdbase.org/detail.go?type=gene&acc=10449,,,10449.0,ACAA2,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ACAA2 mRNA,,,PMID:22334560,https://www.ncbi.nlm.nih.gov/pubmed/22334560,22334560,,
1829,1487824,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ACACA mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1830,1487825,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,27034,ACAD8,https://ctdbase.org/detail.go?type=gene&acc=27034,,,27034.0,ACAD8,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ACAD8 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1831,1487826,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,28976,ACAD9,https://ctdbase.org/detail.go?type=gene&acc=28976,,,28976.0,ACAD9,10116.0,Rattus norvegicus (Norway rat),Epoxiconazole results in increased expression of ACAD9 mRNA,,,PMID:29038839,https://www.ncbi.nlm.nih.gov/pubmed/29038839,29038839,,
1832,1487827,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,33,ACADL,https://ctdbase.org/detail.go?type=gene&acc=33,,,33.0,ACADL,7955.0,Danio rerio (zebrafish),Epoxiconazole results in decreased expression of ACADL mRNA,,,PMID:28601015,https://www.ncbi.nlm.nih.gov/pubmed/28601015,28601015,,
1833,1488100,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,34,ACADM,https://ctdbase.org/detail.go?type=gene&acc=34,,,34.0,ACADM,7955.0,Danio rerio (zebrafish),Epoxiconazole results in decreased expression of ACADM mRNA,,,PMID:28601015,https://www.ncbi.nlm.nih.gov/pubmed/28601015,28601015,,
1834,1488101,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,37,ACADVL,https://ctdbase.org/detail.go?type=gene&acc=37,,,37.0,ACADVL,7955.0,Danio rerio (zebrafish),Epoxiconazole results in decreased expression of ACADVL mRNA,,,PMID:28601015,https://www.ncbi.nlm.nih.gov/pubmed/28601015,28601015,,
1835,1488102,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,37,ACADVL,https://ctdbase.org/detail.go?type=gene&acc=37,,,37.0,ACADVL,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ACADVL mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1836,1488103,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,38,ACAT1,https://ctdbase.org/detail.go?type=gene&acc=38,,,38.0,ACAT1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ACAT1 mRNA,,,PMID:22334560,https://www.ncbi.nlm.nih.gov/pubmed/22334560,22334560,,
1837,1488104,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,39,ACAT2,https://ctdbase.org/detail.go?type=gene&acc=39,,,39.0,ACAT2,10116.0,Rattus norvegicus (Norway rat),[cyproconazole co-treated with epoxiconazole] results in increased expression of ACAT2 mRNA,,,PMID:29038839,https://www.ncbi.nlm.nih.gov/pubmed/29038839,29038839,,
1838,1488105,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,224530,ACAT3,https://ctdbase.org/detail.go?type=gene&acc=224530,,,224530.0,Acat3,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of ACAT3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1839,1488106,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,84680,ACCS,https://ctdbase.org/detail.go?type=gene&acc=84680,,,84680.0,ACCS,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of ACCS mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1840,1515815,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,126969,SLC44A3,https://ctdbase.org/detail.go?type=gene&acc=126969,,,126969.0,SLC44A3,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLC44A3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1841,1515816,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,85414,SLC45A3,https://ctdbase.org/detail.go?type=gene&acc=85414,,,85414.0,SLC45A3,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLC45A3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1842,1515817,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,283537,SLC46A3,https://ctdbase.org/detail.go?type=gene&acc=283537,,,283537.0,SLC46A3,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of SLC46A3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1843,1515818,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,146802,SLC47A2,https://ctdbase.org/detail.go?type=gene&acc=146802,,,146802.0,SLC47A2,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLC47A2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1844,1515819,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,55652,SLC48A1,https://ctdbase.org/detail.go?type=gene&acc=55652,,,55652.0,SLC48A1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLC48A1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1845,1515820,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,55652,SLC48A1,https://ctdbase.org/detail.go?type=gene&acc=55652,,,55652.0,SLC48A1,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLC48A1 mRNA,,,PMID:22334560,https://www.ncbi.nlm.nih.gov/pubmed/22334560,22334560,,
1846,1515821,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,55974,SLC50A1,https://ctdbase.org/detail.go?type=gene&acc=55974,,,55974.0,SLC50A1,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLC50A1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1847,1515822,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,200931,SLC51A,https://ctdbase.org/detail.go?type=gene&acc=200931,,,200931.0,SLC51A,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of SLC51A mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1848,1515823,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,123264,SLC51B,https://ctdbase.org/detail.go?type=gene&acc=123264,,,123264.0,SLC51B,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLC51B mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1849,1515824,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,79581,SLC52A2,https://ctdbase.org/detail.go?type=gene&acc=79581,,,79581.0,SLC52A2,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLC52A2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1850,1516400,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,139065,SLITRK4,https://ctdbase.org/detail.go?type=gene&acc=139065,,,139065.0,SLITRK4,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLITRK4 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1851,1516401,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,26050,SLITRK5,https://ctdbase.org/detail.go?type=gene&acc=26050,,,26050.0,SLITRK5,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLITRK5 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1852,1516402,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,57152,SLURP1,https://ctdbase.org/detail.go?type=gene&acc=57152,,,57152.0,SLURP1,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLURP1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1853,1516403,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,79008,SLX1B,https://ctdbase.org/detail.go?type=gene&acc=79008,,,79008.0,SLX1B,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLX1B mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1854,1518079,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6430,SRSF5,https://ctdbase.org/detail.go?type=gene&acc=6430,,,6430.0,SRSF5,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SRSF5 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1855,1518080,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,8683,SRSF9,https://ctdbase.org/detail.go?type=gene&acc=8683,,,8683.0,SRSF9,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SRSF9 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1856,1518081,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,140809,SRXN1,https://ctdbase.org/detail.go?type=gene&acc=140809,,,140809.0,SRXN1,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SRXN1 mRNA,,,PMID:22334560|PMID:23970803,https://www.ncbi.nlm.nih.gov/pubmed/22334560|https://www.ncbi.nlm.nih.gov/pubmed/23970803,22334560|23970803,,
1857,1518082,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6741,SSB,https://ctdbase.org/detail.go?type=gene&acc=6741,,,6741.0,SSB,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SSB mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1858,1518083,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,23635,SSBP2,https://ctdbase.org/detail.go?type=gene&acc=23635,,,23635.0,SSBP2,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SSBP2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1859,1518084,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,23648,SSBP3,https://ctdbase.org/detail.go?type=gene&acc=23648,,,23648.0,SSBP3,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SSBP3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1860,1518903,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6812,STXBP1,https://ctdbase.org/detail.go?type=gene&acc=6812,,,6812.0,STXBP1,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in increased expression of STXBP1 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
1861,1518904,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6815,STYX,https://ctdbase.org/detail.go?type=gene&acc=6815,,,6815.0,STYX,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of STYX mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1862,1519693,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,9015,TAF1A,https://ctdbase.org/detail.go?type=gene&acc=9015,,,9015.0,TAF1A,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of TAF1A mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1863,1519694,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6875,TAF4B,https://ctdbase.org/detail.go?type=gene&acc=6875,,,6875.0,TAF4B,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of TAF4B mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1864,1519695,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6877,TAF5,https://ctdbase.org/detail.go?type=gene&acc=6877,,,6877.0,TAF5,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of TAF5 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1865,1519696,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,27097,TAF5L,https://ctdbase.org/detail.go?type=gene&acc=27097,,,27097.0,TAF5L,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of TAF5L mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1866,1519697,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,619332,TAF7L2,https://ctdbase.org/detail.go?type=gene&acc=619332,,,619332.0,Taf7l2,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of TAF7L2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1867,1519698,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,338811,TAFA2,https://ctdbase.org/detail.go?type=gene&acc=338811,,,338811.0,TAFA2,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of TAFA2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
1868,1521235,107917,Comparative Toxicogenomics Database (CTD),1-Hydroxymidazolam,C040081,1-hydroxymethylmidazolam,https://ctdbase.org/detail.go?type=chem&acc=C040081,13112,CYP3A11,https://ctdbase.org/detail.go?type=gene&acc=13112,,,13112.0,Cyp3a11,10090.0,Mus musculus (house mouse),CYP3A11 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam,,,PMID:29415953,https://www.ncbi.nlm.nih.gov/pubmed/29415953,29415953,,
1869,1521236,107917,Comparative Toxicogenomics Database (CTD),1-Hydroxymidazolam,C040081,1-hydroxymethylmidazolam,https://ctdbase.org/detail.go?type=chem&acc=C040081,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),[[6-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[sinensetin results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[alpha-naphthoflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[artemetin results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[galangin results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[eupatilin results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[3-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[beta-naphthoflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[7-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[chrysin results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[5-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[flavone results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[tangeretin results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[sinensetin analog results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[nobiletin results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|[[6-methylflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam,,,PMID:31756459,https://www.ncbi.nlm.nih.gov/pubmed/31756459,31756459,,
1870,1430052,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,9536,PTGES,https://ctdbase.org/detail.go?type=gene&acc=9536,,,9536.0,PTGES,9606.0,Homo sapiens (human),Cobaltiprotoporphyrin inhibits the reaction [IL1B protein results in increased expression of PTGES protein]|hmox1 protein promotes the reaction [cobaltiprotoporphyrin inhibits the reaction [IL1B protein results in increased expression of PTGES protein]],,,PMID:21954917,https://www.ncbi.nlm.nih.gov/pubmed/21954917,21954917,,
1871,1430053,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,9536,PTGES,https://ctdbase.org/detail.go?type=gene&acc=9536,,,9536.0,PTGES,9606.0,Homo sapiens (human),HMOX1 protein promotes the reaction [cobaltiprotoporphyrin inhibits the reaction [[IL1B protein results in increased expression of PTGES protein] which results in increased abundance of dinoprostone]]|cobaltiprotoporphyrin inhibits the reaction [[IL1B protein results in increased expression of PTGES protein] which results in increased abundance of dinoprostone],,,PMID:19428335,https://www.ncbi.nlm.nih.gov/pubmed/19428335,19428335,,
1872,1430054,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,5742,PTGS1,https://ctdbase.org/detail.go?type=gene&acc=5742,,,5742.0,PTGS1,10090.0,Mus musculus (house mouse),Cobaltiprotoporphyrin results in increased expression of PTGS1 mrna|foxo1 mutant form inhibits the reaction [cobaltiprotoporphyrin results in increased expression of PTGS1 mrna],,,PMID:24255720,https://www.ncbi.nlm.nih.gov/pubmed/24255720,24255720,,
1873,1430055,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Cobaltiprotoporphyrin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mrna],,,PMID:22155307,https://www.ncbi.nlm.nih.gov/pubmed/22155307,22155307,,
1874,1430056,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Cobaltiprotoporphyrin inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein],,,PMID:21954917|PMID:22155307,https://www.ncbi.nlm.nih.gov/pubmed/21954917|https://www.ncbi.nlm.nih.gov/pubmed/22155307,21954917|22155307,,
1875,1430057,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),HMOX1 protein promotes the reaction [cobaltiprotoporphyrin inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]],,,PMID:21954917,https://www.ncbi.nlm.nih.gov/pubmed/21954917,21954917,,
1876,1430058,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Cobaltiprotoporphyrin inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 protein],,,PMID:21256160,https://www.ncbi.nlm.nih.gov/pubmed/21256160,21256160,,
1877,1430059,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),FOXO1 mutant form inhibits the reaction [cobaltiprotoporphyrin results in increased expression of PTGS2 mrna]|cobaltiprotoporphyrin results in increased expression of PTGS2 mrna|cobaltiprotoporphyrin results in increased expression of PTGS2 protein|foxo1 mutant form inhibits the reaction [cobaltiprotoporphyrin results in increased expression of PTGS2 protein],,,PMID:24255720,https://www.ncbi.nlm.nih.gov/pubmed/24255720,24255720,,
1878,1430060,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Cobaltiprotoporphyrin inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 mrna]|ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate promotes the reaction [cobaltiprotoporphyrin results in decreased expression of PTGS2 mrna]|cobaltiprotoporphyrin results in decreased expression of PTGS2 mrna|cobaltiprotoporphyrin promotes the reaction [ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate results in decreased expression of PTGS2 mrna],,,PMID:25343247,https://www.ncbi.nlm.nih.gov/pubmed/25343247,25343247,,
1879,1430825,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Cobaltiprotoporphyrin results in decreased expression of TNF mRNA,,,PMID:25780291,https://www.ncbi.nlm.nih.gov/pubmed/25780291,25780291,,
1880,1430826,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),[cobaltiprotoporphyrin results in increased expression of HMOX1 protein] which results in decreased expression of TNF mRNA,,,PMID:12352873,https://www.ncbi.nlm.nih.gov/pubmed/12352873,12352873,,
1881,1430827,108007,Comparative Toxicogenomics Database (CTD),Cobalt protoporphyrin,C007095,cobaltiprotoporphyrin,https://ctdbase.org/detail.go?type=chem&acc=C007095,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),[cobaltiprotoporphyrin results in increased expression of HMOX1 protein] which results in decreased expression of TNF protein,,,PMID:18334666,https://www.ncbi.nlm.nih.gov/pubmed/18334666,18334666,,
1882,1518085,108065,Comparative Toxicogenomics Database (CTD),Proanthocyanidin,C013221,proanthocyanidin,https://ctdbase.org/detail.go?type=chem&acc=C013221,1232,CCR3,https://ctdbase.org/detail.go?type=gene&acc=1232,,,1232.0,CCR3,9606.0,Homo sapiens (human),Proanthocyanidin results in decreased expression of CCR3 mrna|proanthocyanidin results in decreased expression of CCR3 protein,,,PMID:12462994,https://www.ncbi.nlm.nih.gov/pubmed/12462994,12462994,,
1883,1518086,108065,Comparative Toxicogenomics Database (CTD),Proanthocyanidin,C013221,proanthocyanidin,https://ctdbase.org/detail.go?type=chem&acc=C013221,1234,CCR5,https://ctdbase.org/detail.go?type=gene&acc=1234,,,1234.0,CCR5,9606.0,Homo sapiens (human),Proanthocyanidin results in decreased expression of CCR5 mRNA,,,PMID:12462994,https://www.ncbi.nlm.nih.gov/pubmed/12462994,12462994,,
1884,1518087,108078,Comparative Toxicogenomics Database (CTD),2-chloro-N-[(4-chlorophenyl)carbamoyl]benzamide,C000608332,chlorbenzuron,https://ctdbase.org/detail.go?type=chem&acc=C000608332,41503,GSTD1,https://ctdbase.org/detail.go?type=gene&acc=41503,,,41503.0,GstD1,192188.0,Grapholita molesta (oriental fruit moth),Chlorbenzuron results in decreased activity of GSTD1 protein,,,PMID:30387866,https://www.ncbi.nlm.nih.gov/pubmed/30387866,30387866,,
1885,1518088,108092,Drug Gene Interaction database (DGIdb),Tesmilifene,,TESMILIFENE,https://www.dgidb.org/drugs/ncit:C75196,,CYP3A7,https://www.dgidb.org/genes/hgnc:2640,,,1551.0,CYP3A7,9606.0,Homo sapiens (human),,,,,,,,
1886,1518089,108152,IUPHAR/BPS Guide to PHARMACOLOGY,"9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid, 2,3,9,10,11,12-hexahydro-10-methoxy-2,9-dimethyl-1-oxo-, methyl ester, (9S,10R,12R)-",338,KT 5823,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=338,14,M2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=14,P08172,Muscarinic acetylcholine receptor M2,1129.0,CHRM2,9606.0,Homo sapiens (human),Positive,pKd,5.7,PMID:10860942,https://www.ncbi.nlm.nih.gov/pubmed/10860942,10860942,,
1887,1529400,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,716,C1S,https://ctdbase.org/detail.go?type=gene&acc=716,,,716.0,C1S,10116.0,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of C1S mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
1888,1529401,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,93664,CADPS2,https://ctdbase.org/detail.go?type=gene&acc=93664,,,93664.0,CADPS2,10116.0,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of CADPS2 mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
1889,1529402,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,793,CALB1,https://ctdbase.org/detail.go?type=gene&acc=793,,,793.0,CALB1,10116.0,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of CALB1 protein,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
1890,1529403,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,12319,CAR8,https://ctdbase.org/detail.go?type=gene&acc=12319,,,12319.0,Car8,10116.0,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of CAR8 mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
1891,1529610,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,10462,CLEC10A,https://ctdbase.org/detail.go?type=gene&acc=10462,,,10462.0,CLEC10A,10116.0,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CLEC10A mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
1892,1518399,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,4535,ND1,https://ctdbase.org/detail.go?type=gene&acc=4535,,,4535.0,ND1,9606.0,Homo sapiens (human),Deoxyglucose inhibits the reaction [HMGA2 protein results in decreased expression of ND1 protein]|deoxyglucose inhibits the reaction [carbonyl cyanide m-chlorophenyl hydrazone results in decreased expression of ND1 protein],,,PMID:34481905,https://www.ncbi.nlm.nih.gov/pubmed/34481905,34481905,,
1893,1518400,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),Deoxyglucose results in decreased expression of NFKB1 mrna|[demycarosyl-3D-digitoxosylmithramycin SK co-treated with deoxyglucose] affects the expression of NFKB1 mRNA,,,PMID:26079942,https://www.ncbi.nlm.nih.gov/pubmed/26079942,26079942,,
1894,1518401,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606.0,Homo sapiens (human),Deoxyglucose promotes the reaction [STO 609 inhibits the reaction [histamine results in increased phosphorylation of NOS2 protein]],,,PMID:21145922,https://www.ncbi.nlm.nih.gov/pubmed/21145922,21145922,,
1895,1520617,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606.0,Homo sapiens (human),TNF protein inhibits the reaction [INS protein results in increased uptake of deoxyglucose],,,PMID:29991592,https://www.ncbi.nlm.nih.gov/pubmed/29991592,29991592,,
1896,1520618,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606.0,Homo sapiens (human),Wortmannin inhibits the reaction [INS protein results in increased uptake of deoxyglucose]|troglitazone promotes the reaction [INS protein results in increased uptake of deoxyglucose],,,PMID:11334413,https://www.ncbi.nlm.nih.gov/pubmed/11334413,11334413,,
1897,1520619,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),Dimercaprol inhibits the reaction [p-aminophenylarsine oxide inhibits the reaction [INS1 protein results in increased transport of deoxyglucose]]|ins1 protein results in increased transport of deoxyglucose|dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [INS1 protein results in increased transport of deoxyglucose]]|oxophenylarsine inhibits the reaction [INS1 protein results in increased transport of deoxyglucose]|p-aminophenylarsine oxide inhibits the reaction [INS1 protein results in increased transport of deoxyglucose]|acetylaminophenylarsine oxide inhibits the reaction [INS1 protein results in increased transport of deoxyglucose],,,PMID:2202293,https://www.ncbi.nlm.nih.gov/pubmed/2202293,2202293,,
1898,1520620,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),Kaempferol inhibits the reaction [INS1 protein results in increased uptake of deoxyglucose]|genistein inhibits the reaction [INS1 protein results in increased uptake of deoxyglucose]|epigallocatechin gallate inhibits the reaction [INS1 protein results in increased uptake of deoxyglucose]|silybin inhibits the reaction [INS1 protein results in increased uptake of deoxyglucose]|fisetin inhibits the reaction [INS1 protein results in increased uptake of deoxyglucose]|apigenin inhibits the reaction [INS1 protein results in increased uptake of deoxyglucose]|theaflavin inhibits the reaction [INS1 protein results in increased uptake of deoxyglucose]|luteolin inhibits the reaction [INS1 protein results in increased uptake of deoxyglucose],,,PMID:18591783,https://www.ncbi.nlm.nih.gov/pubmed/18591783,18591783,,
1899,1520621,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),Deoxyglucose results in increased secretion of INS1 protein,,,PMID:1378463,https://www.ncbi.nlm.nih.gov/pubmed/1378463,1378463,,
1900,1520622,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [INS1 protein results in increased uptake of deoxyglucose]]|oxophenylarsine inhibits the reaction [INS1 protein results in increased uptake of deoxyglucose],,,PMID:3882699,https://www.ncbi.nlm.nih.gov/pubmed/3882699,3882699,,
1901,1520623,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),Dorsomorphin inhibits the reaction [quercetin inhibits the reaction [INS1 protein results in increased uptake of deoxyglucose]],,,PMID:26627467,https://www.ncbi.nlm.nih.gov/pubmed/26627467,26627467,,
1902,1520624,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,9901,SRGAP3,https://ctdbase.org/detail.go?type=gene&acc=9901,,,9901.0,SRGAP3,9606.0,Homo sapiens (human),Deoxyglucose results in decreased expression of SRGAP3 mRNA,,,PMID:33770205,https://www.ncbi.nlm.nih.gov/pubmed/33770205,33770205,,
1903,1520762,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),Wortmannin inhibits the reaction [raffinose promotes the reaction [INS1 protein results in increased uptake of deoxyglucose]]|genistein inhibits the reaction [raffinose promotes the reaction [INS1 protein results in increased uptake of deoxyglucose]]|raffinose promotes the reaction [INS1 protein results in increased uptake of deoxyglucose],,,PMID:29458019,https://www.ncbi.nlm.nih.gov/pubmed/29458019,29458019,,
1904,1520763,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),INS1 protein affects the transport of deoxyglucose,,,PMID:1536656,https://www.ncbi.nlm.nih.gov/pubmed/1536656,1536656,,
1905,1432133,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of AIFM1 mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1906,1432134,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of AR mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1907,1432251,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,666,BOK,https://ctdbase.org/detail.go?type=gene&acc=666,,,666.0,BOK,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of BOK mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1908,1432252,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of CASP3 mRNA,,,PMID:35861251,https://www.ncbi.nlm.nih.gov/pubmed/35861251,35861251,,
1909,1432253,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CASP3 mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1910,1432254,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CASP8 mRNA,,,PMID:35861251,https://www.ncbi.nlm.nih.gov/pubmed/35861251,35861251,,
1911,1432255,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CASP8 mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1912,1432256,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CAT mRNA,,,PMID:35861251,https://www.ncbi.nlm.nih.gov/pubmed/35861251,35861251,,
1913,1432257,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CAT mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1914,1432258,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890.0,CCNA2,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCNA2 mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1915,1432554,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP19A1 mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1916,1432555,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CYP1A1 mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1917,1432556,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,10090.0,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP1B1 mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
1918,1432557,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,23405,DICER1,https://ctdbase.org/detail.go?type=gene&acc=23405,,,23405.0,DICER1,9606.0,Homo sapiens (human),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of DICER1 mRNA,,,PMID:35861251,https://www.ncbi.nlm.nih.gov/pubmed/35861251,35861251,,
1919,1432558,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786.0,DNMT1,9606.0,Homo sapiens (human),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of DNMT1 mrna|[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of DNMT1 mRNA,,,PMID:35861251,https://www.ncbi.nlm.nih.gov/pubmed/35861251,35861251,,
1920,1432559,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,29102,DROSHA,https://ctdbase.org/detail.go?type=gene&acc=29102,,,29102.0,DROSHA,9606.0,Homo sapiens (human),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of DROSHA mRNA,,,PMID:35861251,https://www.ncbi.nlm.nih.gov/pubmed/35861251,35861251,,
1921,1432560,110394,Comparative Toxicogenomics Database (CTD),Monoisononyl phthalate,C471400,monoisononylphthalate,https://ctdbase.org/detail.go?type=chem&acc=C471400,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of ESR1 mRNA,,,PMID:35861251,https://www.ncbi.nlm.nih.gov/pubmed/35861251,35861251,,
1922,1431673,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,226,ALDOA,https://ctdbase.org/detail.go?type=gene&acc=226,,,226.0,ALDOA,10116.0,Rattus norvegicus (Norway rat),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of ALDOA mRNA",,,PMID:33126064,https://www.ncbi.nlm.nih.gov/pubmed/33126064,33126064,,
1923,1431952,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,410,ARSA,https://ctdbase.org/detail.go?type=gene&acc=410,,,410.0,ARSA,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of ARSA mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1924,1432389,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,70237,BHLHB9,https://ctdbase.org/detail.go?type=gene&acc=70237,,,70237.0,Bhlhb9,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of BHLHB9 mRNA",,,PMID:27553808|PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/27553808|https://www.ncbi.nlm.nih.gov/pubmed/35832492,27553808|35832492,,
1925,1432390,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,656,BMP8B,https://ctdbase.org/detail.go?type=gene&acc=656,,,656.0,BMP8B,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of BMP8B mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1926,1432391,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,266655,BRD3OS,https://ctdbase.org/detail.go?type=gene&acc=266655,,,266655.0,BRD3OS,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of BRD3OS mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1927,1432392,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,284697,BTBD8,https://ctdbase.org/detail.go?type=gene&acc=284697,,,284697.0,BTBD8,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of BTBD8 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1928,1432393,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,388581,C1QTNF12,https://ctdbase.org/detail.go?type=gene&acc=388581,,,388581.0,C1QTNF12,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of C1QTNF12 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1929,1432394,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,50908,C1S1,https://ctdbase.org/detail.go?type=gene&acc=50908,,,50908.0,C1s1,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of C1S1 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1930,1433921,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,178,AGL,https://ctdbase.org/detail.go?type=gene&acc=178,,,178.0,AGL,10116.0,Rattus norvegicus (Norway rat),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of AGL mRNA",,,PMID:33126064,https://www.ncbi.nlm.nih.gov/pubmed/33126064,33126064,,
1931,1433922,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,375790,AGRN,https://ctdbase.org/detail.go?type=gene&acc=375790,,,375790.0,AGRN,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of AGRN mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1932,1433923,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,150209,AIFM3,https://ctdbase.org/detail.go?type=gene&acc=150209,,,150209.0,AIFM3,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of AIFM3 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1933,1434338,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,34,ACADM,https://ctdbase.org/detail.go?type=gene&acc=34,,,34.0,ACADM,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate affects the expression of ACADM mRNA",,,PMID:32138627,https://www.ncbi.nlm.nih.gov/pubmed/32138627,32138627,,
1934,1434339,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,34,ACADM,https://ctdbase.org/detail.go?type=gene&acc=34,,,34.0,ACADM,10114.0,Rattus,"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of ACADM mRNA",,,PMID:34952357,https://www.ncbi.nlm.nih.gov/pubmed/34952357,34952357,,
1935,1434340,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,34,ACADM,https://ctdbase.org/detail.go?type=gene&acc=34,,,34.0,ACADM,10116.0,Rattus norvegicus (Norway rat),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of ACADM mRNA",,,PMID:30920876|PMID:33126064|PMID:33983380,https://www.ncbi.nlm.nih.gov/pubmed/30920876|https://www.ncbi.nlm.nih.gov/pubmed/33126064|https://www.ncbi.nlm.nih.gov/pubmed/33983380,30920876|33126064|33983380,,
1936,1434341,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,59272,ACE2,https://ctdbase.org/detail.go?type=gene&acc=59272,,,59272.0,ACE2,10090.0,Mus musculus (house mouse),"[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of ACE2 mRNA",,,PMID:36270329,https://www.ncbi.nlm.nih.gov/pubmed/36270329,36270329,,
1937,1434342,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,51554,ACKR4,https://ctdbase.org/detail.go?type=gene&acc=51554,,,51554.0,ACKR4,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of ACKR4 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1938,1434343,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,130013,ACMSD,https://ctdbase.org/detail.go?type=gene&acc=130013,,,130013.0,ACMSD,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of ACMSD mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1939,1434344,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,48,ACO1,https://ctdbase.org/detail.go?type=gene&acc=48,,,48.0,ACO1,10116.0,Rattus norvegicus (Norway rat),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of ACO1 mRNA",,,PMID:33126064,https://www.ncbi.nlm.nih.gov/pubmed/33126064,33126064,,
1940,1434345,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,50,ACO2,https://ctdbase.org/detail.go?type=gene&acc=50,,,50.0,ACO2,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of ACO2 mRNA",,,PMID:36436258,https://www.ncbi.nlm.nih.gov/pubmed/36436258,36436258,,
1941,1489112,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,30816,ERVW-1,https://ctdbase.org/detail.go?type=gene&acc=30816,,,30816.0,ERVW-1,9606.0,Homo sapiens (human),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of ERVW-1 mRNA",,,PMID:32790152,https://www.ncbi.nlm.nih.gov/pubmed/32790152,32790152,,
1942,1489606,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,9606.0,Homo sapiens (human),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of FABP1 mRNA",,,PMID:32790152,https://www.ncbi.nlm.nih.gov/pubmed/32790152,32790152,,
1943,1489607,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate affects the expression of FABP1 mRNA",,,PMID:32138627,https://www.ncbi.nlm.nih.gov/pubmed/32138627,32138627,,
1944,1489608,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,10114.0,Rattus,"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of FABP1 mRNA",,,PMID:34952357,https://www.ncbi.nlm.nih.gov/pubmed/34952357,34952357,,
1945,1489609,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,10116.0,Rattus norvegicus (Norway rat),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of FABP1 mRNA",,,PMID:30920876|PMID:33126064|PMID:33983380,https://www.ncbi.nlm.nih.gov/pubmed/30920876|https://www.ncbi.nlm.nih.gov/pubmed/33126064|https://www.ncbi.nlm.nih.gov/pubmed/33983380,30920876|33126064|33983380,,
1946,1489610,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2169,FABP2,https://ctdbase.org/detail.go?type=gene&acc=2169,,,2169.0,FABP2,10116.0,Rattus norvegicus (Norway rat),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of FABP2 mRNA",,,PMID:33126064,https://www.ncbi.nlm.nih.gov/pubmed/33126064,33126064,,
1947,1489611,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2170,FABP3,https://ctdbase.org/detail.go?type=gene&acc=2170,,,2170.0,FABP3,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of FABP3 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1948,1489612,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,9606.0,Homo sapiens (human),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of FABP4 mRNA",,,PMID:35337807,https://www.ncbi.nlm.nih.gov/pubmed/35337807,35337807,,
1949,1489613,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of FABP4 mRNA",,,PMID:27553808|PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/27553808|https://www.ncbi.nlm.nih.gov/pubmed/35832492,27553808|35832492,,
1950,1491475,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,107141,CYP2C50,https://ctdbase.org/detail.go?type=gene&acc=107141,,,107141.0,Cyp2c50,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CYP2C50 mRNA",,,PMID:27553808|PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/27553808|https://www.ncbi.nlm.nih.gov/pubmed/35832492,27553808|35832492,,
1951,1491476,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,404195,CYP2C54,https://ctdbase.org/detail.go?type=gene&acc=404195,,,404195.0,Cyp2c54,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CYP2C54 mRNA",,,PMID:27553808|PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/27553808|https://www.ncbi.nlm.nih.gov/pubmed/35832492,27553808|35832492,,
1952,1491477,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,545288,CYP2C67,https://ctdbase.org/detail.go?type=gene&acc=545288,,,545288.0,Cyp2c67,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CYP2C67 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1953,1491478,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,100043108,CYP2C69,https://ctdbase.org/detail.go?type=gene&acc=100043108,,,100043108.0,Cyp2c69,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CYP2C69 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1954,1491479,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,226105,CYP2C70,https://ctdbase.org/detail.go?type=gene&acc=226105,,,226105.0,Cyp2c70,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CYP2C70 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1955,1491480,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,380997,CYP2D12,https://ctdbase.org/detail.go?type=gene&acc=380997,,,380997.0,Cyp2d12,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CYP2D12 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1956,1491481,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,71754,CYP2D40,https://ctdbase.org/detail.go?type=gene&acc=71754,,,71754.0,Cyp2d40,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CYP2D40 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1957,1491482,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,51302,CYP39A1,https://ctdbase.org/detail.go?type=gene&acc=51302,,,51302.0,CYP39A1,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CYP39A1 mRNA",,,PMID:27553808|PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/27553808|https://www.ncbi.nlm.nih.gov/pubmed/35832492,27553808|35832492,,
1958,1491934,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,13119,CYP4A14,https://ctdbase.org/detail.go?type=gene&acc=13119,,,13119.0,Cyp4a14,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of CYP4A14 mRNA",,,PMID:27553808|PMID:36115532,https://www.ncbi.nlm.nih.gov/pubmed/27553808|https://www.ncbi.nlm.nih.gov/pubmed/36115532,27553808|36115532,,
1959,1491935,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,284541,CYP4A22,https://ctdbase.org/detail.go?type=gene&acc=284541,,,284541.0,CYP4A22,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate affects the expression of CYP4A22 mRNA",,,PMID:32138627,https://www.ncbi.nlm.nih.gov/pubmed/32138627,32138627,,
1960,1491936,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,666168,CYP4A31,https://ctdbase.org/detail.go?type=gene&acc=666168,,,666168.0,Cyp4a31,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of CYP4A31 mRNA",,,PMID:27553808|PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/27553808|https://www.ncbi.nlm.nih.gov/pubmed/35832492,27553808|35832492,,
1961,1491937,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,100040843,CYP4A32,https://ctdbase.org/detail.go?type=gene&acc=100040843,,,100040843.0,Cyp4a32,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of CYP4A32 mRNA",,,PMID:27553808|PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/27553808|https://www.ncbi.nlm.nih.gov/pubmed/35832492,27553808|35832492,,
1962,1491938,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,64385,CYP4F14,https://ctdbase.org/detail.go?type=gene&acc=64385,,,64385.0,Cyp4f14,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CYP4F14 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1963,1491939,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10114.0,Rattus,"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CYP7A1 mRNA",,,PMID:34952357,https://www.ncbi.nlm.nih.gov/pubmed/34952357,34952357,,
1964,1491940,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,4519,CYTB,https://ctdbase.org/detail.go?type=gene&acc=4519,,,4519.0,CYTB,7955.0,Danio rerio (zebrafish),"[ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate co-treated with perfluorooctanoic acid] results in decreased expression of CYTB mrna|ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CYTB mRNA",,,PMID:36356740,https://www.ncbi.nlm.nih.gov/pubmed/36356740,36356740,,
1965,1495708,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2589,GALNT1,https://ctdbase.org/detail.go?type=gene&acc=2589,,,2589.0,GALNT1,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of GALNT1 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1966,1495709,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,11226,GALNT6,https://ctdbase.org/detail.go?type=gene&acc=11226,,,11226.0,GALNT6,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of GALNT6 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1967,1495710,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,10116.0,Rattus norvegicus (Norway rat),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of GAPDH mRNA",,,PMID:33126064,https://www.ncbi.nlm.nih.gov/pubmed/33126064,33126064,,
1968,1495711,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2621,GAS6,https://ctdbase.org/detail.go?type=gene&acc=2621,,,2621.0,GAS6,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of GAS6 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1969,1495712,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,729085,GASK1A,https://ctdbase.org/detail.go?type=gene&acc=729085,,,729085.0,GASK1A,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of GASK1A mRNA",,,PMID:27553808,https://www.ncbi.nlm.nih.gov/pubmed/27553808,27553808,,
1970,1495713,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2627,GATA6,https://ctdbase.org/detail.go?type=gene&acc=2627,,,2627.0,GATA6,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of GATA6 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1971,1496591,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,57531,HACE1,https://ctdbase.org/detail.go?type=gene&acc=57531,,,57531.0,HACE1,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of HACE1 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1972,1496592,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,51179,HAO2,https://ctdbase.org/detail.go?type=gene&acc=51179,,,51179.0,HAO2,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of HAO2 mRNA",,,PMID:27553808|PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/27553808|https://www.ncbi.nlm.nih.gov/pubmed/35832492,27553808|35832492,,
1973,1496593,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,15129,HBB-B1,https://ctdbase.org/detail.go?type=gene&acc=15129,,,15129.0,Hbb-b1,10090.0,Mus musculus (house mouse),"[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of HBB-B1 mRNA",,,PMID:36270329,https://www.ncbi.nlm.nih.gov/pubmed/36270329,36270329,,
1974,1496594,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,8916,HERC3,https://ctdbase.org/detail.go?type=gene&acc=8916,,,8916.0,HERC3,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of HERC3 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1975,1497651,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,112752,IFT43,https://ctdbase.org/detail.go?type=gene&acc=112752,,,112752.0,IFT43,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of IFT43 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1976,1497652,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,51098,IFT52,https://ctdbase.org/detail.go?type=gene&acc=51098,,,51098.0,IFT52,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of IFT52 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1977,1497653,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,55081,IFT57,https://ctdbase.org/detail.go?type=gene&acc=55081,,,55081.0,IFT57,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of IFT57 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1978,1497654,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,3481,IGF2,https://ctdbase.org/detail.go?type=gene&acc=3481,,,3481.0,IGF2,9606.0,Homo sapiens (human),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of IGF2 mRNA",,,PMID:35548680,https://www.ncbi.nlm.nih.gov/pubmed/35548680,35548680,,
1979,1497655,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,3483,IGFALS,https://ctdbase.org/detail.go?type=gene&acc=3483,,,3483.0,IGFALS,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of IGFALS mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1980,1497656,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,3488,IGFBP5,https://ctdbase.org/detail.go?type=gene&acc=3488,,,3488.0,IGFBP5,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of IGFBP5 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1981,1497657,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,404711,IGHG2C,https://ctdbase.org/detail.go?type=gene&acc=404711,,,404711.0,Ighg2c,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of IGHG2C mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1982,1497658,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,384411,IGKV12-89,https://ctdbase.org/detail.go?type=gene&acc=384411,,,384411.0,Igkv12-89,10090.0,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of IGKV12-89 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
1983,1522559,114919,ChEMBL,2'-O-Acetylerythromycin A,CHEMBL2110577,ERYTHROMYCIN ACISTRATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110577/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P62399,50S ribosomal protein L5,83577893.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:20876130,https://www.ncbi.nlm.nih.gov/pubmed/20876130,20876130,,
1984,1522560,114919,ChEMBL,2'-O-Acetylerythromycin A,CHEMBL2110577,ERYTHROMYCIN ACISTRATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110577/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P68679,30S ribosomal protein S21,947814.0,rpsC,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:20876130,https://www.ncbi.nlm.nih.gov/pubmed/20876130,20876130,,
1985,1522561,114919,ChEMBL,2'-O-Acetylerythromycin A,CHEMBL2110577,ERYTHROMYCIN ACISTRATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110577/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P68919,50S ribosomal protein L25,84234843.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:20876130,https://www.ncbi.nlm.nih.gov/pubmed/20876130,20876130,,
1986,1522562,114919,ChEMBL,2'-O-Acetylerythromycin A,CHEMBL2110577,ERYTHROMYCIN ACISTRATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110577/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,Q2EEQ2,50S ribosomal protein L36 2,947793.0,rpsD,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:20876130,https://www.ncbi.nlm.nih.gov/pubmed/20876130,20876130,,
1987,1522563,114948,Therapeutic Target Database (TTD),Dihydroergocryptine,D0UI3L,dihydroergocryptine,https://idrblab.net/ttd/data/drug/details/D0UI3L,T79062,5-HT 7 receptor (HTR7),https://idrblab.net/ttd/data/target/details/T79062,P34969,5-hydroxytryptamine receptor 7,3363.0,HTR7,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1988,1522564,114948,Therapeutic Target Database (TTD),Dihydroergocryptine,D0UI3L,dihydroergocryptine,https://idrblab.net/ttd/data/drug/details/D0UI3L,T31204,5-HT 2B receptor (HTR2B),https://idrblab.net/ttd/data/target/details/T31204,P41595,5-hydroxytryptamine receptor 2B,3357.0,HTR2B,9606.0,Homo sapiens (human),Agonist,,,,,,,
1989,1510668,115056,Comparative Toxicogenomics Database (CTD),Epomediol,C031365,epomediol,https://ctdbase.org/detail.go?type=chem&acc=C031365,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10116.0,Rattus norvegicus (Norway rat),Epomediol results in increased expression of CYP7A1 mRNA,,,PMID:11473529,https://www.ncbi.nlm.nih.gov/pubmed/11473529,11473529,,
1990,1510669,115056,Comparative Toxicogenomics Database (CTD),Epomediol,C031365,epomediol,https://ctdbase.org/detail.go?type=chem&acc=C031365,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10116.0,Rattus norvegicus (Norway rat),[ethinyl estradiol co-treated with epomediol] results in increased activity of GCLM protein,,,PMID:12071332,https://www.ncbi.nlm.nih.gov/pubmed/12071332,12071332,,
1991,1510670,115056,Comparative Toxicogenomics Database (CTD),Epomediol,C031365,epomediol,https://ctdbase.org/detail.go?type=chem&acc=C031365,2678,GGT1,https://ctdbase.org/detail.go?type=gene&acc=2678,,,2678.0,GGT1,10116.0,Rattus norvegicus (Norway rat),[ethinyl estradiol co-treated with epomediol] results in increased activity of GGT1 protein,,,PMID:12071332,https://www.ncbi.nlm.nih.gov/pubmed/12071332,12071332,,
1992,1510671,115056,Comparative Toxicogenomics Database (CTD),Epomediol,C031365,epomediol,https://ctdbase.org/detail.go?type=chem&acc=C031365,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10116.0,Rattus norvegicus (Norway rat),Epomediol results in increased activity of HMGCR protein,,,PMID:10961725|PMID:11473529,https://www.ncbi.nlm.nih.gov/pubmed/10961725|https://www.ncbi.nlm.nih.gov/pubmed/11473529,10961725|11473529,,
1993,1522565,115077,Therapeutic Target Database (TTD),Quadazocine,D02BER,quadazocine,https://idrblab.net/ttd/data/drug/details/D02BER,T58992,Opioid receptor delta (OPRD1),https://idrblab.net/ttd/data/target/details/T58992,P41143,Delta-type opioid receptor,4985.0,OPRD1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1994,1510672,115150,Comparative Toxicogenomics Database (CTD),"4,4'-(1,2-Dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",C070899,"4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",https://ctdbase.org/detail.go?type=chem&acc=C070899,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,10116.0,Rattus norvegicus (Norway rat),"4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione inhibits the reaction [doxorubicin results in increased expression of H2AX protein]|4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione inhibits the reaction [etoposide results in increased expression of H2AX protein]",,,PMID:17875725,https://www.ncbi.nlm.nih.gov/pubmed/17875725,17875725,,
1995,1510673,115150,Comparative Toxicogenomics Database (CTD),"4,4'-(1,2-Dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",C070899,"4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",https://ctdbase.org/detail.go?type=chem&acc=C070899,7155,TOP2B,https://ctdbase.org/detail.go?type=gene&acc=7155,,,7155.0,TOP2B,10116.0,Rattus norvegicus (Norway rat),"4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione results in increased degradation of and results in decreased expression of TOP2B protein|bortezomib inhibits the reaction [4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione results in increased degradation of and results in decreased expression of TOP2B protein]",,,PMID:17875725,https://www.ncbi.nlm.nih.gov/pubmed/17875725,17875725,,
1996,1433639,119031,Comparative Toxicogenomics Database (CTD),Marimastat,C100342,marimastat,https://ctdbase.org/detail.go?type=chem&acc=C100342,7039,TGFA,https://ctdbase.org/detail.go?type=gene&acc=7039,,,7039.0,TGFA,9606.0,Homo sapiens (human),Marimastat inhibits the reaction [GRP protein results in increased cleavage of and results in increased secretion of TGFA protein],,,PMID:15342401,https://www.ncbi.nlm.nih.gov/pubmed/15342401,15342401,,
1997,1435307,119093,Drug Gene Interaction database (DGIdb),Cynaropicrin,,CYNAROPICRIN,https://www.dgidb.org/drugs/chembl:CHEMBL374146,,RELA,https://www.dgidb.org/genes/hgnc:9955,,,5970.0,RELA,9606.0,Homo sapiens (human),,,,,,,,
1998,1435308,119096,Comparative Toxicogenomics Database (CTD),Mono(2-ethyl-5-oxohexyl)phthalate,C080276,mono(2-ethyl-5-oxohexyl)phthalate,https://ctdbase.org/detail.go?type=chem&acc=C080276,22985,ACIN1,https://ctdbase.org/detail.go?type=gene&acc=22985,,,22985.0,ACIN1,9606.0,Homo sapiens (human),Mono(2-ethyl-5-oxohexyl)phthalate affects the expression of ACIN1 mRNA,,,PMID:34478338,https://www.ncbi.nlm.nih.gov/pubmed/34478338,34478338,,
1999,1435309,119096,Comparative Toxicogenomics Database (CTD),Mono(2-ethyl-5-oxohexyl)phthalate,C080276,mono(2-ethyl-5-oxohexyl)phthalate,https://ctdbase.org/detail.go?type=chem&acc=C080276,80332,ADAM33,https://ctdbase.org/detail.go?type=gene&acc=80332,,,80332.0,ADAM33,9606.0,Homo sapiens (human),[[endocrine disruptors results in increased abundance of mono(2-ethyl-5-oxohexyl)phthalate] which results in increased methylation of ADAM33 intron] which results in increased expression of ADAM33 mRNA,,,PMID:30226539,https://www.ncbi.nlm.nih.gov/pubmed/30226539,30226539|30226539,,
2000,1435310,119096,Comparative Toxicogenomics Database (CTD),Mono(2-ethyl-5-oxohexyl)phthalate,C080276,mono(2-ethyl-5-oxohexyl)phthalate,https://ctdbase.org/detail.go?type=chem&acc=C080276,55608,ANKRD10,https://ctdbase.org/detail.go?type=gene&acc=55608,,,55608.0,ANKRD10,9606.0,Homo sapiens (human),Mono(2-ethyl-5-oxohexyl)phthalate affects the expression of ANKRD10 mRNA,,,PMID:34478338,https://www.ncbi.nlm.nih.gov/pubmed/34478338,34478338,,
2001,1435311,119096,Comparative Toxicogenomics Database (CTD),Mono(2-ethyl-5-oxohexyl)phthalate,C080276,mono(2-ethyl-5-oxohexyl)phthalate,https://ctdbase.org/detail.go?type=chem&acc=C080276,8906,AP1G2,https://ctdbase.org/detail.go?type=gene&acc=8906,,,8906.0,AP1G2,9606.0,Homo sapiens (human),Mono(2-ethyl-5-oxohexyl)phthalate affects the expression of AP1G2 mRNA,,,PMID:34478338,https://www.ncbi.nlm.nih.gov/pubmed/34478338,34478338,,
2002,1435312,119096,Comparative Toxicogenomics Database (CTD),Mono(2-ethyl-5-oxohexyl)phthalate,C080276,mono(2-ethyl-5-oxohexyl)phthalate,https://ctdbase.org/detail.go?type=chem&acc=C080276,55082,ARGLU1,https://ctdbase.org/detail.go?type=gene&acc=55082,,,55082.0,ARGLU1,9606.0,Homo sapiens (human),Mono(2-ethyl-5-oxohexyl)phthalate affects the expression of ARGLU1 mRNA,,,PMID:34478338,https://www.ncbi.nlm.nih.gov/pubmed/34478338,34478338,,
2003,1435313,119096,Comparative Toxicogenomics Database (CTD),Mono(2-ethyl-5-oxohexyl)phthalate,C080276,mono(2-ethyl-5-oxohexyl)phthalate,https://ctdbase.org/detail.go?type=chem&acc=C080276,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Mono(2-ethyl-5-oxohexyl)phthalate results in decreased expression of CCL2 mRNA,,,PMID:32015430,https://www.ncbi.nlm.nih.gov/pubmed/32015430,32015430,,
2004,1435314,119096,Comparative Toxicogenomics Database (CTD),Mono(2-ethyl-5-oxohexyl)phthalate,C080276,mono(2-ethyl-5-oxohexyl)phthalate,https://ctdbase.org/detail.go?type=chem&acc=C080276,57018,CCNL1,https://ctdbase.org/detail.go?type=gene&acc=57018,,,57018.0,CCNL1,9606.0,Homo sapiens (human),Mono(2-ethyl-5-oxohexyl)phthalate affects the expression of CCNL1 mRNA,,,PMID:34478338,https://www.ncbi.nlm.nih.gov/pubmed/34478338,34478338,,
2005,1435315,119096,Comparative Toxicogenomics Database (CTD),Mono(2-ethyl-5-oxohexyl)phthalate,C080276,mono(2-ethyl-5-oxohexyl)phthalate,https://ctdbase.org/detail.go?type=chem&acc=C080276,968,CD68,https://ctdbase.org/detail.go?type=gene&acc=968,,,968.0,CD68,9606.0,Homo sapiens (human),Mono(2-ethyl-5-oxohexyl)phthalate results in decreased expression of CD68 mRNA,,,PMID:32015430,https://www.ncbi.nlm.nih.gov/pubmed/32015430,32015430,,
2006,1429520,119245,Comparative Toxicogenomics Database (CTD),Dioscin,C019357,dioscin,https://ctdbase.org/detail.go?type=chem&acc=C019357,6554,SLC10A1,https://ctdbase.org/detail.go?type=gene&acc=6554,,,6554.0,SLC10A1,10116.0,Rattus norvegicus (Norway rat),Dioscin inhibits the reaction [1-naphthylisothiocyanate results in decreased expression of SLC10A1 mrna],,,PMID:27317372,https://www.ncbi.nlm.nih.gov/pubmed/27317372,27317372,,
2007,1429521,119245,Comparative Toxicogenomics Database (CTD),Dioscin,C019357,dioscin,https://ctdbase.org/detail.go?type=chem&acc=C019357,28248,SLCO1A1,https://ctdbase.org/detail.go?type=gene&acc=28248,,,28248.0,Slco1a1,10116.0,Rattus norvegicus (Norway rat),Dioscin inhibits the reaction [1-naphthylisothiocyanate results in decreased expression of SLCO1A1 mrna]|dioscin inhibits the reaction [1-naphthylisothiocyanate results in decreased expression of SLCO1A1 protein]|dioscin results in increased expression of SLCO1A1 mRNA,,,PMID:27317372,https://www.ncbi.nlm.nih.gov/pubmed/27317372,27317372,,
2008,1429522,119245,Comparative Toxicogenomics Database (CTD),Dioscin,C019357,dioscin,https://ctdbase.org/detail.go?type=chem&acc=C019357,6579,SLCO1A2,https://ctdbase.org/detail.go?type=gene&acc=6579,,,6579.0,SLCO1A2,10116.0,Rattus norvegicus (Norway rat),Dioscin results in increased expression of SLCO1A2 mRNA,,,PMID:27317372,https://www.ncbi.nlm.nih.gov/pubmed/27317372,27317372,,
2009,1429523,119245,Comparative Toxicogenomics Database (CTD),Dioscin,C019357,dioscin,https://ctdbase.org/detail.go?type=chem&acc=C019357,28253,SLCO1B2,https://ctdbase.org/detail.go?type=gene&acc=28253,,,28253.0,Slco1b2,10116.0,Rattus norvegicus (Norway rat),Dioscin inhibits the reaction [1-naphthylisothiocyanate results in decreased expression of SLCO1B2 mrna]|dioscin results in increased expression of SLCO1B2 mrna|dioscin inhibits the reaction [1-naphthylisothiocyanate results in decreased expression of SLCO1B2 protein],,,PMID:27317372,https://www.ncbi.nlm.nih.gov/pubmed/27317372,27317372,,
2010,1429524,119245,Comparative Toxicogenomics Database (CTD),Dioscin,C019357,dioscin,https://ctdbase.org/detail.go?type=chem&acc=C019357,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,9606.0,Homo sapiens (human),Dioscin inhibits the reaction [VEGFA protein results in increased phosphorylation of SRC protein],,,PMID:25111127,https://www.ncbi.nlm.nih.gov/pubmed/25111127,25111127,,
2011,1511326,119258,Comparative Toxicogenomics Database (CTD),Astilbin,C099069,astilbin,https://ctdbase.org/detail.go?type=chem&acc=C099069,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606.0,Homo sapiens (human),Astilbin promotes the reaction [cisplatin results in increased expression of NQO1 mrna],,,PMID:29471006,https://www.ncbi.nlm.nih.gov/pubmed/29471006,29471006,,
2012,1511327,119258,Comparative Toxicogenomics Database (CTD),Astilbin,C099069,astilbin,https://ctdbase.org/detail.go?type=chem&acc=C099069,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Astilbin inhibits the reaction [cisplatin results in increased cleavage of PARP1 protein],,,PMID:29471006,https://www.ncbi.nlm.nih.gov/pubmed/29471006,29471006,,
2013,1523520,119346,Comparative Toxicogenomics Database (CTD),"3,3',4',5-Tetrachlorobiphenyl-4-OL",C111117,"3,3',4',5-tetrachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111117,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,9606.0,Homo sapiens (human),"3,3',4',5-tetrachloro-4-hydroxybiphenyl results in increased activity of NR1I3 protein",,,PMID:26231822,https://www.ncbi.nlm.nih.gov/pubmed/26231822,26231822,,
2014,1523521,119357,IUPHAR/BPS Guide to PHARMACOLOGY,"N-[2-[2-[(dipropylamino)methyl]piperidin-1-yl]ethyl]-6-oxo-5H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide",368,[3H]AF DX-384,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=368,16,M4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=16,P08173,Muscarinic acetylcholine receptor M4,1132.0,CHRM4,9606.0,Homo sapiens (human),Antagonist,pKd,8.7,PMID:1941609|PMID:29515448|PMID:32079174,https://www.ncbi.nlm.nih.gov/pubmed/1941609|https://www.ncbi.nlm.nih.gov/pubmed/29515448|https://www.ncbi.nlm.nih.gov/pubmed/32079174,1941609|29515448|32079174,,
2015,1523522,119357,IUPHAR/BPS Guide to PHARMACOLOGY,"N-[2-[2-[(dipropylamino)methyl]piperidin-1-yl]ethyl]-6-oxo-5H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide",3264,AFDX384,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3264,16,M4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=16,P08173,Muscarinic acetylcholine receptor M4,1132.0,CHRM4,9606.0,Homo sapiens (human),Antagonist,pKi,7.3 - 8,PMID:1994002|PMID:27085897,https://www.ncbi.nlm.nih.gov/pubmed/1994002|https://www.ncbi.nlm.nih.gov/pubmed/27085897,1994002|27085897,,
2016,1523523,119357,IUPHAR/BPS Guide to PHARMACOLOGY,"N-[2-[2-[(dipropylamino)methyl]piperidin-1-yl]ethyl]-6-oxo-5H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide",3264,AFDX384,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3264,15,M3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=15,P20309,Muscarinic acetylcholine receptor M3,1131.0,CHRM3,9606.0,Homo sapiens (human),Antagonist,pKi,7.2,PMID:1994002,https://www.ncbi.nlm.nih.gov/pubmed/1994002,1994002,,
2017,1523524,119357,IUPHAR/BPS Guide to PHARMACOLOGY,"N-[2-[2-[(dipropylamino)methyl]piperidin-1-yl]ethyl]-6-oxo-5H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide",3264,AFDX384,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3264,14,M2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=14,P08172,Muscarinic acetylcholine receptor M2,1129.0,CHRM2,9606.0,Homo sapiens (human),Antagonist,pKi,8.1 - 8.2,PMID:1994002|PMID:27085897,https://www.ncbi.nlm.nih.gov/pubmed/1994002|https://www.ncbi.nlm.nih.gov/pubmed/27085897,1994002|27085897,,
2018,1523525,119357,IUPHAR/BPS Guide to PHARMACOLOGY,"N-[2-[2-[(dipropylamino)methyl]piperidin-1-yl]ethyl]-6-oxo-5H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide",368,[3H]AF DX-384,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=368,14,M2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=14,P08172,Muscarinic acetylcholine receptor M2,1129.0,CHRM2,9606.0,Homo sapiens (human),Antagonist,pKd,9,PMID:1941609|PMID:29515448|PMID:32079174,https://www.ncbi.nlm.nih.gov/pubmed/1941609|https://www.ncbi.nlm.nih.gov/pubmed/29515448|https://www.ncbi.nlm.nih.gov/pubmed/32079174,1941609|29515448|32079174,,
2019,1523526,119406,Comparative Toxicogenomics Database (CTD),2-(4-methoxy-1H-indol-3-yl)acetonitrile,C500823,arvelexin,https://ctdbase.org/detail.go?type=chem&acc=C500823,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116.0,Rattus norvegicus (Norway rat),Arvelexin analog inhibits the reaction [carrageenan results in increased expression of MPO protein],,,PMID:25451575,https://www.ncbi.nlm.nih.gov/pubmed/25451575,25451575,,
2020,1523527,119406,Comparative Toxicogenomics Database (CTD),2-(4-methoxy-1H-indol-3-yl)acetonitrile,C500823,arvelexin,https://ctdbase.org/detail.go?type=chem&acc=C500823,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Arvelexin analog inhibits the reaction [lipopolysaccharides results in increased secretion of IL6 protein]|arvelexin analog inhibits the reaction [lipopolysaccharides results in increased expression of IL6 mrna],,,PMID:25451575,https://www.ncbi.nlm.nih.gov/pubmed/25451575,25451575,,
2021,1523528,119406,Comparative Toxicogenomics Database (CTD),2-(4-methoxy-1H-indol-3-yl)acetonitrile,C500823,arvelexin,https://ctdbase.org/detail.go?type=chem&acc=C500823,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),Arvelexin analog inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 protein]|arvelexin analog inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 mrna],,,PMID:25451575,https://www.ncbi.nlm.nih.gov/pubmed/25451575,25451575,,
2022,1481351,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of IFNG,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2023,1481352,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,51668,IFT25,https://ctdbase.org/detail.go?type=gene&acc=51668,,,51668.0,IFT25,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of IFT25 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2024,1481353,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,3486,IGFBP3,https://ctdbase.org/detail.go?type=gene&acc=3486,,,3486.0,IGFBP3,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of IGFBP3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2025,1481354,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,238447,IGHA,https://ctdbase.org/detail.go?type=gene&acc=238447,,,238447.0,Igha,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of IGHA mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2026,1481355,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,3597,IL13RA1,https://ctdbase.org/detail.go?type=gene&acc=3597,,,3597.0,IL13RA1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of IL13RA1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2027,1481356,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of IL6,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2028,1481357,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,55364,IMPACT,https://ctdbase.org/detail.go?type=gene&acc=55364,,,55364.0,IMPACT,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of IMPACT mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2029,1481358,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,3626,INHBC,https://ctdbase.org/detail.go?type=gene&acc=3626,,,3626.0,INHBC,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of INHBC mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2030,1481359,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,83729,INHBE,https://ctdbase.org/detail.go?type=gene&acc=83729,,,83729.0,INHBE,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of INHBE mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2031,1482500,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,4047,LSS,https://ctdbase.org/detail.go?type=gene&acc=4047,,,4047.0,LSS,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of LSS mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2032,1482908,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,23608,MKRN1,https://ctdbase.org/detail.go?type=gene&acc=23608,,,23608.0,MKRN1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of MKRN1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2033,1482909,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,8028,MLLT10,https://ctdbase.org/detail.go?type=gene&acc=8028,,,8028.0,MLLT10,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of MLLT10 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2034,1482910,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,93380,MMGT1,https://ctdbase.org/detail.go?type=gene&acc=93380,,,93380.0,MMGT1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of MMGT1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2035,1482911,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,158747,MOSPD2,https://ctdbase.org/detail.go?type=gene&acc=158747,,,158747.0,MOSPD2,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of MOSPD2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2036,1484224,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,5202,PFDN2,https://ctdbase.org/detail.go?type=gene&acc=5202,,,5202.0,PFDN2,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of PFDN2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2037,1484225,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,5207,PFKFB1,https://ctdbase.org/detail.go?type=gene&acc=5207,,,5207.0,PFKFB1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of PFKFB1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2038,1484226,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,10424,PGRMC2,https://ctdbase.org/detail.go?type=gene&acc=10424,,,10424.0,PGRMC2,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of PGRMC2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2039,1484227,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,26227,PHGDH,https://ctdbase.org/detail.go?type=gene&acc=26227,,,26227.0,PHGDH,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of PHGDH mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2040,1484228,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,7262,PHLDA2,https://ctdbase.org/detail.go?type=gene&acc=7262,,,7262.0,PHLDA2,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of PHLDA2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2041,1484229,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,23612,PHLDA3,https://ctdbase.org/detail.go?type=gene&acc=23612,,,23612.0,PHLDA3,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of PHLDA3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2042,1484850,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,26472,PPP1R14B,https://ctdbase.org/detail.go?type=gene&acc=26472,,,26472.0,PPP1R14B,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of PPP1R14B mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2043,1484851,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,79660,PPP1R3B,https://ctdbase.org/detail.go?type=gene&acc=79660,,,79660.0,PPP1R3B,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of PPP1R3B mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2044,1484852,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,5519,PPP2R1B,https://ctdbase.org/detail.go?type=gene&acc=5519,,,5519.0,PPP2R1B,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of PPP2R1B mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2045,1484853,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,5529,PPP2R5E,https://ctdbase.org/detail.go?type=gene&acc=5529,,,5529.0,PPP2R5E,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of PPP2R5E mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2046,1484854,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,5547,PRCP,https://ctdbase.org/detail.go?type=gene&acc=5547,,,5547.0,PRCP,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of PRCP mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2047,1484855,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,5625,PRODH,https://ctdbase.org/detail.go?type=gene&acc=5625,,,5625.0,PRODH,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of PRODH mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2048,1484856,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,27339,PRPF19,https://ctdbase.org/detail.go?type=gene&acc=27339,,,27339.0,PRPF19,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of PRPF19 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2049,1484857,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,5631,PRPS1,https://ctdbase.org/detail.go?type=gene&acc=5631,,,5631.0,PRPS1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of PRPS1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2050,1484858,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,11168,PSIP1,https://ctdbase.org/detail.go?type=gene&acc=11168,,,11168.0,PSIP1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of PSIP1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2051,1486667,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,6117,RPA1,https://ctdbase.org/detail.go?type=gene&acc=6117,,,6117.0,RPA1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of RPA1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2052,1486668,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,56475,RPRM,https://ctdbase.org/detail.go?type=gene&acc=56475,,,56475.0,RPRM,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of RPRM mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2053,1486669,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,6241,RRM2,https://ctdbase.org/detail.go?type=gene&acc=6241,,,6241.0,RRM2,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of RRM2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2054,1486670,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,1901,S1PR1,https://ctdbase.org/detail.go?type=gene&acc=1901,,,1901.0,S1PR1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of S1PR1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2055,1486671,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,148398,SAMD11,https://ctdbase.org/detail.go?type=gene&acc=148398,,,148398.0,SAMD11,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of SAMD11 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2056,1487967,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,6712,SPTBN2,https://ctdbase.org/detail.go?type=gene&acc=6712,,,6712.0,SPTBN2,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of SPTBN2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2057,1487968,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,6713,SQLE,https://ctdbase.org/detail.go?type=gene&acc=6713,,,6713.0,SQLE,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of SQLE mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2058,1487969,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,79644,SRD5A3,https://ctdbase.org/detail.go?type=gene&acc=79644,,,79644.0,SRD5A3,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of SRD5A3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2059,1487970,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720.0,SREBF1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of SREBF1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2060,1487971,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,6721,SREBF2,https://ctdbase.org/detail.go?type=gene&acc=6721,,,6721.0,SREBF2,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of SREBF2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2061,1487972,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,6717,SRI,https://ctdbase.org/detail.go?type=gene&acc=6717,,,6717.0,SRI,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of SRI mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2062,1487973,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,6723,SRM,https://ctdbase.org/detail.go?type=gene&acc=6723,,,6723.0,SRM,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of SRM mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2063,1487974,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,6480,ST6GAL1,https://ctdbase.org/detail.go?type=gene&acc=6480,,,6480.0,ST6GAL1,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of ST6GAL1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2064,1487975,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,51046,ST8SIA3,https://ctdbase.org/detail.go?type=gene&acc=51046,,,51046.0,ST8SIA3,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of ST8SIA3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2065,1487976,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,246329,STAC3,https://ctdbase.org/detail.go?type=gene&acc=246329,,,246329.0,STAC3,10116.0,Rattus norvegicus (Norway rat),Valdecoxib results in decreased expression of STAC3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2066,1524828,121846,Comparative Toxicogenomics Database (CTD),Chromanol 293B,C103474,"6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane",https://ctdbase.org/detail.go?type=chem&acc=C103474,3784,KCNQ1,https://ctdbase.org/detail.go?type=gene&acc=3784,,,3784.0,KCNQ1,9606.0,Homo sapiens (human),"6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane results in decreased activity of [KCNQ1 protein binds to KCNE3 protein]",,,PMID:16055675,https://www.ncbi.nlm.nih.gov/pubmed/16055675,16055675,,
2067,1524829,121891,Therapeutic Target Database (TTD),Mitiglinide,D0P2YU,Mitiglinide,https://idrblab.net/ttd/data/drug/details/D0P2YU,T09423,Inward rectifier potassium channel Kir1.2 (KCNJ10),https://idrblab.net/ttd/data/target/details/T09423,P78508,ATP-sensitive inward rectifier potassium channel 10,3766.0,KCNJ10,9606.0,Homo sapiens (human),Blocker,,,,,,,
2068,1524830,121925,Drug Gene Interaction database (DGIdb),Indanidine,,NITROBENZYLMERCAPTOPURINE RIBONUCLEOSIDE,https://www.dgidb.org/drugs/iuphar.ligand:4512,,SLC29A1,https://www.dgidb.org/genes/hgnc:11003,,,2030.0,SLC29A1,9606.0,Homo sapiens (human),,,,,,,,
2069,1490833,122068,Comparative Toxicogenomics Database (CTD),Desethylamodiaquine,C047386,desethylamodiaquine,https://ctdbase.org/detail.go?type=chem&acc=C047386,1553,CYP2A13,https://ctdbase.org/detail.go?type=gene&acc=1553,,,1553.0,CYP2A13,9606.0,Homo sapiens (human),[CYP2A13 protein results in increased metabolism of amodiaquine] which results in increased abundance of desethylamodiaquine,,,PMID:31629065,https://www.ncbi.nlm.nih.gov/pubmed/31629065,31629065,,
2070,1490834,122068,Comparative Toxicogenomics Database (CTD),Desethylamodiaquine,C047386,desethylamodiaquine,https://ctdbase.org/detail.go?type=chem&acc=C047386,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548.0,CYP2A6,9606.0,Homo sapiens (human),[CYP2A6 protein results in increased metabolism of amodiaquine] which results in increased abundance of desethylamodiaquine,,,PMID:31629065,https://www.ncbi.nlm.nih.gov/pubmed/31629065,31629065,,
2071,1490835,122068,Comparative Toxicogenomics Database (CTD),Desethylamodiaquine,C047386,desethylamodiaquine,https://ctdbase.org/detail.go?type=chem&acc=C047386,1555,CYP2B6,https://ctdbase.org/detail.go?type=gene&acc=1555,,,1555.0,CYP2B6,9606.0,Homo sapiens (human),[CYP2B6 protein results in increased metabolism of amodiaquine] which results in increased abundance of desethylamodiaquine,,,PMID:31629065,https://www.ncbi.nlm.nih.gov/pubmed/31629065,31629065,,
2072,1490836,122068,Comparative Toxicogenomics Database (CTD),Desethylamodiaquine,C047386,desethylamodiaquine,https://ctdbase.org/detail.go?type=chem&acc=C047386,1562,CYP2C18,https://ctdbase.org/detail.go?type=gene&acc=1562,,,1562.0,CYP2C18,9606.0,Homo sapiens (human),[CYP2C18 protein results in increased metabolism of amodiaquine] which results in increased abundance of desethylamodiaquine,,,PMID:31629065,https://www.ncbi.nlm.nih.gov/pubmed/31629065,31629065,,
2073,1490837,122068,Comparative Toxicogenomics Database (CTD),Desethylamodiaquine,C047386,desethylamodiaquine,https://ctdbase.org/detail.go?type=chem&acc=C047386,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),[CYP2C19 protein results in increased metabolism of amodiaquine] which results in increased abundance of desethylamodiaquine,,,PMID:31629065,https://www.ncbi.nlm.nih.gov/pubmed/31629065,31629065,,
2074,1490838,122068,Comparative Toxicogenomics Database (CTD),Desethylamodiaquine,C047386,desethylamodiaquine,https://ctdbase.org/detail.go?type=chem&acc=C047386,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),Desethylamodiaquine results in decreased activity of CYP2C19 protein,,,PMID:11124226,https://www.ncbi.nlm.nih.gov/pubmed/11124226,11124226,,
2075,1490839,122068,Comparative Toxicogenomics Database (CTD),Desethylamodiaquine,C047386,desethylamodiaquine,https://ctdbase.org/detail.go?type=chem&acc=C047386,1558,CYP2C8,https://ctdbase.org/detail.go?type=gene&acc=1558,,,1558.0,CYP2C8,9606.0,Homo sapiens (human),CYP2C8 protein results in increased chemical synthesis of desethylamodiaquine,,,PMID:15155557|PMID:28478157,https://www.ncbi.nlm.nih.gov/pubmed/15155557|https://www.ncbi.nlm.nih.gov/pubmed/28478157,15155557|28478157,,
2076,1490840,122068,Comparative Toxicogenomics Database (CTD),Desethylamodiaquine,C047386,desethylamodiaquine,https://ctdbase.org/detail.go?type=chem&acc=C047386,1558,CYP2C8,https://ctdbase.org/detail.go?type=gene&acc=1558,,,1558.0,CYP2C8,9606.0,Homo sapiens (human),[CYP2C8 protein results in increased metabolism of amodiaquine] which results in increased abundance of and results in increased secretion of desethylamodiaquine,,,PMID:31629065,https://www.ncbi.nlm.nih.gov/pubmed/31629065,31629065,,
2077,1491483,122068,Comparative Toxicogenomics Database (CTD),Desethylamodiaquine,C047386,desethylamodiaquine,https://ctdbase.org/detail.go?type=chem&acc=C047386,4835,NQO2,https://ctdbase.org/detail.go?type=gene&acc=4835,,,4835.0,NQO2,9606.0,Homo sapiens (human),NQO2 protein results in increased reduction of and results in decreased glutathionylation of desethylamodiaquine metabolite,,,PMID:29281794,https://www.ncbi.nlm.nih.gov/pubmed/29281794,29281794,,
2078,1491484,122077,Drug Gene Interaction database (DGIdb),Lintitript,,LINTITRIPT,https://www.dgidb.org/drugs/ncit:C66017,,VDR,https://www.dgidb.org/genes/hgnc:12679,,,7421.0,VDR,9606.0,Homo sapiens (human),,,,,,,,
2079,1491485,122077,Drug Gene Interaction database (DGIdb),Lintitript,,LINTITRIPT,https://www.dgidb.org/drugs/ncit:C66017,,USP1,https://www.dgidb.org/genes/hgnc:12607,,,7398.0,USP1,9606.0,Homo sapiens (human),,,,,,,,
2080,1434510,122162,IUPHAR/BPS Guide to PHARMACOLOGY,Luzindole,1363,luzindole,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1363,287,MT1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=287,P48039,Melatonin receptor type 1A,4543.0,MTNR1A,9606.0,Homo sapiens (human),Antagonist,pKi,6.2 - 6.8,PMID:10696085|PMID:12764576|PMID:9089668|PMID:2843633,https://www.ncbi.nlm.nih.gov/pubmed/10696085|https://www.ncbi.nlm.nih.gov/pubmed/12764576|https://www.ncbi.nlm.nih.gov/pubmed/9089668|https://www.ncbi.nlm.nih.gov/pubmed/2843633,10696085|12764576|9089668|2843633,,
2081,1434511,122162,IUPHAR/BPS Guide to PHARMACOLOGY,Luzindole,1363,luzindole,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1363,288,MT2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=288,P49286,Melatonin receptor type 1B,4544.0,MTNR1B,9606.0,Homo sapiens (human),Antagonist,pKi,7.6 - 8.1,PMID:10696085|PMID:12764576|PMID:9089668|PMID:9737724|PMID:2843633,https://www.ncbi.nlm.nih.gov/pubmed/10696085|https://www.ncbi.nlm.nih.gov/pubmed/12764576|https://www.ncbi.nlm.nih.gov/pubmed/9089668|https://www.ncbi.nlm.nih.gov/pubmed/9737724|https://www.ncbi.nlm.nih.gov/pubmed/2843633,10696085|12764576|9089668|9737724|2843633,,
2082,1434512,122433,BindingDB,"1H-Imidazole-4-methanol, 5-methyl-",7956,(4-methyl-1H-imidazol-5-yl)methanol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7956,986,Glutaminyl-peptide cyclotransferase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=986,Q16769,Glutaminyl-peptide cyclotransferase,25797.0,QPCT,9606.0,Homo sapiens (human),,Ki (nM),129000,PMID:14522962|DOI:10.1074/jbc.M309077200,https://www.ncbi.nlm.nih.gov/pubmed/14522962|https://doi.org/10.1074/jbc.M309077200,14522962,10.1074/jbc.M309077200,
2083,1434513,122623,DrugBank,Z-Pro-prolinal,DB03535,Z-Pro-Prolinal,https://www.drugbank.ca/drugs/DB03535,BE0002148,Prolyl endopeptidase,https://www.drugbank.ca/bio_entities/BE0002148,P48147,Prolyl endopeptidase,5550.0,PREP,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
2084,1434514,122651,Drug Gene Interaction database (DGIdb),Didemnin B,,DIDEMNIN B,https://www.dgidb.org/drugs/ncit:C1364,,IL2,https://www.dgidb.org/genes/hgnc:6001,,,3558.0,IL2,9606.0,Homo sapiens (human),,,,,,,,
2085,1434515,122724,IUPHAR/BPS Guide to PHARMACOLOGY,Celastrol,10386,celastrol,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10386,2801,regulator of G-protein signaling 17,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2801,Q9UGC6,Regulator of G-protein signaling 17,26575.0,RGS17,9606.0,Homo sapiens (human),Inhibition,pIC50,4.98,PMID:28621943,https://www.ncbi.nlm.nih.gov/pubmed/28621943,28621943,,
2086,1525521,122738,Comparative Toxicogenomics Database (CTD),"Procyanidin B2, (+)-",C479580,procyanidin B2,https://ctdbase.org/detail.go?type=chem&acc=C479580,29108,PYCARD,https://ctdbase.org/detail.go?type=gene&acc=29108,,,29108.0,PYCARD,10116.0,Rattus norvegicus (Norway rat),Procyanidin B2 inhibits the reaction [paraquat results in increased expression of PYCARD protein],,,PMID:30025709,https://www.ncbi.nlm.nih.gov/pubmed/30025709,30025709,,
2087,1525522,122738,Comparative Toxicogenomics Database (CTD),"Procyanidin B2, (+)-",C479580,procyanidin B2,https://ctdbase.org/detail.go?type=chem&acc=C479580,5268,SERPINB5,https://ctdbase.org/detail.go?type=gene&acc=5268,,,5268.0,SERPINB5,9606.0,Homo sapiens (human),Procyanidin B2 results in increased expression of SERPINB5 mRNA,,,PMID:25839702,https://www.ncbi.nlm.nih.gov/pubmed/25839702,25839702,,
2088,1525523,122738,Comparative Toxicogenomics Database (CTD),"Procyanidin B2, (+)-",C479580,procyanidin B2,https://ctdbase.org/detail.go?type=chem&acc=C479580,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Procyanidin B2 inhibits the reaction [carrageenan results in increased expression of TNF protein],,,PMID:28844677,https://www.ncbi.nlm.nih.gov/pubmed/28844677,28844677,,
2089,1525524,122738,Comparative Toxicogenomics Database (CTD),"Procyanidin B2, (+)-",C479580,procyanidin B2,https://ctdbase.org/detail.go?type=chem&acc=C479580,7153,TOP2A,https://ctdbase.org/detail.go?type=gene&acc=7153,,,7153.0,TOP2A,9606.0,Homo sapiens (human),Procyanidin B2 results in decreased activity of TOP2A protein,,,PMID:16536579,https://www.ncbi.nlm.nih.gov/pubmed/16536579,16536579,,
2090,1525525,122738,Comparative Toxicogenomics Database (CTD),"Procyanidin B2, (+)-",C479580,procyanidin B2,https://ctdbase.org/detail.go?type=chem&acc=C479580,54575,UGT1A10,https://ctdbase.org/detail.go?type=gene&acc=54575,,,54575.0,UGT1A10,9606.0,Homo sapiens (human),Procyanidin B2 results in decreased activity of UGT1A10 protein,,,PMID:35868516,https://www.ncbi.nlm.nih.gov/pubmed/35868516,35868516,,
2091,1525526,122738,Comparative Toxicogenomics Database (CTD),"Procyanidin B2, (+)-",C479580,procyanidin B2,https://ctdbase.org/detail.go?type=chem&acc=C479580,54578,UGT1A6,https://ctdbase.org/detail.go?type=gene&acc=54578,,,54578.0,UGT1A6,9606.0,Homo sapiens (human),Procyanidin B2 results in decreased activity of UGT1A6 protein,,,PMID:35868516,https://www.ncbi.nlm.nih.gov/pubmed/35868516,35868516,,
2092,1525527,122738,Comparative Toxicogenomics Database (CTD),"Procyanidin B2, (+)-",C479580,procyanidin B2,https://ctdbase.org/detail.go?type=chem&acc=C479580,54577,UGT1A7,https://ctdbase.org/detail.go?type=gene&acc=54577,,,54577.0,UGT1A7,9606.0,Homo sapiens (human),Procyanidin B2 results in decreased activity of UGT1A7 protein,,,PMID:35868516,https://www.ncbi.nlm.nih.gov/pubmed/35868516,35868516,,
2093,1430817,123072,BindingDB,"4,4'-Difluorobenzil",22730,"1,2-bis(4-fluorophenyl)ethane-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22730,8446,Coagulation factor XII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8446,P00748,Coagulation factor XII,2161.0,F12,9606.0,Homo sapiens (human),,Ki (nM),167,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
2094,1491941,123465,BindingDB,2-Ethoxybenzylamine,50446751,CHEMBL3114403,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50446751,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),140,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
2095,1491942,123465,BindingDB,2-Ethoxybenzylamine,50446751,CHEMBL3114403,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50446751,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),110,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
2096,1430818,123493,BindingDB,"Ethanedione, bis(3-methoxyphenyl)-",22744,"1,2-bis(3-methoxyphenyl)ethane-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22744,8446,Coagulation factor XII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8446,P00748,Coagulation factor XII,2161.0,F12,9606.0,Homo sapiens (human),,Ki (nM),139,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
2097,1430819,123493,BindingDB,"Ethanedione, bis(3-methoxyphenyl)-",22744,"1,2-bis(3-methoxyphenyl)ethane-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22744,7016,Liver carboxylesterase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7016,P23141,Liver carboxylesterase 1,1066.0,CES1,9606.0,Homo sapiens (human),,Ki (nM),1540,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
2098,1430820,123493,BindingDB,"Ethanedione, bis(3-methoxyphenyl)-",22744,"1,2-bis(3-methoxyphenyl)ethane-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22744,2315,Liver carboxylesterase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2315,P12337,Liver carboxylesterase 1,100009551.0,CES1,9986.0,Oryctolagus cuniculus (rabbit),,Ki (nM),72.1,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
2099,1430821,123493,BindingDB,"Ethanedione, bis(3-methoxyphenyl)-",22744,"1,2-bis(3-methoxyphenyl)ethane-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22744,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
2100,1430822,123493,BindingDB,"Ethanedione, bis(3-methoxyphenyl)-",22744,"1,2-bis(3-methoxyphenyl)ethane-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22744,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
2101,1491943,123538,BindingDB,3-Bromo-2-methylaniline,626200,EN300-66138,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626200,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),2130,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
2102,1435995,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of SPP1 mRNA,,,PMID:20471445,https://www.ncbi.nlm.nih.gov/pubmed/20471445,20471445,,
2103,1436497,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,23118,TAB2,https://ctdbase.org/detail.go?type=gene&acc=23118,,,23118.0,TAB2,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of TAB2 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2104,1436498,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,6869,TACR1,https://ctdbase.org/detail.go?type=gene&acc=6869,,,6869.0,TACR1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TACR1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2105,1436499,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,6883,TAF12,https://ctdbase.org/detail.go?type=gene&acc=6883,,,6883.0,TAF12,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TAF12 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2106,1436500,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,6875,TAF4B,https://ctdbase.org/detail.go?type=gene&acc=6875,,,6875.0,TAF4B,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TAF4B mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2107,1436501,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,10629,TAF6L,https://ctdbase.org/detail.go?type=gene&acc=10629,,,10629.0,TAF6L,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of TAF6L mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2108,1436502,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,6886,TAL1,https://ctdbase.org/detail.go?type=gene&acc=6886,,,6886.0,TAL1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of TAL1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2109,1437765,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,29978,UBQLN2,https://ctdbase.org/detail.go?type=gene&acc=29978,,,29978.0,UBQLN2,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of UBQLN2 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2110,1437766,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,56893,UBQLN4,https://ctdbase.org/detail.go?type=gene&acc=56893,,,56893.0,UBQLN4,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of UBQLN4 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2111,1438239,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,90113,VWA5B2,https://ctdbase.org/detail.go?type=gene&acc=90113,,,90113.0,VWA5B2,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of VWA5B2 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2112,1438240,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,23325,WASHC4,https://ctdbase.org/detail.go?type=gene&acc=23325,,,23325.0,WASHC4,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of WASHC4 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2113,1438241,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,57728,WDR19,https://ctdbase.org/detail.go?type=gene&acc=57728,,,57728.0,WDR19,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of WDR19 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2114,1438242,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,11180,WDR6,https://ctdbase.org/detail.go?type=gene&acc=11180,,,11180.0,WDR6,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of WDR6 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2115,1438243,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,349136,WDR86,https://ctdbase.org/detail.go?type=gene&acc=349136,,,349136.0,WDR86,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of WDR86 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2116,1438244,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,25861,WHRN,https://ctdbase.org/detail.go?type=gene&acc=25861,,,25861.0,WHRN,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of WHRN mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2117,1438245,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,65266,WNK4,https://ctdbase.org/detail.go?type=gene&acc=65266,,,65266.0,WNK4,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of WNK4 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2118,1438246,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,7473,WNT3,https://ctdbase.org/detail.go?type=gene&acc=7473,,,7473.0,WNT3,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of WNT3 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2119,1438963,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,D037741,Fullerenes,https://ctdbase.org/detail.go?type=chem&acc=D037741,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,9606.0,Homo sapiens (human),Fullerenes analog results in increased expression of IL10 mRNA,,,PMID:22342292,https://www.ncbi.nlm.nih.gov/pubmed/22342292,22342292,,
2120,1438964,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,D037741,Fullerenes,https://ctdbase.org/detail.go?type=chem&acc=D037741,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9606.0,Homo sapiens (human),Fullerenes analog results in increased expression of IL1A mRNA,,,PMID:22342292,https://www.ncbi.nlm.nih.gov/pubmed/22342292,22342292,,
2121,1438965,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,D037741,Fullerenes,https://ctdbase.org/detail.go?type=chem&acc=D037741,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Fullerenes analog affects the expression of IL1B mRNA,,,PMID:22342292,https://www.ncbi.nlm.nih.gov/pubmed/22342292,22342292,,
2122,1438966,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,D037741,Fullerenes,https://ctdbase.org/detail.go?type=chem&acc=D037741,3554,IL1R1,https://ctdbase.org/detail.go?type=gene&acc=3554,,,3554.0,IL1R1,9606.0,Homo sapiens (human),Fullerenes analog results in increased expression of IL1R1 mRNA,,,PMID:22342292,https://www.ncbi.nlm.nih.gov/pubmed/22342292,22342292,,
2123,1438967,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,D037741,Fullerenes,https://ctdbase.org/detail.go?type=chem&acc=D037741,3556,IL1RAP,https://ctdbase.org/detail.go?type=gene&acc=3556,,,3556.0,IL1RAP,9606.0,Homo sapiens (human),Fullerenes analog results in increased expression of IL1RAP mRNA,,,PMID:22342292,https://www.ncbi.nlm.nih.gov/pubmed/22342292,22342292,,
2124,1438968,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,D037741,Fullerenes,https://ctdbase.org/detail.go?type=chem&acc=D037741,8808,IL1RL2,https://ctdbase.org/detail.go?type=gene&acc=8808,,,8808.0,IL1RL2,9606.0,Homo sapiens (human),Fullerenes analog affects the expression of IL1RL2 mRNA,,,PMID:22342292,https://www.ncbi.nlm.nih.gov/pubmed/22342292,22342292,,
2125,1526726,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,177,AGER,https://ctdbase.org/detail.go?type=gene&acc=177,,,177.0,AGER,10090.0,Mus musculus (house mouse),[[fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein] which results in increased expression of RAC1 protein|[fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein,,,PMID:31504961,https://www.ncbi.nlm.nih.gov/pubmed/31504961,31504961,,
2126,1526727,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,25909,AHCTF1,https://ctdbase.org/detail.go?type=gene&acc=25909,,,25909.0,AHCTF1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of AHCTF1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2127,1526728,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,10768,AHCYL1,https://ctdbase.org/detail.go?type=gene&acc=10768,,,10768.0,AHCYL1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of AHCYL1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2128,1526729,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of AHR mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2129,1526730,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,84883,AIFM2,https://ctdbase.org/detail.go?type=gene&acc=84883,,,84883.0,AIFM2,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of AIFM2 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2130,1526731,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,10566,AKAP3,https://ctdbase.org/detail.go?type=gene&acc=10566,,,10566.0,AKAP3,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of AKAP3 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2131,1526732,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,80709,AKNA,https://ctdbase.org/detail.go?type=gene&acc=80709,,,80709.0,AKNA,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of AKNA mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2132,1526733,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,254268,AKNAD1,https://ctdbase.org/detail.go?type=gene&acc=254268,,,254268.0,AKNAD1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of AKNAD1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2133,1526734,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,298931,AKR1B1-PS1,https://ctdbase.org/detail.go?type=gene&acc=298931,,,298931.0,Akr1b1-ps1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of AKR1B1-PS1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2134,1527100,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,57463,AMIGO1,https://ctdbase.org/detail.go?type=gene&acc=57463,,,57463.0,AMIGO1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of AMIGO1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2135,1527101,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,81693,AMN,https://ctdbase.org/detail.go?type=gene&acc=81693,,,81693.0,AMN,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of AMN mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2136,1527102,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,271,AMPD2,https://ctdbase.org/detail.go?type=gene&acc=271,,,271.0,AMPD2,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of AMPD2 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2137,1527103,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,51129,ANGPTL4,https://ctdbase.org/detail.go?type=gene&acc=51129,,,51129.0,ANGPTL4,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of ANGPTL4 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2138,1527104,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,88455,ANKRD13A,https://ctdbase.org/detail.go?type=gene&acc=88455,,,88455.0,ANKRD13A,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of ANKRD13A mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2139,1527105,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,651746,ANKRD33B,https://ctdbase.org/detail.go?type=gene&acc=651746,,,651746.0,ANKRD33B,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of ANKRD33B mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2140,1527106,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,23294,ANKS1A,https://ctdbase.org/detail.go?type=gene&acc=23294,,,23294.0,ANKS1A,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of ANKS1A mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2141,1527107,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,290,ANPEP,https://ctdbase.org/detail.go?type=gene&acc=290,,,290.0,ANPEP,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of ANPEP mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2142,1527108,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,309,ANXA6,https://ctdbase.org/detail.go?type=gene&acc=309,,,309.0,ANXA6,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of ANXA6 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2143,1527109,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,162,AP1B1,https://ctdbase.org/detail.go?type=gene&acc=162,,,162.0,AP1B1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of AP1B1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2144,1528284,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,582,BBS1,https://ctdbase.org/detail.go?type=gene&acc=582,,,582.0,BBS1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of BBS1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2145,1528655,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,79184,BRCC3,https://ctdbase.org/detail.go?type=gene&acc=79184,,,79184.0,BRCC3,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of BRCC3 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2146,1528656,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,8927,BSN,https://ctdbase.org/detail.go?type=gene&acc=8927,,,8927.0,BSN,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of BSN mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2147,1528657,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,84280,BTBD10,https://ctdbase.org/detail.go?type=gene&acc=84280,,,84280.0,BTBD10,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of BTBD10 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
2148,1491944,123596,ChEMBL,Imatinib Mesylate,CHEMBL1642,IMATINIB MESYLATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1642/,CHEMBL1862,Tyrosine-protein kinase ABL,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1862/,P00519,Tyrosine-protein kinase ABL1,25.0,ABL1,9606.0,Homo sapiens (human),Tyrosine-protein kinase ABL inhibitor,,,,,,,
2149,1430823,123606,Drug Gene Interaction database (DGIdb),Almotriptan,,ALMOTRIPTAN,https://www.dgidb.org/drugs/rxcui:279645,,HTR1B,https://www.dgidb.org/genes/hgnc:5287,,,3351.0,HTR1B,9606.0,Homo sapiens (human),,,,,,,,
2150,1436809,123630,DrugBank,Tazobactam,DB01606,Tazobactam,https://www.drugbank.ca/drugs/DB01606,BE0009681,Beta-lactamase Ohio-1,https://www.drugbank.ca/bio_entities/BE0009681,P18251,Beta-lactamase Ohio-1,,,550.0,Enterobacter cloacae,Inhibitor,,,PMID:9066111,https://www.ncbi.nlm.nih.gov/pubmed/9066111,9066111,,
2151,1436810,123630,DrugBank,Tazobactam,DB01606,Tazobactam,https://www.drugbank.ca/drugs/DB01606,BE0002015,Beta-lactamase SHV-1,https://www.drugbank.ca/bio_entities/BE0002015,P0AD63,Beta-lactamase SHV-1,,,562.0,Escherichia coli,Inhibitor,,,PMID:14757767|PMID:9066111,https://www.ncbi.nlm.nih.gov/pubmed/14757767|https://www.ncbi.nlm.nih.gov/pubmed/9066111,14757767|9066111,,
2152,1436811,123630,DrugBank,Tazobactam,DB01606,Tazobactam,https://www.drugbank.ca/drugs/DB01606,BE0001066,Solute carrier family 22 member 6,https://www.drugbank.ca/bio_entities/BE0001066,Q4U2R8,Solute carrier family 22 member 6,9356.0,SLC22A6,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:29277663,https://www.ncbi.nlm.nih.gov/pubmed/29277663,29277663,,
2153,1436812,123630,DrugBank,Tazobactam,DB01606,Tazobactam,https://www.drugbank.ca/drugs/DB01606,BE0003645,Solute carrier family 22 member 8,https://www.drugbank.ca/bio_entities/BE0003645,Q8TCC7,Solute carrier family 22 member 8,9376.0,SLC22A8,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:29277663,https://www.ncbi.nlm.nih.gov/pubmed/29277663,29277663,,
2154,1430824,123631,Drug Gene Interaction database (DGIdb),Gefitinib,,GEFITINIB,https://www.dgidb.org/drugs/rxcui:328134,,ERBB2,https://www.dgidb.org/genes/hgnc:3430,,,2064.0,ERBB2,9606.0,Homo sapiens (human),,,,,,,,
2155,1436813,123631,Drug Gene Interaction database (DGIdb),Gefitinib,,GEFITINIB,https://www.dgidb.org/drugs/rxcui:328134,,EGFR,https://www.dgidb.org/genes/hgnc:3236,,,1956.0,EGFR,9606.0,Homo sapiens (human),,,,,,,,
2156,1436814,123631,Drug Gene Interaction database (DGIdb),Gefitinib,,GEFITINIB,https://www.dgidb.org/drugs/rxcui:328134,,EGFR,https://www.dgidb.org/genes/hgnc:3236,,,1956.0,EGFR,9606.0,Homo sapiens (human),,,,,,,,
2157,1436815,123631,Drug Gene Interaction database (DGIdb),Gefitinib,,GEFITINIB,https://www.dgidb.org/drugs/rxcui:328134,,EGFR,https://www.dgidb.org/genes/hgnc:3236,,,1956.0,EGFR,9606.0,Homo sapiens (human),,,,,,,,
2158,1492390,123683,Comparative Toxicogenomics Database (CTD),IB-Meca,C084956,N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,https://ctdbase.org/detail.go?type=chem&acc=C084956,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in decreased expression of BCL2 protein,,,PMID:16025880,https://www.ncbi.nlm.nih.gov/pubmed/16025880,16025880,,
2159,1492391,123683,Comparative Toxicogenomics Database (CTD),IB-Meca,C084956,N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,https://ctdbase.org/detail.go?type=chem&acc=C084956,330,BIRC3,https://ctdbase.org/detail.go?type=gene&acc=330,,,330.0,BIRC3,9606.0,Homo sapiens (human),BIRC3 protein results in decreased susceptibility to N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine|n(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in decreased expression of BIRC3 mRNA,,,PMID:16088125,https://www.ncbi.nlm.nih.gov/pubmed/16088125,16088125,,
2160,1492392,123683,Comparative Toxicogenomics Database (CTD),IB-Meca,C084956,N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,https://ctdbase.org/detail.go?type=chem&acc=C084956,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606.0,Homo sapiens (human),BIRC5 protein results in decreased susceptibility to N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,,,PMID:16088125,https://www.ncbi.nlm.nih.gov/pubmed/16088125,16088125,,
2161,1492393,123683,Comparative Toxicogenomics Database (CTD),IB-Meca,C084956,N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,https://ctdbase.org/detail.go?type=chem&acc=C084956,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in increased expression of CASP3 protein,,,PMID:16025880,https://www.ncbi.nlm.nih.gov/pubmed/16025880,16025880,,
2162,1492394,123683,Comparative Toxicogenomics Database (CTD),IB-Meca,C084956,N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,https://ctdbase.org/detail.go?type=chem&acc=C084956,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10116.0,Rattus norvegicus (Norway rat),N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [phenylephrine results in increased expression of FOS mrna],,,PMID:15452191,https://www.ncbi.nlm.nih.gov/pubmed/15452191,15452191,,
2163,1492395,123683,Comparative Toxicogenomics Database (CTD),IB-Meca,C084956,N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,https://ctdbase.org/detail.go?type=chem&acc=C084956,3592,IL12A,https://ctdbase.org/detail.go?type=gene&acc=3592,,,3592.0,IL12A,9606.0,Homo sapiens (human),N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in decreased expression of [IL12A protein binds to IL12B protein]|wortmannin inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in decreased expression of [IL12A protein binds to IL12B protein]]|pertussis toxin inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in decreased expression of [IL12A protein binds to IL12B protein]],,,PMID:16116186,https://www.ncbi.nlm.nih.gov/pubmed/16116186,16116186,,
2164,1492396,123683,Comparative Toxicogenomics Database (CTD),IB-Meca,C084956,N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,https://ctdbase.org/detail.go?type=chem&acc=C084956,3593,IL12B,https://ctdbase.org/detail.go?type=gene&acc=3593,,,3593.0,IL12B,9606.0,Homo sapiens (human),N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in decreased expression of [IL12A protein binds to IL12B protein]|wortmannin inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in decreased expression of [IL12A protein binds to IL12B protein]]|pertussis toxin inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in decreased expression of [IL12A protein binds to IL12B protein]],,,PMID:16116186,https://www.ncbi.nlm.nih.gov/pubmed/16116186,16116186,,
2165,1492397,123683,Comparative Toxicogenomics Database (CTD),IB-Meca,C084956,N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,https://ctdbase.org/detail.go?type=chem&acc=C084956,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in increased phosphorylation of MAPK1 protein|u 0126 inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in increased phosphorylation of MAPK1 protein],,,PMID:16025880,https://www.ncbi.nlm.nih.gov/pubmed/16025880,16025880,,
2166,1439907,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),Angiotensin I (1-7) inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein],,,PMID:16672906,https://www.ncbi.nlm.nih.gov/pubmed/16672906,16672906,,
2167,1439908,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10116.0,Rattus norvegicus (Norway rat),Angiotensin I (1-7) inhibits the reaction [AGT protein results in increased phosphorylation of MAPK8 protein],,,PMID:16672906,https://www.ncbi.nlm.nih.gov/pubmed/16672906,16672906,,
2168,1439909,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,4142,MAS1,https://ctdbase.org/detail.go?type=gene&acc=4142,,,4142.0,MAS1,10090.0,Mus musculus (house mouse),"Angiotensin I (1-7) inhibits the reaction [AGT protein results in decreased expression of MAS1 protein]|2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [angiotensin I (1-7) inhibits the reaction [AGT protein results in decreased expression of MAS1 protein]]|7-ala-angiotensin (1-7) inhibits the reaction [angiotensin I (1-7) inhibits the reaction [AGT protein results in decreased expression of MAS1 protein]]",,,PMID:33007385,https://www.ncbi.nlm.nih.gov/pubmed/33007385,33007385,,
2169,1439910,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10116.0,Rattus norvegicus (Norway rat),Angiotensin I (1-7) inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]|angiotensin I (1-7) inhibits the reaction [AGT protein results in increased expression of TGFB1 protein]|angiotensin I (1-7) inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]|angiotensin I (1-7) inhibits the reaction [AGT protein results in increased phosphorylation of MAPK8 protein],,,PMID:16672906,https://www.ncbi.nlm.nih.gov/pubmed/16672906,16672906,,
2170,1439911,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,4142,MAS1,https://ctdbase.org/detail.go?type=gene&acc=4142,,,4142.0,MAS1,10090.0,Mus musculus (house mouse),7-ala-angiotensin (1-7) inhibits the reaction [angiotensin I (1-7) promotes the reaction [rotenone results in increased expression of MAS1 mrna]]|angiotensin I (1-7) promotes the reaction [rotenone results in increased expression of MAS1 protein]|7-ala-angiotensin (1-7) inhibits the reaction [angiotensin I (1-7) promotes the reaction [rotenone results in increased expression of MAS1 protein]]|angiotensin I (1-7) promotes the reaction [rotenone results in increased expression of MAS1 mrna],,,PMID:29665408,https://www.ncbi.nlm.nih.gov/pubmed/29665408,29665408,,
2171,1440435,123865,Comparative Toxicogenomics Database (CTD),Geneticin,C010680,antibiotic G 418,https://ctdbase.org/detail.go?type=chem&acc=C010680,3758,KCNJ1,https://ctdbase.org/detail.go?type=gene&acc=3758,,,3758.0,KCNJ1,9606.0,Homo sapiens (human),Antibiotic G 418 results in increased expression of KCNJ1 protein mutant form,,,PMID:12911542,https://www.ncbi.nlm.nih.gov/pubmed/12911542,12911542,,
2172,1440436,123865,Comparative Toxicogenomics Database (CTD),Geneticin,C010680,antibiotic G 418,https://ctdbase.org/detail.go?type=chem&acc=C010680,4594,MMUT,https://ctdbase.org/detail.go?type=gene&acc=4594,,,4594.0,MMUT,9606.0,Homo sapiens (human),Antibiotic G 418 affects the expression of MMUT mRNA mutant form|[antibiotic G 418 co-treated with gentamicins] affects the activity of MMUT protein mutant form|antibiotic G 418 promotes the reaction [gentamicins affects the expression of MMUT protein mutant form]|[antibiotic G 418 co-treated with gentamicins] affects the expression of MMUT mRNA mutant form,,,PMID:19427250,https://www.ncbi.nlm.nih.gov/pubmed/19427250,19427250,,
2173,1440437,123865,Comparative Toxicogenomics Database (CTD),Geneticin,C010680,antibiotic G 418,https://ctdbase.org/detail.go?type=chem&acc=C010680,8671,SLC4A4,https://ctdbase.org/detail.go?type=gene&acc=8671,,,8671.0,SLC4A4,9606.0,Homo sapiens (human),Antibiotic G 418 results in increased expression of SLC4A4 protein mutant form,,,PMID:18614622,https://www.ncbi.nlm.nih.gov/pubmed/18614622,18614622,,
2174,1440438,123865,Comparative Toxicogenomics Database (CTD),Geneticin,C010680,antibiotic G 418,https://ctdbase.org/detail.go?type=chem&acc=C010680,6607,SMN2,https://ctdbase.org/detail.go?type=gene&acc=6607,,,6607.0,SMN2,9606.0,Homo sapiens (human),Antibiotic G 418 results in increased expression of SMN2 protein,,,PMID:19150990,https://www.ncbi.nlm.nih.gov/pubmed/19150990,19150990,,
2175,1440439,123865,Comparative Toxicogenomics Database (CTD),Geneticin,C010680,antibiotic G 418,https://ctdbase.org/detail.go?type=chem&acc=C010680,5976,UPF1,https://ctdbase.org/detail.go?type=gene&acc=5976,,,5976.0,UPF1,9606.0,Homo sapiens (human),Antibiotic G 418 affects the localization of UPF1 protein,,,PMID:28743738,https://www.ncbi.nlm.nih.gov/pubmed/28743738,28743738,,
2176,1431122,123870,Therapeutic Target Database (TTD),para-Iodoamphetamine,D0L8SN,P-IODOAMPHETAMINE,https://idrblab.net/ttd/data/drug/details/D0L8SN,T92072,Adenosine A1 receptor (ADORA1),https://idrblab.net/ttd/data/target/details/T92072,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2177,1431123,123893,Comparative Toxicogenomics Database (CTD),"Azacyclotridec-1-en-2-amine, N-(2-phenylcyclopentyl)-, cis-",C014925,RMI 12330A,https://ctdbase.org/detail.go?type=chem&acc=C014925,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10116.0,Rattus norvegicus (Norway rat),RMI 12330A inhibits the reaction [taurolithocholic acid results in decreased activity of and affects the localization of ABCC2 protein],,,PMID:31300867,https://www.ncbi.nlm.nih.gov/pubmed/31300867,31300867,,
2178,1440440,123895,DrugBank,N-omega-Hydroxy-L-arginine,DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,https://www.drugbank.ca/drugs/DB03144,BE0000263,"Nitric oxide synthase, endothelial",https://www.drugbank.ca/bio_entities/BE0000263,P29474,"Nitric oxide synthase, endothelial",4846.0,NOS3,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
2179,1440441,123895,DrugBank,N-omega-Hydroxy-L-arginine,DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,https://www.drugbank.ca/drugs/DB03144,BE0001433,Nitric oxide synthase oxygenase,https://www.drugbank.ca/bio_entities/BE0001433,O34453,Nitric oxide synthase oxygenase,938802.0,nosA,224308.0,Bacillus subtilis subsp. subtilis str. 168,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
2180,1526453,124072,Comparative Toxicogenomics Database (CTD),Tetrahydrocurcumin,C096277,tetrahydrocurcumin,https://ctdbase.org/detail.go?type=chem&acc=C096277,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Tetrahydrocurcumin inhibits the reaction [acetaminophen results in decreased expression of CAT protein],,,PMID:30423402,https://www.ncbi.nlm.nih.gov/pubmed/30423402,30423402,,
2181,1526454,124072,Comparative Toxicogenomics Database (CTD),Tetrahydrocurcumin,C096277,tetrahydrocurcumin,https://ctdbase.org/detail.go?type=chem&acc=C096277,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Tetrahydrocurcumin inhibits the reaction [chloroquine results in decreased activity of CAT protein],,,PMID:17076682,https://www.ncbi.nlm.nih.gov/pubmed/17076682,17076682,,
2182,1526455,124072,Comparative Toxicogenomics Database (CTD),Tetrahydrocurcumin,C096277,tetrahydrocurcumin,https://ctdbase.org/detail.go?type=chem&acc=C096277,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Tetrahydrocurcumin inhibits the reaction [sodium arsenite results in decreased activity of CAT protein],,,PMID:25869292,https://www.ncbi.nlm.nih.gov/pubmed/25869292,25869292,,
2183,1526456,124072,Comparative Toxicogenomics Database (CTD),Tetrahydrocurcumin,C096277,tetrahydrocurcumin,https://ctdbase.org/detail.go?type=chem&acc=C096277,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Tetrahydrocurcumin inhibits the reaction [vincristine results in decreased expression of CAT protein],,,PMID:26102012,https://www.ncbi.nlm.nih.gov/pubmed/26102012,26102012,,
2184,1526457,124072,Comparative Toxicogenomics Database (CTD),Tetrahydrocurcumin,C096277,tetrahydrocurcumin,https://ctdbase.org/detail.go?type=chem&acc=C096277,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,10090.0,Mus musculus (house mouse),Tetrahydrocurcumin inhibits the reaction [[dietary fats co-treated with fructose] results in increased expression of CYP1A2 mrna],,,PMID:26102010,https://www.ncbi.nlm.nih.gov/pubmed/26102010,26102010,,
2185,1526458,124072,Comparative Toxicogenomics Database (CTD),Tetrahydrocurcumin,C096277,tetrahydrocurcumin,https://ctdbase.org/detail.go?type=chem&acc=C096277,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,10090.0,Mus musculus (house mouse),Tetrahydrocurcumin inhibits the reaction [[dietary fats co-treated with fructose] results in increased expression of CYP1B1 mrna]|tetrahydrocurcumin inhibits the reaction [[dietary fats co-treated with fructose] results in increased expression of CYP1B1 protein],,,PMID:26102010,https://www.ncbi.nlm.nih.gov/pubmed/26102010,26102010,,
2186,1526459,124072,Comparative Toxicogenomics Database (CTD),Tetrahydrocurcumin,C096277,tetrahydrocurcumin,https://ctdbase.org/detail.go?type=chem&acc=C096277,13088,CYP2B10,https://ctdbase.org/detail.go?type=gene&acc=13088,,,13088.0,Cyp2b10,10090.0,Mus musculus (house mouse),Tetrahydrocurcumin results in decreased expression of CYP2B10 mRNA,,,PMID:26102010,https://www.ncbi.nlm.nih.gov/pubmed/26102010,26102010,,
2187,1526460,124072,Comparative Toxicogenomics Database (CTD),Tetrahydrocurcumin,C096277,tetrahydrocurcumin,https://ctdbase.org/detail.go?type=chem&acc=C096277,13094,CYP2B9,https://ctdbase.org/detail.go?type=gene&acc=13094,,,13094.0,Cyp2b9,10090.0,Mus musculus (house mouse),Tetrahydrocurcumin results in decreased expression of CYP2B9 mRNA,,,PMID:26102010,https://www.ncbi.nlm.nih.gov/pubmed/26102010,26102010,,
2188,1493594,124087,Comparative Toxicogenomics Database (CTD),Desloratadine,C121345,desloratadine,https://ctdbase.org/detail.go?type=chem&acc=C121345,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606.0,Homo sapiens (human),Desloratadine results in decreased expression of CCNB1 protein,,,PMID:36617552,https://www.ncbi.nlm.nih.gov/pubmed/36617552,36617552,,
2189,1493595,124087,Comparative Toxicogenomics Database (CTD),Desloratadine,C121345,desloratadine,https://ctdbase.org/detail.go?type=chem&acc=C121345,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Desloratadine results in increased phosphorylation of CDK1 protein,,,PMID:36617552,https://www.ncbi.nlm.nih.gov/pubmed/36617552,36617552,,
2190,1493596,124087,Comparative Toxicogenomics Database (CTD),Desloratadine,C121345,desloratadine,https://ctdbase.org/detail.go?type=chem&acc=C121345,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),[montelukast co-treated with desloratadine] results in decreased expression of CXCL8 protein,,,PMID:15061398,https://www.ncbi.nlm.nih.gov/pubmed/15061398,15061398,,
2191,1493597,124087,Comparative Toxicogenomics Database (CTD),Desloratadine,C121345,desloratadine,https://ctdbase.org/detail.go?type=chem&acc=C121345,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),CYP2D6 protein affects the chemical synthesis of desloratadine,,,PMID:15932952,https://www.ncbi.nlm.nih.gov/pubmed/15932952,15932952,,
2192,1493598,124087,Comparative Toxicogenomics Database (CTD),Desloratadine,C121345,desloratadine,https://ctdbase.org/detail.go?type=chem&acc=C121345,2152,F3,https://ctdbase.org/detail.go?type=gene&acc=2152,,,2152.0,F3,9606.0,Homo sapiens (human),Desloratadine results in increased expression of F3 protein,,,PMID:25569083,https://www.ncbi.nlm.nih.gov/pubmed/25569083,25569083,,
2193,1493599,124087,Comparative Toxicogenomics Database (CTD),Desloratadine,C121345,desloratadine,https://ctdbase.org/detail.go?type=chem&acc=C121345,3241,HPCAL1,https://ctdbase.org/detail.go?type=gene&acc=3241,,,3241.0,HPCAL1,9606.0,Homo sapiens (human),Ammonium chloride inhibits the reaction [desloratadine results in increased degradation of HPCAL1 protein]|hpcal1 protein affects the susceptibility to desloratadine|desloratadine results in decreased expression of and results in increased degradation of HPCAL1 protein|desloratadine results in decreased expression of HPCAL1 protein|desloratadine results in decreased myristoylation of HPCAL1 protein,,,PMID:36617552,https://www.ncbi.nlm.nih.gov/pubmed/36617552,36617552,,
2194,1513968,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,10090.0,Mus musculus (house mouse),ABCC1 protein promotes the reaction [nitric oxide results in increased secretion of glutathione],,,PMID:16679408,https://www.ncbi.nlm.nih.gov/pubmed/16679408,16679408,,
2195,1513969,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,10116.0,Rattus norvegicus (Norway rat),[verlukast results in decreased activity of ABCC1 protein] inhibits the reaction [arsenates results in increased export of glutathione],,,PMID:23542460,https://www.ncbi.nlm.nih.gov/pubmed/23542460,23542460,,
2196,1513970,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606.0,Homo sapiens (human),ABCC1 protein affects the export of glutathione,,,PMID:15845416,https://www.ncbi.nlm.nih.gov/pubmed/15845416,15845416,,
2197,1513971,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606.0,Homo sapiens (human),ABCC1 protein promotes the reaction [verapamil results in decreased abundance of glutathione]|abcc1 protein promotes the reaction [5-oxo-hexahydroquinoline analog results in decreased abundance of glutathione],,,PMID:30391378,https://www.ncbi.nlm.nih.gov/pubmed/30391378,30391378,,
2198,1515073,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,10116.0,Rattus norvegicus (Norway rat),Glutathione inhibits the reaction [diphenyldiselenide results in decreased activity of ALAD protein],,,PMID:21620807,https://www.ncbi.nlm.nih.gov/pubmed/21620807,21620807,,
2199,1515074,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9913.0,Bos taurus (cattle),Glutathione binds to ALB protein modified form|glutathione inhibits the reaction [[acrolein affects the metabolism of ALB protein] which results in decreased activity of GAPDH protein],,,PMID:12032148,https://www.ncbi.nlm.nih.gov/pubmed/12032148,12032148,,
2200,1518542,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,226143,CYP2C23,https://ctdbase.org/detail.go?type=gene&acc=226143,,,226143.0,Cyp2c23,10116.0,Rattus norvegicus (Norway rat),Glutathione deficiency results in increased expression of CYP2C23 mRNA,,,PMID:15345336,https://www.ncbi.nlm.nih.gov/pubmed/15345336,15345336,,
2201,1520451,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,14325,FTL1,https://ctdbase.org/detail.go?type=gene&acc=14325,,,14325.0,Ftl1,10116.0,Rattus norvegicus (Norway rat),Glutathione inhibits the reaction [arsenite results in increased expression of FTL1 protein],,,PMID:15175009,https://www.ncbi.nlm.nih.gov/pubmed/15175009,15175009,,
2202,1521385,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10090.0,Mus musculus (house mouse),GCLM gene mutant form results in decreased abundance of glutathione,,,PMID:20417186|PMID:23704229|PMID:24107266|PMID:25446851,https://www.ncbi.nlm.nih.gov/pubmed/20417186|https://www.ncbi.nlm.nih.gov/pubmed/23704229|https://www.ncbi.nlm.nih.gov/pubmed/24107266|https://www.ncbi.nlm.nih.gov/pubmed/25446851,20417186|23704229|24107266|25446851,,
2203,1521386,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10090.0,Mus musculus (house mouse),[GCLM gene mutant form results in decreased abundance of glutathione] which results in decreased susceptibility to benzo(a)pyrene,,,PMID:24107266,https://www.ncbi.nlm.nih.gov/pubmed/24107266,24107266,,
2204,1521387,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10090.0,Mus musculus (house mouse),[GCLM gene mutant form results in decreased abundance of glutathione] which results in increased expression of CBR3 protein,,,PMID:25446851,https://www.ncbi.nlm.nih.gov/pubmed/25446851,25446851,,
2205,1521388,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10090.0,Mus musculus (house mouse),GCLM protein mutant form results in decreased abundance of glutathione|gclm protein affects the metabolism of glutathione,,,PMID:22253057,https://www.ncbi.nlm.nih.gov/pubmed/22253057,22253057,,
2206,1521389,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10090.0,Mus musculus (house mouse),[GCLC protein co-treated with GCLM protein] results in increased chemical synthesis of glutathione|gclm protein affects the susceptibility to glutathione,,,PMID:17584759,https://www.ncbi.nlm.nih.gov/pubmed/17584759,17584759,,
2207,1521390,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10090.0,Mus musculus (house mouse),GCLM protein inhibits the reaction [IKBKB protein mutant form results in decreased abundance of glutathione],,,PMID:20159942,https://www.ncbi.nlm.nih.gov/pubmed/20159942,20159942,,
2208,1521391,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10090.0,Mus musculus (house mouse),GCLM protein results in increased chemical synthesis of glutathione,,,PMID:22253057|PMID:23135907,https://www.ncbi.nlm.nih.gov/pubmed/22253057|https://www.ncbi.nlm.nih.gov/pubmed/23135907,22253057|23135907,,
2209,1524653,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3037,HAS2,https://ctdbase.org/detail.go?type=gene&acc=3037,,,3037.0,HAS2,10090.0,Mus musculus (house mouse),Glutathione inhibits the reaction [LHB protein results in increased abundance of HAS2 mrna],,,PMID:21220312,https://www.ncbi.nlm.nih.gov/pubmed/21220312,21220312,,
2210,1524654,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3077,HFE,https://ctdbase.org/detail.go?type=gene&acc=3077,,,3077.0,HFE,10116.0,Rattus norvegicus (Norway rat),Glutathione deficiency results in increased expression of HFE mRNA,,,PMID:15345336,https://www.ncbi.nlm.nih.gov/pubmed/15345336,15345336,,
2211,1524655,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3082,HGF,https://ctdbase.org/detail.go?type=gene&acc=3082,,,3082.0,HGF,10116.0,Rattus norvegicus (Norway rat),[HGF protein results in increased activity of GCLC protein] which results in increased chemical synthesis of glutathione|hgf protein results in increased abundance of glutathione,,,PMID:10544272,https://www.ncbi.nlm.nih.gov/pubmed/10544272,10544272,,
2212,1524656,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),"Glutathione inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of HIF1A protein]",,,PMID:17658243,https://www.ncbi.nlm.nih.gov/pubmed/17658243,17658243,,
2213,1525252,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3265,HRAS,https://ctdbase.org/detail.go?type=gene&acc=3265,,,3265.0,HRAS,9606.0,Homo sapiens (human),[zinostatin co-treated with glutathione] results in increased cleavage of HRAS gene|dactinomycin promotes the reaction [[zinostatin co-treated with glutathione] results in increased cleavage of HRAS gene],,,PMID:9345283,https://www.ncbi.nlm.nih.gov/pubmed/9345283,9345283,,
2214,1525253,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3292,HSD17B1,https://ctdbase.org/detail.go?type=gene&acc=3292,,,3292.0,HSD17B1,10116.0,Rattus norvegicus (Norway rat),Glutathione inhibits the reaction [sodium arsenite results in decreased activity of HSD17B1 protein],,,PMID:20580664,https://www.ncbi.nlm.nih.gov/pubmed/20580664,20580664,,
2215,1525254,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3283,HSD3B1,https://ctdbase.org/detail.go?type=gene&acc=3283,,,3283.0,HSD3B1,10116.0,Rattus norvegicus (Norway rat),Glutathione inhibits the reaction [sodium arsenite results in decreased activity of HSD3B1 protein],,,PMID:20580664,https://www.ncbi.nlm.nih.gov/pubmed/20580664,20580664,,
2216,1525255,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3320,HSP90AA1,https://ctdbase.org/detail.go?type=gene&acc=3320,,,3320.0,HSP90AA1,9823.0,Sus scrofa (pig),[glutathione co-treated with paraquat] results in decreased expression of HSP90AA1 mRNA,,,PMID:36615853,https://www.ncbi.nlm.nih.gov/pubmed/36615853,36615853,,
2217,1525256,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3304,HSPA1B,https://ctdbase.org/detail.go?type=gene&acc=3304,,,3304.0,HSPA1B,10116.0,Rattus norvegicus (Norway rat),Glutathione inhibits the reaction [arsenite results in increased expression of HSPA1B protein],,,PMID:15175009,https://www.ncbi.nlm.nih.gov/pubmed/15175009,15175009,,
2218,1525257,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,10090.0,Mus musculus (house mouse),Glutathione inhibits the reaction [brefeldin A results in increased expression of HSPA5 protein]|glutathione inhibits the reaction [thapsigargin results in increased expression of HSPA5 protein],,,PMID:20493918,https://www.ncbi.nlm.nih.gov/pubmed/20493918,20493918,,
2219,1525258,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3315,HSPB1,https://ctdbase.org/detail.go?type=gene&acc=3315,,,3315.0,HSPB1,10116.0,Rattus norvegicus (Norway rat),Glutathione inhibits the reaction [arsenite results in increased expression of HSPB1 protein],,,PMID:15175009,https://www.ncbi.nlm.nih.gov/pubmed/15175009,15175009,,
2220,1525259,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3375,IAPP,https://ctdbase.org/detail.go?type=gene&acc=3375,,,3375.0,IAPP,9606.0,Homo sapiens (human),IAPP protein inhibits the reaction [[copper co-treated with glutathione] results in increased abundance of hydrogen peroxide],,,PMID:23793354,https://www.ncbi.nlm.nih.gov/pubmed/23793354,23793354,,
2221,1526837,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Glutathione inhibits the reaction [pyrrolidine dithiocarbamic acid results in decreased activity of MAPK1 protein],,,PMID:10658192,https://www.ncbi.nlm.nih.gov/pubmed/10658192,10658192,,
2222,1528144,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090.0,Mus musculus (house mouse),[ATG5 gene mutant form results in increased activity of NFE2L2 protein] which affects the abundance of glutathione|[atg5 gene mutant form results in increased activity of NFE2L2 protein] affects the reaction [acetaminophen affects the abundance of glutathione],,,PMID:22491424,https://www.ncbi.nlm.nih.gov/pubmed/22491424,22491424,,
2223,1528145,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090.0,Mus musculus (house mouse),"Glutathione inhibits the reaction [2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene results in increased expression of NFE2L2 protein]",,,PMID:20800667,https://www.ncbi.nlm.nih.gov/pubmed/20800667,20800667,,
2224,1529748,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,5071,PRKN,https://ctdbase.org/detail.go?type=gene&acc=5071,,,5071.0,PRKN,10090.0,Mus musculus (house mouse),PRKN protein affects the abundance of glutathione,,,PMID:12915482,https://www.ncbi.nlm.nih.gov/pubmed/12915482,12915482,,
2225,1529749,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,5621,PRNP,https://ctdbase.org/detail.go?type=gene&acc=5621,,,5621.0,PRNP,10090.0,Mus musculus (house mouse),PRNP protein inhibits the reaction [manganese chloride results in decreased abundance of glutathione],,,PMID:17483122,https://www.ncbi.nlm.nih.gov/pubmed/17483122,17483122,,
2226,1529750,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,5621,PRNP,https://ctdbase.org/detail.go?type=gene&acc=5621,,,5621.0,PRNP,9940.0,Ovis aries (sheep),Glutathione inhibits the reaction [copper sulfate affects the reaction [peroxynitrous acid results in decreased activity of PRNP protein]],,,PMID:14713301,https://www.ncbi.nlm.nih.gov/pubmed/14713301,14713301,,
2227,1529751,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,10544,PROCR,https://ctdbase.org/detail.go?type=gene&acc=10544,,,10544.0,PROCR,9606.0,Homo sapiens (human),Glutathione inhibits the reaction [doxorubicin results in decreased expression of PROCR protein],,,PMID:17172434,https://www.ncbi.nlm.nih.gov/pubmed/17172434,17172434,,
2228,1529752,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,5725,PTBP1,https://ctdbase.org/detail.go?type=gene&acc=5725,,,5725.0,PTBP1,10116.0,Rattus norvegicus (Norway rat),Glutathione deficiency results in increased expression of PTBP1 mRNA,,,PMID:15345336,https://www.ncbi.nlm.nih.gov/pubmed/15345336,15345336,,
2229,1494280,125483,Comparative Toxicogenomics Database (CTD),4-Nitrososulfamethoxazole,C072956,4-nitrososulfamethoxazole,https://ctdbase.org/detail.go?type=chem&acc=C072956,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),4-nitrososulfamethoxazole results in increased secretion of IL6 protein,,,PMID:28444390,https://www.ncbi.nlm.nih.gov/pubmed/28444390,28444390,,
2230,1494281,125483,Comparative Toxicogenomics Database (CTD),4-Nitrososulfamethoxazole,C072956,4-nitrososulfamethoxazole,https://ctdbase.org/detail.go?type=chem&acc=C072956,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9606.0,Homo sapiens (human),4-nitrososulfamethoxazole binds to MPO protein|[[mpo protein co-treated with hydrogen peroxide] results in increased oxidation of sulfamethoxazole] which results in increased chemical synthesis of 4-nitrososulfamethoxazole,,,PMID:25531135,https://www.ncbi.nlm.nih.gov/pubmed/25531135,25531135,,
2231,1526959,125516,ChEMBL,Miridesap,CHEMBL25263,MIRIDESAP,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL25263/,CHEMBL4929,Serum amyloid P-component,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL4929/,P02743,Serum amyloid P-component,325.0,APCS,9606.0,Homo sapiens (human),Serum amyloid P-component cross-linking agent,,,PMID:31877231,https://www.ncbi.nlm.nih.gov/pubmed/31877231,31877231,,
2232,1431542,126565,Drug Gene Interaction database (DGIdb),Lestaurtinib,,LESTAURTINIB,https://www.dgidb.org/drugs/ncit:C48402,,NTRK2,https://www.dgidb.org/genes/hgnc:8032,,,4915.0,NTRK2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2233,1431543,126565,Drug Gene Interaction database (DGIdb),Lestaurtinib,,LESTAURTINIB,https://www.dgidb.org/drugs/ncit:C48402,,NTRK3,https://www.dgidb.org/genes/hgnc:8033,,,4916.0,NTRK3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2234,1431544,126565,IUPHAR/BPS Guide to PHARMACOLOGY,Lestaurtinib,5672,lestaurtinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5672,1807,fms related receptor tyrosine kinase 3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1807,P36888,Receptor-type tyrosine-protein kinase FLT3,2322.0,FLT3,9606.0,Homo sapiens (human),Inhibition,pKd,8.07,PMID:22037378,https://www.ncbi.nlm.nih.gov/pubmed/22037378,22037378,,
2235,1431545,126810,Therapeutic Target Database (TTD),"2,5-Dihydro-2,5-dioxo-3-hydroxy-8-methyl-1H-benzazepine",D01XWL,"3-Hydroxy-8-methyl-1H-benzo[b]azepine-2,5-dione",https://idrblab.net/ttd/data/drug/details/D01XWL,T62276,Glutamate receptor ionotropic NMDA 1 (NMDAR1),https://idrblab.net/ttd/data/target/details/T62276,Q05586,"Glutamate receptor ionotropic, NMDA 1",2902.0,GRIN1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2236,1431546,126810,Therapeutic Target Database (TTD),"2,5-Dihydro-2,5-dioxo-3-hydroxy-8-methyl-1H-benzazepine",D01XWL,"3-Hydroxy-8-methyl-1H-benzo[b]azepine-2,5-dione",https://idrblab.net/ttd/data/drug/details/D01XWL,T22285,Glutamate receptor ionotropic NMDA 2A (NMDAR2A),https://idrblab.net/ttd/data/target/details/T22285,Q12879,"Glutamate receptor ionotropic, NMDA 2A",2903.0,GRIN2A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2237,1431547,126810,Therapeutic Target Database (TTD),"2,5-Dihydro-2,5-dioxo-3-hydroxy-8-methyl-1H-benzazepine",D01XWL,"3-Hydroxy-8-methyl-1H-benzo[b]azepine-2,5-dione",https://idrblab.net/ttd/data/drug/details/D01XWL,T76414,Glutamate receptor ionotropic NMDA 2B (NMDAR2B),https://idrblab.net/ttd/data/target/details/T76414,Q13224,"Glutamate receptor ionotropic, NMDA 2B",2904.0,GRIN2B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2238,1431548,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,AFP,https://www.dgidb.org/genes/hgnc:317,,,174.0,AFP,9606.0,Homo sapiens (human),,,,,,,,
2239,1432858,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,976,ADGRE5,https://ctdbase.org/detail.go?type=gene&acc=976,,,976.0,ADGRE5,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of ADGRE5 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2240,1432859,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,23266,ADGRL2,https://ctdbase.org/detail.go?type=gene&acc=23266,,,23266.0,ADGRL2,9606.0,Homo sapiens (human),ADGRL2 protein affects the susceptibility to methotrexate,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
2241,1432860,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,137872,ADHFE1,https://ctdbase.org/detail.go?type=gene&acc=137872,,,137872.0,ADHFE1,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of ADHFE1 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2242,1432861,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,55256,ADI1,https://ctdbase.org/detail.go?type=gene&acc=55256,,,55256.0,ADI1,9606.0,Homo sapiens (human),[antirheumatic agents co-treated with methotrexate] results in decreased expression of ADI1 mRNA,,,PMID:16817978,https://www.ncbi.nlm.nih.gov/pubmed/16817978,16817978,,
2243,1432862,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,51094,ADIPOR1,https://ctdbase.org/detail.go?type=gene&acc=51094,,,51094.0,ADIPOR1,9606.0,Homo sapiens (human),Methotrexate results in increased expression of ADIPOR1 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
2244,1432863,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,79602,ADIPOR2,https://ctdbase.org/detail.go?type=gene&acc=79602,,,79602.0,ADIPOR2,9606.0,Homo sapiens (human),Methotrexate results in increased expression of ADIPOR2 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
2245,1432864,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,10974,ADIRF,https://ctdbase.org/detail.go?type=gene&acc=10974,,,10974.0,ADIRF,9606.0,Homo sapiens (human),ADIRF protein affects the susceptibility to methotrexate,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
2246,1432865,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,133,ADM,https://ctdbase.org/detail.go?type=gene&acc=133,,,133.0,ADM,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of ADM mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
2247,1432866,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,199800,ADM5,https://ctdbase.org/detail.go?type=gene&acc=199800,,,199800.0,ADM5,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of ADM5 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2248,1433790,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,8639,AOC3,https://ctdbase.org/detail.go?type=gene&acc=8639,,,8639.0,AOC3,9606.0,Homo sapiens (human),[methotrexate analog binds to lipids] which results in decreased expression of AOC3 mRNA,,,PMID:24065615,https://www.ncbi.nlm.nih.gov/pubmed/24065615,24065615,,
2249,1433791,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,9606.0,Homo sapiens (human),AOX1 protein affects the metabolism of methotrexate,,,PMID:20444863,https://www.ncbi.nlm.nih.gov/pubmed/20444863,20444863,,
2250,1433792,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of AOX1 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2251,1433793,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,9606.0,Homo sapiens (human),Methotrexate results in increased expression of AOX1 mRNA,,,PMID:19192274,https://www.ncbi.nlm.nih.gov/pubmed/19192274,19192274,,
2252,1433913,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,347,APOD,https://ctdbase.org/detail.go?type=gene&acc=347,,,347.0,APOD,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of APOD mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2253,1433914,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,319,APOF,https://ctdbase.org/detail.go?type=gene&acc=319,,,319.0,APOF,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of APOF mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2254,1433915,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of APP mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
2255,1433916,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606.0,Homo sapiens (human),Methotrexate results in increased expression of APP mRNA,,,PMID:21678067,https://www.ncbi.nlm.nih.gov/pubmed/21678067,21678067,,
2256,1433917,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,54840,APTX,https://ctdbase.org/detail.go?type=gene&acc=54840,,,54840.0,APTX,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of APTX mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2257,1433918,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,359,AQP2,https://ctdbase.org/detail.go?type=gene&acc=359,,,359.0,AQP2,10116.0,Rattus norvegicus (Norway rat),Methotrexate affects the expression of AQP2 protein,,,PMID:31039415,https://www.ncbi.nlm.nih.gov/pubmed/31039415,31039415,,
2258,1433919,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,360,AQP3,https://ctdbase.org/detail.go?type=gene&acc=360,,,360.0,AQP3,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of AQP3 mRNA,,,PMID:17696278,https://www.ncbi.nlm.nih.gov/pubmed/17696278,17696278,,
2259,1433920,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606.0,Homo sapiens (human),Methotrexate binds to and results in decreased activity of AR protein,,,PMID:25752796,https://www.ncbi.nlm.nih.gov/pubmed/25752796,25752796,,
2260,1434336,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,83734,ATG10,https://ctdbase.org/detail.go?type=gene&acc=83734,,,83734.0,ATG10,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of ATG10 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2261,1434337,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,9140,ATG12,https://ctdbase.org/detail.go?type=gene&acc=9140,,,9140.0,ATG12,9606.0,Homo sapiens (human),Methotrexate results in increased expression of ATG12 mRNA,,,PMID:21678067,https://www.ncbi.nlm.nih.gov/pubmed/21678067,21678067,,
2262,1435305,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,54880,BCOR,https://ctdbase.org/detail.go?type=gene&acc=54880,,,54880.0,BCOR,10090.0,Mus musculus (house mouse),Methotrexate results in increased mutagenesis of BCOR gene,,,PMID:22806879,https://www.ncbi.nlm.nih.gov/pubmed/22806879,22806879,,
2263,1435306,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,617,BCS1L,https://ctdbase.org/detail.go?type=gene&acc=617,,,617.0,BCS1L,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of BCS1L mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2264,1436148,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,59283,CACNG8,https://ctdbase.org/detail.go?type=gene&acc=59283,,,59283.0,CACNG8,9606.0,Homo sapiens (human),Methotrexate results in increased expression of CACNG8 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2265,1436149,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,23705,CADM1,https://ctdbase.org/detail.go?type=gene&acc=23705,,,23705.0,CADM1,9606.0,Homo sapiens (human),Methotrexate results in increased expression of CADM1 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2266,1436150,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,805,CALM2,https://ctdbase.org/detail.go?type=gene&acc=805,,,805.0,CALM2,9606.0,Homo sapiens (human),Methotrexate results in increased expression of CALM2 mRNA,,,PMID:21678067,https://www.ncbi.nlm.nih.gov/pubmed/21678067,21678067,,
2267,1436151,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,808,CALM3,https://ctdbase.org/detail.go?type=gene&acc=808,,,808.0,CALM3,9606.0,Homo sapiens (human),Methotrexate results in increased expression of CALM3 mRNA,,,PMID:21678067,https://www.ncbi.nlm.nih.gov/pubmed/21678067,21678067,,
2268,1436152,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,83698,CALN1,https://ctdbase.org/detail.go?type=gene&acc=83698,,,83698.0,CALN1,9606.0,Homo sapiens (human),Methotrexate results in increased expression of CALN1 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2269,1437930,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,919,CD247,https://ctdbase.org/detail.go?type=gene&acc=919,,,919.0,CD247,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of CD247 mRNA,,,PMID:17400583|PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/17400583|https://www.ncbi.nlm.nih.gov/pubmed/24449571,17400583|24449571,,
2270,1437931,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,939,CD27,https://ctdbase.org/detail.go?type=gene&acc=939,,,939.0,CD27,9606.0,Homo sapiens (human),[hydroxychloroquine co-treated with methotrexate co-treated with sulfasalazine] results in decreased expression of CD27 mRNA,,,PMID:28863153,https://www.ncbi.nlm.nih.gov/pubmed/28863153,28863153,,
2271,1437932,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,29126,CD274,https://ctdbase.org/detail.go?type=gene&acc=29126,,,29126.0,CD274,9606.0,Homo sapiens (human),[folic acid deficiency co-treated with methotrexate] results in increased expression of CD274 mRNA,,,PMID:24657277,https://www.ncbi.nlm.nih.gov/pubmed/24657277,24657277,,
2272,1437933,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,940,CD28,https://ctdbase.org/detail.go?type=gene&acc=940,,,940.0,CD28,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of CD28 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
2273,1437934,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,9936,CD302,https://ctdbase.org/detail.go?type=gene&acc=9936,,,9936.0,CD302,9606.0,Homo sapiens (human),CD302 protein affects the susceptibility to methotrexate,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
2274,1437935,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,9606.0,Homo sapiens (human),Methotrexate results in increased expression of CD36 mRNA,,,PMID:32535746,https://www.ncbi.nlm.nih.gov/pubmed/32535746,32535746,,
2275,1437936,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,951,CD37,https://ctdbase.org/detail.go?type=gene&acc=951,,,951.0,CD37,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of CD37 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2276,1438526,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Methotrexate inhibits the reaction [TP53 protein results in increased expression of CDKN1A protein],,,PMID:19548002,https://www.ncbi.nlm.nih.gov/pubmed/19548002,19548002,,
2277,1438647,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1040,CDS1,https://ctdbase.org/detail.go?type=gene&acc=1040,,,1040.0,CDS1,9606.0,Homo sapiens (human),Methotrexate results in increased expression of CDS1 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2278,1438648,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,634,CEACAM1,https://ctdbase.org/detail.go?type=gene&acc=634,,,634.0,CEACAM1,9606.0,Homo sapiens (human),[folic acid deficiency co-treated with methotrexate] results in increased expression of CEACAM1 mRNA,,,PMID:24657277,https://www.ncbi.nlm.nih.gov/pubmed/24657277,24657277,,
2279,1438649,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1084,CEACAM3,https://ctdbase.org/detail.go?type=gene&acc=1084,,,1084.0,CEACAM3,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of CEACAM3 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
2280,1438650,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1048,CEACAM5,https://ctdbase.org/detail.go?type=gene&acc=1048,,,1048.0,CEACAM5,9606.0,Homo sapiens (human),Methotrexate results in increased expression of CEACAM5 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
2281,1438651,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,4680,CEACAM6,https://ctdbase.org/detail.go?type=gene&acc=4680,,,4680.0,CEACAM6,9606.0,Homo sapiens (human),Methotrexate results in increased expression of CEACAM6 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
2282,1438652,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,9606.0,Homo sapiens (human),Methotrexate results in increased expression of CEBPB mrna|[folic acid deficiency co-treated with methotrexate] results in increased expression of CEBPB mRNA,,,PMID:24657277,https://www.ncbi.nlm.nih.gov/pubmed/24657277,24657277,,
2283,1440581,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of CXCL2 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2284,1440582,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10116.0,Rattus norvegicus (Norway rat),Methotrexate inhibits the reaction [freund's adjuvant results in increased expression of CXCL2 protein],,,PMID:32061742,https://www.ncbi.nlm.nih.gov/pubmed/32061742,32061742,,
2285,1440583,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,2921,CXCL3,https://ctdbase.org/detail.go?type=gene&acc=2921,,,2921.0,CXCL3,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of CXCL3 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2286,1481812,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,113419,TEX261,https://ctdbase.org/detail.go?type=gene&acc=113419,,,113419.0,TEX261,10090.0,Mus musculus (house mouse),Methotrexate results in increased expression of TEX261 mRNA,,,PMID:21621594,https://www.ncbi.nlm.nih.gov/pubmed/21621594,21621594,,
2287,1481813,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,374618,TEX9,https://ctdbase.org/detail.go?type=gene&acc=374618,,,374618.0,TEX9,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of TEX9 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2288,1481814,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7020,TFAP2A,https://ctdbase.org/detail.go?type=gene&acc=7020,,,7020.0,TFAP2A,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of TFAP2A mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2289,1481815,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7024,TFCP2,https://ctdbase.org/detail.go?type=gene&acc=7024,,,7024.0,TFCP2,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of TFCP2 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2290,1481816,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7980,TFPI2,https://ctdbase.org/detail.go?type=gene&acc=7980,,,7980.0,TFPI2,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of TFPI2 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
2291,1481817,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7039,TGFA,https://ctdbase.org/detail.go?type=gene&acc=7039,,,7039.0,TGFA,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of TGFA mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2292,1481818,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7039,TGFA,https://ctdbase.org/detail.go?type=gene&acc=7039,,,7039.0,TGFA,9606.0,Homo sapiens (human),Methotrexate results in increased expression of TGFA mRNA,,,PMID:21678067,https://www.ncbi.nlm.nih.gov/pubmed/21678067,21678067,,
2293,1481819,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7039,TGFA,https://ctdbase.org/detail.go?type=gene&acc=7039,,,7039.0,TGFA,10116.0,Rattus norvegicus (Norway rat),TGFA protein inhibits the reaction [methotrexate results in increased expression of BAX mrna]|tgfa protein inhibits the reaction [methotrexate results in decreased expression of BCL2 protein]|tgfa protein inhibits the reaction [methotrexate results in increased expression of BAX protein]|tgfa protein inhibits the reaction [methotrexate results in decreased expression of BCL2 mrna],,,PMID:18803016,https://www.ncbi.nlm.nih.gov/pubmed/18803016,18803016,,
2294,1481820,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,9606.0,Homo sapiens (human),[methotrexate analog binds to lipids] which results in increased expression of TGFB1 mRNA,,,PMID:24065615,https://www.ncbi.nlm.nih.gov/pubmed/24065615,24065615,,
2295,1483813,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,3604,TNFRSF9,https://ctdbase.org/detail.go?type=gene&acc=3604,,,3604.0,TNFRSF9,9606.0,Homo sapiens (human),[methotrexate co-treated with CDKN1A protein] results in increased expression of TNFRSF9 mRNA,,,PMID:18483502,https://www.ncbi.nlm.nih.gov/pubmed/18483502,18483502,,
2296,1483814,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,3604,TNFRSF9,https://ctdbase.org/detail.go?type=gene&acc=3604,,,3604.0,TNFRSF9,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of TNFRSF9 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
2297,1483815,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,3604,TNFRSF9,https://ctdbase.org/detail.go?type=gene&acc=3604,,,3604.0,TNFRSF9,9606.0,Homo sapiens (human),Methotrexate results in increased expression of TNFRSF9 mRNA,,,PMID:18483502|PMID:24657277,https://www.ncbi.nlm.nih.gov/pubmed/18483502|https://www.ncbi.nlm.nih.gov/pubmed/24657277,18483502|24657277,,
2298,1483816,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,9606.0,Homo sapiens (human),Methotrexate results in increased expression of TNFSF10 mRNA,,,PMID:17696278|PMID:21678067,https://www.ncbi.nlm.nih.gov/pubmed/17696278|https://www.ncbi.nlm.nih.gov/pubmed/21678067,17696278|21678067,,
2299,1483817,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600.0,TNFSF11,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of TNFSF11 protein|methotrexate results in decreased expression of TNFSF11 mRNA,,,PMID:15593184,https://www.ncbi.nlm.nih.gov/pubmed/15593184,15593184,,
2300,1483818,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600.0,TNFSF11,10116.0,Rattus norvegicus (Norway rat),Methotrexate inhibits the reaction [freund's adjuvant results in increased expression of TNFSF11 mrna],,,PMID:27613480|PMID:30025850,https://www.ncbi.nlm.nih.gov/pubmed/27613480|https://www.ncbi.nlm.nih.gov/pubmed/30025850,27613480|30025850,,
2301,1483819,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600.0,TNFSF11,10116.0,Rattus norvegicus (Norway rat),Methotrexate inhibits the reaction [freund's adjuvant results in increased expression of TNFSF11 protein],,,PMID:27613480,https://www.ncbi.nlm.nih.gov/pubmed/27613480,27613480,,
2302,1484550,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),TP53 protein promotes the reaction [methotrexate results in increased expression of CASP8 protein],,,PMID:17637740|PMID:22010212,https://www.ncbi.nlm.nih.gov/pubmed/17637740|https://www.ncbi.nlm.nih.gov/pubmed/22010212,17637740|22010212,,
2303,1484551,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),TP53 protein promotes the reaction [methotrexate results in increased susceptibility to antineoplastic agents]|tp53 protein promotes the reaction [methotrexate results in increased susceptibility to cyclophosphamide metabolite],,,PMID:22010212,https://www.ncbi.nlm.nih.gov/pubmed/22010212,22010212,,
2304,1484552,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116.0,Rattus norvegicus (Norway rat),Methotrexate results in increased expression of and results in increased phosphorylation of TP53 protein,,,PMID:35842499,https://www.ncbi.nlm.nih.gov/pubmed/35842499,35842499,,
2305,1484553,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116.0,Rattus norvegicus (Norway rat),Methotrexate results in increased expression of TP53 protein|thioctic acid inhibits the reaction [methotrexate results in increased expression of TP53 protein],,,PMID:19900424,https://www.ncbi.nlm.nih.gov/pubmed/19900424,19900424,,
2306,1484554,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,9540,TP53I3,https://ctdbase.org/detail.go?type=gene&acc=9540,,,9540.0,TP53I3,9606.0,Homo sapiens (human),[folic acid deficiency co-treated with methotrexate] results in increased expression of TP53I3 mRNA,,,PMID:24657277,https://www.ncbi.nlm.nih.gov/pubmed/24657277,24657277,,
2307,1484555,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,9540,TP53I3,https://ctdbase.org/detail.go?type=gene&acc=9540,,,9540.0,TP53I3,9606.0,Homo sapiens (human),Methotrexate results in increased expression of TP53I3 mRNA,,,PMID:21678067|PMID:24657277,https://www.ncbi.nlm.nih.gov/pubmed/21678067|https://www.ncbi.nlm.nih.gov/pubmed/24657277,21678067|24657277,,
2308,1485286,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,84617,TUBB6,https://ctdbase.org/detail.go?type=gene&acc=84617,,,84617.0,TUBB6,10116.0,Rattus norvegicus (Norway rat),Methotrexate results in decreased expression of TUBB6 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2309,1485287,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,51174,TUBD1,https://ctdbase.org/detail.go?type=gene&acc=51174,,,51174.0,TUBD1,9606.0,Homo sapiens (human),Methotrexate results in increased expression of TUBD1 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2310,1485288,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7288,TULP2,https://ctdbase.org/detail.go?type=gene&acc=7288,,,7288.0,TULP2,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of TULP2 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2311,1485289,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,285194,TUSC7,https://ctdbase.org/detail.go?type=gene&acc=285194,,,285194.0,TUSC7,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of TUSC7 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2312,1485290,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,9606.0,Homo sapiens (human),Methotrexate results in increased expression of TXNIP mRNA,,,PMID:19192274,https://www.ncbi.nlm.nih.gov/pubmed/19192274,19192274,,
2313,1485291,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7296,TXNRD1,https://ctdbase.org/detail.go?type=gene&acc=7296,,,7296.0,TXNRD1,9606.0,Homo sapiens (human),Methotrexate results in increased expression of TXNRD1 mRNA,,,PMID:21678067,https://www.ncbi.nlm.nih.gov/pubmed/21678067,21678067,,
2314,1485292,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,10587,TXNRD2,https://ctdbase.org/detail.go?type=gene&acc=10587,,,10587.0,TXNRD2,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of TXNRD2 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
2315,1485293,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7297,TYK2,https://ctdbase.org/detail.go?type=gene&acc=7297,,,7297.0,TYK2,9606.0,Homo sapiens (human),TYK2 protein affects the susceptibility to methotrexate,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
2316,1485294,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7298,TYMS,https://ctdbase.org/detail.go?type=gene&acc=7298,,,7298.0,TYMS,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of TYMS mRNA,,,PMID:23897011,https://www.ncbi.nlm.nih.gov/pubmed/23897011,23897011,,
2317,1485295,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7298,TYMS,https://ctdbase.org/detail.go?type=gene&acc=7298,,,7298.0,TYMS,9606.0,Homo sapiens (human),Methotrexate results in increased expression of TYMS mRNA,,,PMID:23838799,https://www.ncbi.nlm.nih.gov/pubmed/23838799,23838799,,
2318,1495358,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,GATA3,https://www.dgidb.org/genes/hgnc:4172,,,2625.0,GATA3,9606.0,Homo sapiens (human),,,,,,,,
2319,1495359,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,NALCN,https://www.dgidb.org/genes/hgnc:19082,,,259232.0,NALCN,9606.0,Homo sapiens (human),,,,,,,,
2320,1495360,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,PYGL,https://www.dgidb.org/genes/hgnc:9725,,,5836.0,PYGL,9606.0,Homo sapiens (human),,,,,,,,
2321,1495361,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,ADORA2A-AS1,https://www.dgidb.org/genes/hgnc:37122,,,646023.0,ADORA2A-AS1,9606.0,Homo sapiens (human),,,,,,,,
2322,1495362,126941,Drug Gene Interaction database (DGIdb),Methotrexate,,METHOTREXATE,https://www.dgidb.org/drugs/rxcui:6851,,ARID5B,https://www.dgidb.org/genes/hgnc:17362,,,84159.0,ARID5B,9606.0,Homo sapiens (human),,,,,,,,
2323,1528658,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719.0,DHFR,9606.0,Homo sapiens (human),[ADAR protein results in increased expression of DHFR protein] which results in decreased susceptibility to methotrexate,,,PMID:28188287,https://www.ncbi.nlm.nih.gov/pubmed/28188287,28188287,,
2324,1528659,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719.0,DHFR,9606.0,Homo sapiens (human),[DHFR 3' UTR SNP affects the stability of DHFR mrna] which affects the susceptibility to methotrexate|[dhfr 3' UTR SNP affects the expression of DHFR protein] which affects the susceptibility to methotrexate,,,PMID:17686970,https://www.ncbi.nlm.nih.gov/pubmed/17686970,17686970|17686970,,
2325,1528660,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719.0,DHFR,9606.0,Homo sapiens (human),DHFR 3' UTR SNP affects the susceptibility to methotrexate,,,PMID:17686970,https://www.ncbi.nlm.nih.gov/pubmed/17686970,17686970,,
2326,1528661,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719.0,DHFR,9606.0,Homo sapiens (human),DHFR mRNA results in decreased susceptibility to methotrexate,,,PMID:18694510|PMID:19732436,https://www.ncbi.nlm.nih.gov/pubmed/18694510|https://www.ncbi.nlm.nih.gov/pubmed/19732436,18694510|19732436,,
2327,1528662,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719.0,DHFR,9606.0,Homo sapiens (human),DHFR protein results in decreased susceptibility to methotrexate,,,PMID:14679136|PMID:28188287,https://www.ncbi.nlm.nih.gov/pubmed/14679136|https://www.ncbi.nlm.nih.gov/pubmed/28188287,14679136|28188287,,
2328,1528663,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719.0,DHFR,9606.0,Homo sapiens (human),[folic acid deficiency co-treated with methotrexate] results in decreased expression of DHFR mRNA,,,PMID:24657277,https://www.ncbi.nlm.nih.gov/pubmed/24657277,24657277,,
2329,1528664,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719.0,DHFR,9606.0,Homo sapiens (human),Methotrexate binds to and results in decreased activity of DHFR protein,,,PMID:34953855,https://www.ncbi.nlm.nih.gov/pubmed/34953855,34953855,,
2330,1528665,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719.0,DHFR,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of DHFR mRNA,,,PMID:23897011|PMID:24657277,https://www.ncbi.nlm.nih.gov/pubmed/23897011|https://www.ncbi.nlm.nih.gov/pubmed/24657277,23897011|24657277,,
2331,1440584,127382,Therapeutic Target Database (TTD),"Tert-butyl 5-methyl-6-oxo-5,6-dihydro-4h-imidazo[1,5-a]thieno[2,3-f][1,4]diazepine-3-carboxylate",D0UQ6J,RO-194603,https://idrblab.net/ttd/data/drug/details/D0UQ6J,T51487,GABA(A) receptor alpha-1 (GABRA1),https://idrblab.net/ttd/data/target/details/T51487,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2332,1440585,127382,Therapeutic Target Database (TTD),"Tert-butyl 5-methyl-6-oxo-5,6-dihydro-4h-imidazo[1,5-a]thieno[2,3-f][1,4]diazepine-3-carboxylate",D0UQ6J,RO-194603,https://idrblab.net/ttd/data/drug/details/D0UQ6J,T80387,GABA(A) receptor beta-2 (GABRB2),https://idrblab.net/ttd/data/target/details/T80387,P47870,Gamma-aminobutyric acid receptor subunit beta-2,2561.0,GABRB2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2333,1440586,127382,Therapeutic Target Database (TTD),"Tert-butyl 5-methyl-6-oxo-5,6-dihydro-4h-imidazo[1,5-a]thieno[2,3-f][1,4]diazepine-3-carboxylate",D0UQ6J,RO-194603,https://idrblab.net/ttd/data/drug/details/D0UQ6J,T08910,GABA(A) receptor gamma-2 (GABRG2),https://idrblab.net/ttd/data/target/details/T08910,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2334,1440587,127714,Therapeutic Target Database (TTD),"3',6-Dinitroflavone",D0J9SS,6-Nitro-2-(3-nitro-phenyl)-chromen-4-one,https://idrblab.net/ttd/data/drug/details/D0J9SS,T51487,GABA(A) receptor alpha-1 (GABRA1),https://idrblab.net/ttd/data/target/details/T51487,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2335,1488953,129228,DrugBank,Rufinamide,DB06201,Rufinamide,https://www.drugbank.ca/drugs/DB06201,BE0003533,Cytochrome P450 2E1,https://www.drugbank.ca/bio_entities/BE0003533,P05181,Cytochrome P450 2E1,1571.0,CYP2E1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2336,1488954,129228,DrugBank,Rufinamide,DB06201,Rufinamide,https://www.drugbank.ca/drugs/DB06201,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Inducer,,,PMID:18503564,https://www.ncbi.nlm.nih.gov/pubmed/18503564,18503564,,
2337,1488955,129228,DrugBank,Rufinamide,DB06201,Rufinamide,https://www.drugbank.ca/drugs/DB06201,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606.0,Homo sapiens (human),Substrate,,,,,,,
2338,1488956,129786,Therapeutic Target Database (TTD),Guanylpirenzepine,D0I9AL,guanylpirenzepine,https://idrblab.net/ttd/data/drug/details/D0I9AL,T67684,Muscarinic acetylcholine receptor M3 (CHRM3),https://idrblab.net/ttd/data/target/details/T67684,P20309,Muscarinic acetylcholine receptor M3,1131.0,CHRM3,9606.0,Homo sapiens (human),Antagonist,,,,,,,
2339,1488957,130021,Comparative Toxicogenomics Database (CTD),(3-Aminopropyl)(n-butyl)phosphinic acid,C079148,(3-aminopropyl)(n-butyl)phosphinic acid,https://ctdbase.org/detail.go?type=chem&acc=C079148,9456,HOMER1,https://ctdbase.org/detail.go?type=gene&acc=9456,,,9456.0,HOMER1,10116.0,Rattus norvegicus (Norway rat),HOMER1 mRNA modified form results in decreased susceptibility to (3-aminopropyl)(n-butyl)phosphinic acid,,,PMID:17540011,https://www.ncbi.nlm.nih.gov/pubmed/17540011,17540011,,
2340,1488958,130169,Therapeutic Target Database (TTD),Silahexocyclium,D00NRJ,silahexocyclium,https://idrblab.net/ttd/data/drug/details/D00NRJ,T67684,Muscarinic acetylcholine receptor M3 (CHRM3),https://idrblab.net/ttd/data/target/details/T67684,P20309,Muscarinic acetylcholine receptor M3,1131.0,CHRM3,9606.0,Homo sapiens (human),Antagonist,,,,,,,
2341,1488959,130169,Drug Gene Interaction database (DGIdb),Silahexocyclium,,ACTH,https://www.dgidb.org/drugs/iuphar.ligand:1331,,LDLR,https://www.dgidb.org/genes/hgnc:6547,,,3949.0,LDLR,9606.0,Homo sapiens (human),,,,,,,,
2342,1488960,130169,Drug Gene Interaction database (DGIdb),Silahexocyclium,,ACTH,https://www.dgidb.org/drugs/iuphar.ligand:1331,,BDNF,https://www.dgidb.org/genes/hgnc:1033,,,627.0,BDNF,9606.0,Homo sapiens (human),,,,,,,,
2343,1488961,130315,Comparative Toxicogenomics Database (CTD),AphiG,C068151,aphidicolin glycinate,https://ctdbase.org/detail.go?type=chem&acc=C068151,7078,TIMP3,https://ctdbase.org/detail.go?type=gene&acc=7078,,,7078.0,TIMP3,9606.0,Homo sapiens (human),TIMP3 gene modified form results in decreased susceptibility to aphidicolin glycinate,,,PMID:18202788,https://www.ncbi.nlm.nih.gov/pubmed/18202788,18202788,,
2344,1489931,132971,DrugBank,Abiraterone,DB05812,Abiraterone,https://www.drugbank.ca/drugs/DB05812,BE0002887,Cytochrome P450 2C8,https://www.drugbank.ca/bio_entities/BE0002887,P10632,Cytochrome P450 2C8,1558.0,CYP2C8,9606.0,Homo sapiens (human),Inhibitor,,,PMID:26721703|PMID:27504016,https://www.ncbi.nlm.nih.gov/pubmed/26721703|https://www.ncbi.nlm.nih.gov/pubmed/27504016,26721703|27504016,,
2345,1489932,132971,DrugBank,Abiraterone,DB05812,Abiraterone,https://www.drugbank.ca/drugs/DB05812,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606.0,Homo sapiens (human),Inhibitor,,,PMID:22714819,https://www.ncbi.nlm.nih.gov/pubmed/22714819,22714819,,
2346,1489933,132971,DrugBank,Abiraterone,DB05812,Abiraterone,https://www.drugbank.ca/drugs/DB05812,BE0003536,Cytochrome P450 2C19,https://www.drugbank.ca/bio_entities/BE0003536,P33261,Cytochrome P450 2C19,1557.0,CYP2C19,9606.0,Homo sapiens (human),Inhibitor,,,PMID:23599666|PMID:22714819,https://www.ncbi.nlm.nih.gov/pubmed/23599666|https://www.ncbi.nlm.nih.gov/pubmed/22714819,23599666|22714819,,
2347,1489934,132971,DrugBank,Abiraterone,DB05812,Abiraterone,https://www.drugbank.ca/drugs/DB05812,BE0002362,Cytochrome P450 3A5,https://www.drugbank.ca/bio_entities/BE0002362,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2348,1489935,132971,DrugBank,Abiraterone,DB05812,Abiraterone,https://www.drugbank.ca/drugs/DB05812,BE0000886,Bile salt sulfotransferase,https://www.drugbank.ca/bio_entities/BE0000886,Q06520,Sulfotransferase 2A1,6822.0,SULT2A1,9606.0,Homo sapiens (human),Substrate,,,PMID:22714819,https://www.ncbi.nlm.nih.gov/pubmed/22714819,22714819,,
2349,1489936,132971,DrugBank,Abiraterone,DB05812,Abiraterone,https://www.drugbank.ca/drugs/DB05812,BE0000785,Multidrug resistance-associated protein 1,https://www.drugbank.ca/bio_entities/BE0000785,P33527,Multidrug resistance-associated protein 1 ,4363.0,ABCC1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:22714819|PMID:27106175,https://www.ncbi.nlm.nih.gov/pubmed/22714819|https://www.ncbi.nlm.nih.gov/pubmed/27106175,22714819|27106175,,
2350,1489937,132971,DrugBank,Abiraterone,DB05812,Abiraterone,https://www.drugbank.ca/drugs/DB05812,BE0001004,Solute carrier organic anion transporter family member 1B1,https://www.drugbank.ca/bio_entities/BE0001004,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2351,1489938,132971,DrugBank,Abiraterone,DB05812,Abiraterone,https://www.drugbank.ca/drugs/DB05812,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606.0,Homo sapiens (human),Binder,,,PMID:23199349,https://www.ncbi.nlm.nih.gov/pubmed/23199349,23199349,,
2352,1489939,132971,DrugBank,Abiraterone,DB05812,Abiraterone,https://www.drugbank.ca/drugs/DB05812,BE0000925,Alpha-1-acid glycoprotein 1,https://www.drugbank.ca/bio_entities/BE0000925,P02763,Alpha-1-acid glycoprotein 1,5004.0,ORM1,9606.0,Homo sapiens (human),Binder,,,PMID:23199349,https://www.ncbi.nlm.nih.gov/pubmed/23199349,23199349,,
2353,1489940,132980,Drug Gene Interaction database (DGIdb),"1-[(3R)-5-(3-azabicyclo[3.2.2]nonan-3-yl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea",,CP-547632,https://www.dgidb.org/drugs/iuphar.ligand:7881,,ABL1,https://www.dgidb.org/genes/hgnc:76,,,25.0,ABL1,9606.0,Homo sapiens (human),,,,,,,,
2354,1498416,133002,Comparative Toxicogenomics Database (CTD),(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-(4-bromophenyl)propanoate,C087567,N-methyltropan-3-yl 2-(4-bromophenyl)propionate,https://ctdbase.org/detail.go?type=chem&acc=C087567,1132,CHRM4,https://ctdbase.org/detail.go?type=gene&acc=1132,,,1132.0,CHRM4,10090.0,Mus musculus (house mouse),N-methyltropan-3-yl 2-(4-bromophenyl)propionate binds to CHRM4 protein,,,PMID:9495837,https://www.ncbi.nlm.nih.gov/pubmed/9495837,9495837,,
2355,1498417,133002,Comparative Toxicogenomics Database (CTD),(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-(4-bromophenyl)propanoate,C087567,N-methyltropan-3-yl 2-(4-bromophenyl)propionate,https://ctdbase.org/detail.go?type=chem&acc=C087567,4803,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803.0,NGF,10090.0,Mus musculus (house mouse),N-methyltropan-3-yl 2-(4-bromophenyl)propionate results in increased expression of NGF protein,,,PMID:9869257,https://www.ncbi.nlm.nih.gov/pubmed/9869257,9869257,,
2356,1498418,133633,IUPHAR/BPS Guide to PHARMACOLOGY,3-(4-(4-Chlorophenyl-4-hydroxypiperidino)methyl)indole,177,"L-741,626",https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=177,6,5-HT2A receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=6,P28223,5-hydroxytryptamine receptor 2A,3356.0,HTR2A,9606.0,Homo sapiens (human),Antagonist,pKi,6.5,PMID:10869410,https://www.ncbi.nlm.nih.gov/pubmed/10869410,10869410,,
2357,1498419,134018,Drug Gene Interaction database (DGIdb),Febuxostat,,FEBUXOSTAT,https://www.dgidb.org/drugs/rxcui:73689,,UGT1A5,https://www.dgidb.org/genes/hgnc:12537,,,54579.0,UGT1A5,9606.0,Homo sapiens (human),,,,,,,,
2358,1498420,134018,Drug Gene Interaction database (DGIdb),Febuxostat,,FEBUXOSTAT,https://www.dgidb.org/drugs/rxcui:73689,,UGT1A9,https://www.dgidb.org/genes/hgnc:12541,,,54600.0,UGT1A9,9606.0,Homo sapiens (human),,,,,,,,
2359,1498421,134018,Drug Gene Interaction database (DGIdb),Febuxostat,,FEBUXOSTAT,https://www.dgidb.org/drugs/rxcui:73689,,UGT1A7,https://www.dgidb.org/genes/hgnc:12539,,,54577.0,UGT1A7,9606.0,Homo sapiens (human),,,,,,,,
2360,1498422,134018,Drug Gene Interaction database (DGIdb),Febuxostat,,FEBUXOSTAT,https://www.dgidb.org/drugs/rxcui:73689,,UGT1A10,https://www.dgidb.org/genes/hgnc:12531,,,54575.0,UGT1A10,9606.0,Homo sapiens (human),,,,,,,,
2361,1498423,134018,Drug Gene Interaction database (DGIdb),Febuxostat,,FEBUXOSTAT,https://www.dgidb.org/drugs/rxcui:73689,,UGT1A4,https://www.dgidb.org/genes/hgnc:12536,,,54657.0,UGT1A4,9606.0,Homo sapiens (human),,,,,,,,
2362,1498424,134018,ChEMBL,Febuxostat,CHEMBL1164729,FEBUXOSTAT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1164729/,CHEMBL1929,Xanthine dehydrogenase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1929/,P47989,Xanthine dehydrogenase/oxidase,7498.0,XDH,9606.0,Homo sapiens (human),Xanthine dehydrogenase inhibitor,,,,,,,
2363,1441591,134553,Toxin and Toxin Target Database (T3DB),Lysergic acid alpha-hydroxyethylamide,T3D3687,Lysergic acid hydroxyethylamide,http://www.t3db.ca/toxins/T3D3687,BE0000501,Alpha-1A adrenergic receptor,http://www.t3db.ca/biodb/bio_entities/BE0000501,P35348,Alpha-1A adrenergic receptor,148.0,ADRA1A,9606.0,Homo sapiens (human),LSH is partitally agonistic of alpha-adrenergic receptors. (A2919),,,PMID:13705953,https://www.ncbi.nlm.nih.gov/pubmed/13705953,13705953,,
2364,1441592,134553,Toxin and Toxin Target Database (T3DB),Lysergic acid alpha-hydroxyethylamide,T3D3687,Lysergic acid hydroxyethylamide,http://www.t3db.ca/toxins/T3D3687,BE0000575,Alpha-1B adrenergic receptor,http://www.t3db.ca/biodb/bio_entities/BE0000575,P35368,Alpha-1B adrenergic receptor,147.0,ADRA1B,9606.0,Homo sapiens (human),LSH is partitally agonistic of alpha-adrenergic receptors. (A2919),,,PMID:13705953,https://www.ncbi.nlm.nih.gov/pubmed/13705953,13705953,,
2365,1441593,134553,Toxin and Toxin Target Database (T3DB),Lysergic acid alpha-hydroxyethylamide,T3D3687,Lysergic acid hydroxyethylamide,http://www.t3db.ca/toxins/T3D3687,BE0000715,Alpha-1D adrenergic receptor,http://www.t3db.ca/biodb/bio_entities/BE0000715,P25100,Alpha-1D adrenergic receptor,146.0,ADRA1D,9606.0,Homo sapiens (human),LSH is partitally agonistic of alpha-adrenergic receptors. (A2919),,,PMID:13705953,https://www.ncbi.nlm.nih.gov/pubmed/13705953,13705953,,
2366,1441594,134553,Toxin and Toxin Target Database (T3DB),Lysergic acid alpha-hydroxyethylamide,T3D3687,Lysergic acid hydroxyethylamide,http://www.t3db.ca/toxins/T3D3687,BE0000289,Alpha-2A adrenergic receptor,http://www.t3db.ca/biodb/bio_entities/BE0000289,P08913,Alpha-2A adrenergic receptor,150.0,ADRA2A,9606.0,Homo sapiens (human),LSH is partitally agonistic of alpha-adrenergic receptors. (A2919),,,PMID:13705953,https://www.ncbi.nlm.nih.gov/pubmed/13705953,13705953,,
2367,1441595,134553,Toxin and Toxin Target Database (T3DB),Lysergic acid alpha-hydroxyethylamide,T3D3687,Lysergic acid hydroxyethylamide,http://www.t3db.ca/toxins/T3D3687,BE0000572,Alpha-2B adrenergic receptor,http://www.t3db.ca/biodb/bio_entities/BE0000572,P18089,Alpha-2B adrenergic receptor,151.0,ADRA2B,9606.0,Homo sapiens (human),LSH is partitally agonistic of alpha-adrenergic receptors. (A2919),,,PMID:13705953,https://www.ncbi.nlm.nih.gov/pubmed/13705953,13705953,,
2368,1441596,134553,Toxin and Toxin Target Database (T3DB),Lysergic acid alpha-hydroxyethylamide,T3D3687,Lysergic acid hydroxyethylamide,http://www.t3db.ca/toxins/T3D3687,BE0000342,Alpha-2C adrenergic receptor,http://www.t3db.ca/biodb/bio_entities/BE0000342,P18825,Alpha-2C adrenergic receptor,152.0,ADRA2C,9606.0,Homo sapiens (human),LSH is partitally agonistic of alpha-adrenergic receptors. (A2919),,,PMID:13705953,https://www.ncbi.nlm.nih.gov/pubmed/13705953,13705953,,
2369,1442161,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,57412,AS3MT,https://ctdbase.org/detail.go?type=gene&acc=57412,,,57412.0,AS3MT,9606.0,Homo sapiens (human),Flame retardants results in decreased expression of AS3MT mRNA,,,PMID:27219277,https://www.ncbi.nlm.nih.gov/pubmed/27219277,27219277,,
2370,1442162,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,429,ASCL1,https://ctdbase.org/detail.go?type=gene&acc=429,,,429.0,ASCL1,79684.0,Microtus ochrogaster (prairie vole),[flame retardants results in increased abundance of firemaster 550] which affects the expression of ASCL1 mRNA,,,PMID:37562579,https://www.ncbi.nlm.nih.gov/pubmed/37562579,37562579,,
2371,1442163,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,430,ASCL2,https://ctdbase.org/detail.go?type=gene&acc=430,,,430.0,ASCL2,79684.0,Microtus ochrogaster (prairie vole),[flame retardants results in increased abundance of firemaster 550] which affects the expression of ASCL2 mRNA,,,PMID:37562579,https://www.ncbi.nlm.nih.gov/pubmed/37562579,37562579,,
2372,1442164,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,445,ASS1,https://ctdbase.org/detail.go?type=gene&acc=445,,,445.0,ASS1,9606.0,Homo sapiens (human),[plasticizers co-treated with cosmetics co-treated with flame retardants co-treated with perfluorooctanoic acid co-treated with phytoestrogens] results in decreased expression of ASS1 mRNA,,,PMID:33325755,https://www.ncbi.nlm.nih.gov/pubmed/33325755,33325755,,
2373,1442165,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,506,ATP5F1B,https://ctdbase.org/detail.go?type=gene&acc=506,,,506.0,ATP5F1B,10090.0,Mus musculus (house mouse),Flame retardants results in increased expression of ATP5F1B protein,,,PMID:16451863|PMID:18550172,https://www.ncbi.nlm.nih.gov/pubmed/16451863|https://www.ncbi.nlm.nih.gov/pubmed/18550172,16451863|18550172,,
2374,1442166,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,10476,ATP5PD,https://ctdbase.org/detail.go?type=gene&acc=10476,,,10476.0,ATP5PD,10090.0,Mus musculus (house mouse),Flame retardants results in decreased expression of ATP5PD protein,,,PMID:18550172,https://www.ncbi.nlm.nih.gov/pubmed/18550172,18550172,,
2375,1442167,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,522,ATP5PF,https://ctdbase.org/detail.go?type=gene&acc=522,,,522.0,ATP5PF,10090.0,Mus musculus (house mouse),Flame retardants results in decreased expression of ATP5PF protein,,,PMID:18550172,https://www.ncbi.nlm.nih.gov/pubmed/18550172,18550172,,
2376,1442294,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,7955.0,Danio rerio (zebrafish),Flame retardants results in increased expression of BBC3 mRNA,,,PMID:19356805,https://www.ncbi.nlm.nih.gov/pubmed/19356805,19356805,,
2377,1442295,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,54828,BCAS3,https://ctdbase.org/detail.go?type=gene&acc=54828,,,54828.0,BCAS3,9606.0,Homo sapiens (human),[plasticizers co-treated with cosmetics co-treated with flame retardants co-treated with perfluorooctanoic acid co-treated with phytoestrogens] results in increased expression of BCAS3 mRNA,,,PMID:33325755,https://www.ncbi.nlm.nih.gov/pubmed/33325755,33325755,,
2378,1442296,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,7955.0,Danio rerio (zebrafish),Flame retardants results in decreased expression of BCL2 mRNA,,,PMID:19356805,https://www.ncbi.nlm.nih.gov/pubmed/19356805,19356805,,
2379,1442297,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),[plasticizers co-treated with cosmetics co-treated with flame retardants co-treated with perfluorooctanoic acid co-treated with phytoestrogens] results in increased expression of BCL2L1 mRNA,,,PMID:33325755,https://www.ncbi.nlm.nih.gov/pubmed/33325755,33325755,,
2380,1442298,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,623,BDKRB1,https://ctdbase.org/detail.go?type=gene&acc=623,,,623.0,BDKRB1,9606.0,Homo sapiens (human),Flame retardants results in decreased expression of BDKRB1 mRNA,,,PMID:27219277,https://www.ncbi.nlm.nih.gov/pubmed/27219277,27219277,,
2381,1442299,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,635,BHMT,https://ctdbase.org/detail.go?type=gene&acc=635,,,635.0,BHMT,7955.0,Danio rerio (zebrafish),Flame retardants results in increased expression of BHMT protein,,,PMID:18258299,https://www.ncbi.nlm.nih.gov/pubmed/18258299,18258299,,
2382,1442300,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,140707,BRI3BP,https://ctdbase.org/detail.go?type=gene&acc=140707,,,140707.0,BRI3BP,9606.0,Homo sapiens (human),[plasticizers co-treated with cosmetics co-treated with flame retardants co-treated with perfluorooctanoic acid co-treated with phytoestrogens] results in decreased expression of BRI3BP mRNA,,,PMID:33325755,https://www.ncbi.nlm.nih.gov/pubmed/33325755,33325755,,
2383,1442301,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,685,BTC,https://ctdbase.org/detail.go?type=gene&acc=685,,,685.0,BTC,10116.0,Rattus norvegicus (Norway rat),[flame retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in increased expression of BTC mRNA,,,PMID:32207525,https://www.ncbi.nlm.nih.gov/pubmed/32207525,32207525,,
2384,1442420,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,79762,C1ORF115,https://ctdbase.org/detail.go?type=gene&acc=79762,,,79762.0,C1orf115,9606.0,Homo sapiens (human),[plasticizers co-treated with cosmetics co-treated with flame retardants co-treated with perfluorooctanoic acid co-treated with phytoestrogens] results in increased expression of C1ORF115 mRNA,,,PMID:33325755,https://www.ncbi.nlm.nih.gov/pubmed/33325755,33325755,,
2385,1442421,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,708,C1QBP,https://ctdbase.org/detail.go?type=gene&acc=708,,,708.0,C1QBP,9606.0,Homo sapiens (human),[plasticizers co-treated with cosmetics co-treated with flame retardants co-treated with perfluorooctanoic acid co-treated with phytoestrogens] results in decreased expression of C1QBP mRNA,,,PMID:33325755,https://www.ncbi.nlm.nih.gov/pubmed/33325755,33325755,,
2386,1442422,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,11094,CACFD1,https://ctdbase.org/detail.go?type=gene&acc=11094,,,11094.0,CACFD1,9606.0,Homo sapiens (human),[plasticizers co-treated with cosmetics co-treated with flame retardants co-treated with perfluorooctanoic acid co-treated with phytoestrogens] results in increased expression of CACFD1 mRNA,,,PMID:33325755,https://www.ncbi.nlm.nih.gov/pubmed/33325755,33325755,,
2387,1442423,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,8913,CACNA1G,https://ctdbase.org/detail.go?type=gene&acc=8913,,,8913.0,CACNA1G,10090.0,Mus musculus (house mouse),Flame retardants results in increased expression of CACNA1G mrna|esr1 gene mutant form inhibits the reaction [flame retardants results in increased expression of CACNA1G mrna],,,PMID:29112739,https://www.ncbi.nlm.nih.gov/pubmed/29112739,29112739,,
2388,1442424,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,8912,CACNA1H,https://ctdbase.org/detail.go?type=gene&acc=8912,,,8912.0,CACNA1H,10090.0,Mus musculus (house mouse),Flame retardants results in increased expression of CACNA1H mrna|esr1 gene mutant form inhibits the reaction [flame retardants results in increased expression of CACNA1H mrna],,,PMID:29112739,https://www.ncbi.nlm.nih.gov/pubmed/29112739,29112739,,
2389,1442425,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,8911,CACNA1I,https://ctdbase.org/detail.go?type=gene&acc=8911,,,8911.0,CACNA1I,10090.0,Mus musculus (house mouse),Flame retardants results in increased expression of CACNA1I mrna|esr1 gene mutant form inhibits the reaction [flame retardants results in increased expression of CACNA1I mrna],,,PMID:29112739,https://www.ncbi.nlm.nih.gov/pubmed/29112739,29112739,,
2390,1442426,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,811,CALR,https://ctdbase.org/detail.go?type=gene&acc=811,,,811.0,CALR,10090.0,Mus musculus (house mouse),Flame retardants results in decreased expression of CALR protein,,,PMID:18550172,https://www.ncbi.nlm.nih.gov/pubmed/18550172,18550172,,
2391,1442427,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,815,CAMK2A,https://ctdbase.org/detail.go?type=gene&acc=815,,,815.0,CAMK2A,10090.0,Mus musculus (house mouse),Flame retardants results in decreased expression of CAMK2A protein modified form,,,PMID:17589592,https://www.ncbi.nlm.nih.gov/pubmed/17589592,17589592,,
2392,1442546,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,9606.0,Homo sapiens (human),Flame retardants results in increased expression of CASP1 mRNA,,,PMID:26808241,https://www.ncbi.nlm.nih.gov/pubmed/26808241,26808241,,
2393,1442547,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,843,CASP10,https://ctdbase.org/detail.go?type=gene&acc=843,,,843.0,CASP10,9606.0,Homo sapiens (human),Flame retardants results in increased expression of CASP10 mRNA,,,PMID:26808241,https://www.ncbi.nlm.nih.gov/pubmed/26808241,26808241,,
2394,1442548,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,7955.0,Danio rerio (zebrafish),Flame retardants results in increased expression of CASP3 mrna|flame retardants results in increased activity of CASP3 protein,,,PMID:19356805,https://www.ncbi.nlm.nih.gov/pubmed/19356805,19356805,,
2395,1442549,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Flame retardants results in increased activity of CASP3 protein,,,PMID:22547355,https://www.ncbi.nlm.nih.gov/pubmed/22547355,22547355,,
2396,1442550,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Flame retardants results in decreased expression of and results in decreased cleavage of CASP3 protein,,,PMID:31241157,https://www.ncbi.nlm.nih.gov/pubmed/31241157,31241157,,
2397,1442551,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,7955.0,Danio rerio (zebrafish),Flame retardants results in increased expression of CASP9 mrna|flame retardants results in increased activity of CASP9 protein,,,PMID:19356805,https://www.ncbi.nlm.nih.gov/pubmed/19356805,19356805,,
2398,1362818,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),Fluoxetine analog inhibits the reaction [[lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of nitric oxide],,,PMID:21467642,https://www.ncbi.nlm.nih.gov/pubmed/21467642,21467642,,
2399,1362819,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),Ginkgo biloba extract inhibits the reaction [[lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of nitric oxide]|sb 203580 inhibits the reaction [[lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of nitric oxide],,,PMID:11518563,https://www.ncbi.nlm.nih.gov/pubmed/11518563,11518563,,
2400,1362820,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),Timosaponin BIII inhibits the reaction [[lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of nitric oxide]|hinokiresinol inhibits the reaction [[lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of nitric oxide],,,PMID:30322157,https://www.ncbi.nlm.nih.gov/pubmed/30322157,30322157,,
2401,1362821,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),[[lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mrna] which results in increased chemical synthesis of nitric oxide|quercetin inhibits the reaction [[[lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mrna] which results in increased chemical synthesis of nitric oxide]|resveratrol inhibits the reaction [[[lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mrna] which results in increased chemical synthesis of nitric oxide],,,PMID:11020457,https://www.ncbi.nlm.nih.gov/pubmed/11020457,11020457,,
2402,1362822,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),[[lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased abundance of nitric oxide|[[[lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased abundance of nitric oxide] which results in decreased expression of CCN2 protein,,,PMID:24412304,https://www.ncbi.nlm.nih.gov/pubmed/24412304,24412304,,
2403,1362823,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of nitric oxide],,,PMID:20417174|PMID:20527891|PMID:23727179,https://www.ncbi.nlm.nih.gov/pubmed/20417174|https://www.ncbi.nlm.nih.gov/pubmed/20527891|https://www.ncbi.nlm.nih.gov/pubmed/23727179,20417174|20527891|23727179,,
2404,1431953,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),[ouabain results in increased expression of PTGS2 protein] which results in increased chemical synthesis of nitric oxide,,,PMID:18976649,https://www.ncbi.nlm.nih.gov/pubmed/18976649,18976649,,
2405,1431954,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,5747,PTK2,https://ctdbase.org/detail.go?type=gene&acc=5747,,,5747.0,PTK2,10090.0,Mus musculus (house mouse),Nitric oxide deficiency results in decreased expression of PTK2 mRNA,,,PMID:15878706,https://www.ncbi.nlm.nih.gov/pubmed/15878706,15878706,,
2406,1431955,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,9232,PTTG1,https://ctdbase.org/detail.go?type=gene&acc=9232,,,9232.0,PTTG1,10090.0,Mus musculus (house mouse),Nitric oxide deficiency results in increased expression of PTTG1 mRNA,,,PMID:15878706,https://www.ncbi.nlm.nih.gov/pubmed/15878706,15878706,,
2407,1431956,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,5894,RAF1,https://ctdbase.org/detail.go?type=gene&acc=5894,,,5894.0,RAF1,10116.0,Rattus norvegicus (Norway rat),[lipopolysaccharides results in increased activity of RAF1 protein] which results in decreased secretion of nitric oxide,,,PMID:19039081,https://www.ncbi.nlm.nih.gov/pubmed/19039081,19039081,,
2408,1431957,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,10267,RAMP1,https://ctdbase.org/detail.go?type=gene&acc=10267,,,10267.0,RAMP1,10116.0,Rattus norvegicus (Norway rat),Nitric oxide deficiency results in increased expression of RAMP1 mrna|nitric oxide deficiency results in increased expression of RAMP1 protein,,,PMID:16326922,https://www.ncbi.nlm.nih.gov/pubmed/16326922,16326922,,
2409,1431958,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,10266,RAMP2,https://ctdbase.org/detail.go?type=gene&acc=10266,,,10266.0,RAMP2,10116.0,Rattus norvegicus (Norway rat),Hydralazine inhibits the reaction [nitric oxide deficiency results in increased expression of RAMP2 protein]|nitric oxide deficiency results in increased expression of RAMP2 protein|hydrochlorothiazide inhibits the reaction [nitric oxide deficiency results in increased expression of RAMP2 protein]|nitric oxide deficiency results in increased expression of RAMP2 mRNA,,,PMID:16326922,https://www.ncbi.nlm.nih.gov/pubmed/16326922,16326922,,
2410,1431959,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,10268,RAMP3,https://ctdbase.org/detail.go?type=gene&acc=10268,,,10268.0,RAMP3,10116.0,Rattus norvegicus (Norway rat),Nitric oxide deficiency results in increased expression of RAMP3 protein|hydralazine inhibits the reaction [nitric oxide deficiency results in increased expression of RAMP3 protein]|hydrochlorothiazide inhibits the reaction [nitric oxide deficiency results in increased expression of RAMP3 protein]|nitric oxide deficiency results in increased expression of RAMP3 mRNA,,,PMID:16326922,https://www.ncbi.nlm.nih.gov/pubmed/16326922,16326922,,
2411,1431960,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,5906,RAP1A,https://ctdbase.org/detail.go?type=gene&acc=5906,,,5906.0,RAP1A,9606.0,Homo sapiens (human),Nitric oxide promotes the reaction [ITGB2 protein results in increased activity of RAP1A protein],,,PMID:16963453,https://www.ncbi.nlm.nih.gov/pubmed/16963453,16963453,,
2412,1431961,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,5911,RAP2A,https://ctdbase.org/detail.go?type=gene&acc=5911,,,5911.0,RAP2A,9606.0,Homo sapiens (human),Nitric oxide promotes the reaction [ITGB2 protein results in increased activity of RAP2A protein],,,PMID:16963453,https://www.ncbi.nlm.nih.gov/pubmed/16963453,16963453,,
2413,1432857,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,56729,RETN,https://ctdbase.org/detail.go?type=gene&acc=56729,,,56729.0,RETN,10090.0,Mus musculus (house mouse),[[TNF protein results in increased expression of NOS2 protein] which results in increased abundance of nitric oxide] which results in decreased expression of RETN mRNA,,,PMID:18369347,https://www.ncbi.nlm.nih.gov/pubmed/18369347,18369347,,
2414,1438392,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0003990,Cytochrome c oxidase subunit 6C,http://www.t3db.ca/biodb/bio_entities/BE0003990,P09669,Cytochrome c oxidase subunit 6C,1345.0,COX6C,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
2415,1438393,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0003996,"Cytochrome c oxidase subunit 7A1, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003996,P24310,"Cytochrome c oxidase subunit 7A1, mitochondrial",1346.0,COX7A1,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
2416,1438518,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0003993,"Cytochrome c oxidase subunit 8A, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003993,P10176,"Cytochrome c oxidase subunit 8A, mitochondrial",1351.0,COX8A,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
2417,1438519,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0005022,"Cytochrome c oxidase subunit 8C, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005022,Q7Z4L0,"Cytochrome c oxidase subunit 8C, mitochondrial",341947.0,COX8C,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
2418,1438520,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0000820,Epididymal secretory glutathione peroxidase,http://www.t3db.ca/biodb/bio_entities/BE0000820,O75715,Epididymal secretory glutathione peroxidase,2880.0,GPX5,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
2419,1438521,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0005057,Extracellular superoxide dismutase [Cu-Zn],http://www.t3db.ca/biodb/bio_entities/BE0005057,P08294,Extracellular superoxide dismutase [Cu-Zn],6649.0,SOD3,9606.0,Homo sapiens (human),Cyanide inhibits superoxide dismutase [cu-zn]. (A72),,,PMID:15856906,https://www.ncbi.nlm.nih.gov/pubmed/15856906,15856906,,
2420,1438522,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0000816,Glutathione peroxidase 1,http://www.t3db.ca/biodb/bio_entities/BE0000816,P07203,Glutathione peroxidase 1,2876.0,GPX1,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
2421,1438523,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0000817,Glutathione peroxidase 2,http://www.t3db.ca/biodb/bio_entities/BE0000817,P18283,Glutathione peroxidase 2,2877.0,GPX2,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
2422,1438524,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0000821,Glutathione peroxidase 3,http://www.t3db.ca/biodb/bio_entities/BE0000821,P22352,Glutathione peroxidase 3,2878.0,GPX3,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
2423,1438525,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0002286,Glutathione peroxidase 6,http://www.t3db.ca/biodb/bio_entities/BE0002286,P59796,Glutathione peroxidase 6,257202.0,GPX6,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
2424,1438642,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0002288,Probable glutathione peroxidase 8,http://www.t3db.ca/biodb/bio_entities/BE0002288,Q8TED1,Probable glutathione peroxidase 8,493869.0,GPX8,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
2425,1438643,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0005082,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005082,O60397,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",,,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
2426,1438644,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0002252,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002252,O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",6392.0,SDHD,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
2427,1438645,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0000176,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000176,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",6389.0,SDHA,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
2428,1438646,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0002254,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002254,P21912,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",6390.0,SDHB,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
2429,1438758,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0002257,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002257,Q99643,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",6391.0,SDHC,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
2430,1438759,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0002390,Superoxide dismutase [Cu-Zn],http://www.t3db.ca/biodb/bio_entities/BE0002390,P00441,Superoxide dismutase [Cu-Zn],6647.0,SOD1,9606.0,Homo sapiens (human),Cyanide inhibits superoxide dismutase [cu-zn]. (A72),,,PMID:15856906,https://www.ncbi.nlm.nih.gov/pubmed/15856906,15856906,,
2431,1438760,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0000252,Tyrosinase,http://www.t3db.ca/biodb/bio_entities/BE0000252,P14679,Tyrosinase,7299.0,TYR,9606.0,Homo sapiens (human),Cyanide inhibits tyrosinase. (A77),,,PMID:16950829,https://www.ncbi.nlm.nih.gov/pubmed/16950829,16950829,,
2432,1443457,145858,Comparative Toxicogenomics Database (CTD),Flavylium,D000872,Anthocyanins,https://ctdbase.org/detail.go?type=chem&acc=D000872,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10116.0,Rattus norvegicus (Norway rat),Anthocyanins inhibits the reaction [paraquat results in increased expression of COL1A1 mrna],,,PMID:30403199,https://www.ncbi.nlm.nih.gov/pubmed/30403199,30403199,,
2433,1443458,145858,Comparative Toxicogenomics Database (CTD),Flavylium,D000872,Anthocyanins,https://ctdbase.org/detail.go?type=chem&acc=D000872,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,10090.0,Mus musculus (house mouse),Anthocyanins inhibits the reaction [carbon tetrachloride results in increased expression of COL3A1 protein],,,PMID:30056145,https://www.ncbi.nlm.nih.gov/pubmed/30056145,30056145,,
2434,1443459,145858,Comparative Toxicogenomics Database (CTD),Flavylium,D000872,Anthocyanins,https://ctdbase.org/detail.go?type=chem&acc=D000872,1509,CTSD,https://ctdbase.org/detail.go?type=gene&acc=1509,,,1509.0,CTSD,10116.0,Rattus norvegicus (Norway rat),Anthocyanins inhibits the reaction [cyclophosphamide results in increased activity of CTSD protein],,,PMID:25451569,https://www.ncbi.nlm.nih.gov/pubmed/25451569,25451569,,
2435,1443460,145858,Comparative Toxicogenomics Database (CTD),Flavylium,D000872,Anthocyanins,https://ctdbase.org/detail.go?type=chem&acc=D000872,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090.0,Mus musculus (house mouse),Anthocyanins inhibits the reaction [carbon tetrachloride results in increased expression of CXCL2],,,PMID:30056145,https://www.ncbi.nlm.nih.gov/pubmed/30056145,30056145,,
2436,1443461,145858,Comparative Toxicogenomics Database (CTD),Flavylium,D000872,Anthocyanins,https://ctdbase.org/detail.go?type=chem&acc=D000872,100328933,CYP2C,https://ctdbase.org/detail.go?type=gene&acc=100328933,,,100328933.0,CYP2C,10116.0,Rattus norvegicus (Norway rat),Anthocyanins results in increased expression of CYP2C mRNA,,,PMID:18803703,https://www.ncbi.nlm.nih.gov/pubmed/18803703,18803703,,
2437,1443462,145858,Comparative Toxicogenomics Database (CTD),Flavylium,D000872,Anthocyanins,https://ctdbase.org/detail.go?type=chem&acc=D000872,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10116.0,Rattus norvegicus (Norway rat),Anthocyanins results in increased expression of CYP2E1 mRNA,,,PMID:18803703,https://www.ncbi.nlm.nih.gov/pubmed/18803703,18803703,,
2438,1443463,145858,Comparative Toxicogenomics Database (CTD),Flavylium,D000872,Anthocyanins,https://ctdbase.org/detail.go?type=chem&acc=D000872,266682,CYP3A2,https://ctdbase.org/detail.go?type=gene&acc=266682,,,266682.0,Cyp3a2,10116.0,Rattus norvegicus (Norway rat),Anthocyanins results in increased expression of CYP3A2 mRNA,,,PMID:18803703,https://www.ncbi.nlm.nih.gov/pubmed/18803703,18803703,,
2439,1443464,145858,Comparative Toxicogenomics Database (CTD),Flavylium,D000872,Anthocyanins,https://ctdbase.org/detail.go?type=chem&acc=D000872,25642,CYP3A23-3A1,https://ctdbase.org/detail.go?type=gene&acc=25642,,,25642.0,Cyp3a23-3a1,10116.0,Rattus norvegicus (Norway rat),Anthocyanins results in increased expression of CYP3A23-3A1 mRNA,,,PMID:18803703,https://www.ncbi.nlm.nih.gov/pubmed/18803703,18803703,,
2440,1439132,148124,Drug Gene Interaction database (DGIdb),Docetaxel,,DOCETAXEL ANHYDROUS,https://www.dgidb.org/drugs/rxcui:1299922,,SLCO1B1,https://www.dgidb.org/genes/hgnc:10959,,,10599.0,SLCO1B1,9606.0,Homo sapiens (human),,,,,,,,
2441,1439133,148124,Drug Gene Interaction database (DGIdb),Docetaxel,,DOCETAXEL ANHYDROUS,https://www.dgidb.org/drugs/rxcui:1299922,,TUBB,https://www.dgidb.org/genes/hgnc:20778,,,203068.0,TUBB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2442,1439134,148124,Drug Gene Interaction database (DGIdb),Docetaxel,,DOCETAXEL ANHYDROUS,https://www.dgidb.org/drugs/rxcui:1299922,,TUBB3,https://www.dgidb.org/genes/hgnc:20772,,,10381.0,TUBB3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2443,1439135,148124,Drug Gene Interaction database (DGIdb),Docetaxel,,DOCETAXEL ANHYDROUS,https://www.dgidb.org/drugs/rxcui:1299922,,ACSS2,https://www.dgidb.org/genes/hgnc:15814,,,55902.0,ACSS2,9606.0,Homo sapiens (human),,,,,,,,
2444,1439136,148124,Drug Gene Interaction database (DGIdb),Docetaxel,,DOCETAXEL ANHYDROUS,https://www.dgidb.org/drugs/rxcui:1299922,,ABCG2,https://www.dgidb.org/genes/hgnc:74,,,9429.0,ABCG2,9606.0,Homo sapiens (human),,,,,,,,
2445,1439137,148124,Drug Gene Interaction database (DGIdb),Docetaxel,,DOCETAXEL ANHYDROUS,https://www.dgidb.org/drugs/rxcui:1299922,,CHST3,https://www.dgidb.org/genes/hgnc:1971,,,9469.0,CHST3,9606.0,Homo sapiens (human),,,,,,,,
2446,1439138,148124,Drug Gene Interaction database (DGIdb),Docetaxel,,DOCETAXEL ANHYDROUS,https://www.dgidb.org/drugs/rxcui:1299922,,ATP7A,https://www.dgidb.org/genes/hgnc:869,,,538.0,ATP7A,9606.0,Homo sapiens (human),,,,,,,,
2447,1439139,148124,Drug Gene Interaction database (DGIdb),Docetaxel,,DOCETAXEL ANHYDROUS,https://www.dgidb.org/drugs/rxcui:1299922,,SPG7,https://www.dgidb.org/genes/hgnc:11237,,,6687.0,SPG7,9606.0,Homo sapiens (human),,,,,,,,
2448,1439140,148124,Drug Gene Interaction database (DGIdb),Docetaxel,,DOCETAXEL ANHYDROUS,https://www.dgidb.org/drugs/rxcui:1299922,,CYP2A6,https://www.dgidb.org/genes/hgnc:2610,,,1548.0,CYP2A6,9606.0,Homo sapiens (human),,,,,,,,
2449,1492549,148198,BindingDB,2-[6-(4-Chlorophenoxy)hexyl]-1-cyano-3-pyridin-4-ylguanidine,81396,GMX1778,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81396,4910,Nicotinamide phosphoribosyltransferase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4910,P43490,Nicotinamide phosphoribosyltransferase,10135.0,NAMPT,9606.0,Homo sapiens (human),,IC50 (nM),0.07,PMID:20609415|DOI:10.1016/j.chembiol.2010.05.008,https://www.ncbi.nlm.nih.gov/pubmed/20609415|https://doi.org/10.1016/j.chembiol.2010.05.008,20609415,10.1016/j.chembiol.2010.05.008,
2450,1452324,150258,Toxin and Toxin Target Database (T3DB),Trimethyloxonium hexachloroantimonate,T3D1891,Trimethyloxonium hexachlorantimonate,http://www.t3db.ca/toxins/T3D1891,BE0002290,Microsomal glutathione S-transferase 2,http://www.t3db.ca/biodb/bio_entities/BE0002290,Q99735,Microsomal glutathione S-transferase 2,4258.0,MGST2,9606.0,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
2451,1452325,150258,Toxin and Toxin Target Database (T3DB),Trimethyloxonium hexachloroantimonate,T3D1891,Trimethyloxonium hexachlorantimonate,http://www.t3db.ca/toxins/T3D1891,BE0002279,Microsomal glutathione S-transferase 3,http://www.t3db.ca/biodb/bio_entities/BE0002279,O14880,Microsomal glutathione S-transferase 3,4259.0,MGST3,9606.0,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
2452,1452326,151114,Drug Gene Interaction database (DGIdb),Exatecan mesilate hydrate,,EXATECAN MESYLATE,https://www.dgidb.org/drugs/ncit:C1679,,MGMT,https://www.dgidb.org/genes/hgnc:7059,,,4255.0,MGMT,9606.0,Homo sapiens (human),,,,,,,,
2453,1452327,151166,ChEMBL,Lumiracoxib,CHEMBL404108,LUMIRACOXIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL404108/,CHEMBL230,Cyclooxygenase-2,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL230/,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606.0,Homo sapiens (human),Cyclooxygenase-2 inhibitor,,,PMID:28351678|PMID:24870608|PMID:24060487,https://www.ncbi.nlm.nih.gov/pubmed/28351678|https://www.ncbi.nlm.nih.gov/pubmed/24870608|https://www.ncbi.nlm.nih.gov/pubmed/24060487,28351678|24870608|24060487,,
2454,1444314,151194,Drug Gene Interaction database (DGIdb),Vatalanib,,VATALANIB,https://www.dgidb.org/drugs/ncit:C1868,,KDR,https://www.dgidb.org/genes/hgnc:6307,,,3791.0,KDR,9606.0,Homo sapiens (human),,,,,,,,
2455,1452328,151221,Therapeutic Target Database (TTD),"3,3-Diphenyl-N-dimethylpropylamine",D02SDX,"N,N-Dimethyl-3,3-diphenylpropan-1-amine",https://idrblab.net/ttd/data/drug/details/D02SDX,T77913,Histamine H1 receptor (H1R),https://idrblab.net/ttd/data/target/details/T77913,P35367,Histamine H1 receptor,3269.0,HRH1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2456,1444315,151243,DrugBank,L-Tyrosinamide,DB03380,L-tyrosinamide,https://www.drugbank.ca/drugs/DB03380,BE0003476,Pro-neuropeptide Y,https://www.drugbank.ca/bio_entities/BE0003476,P01303,Pro-neuropeptide Y,4852.0,NPY,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
2457,1444316,151243,DrugBank,L-Tyrosinamide,DB03380,L-tyrosinamide,https://www.drugbank.ca/drugs/DB03380,BE0004370,Valacyclovir hydrolase,https://www.drugbank.ca/bio_entities/BE0004370,Q86WA6,Valacyclovir hydrolase,670.0,BPHL,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
2458,1444317,151437,DrugBank,4-Nitrophenyl-ara,DB03196,4-Nitrophenyl-Ara,https://www.drugbank.ca/drugs/DB03196,BE0001766,Intracellular exo-alpha-(1->5)-L-arabinofuranosidase,https://www.drugbank.ca/bio_entities/BE0001766,Q9XBQ3,Intracellular exo-alpha-(1->5)-L-arabinofuranosidase,,,1422.0,Geobacillus stearothermophilus,,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
2459,1444318,151723,Comparative Toxicogenomics Database (CTD),Methylmercury cysteine,C030589,methylmercury cysteine,https://ctdbase.org/detail.go?type=chem&acc=C030589,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606.0,Homo sapiens (human),ABCC2 protein affects the susceptibility to methylmercury cysteine|abcc2 protein affects the transport of methylmercury cysteine,,,PMID:21134393,https://www.ncbi.nlm.nih.gov/pubmed/21134393,21134393,,
2460,1444319,151723,Comparative Toxicogenomics Database (CTD),Methylmercury cysteine,C030589,methylmercury cysteine,https://ctdbase.org/detail.go?type=chem&acc=C030589,221188,ADGRG5,https://ctdbase.org/detail.go?type=gene&acc=221188,,,221188.0,ADGRG5,10090.0,Mus musculus (house mouse),Methylmercury cysteine results in increased expression of ADGRG5 mRNA,,,PMID:19465457,https://www.ncbi.nlm.nih.gov/pubmed/19465457,19465457,,
2461,1444320,151723,Comparative Toxicogenomics Database (CTD),Methylmercury cysteine,C030589,methylmercury cysteine,https://ctdbase.org/detail.go?type=chem&acc=C030589,284,ANGPT1,https://ctdbase.org/detail.go?type=gene&acc=284,,,284.0,ANGPT1,10090.0,Mus musculus (house mouse),Methylmercury cysteine results in increased expression of ANGPT1 mRNA,,,PMID:19465457,https://www.ncbi.nlm.nih.gov/pubmed/19465457,19465457,,
2462,1493432,151782,BindingDB,"1,10-Decanediamine, N,N'-di-4-quinolinyl-",10455,Bivalent 4-Aminoquinoline 9i,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10455,1044,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1044,,,,,,,,IC50 (nM),2150,PMID:10632067|DOI:10.1016/s0968-0896(99)00178-9,https://www.ncbi.nlm.nih.gov/pubmed/10632067|https://doi.org/10.1016/s0968-0896(99)00178-9,10632067,10.1016/s0968-0896(99)00178-9,
2463,1493433,152946,Drug Gene Interaction database (DGIdb),Moxifloxacin,,MOXIFLOXACIN,https://www.dgidb.org/drugs/rxcui:139462,,UGT1A1,https://www.dgidb.org/genes/hgnc:12530,,,54658.0,UGT1A1,9606.0,Homo sapiens (human),,,,,,,,
2464,1493434,152961,Comparative Toxicogenomics Database (CTD),2-Chloro-1-(1H-indol-3-yl)ethanone,C056007,3-chloroacetylindole,https://ctdbase.org/detail.go?type=chem&acc=C056007,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10116.0,Rattus norvegicus (Norway rat),3-chloroacetylindole inhibits the reaction [taurolithocholic acid results in decreased activity of ABCC2 protein],,,PMID:31300867,https://www.ncbi.nlm.nih.gov/pubmed/31300867,31300867,,
2465,1493435,152961,Comparative Toxicogenomics Database (CTD),2-Chloro-1-(1H-indol-3-yl)ethanone,C056007,3-chloroacetylindole,https://ctdbase.org/detail.go?type=chem&acc=C056007,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10116.0,Rattus norvegicus (Norway rat),3-chloroacetylindole affects the reaction [[pilocarpine co-treated with lithium chloride] affects the expression of PARP1 protein],,,PMID:31396050,https://www.ncbi.nlm.nih.gov/pubmed/31396050,31396050,,
2466,1493436,152961,Comparative Toxicogenomics Database (CTD),2-Chloro-1-(1H-indol-3-yl)ethanone,C056007,3-chloroacetylindole,https://ctdbase.org/detail.go?type=chem&acc=C056007,8682,PEA15,https://ctdbase.org/detail.go?type=gene&acc=8682,,,8682.0,PEA15,10116.0,Rattus norvegicus (Norway rat),[pilocarpine co-treated with lithium chloride co-treated with 3-chloroacetylindole] results in decreased phosphorylation of PEA15 protein,,,PMID:31396050,https://www.ncbi.nlm.nih.gov/pubmed/31396050,31396050,,
2467,1493437,152961,Comparative Toxicogenomics Database (CTD),2-Chloro-1-(1H-indol-3-yl)ethanone,C056007,3-chloroacetylindole,https://ctdbase.org/detail.go?type=chem&acc=C056007,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),3-chloroacetylindole affects the reaction [[pilocarpine co-treated with lithium chloride] results in increased phosphorylation of RELA protein],,,PMID:31396050,https://www.ncbi.nlm.nih.gov/pubmed/31396050,31396050,,
2468,1442958,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606.0,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of CYCS mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
2469,1442959,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,1540,CYLD,https://ctdbase.org/detail.go?type=gene&acc=1540,,,1540.0,CYLD,9606.0,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of CYLD mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
2470,1442960,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,1540,CYLD,https://ctdbase.org/detail.go?type=gene&acc=1540,,,1540.0,CYLD,9606.0,Homo sapiens (human),Moringin results in decreased expression of CYLD mRNA,,,PMID:31801206,https://www.ncbi.nlm.nih.gov/pubmed/31801206,31801206,,
2471,1442961,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,54541,DDIT4,https://ctdbase.org/detail.go?type=gene&acc=54541,,,54541.0,DDIT4,9606.0,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of DDIT4 mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
2472,1442962,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,56616,DIABLO,https://ctdbase.org/detail.go?type=gene&acc=56616,,,56616.0,DIABLO,9606.0,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of DIABLO mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
2473,1442963,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,1975,EIF4B,https://ctdbase.org/detail.go?type=gene&acc=1975,,,1975.0,EIF4B,9606.0,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of EIF4B mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
2474,1442964,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,1977,EIF4E,https://ctdbase.org/detail.go?type=gene&acc=1977,,,1977.0,EIF4E,9606.0,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of EIF4E mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
2475,1443608,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,4691,NCL,https://ctdbase.org/detail.go?type=gene&acc=4691,,,4691.0,NCL,9606.0,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of NCL mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
2476,1443609,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,9611,NCOR1,https://ctdbase.org/detail.go?type=gene&acc=9611,,,9611.0,NCOR1,9606.0,Homo sapiens (human),Moringin results in decreased expression of NCOR1 mRNA,,,PMID:31801206,https://www.ncbi.nlm.nih.gov/pubmed/31801206,31801206,,
2477,1443610,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,4700,NDUFA6,https://ctdbase.org/detail.go?type=gene&acc=4700,,,4700.0,NDUFA6,9606.0,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of NDUFA6 mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
2478,1443611,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,10763,NES,https://ctdbase.org/detail.go?type=gene&acc=10763,,,10763.0,NES,9606.0,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of NES protein,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
2479,1443612,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,4783,NFIL3,https://ctdbase.org/detail.go?type=gene&acc=4783,,,4783.0,NFIL3,9606.0,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of NFIL3 mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
2480,1443613,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of NFKB1 mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
2481,1443614,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of NFKBIA mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
2482,1443615,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,4893,NRAS,https://ctdbase.org/detail.go?type=gene&acc=4893,,,4893.0,NRAS,9606.0,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of NRAS mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
2483,1493438,153921,Comparative Toxicogenomics Database (CTD),Gadodiamide,C064925,gadodiamide,https://ctdbase.org/detail.go?type=chem&acc=C064925,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [gadodiamide results in increased phosphorylation of MAPK1 protein]|gadodiamide results in increased phosphorylation of MAPK1 protein|u 0126 inhibits the reaction [gadodiamide results in increased phosphorylation of MAPK1 protein],,,PMID:19561517,https://www.ncbi.nlm.nih.gov/pubmed/19561517,19561517,,
2484,1493439,153921,Comparative Toxicogenomics Database (CTD),Gadodiamide,C064925,gadodiamide,https://ctdbase.org/detail.go?type=chem&acc=C064925,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),U 0126 inhibits the reaction [gadodiamide results in increased phosphorylation of MAPK3 protein]|gadodiamide results in increased phosphorylation of MAPK3 protein|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [gadodiamide results in increased phosphorylation of MAPK3 protein],,,PMID:19561517,https://www.ncbi.nlm.nih.gov/pubmed/19561517,19561517,,
2485,1493440,153921,Comparative Toxicogenomics Database (CTD),Gadodiamide,C064925,gadodiamide,https://ctdbase.org/detail.go?type=chem&acc=C064925,4312,MMP1,https://ctdbase.org/detail.go?type=gene&acc=4312,,,4312.0,MMP1,9606.0,Homo sapiens (human),Gadodiamide results in increased expression of MMP1 mrna|u 0126 inhibits the reaction [gadodiamide results in increased expression of MMP1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [gadodiamide results in increased expression of MMP1 protein]|gadodiamide results in increased expression of MMP1 protein,,,PMID:19561517,https://www.ncbi.nlm.nih.gov/pubmed/19561517,19561517,,
2486,1494408,153921,Comparative Toxicogenomics Database (CTD),Gadodiamide,C064925,gadodiamide,https://ctdbase.org/detail.go?type=chem&acc=C064925,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Gadodiamide affects the expression of IL6 protein|gadodiamide results in increased expression of IL6 mRNA,,,PMID:19404939,https://www.ncbi.nlm.nih.gov/pubmed/19404939,19404939,,
2487,1494409,153921,Comparative Toxicogenomics Database (CTD),Gadodiamide,C064925,gadodiamide,https://ctdbase.org/detail.go?type=chem&acc=C064925,4254,KITLG,https://ctdbase.org/detail.go?type=gene&acc=4254,,,4254.0,KITLG,10116.0,Rattus norvegicus (Norway rat),Gadodiamide results in increased expression of KITLG protein,,,PMID:20938346,https://www.ncbi.nlm.nih.gov/pubmed/20938346,20938346,,
2488,1494762,154257,DrugBank,Bazedoxifene,DB06401,Bazedoxifene,https://www.drugbank.ca/drugs/DB06401,BE0003682,UDP-glucuronosyltransferase 1-8,https://www.drugbank.ca/bio_entities/BE0003682,Q9HAW9,UDP-glucuronosyltransferase 1A8,54576.0,UGT1A8,9606.0,Homo sapiens (human),Substrate,,,PMID:20516255,https://www.ncbi.nlm.nih.gov/pubmed/20516255,20516255,,
2489,1494763,154257,DrugBank,Bazedoxifene,DB06401,Bazedoxifene,https://www.drugbank.ca/drugs/DB06401,BE0003678,UDP-glucuronosyltransferase 1-10,https://www.drugbank.ca/bio_entities/BE0003678,Q9HAW8,UDP-glucuronosyltransferase 1A10,54575.0,UGT1A10,9606.0,Homo sapiens (human),Substrate,,,PMID:20516255,https://www.ncbi.nlm.nih.gov/pubmed/20516255,20516255,,
2490,1494764,154257,IUPHAR/BPS Guide to PHARMACOLOGY,Bazedoxifene,7355,bazedoxifene,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7355,620,Estrogen receptor-α,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=620,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),Antagonist,pIC50,7.64,PMID:11356100,https://www.ncbi.nlm.nih.gov/pubmed/11356100,11356100,,
2491,1494765,154257,IUPHAR/BPS Guide to PHARMACOLOGY,Bazedoxifene,7355,bazedoxifene,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7355,621,Estrogen receptor-β,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=621,Q92731,Estrogen receptor beta,2100.0,ESR2,9606.0,Homo sapiens (human),Antagonist,pIC50,7.07,PMID:11356100,https://www.ncbi.nlm.nih.gov/pubmed/11356100,11356100,,
2492,1494766,155011,Comparative Toxicogenomics Database (CTD),Aurantio-obtusin,C000595611,aurantio-obtusin,https://ctdbase.org/detail.go?type=chem&acc=C000595611,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606.0,Homo sapiens (human),Aurantio-obtusin inhibits the reaction [ABCB11 protein results in increased transport of taurodeoxycholic acid],,,PMID:35101544,https://www.ncbi.nlm.nih.gov/pubmed/35101544,35101544,,
2493,1495363,155011,Comparative Toxicogenomics Database (CTD),Aurantio-obtusin,C000595611,aurantio-obtusin,https://ctdbase.org/detail.go?type=chem&acc=C000595611,6693,SPN,https://ctdbase.org/detail.go?type=gene&acc=6693,,,6693.0,SPN,10090.0,Mus musculus (house mouse),Aurantio-obtusin results in increased expression of SPN mRNA,,,PMID:34718095,https://www.ncbi.nlm.nih.gov/pubmed/34718095,34718095,,
2494,1495364,155011,Comparative Toxicogenomics Database (CTD),Aurantio-obtusin,C000595611,aurantio-obtusin,https://ctdbase.org/detail.go?type=chem&acc=C000595611,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Aurantio-obtusin results in increased expression of TNF mRNA,,,PMID:34718095,https://www.ncbi.nlm.nih.gov/pubmed/34718095,34718095,,
2495,1495365,155011,Comparative Toxicogenomics Database (CTD),Aurantio-obtusin,C000595611,aurantio-obtusin,https://ctdbase.org/detail.go?type=chem&acc=C000595611,554167,TNFB,https://ctdbase.org/detail.go?type=gene&acc=554167,,,554167.0,tnfb,7955.0,Danio rerio (zebrafish),Aurantio-obtusin results in increased expression of TNFB mRNA,,,PMID:34718095,https://www.ncbi.nlm.nih.gov/pubmed/34718095,34718095,,
2496,1495366,155011,Comparative Toxicogenomics Database (CTD),Aurantio-obtusin,C000595611,aurantio-obtusin,https://ctdbase.org/detail.go?type=chem&acc=C000595611,7514,XPO1,https://ctdbase.org/detail.go?type=gene&acc=7514,,,7514.0,XPO1,10090.0,Mus musculus (house mouse),Aurantio-obtusin results in decreased expression of XPO1 mRNA,,,PMID:34718095,https://www.ncbi.nlm.nih.gov/pubmed/34718095,34718095,,
2497,1445463,155160,Therapeutic Target Database (TTD),4-O-Methylhonokiol,D01OFH,METHYLHONOKIOL,https://idrblab.net/ttd/data/drug/details/D01OFH,T66665,Prostaglandin G/H synthase 2 (COX-2),https://idrblab.net/ttd/data/target/details/T66665,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2498,1445464,155160,Therapeutic Target Database (TTD),4-O-Methylhonokiol,D01OFH,METHYLHONOKIOL,https://idrblab.net/ttd/data/drug/details/D01OFH,T60529,Prostaglandin G/H synthase 1 (COX-1),https://idrblab.net/ttd/data/target/details/T60529,P23219,Prostaglandin G/H synthase 1,5742.0,PTGS1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2499,1495367,155160,BindingDB,4-O-Methylhonokiol,50295926,"4&#39;-O-methylhonokiol, MH",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50295926,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),43.9,PMID:21867920|DOI:10.1016/j.chembiol.2011.05.012,https://www.ncbi.nlm.nih.gov/pubmed/21867920|https://doi.org/10.1016/j.chembiol.2011.05.012,21867920,10.1016/j.chembiol.2011.05.012,
2500,1445297,155434,Drug Gene Interaction database (DGIdb),Acamprosate Calcium,,ACAMPROSATE CALCIUM,https://www.dgidb.org/drugs/rxcui:152761,,GABRA5,https://www.dgidb.org/genes/hgnc:4079,,,2558.0,GABRA5,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
2501,1445298,155434,Drug Gene Interaction database (DGIdb),Acamprosate Calcium,,ACAMPROSATE CALCIUM,https://www.dgidb.org/drugs/rxcui:152761,,GABRB2,https://www.dgidb.org/genes/hgnc:4082,,,2561.0,GABRB2,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
2502,1445465,155434,Comparative Toxicogenomics Database (CTD),Acamprosate Calcium,D000077443,Acamprosate,https://ctdbase.org/detail.go?type=chem&acc=D000077443,1813,DRD2,https://ctdbase.org/detail.go?type=gene&acc=1813,,,1813.0,DRD2,9606.0,Homo sapiens (human),DRD2 affects the susceptibility to acamprosate,,,PMID:19523047,https://www.ncbi.nlm.nih.gov/pubmed/19523047,19523047,,
2503,1445466,155434,Comparative Toxicogenomics Database (CTD),Acamprosate Calcium,D000077443,Acamprosate,https://ctdbase.org/detail.go?type=chem&acc=D000077443,2332,FMR1,https://ctdbase.org/detail.go?type=gene&acc=2332,,,2332.0,FMR1,10090.0,Mus musculus (house mouse),Acamprosate inhibits the reaction [FMR1 protein affects the phosphorylation of MAPK3 protein]|acamprosate inhibits the reaction [FMR1 protein affects the phosphorylation of MAPK1 protein],,,PMID:28616095,https://www.ncbi.nlm.nih.gov/pubmed/28616095,28616095,,
2504,1445467,155434,Comparative Toxicogenomics Database (CTD),Acamprosate Calcium,D000077443,Acamprosate,https://ctdbase.org/detail.go?type=chem&acc=D000077443,2559,GABRA6,https://ctdbase.org/detail.go?type=gene&acc=2559,,,2559.0,GABRA6,9606.0,Homo sapiens (human),GABRA6 affects the susceptibility to acamprosate,,,PMID:19523047,https://www.ncbi.nlm.nih.gov/pubmed/19523047,19523047,,
2505,1445468,155434,Comparative Toxicogenomics Database (CTD),Acamprosate Calcium,D000077443,Acamprosate,https://ctdbase.org/detail.go?type=chem&acc=D000077443,2561,GABRB2,https://ctdbase.org/detail.go?type=gene&acc=2561,,,2561.0,GABRB2,9606.0,Homo sapiens (human),GABRB2 affects the susceptibility to acamprosate,,,PMID:19523047,https://www.ncbi.nlm.nih.gov/pubmed/19523047,19523047,,
2506,1445469,155434,Comparative Toxicogenomics Database (CTD),Acamprosate Calcium,D000077443,Acamprosate,https://ctdbase.org/detail.go?type=chem&acc=D000077443,2915,GRM5,https://ctdbase.org/detail.go?type=gene&acc=2915,,,2915.0,GRM5,10090.0,Mus musculus (house mouse),GRM5 affects the susceptibility to acamprosate,,,PMID:18377703,https://www.ncbi.nlm.nih.gov/pubmed/18377703,18377703,,
2507,1445470,155434,Comparative Toxicogenomics Database (CTD),Acamprosate Calcium,D000077443,Acamprosate,https://ctdbase.org/detail.go?type=chem&acc=D000077443,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090.0,Mus musculus (house mouse),Acamprosate inhibits the reaction [FMR1 protein affects the phosphorylation of MAPK1 protein],,,PMID:28616095,https://www.ncbi.nlm.nih.gov/pubmed/28616095,28616095,,
2508,1445299,155774,IUPHAR/BPS Guide to PHARMACOLOGY,Xamoterol,538,xamoterol,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=538,28,β1-adrenoceptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=28,P08588,Beta-1 adrenergic receptor,153.0,ADRB1,9606.0,Homo sapiens (human),Partial agonist,pKi,7,PMID:10531390,https://www.ncbi.nlm.nih.gov/pubmed/10531390,10531390,,
2509,1445300,156126,DrugBank,L-Vinylglycine,DB03214,Vinylglycine,https://www.drugbank.ca/drugs/DB03214,BE0004566,L-amino-acid oxidase,https://www.drugbank.ca/bio_entities/BE0004566,Q96RQ9,L-amino-acid oxidase,259307.0,IL4I1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
2510,1445301,156126,DrugBank,L-Vinylglycine,DB03214,Vinylglycine,https://www.drugbank.ca/drugs/DB03214,BE0003515,1-aminocyclopropane-1-carboxylate synthase-like protein 1,https://www.drugbank.ca/bio_entities/BE0003515,Q96QU6,1-aminocyclopropane-1-carboxylate synthase-like protein 1,84680.0,ACCS,9606.0,Homo sapiens (human),,,,PMID:16667107,https://www.ncbi.nlm.nih.gov/pubmed/16667107,16667107,,
2511,1445302,156297,IUPHAR/BPS Guide to PHARMACOLOGY,"1-(3,4-Dimethoxyphenethylamino)-3-(3,4-dihydroxyphenoxy)-2-propanol",5571,(-)-Ro 363,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5571,28,β1-adrenoceptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=28,P08588,Beta-1 adrenergic receptor,153.0,ADRB1,9606.0,Homo sapiens (human),Agonist,pKi,8,PMID:9117106,https://www.ncbi.nlm.nih.gov/pubmed/9117106,9117106,,
2512,1445303,156418,Drug Gene Interaction database (DGIdb),Cinacalcet Hydrochloride,,CINACALCET HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:384379,,CASR,https://www.dgidb.org/genes/hgnc:1514,,,846.0,CASR,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
2513,1446037,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,51181,DCXR,https://ctdbase.org/detail.go?type=gene&acc=51181,,,51181.0,DCXR,9606.0,Homo sapiens (human),"[DCXR protein results in increased metabolism of 9,10-phenanthrenequinone] which results in increased chemical synthesis of hydroxyl radical|dcxr protein results in increased chemical synthesis of hydroxyl radical",,,PMID:28595002,https://www.ncbi.nlm.nih.gov/pubmed/28595002,28595002,,
2514,1446038,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,54541,DDIT4,https://ctdbase.org/detail.go?type=gene&acc=54541,,,54541.0,DDIT4,9606.0,Homo sapiens (human),[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mrna] which results in decreased expression of DDIT4 mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
2515,1446039,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,110806271,DDIT4-AS1,https://ctdbase.org/detail.go?type=gene&acc=110806271,,,110806271.0,DDIT4-AS1,9606.0,Homo sapiens (human),[hydroxyl radical results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mrna|[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mrna] which results in decreased expression of DDIT4 mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
2516,1446040,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,83479,DDX59,https://ctdbase.org/detail.go?type=gene&acc=83479,,,83479.0,DDX59,9606.0,Homo sapiens (human),[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in increased expression of DDX59-AS1 mrna] which results in increased expression of DDX59 mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
2517,1446373,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,668,FOXL2,https://ctdbase.org/detail.go?type=gene&acc=668,,,668.0,FOXL2,9606.0,Homo sapiens (human),[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC01391 mrna] which results in increased expression of FOXL2 mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
2518,1446374,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,2495,FTH1,https://ctdbase.org/detail.go?type=gene&acc=2495,,,2495.0,FTH1,9796.0,Equus caballus (horse),[salsolinol co-treated with [FTH1 protein binds to FTL protein]] results in increased abundance of hydroxyl radical,,,PMID:19433265,https://www.ncbi.nlm.nih.gov/pubmed/19433265,19433265,,
2519,1446375,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,2512,FTL,https://ctdbase.org/detail.go?type=gene&acc=2512,,,2512.0,FTL,9796.0,Equus caballus (horse),[salsolinol co-treated with [FTH1 protein binds to FTL protein]] results in increased abundance of hydroxyl radical,,,PMID:19433265,https://www.ncbi.nlm.nih.gov/pubmed/19433265,19433265,,
2520,1446376,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,9648,GCC2,https://ctdbase.org/detail.go?type=gene&acc=9648,,,9648.0,GCC2,9606.0,Homo sapiens (human),[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mrna] which results in increased expression of GCC2 mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
2521,1446377,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,644903,GCC2-AS1,https://ctdbase.org/detail.go?type=gene&acc=644903,,,644903.0,GCC2-AS1,9606.0,Homo sapiens (human),[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mrna] which results in increased expression of GCC2 mrna|[hydroxyl radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
2522,1496278,157920,IUPHAR/BPS Guide to PHARMACOLOGY,Lubiprostone,4242,lubiprostone,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4242,699,ClC-2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=699,P51788,Chloride channel protein 2,1181.0,CLCN2,9606.0,Homo sapiens (human),,,7.52,,,,,
2523,1496279,158333,Comparative Toxicogenomics Database (CTD),tert-Butylphenyl diphenyl phosphate,C046393,tert-butylphenyl diphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046393,11607,AGTR1A,https://ctdbase.org/detail.go?type=gene&acc=11607,,,11607.0,Agtr1a,10090.0,Mus musculus (house mouse),Tert-butylphenyl diphenyl phosphate results in increased expression of AGTR1A mRNA,,,PMID:32976586,https://www.ncbi.nlm.nih.gov/pubmed/32976586,32976586,,
2524,1496280,158333,Comparative Toxicogenomics Database (CTD),tert-Butylphenyl diphenyl phosphate,C046393,tert-butylphenyl diphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046393,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211.0,ALAS1,9031.0,Gallus gallus (chicken),Tert-butylphenyl diphenyl phosphate results in increased expression of ALAS1 mRNA,,,PMID:30133003,https://www.ncbi.nlm.nih.gov/pubmed/30133003,30133003,,
2525,1496281,158333,Comparative Toxicogenomics Database (CTD),tert-Butylphenyl diphenyl phosphate,C046393,tert-butylphenyl diphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046393,285,ANGPT2,https://ctdbase.org/detail.go?type=gene&acc=285,,,285.0,ANGPT2,10090.0,Mus musculus (house mouse),Tert-butylphenyl diphenyl phosphate results in decreased expression of ANGPT2 mRNA,,,PMID:32976586,https://www.ncbi.nlm.nih.gov/pubmed/32976586,32976586,,
2526,1496282,158333,Comparative Toxicogenomics Database (CTD),tert-Butylphenyl diphenyl phosphate,C046393,tert-butylphenyl diphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046393,55509,BATF3,https://ctdbase.org/detail.go?type=gene&acc=55509,,,55509.0,BATF3,10090.0,Mus musculus (house mouse),Tert-butylphenyl diphenyl phosphate results in decreased expression of BATF3 mRNA,,,PMID:32976586,https://www.ncbi.nlm.nih.gov/pubmed/32976586,32976586,,
2527,1496283,158333,Comparative Toxicogenomics Database (CTD),tert-Butylphenyl diphenyl phosphate,C046393,tert-butylphenyl diphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046393,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,9606.0,Homo sapiens (human),[tert-butylphenyl diphenyl phosphate co-treated with NADP] results in decreased activity of BCHE protein,,,PMID:23085349,https://www.ncbi.nlm.nih.gov/pubmed/23085349,23085349,,
2528,1496284,158333,Comparative Toxicogenomics Database (CTD),tert-Butylphenyl diphenyl phosphate,C046393,tert-butylphenyl diphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046393,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090.0,Mus musculus (house mouse),Tert-butylphenyl diphenyl phosphate results in decreased expression of BCL2 mRNA,,,PMID:32976586,https://www.ncbi.nlm.nih.gov/pubmed/32976586,32976586,,
2529,1496285,158333,Comparative Toxicogenomics Database (CTD),tert-Butylphenyl diphenyl phosphate,C046393,tert-butylphenyl diphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046393,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090.0,Mus musculus (house mouse),Tert-butylphenyl diphenyl phosphate results in decreased expression of CCND1 mRNA,,,PMID:32976586,https://www.ncbi.nlm.nih.gov/pubmed/32976586,32976586,,
2530,1440442,158376,DrugBank,"Furo[2,3d]pyrimidine antifolate",DB02026,"Furo[2,3d]Pyrimidine Antifolate",https://www.drugbank.ca/drugs/DB02026,BE0001555,Dihydrofolate reductase,https://www.drugbank.ca/bio_entities/BE0001555,P16184,Dihydrofolate reductase,,,4754.0,Pneumocystis carinii,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
2531,1440443,158376,Therapeutic Target Database (TTD),"Furo[2,3d]pyrimidine antifolate",D06DIH,"Furo[2,3d]Pyrimidine Antifolate",https://idrblab.net/ttd/data/drug/details/D06DIH,T89515,Polypeptide deformylase (PDF),https://idrblab.net/ttd/data/target/details/T89515,Q9HBH1,"Peptide deformylase, mitochondrial",64146.0,PDF,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2532,1440444,158397,DrugBank,(S)-Ampa,DB02057,(S)-AMPA,https://www.drugbank.ca/drugs/DB02057,BE0000829,Glutamate receptor 2,https://www.drugbank.ca/bio_entities/BE0000829,P42262,Glutamate receptor 2,2891.0,GRIA2,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
2533,1497798,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,817,CAMK2D,https://ctdbase.org/detail.go?type=gene&acc=817,,,817.0,CAMK2D,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of CAMK2D mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2534,1497799,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,8573,CASK,https://ctdbase.org/detail.go?type=gene&acc=8573,,,8573.0,CASK,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of CASK mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2535,1497800,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,867,CBL,https://ctdbase.org/detail.go?type=gene&acc=867,,,867.0,CBL,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of CBL mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2536,1497801,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,55704,CCDC88A,https://ctdbase.org/detail.go?type=gene&acc=55704,,,55704.0,CCDC88A,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of CCDC88A mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2537,1497802,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of CCN1 mRNA,,,PMID:19164467|PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/19164467|https://www.ncbi.nlm.nih.gov/pubmed/23228038,19164467|23228038,,
2538,1497803,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,126731,CCSAP,https://ctdbase.org/detail.go?type=gene&acc=126731,,,126731.0,CCSAP,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of CCSAP mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2539,1497804,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,54462,CCSER2,https://ctdbase.org/detail.go?type=gene&acc=54462,,,54462.0,CCSER2,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of CCSER2 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2540,1497805,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,961,CD47,https://ctdbase.org/detail.go?type=gene&acc=961,,,961.0,CD47,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of CD47 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2541,1498546,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,1629,DBT,https://ctdbase.org/detail.go?type=gene&acc=1629,,,1629.0,DBT,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of DBT mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2542,1498547,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,54876,DCAF16,https://ctdbase.org/detail.go?type=gene&acc=54876,,,54876.0,DCAF16,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of DCAF16 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2543,1498548,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,10238,DCAF7,https://ctdbase.org/detail.go?type=gene&acc=10238,,,10238.0,DCAF7,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of DCAF7 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2544,1498549,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,84516,DCTN5,https://ctdbase.org/detail.go?type=gene&acc=84516,,,84516.0,DCTN5,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of DCTN5 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2545,1498550,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,79982,DNAJB14,https://ctdbase.org/detail.go?type=gene&acc=79982,,,79982.0,DNAJB14,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of DNAJB14 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2546,1498551,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,56521,DNAJC12,https://ctdbase.org/detail.go?type=gene&acc=56521,,,56521.0,DNAJC12,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of DNAJC12 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2547,1498722,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,1889,ECE1,https://ctdbase.org/detail.go?type=gene&acc=1889,,,1889.0,ECE1,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of ECE1 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2548,1498723,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,10116.0,Rattus norvegicus (Norway rat),Torcetrapib affects the expression of and affects the activity of EDN1 protein,,,PMID:21920972,https://www.ncbi.nlm.nih.gov/pubmed/21920972,21920972,,
2549,1498724,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,26098,EDRF1,https://ctdbase.org/detail.go?type=gene&acc=26098,,,26098.0,EDRF1,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of EDRF1 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2550,1498725,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,54583,EGLN1,https://ctdbase.org/detail.go?type=gene&acc=54583,,,54583.0,EGLN1,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of EGLN1 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2551,1498726,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,23301,EHBP1,https://ctdbase.org/detail.go?type=gene&acc=23301,,,23301.0,EHBP1,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of EHBP1 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2552,1498727,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,23741,EID1,https://ctdbase.org/detail.go?type=gene&acc=23741,,,23741.0,EID1,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of EID1 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2553,1499186,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,201562,HACD2,https://ctdbase.org/detail.go?type=gene&acc=201562,,,201562.0,HACD2,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of HACD2 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2554,1499187,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,29035,HAPSTR1,https://ctdbase.org/detail.go?type=gene&acc=29035,,,29035.0,HAPSTR1,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of HAPSTR1 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2555,1499188,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,55142,HAUS2,https://ctdbase.org/detail.go?type=gene&acc=55142,,,55142.0,HAUS2,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of HAUS2 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2556,1499189,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,55127,HEATR1,https://ctdbase.org/detail.go?type=gene&acc=55127,,,55127.0,HEATR1,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of HEATR1 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2557,1499190,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,25831,HECTD1,https://ctdbase.org/detail.go?type=gene&acc=25831,,,25831.0,HECTD1,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of HECTD1 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2558,1499191,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,3077,HFE,https://ctdbase.org/detail.go?type=gene&acc=3077,,,3077.0,HFE,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of HFE mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2559,1499192,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,28996,HIPK2,https://ctdbase.org/detail.go?type=gene&acc=28996,,,28996.0,HIPK2,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of HIPK2 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2560,1499193,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,3284,HSD3B2,https://ctdbase.org/detail.go?type=gene&acc=3284,,,3284.0,HSD3B2,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of HSD3B2 mRNA,,,PMID:28235592,https://www.ncbi.nlm.nih.gov/pubmed/28235592,28235592,,
2561,1499194,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,10808,HSPH1,https://ctdbase.org/detail.go?type=gene&acc=10808,,,10808.0,HSPH1,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of HSPH1 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2562,1499195,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,27336,HTATSF1,https://ctdbase.org/detail.go?type=gene&acc=27336,,,27336.0,HTATSF1,9606.0,Homo sapiens (human),Torcetrapib results in increased expression of HTATSF1 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
2563,1480869,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,54956,PARP16,https://ctdbase.org/detail.go?type=gene&acc=54956,,,54956.0,PARP16,9606.0,Homo sapiens (human),Abrine results in increased expression of PARP16 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2564,1480870,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,56965,PARP6,https://ctdbase.org/detail.go?type=gene&acc=56965,,,56965.0,PARP6,9606.0,Homo sapiens (human),Abrine results in increased expression of PARP6 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2565,1480871,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79668,PARP8,https://ctdbase.org/detail.go?type=gene&acc=79668,,,79668.0,PARP8,9606.0,Homo sapiens (human),Abrine results in increased expression of PARP8 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2566,1480872,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,83666,PARP9,https://ctdbase.org/detail.go?type=gene&acc=83666,,,83666.0,PARP9,9606.0,Homo sapiens (human),Abrine results in decreased expression of PARP9 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2567,1480873,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,64098,PARVG,https://ctdbase.org/detail.go?type=gene&acc=64098,,,64098.0,PARVG,9606.0,Homo sapiens (human),Abrine results in decreased expression of PARVG mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2568,1480874,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,139135,PASD1,https://ctdbase.org/detail.go?type=gene&acc=139135,,,139135.0,PASD1,9606.0,Homo sapiens (human),Abrine results in increased expression of PASD1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2569,1480875,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,23178,PASK,https://ctdbase.org/detail.go?type=gene&acc=23178,,,23178.0,PASK,9606.0,Homo sapiens (human),Abrine results in decreased expression of PASK mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2570,1480876,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,219988,PATL1,https://ctdbase.org/detail.go?type=gene&acc=219988,,,219988.0,PATL1,9606.0,Homo sapiens (human),Abrine results in increased expression of PATL1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2571,1480877,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,197135,PATL2,https://ctdbase.org/detail.go?type=gene&acc=197135,,,197135.0,PATL2,9606.0,Homo sapiens (human),Abrine results in increased expression of PATL2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2572,1480878,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5074,PAWR,https://ctdbase.org/detail.go?type=gene&acc=5074,,,5074.0,PAWR,9606.0,Homo sapiens (human),Abrine results in increased expression of PAWR mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2573,1480879,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5079,PAX5,https://ctdbase.org/detail.go?type=gene&acc=5079,,,5079.0,PAX5,9606.0,Homo sapiens (human),Abrine results in increased expression of PAX5 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2574,1481665,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,57524,CASKIN1,https://ctdbase.org/detail.go?type=gene&acc=57524,,,57524.0,CASKIN1,9606.0,Homo sapiens (human),Abrine results in decreased expression of CASKIN1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2575,1481666,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,9606.0,Homo sapiens (human),Abrine results in decreased expression of CASP1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2576,1481667,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,9606.0,Homo sapiens (human),Abrine results in decreased expression of CASP2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2577,1481668,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Abrine results in increased cleavage of and results in increased activity of CASP3 protein,,,PMID:23788630,https://www.ncbi.nlm.nih.gov/pubmed/23788630,23788630,,
2578,1481669,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,837,CASP4,https://ctdbase.org/detail.go?type=gene&acc=837,,,837.0,CASP4,10090.0,Mus musculus (house mouse),Abrine results in increased expression of CASP4 mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
2579,1482653,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,90557,CCDC74A,https://ctdbase.org/detail.go?type=gene&acc=90557,,,90557.0,CCDC74A,9606.0,Homo sapiens (human),Abrine results in decreased expression of CCDC74A mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2580,1482654,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,91409,CCDC74B,https://ctdbase.org/detail.go?type=gene&acc=91409,,,91409.0,CCDC74B,9606.0,Homo sapiens (human),Abrine results in decreased expression of CCDC74B mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2581,1483250,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),Abrine results in decreased expression of CCND1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2582,1483251,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896.0,CCND3,9606.0,Homo sapiens (human),Abrine results in decreased expression of CCND3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2583,1483252,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),Abrine results in decreased expression of CCNE1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2584,1483253,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,9134,CCNE2,https://ctdbase.org/detail.go?type=gene&acc=9134,,,9134.0,CCNE2,9606.0,Homo sapiens (human),Abrine results in decreased expression of CCNE2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2585,1483254,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,902,CCNH,https://ctdbase.org/detail.go?type=gene&acc=902,,,902.0,CCNH,9606.0,Homo sapiens (human),Abrine results in increased expression of CCNH mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2586,1483255,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79616,CCNJL,https://ctdbase.org/detail.go?type=gene&acc=79616,,,79616.0,CCNJL,9606.0,Homo sapiens (human),Abrine results in decreased expression of CCNJL mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2587,1483256,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,57018,CCNL1,https://ctdbase.org/detail.go?type=gene&acc=57018,,,57018.0,CCNL1,9606.0,Homo sapiens (human),Abrine results in increased expression of CCNL1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2588,1483257,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10309,CCNO,https://ctdbase.org/detail.go?type=gene&acc=10309,,,10309.0,CCNO,9606.0,Homo sapiens (human),Abrine results in decreased expression of CCNO mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2589,1483394,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55825,PECR,https://ctdbase.org/detail.go?type=gene&acc=55825,,,55825.0,PECR,9606.0,Homo sapiens (human),Abrine results in decreased expression of PECR mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2590,1483395,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,387521,PEDS1,https://ctdbase.org/detail.go?type=gene&acc=387521,,,387521.0,PEDS1,9606.0,Homo sapiens (human),Abrine results in decreased expression of PEDS1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2591,1485168,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,80235,PIGZ,https://ctdbase.org/detail.go?type=gene&acc=80235,,,80235.0,PIGZ,9606.0,Homo sapiens (human),Abrine results in decreased expression of PIGZ mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2592,1485169,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,118788,PIK3AP1,https://ctdbase.org/detail.go?type=gene&acc=118788,,,118788.0,PIK3AP1,9606.0,Homo sapiens (human),Abrine results in decreased expression of PIK3AP1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2593,1485170,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5287,PIK3C2B,https://ctdbase.org/detail.go?type=gene&acc=5287,,,5287.0,PIK3C2B,9606.0,Homo sapiens (human),Abrine results in decreased expression of PIK3C2B mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2594,1485171,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5291,PIK3CB,https://ctdbase.org/detail.go?type=gene&acc=5291,,,5291.0,PIK3CB,9606.0,Homo sapiens (human),Abrine results in decreased expression of PIK3CB mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2595,1485172,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5293,PIK3CD,https://ctdbase.org/detail.go?type=gene&acc=5293,,,5293.0,PIK3CD,9606.0,Homo sapiens (human),Abrine results in increased expression of PIK3CD mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2596,1485173,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5294,PIK3CG,https://ctdbase.org/detail.go?type=gene&acc=5294,,,5294.0,PIK3CG,9606.0,Homo sapiens (human),Abrine results in increased expression of PIK3CG mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2597,1485174,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,113791,PIK3IP1,https://ctdbase.org/detail.go?type=gene&acc=113791,,,113791.0,PIK3IP1,9606.0,Homo sapiens (human),Abrine results in increased expression of PIK3IP1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2598,1485175,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5295,PIK3R1,https://ctdbase.org/detail.go?type=gene&acc=5295,,,5295.0,PIK3R1,9606.0,Homo sapiens (human),Abrine results in decreased expression of PIK3R1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2599,1485456,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,375298,CERKL,https://ctdbase.org/detail.go?type=gene&acc=375298,,,375298.0,CERKL,9606.0,Homo sapiens (human),Abrine results in decreased expression of CERKL mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2600,1485457,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79603,CERS4,https://ctdbase.org/detail.go?type=gene&acc=79603,,,79603.0,CERS4,9606.0,Homo sapiens (human),Abrine results in decreased expression of CERS4 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2601,1485458,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,253782,CERS6,https://ctdbase.org/detail.go?type=gene&acc=253782,,,253782.0,CERS6,9606.0,Homo sapiens (human),Abrine results in decreased expression of CERS6 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2602,1485459,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,253782,CERS6,https://ctdbase.org/detail.go?type=gene&acc=253782,,,253782.0,CERS6,10090.0,Mus musculus (house mouse),Abrine results in decreased expression of CERS6 mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
2603,1485460,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1066,CES1,https://ctdbase.org/detail.go?type=gene&acc=1066,,,1066.0,CES1,9606.0,Homo sapiens (human),Abrine results in increased expression of CES1 protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2604,1485461,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8824,CES2,https://ctdbase.org/detail.go?type=gene&acc=8824,,,8824.0,CES2,9606.0,Homo sapiens (human),Abrine results in increased expression of CES2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2605,1485462,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1069,CETN2,https://ctdbase.org/detail.go?type=gene&acc=1069,,,1069.0,CETN2,9606.0,Homo sapiens (human),Abrine results in decreased expression of CETN2 protein|abrine results in decreased expression of CETN2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2606,1485463,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,90835,CFAP119,https://ctdbase.org/detail.go?type=gene&acc=90835,,,90835.0,CFAP119,9606.0,Homo sapiens (human),Abrine results in increased expression of CFAP119 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2607,1485464,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,161502,CFAP161,https://ctdbase.org/detail.go?type=gene&acc=161502,,,161502.0,CFAP161,9606.0,Homo sapiens (human),Abrine results in increased expression of CFAP161 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2608,1485465,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,257236,CFAP184,https://ctdbase.org/detail.go?type=gene&acc=257236,,,257236.0,CFAP184,9606.0,Homo sapiens (human),Abrine results in increased expression of CFAP184 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2609,1485745,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,3075,CFH,https://ctdbase.org/detail.go?type=gene&acc=3075,,,3075.0,CFH,9606.0,Homo sapiens (human),Abrine results in decreased expression of CFH mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2610,1485746,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,3078,CFHR1,https://ctdbase.org/detail.go?type=gene&acc=3078,,,3078.0,CFHR1,9606.0,Homo sapiens (human),Abrine results in decreased expression of CFHR1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2611,1485747,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10878,CFHR3,https://ctdbase.org/detail.go?type=gene&acc=10878,,,10878.0,CFHR3,9606.0,Homo sapiens (human),Abrine results in decreased expression of CFHR3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2612,1485748,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,3426,CFI,https://ctdbase.org/detail.go?type=gene&acc=3426,,,3426.0,CFI,9606.0,Homo sapiens (human),Abrine results in decreased expression of CFI mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2613,1485749,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8837,CFLAR,https://ctdbase.org/detail.go?type=gene&acc=8837,,,8837.0,CFLAR,9606.0,Homo sapiens (human),Abrine results in increased expression of CFLAR mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2614,1485750,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8837,CFLAR,https://ctdbase.org/detail.go?type=gene&acc=8837,,,8837.0,CFLAR,10090.0,Mus musculus (house mouse),Abrine results in increased expression of CFLAR mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
2615,1485751,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,115004,CGAS,https://ctdbase.org/detail.go?type=gene&acc=115004,,,115004.0,CGAS,9606.0,Homo sapiens (human),Abrine results in increased expression of CGAS mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2616,1485752,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,114335,CGB1,https://ctdbase.org/detail.go?type=gene&acc=114335,,,114335.0,CGB1,9606.0,Homo sapiens (human),Abrine results in increased expression of CGB1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2617,1485753,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,93659,CGB5,https://ctdbase.org/detail.go?type=gene&acc=93659,,,93659.0,CGB5,9606.0,Homo sapiens (human),Abrine results in increased expression of CGB5 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2618,1485754,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,94027,CGB7,https://ctdbase.org/detail.go?type=gene&acc=94027,,,94027.0,CGB7,9606.0,Homo sapiens (human),Abrine results in increased expression of CGB7 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2619,1485882,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,51142,CHCHD2,https://ctdbase.org/detail.go?type=gene&acc=51142,,,51142.0,CHCHD2,9606.0,Homo sapiens (human),Abrine results in decreased expression of CHCHD2 protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2620,1485883,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1106,CHD2,https://ctdbase.org/detail.go?type=gene&acc=1106,,,1106.0,CHD2,9606.0,Homo sapiens (human),Abrine results in increased expression of CHD2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2621,1485884,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55636,CHD7,https://ctdbase.org/detail.go?type=gene&acc=55636,,,55636.0,CHD7,9606.0,Homo sapiens (human),Abrine results in decreased expression of CHD7 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2622,1485885,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55349,CHDH,https://ctdbase.org/detail.go?type=gene&acc=55349,,,55349.0,CHDH,9606.0,Homo sapiens (human),Abrine results in decreased expression of CHDH mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2623,1485886,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55743,CHFR,https://ctdbase.org/detail.go?type=gene&acc=55743,,,55743.0,CHFR,9606.0,Homo sapiens (human),Abrine results in increased expression of CHFR mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2624,1485887,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5308,PITX2,https://ctdbase.org/detail.go?type=gene&acc=5308,,,5308.0,PITX2,10090.0,Mus musculus (house mouse),Abrine results in decreased expression of PITX2 mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
2625,1485888,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55124,PIWIL2,https://ctdbase.org/detail.go?type=gene&acc=55124,,,55124.0,PIWIL2,9606.0,Homo sapiens (human),Abrine results in increased expression of PIWIL2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2626,1485889,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,168507,PKD1L1,https://ctdbase.org/detail.go?type=gene&acc=168507,,,168507.0,PKD1L1,9606.0,Homo sapiens (human),Abrine results in increased expression of PKD1L1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2627,1485890,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,114780,PKD1L2,https://ctdbase.org/detail.go?type=gene&acc=114780,,,114780.0,PKD1L2,9606.0,Homo sapiens (human),Abrine results in increased expression of PKD1L2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2628,1485891,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,105369154,PKD1P6-NPIPP1,https://ctdbase.org/detail.go?type=gene&acc=105369154,,,105369154.0,PKD1P6-NPIPP1,9606.0,Homo sapiens (human),Abrine results in increased expression of PKD1P6-NPIPP1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2629,1486951,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,23207,PLEKHM2,https://ctdbase.org/detail.go?type=gene&acc=23207,,,23207.0,PLEKHM2,9606.0,Homo sapiens (human),Abrine results in increased expression of PLEKHM2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2630,1486952,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,389072,PLEKHM3,https://ctdbase.org/detail.go?type=gene&acc=389072,,,389072.0,PLEKHM3,9606.0,Homo sapiens (human),Abrine results in decreased expression of PLEKHM3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2631,1486953,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,84069,PLEKHN1,https://ctdbase.org/detail.go?type=gene&acc=84069,,,84069.0,PLEKHN1,9606.0,Homo sapiens (human),Abrine results in increased expression of PLEKHN1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2632,1487377,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10687,PNMA2,https://ctdbase.org/detail.go?type=gene&acc=10687,,,10687.0,PNMA2,9606.0,Homo sapiens (human),Abrine results in decreased expression of PNMA2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2633,1487378,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,29944,PNMA3,https://ctdbase.org/detail.go?type=gene&acc=29944,,,29944.0,PNMA3,9606.0,Homo sapiens (human),Abrine results in decreased expression of PNMA3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2634,1487379,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55228,PNMA8A,https://ctdbase.org/detail.go?type=gene&acc=55228,,,55228.0,PNMA8A,9606.0,Homo sapiens (human),Abrine results in decreased expression of PNMA8A mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2635,1487380,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,56902,PNO1,https://ctdbase.org/detail.go?type=gene&acc=56902,,,56902.0,PNO1,9606.0,Homo sapiens (human),Abrine results in increased expression of PNO1 mrna|abrine results in decreased expression of PNO1 protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2636,1487381,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,57104,PNPLA2,https://ctdbase.org/detail.go?type=gene&acc=57104,,,57104.0,PNPLA2,9606.0,Homo sapiens (human),Abrine results in increased expression of PNPLA2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2637,1487382,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10908,PNPLA6,https://ctdbase.org/detail.go?type=gene&acc=10908,,,10908.0,PNPLA6,9606.0,Homo sapiens (human),Abrine results in decreased expression of PNPLA6 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2638,1487383,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,375775,PNPLA7,https://ctdbase.org/detail.go?type=gene&acc=375775,,,375775.0,PNPLA7,9606.0,Homo sapiens (human),Abrine results in decreased expression of PNPLA7 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2639,1487384,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,50640,PNPLA8,https://ctdbase.org/detail.go?type=gene&acc=50640,,,50640.0,PNPLA8,9606.0,Homo sapiens (human),Abrine results in increased expression of PNPLA8 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2640,1487385,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10957,PNRC1,https://ctdbase.org/detail.go?type=gene&acc=10957,,,10957.0,PNRC1,9606.0,Homo sapiens (human),Abrine results in increased expression of PNRC1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2641,1487663,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,113540,CMTM1,https://ctdbase.org/detail.go?type=gene&acc=113540,,,113540.0,CMTM1,9606.0,Homo sapiens (human),Abrine results in decreased expression of CMTM1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2642,1487664,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,146223,CMTM4,https://ctdbase.org/detail.go?type=gene&acc=146223,,,146223.0,CMTM4,9606.0,Homo sapiens (human),Abrine results in decreased expression of CMTM4 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2643,1487665,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,112616,CMTM7,https://ctdbase.org/detail.go?type=gene&acc=112616,,,112616.0,CMTM7,9606.0,Homo sapiens (human),Abrine results in decreased expression of CMTM7 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2644,1487666,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,152189,CMTM8,https://ctdbase.org/detail.go?type=gene&acc=152189,,,152189.0,CMTM8,9606.0,Homo sapiens (human),Abrine results in decreased expression of CMTM8 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2645,1487667,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,54714,CNGB3,https://ctdbase.org/detail.go?type=gene&acc=54714,,,54714.0,CNGB3,10090.0,Mus musculus (house mouse),Abrine results in decreased expression of CNGB3 mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
2646,1487668,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10256,CNKSR1,https://ctdbase.org/detail.go?type=gene&acc=10256,,,10256.0,CNKSR1,9606.0,Homo sapiens (human),Abrine results in increased expression of CNKSR1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2647,1487669,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,22866,CNKSR2,https://ctdbase.org/detail.go?type=gene&acc=22866,,,22866.0,CNKSR2,9606.0,Homo sapiens (human),Abrine results in decreased expression of CNKSR2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2648,1487670,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,154043,CNKSR3,https://ctdbase.org/detail.go?type=gene&acc=154043,,,154043.0,CNKSR3,9606.0,Homo sapiens (human),Abrine results in increased expression of CNKSR3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2649,1487671,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1264,CNN1,https://ctdbase.org/detail.go?type=gene&acc=1264,,,1264.0,CNN1,9606.0,Homo sapiens (human),Abrine results in increased expression of CNN1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2650,1488785,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,7464,CORO2A,https://ctdbase.org/detail.go?type=gene&acc=7464,,,7464.0,CORO2A,9606.0,Homo sapiens (human),Abrine results in decreased expression of CORO2A mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2651,1488786,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,23406,COTL1,https://ctdbase.org/detail.go?type=gene&acc=23406,,,23406.0,COTL1,9606.0,Homo sapiens (human),Abrine results in increased expression of COTL1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2652,1488787,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1355,COX15,https://ctdbase.org/detail.go?type=gene&acc=1355,,,1355.0,COX15,9606.0,Homo sapiens (human),Abrine results in decreased expression of COX15 protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2653,1488788,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,90639,COX19,https://ctdbase.org/detail.go?type=gene&acc=90639,,,90639.0,COX19,9606.0,Homo sapiens (human),Abrine results in increased expression of COX19 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2654,1488789,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1356,CP,https://ctdbase.org/detail.go?type=gene&acc=1356,,,1356.0,CP,9606.0,Homo sapiens (human),Abrine results in decreased expression of CP mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2655,1488790,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1358,CPA2,https://ctdbase.org/detail.go?type=gene&acc=1358,,,1358.0,CPA2,9606.0,Homo sapiens (human),Abrine results in increased expression of CPA2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2656,1488791,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,51200,CPA4,https://ctdbase.org/detail.go?type=gene&acc=51200,,,51200.0,CPA4,9606.0,Homo sapiens (human),Abrine results in increased expression of CPA4 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2657,1488792,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,57094,CPA6,https://ctdbase.org/detail.go?type=gene&acc=57094,,,57094.0,CPA6,9606.0,Homo sapiens (human),Abrine results in decreased expression of CPA6 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2658,1488793,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,27151,CPAMD8,https://ctdbase.org/detail.go?type=gene&acc=27151,,,27151.0,CPAMD8,9606.0,Homo sapiens (human),Abrine results in increased expression of CPAMD8 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2659,1488962,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1361,CPB2,https://ctdbase.org/detail.go?type=gene&acc=1361,,,1361.0,CPB2,9606.0,Homo sapiens (human),Abrine results in decreased expression of CPB2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2660,1489605,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10084,PQBP1,https://ctdbase.org/detail.go?type=gene&acc=10084,,,10084.0,PQBP1,9606.0,Homo sapiens (human),Abrine results in decreased expression of PQBP1 protein|abrine results in increased expression of PQBP1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2661,1489941,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1407,CRY1,https://ctdbase.org/detail.go?type=gene&acc=1407,,,1407.0,CRY1,9606.0,Homo sapiens (human),Abrine results in increased expression of CRY1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2662,1490987,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1727,CYB5R3,https://ctdbase.org/detail.go?type=gene&acc=1727,,,1727.0,CYB5R3,9606.0,Homo sapiens (human),Abrine results in decreased expression of CYB5R3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2663,1490988,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,51167,CYB5R4,https://ctdbase.org/detail.go?type=gene&acc=51167,,,51167.0,CYB5R4,9606.0,Homo sapiens (human),Abrine results in increased expression of CYB5R4 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2664,1490989,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1535,CYBA,https://ctdbase.org/detail.go?type=gene&acc=1535,,,1535.0,CYBA,9606.0,Homo sapiens (human),Abrine results in decreased expression of CYBA protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2665,1490990,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79415,CYBC1,https://ctdbase.org/detail.go?type=gene&acc=79415,,,79415.0,CYBC1,9606.0,Homo sapiens (human),Abrine results in decreased expression of CYBC1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2666,1490991,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79901,CYBRD1,https://ctdbase.org/detail.go?type=gene&acc=79901,,,79901.0,CYBRD1,9606.0,Homo sapiens (human),Abrine results in decreased expression of CYBRD1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2667,1490992,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,23191,CYFIP1,https://ctdbase.org/detail.go?type=gene&acc=23191,,,23191.0,CYFIP1,9606.0,Homo sapiens (human),Abrine results in increased expression of CYFIP1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2668,1490993,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1540,CYLD,https://ctdbase.org/detail.go?type=gene&acc=1540,,,1540.0,CYLD,9606.0,Homo sapiens (human),Abrine results in increased expression of CYLD mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2669,1490994,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Abrine results in increased expression of CYP1A1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2670,1492101,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5727,PTCH1,https://ctdbase.org/detail.go?type=gene&acc=5727,,,5727.0,PTCH1,9606.0,Homo sapiens (human),Abrine results in decreased expression of PTCH1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2671,1492102,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8643,PTCH2,https://ctdbase.org/detail.go?type=gene&acc=8643,,,8643.0,PTCH2,9606.0,Homo sapiens (human),Abrine results in increased expression of PTCH2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2672,1492103,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,442213,PTCHD4,https://ctdbase.org/detail.go?type=gene&acc=442213,,,442213.0,PTCHD4,9606.0,Homo sapiens (human),Abrine results in increased expression of PTCHD4 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2673,1492924,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1607,DGKB,https://ctdbase.org/detail.go?type=gene&acc=1607,,,1607.0,DGKB,10090.0,Mus musculus (house mouse),Abrine results in decreased expression of DGKB mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
2674,1492925,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8526,DGKE,https://ctdbase.org/detail.go?type=gene&acc=8526,,,8526.0,DGKE,9606.0,Homo sapiens (human),Abrine results in increased expression of DGKE mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2675,1493104,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,200895,DHFR2,https://ctdbase.org/detail.go?type=gene&acc=200895,,,200895.0,DHFR2,9606.0,Homo sapiens (human),Abrine results in decreased expression of DHFR2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2676,1493105,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1723,DHODH,https://ctdbase.org/detail.go?type=gene&acc=1723,,,1723.0,DHODH,9606.0,Homo sapiens (human),Abrine results in decreased expression of DHODH mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2677,1493106,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79758,DHRS12,https://ctdbase.org/detail.go?type=gene&acc=79758,,,79758.0,DHRS12,9606.0,Homo sapiens (human),Abrine results in increased expression of DHRS12 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2678,1493107,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,147015,DHRS13,https://ctdbase.org/detail.go?type=gene&acc=147015,,,147015.0,DHRS13,9606.0,Homo sapiens (human),Abrine results in decreased expression of DHRS13 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2679,1493108,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10202,DHRS2,https://ctdbase.org/detail.go?type=gene&acc=10202,,,10202.0,DHRS2,9606.0,Homo sapiens (human),Abrine results in increased expression of DHRS2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2680,1493109,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10901,DHRS4,https://ctdbase.org/detail.go?type=gene&acc=10901,,,10901.0,DHRS4,9606.0,Homo sapiens (human),Abrine results in increased expression of DHRS4 protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2681,1493110,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,51635,DHRS7,https://ctdbase.org/detail.go?type=gene&acc=51635,,,51635.0,DHRS7,9606.0,Homo sapiens (human),Abrine results in decreased expression of DHRS7 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2682,1493111,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,25979,DHRS7B,https://ctdbase.org/detail.go?type=gene&acc=25979,,,25979.0,DHRS7B,9606.0,Homo sapiens (human),Abrine results in increased expression of DHRS7B mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2683,1494098,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,25782,RAB3GAP2,https://ctdbase.org/detail.go?type=gene&acc=25782,,,25782.0,RAB3GAP2,9606.0,Homo sapiens (human),Abrine results in increased expression of RAB3GAP2 mrna|abrine results in increased expression of RAB3GAP2 protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2684,1494099,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,117177,RAB3IP,https://ctdbase.org/detail.go?type=gene&acc=117177,,,117177.0,RAB3IP,9606.0,Homo sapiens (human),Abrine results in increased expression of RAB3IP mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2685,1494100,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10966,RAB40B,https://ctdbase.org/detail.go?type=gene&acc=10966,,,10966.0,RAB40B,9606.0,Homo sapiens (human),Abrine results in decreased expression of RAB40B mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2686,1494101,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,57799,RAB40C,https://ctdbase.org/detail.go?type=gene&acc=57799,,,57799.0,RAB40C,9606.0,Homo sapiens (human),Abrine results in decreased expression of RAB40C mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2687,1494102,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,339122,RAB43,https://ctdbase.org/detail.go?type=gene&acc=339122,,,339122.0,RAB43,9606.0,Homo sapiens (human),Abrine results in decreased expression of RAB43 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2688,1494103,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5867,RAB4A,https://ctdbase.org/detail.go?type=gene&acc=5867,,,5867.0,RAB4A,9606.0,Homo sapiens (human),Abrine results in decreased expression of RAB4A mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2689,1494104,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5868,RAB5A,https://ctdbase.org/detail.go?type=gene&acc=5868,,,5868.0,RAB5A,9606.0,Homo sapiens (human),Abrine results in increased expression of RAB5A mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2690,1494105,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,51560,RAB6B,https://ctdbase.org/detail.go?type=gene&acc=51560,,,51560.0,RAB6B,9606.0,Homo sapiens (human),Abrine results in decreased expression of RAB6B mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
2691,1445680,160615,Comparative Toxicogenomics Database (CTD),4-Hydroxytestosterone,C032278,"4,17 beta-dihydroxy-4-androstene-3-one",https://ctdbase.org/detail.go?type=chem&acc=C032278,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606.0,Homo sapiens (human),"4,17 beta-dihydroxy-4-androstene-3-one results in increased expression of AR mRNA",,,PMID:29702199,https://www.ncbi.nlm.nih.gov/pubmed/29702199,29702199,,
2692,1445681,160615,Comparative Toxicogenomics Database (CTD),4-Hydroxytestosterone,C032278,"4,17 beta-dihydroxy-4-androstene-3-one",https://ctdbase.org/detail.go?type=chem&acc=C032278,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),"4,17 beta-dihydroxy-4-androstene-3-one inhibits the reaction [estradiol results in increased expression of CYP1A1 mrna]",,,PMID:10619402,https://www.ncbi.nlm.nih.gov/pubmed/10619402,10619402,,
2693,1445682,160615,Comparative Toxicogenomics Database (CTD),4-Hydroxytestosterone,C032278,"4,17 beta-dihydroxy-4-androstene-3-one",https://ctdbase.org/detail.go?type=chem&acc=C032278,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),"4,17 beta-dihydroxy-4-androstene-3-one inhibits the reaction [estradiol results in increased expression of ESR1 mrna]",,,PMID:29702199,https://www.ncbi.nlm.nih.gov/pubmed/29702199,29702199,,
2694,1445683,160615,Comparative Toxicogenomics Database (CTD),4-Hydroxytestosterone,C032278,"4,17 beta-dihydroxy-4-androstene-3-one",https://ctdbase.org/detail.go?type=chem&acc=C032278,412,STS,https://ctdbase.org/detail.go?type=gene&acc=412,,,412.0,STS,9606.0,Homo sapiens (human),"4,17 beta-dihydroxy-4-androstene-3-one metabolite results in decreased activity of STS protein",,,PMID:11600235,https://www.ncbi.nlm.nih.gov/pubmed/11600235,11600235,,
2695,1494590,161350,Toxin and Toxin Target Database (T3DB),Cobalt mesoporphyrin,T3D0664,Cobalt(II) mesoporphyrin,http://www.t3db.ca/toxins/T3D0664,BE0000322,Carbonic anhydrase 2,http://www.t3db.ca/biodb/bio_entities/BE0000322,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),"Cobalt inhibits carbonic anhydrases.(a38, A98)",,,PMID:18237030|PMID:12164389,https://www.ncbi.nlm.nih.gov/pubmed/18237030|https://www.ncbi.nlm.nih.gov/pubmed/12164389,18237030|12164389,,
2696,1494591,161350,Toxin and Toxin Target Database (T3DB),Cobalt mesoporphyrin,T3D0664,Cobalt(II) mesoporphyrin,http://www.t3db.ca/toxins/T3D0664,BE0000535,Carbonic anhydrase 4,http://www.t3db.ca/biodb/bio_entities/BE0000535,P22748,Carbonic anhydrase 4,762.0,CA4,9606.0,Homo sapiens (human),"Cobalt inhibits carbonic anhydrases.(a38, A98)",,,PMID:18237030|PMID:12164389,https://www.ncbi.nlm.nih.gov/pubmed/18237030|https://www.ncbi.nlm.nih.gov/pubmed/12164389,18237030|12164389,,
2697,1494592,161350,Toxin and Toxin Target Database (T3DB),Cobalt mesoporphyrin,T3D0664,Cobalt(II) mesoporphyrin,http://www.t3db.ca/toxins/T3D0664,BE0000898,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000898,P22557,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",212.0,ALAS2,9606.0,Homo sapiens (human),Cobalt inhibits heme synthesis by preventing synthesis of 5-aminolaevulinate via inhibition of 5-aminolaevulinate synthase. (L22),,,,,,,
2698,1494593,161350,Toxin and Toxin Target Database (T3DB),Cobalt mesoporphyrin,T3D0664,Cobalt(II) mesoporphyrin,http://www.t3db.ca/toxins/T3D0664,BE0000409,"5-aminolevulinate synthase, nonspecific, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000409,P13196,"5-aminolevulinate synthase, nonspecific, mitochondrial",211.0,ALAS1,9606.0,Homo sapiens (human),Cobalt inhibits heme synthesis by preventing synthesis of 5-aminolaevulinate via inhibition of 5-aminolaevulinate synthase. (L22),,,,,,,
2699,1494594,161350,Toxin and Toxin Target Database (T3DB),Cobalt mesoporphyrin,T3D0664,Cobalt(II) mesoporphyrin,http://www.t3db.ca/toxins/T3D0664,BE0005051,DNA repair protein complementing XP-A cells,http://www.t3db.ca/biodb/bio_entities/BE0005051,P23025,DNA repair protein complementing XP-A cells,7507.0,XPA,9606.0,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,
2700,1494595,161350,Toxin and Toxin Target Database (T3DB),Cobalt mesoporphyrin,T3D0664,Cobalt(II) mesoporphyrin,http://www.t3db.ca/toxins/T3D0664,BE0005097,Ig alpha-1 chain C region,http://www.t3db.ca/biodb/bio_entities/BE0005097,P01876,Immunoglobulin heavy constant alpha 1,,,9606.0,Homo sapiens (human),"Cobalt interacts with specific iga antibodies, resulting in immunosensitization. (A102)",,,PMID:6663071,https://www.ncbi.nlm.nih.gov/pubmed/6663071,6663071,,
2701,1494596,161350,Toxin and Toxin Target Database (T3DB),Cobalt mesoporphyrin,T3D0664,Cobalt(II) mesoporphyrin,http://www.t3db.ca/toxins/T3D0664,BE0004610,Ig alpha-2 chain C region,http://www.t3db.ca/biodb/bio_entities/BE0004610,P01877,Immunoglobulin heavy constant alpha 2,,,9606.0,Homo sapiens (human),"Cobalt interacts with specific iga antibodies, resulting in immunosensitization. (A102)",,,PMID:6663071,https://www.ncbi.nlm.nih.gov/pubmed/6663071,6663071,,
2702,1494597,161350,Toxin and Toxin Target Database (T3DB),Cobalt mesoporphyrin,T3D0664,Cobalt(II) mesoporphyrin,http://www.t3db.ca/toxins/T3D0664,BE0002867,Ig epsilon chain C region,http://www.t3db.ca/biodb/bio_entities/BE0002867,P01854,Immunoglobulin heavy constant epsilon,,,9606.0,Homo sapiens (human),"Cobalt interacts with specific ige antibodies, resulting in immunosensitization. (A101)",,,PMID:3233723,https://www.ncbi.nlm.nih.gov/pubmed/3233723,3233723,,
2703,1494930,161350,Toxin and Toxin Target Database (T3DB),Cobalt mesoporphyrin,T3D0664,Cobalt(II) mesoporphyrin,http://www.t3db.ca/toxins/T3D0664,BE0005110,Voltage-dependent calcium channel gamma-4 subunit,http://www.t3db.ca/biodb/bio_entities/BE0005110,Q9UBN1,Voltage-dependent calcium channel gamma-4 subunit,27092.0,CACNG4,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
2704,1445684,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C406082,monomethylarsonous acid,https://ctdbase.org/detail.go?type=chem&acc=C406082,55256,ADI1,https://ctdbase.org/detail.go?type=gene&acc=55256,,,55256.0,ADI1,9606.0,Homo sapiens (human),Monomethylarsonous acid results in decreased expression of ADI1 protein,,,PMID:24625837,https://www.ncbi.nlm.nih.gov/pubmed/24625837,24625837,,
2705,1442428,163091,Drug Gene Interaction database (DGIdb),Asenapine,,ASENAPINE,https://www.dgidb.org/drugs/rxcui:784649,,ADRA2C,https://www.dgidb.org/genes/hgnc:283,,,152.0,ADRA2C,9606.0,Homo sapiens (human),,,,,,,,
2706,1442429,163091,Drug Gene Interaction database (DGIdb),Asenapine,,ASENAPINE,https://www.dgidb.org/drugs/rxcui:784649,,ADRA2B,https://www.dgidb.org/genes/hgnc:282,,,151.0,ADRA2B,9606.0,Homo sapiens (human),,,,,,,,
2707,1442552,164908,DrugBank,Adenylyl-3'-5'-phospho-uridine-3'-monophosphate,DB01792,Adenylyl-(3'-5')-uridine 3'-monophosphate,https://www.drugbank.ca/drugs/DB01792,BE0001370,Diphtheria toxin,https://www.drugbank.ca/bio_entities/BE0001370,P00587,Diphtheria toxin,,,10714.0,Corynephage omega,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
2708,1442553,165002,Drug Gene Interaction database (DGIdb),"(2S)-3-(2-methoxyphenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine",,DEXTROMEPROMAZINE,https://www.dgidb.org/drugs/chembl:CHEMBL1323355,,CYP2D6,https://www.dgidb.org/genes/hgnc:2625,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),,,,,,,,
2709,1442554,165151,Therapeutic Target Database (TTD),3'-Deoxythymidine-5'-monophosphate,D0SC7C,"2',3'-Dideoxythymidine-5'-Monophosphate",https://idrblab.net/ttd/data/drug/details/D0SC7C,T94400,Mycobacterium Thymidine monophosphate kinase (MycB tmk),https://idrblab.net/ttd/data/target/details/T94400,P9WKE1,Thymidylate kinase,888740.0,tmk,83332.0,Mycobacterium tuberculosis H37Rv,Inhibitor,,,,,,,
2710,1442555,165230,Therapeutic Target Database (TTD),2'-Monophosphoadenosine-5'-diphosphate,D0CH7U,2'-Monophosphoadenosine-5'-Diphosphate,https://idrblab.net/ttd/data/drug/details/D0CH7U,T89515,Polypeptide deformylase (PDF),https://idrblab.net/ttd/data/target/details/T89515,Q9HBH1,"Peptide deformylase, mitochondrial",64146.0,PDF,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2711,1442556,165339,Therapeutic Target Database (TTD),S-Hydroxycysteine,D0V6UC,Cysteine Sulfenic Acid,https://idrblab.net/ttd/data/drug/details/D0V6UC,T89529,PTPN1 messenger RNA (PTPN1 mRNA),https://idrblab.net/ttd/data/target/details/T89529,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2712,1442684,165381,DrugBank,Diadenosine triphosphate,DB01690,Bis(Adenosine)-5'-Triphosphate,https://www.drugbank.ca/drugs/DB01690,BE0001231,Dephospho-CoA kinase,https://www.drugbank.ca/bio_entities/BE0001231,P0A6I9,Dephospho-CoA kinase,75202081.0,,83333.0,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
2713,1442685,165390,DrugBank,methacrylyl-CoA,DB01675,Methacrylyl-Coenzyme A,https://www.drugbank.ca/drugs/DB01675,BE0000605,"Isobutyryl-CoA dehydrogenase, mitochondrial",https://www.drugbank.ca/bio_entities/BE0000605,Q9UKU7,"Isobutyryl-CoA dehydrogenase, mitochondrial",27034.0,ACAD8,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
2714,1442686,165491,Comparative Toxicogenomics Database (CTD),Nicotinic acid adenine dinucleotide,C018348,nicotinic acid adenine dinucleotide,https://ctdbase.org/detail.go?type=chem&acc=C018348,2589,GALNT1,https://ctdbase.org/detail.go?type=gene&acc=2589,,,2589.0,GALNT1,9606.0,Homo sapiens (human),Nicotinic acid adenine dinucleotide results in increased expression of GALNT1 mRNA,,,PMID:29935245,https://www.ncbi.nlm.nih.gov/pubmed/29935245,29935245,,
2715,1442687,165491,Comparative Toxicogenomics Database (CTD),Nicotinic acid adenine dinucleotide,C018348,nicotinic acid adenine dinucleotide,https://ctdbase.org/detail.go?type=chem&acc=C018348,4583,MUC2,https://ctdbase.org/detail.go?type=gene&acc=4583,,,4583.0,MUC2,9606.0,Homo sapiens (human),Nicotinic acid adenine dinucleotide results in increased expression of MUC2 mRNA,,,PMID:29935245,https://www.ncbi.nlm.nih.gov/pubmed/29935245,29935245,,
2716,1442812,165879,DrugBank,4-Nitrocatechol sulfate,DB01800,4-Nitrocatechol sulfate,https://www.drugbank.ca/drugs/DB01800,BE0001352,Tyrosine-protein phosphatase YopH,https://www.drugbank.ca/bio_entities/BE0001352,P15273,Tyrosine-protein phosphatase YopH,,,630.0,Yersinia enterocolitica,,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
2717,1442813,167250,Therapeutic Target Database (TTD),Dimethylarsinate,D09TVP,Cacodylate Ion,https://idrblab.net/ttd/data/drug/details/D09TVP,T98933,Thyroid hormone receptor beta (THRB),https://idrblab.net/ttd/data/target/details/T98933,P10828,Thyroid hormone receptor beta,7068.0,THRB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2718,1442814,167250,Therapeutic Target Database (TTD),Dimethylarsinate,D09TVP,Cacodylate Ion,https://idrblab.net/ttd/data/drug/details/D09TVP,T85944,Pseudomonas UDP-3-O-acyl-GlcNAc deacetylase (Pseudo lpxC),https://idrblab.net/ttd/data/target/details/T85944,P47205,UDP-3-O-acyl-N-acetylglucosamine deacetylase,881292.0,lpxC,208964.0,Pseudomonas aeruginosa PAO1,Inhibitor,,,,,,,
2719,1442815,167250,Therapeutic Target Database (TTD),Dimethylarsinate,D09TVP,Cacodylate Ion,https://idrblab.net/ttd/data/drug/details/D09TVP,T06046,Nitric-oxide synthase endothelial (NOS3),https://idrblab.net/ttd/data/target/details/T06046,P29474,"Nitric oxide synthase, endothelial",4846.0,NOS3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2720,1442816,167250,Therapeutic Target Database (TTD),Dimethylarsinate,D09TVP,Cacodylate Ion,https://idrblab.net/ttd/data/drug/details/D09TVP,T85616,Thioredoxin (TXN),https://idrblab.net/ttd/data/target/details/T85616,P10599,Thioredoxin,7295.0,TXN,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2721,1442817,167250,Therapeutic Target Database (TTD),Dimethylarsinate,D09TVP,Cacodylate Ion,https://idrblab.net/ttd/data/drug/details/D09TVP,T39610,Calmodulin (CALM),https://idrblab.net/ttd/data/target/details/T39610,P0DP23,Calmodulin-1,808.0,CALM3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2722,1442818,167250,Therapeutic Target Database (TTD),Dimethylarsinate,D09TVP,Cacodylate Ion,https://idrblab.net/ttd/data/drug/details/D09TVP,T39610,Calmodulin (CALM),https://idrblab.net/ttd/data/target/details/T39610,P0DP24,Calmodulin-2,808.0,CALM3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2723,1442819,167250,Therapeutic Target Database (TTD),Dimethylarsinate,D09TVP,Cacodylate Ion,https://idrblab.net/ttd/data/drug/details/D09TVP,T39610,Calmodulin (CALM),https://idrblab.net/ttd/data/target/details/T39610,P0DP25,Calmodulin-3,801.0,CALM1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2724,1442820,168038,Drug Gene Interaction database (DGIdb),(22S)-22-hydroxycholesterol,,CHEMBL:CHEMBL1243244,https://www.dgidb.org/drugs/chembl:CHEMBL1243244,,NR1H3,https://www.dgidb.org/genes/hgnc:7966,,,10062.0,NR1H3,9606.0,Homo sapiens (human),,,,,,,,
2725,1443797,169132,Toxin and Toxin Target Database (T3DB),Isophorone diisocyanate,T3D1662,Isophorone diisocyanate,http://www.t3db.ca/toxins/T3D1662,BE0000560,Muscarinic acetylcholine receptor M2,http://www.t3db.ca/biodb/bio_entities/BE0000560,P08172,Muscarinic acetylcholine receptor M2,1129.0,CHRM2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
2726,1450138,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,45960,ALY,https://ctdbase.org/detail.go?type=gene&acc=45960,,,45960.0,aly,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of ALY mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2727,1450139,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,41532,AOS1,https://ctdbase.org/detail.go?type=gene&acc=41532,,,41532.0,Aos1,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of AOS1 mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2728,1450140,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,396,ARHGDIA,https://ctdbase.org/detail.go?type=gene&acc=396,,,396.0,ARHGDIA,9606.0,Homo sapiens (human),[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of ARHGDIA mRNA,,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2729,1450498,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased expression of CCL2 mrna]],,,PMID:11006087,https://www.ncbi.nlm.nih.gov/pubmed/11006087,11006087,,
2730,1450499,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,6348,CCL3,https://ctdbase.org/detail.go?type=gene&acc=6348,,,6348.0,CCL3,9606.0,Homo sapiens (human),[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of CCL3 mrna],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2731,1450500,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,6349,CCL3L1,https://ctdbase.org/detail.go?type=gene&acc=6349,,,6349.0,CCL3L1,9606.0,Homo sapiens (human),[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of CCL3L1 mrna],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2732,1450501,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,22948,CCT5,https://ctdbase.org/detail.go?type=gene&acc=22948,,,22948.0,CCT5,9606.0,Homo sapiens (human),[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of CCT5 mrna]|bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of CCT5 mrna]],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2733,1450502,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,4345,CD200,https://ctdbase.org/detail.go?type=gene&acc=4345,,,4345.0,CD200,9606.0,Homo sapiens (human),[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of CD200 mrna],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2734,1450503,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,960,CD44,https://ctdbase.org/detail.go?type=gene&acc=960,,,960.0,CD44,9606.0,Homo sapiens (human),[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of CD44 mrna],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2735,1450504,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,33144,CDA4,https://ctdbase.org/detail.go?type=gene&acc=33144,,,33144.0,Cda4,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of CDA4 mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2736,1452009,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,41086,HYX,https://ctdbase.org/detail.go?type=gene&acc=41086,,,41086.0,hyx,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in increased expression of HYX mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2737,1452010,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,33277,IA-2,https://ctdbase.org/detail.go?type=gene&acc=33277,,,33277.0,IA-2,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in increased expression of IA-2 mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2738,1452011,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,31926,IDGF4,https://ctdbase.org/detail.go?type=gene&acc=31926,,,31926.0,Idgf4,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of IDGF4 mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2739,1452012,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558.0,IL2,9606.0,Homo sapiens (human),Bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of IL2 mrna]],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2740,1452013,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,3559,IL2RA,https://ctdbase.org/detail.go?type=gene&acc=3559,,,3559.0,IL2RA,10090.0,Mus musculus (house mouse),"Bathocuproine sulfonate inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of IL2RA protein]]",,,PMID:23134680,https://www.ncbi.nlm.nih.gov/pubmed/23134680,23134680,,
2741,1452014,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,3560,IL2RB,https://ctdbase.org/detail.go?type=gene&acc=3560,,,3560.0,IL2RB,9606.0,Homo sapiens (human),[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of IL2RB mrna],,,PMID:15477007,https://www.ncbi.nlm.nih.gov/pubmed/15477007,15477007,,
2742,1452015,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,44266,INX3,https://ctdbase.org/detail.go?type=gene&acc=44266,,,44266.0,Inx3,7227.0,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of INX3 mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2743,1450934,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [nickel monoxide results in increased expression of CXCL2 protein],,,PMID:35006638,https://www.ncbi.nlm.nih.gov/pubmed/35006638,35006638,,
2744,1450935,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090.0,Mus musculus (house mouse),"SB 203580 inhibits the reaction [paraquat results in increased expression of CXCL2 protein]|sb 203580 inhibits the reaction [paraquat promotes the reaction [endotoxin, escherichia coli results in increased expression of CXCL2 protein]]|sb 203580 inhibits the reaction [endotoxin, escherichia coli results in increased expression of CXCL2 protein]",,,PMID:16919916,https://www.ncbi.nlm.nih.gov/pubmed/16919916,16919916,,
2745,1450936,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090.0,Mus musculus (house mouse),"SB 203580 inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased secretion of CXCL2 protein]",,,PMID:21507677,https://www.ncbi.nlm.nih.gov/pubmed/21507677,21507677,,
2746,1450937,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [[paraquat results in increased abundance of reactive oxygen species] which results in increased secretion of CXCL2 protein],,,PMID:24376630,https://www.ncbi.nlm.nih.gov/pubmed/24376630,24376630,,
2747,1450938,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [resveratrol results in decreased expression of CXCL2 protein],,,PMID:21192278,https://www.ncbi.nlm.nih.gov/pubmed/21192278,21192278,,
2748,1450939,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [tropisetron results in decreased expression of CXCL2 protein],,,PMID:23285267,https://www.ncbi.nlm.nih.gov/pubmed/23285267,23285267,,
2749,1450940,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),"SB 203580 affects the reaction [4,4'-diphenylmethane diisocyanate results in increased secretion of CXCL8 protein]|sb 203580 affects the reaction [4-phenylenediamine results in increased secretion of CXCL8 protein]|sb 203580 affects the reaction [penicillin G results in increased secretion of CXCL8 protein]|sb 203580 affects the reaction [cinnamaldehyde results in increased secretion of CXCL8 protein]|sb 203580 affects the reaction [nickel sulfate results in increased secretion of CXCL8 protein]|sb 203580 affects the reaction [thiram results in increased secretion of CXCL8 protein]|sb 203580 affects the reaction [ammonium hexachloroplatinate results in increased secretion of CXCL8 protein]|sb 203580 affects the reaction [dinitrochlorobenzene results in increased secretion of CXCL8 protein]",,,PMID:18494145,https://www.ncbi.nlm.nih.gov/pubmed/18494145,18494145,,
2750,1450941,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),SB 203580 affects the reaction [IL1B results in increased expression of CXCL8 protein],,,PMID:19626664,https://www.ncbi.nlm.nih.gov/pubmed/19626664,19626664,,
2751,1451852,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),"SB 203580 inhibits the reaction [[toluene 2,4-diisocyanate binds to ALB protein] which results in increased expression of CXCL8 protein]",,,PMID:16908450,https://www.ncbi.nlm.nih.gov/pubmed/16908450,16908450,,
2752,1452463,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1676,DFFA,https://ctdbase.org/detail.go?type=gene&acc=1676,,,1676.0,DFFA,10029.0,Cricetulus griseus (Chinese hamster),SB 203580 inhibits the reaction [acrolein results in increased cleavage of DFFA protein],,,PMID:17196791,https://www.ncbi.nlm.nih.gov/pubmed/17196791,17196791,,
2753,1452464,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1734,DIO2,https://ctdbase.org/detail.go?type=gene&acc=1734,,,1734.0,DIO2,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [hydrogen peroxide results in increased expression of DIO2 mrna],,,PMID:18420745,https://www.ncbi.nlm.nih.gov/pubmed/18420745,18420745,,
2754,1452465,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1735,DIO3,https://ctdbase.org/detail.go?type=gene&acc=1735,,,1735.0,DIO3,9606.0,Homo sapiens (human),SB 203580 results in decreased expression of DIO3,,,PMID:26825960,https://www.ncbi.nlm.nih.gov/pubmed/26825960,26825960,,
2755,1452466,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1735,DIO3,https://ctdbase.org/detail.go?type=gene&acc=1735,,,1735.0,DIO3,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [fluoxetine results in increased expression of DIO3 mrna],,,PMID:15456934,https://www.ncbi.nlm.nih.gov/pubmed/15456934,15456934,,
2756,1466207,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [indoleacetic acid affects the localization of NFKB1 protein],,,PMID:30324315,https://www.ncbi.nlm.nih.gov/pubmed/30324315,30324315,,
2757,1466208,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10090.0,Mus musculus (house mouse),"SB 203580 inhibits the reaction [paraquat affects the localization of [NFKB1 protein binds to RELA protein]]|sb 203580 inhibits the reaction [paraquat promotes the reaction [endotoxin, escherichia coli affects the localization of [NFKB1 protein binds to RELA protein]]]",,,PMID:16919916,https://www.ncbi.nlm.nih.gov/pubmed/16919916,16919916,,
2758,1466209,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),"SB 203580 results in decreased expression of NFKBIA protein|sb 203580 inhibits the reaction [1,2,5,8-tetrahydroxy anthraquinone results in increased expression of NFKBIA protein]",,,PMID:33030807,https://www.ncbi.nlm.nih.gov/pubmed/33030807,33030807,,
2759,1481955,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,255967,PAN3,https://ctdbase.org/detail.go?type=gene&acc=255967,,,255967.0,PAN3,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PAN3 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2760,1481956,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,8850,KAT2B,https://ctdbase.org/detail.go?type=gene&acc=8850,,,8850.0,KAT2B,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KAT2B mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2761,1481957,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,11104,KATNA1,https://ctdbase.org/detail.go?type=gene&acc=11104,,,11104.0,KATNA1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KATNA1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2762,1481958,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,23254,KAZN,https://ctdbase.org/detail.go?type=gene&acc=23254,,,23254.0,KAZN,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KAZN mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2763,1481959,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,7881,KCNAB1,https://ctdbase.org/detail.go?type=gene&acc=7881,,,7881.0,KCNAB1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KCNAB1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2764,1481960,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,3745,KCNB1,https://ctdbase.org/detail.go?type=gene&acc=3745,,,3745.0,KCNB1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KCNB1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2765,1496875,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,79719,AAGAB,https://ctdbase.org/detail.go?type=gene&acc=79719,,,79719.0,AAGAB,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in increased expression of AAGAB mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2766,1496876,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,22848,AAK1,https://ctdbase.org/detail.go?type=gene&acc=22848,,,22848.0,AAK1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of AAK1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2767,1496877,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,18,ABAT,https://ctdbase.org/detail.go?type=gene&acc=18,,,18.0,ABAT,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of ABAT mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2768,1496878,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,21,ABCA3,https://ctdbase.org/detail.go?type=gene&acc=21,,,21.0,ABCA3,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of ABCA3 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2769,1444800,178052,ChEMBL,Pozanicline,CHEMBL127071,POZANICLINE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL127071/,CHEMBL3038461,Nicotinic acetylcholine receptor alpha4/beta2/alpha5,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3038461/,P30532,Neuronal acetylcholine receptor subunit alpha-5,1138.0,CHRNA5,9606.0,Homo sapiens (human),Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist,,,PMID:9336329|PMID:19481067,https://www.ncbi.nlm.nih.gov/pubmed/9336329|https://www.ncbi.nlm.nih.gov/pubmed/19481067,9336329|19481067,,
2770,1444801,178052,ChEMBL,Pozanicline,CHEMBL127071,POZANICLINE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL127071/,CHEMBL3038461,Nicotinic acetylcholine receptor alpha4/beta2/alpha5,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3038461/,P43681,Neuronal acetylcholine receptor subunit alpha-4,1137.0,CHRNA4,9606.0,Homo sapiens (human),Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist,,,PMID:9336329|PMID:19481067,https://www.ncbi.nlm.nih.gov/pubmed/9336329|https://www.ncbi.nlm.nih.gov/pubmed/19481067,9336329|19481067,,
2771,1444802,178052,ChEMBL,Pozanicline,CHEMBL127071,POZANICLINE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL127071/,CHEMBL2109237,Neuronal acetylcholine receptor; alpha6/beta2,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2109237/,P17787,Neuronal acetylcholine receptor subunit beta-2,1141.0,CHRNB2,9606.0,Homo sapiens (human),Neuronal acetylcholine receptor; alpha6/beta2 partial agonist,,,PMID:19481067,https://www.ncbi.nlm.nih.gov/pubmed/19481067,19481067,,
2772,1444803,178052,ChEMBL,Pozanicline,CHEMBL127071,POZANICLINE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL127071/,CHEMBL2109237,Neuronal acetylcholine receptor; alpha6/beta2,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2109237/,Q15825,Neuronal acetylcholine receptor subunit alpha-6,8973.0,CHRNA6,9606.0,Homo sapiens (human),Neuronal acetylcholine receptor; alpha6/beta2 partial agonist,,,PMID:19481067,https://www.ncbi.nlm.nih.gov/pubmed/19481067,19481067,,
2773,1444804,178103,ChEMBL,Enrasentan,CHEMBL431651,ENRASENTAN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL431651/,CHEMBL252,Endothelin receptor ET-A,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL252/,P25101,Endothelin-1 receptor,1909.0,EDNRA,9606.0,Homo sapiens (human),Endothelin receptor ET-A antagonist,,,PMID:8632328,https://www.ncbi.nlm.nih.gov/pubmed/8632328,8632328,,
2774,1445294,185698,Therapeutic Target Database (TTD),alpha-D-Mannopyranose,D07LUR,Alpha-D-Mannose,https://idrblab.net/ttd/data/drug/details/D07LUR,T67258,Heparin cofactor II (SERPIND1),https://idrblab.net/ttd/data/target/details/T67258,P05546,Heparin cofactor 2,3053.0,SERPIND1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2775,1445295,185698,Therapeutic Target Database (TTD),alpha-D-Mannopyranose,D07LUR,Alpha-D-Mannose,https://idrblab.net/ttd/data/drug/details/D07LUR,T86674,Influenza Hemagglutinin (Influ HA),https://idrblab.net/ttd/data/target/details/T86674,P03452,Hemagglutinin,956529.0,HA,211044.0,Influenza A virus (A/Puerto Rico/8/1934(H1N1)),Inhibitor,,,,,,,
2776,1445296,185698,Therapeutic Target Database (TTD),alpha-D-Mannopyranose,D07LUR,Alpha-D-Mannose,https://idrblab.net/ttd/data/drug/details/D07LUR,T86885,Beta-2-glycoprotein 1 (APOH),https://idrblab.net/ttd/data/target/details/T86885,P02749,Beta-2-glycoprotein 1,350.0,APOH,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2777,1364553,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10810,WASF3,https://ctdbase.org/detail.go?type=gene&acc=10810,,,10810.0,WASF3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of WASF3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2778,1364554,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,28006,WASHC2,https://ctdbase.org/detail.go?type=gene&acc=28006,,,28006.0,Washc2,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of WASHC2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2779,1364555,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,387680,WASHC2A,https://ctdbase.org/detail.go?type=gene&acc=387680,,,387680.0,WASHC2A,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of WASHC2A gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2780,1364556,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,253725,WASHC2C,https://ctdbase.org/detail.go?type=gene&acc=253725,,,253725.0,WASHC2C,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of WASHC2C gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2781,1429514,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1107,CHD3,https://ctdbase.org/detail.go?type=gene&acc=1107,,,1107.0,CHD3,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CHD3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2782,1429515,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,26038,CHD5,https://ctdbase.org/detail.go?type=gene&acc=26038,,,26038.0,CHD5,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CHD5 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2783,1429516,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84181,CHD6,https://ctdbase.org/detail.go?type=gene&acc=84181,,,84181.0,CHD6,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CHD6 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2784,1429517,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84181,CHD6,https://ctdbase.org/detail.go?type=gene&acc=84181,,,84181.0,CHD6,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CHD6 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2785,1429518,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,80205,CHD9,https://ctdbase.org/detail.go?type=gene&acc=80205,,,80205.0,CHD9,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CHD9 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2786,1429519,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55349,CHDH,https://ctdbase.org/detail.go?type=gene&acc=55349,,,55349.0,CHDH,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of CHDH mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2787,1429600,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,81554,RCC1L,https://ctdbase.org/detail.go?type=gene&acc=81554,,,81554.0,RCC1L,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of RCC1L mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2788,1429601,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55920,RCC2,https://ctdbase.org/detail.go?type=gene&acc=55920,,,55920.0,RCC2,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of RCC2 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2789,1429711,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,5957,RCVRN,https://ctdbase.org/detail.go?type=gene&acc=5957,,,5957.0,RCVRN,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of RCVRN gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2790,1429822,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,157506,RDH10,https://ctdbase.org/detail.go?type=gene&acc=157506,,,157506.0,RDH10,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of RDH10 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
2791,1429823,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51109,RDH11,https://ctdbase.org/detail.go?type=gene&acc=51109,,,51109.0,RDH11,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of RDH11 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2792,1429824,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51109,RDH11,https://ctdbase.org/detail.go?type=gene&acc=51109,,,51109.0,RDH11,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of RDH11 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2793,1429825,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,112724,RDH13,https://ctdbase.org/detail.go?type=gene&acc=112724,,,112724.0,RDH13,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of RDH13 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2794,1429826,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8608,RDH16,https://ctdbase.org/detail.go?type=gene&acc=8608,,,8608.0,RDH16,9031.0,Gallus gallus (chicken),[aflatoxin B1 co-treated with selenium deficiency] results in decreased expression of RDH16 protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
2795,1429827,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8608,RDH16,https://ctdbase.org/detail.go?type=gene&acc=8608,,,8608.0,RDH16,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of RDH16 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2796,1429828,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8608,RDH16,https://ctdbase.org/detail.go?type=gene&acc=8608,,,8608.0,RDH16,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of RDH16 mRNA,,,PMID:22100608|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756,22100608|27153756,,
2797,1429829,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8608,RDH16,https://ctdbase.org/detail.go?type=gene&acc=8608,,,8608.0,RDH16,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of RDH16 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2798,1429830,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8608,RDH16,https://ctdbase.org/detail.go?type=gene&acc=8608,,,8608.0,RDH16,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of RDH16 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2799,1429946,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,5965,RECQL,https://ctdbase.org/detail.go?type=gene&acc=5965,,,5965.0,RECQL,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of RECQL protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2800,1429947,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,5965,RECQL,https://ctdbase.org/detail.go?type=gene&acc=5965,,,5965.0,RECQL,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of RECQL gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2801,1429948,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9400,RECQL5,https://ctdbase.org/detail.go?type=gene&acc=9400,,,9400.0,RECQL5,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of RECQL5 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2802,1429949,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,65055,REEP1,https://ctdbase.org/detail.go?type=gene&acc=65055,,,65055.0,REEP1,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of REEP1 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2803,1429950,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,65055,REEP1,https://ctdbase.org/detail.go?type=gene&acc=65055,,,65055.0,REEP1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of REEP1 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2804,1430962,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6004,RGS16,https://ctdbase.org/detail.go?type=gene&acc=6004,,,6004.0,RGS16,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of RGS16 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2805,1430963,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6004,RGS16,https://ctdbase.org/detail.go?type=gene&acc=6004,,,6004.0,RGS16,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of RGS16 mRNA,,,PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/25378103,25378103,,
2806,1430964,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,64407,RGS18,https://ctdbase.org/detail.go?type=gene&acc=64407,,,64407.0,RGS18,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of RGS18 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2807,1430965,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,64407,RGS18,https://ctdbase.org/detail.go?type=gene&acc=64407,,,64407.0,RGS18,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of RGS18 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2808,1430966,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10287,RGS19,https://ctdbase.org/detail.go?type=gene&acc=10287,,,10287.0,RGS19,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of RGS19 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2809,1430967,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,5997,RGS2,https://ctdbase.org/detail.go?type=gene&acc=5997,,,5997.0,RGS2,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of RGS2 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2810,1431274,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54933,RHBDL2,https://ctdbase.org/detail.go?type=gene&acc=54933,,,54933.0,RHBDL2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of RHBDL2 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2811,1431275,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54933,RHBDL2,https://ctdbase.org/detail.go?type=gene&acc=54933,,,54933.0,RHBDL2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of RHBDL2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2812,1431276,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54933,RHBDL2,https://ctdbase.org/detail.go?type=gene&acc=54933,,,54933.0,RHBDL2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of RHBDL2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2813,1431277,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,162494,RHBDL3,https://ctdbase.org/detail.go?type=gene&acc=162494,,,162494.0,RHBDL3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of RHBDL3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2814,1431962,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,129607,CMPK2,https://ctdbase.org/detail.go?type=gene&acc=129607,,,129607.0,CMPK2,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CMPK2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2815,1432705,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100506380,RNF32-DT,https://ctdbase.org/detail.go?type=gene&acc=100506380,,,100506380.0,RNF32-DT,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of RNF32-DT intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2816,1432706,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100506380,RNF32-DT,https://ctdbase.org/detail.go?type=gene&acc=100506380,,,100506380.0,RNF32-DT,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of RNF32-DT mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2817,1432707,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,80196,RNF34,https://ctdbase.org/detail.go?type=gene&acc=80196,,,80196.0,RNF34,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of RNF34 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2818,1432988,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,340267,COL28A1,https://ctdbase.org/detail.go?type=gene&acc=340267,,,340267.0,COL28A1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of COL28A1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2819,1432989,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of COL3A1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2820,1432990,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1282,COL4A1,https://ctdbase.org/detail.go?type=gene&acc=1282,,,1282.0,COL4A1,9031.0,Gallus gallus (chicken),[aflatoxin B1 co-treated with selenium deficiency] results in increased expression of COL4A1 protein|aflatoxin B1 results in increased expression of COL4A1 protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
2821,1432991,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1282,COL4A1,https://ctdbase.org/detail.go?type=gene&acc=1282,,,1282.0,COL4A1,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of COL4A1 intron|aflatoxin B1 results in decreased methylation of COL4A1 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2822,1432992,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1282,COL4A1,https://ctdbase.org/detail.go?type=gene&acc=1282,,,1282.0,COL4A1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of COL4A1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2823,1432993,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6738,RO60,https://ctdbase.org/detail.go?type=gene&acc=6738,,,6738.0,RO60,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of RO60 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2824,1432994,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6738,RO60,https://ctdbase.org/detail.go?type=gene&acc=6738,,,6738.0,RO60,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of RO60 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2825,1432995,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6738,RO60,https://ctdbase.org/detail.go?type=gene&acc=6738,,,6738.0,RO60,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of RO60 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2826,1432996,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6091,ROBO1,https://ctdbase.org/detail.go?type=gene&acc=6091,,,6091.0,ROBO1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of ROBO1 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2827,1432997,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6091,ROBO1,https://ctdbase.org/detail.go?type=gene&acc=6091,,,6091.0,ROBO1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ROBO1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2828,1433091,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1287,COL4A5,https://ctdbase.org/detail.go?type=gene&acc=1287,,,1287.0,COL4A5,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of COL4A5 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2829,1433092,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1288,COL4A6,https://ctdbase.org/detail.go?type=gene&acc=1288,,,1288.0,COL4A6,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of COL4A6 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2830,1433093,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1289,COL5A1,https://ctdbase.org/detail.go?type=gene&acc=1289,,,1289.0,COL5A1,9031.0,Gallus gallus (chicken),[aflatoxin B1 co-treated with selenium deficiency] results in increased expression of COL5A1 protein|aflatoxin B1 results in increased expression of COL5A1 protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
2831,1433094,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6093,ROCK1,https://ctdbase.org/detail.go?type=gene&acc=6093,,,6093.0,ROCK1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ROCK1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2832,1433095,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9475,ROCK2,https://ctdbase.org/detail.go?type=gene&acc=9475,,,9475.0,ROCK2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of ROCK2 mrna|aflatoxin B1 results in decreased methylation of ROCK2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2833,1433096,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54763,ROPN1,https://ctdbase.org/detail.go?type=gene&acc=54763,,,54763.0,ROPN1,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of ROPN1 mRNA,,,PMID:23630614|PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/25378103,23630614|25378103,,
2834,1433097,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4919,ROR1,https://ctdbase.org/detail.go?type=gene&acc=4919,,,4919.0,ROR1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of ROR1 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
2835,1433098,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4919,ROR1,https://ctdbase.org/detail.go?type=gene&acc=4919,,,4919.0,ROR1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of ROR1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2836,1433099,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4920,ROR2,https://ctdbase.org/detail.go?type=gene&acc=4920,,,4920.0,ROR2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ROR2 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2837,1433100,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6095,RORA,https://ctdbase.org/detail.go?type=gene&acc=6095,,,6095.0,RORA,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of RORA protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2838,1433101,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6095,RORA,https://ctdbase.org/detail.go?type=gene&acc=6095,,,6095.0,RORA,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of RORA mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2839,1434059,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1329,COX5B,https://ctdbase.org/detail.go?type=gene&acc=1329,,,1329.0,COX5B,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of COX5B mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2840,1434060,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1339,COX6A2,https://ctdbase.org/detail.go?type=gene&acc=1339,,,1339.0,COX6A2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of COX6A2 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2841,1434061,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1339,COX6A2,https://ctdbase.org/detail.go?type=gene&acc=1339,,,1339.0,COX6A2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of COX6A2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2842,1434062,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1347,COX7A2,https://ctdbase.org/detail.go?type=gene&acc=1347,,,1347.0,COX7A2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of COX7A2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2843,1434063,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1349,COX7B,https://ctdbase.org/detail.go?type=gene&acc=1349,,,1349.0,COX7B,9031.0,Gallus gallus (chicken),[aflatoxin B1 co-treated with selenium deficiency] results in decreased expression of COX7B protein|aflatoxin B1 results in decreased expression of COX7B protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
2844,1434064,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1349,COX7B,https://ctdbase.org/detail.go?type=gene&acc=1349,,,1349.0,COX7B,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of COX7B mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2845,1434065,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1350,COX7C,https://ctdbase.org/detail.go?type=gene&acc=1350,,,1350.0,COX7C,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of COX7C mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2846,1434880,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57035,RSRP1,https://ctdbase.org/detail.go?type=gene&acc=57035,,,57035.0,RSRP1,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of RSRP1 mRNA,,,PMID:23630614|PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/33354967,23630614|33354967,,
2847,1434881,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6251,RSU1,https://ctdbase.org/detail.go?type=gene&acc=6251,,,6251.0,RSU1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of RSU1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2848,1434882,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54504,CPVL,https://ctdbase.org/detail.go?type=gene&acc=54504,,,54504.0,CPVL,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of CPVL mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2849,1434883,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,53336,CPXCR1,https://ctdbase.org/detail.go?type=gene&acc=53336,,,53336.0,CPXCR1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CPXCR1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2850,1434884,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,119587,CPXM2,https://ctdbase.org/detail.go?type=gene&acc=119587,,,119587.0,CPXM2,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of CPXM2 mRNA,,,PMID:23630614,https://www.ncbi.nlm.nih.gov/pubmed/23630614,23630614,,
2851,1434885,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1379,CR1L,https://ctdbase.org/detail.go?type=gene&acc=1379,,,1379.0,CR1L,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CR1L intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2852,1434886,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1379,CR1L,https://ctdbase.org/detail.go?type=gene&acc=1379,,,1379.0,CR1L,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of CR1L mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2853,1434887,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1379,CR1L,https://ctdbase.org/detail.go?type=gene&acc=1379,,,1379.0,CR1L,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of CR1L mRNA,,,PMID:15890375|PMID:22484513|PMID:23630614|PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/15890375|https://www.ncbi.nlm.nih.gov/pubmed/22484513|https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/33354967,15890375|22484513|23630614|33354967,,
2854,1434888,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1380,CR2,https://ctdbase.org/detail.go?type=gene&acc=1380,,,1380.0,CR2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CR2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2855,1434889,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1381,CRABP1,https://ctdbase.org/detail.go?type=gene&acc=1381,,,1381.0,CRABP1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CRABP1 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2856,1434890,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1382,CRABP2,https://ctdbase.org/detail.go?type=gene&acc=1382,,,1382.0,CRABP2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of CRABP2 mRNA,,,PMID:21527772|PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/21527772|https://www.ncbi.nlm.nih.gov/pubmed/22100608,21527772|22100608,,
2857,1435002,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8738,CRADD,https://ctdbase.org/detail.go?type=gene&acc=8738,,,8738.0,CRADD,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CRADD gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2858,1435003,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57585,CRAMP1,https://ctdbase.org/detail.go?type=gene&acc=57585,,,57585.0,CRAMP1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CRAMP1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2859,1435004,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57585,CRAMP1,https://ctdbase.org/detail.go?type=gene&acc=57585,,,57585.0,CRAMP1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CRAMP1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2860,1435122,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,101926928,CRAT37,https://ctdbase.org/detail.go?type=gene&acc=101926928,,,101926928.0,CRAT37,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CRAT37 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2861,1435123,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23418,CRB1,https://ctdbase.org/detail.go?type=gene&acc=23418,,,23418.0,CRB1,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of CRB1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2862,1435124,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,286204,CRB2,https://ctdbase.org/detail.go?type=gene&acc=286204,,,286204.0,CRB2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CRB2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2863,1435125,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,286204,CRB2,https://ctdbase.org/detail.go?type=gene&acc=286204,,,286204.0,CRB2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CRB2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2864,1435126,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,27297,CRCP,https://ctdbase.org/detail.go?type=gene&acc=27297,,,27297.0,CRCP,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CRCP mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2865,1435127,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CREB1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2866,1435128,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10488,CREB3,https://ctdbase.org/detail.go?type=gene&acc=10488,,,10488.0,CREB3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CREB3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2867,1435129,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84699,CREB3L3,https://ctdbase.org/detail.go?type=gene&acc=84699,,,84699.0,CREB3L3,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of CREB3L3 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2868,1435130,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,148327,CREB3L4,https://ctdbase.org/detail.go?type=gene&acc=148327,,,148327.0,CREB3L4,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of CREB3L4 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2869,1435716,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6282,S100A11,https://ctdbase.org/detail.go?type=gene&acc=6282,,,6282.0,S100A11,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of S100A11 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2870,1435717,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6282,S100A11,https://ctdbase.org/detail.go?type=gene&acc=6282,,,6282.0,S100A11,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of S100A11 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2871,1435718,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6282,S100A11,https://ctdbase.org/detail.go?type=gene&acc=6282,,,6282.0,S100A11,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of S100A11 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2872,1435719,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6282,S100A11,https://ctdbase.org/detail.go?type=gene&acc=6282,,,6282.0,S100A11,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of S100A11 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2873,1435720,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6284,S100A13,https://ctdbase.org/detail.go?type=gene&acc=6284,,,6284.0,S100A13,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of S100A13 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2874,1435721,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6284,S100A13,https://ctdbase.org/detail.go?type=gene&acc=6284,,,6284.0,S100A13,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of S100A13 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2875,1435722,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57402,S100A14,https://ctdbase.org/detail.go?type=gene&acc=57402,,,57402.0,S100A14,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of S100A14 mrna|aflatoxin B1 results in increased methylation of S100A14 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2876,1435723,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57402,S100A14,https://ctdbase.org/detail.go?type=gene&acc=57402,,,57402.0,S100A14,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of S100A14 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2877,1435724,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,140576,S100A16,https://ctdbase.org/detail.go?type=gene&acc=140576,,,140576.0,S100A16,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of S100A16 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2878,1435725,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6273,S100A2,https://ctdbase.org/detail.go?type=gene&acc=6273,,,6273.0,S100A2,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of S100A2 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2879,1435726,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10491,CRTAP,https://ctdbase.org/detail.go?type=gene&acc=10491,,,10491.0,CRTAP,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CRTAP intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2880,1435848,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55057,CRYBG2,https://ctdbase.org/detail.go?type=gene&acc=55057,,,55057.0,CRYBG2,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CRYBG2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2881,1435849,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1420,CRYGC,https://ctdbase.org/detail.go?type=gene&acc=1420,,,1420.0,CRYGC,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CRYGC gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2882,1435850,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1427,CRYGS,https://ctdbase.org/detail.go?type=gene&acc=1427,,,1427.0,CRYGS,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CRYGS gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2883,1435851,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51084,CRYL1,https://ctdbase.org/detail.go?type=gene&acc=51084,,,51084.0,CRYL1,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of CRYL1 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2884,1435852,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51084,CRYL1,https://ctdbase.org/detail.go?type=gene&acc=51084,,,51084.0,CRYL1,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of CRYL1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2885,1435853,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51084,CRYL1,https://ctdbase.org/detail.go?type=gene&acc=51084,,,51084.0,CRYL1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of CRYL1 mRNA,,,PMID:21641981|PMID:22100608|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756,21641981|22100608|27153756,,
2886,1439425,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1555,CYP2B6,https://ctdbase.org/detail.go?type=gene&acc=1555,,,1555.0,CYP2B6,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of CYP2B6 mRNA,,,PMID:21994236,https://www.ncbi.nlm.nih.gov/pubmed/21994236,21994236,,
2887,1439426,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1556,CYP2B7P,https://ctdbase.org/detail.go?type=gene&acc=1556,,,1556.0,CYP2B7P,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of CYP2B7P protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2888,1439427,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1556,CYP2B7P,https://ctdbase.org/detail.go?type=gene&acc=1556,,,1556.0,CYP2B7P,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of CYP2B7P mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2889,1439428,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,29277,CYP2C11,https://ctdbase.org/detail.go?type=gene&acc=29277,,,29277.0,Cyp2c11,10116.0,Rattus norvegicus (Norway rat),CYP2C11 protein results in increased activity of aflatoxin B1,,,PMID:11346484,https://www.ncbi.nlm.nih.gov/pubmed/11346484,11346484,,
2890,1439429,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,25011,CYP2C12,https://ctdbase.org/detail.go?type=gene&acc=25011,,,25011.0,Cyp2c12,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of CYP2C12 mRNA,,,PMID:23052194|PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/23052194|https://www.ncbi.nlm.nih.gov/pubmed/33354967,23052194|33354967,,
2891,1439430,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1562,CYP2C18,https://ctdbase.org/detail.go?type=gene&acc=1562,,,1562.0,CYP2C18,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of CYP2C18 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2892,1439431,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1562,CYP2C18,https://ctdbase.org/detail.go?type=gene&acc=1562,,,1562.0,CYP2C18,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of CYP2C18 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2893,1439432,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1562,CYP2C18,https://ctdbase.org/detail.go?type=gene&acc=1562,,,1562.0,CYP2C18,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CYP2C18 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2894,1439433,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of CYP2C19 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2895,1439553,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to aflatoxin B1,,,PMID:23397584,https://www.ncbi.nlm.nih.gov/pubmed/23397584,23397584,,
2896,1439554,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,171518,CYP2C22,https://ctdbase.org/detail.go?type=gene&acc=171518,,,171518.0,Cyp2c22,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of CYP2C22 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2897,1439555,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,226143,CYP2C23,https://ctdbase.org/detail.go?type=gene&acc=226143,,,226143.0,Cyp2c23,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of CYP2C23 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2898,1439556,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,414746,CYP2C23A,https://ctdbase.org/detail.go?type=gene&acc=414746,,,414746.0,CYP2C23a,9031.0,Gallus gallus (chicken),Aflatoxin B1 results in increased expression of CYP2C23A mRNA,,,PMID:29327633,https://www.ncbi.nlm.nih.gov/pubmed/29327633,29327633,,
2899,1439557,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,499353,CYP2C24,https://ctdbase.org/detail.go?type=gene&acc=499353,,,499353.0,Cyp2c24,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of CYP2C24 mRNA,,,PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/25378103,25378103,,
2900,1439558,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,13096,CYP2C37,https://ctdbase.org/detail.go?type=gene&acc=13096,,,13096.0,Cyp2c37,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of CYP2C37 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2901,1451248,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,79724,ZNF768,https://ctdbase.org/detail.go?type=gene&acc=79724,,,79724.0,ZNF768,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of ZNF768 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2902,1451249,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,374928,ZNF773,https://ctdbase.org/detail.go?type=gene&acc=374928,,,374928.0,ZNF773,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZNF773 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2903,1451250,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7633,ZNF79,https://ctdbase.org/detail.go?type=gene&acc=7633,,,7633.0,ZNF79,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of ZNF79 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2904,1451251,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7633,ZNF79,https://ctdbase.org/detail.go?type=gene&acc=7633,,,7633.0,ZNF79,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of ZNF79 mRNA,,,PMID:21641981|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/27153756,21641981|27153756,,
2905,1451252,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,390927,ZNF793,https://ctdbase.org/detail.go?type=gene&acc=390927,,,390927.0,ZNF793,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZNF793 3' UTR,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2906,1451253,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7634,ZNF80,https://ctdbase.org/detail.go?type=gene&acc=7634,,,7634.0,ZNF80,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZNF80 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2907,1451254,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,91752,ZNF804A,https://ctdbase.org/detail.go?type=gene&acc=91752,,,91752.0,ZNF804A,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZNF804A gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2908,1451255,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,91752,ZNF804A,https://ctdbase.org/detail.go?type=gene&acc=91752,,,91752.0,ZNF804A,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZNF804A intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2909,1451256,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,219578,ZNF804B,https://ctdbase.org/detail.go?type=gene&acc=219578,,,219578.0,ZNF804B,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZNF804B gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2910,1481021,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8379,MAD1L1,https://ctdbase.org/detail.go?type=gene&acc=8379,,,8379.0,MAD1L1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of MAD1L1 mRNA,,,PMID:22100608|PMID:27153756|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756|https://www.ncbi.nlm.nih.gov/pubmed/32234424,22100608|27153756|32234424,,
2911,1481022,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4085,MAD2L1,https://ctdbase.org/detail.go?type=gene&acc=4085,,,4085.0,MAD2L1,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of MAD2L1 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2912,1481023,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4085,MAD2L1,https://ctdbase.org/detail.go?type=gene&acc=4085,,,4085.0,MAD2L1,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of MAD2L1 mRNA,,,PMID:23630614|PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/25378103,23630614|25378103,,
2913,1481024,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10459,MAD2L2,https://ctdbase.org/detail.go?type=gene&acc=10459,,,10459.0,MAD2L2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of MAD2L2 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2914,1481177,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4105,MAGEA6,https://ctdbase.org/detail.go?type=gene&acc=4105,,,4105.0,MAGEA6,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MAGEA6 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2915,1481178,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4112,MAGEB1,https://ctdbase.org/detail.go?type=gene&acc=4112,,,4112.0,MAGEB1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MAGEB1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2916,1483084,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,282991,BLOC1S2,https://ctdbase.org/detail.go?type=gene&acc=282991,,,282991.0,BLOC1S2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of BLOC1S2 mRNA,,,PMID:21632981|PMID:21641981|PMID:22100608|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756,21632981|21641981|22100608|27153756,,
2917,1483085,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,282991,BLOC1S2,https://ctdbase.org/detail.go?type=gene&acc=282991,,,282991.0,BLOC1S2,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of BLOC1S2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2918,1483086,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,26258,BLOC1S6,https://ctdbase.org/detail.go?type=gene&acc=26258,,,26258.0,BLOC1S6,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of BLOC1S6 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2919,1483087,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,26258,BLOC1S6,https://ctdbase.org/detail.go?type=gene&acc=26258,,,26258.0,BLOC1S6,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of BLOC1S6 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2920,1483088,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9703,BLTP2,https://ctdbase.org/detail.go?type=gene&acc=9703,,,9703.0,BLTP2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of BLTP2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2921,1483089,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8548,BLZF1,https://ctdbase.org/detail.go?type=gene&acc=8548,,,8548.0,BLZF1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of BLZF1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2922,1483954,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,118426,BORCS5,https://ctdbase.org/detail.go?type=gene&acc=118426,,,118426.0,BORCS5,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of BORCS5 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2923,1483955,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54785,BORCS6,https://ctdbase.org/detail.go?type=gene&acc=54785,,,54785.0,BORCS6,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of BORCS6 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2924,1484230,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7867,MAPKAPK3,https://ctdbase.org/detail.go?type=gene&acc=7867,,,7867.0,MAPKAPK3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of MAPKAPK3 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2925,1484231,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7867,MAPKAPK3,https://ctdbase.org/detail.go?type=gene&acc=7867,,,7867.0,MAPKAPK3,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of MAPKAPK3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2926,1484232,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23005,MAPKBP1,https://ctdbase.org/detail.go?type=gene&acc=23005,,,23005.0,MAPKBP1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of MAPKBP1 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
2927,1484233,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,22919,MAPRE1,https://ctdbase.org/detail.go?type=gene&acc=22919,,,22919.0,MAPRE1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of MAPRE1 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2928,1484234,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10982,MAPRE2,https://ctdbase.org/detail.go?type=gene&acc=10982,,,10982.0,MAPRE2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MAPRE2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2929,1486467,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100505761,C10ORF95-AS1,https://ctdbase.org/detail.go?type=gene&acc=100505761,,,100505761.0,C10orf95-AS1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of C10ORF95-AS1 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2930,1486468,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,53838,C11ORF24,https://ctdbase.org/detail.go?type=gene&acc=53838,,,53838.0,C11orf24,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of C11ORF24 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2931,1486469,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,91894,C11ORF52,https://ctdbase.org/detail.go?type=gene&acc=91894,,,91894.0,C11orf52,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of C11ORF52 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2932,1486470,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,91894,C11ORF52,https://ctdbase.org/detail.go?type=gene&acc=91894,,,91894.0,C11orf52,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of C11ORF52 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2933,1486471,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,91894,C11ORF52,https://ctdbase.org/detail.go?type=gene&acc=91894,,,91894.0,C11orf52,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of C11ORF52 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2934,1486472,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,28970,C11ORF54,https://ctdbase.org/detail.go?type=gene&acc=28970,,,28970.0,C11orf54,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of C11ORF54 mRNA,,,PMID:22100608|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756,22100608|27153756,,
2935,1486473,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54494,C11ORF71,https://ctdbase.org/detail.go?type=gene&acc=54494,,,54494.0,C11orf71,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of C11ORF71 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2936,1486474,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,387763,C11ORF96,https://ctdbase.org/detail.go?type=gene&acc=387763,,,387763.0,C11orf96,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of C11ORF96 mRNA,,,PMID:21632981|PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/21641981,21632981|21641981,,
2937,1486475,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23263,MCF2L,https://ctdbase.org/detail.go?type=gene&acc=23263,,,23263.0,MCF2L,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MCF2L mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2938,1486476,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23101,MCF2L2,https://ctdbase.org/detail.go?type=gene&acc=23101,,,23101.0,MCF2L2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MCF2L2 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2939,1487386,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,63933,MCUR1,https://ctdbase.org/detail.go?type=gene&acc=63933,,,63933.0,MCUR1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MCUR1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2940,1488097,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,284739,C20ORF204,https://ctdbase.org/detail.go?type=gene&acc=284739,,,284739.0,C20orf204,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of C20ORF204 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2941,1488098,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,140680,C20ORF96,https://ctdbase.org/detail.go?type=gene&acc=140680,,,140680.0,C20orf96,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of C20ORF96 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2942,1488099,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54149,C21ORF91,https://ctdbase.org/detail.go?type=gene&acc=54149,,,54149.0,C21orf91,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of C21ORF91 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2943,1488274,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9442,MED27,https://ctdbase.org/detail.go?type=gene&acc=9442,,,9442.0,MED27,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MED27 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2944,1488275,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,80306,MED28,https://ctdbase.org/detail.go?type=gene&acc=80306,,,80306.0,MED28,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MED28 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2945,1488276,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55588,MED29,https://ctdbase.org/detail.go?type=gene&acc=55588,,,55588.0,MED29,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MED29 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2946,1489113,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,375444,C5ORF34,https://ctdbase.org/detail.go?type=gene&acc=375444,,,375444.0,C5orf34,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of C5ORF34 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2947,1489114,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,285679,C5ORF60,https://ctdbase.org/detail.go?type=gene&acc=285679,,,285679.0,C5orf60,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of C5ORF60 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2948,1489115,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,401207,C5ORF63,https://ctdbase.org/detail.go?type=gene&acc=401207,,,401207.0,C5orf63,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of C5ORF63 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2949,1489116,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,101928448,C5ORF67,https://ctdbase.org/detail.go?type=gene&acc=101928448,,,101928448.0,C5orf67,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of C5ORF67 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2950,1489117,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,729,C6,https://ctdbase.org/detail.go?type=gene&acc=729,,,729.0,C6,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of C6 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2951,1489118,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,729,C6,https://ctdbase.org/detail.go?type=gene&acc=729,,,729.0,C6,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of C6 mRNA,,,PMID:21641981|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/27153756,21641981|27153756,,
2952,1489119,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,729,C6,https://ctdbase.org/detail.go?type=gene&acc=729,,,729.0,C6,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of C6 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2953,1489120,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,729,C6,https://ctdbase.org/detail.go?type=gene&acc=729,,,729.0,C6,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of C6 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2954,1489121,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,729,C6,https://ctdbase.org/detail.go?type=gene&acc=729,,,729.0,C6,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of C6 mRNA,,,PMID:23630614|PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/25378103,23630614|25378103,,
2955,1489122,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,168090,C6ORF118,https://ctdbase.org/detail.go?type=gene&acc=168090,,,168090.0,C6orf118,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of C6ORF118 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2956,1489614,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,731,C8A,https://ctdbase.org/detail.go?type=gene&acc=731,,,731.0,C8A,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of C8A protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2957,1489615,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,731,C8A,https://ctdbase.org/detail.go?type=gene&acc=731,,,731.0,C8A,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of C8A mRNA,,,PMID:21641981|PMID:22100608|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756,21641981|22100608|27153756,,
2958,1490670,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,777,CACNA1E,https://ctdbase.org/detail.go?type=gene&acc=777,,,777.0,CACNA1E,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of CACNA1E mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2959,1490671,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,778,CACNA1F,https://ctdbase.org/detail.go?type=gene&acc=778,,,778.0,CACNA1F,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CACNA1F exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2960,1490672,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8913,CACNA1G,https://ctdbase.org/detail.go?type=gene&acc=8913,,,8913.0,CACNA1G,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CACNA1G exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2961,1490673,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8912,CACNA1H,https://ctdbase.org/detail.go?type=gene&acc=8912,,,8912.0,CACNA1H,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of CACNA1H intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2962,1490674,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8911,CACNA1I,https://ctdbase.org/detail.go?type=gene&acc=8911,,,8911.0,CACNA1I,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CACNA1I intron|aflatoxin B1 results in increased methylation of CACNA1I exon|aflatoxin B1 results in decreased methylation of CACNA1I 3' UTR,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2963,1490675,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8911,CACNA1I,https://ctdbase.org/detail.go?type=gene&acc=8911,,,8911.0,CACNA1I,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CACNA1I gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2964,1490676,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,779,CACNA1S,https://ctdbase.org/detail.go?type=gene&acc=779,,,779.0,CACNA1S,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CACNA1S intron|aflatoxin B1 affects the methylation of CACNA1S exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2965,1491123,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,785,CACNB4,https://ctdbase.org/detail.go?type=gene&acc=785,,,785.0,CACNB4,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of CACNB4 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
2966,1491124,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,785,CACNB4,https://ctdbase.org/detail.go?type=gene&acc=785,,,785.0,CACNB4,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CACNB4 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2967,1491125,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,785,CACNB4,https://ctdbase.org/detail.go?type=gene&acc=785,,,785.0,CACNB4,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CACNB4 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2968,1491126,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,786,CACNG1,https://ctdbase.org/detail.go?type=gene&acc=786,,,786.0,CACNG1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CACNG1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2969,1491127,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10369,CACNG2,https://ctdbase.org/detail.go?type=gene&acc=10369,,,10369.0,CACNG2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CACNG2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2970,1491128,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10369,CACNG2,https://ctdbase.org/detail.go?type=gene&acc=10369,,,10369.0,CACNG2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CACNG2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2971,1491129,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10368,CACNG3,https://ctdbase.org/detail.go?type=gene&acc=10368,,,10368.0,CACNG3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CACNG3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2972,1491130,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,27092,CACNG4,https://ctdbase.org/detail.go?type=gene&acc=27092,,,27092.0,CACNG4,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CACNG4 3' UTR,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2973,1491131,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,27091,CACNG5,https://ctdbase.org/detail.go?type=gene&acc=27091,,,27091.0,CACNG5,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CACNG5 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2974,1491313,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4281,MID1,https://ctdbase.org/detail.go?type=gene&acc=4281,,,4281.0,MID1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MID1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2975,1491314,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,58526,MID1IP1,https://ctdbase.org/detail.go?type=gene&acc=58526,,,58526.0,MID1IP1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of MID1IP1 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2976,1491315,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,58526,MID1IP1,https://ctdbase.org/detail.go?type=gene&acc=58526,,,58526.0,MID1IP1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of MID1IP1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2977,1491316,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,11043,MID2,https://ctdbase.org/detail.go?type=gene&acc=11043,,,11043.0,MID2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MID2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2978,1491317,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,90007,MIDN,https://ctdbase.org/detail.go?type=gene&acc=90007,,,90007.0,MIDN,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of MIDN mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2979,1491318,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84299,MIEN1,https://ctdbase.org/detail.go?type=gene&acc=84299,,,84299.0,MIEN1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of MIEN1 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2980,1491319,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57708,MIER1,https://ctdbase.org/detail.go?type=gene&acc=57708,,,57708.0,MIER1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of MIER1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2981,1491320,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54531,MIER2,https://ctdbase.org/detail.go?type=gene&acc=54531,,,54531.0,MIER2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MIER2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2982,1491321,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,374986,MIGA1,https://ctdbase.org/detail.go?type=gene&acc=374986,,,374986.0,MIGA1,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of MIGA1 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2983,1491322,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23251,MINAR1,https://ctdbase.org/detail.go?type=gene&acc=23251,,,23251.0,MINAR1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MINAR1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2984,1491323,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54629,MINDY2,https://ctdbase.org/detail.go?type=gene&acc=54629,,,54629.0,MINDY2,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of MINDY2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2985,1491784,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,255022,CALHM1,https://ctdbase.org/detail.go?type=gene&acc=255022,,,255022.0,CALHM1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CALHM1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2986,1491785,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,255022,CALHM1,https://ctdbase.org/detail.go?type=gene&acc=255022,,,255022.0,CALHM1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of CALHM1 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
2987,1491786,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51063,CALHM2,https://ctdbase.org/detail.go?type=gene&acc=51063,,,51063.0,CALHM2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of CALHM2 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
2988,1491787,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,805,CALM2,https://ctdbase.org/detail.go?type=gene&acc=805,,,805.0,CALM2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CALM2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2989,1491788,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,83698,CALN1,https://ctdbase.org/detail.go?type=gene&acc=83698,,,83698.0,CALN1,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of CALN1 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2990,1491789,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,83698,CALN1,https://ctdbase.org/detail.go?type=gene&acc=83698,,,83698.0,CALN1,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of CALN1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2991,1491790,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,811,CALR,https://ctdbase.org/detail.go?type=gene&acc=811,,,811.0,CALR,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CALR gene,,,PMID:28458013,https://www.ncbi.nlm.nih.gov/pubmed/28458013,28458013,,
2992,1491791,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,811,CALR,https://ctdbase.org/detail.go?type=gene&acc=811,,,811.0,CALR,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CALR intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2993,1491792,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57118,CAMK1D,https://ctdbase.org/detail.go?type=gene&acc=57118,,,57118.0,CAMK1D,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of CAMK1D mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2994,1491793,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,399959,MIR100HG,https://ctdbase.org/detail.go?type=gene&acc=399959,,,399959.0,MIR100HG,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of MIR100HG mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2995,1495704,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,147372,CCBE1,https://ctdbase.org/detail.go?type=gene&acc=147372,,,147372.0,CCBE1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCBE1 exon|aflatoxin B1 results in increased methylation of CCBE1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2996,1495705,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,256309,CCDC110,https://ctdbase.org/detail.go?type=gene&acc=256309,,,256309.0,CCDC110,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCDC110 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2997,1495706,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,160857,CCDC122,https://ctdbase.org/detail.go?type=gene&acc=160857,,,160857.0,CCDC122,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CCDC122 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2998,1495707,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,160857,CCDC122,https://ctdbase.org/detail.go?type=gene&acc=160857,,,160857.0,CCDC122,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CCDC122 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2999,1496595,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51244,CCDC174,https://ctdbase.org/detail.go?type=gene&acc=51244,,,51244.0,CCDC174,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCDC174 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3000,1496596,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,56936,CCDC177,https://ctdbase.org/detail.go?type=gene&acc=56936,,,56936.0,CCDC177,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CCDC177 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3001,1496597,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,374864,CCDC178,https://ctdbase.org/detail.go?type=gene&acc=374864,,,374864.0,CCDC178,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CCDC178 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3002,1496598,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,374864,CCDC178,https://ctdbase.org/detail.go?type=gene&acc=374864,,,374864.0,CCDC178,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCDC178 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3003,1496599,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55088,CCDC186,https://ctdbase.org/detail.go?type=gene&acc=55088,,,55088.0,CCDC186,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CCDC186 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3004,1497506,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,25874,MPC2,https://ctdbase.org/detail.go?type=gene&acc=25874,,,25874.0,MPC2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MPC2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3005,1497507,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8777,MPDZ,https://ctdbase.org/detail.go?type=gene&acc=8777,,,8777.0,MPDZ,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of MPDZ mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3006,1497508,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10200,MPHOSPH6,https://ctdbase.org/detail.go?type=gene&acc=10200,,,10200.0,MPHOSPH6,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of MPHOSPH6 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3007,1497509,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54737,MPHOSPH8,https://ctdbase.org/detail.go?type=gene&acc=54737,,,54737.0,MPHOSPH8,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of MPHOSPH8 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3008,1497510,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10198,MPHOSPH9,https://ctdbase.org/detail.go?type=gene&acc=10198,,,10198.0,MPHOSPH9,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MPHOSPH9 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3009,1497511,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10198,MPHOSPH9,https://ctdbase.org/detail.go?type=gene&acc=10198,,,10198.0,MPHOSPH9,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of MPHOSPH9 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3010,1497512,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84954,MPND,https://ctdbase.org/detail.go?type=gene&acc=84954,,,84954.0,MPND,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of MPND protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3011,1497513,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84954,MPND,https://ctdbase.org/detail.go?type=gene&acc=84954,,,84954.0,MPND,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of MPND mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3012,1497514,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MPO intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3013,1498103,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,56477,CCL28,https://ctdbase.org/detail.go?type=gene&acc=56477,,,56477.0,CCL28,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCL28 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3014,1498104,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6348,CCL3,https://ctdbase.org/detail.go?type=gene&acc=6348,,,6348.0,CCL3,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of CCL3 mRNA,,,PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/25378103,25378103,,
3015,1498105,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6349,CCL3L1,https://ctdbase.org/detail.go?type=gene&acc=6349,,,6349.0,CCL3L1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CCL3L1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3016,1498106,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,414062,CCL3L3,https://ctdbase.org/detail.go?type=gene&acc=414062,,,414062.0,CCL3L3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CCL3L3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3017,1498107,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,20305,CCL6,https://ctdbase.org/detail.go?type=gene&acc=20305,,,20305.0,Ccl6,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of CCL6 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
3018,1498717,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896.0,CCND3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCND3 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3019,1498718,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23582,CCNDBP1,https://ctdbase.org/detail.go?type=gene&acc=23582,,,23582.0,CCNDBP1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCNDBP1 gene|aflatoxin B1 results in increased expression of CCNDBP1 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3020,1498719,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of CCNE1 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
3021,1498720,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCNE1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3022,1498721,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),[zearalenone co-treated with aflatoxin B1] results in increased expression of CCNE1 mRNA,,,PMID:28965971,https://www.ncbi.nlm.nih.gov/pubmed/28965971,28965971,,
3023,1512098,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6540,SLC6A13,https://ctdbase.org/detail.go?type=gene&acc=6540,,,6540.0,SLC6A13,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SLC6A13 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3024,1512264,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,393,ARHGAP4,https://ctdbase.org/detail.go?type=gene&acc=393,,,393.0,ARHGAP4,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ARHGAP4 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3025,1512265,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,143872,ARHGAP42,https://ctdbase.org/detail.go?type=gene&acc=143872,,,143872.0,ARHGAP42,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of ARHGAP42 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3026,1512266,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,143872,ARHGAP42,https://ctdbase.org/detail.go?type=gene&acc=143872,,,143872.0,ARHGAP42,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of ARHGAP42 mrna|aflatoxin B1 results in increased methylation of ARHGAP42 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3027,1512267,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,143872,ARHGAP42,https://ctdbase.org/detail.go?type=gene&acc=143872,,,143872.0,ARHGAP42,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ARHGAP42 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3028,1512268,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9912,ARHGAP44,https://ctdbase.org/detail.go?type=gene&acc=9912,,,9912.0,ARHGAP44,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of ARHGAP44 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
3029,1512269,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9912,ARHGAP44,https://ctdbase.org/detail.go?type=gene&acc=9912,,,9912.0,ARHGAP44,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ARHGAP44 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3030,1512270,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,394,ARHGAP5,https://ctdbase.org/detail.go?type=gene&acc=394,,,394.0,ARHGAP5,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ARHGAP5 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3031,1513471,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,81892,SLIRP,https://ctdbase.org/detail.go?type=gene&acc=81892,,,81892.0,SLIRP,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SLIRP gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3032,1513472,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6585,SLIT1,https://ctdbase.org/detail.go?type=gene&acc=6585,,,6585.0,SLIT1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SLIT1 3' utr|aflatoxin B1 results in increased methylation of SLIT1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3033,1513473,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9353,SLIT2,https://ctdbase.org/detail.go?type=gene&acc=9353,,,9353.0,SLIT2,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of SLIT2 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3034,1513474,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9353,SLIT2,https://ctdbase.org/detail.go?type=gene&acc=9353,,,9353.0,SLIT2,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of SLIT2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3035,1513475,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9353,SLIT2,https://ctdbase.org/detail.go?type=gene&acc=9353,,,9353.0,SLIT2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SLIT2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3036,1513476,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6586,SLIT3,https://ctdbase.org/detail.go?type=gene&acc=6586,,,6586.0,SLIT3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SLIT3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3037,1513477,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6586,SLIT3,https://ctdbase.org/detail.go?type=gene&acc=6586,,,6586.0,SLIT3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SLIT3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3038,1513478,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,114798,SLITRK1,https://ctdbase.org/detail.go?type=gene&acc=114798,,,114798.0,SLITRK1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SLITRK1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3039,1513653,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,79008,SLX1B,https://ctdbase.org/detail.go?type=gene&acc=79008,,,79008.0,SLX1B,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SLX1B gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3040,1513818,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of GPX1 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
3041,1513819,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of GPX1 protein,,,PMID:34089297,https://www.ncbi.nlm.nih.gov/pubmed/34089297,34089297,,
3042,1513820,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of GPX1 polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3043,1513821,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased activity of GPX1 protein|benzopyrans inhibits the reaction [aflatoxin B1 results in decreased activity of GPX1 protein],,,PMID:25154877,https://www.ncbi.nlm.nih.gov/pubmed/25154877,25154877,,
3044,1513822,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of GPX1 mRNA,,,PMID:28442411,https://www.ncbi.nlm.nih.gov/pubmed/28442411,28442411,,
3045,1513823,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84464,SLX4,https://ctdbase.org/detail.go?type=gene&acc=84464,,,84464.0,SLX4,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SLX4 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3046,1513824,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,128710,SLX4IP,https://ctdbase.org/detail.go?type=gene&acc=128710,,,128710.0,SLX4IP,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SLX4IP gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3047,1513825,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,85395,SLX9,https://ctdbase.org/detail.go?type=gene&acc=85395,,,85395.0,SLX9,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SLX9 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3048,1513826,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4086,SMAD1,https://ctdbase.org/detail.go?type=gene&acc=4086,,,4086.0,SMAD1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SMAD1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3049,1513827,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4088,SMAD3,https://ctdbase.org/detail.go?type=gene&acc=4088,,,4088.0,SMAD3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of SMAD3 mRNA,,,PMID:21641981|PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/22100608,21641981|22100608,,
3050,1513828,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4089,SMAD4,https://ctdbase.org/detail.go?type=gene&acc=4089,,,4089.0,SMAD4,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SMAD4 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3051,1514433,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of GREB1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
3052,1514434,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of GREB1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3053,1514435,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of GREB1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3054,1514436,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,64388,GREM2,https://ctdbase.org/detail.go?type=gene&acc=64388,,,64388.0,GREM2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of GREM2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3055,1514437,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,64388,GREM2,https://ctdbase.org/detail.go?type=gene&acc=64388,,,64388.0,GREM2,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of GREM2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3056,1514438,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57822,GRHL3,https://ctdbase.org/detail.go?type=gene&acc=57822,,,57822.0,GRHL3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of GRHL3 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
3057,1514439,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9380,GRHPR,https://ctdbase.org/detail.go?type=gene&acc=9380,,,9380.0,GRHPR,9031.0,Gallus gallus (chicken),Aflatoxin B1 results in decreased expression of GRHPR protein|[aflatoxin B1 co-treated with selenium deficiency] results in decreased expression of GRHPR protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
3058,1514440,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9380,GRHPR,https://ctdbase.org/detail.go?type=gene&acc=9380,,,9380.0,GRHPR,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of GRHPR protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3059,1514729,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,415,ARSL,https://ctdbase.org/detail.go?type=gene&acc=415,,,415.0,ARSL,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of ARSL protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3060,1514730,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,415,ARSL,https://ctdbase.org/detail.go?type=gene&acc=415,,,415.0,ARSL,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of ARSL mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3061,1514731,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,420,ART4,https://ctdbase.org/detail.go?type=gene&acc=420,,,420.0,ART4,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of ART4 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3062,1514732,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,421,ARVCF,https://ctdbase.org/detail.go?type=gene&acc=421,,,421.0,ARVCF,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of ARVCF mRNA,,,PMID:21641981|PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/22100608,21641981|22100608,,
3063,1514733,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,421,ARVCF,https://ctdbase.org/detail.go?type=gene&acc=421,,,421.0,ARVCF,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ARVCF mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3064,1514734,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,170302,ARX,https://ctdbase.org/detail.go?type=gene&acc=170302,,,170302.0,ARX,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ARX intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3065,1514735,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57412,AS3MT,https://ctdbase.org/detail.go?type=gene&acc=57412,,,57412.0,AS3MT,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of AS3MT protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3066,1514736,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57412,AS3MT,https://ctdbase.org/detail.go?type=gene&acc=57412,,,57412.0,AS3MT,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of AS3MT mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3067,1514737,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,56624,ASAH2,https://ctdbase.org/detail.go?type=gene&acc=56624,,,56624.0,ASAH2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ASAH2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3068,1515689,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,40,ASIC2,https://ctdbase.org/detail.go?type=gene&acc=40,,,40.0,ASIC2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ASIC2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3069,1515690,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,40,ASIC2,https://ctdbase.org/detail.go?type=gene&acc=40,,,40.0,ASIC2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ASIC2 promoter|aflatoxin B1 results in decreased methylation of ASIC2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3070,1515691,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51802,ASIC5,https://ctdbase.org/detail.go?type=gene&acc=51802,,,51802.0,ASIC5,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ASIC5 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3071,1515692,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51802,ASIC5,https://ctdbase.org/detail.go?type=gene&acc=51802,,,51802.0,ASIC5,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of ASIC5 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3072,1515693,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,435,ASL,https://ctdbase.org/detail.go?type=gene&acc=435,,,435.0,ASL,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of ASL protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3073,1515694,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,435,ASL,https://ctdbase.org/detail.go?type=gene&acc=435,,,435.0,ASL,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of ASL mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3074,1515695,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,435,ASL,https://ctdbase.org/detail.go?type=gene&acc=435,,,435.0,ASL,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of ASL mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3075,1515696,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8623,ASMTL,https://ctdbase.org/detail.go?type=gene&acc=8623,,,8623.0,ASMTL,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of ASMTL mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3076,1516557,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,26799,SNORD50A,https://ctdbase.org/detail.go?type=gene&acc=26799,,,26799.0,SNORD50A,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SNORD50A gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3077,1516558,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,692088,SNORD50B,https://ctdbase.org/detail.go?type=gene&acc=692088,,,692088.0,SNORD50B,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SNORD50B gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3078,1516559,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,692107,SNORD66,https://ctdbase.org/detail.go?type=gene&acc=692107,,,692107.0,SNORD66,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SNORD66 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3079,1516560,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8944,SNORD73A,https://ctdbase.org/detail.go?type=gene&acc=8944,,,8944.0,SNORD73A,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SNORD73A gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3080,1516561,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,641648,SNORD87,https://ctdbase.org/detail.go?type=gene&acc=641648,,,641648.0,SNORD87,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SNORD87 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3081,1516562,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,692053,SNORD9,https://ctdbase.org/detail.go?type=gene&acc=692053,,,692053.0,SNORD9,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SNORD9 polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3082,1516563,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,692206,SNORD90,https://ctdbase.org/detail.go?type=gene&acc=692206,,,692206.0,SNORD90,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SNORD90 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3083,1516564,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,692207,SNORD91A,https://ctdbase.org/detail.go?type=gene&acc=692207,,,692207.0,SNORD91A,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SNORD91A gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3084,1516852,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ATF2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3085,1516853,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of ATF3 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3086,1516854,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of ATF3 mRNA,,,PMID:21641981|PMID:22100608|PMID:27153756|PMID:32607778,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756|https://www.ncbi.nlm.nih.gov/pubmed/32607778,21641981|22100608|27153756|32607778,,
3087,1516855,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ATF3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3088,1516856,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ATF3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3089,1516857,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ATF3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3090,1517187,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2975,GTF3C1,https://ctdbase.org/detail.go?type=gene&acc=2975,,,2975.0,GTF3C1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of GTF3C1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3091,1517375,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51512,GTSE1,https://ctdbase.org/detail.go?type=gene&acc=51512,,,51512.0,GTSE1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of GTSE1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3092,1517376,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51512,GTSE1,https://ctdbase.org/detail.go?type=gene&acc=51512,,,51512.0,GTSE1,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of GTSE1 mRNA,,,PMID:23630614|PMID:25378103|PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/25378103|https://www.ncbi.nlm.nih.gov/pubmed/33354967,23630614|25378103|33354967,,
3093,1517377,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9626,GUCA1C,https://ctdbase.org/detail.go?type=gene&acc=9626,,,9626.0,GUCA1C,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of GUCA1C intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3094,1517378,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2980,GUCA2A,https://ctdbase.org/detail.go?type=gene&acc=2980,,,2980.0,GUCA2A,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of GUCA2A mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3095,1517379,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2977,GUCY1A2,https://ctdbase.org/detail.go?type=gene&acc=2977,,,2977.0,GUCY1A2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of GUCY1A2 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
3096,1517380,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2984,GUCY2C,https://ctdbase.org/detail.go?type=gene&acc=2984,,,2984.0,GUCY2C,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of GUCY2C gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3097,1517381,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2984,GUCY2C,https://ctdbase.org/detail.go?type=gene&acc=2984,,,2984.0,GUCY2C,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of GUCY2C mRNA,,,PMID:23630614,https://www.ncbi.nlm.nih.gov/pubmed/23630614,23630614,,
3098,1519072,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8344,H2BC6,https://ctdbase.org/detail.go?type=gene&acc=8344,,,8344.0,H2BC6,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of H2BC6 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3099,1519073,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8343,H2BC7,https://ctdbase.org/detail.go?type=gene&acc=8343,,,8343.0,H2BC7,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of H2BC7 mrna|aflatoxin B1 results in decreased methylation of H2BC7 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3100,1519074,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8339,H2BC8,https://ctdbase.org/detail.go?type=gene&acc=8339,,,8339.0,H2BC8,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of H2BC8 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3101,1519075,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8339,H2BC8,https://ctdbase.org/detail.go?type=gene&acc=8339,,,8339.0,H2BC8,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of H2BC8 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3102,1519076,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8345,H2BC9,https://ctdbase.org/detail.go?type=gene&acc=8345,,,8345.0,H2BC9,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of H2BC9 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3103,1519077,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,337875,H2BP1,https://ctdbase.org/detail.go?type=gene&acc=337875,,,337875.0,H2BP1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of H2BP1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3104,1519078,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,14964,H2-D1,https://ctdbase.org/detail.go?type=gene&acc=14964,,,14964.0,H2-D1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of H2-D1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3105,1519255,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8357,H3C10,https://ctdbase.org/detail.go?type=gene&acc=8357,,,8357.0,H3C10,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of H3C10 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3106,1519256,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8356,H3C12,https://ctdbase.org/detail.go?type=gene&acc=8356,,,8356.0,H3C12,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of H3C12 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
3107,1519257,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,653604,H3C13,https://ctdbase.org/detail.go?type=gene&acc=653604,,,653604.0,H3C13,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of H3C13 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3108,1519258,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,333932,H3C15,https://ctdbase.org/detail.go?type=gene&acc=333932,,,333932.0,H3C15,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of H3C15 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3109,1519259,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8358,H3C2,https://ctdbase.org/detail.go?type=gene&acc=8358,,,8358.0,H3C2,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of H3C2 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3110,1519260,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8358,H3C2,https://ctdbase.org/detail.go?type=gene&acc=8358,,,8358.0,H3C2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of H3C2 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
3111,1519261,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8358,H3C2,https://ctdbase.org/detail.go?type=gene&acc=8358,,,8358.0,H3C2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of H3C2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3112,1519262,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8352,H3C3,https://ctdbase.org/detail.go?type=gene&acc=8352,,,8352.0,H3C3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of H3C3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3113,1519263,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8351,H3C4,https://ctdbase.org/detail.go?type=gene&acc=8351,,,8351.0,H3C4,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of H3C4 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3114,1521088,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10866,HCP5,https://ctdbase.org/detail.go?type=gene&acc=10866,,,10866.0,HCP5,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of HCP5 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3115,1521089,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3061,HCRTR1,https://ctdbase.org/detail.go?type=gene&acc=3061,,,3061.0,HCRTR1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of HCRTR1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3116,1521090,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3062,HCRTR2,https://ctdbase.org/detail.go?type=gene&acc=3062,,,3062.0,HCRTR2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HCRTR2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3117,1521091,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3062,HCRTR2,https://ctdbase.org/detail.go?type=gene&acc=3062,,,3062.0,HCRTR2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of HCRTR2 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3118,1521092,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,79885,HDAC11,https://ctdbase.org/detail.go?type=gene&acc=79885,,,79885.0,HDAC11,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of HDAC11 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3119,1521093,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3066,HDAC2,https://ctdbase.org/detail.go?type=gene&acc=3066,,,3066.0,HDAC2,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of HDAC2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3120,1521094,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8841,HDAC3,https://ctdbase.org/detail.go?type=gene&acc=8841,,,8841.0,HDAC3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of HDAC3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3121,1521095,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9759,HDAC4,https://ctdbase.org/detail.go?type=gene&acc=9759,,,9759.0,HDAC4,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of HDAC4 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3122,1522204,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9709,HERPUD1,https://ctdbase.org/detail.go?type=gene&acc=9709,,,9709.0,HERPUD1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of HERPUD1 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
3123,1522205,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9709,HERPUD1,https://ctdbase.org/detail.go?type=gene&acc=9709,,,9709.0,HERPUD1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HERPUD1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3124,1522206,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9709,HERPUD1,https://ctdbase.org/detail.go?type=gene&acc=9709,,,9709.0,HERPUD1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of HERPUD1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3125,1522207,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,64224,HERPUD2,https://ctdbase.org/detail.go?type=gene&acc=64224,,,64224.0,HERPUD2,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of HERPUD2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3126,1522208,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3280,HES1,https://ctdbase.org/detail.go?type=gene&acc=3280,,,3280.0,HES1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HES1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3127,1522409,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,388585,HES5,https://ctdbase.org/detail.go?type=gene&acc=388585,,,388585.0,HES5,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of HES5 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
3128,1522410,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55502,HES6,https://ctdbase.org/detail.go?type=gene&acc=55502,,,55502.0,HES6,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of HES6 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3129,1522411,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55502,HES6,https://ctdbase.org/detail.go?type=gene&acc=55502,,,55502.0,HES6,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of HES6 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
3130,1522412,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84667,HES7,https://ctdbase.org/detail.go?type=gene&acc=84667,,,84667.0,HES7,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HES7 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3131,1522413,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8820,HESX1,https://ctdbase.org/detail.go?type=gene&acc=8820,,,8820.0,HESX1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of HESX1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3132,1522414,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3074,HEXB,https://ctdbase.org/detail.go?type=gene&acc=3074,,,3074.0,HEXB,9031.0,Gallus gallus (chicken),[aflatoxin B1 co-treated with selenium deficiency] results in increased expression of HEXB protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
3133,1522415,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,284004,HEXD,https://ctdbase.org/detail.go?type=gene&acc=284004,,,284004.0,HEXD,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of HEXD intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3134,1522555,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8424,BBOX1,https://ctdbase.org/detail.go?type=gene&acc=8424,,,8424.0,BBOX1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of BBOX1 polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3135,1522556,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8424,BBOX1,https://ctdbase.org/detail.go?type=gene&acc=8424,,,8424.0,BBOX1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of BBOX1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3136,1522557,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,103695435,BBOX1-AS1,https://ctdbase.org/detail.go?type=gene&acc=103695435,,,103695435.0,BBOX1-AS1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of BBOX1-AS1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3137,1522558,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,582,BBS1,https://ctdbase.org/detail.go?type=gene&acc=582,,,582.0,BBS1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of BBS1 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
3138,1523398,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8479,HIRIP3,https://ctdbase.org/detail.go?type=gene&acc=8479,,,8479.0,HIRIP3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of HIRIP3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3139,1523399,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,64627,HIST1H4B,https://ctdbase.org/detail.go?type=gene&acc=64627,,,64627.0,Hist1h4b,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of HIST1H4B mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
3140,1523400,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3097,HIVEP2,https://ctdbase.org/detail.go?type=gene&acc=3097,,,3097.0,HIVEP2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of HIVEP2 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3141,1523401,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3097,HIVEP2,https://ctdbase.org/detail.go?type=gene&acc=3097,,,3097.0,HIVEP2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of HIVEP2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3142,1523402,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,59269,HIVEP3,https://ctdbase.org/detail.go?type=gene&acc=59269,,,59269.0,HIVEP3,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of HIVEP3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3143,1523403,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55355,HJURP,https://ctdbase.org/detail.go?type=gene&acc=55355,,,55355.0,HJURP,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of HJURP protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3144,1523404,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55355,HJURP,https://ctdbase.org/detail.go?type=gene&acc=55355,,,55355.0,HJURP,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of HJURP mRNA,,,PMID:31555880,https://www.ncbi.nlm.nih.gov/pubmed/31555880,31555880,,
3145,1523405,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55355,HJURP,https://ctdbase.org/detail.go?type=gene&acc=55355,,,55355.0,HJURP,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of HJURP gene,,,PMID:27153756|PMID:31555880,https://www.ncbi.nlm.nih.gov/pubmed/27153756|https://www.ncbi.nlm.nih.gov/pubmed/31555880,27153756|31555880,,
3146,1523406,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55355,HJURP,https://ctdbase.org/detail.go?type=gene&acc=55355,,,55355.0,HJURP,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of HJURP mRNA,,,PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/25378103,25378103,,
3147,1524474,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,622,BDH1,https://ctdbase.org/detail.go?type=gene&acc=622,,,622.0,BDH1,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of BDH1 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3148,1524475,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,622,BDH1,https://ctdbase.org/detail.go?type=gene&acc=622,,,622.0,BDH1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of BDH1 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3149,1525518,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,29911,HOOK2,https://ctdbase.org/detail.go?type=gene&acc=29911,,,29911.0,HOOK2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of HOOK2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3150,1525519,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84525,HOPX,https://ctdbase.org/detail.go?type=gene&acc=84525,,,84525.0,HOPX,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of HOPX protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
3151,1525520,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84525,HOPX,https://ctdbase.org/detail.go?type=gene&acc=84525,,,84525.0,HOPX,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HOPX gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3152,1526320,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3237,HOXD11,https://ctdbase.org/detail.go?type=gene&acc=3237,,,3237.0,HOXD11,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HOXD11 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3153,1526321,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3238,HOXD12,https://ctdbase.org/detail.go?type=gene&acc=3238,,,3238.0,HOXD12,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HOXD12 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3154,1526322,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3239,HOXD13,https://ctdbase.org/detail.go?type=gene&acc=3239,,,3239.0,HOXD13,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HOXD13 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3155,1526323,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3232,HOXD3,https://ctdbase.org/detail.go?type=gene&acc=3232,,,3232.0,HOXD3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HOXD3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3156,1526324,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3233,HOXD4,https://ctdbase.org/detail.go?type=gene&acc=3233,,,3233.0,HOXD4,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HOXD4 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3157,1526325,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3234,HOXD8,https://ctdbase.org/detail.go?type=gene&acc=3234,,,3234.0,HOXD8,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HOXD8 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3158,1526326,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3235,HOXD9,https://ctdbase.org/detail.go?type=gene&acc=3235,,,3235.0,HOXD9,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HOXD9 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3159,1526327,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3240,HP,https://ctdbase.org/detail.go?type=gene&acc=3240,,,3240.0,HP,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of HP mRNA,,,PMID:21641981|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/27153756,21641981|27153756,,
3160,1526328,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3240,HP,https://ctdbase.org/detail.go?type=gene&acc=3240,,,3240.0,HP,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HP gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
3161,1526329,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3240,HP,https://ctdbase.org/detail.go?type=gene&acc=3240,,,3240.0,HP,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of HP mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
3162,1604613,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8871,SYNJ2,https://ctdbase.org/detail.go?type=gene&acc=8871,,,8871.0,SYNJ2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of SYNJ2 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
3163,1604614,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8871,SYNJ2,https://ctdbase.org/detail.go?type=gene&acc=8871,,,8871.0,SYNJ2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SYNJ2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3164,1604615,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8871,SYNJ2,https://ctdbase.org/detail.go?type=gene&acc=8871,,,8871.0,SYNJ2,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of SYNJ2 mRNA,,,PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/25378103,25378103,,
3165,1604616,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23336,SYNM,https://ctdbase.org/detail.go?type=gene&acc=23336,,,23336.0,SYNM,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SYNM intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
3166,1604617,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23336,SYNM,https://ctdbase.org/detail.go?type=gene&acc=23336,,,23336.0,SYNM,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of SYNM mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
3167,1437597,187079,Comparative Toxicogenomics Database (CTD),"5-[1-(3,4-dimethoxybenzoyl)-3,4-dihydro-2H-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one",C070609,EMD 53998,https://ctdbase.org/detail.go?type=chem&acc=C070609,25642,CYP3A23-3A1,https://ctdbase.org/detail.go?type=gene&acc=25642,,,25642.0,Cyp3a23-3a1,10116.0,Rattus norvegicus (Norway rat),EMD 53998 analog results in increased expression of CYP3A23-3A1 mRNA,,,PMID:24977338,https://www.ncbi.nlm.nih.gov/pubmed/24977338,24977338,,
3168,1437598,187079,Comparative Toxicogenomics Database (CTD),"5-[1-(3,4-dimethoxybenzoyl)-3,4-dihydro-2H-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one",C070609,EMD 53998,https://ctdbase.org/detail.go?type=chem&acc=C070609,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10116.0,Rattus norvegicus (Norway rat),EMD 53998 analog results in increased expression of CYP7A1 mRNA,,,PMID:24977338,https://www.ncbi.nlm.nih.gov/pubmed/24977338,24977338,,
3169,1437599,187079,Comparative Toxicogenomics Database (CTD),"5-[1-(3,4-dimethoxybenzoyl)-3,4-dihydro-2H-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one",C070609,EMD 53998,https://ctdbase.org/detail.go?type=chem&acc=C070609,1809,DPYSL3,https://ctdbase.org/detail.go?type=gene&acc=1809,,,1809.0,DPYSL3,10116.0,Rattus norvegicus (Norway rat),EMD 53998 analog results in decreased expression of DPYSL3 mRNA,,,PMID:24977338,https://www.ncbi.nlm.nih.gov/pubmed/24977338,24977338,,
3170,1437600,187079,Comparative Toxicogenomics Database (CTD),"5-[1-(3,4-dimethoxybenzoyl)-3,4-dihydro-2H-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one",C070609,EMD 53998,https://ctdbase.org/detail.go?type=chem&acc=C070609,1834,DSPP,https://ctdbase.org/detail.go?type=gene&acc=1834,,,1834.0,DSPP,10116.0,Rattus norvegicus (Norway rat),EMD 53998 analog results in decreased expression of DSPP mRNA,,,PMID:24977338,https://www.ncbi.nlm.nih.gov/pubmed/24977338,24977338,,
3171,1437601,187079,Comparative Toxicogenomics Database (CTD),"5-[1-(3,4-dimethoxybenzoyl)-3,4-dihydro-2H-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one",C070609,EMD 53998,https://ctdbase.org/detail.go?type=chem&acc=C070609,2237,FEN1,https://ctdbase.org/detail.go?type=gene&acc=2237,,,2237.0,FEN1,10116.0,Rattus norvegicus (Norway rat),EMD 53998 analog results in increased expression of FEN1 mRNA,,,PMID:24977338,https://www.ncbi.nlm.nih.gov/pubmed/24977338,24977338,,
3172,1437602,187079,Comparative Toxicogenomics Database (CTD),"5-[1-(3,4-dimethoxybenzoyl)-3,4-dihydro-2H-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one",C070609,EMD 53998,https://ctdbase.org/detail.go?type=chem&acc=C070609,2266,FGG,https://ctdbase.org/detail.go?type=gene&acc=2266,,,2266.0,FGG,10116.0,Rattus norvegicus (Norway rat),EMD 53998 analog results in decreased expression of FGG mRNA,,,PMID:24977338,https://www.ncbi.nlm.nih.gov/pubmed/24977338,24977338,,
3173,1437603,187079,Comparative Toxicogenomics Database (CTD),"5-[1-(3,4-dimethoxybenzoyl)-3,4-dihydro-2H-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one",C070609,EMD 53998,https://ctdbase.org/detail.go?type=chem&acc=C070609,2286,FKBP2,https://ctdbase.org/detail.go?type=gene&acc=2286,,,2286.0,FKBP2,10116.0,Rattus norvegicus (Norway rat),EMD 53998 analog results in increased expression of FKBP2 mRNA,,,PMID:24977338,https://www.ncbi.nlm.nih.gov/pubmed/24977338,24977338,,
3174,1437604,187079,Comparative Toxicogenomics Database (CTD),"5-[1-(3,4-dimethoxybenzoyl)-3,4-dihydro-2H-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one",C070609,EMD 53998,https://ctdbase.org/detail.go?type=chem&acc=C070609,11167,FSTL1,https://ctdbase.org/detail.go?type=gene&acc=11167,,,11167.0,FSTL1,10116.0,Rattus norvegicus (Norway rat),EMD 53998 analog results in decreased expression of FSTL1 mRNA,,,PMID:24977338,https://www.ncbi.nlm.nih.gov/pubmed/24977338,24977338,,
3175,1437605,187079,Comparative Toxicogenomics Database (CTD),"5-[1-(3,4-dimethoxybenzoyl)-3,4-dihydro-2H-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one",C070609,EMD 53998,https://ctdbase.org/detail.go?type=chem&acc=C070609,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,10116.0,Rattus norvegicus (Norway rat),EMD 53998 analog results in increased expression of GAPDH mRNA,,,PMID:24977338,https://www.ncbi.nlm.nih.gov/pubmed/24977338,24977338,,
3176,1437606,187079,Comparative Toxicogenomics Database (CTD),"5-[1-(3,4-dimethoxybenzoyl)-3,4-dihydro-2H-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one",C070609,EMD 53998,https://ctdbase.org/detail.go?type=chem&acc=C070609,60674,GAS5,https://ctdbase.org/detail.go?type=gene&acc=60674,,,60674.0,GAS5,10116.0,Rattus norvegicus (Norway rat),EMD 53998 analog results in increased expression of GAS5 mRNA,,,PMID:24977338,https://www.ncbi.nlm.nih.gov/pubmed/24977338,24977338,,
3177,1518905,189821,ChEMBL,Deflazacort,CHEMBL1201891,DEFLAZACORT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201891/,CHEMBL2034,Glucocorticoid receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2034/,P04150,Glucocorticoid receptor,2908.0,NR3C1,9606.0,Homo sapiens (human),Glucocorticoid receptor agonist,,,,,,,
3178,1518906,190945,IUPHAR/BPS Guide to PHARMACOLOGY,tert-butyl N-[(2S)-1-[[(2R)-2-(8-hydroxyoctylamino)-2-methyl-3-phenylpropanoyl]amino]-1-oxo-3-phenylpropan-2-yl]carbamate,5766,PD 154740,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5766,362,NK3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=362,P29371,Neuromedin-K receptor,6870.0,TACR3,9606.0,Homo sapiens (human),Antagonist,pIC50,6.17 - 6.24,PMID:7476898,https://www.ncbi.nlm.nih.gov/pubmed/7476898,7476898,,
3179,1518907,190945,IUPHAR/BPS Guide to PHARMACOLOGY,tert-butyl N-[(2S)-1-[[(2R)-2-(8-hydroxyoctylamino)-2-methyl-3-phenylpropanoyl]amino]-1-oxo-3-phenylpropan-2-yl]carbamate,5766,PD 154740,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5766,362,NK3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=362,P29371,Neuromedin-K receptor,6870.0,TACR3,9606.0,Homo sapiens (human),Antagonist,pKi,7.4,PMID:7476898,https://www.ncbi.nlm.nih.gov/pubmed/7476898,7476898,,
3180,1518908,192706,Drug Gene Interaction database (DGIdb),Phenserine,,PHENSERINE,https://www.dgidb.org/drugs/drugbank:DB04892,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
3181,1518909,194902,Comparative Toxicogenomics Database (CTD),Hddfp,C058691,"5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate",https://ctdbase.org/detail.go?type=chem&acc=C058691,240,ALOX5,https://ctdbase.org/detail.go?type=gene&acc=240,,,240.0,ALOX5,10141.0,Cavia porcellus (domestic guinea pig),"5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate analog results in decreased activity of ALOX5 protein",,,PMID:2724698,https://www.ncbi.nlm.nih.gov/pubmed/2724698,2724698,,
3182,1518910,196416,IUPHAR/BPS Guide to PHARMACOLOGY,Datpalphas,1715,dATPαS,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1715,323,P2Y1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=323,P47900,P2Y purinoceptor 1,5028.0,P2RY1,9606.0,Homo sapiens (human),Partial agonist,pIC50,7.7,PMID:9154346,https://www.ncbi.nlm.nih.gov/pubmed/9154346,9154346,,
3183,1518911,196875,Drug Gene Interaction database (DGIdb),"8-[3-(4-Fluorobenzoyl)propyl]-1-phenyl-3-[4-(isothiocyanato)phenethyl]-1,3,8-triazaspiro[4.5]decan-4-one",,CHEMBL:CHEMBL1257081,https://www.dgidb.org/drugs/chembl:CHEMBL1257081,,CYP2C19,https://www.dgidb.org/genes/hgnc:2621,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,,,,,
3184,1518912,196970,Drug Gene Interaction database (DGIdb),N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide,,E-7820,https://www.dgidb.org/drugs/chembl:CHEMBL4297376,,ITGA2,https://www.dgidb.org/genes/hgnc:6137,,,3673.0,ITGA2,9606.0,Homo sapiens (human),,,,,,,,
3185,1518913,197033,Drug Gene Interaction database (DGIdb),Latrepirdine,,LATREPIRDINE,https://www.dgidb.org/drugs/ncit:C78757,,GRIN3B,https://www.dgidb.org/genes/hgnc:16768,,,116444.0,GRIN3B,9606.0,Homo sapiens (human),,,,,,,,
3186,1526584,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,5825,ABCD3,https://ctdbase.org/detail.go?type=gene&acc=5825,,,5825.0,ABCD3,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of ABCD3 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3187,1526585,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,64240,ABCG5,https://ctdbase.org/detail.go?type=gene&acc=64240,,,64240.0,ABCG5,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of ABCG5 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3188,1526586,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,84696,ABHD1,https://ctdbase.org/detail.go?type=gene&acc=84696,,,84696.0,ABHD1,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of ABHD1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3189,1526587,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,28,ABO,https://ctdbase.org/detail.go?type=gene&acc=28,,,28.0,ABO,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of ABO mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3190,1526588,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,30,ACAA1,https://ctdbase.org/detail.go?type=gene&acc=30,,,30.0,ACAA1,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of ACAA1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3191,1526589,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,10449,ACAA2,https://ctdbase.org/detail.go?type=gene&acc=10449,,,10449.0,ACAA2,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of ACAA2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3192,1526590,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,34,ACADM,https://ctdbase.org/detail.go?type=gene&acc=34,,,34.0,ACADM,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of ACADM mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3193,1526591,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,37,ACADVL,https://ctdbase.org/detail.go?type=gene&acc=37,,,37.0,ACADVL,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of ACADVL mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3194,1526592,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,38,ACAT1,https://ctdbase.org/detail.go?type=gene&acc=38,,,38.0,ACAT1,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of ACAT1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3195,1527224,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,51129,ANGPTL4,https://ctdbase.org/detail.go?type=gene&acc=51129,,,51129.0,ANGPTL4,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of ANGPTL4 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3196,1528536,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,8973,CHRNA6,https://ctdbase.org/detail.go?type=gene&acc=8973,,,8973.0,CHRNA6,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in decreased expression of CHRNA6 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3197,1528537,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,1146,CHRNG,https://ctdbase.org/detail.go?type=gene&acc=1146,,,1146.0,CHRNG,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in decreased expression of CHRNG mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3198,1528538,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,4435,CITED1,https://ctdbase.org/detail.go?type=gene&acc=4435,,,4435.0,CITED1,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in decreased expression of CITED1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3199,1528539,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,10370,CITED2,https://ctdbase.org/detail.go?type=gene&acc=10370,,,10370.0,CITED2,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in decreased expression of CITED2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3200,1528540,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,9076,CLDN1,https://ctdbase.org/detail.go?type=gene&acc=9076,,,9076.0,CLDN1,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of CLDN1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3201,1529404,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,286905,CYP4F5,https://ctdbase.org/detail.go?type=gene&acc=286905,,,286905.0,Cyp4f5,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in decreased expression of CYP4F5 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3202,1529405,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of CYP7A1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3203,1529406,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,1582,CYP8B1,https://ctdbase.org/detail.go?type=gene&acc=1582,,,1582.0,CYP8B1,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of CYP8B1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3204,1529407,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,9201,DCLK1,https://ctdbase.org/detail.go?type=gene&acc=9201,,,9201.0,DCLK1,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in decreased expression of DCLK1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3205,1529408,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,54541,DDIT4,https://ctdbase.org/detail.go?type=gene&acc=54541,,,54541.0,DDIT4,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of DDIT4 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3206,1529409,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,1666,DECR1,https://ctdbase.org/detail.go?type=gene&acc=1666,,,1666.0,DECR1,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of DECR1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3207,1529410,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,26063,DECR2,https://ctdbase.org/detail.go?type=gene&acc=26063,,,26063.0,DECR2,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of DECR2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3208,1512837,208901,Drug Gene Interaction database (DGIdb),Tesaglitazar,,TESAGLITAZAR,https://www.dgidb.org/drugs/ncit:C75985,,PPARA,https://www.dgidb.org/genes/hgnc:9232,,,5465.0,PPARA,9606.0,Homo sapiens (human),,,,,,,,
3209,1512838,208901,BindingDB,Tesaglitazar,28798,(2S)-2-ethoxy-3-(4-{2-[4-(methanesulfonyloxy)phenyl]ethoxy}phenyl)propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28798,2209,Peroxisome proliferator-activated receptor gamma,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2209,P37231,Peroxisome proliferator-activated receptor gamma,5468.0,PPARG,9606.0,Homo sapiens (human),,,,PMID:17157019|DOI:10.1016/j.bmcl.2006.11.050,https://www.ncbi.nlm.nih.gov/pubmed/17157019|https://doi.org/10.1016/j.bmcl.2006.11.050,17157019,10.1016/j.bmcl.2006.11.050,
3210,1512839,208901,BindingDB,Tesaglitazar,28798,(2S)-2-ethoxy-3-(4-{2-[4-(methanesulfonyloxy)phenyl]ethoxy}phenyl)propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28798,9947,Peroxisome proliferator-activated receptor alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9947,Q07869,Peroxisome proliferator-activated receptor alpha,5465.0,PPARA,9606.0,Homo sapiens (human),,,,PMID:17157019|DOI:10.1016/j.bmcl.2006.11.050,https://www.ncbi.nlm.nih.gov/pubmed/17157019|https://doi.org/10.1016/j.bmcl.2006.11.050,17157019,10.1016/j.bmcl.2006.11.050,
3211,1512840,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,127550,A3GALT2,https://ctdbase.org/detail.go?type=gene&acc=127550,,,127550.0,A3GALT2,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of A3GALT2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3212,1512841,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,9625,AATK,https://ctdbase.org/detail.go?type=gene&acc=9625,,,9625.0,AATK,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of AATK mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3213,1514891,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,929,CD14,https://ctdbase.org/detail.go?type=gene&acc=929,,,929.0,CD14,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of CD14 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3214,1514892,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of CD36 mRNA,,,PMID:21270424|PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21270424|https://www.ncbi.nlm.nih.gov/pubmed/21515302,21270424|21515302,,
3215,1517033,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,30001,ERO1A,https://ctdbase.org/detail.go?type=gene&acc=30001,,,30001.0,ERO1A,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of ERO1A mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3216,1517034,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,2110,ETFDH,https://ctdbase.org/detail.go?type=gene&acc=2110,,,2110.0,ETFDH,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of ETFDH mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3217,1517035,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,2153,F5,https://ctdbase.org/detail.go?type=gene&acc=2153,,,2153.0,F5,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of F5 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3218,1517036,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,2582,GALE,https://ctdbase.org/detail.go?type=gene&acc=2582,,,2582.0,GALE,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of GALE mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3219,1517037,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,9606.0,Homo sapiens (human),[tesaglitazar results in increased activity of PPARA protein] which results in increased expression of FABP1 protein|tesaglitazar results in increased expression of FABP1 protein,,,PMID:12401884,https://www.ncbi.nlm.nih.gov/pubmed/12401884,12401884,,
3220,1517038,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of FABP1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3221,1517039,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,2170,FABP3,https://ctdbase.org/detail.go?type=gene&acc=2170,,,2170.0,FABP3,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of FABP3 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3222,1517040,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of FABP4 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3223,1517746,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,346562,GNAT3,https://ctdbase.org/detail.go?type=gene&acc=346562,,,346562.0,GNAT3,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of GNAT3 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3224,1517747,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,84572,GNPTG,https://ctdbase.org/detail.go?type=gene&acc=84572,,,84572.0,GNPTG,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of GNPTG mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3225,1517748,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,57678,GPAM,https://ctdbase.org/detail.go?type=gene&acc=57678,,,57678.0,GPAM,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of GPAM mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3226,1517749,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,2719,GPC3,https://ctdbase.org/detail.go?type=gene&acc=2719,,,2719.0,GPC3,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of GPC3 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3227,1517750,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,2819,GPD1,https://ctdbase.org/detail.go?type=gene&acc=2819,,,2819.0,GPD1,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of GPD1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3228,1517751,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,2820,GPD2,https://ctdbase.org/detail.go?type=gene&acc=2820,,,2820.0,GPD2,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of GPD2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3229,1519068,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,3991,LIPE,https://ctdbase.org/detail.go?type=gene&acc=3991,,,3991.0,LIPE,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of LIPE mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3230,1519069,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,200879,LIPH,https://ctdbase.org/detail.go?type=gene&acc=200879,,,200879.0,LIPH,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of LIPH mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3231,1519070,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,442721,LMOD2,https://ctdbase.org/detail.go?type=gene&acc=442721,,,442721.0,LMOD2,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of LMOD2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3232,1519071,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,83752,LONP2,https://ctdbase.org/detail.go?type=gene&acc=83752,,,83752.0,LONP2,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of LONP2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3233,1519975,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,222236,NAPEPLD,https://ctdbase.org/detail.go?type=gene&acc=222236,,,222236.0,NAPEPLD,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of NAPEPLD mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3234,1519976,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,10397,NDRG1,https://ctdbase.org/detail.go?type=gene&acc=10397,,,10397.0,NDRG1,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of NDRG1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3235,1519977,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,4753,NELL2,https://ctdbase.org/detail.go?type=gene&acc=4753,,,4753.0,NELL2,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of NELL2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3236,1519978,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,4771,NF2,https://ctdbase.org/detail.go?type=gene&acc=4771,,,4771.0,NF2,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of NF2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3237,1519979,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,116496,NIBAN1,https://ctdbase.org/detail.go?type=gene&acc=116496,,,116496.0,NIBAN1,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of NIBAN1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3238,1520625,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of PCK1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
3239,1525852,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,1394,CRHR1,https://ctdbase.org/detail.go?type=gene&acc=1394,,,1394.0,CRHR1,7955.0,Danio rerio (zebrafish),Acetamiprid results in increased expression of CRHR1 mRNA,,,PMID:36084721,https://www.ncbi.nlm.nih.gov/pubmed/36084721,36084721,,
3240,1525853,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,795785,CXCL18B,https://ctdbase.org/detail.go?type=gene&acc=795785,,,795785.0,cxcl18b,7955.0,Danio rerio (zebrafish),Acetamiprid results in increased expression of CXCL18B mrna|[pyrimethanil co-treated with pyrachlostrobin co-treated with acetamiprid] results in decreased expression of CXCL18B mrna|[iprodione co-treated with pyrimethanil co-treated with acetamiprid] affects the expression of CXCL18B mrna|[iprodione co-treated with pyrimethanil co-treated with pyrachlostrobin co-treated with acetamiprid] results in increased expression of CXCL18B mrna|[iprodione co-treated with acetamiprid] results in increased expression of CXCL18B mrna|[pyrachlostrobin co-treated with acetamiprid] affects the expression of CXCL18B mRNA,,,PMID:29091792,https://www.ncbi.nlm.nih.gov/pubmed/29091792,29091792,,
3241,1525854,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,100313513,CYP11A,https://ctdbase.org/detail.go?type=gene&acc=100313513,,,100313513.0,,10116.0,Rattus norvegicus (Norway rat),Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A mrna]|vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A protein],,,PMID:28395332,https://www.ncbi.nlm.nih.gov/pubmed/28395332,28395332,,
3242,1525855,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10090.0,Mus musculus (house mouse),Acetamiprid results in decreased expression of CYP11A1 mRNA,,,PMID:30103633,https://www.ncbi.nlm.nih.gov/pubmed/30103633,30103633,,
3243,1525856,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116.0,Rattus norvegicus (Norway rat),Acetamiprid results in decreased expression of CYP11A1 protein|acetamiprid results in decreased expression of CYP11A1 mRNA,,,PMID:28395332,https://www.ncbi.nlm.nih.gov/pubmed/28395332,28395332,,
3244,1525857,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,80374,CYP11A1.1,https://ctdbase.org/detail.go?type=gene&acc=80374,,,80374.0,cyp11a1.1,7955.0,Danio rerio (zebrafish),Acetamiprid affects the expression of CYP11A1.1 mRNA,,,PMID:36006007,https://www.ncbi.nlm.nih.gov/pubmed/36006007,36006007,,
3245,1525858,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586.0,CYP17A1,7955.0,Danio rerio (zebrafish),Acetamiprid affects the expression of CYP17A1 mRNA,,,PMID:36006007,https://www.ncbi.nlm.nih.gov/pubmed/36006007,36006007,,
3246,1525859,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586.0,CYP17A1,10090.0,Mus musculus (house mouse),Acetamiprid results in decreased expression of CYP17A1 mRNA,,,PMID:30103633,https://www.ncbi.nlm.nih.gov/pubmed/30103633,30103633,,
3247,1526056,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,7955.0,Danio rerio (zebrafish),[iprodione co-treated with acetamiprid] affects the expression of ESR1 mrna|acetamiprid results in decreased expression of ESR1 mrna|[iprodione co-treated with pyrimethanil co-treated with pyrachlostrobin co-treated with acetamiprid] affects the expression of ESR1 mrna|[pyrimethanil co-treated with acetamiprid] results in increased expression of ESR1 mrna|[iprodione co-treated with pyrimethanil co-treated with acetamiprid] results in increased expression of ESR1 mrna|[pyrimethanil co-treated with pyrachlostrobin co-treated with acetamiprid] results in increased expression of ESR1 mRNA,,,PMID:29091792,https://www.ncbi.nlm.nih.gov/pubmed/29091792,29091792,,
3248,1526057,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,7955.0,Danio rerio (zebrafish),Acetamiprid results in increased expression of ESR1 mRNA,,,PMID:36084721,https://www.ncbi.nlm.nih.gov/pubmed/36084721,36084721,,
3249,1440743,213039,Drug Gene Interaction database (DGIdb),Darunavir,,DARUNAVIR,https://www.dgidb.org/drugs/rxcui:460132,,SLCO3A1,https://www.dgidb.org/genes/hgnc:10952,,,28232.0,SLCO3A1,9606.0,Homo sapiens (human),,,,,,,,
3250,1440744,213039,BindingDB,Darunavir,8125,"(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=8125,125,"Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=125,P03367,Gag-Pol polyprotein,,,11686.0,Human immunodeficiency virus type 1 (BRU ISOLATE),,Ki (nM),0.016,PMID:19746963|DOI:10.1021/jm900695w,https://www.ncbi.nlm.nih.gov/pubmed/19746963|https://doi.org/10.1021/jm900695w,19746963,10.1021/jm900695w,
3251,1440745,213046,Comparative Toxicogenomics Database (CTD),Lurasidone,D000069056,Lurasidone Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069056,150,ADRA2A,https://ctdbase.org/detail.go?type=gene&acc=150,,,150.0,ADRA2A,9606.0,Homo sapiens (human),Lurasidone hydrochloride binds to ADRA2A protein,,,PMID:20404009,https://www.ncbi.nlm.nih.gov/pubmed/20404009,20404009,,
3252,1440746,213046,Comparative Toxicogenomics Database (CTD),Lurasidone,D000069056,Lurasidone Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069056,152,ADRA2C,https://ctdbase.org/detail.go?type=gene&acc=152,,,152.0,ADRA2C,9606.0,Homo sapiens (human),Lurasidone hydrochloride binds to ADRA2C protein,,,PMID:20404009,https://www.ncbi.nlm.nih.gov/pubmed/20404009,20404009,,
3253,1440747,213046,Comparative Toxicogenomics Database (CTD),Lurasidone,D000069056,Lurasidone Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069056,1813,DRD2,https://ctdbase.org/detail.go?type=gene&acc=1813,,,1813.0,DRD2,9606.0,Homo sapiens (human),Lurasidone hydrochloride binds to and results in decreased activity of DRD2 protein,,,PMID:20404009,https://www.ncbi.nlm.nih.gov/pubmed/20404009,20404009,,
3254,1440748,213046,Comparative Toxicogenomics Database (CTD),Lurasidone,D000069056,Lurasidone Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069056,3350,HTR1A,https://ctdbase.org/detail.go?type=gene&acc=3350,,,3350.0,HTR1A,9606.0,Homo sapiens (human),Lurasidone hydrochloride binds to and results in increased activity of HTR1A protein,,,PMID:20404009,https://www.ncbi.nlm.nih.gov/pubmed/20404009,20404009,,
3255,1440749,213046,Comparative Toxicogenomics Database (CTD),Lurasidone,D000069056,Lurasidone Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069056,3356,HTR2A,https://ctdbase.org/detail.go?type=gene&acc=3356,,,3356.0,HTR2A,9606.0,Homo sapiens (human),Lurasidone hydrochloride binds to HTR2A protein,,,PMID:20404009,https://www.ncbi.nlm.nih.gov/pubmed/20404009,20404009,,
3256,1440750,213046,Comparative Toxicogenomics Database (CTD),Lurasidone,D000069056,Lurasidone Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D000069056,3358,HTR2C,https://ctdbase.org/detail.go?type=gene&acc=3358,,,3358.0,HTR2C,9606.0,Homo sapiens (human),Lurasidone hydrochloride binds to HTR2C protein,,,PMID:20404009,https://www.ncbi.nlm.nih.gov/pubmed/20404009,20404009,,
3257,1440859,216235,Drug Gene Interaction database (DGIdb),Sitaxentan,,SITAXENTAN,https://www.dgidb.org/drugs/ncit:C73038,,EDNRB,https://www.dgidb.org/genes/hgnc:3180,,,1910.0,EDNRB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3258,1440860,216239,Drug Gene Interaction database (DGIdb),Sorafenib,,SORAFENIB,https://www.dgidb.org/drugs/rxcui:495881,,ARAF,https://www.dgidb.org/genes/hgnc:646,,,369.0,ARAF,9606.0,Homo sapiens (human),,,,,,,,
3259,1440861,216239,Drug Gene Interaction database (DGIdb),Sorafenib,,SORAFENIB,https://www.dgidb.org/drugs/rxcui:495881,,MAPK10,https://www.dgidb.org/genes/hgnc:6872,,,5602.0,MAPK10,9606.0,Homo sapiens (human),,,,,,,,
3260,1440862,216239,Drug Gene Interaction database (DGIdb),Sorafenib,,SORAFENIB,https://www.dgidb.org/drugs/rxcui:495881,,PDGFRA,https://www.dgidb.org/genes/hgnc:8803,,,5156.0,PDGFRA,9606.0,Homo sapiens (human),,,,,,,,
3261,1440863,216239,Drug Gene Interaction database (DGIdb),Sorafenib,,SORAFENIB,https://www.dgidb.org/drugs/rxcui:495881,,KIT,https://www.dgidb.org/genes/hgnc:6342,,,3815.0,KIT,9606.0,Homo sapiens (human),,,,,,,,
3262,1440864,216239,Drug Gene Interaction database (DGIdb),Sorafenib,,SORAFENIB,https://www.dgidb.org/drugs/rxcui:495881,,ARAF,https://www.dgidb.org/genes/hgnc:646,,,369.0,ARAF,9606.0,Homo sapiens (human),,,,,,,,
3263,1440865,216239,Drug Gene Interaction database (DGIdb),Sorafenib,,SORAFENIB,https://www.dgidb.org/drugs/rxcui:495881,,MAPK3,https://www.dgidb.org/genes/hgnc:6877,,,5595.0,MAPK3,9606.0,Homo sapiens (human),,,,,,,,
3264,1440866,216239,Drug Gene Interaction database (DGIdb),Sorafenib,,SORAFENIB,https://www.dgidb.org/drugs/rxcui:495881,,KIT,https://www.dgidb.org/genes/hgnc:6342,,,3815.0,KIT,9606.0,Homo sapiens (human),,,,,,,,
3265,1440867,216239,Drug Gene Interaction database (DGIdb),Sorafenib,,SORAFENIB,https://www.dgidb.org/drugs/rxcui:495881,,CBL,https://www.dgidb.org/genes/hgnc:1541,,,867.0,CBL,9606.0,Homo sapiens (human),,,,,,,,
3266,1519415,216239,Drug Gene Interaction database (DGIdb),Sorafenib,,SORAFENIB,https://www.dgidb.org/drugs/rxcui:495881,,GMNN,https://www.dgidb.org/genes/hgnc:17493,,,51053.0,GMNN,9606.0,Homo sapiens (human),,,,,,,,
3267,1519416,216239,Drug Gene Interaction database (DGIdb),Sorafenib,,SORAFENIB,https://www.dgidb.org/drugs/rxcui:495881,,FLT3,https://www.dgidb.org/genes/hgnc:3765,,,2322.0,FLT3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3268,1519550,216239,Drug Gene Interaction database (DGIdb),Sorafenib,,SORAFENIB,https://www.dgidb.org/drugs/rxcui:495881,,NTRK1,https://www.dgidb.org/genes/hgnc:8031,,,4914.0,NTRK1,9606.0,Homo sapiens (human),,,,,,,,
3269,1519551,216327,Drug Gene Interaction database (DGIdb),Senicapoc,,SENICAPOC,https://www.dgidb.org/drugs/ncit:C76882,,KCNN4,https://www.dgidb.org/genes/hgnc:6293,,,3783.0,KCNN4,9606.0,Homo sapiens (human),Blocker,,,,,,,
3270,1519552,219077,IUPHAR/BPS Guide to PHARMACOLOGY,Osanetant,3480,[3H]osanetant,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3480,362,NK3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=362,P29371,Neuromedin-K receptor,6870.0,TACR3,9606.0,Homo sapiens (human),Antagonist,pKd,9.9,,,,,
3271,1519553,219077,IUPHAR/BPS Guide to PHARMACOLOGY,Osanetant,2110,osanetant,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2110,361,NK2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=361,P21452,Substance-K receptor,6865.0,TACR2,9606.0,Homo sapiens (human),Antagonist,pKi,7.3 - 7.8,PMID:9190866|PMID:12206858,https://www.ncbi.nlm.nih.gov/pubmed/9190866|https://www.ncbi.nlm.nih.gov/pubmed/12206858,9190866|12206858,,
3272,1519554,219077,IUPHAR/BPS Guide to PHARMACOLOGY,Osanetant,2110,osanetant,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2110,360,NK1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=360,P25103,Substance-P receptor,6869.0,TACR1,9606.0,Homo sapiens (human),Antagonist,pIC50,5.6,PMID:9042606,https://www.ncbi.nlm.nih.gov/pubmed/9042606,9042606,,
3273,1519555,219077,IUPHAR/BPS Guide to PHARMACOLOGY,Osanetant,2110,osanetant,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2110,360,NK1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=360,P25103,Substance-P receptor,6869.0,TACR1,9606.0,Homo sapiens (human),Antagonist,pKi,6 - 6.6,PMID:12206858,https://www.ncbi.nlm.nih.gov/pubmed/12206858,12206858,,
3274,1438866,220338,Comparative Toxicogenomics Database (CTD),Pimaric acid,C008911,pimaric acid,https://ctdbase.org/detail.go?type=chem&acc=C008911,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),Pimaric acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein],,,PMID:22705379,https://www.ncbi.nlm.nih.gov/pubmed/22705379,22705379,,
3275,1438867,220338,Comparative Toxicogenomics Database (CTD),Pimaric acid,C008911,pimaric acid,https://ctdbase.org/detail.go?type=chem&acc=C008911,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Pimaric acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein],,,PMID:22705379,https://www.ncbi.nlm.nih.gov/pubmed/22705379,22705379,,
3276,1438868,220338,Comparative Toxicogenomics Database (CTD),Pimaric acid,C008911,pimaric acid,https://ctdbase.org/detail.go?type=chem&acc=C008911,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Pimaric acid inhibits the reaction [TNF protein results in increased expression of and results in increased activity of MMP9 protein]|pimaric acid inhibits the reaction [TNF protein results in increased expression of MMP9 mrna],,,PMID:22705379,https://www.ncbi.nlm.nih.gov/pubmed/22705379,22705379,,
3277,1438869,220338,Comparative Toxicogenomics Database (CTD),Pimaric acid,C008911,pimaric acid,https://ctdbase.org/detail.go?type=chem&acc=C008911,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Pimaric acid inhibits the reaction [TNF protein results in increased expression of RELA protein],,,PMID:22705379,https://www.ncbi.nlm.nih.gov/pubmed/22705379,22705379,,
3278,1438870,220338,Comparative Toxicogenomics Database (CTD),Pimaric acid,C008911,pimaric acid,https://ctdbase.org/detail.go?type=chem&acc=C008911,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),[pimaric acid co-treated with TNF protein] results in decreased expression of ATF2 protein modified form|pimaric acid inhibits the reaction [TNF protein results in increased expression of RELA protein]|pimaric acid inhibits the reaction [TNF protein results in increased expression of MMP9 mrna]|[pimaric acid co-treated with TNF protein] results in decreased expression of JUND protein|pimaric acid inhibits the reaction [TNF protein results in increased expression of FOS protein]|pimaric acid inhibits the reaction [TNF protein results in increased expression of and results in increased activity of MMP9 protein]|pimaric acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]|pimaric acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein],,,PMID:22705379,https://www.ncbi.nlm.nih.gov/pubmed/22705379,22705379,,
3279,1430766,220401,Comparative Toxicogenomics Database (CTD),Demecolcine,D003703,Demecolcine,https://ctdbase.org/detail.go?type=chem&acc=D003703,9638,FEZ1,https://ctdbase.org/detail.go?type=gene&acc=9638,,,9638.0,FEZ1,9606.0,Homo sapiens (human),Demecolcine results in increased expression of FEZ1 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
3280,1438871,220401,Drug Gene Interaction database (DGIdb),Demecolcine,,DEMECOLCINE,https://www.dgidb.org/drugs/ncit:C419,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606.0,Homo sapiens (human),,,,,,,,
3281,1519556,220490,Drug Gene Interaction database (DGIdb),"4-[[4-(dimethylamino)phenyl]-(4-nitrophenyl)methyl]-N,N-dimethylaniline",,CHEMBL:CHEMBL1270169,https://www.dgidb.org/drugs/chembl:CHEMBL1270169,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
3282,1439551,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0000821,Glutathione peroxidase 3,http://www.t3db.ca/biodb/bio_entities/BE0000821,P22352,Glutathione peroxidase 3,2878.0,GPX3,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
3283,1439552,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0002286,Glutathione peroxidase 6,http://www.t3db.ca/biodb/bio_entities/BE0002286,P59796,Glutathione peroxidase 6,257202.0,GPX6,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
3284,1439660,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0002289,Glutathione peroxidase 7,http://www.t3db.ca/biodb/bio_entities/BE0002289,Q96SL4,Glutathione peroxidase 7,2882.0,GPX7,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
3285,1439661,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0000648,"Glutathione reductase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000648,P00390,"Glutathione reductase, mitochondrial",2936.0,GSR,9606.0,Homo sapiens (human),Cyanide inhibits glutathione reductase. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
3286,1439662,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0001135,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0001135,P36969,Phospholipid hydroperoxide glutathione peroxidase,2879.0,GPX4,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
3287,1439663,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0002288,Probable glutathione peroxidase 8,http://www.t3db.ca/biodb/bio_entities/BE0002288,Q8TED1,Probable glutathione peroxidase 8,493869.0,GPX8,9606.0,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
3288,1439774,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0002257,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002257,Q99643,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",6391.0,SDHC,9606.0,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
3289,1439775,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0002390,Superoxide dismutase [Cu-Zn],http://www.t3db.ca/biodb/bio_entities/BE0002390,P00441,Superoxide dismutase [Cu-Zn],6647.0,SOD1,9606.0,Homo sapiens (human),Cyanide inhibits superoxide dismutase [cu-zn]. (A72),,,PMID:15856906,https://www.ncbi.nlm.nih.gov/pubmed/15856906,15856906,,
3290,1439776,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0000252,Tyrosinase,http://www.t3db.ca/biodb/bio_entities/BE0000252,P14679,Tyrosinase,7299.0,TYR,9606.0,Homo sapiens (human),Cyanide inhibits tyrosinase. (A77),,,PMID:16950829,https://www.ncbi.nlm.nih.gov/pubmed/16950829,16950829,,
3291,1439777,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0000896,"Alkaline phosphatase, placental-like",http://www.t3db.ca/biodb/bio_entities/BE0000896,P10696,"Alkaline phosphatase, germ cell type",251.0,ALPG,9606.0,Homo sapiens (human),Cyanide inhibits alkaline phosphatases. (A73),,,PMID:924371,https://www.ncbi.nlm.nih.gov/pubmed/924371,924371,,
3292,1439778,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0003546,"Alkaline phosphatase, tissue-nonspecific isozyme",http://www.t3db.ca/biodb/bio_entities/BE0003546,P05186,"Alkaline phosphatase, tissue-nonspecific isozyme",249.0,ALPL,9606.0,Homo sapiens (human),Cyanide inhibits alkaline phosphatases. (A73),,,PMID:924371,https://www.ncbi.nlm.nih.gov/pubmed/924371,924371,,
3293,1439779,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0001207,Catalase,http://www.t3db.ca/biodb/bio_entities/BE0001207,P04040,Catalase,847.0,CAT,9606.0,Homo sapiens (human),Cyanide inhibits catalase. (A74),,,PMID:16728955,https://www.ncbi.nlm.nih.gov/pubmed/16728955,16728955,,
3294,1438872,221071,Comparative Toxicogenomics Database (CTD),Santonin,D012500,Santonin,https://ctdbase.org/detail.go?type=chem&acc=D012500,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),[santonin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA,,,PMID:25455453,https://www.ncbi.nlm.nih.gov/pubmed/25455453,25455453,,
3295,1438873,221071,Comparative Toxicogenomics Database (CTD),Santonin,D012500,Santonin,https://ctdbase.org/detail.go?type=chem&acc=D012500,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606.0,Homo sapiens (human),Santonin results in increased activity of NR1I2 protein|[santonin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA,,,PMID:25455453,https://www.ncbi.nlm.nih.gov/pubmed/25455453,25455453,,
3296,1430968,221373,Comparative Toxicogenomics Database (CTD),4-Methylidene-5-oxo-2-tridecyloxolane-3-carboxylic acid,C095781,protolichesterinic acid,https://ctdbase.org/detail.go?type=chem&acc=C095781,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Protolichesterinic acid results in decreased expression of BCL2 protein,,,PMID:22063921,https://www.ncbi.nlm.nih.gov/pubmed/22063921,22063921,,
3297,1430969,221373,Comparative Toxicogenomics Database (CTD),4-Methylidene-5-oxo-2-tridecyloxolane-3-carboxylic acid,C095781,protolichesterinic acid,https://ctdbase.org/detail.go?type=chem&acc=C095781,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Protolichesterinic acid results in increased activity of CASP3 protein,,,PMID:22063921,https://www.ncbi.nlm.nih.gov/pubmed/22063921,22063921,,
3298,1430970,221373,Comparative Toxicogenomics Database (CTD),4-Methylidene-5-oxo-2-tridecyloxolane-3-carboxylic acid,C095781,protolichesterinic acid,https://ctdbase.org/detail.go?type=chem&acc=C095781,3303,HSPA1A,https://ctdbase.org/detail.go?type=gene&acc=3303,,,3303.0,HSPA1A,9606.0,Homo sapiens (human),Protolichesterinic acid results in decreased expression of HSPA1A protein,,,PMID:22063921,https://www.ncbi.nlm.nih.gov/pubmed/22063921,22063921,,
3299,1430971,221373,Comparative Toxicogenomics Database (CTD),4-Methylidene-5-oxo-2-tridecyloxolane-3-carboxylic acid,C095781,protolichesterinic acid,https://ctdbase.org/detail.go?type=chem&acc=C095781,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606.0,Homo sapiens (human),Protolichesterinic acid results in decreased expression of NOS2 protein,,,PMID:22063921,https://www.ncbi.nlm.nih.gov/pubmed/22063921,22063921,,
3300,1430972,221373,Comparative Toxicogenomics Database (CTD),4-Methylidene-5-oxo-2-tridecyloxolane-3-carboxylic acid,C095781,protolichesterinic acid,https://ctdbase.org/detail.go?type=chem&acc=C095781,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,9606.0,Homo sapiens (human),Protolichesterinic acid results in increased expression of TNFSF10 protein,,,PMID:22063921,https://www.ncbi.nlm.nih.gov/pubmed/22063921,22063921,,
3301,1438874,221493,IUPHAR/BPS Guide to PHARMACOLOGY,Cholic Acid,609,cholic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=609,37,GPBA receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=37,Q8TDU6,G-protein coupled bile acid receptor 1,151306.0,GPBAR1,9606.0,Homo sapiens (human),Full agonist,pEC50,5,PMID:12419312,https://www.ncbi.nlm.nih.gov/pubmed/12419312,12419312,,
3302,1519557,221493,Drug Gene Interaction database (DGIdb),Cholic Acid,,CHOLIC ACID,https://www.dgidb.org/drugs/rxcui:1440856,,ABCB11,https://www.dgidb.org/genes/hgnc:42,,,8647.0,ABCB11,9606.0,Homo sapiens (human),,,,,,,,
3303,1519558,221493,BindingDB,Cholic Acid,21680,"(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21680,9478,Ubiquitin carboxyl-terminal hydrolase 2 [258-605],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9478,O75604,Ubiquitin carboxyl-terminal hydrolase 2,9099.0,USP2,9606.0,Homo sapiens (human),,IC50 (nM),>1.00e+5,PMID:28343940|DOI:10.1016/j.chembiol.2017.03.002,https://www.ncbi.nlm.nih.gov/pubmed/28343940|https://doi.org/10.1016/j.chembiol.2017.03.002,28343940,10.1016/j.chembiol.2017.03.002,
3304,1519559,221580,Drug Gene Interaction database (DGIdb),Sandaracopimaric acid,,SANDARACOPIMARIC ACID,https://www.dgidb.org/drugs/chembl:CHEMBL513197,,GABRB2,https://www.dgidb.org/genes/hgnc:4082,,,2561.0,GABRB2,9606.0,Homo sapiens (human),,,,,,,,
3305,1438875,222528,IUPHAR/BPS Guide to PHARMACOLOGY,Deoxycholic Acid,610,deoxycholic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=610,37,GPBA receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=37,Q8TDU6,G-protein coupled bile acid receptor 1,151306.0,GPBAR1,9606.0,Homo sapiens (human),Full agonist,pEC50,6.2,PMID:12419312,https://www.ncbi.nlm.nih.gov/pubmed/12419312,12419312,,
3306,1430973,222757,Drug Gene Interaction database (DGIdb),Estradiol Benzoate,,ESTRADIOL 3-BENZOATE,https://www.dgidb.org/drugs/rxcui:60661,,CAMK4,https://www.dgidb.org/genes/hgnc:1464,,,814.0,CAMK4,9606.0,Homo sapiens (human),,,,,,,,
3307,1441133,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,126767,AADACL3,https://ctdbase.org/detail.go?type=gene&acc=126767,,,126767.0,AADACL3,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in decreased expression of AADACL3 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3308,1441134,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10116.0,Rattus norvegicus (Norway rat),Estradiol 3-benzoate results in increased expression of ABCB1A mrna|estradiol 3-benzoate results in decreased expression of ABCB1A mrna|fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of ABCB1A mrna],,,PMID:23707492,https://www.ncbi.nlm.nih.gov/pubmed/23707492,23707492,,
3309,1441135,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,18669,ABCB1B,https://ctdbase.org/detail.go?type=gene&acc=18669,,,18669.0,Abcb1b,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of ABCB1B mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3310,1441862,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,313,AOAH,https://ctdbase.org/detail.go?type=gene&acc=313,,,313.0,AOAH,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of AOAH mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3311,1441863,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,8905,AP1S2,https://ctdbase.org/detail.go?type=gene&acc=8905,,,8905.0,AP1S2,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of AP1S2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3312,1441864,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,321,APBA2,https://ctdbase.org/detail.go?type=gene&acc=321,,,321.0,APBA2,10116.0,Rattus norvegicus (Norway rat),Estradiol 3-benzoate results in decreased expression of APBA2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3313,1443122,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,151887,CCDC80,https://ctdbase.org/detail.go?type=gene&acc=151887,,,151887.0,CCDC80,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CCDC80 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3314,1443123,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,79780,CCDC82,https://ctdbase.org/detail.go?type=gene&acc=79780,,,79780.0,CCDC82,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CCDC82 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3315,1443124,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,6356,CCL11,https://ctdbase.org/detail.go?type=gene&acc=6356,,,6356.0,CCL11,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CCL11 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3316,1443125,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,20293,CCL12,https://ctdbase.org/detail.go?type=gene&acc=20293,,,20293.0,Ccl12,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CCL12 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3317,1443126,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,6363,CCL19,https://ctdbase.org/detail.go?type=gene&acc=6363,,,6363.0,CCL19,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CCL19 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3318,1443127,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CCL2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3319,1443128,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,56477,CCL28,https://ctdbase.org/detail.go?type=gene&acc=56477,,,56477.0,CCL28,10116.0,Rattus norvegicus (Norway rat),Estradiol 3-benzoate results in increased expression of CCL28 mrna|[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CCL28 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3320,1444004,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,1114,CHGB,https://ctdbase.org/detail.go?type=gene&acc=1114,,,1114.0,CHGB,10116.0,Rattus norvegicus (Norway rat),Estradiol 3-benzoate results in increased expression of CHGB mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3321,1444005,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,1116,CHI3L1,https://ctdbase.org/detail.go?type=gene&acc=1116,,,1116.0,CHI3L1,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CHI3L1 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3322,1444128,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,150468,CKAP2L,https://ctdbase.org/detail.go?type=gene&acc=150468,,,150468.0,CKAP2L,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CKAP2L mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3323,1444129,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,12716,CKMT1,https://ctdbase.org/detail.go?type=gene&acc=12716,,,12716.0,Ckmt1,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CKMT1 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3324,1444130,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,1179,CLCA1,https://ctdbase.org/detail.go?type=gene&acc=1179,,,1179.0,CLCA1,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CLCA1 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3325,1444131,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,9635,CLCA2,https://ctdbase.org/detail.go?type=gene&acc=9635,,,9635.0,CLCA2,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CLCA2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3326,1444132,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,499721,CLCA4L,https://ctdbase.org/detail.go?type=gene&acc=499721,,,499721.0,Clca4l,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CLCA4L mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3327,1444133,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,362052,CLCA5,https://ctdbase.org/detail.go?type=gene&acc=362052,,,362052.0,Clca5,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CLCA5 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3328,1444134,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,1188,CLCNKB,https://ctdbase.org/detail.go?type=gene&acc=1188,,,1188.0,CLCNKB,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in decreased expression of CLCNKB mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3329,1444135,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,9071,CLDN10,https://ctdbase.org/detail.go?type=gene&acc=9071,,,9071.0,CLDN10,10116.0,Rattus norvegicus (Norway rat),Estradiol 3-benzoate results in increased expression of CLDN10 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3330,1444136,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,10462,CLEC10A,https://ctdbase.org/detail.go?type=gene&acc=10462,,,10462.0,CLEC10A,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CLEC10A mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3331,1444137,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,160364,CLEC12A,https://ctdbase.org/detail.go?type=gene&acc=160364,,,160364.0,CLEC12A,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CLEC12A mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3332,1444489,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,1265,CNN2,https://ctdbase.org/detail.go?type=gene&acc=1265,,,1265.0,CNN2,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CNN2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3333,1444490,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,1269,CNR2,https://ctdbase.org/detail.go?type=gene&acc=1269,,,1269.0,CNR2,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CNR2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3334,1444491,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,8506,CNTNAP1,https://ctdbase.org/detail.go?type=gene&acc=8506,,,8506.0,CNTNAP1,10116.0,Rattus norvegicus (Norway rat),Estradiol 3-benzoate results in increased methylation of CNTNAP1 promoter,,,PMID:27415467,https://www.ncbi.nlm.nih.gov/pubmed/27415467,27415467,,
3335,1444492,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,80347,COASY,https://ctdbase.org/detail.go?type=gene&acc=80347,,,80347.0,COASY,10116.0,Rattus norvegicus (Norway rat),Estradiol 3-benzoate results in decreased methylation of COASY promoter,,,PMID:27415467,https://www.ncbi.nlm.nih.gov/pubmed/27415467,27415467,,
3336,1444493,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,1306,COL15A1,https://ctdbase.org/detail.go?type=gene&acc=1306,,,1306.0,COL15A1,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of COL15A1 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
3337,1444494,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,10114.0,Rattus,Estradiol 3-benzoate results in decreased expression of COL3A1 mRNA,,,PMID:14967907,https://www.ncbi.nlm.nih.gov/pubmed/14967907,14967907,,
3338,1519560,222757,Drug Gene Interaction database (DGIdb),Estradiol Benzoate,,ESTRADIOL 3-BENZOATE,https://www.dgidb.org/drugs/rxcui:60661,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606.0,Homo sapiens (human),,,,,,,,
3339,1430974,222786,Drug Gene Interaction database (DGIdb),Cortisone,,CORTISONE,https://www.dgidb.org/drugs/rxcui:2878,,HEXB,https://www.dgidb.org/genes/hgnc:4879,,,3074.0,HEXB,9606.0,Homo sapiens (human),,,,,,,,
3340,1430975,222786,Drug Gene Interaction database (DGIdb),Cortisone,,CORTISONE,https://www.dgidb.org/drugs/rxcui:2878,,PPY,https://www.dgidb.org/genes/hgnc:9327,,,5539.0,PPY,9606.0,Homo sapiens (human),,,,,,,,
3341,1430976,222819,BindingDB,"(1R,2R,5S,6S,10S,13S,15R)-5-acetyl-13-hydroxy-6,10-dimethylpentacyclo[13.2.2.0^{1,9}.0^{2,6}.0^{10,15}]nonadeca-8,18-diene-16,17-dicarboxylic acid",25465,"(1R,2R,5S,6S,10S,13S,15R)-5-acetyl-13-hydroxy-6,10-dimethylpentacyclo[13.2.2.0^{1,9}.0^{2,6}.0^{10,15}]nonadeca-8,18-diene-16,17-dicarboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25465,2826,Adenosine 5'-phosphosulfate reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2826,P9WIK2,Probable phosphoadenosine phosphosulfate reductase,45426378.0,MCAN_RS12710,83331.0,Mycobacterium tuberculosis CDC1551,,,,PMID:18855373|DOI:10.1021/jm800571m,https://www.ncbi.nlm.nih.gov/pubmed/18855373|https://doi.org/10.1021/jm800571m,18855373,10.1021/jm800571m,
3342,1430977,222865,DrugBank,Androstanedione,DB01561,Androstanedione,https://www.drugbank.ca/drugs/DB01561,BE0000194,Estradiol 17-beta-dehydrogenase 1,https://www.drugbank.ca/bio_entities/BE0000194,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
3343,1430978,222865,DrugBank,Androstanedione,DB01561,Androstanedione,https://www.drugbank.ca/drugs/DB01561,BE0001607,Steroid Delta-isomerase,https://www.drugbank.ca/bio_entities/BE0001607,P00947,Steroid Delta-isomerase,64000200.0,,285.0,Comamonas testosteroni,,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
3344,1429602,227037,Comparative Toxicogenomics Database (CTD),Epoxycholesterol,C002415,cholesterol alpha-oxide,https://ctdbase.org/detail.go?type=chem&acc=C002415,36780,JHE,https://ctdbase.org/detail.go?type=gene&acc=36780,,,36780.0,Jhe,7111.0,Trichoplusia ni (cabbage looper),Cholesterol alpha-oxide results in decreased activity of JHE protein,,,PMID:15893999,https://www.ncbi.nlm.nih.gov/pubmed/15893999,15893999,,
3345,1429603,227037,Comparative Toxicogenomics Database (CTD),Epoxycholesterol,C002415,cholesterol alpha-oxide,https://ctdbase.org/detail.go?type=chem&acc=C002415,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),RTKI cpd inhibits the reaction [cholesterol alpha-oxide results in increased phosphorylation of MAPK1 protein]|cholesterol alpha-oxide results in increased phosphorylation of MAPK1 protein,,,PMID:20466046,https://www.ncbi.nlm.nih.gov/pubmed/20466046,20466046,,
3346,1429604,227037,Comparative Toxicogenomics Database (CTD),Epoxycholesterol,C002415,cholesterol alpha-oxide,https://ctdbase.org/detail.go?type=chem&acc=C002415,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),Cholesterol alpha-oxide results in increased phosphorylation of MAPK3 protein|rtki cpd inhibits the reaction [cholesterol alpha-oxide results in increased phosphorylation of MAPK3 protein],,,PMID:20466046,https://www.ncbi.nlm.nih.gov/pubmed/20466046,20466046,,
3347,1429605,227037,Comparative Toxicogenomics Database (CTD),Epoxycholesterol,C002415,cholesterol alpha-oxide,https://ctdbase.org/detail.go?type=chem&acc=C002415,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10116.0,Rattus norvegicus (Norway rat),Cholesterol alpha-oxide results in increased expression of MMP2 mRNA,,,PMID:20466046,https://www.ncbi.nlm.nih.gov/pubmed/20466046,20466046,,
3348,1429606,227037,Comparative Toxicogenomics Database (CTD),Epoxycholesterol,C002415,cholesterol alpha-oxide,https://ctdbase.org/detail.go?type=chem&acc=C002415,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,10116.0,Rattus norvegicus (Norway rat),Cholesterol alpha-oxide results in increased expression of MMP9 mRNA,,,PMID:20466046,https://www.ncbi.nlm.nih.gov/pubmed/20466046,20466046,,
3349,1429607,227037,Comparative Toxicogenomics Database (CTD),Epoxycholesterol,C002415,cholesterol alpha-oxide,https://ctdbase.org/detail.go?type=chem&acc=C002415,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,10116.0,Rattus norvegicus (Norway rat),Cholesterol alpha-oxide results in increased phosphorylation of MTOR protein|rtki cpd inhibits the reaction [cholesterol alpha-oxide results in increased phosphorylation of MTOR protein],,,PMID:20466046,https://www.ncbi.nlm.nih.gov/pubmed/20466046,20466046,,
3350,1429608,228618,BindingDB,[(e)-(4-Methoxyphenyl)diazenyl]propanedinitrile,4381,[(p-Methoxyphenyl)hydrazono]malononitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4381,520,Epidermal growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=520,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),,IC50 (nM),600000,PMID:2552117|DOI:10.1021/jm00130a020,https://www.ncbi.nlm.nih.gov/pubmed/2552117|https://doi.org/10.1021/jm00130a020,2552117,10.1021/jm00130a020,
3351,1429609,234102,Therapeutic Target Database (TTD),11-Oxoursolic acid acetate,D0J5RQ,3-acetyl-11-keto-ursolic acid,https://idrblab.net/ttd/data/drug/details/D0J5RQ,T65200,Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1),https://idrblab.net/ttd/data/target/details/T65200,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3352,1429610,235240,Drug Gene Interaction database (DGIdb),"2-(3,4-Dihydroxyphenyl)-3,6,7-trihydroxy-2,3-dihydro-4H-chromen-4-one",,CHEMBL:CHEMBL483206,https://www.dgidb.org/drugs/chembl:CHEMBL483206,,POLK,https://www.dgidb.org/genes/hgnc:9183,,,51426.0,POLK,9606.0,Homo sapiens (human),,,,,,,,
3353,1429712,244824,Therapeutic Target Database (TTD),2-[4-(Carboxymethylsulfanylcarbothioyl)piperazine-1-carbothioyl]sulfanylacetic acid,D0H1YK,NSC-56071,https://idrblab.net/ttd/data/drug/details/D0H1YK,T65501,DNA [cytosine-5]-methyltransferase 3B (DNMT3B),https://idrblab.net/ttd/data/target/details/T65501,Q9UBC3,DNA (cytosine-5)-methyltransferase 3B,1789.0,DNMT3B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3354,1441117,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,23294,ANKS1A,https://ctdbase.org/detail.go?type=gene&acc=23294,,,23294.0,ANKS1A,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of ANKS1A protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3355,1441118,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,55129,ANO10,https://ctdbase.org/detail.go?type=gene&acc=55129,,,55129.0,ANO10,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of ANO10 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3356,1441119,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,8125,ANP32A,https://ctdbase.org/detail.go?type=gene&acc=8125,,,8125.0,ANP32A,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of ANP32A protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3357,1441120,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1173,AP2M1,https://ctdbase.org/detail.go?type=gene&acc=1173,,,1173.0,AP2M1,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of AP2M1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3358,1441121,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,339,APOBEC1,https://ctdbase.org/detail.go?type=gene&acc=339,,,339.0,APOBEC1,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of APOBEC1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3359,1441122,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,344,APOC2,https://ctdbase.org/detail.go?type=gene&acc=344,,,344.0,APOC2,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of APOC2 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3360,1441245,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,393940,ATP2A2A,https://ctdbase.org/detail.go?type=gene&acc=393940,,,393940.0,atp2a2a,7955.0,Danio rerio (zebrafish),Aconitine affects the expression of ATP2A2A mRNA,,,PMID:31975431,https://www.ncbi.nlm.nih.gov/pubmed/31975431,31975431,,
3361,1441865,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1072,CFL1,https://ctdbase.org/detail.go?type=gene&acc=1072,,,1072.0,CFL1,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of CFL1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3362,1441866,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,57530,CGN,https://ctdbase.org/detail.go?type=gene&acc=57530,,,57530.0,CGN,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of CGN protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3363,1441867,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1139,CHRNA7,https://ctdbase.org/detail.go?type=gene&acc=1139,,,1139.0,CHRNA7,9606.0,Homo sapiens (human),Aconitine analog binds to and results in decreased activity of CHRNA7 protein,,,PMID:16862215,https://www.ncbi.nlm.nih.gov/pubmed/16862215,16862215,,
3364,1441868,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1153,CIRBP,https://ctdbase.org/detail.go?type=gene&acc=1153,,,1153.0,CIRBP,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of CIRBP protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3365,1441869,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,161198,CLEC14A,https://ctdbase.org/detail.go?type=gene&acc=161198,,,161198.0,CLEC14A,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of CLEC14A protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3366,1441870,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1192,CLIC1,https://ctdbase.org/detail.go?type=gene&acc=1192,,,1192.0,CLIC1,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of CLIC1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3367,1441871,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1211,CLTA,https://ctdbase.org/detail.go?type=gene&acc=1211,,,1211.0,CLTA,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of CLTA protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3368,1441872,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1289,COL5A1,https://ctdbase.org/detail.go?type=gene&acc=1289,,,1289.0,COL5A1,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of COL5A1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3369,1442002,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,729920,CRPPA,https://ctdbase.org/detail.go?type=gene&acc=729920,,,729920.0,CRPPA,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of CRPPA protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3370,1443129,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,10021,HCN4,https://ctdbase.org/detail.go?type=gene&acc=10021,,,10021.0,HCN4,9606.0,Homo sapiens (human),Aconitine affects the expression of HCN4 mrna|aconitine results in increased expression of HCN4 mrna|aconitine affects the reaction [NOTCH1 protein modified form binds to HCN4 promoter]|crenigacestat affects the reaction [aconitine affects the expression of HCN4 protein]|aconitine affects the expression of HCN4 protein|aconitine promotes the reaction [NOTCH1 protein modified form binds to HCN4 promoter],,,PMID:32234357,https://www.ncbi.nlm.nih.gov/pubmed/32234357,32234357,,
3371,1443130,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,3066,HDAC2,https://ctdbase.org/detail.go?type=gene&acc=3066,,,3066.0,HDAC2,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of HDAC2 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3372,1443131,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,50810,HDGFL3,https://ctdbase.org/detail.go?type=gene&acc=50810,,,50810.0,HDGFL3,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of HDGFL3 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3373,1443132,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,50865,HEBP1,https://ctdbase.org/detail.go?type=gene&acc=50865,,,50865.0,HEBP1,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of HEBP1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3374,1444138,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,60560,NAA35,https://ctdbase.org/detail.go?type=gene&acc=60560,,,60560.0,NAA35,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of NAA35 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3375,1445865,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,222068,TMED4,https://ctdbase.org/detail.go?type=gene&acc=222068,,,222068.0,TMED4,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of TMED4 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3376,1445866,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,84233,TMEM126A,https://ctdbase.org/detail.go?type=gene&acc=84233,,,84233.0,TMEM126A,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of TMEM126A protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3377,1445867,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,153339,TMEM167A,https://ctdbase.org/detail.go?type=gene&acc=153339,,,153339.0,TMEM167A,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of TMEM167A protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3378,1445868,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,130827,TMEM182,https://ctdbase.org/detail.go?type=gene&acc=130827,,,130827.0,TMEM182,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of TMEM182 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3379,1445869,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,25880,TMEM186,https://ctdbase.org/detail.go?type=gene&acc=25880,,,25880.0,TMEM186,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of TMEM186 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3380,1445870,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,79041,TMEM38A,https://ctdbase.org/detail.go?type=gene&acc=79041,,,79041.0,TMEM38A,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of TMEM38A protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3381,1445871,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,157378,TMEM65,https://ctdbase.org/detail.go?type=gene&acc=157378,,,157378.0,TMEM65,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of TMEM65 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3382,1446184,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,140739,UBE2F,https://ctdbase.org/detail.go?type=gene&acc=140739,,,140739.0,UBE2F,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of UBE2F protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3383,1446185,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,7337,UBE3A,https://ctdbase.org/detail.go?type=gene&acc=7337,,,7337.0,UBE3A,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of UBE3A protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3384,1446186,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,59286,UBL5,https://ctdbase.org/detail.go?type=gene&acc=59286,,,59286.0,UBL5,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of UBL5 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3385,1446187,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,29978,UBQLN2,https://ctdbase.org/detail.go?type=gene&acc=29978,,,29978.0,UBQLN2,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of UBQLN2 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3386,1446188,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,23376,UFL1,https://ctdbase.org/detail.go?type=gene&acc=23376,,,23376.0,UFL1,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of UFL1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3387,1446189,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,51569,UFM1,https://ctdbase.org/detail.go?type=gene&acc=51569,,,51569.0,UFM1,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of UFM1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3388,1446190,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,55898,UNC45A,https://ctdbase.org/detail.go?type=gene&acc=55898,,,55898.0,UNC45A,10116.0,Rattus norvegicus (Norway rat),Aconitine results in increased expression of UNC45A protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3389,1446191,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,7378,UPP1,https://ctdbase.org/detail.go?type=gene&acc=7378,,,7378.0,UPP1,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of UPP1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3390,1446192,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,55245,UQCC1,https://ctdbase.org/detail.go?type=gene&acc=55245,,,55245.0,UQCC1,10116.0,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of UQCC1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
3391,1429713,246520,Comparative Toxicogenomics Database (CTD),Cholesteryl palmitate,C026651,cholesteryl palmitate,https://ctdbase.org/detail.go?type=chem&acc=C026651,3990,LIPC,https://ctdbase.org/detail.go?type=gene&acc=3990,,,3990.0,LIPC,10090.0,Mus musculus (house mouse),[LIPC gene mutant form co-treated with LIPG gene mutant form] results in increased abundance of cholesteryl palmitate,,,PMID:24777581,https://www.ncbi.nlm.nih.gov/pubmed/24777581,24777581,,
3392,1429714,246520,Comparative Toxicogenomics Database (CTD),Cholesteryl palmitate,C026651,cholesteryl palmitate,https://ctdbase.org/detail.go?type=chem&acc=C026651,9388,LIPG,https://ctdbase.org/detail.go?type=gene&acc=9388,,,9388.0,LIPG,10090.0,Mus musculus (house mouse),[LIPC gene mutant form co-treated with LIPG gene mutant form] results in increased abundance of cholesteryl palmitate|lipg gene mutant form results in increased abundance of cholesteryl palmitate,,,PMID:24777581,https://www.ncbi.nlm.nih.gov/pubmed/24777581,24777581,,
3393,1446515,246598,Comparative Toxicogenomics Database (CTD),"O,P'-Dde",C054919,"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene",https://ctdbase.org/detail.go?type=chem&acc=C054919,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,9606.0,Homo sapiens (human),"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene results in increased activity of NR1I3 protein",,,PMID:28927721,https://www.ncbi.nlm.nih.gov/pubmed/28927721,28927721,,
3394,1446516,246598,Comparative Toxicogenomics Database (CTD),"O,P'-Dde",C054919,"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene",https://ctdbase.org/detail.go?type=chem&acc=C054919,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,10090.0,Mus musculus (house mouse),"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene affects the expression of NR1I3 mrna|2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene results in increased expression of NR1I3 protein",,,PMID:32721735,https://www.ncbi.nlm.nih.gov/pubmed/32721735,32721735,,
3395,1446517,246598,Comparative Toxicogenomics Database (CTD),"O,P'-Dde",C054919,"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene",https://ctdbase.org/detail.go?type=chem&acc=C054919,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,9989.0,Rodentia (rodent),"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene binds to and results in increased activity of NR1I3 protein",,,PMID:16054614,https://www.ncbi.nlm.nih.gov/pubmed/16054614,16054614,,
3396,1446518,246598,Comparative Toxicogenomics Database (CTD),"O,P'-Dde",C054919,"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene",https://ctdbase.org/detail.go?type=chem&acc=C054919,23636,NUP62,https://ctdbase.org/detail.go?type=gene&acc=23636,,,23636.0,NUP62,10090.0,Mus musculus (house mouse),"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene affects the expression of NUP62 mrna|2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene results in increased expression of NUP62 protein",,,PMID:32721735,https://www.ncbi.nlm.nih.gov/pubmed/32721735,32721735,,
3397,1446519,246598,Comparative Toxicogenomics Database (CTD),"O,P'-Dde",C054919,"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene",https://ctdbase.org/detail.go?type=chem&acc=C054919,5020,OXT,https://ctdbase.org/detail.go?type=gene&acc=5020,,,5020.0,OXT,9913.0,Bos taurus (cattle),"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene results in increased expression of OXT mRNA",,,PMID:19383538,https://www.ncbi.nlm.nih.gov/pubmed/19383538,19383538,,
3398,1446520,246598,Comparative Toxicogenomics Database (CTD),"O,P'-Dde",C054919,"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene",https://ctdbase.org/detail.go?type=chem&acc=C054919,5066,PAM,https://ctdbase.org/detail.go?type=gene&acc=5066,,,5066.0,PAM,9913.0,Bos taurus (cattle),"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene results in increased expression of PAM mRNA",,,PMID:19383538,https://www.ncbi.nlm.nih.gov/pubmed/19383538,19383538,,
3399,1446521,246598,Comparative Toxicogenomics Database (CTD),"O,P'-Dde",C054919,"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene",https://ctdbase.org/detail.go?type=chem&acc=C054919,5156,PDGFRA,https://ctdbase.org/detail.go?type=gene&acc=5156,,,5156.0,PDGFRA,9606.0,Homo sapiens (human),"[dichlorodiphenyldichloroethane co-treated with dichlorodiphenyl dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with aldrin co-treated with dieldrin] results in increased expression of PDGFRA mRNA",,,PMID:19422813,https://www.ncbi.nlm.nih.gov/pubmed/19422813,19422813,,
3400,1446522,246598,Comparative Toxicogenomics Database (CTD),"O,P'-Dde",C054919,"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene",https://ctdbase.org/detail.go?type=chem&acc=C054919,5159,PDGFRB,https://ctdbase.org/detail.go?type=gene&acc=5159,,,5159.0,PDGFRB,9606.0,Homo sapiens (human),"[dichlorodiphenyldichloroethane co-treated with dichlorodiphenyl dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with aldrin co-treated with dieldrin] results in increased expression of PDGFRB mRNA",,,PMID:19422813,https://www.ncbi.nlm.nih.gov/pubmed/19422813,19422813,,
3401,1446523,246598,Comparative Toxicogenomics Database (CTD),"O,P'-Dde",C054919,"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene",https://ctdbase.org/detail.go?type=chem&acc=C054919,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9031.0,Gallus gallus (chicken),"2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene inhibits the reaction [progesterone binds to PGR protein]",,,PMID:2053848,https://www.ncbi.nlm.nih.gov/pubmed/2053848,2053848,,
3402,1429715,246876,Comparative Toxicogenomics Database (CTD),16-Ketoestrone,C002591,16-ketoestrone,https://ctdbase.org/detail.go?type=chem&acc=C002591,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),16-ketoestrone binds to ESR2 protein,,,PMID:16728493,https://www.ncbi.nlm.nih.gov/pubmed/16728493,16728493,,
3403,1429716,247704,IUPHAR/BPS Guide to PHARMACOLOGY,(S)-adrenaline,4450,(+)-adrenaline,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4450,23,α1B-adrenoceptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=23,P35368,Alpha-1B adrenergic receptor,147.0,ADRA1B,9606.0,Homo sapiens (human),Full agonist,pKi,5.1,PMID:7651358,https://www.ncbi.nlm.nih.gov/pubmed/7651358,7651358,,
3404,1429717,247704,IUPHAR/BPS Guide to PHARMACOLOGY,(S)-adrenaline,4450,(+)-adrenaline,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4450,22,α1A-adrenoceptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=22,P35348,Alpha-1A adrenergic receptor,148.0,ADRA1A,9606.0,Homo sapiens (human),Full agonist,pKi,5,PMID:7651358,https://www.ncbi.nlm.nih.gov/pubmed/7651358,7651358,,
3405,1429718,250948,Comparative Toxicogenomics Database (CTD),Melengestrol Acetate,D008552,Melengestrol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D008552,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,9606.0,Homo sapiens (human),Melengestrol acetate inhibits the reaction [[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]|[melengestrol acetate co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein,,,PMID:29782964,https://www.ncbi.nlm.nih.gov/pubmed/29782964,29782964,,
3406,1429719,250948,Comparative Toxicogenomics Database (CTD),Melengestrol Acetate,D008552,Melengestrol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D008552,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,8479.0,Chrysemys picta (Painted turtle),Melengestrol acetate inhibits the reaction [[6-fluorotestosterone co-treated with norgestrel] binds to and results in increased activity of AR protein],,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
3407,1429720,250948,Comparative Toxicogenomics Database (CTD),Melengestrol Acetate,D008552,Melengestrol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D008552,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606.0,Homo sapiens (human),Melengestrol acetate affects the localization of AR protein|melengestrol acetate binds to and results in increased activity of AR protein,,,PMID:28478275,https://www.ncbi.nlm.nih.gov/pubmed/28478275,28478275,,
3408,1520136,252042,Comparative Toxicogenomics Database (CTD),Nymphayol,C000594859,nymphayol,https://ctdbase.org/detail.go?type=chem&acc=C000594859,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10116.0,Rattus norvegicus (Norway rat),Nymphayol results in increased expression of SLC2A1 protein,,,PMID:25499137,https://www.ncbi.nlm.nih.gov/pubmed/25499137,25499137,,
3409,1520137,252042,Comparative Toxicogenomics Database (CTD),Nymphayol,C000594859,nymphayol,https://ctdbase.org/detail.go?type=chem&acc=C000594859,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Nymphayol inhibits the reaction [ethanol results in increased expression of TNF protein],,,PMID:25289771,https://www.ncbi.nlm.nih.gov/pubmed/25289771,25289771,,
3410,1520138,258027,Toxin and Toxin Target Database (T3DB),Tris(4-bromophenyl)amine,T3D1900,Tris(4-bromophenyl)aminium hexachloroantimonate,http://www.t3db.ca/toxins/T3D1900,BE0002281,Glutathione S-transferase A1,http://www.t3db.ca/biodb/bio_entities/BE0002281,P08263,Glutathione S-transferase A1,2938.0,GSTA1,9606.0,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
3411,1446657,275196,Comparative Toxicogenomics Database (CTD),Noscapine,D009665,Noscapine,https://ctdbase.org/detail.go?type=chem&acc=D009665,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Noscapine results in decreased expression of BCL2 protein|noscapine promotes the reaction [cisplatin results in decreased expression of BCL2 protein],,,PMID:20674069,https://www.ncbi.nlm.nih.gov/pubmed/20674069,20674069,,
3412,1446658,275196,Comparative Toxicogenomics Database (CTD),Noscapine,D009665,Noscapine,https://ctdbase.org/detail.go?type=chem&acc=D009665,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606.0,Homo sapiens (human),Noscapine results in increased expression of BIRC5 mrna|birc5 protein results in decreased susceptibility to noscapine|noscapine results in increased expression of BIRC5 protein,,,PMID:22848370,https://www.ncbi.nlm.nih.gov/pubmed/22848370,22848370,,
3413,1446659,275196,Comparative Toxicogenomics Database (CTD),Noscapine,D009665,Noscapine,https://ctdbase.org/detail.go?type=chem&acc=D009665,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606.0,Homo sapiens (human),Noscapine promotes the reaction [cisplatin results in decreased expression of BIRC5 protein]|noscapine results in decreased expression of BIRC5 protein,,,PMID:20674069,https://www.ncbi.nlm.nih.gov/pubmed/20674069,20674069,,
3414,1429831,283995,BindingDB,N-[4-(hydroxysulfamoyl)phenyl]acetamide,11382,Hydroxysulfonamide 63,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11382,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),29,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
3415,1429832,283995,BindingDB,N-[4-(hydroxysulfamoyl)phenyl]acetamide,11382,Hydroxysulfonamide 63,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11382,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),40,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
3416,1433513,287064,Comparative Toxicogenomics Database (CTD),"Protocatechuic acid, methyl ester",C531013,protocatechuic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C531013,50507,NOX4,https://ctdbase.org/detail.go?type=gene&acc=50507,,,50507.0,NOX4,10116.0,Rattus norvegicus (Norway rat),Protocatechuic acid methyl ester inhibits the reaction [sodium fluoride results in increased expression of NOX4 protein],,,PMID:29758312,https://www.ncbi.nlm.nih.gov/pubmed/29758312,29758312,,
3417,1433514,287064,Comparative Toxicogenomics Database (CTD),"Protocatechuic acid, methyl ester",C531013,protocatechuic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C531013,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606.0,Homo sapiens (human),Protocatechuic acid methyl ester inhibits the reaction [sodium fluoride results in increased expression of NQO1 mrna],,,PMID:28012895,https://www.ncbi.nlm.nih.gov/pubmed/28012895,28012895,,
3418,1433515,287064,Comparative Toxicogenomics Database (CTD),"Protocatechuic acid, methyl ester",C531013,protocatechuic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C531013,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10116.0,Rattus norvegicus (Norway rat),Protocatechuic acid methyl ester inhibits the reaction [sodium fluoride results in increased expression of PARP1 protein],,,PMID:29758312,https://www.ncbi.nlm.nih.gov/pubmed/29758312,29758312,,
3419,1433516,287064,Comparative Toxicogenomics Database (CTD),"Protocatechuic acid, methyl ester",C531013,protocatechuic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C531013,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Protocatechuic acid methyl ester inhibits the reaction [sodium fluoride results in increased expression of PTGS2 mrna],,,PMID:28012895,https://www.ncbi.nlm.nih.gov/pubmed/28012895,28012895,,
3420,1433517,287064,Comparative Toxicogenomics Database (CTD),"Protocatechuic acid, methyl ester",C531013,protocatechuic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C531013,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Protocatechuic acid methyl ester inhibits the reaction [sodium fluoride results in increased expression of PTGS2 mrna],,,PMID:29758312,https://www.ncbi.nlm.nih.gov/pubmed/29758312,29758312,,
3421,1433518,287064,Comparative Toxicogenomics Database (CTD),"Protocatechuic acid, methyl ester",C531013,protocatechuic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C531013,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Protocatechuic acid methyl ester inhibits the reaction [sodium fluoride results in increased expression of RELA mrna],,,PMID:28012895,https://www.ncbi.nlm.nih.gov/pubmed/28012895,28012895,,
3422,1433519,287064,Comparative Toxicogenomics Database (CTD),"Protocatechuic acid, methyl ester",C531013,protocatechuic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C531013,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Protocatechuic acid methyl ester inhibits the reaction [sodium fluoride results in increased expression of RELA mrna],,,PMID:29758312,https://www.ncbi.nlm.nih.gov/pubmed/29758312,29758312,,
3423,1433520,287064,Comparative Toxicogenomics Database (CTD),"Protocatechuic acid, methyl ester",C531013,protocatechuic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C531013,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116.0,Rattus norvegicus (Norway rat),Protocatechuic acid methyl ester inhibits the reaction [sodium fluoride results in increased expression of TGFB1 mrna],,,PMID:29758312,https://www.ncbi.nlm.nih.gov/pubmed/29758312,29758312,,
3424,1433521,287064,Comparative Toxicogenomics Database (CTD),"Protocatechuic acid, methyl ester",C531013,protocatechuic acid methyl ester,https://ctdbase.org/detail.go?type=chem&acc=C531013,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,10116.0,Rattus norvegicus (Norway rat),Protocatechuic acid methyl ester inhibits the reaction [sodium fluoride results in increased expression of VIM mrna],,,PMID:29758312,https://www.ncbi.nlm.nih.gov/pubmed/29758312,29758312,,
3425,1431386,287180,DrugBank,Rosoxacin,DB00817,Rosoxacin,https://www.drugbank.ca/drugs/DB00817,BE0000798,DNA topoisomerase 4 subunit A,https://www.drugbank.ca/bio_entities/BE0000798,P0AFI2,DNA topoisomerase 4 subunit A,947499.0,parC,83333.0,Escherichia coli K-12,Inhibitor,,,PMID:17139284|PMID:17016423|PMID:3010848,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/3010848,17139284|17016423|3010848,,
3426,1431387,287180,DrugBank,Rosoxacin,DB00817,Rosoxacin,https://www.drugbank.ca/drugs/DB00817,BE0002433,Cytochrome P450 1A2,https://www.drugbank.ca/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:19026171|PMID:22707017|PMID:21190921,https://www.ncbi.nlm.nih.gov/pubmed/19026171|https://www.ncbi.nlm.nih.gov/pubmed/22707017|https://www.ncbi.nlm.nih.gov/pubmed/21190921,19026171|22707017|21190921,,
3427,1433640,290730,Therapeutic Target Database (TTD),2-Amino-2-(3-chlorophenyl)acetic acid,D08ZGW,2-amino-2-(3-chlorophenyl)acetic acid,https://idrblab.net/ttd/data/drug/details/D08ZGW,T84316,Voltage-gated calcium channel alpha-2/delta-1 (CACNA2D1),https://idrblab.net/ttd/data/target/details/T84316,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,781.0,CACNA2D1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3428,1433641,296008,Therapeutic Target Database (TTD),"2-(2-Iodo-phenyl)-benzo[d][1,3]oxazin-4-one",D0J2SM,"2-(2-Iodo-phenyl)-benzo[d][1,3]oxazin-4-one",https://idrblab.net/ttd/data/drug/details/D0J2SM,T27602,Cationic trypsinogen (PRSS1),https://idrblab.net/ttd/data/target/details/T27602,P07477,Trypsin-1,5644.0,PRSS1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3429,1433642,301798,Therapeutic Target Database (TTD),Poriol,D0WN7V,NSC-180246,https://idrblab.net/ttd/data/drug/details/D0WN7V,T38338,Voltage-gated calcium channel alpha Cav2.2 (CACNA1B),https://idrblab.net/ttd/data/target/details/T38338,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,774.0,CACNA1B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3430,1433643,301798,Therapeutic Target Database (TTD),Poriol,D0WN7V,NSC-180246,https://idrblab.net/ttd/data/drug/details/D0WN7V,T14912,Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1),https://idrblab.net/ttd/data/target/details/T14912,Q07820,Induced myeloid leukemia cell differentiation protein Mcl-1,4170.0,MCL1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3431,1433644,307919,Therapeutic Target Database (TTD),"1-Aminopropane-1,2,3-tricarboxylic acid",D08KUO,"1-Aminopropane-1,2,3-tricarboxylic acid",https://idrblab.net/ttd/data/drug/details/D08KUO,T38179,Staphylococcus Beta-lactamase (Stap-coc blaZ),https://idrblab.net/ttd/data/target/details/T38179,P00807,Beta-lactamase,79052806.0,,1280.0,Staphylococcus aureus,Inhibitor,,,,,,,
3432,1433645,307957,Drug Gene Interaction database (DGIdb),(-)-Pilocarpine,,SALAGEN,https://www.dgidb.org/drugs/chembl:CHEMBL611494,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,,,,,
3433,1431388,312145,IUPHAR/BPS Guide to PHARMACOLOGY,Wortmannin,6060,wortmannin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6060,2156,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2156,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),Inhibition,pKd,7.82,PMID:30380865,https://www.ncbi.nlm.nih.gov/pubmed/30380865,30380865,,
3434,1431389,312145,IUPHAR/BPS Guide to PHARMACOLOGY,Wortmannin,6060,wortmannin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6060,2155,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2155,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",5293.0,PIK3CD,9606.0,Homo sapiens (human),Inhibition,pKd,8.26,PMID:30380865,https://www.ncbi.nlm.nih.gov/pubmed/30380865,30380865,,
3435,1431390,312145,IUPHAR/BPS Guide to PHARMACOLOGY,Wortmannin,6060,wortmannin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6060,2154,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2154,P42338,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",5291.0,PIK3CB,9606.0,Homo sapiens (human),Inhibition,pKd,8.12,PMID:30380865,https://www.ncbi.nlm.nih.gov/pubmed/30380865,30380865,,
3436,1433646,312145,Drug Gene Interaction database (DGIdb),Wortmannin,,WORTMANNIN,https://www.dgidb.org/drugs/ncit:C1277,,PLK2,https://www.dgidb.org/genes/hgnc:19699,,,10769.0,PLK2,9606.0,Homo sapiens (human),,,,,,,,
3437,1433647,312145,Drug Gene Interaction database (DGIdb),Wortmannin,,WORTMANNIN,https://www.dgidb.org/drugs/ncit:C1277,,VDR,https://www.dgidb.org/genes/hgnc:12679,,,7421.0,VDR,9606.0,Homo sapiens (human),,,,,,,,
3438,1433648,312145,IUPHAR/BPS Guide to PHARMACOLOGY,Wortmannin,6060,wortmannin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6060,2153,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2153,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",5290.0,PIK3CA,9606.0,Homo sapiens (human),Inhibition,pKd,8.27,PMID:30380865,https://www.ncbi.nlm.nih.gov/pubmed/30380865,30380865,,
3439,1549193,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Wortmannin inhibits the reaction [leukotriene B4 results in increased expression of BAX protein],,,PMID:15970427,https://www.ncbi.nlm.nih.gov/pubmed/15970427,15970427,,
3440,1431391,315810,BindingDB,4-tert-butyl-N-(4-sulfamoylphenyl)benzamide,10893,4-(4-tert-Butylphenylcarboxamido)benzenesulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10893,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),133,PMID:16539401|DOI:10.1021/jm0512600,https://www.ncbi.nlm.nih.gov/pubmed/16539401|https://doi.org/10.1021/jm0512600,16539401,10.1021/jm0512600,
3441,1431392,315810,BindingDB,4-tert-butyl-N-(4-sulfamoylphenyl)benzamide,10893,4-(4-tert-Butylphenylcarboxamido)benzenesulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10893,1194,CARBONIC ANHYDRASE,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1194,,,,,,,,Ki (nM),79,PMID:16539401|DOI:10.1021/jm0512600,https://www.ncbi.nlm.nih.gov/pubmed/16539401|https://doi.org/10.1021/jm0512600,16539401,10.1021/jm0512600,
3442,1431393,315810,BindingDB,4-tert-butyl-N-(4-sulfamoylphenyl)benzamide,10893,4-(4-tert-Butylphenylcarboxamido)benzenesulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10893,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),14250,PMID:16539401|DOI:10.1021/jm0512600,https://www.ncbi.nlm.nih.gov/pubmed/16539401|https://doi.org/10.1021/jm0512600,16539401,10.1021/jm0512600,
3443,1429951,321710,Comparative Toxicogenomics Database (CTD),Oxindole,C022960,2-oxindole,https://ctdbase.org/detail.go?type=chem&acc=C022960,8452,CUL3,https://ctdbase.org/detail.go?type=gene&acc=8452,,,8452.0,CUL3,9606.0,Homo sapiens (human),2-oxindole inhibits the reaction [CUL3 protein binds to KEAP1 protein],,,PMID:22245129,https://www.ncbi.nlm.nih.gov/pubmed/22245129,22245129,,
3444,1429952,321710,Comparative Toxicogenomics Database (CTD),Oxindole,C022960,2-oxindole,https://ctdbase.org/detail.go?type=chem&acc=C022960,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [2-oxindole results in increased expression of CYP1A2 protein]|ifng protein inhibits the reaction [2-oxindole results in increased expression of CYP1A2 protein]|2-oxindole results in increased expression of CYP1A2 protein,,,PMID:36368423,https://www.ncbi.nlm.nih.gov/pubmed/36368423,36368423,,
3445,1429953,321710,Comparative Toxicogenomics Database (CTD),Oxindole,C022960,2-oxindole,https://ctdbase.org/detail.go?type=chem&acc=C022960,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),2-oxindole results in increased expression of HMOX1 protein,,,PMID:22245129,https://www.ncbi.nlm.nih.gov/pubmed/22245129,22245129,,
3446,1429954,321710,Comparative Toxicogenomics Database (CTD),Oxindole,C022960,2-oxindole,https://ctdbase.org/detail.go?type=chem&acc=C022960,3620,IDO1,https://ctdbase.org/detail.go?type=gene&acc=3620,,,3620.0,IDO1,9606.0,Homo sapiens (human),2-oxindole results in increased expression of IDO1 protein,,,PMID:36368423,https://www.ncbi.nlm.nih.gov/pubmed/36368423,36368423,,
3447,1429955,321710,Comparative Toxicogenomics Database (CTD),Oxindole,C022960,2-oxindole,https://ctdbase.org/detail.go?type=chem&acc=C022960,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606.0,Homo sapiens (human),IFNG protein inhibits the reaction [2-oxindole results in increased expression of CYP1A2 protein]|2-oxindole promotes the reaction [IFNG protein results in increased expression of CD274 protein],,,PMID:36368423,https://www.ncbi.nlm.nih.gov/pubmed/36368423,36368423,,
3448,1431394,321779,BindingDB,(4-Morpholin-4-ylbenzylidene)malononitrile,4322,(4-Morpholinobenzylidene)malononitrile,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4322,520,Epidermal growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=520,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),,Ki (nM),>250000,PMID:2552117|DOI:10.1021/jm00130a020,https://www.ncbi.nlm.nih.gov/pubmed/2552117|https://doi.org/10.1021/jm00130a020,2552117,10.1021/jm00130a020,
3449,1511202,343759,Therapeutic Target Database (TTD),"4-Ethoxynaphthalene-1,2-dione",D07REK,"4-ethoxynaphthalene-1,2-dione",https://idrblab.net/ttd/data/drug/details/D07REK,T46365,M-phase inducer phosphatase 2 (MPIP2),https://idrblab.net/ttd/data/target/details/T46365,P30305,M-phase inducer phosphatase 2,994.0,CDC25B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3450,1432124,349435,Drug Gene Interaction database (DGIdb),"Isoquinoline-1,3(2H,4H)-dione",,CHEMBL:CHEMBL1210769,https://www.dgidb.org/drugs/chembl:CHEMBL1210769,,SENP8,https://www.dgidb.org/genes/hgnc:22992,,,123228.0,SENP8,9606.0,Homo sapiens (human),,,,,,,,
3451,1432125,352209,Toxin and Toxin Target Database (T3DB),"5-(Furan-2-yl)-1,3,4-oxadiazol-2(3H)-one",T3D1264,Niobium tin,http://www.t3db.ca/toxins/T3D1264,BE0000227,Alcohol dehydrogenase 1A,http://www.t3db.ca/biodb/bio_entities/BE0000227,P07327,Alcohol dehydrogenase 1A,124.0,ADH1A,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
3452,1432126,352209,Toxin and Toxin Target Database (T3DB),"5-(Furan-2-yl)-1,3,4-oxadiazol-2(3H)-one",T3D1264,Niobium tin,http://www.t3db.ca/toxins/T3D1264,BE0000400,Alcohol dehydrogenase 1B,http://www.t3db.ca/biodb/bio_entities/BE0000400,P00325,All-trans-retinol dehydrogenase [NAD(+)] ADH1B,125.0,ADH1B,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
3453,1432127,352209,Toxin and Toxin Target Database (T3DB),"5-(Furan-2-yl)-1,3,4-oxadiazol-2(3H)-one",T3D1264,Niobium tin,http://www.t3db.ca/toxins/T3D1264,BE0000465,Alcohol dehydrogenase 1C,http://www.t3db.ca/biodb/bio_entities/BE0000465,P00326,Alcohol dehydrogenase 1C,126.0,ADH1C,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
3454,1432128,352209,Toxin and Toxin Target Database (T3DB),"5-(Furan-2-yl)-1,3,4-oxadiazol-2(3H)-one",T3D1264,Niobium tin,http://www.t3db.ca/toxins/T3D1264,BE0000360,Alcohol dehydrogenase 4,http://www.t3db.ca/biodb/bio_entities/BE0000360,P08319,All-trans-retinol dehydrogenase [NAD(+)] ADH4,127.0,ADH4,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
3455,1432129,352209,Toxin and Toxin Target Database (T3DB),"5-(Furan-2-yl)-1,3,4-oxadiazol-2(3H)-one",T3D1264,Niobium tin,http://www.t3db.ca/toxins/T3D1264,BE0003545,Alcohol dehydrogenase 6,http://www.t3db.ca/biodb/bio_entities/BE0003545,P28332,Alcohol dehydrogenase 6,130.0,ADH6,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
3456,1432130,352209,Toxin and Toxin Target Database (T3DB),"5-(Furan-2-yl)-1,3,4-oxadiazol-2(3H)-one",T3D1264,Niobium tin,http://www.t3db.ca/toxins/T3D1264,BE0000522,Alcohol dehydrogenase class 4 mu/sigma chain,http://www.t3db.ca/biodb/bio_entities/BE0000522,P40394,All-trans-retinol dehydrogenase [NAD,131.0,ADH7,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
3457,1432131,352209,Toxin and Toxin Target Database (T3DB),"5-(Furan-2-yl)-1,3,4-oxadiazol-2(3H)-one",T3D1264,Niobium tin,http://www.t3db.ca/toxins/T3D1264,BE0000009,Alcohol dehydrogenase class-3,http://www.t3db.ca/biodb/bio_entities/BE0000009,P11766,Alcohol dehydrogenase class-3,128.0,ADH5,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
3458,1432132,352863,BindingDB,4-chloro-N-hydroxybenzene-1-sulfonamide,11374,4-chloro-N-hydroxybenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11374,1245,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1245,Q95323,Carbonic anhydrase 4,280741.0,CA4,9913.0,Bos taurus (cattle),,Ki (nM),120,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
3459,1432249,352863,BindingDB,4-chloro-N-hydroxybenzene-1-sulfonamide,11374,4-chloro-N-hydroxybenzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11374,1258,Collagenase ColG,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1258,Q9X721,Collagenase ColG,,,1498.0,Hathewaya histolytica,,Ki (nM),80000,PMID:11020282|DOI:10.1021/jm000027t,https://www.ncbi.nlm.nih.gov/pubmed/11020282|https://doi.org/10.1021/jm000027t,11020282,10.1021/jm000027t,
3460,1432250,355450,Comparative Toxicogenomics Database (CTD),Endalin,C034504,digoxin-like factors,https://ctdbase.org/detail.go?type=chem&acc=C034504,477,ATP1A2,https://ctdbase.org/detail.go?type=gene&acc=477,,,477.0,ATP1A2,10090.0,Mus musculus (house mouse),Digoxin-like factors results in decreased activity of ATP1A2 protein,,,PMID:17980562,https://www.ncbi.nlm.nih.gov/pubmed/17980562,17980562,,
3461,1434516,360772,Therapeutic Target Database (TTD),"7,12-Dihydro-5,7,12-triaza-indeno[1,2-a]fluorene",D0P2DB,"7,12-Dihydro-5,7,12-triaza-indeno[1,2-a]fluorene",https://idrblab.net/ttd/data/drug/details/D0P2DB,T51487,GABA(A) receptor alpha-1 (GABRA1),https://idrblab.net/ttd/data/target/details/T51487,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3462,1434517,363417,Drug Gene Interaction database (DGIdb),Palmitoyl-DL-carnitine chloride,,CHEMBL:CHEMBL1256761,https://www.dgidb.org/drugs/chembl:CHEMBL1256761,,HSP90AA1,https://www.dgidb.org/genes/hgnc:5253,,,3320.0,HSP90AA1,9606.0,Homo sapiens (human),,,,,,,,
3463,1434518,367432,Drug Gene Interaction database (DGIdb),Diethyl (4-bromobenzylidene)malonate,,CHEMBL:CHEMBL1362503,https://www.dgidb.org/drugs/chembl:CHEMBL1362503,,IDH1,https://www.dgidb.org/genes/hgnc:5382,,,3417.0,IDH1,9606.0,Homo sapiens (human),,,,,,,,
3464,1434519,367432,Drug Gene Interaction database (DGIdb),Diethyl (4-bromobenzylidene)malonate,,CHEMBL:CHEMBL1362503,https://www.dgidb.org/drugs/chembl:CHEMBL1362503,,PLK1,https://www.dgidb.org/genes/hgnc:9077,,,5347.0,PLK1,9606.0,Homo sapiens (human),,,,,,,,
3465,1434660,382414,Therapeutic Target Database (TTD),"6-Imino-1-methyl-3-phenyl-2,6-dihydro-5(1H)-quinolinone hydrazone",D03GWA,NSC-669977,https://idrblab.net/ttd/data/drug/details/D03GWA,T75498,Quinone reductase 2 (NQO2),https://idrblab.net/ttd/data/target/details/T75498,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],4835.0,NQO2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3466,1434661,386223,Therapeutic Target Database (TTD),"Diindolo[2,2-h]quinolizine",D02DOX,NSC-677939,https://idrblab.net/ttd/data/drug/details/D02DOX,T75498,Quinone reductase 2 (NQO2),https://idrblab.net/ttd/data/target/details/T75498,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],4835.0,NQO2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3467,1433242,387447,Drug Gene Interaction database (DGIdb),Bortezomib,,BORTEZOMIB,https://www.dgidb.org/drugs/rxcui:358258,,PSMD14,https://www.dgidb.org/genes/hgnc:16889,,,10213.0,PSMD14,9606.0,Homo sapiens (human),,,,,,,,
3468,1433243,387447,Drug Gene Interaction database (DGIdb),Bortezomib,,BORTEZOMIB,https://www.dgidb.org/drugs/rxcui:358258,,PSMC5,https://www.dgidb.org/genes/hgnc:9552,,,5705.0,PSMC5,9606.0,Homo sapiens (human),,,,,,,,
3469,1433244,387447,Drug Gene Interaction database (DGIdb),Bortezomib,,BORTEZOMIB,https://www.dgidb.org/drugs/rxcui:358258,,SEM1,https://www.dgidb.org/genes/hgnc:10845,,,7979.0,SEM1,9606.0,Homo sapiens (human),,,,,,,,
3470,1433245,387447,Drug Gene Interaction database (DGIdb),Bortezomib,,BORTEZOMIB,https://www.dgidb.org/drugs/rxcui:358258,,PSMD11,https://www.dgidb.org/genes/hgnc:9556,,,5717.0,PSMD11,9606.0,Homo sapiens (human),,,,,,,,
3471,1434662,387447,ChEMBL,Bortezomib,CHEMBL325041,BORTEZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL325041/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,Q9UNM6,26S proteasome non-ATPase regulatory subunit 13,5719.0,PSMD13,9606.0,Homo sapiens (human),26S proteosome inhibitor,,,PMID:21606441,https://www.ncbi.nlm.nih.gov/pubmed/21606441,21606441,,
3472,1434663,387447,ChEMBL,Bortezomib,CHEMBL325041,BORTEZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL325041/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,Q99436,Proteasome subunit beta type-7,5695.0,PSMB7,9606.0,Homo sapiens (human),26S proteosome inhibitor,,,PMID:21606441,https://www.ncbi.nlm.nih.gov/pubmed/21606441,21606441,,
3473,1434664,387447,ChEMBL,Bortezomib,CHEMBL325041,BORTEZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL325041/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P60896,26S proteasome complex subunit SEM1,7979.0,SEM1,9606.0,Homo sapiens (human),26S proteosome inhibitor,,,PMID:21606441,https://www.ncbi.nlm.nih.gov/pubmed/21606441,21606441,,
3474,1434665,387447,Drug Gene Interaction database (DGIdb),Bortezomib,,BORTEZOMIB,https://www.dgidb.org/drugs/rxcui:358258,,DDIT3,https://www.dgidb.org/genes/hgnc:2726,,,1649.0,DDIT3,9606.0,Homo sapiens (human),,,,,,,,
3475,1434666,387447,Drug Gene Interaction database (DGIdb),Bortezomib,,BORTEZOMIB,https://www.dgidb.org/drugs/rxcui:358258,,BCL2L2,https://www.dgidb.org/genes/hgnc:995,,,599.0,BCL2L2,9606.0,Homo sapiens (human),,,,,,,,
3476,1434667,387447,Drug Gene Interaction database (DGIdb),Bortezomib,,BORTEZOMIB,https://www.dgidb.org/drugs/rxcui:358258,,XIAP,https://www.dgidb.org/genes/hgnc:592,,,331.0,XIAP,9606.0,Homo sapiens (human),,,,,,,,
3477,1434668,387447,Drug Gene Interaction database (DGIdb),Bortezomib,,BORTEZOMIB,https://www.dgidb.org/drugs/rxcui:358258,,PSMC2,https://www.dgidb.org/genes/hgnc:9548,,,5701.0,PSMC2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3478,1516691,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),ZFAND2A protein inhibits the reaction [bortezomib results in increased cleavage of CASP3 protein]|bortezomib promotes the reaction [ZFAND2A protein affects the cleavage of CASP3 protein],,,PMID:31540997,https://www.ncbi.nlm.nih.gov/pubmed/31540997,31540997,,
3479,1516692,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Bortezomib results in increased activity of CASP3 protein,,,PMID:16357177|PMID:18223318|PMID:18342500|PMID:18534018|PMID:19100720|PMID:20022965|PMID:20150630|PMID:20383943|PMID:20524303|PMID:23300809,https://www.ncbi.nlm.nih.gov/pubmed/16357177|https://www.ncbi.nlm.nih.gov/pubmed/18223318|https://www.ncbi.nlm.nih.gov/pubmed/18342500|https://www.ncbi.nlm.nih.gov/pubmed/18534018|https://www.ncbi.nlm.nih.gov/pubmed/19100720|https://www.ncbi.nlm.nih.gov/pubmed/20022965|https://www.ncbi.nlm.nih.gov/pubmed/20150630|https://www.ncbi.nlm.nih.gov/pubmed/20383943|https://www.ncbi.nlm.nih.gov/pubmed/20524303|https://www.ncbi.nlm.nih.gov/pubmed/23300809,16357177|18223318|18342500|18534018|19100720|20022965|20150630|20383943|20524303|23300809,,
3480,1516693,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Bortezomib results in increased cleavage of and results in increased activity of CASP3 protein,,,PMID:16024631|PMID:16778179|PMID:17510429|PMID:17898787|PMID:22842577,https://www.ncbi.nlm.nih.gov/pubmed/16024631|https://www.ncbi.nlm.nih.gov/pubmed/16778179|https://www.ncbi.nlm.nih.gov/pubmed/17510429|https://www.ncbi.nlm.nih.gov/pubmed/17898787|https://www.ncbi.nlm.nih.gov/pubmed/22842577,16024631|16778179|17510429|17898787|22842577,,
3481,1516694,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Bortezomib results in increased cleavage of CASP3 protein,,,PMID:12393500|PMID:15509775|PMID:16118318|PMID:16617327|PMID:17898295|PMID:18223231|PMID:18223318|PMID:18790767|PMID:20051518|PMID:22262760|PMID:24333736|PMID:30482226|PMID:31540997,https://www.ncbi.nlm.nih.gov/pubmed/12393500|https://www.ncbi.nlm.nih.gov/pubmed/15509775|https://www.ncbi.nlm.nih.gov/pubmed/16118318|https://www.ncbi.nlm.nih.gov/pubmed/16617327|https://www.ncbi.nlm.nih.gov/pubmed/17898295|https://www.ncbi.nlm.nih.gov/pubmed/18223231|https://www.ncbi.nlm.nih.gov/pubmed/18223318|https://www.ncbi.nlm.nih.gov/pubmed/18790767|https://www.ncbi.nlm.nih.gov/pubmed/20051518|https://www.ncbi.nlm.nih.gov/pubmed/22262760|https://www.ncbi.nlm.nih.gov/pubmed/24333736|https://www.ncbi.nlm.nih.gov/pubmed/30482226|https://www.ncbi.nlm.nih.gov/pubmed/31540997,12393500|15509775|16118318|16617327|17898295|18223231|18223318|18790767|20051518|22262760|24333736|30482226|31540997,,
3482,1516695,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Bortezomib results in increased expression of CASP3 protein,,,PMID:17156654,https://www.ncbi.nlm.nih.gov/pubmed/17156654,17156654,,
3483,1516696,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),[bortezomib results in increased susceptibility to and results in increased activity of TNFSF10 protein] which results in increased cleavage of CASP3 protein,,,PMID:17326159,https://www.ncbi.nlm.nih.gov/pubmed/17326159,17326159,,
3484,1519801,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,9606.0,Homo sapiens (human),[bortezomib co-treated with butyrates] results in increased cleavage of CDKN1B protein|[bortezomib co-treated with vorinostat] results in increased cleavage of CDKN1B protein,,,PMID:15173093,https://www.ncbi.nlm.nih.gov/pubmed/15173093,15173093,,
3485,1519802,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,9606.0,Homo sapiens (human),Bortezomib promotes the reaction [lapatinib results in increased expression of CDKN1B protein]|lapatinib promotes the reaction [bortezomib results in increased expression of CDKN1B protein],,,PMID:20701607,https://www.ncbi.nlm.nih.gov/pubmed/20701607,20701607,,
3486,1519803,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,9606.0,Homo sapiens (human),Bortezomib results in increased expression of CDKN1B protein,,,PMID:14749476|PMID:15173093|PMID:18223318|PMID:18445700|PMID:18850583|PMID:19636294|PMID:20701607,https://www.ncbi.nlm.nih.gov/pubmed/14749476|https://www.ncbi.nlm.nih.gov/pubmed/15173093|https://www.ncbi.nlm.nih.gov/pubmed/18223318|https://www.ncbi.nlm.nih.gov/pubmed/18445700|https://www.ncbi.nlm.nih.gov/pubmed/18850583|https://www.ncbi.nlm.nih.gov/pubmed/19636294|https://www.ncbi.nlm.nih.gov/pubmed/20701607,14749476|15173093|18223318|18445700|18850583|19636294|20701607,,
3487,1522947,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1965,EIF2S1,https://ctdbase.org/detail.go?type=gene&acc=1965,,,1965.0,EIF2S1,10090.0,Mus musculus (house mouse),Bortezomib results in increased phosphorylation of EIF2S1 protein,,,PMID:21090173,https://www.ncbi.nlm.nih.gov/pubmed/21090173,21090173,,
3488,1522948,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1968,EIF2S3,https://ctdbase.org/detail.go?type=gene&acc=1968,,,1968.0,EIF2S3,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of EIF2S3 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3489,1522949,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,9606.0,Homo sapiens (human),[trichostatin A co-treated with bortezomib] results in decreased phosphorylation of EIF4EBP1 protein,,,PMID:21345073,https://www.ncbi.nlm.nih.gov/pubmed/21345073,21345073,,
3490,1522950,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1984,EIF5A,https://ctdbase.org/detail.go?type=gene&acc=1984,,,1984.0,EIF5A,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of EIF5A mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3491,1522951,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,23587,ELP5,https://ctdbase.org/detail.go?type=gene&acc=23587,,,23587.0,ELP5,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of ELP5 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3492,1522952,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,2026,ENO2,https://ctdbase.org/detail.go?type=gene&acc=2026,,,2026.0,ENO2,9606.0,Homo sapiens (human),Bortezomib results in increased expression of ENO2 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3493,1522953,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,2041,EPHA1,https://ctdbase.org/detail.go?type=gene&acc=2041,,,2041.0,EPHA1,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of EPHA1 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3494,1522954,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,2048,EPHB2,https://ctdbase.org/detail.go?type=gene&acc=2048,,,2048.0,EPHB2,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of EPHB2 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3495,1523255,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,2056,EPO,https://ctdbase.org/detail.go?type=gene&acc=2056,,,2056.0,EPO,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of EPO mRNA,,,PMID:18174379,https://www.ncbi.nlm.nih.gov/pubmed/18174379,18174379,,
3496,1523256,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,11124,FAF1,https://ctdbase.org/detail.go?type=gene&acc=11124,,,11124.0,FAF1,9606.0,Homo sapiens (human),Bortezomib results in increased expression of FAF1 mRNA,,,PMID:17895889,https://www.ncbi.nlm.nih.gov/pubmed/17895889,17895889,,
3497,1523257,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,2064,ERBB2,https://ctdbase.org/detail.go?type=gene&acc=2064,,,2064.0,ERBB2,9606.0,Homo sapiens (human),Bortezomib promotes the reaction [lapatinib results in decreased phosphorylation of ERBB2 protein]|lapatinib promotes the reaction [bortezomib results in decreased phosphorylation of ERBB2 protein]|bortezomib results in decreased phosphorylation of ERBB2 protein,,,PMID:20701607,https://www.ncbi.nlm.nih.gov/pubmed/20701607,20701607,,
3498,1523258,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,2071,ERCC3,https://ctdbase.org/detail.go?type=gene&acc=2071,,,2071.0,ERCC3,9606.0,Homo sapiens (human),ERCC3 gene SNP results in increased susceptibility to bortezomib,,,PMID:20864405,https://www.ncbi.nlm.nih.gov/pubmed/20864405,20864405,,
3499,1523259,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,2072,ERCC4,https://ctdbase.org/detail.go?type=gene&acc=2072,,,2072.0,ERCC4,9606.0,Homo sapiens (human),ERCC4 gene SNP results in increased susceptibility to bortezomib,,,PMID:20864405,https://www.ncbi.nlm.nih.gov/pubmed/20864405,20864405,,
3500,1523260,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,11160,ERLIN2,https://ctdbase.org/detail.go?type=gene&acc=11160,,,11160.0,ERLIN2,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of ERLIN2 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3501,1524159,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,10129,FRY,https://ctdbase.org/detail.go?type=gene&acc=10129,,,10129.0,FRY,9606.0,Homo sapiens (human),Bortezomib results in increased expression of FRY mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3502,1524160,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,83856,FSD1L,https://ctdbase.org/detail.go?type=gene&acc=83856,,,83856.0,FSD1L,9606.0,Homo sapiens (human),Bortezomib results in increased expression of FSD1L mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3503,1524161,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,2535,FZD2,https://ctdbase.org/detail.go?type=gene&acc=2535,,,2535.0,FZD2,9606.0,Homo sapiens (human),[BRCA1 mutant form results in increased susceptibility to bortezomib] which results in decreased expression of FZD2 mRNA,,,PMID:25522274,https://www.ncbi.nlm.nih.gov/pubmed/25522274,25522274,,
3504,1524831,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,80318,GKAP1,https://ctdbase.org/detail.go?type=gene&acc=80318,,,80318.0,GKAP1,9606.0,Homo sapiens (human),Bortezomib results in increased expression of GKAP1 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3505,1524832,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,2717,GLA,https://ctdbase.org/detail.go?type=gene&acc=2717,,,2717.0,GLA,9606.0,Homo sapiens (human),Bortezomib results in increased expression of GLA mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3506,1524833,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,2773,GNAI3,https://ctdbase.org/detail.go?type=gene&acc=2773,,,2773.0,GNAI3,9606.0,Homo sapiens (human),Bortezomib results in increased expression of GNAI3 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3507,1524834,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,9570,GOSR2,https://ctdbase.org/detail.go?type=gene&acc=9570,,,9570.0,GOSR2,9606.0,Homo sapiens (human),Bortezomib results in increased expression of GOSR2 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3508,1524835,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,7918,GPANK1,https://ctdbase.org/detail.go?type=gene&acc=7918,,,7918.0,GPANK1,9606.0,Homo sapiens (human),Bortezomib results in increased expression of GPANK1 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3509,1524836,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,84803,GPAT3,https://ctdbase.org/detail.go?type=gene&acc=84803,,,84803.0,GPAT3,9606.0,Homo sapiens (human),Bortezomib results in increased expression of GPAT3 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3510,1524837,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,55668,GPATCH2L,https://ctdbase.org/detail.go?type=gene&acc=55668,,,55668.0,GPATCH2L,9606.0,Homo sapiens (human),Bortezomib results in increased expression of GPATCH2L mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3511,1524838,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,10243,GPHN,https://ctdbase.org/detail.go?type=gene&acc=10243,,,10243.0,GPHN,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of GPHN mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3512,1526582,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3416,IDE,https://ctdbase.org/detail.go?type=gene&acc=3416,,,3416.0,IDE,9606.0,Homo sapiens (human),Bortezomib results in increased expression of IDE mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
3513,1526583,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3419,IDH3A,https://ctdbase.org/detail.go?type=gene&acc=3419,,,3419.0,IDH3A,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of IDH3A mRNA,,,PMID:30818834,https://www.ncbi.nlm.nih.gov/pubmed/30818834,30818834,,
3514,1434669,389898,IUPHAR/BPS Guide to PHARMACOLOGY,MEK Inhibitor II,6007,MEK inhibitor II,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6007,2083,mitogen-activated protein kinase kinase kinase 8,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2083,P41279,Mitogen-activated protein kinase kinase kinase 8,1326.0,MAP3K8,9606.0,Homo sapiens (human),Inhibition,pIC50,7.3,PMID:18077363,https://www.ncbi.nlm.nih.gov/pubmed/18077363,18077363,,
3515,1433246,392622,DrugBank,Ritonavir,DB00503,Ritonavir,https://www.drugbank.ca/drugs/DB00503,BE0000956,Nuclear receptor subfamily 1 group I member 2,https://www.drugbank.ca/bio_entities/BE0000956,O75469,Nuclear receptor subfamily 1 group I member 2,8856.0,NR1I2,9606.0,Homo sapiens (human),Activator,,,PMID:14977870|PMID:15849716,https://www.ncbi.nlm.nih.gov/pubmed/14977870|https://www.ncbi.nlm.nih.gov/pubmed/15849716,14977870|15849716,,
3516,1433247,392622,DrugBank,Ritonavir,DB00503,Ritonavir,https://www.drugbank.ca/drugs/DB00503,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:20937904,https://www.ncbi.nlm.nih.gov/pubmed/20937904,20937904,,
3517,1433367,392622,DrugBank,Ritonavir,DB00503,Ritonavir,https://www.drugbank.ca/drugs/DB00503,BE0002362,Cytochrome P450 3A5,https://www.drugbank.ca/bio_entities/BE0002362,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,,,,,
3518,1433368,392622,DrugBank,Ritonavir,DB00503,Ritonavir,https://www.drugbank.ca/drugs/DB00503,BE0003612,Cytochrome P450 3A7,https://www.drugbank.ca/bio_entities/BE0003612,P24462,Cytochrome P450 3A7,100861540.0,CYP3A7-CYP3A51P,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,,,,,
3519,1433369,392622,DrugBank,Ritonavir,DB00503,Ritonavir,https://www.drugbank.ca/drugs/DB00503,BE0009758,UDP-glucuronosyltransferase 1-1,https://www.drugbank.ca/bio_entities/BE0009758,P22309,UDP-glucuronosyltransferase 1A1 ,54658.0,UGT1A1,9606.0,Homo sapiens (human),Inducer,,,PMID:28627229,https://www.ncbi.nlm.nih.gov/pubmed/28627229,28627229,,
3520,1433370,392622,DrugBank,Ritonavir,DB00503,Ritonavir,https://www.drugbank.ca/drugs/DB00503,BE0009758,UDP-glucuronosyltransferase 1-10,https://www.drugbank.ca/bio_entities/BE0009758,Q9HAW8,UDP-glucuronosyltransferase 1A10,54575.0,UGT1A10,9606.0,Homo sapiens (human),Inducer,,,PMID:28627229,https://www.ncbi.nlm.nih.gov/pubmed/28627229,28627229,,
3521,1433371,392622,DrugBank,Ritonavir,DB00503,Ritonavir,https://www.drugbank.ca/drugs/DB00503,BE0009758,UDP-glucuronosyltransferase 1-3,https://www.drugbank.ca/bio_entities/BE0009758,P35503,UDP-glucuronosyltransferase 1A3,54659.0,UGT1A3,9606.0,Homo sapiens (human),Inducer,,,PMID:28627229,https://www.ncbi.nlm.nih.gov/pubmed/28627229,28627229,,
3522,1433372,392622,DrugBank,Ritonavir,DB00503,Ritonavir,https://www.drugbank.ca/drugs/DB00503,BE0009758,UDP-glucuronosyltransferase 1-4,https://www.drugbank.ca/bio_entities/BE0009758,P22310,UDP-glucuronosyltransferase 1A4,54657.0,UGT1A4,9606.0,Homo sapiens (human),Inducer,,,PMID:28627229,https://www.ncbi.nlm.nih.gov/pubmed/28627229,28627229,,
3523,1433373,392622,DrugBank,Ritonavir,DB00503,Ritonavir,https://www.drugbank.ca/drugs/DB00503,BE0009758,UDP-glucuronosyltransferase 1-6,https://www.drugbank.ca/bio_entities/BE0009758,P19224,UDP-glucuronosyltransferase 1-6,54578.0,UGT1A6,9606.0,Homo sapiens (human),Inducer,,,PMID:28627229,https://www.ncbi.nlm.nih.gov/pubmed/28627229,28627229,,
3524,1433374,392622,DrugBank,Ritonavir,DB00503,Ritonavir,https://www.drugbank.ca/drugs/DB00503,BE0009758,UDP-glucuronosyltransferase 1-7,https://www.drugbank.ca/bio_entities/BE0009758,Q9HAW7,UDP-glucuronosyltransferase 1A7,54577.0,UGT1A7,9606.0,Homo sapiens (human),Inducer,,,PMID:28627229,https://www.ncbi.nlm.nih.gov/pubmed/28627229,28627229,,
3525,1433375,392622,DrugBank,Ritonavir,DB00503,Ritonavir,https://www.drugbank.ca/drugs/DB00503,BE0009758,UDP-glucuronosyltransferase 1-8,https://www.drugbank.ca/bio_entities/BE0009758,Q9HAW9,UDP-glucuronosyltransferase 1A8,54576.0,UGT1A8,9606.0,Homo sapiens (human),Inducer,,,PMID:28627229,https://www.ncbi.nlm.nih.gov/pubmed/28627229,28627229,,
3526,1512261,392622,Comparative Toxicogenomics Database (CTD),Ritonavir,D019438,Ritonavir,https://ctdbase.org/detail.go?type=chem&acc=D019438,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Ritonavir results in decreased activity of CYP3A4 protein,,,PMID:15523003|PMID:15860655|PMID:26626330,https://www.ncbi.nlm.nih.gov/pubmed/15523003|https://www.ncbi.nlm.nih.gov/pubmed/15860655|https://www.ncbi.nlm.nih.gov/pubmed/26626330,15523003|15860655|26626330,,
3527,1512262,392622,Comparative Toxicogenomics Database (CTD),Ritonavir,D019438,Ritonavir,https://ctdbase.org/detail.go?type=chem&acc=D019438,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Ritonavir results in increased expression of CYP3A4 mRNA,,,PMID:16837568,https://www.ncbi.nlm.nih.gov/pubmed/16837568,16837568,,
3528,1512263,392622,Comparative Toxicogenomics Database (CTD),Ritonavir,D019438,Ritonavir,https://ctdbase.org/detail.go?type=chem&acc=D019438,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),CYP3A4 protein affects the metabolism of ritonavir,,,PMID:11197575,https://www.ncbi.nlm.nih.gov/pubmed/11197575,11197575,,
3529,1513143,392622,Comparative Toxicogenomics Database (CTD),Ritonavir,D019438,Ritonavir,https://ctdbase.org/detail.go?type=chem&acc=D019438,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Ritonavir results in increased expression of IL6 protein|diphenyleneiodonium inhibits the reaction [ritonavir results in increased expression of IL6 protein],,,PMID:17668557,https://www.ncbi.nlm.nih.gov/pubmed/17668557,17668557,,
3530,1515210,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Bardoxolone methyl results in decreased expression of HMOX1 mRNA,,,PMID:35724838,https://www.ncbi.nlm.nih.gov/pubmed/35724838,35724838,,
3531,1515211,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Bardoxolone methyl results in increased expression of HMOX1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
3532,1515212,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Bardoxolone methyl results in increased expression of HMOX1 protein,,,PMID:25246272|PMID:28790194|PMID:34480604|PMID:35724838,https://www.ncbi.nlm.nih.gov/pubmed/25246272|https://www.ncbi.nlm.nih.gov/pubmed/28790194|https://www.ncbi.nlm.nih.gov/pubmed/34480604|https://www.ncbi.nlm.nih.gov/pubmed/35724838,25246272|28790194|34480604|35724838,,
3533,1515213,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),GSK3B protein mutant form inhibits the reaction [bardoxolone methyl results in increased expression of HMOX1 protein],,,PMID:25246272,https://www.ncbi.nlm.nih.gov/pubmed/25246272,25246272,,
3534,1515214,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),NFE2L2 protein affects the reaction [bardoxolone methyl results in increased expression of HMOX1 protein],,,PMID:28790194,https://www.ncbi.nlm.nih.gov/pubmed/28790194,28790194,,
3535,1515215,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),Bardoxolone methyl promotes the reaction [aristolochic acid I results in increased expression of HMOX1 protein]|[bardoxolone methyl co-treated with aristolochic acid I] results in increased expression of HMOX1 mRNA,,,PMID:24530882,https://www.ncbi.nlm.nih.gov/pubmed/24530882,24530882,,
3536,1515216,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),Bardoxolone methyl results in increased expression of HMOX1 mRNA,,,PMID:21289052,https://www.ncbi.nlm.nih.gov/pubmed/21289052,21289052,,
3537,1515217,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),Bardoxolone methyl results in increased expression of HMOX1 protein,,,PMID:21289052|PMID:24530882,https://www.ncbi.nlm.nih.gov/pubmed/21289052|https://www.ncbi.nlm.nih.gov/pubmed/24530882,21289052|24530882,,
3538,1515218,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,3269,HRH1,https://ctdbase.org/detail.go?type=gene&acc=3269,,,3269.0,HRH1,9606.0,Homo sapiens (human),Bardoxolone methyl results in decreased activity of HRH1 protein,,,PMID:28790194,https://www.ncbi.nlm.nih.gov/pubmed/28790194,28790194,,
3539,1515219,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,3297,HSF1,https://ctdbase.org/detail.go?type=gene&acc=3297,,,3297.0,HSF1,9606.0,Homo sapiens (human),Bardoxolone methyl results in increased activity of HSF1 protein,,,PMID:34170685,https://www.ncbi.nlm.nih.gov/pubmed/34170685,34170685,,
3540,1516847,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198.0,RPS6KB1,9606.0,Homo sapiens (human),Bardoxolone methyl results in decreased phosphorylation of RPS6KB1 protein,,,PMID:35929395,https://www.ncbi.nlm.nih.gov/pubmed/35929395,35929395,,
3541,1516848,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,9606.0,Homo sapiens (human),Bardoxolone methyl affects the expression of SCARB1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
3542,1516849,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,9467,SH3BP5,https://ctdbase.org/detail.go?type=gene&acc=9467,,,9467.0,SH3BP5,9606.0,Homo sapiens (human),Bardoxolone methyl affects the expression of SH3BP5 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
3543,1516850,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,10280,SIGMAR1,https://ctdbase.org/detail.go?type=gene&acc=10280,,,10280.0,SIGMAR1,9606.0,Homo sapiens (human),Ursolic acid inhibits the reaction [bardoxolone methyl results in decreased expression of SIGMAR1 protein]|bardoxolone methyl results in decreased expression of SIGMAR1 protein,,,PMID:36587836,https://www.ncbi.nlm.nih.gov/pubmed/36587836,36587836,,
3544,1516851,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,6510,SLC1A5,https://ctdbase.org/detail.go?type=gene&acc=6510,,,6510.0,SLC1A5,9606.0,Homo sapiens (human),Bardoxolone methyl results in decreased glycosylation of SLC1A5 protein|bardoxolone methyl results in decreased expression of SLC1A5 protein,,,PMID:35929395,https://www.ncbi.nlm.nih.gov/pubmed/35929395,35929395,,
3545,1363855,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,176988,COL-109,https://ctdbase.org/detail.go?type=gene&acc=176988,,,176988.0,col-109,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of COL-109 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3546,1435464,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,166785,MMAA,https://ctdbase.org/detail.go?type=gene&acc=166785,,,166785.0,MMAA,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of MMAA mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3547,1435587,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4325,MMP16,https://ctdbase.org/detail.go?type=gene&acc=4325,,,4325.0,MMP16,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of MMP16 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3548,1435996,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,34,ACADM,https://ctdbase.org/detail.go?type=gene&acc=34,,,34.0,ACADM,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of ACADM mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3549,1435997,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,34,ACADM,https://ctdbase.org/detail.go?type=gene&acc=34,,,34.0,ACADM,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of ACADM mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3550,1435998,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,35,ACADS,https://ctdbase.org/detail.go?type=gene&acc=35,,,35.0,ACADS,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of ACADS mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3551,1435999,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,36,ACADSB,https://ctdbase.org/detail.go?type=gene&acc=36,,,36.0,ACADSB,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ACADSB mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3552,1436000,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,37,ACADVL,https://ctdbase.org/detail.go?type=gene&acc=37,,,37.0,ACADVL,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of ACADVL mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3553,1436001,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,64746,ACBD3,https://ctdbase.org/detail.go?type=gene&acc=64746,,,64746.0,ACBD3,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of ACBD3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3554,1436002,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,79777,ACBD4,https://ctdbase.org/detail.go?type=gene&acc=79777,,,79777.0,ACBD4,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of ACBD4 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3555,1436003,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,91452,ACBD5,https://ctdbase.org/detail.go?type=gene&acc=91452,,,91452.0,ACBD5,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of ACBD5 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3556,1436004,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,91452,ACBD5,https://ctdbase.org/detail.go?type=gene&acc=91452,,,91452.0,ACBD5,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of ACBD5 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3557,1436005,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,171992,ACD-2,https://ctdbase.org/detail.go?type=gene&acc=171992,,,171992.0,acd-2,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of ACD-2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3558,1436319,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,79590,MRPL24,https://ctdbase.org/detail.go?type=gene&acc=79590,,,79590.0,MRPL24,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of MRPL24 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3559,1436320,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51263,MRPL30,https://ctdbase.org/detail.go?type=gene&acc=51263,,,51263.0,MRPL30,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of MRPL30 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3560,1436321,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,64978,MRPL38,https://ctdbase.org/detail.go?type=gene&acc=64978,,,64978.0,MRPL38,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of MRPL38 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3561,1436322,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,64976,MRPL40,https://ctdbase.org/detail.go?type=gene&acc=64976,,,64976.0,MRPL40,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of MRPL40 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3562,1436967,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4493,MT1E,https://ctdbase.org/detail.go?type=gene&acc=4493,,,4493.0,MT1E,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of MT1E mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3563,1437469,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,41202,MTNA,https://ctdbase.org/detail.go?type=gene&acc=41202,,,41202.0,MtnA,7227.0,Drosophila melanogaster (fruit fly),[cadmium chloride co-treated with methylmercuric chloride co-treated with diethylhexyl phthalate co-treated with bisphenol A co-treated with 4-nonylphenol co-treated with benzo(a)pyrene co-treated with glyphosate] results in increased expression of MTNA mRNA,,,PMID:36603486,https://www.ncbi.nlm.nih.gov/pubmed/36603486,36603486,,
3564,1437470,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55028,MTNAP1,https://ctdbase.org/detail.go?type=gene&acc=55028,,,55028.0,MTNAP1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of MTNAP1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3565,1437471,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,42424,MTNB,https://ctdbase.org/detail.go?type=gene&acc=42424,,,42424.0,MtnB,7227.0,Drosophila melanogaster (fruit fly),[cadmium chloride co-treated with methylmercuric chloride co-treated with diethylhexyl phthalate co-treated with bisphenol A co-treated with 4-nonylphenol co-treated with benzo(a)pyrene co-treated with glyphosate] results in increased expression of MTNB mRNA,,,PMID:36603486,https://www.ncbi.nlm.nih.gov/pubmed/36603486,36603486,,
3566,1437472,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,10090.0,Mus musculus (house mouse),Methylmercuric chloride results in increased phosphorylation of MTOR protein|ghrl protein inhibits the reaction [methylmercuric chloride results in increased phosphorylation of MTOR protein],,,PMID:33301842,https://www.ncbi.nlm.nih.gov/pubmed/33301842,33301842,,
3567,1437596,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4595,MUTYH,https://ctdbase.org/detail.go?type=gene&acc=4595,,,4595.0,MUTYH,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of MUTYH mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
3568,1438969,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,190436,ALGN-7,https://ctdbase.org/detail.go?type=gene&acc=190436,,,190436.0,algn-7,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of ALGN-7 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3569,1439281,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4707,NDUFB1,https://ctdbase.org/detail.go?type=gene&acc=4707,,,4707.0,NDUFB1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NDUFB1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3570,1439282,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4707,NDUFB1,https://ctdbase.org/detail.go?type=gene&acc=4707,,,4707.0,NDUFB1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of NDUFB1 mRNA,,,PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/34089799,34089799,,
3571,1439283,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4710,NDUFB4,https://ctdbase.org/detail.go?type=gene&acc=4710,,,4710.0,NDUFB4,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NDUFB4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3572,1439284,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4719,NDUFS1,https://ctdbase.org/detail.go?type=gene&acc=4719,,,4719.0,NDUFS1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NDUFS1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3573,1439285,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,283131,NEAT1,https://ctdbase.org/detail.go?type=gene&acc=283131,,,283131.0,NEAT1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NEAT1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3574,1440029,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,309,ANXA6,https://ctdbase.org/detail.go?type=gene&acc=309,,,309.0,ANXA6,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of ANXA6 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3575,1440030,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,309,ANXA6,https://ctdbase.org/detail.go?type=gene&acc=309,,,309.0,ANXA6,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ANXA6 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
3576,1440031,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,84909,AOPEP,https://ctdbase.org/detail.go?type=gene&acc=84909,,,84909.0,AOPEP,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of AOPEP mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3577,1440032,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of AOX1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3578,1440033,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of AOX1 mRNA,,,PMID:29581082,https://www.ncbi.nlm.nih.gov/pubmed/29581082,29581082,,
3579,1440034,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,10116.0,Rattus norvegicus (Norway rat),"[hydrocarbons, chlorinated co-treated with polychlorinated biphenyls co-treated with methylmercuric chloride co-treated with dibenzofurans, polychlorinated co-treated with polychlorinated dibenzodioxins] results in increased expression of AOX1 mRNA",,,PMID:30744511,https://www.ncbi.nlm.nih.gov/pubmed/30744511,30744511,,
3580,1440035,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8906,AP1G2,https://ctdbase.org/detail.go?type=gene&acc=8906,,,8906.0,AP1G2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of AP1G2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3581,1440036,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,447897,AP1S3B,https://ctdbase.org/detail.go?type=gene&acc=447897,,,447897.0,ap1s3b,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of AP1S3B mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3582,1440037,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100306784,AP2A,https://ctdbase.org/detail.go?type=gene&acc=100306784,,,100306784.0,,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of AP2A mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3583,1440276,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,147495,APCDD1,https://ctdbase.org/detail.go?type=gene&acc=147495,,,147495.0,APCDD1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of APCDD1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3584,1440277,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,147495,APCDD1,https://ctdbase.org/detail.go?type=gene&acc=147495,,,147495.0,APCDD1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of APCDD1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
3585,1440278,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,325,APCS,https://ctdbase.org/detail.go?type=gene&acc=325,,,325.0,APCS,10090.0,Mus musculus (house mouse),Methylmercuric chloride results in increased expression of APCS protein,,,PMID:24055825,https://www.ncbi.nlm.nih.gov/pubmed/24055825,24055825,,
3586,1440279,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100506013,APELA,https://ctdbase.org/detail.go?type=gene&acc=100506013,,,100506013.0,APELA,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of APELA mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3587,1440280,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8539,API5,https://ctdbase.org/detail.go?type=gene&acc=8539,,,8539.0,API5,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of API5 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3588,1440281,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8862,APLN,https://ctdbase.org/detail.go?type=gene&acc=8862,,,8862.0,APLN,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of APLN mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3589,1440282,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,333,APLP1,https://ctdbase.org/detail.go?type=gene&acc=333,,,333.0,APLP1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of APLP1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3590,1440283,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,334,APLP2,https://ctdbase.org/detail.go?type=gene&acc=334,,,334.0,APLP2,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of APLP2 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3591,1440284,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,172180,APM-1,https://ctdbase.org/detail.go?type=gene&acc=172180,,,172180.0,apm-1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of APM-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3592,1440588,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178708,NHR-115,https://ctdbase.org/detail.go?type=gene&acc=178708,,,178708.0,nhr-115,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of NHR-115 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3593,1440589,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,179403,NHR-12,https://ctdbase.org/detail.go?type=gene&acc=179403,,,179403.0,nhr-12,6239.0,Caenorhabditis elegans,NHR-12 protein results in increased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3594,1440590,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,181102,NHR-14,https://ctdbase.org/detail.go?type=gene&acc=181102,,,181102.0,nhr-14,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of NHR-14 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3595,1441012,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,378998,ARHGAP29B,https://ctdbase.org/detail.go?type=gene&acc=378998,,,378998.0,arhgap29b,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of ARHGAP29B mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3596,1441013,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9743,ARHGAP32,https://ctdbase.org/detail.go?type=gene&acc=9743,,,9743.0,ARHGAP32,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARHGAP32 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3597,1441014,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,158763,ARHGAP36,https://ctdbase.org/detail.go?type=gene&acc=158763,,,158763.0,ARHGAP36,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of ARHGAP36 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3598,1441015,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,394,ARHGAP5,https://ctdbase.org/detail.go?type=gene&acc=394,,,394.0,ARHGAP5,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARHGAP5 mRNA,,,PMID:23179753|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|27188386|28001369,,
3599,1441016,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of ARHGDIB mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3600,1441017,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9828,ARHGEF17,https://ctdbase.org/detail.go?type=gene&acc=9828,,,9828.0,ARHGEF17,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of ARHGEF17 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3601,1441018,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,128272,ARHGEF19,https://ctdbase.org/detail.go?type=gene&acc=128272,,,128272.0,ARHGEF19,10116.0,Rattus norvegicus (Norway rat),"[hydrocarbons, chlorinated co-treated with polychlorinated biphenyls co-treated with methylmercuric chloride co-treated with dibenzofurans, polychlorinated co-treated with polychlorinated dibenzodioxins] results in increased expression of ARHGEF19 mRNA",,,PMID:30744511,https://www.ncbi.nlm.nih.gov/pubmed/30744511,30744511,,
3602,1441019,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,26084,ARHGEF26,https://ctdbase.org/detail.go?type=gene&acc=26084,,,26084.0,ARHGEF26,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARHGEF26 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3603,1441020,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,50650,ARHGEF3,https://ctdbase.org/detail.go?type=gene&acc=50650,,,50650.0,ARHGEF3,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of ARHGEF3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3604,1441269,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1820,ARID3A,https://ctdbase.org/detail.go?type=gene&acc=1820,,,1820.0,ARID3A,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of ARID3A mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3605,1441270,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51742,ARID4B,https://ctdbase.org/detail.go?type=gene&acc=51742,,,51742.0,ARID4B,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of ARID4B mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3606,1441271,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10865,ARID5A,https://ctdbase.org/detail.go?type=gene&acc=10865,,,10865.0,ARID5A,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of ARID5A mRNA,,,PMID:31378766,https://www.ncbi.nlm.nih.gov/pubmed/31378766,31378766,,
3607,1441272,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,25820,ARIH1,https://ctdbase.org/detail.go?type=gene&acc=25820,,,25820.0,ARIH1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of ARIH1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3608,1441273,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10425,ARIH2,https://ctdbase.org/detail.go?type=gene&acc=10425,,,10425.0,ARIH2,10090.0,Mus musculus (house mouse),Methylmercuric chloride results in increased expression of ARIH2 mRNA,,,PMID:20061341,https://www.ncbi.nlm.nih.gov/pubmed/20061341,20061341,,
3609,1441408,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,145407,ARMH4,https://ctdbase.org/detail.go?type=gene&acc=145407,,,145407.0,ARMH4,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARMH4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3610,1441409,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10552,ARPC1A,https://ctdbase.org/detail.go?type=gene&acc=10552,,,10552.0,ARPC1A,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of ARPC1A mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3611,1441410,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10095,ARPC1B,https://ctdbase.org/detail.go?type=gene&acc=10095,,,10095.0,ARPC1B,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARPC1B mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3612,1441411,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,348110,ARPIN,https://ctdbase.org/detail.go?type=gene&acc=348110,,,348110.0,ARPIN,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARPIN mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3613,1441722,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4851,NOTCH1,https://ctdbase.org/detail.go?type=gene&acc=4851,,,4851.0,NOTCH1,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride affects the expression of NOTCH1 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
3614,1441723,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4858,NOVA2,https://ctdbase.org/detail.go?type=gene&acc=4858,,,4858.0,NOVA2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NOVA2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3615,1441724,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,572245,NOXO1A,https://ctdbase.org/detail.go?type=gene&acc=572245,,,572245.0,noxo1a,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of NOXO1A mRNA,,,PMID:34954246,https://www.ncbi.nlm.nih.gov/pubmed/34954246,34954246,,
3616,1441725,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,286958,NP4,https://ctdbase.org/detail.go?type=gene&acc=286958,,,286958.0,Np4,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of NP4 mRNA,,,PMID:31378766,https://www.ncbi.nlm.nih.gov/pubmed/31378766,31378766,,
3617,1441726,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,64067,NPAS3,https://ctdbase.org/detail.go?type=gene&acc=64067,,,64067.0,NPAS3,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of NPAS3 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3618,1441727,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,266743,NPAS4,https://ctdbase.org/detail.go?type=gene&acc=266743,,,266743.0,NPAS4,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of NPAS4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3619,1441728,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4863,NPAT,https://ctdbase.org/detail.go?type=gene&acc=4863,,,4863.0,NPAT,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NPAT mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3620,1442965,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,189662,NSPE-5,https://ctdbase.org/detail.go?type=gene&acc=189662,,,189662.0,nspe-5,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of NSPE-5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3621,1442966,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,177224,NSPG-10,https://ctdbase.org/detail.go?type=gene&acc=177224,,,177224.0,nspg-10,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of NSPG-10 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3622,1442967,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,180796,NSPG-13,https://ctdbase.org/detail.go?type=gene&acc=180796,,,180796.0,nspg-13,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of NSPG-13 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3623,1442968,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,180795,NSPG-14,https://ctdbase.org/detail.go?type=gene&acc=180795,,,180795.0,nspg-14,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of NSPG-14 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3624,1443606,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,11249,NXPH2,https://ctdbase.org/detail.go?type=gene&acc=11249,,,11249.0,NXPH2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NXPH2 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3625,1443607,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,11248,NXPH3,https://ctdbase.org/detail.go?type=gene&acc=11248,,,11248.0,NXPH3,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NXPH3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3626,1443787,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,572,BAD,https://ctdbase.org/detail.go?type=gene&acc=572,,,572.0,BAD,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of BAD mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3627,1443788,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,572,BAD,https://ctdbase.org/detail.go?type=gene&acc=572,,,572.0,BAD,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of BAD protein,,,PMID:28821999,https://www.ncbi.nlm.nih.gov/pubmed/28821999,28821999,,
3628,1443789,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,176330,BAF-1,https://ctdbase.org/detail.go?type=gene&acc=176330,,,176330.0,baf-1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of BAF-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3629,1443790,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,573,BAG1,https://ctdbase.org/detail.go?type=gene&acc=573,,,573.0,BAG1,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of BAG1 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3630,1443791,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9532,BAG2,https://ctdbase.org/detail.go?type=gene&acc=9532,,,9532.0,BAG2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of BAG2 mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
3631,1443792,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9532,BAG2,https://ctdbase.org/detail.go?type=gene&acc=9532,,,9532.0,BAG2,9606.0,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3632,1443793,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9531,BAG3,https://ctdbase.org/detail.go?type=gene&acc=9531,,,9531.0,BAG3,7955.0,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of BAG3 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
3633,1443794,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9531,BAG3,https://ctdbase.org/detail.go?type=gene&acc=9531,,,9531.0,BAG3,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of BAG3 mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
3634,1443795,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9531,BAG3,https://ctdbase.org/detail.go?type=gene&acc=9531,,,9531.0,BAG3,9606.0,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3635,1443796,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9529,BAG5,https://ctdbase.org/detail.go?type=gene&acc=9529,,,9529.0,BAG5,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of BAG5 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3636,1443973,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,172323,OAC-9,https://ctdbase.org/detail.go?type=gene&acc=172323,,,172323.0,oac-9,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of OAC-9 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
3637,1443974,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,221443,OARD1,https://ctdbase.org/detail.go?type=gene&acc=221443,,,221443.0,OARD1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of OARD1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3638,1443975,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,37264,OBP56A,https://ctdbase.org/detail.go?type=gene&acc=37264,,,37264.0,Obp56a,7227.0,Drosophila melanogaster (fruit fly),[methylmercuric chloride results in decreased susceptibility to methylmercuric chloride] which results in increased expression of OBP56A mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
3639,1443976,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,37271,OBP56H,https://ctdbase.org/detail.go?type=gene&acc=37271,,,37271.0,Obp56h,7227.0,Drosophila melanogaster (fruit fly),[methylmercuric chloride results in decreased susceptibility to methylmercuric chloride] which results in decreased expression of OBP56H mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
3640,1443977,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,40746,OBP83CD,https://ctdbase.org/detail.go?type=gene&acc=40746,,,40746.0,Obp83cd,7227.0,Drosophila melanogaster (fruit fly),[methylmercuric chloride results in decreased susceptibility to methylmercuric chloride] which results in decreased expression of OBP83CD mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
3641,1443978,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,43494,OBP99C,https://ctdbase.org/detail.go?type=gene&acc=43494,,,43494.0,Obp99c,7227.0,Drosophila melanogaster (fruit fly),Methylmercuric chloride results in decreased expression of OBP99C mrna|[methylmercuric chloride results in decreased susceptibility to methylmercuric chloride] which results in decreased expression of OBP99C mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
3642,1443979,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,84033,OBSCN,https://ctdbase.org/detail.go?type=gene&acc=84033,,,84033.0,OBSCN,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of OBSCN mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3643,1443980,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23363,OBSL1,https://ctdbase.org/detail.go?type=gene&acc=23363,,,23363.0,OBSL1,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of OBSL1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3644,1444667,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,56898,BDH2,https://ctdbase.org/detail.go?type=gene&acc=56898,,,56898.0,BDH2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of BDH2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3645,1446031,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5100,PCDH8,https://ctdbase.org/detail.go?type=gene&acc=5100,,,5100.0,PCDH8,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride affects the expression of PCDH8 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
3646,1446032,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5101,PCDH9,https://ctdbase.org/detail.go?type=gene&acc=5101,,,5101.0,PCDH9,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of PCDH9 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
3647,1446033,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,56142,PCDHA6,https://ctdbase.org/detail.go?type=gene&acc=56142,,,56142.0,PCDHA6,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of PCDHA6 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3648,1446034,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,56134,PCDHAC2,https://ctdbase.org/detail.go?type=gene&acc=56134,,,56134.0,PCDHAC2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PCDHAC2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3649,1446035,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,56122,PCDHB14,https://ctdbase.org/detail.go?type=gene&acc=56122,,,56122.0,PCDHB14,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PCDHB14 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3650,1446036,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,56131,PCDHB4,https://ctdbase.org/detail.go?type=gene&acc=56131,,,56131.0,PCDHB4,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PCDHB4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3651,1446367,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,27250,PDCD4,https://ctdbase.org/detail.go?type=gene&acc=27250,,,27250.0,PDCD4,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PDCD4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3652,1446368,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10015,PDCD6IP,https://ctdbase.org/detail.go?type=gene&acc=10015,,,10015.0,PDCD6IP,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PDCD6IP mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3653,1446369,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,50940,PDE11A,https://ctdbase.org/detail.go?type=gene&acc=50940,,,50940.0,PDE11A,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PDE11A mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3654,1446370,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,50940,PDE11A,https://ctdbase.org/detail.go?type=gene&acc=50940,,,50940.0,PDE11A,10116.0,Rattus norvegicus (Norway rat),Methylmercuric chloride results in decreased expression of PDE11A mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
3655,1446371,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5136,PDE1A,https://ctdbase.org/detail.go?type=gene&acc=5136,,,5136.0,PDE1A,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of PDE1A mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3656,1446372,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5137,PDE1C,https://ctdbase.org/detail.go?type=gene&acc=5137,,,5137.0,PDE1C,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PDE1C mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3657,1466432,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6591,SNAI2,https://ctdbase.org/detail.go?type=gene&acc=6591,,,6591.0,SNAI2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SNAI2 mRNA,,,PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,26272509|28001369,,
3658,1466433,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8773,SNAP23,https://ctdbase.org/detail.go?type=gene&acc=8773,,,8773.0,SNAP23,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SNAP23 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3659,1466434,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6616,SNAP25,https://ctdbase.org/detail.go?type=gene&acc=6616,,,6616.0,SNAP25,9483.0,Callithrix jacchus (white-tufted-ear marmoset),Methylmercuric chloride affects the expression of SNAP25 protein,,,PMID:27012723,https://www.ncbi.nlm.nih.gov/pubmed/27012723,27012723,,
3660,1466435,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6616,SNAP25,https://ctdbase.org/detail.go?type=gene&acc=6616,,,6616.0,SNAP25,9483.0,Callithrix jacchus (white-tufted-ear marmoset),Methylmercuric chloride results in decreased expression of SNAP25 protein,,,PMID:25809596,https://www.ncbi.nlm.nih.gov/pubmed/25809596,25809596,,
3661,1466436,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6616,SNAP25,https://ctdbase.org/detail.go?type=gene&acc=6616,,,6616.0,SNAP25,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of SNAP25 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3662,1466437,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9342,SNAP29,https://ctdbase.org/detail.go?type=gene&acc=9342,,,9342.0,SNAP29,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of SNAP29 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3663,1480737,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8363,H4C11,https://ctdbase.org/detail.go?type=gene&acc=8363,,,8363.0,H4C11,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of H4C11 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3664,1480738,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8364,H4C3,https://ctdbase.org/detail.go?type=gene&acc=8364,,,8364.0,H4C3,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of H4C3 mRNA,,,PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/34089799,34089799,,
3665,1480739,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9563,H6PD,https://ctdbase.org/detail.go?type=gene&acc=9563,,,9563.0,H6PD,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of H6PD mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3666,1481670,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55002,TMCO3,https://ctdbase.org/detail.go?type=gene&acc=55002,,,55002.0,TMCO3,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of TMCO3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3667,1481671,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10959,TMED2,https://ctdbase.org/detail.go?type=gene&acc=10959,,,10959.0,TMED2,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of TMED2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
3668,1481672,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10959,TMED2,https://ctdbase.org/detail.go?type=gene&acc=10959,,,10959.0,TMED2,9606.0,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMED2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3669,1481673,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,222068,TMED4,https://ctdbase.org/detail.go?type=gene&acc=222068,,,222068.0,TMED4,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of TMED4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3670,1482364,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9843,HEPH,https://ctdbase.org/detail.go?type=gene&acc=9843,,,9843.0,HEPH,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of HEPH mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3671,1486035,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,7249,TSC2,https://ctdbase.org/detail.go?type=gene&acc=7249,,,7249.0,TSC2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of TSC2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3672,1486036,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,80746,TSEN2,https://ctdbase.org/detail.go?type=gene&acc=80746,,,80746.0,TSEN2,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of TSEN2 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3673,1486037,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,80746,TSEN2,https://ctdbase.org/detail.go?type=gene&acc=80746,,,80746.0,TSEN2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of TSEN2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3674,1486038,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,283989,TSEN54,https://ctdbase.org/detail.go?type=gene&acc=283989,,,283989.0,TSEN54,8049.0,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of TSEN54 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
3675,1486039,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,32821,TSF1,https://ctdbase.org/detail.go?type=gene&acc=32821,,,32821.0,Tsf1,7227.0,Drosophila melanogaster (fruit fly),Methylmercuric chloride results in decreased expression of TSF1 mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
3676,1486040,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,80705,TSGA10,https://ctdbase.org/detail.go?type=gene&acc=80705,,,80705.0,TSGA10,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of TSGA10 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3677,1486041,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10194,TSHZ1,https://ctdbase.org/detail.go?type=gene&acc=10194,,,10194.0,TSHZ1,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of TSHZ1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3678,1486042,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,128553,TSHZ2,https://ctdbase.org/detail.go?type=gene&acc=128553,,,128553.0,TSHZ2,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of TSHZ2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
3679,1444985,412201,Therapeutic Target Database (TTD),(4-Amino-benzenesulfonylamino)-acetic acid,D01UNC,2-(4-aminophenylsulfonamido)acetic acid,https://idrblab.net/ttd/data/drug/details/D01UNC,T26623,Aldose reductase (AKR1B1),https://idrblab.net/ttd/data/target/details/T26623,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3680,1444986,413225,Therapeutic Target Database (TTD),5-Hydroxy-8-[4-(4-sulfo-phenylazo)-phenylazo]-naphthalene-1-sulfonic acid,D03NSJ,NSC-45592,https://idrblab.net/ttd/data/drug/details/D03NSJ,T04741,Phosphoribosylaminoimidazolecarboxamide formyltransferase (ATIC),https://idrblab.net/ttd/data/target/details/T04741,P31939,Bifunctional purine biosynthesis protein ATIC,471.0,ATIC,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3681,1444987,413448,Therapeutic Target Database (TTD),"1H-Pyrrole-2-methanamine, N-(phenylmethyl)-",D0O2UK,"N-(benzyl),N-(pyrrol-2-ylmethyl)amine",https://idrblab.net/ttd/data/drug/details/D0O2UK,T83011,Monoamine oxidase type B (MAO-B),https://idrblab.net/ttd/data/target/details/T83011,P27338,Amine oxidase [flavin-containing] B,4129.0,MAOB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3682,1444988,413448,Therapeutic Target Database (TTD),"1H-Pyrrole-2-methanamine, N-(phenylmethyl)-",D0O2UK,"N-(benzyl),N-(pyrrol-2-ylmethyl)amine",https://idrblab.net/ttd/data/drug/details/D0O2UK,T83875,Monoamine oxidase type A (MAO-A),https://idrblab.net/ttd/data/target/details/T83875,P21397,Amine oxidase [flavin-containing] A,4128.0,MAOA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3683,1444989,413728,Comparative Toxicogenomics Database (CTD),[4-[Bis[4-(diethylamino)phenyl]methylidene]naphthalen-1-ylidene]-ethylazanium,C066850,Cascade Blue,https://ctdbase.org/detail.go?type=chem&acc=C066850,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),ABCG2 protein affects the transport of cascade blue,,,PMID:32473861,https://www.ncbi.nlm.nih.gov/pubmed/32473861,32473861,,
3684,1444990,413728,Comparative Toxicogenomics Database (CTD),[4-[Bis[4-(diethylamino)phenyl]methylidene]naphthalen-1-ylidene]-ethylazanium,C066850,Cascade Blue,https://ctdbase.org/detail.go?type=chem&acc=C066850,11309,SLCO2B1,https://ctdbase.org/detail.go?type=gene&acc=11309,,,11309.0,SLCO2B1,9606.0,Homo sapiens (human),Docetaxel inhibits the reaction [SLCO2B1 protein results in increased uptake of cascade blue]|tamoxifen inhibits the reaction [SLCO2B1 protein results in increased uptake of cascade blue]|teniposide inhibits the reaction [SLCO2B1 protein results in increased uptake of cascade blue]|thiotepa inhibits the reaction [SLCO2B1 protein results in increased uptake of cascade blue]|bleomycin inhibits the reaction [SLCO2B1 protein results in increased uptake of cascade blue]|slco2b1 protein results in increased uptake of cascade blue|etoposide inhibits the reaction [SLCO2B1 protein results in increased uptake of cascade blue]|capecitabine inhibits the reaction [SLCO2B1 protein results in increased uptake of cascade blue]|irinotecan inhibits the reaction [SLCO2B1 protein results in increased uptake of cascade blue]|methotrexate inhibits the reaction [SLCO2B1 protein results in increased uptake of cascade blue],,,PMID:30863990,https://www.ncbi.nlm.nih.gov/pubmed/30863990,30863990,,
3685,1444991,414513,BindingDB,"1-N,4-N-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]phthalazine-1,4-diamine",33257,"phthalazine-based compound, 8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33257,291,"Genome polyprotein [1394-1440]/[1476-1660,T1585M]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=291,P27915,Genome polyprotein,,,408870.0,Dengue virus 3 Philippines/H87/1956,,IC50 (nM),27900,PMID:19682971|DOI:10.1016/j.ab.2009.08.013,https://www.ncbi.nlm.nih.gov/pubmed/19682971|https://doi.org/10.1016/j.ab.2009.08.013,19682971,10.1016/j.ab.2009.08.013,
3686,1525006,419951,Toxin and Toxin Target Database (T3DB),Cobalt(ii)iodide,T3D0661,Cobalt(II) iodide,http://www.t3db.ca/toxins/T3D0661,BE0002396,Voltage-dependent calcium channel subunit alpha-2/delta-2,http://www.t3db.ca/biodb/bio_entities/BE0002396,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,9254.0,CACNA2D2,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
3687,1525007,419951,Toxin and Toxin Target Database (T3DB),Cobalt(ii)iodide,T3D0661,Cobalt(II) iodide,http://www.t3db.ca/toxins/T3D0661,BE0003563,Voltage-dependent calcium channel subunit alpha-2/delta-3,http://www.t3db.ca/biodb/bio_entities/BE0003563,Q8IZS8,Voltage-dependent calcium channel subunit alpha-2/delta-3,55799.0,CACNA2D3,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
3688,1525008,419951,Toxin and Toxin Target Database (T3DB),Cobalt(ii)iodide,T3D0661,Cobalt(II) iodide,http://www.t3db.ca/toxins/T3D0661,BE0005100,Voltage-dependent calcium channel subunit alpha-2/delta-4,http://www.t3db.ca/biodb/bio_entities/BE0005100,Q7Z3S7,Voltage-dependent calcium channel subunit alpha-2/delta-4,93589.0,CACNA2D4,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
3689,1525009,421105,Drug Gene Interaction database (DGIdb),4-((6-Chloro-2-methoxyacridin-9-yl)amino)-2-((4-methylpiperazin-1-yl)methyl)phenol,,CHEMBL:CHEMBL463783,https://www.dgidb.org/drugs/chembl:CHEMBL463783,,RACGAP1,https://www.dgidb.org/genes/hgnc:9804,,,29127.0,RACGAP1,9606.0,Homo sapiens (human),,,,,,,,
3690,1525010,421105,Drug Gene Interaction database (DGIdb),4-((6-Chloro-2-methoxyacridin-9-yl)amino)-2-((4-methylpiperazin-1-yl)methyl)phenol,,CHEMBL:CHEMBL463783,https://www.dgidb.org/drugs/chembl:CHEMBL463783,,FEN1,https://www.dgidb.org/genes/hgnc:3650,,,2237.0,FEN1,9606.0,Homo sapiens (human),,,,,,,,
3691,1518229,429922,Toxin and Toxin Target Database (T3DB),15-Acetoxyscirpenol,T3D3699,Monoacetoxyscirpenol,http://www.t3db.ca/toxins/T3D3699,BE0001122,Transient receptor potential cation channel subfamily A member 1,http://www.t3db.ca/biodb/bio_entities/BE0001122,O75762,Transient receptor potential cation channel subfamily A member 1,8989.0,TRPA1,9606.0,Homo sapiens (human),,,,PMID:21078588,https://www.ncbi.nlm.nih.gov/pubmed/21078588,21078588,,
3692,1518230,429923,Toxin and Toxin Target Database (T3DB),Diacetylnivalenol,T3D3704,Diacetylnivalenol,http://www.t3db.ca/toxins/T3D3704,BE0005432,"28S ribosomal protein S5, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005432,P82675,"28S ribosomal protein S5, mitochondrial",64969.0,MRPS5,9606.0,Homo sapiens (human),"Trichothecenes move freely across the plasma membrane and bind specifically to ribosomes with high-affinity. specifically, they interfere with the active site of peptidyl transferase at the 3'-end of large 28S ribosomal RNA and inhibit the initiation, elongation or termination step of protein synthesis, as well as cause polyribosomal disaggregation. trichothecenes are cytotoxic because protein synthesis is an essential function in all tissues. additionally, binding to ribosomes is thought to activate proteins in downstream signalling events related to immune response and apoptosis, such as mitogen-activated protein kinases. this is known as ribotoxic stress response. (L1949, A2962, A2980)",,,PMID:19238623|PMID:18502741,https://www.ncbi.nlm.nih.gov/pubmed/19238623|https://www.ncbi.nlm.nih.gov/pubmed/18502741,19238623|18502741,,
3693,1518231,429923,Toxin and Toxin Target Database (T3DB),Diacetylnivalenol,T3D3704,Diacetylnivalenol,http://www.t3db.ca/toxins/T3D3704,BE0001122,Transient receptor potential cation channel subfamily A member 1,http://www.t3db.ca/biodb/bio_entities/BE0001122,O75762,Transient receptor potential cation channel subfamily A member 1,8989.0,TRPA1,9606.0,Homo sapiens (human),,,,PMID:21078588,https://www.ncbi.nlm.nih.gov/pubmed/21078588,21078588,,
3694,1518232,430147,Toxin and Toxin Target Database (T3DB),Vomitoxin,T3D3668,Deoxynivalenol,http://www.t3db.ca/toxins/T3D3668,BE0005432,"28S ribosomal protein S5, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005432,P82675,"28S ribosomal protein S5, mitochondrial",64969.0,MRPS5,9606.0,Homo sapiens (human),"Trichothecenes move freely across the plasma membrane and bind specifically to ribosomes with high-affinity. specifically, they interfere with the active site of peptidyl transferase at the 3'-end of large 28S ribosomal RNA and inhibit the initiation, elongation or termination step of protein synthesis, as well as cause polyribosomal disaggregation. trichothecenes are cytotoxic because protein synthesis is an essential function in all tissues. additionally, binding to ribosomes is thought to activate proteins in downstream signalling events related to immune response and apoptosis, such as mitogen-activated protein kinases. this is known as ribotoxic stress response. (L1949, A2962, A2980)",,,PMID:19238623|PMID:18502741,https://www.ncbi.nlm.nih.gov/pubmed/19238623|https://www.ncbi.nlm.nih.gov/pubmed/18502741,19238623|18502741,,
3695,1518233,430147,Toxin and Toxin Target Database (T3DB),Vomitoxin,T3D3668,Deoxynivalenol,http://www.t3db.ca/toxins/T3D3668,BE0001122,Transient receptor potential cation channel subfamily A member 1,http://www.t3db.ca/biodb/bio_entities/BE0001122,O75762,Transient receptor potential cation channel subfamily A member 1,8989.0,TRPA1,9606.0,Homo sapiens (human),,,,PMID:21078588,https://www.ncbi.nlm.nih.gov/pubmed/21078588,21078588,,
3696,1518234,430297,Drug Gene Interaction database (DGIdb),"1,4,5,6,7,16,17,18,19,19,20,20-Dodecachloro-12-sulfohexacyclo[14.2.1.1^{4,7}.0^{2,15}.0^{3,8}.0^{9,14}]icosa-5,9(14),10,12,17-pentaene-11-carboxylic acid",,CHEMBL:CHEMBL401844,https://www.dgidb.org/drugs/chembl:CHEMBL401844,,ADCY5,https://www.dgidb.org/genes/hgnc:236,,,111.0,ADCY5,9606.0,Homo sapiens (human),,,,,,,,
3697,1518235,430297,Drug Gene Interaction database (DGIdb),"1,4,5,6,7,16,17,18,19,19,20,20-Dodecachloro-12-sulfohexacyclo[14.2.1.1^{4,7}.0^{2,15}.0^{3,8}.0^{9,14}]icosa-5,9(14),10,12,17-pentaene-11-carboxylic acid",,CHEMBL:CHEMBL401844,https://www.dgidb.org/drugs/chembl:CHEMBL401844,,ADCY9,https://www.dgidb.org/genes/hgnc:240,,,115.0,ADCY9,9606.0,Homo sapiens (human),,,,,,,,
3698,1518236,430297,Drug Gene Interaction database (DGIdb),"1,4,5,6,7,16,17,18,19,19,20,20-Dodecachloro-12-sulfohexacyclo[14.2.1.1^{4,7}.0^{2,15}.0^{3,8}.0^{9,14}]icosa-5,9(14),10,12,17-pentaene-11-carboxylic acid",,CHEMBL:CHEMBL401844,https://www.dgidb.org/drugs/chembl:CHEMBL401844,,ADCY2,https://www.dgidb.org/genes/hgnc:233,,,108.0,ADCY2,9606.0,Homo sapiens (human),,,,,,,,
3699,1518237,431810,Toxin and Toxin Target Database (T3DB),"[11-Hydroxy-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-10-yl] acetate",T3D3698,"3-Acetoxyscirpene-4,15-diol",http://www.t3db.ca/toxins/T3D3698,BE0005432,"28S ribosomal protein S5, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005432,P82675,"28S ribosomal protein S5, mitochondrial",64969.0,MRPS5,9606.0,Homo sapiens (human),"Trichothecenes move freely across the plasma membrane and bind specifically to ribosomes with high-affinity. specifically, they interfere with the active site of peptidyl transferase at the 3'-end of large 28S ribosomal RNA and inhibit the initiation, elongation or termination step of protein synthesis, as well as cause polyribosomal disaggregation. trichothecenes are cytotoxic because protein synthesis is an essential function in all tissues. additionally, binding to ribosomes is thought to activate proteins in downstream signalling events related to immune response and apoptosis, such as mitogen-activated protein kinases. this is known as ribotoxic stress response. (L1949, A2962, A2980)",,,PMID:19238623|PMID:18502741,https://www.ncbi.nlm.nih.gov/pubmed/19238623|https://www.ncbi.nlm.nih.gov/pubmed/18502741,19238623|18502741,,
3700,1450131,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,7138,TNNT1,https://ctdbase.org/detail.go?type=gene&acc=7138,,,7138.0,TNNT1,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of TNNT1 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3701,1450132,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,7156,TOP3A,https://ctdbase.org/detail.go?type=gene&acc=7156,,,7156.0,TOP3A,9606.0,Homo sapiens (human),Lithium chloride results in decreased expression of TOP3A mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3702,1450133,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9913.0,Bos taurus (cattle),TP53 protein promotes the reaction [lithium chloride results in increased expression of MMP1 mrna],,,PMID:19407340,https://www.ncbi.nlm.nih.gov/pubmed/19407340,19407340,,
3703,1450134,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of TP53 protein,,,PMID:17210701,https://www.ncbi.nlm.nih.gov/pubmed/17210701,17210701,,
3704,1450135,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,8626,TP63,https://ctdbase.org/detail.go?type=gene&acc=8626,,,8626.0,TP63,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of TP63 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3705,1450136,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,7164,TPD52L1,https://ctdbase.org/detail.go?type=gene&acc=7164,,,7164.0,TPD52L1,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of TPD52L1 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3706,1450137,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,7166,TPH1,https://ctdbase.org/detail.go?type=gene&acc=7166,,,7166.0,TPH1,10090.0,Mus musculus (house mouse),Lithium chloride results in decreased expression of TPH1 mRNA,,,PMID:33901603,https://www.ncbi.nlm.nih.gov/pubmed/33901603,33901603,,
3707,1450494,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,7471,WNT1,https://ctdbase.org/detail.go?type=gene&acc=7471,,,7471.0,WNT1,9606.0,Homo sapiens (human),Lithium chloride inhibits the reaction [quinocetone results in decreased expression of WNT1 protein],,,PMID:28343033,https://www.ncbi.nlm.nih.gov/pubmed/28343033,28343033,,
3708,1450495,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,34011,WNT10,https://ctdbase.org/detail.go?type=gene&acc=34011,,,34011.0,Wnt10,7668.0,Strongylocentrotus purpuratus (purple sea urchin),Lithium chloride results in increased expression of WNT10 mRNA,,,PMID:17506889,https://www.ncbi.nlm.nih.gov/pubmed/17506889,17506889,,
3709,1450496,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,51384,WNT16,https://ctdbase.org/detail.go?type=gene&acc=51384,,,51384.0,WNT16,7668.0,Strongylocentrotus purpuratus (purple sea urchin),Lithium chloride results in increased expression of WNT16 mRNA,,,PMID:17506889,https://www.ncbi.nlm.nih.gov/pubmed/17506889,17506889,,
3710,1450497,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,7473,WNT3,https://ctdbase.org/detail.go?type=gene&acc=7473,,,7473.0,WNT3,10090.0,Mus musculus (house mouse),Lithium chloride results in decreased expression of WNT3 mRNA,,,PMID:26272751,https://www.ncbi.nlm.nih.gov/pubmed/26272751,26272751,,
3711,1451087,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,176785,ACS-5,https://ctdbase.org/detail.go?type=gene&acc=176785,,,176785.0,acs-5,6239.0,Caenorhabditis elegans,Lithium chloride results in decreased expression of ACS-5 mRNA,,,PMID:25645087,https://www.ncbi.nlm.nih.gov/pubmed/25645087,25645087,,
3712,1451088,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,577,ADGRB3,https://ctdbase.org/detail.go?type=gene&acc=577,,,577.0,ADGRB3,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of ADGRB3 mRNA,,,PMID:15711924,https://www.ncbi.nlm.nih.gov/pubmed/15711924,15711924,,
3713,1451089,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,976,ADGRE5,https://ctdbase.org/detail.go?type=gene&acc=976,,,976.0,ADGRE5,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of ADGRE5 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3714,1451090,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,114896,AFG3L1,https://ctdbase.org/detail.go?type=gene&acc=114896,,,114896.0,Afg3l1,9606.0,Homo sapiens (human),Lithium chloride results in decreased expression of AFG3L1 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
3715,1451091,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,11607,AGTR1A,https://ctdbase.org/detail.go?type=gene&acc=11607,,,11607.0,Agtr1a,10116.0,Rattus norvegicus (Norway rat),[lithium chloride co-treated with pilocarpine] affects the reaction [dexamethasone results in increased expression of AGTR1A protein],,,PMID:32494933,https://www.ncbi.nlm.nih.gov/pubmed/32494933,32494933,,
3716,1451092,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,186,AGTR2,https://ctdbase.org/detail.go?type=gene&acc=186,,,186.0,AGTR2,10116.0,Rattus norvegicus (Norway rat),[dexamethasone co-treated with lithium chloride co-treated with pilocarpine] affects the expression of AGTR2 mRNA,,,PMID:32494933,https://www.ncbi.nlm.nih.gov/pubmed/32494933,32494933,,
3717,1451093,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10090.0,Mus musculus (house mouse),[lithium chloride results in decreased activity of GSK3B protein] which results in increased expression of AHR mRNA,,,PMID:21498875,https://www.ncbi.nlm.nih.gov/pubmed/21498875,21498875,,
3718,1452184,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Lithium chloride inhibits the reaction [staurosporine results in increased activity of CASP3 protein],,,PMID:19101580,https://www.ncbi.nlm.nih.gov/pubmed/19101580,19101580,,
3719,1452185,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),[lithium chloride results in increased abundance of lithium] inhibits the reaction [paraquat results in increased activity of CASP3 protein],,,PMID:26074776,https://www.ncbi.nlm.nih.gov/pubmed/26074776,26074776,,
3720,1452186,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Lithium chloride affects the reaction [[gastrodin co-treated with rhyncophylline] affects the reaction [1-methyl-4-phenylpyridinium affects the expression of CASP3 mrna]],,,PMID:33645131,https://www.ncbi.nlm.nih.gov/pubmed/33645131,33645131,,
3721,1485016,437740,Drug Gene Interaction database (DGIdb),4-Isothioureidobutyronitrile,,THIOUREIDOBUTYRONITRILE,https://www.dgidb.org/drugs/ncit:C102881,,TP53,https://www.dgidb.org/genes/hgnc:11998,,,7157.0,TP53,9606.0,Homo sapiens (human),,,,,,,,
3722,1485017,439155,DrugBank,S-adenosyl-L-homocysteine,DB01752,S-adenosyl-L-homocysteine,https://www.drugbank.ca/drugs/DB01752,BE0001402,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,https://www.drugbank.ca/bio_entities/BE0001402,P07617,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,3707551.0,J3R,10254.0,Vaccinia virus WR,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
3723,1485018,439155,DrugBank,S-adenosyl-L-homocysteine,DB01752,S-adenosyl-L-homocysteine,https://www.drugbank.ca/drugs/DB01752,BE0001398,Cobalt-precorrin-4 C(11)-methyltransferase,https://www.drugbank.ca/bio_entities/BE0001398,O87696,Cobalt-precorrin-4 C(11)-methyltransferase,,,1404.0,Priestia megaterium,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
3724,1485019,439155,DrugBank,S-adenosyl-L-homocysteine,DB01752,S-adenosyl-L-homocysteine,https://www.drugbank.ca/drugs/DB01752,BE0001144,Protein-L-isoaspartate(D-aspartate) O-methyltransferase,https://www.drugbank.ca/bio_entities/BE0001144,P22061,Protein-L-isoaspartate(D-aspartate) O-methyltransferase,5110.0,PCMT1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
3725,1485020,439155,DrugBank,S-adenosyl-L-homocysteine,DB01752,S-adenosyl-L-homocysteine,https://www.drugbank.ca/drugs/DB01752,BE0001261,Genome polyprotein,https://www.drugbank.ca/bio_entities/BE0001261,P12823,Genome polyprotein,,,11066.0,Dengue virus 2 Puerto Rico/PR159-S1/1969,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
3726,1485021,439155,DrugBank,S-adenosyl-L-homocysteine,DB01752,S-adenosyl-L-homocysteine,https://www.drugbank.ca/drugs/DB01752,BE0000865,Phenylethanolamine N-methyltransferase,https://www.drugbank.ca/bio_entities/BE0000865,P11086,Phenylethanolamine N-methyltransferase,5409.0,PNMT,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
3727,1485022,439155,DrugBank,S-adenosyl-L-homocysteine,DB01752,S-adenosyl-L-homocysteine,https://www.drugbank.ca/drugs/DB01752,BE0001211,Cyclopropane mycolic acid synthase 2,https://www.drugbank.ca/bio_entities/BE0001211,P9WPB5,Cyclopropane mycolic acid synthase 2,887264.0,cmaA2,83332.0,Mycobacterium tuberculosis H37Rv,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
3728,1485023,439155,DrugBank,S-adenosyl-L-homocysteine,DB01752,S-adenosyl-L-homocysteine,https://www.drugbank.ca/drugs/DB01752,BE0001456,Modification methylase RsrI,https://www.drugbank.ca/bio_entities/BE0001456,P14751,Modification methylase RsrI,,,1063.0,Cereibacter sphaeroides,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
3729,1485024,439155,DrugBank,S-adenosyl-L-homocysteine,DB01752,S-adenosyl-L-homocysteine,https://www.drugbank.ca/drugs/DB01752,BE0004586,Catechol O-methyltransferase domain-containing protein 1,https://www.drugbank.ca/bio_entities/BE0004586,Q86VU5,Catechol O-methyltransferase domain-containing protein 1,118881.0,COMTD1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
3730,1433784,439176,Comparative Toxicogenomics Database (CTD),5'-Deoxy-5'-methylthioadenosine,C008500,5'-methylthioadenosine,https://ctdbase.org/detail.go?type=chem&acc=C008500,1278,COL1A2,https://ctdbase.org/detail.go?type=gene&acc=1278,,,1278.0,COL1A2,9606.0,Homo sapiens (human),5'-methylthioadenosine results in decreased expression of COL1A2 mRNA,,,PMID:15983038,https://www.ncbi.nlm.nih.gov/pubmed/15983038,15983038,,
3731,1433785,439176,Comparative Toxicogenomics Database (CTD),5'-Deoxy-5'-methylthioadenosine,C008500,5'-methylthioadenosine,https://ctdbase.org/detail.go?type=chem&acc=C008500,3418,IDH2,https://ctdbase.org/detail.go?type=gene&acc=3418,,,3418.0,IDH2,10090.0,Mus musculus (house mouse),IDH2 protein mutant form results in increased abundance of 5'-methylthioadenosine|triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of 5'-methylthioadenosine],,,PMID:27469509,https://www.ncbi.nlm.nih.gov/pubmed/27469509,27469509,,
3732,1433786,439176,Comparative Toxicogenomics Database (CTD),5'-Deoxy-5'-methylthioadenosine,C008500,5'-methylthioadenosine,https://ctdbase.org/detail.go?type=chem&acc=C008500,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606.0,Homo sapiens (human),5'-methylthioadenosine results in decreased secretion of IFNG protein,,,PMID:31712395,https://www.ncbi.nlm.nih.gov/pubmed/31712395,31712395,,
3733,1433787,439176,Comparative Toxicogenomics Database (CTD),5'-Deoxy-5'-methylthioadenosine,C008500,5'-methylthioadenosine,https://ctdbase.org/detail.go?type=chem&acc=C008500,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090.0,Mus musculus (house mouse),5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of IFNG mrna],,,PMID:17080400,https://www.ncbi.nlm.nih.gov/pubmed/17080400,17080400,,
3734,1433788,439176,Comparative Toxicogenomics Database (CTD),5'-Deoxy-5'-methylthioadenosine,C008500,5'-methylthioadenosine,https://ctdbase.org/detail.go?type=chem&acc=C008500,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of IL1B mrna],,,PMID:17080400,https://www.ncbi.nlm.nih.gov/pubmed/17080400,17080400,,
3735,1433789,439176,Comparative Toxicogenomics Database (CTD),5'-Deoxy-5'-methylthioadenosine,C008500,5'-methylthioadenosine,https://ctdbase.org/detail.go?type=chem&acc=C008500,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558.0,IL2,9606.0,Homo sapiens (human),5'-methylthioadenosine results in decreased secretion of IL2 protein,,,PMID:31712395,https://www.ncbi.nlm.nih.gov/pubmed/31712395,31712395,,
3736,1525011,439177,Comparative Toxicogenomics Database (CTD),"(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R,5R,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",D006003,Glycogen,https://ctdbase.org/detail.go?type=chem&acc=D006003,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116.0,Rattus norvegicus (Norway rat),Diethylhexyl phthalate inhibits the reaction [INS1 protein results in increased abundance of glycogen]|mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased abundance of glycogen],,,PMID:28526321,https://www.ncbi.nlm.nih.gov/pubmed/28526321,28526321,,
3737,1525012,439177,Comparative Toxicogenomics Database (CTD),"(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R,5R,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",D006003,Glycogen,https://ctdbase.org/detail.go?type=chem&acc=D006003,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116.0,Rattus norvegicus (Norway rat),Rosiglitazone inhibits the reaction [INS1 protein results in increased abundance of glycogen]|ins1 protein results in increased abundance of glycogen,,,PMID:19211718,https://www.ncbi.nlm.nih.gov/pubmed/19211718,19211718,,
3738,1525013,439177,Comparative Toxicogenomics Database (CTD),"(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R,5R,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",D006003,Glycogen,https://ctdbase.org/detail.go?type=chem&acc=D006003,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116.0,Rattus norvegicus (Norway rat),INS1 protein results in increased chemical synthesis of glycogen,,,PMID:1847587,https://www.ncbi.nlm.nih.gov/pubmed/1847587,1847587,,
3739,1525014,439177,Comparative Toxicogenomics Database (CTD),"(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R,5R,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",D006003,Glycogen,https://ctdbase.org/detail.go?type=chem&acc=D006003,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090.0,Mus musculus (house mouse),NFE2L2 protein affects the reaction [streptozocin results in decreased abundance of glycogen],,,PMID:20086057,https://www.ncbi.nlm.nih.gov/pubmed/20086057,20086057,,
3740,1525136,439177,Comparative Toxicogenomics Database (CTD),"(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R,5R,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",D006003,Glycogen,https://ctdbase.org/detail.go?type=chem&acc=D006003,178,AGL,https://ctdbase.org/detail.go?type=gene&acc=178,,,178.0,AGL,9606.0,Homo sapiens (human),AGL protein affects the metabolism of glycogen,,,PMID:24700805,https://www.ncbi.nlm.nih.gov/pubmed/24700805,24700805,,
3741,1525137,439177,Comparative Toxicogenomics Database (CTD),"(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R,5R,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",D006003,Glycogen,https://ctdbase.org/detail.go?type=chem&acc=D006003,1850,DUSP8,https://ctdbase.org/detail.go?type=gene&acc=1850,,,1850.0,DUSP8,10090.0,Mus musculus (house mouse),[DUSP8 protein affects the susceptibility to dietary fats] which affects the abundance of glycogen,,,PMID:32780722,https://www.ncbi.nlm.nih.gov/pubmed/32780722,32780722,,
3742,1525138,439177,Comparative Toxicogenomics Database (CTD),"(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R,5R,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",D006003,Glycogen,https://ctdbase.org/detail.go?type=chem&acc=D006003,3357,HTR2B,https://ctdbase.org/detail.go?type=gene&acc=3357,,,3357.0,HTR2B,10090.0,Mus musculus (house mouse),[fluoxetine results in increased expression of and results in increased activity of HTR2B protein] which results in increased metabolism of glycogen,,,PMID:11930908,https://www.ncbi.nlm.nih.gov/pubmed/11930908,11930908,,
3743,1525139,439177,Comparative Toxicogenomics Database (CTD),"(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R,5R,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",D006003,Glycogen,https://ctdbase.org/detail.go?type=chem&acc=D006003,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606.0,Homo sapiens (human),Testosterone promotes the reaction [INS protein results in increased chemical synthesis of glycogen]|estradiol promotes the reaction [INS protein results in increased chemical synthesis of glycogen],,,PMID:21632903,https://www.ncbi.nlm.nih.gov/pubmed/21632903,21632903,,
3744,1525140,439177,Comparative Toxicogenomics Database (CTD),"(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R,5R,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",D006003,Glycogen,https://ctdbase.org/detail.go?type=chem&acc=D006003,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606.0,Homo sapiens (human),Glucose inhibits the reaction [INS protein results in increased chemical synthesis of glycogen],,,PMID:15864539,https://www.ncbi.nlm.nih.gov/pubmed/15864539,15864539,,
3745,1525141,439177,Comparative Toxicogenomics Database (CTD),"(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R,5R,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",D006003,Glycogen,https://ctdbase.org/detail.go?type=chem&acc=D006003,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606.0,Homo sapiens (human),Mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased abundance of glycogen]|ins protein results in increased abundance of glycogen|rbp4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased abundance of glycogen]],,,PMID:31228551,https://www.ncbi.nlm.nih.gov/pubmed/31228551,31228551,,
3746,1525142,439177,Comparative Toxicogenomics Database (CTD),"(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R,5R,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",D006003,Glycogen,https://ctdbase.org/detail.go?type=chem&acc=D006003,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606.0,Homo sapiens (human),INS protein results in increased chemical synthesis of glycogen,,,PMID:15864539|PMID:21632903,https://www.ncbi.nlm.nih.gov/pubmed/15864539|https://www.ncbi.nlm.nih.gov/pubmed/21632903,15864539|21632903,,
3747,1525143,439177,Comparative Toxicogenomics Database (CTD),"(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R,5R,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",D006003,Glycogen,https://ctdbase.org/detail.go?type=chem&acc=D006003,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606.0,Homo sapiens (human),INS protein results in increased chemical synthesis of glycogen,,,PMID:11162573|PMID:1554362,https://www.ncbi.nlm.nih.gov/pubmed/11162573|https://www.ncbi.nlm.nih.gov/pubmed/1554362,11162573|1554362,,
3748,1525958,439224,Comparative Toxicogenomics Database (CTD),Carnosine,D002336,Carnosine,https://ctdbase.org/detail.go?type=chem&acc=D002336,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606.0,Homo sapiens (human),Carnosine inhibits the reaction [cupric chloride results in decreased activity of GSR protein],,,PMID:32745495,https://www.ncbi.nlm.nih.gov/pubmed/32745495,32745495,,
3749,1525959,439224,Comparative Toxicogenomics Database (CTD),Carnosine,D002336,Carnosine,https://ctdbase.org/detail.go?type=chem&acc=D002336,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,10116.0,Rattus norvegicus (Norway rat),Carnosine inhibits the reaction [sodium nitrite results in increased expression of HIF1A protein],,,PMID:28266762,https://www.ncbi.nlm.nih.gov/pubmed/28266762,28266762,,
3750,1525960,439224,Comparative Toxicogenomics Database (CTD),Carnosine,D002336,Carnosine,https://ctdbase.org/detail.go?type=chem&acc=D002336,3304,HSPA1B,https://ctdbase.org/detail.go?type=gene&acc=3304,,,3304.0,HSPA1B,10116.0,Rattus norvegicus (Norway rat),Carnosine results in increased expression of HSPA1B protein,,,PMID:16984587,https://www.ncbi.nlm.nih.gov/pubmed/16984587,16984587,,
3751,1525961,439224,Comparative Toxicogenomics Database (CTD),Carnosine,D002336,Carnosine,https://ctdbase.org/detail.go?type=chem&acc=D002336,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10090.0,Mus musculus (house mouse),Carnosine inhibits the reaction [cisplatin results in increased expression of ICAM1 mrna],,,PMID:29191451,https://www.ncbi.nlm.nih.gov/pubmed/29191451,29191451,,
3752,1525962,439224,Comparative Toxicogenomics Database (CTD),Carnosine,D002336,Carnosine,https://ctdbase.org/detail.go?type=chem&acc=D002336,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606.0,Homo sapiens (human),Carnosine inhibits the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased expression of PARP1 protein],,,PMID:23011206,https://www.ncbi.nlm.nih.gov/pubmed/23011206,23011206,,
3753,1526461,439224,Comparative Toxicogenomics Database (CTD),Carnosine,D002336,Carnosine,https://ctdbase.org/detail.go?type=chem&acc=D002336,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606.0,Homo sapiens (human),Carnosine inhibits the reaction [cupric chloride results in decreased activity of SOD1 protein],,,PMID:32745495,https://www.ncbi.nlm.nih.gov/pubmed/32745495,32745495,,
3754,1526462,439224,Comparative Toxicogenomics Database (CTD),Carnosine,D002336,Carnosine,https://ctdbase.org/detail.go?type=chem&acc=D002336,6667,SP1,https://ctdbase.org/detail.go?type=gene&acc=6667,,,6667.0,SP1,10090.0,Mus musculus (house mouse),Carnosine results in decreased expression of SP1 mRNA,,,PMID:30485136,https://www.ncbi.nlm.nih.gov/pubmed/30485136,30485136,,
3755,1526463,439224,Comparative Toxicogenomics Database (CTD),Carnosine,D002336,Carnosine,https://ctdbase.org/detail.go?type=chem&acc=D002336,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10090.0,Mus musculus (house mouse),Carnosine inhibits the reaction [norepinephrine results in increased phosphorylation of STAT3 protein],,,PMID:34609854,https://www.ncbi.nlm.nih.gov/pubmed/34609854,34609854,,
3756,1446524,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,2152,F3,https://ctdbase.org/detail.go?type=gene&acc=2152,,,2152.0,F3,9606.0,Homo sapiens (human),Mevalonic acid inhibits the reaction [simvastatin results in decreased expression of F3],,,PMID:12753293,https://www.ncbi.nlm.nih.gov/pubmed/12753293,12753293,,
3757,1446660,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10116.0,Rattus norvegicus (Norway rat),Mevalonic acid inhibits the reaction [simvastatin results in increased expression of HMGCR mrna]|mevalonic acid inhibits the reaction [atorvastatin results in increased activity of HMGCR protein]|mevalonic acid inhibits the reaction [simvastatin results in increased activity of HMGCR protein]|mevalonic acid inhibits the reaction [atorvastatin results in increased expression of HMGCR mrna],,,PMID:12056585,https://www.ncbi.nlm.nih.gov/pubmed/12056585,12056585,,
3758,1434214,439260,Toxin and Toxin Target Database (T3DB),Norepinephrine,T3D4154,Norepinephrine,http://www.t3db.ca/toxins/T3D4154,BE0003580,Nischarin,http://www.t3db.ca/biodb/bio_entities/BE0003580,Q9Y2I1,Nischarin,11188.0,NISCH,9606.0,Homo sapiens (human),,,,PMID:25041433|PMID:22419041|PMID:8632424,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041|https://www.ncbi.nlm.nih.gov/pubmed/8632424,25041433|22419041|8632424,,
3759,1434215,439260,Toxin and Toxin Target Database (T3DB),Norepinephrine,T3D4154,Norepinephrine,http://www.t3db.ca/toxins/T3D4154,BE0005578,Klotho,http://www.t3db.ca/biodb/bio_entities/BE0005578,Q9UEF7,Klotho,9365.0,KL,9606.0,Homo sapiens (human),,,,PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,25041433|22419041,,
3760,1434216,439260,Toxin and Toxin Target Database (T3DB),Norepinephrine,T3D4154,Norepinephrine,http://www.t3db.ca/toxins/T3D4154,BE0005579,NADPH oxidase 4,http://www.t3db.ca/biodb/bio_entities/BE0005579,Q9NPH5,NADPH oxidase 4,50507.0,NOX4,9606.0,Homo sapiens (human),,,,PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,25041433|22419041,,
3761,1434217,439260,Toxin and Toxin Target Database (T3DB),Norepinephrine,T3D4154,Norepinephrine,http://www.t3db.ca/toxins/T3D4154,BE0003645,Solute carrier family 22 member 8,http://www.t3db.ca/biodb/bio_entities/BE0003645,Q8TCC7,Solute carrier family 22 member 8,9376.0,SLC22A8,9606.0,Homo sapiens (human),,,,PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,25041433|22419041,,
3762,1434218,439260,Drug Gene Interaction database (DGIdb),Norepinephrine,,NOREPINEPHRINE,https://www.dgidb.org/drugs/rxcui:7512,,ADRB1,https://www.dgidb.org/genes/hgnc:285,,,153.0,ADRB1,9606.0,Homo sapiens (human),,,,,,,,
3763,1451391,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116.0,Rattus norvegicus (Norway rat),Norepinephrine results in increased expression of PPARG mRNA,,,PMID:19109942,https://www.ncbi.nlm.nih.gov/pubmed/19109942,19109942,,
3764,1451392,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10090.0,Mus musculus (house mouse),Norepinephrine results in increased expression of PPARGC1A mrna|[propranolol co-treated with prazosin] inhibits the reaction [norepinephrine results in increased expression of PPARGC1A mrna]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [norepinephrine results in increased expression of PPARGC1A mrna],,,PMID:16513826,https://www.ncbi.nlm.nih.gov/pubmed/16513826,16513826,,
3765,1451393,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10116.0,Rattus norvegicus (Norway rat),Norepinephrine inhibits the reaction [testosterone results in decreased expression of PPARGC1A mrna],,,PMID:16954335,https://www.ncbi.nlm.nih.gov/pubmed/16954335,16954335,,
3766,1451394,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,4659,PPP1R12A,https://ctdbase.org/detail.go?type=gene&acc=4659,,,4659.0,PPP1R12A,9606.0,Homo sapiens (human),CRT 0066101 inhibits the reaction [norepinephrine results in increased phosphorylation of PPP1R12A protein]|fasudil inhibits the reaction [norepinephrine results in increased phosphorylation of PPP1R12A protein]|norepinephrine results in increased phosphorylation of PPP1R12A protein|prkd1 protein affects the reaction [norepinephrine results in increased phosphorylation of PPP1R12A protein],,,PMID:37963515,https://www.ncbi.nlm.nih.gov/pubmed/37963515,37963515,,
3767,1451395,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,94274,PPP1R14A,https://ctdbase.org/detail.go?type=gene&acc=94274,,,94274.0,PPP1R14A,10116.0,Rattus norvegicus (Norway rat),Chelerythrine inhibits the reaction [norepinephrine results in increased phosphorylation of PPP1R14A protein]|norepinephrine results in increased phosphorylation of PPP1R14A protein,,,PMID:37963515,https://www.ncbi.nlm.nih.gov/pubmed/37963515,37963515,,
3768,1451396,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606.0,Homo sapiens (human),PRKCD protein affects the reaction [norepinephrine results in increased phosphorylation of SHC1 protein alternative form],,,PMID:19168439,https://www.ncbi.nlm.nih.gov/pubmed/19168439,19168439,,
3769,1434219,439262,Comparative Toxicogenomics Database (CTD),beta-Glucan,D047071,beta-Glucans,https://ctdbase.org/detail.go?type=chem&acc=D047071,958,CD40,https://ctdbase.org/detail.go?type=gene&acc=958,,,958.0,CD40,10090.0,Mus musculus (house mouse),Beta-glucans results in increased expression of CD40 protein,,,PMID:17572156,https://www.ncbi.nlm.nih.gov/pubmed/17572156,17572156,,
3770,1434220,439262,Comparative Toxicogenomics Database (CTD),beta-Glucan,D047071,beta-Glucans,https://ctdbase.org/detail.go?type=chem&acc=D047071,969,CD69,https://ctdbase.org/detail.go?type=gene&acc=969,,,969.0,CD69,10090.0,Mus musculus (house mouse),Beta-glucans results in increased expression of CD69 protein,,,PMID:17572156,https://www.ncbi.nlm.nih.gov/pubmed/17572156,17572156,,
3771,1434221,439262,Comparative Toxicogenomics Database (CTD),beta-Glucan,D047071,beta-Glucans,https://ctdbase.org/detail.go?type=chem&acc=D047071,25,ABL1,https://ctdbase.org/detail.go?type=gene&acc=25,,,25.0,ABL1,9606.0,Homo sapiens (human),Beta-glucans results in decreased expression of ABL1 mRNA,,,PMID:25970150,https://www.ncbi.nlm.nih.gov/pubmed/25970150,25970150,,
3772,1434222,439262,Comparative Toxicogenomics Database (CTD),beta-Glucan,D047071,beta-Glucans,https://ctdbase.org/detail.go?type=chem&acc=D047071,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,8128.0,Oreochromis niloticus (Nile tilapia),Beta-glucans inhibits the reaction [cupric oxide results in increased expression of APAF1 mrna],,,PMID:35182770,https://www.ncbi.nlm.nih.gov/pubmed/35182770,35182770,,
3773,1436142,439533,Comparative Toxicogenomics Database (CTD),Taxifolin,C003377,taxifolin,https://ctdbase.org/detail.go?type=chem&acc=C003377,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090.0,Mus musculus (house mouse),Taxifolin results in decreased expression of NFE2L2 protein|chlorpyrifos inhibits the reaction [taxifolin results in decreased expression of NFE2L2 protein],,,PMID:31152760,https://www.ncbi.nlm.nih.gov/pubmed/31152760,31152760,,
3774,1436143,439533,Comparative Toxicogenomics Database (CTD),Taxifolin,C003377,taxifolin,https://ctdbase.org/detail.go?type=chem&acc=C003377,6662,SOX9,https://ctdbase.org/detail.go?type=gene&acc=6662,,,6662.0,SOX9,10116.0,Rattus norvegicus (Norway rat),Taxifolin inhibits the reaction [dibutyl phthalate results in decreased expression of SOX9 mrna],,,PMID:32525071,https://www.ncbi.nlm.nih.gov/pubmed/32525071,32525071,,
3775,1436144,439533,Comparative Toxicogenomics Database (CTD),Taxifolin,C003377,taxifolin,https://ctdbase.org/detail.go?type=chem&acc=C003377,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein]]|taxifolin inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein]|taxifolin promotes the reaction [fluvastatin inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein]],,,PMID:35465754,https://www.ncbi.nlm.nih.gov/pubmed/35465754,35465754,,
3776,1436145,439533,Comparative Toxicogenomics Database (CTD),Taxifolin,C003377,taxifolin,https://ctdbase.org/detail.go?type=chem&acc=C003377,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10116.0,Rattus norvegicus (Norway rat),Taxifolin inhibits the reaction [rotenone results in increased expression of NFKB1 mrna],,,PMID:35187747,https://www.ncbi.nlm.nih.gov/pubmed/35187747,35187747,,
3777,1436146,439533,Comparative Toxicogenomics Database (CTD),Taxifolin,C003377,taxifolin,https://ctdbase.org/detail.go?type=chem&acc=C003377,114548,NLRP3,https://ctdbase.org/detail.go?type=gene&acc=114548,,,114548.0,NLRP3,10116.0,Rattus norvegicus (Norway rat),Taxifolin promotes the reaction [fluvastatin inhibits the reaction [bisphenol A results in increased expression of NLRP3 protein]]|fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in increased expression of NLRP3 protein]]|taxifolin inhibits the reaction [bisphenol A results in increased expression of NLRP3 protein],,,PMID:35465754,https://www.ncbi.nlm.nih.gov/pubmed/35465754,35465754,,
3778,1436147,439533,Comparative Toxicogenomics Database (CTD),Taxifolin,C003377,taxifolin,https://ctdbase.org/detail.go?type=chem&acc=C003377,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606.0,Homo sapiens (human),Taxifolin results in increased activity of NQO1 protein|taxifolin results in increased expression of NQO1 mRNA,,,PMID:17541156,https://www.ncbi.nlm.nih.gov/pubmed/17541156,17541156,,
3779,1436661,439763,Comparative Toxicogenomics Database (CTD),Taurolithocholic acid,D013658,Taurolithocholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D013658,1131,CHRM3,https://ctdbase.org/detail.go?type=gene&acc=1131,,,1131.0,CHRM3,9606.0,Homo sapiens (human),[taurolithocholic acid binds to and affects the activity of CHRM3 protein] which results in increased abundance of inositol phosphates|taurolithocholic acid binds to and affects the activity of CHRM3 protein,,,PMID:12379313,https://www.ncbi.nlm.nih.gov/pubmed/12379313,12379313,,
3780,1436662,439763,Comparative Toxicogenomics Database (CTD),Taurolithocholic acid,D013658,Taurolithocholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D013658,1131,CHRM3,https://ctdbase.org/detail.go?type=gene&acc=1131,,,1131.0,CHRM3,9606.0,Homo sapiens (human),Taurolithocholic acid binds to CHRM3 protein,,,PMID:12464352,https://www.ncbi.nlm.nih.gov/pubmed/12464352,12464352,,
3781,1487063,440005,Therapeutic Target Database (TTD),Nitroarginine,D0GC1Y,Nitroarginine,https://idrblab.net/ttd/data/drug/details/D0GC1Y,T06046,Nitric-oxide synthase endothelial (NOS3),https://idrblab.net/ttd/data/target/details/T06046,P29474,"Nitric oxide synthase, endothelial",4846.0,NOS3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3782,1487064,440121,Therapeutic Target Database (TTD),N-Trimethyllysine,D01UJL,N-Trimethyllysine,https://idrblab.net/ttd/data/drug/details/D01UJL,T39610,Calmodulin (CALM),https://idrblab.net/ttd/data/target/details/T39610,P0DP23,Calmodulin-1,808.0,CALM3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3783,1487517,440210,DrugBank,Bis(adenosine)-5'-pentaphosphate,DB01717,Bis(Adenosine)-5'-Pentaphosphate,https://www.drugbank.ca/drugs/DB01717,BE0001254,Adenylate kinase,https://www.drugbank.ca/bio_entities/BE0001254,P27142,Adenylate kinase,69835471.0,,1422.0,Geobacillus stearothermophilus,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
3784,1487518,440210,DrugBank,Bis(adenosine)-5'-pentaphosphate,DB01717,Bis(Adenosine)-5'-Pentaphosphate,https://www.drugbank.ca/drugs/DB01717,BE0001255,Adenylate kinase,https://www.drugbank.ca/bio_entities/BE0001255,P84139,Adenylate kinase,,,1459.0,Sporosarcina globispora,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
3785,1487519,441071,Drug Gene Interaction database (DGIdb),Strychnine,,6-HYDROXYMELATONIN,https://www.dgidb.org/drugs/iuphar.ligand:1347,,APEX1,https://www.dgidb.org/genes/hgnc:587,,,328.0,APEX1,9606.0,Homo sapiens (human),,,,,,,,
3786,1487520,441071,Drug Gene Interaction database (DGIdb),Strychnine,,6-HYDROXYMELATONIN,https://www.dgidb.org/drugs/iuphar.ligand:1347,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
3787,1487521,441071,Drug Gene Interaction database (DGIdb),Strychnine,,6-HYDROXYMELATONIN,https://www.dgidb.org/drugs/iuphar.ligand:1347,,RACGAP1,https://www.dgidb.org/genes/hgnc:9804,,,29127.0,RACGAP1,9606.0,Homo sapiens (human),,,,,,,,
3788,1487522,441145,Comparative Toxicogenomics Database (CTD),Monensin,D008985,Monensin,https://ctdbase.org/detail.go?type=chem&acc=D008985,7226,TRPM2,https://ctdbase.org/detail.go?type=gene&acc=7226,,,7226.0,TRPM2,9606.0,Homo sapiens (human),Monensin results in decreased expression of TRPM2 protein alternative form|monensin results in increased expression of TRPM2 protein alternative form|lithium inhibits the reaction [monensin results in increased expression of TRPM2 protein alternative form],,,PMID:20799912,https://www.ncbi.nlm.nih.gov/pubmed/20799912,20799912,,
3789,1487523,441145,Comparative Toxicogenomics Database (CTD),Monensin,D008985,Monensin,https://ctdbase.org/detail.go?type=chem&acc=D008985,6935,ZEB1,https://ctdbase.org/detail.go?type=gene&acc=6935,,,6935.0,ZEB1,9606.0,Homo sapiens (human),ZEB1 protein results in increased susceptibility to monensin,,,PMID:30718715,https://www.ncbi.nlm.nih.gov/pubmed/30718715,30718715,,
3790,1492250,441243,Comparative Toxicogenomics Database (CTD),Saquinavir,D019258,Saquinavir,https://ctdbase.org/detail.go?type=chem&acc=D019258,56246,MRAP,https://ctdbase.org/detail.go?type=gene&acc=56246,,,56246.0,MRAP,10090.0,Mus musculus (house mouse),[zidovudine co-treated with lamivudine co-treated with saquinavir] results in decreased expression of MRAP mRNA,,,PMID:16931933,https://www.ncbi.nlm.nih.gov/pubmed/16931933,16931933,,
3791,1492251,441243,Comparative Toxicogenomics Database (CTD),Saquinavir,D019258,Saquinavir,https://ctdbase.org/detail.go?type=chem&acc=D019258,4654,MYOD1,https://ctdbase.org/detail.go?type=gene&acc=4654,,,4654.0,MYOD1,10090.0,Mus musculus (house mouse),[zidovudine co-treated with lamivudine co-treated with saquinavir] results in increased expression of MYOD1 mRNA,,,PMID:16931933,https://www.ncbi.nlm.nih.gov/pubmed/16931933,16931933,,
3792,1492252,441243,Comparative Toxicogenomics Database (CTD),Saquinavir,D019258,Saquinavir,https://ctdbase.org/detail.go?type=chem&acc=D019258,266812,NAP1L5,https://ctdbase.org/detail.go?type=gene&acc=266812,,,266812.0,NAP1L5,10090.0,Mus musculus (house mouse),[zidovudine co-treated with lamivudine co-treated with saquinavir] results in increased expression of NAP1L5 mRNA,,,PMID:16931933,https://www.ncbi.nlm.nih.gov/pubmed/16931933,16931933,,
3793,1492253,441243,Comparative Toxicogenomics Database (CTD),Saquinavir,D019258,Saquinavir,https://ctdbase.org/detail.go?type=chem&acc=D019258,25819,NOCT,https://ctdbase.org/detail.go?type=gene&acc=25819,,,25819.0,NOCT,10090.0,Mus musculus (house mouse),[zidovudine co-treated with lamivudine co-treated with saquinavir] results in decreased expression of NOCT mRNA,,,PMID:16931933,https://www.ncbi.nlm.nih.gov/pubmed/16931933,16931933,,
3794,1520754,441300,Drug Gene Interaction database (DGIdb),Abacavir,,ABACAVIR,https://www.dgidb.org/drugs/rxcui:190521,,LTA,https://www.dgidb.org/genes/hgnc:6709,,,4049.0,LTA,9606.0,Homo sapiens (human),,,,,,,,
3795,1520755,441313,ChEMBL,Perindopril Erbumine,CHEMBL1200343,PERINDOPRIL ERBUMINE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200343/,CHEMBL1808,Angiotensin-converting enzyme,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1808/,P12821,Angiotensin-converting enzyme ,1636.0,ACE,9606.0,Homo sapiens (human),Angiotensin-converting enzyme inhibitor,,,,,,,
3796,1520756,441325,Drug Gene Interaction database (DGIdb),Amiodarone Hydrochloride,,AMIODARONE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203114,,CALCA,https://www.dgidb.org/genes/hgnc:1437,,,796.0,CALCA,9606.0,Homo sapiens (human),,,,,,,,
3797,1520757,441344,Drug Gene Interaction database (DGIdb),Dicyclomine Hydrochloride,,DICYCLOMINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:152021,,CYP2D6,https://www.dgidb.org/genes/hgnc:2625,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),,,,,,,,
3798,1520758,441344,Drug Gene Interaction database (DGIdb),Dicyclomine Hydrochloride,,DICYCLOMINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:152021,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
3799,1520759,441345,Drug Gene Interaction database (DGIdb),Flavoxate Hydrochloride,,FLAVOXATE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:142437,,PDE8B,https://www.dgidb.org/genes/hgnc:8794,,,8622.0,PDE8B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3800,1520760,441347,Drug Gene Interaction database (DGIdb),Reglan,,METOCLOPRAMIDE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:267036,,CYP1A2,https://www.dgidb.org/genes/hgnc:2596,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),,,,,,,,
3801,1520761,441350,Drug Gene Interaction database (DGIdb),Metyrosine,,METYROSINE,https://www.dgidb.org/drugs/rxcui:266604,,TH,https://www.dgidb.org/genes/hgnc:11782,,,7054.0,TH,9606.0,Homo sapiens (human),,,,,,,,
3802,1490548,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,10116.0,Rattus norvegicus (Norway rat),Erythromycin estolate results in increased expression of GPX2 mRNA,,,PMID:24412560,https://www.ncbi.nlm.nih.gov/pubmed/24412560,24412560,,
3803,1490549,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,2947,GSTM3,https://ctdbase.org/detail.go?type=gene&acc=2947,,,2947.0,GSTM3,10116.0,Rattus norvegicus (Norway rat),Erythromycin estolate results in decreased expression of GSTM3 mRNA,,,PMID:17522070,https://www.ncbi.nlm.nih.gov/pubmed/17522070,17522070,,
3804,1490550,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,11112,HIBADH,https://ctdbase.org/detail.go?type=gene&acc=11112,,,11112.0,HIBADH,10116.0,Rattus norvegicus (Norway rat),Erythromycin estolate results in decreased expression of HIBADH mRNA,,,PMID:17522070,https://www.ncbi.nlm.nih.gov/pubmed/17522070,17522070,,
3805,1490551,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,3161,HMMR,https://ctdbase.org/detail.go?type=gene&acc=3161,,,3161.0,HMMR,10116.0,Rattus norvegicus (Norway rat),Erythromycin estolate results in decreased expression of HMMR mrna|erythromycin estolate results in increased expression of HMMR mRNA,,,PMID:24412560,https://www.ncbi.nlm.nih.gov/pubmed/24412560,24412560,,
3806,1490552,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,3482,IGF2R,https://ctdbase.org/detail.go?type=gene&acc=3482,,,3482.0,IGF2R,10116.0,Rattus norvegicus (Norway rat),Erythromycin estolate results in increased expression of IGF2R mRNA,,,PMID:24412560,https://www.ncbi.nlm.nih.gov/pubmed/24412560,24412560,,
3807,1490553,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,3484,IGFBP1,https://ctdbase.org/detail.go?type=gene&acc=3484,,,3484.0,IGFBP1,10116.0,Rattus norvegicus (Norway rat),Erythromycin estolate results in increased expression of IGFBP1 mRNA,,,PMID:17522070,https://www.ncbi.nlm.nih.gov/pubmed/17522070,17522070,,
3808,1490554,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,3485,IGFBP2,https://ctdbase.org/detail.go?type=gene&acc=3485,,,3485.0,IGFBP2,10116.0,Rattus norvegicus (Norway rat),Erythromycin estolate results in increased expression of IGFBP2 mRNA,,,PMID:24412560,https://www.ncbi.nlm.nih.gov/pubmed/24412560,24412560,,
3809,1491647,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10116.0,Rattus norvegicus (Norway rat),Erythromycin estolate results in increased expression of TIMP1 mRNA,,,PMID:17522070,https://www.ncbi.nlm.nih.gov/pubmed/17522070,17522070,,
3810,1491648,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,23023,TMCC1,https://ctdbase.org/detail.go?type=gene&acc=23023,,,23023.0,TMCC1,10116.0,Rattus norvegicus (Norway rat),Erythromycin estolate results in decreased expression of TMCC1 mRNA,,,PMID:24412560,https://www.ncbi.nlm.nih.gov/pubmed/24412560,24412560,,
3811,1491649,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,7128,TNFAIP3,https://ctdbase.org/detail.go?type=gene&acc=7128,,,7128.0,TNFAIP3,10116.0,Rattus norvegicus (Norway rat),Erythromycin estolate results in decreased expression of TNFAIP3 mRNA,,,PMID:24412560,https://www.ncbi.nlm.nih.gov/pubmed/24412560,24412560,,
3812,1491650,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,7132,TNFRSF1A,https://ctdbase.org/detail.go?type=gene&acc=7132,,,7132.0,TNFRSF1A,10116.0,Rattus norvegicus (Norway rat),Erythromycin estolate results in increased expression of TNFRSF1A mRNA,,,PMID:17522070,https://www.ncbi.nlm.nih.gov/pubmed/17522070,17522070,,
3813,1491651,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116.0,Rattus norvegicus (Norway rat),Erythromycin estolate results in decreased expression of TP53 mRNA,,,PMID:17522070,https://www.ncbi.nlm.nih.gov/pubmed/17522070,17522070,,
3814,1491652,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,1831,TSC22D3,https://ctdbase.org/detail.go?type=gene&acc=1831,,,1831.0,TSC22D3,10116.0,Rattus norvegicus (Norway rat),Erythromycin estolate results in decreased expression of TSC22D3 mRNA,,,PMID:24412560,https://www.ncbi.nlm.nih.gov/pubmed/24412560,24412560,,
3815,1527879,441401,Drug Gene Interaction database (DGIdb),Linezolid,,LINEZOLID,https://www.dgidb.org/drugs/rxcui:190376,,RPSA,https://www.dgidb.org/genes/hgnc:6502,,,3921.0,RPSA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3816,1494272,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,2752,GLUL,https://ctdbase.org/detail.go?type=gene&acc=2752,,,2752.0,GLUL,10116.0,Rattus norvegicus (Norway rat),Propiverine binds to GLUL protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
3817,1494273,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,10020,GNE,https://ctdbase.org/detail.go?type=gene&acc=10020,,,10020.0,GNE,10116.0,Rattus norvegicus (Norway rat),Propiverine binds to GNE protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
3818,1494274,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,2806,GOT2,https://ctdbase.org/detail.go?type=gene&acc=2806,,,2806.0,GOT2,10116.0,Rattus norvegicus (Norway rat),Propiverine binds to GOT2 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
3819,1494275,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,221357,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357.0,GSTA5,10116.0,Rattus norvegicus (Norway rat),Propiverine binds to GSTA5 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
3820,1494276,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,10116.0,Rattus norvegicus (Norway rat),Propiverine binds to GSTP1 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
3821,1494277,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,23498,HAAO,https://ctdbase.org/detail.go?type=gene&acc=23498,,,23498.0,HAAO,10116.0,Rattus norvegicus (Norway rat),Propiverine binds to HAAO protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
3822,1494278,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,51179,HAO2,https://ctdbase.org/detail.go?type=gene&acc=51179,,,51179.0,HAO2,10116.0,Rattus norvegicus (Norway rat),Propiverine binds to HAO2 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
3823,1494279,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,3183,HNRNPC,https://ctdbase.org/detail.go?type=gene&acc=3183,,,3183.0,HNRNPC,10116.0,Rattus norvegicus (Norway rat),Propiverine binds to HNRNPC protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
3824,1451397,441542,Comparative Toxicogenomics Database (CTD),Phalloidin,D010590,Phalloidine,https://ctdbase.org/detail.go?type=chem&acc=D010590,17748,MT1,https://ctdbase.org/detail.go?type=gene&acc=17748,,,17748.0,Mt1,10090.0,Mus musculus (house mouse),Phalloidine results in increased expression of MT1 mrna|[nfe2l2 gene mutant form results in increased susceptibility to phalloidine] which results in decreased expression of MT1 mrna|[keap1 gene mutant form results in decreased susceptibility to phalloidine] which results in increased expression of MT1 mrna|oleanolic acid promotes the reaction [phalloidine results in increased expression of MT1 mrna],,,PMID:25280775,https://www.ncbi.nlm.nih.gov/pubmed/25280775,25280775,,
3825,1451398,441542,Comparative Toxicogenomics Database (CTD),Phalloidin,D010590,Phalloidine,https://ctdbase.org/detail.go?type=chem&acc=D010590,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090.0,Mus musculus (house mouse),[NFE2L2 gene mutant form results in increased susceptibility to phalloidine] which results in increased expression of GADD45A mrna|nfe2l2 gene mutant form results in increased susceptibility to phalloidine|nfe2l2 gene mutant form promotes the reaction [phalloidine results in increased expression of GADD45A mrna]|nfe2l2 gene mutant form promotes the reaction [phalloidine results in increased expression of CXCL1 mrna]|[nfe2l2 gene mutant form results in increased susceptibility to phalloidine] which results in increased expression of CXCL1 mrna|nfe2l2 gene mutant form promotes the reaction [phalloidine results in increased expression of CXCL2 mrna]|[nfe2l2 gene mutant form results in increased susceptibility to phalloidine] which results in increased expression of SLCO1B2 mrna|nfe2l2 gene mutant form promotes the reaction [phalloidine results in increased expression of DDIT3 mrna]|[nfe2l2 gene mutant form results in increased susceptibility to phalloidine] which results in increased expression of HMOX1 mrna|oleanolic acid promotes the reaction [phalloidine results in increased expression of NFE2L2 mrna]|nfe2l2 gene mutant form promotes the reaction [phalloidine results in increased expression of HMOX1 mrna]|phalloidine promotes the reaction [KEAP1 gene mutant form results in increased expression of NFE2L2 mrna]|phalloidine promotes the reaction [oleanolic acid results in increased expression of NFE2L2 mrna]|phalloidine results in increased expression of NFE2L2 mrna|[nfe2l2 gene mutant form results in increased susceptibility to phalloidine] which results in increased expression of CXCL2 mrna|[nfe2l2 gene mutant form results in increased susceptibility to phalloidine] which results in decreased expression of MT1 mrna|[nfe2l2 gene mutant form results in increased susceptibility to phalloidine] which results in increased expression of DDIT3 mRNA,,,PMID:25280775,https://www.ncbi.nlm.nih.gov/pubmed/25280775,25280775,,
3826,1451399,441542,Comparative Toxicogenomics Database (CTD),Phalloidin,D010590,Phalloidine,https://ctdbase.org/detail.go?type=chem&acc=D010590,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090.0,Mus musculus (house mouse),Phalloidine promotes the reaction [oleanolic acid results in increased expression of NQO1 mrna]|phalloidine promotes the reaction [KEAP1 gene mutant form results in increased expression of NQO1 mrna],,,PMID:25280775,https://www.ncbi.nlm.nih.gov/pubmed/25280775,25280775,,
3827,1451400,441542,Comparative Toxicogenomics Database (CTD),Phalloidin,D010590,Phalloidine,https://ctdbase.org/detail.go?type=chem&acc=D010590,10599,SLCO1B1,https://ctdbase.org/detail.go?type=gene&acc=10599,,,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Bile acids and salts inhibits the reaction [SLCO1B1 protein results in increased uptake of phalloidine],,,PMID:19464309,https://www.ncbi.nlm.nih.gov/pubmed/19464309,19464309,,
3828,1451401,441542,Comparative Toxicogenomics Database (CTD),Phalloidin,D010590,Phalloidine,https://ctdbase.org/detail.go?type=chem&acc=D010590,10599,SLCO1B1,https://ctdbase.org/detail.go?type=gene&acc=10599,,,10599.0,SLCO1B1,9606.0,Homo sapiens (human),SLCO1B1 protein results in increased uptake of phalloidine,,,PMID:19464309|PMID:25280775,https://www.ncbi.nlm.nih.gov/pubmed/19464309|https://www.ncbi.nlm.nih.gov/pubmed/25280775,19464309|25280775,,
3829,1438385,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),Cyanidin-3-O-beta-glucopyranoside inhibits the reaction [oxygen deficiency results in increased expression of HIF1A protein]|cyanidin-3-O-beta-glucopyranoside results in decreased expression of HIF1A protein,,,PMID:24518827,https://www.ncbi.nlm.nih.gov/pubmed/24518827,24518827,,
3830,1438386,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Cyanidin-3-O-beta-glucopyranoside inhibits the reaction [AGT protein results in decreased expression of HMOX1 protein],,,PMID:27983965,https://www.ncbi.nlm.nih.gov/pubmed/27983965,27983965,,
3831,1438387,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Cyanidin-3-O-beta-glucopyranoside results in increased expression of HMOX1 mRNA,,,PMID:24518827|PMID:26422990|PMID:27793764,https://www.ncbi.nlm.nih.gov/pubmed/24518827|https://www.ncbi.nlm.nih.gov/pubmed/26422990|https://www.ncbi.nlm.nih.gov/pubmed/27793764,24518827|26422990|27793764,,
3832,1438388,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of HMOX1 mRNA,,,PMID:27818126,https://www.ncbi.nlm.nih.gov/pubmed/27818126,27818126,,
3833,1438389,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,111785,HSD3B,https://ctdbase.org/detail.go?type=gene&acc=111785,,,111785.0,Hsd3b,10090.0,Mus musculus (house mouse),Cyanidin-3-O-beta-glucopyranoside inhibits the reaction [cadmium chloride results in decreased expression of HSD3B protein],,,PMID:31014900,https://www.ncbi.nlm.nih.gov/pubmed/31014900,31014900,,
3834,1438390,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606.0,Homo sapiens (human),[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of GCLC mrna|[il1a protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of HMOX1 mrna|mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of PPARG protein]|[il1a protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased activity of NFE2L2 protein|[il1a protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of PPARG protein|cyanidin-3-O-beta-glucopyranoside promotes the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of GCLM mrna],,,PMID:27818126,https://www.ncbi.nlm.nih.gov/pubmed/27818126,27818126,,
3835,1438391,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9606.0,Homo sapiens (human),[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of GCLC mrna|[il1a protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of HMOX1 mrna|mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of PPARG protein]|[il1a protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased activity of NFE2L2 protein|[il1a protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of PPARG protein|cyanidin-3-O-beta-glucopyranoside promotes the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of GCLM mrna],,,PMID:27818126,https://www.ncbi.nlm.nih.gov/pubmed/27818126,27818126,,
3836,1521392,441737,Comparative Toxicogenomics Database (CTD),Hypaconitine,C058309,hypaconitine,https://ctdbase.org/detail.go?type=chem&acc=C058309,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606.0,Homo sapiens (human),[verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of hypaconitine,,,PMID:23200901,https://www.ncbi.nlm.nih.gov/pubmed/23200901,23200901,,
3837,1521393,441737,Comparative Toxicogenomics Database (CTD),Hypaconitine,C058309,hypaconitine,https://ctdbase.org/detail.go?type=chem&acc=C058309,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10090.0,Mus musculus (house mouse),ABCC2 protein affects the susceptibility to hypaconitine,,,PMID:33171190,https://www.ncbi.nlm.nih.gov/pubmed/33171190,33171190,,
3838,1521394,441737,Comparative Toxicogenomics Database (CTD),Hypaconitine,C058309,hypaconitine,https://ctdbase.org/detail.go?type=chem&acc=C058309,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9615.0,Canis lupus familiaris (dog),"[3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester results in decreased activity of ABCG2 protein] which results in decreased transport of hypaconitine|abcg2 protein results in increased transport of hypaconitine",,,PMID:23200901,https://www.ncbi.nlm.nih.gov/pubmed/23200901,23200901,,
3839,1527880,441853,Comparative Toxicogenomics Database (CTD),Cymarin,D003529,Cymarine,https://ctdbase.org/detail.go?type=chem&acc=D003529,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Cymarine inhibits the reaction [ABCB1 protein results in increased transport of quinidinium],,,PMID:23104431,https://www.ncbi.nlm.nih.gov/pubmed/23104431,23104431,,
3840,1527881,442009,Comparative Toxicogenomics Database (CTD),Carnosol,C068623,carnosol,https://ctdbase.org/detail.go?type=chem&acc=C068623,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606.0,Homo sapiens (human),Carnosol inhibits the reaction [tetrachlorodibenzodioxin results in increased activity of AHR protein],,,PMID:14646185,https://www.ncbi.nlm.nih.gov/pubmed/14646185,14646185,,
3841,1527882,442009,Comparative Toxicogenomics Database (CTD),Carnosol,C068623,carnosol,https://ctdbase.org/detail.go?type=chem&acc=C068623,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Carnosol inhibits the reaction [palmitic acid results in increased expression of BAX protein]|prdx3 protein promotes the reaction [carnosol inhibits the reaction [palmitic acid results in increased expression of BAX protein]]|carnosol inhibits the reaction [dietary fats results in increased expression of BAX protein],,,PMID:34678374,https://www.ncbi.nlm.nih.gov/pubmed/34678374,34678374,,
3842,1527883,442009,Comparative Toxicogenomics Database (CTD),Carnosol,C068623,carnosol,https://ctdbase.org/detail.go?type=chem&acc=C068623,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090.0,Mus musculus (house mouse),PRDX3 protein promotes the reaction [carnosol inhibits the reaction [palmitic acid results in decreased expression of BCL2 protein]]|carnosol inhibits the reaction [palmitic acid results in decreased expression of BCL2 protein]|carnosol inhibits the reaction [dietary fats results in decreased expression of BCL2 protein],,,PMID:34678374,https://www.ncbi.nlm.nih.gov/pubmed/34678374,34678374,,
3843,1527884,442009,Comparative Toxicogenomics Database (CTD),Carnosol,C068623,carnosol,https://ctdbase.org/detail.go?type=chem&acc=C068623,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),Carnosol inhibits the reaction [dietary fats results in increased expression of CASP3 protein modified form],,,PMID:34678374,https://www.ncbi.nlm.nih.gov/pubmed/34678374,34678374,,
3844,1528531,442009,Comparative Toxicogenomics Database (CTD),Carnosol,C068623,carnosol,https://ctdbase.org/detail.go?type=chem&acc=C068623,7299,TYR,https://ctdbase.org/detail.go?type=gene&acc=7299,,,7299.0,TYR,10090.0,Mus musculus (house mouse),Carnosol results in decreased expression of TYR mrna|carnosol results in decreased expression of TYR protein,,,PMID:21071833,https://www.ncbi.nlm.nih.gov/pubmed/21071833,21071833,,
3845,1495938,442021,Toxin and Toxin Target Database (T3DB),Brucine,T3D3075,Brucine,http://www.t3db.ca/toxins/T3D3075,BE0000745,Glycine receptor subunit alpha-2,http://www.t3db.ca/biodb/bio_entities/BE0000745,P23416,Glycine receptor subunit alpha-2,2742.0,GLRA2,9606.0,Homo sapiens (human),"Brucine acts as an antagonist at the inhibitory or strychnine-sensitive glycine receptor, a ligand-gated chloride channel in the spinal cord and the brain. (L1230)",,,,,,,
3846,1495939,442021,Toxin and Toxin Target Database (T3DB),Brucine,T3D3075,Brucine,http://www.t3db.ca/toxins/T3D3075,BE0000414,Glycine receptor subunit alpha-3,http://www.t3db.ca/biodb/bio_entities/BE0000414,O75311,Glycine receptor subunit alpha-3,8001.0,GLRA3,9606.0,Homo sapiens (human),"Brucine acts as an antagonist at the inhibitory or strychnine-sensitive glycine receptor, a ligand-gated chloride channel in the spinal cord and the brain. (L1230)",,,,,,,
3847,1495940,442021,Toxin and Toxin Target Database (T3DB),Brucine,T3D3075,Brucine,http://www.t3db.ca/toxins/T3D3075,BE0000055,Glycine receptor subunit beta,http://www.t3db.ca/biodb/bio_entities/BE0000055,P48167,Glycine receptor subunit beta,2743.0,GLRB,9606.0,Homo sapiens (human),"Brucine acts as an antagonist at the inhibitory or strychnine-sensitive glycine receptor, a ligand-gated chloride channel in the spinal cord and the brain. (L1230)",,,,,,,
3848,1528532,442153,Therapeutic Target Database (TTD),Abyssinone V,D0L3IQ,ABYSSINONE V,https://idrblab.net/ttd/data/drug/details/D0L3IQ,T31479,Phospholipase A2 (PLA2G1B),https://idrblab.net/ttd/data/target/details/T31479,P04054,Phospholipase A2,5319.0,PLA2G1B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
3849,1481534,442424,Comparative Toxicogenomics Database (CTD),Genipin,C007834,genipin,https://ctdbase.org/detail.go?type=chem&acc=C007834,929,CD14,https://ctdbase.org/detail.go?type=gene&acc=929,,,929.0,CD14,10090.0,Mus musculus (house mouse),Genipin inhibits the reaction [lipopolysaccharides results in increased expression of CD14 mrna],,,PMID:22687549,https://www.ncbi.nlm.nih.gov/pubmed/22687549,22687549,,
3850,1481535,442424,Comparative Toxicogenomics Database (CTD),Genipin,C007834,genipin,https://ctdbase.org/detail.go?type=chem&acc=C007834,958,CD40,https://ctdbase.org/detail.go?type=gene&acc=958,,,958.0,CD40,10090.0,Mus musculus (house mouse),Genipin inhibits the reaction [lipopolysaccharides results in increased expression of CD40 mrna],,,PMID:22687549,https://www.ncbi.nlm.nih.gov/pubmed/22687549,22687549,,
3851,1481536,442424,Comparative Toxicogenomics Database (CTD),Genipin,C007834,genipin,https://ctdbase.org/detail.go?type=chem&acc=C007834,1052,CEBPD,https://ctdbase.org/detail.go?type=gene&acc=1052,,,1052.0,CEBPD,10090.0,Mus musculus (house mouse),Genipin inhibits the reaction [lipopolysaccharides results in increased expression of CEBPD mrna],,,PMID:22687549,https://www.ncbi.nlm.nih.gov/pubmed/22687549,22687549,,
3852,1481537,442424,Comparative Toxicogenomics Database (CTD),Genipin,C007834,genipin,https://ctdbase.org/detail.go?type=chem&acc=C007834,1440,CSF3,https://ctdbase.org/detail.go?type=gene&acc=1440,,,1440.0,CSF3,10090.0,Mus musculus (house mouse),Genipin inhibits the reaction [lipopolysaccharides results in increased expression of CSF3 mrna],,,PMID:22687549,https://www.ncbi.nlm.nih.gov/pubmed/22687549,22687549,,
3853,1481538,442424,Comparative Toxicogenomics Database (CTD),Genipin,C007834,genipin,https://ctdbase.org/detail.go?type=chem&acc=C007834,3627,CXCL10,https://ctdbase.org/detail.go?type=gene&acc=3627,,,3627.0,CXCL10,10090.0,Mus musculus (house mouse),Genipin inhibits the reaction [lipopolysaccharides results in increased expression of CXCL10 mrna],,,PMID:22687549,https://www.ncbi.nlm.nih.gov/pubmed/22687549,22687549,,
3854,1481539,442424,Comparative Toxicogenomics Database (CTD),Genipin,C007834,genipin,https://ctdbase.org/detail.go?type=chem&acc=C007834,6374,CXCL5,https://ctdbase.org/detail.go?type=gene&acc=6374,,,6374.0,CXCL5,10090.0,Mus musculus (house mouse),Genipin inhibits the reaction [lipopolysaccharides results in increased expression of CXCL5 mrna],,,PMID:22687549,https://www.ncbi.nlm.nih.gov/pubmed/22687549,22687549,,
3855,1528533,442583,Comparative Toxicogenomics Database (CTD),"5,6,7-Trimethoxyflavone",C107364,"5,6,7-trimethoxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C107364,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10090.0,Mus musculus (house mouse),"5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased phosphorylation of and results in increased degradation of NFKBIA protein]",,,PMID:24161485,https://www.ncbi.nlm.nih.gov/pubmed/24161485,24161485,,
3856,1528534,442583,Comparative Toxicogenomics Database (CTD),"5,6,7-Trimethoxyflavone",C107364,"5,6,7-trimethoxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C107364,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,10090.0,Mus musculus (house mouse),"5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased phosphorylation of STAT1 protein]|5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 affects the localization of STAT1 protein]",,,PMID:24161485,https://www.ncbi.nlm.nih.gov/pubmed/24161485,24161485,,
3857,1528535,442583,Comparative Toxicogenomics Database (CTD),"5,6,7-Trimethoxyflavone",C107364,"5,6,7-trimethoxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C107364,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10090.0,Mus musculus (house mouse),"5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased phosphorylation of STAT3 protein]|5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 affects the localization of STAT3 protein]",,,PMID:24161485,https://www.ncbi.nlm.nih.gov/pubmed/24161485,24161485,,
3858,1438865,442971,Comparative Toxicogenomics Database (CTD),alpha-Chaconine,C011860,alpha-chaconine,https://ctdbase.org/detail.go?type=chem&acc=C011860,6885,MAP3K7,https://ctdbase.org/detail.go?type=gene&acc=6885,,,6885.0,MAP3K7,10090.0,Mus musculus (house mouse),"Alpha-chaconine inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased phosphorylation of MAP3K7 protein]",,,PMID:25913072,https://www.ncbi.nlm.nih.gov/pubmed/25913072,25913072,,
3859,1496729,443278,Comparative Toxicogenomics Database (CTD),Pifithrin-Beta,C558699,pifithrin-beta,https://ctdbase.org/detail.go?type=chem&acc=C558699,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059.0,Trp53,9606.0,Homo sapiens (human),5'-fluoro-5'-deoxyadenosine inhibits the reaction [pifithrin-beta results in decreased expression of TRP53 protein]|pifithrin-beta results in decreased expression of TRP53 protein|pifithrin-beta inhibits the reaction [5'-fluoro-5'-deoxyadenosine results in increased expression of TRP53 protein],,,PMID:35866996,https://www.ncbi.nlm.nih.gov/pubmed/35866996,35866996,,
3860,1496730,443291,Therapeutic Target Database (TTD),cyclo[D-Asp-Pro-D-Gly(thien-2-yl)-Leu-D-Trp],D07DGM,BQ-518,https://idrblab.net/ttd/data/drug/details/D07DGM,T23499,Endothelin A receptor (EDNRA),https://idrblab.net/ttd/data/target/details/T23499,P25101,Endothelin-1 receptor,1909.0,EDNRA,9606.0,Homo sapiens (human),Modulator,,,,,,,
3861,1356108,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5336,PLCG2,https://ctdbase.org/detail.go?type=gene&acc=5336,,,5336.0,PLCG2,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PLCG2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3862,1356109,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5336,PLCG2,https://ctdbase.org/detail.go?type=gene&acc=5336,,,5336.0,PLCG2,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of PLCG2 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
3863,1440177,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10142,AKAP9,https://ctdbase.org/detail.go?type=gene&acc=10142,,,10142.0,AKAP9,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of AKAP9 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3864,1440178,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10142,AKAP9,https://ctdbase.org/detail.go?type=gene&acc=10142,,,10142.0,AKAP9,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of AKAP9 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
3865,1440179,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10142,AKAP9,https://ctdbase.org/detail.go?type=gene&acc=10142,,,10142.0,AKAP9,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of AKAP9 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
3866,1440180,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,11648,AKP3,https://ctdbase.org/detail.go?type=gene&acc=11648,,,11648.0,Akp3,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of AKP3 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3867,1440181,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,11648,AKP3,https://ctdbase.org/detail.go?type=gene&acc=11648,,,11648.0,Akp3,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of AKP3 mRNA,,,PMID:37668303,https://www.ncbi.nlm.nih.gov/pubmed/37668303,37668303,,
3868,1440182,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10327,AKR1A1,https://ctdbase.org/detail.go?type=gene&acc=10327,,,10327.0,AKR1A1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of AKR1A1 mRNA,,,PMID:19072884,https://www.ncbi.nlm.nih.gov/pubmed/19072884,19072884,,
3869,1440183,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10327,AKR1A1,https://ctdbase.org/detail.go?type=gene&acc=10327,,,10327.0,AKR1A1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of AKR1A1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3870,1440184,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,445326,AKR1A1A,https://ctdbase.org/detail.go?type=gene&acc=445326,,,445326.0,akr1a1a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of AKR1A1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3871,1441010,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [sodium arsenite results in decreased phosphorylation of AKT1 protein],,,PMID:27966075,https://www.ncbi.nlm.nih.gov/pubmed/27966075,27966075,,
3872,1441011,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),[hydrogen peroxide co-treated with sodium arsenite] results in increased phosphorylation of AKT1 protein|cycloheximide inhibits the reaction [[hydrogen peroxide co-treated with sodium arsenite] results in increased phosphorylation of AKT1 protein],,,PMID:12472888,https://www.ncbi.nlm.nih.gov/pubmed/12472888,12472888,,
3873,1441136,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),Polysaccharides inhibits the reaction [sodium arsenite results in decreased expression of AKT1 protein]|succimer inhibits the reaction [sodium arsenite results in decreased expression of AKT1 protein],,,PMID:31163222,https://www.ncbi.nlm.nih.gov/pubmed/31163222,31163222,,
3874,1441137,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of AKT1 protein,,,PMID:29657918|PMID:31163222,https://www.ncbi.nlm.nih.gov/pubmed/29657918|https://www.ncbi.nlm.nih.gov/pubmed/31163222,29657918|31163222,,
3875,1441138,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased phosphorylation of AKT1 protein,,,PMID:27966075|PMID:34920032,https://www.ncbi.nlm.nih.gov/pubmed/27966075|https://www.ncbi.nlm.nih.gov/pubmed/34920032,27966075|34920032,,
3876,1441139,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of AKT1 protein|sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of AKT1 protein],,,PMID:30835071,https://www.ncbi.nlm.nih.gov/pubmed/30835071,30835071,,
3877,1441140,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9823.0,Sus scrofa (pig),Sodium arsenite results in increased degradation of AKT1 protein|wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein]|sodium arsenite results in decreased expression of and results in increased phosphorylation of AKT1 protein|benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sodium arsenite results in increased degradation of AKT1 protein],,,PMID:16239170,https://www.ncbi.nlm.nih.gov/pubmed/16239170,16239170,,
3878,1441264,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64400,AKTIP,https://ctdbase.org/detail.go?type=gene&acc=64400,,,64400.0,AKTIP,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of AKTIP mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3879,1441265,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64400,AKTIP,https://ctdbase.org/detail.go?type=gene&acc=64400,,,64400.0,AKTIP,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of AKTIP mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3880,1441266,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of ALAD mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3881,1441267,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ALAD mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3882,1441268,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased activity of ALAD protein,,,PMID:16828073|PMID:17613011|PMID:18183357,https://www.ncbi.nlm.nih.gov/pubmed/16828073|https://www.ncbi.nlm.nih.gov/pubmed/17613011|https://www.ncbi.nlm.nih.gov/pubmed/18183357,16828073|17613011|18183357,,
3883,1442003,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,221,ALDH3B1,https://ctdbase.org/detail.go?type=gene&acc=221,,,221.0,ALDH3B1,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of ALDH3B1 protein,,,PMID:29044176,https://www.ncbi.nlm.nih.gov/pubmed/29044176,29044176,,
3884,1442004,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,222,ALDH3B2,https://ctdbase.org/detail.go?type=gene&acc=222,,,222.0,ALDH3B2,9606.0,Homo sapiens (human),[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of ALDH3B2 mRNA,,,PMID:32076005,https://www.ncbi.nlm.nih.gov/pubmed/32076005,32076005,,
3885,1442005,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8659,ALDH4A1,https://ctdbase.org/detail.go?type=gene&acc=8659,,,8659.0,ALDH4A1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ALDH4A1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3886,1442006,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8659,ALDH4A1,https://ctdbase.org/detail.go?type=gene&acc=8659,,,8659.0,ALDH4A1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of ALDH4A1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3887,1442007,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7915,ALDH5A1,https://ctdbase.org/detail.go?type=gene&acc=7915,,,7915.0,ALDH5A1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of ALDH5A1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3888,1442008,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7915,ALDH5A1,https://ctdbase.org/detail.go?type=gene&acc=7915,,,7915.0,ALDH5A1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of ALDH5A1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3889,1442009,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4329,ALDH6A1,https://ctdbase.org/detail.go?type=gene&acc=4329,,,4329.0,ALDH6A1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of ALDH6A1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3890,1442010,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4329,ALDH6A1,https://ctdbase.org/detail.go?type=gene&acc=4329,,,4329.0,ALDH6A1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of ALDH6A1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3891,1442011,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,501,ALDH7A1,https://ctdbase.org/detail.go?type=gene&acc=501,,,501.0,ALDH7A1,9606.0,Homo sapiens (human),[sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of ALDH7A1 promoter,,,PMID:18448484,https://www.ncbi.nlm.nih.gov/pubmed/18448484,18448484,,
3892,1442012,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,501,ALDH7A1,https://ctdbase.org/detail.go?type=gene&acc=501,,,501.0,ALDH7A1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of ALDH7A1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3893,1443280,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,559784,AMOTL2B,https://ctdbase.org/detail.go?type=gene&acc=559784,,,559784.0,amotl2b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of AMOTL2B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3894,1443281,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,173891,AMPD-1,https://ctdbase.org/detail.go?type=gene&acc=173891,,,173891.0,ampd-1,6239.0,Caenorhabditis elegans,AMPD-1 mRNA promotes the reaction [sodium arsenite results in increased expression of GCS-1 protein],,,PMID:25204677,https://www.ncbi.nlm.nih.gov/pubmed/25204677,25204677,,
3895,1443282,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,571355,AMPD2B,https://ctdbase.org/detail.go?type=gene&acc=571355,,,571355.0,ampd2b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of AMPD2B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3896,1443283,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,272,AMPD3,https://ctdbase.org/detail.go?type=gene&acc=272,,,272.0,AMPD3,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of AMPD3 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3897,1443284,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,272,AMPD3,https://ctdbase.org/detail.go?type=gene&acc=272,,,272.0,AMPD3,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of AMPD3 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3898,1443285,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,333997,AMPD3B,https://ctdbase.org/detail.go?type=gene&acc=333997,,,333997.0,ampd3b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of AMPD3B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3899,1443286,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,275,AMT,https://ctdbase.org/detail.go?type=gene&acc=275,,,275.0,AMT,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of AMT mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3900,1443287,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,401138,AMTN,https://ctdbase.org/detail.go?type=gene&acc=401138,,,401138.0,AMTN,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of AMTN mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3901,1444657,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,50636,ANO7,https://ctdbase.org/detail.go?type=gene&acc=50636,,,50636.0,ANO7,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of ANO7 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3902,1445146,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,653145,ANXA8,https://ctdbase.org/detail.go?type=gene&acc=653145,,,653145.0,ANXA8,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ANXA8 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3903,1445147,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8416,ANXA9,https://ctdbase.org/detail.go?type=gene&acc=8416,,,8416.0,ANXA9,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ANXA9 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3904,1445148,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,313,AOAH,https://ctdbase.org/detail.go?type=gene&acc=313,,,313.0,AOAH,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of AOAH gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3905,1445149,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,26,AOC1,https://ctdbase.org/detail.go?type=gene&acc=26,,,26.0,AOC1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of AOC1 mRNA,,,PMID:12727804|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/12727804|https://www.ncbi.nlm.nih.gov/pubmed/34032870,12727804|34032870,,
3906,1445150,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,26,AOC1,https://ctdbase.org/detail.go?type=gene&acc=26,,,26.0,AOC1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of AOC1 mrna|sodium arsenite results in increased methylation of AOC1 gene,,,PMID:24570342,https://www.ncbi.nlm.nih.gov/pubmed/24570342,24570342,,
3907,1445151,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of AOX1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3908,1445152,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of AOX1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3909,1445153,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of AOX1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3910,1445154,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,213043,AOX2,https://ctdbase.org/detail.go?type=gene&acc=213043,,,213043.0,Aox2,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of AOX2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3911,1446182,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,341,APOC1,https://ctdbase.org/detail.go?type=gene&acc=341,,,341.0,APOC1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of APOC1 protein,,,PMID:31874112,https://www.ncbi.nlm.nih.gov/pubmed/31874112,31874112,,
3912,1446183,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,344,APOC2,https://ctdbase.org/detail.go?type=gene&acc=344,,,344.0,APOC2,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of APOC2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3913,1446514,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,223672,APOL9A,https://ctdbase.org/detail.go?type=gene&acc=223672,,,223672.0,Apol9a,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in decreased expression of APOL9A mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3914,1450788,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,10116.0,Rattus norvegicus (Norway rat),Melatonin inhibits the reaction [sodium arsenite results in increased expression of ATF4 protein],,,PMID:17645694,https://www.ncbi.nlm.nih.gov/pubmed/17645694,17645694,,
3915,1450789,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of ATF4 protein,,,PMID:17645694|PMID:17681577,https://www.ncbi.nlm.nih.gov/pubmed/17645694|https://www.ncbi.nlm.nih.gov/pubmed/17681577,17645694|17681577,,
3916,1451569,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,471,ATIC,https://ctdbase.org/detail.go?type=gene&acc=471,,,471.0,ATIC,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of ATIC mRNA,,,PMID:32068019,https://www.ncbi.nlm.nih.gov/pubmed/32068019,32068019,,
3917,1451570,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51062,ATL1,https://ctdbase.org/detail.go?type=gene&acc=51062,,,51062.0,ATL1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATL1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3918,1451571,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51062,ATL1,https://ctdbase.org/detail.go?type=gene&acc=51062,,,51062.0,ATL1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ATL1 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3919,1451572,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,25923,ATL3,https://ctdbase.org/detail.go?type=gene&acc=25923,,,25923.0,ATL3,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ATL3 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3920,1451573,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,472,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472.0,ATM,9606.0,Homo sapiens (human),ATM gene mutant form inhibits the reaction [sodium arsenite results in increased expression of CDKN1A protein]|atm gene mutant form inhibits the reaction [sodium arsenite results in increased expression of TP53 protein]|atm gene mutant form results in increased susceptibility to sodium arsenite,,,PMID:11507245,https://www.ncbi.nlm.nih.gov/pubmed/11507245,11507245,,
3921,1451574,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,472,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472.0,ATM,10090.0,Mus musculus (house mouse),ATM protein affects the reaction [sodium arsenite results in decreased expression of HSP90AB1 mrna]|sodium arsenite results in increased phosphorylation of ATM protein|atm protein affects the reaction [sodium arsenite results in increased phosphorylation of TRP53 protein],,,PMID:18996350,https://www.ncbi.nlm.nih.gov/pubmed/18996350,18996350,,
3922,1451575,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23300,ATMIN,https://ctdbase.org/detail.go?type=gene&acc=23300,,,23300.0,ATMIN,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ATMIN mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
3923,1451576,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,474,ATOH1,https://ctdbase.org/detail.go?type=gene&acc=474,,,474.0,ATOH1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ATOH1 mRNA,,,PMID:33957193,https://www.ncbi.nlm.nih.gov/pubmed/33957193,33957193,,
3924,1451577,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84913,ATOH8,https://ctdbase.org/detail.go?type=gene&acc=84913,,,84913.0,ATOH8,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ATOH8 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
3925,1451716,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,30834,POLR1H,https://ctdbase.org/detail.go?type=gene&acc=30834,,,30834.0,POLR1H,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of POLR1H mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3926,1451717,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5430,POLR2A,https://ctdbase.org/detail.go?type=gene&acc=5430,,,5430.0,POLR2A,9606.0,Homo sapiens (human),Sodium arsenite results in increased phosphorylation of POLR2A protein|[dactinomycin co-treated with sodium arsenite] results in increased phosphorylation of POLR2A protein|sodium arsenite inhibits the reaction [dichlororibofuranosylbenzimidazole results in decreased phosphorylation of POLR2A protein]|sodium arsenite inhibits the reaction [N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide results in decreased phosphorylation of POLR2A protein],,,PMID:8126066,https://www.ncbi.nlm.nih.gov/pubmed/8126066,8126066,,
3927,1451718,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5431,POLR2B,https://ctdbase.org/detail.go?type=gene&acc=5431,,,5431.0,POLR2B,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of POLR2B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3928,1451719,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5432,POLR2C,https://ctdbase.org/detail.go?type=gene&acc=5432,,,5432.0,POLR2C,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of POLR2C mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3929,1466062,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,112770,GLMP,https://ctdbase.org/detail.go?type=gene&acc=112770,,,112770.0,GLMP,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GLMP mRNA,,,PMID:37668303,https://www.ncbi.nlm.nih.gov/pubmed/37668303,37668303,,
3930,1466063,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,175130,GLNA-1,https://ctdbase.org/detail.go?type=gene&acc=175130,,,175130.0,glna-1,6239.0,Caenorhabditis elegans,Sodium arsenite results in increased sumoylation of GLNA-1 protein,,,PMID:29348603,https://www.ncbi.nlm.nih.gov/pubmed/29348603,29348603,,
3931,1466064,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2739,GLO1,https://ctdbase.org/detail.go?type=gene&acc=2739,,,2739.0,GLO1,9606.0,Homo sapiens (human),Protocatechualdehyde inhibits the reaction [sodium arsenite results in increased activity of GLO1 protein]|sodium arsenite results in increased activity of GLO1 protein,,,PMID:29732668,https://www.ncbi.nlm.nih.gov/pubmed/29732668,29732668,,
3932,1466065,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2739,GLO1,https://ctdbase.org/detail.go?type=gene&acc=2739,,,2739.0,GLO1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of GLO1 protein|sodium arsenite results in decreased expression of GLO1 protein,,,PMID:21925251,https://www.ncbi.nlm.nih.gov/pubmed/21925251,21925251,,
3933,1466066,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51031,GLOD4,https://ctdbase.org/detail.go?type=gene&acc=51031,,,51031.0,GLOD4,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of GLOD4 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
3934,1466430,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2752,GLUL,https://ctdbase.org/detail.go?type=gene&acc=2752,,,2752.0,GLUL,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of GLUL mRNA,,,PMID:21396911,https://www.ncbi.nlm.nih.gov/pubmed/21396911,21396911,,
3935,1466431,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2752,GLUL,https://ctdbase.org/detail.go?type=gene&acc=2752,,,2752.0,GLUL,10116.0,Rattus norvegicus (Norway rat),[sodium arsenite co-treated with lead acetate co-treated with cadmium chloride] results in decreased expression of GLUL protein,,,PMID:23680456,https://www.ncbi.nlm.nih.gov/pubmed/23680456,23680456,,
3936,1481014,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23608,MKRN1,https://ctdbase.org/detail.go?type=gene&acc=23608,,,23608.0,MKRN1,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of MKRN1 mRNA,,,PMID:20883709,https://www.ncbi.nlm.nih.gov/pubmed/20883709,20883709,,
3937,1481015,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100149633,MKRN2OS.1,https://ctdbase.org/detail.go?type=gene&acc=100149633,,,100149633.0,mkrn2os.1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MKRN2OS.1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3938,1481016,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,54903,MKS1,https://ctdbase.org/detail.go?type=gene&acc=54903,,,54903.0,MKS1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MKS1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3939,1481017,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,283078,MKX,https://ctdbase.org/detail.go?type=gene&acc=283078,,,283078.0,MKX,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of and affects the splicing of MKX mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
3940,1481018,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,283078,MKX,https://ctdbase.org/detail.go?type=gene&acc=283078,,,283078.0,MKX,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in decreased expression of MKX mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3941,1481019,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,283078,MKX,https://ctdbase.org/detail.go?type=gene&acc=283078,,,283078.0,MKX,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MKX mRNA,,,PMID:36209798|PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/36209798|https://www.ncbi.nlm.nih.gov/pubmed/37682722,36209798|37682722,,
3942,1481020,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4291,MLF1,https://ctdbase.org/detail.go?type=gene&acc=4291,,,4291.0,MLF1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MLF1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3943,1481179,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4130,MAP1A,https://ctdbase.org/detail.go?type=gene&acc=4130,,,4130.0,MAP1A,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MAP1A mRNA,,,PMID:29301061|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/29301061|https://www.ncbi.nlm.nih.gov/pubmed/34032870,29301061|34032870,,
3944,1481180,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4131,MAP1B,https://ctdbase.org/detail.go?type=gene&acc=4131,,,4131.0,MAP1B,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MAP1B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3945,1481181,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4131,MAP1B,https://ctdbase.org/detail.go?type=gene&acc=4131,,,4131.0,MAP1B,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MAP1B mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3946,1481182,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4131,MAP1B,https://ctdbase.org/detail.go?type=gene&acc=4131,,,4131.0,MAP1B,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of MAP1B protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3947,1481183,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84557,MAP1LC3A,https://ctdbase.org/detail.go?type=gene&acc=84557,,,84557.0,MAP1LC3A,9606.0,Homo sapiens (human),[sodium arsenite results in increased abundance of arsenite] which results in increased lipidation of MAP1LC3A protein,,,PMID:31781319,https://www.ncbi.nlm.nih.gov/pubmed/31781319,31781319,,
3948,1481184,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84557,MAP1LC3A,https://ctdbase.org/detail.go?type=gene&acc=84557,,,84557.0,MAP1LC3A,10090.0,Mus musculus (house mouse),"2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3A protein modified form]|3-methyladenine inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3A protein modified form]|alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide promotes the reaction [sodium arsenite results in increased expression of MAP1LC3A protein modified form]|sodium arsenite results in increased expression of MAP1LC3A protein modified form|il6 protein affects the reaction [sodium arsenite results in increased expression of MAP1LC3A protein modified form]",,,PMID:20008137,https://www.ncbi.nlm.nih.gov/pubmed/20008137,20008137,,
3949,1481185,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84557,MAP1LC3A,https://ctdbase.org/detail.go?type=gene&acc=84557,,,84557.0,MAP1LC3A,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of MAP1LC3A mrna|[sodium arsenite co-treated with dietary fats] results in increased expression of MAP1LC3A mRNA,,,PMID:30097599,https://www.ncbi.nlm.nih.gov/pubmed/30097599,30097599,,
3950,1481186,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MAP1LC3B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3951,1481187,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,9606.0,Homo sapiens (human),Decitabine inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3B protein],,,PMID:19577553,https://www.ncbi.nlm.nih.gov/pubmed/19577553,19577553,,
3952,1482117,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5605,MAP2K2,https://ctdbase.org/detail.go?type=gene&acc=5605,,,5605.0,MAP2K2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MAP2K2 mRNA,,,PMID:24431212,https://www.ncbi.nlm.nih.gov/pubmed/24431212,24431212,,
3953,1482269,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10572,SIVA1,https://ctdbase.org/detail.go?type=gene&acc=10572,,,10572.0,SIVA1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of SIVA1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3954,1482357,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606.0,Homo sapiens (human),Sodium arsenite results in increased secretion of MMP2 protein,,,PMID:19933942|PMID:23052196|PMID:30428081,https://www.ncbi.nlm.nih.gov/pubmed/19933942|https://www.ncbi.nlm.nih.gov/pubmed/23052196|https://www.ncbi.nlm.nih.gov/pubmed/30428081,19933942|23052196|30428081,,
3955,1482358,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10090.0,Mus musculus (house mouse),Melatonin inhibits the reaction [sodium arsenite results in increased expression of MMP2 protein],,,PMID:29763682,https://www.ncbi.nlm.nih.gov/pubmed/29763682,29763682,,
3956,1482359,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MMP2 mRNA,,,PMID:16014739|PMID:18812580|PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/16014739|https://www.ncbi.nlm.nih.gov/pubmed/18812580|https://www.ncbi.nlm.nih.gov/pubmed/37682722,16014739|18812580|37682722,,
3957,1482360,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10090.0,Mus musculus (house mouse),[sodium arsenite results in increased abundance of arsenic] which results in increased secretion of MMP2 protein,,,PMID:37527016,https://www.ncbi.nlm.nih.gov/pubmed/37527016,37527016,,
3958,1482361,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10090.0,Mus musculus (house mouse),[sodium arsenite results in increased expression of MMP14 protein] which results in increased expression of MMP2 protein modified form|[sodium arsenite results in increased expression of MMP14 protein] which results in increased activity of MMP2 protein|sodium arsenite results in increased secretion of MMP2 protein modified form,,,PMID:18569616,https://www.ncbi.nlm.nih.gov/pubmed/18569616,18569616,,
3959,1482362,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of MMP2 mRNA,,,PMID:21134390,https://www.ncbi.nlm.nih.gov/pubmed/21134390,21134390,,
3960,1482363,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of MMP2 protein,,,PMID:21134390|PMID:29763682,https://www.ncbi.nlm.nih.gov/pubmed/21134390|https://www.ncbi.nlm.nih.gov/pubmed/29763682,21134390|29763682,,
3961,1482491,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6497,SKI,https://ctdbase.org/detail.go?type=gene&acc=6497,,,6497.0,SKI,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SKI mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3962,1482492,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,30101,SKIA,https://ctdbase.org/detail.go?type=gene&acc=30101,,,30101.0,skia,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of SKIA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3963,1482493,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6499,SKIC2,https://ctdbase.org/detail.go?type=gene&acc=6499,,,6499.0,SKIC2,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of SKIC2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3964,1482494,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,80349,SKIC8,https://ctdbase.org/detail.go?type=gene&acc=80349,,,80349.0,SKIC8,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of SKIC8 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3965,1482495,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,387640,SKIDA1,https://ctdbase.org/detail.go?type=gene&acc=387640,,,387640.0,SKIDA1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SKIDA1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3966,1482496,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6498,SKIL,https://ctdbase.org/detail.go?type=gene&acc=6498,,,6498.0,SKIL,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of SKIL mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
3967,1482497,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100007653,SKILA,https://ctdbase.org/detail.go?type=gene&acc=100007653,,,100007653.0,skila,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of SKILA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3968,1482498,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,230622,SKINT6,https://ctdbase.org/detail.go?type=gene&acc=230622,,,230622.0,Skint6,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SKINT6 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
3969,1482499,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,177343,SKN-1,https://ctdbase.org/detail.go?type=gene&acc=177343,,,177343.0,skn-1,6239.0,Caenorhabditis elegans,[PRDX-2 protein affects the localization of and results in decreased activity of SKN-1 protein] which results in increased susceptibility to sodium arsenite|skn-1 protein results in decreased susceptibility to sodium arsenite,,,PMID:25808059,https://www.ncbi.nlm.nih.gov/pubmed/25808059,25808059,,
3970,1482779,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,678531,MMP30,https://ctdbase.org/detail.go?type=gene&acc=678531,,,678531.0,mmp30,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of MMP30 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3971,1482780,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4316,MMP7,https://ctdbase.org/detail.go?type=gene&acc=4316,,,4316.0,MMP7,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MMP7 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3972,1482781,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4316,MMP7,https://ctdbase.org/detail.go?type=gene&acc=4316,,,4316.0,MMP7,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MMP7 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
3973,1482912,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,177343,SKN-1,https://ctdbase.org/detail.go?type=gene&acc=177343,,,177343.0,skn-1,6239.0,Caenorhabditis elegans,[SKN-1 protein co-treated with sodium arsenite] results in increased expression of GST-10 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of CDR-1 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of CYP-14A1 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of HMT-1 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GST-35 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of NSPA-8 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of DHS-23 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of PTPS-1 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GST-39 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of DOD-24 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GLRX-10 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GST-8 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GST-7 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of ATF-4 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GSTO-2 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of UGT-58 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of CLEC-198 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of FBXA-116 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of MED-1 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of PCBD-1 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of UGT-48 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of SDZ-8 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of VEM-1 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of PCP-2 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of VHA-16 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of PCP-4 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GST-1 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of MBF-1 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of HIS-66 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GST-13 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GST-38 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GST-6 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GCS-1 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of HIS-8 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of NSPA-5 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of AQP-11 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of NSPA-9 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of TAG-234 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of DOD-17 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of SODH-2 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of FBXA-46 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of NSPA-3 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GST-12 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GST-14 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GST-4 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of FBXA-60 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of BAS-1 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of CAT-4 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of DHS-8 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of NIT-1 mrna|[skn-1 protein co-treated with sodium arsenite] results in increased expression of GST-5 mRNA,,,PMID:19575768,https://www.ncbi.nlm.nih.gov/pubmed/19575768,19575768,,
3974,1482913,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,177343,SKN-1,https://ctdbase.org/detail.go?type=gene&acc=177343,,,177343.0,skn-1,6239.0,Caenorhabditis elegans,Sodium arsenite results in increased activity of SKN-1 protein,,,PMID:23555279,https://www.ncbi.nlm.nih.gov/pubmed/23555279,23555279,,
3975,1482914,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6500,SKP1,https://ctdbase.org/detail.go?type=gene&acc=6500,,,6500.0,SKP1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SKP1 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
3976,1482915,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6500,SKP1,https://ctdbase.org/detail.go?type=gene&acc=6500,,,6500.0,SKP1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of SKP1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
3977,1483080,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6504,SLAMF1,https://ctdbase.org/detail.go?type=gene&acc=6504,,,6504.0,SLAMF1,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of SLAMF1 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3978,1483081,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,114836,SLAMF6,https://ctdbase.org/detail.go?type=gene&acc=114836,,,114836.0,SLAMF6,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of SLAMF6 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3979,1483082,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,57823,SLAMF7,https://ctdbase.org/detail.go?type=gene&acc=57823,,,57823.0,SLAMF7,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of SLAMF7 mRNA,,,PMID:22714537|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/22714537|https://www.ncbi.nlm.nih.gov/pubmed/34032870,22714537|34032870,,
3980,1483083,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,57823,SLAMF7,https://ctdbase.org/detail.go?type=gene&acc=57823,,,57823.0,SLAMF7,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of SLAMF7 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
3981,1483660,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,436637,MOB2A,https://ctdbase.org/detail.go?type=gene&acc=436637,,,436637.0,mob2a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of MOB2A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3982,1483661,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,79817,MOB3B,https://ctdbase.org/detail.go?type=gene&acc=79817,,,79817.0,MOB3B,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MOB3B mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3983,1483662,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,79817,MOB3B,https://ctdbase.org/detail.go?type=gene&acc=79817,,,79817.0,MOB3B,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of MOB3B mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
3984,1483663,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4336,MOBP,https://ctdbase.org/detail.go?type=gene&acc=4336,,,4336.0,MOBP,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of MOBP gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3985,1483664,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4337,MOCS1,https://ctdbase.org/detail.go?type=gene&acc=4337,,,4337.0,MOCS1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of MOCS1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3986,1483665,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4337,MOCS1,https://ctdbase.org/detail.go?type=gene&acc=4337,,,4337.0,MOCS1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MOCS1 protein,,,PMID:21925251,https://www.ncbi.nlm.nih.gov/pubmed/21925251,21925251,,
3987,1483666,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4338,MOCS2,https://ctdbase.org/detail.go?type=gene&acc=4338,,,4338.0,MOCS2,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of MOCS2 mRNA,,,PMID:20883709,https://www.ncbi.nlm.nih.gov/pubmed/20883709,20883709,,
3988,1483667,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,116255,MOGAT1,https://ctdbase.org/detail.go?type=gene&acc=116255,,,116255.0,MOGAT1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MOGAT1 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
3989,1483668,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,80168,MOGAT2,https://ctdbase.org/detail.go?type=gene&acc=80168,,,80168.0,MOGAT2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MOGAT2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
3990,1483669,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,346606,MOGAT3,https://ctdbase.org/detail.go?type=gene&acc=346606,,,346606.0,MOGAT3,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MOGAT3 mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
3991,1483946,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,368274,SLC16A1B,https://ctdbase.org/detail.go?type=gene&acc=368274,,,368274.0,slc16a1b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of SLC16A1B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3992,1483947,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6567,SLC16A2,https://ctdbase.org/detail.go?type=gene&acc=6567,,,6567.0,SLC16A2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SLC16A2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
3993,1483948,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9123,SLC16A3,https://ctdbase.org/detail.go?type=gene&acc=9123,,,9123.0,SLC16A3,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of SLC16A3 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3994,1483949,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9123,SLC16A3,https://ctdbase.org/detail.go?type=gene&acc=9123,,,9123.0,SLC16A3,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of SLC16A3 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
3995,1483950,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9122,SLC16A4,https://ctdbase.org/detail.go?type=gene&acc=9122,,,9122.0,SLC16A4,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SLC16A4 mRNA,,,PMID:36209798|PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/36209798|https://www.ncbi.nlm.nih.gov/pubmed/37682722,36209798|37682722,,
3996,1483951,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,565514,SLC16A5A,https://ctdbase.org/detail.go?type=gene&acc=565514,,,565514.0,slc16a5a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of SLC16A5A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3997,1483952,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,794371,SLC16A5B,https://ctdbase.org/detail.go?type=gene&acc=794371,,,794371.0,slc16a5b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of SLC16A5B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3998,1483953,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,564872,SLC16A6A,https://ctdbase.org/detail.go?type=gene&acc=564872,,,564872.0,slc16a6a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of SLC16A6A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
3999,1484693,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased phosphorylation of MAPK1 protein,,,PMID:11035063|PMID:18996350|PMID:20008137|PMID:26631322|PMID:28843991|PMID:32760496|PMID:34272803|PMID:9671412,https://www.ncbi.nlm.nih.gov/pubmed/11035063|https://www.ncbi.nlm.nih.gov/pubmed/18996350|https://www.ncbi.nlm.nih.gov/pubmed/20008137|https://www.ncbi.nlm.nih.gov/pubmed/26631322|https://www.ncbi.nlm.nih.gov/pubmed/28843991|https://www.ncbi.nlm.nih.gov/pubmed/32760496|https://www.ncbi.nlm.nih.gov/pubmed/34272803|https://www.ncbi.nlm.nih.gov/pubmed/9671412,11035063|18996350|20008137|26631322|28843991|32760496|34272803|9671412,,
4000,1484694,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased activity of MAPK1 protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased activity of MAPK1 protein],,,PMID:14514659,https://www.ncbi.nlm.nih.gov/pubmed/14514659,14514659,,
4001,1484695,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein|[egf protein results in decreased expression of EGFR protein] inhibits the reaction [sodium arsenite results in increased activity of MAPK1 protein]|rtki cpd inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein]|suramin inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein],,,PMID:9710602,https://www.ncbi.nlm.nih.gov/pubmed/9710602,9710602,,
4002,1485755,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6581,SLC22A3,https://ctdbase.org/detail.go?type=gene&acc=6581,,,6581.0,SLC22A3,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of SLC22A3 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4003,1486662,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,253512,SLC25A30,https://ctdbase.org/detail.go?type=gene&acc=253512,,,253512.0,SLC25A30,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of SLC25A30 mRNA,,,PMID:22700541,https://www.ncbi.nlm.nih.gov/pubmed/22700541,22700541,,
4004,1486663,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100874259,SLC25A30-AS1,https://ctdbase.org/detail.go?type=gene&acc=100874259,,,100874259.0,SLC25A30-AS1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SLC25A30-AS1 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
4005,1486664,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,393226,SLC25A32A,https://ctdbase.org/detail.go?type=gene&acc=393226,,,393226.0,slc25a32a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of SLC25A32A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4006,1486665,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,284723,SLC25A34,https://ctdbase.org/detail.go?type=gene&acc=284723,,,284723.0,SLC25A34,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of SLC25A34 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4007,1486666,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,399512,SLC25A35,https://ctdbase.org/detail.go?type=gene&acc=399512,,,399512.0,SLC25A35,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of SLC25A35 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
4008,1486944,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4082,MARCKS,https://ctdbase.org/detail.go?type=gene&acc=4082,,,4082.0,MARCKS,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MARCKS mRNA,,,PMID:16507463,https://www.ncbi.nlm.nih.gov/pubmed/16507463,16507463,,
4009,1486945,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),[sodium arsenite results in increased abundance of arsenic] which results in increased phosphorylation of MAPK3 protein,,,PMID:30889423,https://www.ncbi.nlm.nih.gov/pubmed/30889423,30889423,,
4010,1486946,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased activity of MAPK3 protein,,,PMID:15713539,https://www.ncbi.nlm.nih.gov/pubmed/15713539,15713539,,
4011,1486947,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK3 protein,,,PMID:11723127|PMID:23143138,https://www.ncbi.nlm.nih.gov/pubmed/11723127|https://www.ncbi.nlm.nih.gov/pubmed/23143138,11723127|23143138,,
4012,1486948,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased phosphorylation of MAPK3 protein,,,PMID:11035063|PMID:18996350|PMID:20008137|PMID:26631322|PMID:28843991|PMID:32760496|PMID:34272803,https://www.ncbi.nlm.nih.gov/pubmed/11035063|https://www.ncbi.nlm.nih.gov/pubmed/18996350|https://www.ncbi.nlm.nih.gov/pubmed/20008137|https://www.ncbi.nlm.nih.gov/pubmed/26631322|https://www.ncbi.nlm.nih.gov/pubmed/28843991|https://www.ncbi.nlm.nih.gov/pubmed/32760496|https://www.ncbi.nlm.nih.gov/pubmed/34272803,11035063|18996350|20008137|26631322|28843991|32760496|34272803,,
4013,1486949,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased activity of MAPK3 protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased activity of MAPK3 protein],,,PMID:14514659,https://www.ncbi.nlm.nih.gov/pubmed/14514659,14514659,,
4014,1486950,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),[EGF protein results in decreased expression of EGFR protein] inhibits the reaction [sodium arsenite results in increased activity of MAPK3 protein]|sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK3 protein|suramin inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK3 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK3 protein]|rtki cpd inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK3 protein],,,PMID:9710602,https://www.ncbi.nlm.nih.gov/pubmed/9710602,9710602,,
4015,1487977,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10116.0,Rattus norvegicus (Norway rat),[cadmium chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK8 protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[cadmium chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK8 protein],,,PMID:20829427,https://www.ncbi.nlm.nih.gov/pubmed/20829427,20829427,,
4016,1488458,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9606.0,Homo sapiens (human),Tetramethylpyrazine inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein],,,PMID:26404762,https://www.ncbi.nlm.nih.gov/pubmed/26404762,26404762,,
4017,1488459,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090.0,Mus musculus (house mouse),MAPK9 protein affects the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of HSF1 protein]|cdkn1b protein affects the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein]|mapk9 protein affects the reaction [sodium arsenite results in increased expression of HSPB1 protein]|mapk9 protein affects the reaction [sodium arsenite results in increased expression of HSPA1A protein],,,PMID:20566634,https://www.ncbi.nlm.nih.gov/pubmed/20566634,20566634,,
4018,1488460,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090.0,Mus musculus (house mouse),Curcumin inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein],,,PMID:34272803,https://www.ncbi.nlm.nih.gov/pubmed/34272803,34272803,,
4019,1488461,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090.0,Mus musculus (house mouse),"Sodium arsenite results in increased expression of MAPK9 protein modified form|drugs, chinese herbal inhibits the reaction [sodium arsenite results in increased expression of MAPK9 protein modified form]",,,PMID:28757890,https://www.ncbi.nlm.nih.gov/pubmed/28757890,28757890,,
4020,1488462,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090.0,Mus musculus (house mouse),MAPK9 protein promotes the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|mapk9 protein promotes the reaction [sodium arsenite results in increased activity of CASP3 protein]|mapk9 protein promotes the reaction [sodium arsenite results in increased expression of GADD45A protein]|mapk9 protein promotes the reaction [sodium arsenite results in increased expression of GADD45A mrna]|mapk9 protein promotes the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of JUN protein],,,PMID:16973625,https://www.ncbi.nlm.nih.gov/pubmed/16973625,16973625,,
4021,1488463,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090.0,Mus musculus (house mouse),Sodium arsenite affects the expression of MAPK9,,,PMID:25367288,https://www.ncbi.nlm.nih.gov/pubmed/25367288,25367288,,
4022,1488464,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK9 protein,,,PMID:23143138,https://www.ncbi.nlm.nih.gov/pubmed/23143138,23143138,,
4023,1488465,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased phosphorylation of MAPK9 protein,,,PMID:16973625|PMID:18996350|PMID:28843991|PMID:34272803,https://www.ncbi.nlm.nih.gov/pubmed/16973625|https://www.ncbi.nlm.nih.gov/pubmed/18996350|https://www.ncbi.nlm.nih.gov/pubmed/28843991|https://www.ncbi.nlm.nih.gov/pubmed/34272803,16973625|18996350|28843991|34272803,,
4024,1488466,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10116.0,Rattus norvegicus (Norway rat),[cadmium chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK9 protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[cadmium chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK9 protein],,,PMID:20829427,https://www.ncbi.nlm.nih.gov/pubmed/20829427,20829427,,
4025,1489291,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8685,MARCO,https://ctdbase.org/detail.go?type=gene&acc=8685,,,8685.0,MARCO,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MARCO mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4026,1489292,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8685,MARCO,https://ctdbase.org/detail.go?type=gene&acc=8685,,,8685.0,MARCO,10090.0,Mus musculus (house mouse),Sodium arsenite affects the expression of MARCO mRNA,,,PMID:26674514,https://www.ncbi.nlm.nih.gov/pubmed/26674514,26674514,,
4027,1489293,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9665,MARF1,https://ctdbase.org/detail.go?type=gene&acc=9665,,,9665.0,MARF1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of MARF1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4028,1489294,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9665,MARF1,https://ctdbase.org/detail.go?type=gene&acc=9665,,,9665.0,MARF1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MARF1 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
4029,1489295,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4140,MARK3,https://ctdbase.org/detail.go?type=gene&acc=4140,,,4140.0,MARK3,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of MARK3 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
4030,1489296,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4140,MARK3,https://ctdbase.org/detail.go?type=gene&acc=4140,,,4140.0,MARK3,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MARK3 mRNA,,,PMID:12760830,https://www.ncbi.nlm.nih.gov/pubmed/12760830,12760830,,
4031,1489297,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,767634,MARK3B,https://ctdbase.org/detail.go?type=gene&acc=767634,,,767634.0,mark3b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MARK3B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4032,1489298,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,36498,MARS,https://ctdbase.org/detail.go?type=gene&acc=36498,,,36498.0,mars,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MARS protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
4033,1489299,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4141,MARS1,https://ctdbase.org/detail.go?type=gene&acc=4141,,,4141.0,MARS1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MARS1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4034,1489300,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,92935,MARS2,https://ctdbase.org/detail.go?type=gene&acc=92935,,,92935.0,MARS2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MARS2 mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
4035,1489463,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,10090.0,Mus musculus (house mouse),[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CCN2 protein|[[sodium arsenite results in increased abundance of arsenic] which co-treated with dietary fats] results in increased expression of CCN2 protein,,,PMID:31238026,https://www.ncbi.nlm.nih.gov/pubmed/31238026,31238026,,
4036,1489464,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of CCN2 protein|candesartan cilexetil inhibits the reaction [sodium arsenite results in increased expression of CCN2 protein],,,PMID:27889505,https://www.ncbi.nlm.nih.gov/pubmed/27889505,27889505,,
4037,1489465,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of CCN2 mRNA,,,PMID:32593899,https://www.ncbi.nlm.nih.gov/pubmed/32593899,32593899,,
4038,1489466,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4856,CCN3,https://ctdbase.org/detail.go?type=gene&acc=4856,,,4856.0,CCN3,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of CCN3 mRNA,,,PMID:12016162|PMID:29301061|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/12016162|https://www.ncbi.nlm.nih.gov/pubmed/29301061|https://www.ncbi.nlm.nih.gov/pubmed/34032870,12016162|29301061|34032870,,
4039,1489467,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4856,CCN3,https://ctdbase.org/detail.go?type=gene&acc=4856,,,4856.0,CCN3,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of CCN3 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
4040,1490078,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),Caffeic acid phenethyl ester inhibits the reaction [sodium arsenite results in increased expression of CCND1 protein]|nfkb2 mutant form inhibits the reaction [sodium arsenite results in increased expression of CCND1 protein]|sodium arsenite promotes the reaction [[NFKB2 protein binds to BCL3 protein] which results in increased expression of CCND1 protein],,,PMID:20420878,https://www.ncbi.nlm.nih.gov/pubmed/20420878,20420878,,
4041,1490079,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),[sodium arsenite results in increased abundance of arsenic] which affects the expression of CCND1 protein|cxcl8 protein affects the reaction [[sodium arsenite results in increased abundance of arsenic] which affects the expression of CCND1 protein]|ly 290042 affects the reaction [CXCL8 protein affects the reaction [[sodium arsenite results in increased abundance of arsenic] which affects the expression of CCND1 protein]]|reparixin affects the reaction [[sodium arsenite results in increased abundance of arsenic] which affects the expression of CCND1 protein]|u 0126 affects the reaction [[sodium arsenite results in increased abundance of arsenic] which affects the expression of CCND1 protein]|ly 290042 affects the reaction [[sodium arsenite results in increased abundance of arsenic] which affects the expression of CCND1 protein]|genistein affects the reaction [ERBB2 protein affects the reaction [[sodium arsenite results in increased abundance of arsenic] which affects the expression of CCND1 protein]]|[genistein co-treated with lapatinib] affects the reaction [[sodium arsenite results in increased abundance of arsenic] which affects the expression of CCND1 protein]|lapatinib affects the reaction [CXCL8 protein affects the reaction [[sodium arsenite results in increased abundance of arsenic] which affects the expression of CCND1 protein]]|genistein affects the reaction [[sodium arsenite results in increased abundance of arsenic] which affects the expression of CCND1 protein]|stattic affects the reaction [[sodium arsenite results in increased abundance of arsenic] which affects the expression of CCND1 protein]|u 0126 affects the reaction [CXCL8 protein affects the reaction [[sodium arsenite results in increased abundance of arsenic] which affects the expression of CCND1 protein]]|erbb2 protein affects the reaction [[sodium arsenite results in increased abundance of arsenic] which affects the expression of CCND1 protein],,,PMID:33396024,https://www.ncbi.nlm.nih.gov/pubmed/33396024,33396024,,
4042,1490080,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),EIF4E protein modified form inhibits the reaction [sodium arsenite results in decreased expression of CCND1 protein]|cycloheximide inhibits the reaction [EIF4E protein modified form inhibits the reaction [sodium arsenite results in decreased expression of CCND1 protein]],,,PMID:25923732,https://www.ncbi.nlm.nih.gov/pubmed/25923732,25923732,,
4043,1490244,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),MIR2909 mRNA affects the reaction [sodium arsenite results in increased expression of CCND1 protein],,,PMID:23562784,https://www.ncbi.nlm.nih.gov/pubmed/23562784,23562784,,
4044,1490677,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of CCND1 protein,,,PMID:11559025|PMID:16876216,https://www.ncbi.nlm.nih.gov/pubmed/11559025|https://www.ncbi.nlm.nih.gov/pubmed/16876216,11559025|16876216,,
4045,1490678,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10116.0,Rattus norvegicus (Norway rat),Tretinoin inhibits the reaction [sodium arsenite results in decreased expression of CCND1 protein]|tretinoin inhibits the reaction [sodium arsenite results in decreased expression of CCND1 mrna],,,PMID:21964460,https://www.ncbi.nlm.nih.gov/pubmed/21964460,21964460,,
4046,1490679,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,894,CCND2,https://ctdbase.org/detail.go?type=gene&acc=894,,,894.0,CCND2,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of CCND2 mRNA,,,PMID:12377979|PMID:20886546,https://www.ncbi.nlm.nih.gov/pubmed/12377979|https://www.ncbi.nlm.nih.gov/pubmed/20886546,12377979|20886546,,
4047,1492388,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6536,SLC6A9,https://ctdbase.org/detail.go?type=gene&acc=6536,,,6536.0,SLC6A9,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SLC6A9 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
4048,1492389,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6536,SLC6A9,https://ctdbase.org/detail.go?type=gene&acc=6536,,,6536.0,SLC6A9,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SLC6A9 mRNA,,,PMID:31170414,https://www.ncbi.nlm.nih.gov/pubmed/31170414,31170414,,
4049,1493758,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,969,CD69,https://ctdbase.org/detail.go?type=gene&acc=969,,,969.0,CD69,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of CD69 protein,,,PMID:16275621,https://www.ncbi.nlm.nih.gov/pubmed/16275621,16275621,,
4050,1493759,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,960,CD44,https://ctdbase.org/detail.go?type=gene&acc=960,,,960.0,CD44,9606.0,Homo sapiens (human),CXCL8 protein promotes the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein]|lapatinib inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein]|snai1 protein affects the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein]|[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [CXCL8 protein promotes the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein]]|[genistein co-treated with lapatinib] inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein]|erbb2 protein promotes the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein]|stattic inhibits the reaction [CXCL8 protein promotes the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein]]|u 0126 inhibits the reaction [CXCL8 protein promotes the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein]]|reparixin inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein]|stattic inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein]|lapatinib inhibits the reaction [CXCL8 protein promotes the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein]]|genistein inhibits the reaction [ERBB2 protein promotes the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein]]|u 0126 inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD44 protein],,,PMID:33396024,https://www.ncbi.nlm.nih.gov/pubmed/33396024,33396024,,
4051,1493918,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,81796,SLCO5A1,https://ctdbase.org/detail.go?type=gene&acc=81796,,,81796.0,SLCO5A1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SLCO5A1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
4052,1493919,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,570033,SLCO5A1A,https://ctdbase.org/detail.go?type=gene&acc=570033,,,570033.0,slco5a1a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of SLCO5A1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4053,1493920,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,70866,SLCO6D1,https://ctdbase.org/detail.go?type=gene&acc=70866,,,70866.0,Slco6d1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SLCO6D1 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
4054,1493921,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84250,SLF1,https://ctdbase.org/detail.go?type=gene&acc=84250,,,84250.0,SLF1,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of SLF1 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
4055,1493922,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,237887,SLFN10-PS,https://ctdbase.org/detail.go?type=gene&acc=237887,,,237887.0,Slfn10-ps,10090.0,Mus musculus (house mouse),Sodium arsenite affects the expression of SLFN10-PS mRNA,,,PMID:26674514,https://www.ncbi.nlm.nih.gov/pubmed/26674514,26674514,,
4056,1493923,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,146857,SLFN13,https://ctdbase.org/detail.go?type=gene&acc=146857,,,146857.0,SLFN13,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of SLFN13 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4057,1493924,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,342618,SLFN14,https://ctdbase.org/detail.go?type=gene&acc=342618,,,342618.0,SLFN14,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of SLFN14 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
4058,1493925,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,20557,SLFN3,https://ctdbase.org/detail.go?type=gene&acc=20557,,,20557.0,Slfn3,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of SLFN3 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
4059,1495060,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9308,CD83,https://ctdbase.org/detail.go?type=gene&acc=9308,,,9308.0,CD83,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of CD83 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
4060,1495061,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9308,CD83,https://ctdbase.org/detail.go?type=gene&acc=9308,,,9308.0,CD83,10090.0,Mus musculus (house mouse),[sodium arsenite results in increased abundance of arsenic] inhibits the reaction [lipopolysaccharides results in increased expression of CD83 mrna]|[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of CD83 mrna|[sodium arsenite results in increased abundance of arsenic] inhibits the reaction [lipopolysaccharides results in increased expression of CD83 protein],,,PMID:33049506,https://www.ncbi.nlm.nih.gov/pubmed/33049506,33049506,,
4061,1495062,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8832,CD84,https://ctdbase.org/detail.go?type=gene&acc=8832,,,8832.0,CD84,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of CD84 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
4062,1495063,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,942,CD86,https://ctdbase.org/detail.go?type=gene&acc=942,,,942.0,CD86,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of CD86 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
4063,1495064,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,942,CD86,https://ctdbase.org/detail.go?type=gene&acc=942,,,942.0,CD86,10090.0,Mus musculus (house mouse),[sodium arsenite results in increased abundance of arsenic] inhibits the reaction [lipopolysaccharides results in increased expression of CD86 mrna]|[sodium arsenite results in increased abundance of arsenic] inhibits the reaction [lipopolysaccharides results in increased expression of CD86 protein],,,PMID:33049506,https://www.ncbi.nlm.nih.gov/pubmed/33049506,33049506,,
4064,1495065,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,942,CD86,https://ctdbase.org/detail.go?type=gene&acc=942,,,942.0,CD86,10090.0,Mus musculus (house mouse),[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CD86 mRNA,,,PMID:30889423|PMID:35777461,https://www.ncbi.nlm.nih.gov/pubmed/30889423|https://www.ncbi.nlm.nih.gov/pubmed/35777461,30889423|35777461,,
4065,1495066,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,925,CD8A,https://ctdbase.org/detail.go?type=gene&acc=925,,,925.0,CD8A,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of CD8A gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
4066,1495067,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,925,CD8A,https://ctdbase.org/detail.go?type=gene&acc=925,,,925.0,CD8A,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of CD8A protein,,,PMID:16275621,https://www.ncbi.nlm.nih.gov/pubmed/16275621,16275621,,
4067,1495068,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,925,CD8A,https://ctdbase.org/detail.go?type=gene&acc=925,,,925.0,CD8A,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of CD8A mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
4068,1497061,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5782,PTPN12,https://ctdbase.org/detail.go?type=gene&acc=5782,,,5782.0,PTPN12,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of PTPN12 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
4069,1497062,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5784,PTPN14,https://ctdbase.org/detail.go?type=gene&acc=5784,,,5784.0,PTPN14,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of PTPN14 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4070,1497063,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),CREB1 protein affects the reaction [[CDKN1B protein affects the susceptibility to [sodium arsenite results in increased abundance of arsenite]] which affects the expression of PTGS2 mrna]|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole affects the reaction [[CDKN1B protein affects the susceptibility to [sodium arsenite results in increased abundance of arsenite]] which affects the expression of PTGS2 protein]|[cdkn1b protein affects the susceptibility to [sodium arsenite results in increased abundance of arsenite]] which affects the expression of PTGS2 mrna|[cdkn1b protein affects the susceptibility to [sodium arsenite results in increased abundance of arsenite]] which affects the expression of PTGS2 protein|mapk11 protein affects the reaction [[sodium arsenite results in increased abundance of arsenite] which results in increased expression of PTGS2 protein]|creb1 protein affects the reaction [[CDKN1B protein affects the susceptibility to [sodium arsenite results in increased abundance of arsenite]] which affects the expression of PTGS2 protein]|cdkn1b protein affects the reaction [[sodium arsenite results in increased abundance of arsenite] which results in increased expression of PTGS2 protein]|[sodium arsenite results in increased abundance of arsenite] which results in increased expression of PTGS2 protein|[sodium arsenite results in increased abundance of arsenite] affects the reaction [CDKN1B protein affects the expression of PTGS2 mrna]|mapk12 protein affects the reaction [[sodium arsenite results in increased abundance of arsenite] which results in increased expression of PTGS2 protein],,,PMID:23639288,https://www.ncbi.nlm.nih.gov/pubmed/23639288,23639288,,
4071,1497064,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Sodium arsenite affects the expression of PTGS2 mRNA,,,PMID:16507464,https://www.ncbi.nlm.nih.gov/pubmed/16507464,16507464,,
4072,1497515,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64405,CDH22,https://ctdbase.org/detail.go?type=gene&acc=64405,,,64405.0,CDH22,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of CDH22 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
4073,1497940,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of CDK1 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
4074,1497941,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Sodium arsenite affects the phosphorylation of CDK1 protein,,,PMID:18501396,https://www.ncbi.nlm.nih.gov/pubmed/18501396,18501396,,
4075,1497942,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of and results in decreased phosphorylation of CDK1 protein,,,PMID:28586017,https://www.ncbi.nlm.nih.gov/pubmed/28586017,28586017,,
4076,1497943,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of CDK1 mRNA,,,PMID:32844245,https://www.ncbi.nlm.nih.gov/pubmed/32844245,32844245,,
4077,1497944,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of CDK1 protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
4078,1497945,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),TP53 protein inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of CDK1 protein]|sodium arsenite results in increased expression of and results in increased phosphorylation of CDK1 protein,,,PMID:16614167,https://www.ncbi.nlm.nih.gov/pubmed/16614167,16614167,,
4079,1497946,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of CDK1 mRNA,,,PMID:12016162,https://www.ncbi.nlm.nih.gov/pubmed/12016162,12016162,,
4080,1497947,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of and results in increased phosphorylation of CDK1 protein,,,PMID:30278210,https://www.ncbi.nlm.nih.gov/pubmed/30278210,30278210,,
4081,1498414,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,174940,PTR-18,https://ctdbase.org/detail.go?type=gene&acc=174940,,,174940.0,ptr-18,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of PTR-18 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
4082,1498415,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,138428,PTRH1,https://ctdbase.org/detail.go?type=gene&acc=138428,,,138428.0,PTRH1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PTRH1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4083,1511474,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,106479618,RNU6-118P,https://ctdbase.org/detail.go?type=gene&acc=106479618,,,106479618.0,RNU6-118P,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RNU6-118P mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4084,1511475,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100873741,RNU6-26P,https://ctdbase.org/detail.go?type=gene&acc=100873741,,,100873741.0,RNU6-26P,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RNU6-26P mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4085,1511476,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,106479824,RNU6-583P,https://ctdbase.org/detail.go?type=gene&acc=106479824,,,106479824.0,RNU6-583P,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of RNU6-583P mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4086,1511477,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100147834,RNU7-47P,https://ctdbase.org/detail.go?type=gene&acc=100147834,,,100147834.0,RNU7-47P,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of RNU7-47P mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
4087,1511478,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100151658,RNU7-63P,https://ctdbase.org/detail.go?type=gene&acc=100151658,,,100151658.0,RNU7-63P,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RNU7-63P mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
4088,1511479,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6084,RNY1,https://ctdbase.org/detail.go?type=gene&acc=6084,,,6084.0,RNY1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of RNY1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4089,1511480,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6089,RNY4P3,https://ctdbase.org/detail.go?type=gene&acc=6089,,,6089.0,RNY4P3,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RNY4P3 mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
4090,1511481,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,570832,C7B,https://ctdbase.org/detail.go?type=gene&acc=570832,,,570832.0,c7b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of C7B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4091,1511482,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,731,C8A,https://ctdbase.org/detail.go?type=gene&acc=731,,,731.0,C8A,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of C8A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4092,1511640,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6091,ROBO1,https://ctdbase.org/detail.go?type=gene&acc=6091,,,6091.0,ROBO1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of ROBO1 mRNA,,,PMID:12760830,https://www.ncbi.nlm.nih.gov/pubmed/12760830,12760830,,
4093,1511641,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6092,ROBO2,https://ctdbase.org/detail.go?type=gene&acc=6092,,,6092.0,ROBO2,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of ROBO2 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
4094,1511642,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6092,ROBO2,https://ctdbase.org/detail.go?type=gene&acc=6092,,,6092.0,ROBO2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ROBO2 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
4095,1511643,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64221,ROBO3,https://ctdbase.org/detail.go?type=gene&acc=64221,,,64221.0,ROBO3,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of ROBO3 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4096,1511644,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6093,ROCK1,https://ctdbase.org/detail.go?type=gene&acc=6093,,,6093.0,ROCK1,9606.0,Homo sapiens (human),Sodium arsenite promotes the reaction [ROCK1 protein binds to CAPRIN1 protein],,,PMID:33939924,https://www.ncbi.nlm.nih.gov/pubmed/33939924,33939924,,
4097,1511645,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9475,ROCK2,https://ctdbase.org/detail.go?type=gene&acc=9475,,,9475.0,ROCK2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ROCK2 protein,,,PMID:26135927,https://www.ncbi.nlm.nih.gov/pubmed/26135927,26135927,,
4098,1511646,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9475,ROCK2,https://ctdbase.org/detail.go?type=gene&acc=9475,,,9475.0,ROCK2,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of ROCK2 mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
4099,1512542,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,776,CACNA1D,https://ctdbase.org/detail.go?type=gene&acc=776,,,776.0,CACNA1D,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of CACNA1D mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
4100,1512543,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,403310,CACNA1DA,https://ctdbase.org/detail.go?type=gene&acc=403310,,,403310.0,cacna1da,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of CACNA1DA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4101,1512544,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,777,CACNA1E,https://ctdbase.org/detail.go?type=gene&acc=777,,,777.0,CACNA1E,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of CACNA1E mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
4102,1512545,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8913,CACNA1G,https://ctdbase.org/detail.go?type=gene&acc=8913,,,8913.0,CACNA1G,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of CACNA1G mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4103,1512546,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8913,CACNA1G,https://ctdbase.org/detail.go?type=gene&acc=8913,,,8913.0,CACNA1G,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of CACNA1G mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
4104,1512547,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8912,CACNA1H,https://ctdbase.org/detail.go?type=gene&acc=8912,,,8912.0,CACNA1H,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of CACNA1H gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
4105,1512548,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8912,CACNA1H,https://ctdbase.org/detail.go?type=gene&acc=8912,,,8912.0,CACNA1H,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of CACNA1H mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
4106,1512549,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,560875,CACNA1HA,https://ctdbase.org/detail.go?type=gene&acc=560875,,,560875.0,cacna1ha,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of CACNA1HA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4107,1514295,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,553607,CAMK2N1A,https://ctdbase.org/detail.go?type=gene&acc=553607,,,553607.0,camk2n1a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of CAMK2N1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4108,1514296,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,814,CAMK4,https://ctdbase.org/detail.go?type=gene&acc=814,,,814.0,CAMK4,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of CAMK4 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4109,1514297,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,814,CAMK4,https://ctdbase.org/detail.go?type=gene&acc=814,,,814.0,CAMK4,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of CAMK4 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
4110,1514298,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84254,CAMKK1,https://ctdbase.org/detail.go?type=gene&acc=84254,,,84254.0,CAMKK1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of CAMKK1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4111,1514299,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10645,CAMKK2,https://ctdbase.org/detail.go?type=gene&acc=10645,,,10645.0,CAMKK2,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of CAMKK2 mrna|sodium arsenite results in increased expression of CAMKK2 protein,,,PMID:25089838,https://www.ncbi.nlm.nih.gov/pubmed/25089838,25089838,,
4112,1514738,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,445201,CANT1B,https://ctdbase.org/detail.go?type=gene&acc=445201,,,445201.0,cant1b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of CANT1B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4113,1514739,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,821,CANX,https://ctdbase.org/detail.go?type=gene&acc=821,,,821.0,CANX,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of CANX mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
4114,1515365,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6188,RPS3,https://ctdbase.org/detail.go?type=gene&acc=6188,,,6188.0,RPS3,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of RPS3 mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
4115,1515366,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6189,RPS3A,https://ctdbase.org/detail.go?type=gene&acc=6189,,,6189.0,RPS3A,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of and results in increased activity of RPS3A protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
4116,1515367,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,220433,RPS4XP16,https://ctdbase.org/detail.go?type=gene&acc=220433,,,220433.0,RPS4XP16,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RPS4XP16 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4117,1515368,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6193,RPS5,https://ctdbase.org/detail.go?type=gene&acc=6193,,,6193.0,RPS5,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of and results in increased activity of RPS5 protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
4118,1515369,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6193,RPS5,https://ctdbase.org/detail.go?type=gene&acc=6193,,,6193.0,RPS5,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of RPS5 mRNA,,,PMID:19072884,https://www.ncbi.nlm.nih.gov/pubmed/19072884,19072884,,
4119,1515370,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6193,RPS5,https://ctdbase.org/detail.go?type=gene&acc=6193,,,6193.0,RPS5,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of RPS5 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
4120,1516237,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,58528,RRAGD,https://ctdbase.org/detail.go?type=gene&acc=58528,,,58528.0,RRAGD,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of RRAGD mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4121,1516238,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,58528,RRAGD,https://ctdbase.org/detail.go?type=gene&acc=58528,,,58528.0,RRAGD,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of RRAGD mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
4122,1516239,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6237,RRAS,https://ctdbase.org/detail.go?type=gene&acc=6237,,,6237.0,RRAS,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of RRAS protein|sodium arsenite results in decreased expression of RRAS protein,,,PMID:24431212,https://www.ncbi.nlm.nih.gov/pubmed/24431212,24431212,,
4123,1516240,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,22800,RRAS2,https://ctdbase.org/detail.go?type=gene&acc=22800,,,22800.0,RRAS2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of RRAS2 mRNA,,,PMID:17879257|PMID:20886546,https://www.ncbi.nlm.nih.gov/pubmed/17879257|https://www.ncbi.nlm.nih.gov/pubmed/20886546,17879257|20886546,,
4124,1516241,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,22800,RRAS2,https://ctdbase.org/detail.go?type=gene&acc=22800,,,22800.0,RRAS2,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of RRAS2 mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
4125,1516242,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6238,RRBP1,https://ctdbase.org/detail.go?type=gene&acc=6238,,,6238.0,RRBP1,9606.0,Homo sapiens (human),Sodium arsenite promotes the reaction [RRBP1 protein binds to CAPRIN1 protein],,,PMID:33939924,https://www.ncbi.nlm.nih.gov/pubmed/33939924,33939924,,
4126,1517567,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,284618,RUSC1-AS1,https://ctdbase.org/detail.go?type=gene&acc=284618,,,284618.0,RUSC1-AS1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RUSC1-AS1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4127,1517568,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64755,RUSF1,https://ctdbase.org/detail.go?type=gene&acc=64755,,,64755.0,RUSF1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of and affects the splicing of RUSF1 mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
4128,1517569,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8607,RUVBL1,https://ctdbase.org/detail.go?type=gene&acc=8607,,,8607.0,RUVBL1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of RUVBL1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4129,1517570,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8607,RUVBL1,https://ctdbase.org/detail.go?type=gene&acc=8607,,,8607.0,RUVBL1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of RUVBL1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4130,1517571,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8607,RUVBL1,https://ctdbase.org/detail.go?type=gene&acc=8607,,,8607.0,RUVBL1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of RUVBL1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
4131,1517572,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10856,RUVBL2,https://ctdbase.org/detail.go?type=gene&acc=10856,,,10856.0,RUVBL2,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of RUVBL2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4132,1517741,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,59350,RXFP1,https://ctdbase.org/detail.go?type=gene&acc=59350,,,59350.0,RXFP1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of RXFP1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
4133,1517742,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,122042,RXFP2,https://ctdbase.org/detail.go?type=gene&acc=122042,,,122042.0,RXFP2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of RXFP2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
4134,1517743,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100004589,RXFP3.2B,https://ctdbase.org/detail.go?type=gene&acc=100004589,,,100004589.0,rxfp3.2b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of RXFP3.2B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4135,1517744,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,8078.0,Fundulus heteroclitus (mummichog),Sodium arsenite affects the expression of RXRA mRNA,,,PMID:22058191,https://www.ncbi.nlm.nih.gov/pubmed/22058191,22058191,,
4136,1517745,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of RXRA gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
4137,1517927,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of RXRA mRNA,,,PMID:19822182|PMID:23221991,https://www.ncbi.nlm.nih.gov/pubmed/19822182|https://www.ncbi.nlm.nih.gov/pubmed/23221991,19822182|23221991,,
4138,1517928,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,555578,RXRAA,https://ctdbase.org/detail.go?type=gene&acc=555578,,,555578.0,rxraa,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of RXRAA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4139,1517929,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6258,RXRG,https://ctdbase.org/detail.go?type=gene&acc=6258,,,6258.0,RXRG,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of RXRG mRNA,,,PMID:31532247,https://www.ncbi.nlm.nih.gov/pubmed/31532247,31532247,,
4140,1517930,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,436617,RXRGB,https://ctdbase.org/detail.go?type=gene&acc=436617,,,436617.0,rxrgb,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of RXRGB mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4141,1517931,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,104169670,RXYLT1-AS1,https://ctdbase.org/detail.go?type=gene&acc=104169670,,,104169670.0,RXYLT1-AS1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RXYLT1-AS1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4142,1517932,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23429,RYBP,https://ctdbase.org/detail.go?type=gene&acc=23429,,,23429.0,RYBP,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of RYBP mRNA,,,PMID:35364107,https://www.ncbi.nlm.nih.gov/pubmed/35364107,35364107,,
4143,1517933,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),MAPK8 protein promotes the reaction [sodium arsenite results in increased activity of CASP3 protein]|gadd45a protein promotes the reaction [sodium arsenite results in increased activity of CASP3 protein]|mapk9 protein promotes the reaction [sodium arsenite results in increased activity of CASP3 protein],,,PMID:16973625,https://www.ncbi.nlm.nih.gov/pubmed/16973625,16973625,,
4144,1517934,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased activity of and results in increased cleavage of CASP3 protein|[gclm co-treated with GCLC] inhibits the reaction [sodium arsenite results in increased activity of and results in increased cleavage of CASP3 protein],,,PMID:20006689,https://www.ncbi.nlm.nih.gov/pubmed/20006689,20006689,,
4145,1517935,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),[[lead chloride results in increased abundance of lead] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in increased expression of CASP3 protein|[methylmercuric chloride co-treated with [sodium arsenite results in increased abundance of arsenic]] results in increased expression of CASP3 protein,,,PMID:32179164,https://www.ncbi.nlm.nih.gov/pubmed/32179164,32179164,,
4146,1517936,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),Melatonin inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein],,,PMID:29763682,https://www.ncbi.nlm.nih.gov/pubmed/29763682,29763682,,
4147,1517937,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),SOD2 protein inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein modified form]|ncl protein promotes the reaction [sodium arsenite results in increased expression of CASP3 protein modified form],,,PMID:25561743,https://www.ncbi.nlm.nih.gov/pubmed/25561743,25561743,,
4148,1522049,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Thymoquinone inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]|ebselen inhibits the reaction [sodium arsenite results in decreased activity of CAT protein],,,PMID:30558456,https://www.ncbi.nlm.nih.gov/pubmed/30558456,30558456,,
4149,1523102,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,189714,CLEC-163,https://ctdbase.org/detail.go?type=gene&acc=189714,,,189714.0,clec-163,6239.0,Caenorhabditis elegans,Sodium arsenite results in increased expression of CLEC-163 mRNA,,,PMID:23894281,https://www.ncbi.nlm.nih.gov/pubmed/23894281,23894281,,
4150,1523103,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,185440,CLEC-165,https://ctdbase.org/detail.go?type=gene&acc=185440,,,185440.0,clec-165,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of CLEC-165 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
4151,1523104,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,3565354,CLEC-170,https://ctdbase.org/detail.go?type=gene&acc=3565354,,,3565354.0,clec-170,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of CLEC-170 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
4152,1523105,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,497190,CLEC18B,https://ctdbase.org/detail.go?type=gene&acc=497190,,,497190.0,CLEC18B,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of CLEC18B mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4153,1523106,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,183598,CLEC-198,https://ctdbase.org/detail.go?type=gene&acc=183598,,,183598.0,clec-198,6239.0,Caenorhabditis elegans,[SKN-1 protein co-treated with sodium arsenite] results in increased expression of CLEC-198 mRNA,,,PMID:19575768,https://www.ncbi.nlm.nih.gov/pubmed/19575768,19575768,,
4154,1523107,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51266,CLEC1B,https://ctdbase.org/detail.go?type=gene&acc=51266,,,51266.0,CLEC1B,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of CLEC1B mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
4155,1524289,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9575,CLOCK,https://ctdbase.org/detail.go?type=gene&acc=9575,,,9575.0,CLOCK,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of CLOCK mRNA,,,PMID:30130555,https://www.ncbi.nlm.nih.gov/pubmed/30130555,30130555,,
4156,1524290,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,176122,CLP-1,https://ctdbase.org/detail.go?type=gene&acc=176122,,,176122.0,clp-1,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in increased expression of CLP-1 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
4157,1524291,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,81570,CLPB,https://ctdbase.org/detail.go?type=gene&acc=81570,,,81570.0,CLPB,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of CLPB mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4158,1524292,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8192,CLPP,https://ctdbase.org/detail.go?type=gene&acc=8192,,,8192.0,CLPP,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of CLPP mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4159,1524293,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1208,CLPS,https://ctdbase.org/detail.go?type=gene&acc=1208,,,1208.0,CLPS,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of CLPS mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
4160,1524294,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1208,CLPS,https://ctdbase.org/detail.go?type=gene&acc=1208,,,1208.0,CLPS,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of CLPS mRNA,,,PMID:32068019,https://www.ncbi.nlm.nih.gov/pubmed/32068019,32068019,,
4161,1524295,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1209,CLPTM1,https://ctdbase.org/detail.go?type=gene&acc=1209,,,1209.0,CLPTM1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of CLPTM1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4162,1527348,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1303,COL12A1,https://ctdbase.org/detail.go?type=gene&acc=1303,,,1303.0,COL12A1,9606.0,Homo sapiens (human),Sodium arsenite results in increased stability of COL12A1 mRNA,,,PMID:25493608,https://www.ncbi.nlm.nih.gov/pubmed/25493608,25493608,,
4163,1527349,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,178193,COL-130,https://ctdbase.org/detail.go?type=gene&acc=178193,,,178193.0,col-130,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of COL-130 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
4164,1527350,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1305,COL13A1,https://ctdbase.org/detail.go?type=gene&acc=1305,,,1305.0,COL13A1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of COL13A1 mRNA,,,PMID:20371982,https://www.ncbi.nlm.nih.gov/pubmed/20371982,20371982,,
4165,1527351,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,177559,COL-14,https://ctdbase.org/detail.go?type=gene&acc=177559,,,177559.0,col-14,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of COL-14 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
4166,1527352,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,179296,COL-144,https://ctdbase.org/detail.go?type=gene&acc=179296,,,179296.0,col-144,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of COL-144 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
4167,1527353,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,179351,COL-147,https://ctdbase.org/detail.go?type=gene&acc=179351,,,179351.0,col-147,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of COL-147 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
4168,1527354,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7373,COL14A1,https://ctdbase.org/detail.go?type=gene&acc=7373,,,7373.0,COL14A1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of COL14A1 mRNA,,,PMID:31170414,https://www.ncbi.nlm.nih.gov/pubmed/31170414,31170414,,
4169,1527355,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7373,COL14A1,https://ctdbase.org/detail.go?type=gene&acc=7373,,,7373.0,COL14A1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of COL14A1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
4170,1527356,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,321298,COL14A1A,https://ctdbase.org/detail.go?type=gene&acc=321298,,,321298.0,col14a1a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of COL14A1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4171,1528404,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of COL3A1 protein|sodium arsenite results in increased expression of COL3A1 mRNA,,,PMID:19095001,https://www.ncbi.nlm.nih.gov/pubmed/19095001,19095001,,
4172,1528405,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,10116.0,Rattus norvegicus (Norway rat),Candesartan cilexetil inhibits the reaction [sodium arsenite results in increased expression of COL3A1 protein]|sodium arsenite results in increased expression of COL3A1 protein,,,PMID:27889505,https://www.ncbi.nlm.nih.gov/pubmed/27889505,27889505,,
4173,1528406,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of COL3A1 mRNA,,,PMID:19072884,https://www.ncbi.nlm.nih.gov/pubmed/19072884,19072884,,
4174,1528940,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1290,COL5A2,https://ctdbase.org/detail.go?type=gene&acc=1290,,,1290.0,COL5A2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of COL5A2 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
4175,1528941,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1290,COL5A2,https://ctdbase.org/detail.go?type=gene&acc=1290,,,1290.0,COL5A2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of COL5A2 mRNA,,,PMID:31170414|PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/31170414|https://www.ncbi.nlm.nih.gov/pubmed/37682722,31170414|37682722,,
4176,1529213,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,50509,COL5A3,https://ctdbase.org/detail.go?type=gene&acc=50509,,,50509.0,COL5A3,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of COL5A3 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
4177,1529214,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,50509,COL5A3,https://ctdbase.org/detail.go?type=gene&acc=50509,,,50509.0,COL5A3,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of COL5A3 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
4178,1529215,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100463515,COL5A3B,https://ctdbase.org/detail.go?type=gene&acc=100463515,,,100463515.0,col5a3b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of COL5A3B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4179,1529216,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,187138,COL-65,https://ctdbase.org/detail.go?type=gene&acc=187138,,,187138.0,col-65,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of COL-65 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
4180,1529217,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1291,COL6A1,https://ctdbase.org/detail.go?type=gene&acc=1291,,,1291.0,COL6A1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of COL6A1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4181,1529218,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1291,COL6A1,https://ctdbase.org/detail.go?type=gene&acc=1291,,,1291.0,COL6A1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of COL6A1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
4182,1529219,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1292,COL6A2,https://ctdbase.org/detail.go?type=gene&acc=1292,,,1292.0,COL6A2,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of COL6A2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
4183,1485015,443939,Drug Gene Interaction database (DGIdb),Doxorubicin Hydrochloride,,DOXORUBICIN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:142433,,TP53,https://www.dgidb.org/genes/hgnc:11998,,,7157.0,TP53,9606.0,Homo sapiens (human),,,,,,,,
4184,1495218,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,390439,OR11G2,https://ctdbase.org/detail.go?type=gene&acc=390439,,,390439.0,OR11G2,9606.0,Homo sapiens (human),Maleic acid results in increased expression of OR11G2 mRNA,,,PMID:28392987,https://www.ncbi.nlm.nih.gov/pubmed/28392987,28392987,,
4185,1495219,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,403282,OR6C65,https://ctdbase.org/detail.go?type=gene&acc=403282,,,403282.0,OR6C65,9606.0,Homo sapiens (human),Maleic acid results in increased expression of OR6C65 mRNA,,,PMID:28392987,https://www.ncbi.nlm.nih.gov/pubmed/28392987,28392987,,
4186,1495220,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,56135,PCDHAC1,https://ctdbase.org/detail.go?type=gene&acc=56135,,,56135.0,PCDHAC1,9606.0,Homo sapiens (human),Maleic acid results in increased expression of PCDHAC1 mRNA,,,PMID:28392987,https://www.ncbi.nlm.nih.gov/pubmed/28392987,28392987,,
4187,1495221,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,5170,PDPK1,https://ctdbase.org/detail.go?type=gene&acc=5170,,,5170.0,PDPK1,9606.0,Homo sapiens (human),Maleic acid results in decreased expression of PDPK1 mRNA,,,PMID:28392987,https://www.ncbi.nlm.nih.gov/pubmed/28392987,28392987,,
4188,1495222,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,168507,PKD1L1,https://ctdbase.org/detail.go?type=gene&acc=168507,,,168507.0,PKD1L1,9606.0,Homo sapiens (human),Maleic acid results in increased expression of PKD1L1 mRNA,,,PMID:28392987,https://www.ncbi.nlm.nih.gov/pubmed/28392987,28392987,,
4189,1495223,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,81492,RSPH6A,https://ctdbase.org/detail.go?type=gene&acc=81492,,,81492.0,RSPH6A,9606.0,Homo sapiens (human),Maleic acid results in increased expression of RSPH6A mRNA,,,PMID:28392987,https://www.ncbi.nlm.nih.gov/pubmed/28392987,28392987,,
4190,1495224,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,6274,S100A3,https://ctdbase.org/detail.go?type=gene&acc=6274,,,6274.0,S100A3,9606.0,Homo sapiens (human),Maleic acid results in increased expression of S100A3 mRNA,,,PMID:28392987,https://www.ncbi.nlm.nih.gov/pubmed/28392987,28392987,,
4191,1482772,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7474,WNT5A,https://ctdbase.org/detail.go?type=gene&acc=7474,,,7474.0,WNT5A,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of WNT5A mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4192,1482773,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7474,WNT5A,https://ctdbase.org/detail.go?type=gene&acc=7474,,,7474.0,WNT5A,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of WNT5A mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4193,1482774,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,81029,WNT5B,https://ctdbase.org/detail.go?type=gene&acc=81029,,,81029.0,WNT5B,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WNT5B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4194,1482775,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,81029,WNT5B,https://ctdbase.org/detail.go?type=gene&acc=81029,,,81029.0,WNT5B,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of WNT5B mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4195,1482776,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7475,WNT6,https://ctdbase.org/detail.go?type=gene&acc=7475,,,7475.0,WNT6,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of WNT6 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4196,1486792,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2290,FOXG1,https://ctdbase.org/detail.go?type=gene&acc=2290,,,2290.0,FOXG1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of FOXG1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4197,1486793,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,30274,FOXG1A,https://ctdbase.org/detail.go?type=gene&acc=30274,,,30274.0,foxg1a,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of FOXG1A mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4198,1486794,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8928,FOXH1,https://ctdbase.org/detail.go?type=gene&acc=8928,,,8928.0,FOXH1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXH1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4199,1486795,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8928,FOXH1,https://ctdbase.org/detail.go?type=gene&acc=8928,,,8928.0,FOXH1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of FOXH1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4200,1487513,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6624,FSCN1,https://ctdbase.org/detail.go?type=gene&acc=6624,,,6624.0,FSCN1,9606.0,Homo sapiens (human),Trichostatin A affects the expression of FSCN1 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4201,1487514,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,83856,FSD1L,https://ctdbase.org/detail.go?type=gene&acc=83856,,,83856.0,FSD1L,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FSD1L mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4202,1487515,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,83856,FSD1L,https://ctdbase.org/detail.go?type=gene&acc=83856,,,83856.0,FSD1L,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of FSD1L mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4203,1487516,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10468,FST,https://ctdbase.org/detail.go?type=gene&acc=10468,,,10468.0,FST,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FST mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4204,1490070,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2624,GATA2,https://ctdbase.org/detail.go?type=gene&acc=2624,,,2624.0,GATA2,9606.0,Homo sapiens (human),[decitabine co-treated with trichostatin A] results in increased expression of GATA2 mRNA,,,PMID:17185465,https://www.ncbi.nlm.nih.gov/pubmed/17185465,17185465,,
4205,1490071,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2624,GATA2,https://ctdbase.org/detail.go?type=gene&acc=2624,,,2624.0,GATA2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GATA2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4206,1490072,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2624,GATA2,https://ctdbase.org/detail.go?type=gene&acc=2624,,,2624.0,GATA2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of GATA2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4207,1490073,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2624,GATA2,https://ctdbase.org/detail.go?type=gene&acc=2624,,,2624.0,GATA2,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of GATA2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4208,1490074,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2625,GATA3,https://ctdbase.org/detail.go?type=gene&acc=2625,,,2625.0,GATA3,9606.0,Homo sapiens (human),[decitabine co-treated with trichostatin A] results in decreased expression of GATA3 mRNA,,,PMID:17891453,https://www.ncbi.nlm.nih.gov/pubmed/17891453,17891453,,
4209,1490075,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2625,GATA3,https://ctdbase.org/detail.go?type=gene&acc=2625,,,2625.0,GATA3,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GATA3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4210,1490076,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2625,GATA3,https://ctdbase.org/detail.go?type=gene&acc=2625,,,2625.0,GATA3,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of GATA3 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4211,1490077,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2626,GATA4,https://ctdbase.org/detail.go?type=gene&acc=2626,,,2626.0,GATA4,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in decreased expression of GATA4 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4212,1490544,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8521,GCM1,https://ctdbase.org/detail.go?type=gene&acc=8521,,,8521.0,GCM1,9606.0,Homo sapiens (human),Trichostatin A promotes the reaction [colforsin results in increased acetylation of and results in increased activity of GCM1 protein],,,PMID:16166624,https://www.ncbi.nlm.nih.gov/pubmed/16166624,16166624,,
4213,1490545,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9247,GCM2,https://ctdbase.org/detail.go?type=gene&acc=9247,,,9247.0,GCM2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of GCM2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4214,1490546,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2650,GCNT1,https://ctdbase.org/detail.go?type=gene&acc=2650,,,2650.0,GCNT1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GCNT1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4215,1490547,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2650,GCNT1,https://ctdbase.org/detail.go?type=gene&acc=2650,,,2650.0,GCNT1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of GCNT1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4216,1490841,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,85407,NKD1,https://ctdbase.org/detail.go?type=gene&acc=85407,,,85407.0,NKD1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NKD1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4217,1490842,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,85407,NKD1,https://ctdbase.org/detail.go?type=gene&acc=85407,,,85407.0,NKD1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of NKD1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4218,1490843,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,28512,NKIRAS1,https://ctdbase.org/detail.go?type=gene&acc=28512,,,28512.0,NKIRAS1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKIRAS1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4219,1492104,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,169792,GLIS3,https://ctdbase.org/detail.go?type=gene&acc=169792,,,169792.0,GLIS3,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLIS3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4220,1492105,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,169792,GLIS3,https://ctdbase.org/detail.go?type=gene&acc=169792,,,169792.0,GLIS3,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of GLIS3 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4221,1492106,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,11146,GLMN,https://ctdbase.org/detail.go?type=gene&acc=11146,,,11146.0,GLMN,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of GLMN mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4222,1492107,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2739,GLO1,https://ctdbase.org/detail.go?type=gene&acc=2739,,,2739.0,GLO1,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of GLO1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4223,1492108,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,51031,GLOD4,https://ctdbase.org/detail.go?type=gene&acc=51031,,,51031.0,GLOD4,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of GLOD4 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4224,1492109,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2743,GLRB,https://ctdbase.org/detail.go?type=gene&acc=2743,,,2743.0,GLRB,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of GLRB mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4225,1492110,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2745,GLRX,https://ctdbase.org/detail.go?type=gene&acc=2745,,,2745.0,GLRX,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of GLRX mRNA,,,PMID:24935251|PMID:27188386|PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28542535,24935251|27188386|28542535,,
4226,1492111,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,51022,GLRX2,https://ctdbase.org/detail.go?type=gene&acc=51022,,,51022.0,GLRX2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLRX2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4227,1493430,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9570,GOSR2,https://ctdbase.org/detail.go?type=gene&acc=9570,,,9570.0,GOSR2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of GOSR2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4228,1493431,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55105,GPATCH2,https://ctdbase.org/detail.go?type=gene&acc=55105,,,55105.0,GPATCH2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPATCH2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4229,1493915,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,246094,GPIA,https://ctdbase.org/detail.go?type=gene&acc=246094,,,246094.0,gpia,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of GPIA mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4230,1493916,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2823,GPM6A,https://ctdbase.org/detail.go?type=gene&acc=2823,,,2823.0,GPM6A,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPM6A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4231,1493917,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2823,GPM6A,https://ctdbase.org/detail.go?type=gene&acc=2823,,,2823.0,GPM6A,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of GPM6A mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4232,1494931,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2882,GPX7,https://ctdbase.org/detail.go?type=gene&acc=2882,,,2882.0,GPX7,9606.0,Homo sapiens (human),Trichostatin A promotes the reaction [[decitabine affects the methylation of GPX7 promoter] which affects the expression of GPX7 protein],,,PMID:18664505,https://www.ncbi.nlm.nih.gov/pubmed/18664505,18664505|18664505,,
4233,1494932,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57476,GRAMD1B,https://ctdbase.org/detail.go?type=gene&acc=57476,,,57476.0,GRAMD1B,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of GRAMD1B mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4234,1494933,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54762,GRAMD1C,https://ctdbase.org/detail.go?type=gene&acc=54762,,,54762.0,GRAMD1C,9606.0,Homo sapiens (human),Trichostatin A affects the expression of GRAMD1C mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4235,1494934,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54762,GRAMD1C,https://ctdbase.org/detail.go?type=gene&acc=54762,,,54762.0,GRAMD1C,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of GRAMD1C mrna|trichostatin A results in decreased expression of GRAMD1C mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4236,1494935,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,65983,GRAMD2B,https://ctdbase.org/detail.go?type=gene&acc=65983,,,65983.0,GRAMD2B,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of GRAMD2B mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4237,1494936,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23151,GRAMD4,https://ctdbase.org/detail.go?type=gene&acc=23151,,,23151.0,GRAMD4,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of GRAMD4 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4238,1494937,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2888,GRB14,https://ctdbase.org/detail.go?type=gene&acc=2888,,,2888.0,GRB14,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of GRB14 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4239,1494938,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of GREB1 mrna|trichostatin A results in decreased expression of GREB1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4240,1494939,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,26585,GREM1,https://ctdbase.org/detail.go?type=gene&acc=26585,,,26585.0,GREM1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GREM1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4241,1495225,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84304,NUDT22,https://ctdbase.org/detail.go?type=gene&acc=84304,,,84304.0,NUDT22,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of NUDT22 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4242,1495226,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,4927,NUP88,https://ctdbase.org/detail.go?type=gene&acc=4927,,,4927.0,NUP88,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of NUP88 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4243,1495227,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,11163,NUDT4,https://ctdbase.org/detail.go?type=gene&acc=11163,,,11163.0,NUDT4,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NUDT4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4244,1497217,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,127700,OSCP1,https://ctdbase.org/detail.go?type=gene&acc=127700,,,127700.0,OSCP1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of OSCP1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4245,1497218,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5008,OSM,https://ctdbase.org/detail.go?type=gene&acc=5008,,,5008.0,OSM,10090.0,Mus musculus (house mouse),Trichostatin A inhibits the reaction [IL3 protein results in increased expression of OSM mrna],,,PMID:25769527,https://www.ncbi.nlm.nih.gov/pubmed/25769527,25769527,,
4246,1498097,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55003,PAK1IP1,https://ctdbase.org/detail.go?type=gene&acc=55003,,,55003.0,PAK1IP1,9606.0,Homo sapiens (human),Trichostatin A affects the expression of PAK1IP1 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4247,1498098,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5063,PAK3,https://ctdbase.org/detail.go?type=gene&acc=5063,,,5063.0,PAK3,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAK3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4248,1498099,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5063,PAK3,https://ctdbase.org/detail.go?type=gene&acc=5063,,,5063.0,PAK3,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of PAK3 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4249,1498100,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57144,PAK5,https://ctdbase.org/detail.go?type=gene&acc=57144,,,57144.0,PAK5,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PAK5 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4250,1498101,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23022,PALLD,https://ctdbase.org/detail.go?type=gene&acc=23022,,,23022.0,PALLD,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PALLD mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4251,1498102,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23022,PALLD,https://ctdbase.org/detail.go?type=gene&acc=23022,,,23022.0,PALLD,9606.0,Homo sapiens (human),Trichostatin A affects the expression of PALLD mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4252,1498267,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,121504,H4C16,https://ctdbase.org/detail.go?type=gene&acc=121504,,,121504.0,H4C16,9606.0,Homo sapiens (human),Trichostatin A results in increased acetylation of H4C16 protein,,,PMID:16009488|PMID:16740727|PMID:17330857|PMID:19503093,https://www.ncbi.nlm.nih.gov/pubmed/16009488|https://www.ncbi.nlm.nih.gov/pubmed/16740727|https://www.ncbi.nlm.nih.gov/pubmed/17330857|https://www.ncbi.nlm.nih.gov/pubmed/19503093,16009488|16740727|17330857|19503093,,
4253,1498268,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,22927,HABP4,https://ctdbase.org/detail.go?type=gene&acc=22927,,,22927.0,HABP4,9606.0,Homo sapiens (human),Trichostatin A affects the expression of HABP4 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4254,1498269,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9200,HACD1,https://ctdbase.org/detail.go?type=gene&acc=9200,,,9200.0,HACD1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HACD1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4255,1498864,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,22882,ZHX2,https://ctdbase.org/detail.go?type=gene&acc=22882,,,22882.0,ZHX2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZHX2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4256,1498865,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,22882,ZHX2,https://ctdbase.org/detail.go?type=gene&acc=22882,,,22882.0,ZHX2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of ZHX2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4257,1498866,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7545,ZIC1,https://ctdbase.org/detail.go?type=gene&acc=7545,,,7545.0,ZIC1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZIC1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4258,1498867,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7545,ZIC1,https://ctdbase.org/detail.go?type=gene&acc=7545,,,7545.0,ZIC1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of ZIC1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4259,1498868,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7545,ZIC1,https://ctdbase.org/detail.go?type=gene&acc=7545,,,7545.0,ZIC1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of ZIC1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4260,1498869,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7545,ZIC1,https://ctdbase.org/detail.go?type=gene&acc=7545,,,7545.0,ZIC1,10090.0,Mus musculus (house mouse),Trichostatin A promotes the reaction [decitabine results in increased expression of ZIC1 mrna],,,PMID:17936758,https://www.ncbi.nlm.nih.gov/pubmed/17936758,17936758,,
4261,1511193,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,144165,PRICKLE1,https://ctdbase.org/detail.go?type=gene&acc=144165,,,144165.0,PRICKLE1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRICKLE1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4262,1511194,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,144165,PRICKLE1,https://ctdbase.org/detail.go?type=gene&acc=144165,,,144165.0,PRICKLE1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of PRICKLE1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4263,1511195,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,166336,PRICKLE2,https://ctdbase.org/detail.go?type=gene&acc=166336,,,166336.0,PRICKLE2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PRICKLE2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4264,1511196,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5558,PRIM2,https://ctdbase.org/detail.go?type=gene&acc=5558,,,5558.0,PRIM2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PRIM2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4265,1511197,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,145270,PRIMA1,https://ctdbase.org/detail.go?type=gene&acc=145270,,,145270.0,PRIMA1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PRIMA1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4266,1511198,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5563,PRKAA2,https://ctdbase.org/detail.go?type=gene&acc=5563,,,5563.0,PRKAA2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PRKAA2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4267,1511924,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,115207,KCTD12,https://ctdbase.org/detail.go?type=gene&acc=115207,,,115207.0,KCTD12,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD12 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4268,1511925,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,115207,KCTD12,https://ctdbase.org/detail.go?type=gene&acc=115207,,,115207.0,KCTD12,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of KCTD12 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4269,1511926,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,79047,KCTD15,https://ctdbase.org/detail.go?type=gene&acc=79047,,,79047.0,KCTD15,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of KCTD15 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4270,1511927,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57528,KCTD16,https://ctdbase.org/detail.go?type=gene&acc=57528,,,57528.0,KCTD16,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of KCTD16 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4271,1511928,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,130535,KCTD18,https://ctdbase.org/detail.go?type=gene&acc=130535,,,130535.0,KCTD18,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of KCTD18 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4272,1511929,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54442,KCTD5,https://ctdbase.org/detail.go?type=gene&acc=54442,,,54442.0,KCTD5,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of KCTD5 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4273,1511930,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,154881,KCTD7,https://ctdbase.org/detail.go?type=gene&acc=154881,,,154881.0,KCTD7,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of KCTD7 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4274,1511931,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,11014,KDELR2,https://ctdbase.org/detail.go?type=gene&acc=11014,,,11014.0,KDELR2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4275,1511932,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9729,KIAA0408,https://ctdbase.org/detail.go?type=gene&acc=9729,,,9729.0,KIAA0408,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of KIAA0408 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4276,1511933,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5862,RAB2A,https://ctdbase.org/detail.go?type=gene&acc=5862,,,5862.0,RAB2A,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RAB2A mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4277,1512832,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5886,RAD23A,https://ctdbase.org/detail.go?type=gene&acc=5886,,,5886.0,RAD23A,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of RAD23A mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4278,1512833,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5886,RAD23A,https://ctdbase.org/detail.go?type=gene&acc=5886,,,5886.0,RAD23A,9606.0,Homo sapiens (human),Trichostatin A affects the expression of RAD23A mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4279,1512834,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5887,RAD23B,https://ctdbase.org/detail.go?type=gene&acc=5887,,,5887.0,RAD23B,9606.0,Homo sapiens (human),Trichostatin A affects the expression of RAD23B mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4280,1512835,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5888,RAD51,https://ctdbase.org/detail.go?type=gene&acc=5888,,,5888.0,RAD51,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RAD51 mRNA,,,PMID:23770000,https://www.ncbi.nlm.nih.gov/pubmed/23770000,23770000,,
4281,1512836,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5892,RAD51D,https://ctdbase.org/detail.go?type=gene&acc=5892,,,5892.0,RAD51D,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of RAD51D mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4282,1512999,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5663,PSEN1,https://ctdbase.org/detail.go?type=gene&acc=5663,,,5663.0,PSEN1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of PSEN1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4283,1513000,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5699,PSMB10,https://ctdbase.org/detail.go?type=gene&acc=5699,,,5699.0,PSMB10,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PSMB10 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4284,1513001,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5692,PSMB4,https://ctdbase.org/detail.go?type=gene&acc=5692,,,5692.0,PSMB4,9606.0,Homo sapiens (human),[trichostatin A co-treated with decitabine] results in decreased expression of PSMB4 protein,,,PMID:19294695,https://www.ncbi.nlm.nih.gov/pubmed/19294695,19294695,,
4285,1513002,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5695,PSMB7,https://ctdbase.org/detail.go?type=gene&acc=5695,,,5695.0,PSMB7,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PSMB7 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4286,1513003,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5698,PSMB9,https://ctdbase.org/detail.go?type=gene&acc=5698,,,5698.0,PSMB9,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PSMB9 mrna|trichostatin A results in decreased expression of PSMB9 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4287,1513004,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5701,PSMC2,https://ctdbase.org/detail.go?type=gene&acc=5701,,,5701.0,PSMC2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of PSMC2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4288,1513005,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5713,PSMD7,https://ctdbase.org/detail.go?type=gene&acc=5713,,,5713.0,PSMD7,9606.0,Homo sapiens (human),Trichostatin A affects the expression of PSMD7 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4289,1513006,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23198,PSME4,https://ctdbase.org/detail.go?type=gene&acc=23198,,,23198.0,PSME4,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PSME4 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4290,1515534,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5836,PYGL,https://ctdbase.org/detail.go?type=gene&acc=5836,,,5836.0,PYGL,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PYGL mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4291,1515535,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,393444,PYGMB,https://ctdbase.org/detail.go?type=gene&acc=393444,,,393444.0,pygmb,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of PYGMB mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4292,1515536,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84305,PYM1,https://ctdbase.org/detail.go?type=gene&acc=84305,,,84305.0,PYM1,9606.0,Homo sapiens (human),Trichostatin A affects the expression of PYM1 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4293,1515537,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,30211,PYYA,https://ctdbase.org/detail.go?type=gene&acc=30211,,,30211.0,pyya,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of PYYA mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4294,1515538,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9444,QKI,https://ctdbase.org/detail.go?type=gene&acc=9444,,,9444.0,QKI,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of QKI mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4295,1515539,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9444,QKI,https://ctdbase.org/detail.go?type=gene&acc=9444,,,9444.0,QKI,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of QKI mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4296,1515970,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84440,RAB11FIP4,https://ctdbase.org/detail.go?type=gene&acc=84440,,,84440.0,RAB11FIP4,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RAB11FIP4 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4297,1515971,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5872,RAB13,https://ctdbase.org/detail.go?type=gene&acc=5872,,,5872.0,RAB13,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB13 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4298,1515972,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5872,RAB13,https://ctdbase.org/detail.go?type=gene&acc=5872,,,5872.0,RAB13,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RAB13 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4299,1515973,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,22931,RAB18,https://ctdbase.org/detail.go?type=gene&acc=22931,,,22931.0,RAB18,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RAB18 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4300,1515974,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55647,RAB20,https://ctdbase.org/detail.go?type=gene&acc=55647,,,55647.0,RAB20,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4301,1515975,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55647,RAB20,https://ctdbase.org/detail.go?type=gene&acc=55647,,,55647.0,RAB20,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RAB20 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4302,1515976,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,53917,RAB24,https://ctdbase.org/detail.go?type=gene&acc=53917,,,53917.0,RAB24,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of RAB24 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4303,1515977,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57111,RAB25,https://ctdbase.org/detail.go?type=gene&acc=57111,,,57111.0,RAB25,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB25 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4304,1515978,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57111,RAB25,https://ctdbase.org/detail.go?type=gene&acc=57111,,,57111.0,RAB25,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RAB25 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4305,1516243,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5873,RAB27A,https://ctdbase.org/detail.go?type=gene&acc=5873,,,5873.0,RAB27A,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in decreased expression of RAB27A mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4306,1516244,444732,Drug Gene Interaction database (DGIdb),trichostatin A,,TRICHOSTATIN A,https://www.dgidb.org/drugs/ncit:C1261,,CDKN2D,https://www.dgidb.org/genes/hgnc:1790,,,1032.0,CDKN2D,9606.0,Homo sapiens (human),,,,,,,,
4307,1517030,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5990,RFX2,https://ctdbase.org/detail.go?type=gene&acc=5990,,,5990.0,RFX2,9606.0,Homo sapiens (human),Trichostatin A affects the expression of RFX2 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4308,1517031,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5990,RFX2,https://ctdbase.org/detail.go?type=gene&acc=5990,,,5990.0,RFX2,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of RFX2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4309,1517032,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5991,RFX3,https://ctdbase.org/detail.go?type=gene&acc=5991,,,5991.0,RFX3,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RFX3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4310,1518402,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23504,RIMBP2,https://ctdbase.org/detail.go?type=gene&acc=23504,,,23504.0,RIMBP2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RIMBP2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4311,1518403,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57494,RIMKLB,https://ctdbase.org/detail.go?type=gene&acc=57494,,,57494.0,RIMKLB,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RIMKLB mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4312,1518404,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57494,RIMKLB,https://ctdbase.org/detail.go?type=gene&acc=57494,,,57494.0,RIMKLB,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RIMKLB mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4313,1518405,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,22999,RIMS1,https://ctdbase.org/detail.go?type=gene&acc=22999,,,22999.0,RIMS1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RIMS1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4314,1518406,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,22999,RIMS1,https://ctdbase.org/detail.go?type=gene&acc=22999,,,22999.0,RIMS1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RIMS1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4315,1518407,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9699,RIMS2,https://ctdbase.org/detail.go?type=gene&acc=9699,,,9699.0,RIMS2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RIMS2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4316,1518408,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9699,RIMS2,https://ctdbase.org/detail.go?type=gene&acc=9699,,,9699.0,RIMS2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RIMS2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4317,1519253,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,11236,RNF139,https://ctdbase.org/detail.go?type=gene&acc=11236,,,11236.0,RNF139,9606.0,Homo sapiens (human),Trichostatin A affects the expression of RNF139 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4318,1519254,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9604,RNF14,https://ctdbase.org/detail.go?type=gene&acc=9604,,,9604.0,RNF14,9606.0,Homo sapiens (human),Trichostatin A affects the expression of RNF14 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4319,1520927,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9674,KIAA0040,https://ctdbase.org/detail.go?type=gene&acc=9674,,,9674.0,KIAA0040,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of KIAA0040 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4320,1520928,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23313,KIAA0930,https://ctdbase.org/detail.go?type=gene&acc=23313,,,23313.0,KIAA0930,9606.0,Homo sapiens (human),Trichostatin A affects the expression of KIAA0930 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4321,1520929,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57179,KIAA1191,https://ctdbase.org/detail.go?type=gene&acc=57179,,,57179.0,KIAA1191,9606.0,Homo sapiens (human),Trichostatin A affects the expression of KIAA1191 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4322,1520930,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,56243,KIAA1217,https://ctdbase.org/detail.go?type=gene&acc=56243,,,56243.0,KIAA1217,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of KIAA1217 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4323,1520931,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,25758,KIAA1549L,https://ctdbase.org/detail.go?type=gene&acc=25758,,,25758.0,KIAA1549L,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of KIAA1549L mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4324,1520932,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,85379,KIAA1671,https://ctdbase.org/detail.go?type=gene&acc=85379,,,85379.0,KIAA1671,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIAA1671 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4325,1520933,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,85379,KIAA1671,https://ctdbase.org/detail.go?type=gene&acc=85379,,,85379.0,KIAA1671,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of KIAA1671 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4326,1520934,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,85449,KIAA1755,https://ctdbase.org/detail.go?type=gene&acc=85449,,,85449.0,KIAA1755,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIAA1755 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4327,1521673,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6252,RTN1,https://ctdbase.org/detail.go?type=gene&acc=6252,,,6252.0,RTN1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RTN1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4328,1521674,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6252,RTN1,https://ctdbase.org/detail.go?type=gene&acc=6252,,,6252.0,RTN1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RTN1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4329,1521675,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84623,KIRREL3,https://ctdbase.org/detail.go?type=gene&acc=84623,,,84623.0,KIRREL3,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of KIRREL3 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4330,1521676,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84634,KISS1R,https://ctdbase.org/detail.go?type=gene&acc=84634,,,84634.0,KISS1R,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of KISS1R mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4331,1521677,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3815,KIT,https://ctdbase.org/detail.go?type=gene&acc=3815,,,3815.0,KIT,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIT mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4332,1521678,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3815,KIT,https://ctdbase.org/detail.go?type=gene&acc=3815,,,3815.0,KIT,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of KIT mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4333,1521679,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,4254,KITLG,https://ctdbase.org/detail.go?type=gene&acc=4254,,,4254.0,KITLG,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KITLG mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4334,1521680,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,4254,KITLG,https://ctdbase.org/detail.go?type=gene&acc=4254,,,4254.0,KITLG,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of KITLG mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4335,1521681,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55857,KIZ,https://ctdbase.org/detail.go?type=gene&acc=55857,,,55857.0,KIZ,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIZ mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4336,1521682,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55857,KIZ,https://ctdbase.org/detail.go?type=gene&acc=55857,,,55857.0,KIZ,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of KIZ mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4337,1521683,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7071,KLF10,https://ctdbase.org/detail.go?type=gene&acc=7071,,,7071.0,KLF10,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of KLF10 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4338,1521848,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,28999,KLF15,https://ctdbase.org/detail.go?type=gene&acc=28999,,,28999.0,KLF15,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of KLF15 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4339,1522209,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57565,KLHL14,https://ctdbase.org/detail.go?type=gene&acc=57565,,,57565.0,KLHL14,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of KLHL14 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4340,1522210,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57565,KLHL14,https://ctdbase.org/detail.go?type=gene&acc=57565,,,57565.0,KLHL14,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of KLHL14 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4341,1522211,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,80311,KLHL15,https://ctdbase.org/detail.go?type=gene&acc=80311,,,80311.0,KLHL15,9606.0,Homo sapiens (human),Trichostatin A affects the expression of KLHL15 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4342,1522212,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,11275,KLHL2,https://ctdbase.org/detail.go?type=gene&acc=11275,,,11275.0,KLHL2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4343,1522213,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,11275,KLHL2,https://ctdbase.org/detail.go?type=gene&acc=11275,,,11275.0,KLHL2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of KLHL2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4344,1522214,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9903,KLHL21,https://ctdbase.org/detail.go?type=gene&acc=9903,,,9903.0,KLHL21,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4345,1522955,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57082,KNL1,https://ctdbase.org/detail.go?type=gene&acc=57082,,,57082.0,KNL1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KNL1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4346,1522956,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57082,KNL1,https://ctdbase.org/detail.go?type=gene&acc=57082,,,57082.0,KNL1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of KNL1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4347,1522957,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3841,KPNA5,https://ctdbase.org/detail.go?type=gene&acc=3841,,,3841.0,KPNA5,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KPNA5 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4348,1523674,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,114294,LACTB,https://ctdbase.org/detail.go?type=gene&acc=114294,,,114294.0,LACTB,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LACTB mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4349,1523675,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3908,LAMA2,https://ctdbase.org/detail.go?type=gene&acc=3908,,,3908.0,LAMA2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LAMA2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4350,1523676,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3910,LAMA4,https://ctdbase.org/detail.go?type=gene&acc=3910,,,3910.0,LAMA4,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMA4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4351,1523677,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3910,LAMA4,https://ctdbase.org/detail.go?type=gene&acc=3910,,,3910.0,LAMA4,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LAMA4 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4352,1523678,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3912,LAMB1,https://ctdbase.org/detail.go?type=gene&acc=3912,,,3912.0,LAMB1,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of LAMB1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4353,1523855,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3920,LAMP2,https://ctdbase.org/detail.go?type=gene&acc=3920,,,3920.0,LAMP2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LAMP2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4354,1523856,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,27074,LAMP3,https://ctdbase.org/detail.go?type=gene&acc=27074,,,27074.0,LAMP3,9606.0,Homo sapiens (human),[decitabine co-treated with trichostatin A] results in increased expression of LAMP3 mrna|estradiol inhibits the reaction [[decitabine co-treated with trichostatin A] results in increased expression of LAMP3 mrna]|estradiol inhibits the reaction [trichostatin A results in increased expression of LAMP3 mrna],,,PMID:20678512,https://www.ncbi.nlm.nih.gov/pubmed/20678512,20678512,,
4355,1523857,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,27074,LAMP3,https://ctdbase.org/detail.go?type=gene&acc=27074,,,27074.0,LAMP3,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LAMP3 mRNA,,,PMID:20678512|PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/20678512|https://www.ncbi.nlm.nih.gov/pubmed/24935251,20678512|24935251,,
4356,1523858,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55915,LANCL2,https://ctdbase.org/detail.go?type=gene&acc=55915,,,55915.0,LANCL2,9606.0,Homo sapiens (human),Trichostatin A affects the expression of LANCL2 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4357,1523859,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55915,LANCL2,https://ctdbase.org/detail.go?type=gene&acc=55915,,,55915.0,LANCL2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of LANCL2 mRNA,,,PMID:24935251|PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/28542535,24935251|28542535,,
4358,1523860,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,444201,LAPTM4A.S,https://ctdbase.org/detail.go?type=gene&acc=444201,,,444201.0,laptm4a.S,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in decreased expression of LAPTM4A.S mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4359,1523861,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23367,LARP1,https://ctdbase.org/detail.go?type=gene&acc=23367,,,23367.0,LARP1,9606.0,Homo sapiens (human),Trichostatin A affects the expression of LARP1 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4360,1523862,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55132,LARP1B,https://ctdbase.org/detail.go?type=gene&acc=55132,,,55132.0,LARP1B,9606.0,Homo sapiens (human),Trichostatin A affects the expression of LARP1B mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4361,1524018,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,81606,LBH,https://ctdbase.org/detail.go?type=gene&acc=81606,,,81606.0,LBH,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LBH mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4362,1525632,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10512,SEMA3C,https://ctdbase.org/detail.go?type=gene&acc=10512,,,10512.0,SEMA3C,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SEMA3C mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4363,1525633,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9723,SEMA3E,https://ctdbase.org/detail.go?type=gene&acc=9723,,,9723.0,SEMA3E,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4364,1525634,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9723,SEMA3E,https://ctdbase.org/detail.go?type=gene&acc=9723,,,9723.0,SEMA3E,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SEMA3E mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4365,1525635,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6405,SEMA3F,https://ctdbase.org/detail.go?type=gene&acc=6405,,,6405.0,SEMA3F,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SEMA3F mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4366,1525636,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10507,SEMA4D,https://ctdbase.org/detail.go?type=gene&acc=10507,,,10507.0,SEMA4D,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEMA4D mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4367,1525637,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10507,SEMA4D,https://ctdbase.org/detail.go?type=gene&acc=10507,,,10507.0,SEMA4D,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SEMA4D mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4368,1525850,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,51091,SEPSECS,https://ctdbase.org/detail.go?type=gene&acc=51091,,,51091.0,SEPSECS,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SEPSECS mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4369,1525851,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,151011,SEPTIN10,https://ctdbase.org/detail.go?type=gene&acc=151011,,,151011.0,SEPTIN10,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEPTIN10 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4370,1525963,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,100128822,LINC01003,https://ctdbase.org/detail.go?type=gene&acc=100128822,,,100128822.0,LINC01003,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LINC01003 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4371,1525964,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,100507254,LINC01013,https://ctdbase.org/detail.go?type=gene&acc=100507254,,,100507254.0,LINC01013,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LINC01013 mRNA,,,PMID:26705709,https://www.ncbi.nlm.nih.gov/pubmed/26705709,26705709,,
4372,1525965,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,643837,LINC01128,https://ctdbase.org/detail.go?type=gene&acc=643837,,,643837.0,LINC01128,9606.0,Homo sapiens (human),"Trichostatin A results in decreased expression of LINC01128 mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LINC01128 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4373,1525966,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,643837,LINC01128,https://ctdbase.org/detail.go?type=gene&acc=643837,,,643837.0,LINC01128,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LINC01128 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4374,1525967,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,101927498,LINC01361,https://ctdbase.org/detail.go?type=gene&acc=101927498,,,101927498.0,LINC01361,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LINC01361 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4375,1526330,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3993,LLGL2,https://ctdbase.org/detail.go?type=gene&acc=3993,,,3993.0,LLGL2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of LLGL2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4376,1527225,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,151354,LRATD1,https://ctdbase.org/detail.go?type=gene&acc=151354,,,151354.0,LRATD1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of LRATD1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4377,1527226,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,157638,LRATD2,https://ctdbase.org/detail.go?type=gene&acc=157638,,,157638.0,LRATD2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRATD2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4378,1527227,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,157638,LRATD2,https://ctdbase.org/detail.go?type=gene&acc=157638,,,157638.0,LRATD2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of LRATD2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4379,1527228,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23143,LRCH1,https://ctdbase.org/detail.go?type=gene&acc=23143,,,23143.0,LRCH1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRCH1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4380,1527229,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23143,LRCH1,https://ctdbase.org/detail.go?type=gene&acc=23143,,,23143.0,LRCH1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LRCH1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4381,1527230,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57631,LRCH2,https://ctdbase.org/detail.go?type=gene&acc=57631,,,57631.0,LRCH2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LRCH2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4382,1527231,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,78999,LRFN4,https://ctdbase.org/detail.go?type=gene&acc=78999,,,78999.0,LRFN4,9606.0,Homo sapiens (human),Trichostatin A affects the expression of LRFN4 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4383,1527232,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,26018,LRIG1,https://ctdbase.org/detail.go?type=gene&acc=26018,,,26018.0,LRIG1,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of LRIG1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4384,1527233,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,26018,LRIG1,https://ctdbase.org/detail.go?type=gene&acc=26018,,,26018.0,LRIG1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRIG1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4385,1527234,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,26018,LRIG1,https://ctdbase.org/detail.go?type=gene&acc=26018,,,26018.0,LRIG1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of LRIG1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4386,1527588,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,100380358,SFRS1,https://ctdbase.org/detail.go?type=gene&acc=100380358,,,100380358.0,,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SFRS1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4387,1527589,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,733142,SFRS6,https://ctdbase.org/detail.go?type=gene&acc=733142,,,733142.0,,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SFRS6 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4388,1527590,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,94081,SFXN1,https://ctdbase.org/detail.go?type=gene&acc=94081,,,94081.0,SFXN1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SFXN1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4389,1527591,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,118980,SFXN2,https://ctdbase.org/detail.go?type=gene&acc=118980,,,118980.0,SFXN2,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of SFXN2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4390,1527592,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6443,SGCB,https://ctdbase.org/detail.go?type=gene&acc=6443,,,6443.0,SGCB,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGCB mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4391,1527593,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6443,SGCB,https://ctdbase.org/detail.go?type=gene&acc=6443,,,6443.0,SGCB,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SGCB mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4392,1527741,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,116135,LRRC3B,https://ctdbase.org/detail.go?type=gene&acc=116135,,,116135.0,LRRC3B,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRRC3B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4393,1527742,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,116135,LRRC3B,https://ctdbase.org/detail.go?type=gene&acc=116135,,,116135.0,LRRC3B,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of LRRC3B mRNA,,,PMID:24935251|PMID:26272509|PMID:26705709,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/26705709,24935251|26272509|26705709,,
4394,1527743,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,64101,LRRC4,https://ctdbase.org/detail.go?type=gene&acc=64101,,,64101.0,LRRC4,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRRC4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4395,1527744,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,64101,LRRC4,https://ctdbase.org/detail.go?type=gene&acc=64101,,,64101.0,LRRC4,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of LRRC4 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4396,1527745,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10489,LRRC41,https://ctdbase.org/detail.go?type=gene&acc=10489,,,10489.0,LRRC41,9606.0,Homo sapiens (human),Trichostatin A affects the expression of LRRC41 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4397,1528004,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,166929,SGMS2,https://ctdbase.org/detail.go?type=gene&acc=166929,,,166929.0,SGMS2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SGMS2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4398,1528005,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,166929,SGMS2,https://ctdbase.org/detail.go?type=gene&acc=166929,,,166929.0,SGMS2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SGMS2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4399,1528006,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,81537,SGPP1,https://ctdbase.org/detail.go?type=gene&acc=81537,,,81537.0,SGPP1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGPP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4400,1528007,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,81537,SGPP1,https://ctdbase.org/detail.go?type=gene&acc=81537,,,81537.0,SGPP1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SGPP1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4401,1528008,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,130367,SGPP2,https://ctdbase.org/detail.go?type=gene&acc=130367,,,130367.0,SGPP2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SGPP2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4402,1528009,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,27352,SGSM3,https://ctdbase.org/detail.go?type=gene&acc=27352,,,27352.0,SGSM3,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of SGSM3 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4403,1528010,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54557,SGTB,https://ctdbase.org/detail.go?type=gene&acc=54557,,,54557.0,SGTB,9606.0,Homo sapiens (human),Trichostatin A affects the expression of SGTB mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4404,1528285,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57633,LRRN1,https://ctdbase.org/detail.go?type=gene&acc=57633,,,57633.0,LRRN1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRRN1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4405,1528286,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57633,LRRN1,https://ctdbase.org/detail.go?type=gene&acc=57633,,,57633.0,LRRN1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of LRRN1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4406,1528287,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54674,LRRN3,https://ctdbase.org/detail.go?type=gene&acc=54674,,,54674.0,LRRN3,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRRN3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4407,1528288,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54674,LRRN3,https://ctdbase.org/detail.go?type=gene&acc=54674,,,54674.0,LRRN3,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LRRN3 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4408,1528289,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,164312,LRRN4,https://ctdbase.org/detail.go?type=gene&acc=164312,,,164312.0,LRRN4,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LRRN4 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4409,1528290,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,347730,LRRTM1,https://ctdbase.org/detail.go?type=gene&acc=347730,,,347730.0,LRRTM1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LRRTM1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4410,1528291,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,80059,LRRTM4,https://ctdbase.org/detail.go?type=gene&acc=80059,,,80059.0,LRRTM4,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRRTM4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4411,1528292,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,80059,LRRTM4,https://ctdbase.org/detail.go?type=gene&acc=80059,,,80059.0,LRRTM4,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of LRRTM4 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4412,1528293,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,134353,LSM11,https://ctdbase.org/detail.go?type=gene&acc=134353,,,134353.0,LSM11,9606.0,Homo sapiens (human),Trichostatin A affects the expression of LSM11 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
4413,1528294,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,149986,LSM14B,https://ctdbase.org/detail.go?type=gene&acc=149986,,,149986.0,LSM14B,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LSM14B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4414,1529209,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10586,MAB21L2,https://ctdbase.org/detail.go?type=gene&acc=10586,,,10586.0,MAB21L2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of MAB21L2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4415,1529210,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10586,MAB21L2,https://ctdbase.org/detail.go?type=gene&acc=10586,,,10586.0,MAB21L2,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in decreased expression of MAB21L2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4416,1529211,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,346389,MACC1,https://ctdbase.org/detail.go?type=gene&acc=346389,,,346389.0,MACC1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MACC1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4417,1529212,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,346389,MACC1,https://ctdbase.org/detail.go?type=gene&acc=346389,,,346389.0,MACC1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of MACC1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
4418,1482777,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,64403,CDH24,https://ctdbase.org/detail.go?type=gene&acc=64403,,,64403.0,CDH24,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CDH24 mRNA,,,PMID:23724009|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/23724009|https://www.ncbi.nlm.nih.gov/pubmed/33167477,23724009|33167477,,
4419,1482778,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1001,CDH3,https://ctdbase.org/detail.go?type=gene&acc=1001,,,1001.0,CDH3,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CDH3 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
4420,1483396,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,9606.0,Homo sapiens (human),Tretinoin promotes the reaction [tetradecanoylphorbol acetate results in increased activity of CDK2 protein],,,PMID:12421932,https://www.ncbi.nlm.nih.gov/pubmed/12421932,12421932,,
4421,1483397,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,9606.0,Homo sapiens (human),Tretinoin results in decreased degradation of CDK2 protein,,,PMID:20935519,https://www.ncbi.nlm.nih.gov/pubmed/20935519,20935519,,
4422,1483398,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CDK2 protein,,,PMID:16517207|PMID:17960384,https://www.ncbi.nlm.nih.gov/pubmed/16517207|https://www.ncbi.nlm.nih.gov/pubmed/17960384,16517207|17960384,,
4423,1483399,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10116.0,Rattus norvegicus (Norway rat),Tretinoin inhibits the reaction [FGF2 protein results in increased expression of CDK2 mrna]|tretinoin results in decreased expression of CDK2 protein,,,PMID:11675954,https://www.ncbi.nlm.nih.gov/pubmed/11675954,11675954,,
4424,1483400,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8099,CDK2AP1,https://ctdbase.org/detail.go?type=gene&acc=8099,,,8099.0,CDK2AP1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CDK2AP1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4425,1483401,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CDK4 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4426,1483402,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606.0,Homo sapiens (human),Tretinoin results in increased activity of CDK4 protein,,,PMID:15695403,https://www.ncbi.nlm.nih.gov/pubmed/15695403,15695403,,
4427,1483403,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in decreased expression of CDK4 protein|tretinoin inhibits the reaction [FGF2 protein results in increased expression of CDK4 mrna],,,PMID:11675954,https://www.ncbi.nlm.nih.gov/pubmed/11675954,11675954,,
4428,1486319,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,51286,CEND1,https://ctdbase.org/detail.go?type=gene&acc=51286,,,51286.0,CEND1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CEND1 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4429,1486320,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1058,CENPA,https://ctdbase.org/detail.go?type=gene&acc=1058,,,1058.0,CENPA,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CENPA mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4430,1486321,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1062,CENPE,https://ctdbase.org/detail.go?type=gene&acc=1062,,,1062.0,CENPE,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CENPE mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4431,1486322,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1063,CENPF,https://ctdbase.org/detail.go?type=gene&acc=1063,,,1063.0,CENPF,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CENPF mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4432,1486323,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,64946,CENPH,https://ctdbase.org/detail.go?type=gene&acc=64946,,,64946.0,CENPH,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CENPH mRNA,,,PMID:21934132|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/33167477,21934132|33167477,,
4433,1486324,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2491,CENPI,https://ctdbase.org/detail.go?type=gene&acc=2491,,,2491.0,CENPI,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CENPI mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4434,1486325,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55835,CENPJ,https://ctdbase.org/detail.go?type=gene&acc=55835,,,55835.0,CENPJ,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CENPJ mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4435,1486326,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,64105,CENPK,https://ctdbase.org/detail.go?type=gene&acc=64105,,,64105.0,CENPK,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CENPK mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4436,1486327,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,91687,CENPL,https://ctdbase.org/detail.go?type=gene&acc=91687,,,91687.0,CENPL,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CENPL mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4437,1486328,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,79019,CENPM,https://ctdbase.org/detail.go?type=gene&acc=79019,,,79019.0,CENPM,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CENPM mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4438,1487215,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10715,CERS1,https://ctdbase.org/detail.go?type=gene&acc=10715,,,10715.0,CERS1,10090.0,Mus musculus (house mouse),[bisphenol A co-treated with tretinoin] results in decreased expression of CERS1 mrna|[bisphenol F co-treated with tretinoin] results in decreased expression of CERS1 mrna|[bis(4-hydroxyphenyl)sulfone co-treated with tretinoin] results in decreased expression of CERS1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
4439,1487216,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,29956,CERS2,https://ctdbase.org/detail.go?type=gene&acc=29956,,,29956.0,CERS2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CERS2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4440,1487217,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1066,CES1,https://ctdbase.org/detail.go?type=gene&acc=1066,,,1066.0,CES1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CES1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4441,1487218,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1071,CETP,https://ctdbase.org/detail.go?type=gene&acc=1071,,,1071.0,CETP,9606.0,Homo sapiens (human),Tretinoin promotes the reaction [etoposide results in increased expression of CETP protein]|tretinoin promotes the reaction [etoposide promotes the reaction [RXRA protein results in increased expression of CETP mrna]]|tretinoin promotes the reaction [teniposide promotes the reaction [RXRA protein results in increased expression of CETP mrna]]|[tretinoin co-treated with etoposide] results in increased expression of CETP mrna|[tretinoin co-treated with teniposide] results in increased expression of CETP mrna|tretinoin promotes the reaction [RXRA protein results in increased expression of CETP mrna]|tretinoin promotes the reaction [teniposide results in increased expression of CETP protein]|tretinoin results in increased expression of CETP mRNA,,,PMID:25914138,https://www.ncbi.nlm.nih.gov/pubmed/25914138,25914138,,
4442,1487219,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,257236,CFAP184,https://ctdbase.org/detail.go?type=gene&acc=257236,,,257236.0,CFAP184,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CFAP184 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4443,1487220,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,29105,CFAP20,https://ctdbase.org/detail.go?type=gene&acc=29105,,,29105.0,CFAP20,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CFAP20 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4444,1487221,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,29070,CFAP263,https://ctdbase.org/detail.go?type=gene&acc=29070,,,29070.0,CFAP263,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CFAP263 mRNA,,,PMID:21934132|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/33167477,21934132|33167477,,
4445,1487222,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,112942,CFAP36,https://ctdbase.org/detail.go?type=gene&acc=112942,,,112942.0,CFAP36,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CFAP36 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4446,1487223,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55779,CFAP44,https://ctdbase.org/detail.go?type=gene&acc=55779,,,55779.0,CFAP44,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CFAP44 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4447,1487224,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,220136,CFAP53,https://ctdbase.org/detail.go?type=gene&acc=220136,,,220136.0,CFAP53,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CFAP53 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4448,1494410,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,11151,CORO1A,https://ctdbase.org/detail.go?type=gene&acc=11151,,,11151.0,CORO1A,9606.0,Homo sapiens (human),[chenodeoxycholic acid co-treated with tretinoin] results in decreased expression of CORO1A mRNA,,,PMID:16040207,https://www.ncbi.nlm.nih.gov/pubmed/16040207,16040207,,
4449,1494411,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,11151,CORO1A,https://ctdbase.org/detail.go?type=gene&acc=11151,,,11151.0,CORO1A,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CORO1A mRNA,,,PMID:23830798,https://www.ncbi.nlm.nih.gov/pubmed/23830798,23830798,,
4450,1494412,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,11151,CORO1A,https://ctdbase.org/detail.go?type=gene&acc=11151,,,11151.0,CORO1A,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CORO1A mRNA,,,PMID:15498508|PMID:17218384|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/15498508|https://www.ncbi.nlm.nih.gov/pubmed/17218384|https://www.ncbi.nlm.nih.gov/pubmed/33167477,15498508|17218384|33167477,,
4451,1494413,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,57175,CORO1B,https://ctdbase.org/detail.go?type=gene&acc=57175,,,57175.0,CORO1B,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CORO1B mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4452,1494414,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7464,CORO2A,https://ctdbase.org/detail.go?type=gene&acc=7464,,,7464.0,CORO2A,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CORO2A mRNA,,,PMID:23724009|PMID:23830798|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/23724009|https://www.ncbi.nlm.nih.gov/pubmed/23830798|https://www.ncbi.nlm.nih.gov/pubmed/33167477,23724009|23830798|33167477,,
4453,1494415,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10391,CORO2B,https://ctdbase.org/detail.go?type=gene&acc=10391,,,10391.0,CORO2B,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CORO2B mRNA,,,PMID:23724009|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/23724009|https://www.ncbi.nlm.nih.gov/pubmed/33167477,23724009|33167477,,
4454,1494416,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,23406,COTL1,https://ctdbase.org/detail.go?type=gene&acc=23406,,,23406.0,COTL1,7955.0,Danio rerio (zebrafish),Tretinoin results in decreased expression of COTL1 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
4455,1495530,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1380,CR2,https://ctdbase.org/detail.go?type=gene&acc=1380,,,1380.0,CR2,9606.0,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of CR2 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
4456,1495531,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,692775,CRABP,https://ctdbase.org/detail.go?type=gene&acc=692775,,,692775.0,,10090.0,Mus musculus (house mouse),Tretinoin affects the expression of CRABP mRNA,,,PMID:9894676,https://www.ncbi.nlm.nih.gov/pubmed/9894676,9894676,,
4457,1495532,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1381,CRABP1,https://ctdbase.org/detail.go?type=gene&acc=1381,,,1381.0,CRABP1,9606.0,Homo sapiens (human),CRABP1 protein results in decreased susceptibility to tretinoin,,,PMID:16254461,https://www.ncbi.nlm.nih.gov/pubmed/16254461,16254461,,
4458,1495533,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1381,CRABP1,https://ctdbase.org/detail.go?type=gene&acc=1381,,,1381.0,CRABP1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CRABP1 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
4459,1495534,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1381,CRABP1,https://ctdbase.org/detail.go?type=gene&acc=1381,,,1381.0,CRABP1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CRABP1 mRNA,,,PMID:16012519,https://www.ncbi.nlm.nih.gov/pubmed/16012519,16012519,,
4460,1495535,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1381,CRABP1,https://ctdbase.org/detail.go?type=gene&acc=1381,,,1381.0,CRABP1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CRABP1 protein,,,PMID:16959971,https://www.ncbi.nlm.nih.gov/pubmed/16959971,16959971,,
4461,1495803,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1382,CRABP2,https://ctdbase.org/detail.go?type=gene&acc=1382,,,1382.0,CRABP2,9606.0,Homo sapiens (human),Tretinoin binds to CRABP2 protein,,,PMID:15958702,https://www.ncbi.nlm.nih.gov/pubmed/15958702,15958702,,
4462,1496440,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,58487,CREBZF,https://ctdbase.org/detail.go?type=gene&acc=58487,,,58487.0,CREBZF,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CREBZF mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4463,1496441,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8804,CREG1,https://ctdbase.org/detail.go?type=gene&acc=8804,,,8804.0,CREG1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CREG1 mRNA,,,PMID:15498508|PMID:17218384|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/15498508|https://www.ncbi.nlm.nih.gov/pubmed/17218384|https://www.ncbi.nlm.nih.gov/pubmed/33167477,15498508|17218384|33167477,,
4464,1496442,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,200407,CREG2,https://ctdbase.org/detail.go?type=gene&acc=200407,,,200407.0,CREG2,9606.0,Homo sapiens (human),Tretinoin affects the expression of CREG2 mRNA,,,PMID:31600526,https://www.ncbi.nlm.nih.gov/pubmed/31600526,31600526,,
4465,1496870,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55118,CRTAC1,https://ctdbase.org/detail.go?type=gene&acc=55118,,,55118.0,CRTAC1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CRTAC1 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4466,1496871,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10491,CRTAP,https://ctdbase.org/detail.go?type=gene&acc=10491,,,10491.0,CRTAP,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CRTAP mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4467,1496872,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10491,CRTAP,https://ctdbase.org/detail.go?type=gene&acc=10491,,,10491.0,CRTAP,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CRTAP mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4468,1496873,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10491,CRTAP,https://ctdbase.org/detail.go?type=gene&acc=10491,,,10491.0,CRTAP,10090.0,Mus musculus (house mouse),[bisphenol F co-treated with tretinoin] results in decreased expression of CRTAP mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
4469,1496874,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,200186,CRTC2,https://ctdbase.org/detail.go?type=gene&acc=200186,,,200186.0,CRTC2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CRTC2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4470,1497335,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1414,CRYBB1,https://ctdbase.org/detail.go?type=gene&acc=1414,,,1414.0,CRYBB1,7955.0,Danio rerio (zebrafish),Tretinoin results in decreased expression of CRYBB1 mRNA,,,PMID:23774253,https://www.ncbi.nlm.nih.gov/pubmed/23774253,23774253,,
4471,1497336,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,553473,CRYBB1L1,https://ctdbase.org/detail.go?type=gene&acc=553473,,,553473.0,crybb1l1,7955.0,Danio rerio (zebrafish),Tretinoin results in decreased expression of CRYBB1L1 mRNA,,,PMID:23774253,https://www.ncbi.nlm.nih.gov/pubmed/23774253,23774253,,
4472,1497337,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,560055,CRYBB1L2,https://ctdbase.org/detail.go?type=gene&acc=560055,,,560055.0,crybb1l2,7955.0,Danio rerio (zebrafish),Tretinoin results in decreased expression of CRYBB1L2 mRNA,,,PMID:23774253,https://www.ncbi.nlm.nih.gov/pubmed/23774253,23774253,,
4473,1497338,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1415,CRYBB2,https://ctdbase.org/detail.go?type=gene&acc=1415,,,1415.0,CRYBB2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CRYBB2 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4474,1497339,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,202,CRYBG1,https://ctdbase.org/detail.go?type=gene&acc=202,,,202.0,CRYBG1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CRYBG1 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
4475,1497340,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55057,CRYBG2,https://ctdbase.org/detail.go?type=gene&acc=55057,,,55057.0,CRYBG2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of CRYBG2 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4476,1497341,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,131544,CRYBG3,https://ctdbase.org/detail.go?type=gene&acc=131544,,,131544.0,CRYBG3,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CRYBG3 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4477,1497342,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1419,CRYGB,https://ctdbase.org/detail.go?type=gene&acc=1419,,,1419.0,CRYGB,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of CRYGB mRNA,,,PMID:16788091,https://www.ncbi.nlm.nih.gov/pubmed/16788091,16788091,,
4478,1497343,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1420,CRYGC,https://ctdbase.org/detail.go?type=gene&acc=1420,,,1420.0,CRYGC,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of CRYGC mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
4479,1497344,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,12968,CRYGE,https://ctdbase.org/detail.go?type=gene&acc=12968,,,12968.0,Cryge,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in increased expression of CRYGE mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
4480,1497345,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,12969,CRYGF,https://ctdbase.org/detail.go?type=gene&acc=12969,,,12969.0,Crygf,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of CRYGF mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
4481,1497948,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1441,CSF3R,https://ctdbase.org/detail.go?type=gene&acc=1441,,,1441.0,CSF3R,9606.0,Homo sapiens (human),3-phenoxybenzoic acid inhibits the reaction [tretinoin results in increased expression of CSF3R mrna]|acetylcysteine inhibits the reaction [3-phenoxybenzoic acid inhibits the reaction [tretinoin results in increased expression of CSF3R mrna]]|cypermethrin inhibits the reaction [tretinoin results in increased expression of CSF3R mrna]|acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [tretinoin results in increased expression of CSF3R mrna]],,,PMID:29945211,https://www.ncbi.nlm.nih.gov/pubmed/29945211,29945211,,
4482,1497949,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1441,CSF3R,https://ctdbase.org/detail.go?type=gene&acc=1441,,,1441.0,CSF3R,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CSF3R mRNA,,,PMID:16054129|PMID:29945211|PMID:33167477|PMID:7579340,https://www.ncbi.nlm.nih.gov/pubmed/16054129|https://www.ncbi.nlm.nih.gov/pubmed/29945211|https://www.ncbi.nlm.nih.gov/pubmed/33167477|https://www.ncbi.nlm.nih.gov/pubmed/7579340,16054129|29945211|33167477|7579340,,
4483,1497950,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1441,CSF3R,https://ctdbase.org/detail.go?type=gene&acc=1441,,,1441.0,CSF3R,9606.0,Homo sapiens (human),Tretinoin results in increased expression of CSF3R protein,,,PMID:12441127,https://www.ncbi.nlm.nih.gov/pubmed/12441127,12441127,,
4484,1512396,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5515,PPP2CA,https://ctdbase.org/detail.go?type=gene&acc=5515,,,5515.0,PPP2CA,9606.0,Homo sapiens (human),Tretinoin promotes the reaction [PPP2CA protein binds to RBL2 protein]|tretinoin results in increased expression of and results in decreased phosphorylation of and results in increased activity of PPP2CA protein,,,PMID:16206244,https://www.ncbi.nlm.nih.gov/pubmed/16206244,16206244,,
4485,1512397,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5515,PPP2CA,https://ctdbase.org/detail.go?type=gene&acc=5515,,,5515.0,PPP2CA,9606.0,Homo sapiens (human),Tretinoin promotes the reaction [PPP2CA protein binds to and results in decreased phosphorylation of RBL2 protein],,,PMID:16936753,https://www.ncbi.nlm.nih.gov/pubmed/16936753,16936753,,
4486,1512398,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5519,PPP2R1B,https://ctdbase.org/detail.go?type=gene&acc=5519,,,5519.0,PPP2R1B,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PPP2R1B mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
4487,1512399,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5521,PPP2R2B,https://ctdbase.org/detail.go?type=gene&acc=5521,,,5521.0,PPP2R2B,9606.0,Homo sapiens (human),Tretinoin results in increased expression of PPP2R2B mRNA,,,PMID:16249480|PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/16249480|https://www.ncbi.nlm.nih.gov/pubmed/23724009,16249480|23724009,,
4488,1512400,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55844,PPP2R2D,https://ctdbase.org/detail.go?type=gene&acc=55844,,,55844.0,PPP2R2D,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PPP2R2D mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4489,1512401,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55012,PPP2R3C,https://ctdbase.org/detail.go?type=gene&acc=55012,,,55012.0,PPP2R3C,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PPP2R3C mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4490,1512402,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5525,PPP2R5A,https://ctdbase.org/detail.go?type=gene&acc=5525,,,5525.0,PPP2R5A,9606.0,Homo sapiens (human),Tretinoin results in increased expression of PPP2R5A mRNA,,,PMID:23724009|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/23724009|https://www.ncbi.nlm.nih.gov/pubmed/33167477,23724009|33167477,,
4491,1512403,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5526,PPP2R5B,https://ctdbase.org/detail.go?type=gene&acc=5526,,,5526.0,PPP2R5B,9606.0,Homo sapiens (human),Tretinoin results in increased expression of PPP2R5B mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4492,1514158,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,439949,PRKCQ-AS1,https://ctdbase.org/detail.go?type=gene&acc=439949,,,439949.0,PRKCQ-AS1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PRKCQ-AS1 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4493,1514159,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5587,PRKD1,https://ctdbase.org/detail.go?type=gene&acc=5587,,,5587.0,PRKD1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of PRKD1 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
4494,1514586,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55170,PRMT6,https://ctdbase.org/detail.go?type=gene&acc=55170,,,55170.0,PRMT6,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PRMT6 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4495,1514587,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,54496,PRMT7,https://ctdbase.org/detail.go?type=gene&acc=54496,,,54496.0,PRMT7,7955.0,Danio rerio (zebrafish),Tretinoin results in increased expression of PRMT7 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
4496,1514588,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,23627,PRND,https://ctdbase.org/detail.go?type=gene&acc=23627,,,23627.0,PRND,10090.0,Mus musculus (house mouse),[bis(4-hydroxyphenyl)sulfone co-treated with tretinoin] results in decreased expression of PRND mrna|[bisphenol F co-treated with tretinoin] results in decreased expression of PRND mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
4497,1514589,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5621,PRNP,https://ctdbase.org/detail.go?type=gene&acc=5621,,,5621.0,PRNP,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PRNP mRNA,,,PMID:15498508|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/15498508|https://www.ncbi.nlm.nih.gov/pubmed/33167477,15498508|33167477,,
4498,1514590,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5621,PRNP,https://ctdbase.org/detail.go?type=gene&acc=5621,,,5621.0,PRNP,9606.0,Homo sapiens (human),Tretinoin results in increased expression of PRNP mRNA,,,PMID:21934132|PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/23724009,21934132|23724009,,
4499,1514591,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5621,PRNP,https://ctdbase.org/detail.go?type=gene&acc=5621,,,5621.0,PRNP,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in decreased expression of PRNP mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
4500,1514592,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10544,PROCR,https://ctdbase.org/detail.go?type=gene&acc=10544,,,10544.0,PROCR,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in decreased expression of PROCR mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
4501,1514593,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5625,PRODH,https://ctdbase.org/detail.go?type=gene&acc=5625,,,5625.0,PRODH,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PRODH mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4502,1514882,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8559,PRPF18,https://ctdbase.org/detail.go?type=gene&acc=8559,,,8559.0,PRPF18,9606.0,Homo sapiens (human),[tretinoin co-treated with arsenic trioxide] results in increased expression of PRPF18 mRNA,,,PMID:15894607,https://www.ncbi.nlm.nih.gov/pubmed/15894607,15894607,,
4503,1514883,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8559,PRPF18,https://ctdbase.org/detail.go?type=gene&acc=8559,,,8559.0,PRPF18,9606.0,Homo sapiens (human),Tretinoin results in increased expression of PRPF18 mRNA,,,PMID:15894607|PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/15894607|https://www.ncbi.nlm.nih.gov/pubmed/21934132,15894607|21934132,,
4504,1514884,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,27339,PRPF19,https://ctdbase.org/detail.go?type=gene&acc=27339,,,27339.0,PRPF19,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of PRPF19 protein,,,PMID:20629186,https://www.ncbi.nlm.nih.gov/pubmed/20629186,20629186,,
4505,1514885,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55015,PRPF39,https://ctdbase.org/detail.go?type=gene&acc=55015,,,55015.0,PRPF39,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PRPF39 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4506,1514886,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55660,PRPF40A,https://ctdbase.org/detail.go?type=gene&acc=55660,,,55660.0,PRPF40A,9606.0,Homo sapiens (human),Tretinoin affects the expression of PRPF40A mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
4507,1514887,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10594,PRPF8,https://ctdbase.org/detail.go?type=gene&acc=10594,,,10594.0,PRPF8,9606.0,Homo sapiens (human),Tretinoin results in increased expression of PRPF8 mrna|[tretinoin co-treated with arsenic trioxide] results in increased expression of PRPF8 mRNA,,,PMID:15894607,https://www.ncbi.nlm.nih.gov/pubmed/15894607,15894607,,
4508,1514888,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5630,PRPH,https://ctdbase.org/detail.go?type=gene&acc=5630,,,5630.0,PRPH,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of PRPH mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
4509,1514889,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,567873,PRPH2LB,https://ctdbase.org/detail.go?type=gene&acc=567873,,,567873.0,prph2lb,7955.0,Danio rerio (zebrafish),Tretinoin results in increased expression of PRPH2LB mRNA,,,PMID:30248606,https://www.ncbi.nlm.nih.gov/pubmed/30248606,30248606,,
4510,1514890,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5631,PRPS1,https://ctdbase.org/detail.go?type=gene&acc=5631,,,5631.0,PRPS1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PRPS1 mRNA,,,PMID:15498508|PMID:21934132|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/15498508|https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/33167477,15498508|21934132|33167477,,
4511,1515371,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,112476,PRRT2,https://ctdbase.org/detail.go?type=gene&acc=112476,,,112476.0,PRRT2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PRRT2 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
4512,1515372,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5396,PRRX1,https://ctdbase.org/detail.go?type=gene&acc=5396,,,5396.0,PRRX1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PRRX1 mRNA,,,PMID:17045167,https://www.ncbi.nlm.nih.gov/pubmed/17045167,17045167,,
4513,1515373,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5396,PRRX1,https://ctdbase.org/detail.go?type=gene&acc=5396,,,5396.0,PRRX1,10090.0,Mus musculus (house mouse),[bisphenol A co-treated with tretinoin] results in decreased expression of PRRX1 mrna|[bis(4-hydroxyphenyl)sulfone co-treated with tretinoin] results in decreased expression of PRRX1 mrna|[bisphenol F co-treated with tretinoin] results in decreased expression of PRRX1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
4514,1515374,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,337089,PRRX1B,https://ctdbase.org/detail.go?type=gene&acc=337089,,,337089.0,prrx1b,7955.0,Danio rerio (zebrafish),Tretinoin results in decreased expression of PRRX1B mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
4515,1516245,444795,Drug Gene Interaction database (DGIdb),Tretinoin,,TRETINOIN,https://www.dgidb.org/drugs/rxcui:10753,,PML,https://www.dgidb.org/genes/hgnc:9113,,,5371.0,PML,9606.0,Homo sapiens (human),,,,,,,,
4516,1516246,444795,Drug Gene Interaction database (DGIdb),Tretinoin,,TRETINOIN,https://www.dgidb.org/drugs/rxcui:10753,,BIRC5,https://www.dgidb.org/genes/hgnc:593,,,332.0,BIRC5,9606.0,Homo sapiens (human),,,,,,,,
4517,1516247,444795,Drug Gene Interaction database (DGIdb),Tretinoin,,TRETINOIN,https://www.dgidb.org/drugs/rxcui:10753,,P2RY2,https://www.dgidb.org/genes/hgnc:8541,,,5029.0,P2RY2,9606.0,Homo sapiens (human),,,,,,,,
4518,1516697,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,85476,GFM1,https://ctdbase.org/detail.go?type=gene&acc=85476,,,85476.0,GFM1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GFM1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4519,1516698,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,54438,GFOD1,https://ctdbase.org/detail.go?type=gene&acc=54438,,,54438.0,GFOD1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GFOD1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4520,1516699,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2673,GFPT1,https://ctdbase.org/detail.go?type=gene&acc=2673,,,2673.0,GFPT1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GFPT1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
4521,1516700,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9945,GFPT2,https://ctdbase.org/detail.go?type=gene&acc=9945,,,9945.0,GFPT2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GFPT2 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
4522,1516701,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9945,GFPT2,https://ctdbase.org/detail.go?type=gene&acc=9945,,,9945.0,GFPT2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GFPT2 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4523,1519804,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,26003,GORASP2,https://ctdbase.org/detail.go?type=gene&acc=26003,,,26003.0,GORASP2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GORASP2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4524,1519805,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2806,GOT2,https://ctdbase.org/detail.go?type=gene&acc=2806,,,2806.0,GOT2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GOT2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4525,1519806,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10223,GPA33,https://ctdbase.org/detail.go?type=gene&acc=10223,,,10223.0,GPA33,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GPA33 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4526,1519807,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55425,GPALPP1,https://ctdbase.org/detail.go?type=gene&acc=55425,,,55425.0,GPALPP1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GPALPP1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4527,1519808,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,57678,GPAM,https://ctdbase.org/detail.go?type=gene&acc=57678,,,57678.0,GPAM,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GPAM mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4528,1519809,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,7918,GPANK1,https://ctdbase.org/detail.go?type=gene&acc=7918,,,7918.0,GPANK1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GPANK1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4529,1519810,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,84803,GPAT3,https://ctdbase.org/detail.go?type=gene&acc=84803,,,84803.0,GPAT3,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GPAT3 mRNA,,,PMID:21934132|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/33167477,21934132|33167477,,
4530,1519970,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5872,RAB13,https://ctdbase.org/detail.go?type=gene&acc=5872,,,5872.0,RAB13,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RAB13 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4531,1519971,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,51552,RAB14,https://ctdbase.org/detail.go?type=gene&acc=51552,,,51552.0,RAB14,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RAB14 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4532,1519972,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,376267,RAB15,https://ctdbase.org/detail.go?type=gene&acc=376267,,,376267.0,RAB15,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RAB15 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4533,1519973,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5861,RAB1A,https://ctdbase.org/detail.go?type=gene&acc=5861,,,5861.0,RAB1A,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RAB1A mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
4534,1519974,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5861,RAB1A,https://ctdbase.org/detail.go?type=gene&acc=5861,,,5861.0,RAB1A,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RAB1A mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4535,1520441,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,151556,GPR155,https://ctdbase.org/detail.go?type=gene&acc=151556,,,151556.0,GPR155,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GPR155 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4536,1520442,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,151556,GPR155,https://ctdbase.org/detail.go?type=gene&acc=151556,,,151556.0,GPR155,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GPR155 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4537,1520443,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,80045,GPR157,https://ctdbase.org/detail.go?type=gene&acc=80045,,,80045.0,GPR157,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GPR157 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4538,1520444,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,26996,GPR160,https://ctdbase.org/detail.go?type=gene&acc=26996,,,26996.0,GPR160,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GPR160 mRNA,,,PMID:23830798|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/23830798|https://www.ncbi.nlm.nih.gov/pubmed/33167477,23830798|33167477,,
4539,1520445,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2841,GPR18,https://ctdbase.org/detail.go?type=gene&acc=2841,,,2841.0,GPR18,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GPR18 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4540,1520446,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,11318,GPR182,https://ctdbase.org/detail.go?type=gene&acc=11318,,,11318.0,GPR182,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in decreased expression of GPR182 mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
4541,1520447,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2842,GPR19,https://ctdbase.org/detail.go?type=gene&acc=2842,,,2842.0,GPR19,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GPR19 mRNA,,,PMID:21934132|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/33167477,21934132|33167477,,
4542,1520448,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2827,GPR3,https://ctdbase.org/detail.go?type=gene&acc=2827,,,2827.0,GPR3,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GPR3 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4543,1520449,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2857,GPR34,https://ctdbase.org/detail.go?type=gene&acc=2857,,,2857.0,GPR34,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GPR34 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4544,1520450,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2859,GPR35,https://ctdbase.org/detail.go?type=gene&acc=2859,,,2859.0,GPR35,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GPR35 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4545,1520615,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5878,RAB5C,https://ctdbase.org/detail.go?type=gene&acc=5878,,,5878.0,RAB5C,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RAB5C mRNA,,,PMID:15498508|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/15498508|https://www.ncbi.nlm.nih.gov/pubmed/33167477,15498508|33167477,,
4546,1520616,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55969,RAB5IF,https://ctdbase.org/detail.go?type=gene&acc=55969,,,55969.0,RAB5IF,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RAB5IF mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4547,1522753,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),[tretinoin co-treated with arsenic trioxide] results in decreased expression of RARA mRNA alternative form,,,PMID:19225113,https://www.ncbi.nlm.nih.gov/pubmed/19225113,19225113,,
4548,1522754,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),[tretinoin co-treated with hexamethylene bisacetamide] results in increased cleavage of RARA protein mutant form|[tretinoin co-treated with butyrates] results in increased cleavage of RARA protein mutant form|tretinoin results in increased cleavage of RARA protein mutant form,,,PMID:12130515,https://www.ncbi.nlm.nih.gov/pubmed/12130515,12130515,,
4549,1522755,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),[tretinoin co-treated with RARA protein co-treated with RXRA protein] results in increased expression of CYP26A1 mRNA,,,PMID:17244623,https://www.ncbi.nlm.nih.gov/pubmed/17244623,17244623,,
4550,1522756,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),Tretinoin inhibits the reaction [SIN3A protein binds to RARA protein]|tretinoin inhibits the reaction [PRMT1 protein binds to RARA protein]|tretinoin inhibits the reaction [BTG2 protein binds to RARA protein],,,PMID:16782888,https://www.ncbi.nlm.nih.gov/pubmed/16782888,16782888,,
4551,1522757,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),Tretinoin inhibits the reaction [CCNH protein binds to and results in increased phosphorylation of RARA protein mutant form],,,PMID:16935935,https://www.ncbi.nlm.nih.gov/pubmed/16935935,16935935,,
4552,1522758,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),Tretinoin inhibits the reaction [RARA protein mutant form results in decreased expression of SPI1 protein]|tretinoin inhibits the reaction [RARA protein mutant form results in decreased expression of SPI1 mrna],,,PMID:16352814,https://www.ncbi.nlm.nih.gov/pubmed/16352814,16352814,,
4553,1522759,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),Tretinoin promotes the reaction [CREBBP protein binds to RARA protein],,,PMID:16417649,https://www.ncbi.nlm.nih.gov/pubmed/16417649,16417649,,
4554,1522760,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),Tretinoin promotes the reaction [RARA protein binds to CD1D promoter],,,PMID:17392484,https://www.ncbi.nlm.nih.gov/pubmed/17392484,17392484,,
4555,1522761,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),Tretinoin promotes the reaction [RARA protein binds to FOLR2 promoter],,,PMID:16740727,https://www.ncbi.nlm.nih.gov/pubmed/16740727,16740727,,
4556,1522762,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),Tretinoin promotes the reaction [RARA protein binds to NCOA1 protein]|tretinoin promotes the reaction [RARA protein binds to NCOA2 protein]|tretinoin promotes the reaction [RARA protein binds to NCOA3 protein],,,PMID:15578590,https://www.ncbi.nlm.nih.gov/pubmed/15578590,15578590,,
4557,1523251,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,10090.0,Mus musculus (house mouse),RARA protein inhibits the reaction [tretinoin results in increased activity of [CLOCK protein binds to BMAL1 protein]],,,PMID:17069763,https://www.ncbi.nlm.nih.gov/pubmed/17069763,17069763,,
4558,1523252,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,10090.0,Mus musculus (house mouse),Tretinoin binds to and results in increased activity of RARA protein,,,PMID:12504905|PMID:16839186,https://www.ncbi.nlm.nih.gov/pubmed/12504905|https://www.ncbi.nlm.nih.gov/pubmed/16839186,12504905|16839186,,
4559,1523253,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,10090.0,Mus musculus (house mouse),[tretinoin binds to RARA protein] which binds to NRL promoter,,,PMID:16854989,https://www.ncbi.nlm.nih.gov/pubmed/16854989,16854989,,
4560,1523254,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5915,RARB,https://ctdbase.org/detail.go?type=gene&acc=5915,,,5915.0,RARB,9606.0,Homo sapiens (human),R116010 promotes the reaction [tretinoin results in increased expression of RARB mrna],,,PMID:17486130,https://www.ncbi.nlm.nih.gov/pubmed/17486130,17486130,,
4561,1524476,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,14967,H2-D4,https://ctdbase.org/detail.go?type=gene&acc=14967,,,14967.0,H2-D4,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of H2-D4 mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
4562,1524477,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,14998,H2-DMA,https://ctdbase.org/detail.go?type=gene&acc=14998,,,14998.0,H2-DMa,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of H2-DMA mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
4563,1524478,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,14972,H2-K1,https://ctdbase.org/detail.go?type=gene&acc=14972,,,14972.0,H2-K1,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of H2-K1 protein|azacitidine inhibits the reaction [tretinoin results in increased expression of H2-K1 protein],,,PMID:6197180,https://www.ncbi.nlm.nih.gov/pubmed/6197180,6197180,,
4564,1524479,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,14980,H2-L,https://ctdbase.org/detail.go?type=gene&acc=14980,,,14980.0,H2-L,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of H2-L mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
4565,1524480,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,15018,H2-Q7,https://ctdbase.org/detail.go?type=gene&acc=15018,,,15018.0,H2-Q7,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of H2-Q7 mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
4566,1524481,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,110558,H2-Q9,https://ctdbase.org/detail.go?type=gene&acc=110558,,,110558.0,H2-Q9,10090.0,Mus musculus (house mouse),[bisphenol A co-treated with tretinoin] results in decreased expression of H2-Q9 mrna|[bisphenol F co-treated with tretinoin] results in decreased expression of H2-Q9 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
4567,1524482,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3021,H3-3B,https://ctdbase.org/detail.go?type=gene&acc=3021,,,3021.0,H3-3B,9606.0,Homo sapiens (human),Tretinoin results in increased expression of H3-3B mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4568,1524483,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8290,H3-4,https://ctdbase.org/detail.go?type=gene&acc=8290,,,8290.0,H3-4,9606.0,Homo sapiens (human),[decitabine co-treated with trichostatin A co-treated with tretinoin] affects the methylation of H3-4 protein|[decitabine co-treated with trichostatin A co-treated with tretinoin] affects the reaction [H3-4 protein modified form binds to RARB promoter],,,PMID:15959780,https://www.ncbi.nlm.nih.gov/pubmed/15959780,15959780,,
4569,1524484,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8290,H3-4,https://ctdbase.org/detail.go?type=gene&acc=8290,,,8290.0,H3-4,9606.0,Homo sapiens (human),Tretinoin results in increased acetylation of H3-4 protein,,,PMID:16613989,https://www.ncbi.nlm.nih.gov/pubmed/16613989,16613989,,
4570,1525628,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,30606,RARGA,https://ctdbase.org/detail.go?type=gene&acc=30606,,,30606.0,rarga,7955.0,Danio rerio (zebrafish),Tretinoin affects the expression of RARGA mRNA,,,PMID:23774253,https://www.ncbi.nlm.nih.gov/pubmed/23774253,23774253,,
4571,1525629,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5918,RARRES1,https://ctdbase.org/detail.go?type=gene&acc=5918,,,5918.0,RARRES1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RARRES1 mRNA,,,PMID:17034753,https://www.ncbi.nlm.nih.gov/pubmed/17034753,17034753,,
4572,1525630,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5919,RARRES2,https://ctdbase.org/detail.go?type=gene&acc=5919,,,5919.0,RARRES2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RARRES2 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4573,1525631,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,767688,RARRES3,https://ctdbase.org/detail.go?type=gene&acc=767688,,,767688.0,rarres3,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RARRES3 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4574,1526187,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,50810,HDGFL3,https://ctdbase.org/detail.go?type=gene&acc=50810,,,50810.0,HDGFL3,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HDGFL3 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4575,1526188,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,84064,HDHD2,https://ctdbase.org/detail.go?type=gene&acc=84064,,,84064.0,HDHD2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HDHD2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4576,1526189,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,84064,HDHD2,https://ctdbase.org/detail.go?type=gene&acc=84064,,,84064.0,HDHD2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HDHD2 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4577,1526190,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3069,HDLBP,https://ctdbase.org/detail.go?type=gene&acc=3069,,,3069.0,HDLBP,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HDLBP mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
4578,1526191,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,792176,HE1.3,https://ctdbase.org/detail.go?type=gene&acc=792176,,,792176.0,he1.3,7955.0,Danio rerio (zebrafish),Tretinoin results in increased expression of HE1.3 mRNA,,,PMID:23774253,https://www.ncbi.nlm.nih.gov/pubmed/23774253,23774253,,
4579,1526192,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55127,HEATR1,https://ctdbase.org/detail.go?type=gene&acc=55127,,,55127.0,HEATR1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HEATR1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4580,1526193,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55027,HEATR3,https://ctdbase.org/detail.go?type=gene&acc=55027,,,55027.0,HEATR3,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HEATR3 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4581,1526194,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,50865,HEBP1,https://ctdbase.org/detail.go?type=gene&acc=50865,,,50865.0,HEBP1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HEBP1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4582,1526195,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,23593,HEBP2,https://ctdbase.org/detail.go?type=gene&acc=23593,,,23593.0,HEBP2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HEBP2 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4583,1526960,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,146713,RBFOX3,https://ctdbase.org/detail.go?type=gene&acc=146713,,,146713.0,RBFOX3,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RBFOX3 protein,,,PMID:31521693|PMID:34519134,https://www.ncbi.nlm.nih.gov/pubmed/31521693|https://www.ncbi.nlm.nih.gov/pubmed/34519134,31521693|34519134,,
4584,1526961,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,64080,RBKS,https://ctdbase.org/detail.go?type=gene&acc=64080,,,64080.0,RBKS,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in increased expression of RBKS mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
4585,1526962,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5933,RBL1,https://ctdbase.org/detail.go?type=gene&acc=5933,,,5933.0,RBL1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RBL1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4586,1526963,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5933,RBL1,https://ctdbase.org/detail.go?type=gene&acc=5933,,,5933.0,RBL1,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of RBL1 protein,,,PMID:15231690,https://www.ncbi.nlm.nih.gov/pubmed/15231690,15231690,,
4587,1526964,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5934,RBL2,https://ctdbase.org/detail.go?type=gene&acc=5934,,,5934.0,RBL2,9606.0,Homo sapiens (human),RBL2 protein affects the susceptibility to tretinoin|tretinoin promotes the reaction [PPP2CA protein binds to RBL2 protein],,,PMID:16206244,https://www.ncbi.nlm.nih.gov/pubmed/16206244,16206244,,
4588,1526965,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5934,RBL2,https://ctdbase.org/detail.go?type=gene&acc=5934,,,5934.0,RBL2,9606.0,Homo sapiens (human),Tretinoin results in decreased ubiquitination of RBL2 protein|tretinoin results in increased stability of and results in increased expression of RBL2 protein|tretinoin promotes the reaction [PPP2CA protein binds to and results in decreased phosphorylation of RBL2 protein],,,PMID:16936753,https://www.ncbi.nlm.nih.gov/pubmed/16936753,16936753,,
4589,1526966,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5934,RBL2,https://ctdbase.org/detail.go?type=gene&acc=5934,,,5934.0,RBL2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RBL2 protein,,,PMID:15059897,https://www.ncbi.nlm.nih.gov/pubmed/15059897,15059897,,
4590,1526967,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9904,RBM19,https://ctdbase.org/detail.go?type=gene&acc=9904,,,9904.0,RBM19,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in increased expression of RBM19 mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
4591,1526968,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,282996,RBM20,https://ctdbase.org/detail.go?type=gene&acc=282996,,,282996.0,RBM20,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RBM20 mRNA,,,PMID:21934132|PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/23724009,21934132|23724009,,
4592,1526969,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,221662,RBM24,https://ctdbase.org/detail.go?type=gene&acc=221662,,,221662.0,RBM24,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RBM24 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
4593,1527346,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3094,HINT1,https://ctdbase.org/detail.go?type=gene&acc=3094,,,3094.0,HINT1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HINT1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4594,1527347,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3092,HIP1,https://ctdbase.org/detail.go?type=gene&acc=3092,,,3092.0,HIP1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HIP1 mRNA,,,PMID:21934132|PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/23724009,21934132|23724009,,
4595,1528000,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,107605,RDH1,https://ctdbase.org/detail.go?type=gene&acc=107605,,,107605.0,Rdh1,7955.0,Danio rerio (zebrafish),Tretinoin results in decreased expression of RDH1 mRNA,,,PMID:18230668,https://www.ncbi.nlm.nih.gov/pubmed/18230668,18230668,,
4596,1528001,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,157506,RDH10,https://ctdbase.org/detail.go?type=gene&acc=157506,,,157506.0,RDH10,9606.0,Homo sapiens (human),[PPARG protein results in increased expression of RDH10 protein] which results in increased chemical synthesis of tretinoin,,,PMID:16982809,https://www.ncbi.nlm.nih.gov/pubmed/16982809,16982809,,
4597,1528002,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,157506,RDH10,https://ctdbase.org/detail.go?type=gene&acc=157506,,,157506.0,RDH10,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RDH10 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4598,1528003,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,157506,RDH10,https://ctdbase.org/detail.go?type=gene&acc=157506,,,157506.0,RDH10,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RDH10 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
4599,1528407,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9400,RECQL5,https://ctdbase.org/detail.go?type=gene&acc=9400,,,9400.0,RECQL5,10090.0,Mus musculus (house mouse),Tretinoin results in decreased expression of RECQL5 mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
4600,1528408,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,65055,REEP1,https://ctdbase.org/detail.go?type=gene&acc=65055,,,65055.0,REEP1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of REEP1 mRNA,,,PMID:23830798,https://www.ncbi.nlm.nih.gov/pubmed/23830798,23830798,,
4601,1528409,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,65055,REEP1,https://ctdbase.org/detail.go?type=gene&acc=65055,,,65055.0,REEP1,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of REEP1 mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
4602,1528410,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,80346,REEP4,https://ctdbase.org/detail.go?type=gene&acc=80346,,,80346.0,REEP4,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of REEP4 mRNA,,,PMID:23724009|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/23724009|https://www.ncbi.nlm.nih.gov/pubmed/33167477,23724009|33167477,,
4603,1528411,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5966,REL,https://ctdbase.org/detail.go?type=gene&acc=5966,,,5966.0,REL,9606.0,Homo sapiens (human),Tretinoin results in increased expression of REL mRNA,,,PMID:16140955|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/16140955|https://www.ncbi.nlm.nih.gov/pubmed/33167477,16140955|33167477,,
4604,1528412,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Tretinoin promotes the reaction [arsenic trioxide results in decreased expression of RELA protein]|arsenic trioxide promotes the reaction [tretinoin results in decreased expression of RELA protein],,,PMID:30093655,https://www.ncbi.nlm.nih.gov/pubmed/30093655,30093655,,
4605,1528413,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),[SN50 peptide affects the localization of [RELA protein binds to NFKB1 protein]] inhibits the reaction [tretinoin results in increased expression of GRIN1 protein]|tretinoin affects the localization of RELA protein|[sn50 peptide affects the localization of [RELA protein binds to NFKB1 protein]] inhibits the reaction [tretinoin results in increased expression of SOD2 protein],,,PMID:18280257,https://www.ncbi.nlm.nih.gov/pubmed/18280257,18280257,,
4606,1528414,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),[tretinoin co-treated with paclitaxel] results in decreased expression of RELA protein,,,PMID:17701358|PMID:18098270,https://www.ncbi.nlm.nih.gov/pubmed/17701358|https://www.ncbi.nlm.nih.gov/pubmed/18098270,17701358|18098270,,
4607,1529074,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3183,HNRNPC,https://ctdbase.org/detail.go?type=gene&acc=3183,,,3183.0,HNRNPC,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HNRNPC mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
4608,1529075,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3184,HNRNPD,https://ctdbase.org/detail.go?type=gene&acc=3184,,,3184.0,HNRNPD,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of HNRNPD protein alternative form,,,PMID:16514630,https://www.ncbi.nlm.nih.gov/pubmed/16514630,16514630,,
4609,1529076,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9987,HNRNPDL,https://ctdbase.org/detail.go?type=gene&acc=9987,,,9987.0,HNRNPDL,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HNRNPDL mRNA,,,PMID:15894607,https://www.ncbi.nlm.nih.gov/pubmed/15894607,15894607,,
4610,1529077,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3187,HNRNPH1,https://ctdbase.org/detail.go?type=gene&acc=3187,,,3187.0,HNRNPH1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HNRNPH1 protein|[tretinoin co-treated with tamoxifen] results in increased expression of HNRNPH1 protein,,,PMID:17098229,https://www.ncbi.nlm.nih.gov/pubmed/17098229,17098229,,
4611,1529078,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3188,HNRNPH2,https://ctdbase.org/detail.go?type=gene&acc=3188,,,3188.0,HNRNPH2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HNRNPH2 protein|[tretinoin co-treated with tamoxifen] results in increased expression of HNRNPH2 protein,,,PMID:17098229,https://www.ncbi.nlm.nih.gov/pubmed/17098229,17098229,,
4612,1529079,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3189,HNRNPH3,https://ctdbase.org/detail.go?type=gene&acc=3189,,,3189.0,HNRNPH3,9606.0,Homo sapiens (human),[tretinoin co-treated with tamoxifen] results in decreased expression of HNRNPH3 protein|tretinoin results in decreased expression of HNRNPH3 protein,,,PMID:17098229,https://www.ncbi.nlm.nih.gov/pubmed/17098229,17098229,,
4613,1529080,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,92906,HNRNPLL,https://ctdbase.org/detail.go?type=gene&acc=92906,,,92906.0,HNRNPLL,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HNRNPLL mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
4614,1529081,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3192,HNRNPU,https://ctdbase.org/detail.go?type=gene&acc=3192,,,3192.0,HNRNPU,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HNRNPU mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
4615,1529082,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5979,RET,https://ctdbase.org/detail.go?type=gene&acc=5979,,,5979.0,RET,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in increased expression of RET mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
4616,1529083,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,56729,RETN,https://ctdbase.org/detail.go?type=gene&acc=56729,,,56729.0,RETN,9606.0,Homo sapiens (human),[tretinoin co-treated with arsenic trioxide] results in increased expression of and results in increased secretion of RETN protein|tretinoin results in increased expression of and results in increased secretion of RETN protein|trib3 protein promotes the reaction [tretinoin results in increased expression of and results in increased secretion of RETN protein],,,PMID:32929351,https://www.ncbi.nlm.nih.gov/pubmed/32929351,32929351,,
4617,1529084,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,56729,RETN,https://ctdbase.org/detail.go?type=gene&acc=56729,,,56729.0,RETN,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RETN mRNA,,,PMID:17218384|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/17218384|https://www.ncbi.nlm.nih.gov/pubmed/33167477,17218384|33167477,,
4618,1481811,444865,Comparative Toxicogenomics Database (CTD),Equilenin,D004855,Equilenin,https://ctdbase.org/detail.go?type=chem&acc=D004855,154141,MBOAT1,https://ctdbase.org/detail.go?type=gene&acc=154141,,,154141.0,MBOAT1,8090.0,Oryzias latipes (Japanese medaka),Equilenin results in increased expression of MBOAT1 mRNA,,,PMID:25611945,https://www.ncbi.nlm.nih.gov/pubmed/25611945,25611945,,
4619,1512550,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5875,RABGGTA,https://ctdbase.org/detail.go?type=gene&acc=5875,,,5875.0,RABGGTA,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of RABGGTA mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
4620,1512551,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5876,RABGGTB,https://ctdbase.org/detail.go?type=gene&acc=5876,,,5876.0,RABGGTB,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of RABGGTB mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
4621,1481951,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,313,AOAH,https://ctdbase.org/detail.go?type=gene&acc=313,,,313.0,AOAH,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of AOAH mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4622,1481952,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,84909,AOPEP,https://ctdbase.org/detail.go?type=gene&acc=84909,,,84909.0,AOPEP,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of AOPEP mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4623,1481953,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,10090.0,Mus musculus (house mouse),Resveratrol affects the expression of AOX1 mRNA,,,PMID:23525482,https://www.ncbi.nlm.nih.gov/pubmed/23525482,23525482,,
4624,1481954,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [estradiol results in decreased expression of AOX1 mrna]|resveratrol inhibits the reaction [estradiol results in decreased expression of AOX1],,,PMID:24894866,https://www.ncbi.nlm.nih.gov/pubmed/24894866,24894866,,
4625,1482262,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,324,APC,https://ctdbase.org/detail.go?type=gene&acc=324,,,324.0,APC,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of APC mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4626,1482263,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,10297,APC2,https://ctdbase.org/detail.go?type=gene&acc=10297,,,10297.0,APC2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of APC2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4627,1482264,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,164284,APCDD1L,https://ctdbase.org/detail.go?type=gene&acc=164284,,,164284.0,APCDD1L,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of APCDD1L mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4628,1482265,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,325,APCS,https://ctdbase.org/detail.go?type=gene&acc=325,,,325.0,APCS,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [titanium dioxide results in increased expression of APCS mrna],,,PMID:31298478,https://www.ncbi.nlm.nih.gov/pubmed/31298478,31298478,,
4629,1482266,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,328,APEX1,https://ctdbase.org/detail.go?type=gene&acc=328,,,328.0,APEX1,9606.0,Homo sapiens (human),Resveratrol results in decreased activity of APEX1 protein,,,PMID:16373707,https://www.ncbi.nlm.nih.gov/pubmed/16373707,16373707,,
4630,1482267,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,328,APEX1,https://ctdbase.org/detail.go?type=gene&acc=328,,,328.0,APEX1,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in decreased expression of APEX1 mRNA,,,PMID:33775663,https://www.ncbi.nlm.nih.gov/pubmed/33775663,33775663,,
4631,1482268,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,8539,API5,https://ctdbase.org/detail.go?type=gene&acc=8539,,,8539.0,API5,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of API5 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4632,1482645,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,9606.0,Homo sapiens (human),Resveratrol results in decreased secretion of APOB protein,,,PMID:12612140,https://www.ncbi.nlm.nih.gov/pubmed/12612140,12612140,,
4633,1482646,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,10036.0,Mesocricetus auratus (golden hamster),Resveratrol inhibits the reaction [dietary fats results in increased expression of APOB protein],,,PMID:18166149,https://www.ncbi.nlm.nih.gov/pubmed/18166149,18166149,,
4634,1482647,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,10090.0,Mus musculus (house mouse),Resveratrol results in decreased expression of APOB protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
4635,1482648,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9582,APOBEC3B,https://ctdbase.org/detail.go?type=gene&acc=9582,,,9582.0,APOBEC3B,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of APOBEC3B mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
4636,1482649,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,200316,APOBEC3F,https://ctdbase.org/detail.go?type=gene&acc=200316,,,200316.0,APOBEC3F,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of APOBEC3F mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4637,1482650,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,341,APOC1,https://ctdbase.org/detail.go?type=gene&acc=341,,,341.0,APOC1,143606.0,Gobiocypris rarus,[resveratrol co-treated with bisphenol A] results in decreased expression of APOC1 mRNA,,,PMID:36860429,https://www.ncbi.nlm.nih.gov/pubmed/36860429,36860429,,
4638,1482651,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,341,APOC1,https://ctdbase.org/detail.go?type=gene&acc=341,,,341.0,APOC1,9606.0,Homo sapiens (human),Resveratrol results in increased expression of APOC1 mRNA,,,PMID:25888808,https://www.ncbi.nlm.nih.gov/pubmed/25888808,25888808,,
4639,1482652,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,344,APOC2,https://ctdbase.org/detail.go?type=gene&acc=344,,,344.0,APOC2,143606.0,Gobiocypris rarus,Resveratrol inhibits the reaction [bisphenol A results in decreased expression of APOC2 mrna],,,PMID:36860429,https://www.ncbi.nlm.nih.gov/pubmed/36860429,36860429,,
4640,1483258,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [APP protein results in decreased expression of and results in decreased activity of SIRT1 protein],,,PMID:24254769,https://www.ncbi.nlm.nih.gov/pubmed/24254769,24254769,,
4641,1483259,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [APP protein results in increased secretion of IL6 protein]|resveratrol results in decreased expression of APP protein|resveratrol inhibits the reaction [APP protein results in increased phosphorylation of STAT3 protein]|resveratrol inhibits the reaction [APP protein results in increased phosphorylation of NFKBIA protein]|resveratrol inhibits the reaction [APP protein results in increased secretion of TNF protein]|resveratrol inhibits the reaction [APP protein results in increased phosphorylation of STAT1 protein],,,PMID:22118570,https://www.ncbi.nlm.nih.gov/pubmed/22118570,22118570,,
4642,1483546,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,55872,PBK,https://ctdbase.org/detail.go?type=gene&acc=55872,,,55872.0,PBK,9606.0,Homo sapiens (human),Resveratrol results in decreased expression of PBK mRNA,,,PMID:15767336,https://www.ncbi.nlm.nih.gov/pubmed/15767336,15767336,,
4643,1483547,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,55872,PBK,https://ctdbase.org/detail.go?type=gene&acc=55872,,,55872.0,PBK,9606.0,Homo sapiens (human),Resveratrol results in decreased expression of PBK protein,,,PMID:18089832,https://www.ncbi.nlm.nih.gov/pubmed/18089832,18089832,,
4644,1483548,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,360,AQP3,https://ctdbase.org/detail.go?type=gene&acc=360,,,360.0,AQP3,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of AQP3 mrna],,,PMID:26454884,https://www.ncbi.nlm.nih.gov/pubmed/26454884,26454884,,
4645,1483549,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,360,AQP3,https://ctdbase.org/detail.go?type=gene&acc=360,,,360.0,AQP3,9606.0,Homo sapiens (human),Resveratrol results in increased expression of AQP3 mRNA,,,PMID:20706672|PMID:26454884,https://www.ncbi.nlm.nih.gov/pubmed/20706672|https://www.ncbi.nlm.nih.gov/pubmed/26454884,20706672|26454884,,
4646,1483550,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,363,AQP6,https://ctdbase.org/detail.go?type=gene&acc=363,,,363.0,AQP6,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of AQP6 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4647,1483551,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,364,AQP7,https://ctdbase.org/detail.go?type=gene&acc=364,,,364.0,AQP7,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of AQP7 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4648,1483552,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,343,AQP8,https://ctdbase.org/detail.go?type=gene&acc=343,,,343.0,AQP8,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of AQP8 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4649,1483553,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9716,AQR,https://ctdbase.org/detail.go?type=gene&acc=9716,,,9716.0,AQR,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of AQR mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4650,1483554,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,8289,ARID1A,https://ctdbase.org/detail.go?type=gene&acc=8289,,,8289.0,ARID1A,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of ARID1A mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4651,1483555,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,57492,ARID1B,https://ctdbase.org/detail.go?type=gene&acc=57492,,,57492.0,ARID1B,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in decreased expression of ARID1B mRNA,,,PMID:25905778,https://www.ncbi.nlm.nih.gov/pubmed/25905778,25905778,,
4652,1484090,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,27237,ARHGEF16,https://ctdbase.org/detail.go?type=gene&acc=27237,,,27237.0,ARHGEF16,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of ARHGEF16 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4653,1484091,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9181,ARHGEF2,https://ctdbase.org/detail.go?type=gene&acc=9181,,,9181.0,ARHGEF2,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of ARHGEF2 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
4654,1484092,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,115557,ARHGEF25,https://ctdbase.org/detail.go?type=gene&acc=115557,,,115557.0,ARHGEF25,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of ARHGEF25 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4655,1484093,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in increased expression of PCK1 mRNA,,,PMID:23209300|PMID:23824959,https://www.ncbi.nlm.nih.gov/pubmed/23209300|https://www.ncbi.nlm.nih.gov/pubmed/23824959,23209300|23824959,,
4656,1484094,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5106,PCK2,https://ctdbase.org/detail.go?type=gene&acc=5106,,,5106.0,PCK2,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of PCK2 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
4657,1484095,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9768,PCLAF,https://ctdbase.org/detail.go?type=gene&acc=9768,,,9768.0,PCLAF,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of PCLAF mrna|resveratrol results in increased expression of PCLAF mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
4658,1484096,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9768,PCLAF,https://ctdbase.org/detail.go?type=gene&acc=9768,,,9768.0,PCLAF,9823.0,Sus scrofa (pig),[dietary fats co-treated with resveratrol] results in decreased expression of PCLAF mRNA,,,PMID:21852083,https://www.ncbi.nlm.nih.gov/pubmed/21852083,21852083,,
4659,1484097,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,55251,PCMTD2,https://ctdbase.org/detail.go?type=gene&acc=55251,,,55251.0,PCMTD2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of PCMTD2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4660,1484098,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,7955.0,Danio rerio (zebrafish),Resveratrol inhibits the reaction [trichloroethylene results in increased expression of PCNA protein]|resveratrol inhibits the reaction [trichloroethylene results in increased expression of PCNA mrna],,,PMID:33524428,https://www.ncbi.nlm.nih.gov/pubmed/33524428,33524428,,
4661,1484099,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of PCNA mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
4662,1486174,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5228,PGF,https://ctdbase.org/detail.go?type=gene&acc=5228,,,5228.0,PGF,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of PGF mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4663,1486175,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5228,PGF,https://ctdbase.org/detail.go?type=gene&acc=5228,,,5228.0,PGF,9606.0,Homo sapiens (human),Resveratrol results in decreased expression of PGF mRNA,,,PMID:23224687,https://www.ncbi.nlm.nih.gov/pubmed/23224687,23224687,,
4664,1486176,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5228,PGF,https://ctdbase.org/detail.go?type=gene&acc=5228,,,5228.0,PGF,9606.0,Homo sapiens (human),Resveratrol results in increased expression of PGF mRNA,,,PMID:25888808,https://www.ncbi.nlm.nih.gov/pubmed/25888808,25888808,,
4665,1487828,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,415116,PIM3,https://ctdbase.org/detail.go?type=gene&acc=415116,,,415116.0,PIM3,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of PIM3 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4666,1487829,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,415116,PIM3,https://ctdbase.org/detail.go?type=gene&acc=415116,,,415116.0,PIM3,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [titanium dioxide results in increased expression of PIM3 mrna],,,PMID:31298478,https://www.ncbi.nlm.nih.gov/pubmed/31298478,31298478,,
4667,1489763,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,64748,PLPPR2,https://ctdbase.org/detail.go?type=gene&acc=64748,,,64748.0,PLPPR2,9606.0,Homo sapiens (human),Resveratrol results in increased expression of PLPPR2 mRNA,,,PMID:19371625,https://www.ncbi.nlm.nih.gov/pubmed/19371625,19371625,,
4668,1489764,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5359,PLSCR1,https://ctdbase.org/detail.go?type=gene&acc=5359,,,5359.0,PLSCR1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of PLSCR1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4669,1489765,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5359,PLSCR1,https://ctdbase.org/detail.go?type=gene&acc=5359,,,5359.0,PLSCR1,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in increased expression of PLSCR1 mrna|[resveratrol co-treated with streptozocin] results in increased expression of PLSCR1 mRNA,,,PMID:25905778,https://www.ncbi.nlm.nih.gov/pubmed/25905778,25905778,,
4670,1489766,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,57048,PLSCR3,https://ctdbase.org/detail.go?type=gene&acc=57048,,,57048.0,PLSCR3,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of PLSCR3 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4671,1491897,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of PPARA mRNA,,,PMID:24817795,https://www.ncbi.nlm.nih.gov/pubmed/24817795,24817795,,
4672,1491898,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of PPARA protein,,,PMID:18930334|PMID:23090186,https://www.ncbi.nlm.nih.gov/pubmed/18930334|https://www.ncbi.nlm.nih.gov/pubmed/23090186,18930334|23090186,,
4673,1492063,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [pirinixic acid binds to PPARA protein]|resveratrol binds to PPARA protein,,,PMID:24796862,https://www.ncbi.nlm.nih.gov/pubmed/24796862,24796862,,
4674,1492064,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5467,PPARD,https://ctdbase.org/detail.go?type=gene&acc=5467,,,5467.0,PPARD,9606.0,Homo sapiens (human),Resveratrol analog binds to PPARD protein|resveratrol analog results in increased expression of PPARD mRNA,,,PMID:24759758,https://www.ncbi.nlm.nih.gov/pubmed/24759758,24759758,,
4675,1492065,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5467,PPARD,https://ctdbase.org/detail.go?type=gene&acc=5467,,,5467.0,PPARD,9606.0,Homo sapiens (human),Resveratrol results in decreased expression of PPARD mRNA,,,PMID:12002526|PMID:12569576,https://www.ncbi.nlm.nih.gov/pubmed/12002526|https://www.ncbi.nlm.nih.gov/pubmed/12569576,12002526|12569576,,
4676,1492066,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5467,PPARD,https://ctdbase.org/detail.go?type=gene&acc=5467,,,5467.0,PPARD,10090.0,Mus musculus (house mouse),[dietary fats co-treated with resveratrol] results in increased expression of PPARD mRNA,,,PMID:29197120,https://www.ncbi.nlm.nih.gov/pubmed/29197120,29197120,,
4677,1492067,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5467,PPARD,https://ctdbase.org/detail.go?type=gene&acc=5467,,,5467.0,PPARD,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [dietary fats results in decreased expression of PPARD protein]|[dietary fats co-treated with resveratrol] affects the expression of PPARD mRNA,,,PMID:26055348,https://www.ncbi.nlm.nih.gov/pubmed/26055348,26055348,,
4678,1492540,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Resveratrol metabolite results in decreased expression of PPARG mRNA,,,PMID:22945685,https://www.ncbi.nlm.nih.gov/pubmed/22945685,22945685,,
4679,1492541,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Resveratrol results in decreased expression of PPARG mRNA,,,PMID:16813520|PMID:18555852|PMID:18930334|PMID:21109418|PMID:21467634|PMID:22659145|PMID:23525482|PMID:23748787|PMID:24722352|PMID:25338179,https://www.ncbi.nlm.nih.gov/pubmed/16813520|https://www.ncbi.nlm.nih.gov/pubmed/18555852|https://www.ncbi.nlm.nih.gov/pubmed/18930334|https://www.ncbi.nlm.nih.gov/pubmed/21109418|https://www.ncbi.nlm.nih.gov/pubmed/21467634|https://www.ncbi.nlm.nih.gov/pubmed/22659145|https://www.ncbi.nlm.nih.gov/pubmed/23525482|https://www.ncbi.nlm.nih.gov/pubmed/23748787|https://www.ncbi.nlm.nih.gov/pubmed/24722352|https://www.ncbi.nlm.nih.gov/pubmed/25338179,16813520|18555852|18930334|21109418|21467634|22659145|23525482|23748787|24722352|25338179,,
4680,1492542,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Resveratrol results in decreased expression of PPARG protein,,,PMID:18555852|PMID:18930334|PMID:22935344|PMID:23525482|PMID:25761413,https://www.ncbi.nlm.nih.gov/pubmed/18555852|https://www.ncbi.nlm.nih.gov/pubmed/18930334|https://www.ncbi.nlm.nih.gov/pubmed/22935344|https://www.ncbi.nlm.nih.gov/pubmed/23525482|https://www.ncbi.nlm.nih.gov/pubmed/25761413,18555852|18930334|22935344|23525482|25761413,,
4681,1492543,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of PPARG protein,,,PMID:24036142,https://www.ncbi.nlm.nih.gov/pubmed/24036142,24036142,,
4682,1492544,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Rosiglitazone inhibits the reaction [resveratrol analog results in decreased expression of PPARG mrna],,,PMID:24779192,https://www.ncbi.nlm.nih.gov/pubmed/24779192,24779192,,
4683,1492545,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [ethanol results in increased expression of PPARG mrna],,,PMID:18793633,https://www.ncbi.nlm.nih.gov/pubmed/18793633,18793633,,
4684,1492546,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [palmitic acid results in decreased expression of PPARG mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
4685,1492547,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in decreased acetylation of and results in decreased activity of PPARG protein,,,PMID:28973641,https://www.ncbi.nlm.nih.gov/pubmed/28973641,28973641,,
4686,1492548,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in decreased expression of PPARG mRNA,,,PMID:23848300,https://www.ncbi.nlm.nih.gov/pubmed/23848300,23848300,,
4687,1493101,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10090.0,Mus musculus (house mouse),Resveratrol results in increased activity of PPARGC1A protein,,,PMID:17086191,https://www.ncbi.nlm.nih.gov/pubmed/17086191,17086191,,
4688,1493102,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10090.0,Mus musculus (house mouse),[resveratrol results in increased activity of SIRT1 protein] which results in increased expression of PPARGC1A protein,,,PMID:20561979,https://www.ncbi.nlm.nih.gov/pubmed/20561979,20561979,,
4689,1493103,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5501,PPP1CC,https://ctdbase.org/detail.go?type=gene&acc=5501,,,5501.0,PPP1CC,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of PPP1CC mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4690,1494598,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,190672,PQN-91,https://ctdbase.org/detail.go?type=gene&acc=190672,,,190672.0,pqn-91,6239.0,Caenorhabditis elegans,Resveratrol results in increased expression of PQN-91 mRNA,,,PMID:16256736,https://www.ncbi.nlm.nih.gov/pubmed/16256736,16256736,,
4691,1494599,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,11230,PRAF2,https://ctdbase.org/detail.go?type=gene&acc=11230,,,11230.0,PRAF2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of PRAF2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4692,1496098,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5591,PRKDC,https://ctdbase.org/detail.go?type=gene&acc=5591,,,5591.0,PRKDC,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of PRKDC mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4693,1496099,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5591,PRKDC,https://ctdbase.org/detail.go?type=gene&acc=5591,,,5591.0,PRKDC,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in decreased expression of PRKDC mRNA,,,PMID:33775663,https://www.ncbi.nlm.nih.gov/pubmed/33775663,33775663,,
4694,1497806,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5693,PSMB5,https://ctdbase.org/detail.go?type=gene&acc=5693,,,5693.0,PSMB5,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of PSMB5 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4695,1497807,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5693,PSMB5,https://ctdbase.org/detail.go?type=gene&acc=5693,,,5693.0,PSMB5,9606.0,Homo sapiens (human),PSMB5 protein affects the reaction [resveratrol results in decreased secretion of APP protein],,,PMID:16162502,https://www.ncbi.nlm.nih.gov/pubmed/16162502,16162502,,
4696,1499185,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [particulate matter results in increased expression of PTGS2 mrna],,,PMID:21652769|PMID:28495310,https://www.ncbi.nlm.nih.gov/pubmed/21652769|https://www.ncbi.nlm.nih.gov/pubmed/28495310,21652769|28495310,,
4697,1512404,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),[resveratrol results in decreased activity of AHR protein] inhibits the reaction [sunitinib results in increased expression of CYP1A1 mrna],,,PMID:23288144,https://www.ncbi.nlm.nih.gov/pubmed/23288144,23288144,,
4698,1512405,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Resveratrol results in decreased activity of CYP1A1 protein,,,PMID:11714871|PMID:22867086,https://www.ncbi.nlm.nih.gov/pubmed/11714871|https://www.ncbi.nlm.nih.gov/pubmed/22867086,11714871|22867086,,
4699,1513468,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1B1 mrna],,,PMID:11279601|PMID:15142886|PMID:19376845|PMID:20846786|PMID:29209748,https://www.ncbi.nlm.nih.gov/pubmed/11279601|https://www.ncbi.nlm.nih.gov/pubmed/15142886|https://www.ncbi.nlm.nih.gov/pubmed/19376845|https://www.ncbi.nlm.nih.gov/pubmed/20846786|https://www.ncbi.nlm.nih.gov/pubmed/29209748,11279601|15142886|19376845|20846786|29209748,,
4700,1513469,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1B1 protein],,,PMID:19138946,https://www.ncbi.nlm.nih.gov/pubmed/19138946,19138946,,
4701,1513470,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),Resveratrol results in decreased activity of CYP1B1 protein,,,PMID:11714871,https://www.ncbi.nlm.nih.gov/pubmed/11714871,11714871,,
4702,1515064,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Resveratrol results in increased expression of CYP3A4 mRNA,,,PMID:17210444|PMID:29933105,https://www.ncbi.nlm.nih.gov/pubmed/17210444|https://www.ncbi.nlm.nih.gov/pubmed/29933105,17210444|29933105,,
4703,1515065,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,50549,CYP4A1,https://ctdbase.org/detail.go?type=gene&acc=50549,,,50549.0,Cyp4a1,10116.0,Rattus norvegicus (Norway rat),[resveratrol co-treated with streptozocin] results in decreased expression of CYP4A1 mRNA,,,PMID:25905778,https://www.ncbi.nlm.nih.gov/pubmed/25905778,25905778,,
4704,1515066,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,13117,CYP4A10,https://ctdbase.org/detail.go?type=gene&acc=13117,,,13117.0,Cyp4a10,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CYP4A10 mrna],,,PMID:31298478,https://www.ncbi.nlm.nih.gov/pubmed/31298478,31298478,,
4705,1515067,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,277753,CYP4A12A,https://ctdbase.org/detail.go?type=gene&acc=277753,,,277753.0,Cyp4a12a,10116.0,Rattus norvegicus (Norway rat),Resveratrol affects the expression of CYP4A12A mRNA,,,PMID:15748624,https://www.ncbi.nlm.nih.gov/pubmed/15748624,15748624,,
4706,1515068,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,13119,CYP4A14,https://ctdbase.org/detail.go?type=gene&acc=13119,,,13119.0,Cyp4a14,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CYP4A14 mrna],,,PMID:31298478,https://www.ncbi.nlm.nih.gov/pubmed/31298478,31298478,,
4707,1515069,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,100040843,CYP4A32,https://ctdbase.org/detail.go?type=gene&acc=100040843,,,100040843.0,Cyp4a32,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CYP4A32 mrna],,,PMID:31298478,https://www.ncbi.nlm.nih.gov/pubmed/31298478,31298478,,
4708,1515070,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1580,CYP4B1,https://ctdbase.org/detail.go?type=gene&acc=1580,,,1580.0,CYP4B1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of CYP4B1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4709,1515071,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,8529,CYP4F2,https://ctdbase.org/detail.go?type=gene&acc=8529,,,8529.0,CYP4F2,9606.0,Homo sapiens (human),Resveratrol results in increased expression of CYP4F2 mrna|splitomicin inhibits the reaction [resveratrol results in increased expression of CYP4F2 mrna]|dorsomorphin inhibits the reaction [resveratrol results in increased expression of CYP4F2 mrna],,,PMID:21205922,https://www.ncbi.nlm.nih.gov/pubmed/21205922,21205922,,
4710,1515072,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,13121,CYP51,https://ctdbase.org/detail.go?type=gene&acc=13121,,,13121.0,Cyp51,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of CYP51 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
4711,1515540,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,375791,CYSRT1,https://ctdbase.org/detail.go?type=gene&acc=375791,,,375791.0,CYSRT1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of CYSRT1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4712,1515541,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,116159,CYYR1,https://ctdbase.org/detail.go?type=gene&acc=116159,,,116159.0,CYYR1,10116.0,Rattus norvegicus (Norway rat),[resveratrol co-treated with streptozocin] results in increased expression of CYYR1 mRNA,,,PMID:25905778,https://www.ncbi.nlm.nih.gov/pubmed/25905778,25905778,,
4713,1518533,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,64798,DEPTOR,https://ctdbase.org/detail.go?type=gene&acc=64798,,,64798.0,DEPTOR,9606.0,Homo sapiens (human),Resveratrol results in decreased expression of DEPTOR mRNA,,,PMID:19371625,https://www.ncbi.nlm.nih.gov/pubmed/19371625,19371625,,
4714,1518534,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,64798,DEPTOR,https://ctdbase.org/detail.go?type=gene&acc=64798,,,64798.0,DEPTOR,10090.0,Mus musculus (house mouse),DEPTOR protein affects the susceptibility to resveratrol|resveratrol promotes the reaction [MTOR protein binds to DEPTOR protein],,,PMID:20851890,https://www.ncbi.nlm.nih.gov/pubmed/20851890,20851890,,
4715,1518535,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,51071,DERA,https://ctdbase.org/detail.go?type=gene&acc=51071,,,51071.0,DERA,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of DERA mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
4716,1518536,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,51071,DERA,https://ctdbase.org/detail.go?type=gene&acc=51071,,,51071.0,DERA,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of DERA mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4717,1518537,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,79139,DERL1,https://ctdbase.org/detail.go?type=gene&acc=79139,,,79139.0,DERL1,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of DERL1 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
4718,1518538,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,91319,DERL3,https://ctdbase.org/detail.go?type=gene&acc=91319,,,91319.0,DERL3,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DERL3 mrna],,,PMID:31298478,https://www.ncbi.nlm.nih.gov/pubmed/31298478,31298478,,
4719,1518539,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1674,DES,https://ctdbase.org/detail.go?type=gene&acc=1674,,,1674.0,DES,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of DES mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4720,1518540,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1674,DES,https://ctdbase.org/detail.go?type=gene&acc=1674,,,1674.0,DES,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [carbon tetrachloride affects the expression of DES protein],,,PMID:23262250,https://www.ncbi.nlm.nih.gov/pubmed/23262250,23262250,,
4721,1518541,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,27351,DESI1,https://ctdbase.org/detail.go?type=gene&acc=27351,,,27351.0,DESI1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of DESI1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4722,1522039,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,55715,DOK4,https://ctdbase.org/detail.go?type=gene&acc=55715,,,55715.0,DOK4,9606.0,Homo sapiens (human),Resveratrol results in increased expression of DOK4 mRNA,,,PMID:19371625,https://www.ncbi.nlm.nih.gov/pubmed/19371625,19371625,,
4723,1522040,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,29980,DONSON,https://ctdbase.org/detail.go?type=gene&acc=29980,,,29980.0,DONSON,9606.0,Homo sapiens (human),Resveratrol results in increased expression of DONSON mrna|[coumestrol co-treated with resveratrol] results in increased expression of DONSON mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
4724,1522041,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,23033,DOP1A,https://ctdbase.org/detail.go?type=gene&acc=23033,,,23033.0,DOP1A,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of DOP1A mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4725,1522042,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,8813,DPM1,https://ctdbase.org/detail.go?type=gene&acc=8813,,,8813.0,DPM1,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of DPM1 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
4726,1522043,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1803,DPP4,https://ctdbase.org/detail.go?type=gene&acc=1803,,,1803.0,DPP4,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [bisphenol A results in increased expression of DPP4 protein],,,PMID:37570835,https://www.ncbi.nlm.nih.gov/pubmed/37570835,37570835,,
4727,1522044,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1804,DPP6,https://ctdbase.org/detail.go?type=gene&acc=1804,,,1804.0,DPP6,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of DPP6 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4728,1522045,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,29952,DPP7,https://ctdbase.org/detail.go?type=gene&acc=29952,,,29952.0,DPP7,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in increased expression of DPP7 mRNA,,,PMID:25905778,https://www.ncbi.nlm.nih.gov/pubmed/25905778,25905778,,
4729,1522046,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,54878,DPP8,https://ctdbase.org/detail.go?type=gene&acc=54878,,,54878.0,DPP8,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of DPP8 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4730,1522047,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,400206,DPPA3P2,https://ctdbase.org/detail.go?type=gene&acc=400206,,,400206.0,DPPA3P2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of DPPA3P2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4731,1522048,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,147991,DPY19L3,https://ctdbase.org/detail.go?type=gene&acc=147991,,,147991.0,DPY19L3,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of DPY19L3 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4732,1525144,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,10235,RASGRP2,https://ctdbase.org/detail.go?type=gene&acc=10235,,,10235.0,RASGRP2,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in increased expression of RASGRP2 mrna|[resveratrol co-treated with streptozocin] results in increased expression of RASGRP2 mRNA,,,PMID:25905778,https://www.ncbi.nlm.nih.gov/pubmed/25905778,25905778,,
4733,1525385,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of EGFR mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4734,1525386,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [EGF protein results in decreased expression of CDH1 mrna]|resveratrol inhibits the reaction [EGF protein results in increased expression of VIM mrna]|resveratrol inhibits the reaction [EGF protein results in increased expression of LIMA1 mrna]|resveratrol inhibits the reaction [EGF protein results in increased expression of CFL1 mrna]|resveratrol inhibits the reaction [EGF protein results in increased expression of SNAI1 mrna]|resveratrol inhibits the reaction [EGF protein results in increased expression of TAGLN mrna]|resveratrol inhibits the reaction [EGF protein results in increased expression of ZEB1 mrna]|resveratrol inhibits the reaction [EGF protein results in increased expression of CDH2 mrna]|resveratrol inhibits the reaction [EGF protein results in increased expression of SSH2 mrna]|resveratrol inhibits the reaction [EGF protein results in increased expression of ZEB2 mrna]|resveratrol inhibits the reaction [EGF protein results in increased expression of SSH1 mrna],,,PMID:21794976,https://www.ncbi.nlm.nih.gov/pubmed/21794976,21794976,,
4735,1525387,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [EGF protein results in increased expression of MED28 protein]|resveratrol results in decreased activity of EGF protein|resveratrol inhibits the reaction [EGF protein results in increased expression of and results in increased secretion of MMP9 protein]|resveratrol inhibits the reaction [EGF protein results in increased expression of and results in increased phosphorylation of EGFR protein],,,PMID:21942447,https://www.ncbi.nlm.nih.gov/pubmed/21942447,21942447,,
4736,1526185,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,9606.0,Homo sapiens (human),Resveratrol results in increased activity of EGR1 protein,,,PMID:15308739,https://www.ncbi.nlm.nih.gov/pubmed/15308739,15308739,,
4737,1526186,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1960,EGR3,https://ctdbase.org/detail.go?type=gene&acc=1960,,,1960.0,EGR3,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of EGR3 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
4738,1526838,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1967,EIF2B1,https://ctdbase.org/detail.go?type=gene&acc=1967,,,1967.0,EIF2B1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of EIF2B1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4739,1526839,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,8891,EIF2B3,https://ctdbase.org/detail.go?type=gene&acc=8891,,,8891.0,EIF2B3,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of EIF2B3 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4740,1526840,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,8890,EIF2B4,https://ctdbase.org/detail.go?type=gene&acc=8890,,,8890.0,EIF2B4,9606.0,Homo sapiens (human),Resveratrol results in increased expression of EIF2B4 mRNA,,,PMID:19371625,https://www.ncbi.nlm.nih.gov/pubmed/19371625,19371625,,
4741,1526841,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,8893,EIF2B5,https://ctdbase.org/detail.go?type=gene&acc=8893,,,8893.0,EIF2B5,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of EIF2B5 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4742,1526842,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1965,EIF2S1,https://ctdbase.org/detail.go?type=gene&acc=1965,,,1965.0,EIF2S1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of EIF2S1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4743,1526843,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1965,EIF2S1,https://ctdbase.org/detail.go?type=gene&acc=1965,,,1965.0,EIF2S1,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [ethanol results in increased expression of EIF2S1 protein modified form],,,PMID:24224909,https://www.ncbi.nlm.nih.gov/pubmed/24224909,24224909,,
4744,1526844,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1965,EIF2S1,https://ctdbase.org/detail.go?type=gene&acc=1965,,,1965.0,EIF2S1,9606.0,Homo sapiens (human),Resveratrol results in increased phosphorylation of EIF2S1 protein,,,PMID:17914584|PMID:22898769,https://www.ncbi.nlm.nih.gov/pubmed/17914584|https://www.ncbi.nlm.nih.gov/pubmed/22898769,17914584|22898769,,
4745,1526845,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1965,EIF2S1,https://ctdbase.org/detail.go?type=gene&acc=1965,,,1965.0,EIF2S1,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [acrolein results in increased phosphorylation of EIF2S1 protein],,,PMID:34813903,https://www.ncbi.nlm.nih.gov/pubmed/34813903,34813903,,
4746,1526846,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,8894,EIF2S2,https://ctdbase.org/detail.go?type=gene&acc=8894,,,8894.0,EIF2S2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of EIF2S2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4747,1526847,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1968,EIF2S3,https://ctdbase.org/detail.go?type=gene&acc=1968,,,1968.0,EIF2S3,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of EIF2S3 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4748,1528135,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,79071,ELOVL6,https://ctdbase.org/detail.go?type=gene&acc=79071,,,79071.0,ELOVL6,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of ELOVL6 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
4749,1528136,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,79993,ELOVL7,https://ctdbase.org/detail.go?type=gene&acc=79993,,,79993.0,ELOVL7,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of ELOVL7 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
4750,1528137,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,8518,ELP1,https://ctdbase.org/detail.go?type=gene&acc=8518,,,8518.0,ELP1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of ELP1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4751,1528138,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,55250,ELP2,https://ctdbase.org/detail.go?type=gene&acc=55250,,,55250.0,ELP2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of ELP2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4752,1528139,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,26610,ELP4,https://ctdbase.org/detail.go?type=gene&acc=26610,,,26610.0,ELP4,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of ELP4 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4753,1528140,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,23587,ELP5,https://ctdbase.org/detail.go?type=gene&acc=23587,,,23587.0,ELP5,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of ELP5 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
4754,1528141,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,23065,EMC1,https://ctdbase.org/detail.go?type=gene&acc=23065,,,23065.0,EMC1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of EMC1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4755,1528142,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9694,EMC2,https://ctdbase.org/detail.go?type=gene&acc=9694,,,9694.0,EMC2,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of EMC2 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
4756,1528143,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,51234,EMC4,https://ctdbase.org/detail.go?type=gene&acc=51234,,,51234.0,EMC4,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of EMC4 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4757,1529611,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033.0,EP300,9606.0,Homo sapiens (human),Resveratrol results in increased expression of EP300 mRNA,,,PMID:12002526|PMID:12569576,https://www.ncbi.nlm.nih.gov/pubmed/12002526|https://www.ncbi.nlm.nih.gov/pubmed/12569576,12002526|12569576,,
4758,1529612,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033.0,EP300,10090.0,Mus musculus (house mouse),"Sirtinol inhibits the reaction [resveratrol inhibits the reaction [doxorubicin results in increased expression of EP300 protein]]|6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [doxorubicin results in increased expression of EP300 protein]]|resveratrol inhibits the reaction [doxorubicin results in increased expression of EP300 protein]",,,PMID:25665036,https://www.ncbi.nlm.nih.gov/pubmed/25665036,25665036,,
4759,1529613,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033.0,EP300,10090.0,Mus musculus (house mouse),Resveratrol affects the expression of EP300 protein,,,PMID:24254769,https://www.ncbi.nlm.nih.gov/pubmed/24254769,24254769,,
4760,1529614,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033.0,EP300,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [phenylephrine promotes the reaction [EP300 protein binds to NPPA promoter]]|benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [resveratrol results in decreased expression of EP300 protein]|sirt1 mutant form inhibits the reaction [resveratrol results in decreased expression of EP300 protein]|resveratrol inhibits the reaction [phenylephrine results in increased expression of EP300 protein]|resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of EP300 protein]|resveratrol results in decreased expression of EP300 protein,,,PMID:23297412,https://www.ncbi.nlm.nih.gov/pubmed/23297412,23297412,,
4761,1529615,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033.0,EP300,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in decreased expression of EP300 mRNA,,,PMID:25905778,https://www.ncbi.nlm.nih.gov/pubmed/25905778,25905778,,
4762,1529616,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2036,EPB41L1,https://ctdbase.org/detail.go?type=gene&acc=2036,,,2036.0,EPB41L1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of EPB41L1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4763,1529617,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2043,EPHA4,https://ctdbase.org/detail.go?type=gene&acc=2043,,,2043.0,EPHA4,9606.0,Homo sapiens (human),Resveratrol results in increased expression of EPHA4 mRNA,,,PMID:12569576,https://www.ncbi.nlm.nih.gov/pubmed/12569576,12569576,,
4764,1529618,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2052,EPHX1,https://ctdbase.org/detail.go?type=gene&acc=2052,,,2052.0,EPHX1,9606.0,Homo sapiens (human),Resveratrol promotes the reaction [benzo(a)pyrene results in increased activity of EPHX1 protein],,,PMID:16484233,https://www.ncbi.nlm.nih.gov/pubmed/16484233,16484233,,
4765,1529753,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [TNF protein affects the localization of RELA protein],,,PMID:18549505,https://www.ncbi.nlm.nih.gov/pubmed/18549505,18549505,,
4766,1529754,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein],,,PMID:23527233,https://www.ncbi.nlm.nih.gov/pubmed/23527233,23527233,,
4767,1529755,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Resveratrol results in decreased activity of RELA protein,,,PMID:24020126,https://www.ncbi.nlm.nih.gov/pubmed/24020126,24020126,,
4768,1549194,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4320,MMP11,https://ctdbase.org/detail.go?type=gene&acc=4320,,,4320.0,MMP11,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of MMP11 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
4769,1549195,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,9913.0,Bos taurus (cattle),Resveratrol inhibits the reaction [IL1B protein results in increased expression of MMP13 mrna],,,PMID:19011540,https://www.ncbi.nlm.nih.gov/pubmed/19011540,19011540,,
4770,1549196,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [IL1B protein results in increased expression of MMP13 mrna],,,PMID:21211511|PMID:26526931,https://www.ncbi.nlm.nih.gov/pubmed/21211511|https://www.ncbi.nlm.nih.gov/pubmed/26526931,21211511|26526931,,
4771,1549197,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP13 protein]|resveratrol inhibits the reaction [IL1B protein results in increased expression of MMP13 protein],,,PMID:21211511,https://www.ncbi.nlm.nih.gov/pubmed/21211511,21211511,,
4772,1486033,445314,DrugBank,"8-Hydroxy-2-oxa-bicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid",DB08648,"8-Hydroxy-2-oxa-bicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid",https://www.drugbank.ca/drugs/DB08648,BE0004361,Secreted chorismate mutase,https://www.drugbank.ca/bio_entities/BE0004361,P9WIB9,Secreted chorismate mutase,45425858.0,MCAN_RS09915,83332.0,Mycobacterium tuberculosis H37Rv,,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
4773,1486034,445354,Toxin and Toxin Target Database (T3DB),Retinol,T3D2699,Vitamin A,http://www.t3db.ca/toxins/T3D2699,BE0000682,Retinol-binding protein 5,http://www.t3db.ca/biodb/bio_entities/BE0000682,P82980,Retinol-binding protein 5,83758.0,RBP5,9606.0,Homo sapiens (human),"Vision:vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. this is the event that triggers the nerve impulse to the brain which allows for the perception of light. all-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. all-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. <br/>epithelial differentiation: the role of vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, rars; and retinoid-X receptors, rxrs). these receptors function as ligand-activated transcription factors that modulate gene transcription. when there is not enough vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.",,,PMID:16115871,https://www.ncbi.nlm.nih.gov/pubmed/16115871,16115871,,
4774,1516393,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,570772,BCL2A,https://ctdbase.org/detail.go?type=gene&acc=570772,,,570772.0,bcl2a,7955.0,Danio rerio (zebrafish),Glyphosate promotes the reaction [cyanoginosin LR results in increased expression of BCL2A mrna]|cyanoginosin LR inhibits the reaction [glyphosate results in increased expression of BCL2A mrna],,,PMID:34438504,https://www.ncbi.nlm.nih.gov/pubmed/34438504,34438504,,
4775,1516394,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,570772,BCL2A,https://ctdbase.org/detail.go?type=gene&acc=570772,,,570772.0,bcl2a,7955.0,Danio rerio (zebrafish),Cyanoginosin LR results in increased expression of BCL2A mRNA,,,PMID:22407967|PMID:34438504,https://www.ncbi.nlm.nih.gov/pubmed/22407967|https://www.ncbi.nlm.nih.gov/pubmed/34438504,22407967|34438504,,
4776,1516395,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,10018,BCL2L11,https://ctdbase.org/detail.go?type=gene&acc=10018,,,10018.0,BCL2L11,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in increased expression of BCL2L11 mRNA,,,PMID:17654400,https://www.ncbi.nlm.nih.gov/pubmed/17654400,17654400,,
4777,1516396,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,604,BCL6,https://ctdbase.org/detail.go?type=gene&acc=604,,,604.0,BCL6,8400.0,Lithobates catesbeianus (American bullfrog),Cyanoginosin LR results in increased expression of BCL6 mRNA,,,PMID:34863901,https://www.ncbi.nlm.nih.gov/pubmed/34863901,34863901,,
4778,1516397,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,624,BDKRB2,https://ctdbase.org/detail.go?type=gene&acc=624,,,624.0,BDKRB2,10116.0,Rattus norvegicus (Norway rat),"[dietary fats co-treated with cholesterol, dietary co-treated with cyanoginosin LR] results in increased expression of BDKRB2 mrna|cyanoginosin LR results in increased expression of BDKRB2 mRNA",,,PMID:34740672,https://www.ncbi.nlm.nih.gov/pubmed/34740672,34740672,,
4779,1516398,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,8678,BECN1,https://ctdbase.org/detail.go?type=gene&acc=8678,,,8678.0,BECN1,10090.0,Mus musculus (house mouse),4-methylumbelliferone 8-carbaldehyde inhibits the reaction [cyanoginosin LR results in increased expression of BECN1 protein]|cyanoginosin LR results in increased expression of BECN1 protein|camkk2 protein affects the reaction [cyanoginosin LR results in increased expression of BECN1 protein]|ern1 protein affects the reaction [cyanoginosin LR results in increased expression of BECN1 protein]|sto 609 inhibits the reaction [cyanoginosin LR results in increased expression of BECN1 protein],,,PMID:33290805,https://www.ncbi.nlm.nih.gov/pubmed/33290805,33290805,,
4780,1516399,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,55859,BEX1,https://ctdbase.org/detail.go?type=gene&acc=55859,,,55859.0,BEX1,10116.0,Rattus norvegicus (Norway rat),"Cyanoginosin LR results in increased expression of BEX1 mrna|[dietary fats co-treated with cholesterol, dietary co-treated with cyanoginosin LR] results in increased expression of BEX1 mRNA",,,PMID:34740672,https://www.ncbi.nlm.nih.gov/pubmed/34740672,34740672,,
4781,1517573,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,830,CAPZA2,https://ctdbase.org/detail.go?type=gene&acc=830,,,830.0,CAPZA2,10116.0,Rattus norvegicus (Norway rat),Cyanoginosin LR results in increased expression of CAPZA2 protein,,,PMID:22430071,https://www.ncbi.nlm.nih.gov/pubmed/22430071,22430071,,
4782,1517574,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,832,CAPZB,https://ctdbase.org/detail.go?type=gene&acc=832,,,832.0,CAPZB,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in increased expression of CAPZB mRNA,,,PMID:17654400,https://www.ncbi.nlm.nih.gov/pubmed/17654400,17654400,,
4783,1517575,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,80733,CAR15,https://ctdbase.org/detail.go?type=gene&acc=80733,,,80733.0,Car15,8400.0,Lithobates catesbeianus (American bullfrog),Cyanoginosin LR results in increased expression of CAR15 mRNA,,,PMID:34863901,https://www.ncbi.nlm.nih.gov/pubmed/34863901,34863901,,
4784,1517576,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,10090.0,Mus musculus (house mouse),"FOXO1 affects the reaction [cyanoginosin LR affects the expression of CASP1 protein]|n-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [cyanoginosin LR results in increased expression of and results in increased cleavage of CASP1 protein]|cyanoginosin LR results in increased expression of and results in increased cleavage of CASP1 protein",,,PMID:33078829,https://www.ncbi.nlm.nih.gov/pubmed/33078829,33078829,,
4785,1517577,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,8400.0,Lithobates catesbeianus (American bullfrog),Cyanoginosin LR results in increased expression of CASP2 mRNA,,,PMID:34863901,https://www.ncbi.nlm.nih.gov/pubmed/34863901,34863901,,
4786,1518227,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in increased activity of CAT protein|quercetin inhibits the reaction [cyanoginosin LR results in increased activity of CAT protein],,,PMID:17696131,https://www.ncbi.nlm.nih.gov/pubmed/17696131,17696131,,
4787,1518228,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,56613.0,Poeciliopsis lucida (clearfin livebearer),Cyanoginosin LR results in decreased activity of CAT protein,,,PMID:19720136,https://www.ncbi.nlm.nih.gov/pubmed/19720136,19720136,,
4788,1521542,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,8400.0,Lithobates catesbeianus (American bullfrog),Cyanoginosin LR results in increased expression of CYP1A2 mRNA,,,PMID:34863901,https://www.ncbi.nlm.nih.gov/pubmed/34863901,34863901,,
4789,1521543,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in increased expression of CYP1A2 mRNA,,,PMID:17383702,https://www.ncbi.nlm.nih.gov/pubmed/17383702,17383702,,
4790,1486787,445580,Comparative Toxicogenomics Database (CTD),Doconexent,D004281,Docosahexaenoic Acids,https://ctdbase.org/detail.go?type=chem&acc=D004281,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606.0,Homo sapiens (human),Docosahexaenoic acids promotes the reaction [GW 4064 results in increased expression of ABCB11 mrna],,,PMID:15307955,https://www.ncbi.nlm.nih.gov/pubmed/15307955,15307955,,
4791,1486788,445580,Comparative Toxicogenomics Database (CTD),Doconexent,D004281,Docosahexaenoic Acids,https://ctdbase.org/detail.go?type=chem&acc=D004281,5825,ABCD3,https://ctdbase.org/detail.go?type=gene&acc=5825,,,5825.0,ABCD3,10090.0,Mus musculus (house mouse),PPARA protein promotes the reaction [docosahexaenoic acids results in increased expression of ABCD3 mrna],,,PMID:18489776,https://www.ncbi.nlm.nih.gov/pubmed/18489776,18489776,,
4792,1486789,445580,Comparative Toxicogenomics Database (CTD),Doconexent,D004281,Docosahexaenoic Acids,https://ctdbase.org/detail.go?type=chem&acc=D004281,6059,ABCE1,https://ctdbase.org/detail.go?type=gene&acc=6059,,,6059.0,ABCE1,10090.0,Mus musculus (house mouse),Docosahexaenoic acids results in increased expression of ABCE1 mRNA,,,PMID:16623957,https://www.ncbi.nlm.nih.gov/pubmed/16623957,16623957,,
4793,1486790,445580,Comparative Toxicogenomics Database (CTD),Doconexent,D004281,Docosahexaenoic Acids,https://ctdbase.org/detail.go?type=chem&acc=D004281,109,ADCY3,https://ctdbase.org/detail.go?type=gene&acc=109,,,109.0,ADCY3,10090.0,Mus musculus (house mouse),Docosahexaenoic acids results in increased expression of ADCY3 mRNA,,,PMID:26219414,https://www.ncbi.nlm.nih.gov/pubmed/26219414,26219414,,
4794,1486791,445580,Comparative Toxicogenomics Database (CTD),Doconexent,D004281,Docosahexaenoic Acids,https://ctdbase.org/detail.go?type=chem&acc=D004281,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,9606.0,Homo sapiens (human),Docosahexaenoic acids results in increased secretion of ADIPOQ protein,,,PMID:20814411,https://www.ncbi.nlm.nih.gov/pubmed/20814411,20814411,,
4795,1487662,445580,Comparative Toxicogenomics Database (CTD),Doconexent,D004281,Docosahexaenoic Acids,https://ctdbase.org/detail.go?type=chem&acc=D004281,859,CAV3,https://ctdbase.org/detail.go?type=gene&acc=859,,,859.0,CAV3,10116.0,Rattus norvegicus (Norway rat),Docosahexaenoic acids results in increased expression of CAV3 protein,,,PMID:15560787,https://www.ncbi.nlm.nih.gov/pubmed/15560787,15560787,,
4796,1524162,445713,Comparative Toxicogenomics Database (CTD),Farnesyl diphosphate,C004808,farnesyl pyrophosphate,https://ctdbase.org/detail.go?type=chem&acc=C004808,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308.0,FOXO1,10090.0,Mus musculus (house mouse),Farnesyl pyrophosphate inhibits the reaction [simvastatin results in decreased phosphorylation of FOXO1 protein],,,PMID:33034787,https://www.ncbi.nlm.nih.gov/pubmed/33034787,33034787,,
4797,1524163,445713,Comparative Toxicogenomics Database (CTD),Farnesyl diphosphate,C004808,farnesyl pyrophosphate,https://ctdbase.org/detail.go?type=chem&acc=C004808,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10029.0,Cricetulus griseus (Chinese hamster),Farnesyl pyrophosphate results in increased degradation of HMGCR protein|sodium fluoride inhibits the reaction [farnesyl pyrophosphate results in increased degradation of HMGCR protein],,,PMID:8021239,https://www.ncbi.nlm.nih.gov/pubmed/8021239,8021239,,
4798,1524164,445713,Comparative Toxicogenomics Database (CTD),Farnesyl diphosphate,C004808,farnesyl pyrophosphate,https://ctdbase.org/detail.go?type=chem&acc=C004808,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),[lovastatin results in decreased activity of HMGCR protein] which results in decreased abundance of farnesyl pyrophosphate,,,PMID:17208200,https://www.ncbi.nlm.nih.gov/pubmed/17208200,17208200,,
4799,1524165,445713,Comparative Toxicogenomics Database (CTD),Farnesyl diphosphate,C004808,farnesyl pyrophosphate,https://ctdbase.org/detail.go?type=chem&acc=C004808,3265,HRAS,https://ctdbase.org/detail.go?type=gene&acc=3265,,,3265.0,HRAS,9606.0,Homo sapiens (human),Farnesyl pyrophosphate inhibits the reaction [simvastatin inhibits the reaction [lipopolysaccharides results in increased activity of HRAS protein]]|farnesyl pyrophosphate inhibits the reaction [simvastatin inhibits the reaction [lipopolysaccharides results in increased localization of HRAS protein]],,,PMID:18625914,https://www.ncbi.nlm.nih.gov/pubmed/18625914,18625914,,
4800,1524166,445713,Comparative Toxicogenomics Database (CTD),Farnesyl diphosphate,C004808,farnesyl pyrophosphate,https://ctdbase.org/detail.go?type=chem&acc=C004808,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Farnesyl pyrophosphate inhibits the reaction [simvastatin promotes the reaction [IL1B protein results in increased expression of ICAM1 protein]],,,PMID:10946302,https://www.ncbi.nlm.nih.gov/pubmed/10946302,10946302,,
4801,1524167,445713,Comparative Toxicogenomics Database (CTD),Farnesyl diphosphate,C004808,farnesyl pyrophosphate,https://ctdbase.org/detail.go?type=chem&acc=C004808,3593,IL12B,https://ctdbase.org/detail.go?type=gene&acc=3593,,,3593.0,IL12B,10090.0,Mus musculus (house mouse),"Farnesyl pyrophosphate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12B protein]",,,PMID:15187114,https://www.ncbi.nlm.nih.gov/pubmed/15187114,15187114,,
4802,1524168,445713,Comparative Toxicogenomics Database (CTD),Farnesyl diphosphate,C004808,farnesyl pyrophosphate,https://ctdbase.org/detail.go?type=chem&acc=C004808,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Farnesyl pyrophosphate inhibits the reaction [simvastatin promotes the reaction [IL1B protein results in increased expression of ICAM1 protein]]|farnesyl pyrophosphate inhibits the reaction [simvastatin promotes the reaction [IL1B protein results in increased expression of SELE protein]],,,PMID:10946302,https://www.ncbi.nlm.nih.gov/pubmed/10946302,10946302,,
4803,1524169,445713,Comparative Toxicogenomics Database (CTD),Farnesyl diphosphate,C004808,farnesyl pyrophosphate,https://ctdbase.org/detail.go?type=chem&acc=C004808,3845,KRAS,https://ctdbase.org/detail.go?type=gene&acc=3845,,,3845.0,KRAS,10116.0,Rattus norvegicus (Norway rat),[FNTA protein binds to FNTB protein] binds to [farnesyl pyrophosphate analog co-treated with KRAS protein],,,PMID:10673434,https://www.ncbi.nlm.nih.gov/pubmed/10673434,10673434,,
4804,1524646,446156,BindingDB,Cerivastatin,18376,"(3R,5S,6E)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18376,2085,3-hydroxy-3-methylglutaryl-coenzyme A reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2085,P51639,3-hydroxy-3-methylglutaryl-coenzyme A reductase ,25675.0,Hmgcr,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),9.8,PMID:18412317|DOI:10.1021/jm800001n,https://www.ncbi.nlm.nih.gov/pubmed/18412317|https://doi.org/10.1021/jm800001n,18412317,10.1021/jm800001n,
4805,1524647,446157,BindingDB,Rosuvastatin,18372,"(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18372,2085,3-hydroxy-3-methylglutaryl-coenzyme A reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2085,P51639,3-hydroxy-3-methylglutaryl-coenzyme A reductase ,25675.0,Hmgcr,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),3.1,PMID:18412317|DOI:10.1021/jm800001n,https://www.ncbi.nlm.nih.gov/pubmed/18412317|https://doi.org/10.1021/jm800001n,18412317,10.1021/jm800001n,
4806,1524648,446158,BindingDB,"[4-R-(4-alpha,6-beta,7-beta]-Hexahydro-5,6-DI(hydroxy)-1,3-DI(allyl)-4,7-bisphenylmethyl)-2H-1,3-diazepinone",152,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(prop-2-en-1-yl)-1,3-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=152,56,Dimer of Gag-Pol polyprotein [501-599],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=56,P03367,Gag-Pol polyprotein,,,11686.0,Human immunodeficiency virus type 1 (BRU ISOLATE),,Ki (nM),4.7,PMID:8784449|DOI:10.1021/jm9602571,https://www.ncbi.nlm.nih.gov/pubmed/8784449|https://doi.org/10.1021/jm9602571,8784449,10.1021/jm9602571,
4807,1524649,446158,BindingDB,"[4-R-(4-alpha,6-beta,7-beta]-Hexahydro-5,6-DI(hydroxy)-1,3-DI(allyl)-4,7-bisphenylmethyl)-2H-1,3-diazepinone",152,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(prop-2-en-1-yl)-1,3-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=152,56,Dimer of Gag-Pol polyprotein [501-599],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=56,P03367,Gag-Pol polyprotein,,,11686.0,Human immunodeficiency virus type 1 (BRU ISOLATE),,Ki (nM),4.6,PMID:8784449|DOI:10.1021/jm9602571,https://www.ncbi.nlm.nih.gov/pubmed/8784449|https://doi.org/10.1021/jm9602571,8784449,10.1021/jm9602571,
4808,1511328,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,4360,MRC1,https://ctdbase.org/detail.go?type=gene&acc=4360,,,4360.0,MRC1,10116.0,Rattus norvegicus (Norway rat),Cocaine results in decreased expression of MRC1 mRNA,,,PMID:17898221,https://www.ncbi.nlm.nih.gov/pubmed/17898221,17898221,,
4809,1511329,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,29960,MRM2,https://ctdbase.org/detail.go?type=gene&acc=29960,,,29960.0,MRM2,10090.0,Mus musculus (house mouse),Cocaine results in increased expression of MRM2 mRNA,,,PMID:20056891,https://www.ncbi.nlm.nih.gov/pubmed/20056891,20056891,,
4810,1511330,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,63875,MRPL17,https://ctdbase.org/detail.go?type=gene&acc=63875,,,63875.0,MRPL17,10090.0,Mus musculus (house mouse),Cocaine affects the expression of MRPL17 mRNA,,,PMID:18355967,https://www.ncbi.nlm.nih.gov/pubmed/18355967,18355967,,
4811,1511331,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,63875,MRPL17,https://ctdbase.org/detail.go?type=gene&acc=63875,,,63875.0,MRPL17,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of MRPL17 mRNA,,,PMID:17898221,https://www.ncbi.nlm.nih.gov/pubmed/17898221,17898221,,
4812,1511332,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,84689,MS4A14,https://ctdbase.org/detail.go?type=gene&acc=84689,,,84689.0,MS4A14,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of MS4A14 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
4813,1511333,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,22921,MSRB2,https://ctdbase.org/detail.go?type=gene&acc=22921,,,22921.0,MSRB2,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of MSRB2 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
4814,1511334,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,51537,MTFP1,https://ctdbase.org/detail.go?type=gene&acc=51537,,,51537.0,MTFP1,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of MTFP1 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
4815,1511335,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,30667,MTNR1AA,https://ctdbase.org/detail.go?type=gene&acc=30667,,,30667.0,mtnr1aa,7955.0,Danio rerio (zebrafish),Melatonin affects the reaction [cocaine affects the expression of MTNR1AA mrna]|cocaine affects the expression of MTNR1AA mRNA,,,PMID:17622340,https://www.ncbi.nlm.nih.gov/pubmed/17622340,17622340,,
4816,1511336,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,30669,MTNR1BA,https://ctdbase.org/detail.go?type=gene&acc=30669,,,30669.0,mtnr1ba,7955.0,Danio rerio (zebrafish),Cocaine affects the expression of MTNR1BA mRNA,,,PMID:17622340,https://www.ncbi.nlm.nih.gov/pubmed/17622340,17622340,,
4817,1511638,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,26502,NARF,https://ctdbase.org/detail.go?type=gene&acc=26502,,,26502.0,NARF,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of NARF mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
4818,1511639,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,83988,NCALD,https://ctdbase.org/detail.go?type=gene&acc=83988,,,83988.0,NCALD,10090.0,Mus musculus (house mouse),FOS protein mutant form inhibits the reaction [cocaine results in decreased expression of NCALD mrna]|cocaine results in decreased expression of NCALD mRNA,,,PMID:18355967,https://www.ncbi.nlm.nih.gov/pubmed/18355967,18355967,,
4819,1512694,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10090.0,Mus musculus (house mouse),Cocaine results in increased expression of NOS3 mrna|fos protein mutant form inhibits the reaction [cocaine results in increased expression of NOS3 mrna],,,PMID:18355967,https://www.ncbi.nlm.nih.gov/pubmed/18355967,18355967,,
4820,1513293,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,4915,NTRK2,https://ctdbase.org/detail.go?type=gene&acc=4915,,,4915.0,NTRK2,9606.0,Homo sapiens (human),Cocaine results in decreased expression of NTRK2 mRNA,,,PMID:15009677|PMID:16710320,https://www.ncbi.nlm.nih.gov/pubmed/15009677|https://www.ncbi.nlm.nih.gov/pubmed/16710320,15009677|16710320,,
4821,1513294,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,4915,NTRK2,https://ctdbase.org/detail.go?type=gene&acc=4915,,,4915.0,NTRK2,10090.0,Mus musculus (house mouse),Cocaine affects the reaction [NTRK2 protein affects the expression of KCNB1 mrna]|cocaine results in increased expression of NTRK2 protein|cocaine affects the reaction [NTRK2 protein affects the expression of KCNJ8 mrna]|ntrk2 protein affects the reaction [cocaine affects the expression of FOS protein]|cocaine affects the reaction [NTRK2 protein affects the expression of KCNA2 mrna]|cocaine affects the reaction [NTRK2 protein affects the expression of KCND1 mrna]|cocaine affects the reaction [NTRK2 protein affects the expression of KCNJ4 mrna],,,PMID:20947769,https://www.ncbi.nlm.nih.gov/pubmed/20947769,20947769,,
4822,1513295,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,4915,NTRK2,https://ctdbase.org/detail.go?type=gene&acc=4915,,,4915.0,NTRK2,10090.0,Mus musculus (house mouse),Cocaine results in decreased phosphorylation of NTRK2 protein,,,PMID:24358339,https://www.ncbi.nlm.nih.gov/pubmed/24358339,24358339,,
4823,1513296,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,4915,NTRK2,https://ctdbase.org/detail.go?type=gene&acc=4915,,,4915.0,NTRK2,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of NTRK2 mRNA,,,PMID:12358776|PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/12358776|https://www.ncbi.nlm.nih.gov/pubmed/20187946,12358776|20187946,,
4824,1515814,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443.0,POMC,10116.0,Rattus norvegicus (Norway rat),[CTAP octapeptide binds to and results in decreased activity of OPRM1 protein] inhibits the reaction [POMC protein results in increased susceptibility to cocaine]|pomc results in increased susceptibility to cocaine,,,PMID:19279569,https://www.ncbi.nlm.nih.gov/pubmed/19279569,19279569,,
4825,1515979,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443.0,POMC,10116.0,Rattus norvegicus (Norway rat),Eticlopride inhibits the reaction [cocaine results in increased expression of POMC protein],,,PMID:17001283,https://www.ncbi.nlm.nih.gov/pubmed/17001283,17001283,,
4826,1516565,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,5536,PPP5C,https://ctdbase.org/detail.go?type=gene&acc=5536,,,5536.0,PPP5C,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of PPP5C protein,,,PMID:25100957,https://www.ncbi.nlm.nih.gov/pubmed/25100957,25100957,,
4827,1516566,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,5537,PPP6C,https://ctdbase.org/detail.go?type=gene&acc=5537,,,5537.0,PPP6C,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of PPP6C mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
4828,1516567,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,10084,PQBP1,https://ctdbase.org/detail.go?type=gene&acc=10084,,,10084.0,PQBP1,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of PQBP1 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
4829,1520286,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,117247,SLC16A10,https://ctdbase.org/detail.go?type=gene&acc=117247,,,117247.0,SLC16A10,10116.0,Rattus norvegicus (Norway rat),Cocaine results in decreased expression of SLC16A10 mRNA,,,PMID:27899881,https://www.ncbi.nlm.nih.gov/pubmed/27899881,27899881,,
4830,1520287,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,9123,SLC16A3,https://ctdbase.org/detail.go?type=gene&acc=9123,,,9123.0,SLC16A3,10116.0,Rattus norvegicus (Norway rat),Cocaine results in decreased expression of SLC16A3 mRNA,,,PMID:17898221,https://www.ncbi.nlm.nih.gov/pubmed/17898221,17898221,,
4831,1520288,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,9120,SLC16A6,https://ctdbase.org/detail.go?type=gene&acc=9120,,,9120.0,SLC16A6,10116.0,Rattus norvegicus (Norway rat),Cocaine results in decreased expression of SLC16A6 mRNA,,,PMID:17898221,https://www.ncbi.nlm.nih.gov/pubmed/17898221,17898221,,
4832,1520289,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,23539,SLC16A8,https://ctdbase.org/detail.go?type=gene&acc=23539,,,23539.0,SLC16A8,10116.0,Rattus norvegicus (Norway rat),Cocaine results in decreased expression of SLC16A8 mRNA,,,PMID:27899881,https://www.ncbi.nlm.nih.gov/pubmed/27899881,27899881,,
4833,1520290,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,57084,SLC17A6,https://ctdbase.org/detail.go?type=gene&acc=57084,,,57084.0,SLC17A6,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of SLC17A6 protein,,,PMID:25100957,https://www.ncbi.nlm.nih.gov/pubmed/25100957,25100957,,
4834,1520291,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,57030,SLC17A7,https://ctdbase.org/detail.go?type=gene&acc=57030,,,57030.0,SLC17A7,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of SLC17A7 protein,,,PMID:25100957,https://www.ncbi.nlm.nih.gov/pubmed/25100957,25100957,,
4835,1520292,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,246213,SLC17A8,https://ctdbase.org/detail.go?type=gene&acc=246213,,,246213.0,SLC17A8,10090.0,Mus musculus (house mouse),SLC17A8 protein affects the susceptibility to cocaine,,,PMID:18278042,https://www.ncbi.nlm.nih.gov/pubmed/18278042,18278042,,
4836,1520293,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6571,SLC18A2,https://ctdbase.org/detail.go?type=gene&acc=6571,,,6571.0,SLC18A2,9606.0,Homo sapiens (human),Cocaine results in decreased expression of SLC18A2 protein,,,PMID:12505801,https://www.ncbi.nlm.nih.gov/pubmed/12505801,12505801,,
4837,1520294,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6571,SLC18A2,https://ctdbase.org/detail.go?type=gene&acc=6571,,,6571.0,SLC18A2,10090.0,Mus musculus (house mouse),SLC18A2 protein affects the susceptibility to cocaine,,,PMID:12716422,https://www.ncbi.nlm.nih.gov/pubmed/12716422,12716422,,
4838,1520295,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6571,SLC18A2,https://ctdbase.org/detail.go?type=gene&acc=6571,,,6571.0,SLC18A2,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of SLC18A2 protein,,,PMID:25100957,https://www.ncbi.nlm.nih.gov/pubmed/25100957,25100957,,
4839,1521544,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6532,SLC6A4,https://ctdbase.org/detail.go?type=gene&acc=6532,,,6532.0,SLC6A4,9606.0,Homo sapiens (human),Cocaine results in decreased activity of SLC6A4 protein,,,PMID:18321529,https://www.ncbi.nlm.nih.gov/pubmed/18321529,18321529,,
4840,1521545,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6532,SLC6A4,https://ctdbase.org/detail.go?type=gene&acc=6532,,,6532.0,SLC6A4,9606.0,Homo sapiens (human),Cocaine results in increased expression of SLC6A4 protein,,,PMID:11207425,https://www.ncbi.nlm.nih.gov/pubmed/11207425,11207425,,
4841,1521546,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6532,SLC6A4,https://ctdbase.org/detail.go?type=gene&acc=6532,,,6532.0,SLC6A4,10090.0,Mus musculus (house mouse),SLC6A4 mutant form affects the susceptibility to cocaine,,,PMID:11320258,https://www.ncbi.nlm.nih.gov/pubmed/11320258,11320258,,
4842,1521547,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6532,SLC6A4,https://ctdbase.org/detail.go?type=gene&acc=6532,,,6532.0,SLC6A4,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of SLC6A4 mRNA,,,PMID:11072100,https://www.ncbi.nlm.nih.gov/pubmed/11072100,11072100,,
4843,1521548,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6532,SLC6A4,https://ctdbase.org/detail.go?type=gene&acc=6532,,,6532.0,SLC6A4,10116.0,Rattus norvegicus (Norway rat),SLC6A4 gene mutant form results in increased susceptibility to cocaine,,,PMID:20459657,https://www.ncbi.nlm.nih.gov/pubmed/20459657,20459657,,
4844,1521549,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6532,SLC6A4,https://ctdbase.org/detail.go?type=gene&acc=6532,,,6532.0,SLC6A4,10116.0,Rattus norvegicus (Norway rat),SLC6A4 results in decreased susceptibility to cocaine,,,PMID:18581099,https://www.ncbi.nlm.nih.gov/pubmed/18581099,18581099,,
4845,1521550,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,23657,SLC7A11,https://ctdbase.org/detail.go?type=gene&acc=23657,,,23657.0,SLC7A11,10116.0,Rattus norvegicus (Norway rat),Ceftriaxone inhibits the reaction [cocaine results in decreased expression of SLC7A11 protein]|acetylcysteine inhibits the reaction [cocaine results in decreased expression of SLC7A11 protein]|cocaine results in decreased expression of SLC7A11 protein,,,PMID:19717140,https://www.ncbi.nlm.nih.gov/pubmed/19717140,19717140,,
4846,1521551,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6549,SLC9A2,https://ctdbase.org/detail.go?type=gene&acc=6549,,,6549.0,SLC9A2,9606.0,Homo sapiens (human),Cocaine results in decreased expression of SLC9A2 mRNA,,,PMID:18000554,https://www.ncbi.nlm.nih.gov/pubmed/18000554,18000554,,
4847,1522416,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6712,SPTBN2,https://ctdbase.org/detail.go?type=gene&acc=6712,,,6712.0,SPTBN2,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of SPTBN2 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
4848,1522417,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,10090.0,Mus musculus (house mouse),Cocaine results in decreased expression of SQSTM1 protein,,,PMID:31494168,https://www.ncbi.nlm.nih.gov/pubmed/31494168,31494168,,
4849,1522418,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,149563,SRARP,https://ctdbase.org/detail.go?type=gene&acc=149563,,,149563.0,SRARP,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of SRARP mRNA,,,PMID:27899881,https://www.ncbi.nlm.nih.gov/pubmed/27899881,27899881,,
4850,1522419,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,10090.0,Mus musculus (house mouse),Cocaine results in decreased activity of SRC protein,,,PMID:27506785,https://www.ncbi.nlm.nih.gov/pubmed/27506785,27506785,,
4851,1523669,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,7046,TGFBR1,https://ctdbase.org/detail.go?type=gene&acc=7046,,,7046.0,TGFBR1,10090.0,Mus musculus (house mouse),EHMT2 inhibits the reaction [cocaine results in increased expression of TGFBR1 mrna]|cocaine results in increased expression of TGFBR1 mRNA,,,PMID:20056891,https://www.ncbi.nlm.nih.gov/pubmed/20056891,20056891,,
4852,1523670,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10090.0,Mus musculus (house mouse),Resveratrol promotes the reaction [cocaine results in decreased phosphorylation of TH protein]|cocaine results in decreased phosphorylation of TH protein,,,PMID:23499958,https://www.ncbi.nlm.nih.gov/pubmed/23499958,23499958,,
4853,1523671,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of TH protein,,,PMID:12787079,https://www.ncbi.nlm.nih.gov/pubmed/12787079,12787079,,
4854,1523672,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116.0,Rattus norvegicus (Norway rat),Cocaine promotes the reaction [[DRD2 protein results in increased phosphorylation of TH protein] which results in increased abundance of dopamine]|spiperone inhibits the reaction [cocaine promotes the reaction [[DRD2 protein results in increased phosphorylation of TH protein] which results in increased abundance of dopamine]],,,PMID:20729865,https://www.ncbi.nlm.nih.gov/pubmed/20729865,20729865,,
4855,1523673,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116.0,Rattus norvegicus (Norway rat),Cocaine results in decreased expression of TH protein,,,PMID:11391778,https://www.ncbi.nlm.nih.gov/pubmed/11391778,11391778,,
4856,1523852,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,7086,TKT,https://ctdbase.org/detail.go?type=gene&acc=7086,,,7086.0,TKT,9606.0,Homo sapiens (human),Cocaine affects the expression of TKT protein,,,PMID:19393250,https://www.ncbi.nlm.nih.gov/pubmed/19393250,19393250,,
4857,1523853,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,50999,TMED5,https://ctdbase.org/detail.go?type=gene&acc=50999,,,50999.0,TMED5,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of TMED5 mRNA,,,PMID:17898221,https://www.ncbi.nlm.nih.gov/pubmed/17898221,17898221,,
4858,1523854,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,54732,TMED9,https://ctdbase.org/detail.go?type=gene&acc=54732,,,54732.0,TMED9,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of TMED9 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
4859,1524650,446220,BindingDB,Cocaine,22418,Cocaine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22418,2272,Sodium-dependent dopamine transporter,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2272,Q01959,Sodium-dependent dopamine transporter ,6531.0,SLC6A3,9606.0,Homo sapiens (human),,Ki (nM),272,PMID:17602602|DOI:10.1021/jm0703035,https://www.ncbi.nlm.nih.gov/pubmed/17602602|https://doi.org/10.1021/jm0703035,17602602,10.1021/jm0703035,
4860,1524651,446220,BindingDB,Cocaine,22418,Cocaine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22418,2273,Sodium-dependent serotonin transporter,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2273,P31645,Sodium-dependent serotonin transporter,6532.0,SLC6A4,9606.0,Homo sapiens (human),,Ki (nM),601,PMID:17602602|DOI:10.1021/jm0703035,https://www.ncbi.nlm.nih.gov/pubmed/17602602|https://doi.org/10.1021/jm0703035,17602602,10.1021/jm0703035,
4861,1524652,446220,BindingDB,Cocaine,22418,Cocaine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22418,2274,Sodium-dependent noradrenaline transporter,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2274,P23975,Sodium-dependent noradrenaline transporter ,6530.0,SLC6A2,9606.0,Homo sapiens (human),,Ki (nM),830,PMID:17602602|DOI:10.1021/jm0703035,https://www.ncbi.nlm.nih.gov/pubmed/17602602|https://doi.org/10.1021/jm0703035,17602602,10.1021/jm0703035,
4862,1525134,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,7425,VGF,https://ctdbase.org/detail.go?type=gene&acc=7425,,,7425.0,VGF,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of VGF mRNA,,,PMID:27899881,https://www.ncbi.nlm.nih.gov/pubmed/27899881,27899881,,
4863,1525135,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,154807,VKORC1L1,https://ctdbase.org/detail.go?type=gene&acc=154807,,,154807.0,VKORC1L1,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of VKORC1L1 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
4864,1489468,446515,DrugBank,6-Benzyl-1-benzyloxymethyl-5-isopropyl uracil,DB08634,6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL,https://www.drugbank.ca/drugs/DB08634,BE0001594,Gag-Pol polyprotein,https://www.drugbank.ca/bio_entities/BE0001594,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
4865,1489469,446560,DrugBank,,DB08131,"2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID",https://www.drugbank.ca/drugs/DB08131,BE0001438,Thymidylate synthase,https://www.drugbank.ca/bio_entities/BE0001438,P0A884,Thymidylate synthase,83579666.0,,83333.0,Escherichia coli K-12,,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
4866,1489470,446676,DrugBank,3-Amino-azacyclotridecan-2-one,DB08476,3-AMINO-AZACYCLOTRIDECAN-2-ONE,https://www.drugbank.ca/drugs/DB08476,BE0001182,Neutrophil collagenase,https://www.drugbank.ca/bio_entities/BE0001182,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
4867,1489471,446744,DrugBank,"[N-(2,4-Diaminopteridin-6-YL)-methyl]-dibenz[B,F]azepine",DB08406,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",https://www.drugbank.ca/drugs/DB08406,BE0000330,Dihydrofolate reductase,https://www.drugbank.ca/bio_entities/BE0000330,P00374,Dihydrofolate reductase,1719.0,DHFR,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
4868,1489472,446756,DrugBank,N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine,DB08377,N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine,https://www.drugbank.ca/drugs/DB08377,BE0002815,Ig gamma-1 chain C region,https://www.drugbank.ca/bio_entities/BE0002815,P01857,Immunoglobulin heavy constant gamma 1,,,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
4869,1526058,446925,Comparative Toxicogenomics Database (CTD),Lycopene,D000077276,Lycopene,https://ctdbase.org/detail.go?type=chem&acc=D000077276,22166,TXN1,https://ctdbase.org/detail.go?type=gene&acc=22166,,,22166.0,Txn1,10090.0,Mus musculus (house mouse),Lycopene affects the reaction [atrazine affects the expression of TXN1 mrna],,,PMID:36216167,https://www.ncbi.nlm.nih.gov/pubmed/36216167,36216167,,
4870,1526059,446925,Comparative Toxicogenomics Database (CTD),Lycopene,D000077276,Lycopene,https://ctdbase.org/detail.go?type=chem&acc=D000077276,25828,TXN2,https://ctdbase.org/detail.go?type=gene&acc=25828,,,25828.0,TXN2,10090.0,Mus musculus (house mouse),Lycopene inhibits the reaction [atrazine results in decreased expression of TXN2 mrna]|lycopene results in decreased expression of TXN2 mRNA,,,PMID:36216167,https://www.ncbi.nlm.nih.gov/pubmed/36216167,36216167,,
4871,1526060,446925,Comparative Toxicogenomics Database (CTD),Lycopene,D000077276,Lycopene,https://ctdbase.org/detail.go?type=chem&acc=D000077276,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606.0,Homo sapiens (human),Lycopene inhibits the reaction [HMGB1 protein results in increased expression of VCAM1 mrna]|lycopene inhibits the reaction [HMGB1 protein results in increased expression of VCAM1 protein],,,PMID:22429818,https://www.ncbi.nlm.nih.gov/pubmed/22429818,22429818,,
4872,1526061,446925,Comparative Toxicogenomics Database (CTD),Lycopene,D000077276,Lycopene,https://ctdbase.org/detail.go?type=chem&acc=D000077276,7415,VCP,https://ctdbase.org/detail.go?type=gene&acc=7415,,,7415.0,VCP,9606.0,Homo sapiens (human),Lycopene results in increased expression of VCP mRNA,,,PMID:16886892,https://www.ncbi.nlm.nih.gov/pubmed/16886892,16886892,,
4873,1526062,446925,Comparative Toxicogenomics Database (CTD),Lycopene,D000077276,Lycopene,https://ctdbase.org/detail.go?type=chem&acc=D000077276,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10116.0,Rattus norvegicus (Norway rat),Lycopene inhibits the reaction [chlorodiphenyl (54% chlorine) results in increased expression of VEGFA protein],,,PMID:33592256,https://www.ncbi.nlm.nih.gov/pubmed/33592256,33592256,,
4874,1526063,446925,Comparative Toxicogenomics Database (CTD),Lycopene,D000077276,Lycopene,https://ctdbase.org/detail.go?type=chem&acc=D000077276,7697,ZNF138,https://ctdbase.org/detail.go?type=gene&acc=7697,,,7697.0,ZNF138,9606.0,Homo sapiens (human),Lycopene results in increased expression of ZNF138 mRNA,,,PMID:16886892,https://www.ncbi.nlm.nih.gov/pubmed/16886892,16886892,,
4875,1526064,446925,Comparative Toxicogenomics Database (CTD),Lycopene,D000077276,Lycopene,https://ctdbase.org/detail.go?type=chem&acc=D000077276,7039,TGFA,https://ctdbase.org/detail.go?type=gene&acc=7039,,,7039.0,TGFA,9606.0,Homo sapiens (human),Lycopene results in increased expression of TGFA mRNA,,,PMID:16886892,https://www.ncbi.nlm.nih.gov/pubmed/16886892,16886892,,
4876,1526065,446925,Comparative Toxicogenomics Database (CTD),Lycopene,D000077276,Lycopene,https://ctdbase.org/detail.go?type=chem&acc=D000077276,404552,SCGB1D4,https://ctdbase.org/detail.go?type=gene&acc=404552,,,404552.0,SCGB1D4,10116.0,Rattus norvegicus (Norway rat),Lycopene results in decreased expression of SCGB1D4 mRNA,,,PMID:15084515,https://www.ncbi.nlm.nih.gov/pubmed/15084515,15084515,,
4877,1526066,446925,Comparative Toxicogenomics Database (CTD),Lycopene,D000077276,Lycopene,https://ctdbase.org/detail.go?type=chem&acc=D000077276,4250,SCGB2A2,https://ctdbase.org/detail.go?type=gene&acc=4250,,,4250.0,SCGB2A2,10116.0,Rattus norvegicus (Norway rat),Lycopene results in decreased expression of SCGB2A2 mRNA,,,PMID:15084515,https://www.ncbi.nlm.nih.gov/pubmed/15084515,15084515,,
4878,1526724,447043,ChEMBL,Azithromycin,CHEMBL529,AZITHROMYCIN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL529/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V0,30S ribosomal protein S2,8913847.0,rpmG,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12623020|PMID:15851032|PMID:19071138,https://www.ncbi.nlm.nih.gov/pubmed/12623020|https://www.ncbi.nlm.nih.gov/pubmed/15851032|https://www.ncbi.nlm.nih.gov/pubmed/19071138,12623020|15851032|19071138,,
4879,1526725,447043,ChEMBL,Azithromycin,CHEMBL529,AZITHROMYCIN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL529/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V3,30S ribosomal protein S3,948216.0,rpmH,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12623020|PMID:15851032|PMID:19071138,https://www.ncbi.nlm.nih.gov/pubmed/12623020|https://www.ncbi.nlm.nih.gov/pubmed/15851032|https://www.ncbi.nlm.nih.gov/pubmed/19071138,12623020|15851032|19071138,,
4880,1525249,448222,IUPHAR/BPS Guide to PHARMACOLOGY,5'-N-Ethylcarboxamidoadenosine,377,NECA,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=377,19,A2A receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=19,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),Full agonist,pKi,6.9 - 8.7,PMID:15476669|PMID:15267242|PMID:7775460|PMID:9920286|PMID:9179373|PMID:14662005,https://www.ncbi.nlm.nih.gov/pubmed/15476669|https://www.ncbi.nlm.nih.gov/pubmed/15267242|https://www.ncbi.nlm.nih.gov/pubmed/7775460|https://www.ncbi.nlm.nih.gov/pubmed/9920286|https://www.ncbi.nlm.nih.gov/pubmed/9179373|https://www.ncbi.nlm.nih.gov/pubmed/14662005,15476669|15267242|7775460|9920286|9179373|14662005,,
4881,1525250,448222,IUPHAR/BPS Guide to PHARMACOLOGY,5'-N-Ethylcarboxamidoadenosine,425,[3H]NECA,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=425,19,A2A receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=19,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),Full agonist,pKd,7.7,PMID:9459566,https://www.ncbi.nlm.nih.gov/pubmed/9459566,9459566,,
4882,1525251,448222,IUPHAR/BPS Guide to PHARMACOLOGY,5'-N-Ethylcarboxamidoadenosine,377,NECA,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=377,20,A2B receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=20,P29275,Adenosine receptor A2b,136.0,ADORA2B,9606.0,Homo sapiens (human),Full agonist,pKi,5.7 - 6.9,PMID:16219300|PMID:15267242|PMID:10496952|PMID:11266650|PMID:11093773|PMID:15194002|PMID:14662005,https://www.ncbi.nlm.nih.gov/pubmed/16219300|https://www.ncbi.nlm.nih.gov/pubmed/15267242|https://www.ncbi.nlm.nih.gov/pubmed/10496952|https://www.ncbi.nlm.nih.gov/pubmed/11266650|https://www.ncbi.nlm.nih.gov/pubmed/11093773|https://www.ncbi.nlm.nih.gov/pubmed/15194002|https://www.ncbi.nlm.nih.gov/pubmed/14662005,16219300|15267242|10496952|11266650|11093773|15194002|14662005,,
4883,1527746,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090.0,Mus musculus (house mouse),Diethylstilbestrol results in increased expression of SOD2 mRNA,,,PMID:21041162,https://www.ncbi.nlm.nih.gov/pubmed/21041162,21041162,,
4884,1527747,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,10174,SORBS3,https://ctdbase.org/detail.go?type=gene&acc=10174,,,10174.0,SORBS3,9606.0,Homo sapiens (human),Diethylstilbestrol results in increased expression of SORBS3 mRNA,,,PMID:36621641,https://www.ncbi.nlm.nih.gov/pubmed/36621641,36621641,,
4885,1527748,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,25928,SOSTDC1,https://ctdbase.org/detail.go?type=gene&acc=25928,,,25928.0,SOSTDC1,10116.0,Rattus norvegicus (Norway rat),Diethylstilbestrol results in decreased expression of SOSTDC1 mRNA,,,PMID:17011747,https://www.ncbi.nlm.nih.gov/pubmed/17011747,17011747,,
4886,1527749,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,25928,SOSTDC1,https://ctdbase.org/detail.go?type=gene&acc=25928,,,25928.0,SOSTDC1,10116.0,Rattus norvegicus (Norway rat),Diethylstilbestrol results in increased expression of SOSTDC1 mRNA,,,PMID:17011747|PMID:36653537,https://www.ncbi.nlm.nih.gov/pubmed/17011747|https://www.ncbi.nlm.nih.gov/pubmed/36653537,17011747|36653537,,
4887,1527460,448545,Therapeutic Target Database (TTD),"7-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine",D0Z1NY,BMS214662,https://idrblab.net/ttd/data/drug/details/D0Z1NY,T13127,Farnesyl protein transferase (Ftase),https://idrblab.net/ttd/data/target/details/T13127,P49356,Protein farnesyltransferase subunit beta,2342.0,FNTB,9606.0,Homo sapiens (human),Modulator,,,,,,,
4888,1527461,448812,Comparative Toxicogenomics Database (CTD),Eptifibatide,D000077542,Eptifibatide,https://ctdbase.org/detail.go?type=chem&acc=D000077542,959,CD40LG,https://ctdbase.org/detail.go?type=gene&acc=959,,,959.0,CD40LG,9606.0,Homo sapiens (human),Eptifibatide results in decreased expression of CD40LG protein,,,PMID:16391376,https://www.ncbi.nlm.nih.gov/pubmed/16391376,16391376,,
4889,1527462,448812,Comparative Toxicogenomics Database (CTD),Eptifibatide,D000077542,Eptifibatide,https://ctdbase.org/detail.go?type=chem&acc=D000077542,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401.0,CRP,9606.0,Homo sapiens (human),Eptifibatide results in increased expression of CRP protein,,,PMID:16391376,https://www.ncbi.nlm.nih.gov/pubmed/16391376,16391376,,
4890,1527463,448812,Comparative Toxicogenomics Database (CTD),Eptifibatide,D000077542,Eptifibatide,https://ctdbase.org/detail.go?type=chem&acc=D000077542,2147,F2,https://ctdbase.org/detail.go?type=gene&acc=2147,,,2147.0,F2,9606.0,Homo sapiens (human),Eptifibatide results in increased expression of F2 protein,,,PMID:16391376,https://www.ncbi.nlm.nih.gov/pubmed/16391376,16391376,,
4891,1492398,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,10116.0,Rattus norvegicus (Norway rat),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [bucladesine results in increased expression of FAS mrna],,,PMID:12414803,https://www.ncbi.nlm.nih.gov/pubmed/12414803,12414803,,
4892,1493760,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,5576,PRKAR2A,https://ctdbase.org/detail.go?type=gene&acc=5576,,,5576.0,PRKAR2A,9606.0,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased phosphorylation of PRKAR2A protein|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [resveratrol results in increased phosphorylation of PRKAR2A protein],,,PMID:25943029,https://www.ncbi.nlm.nih.gov/pubmed/25943029,25943029,,
4893,1493761,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578.0,PRKCA,9606.0,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of PRKCA protein,,,PMID:16361081,https://www.ncbi.nlm.nih.gov/pubmed/16361081,16361081,,
4894,1493762,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578.0,PRKCA,9606.0,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of PRKCA protein,,,PMID:17222050,https://www.ncbi.nlm.nih.gov/pubmed/17222050,17222050,,
4895,1493763,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,18814,PRL7D1,https://ctdbase.org/detail.go?type=gene&acc=18814,,,18814.0,Prl7d1,10090.0,Mus musculus (house mouse),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [CGB3 results in increased expression of PRL7D1 protein],,,PMID:21679748,https://www.ncbi.nlm.nih.gov/pubmed/21679748,21679748,,
4896,1493764,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,5731,PTGER1,https://ctdbase.org/detail.go?type=gene&acc=5731,,,5731.0,PTGER1,9606.0,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[dinoprostone co-treated with PTGER1 protein] results in increased phosphorylation of ATF1 protein]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[dinoprostone co-treated with PTGER1 protein] results in increased expression of NR4A2 mrna]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[dinoprostone co-treated with PTGER1 protein] results in increased phosphorylation of RELA protein]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[dinoprostone co-treated with PTGER1 protein] results in increased expression of NR4A2 protein],,,PMID:22188298,https://www.ncbi.nlm.nih.gov/pubmed/22188298,22188298,,
4897,1493765,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]],,,PMID:17640750,https://www.ncbi.nlm.nih.gov/pubmed/17640750,17640750,,
4898,1493766,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of PTGS2 mrna],,,PMID:18938131|PMID:19147701,https://www.ncbi.nlm.nih.gov/pubmed/18938131|https://www.ncbi.nlm.nih.gov/pubmed/19147701,18938131|19147701,,
4899,1493767,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [hydrogen peroxide results in increased expression of PTGS2 mrna]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [LHB protein results in increased abundance of PTGS2 mrna],,,PMID:21220312,https://www.ncbi.nlm.nih.gov/pubmed/21220312,21220312,,
4900,1495069,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [terbutaline inhibits the reaction [shiga toxin results in increased expression of MAPK1 protein]],,,PMID:11675405,https://www.ncbi.nlm.nih.gov/pubmed/11675405,11675405,,
4901,1496286,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517.0,SLC2A4,10090.0,Mus musculus (house mouse),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of SLC2A4 mrna],,,PMID:17407152,https://www.ncbi.nlm.nih.gov/pubmed/17407152,17407152,,
4902,1496287,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,6518,SLC2A5,https://ctdbase.org/detail.go?type=gene&acc=6518,,,6518.0,SLC2A5,9606.0,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [bucladesine results in increased expression of and results in increased stability of SLC2A5 mrna],,,PMID:12820898,https://www.ncbi.nlm.nih.gov/pubmed/12820898,12820898,,
4903,1528799,455592,BindingDB,"7-[2-(4-Methylimidazol-1-yl)-5-methylimidazo[1,5-b]pyridazin-7-yl]-1-phenyl-1-heptanone",3393,"7-[5-methyl-2-(4-methyl-1H-imidazol-1-yl)imidazo[1,5-a]pyridazin-7-yl]-1-phenylheptan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=3393,59,Gag-Pol polyprotein [588-1027]/[588-1147],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=59,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,IC50 (nM),550,PMID:7504733|DOI:10.1021/jm00076a005,https://www.ncbi.nlm.nih.gov/pubmed/7504733|https://doi.org/10.1021/jm00076a005,7504733,10.1021/jm00076a005,
4904,1604704,458204,BindingDB,"1,2-Bis(4-hydroxyphenyl)ethane-1,2-dione",22752,"1,2-bis(4-hydroxyphenyl)ethane-1,2-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22752,2315,Liver carboxylesterase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2315,P12337,Liver carboxylesterase 1,100009551.0,CES1,9986.0,Oryctolagus cuniculus (rabbit),,Ki (nM),>100000,PMID:15828829|DOI:10.1021/jm049011j,https://www.ncbi.nlm.nih.gov/pubmed/15828829|https://doi.org/10.1021/jm049011j,15828829,10.1021/jm049011j,
4905,1604705,460747,Drug Gene Interaction database (DGIdb),"1,3,6-Trimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dione",,CHEMBL:CHEMBL601757,https://www.dgidb.org/drugs/chembl:CHEMBL601757,,RAPGEF3,https://www.dgidb.org/genes/hgnc:16629,,,10411.0,RAPGEF3,9606.0,Homo sapiens (human),,,,,,,,
4906,1604706,460747,Drug Gene Interaction database (DGIdb),"1,3,6-Trimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dione",,CHEMBL:CHEMBL601757,https://www.dgidb.org/drugs/chembl:CHEMBL601757,,GMNN,https://www.dgidb.org/genes/hgnc:17493,,,51053.0,GMNN,9606.0,Homo sapiens (human),,,,,,,,
4907,1498859,480260,BindingDB,"(3R,4R,5S)-4-acetamido-5-amino-3-isobutoxy-cyclohexene-1-carboxylic acid",4991,"(3R,4R,5S)-5-amino-4-acetamido-3-(2-methylpropoxy)cyclohex-1-ene-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4991,753,Neuraminidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=753,P03468,Neuraminidase,956530.0,,211044.0,Influenza A virus (A/Puerto Rico/8/1934(H1N1)),,IC50 (nM),200,PMID:9651151|DOI:10.1021/jm980162u,https://www.ncbi.nlm.nih.gov/pubmed/9651151|https://doi.org/10.1021/jm980162u,9651151,10.1021/jm980162u,
4908,1498860,480261,BindingDB,"(3R,4R,5S)-4-acetamido-5-amino-3-[(1R)-1-methylpropoxy]cyclohexene-1-carboxylic acid",4992,"(3R,4R,5S)-5-amino-3-[(2R)-butan-2-yloxy]-4-acetamidocyclohex-1-ene-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4992,753,Neuraminidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=753,P03468,Neuraminidase,956530.0,,211044.0,Influenza A virus (A/Puerto Rico/8/1934(H1N1)),,IC50 (nM),10,PMID:9651151|DOI:10.1021/jm980162u,https://www.ncbi.nlm.nih.gov/pubmed/9651151|https://doi.org/10.1021/jm980162u,9651151,10.1021/jm980162u,
4909,1498861,480261,BindingDB,"(3R,4R,5S)-4-acetamido-5-amino-3-[(1R)-1-methylpropoxy]cyclohexene-1-carboxylic acid",4992,"(3R,4R,5S)-5-amino-3-[(2R)-butan-2-yloxy]-4-acetamidocyclohex-1-ene-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4992,754,Neuraminidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=754,P03474,Neuraminidase,26824004.0,,518987.0,Influenza B virus (B/Lee/1940),,IC50 (nM),7,PMID:9651151|DOI:10.1021/jm980162u,https://www.ncbi.nlm.nih.gov/pubmed/9651151|https://doi.org/10.1021/jm980162u,9651151,10.1021/jm980162u,
4910,1498862,480263,BindingDB,"(3R,4R,5S)-4-acetamido-5-amino-3-hydroxy-cyclohexene-1-carboxylic acid",4980,"(3R,4R,5S)-5-amino-4-acetamido-3-hydroxycyclohex-1-ene-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4980,753,Neuraminidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=753,P03468,Neuraminidase,956530.0,,211044.0,Influenza A virus (A/Puerto Rico/8/1934(H1N1)),,IC50 (nM),6300,PMID:9651151|DOI:10.1021/jm980162u,https://www.ncbi.nlm.nih.gov/pubmed/9651151|https://doi.org/10.1021/jm980162u,9651151,10.1021/jm980162u,
4911,1498863,480300,BindingDB,"(3R,4R,5S)-4-acetamido-5-amino-3-[(1S)-1-methylpropoxy]cyclohexene-1-carboxylic acid",4993,"(3R,4R,5S)-5-amino-3-[(2S)-butan-2-yloxy]-4-acetamidocyclohex-1-ene-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4993,753,Neuraminidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=753,P03468,Neuraminidase,956530.0,,211044.0,Influenza A virus (A/Puerto Rico/8/1934(H1N1)),,IC50 (nM),9,PMID:9651151|DOI:10.1021/jm980162u,https://www.ncbi.nlm.nih.gov/pubmed/9651151|https://doi.org/10.1021/jm980162u,9651151,10.1021/jm980162u,
4912,1499033,480300,BindingDB,"(3R,4R,5S)-4-acetamido-5-amino-3-[(1S)-1-methylpropoxy]cyclohexene-1-carboxylic acid",4993,"(3R,4R,5S)-5-amino-3-[(2S)-butan-2-yloxy]-4-acetamidocyclohex-1-ene-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4993,754,Neuraminidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=754,P03474,Neuraminidase,26824004.0,,518987.0,Influenza B virus (B/Lee/1940),,IC50 (nM),2,PMID:9651151|DOI:10.1021/jm980162u,https://www.ncbi.nlm.nih.gov/pubmed/9651151|https://doi.org/10.1021/jm980162u,9651151,10.1021/jm980162u,
4913,1499034,480433,BindingDB,"ethyl N-[6-[[(2R,3S)-3-[[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl]oxycarbonylamino]-2-hydroxy-4-phenyl-butyl]-(1,3-benzodioxol-5-ylsulfonyl)amino]-5,5-dimethyl-hexyl]carbamate",4688,"(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[2H-1,3-benzodioxole-5-({6-[(ethoxycarbonyl)amino]-2,2-dimethylhexyl})sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4688,89,"Dimer of Gag-Pol polyprotein [489-587,M535I,L552P,A560V,V571F,I573V]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=89,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,Ki (nM),0.0043,PMID:15533054|DOI:10.1021/bi0488799,https://www.ncbi.nlm.nih.gov/pubmed/15533054|https://doi.org/10.1021/bi0488799,15533054,10.1021/bi0488799,
4914,1499035,480433,BindingDB,"ethyl N-[6-[[(2R,3S)-3-[[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl]oxycarbonylamino]-2-hydroxy-4-phenyl-butyl]-(1,3-benzodioxol-5-ylsulfonyl)amino]-5,5-dimethyl-hexyl]carbamate",4688,"(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[2H-1,3-benzodioxole-5-({6-[(ethoxycarbonyl)amino]-2,2-dimethylhexyl})sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4688,90,"Dimer of Gag-Pol polyprotein [489-587,L499I,L508Q,K509R,E524D,M525I,S526N,M535I,I539V,I543V,I551V,L552P,A560V,V571A,L579M]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=90,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,Ki (nM),0.0012,PMID:15533054|DOI:10.1021/bi0488799,https://www.ncbi.nlm.nih.gov/pubmed/15533054|https://doi.org/10.1021/bi0488799,15533054,10.1021/bi0488799,
4915,1499036,480440,BindingDB,"[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(1S,2R)-3-[1,3-benzodioxol-5-ylsulfonyl-[2,2-dimethyl-5-(methylcarbamoylamino)pentyl]amino]-1-benzyl-2-hydroxy-propyl]carbamate",4699,"(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[2H-1,3-benzodioxole-5-({2,2-dimethyl-5-[(methylcarbamoyl)amino]pentyl})sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4699,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698.0,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,Ki (nM),0.000048,PMID:15013001|DOI:10.1016/j.bmcl.2003.12.008,https://www.ncbi.nlm.nih.gov/pubmed/15013001|https://doi.org/10.1016/j.bmcl.2003.12.008,15013001,10.1016/j.bmcl.2003.12.008,
4916,1499037,480441,BindingDB,"methyl N-[4-[[(2R,3S)-3-[[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl]oxycarbonylamino]-2-hydroxy-4-phenyl-butyl]-(1,3-benzodioxol-5-ylsulfonyl)amino]-3,3-dimethyl-butyl]carbamate",4695,"(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[2H-1,3-benzodioxole-5-({4-[(methoxycarbonyl)amino]-2,2-dimethylbutyl})sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4695,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698.0,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,Ki (nM),0.00016,PMID:15013001|DOI:10.1016/j.bmcl.2003.12.008,https://www.ncbi.nlm.nih.gov/pubmed/15013001|https://doi.org/10.1016/j.bmcl.2003.12.008,15013001,10.1016/j.bmcl.2003.12.008,
4917,1499038,480447,BindingDB,"methyl N-[7-[[(2R,3S)-3-[[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl]oxycarbonylamino]-2-hydroxy-4-phenyl-butyl]-(1,3-benzodioxol-5-ylsulfonyl)amino]-6,6-dimethyl-heptyl]carbamate",4697,"(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[2H-1,3-benzodioxole-5-({7-[(methoxycarbonyl)amino]-2,2-dimethylheptyl})sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4697,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698.0,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,Ki (nM),0.00012,PMID:15013001|DOI:10.1016/j.bmcl.2003.12.008,https://www.ncbi.nlm.nih.gov/pubmed/15013001|https://doi.org/10.1016/j.bmcl.2003.12.008,15013001,10.1016/j.bmcl.2003.12.008,
4918,1512685,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,84898,PLXDC2,https://ctdbase.org/detail.go?type=gene&acc=84898,,,84898.0,PLXDC2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of PLXDC2 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4919,1512686,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5362,PLXNA2,https://ctdbase.org/detail.go?type=gene&acc=5362,,,5362.0,PLXNA2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PLXNA2 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4920,1512687,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,55558,PLXNA3,https://ctdbase.org/detail.go?type=gene&acc=55558,,,55558.0,PLXNA3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of PLXNA3 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4921,1512688,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,23654,PLXNB2,https://ctdbase.org/detail.go?type=gene&acc=23654,,,23654.0,PLXNB2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of PLXNB2 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4922,1512689,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5365,PLXNB3,https://ctdbase.org/detail.go?type=gene&acc=5365,,,5365.0,PLXNB3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PLXNB3 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4923,1512690,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,23129,PLXND1,https://ctdbase.org/detail.go?type=gene&acc=23129,,,23129.0,PLXND1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PLXND1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4924,1512691,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,135293,PM20D2,https://ctdbase.org/detail.go?type=gene&acc=135293,,,135293.0,PM20D2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PM20D2 mRNA,,,PMID:24780913|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/30047161,24780913|30047161,,
4925,1512692,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,56937,PMEPA1,https://ctdbase.org/detail.go?type=gene&acc=56937,,,56937.0,PMEPA1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of PMEPA1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4926,1512693,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,11243,PMF1,https://ctdbase.org/detail.go?type=gene&acc=11243,,,11243.0,PMF1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of PMF1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4927,1515697,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5558,PRIM2,https://ctdbase.org/detail.go?type=gene&acc=5558,,,5558.0,PRIM2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of PRIM2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4928,1515698,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,145270,PRIMA1,https://ctdbase.org/detail.go?type=gene&acc=145270,,,145270.0,PRIMA1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PRIMA1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4929,1515699,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5565,PRKAB2,https://ctdbase.org/detail.go?type=gene&acc=5565,,,5565.0,PRKAB2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PRKAB2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4930,1517177,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,563343,PRUNE,https://ctdbase.org/detail.go?type=gene&acc=563343,,,563343.0,prune,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PRUNE mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4931,1517178,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,58497,PRUNE1,https://ctdbase.org/detail.go?type=gene&acc=58497,,,58497.0,PRUNE1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of PRUNE1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4932,1517179,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,158471,PRUNE2,https://ctdbase.org/detail.go?type=gene&acc=158471,,,158471.0,PRUNE2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PRUNE2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4933,1517180,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5662,PSD,https://ctdbase.org/detail.go?type=gene&acc=5662,,,5662.0,PSD,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of PSD mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4934,1517181,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,84249,PSD2,https://ctdbase.org/detail.go?type=gene&acc=84249,,,84249.0,PSD2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PSD2 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4935,1517182,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,23362,PSD3,https://ctdbase.org/detail.go?type=gene&acc=23362,,,23362.0,PSD3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PSD3 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4936,1517183,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5663,PSEN1,https://ctdbase.org/detail.go?type=gene&acc=5663,,,5663.0,PSEN1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PSEN1 mRNA,,,PMID:24780913|PMID:33150595,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/33150595,24780913|33150595,,
4937,1517184,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5663,PSEN1,https://ctdbase.org/detail.go?type=gene&acc=5663,,,5663.0,PSEN1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased methylation of PSEN1 promoter,,,PMID:33150595,https://www.ncbi.nlm.nih.gov/pubmed/33150595,33150595,,
4938,1517185,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,114872,PSG29,https://ctdbase.org/detail.go?type=gene&acc=114872,,,114872.0,Psg29,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PSG29 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4939,1517186,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,11168,PSIP1,https://ctdbase.org/detail.go?type=gene&acc=11168,,,11168.0,PSIP1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of PSIP1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4940,1518734,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,374462,PTPRQ,https://ctdbase.org/detail.go?type=gene&acc=374462,,,374462.0,PTPRQ,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PTPRQ mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4941,1518735,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5801,PTPRR,https://ctdbase.org/detail.go?type=gene&acc=5801,,,5801.0,PTPRR,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PTPRR mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4942,1518736,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5802,PTPRS,https://ctdbase.org/detail.go?type=gene&acc=5802,,,5802.0,PTPRS,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of PTPRS mRNA,,,PMID:24780913|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/30047161,24780913|30047161,,
4943,1518737,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,11122,PTPRT,https://ctdbase.org/detail.go?type=gene&acc=11122,,,11122.0,PTPRT,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of PTPRT mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4944,1518738,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,10076,PTPRU,https://ctdbase.org/detail.go?type=gene&acc=10076,,,10076.0,PTPRU,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PTPRU mRNA,,,PMID:30047161|PMID:33150595,https://www.ncbi.nlm.nih.gov/pubmed/30047161|https://www.ncbi.nlm.nih.gov/pubmed/33150595,30047161|33150595,,
4945,1519699,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5861,RAB1A,https://ctdbase.org/detail.go?type=gene&acc=5861,,,5861.0,RAB1A,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RAB1A mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4946,1519700,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,55647,RAB20,https://ctdbase.org/detail.go?type=gene&acc=55647,,,55647.0,RAB20,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RAB20 mRNA,,,PMID:24780913|PMID:25825206,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/25825206,24780913|25825206,,
4947,1519701,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,25837,RAB26,https://ctdbase.org/detail.go?type=gene&acc=25837,,,25837.0,RAB26,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RAB26 mRNA,,,PMID:25825206,https://www.ncbi.nlm.nih.gov/pubmed/25825206,25825206,,
4948,1520130,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,23637,RABGAP1,https://ctdbase.org/detail.go?type=gene&acc=23637,,,23637.0,RABGAP1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RABGAP1 mRNA,,,PMID:25825206,https://www.ncbi.nlm.nih.gov/pubmed/25825206,25825206,,
4949,1520131,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,55684,RABL6,https://ctdbase.org/detail.go?type=gene&acc=55684,,,55684.0,RABL6,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RABL6 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4950,1520132,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RAC1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4951,1520133,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5880,RAC2,https://ctdbase.org/detail.go?type=gene&acc=5880,,,5880.0,RAC2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RAC2 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4952,1520134,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5881,RAC3,https://ctdbase.org/detail.go?type=gene&acc=5881,,,5881.0,RAC3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RAC3 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4953,1520135,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,29127,RACGAP1,https://ctdbase.org/detail.go?type=gene&acc=29127,,,29127.0,RACGAP1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RACGAP1 mRNA,,,PMID:24780913|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/30047161,24780913|30047161,,
4954,1520924,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5916,RARG,https://ctdbase.org/detail.go?type=gene&acc=5916,,,5916.0,RARG,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RARG mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4955,1520925,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5918,RARRES1,https://ctdbase.org/detail.go?type=gene&acc=5918,,,5918.0,RARRES1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RARRES1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4956,1520926,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5919,RARRES2,https://ctdbase.org/detail.go?type=gene&acc=5919,,,5919.0,RARRES2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RARRES2 mRNA,,,PMID:24780913|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/30047161,24780913|30047161,,
4957,1521096,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,10156,RASA4,https://ctdbase.org/detail.go?type=gene&acc=10156,,,10156.0,RASA4,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RASA4 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4958,1521097,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,8437,RASAL1,https://ctdbase.org/detail.go?type=gene&acc=8437,,,8437.0,RASAL1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RASAL1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4959,1521838,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,282996,RBM20,https://ctdbase.org/detail.go?type=gene&acc=282996,,,282996.0,RBM20,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RBM20 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4960,1521839,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,55696,RBM22,https://ctdbase.org/detail.go?type=gene&acc=55696,,,55696.0,RBM22,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RBM22 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4961,1521840,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,221662,RBM24,https://ctdbase.org/detail.go?type=gene&acc=221662,,,221662.0,RBM24,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil affects the expression of RBM24 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4962,1521841,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,221662,RBM24,https://ctdbase.org/detail.go?type=gene&acc=221662,,,221662.0,RBM24,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RBM24 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4963,1521842,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,55131,RBM28,https://ctdbase.org/detail.go?type=gene&acc=55131,,,55131.0,RBM28,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RBM28 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4964,1521843,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5935,RBM3,https://ctdbase.org/detail.go?type=gene&acc=5935,,,5935.0,RBM3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RBM3 mRNA,,,PMID:24780913|PMID:25825206,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/25825206,24780913|25825206,,
4965,1521844,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,55544,RBM38,https://ctdbase.org/detail.go?type=gene&acc=55544,,,55544.0,RBM38,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RBM38 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4966,1521845,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,9584,RBM39,https://ctdbase.org/detail.go?type=gene&acc=9584,,,9584.0,RBM39,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RBM39 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4967,1521846,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,10181,RBM5,https://ctdbase.org/detail.go?type=gene&acc=10181,,,10181.0,RBM5,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RBM5 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4968,1521847,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,27303,RBMS3,https://ctdbase.org/detail.go?type=gene&acc=27303,,,27303.0,RBMS3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RBMS3 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4969,1524019,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,10247,RIDA,https://ctdbase.org/detail.go?type=gene&acc=10247,,,10247.0,RIDA,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RIDA mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4970,1524020,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,83547,RILP,https://ctdbase.org/detail.go?type=gene&acc=83547,,,83547.0,RILP,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RILP mRNA,,,PMID:24780913|PMID:25825206|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/25825206|https://www.ncbi.nlm.nih.gov/pubmed/30047161,24780913|25825206|30047161,,
4971,1524021,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,353116,RILPL1,https://ctdbase.org/detail.go?type=gene&acc=353116,,,353116.0,RILPL1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RILPL1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4972,1524022,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,23504,RIMBP2,https://ctdbase.org/detail.go?type=gene&acc=23504,,,23504.0,RIMBP2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RIMBP2 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4973,1524023,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,284716,RIMKLA,https://ctdbase.org/detail.go?type=gene&acc=284716,,,284716.0,RIMKLA,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RIMKLA mRNA,,,PMID:36843608,https://www.ncbi.nlm.nih.gov/pubmed/36843608,36843608,,
4974,1524024,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,57494,RIMKLB,https://ctdbase.org/detail.go?type=gene&acc=57494,,,57494.0,RIMKLB,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RIMKLB mRNA,,,PMID:36843608,https://www.ncbi.nlm.nih.gov/pubmed/36843608,36843608,,
4975,1524025,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,285636,RIMOC1,https://ctdbase.org/detail.go?type=gene&acc=285636,,,285636.0,RIMOC1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RIMOC1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4976,1524026,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,22999,RIMS1,https://ctdbase.org/detail.go?type=gene&acc=22999,,,22999.0,RIMS1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RIMS1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4977,1524027,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,9699,RIMS2,https://ctdbase.org/detail.go?type=gene&acc=9699,,,9699.0,RIMS2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RIMS2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4978,1525004,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,9025,RNF8,https://ctdbase.org/detail.go?type=gene&acc=9025,,,9025.0,RNF8,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RNF8 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
4979,1525005,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,55328,RNLS,https://ctdbase.org/detail.go?type=gene&acc=55328,,,55328.0,RNLS,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RNLS mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4980,1525742,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6139,RPL17,https://ctdbase.org/detail.go?type=gene&acc=6139,,,6139.0,RPL17,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil affects the expression of RPL17 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
4981,1525743,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6144,RPL21,https://ctdbase.org/detail.go?type=gene&acc=6144,,,6144.0,RPL21,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RPL21 mRNA,,,PMID:18077114,https://www.ncbi.nlm.nih.gov/pubmed/18077114,18077114,,
4982,1525744,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6146,RPL22,https://ctdbase.org/detail.go?type=gene&acc=6146,,,6146.0,RPL22,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RPL22 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4983,1525745,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,9349,RPL23,https://ctdbase.org/detail.go?type=gene&acc=9349,,,9349.0,RPL23,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil affects the expression of RPL23 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
4984,1525746,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6152,RPL24,https://ctdbase.org/detail.go?type=gene&acc=6152,,,6152.0,RPL24,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RPL24 mRNA,,,PMID:36843608,https://www.ncbi.nlm.nih.gov/pubmed/36843608,36843608,,
4985,1525747,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6157,RPL27A,https://ctdbase.org/detail.go?type=gene&acc=6157,,,6157.0,RPL27A,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RPL27A mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4986,1527874,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6258,RXRG,https://ctdbase.org/detail.go?type=gene&acc=6258,,,6258.0,RXRG,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RXRG mRNA,,,PMID:24780913|PMID:25825206,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/25825206,24780913|25825206,,
4987,1527875,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,23429,RYBP,https://ctdbase.org/detail.go?type=gene&acc=23429,,,23429.0,RYBP,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RYBP mRNA,,,PMID:36843608,https://www.ncbi.nlm.nih.gov/pubmed/36843608,36843608,,
4988,1527876,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6262,RYR2,https://ctdbase.org/detail.go?type=gene&acc=6262,,,6262.0,RYR2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RYR2 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4989,1527877,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6271,S100A1,https://ctdbase.org/detail.go?type=gene&acc=6271,,,6271.0,S100A1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of S100A1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
4990,1527878,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6281,S100A10,https://ctdbase.org/detail.go?type=gene&acc=6281,,,6281.0,S100A10,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of S100A10 mRNA,,,PMID:24780913|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/30047161,24780913|30047161,,
4991,1604618,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,100038854,CSTDC6,https://ctdbase.org/detail.go?type=gene&acc=100038854,,,100038854.0,Cstdc6,10090.0,Mus musculus (house mouse),[[air pollutants results in increased abundance of particulate matter] which co-treated with ovalbumin] results in increased expression of CSTDC6 mRNA,,,PMID:32846909,https://www.ncbi.nlm.nih.gov/pubmed/32846909,32846909,,
4992,1604619,3277971,Comparative Toxicogenomics Database (CTD),"3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one",D010047,Ovalbumin,https://ctdbase.org/detail.go?type=chem&acc=D010047,1493,CTLA4,https://ctdbase.org/detail.go?type=gene&acc=1493,,,1493.0,CTLA4,10090.0,Mus musculus (house mouse),"[antigens, bacterial co-treated with ovalbumin] results in increased expression of CTLA4 mRNA",,,PMID:29067999,https://www.ncbi.nlm.nih.gov/pubmed/29067999,29067999,,
4993,2002073,14217092,Comparative Toxicogenomics Database (CTD),Nodularin R,C063998,nodularin,https://ctdbase.org/detail.go?type=chem&acc=C063998,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198.0,RPS6KB1,10116.0,Rattus norvegicus (Norway rat),Nodularin results in increased phosphorylation of RPS6KB1 protein|nodularin results in increased phosphorylation of RPS6KB1 protein alternative form,,,PMID:25192816,https://www.ncbi.nlm.nih.gov/pubmed/25192816,25192816,,
4994,2002074,14217092,Comparative Toxicogenomics Database (CTD),Nodularin R,C063998,nodularin,https://ctdbase.org/detail.go?type=chem&acc=C063998,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,7962.0,Cyprinus carpio (common carp),Nodularin results in increased expression of TNF mRNA,,,PMID:33624853,https://www.ncbi.nlm.nih.gov/pubmed/33624853,33624853,,
4995,2002075,14217092,Comparative Toxicogenomics Database (CTD),Nodularin R,C063998,nodularin,https://ctdbase.org/detail.go?type=chem&acc=C063998,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Sauchinone inhibits the reaction [nodularin results in increased secretion of TNF protein]|sauchinone inhibits the reaction [nodularin results in increased expression of TNF mrna]|nodularin results in increased secretion of TNF protein|nodularin results in increased expression of TNF mRNA,,,PMID:27061667,https://www.ncbi.nlm.nih.gov/pubmed/27061667,27061667,,
4996,2002076,14217092,Comparative Toxicogenomics Database (CTD),Nodularin R,C063998,nodularin,https://ctdbase.org/detail.go?type=chem&acc=C063998,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,9606.0,Homo sapiens (human),Nodularin results in increased expression of TNFRSF10B mrna|sauchinone inhibits the reaction [nodularin results in increased expression of TNFRSF10B mrna],,,PMID:27061667,https://www.ncbi.nlm.nih.gov/pubmed/27061667,27061667,,
4997,2002077,14217092,Comparative Toxicogenomics Database (CTD),Nodularin R,C063998,nodularin,https://ctdbase.org/detail.go?type=chem&acc=C063998,7494,XBP1,https://ctdbase.org/detail.go?type=gene&acc=7494,,,7494.0,XBP1,9606.0,Homo sapiens (human),Nodularin results in increased expression of XBP1 mRNA alternative form,,,PMID:27061667,https://www.ncbi.nlm.nih.gov/pubmed/27061667,27061667,,
4998,2011442,15983988,Comparative Toxicogenomics Database (CTD),Trelagliptin,C000595449,trelagliptin,https://ctdbase.org/detail.go?type=chem&acc=C000595449,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Trelagliptin results in decreased expression of TNF protein|trelagliptin inhibits the reaction [dietary fats results in increased expression of TNF protein],,,PMID:33421258,https://www.ncbi.nlm.nih.gov/pubmed/33421258,33421258,,
4999,2011443,15984072,Therapeutic Target Database (TTD),1-(4-iodobenzyl)-1H-imidazole,D0U6QM,1-(4-iodobenzyl)-1H-imidazole,https://idrblab.net/ttd/data/drug/details/D0U6QM,T89041,Steroid 17-alpha-monooxygenase (S17AH),https://idrblab.net/ttd/data/target/details/T89041,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",1586.0,CYP17A1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5000,2011444,15995385,Drug Gene Interaction database (DGIdb),"N-[2-(diethylamino)ethyl]-3-(3-methoxyphenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide",,CHEMBL:CHEMBL589924,https://www.dgidb.org/drugs/chembl:CHEMBL589924,,RAD52,https://www.dgidb.org/genes/hgnc:9824,,,5893.0,RAD52,9606.0,Homo sapiens (human),,,,,,,,
5001,2011445,15995385,Drug Gene Interaction database (DGIdb),"N-[2-(diethylamino)ethyl]-3-(3-methoxyphenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide",,CHEMBL:CHEMBL589924,https://www.dgidb.org/drugs/chembl:CHEMBL589924,,FEN1,https://www.dgidb.org/genes/hgnc:3650,,,2237.0,FEN1,9606.0,Homo sapiens (human),,,,,,,,
5002,2011446,15995385,Drug Gene Interaction database (DGIdb),"N-[2-(diethylamino)ethyl]-3-(3-methoxyphenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide",,CHEMBL:CHEMBL589924,https://www.dgidb.org/drugs/chembl:CHEMBL589924,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
5003,2011447,16004692,Drug Gene Interaction database (DGIdb),Macitentan,,MACITENTAN,https://www.dgidb.org/drugs/rxcui:1442132,,EDNRA,https://www.dgidb.org/genes/hgnc:3179,,,1909.0,EDNRA,9606.0,Homo sapiens (human),,,,,,,,
5004,2011448,16007418,Drug Gene Interaction database (DGIdb),"N-{2-[butyl(ethyl)amino]ethyl}-3-(4-chlorophenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide",,CHEMBL:CHEMBL596633,https://www.dgidb.org/drugs/chembl:CHEMBL596633,,RAD54L,https://www.dgidb.org/genes/hgnc:9826,,,8438.0,RAD54L,9606.0,Homo sapiens (human),,,,,,,,
5005,2011449,16007418,Drug Gene Interaction database (DGIdb),"N-{2-[butyl(ethyl)amino]ethyl}-3-(4-chlorophenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide",,CHEMBL:CHEMBL596633,https://www.dgidb.org/drugs/chembl:CHEMBL596633,,RAD52,https://www.dgidb.org/genes/hgnc:9824,,,5893.0,RAD52,9606.0,Homo sapiens (human),,,,,,,,
5006,2011450,16015353,Drug Gene Interaction database (DGIdb),"N-[2-[2-(2-methylphenoxy)ethylsulfanyl]-1,3-benzothiazol-6-yl]benzamide",,CHEMBL:CHEMBL586078,https://www.dgidb.org/drugs/chembl:CHEMBL586078,,MAPT,https://www.dgidb.org/genes/hgnc:6893,,,4137.0,MAPT,9606.0,Homo sapiens (human),,,,,,,,
5007,2011451,16018313,Drug Gene Interaction database (DGIdb),"2-(4-fluorophenyl)-N-[3-(2-methylpiperidin-1-yl)propyl]imidazo[2,1-b][1,3]benzothiazole-6-carboxamide",,CHEMBL:CHEMBL602946,https://www.dgidb.org/drugs/chembl:CHEMBL602946,,ATXN2,https://www.dgidb.org/genes/hgnc:10555,,,6311.0,ATXN2,9606.0,Homo sapiens (human),,,,,,,,
5008,2011452,16021397,Drug Gene Interaction database (DGIdb),N-{2-[(3-Chlorophenyl)amino]-4-methylquinolin-6-YL}pyridine-3-carboxamide,,CHEMBL:CHEMBL578890,https://www.dgidb.org/drugs/chembl:CHEMBL578890,,TP53,https://www.dgidb.org/genes/hgnc:11998,,,7157.0,TP53,9606.0,Homo sapiens (human),,,,,,,,
5009,2011453,16021397,Drug Gene Interaction database (DGIdb),N-{2-[(3-Chlorophenyl)amino]-4-methylquinolin-6-YL}pyridine-3-carboxamide,,CHEMBL:CHEMBL578890,https://www.dgidb.org/drugs/chembl:CHEMBL578890,,MAPT,https://www.dgidb.org/genes/hgnc:6893,,,4137.0,MAPT,9606.0,Homo sapiens (human),,,,,,,,
5010,2011454,16035342,IUPHAR/BPS Guide to PHARMACOLOGY,"6-[4-[(4-Ethyl-1-piperazinyl)methyl]phenyl]-N-[(1S)-1-phenylethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",7643,AEE788,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7643,1799,erb-b2 receptor tyrosine kinase 4,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1799,Q15303,Receptor tyrosine-protein kinase erbB-4,2066.0,ERBB4,9606.0,Homo sapiens (human),Inhibition,pIC50,7.59,PMID:15256466,https://www.ncbi.nlm.nih.gov/pubmed/15256466,15256466,,
5011,2011455,16035342,IUPHAR/BPS Guide to PHARMACOLOGY,"6-[4-[(4-Ethyl-1-piperazinyl)methyl]phenyl]-N-[(1S)-1-phenylethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",7643,AEE788,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7643,1813,kinase insert domain receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1813,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),Inhibition,pIC50,7.11,PMID:15256466,https://www.ncbi.nlm.nih.gov/pubmed/15256466,15256466,,
5012,2011470,16035342,IUPHAR/BPS Guide to PHARMACOLOGY,"6-[4-[(4-Ethyl-1-piperazinyl)methyl]phenyl]-N-[(1S)-1-phenylethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",7643,AEE788,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7643,1797,epidermal growth factor receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1797,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),Inhibition,pIC50,8.7,PMID:15256466,https://www.ncbi.nlm.nih.gov/pubmed/15256466,15256466,,
5013,2011471,16040172,Therapeutic Target Database (TTD),grandisine D,D0U5QL,Grandisine D,https://idrblab.net/ttd/data/drug/details/D0U5QL,T58992,Opioid receptor delta (OPRD1),https://idrblab.net/ttd/data/target/details/T58992,P41143,Delta-type opioid receptor,4985.0,OPRD1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5014,2011472,16041424,IUPHAR/BPS Guide to PHARMACOLOGY,(E)-N-(5-Methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amine,7885,ENMD-2076,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7885,1813,kinase insert domain receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1813,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),Inhibition,pIC50,7.44,PMID:19320489,https://www.ncbi.nlm.nih.gov/pubmed/19320489,19320489,,
5015,2011473,16041424,IUPHAR/BPS Guide to PHARMACOLOGY,(E)-N-(5-Methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amine,7885,ENMD-2076,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7885,1807,fms related receptor tyrosine kinase 3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1807,P36888,Receptor-type tyrosine-protein kinase FLT3,2322.0,FLT3,9606.0,Homo sapiens (human),Inhibition,pIC50,8.52,PMID:19320489,https://www.ncbi.nlm.nih.gov/pubmed/19320489,19320489,,
5016,2011474,16041424,IUPHAR/BPS Guide to PHARMACOLOGY,(E)-N-(5-Methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amine,7885,ENMD-2076,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7885,1803,platelet derived growth factor receptor alpha,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1803,P16234,Platelet-derived growth factor receptor alpha,5156.0,PDGFRA,9606.0,Homo sapiens (human),Inhibition,pIC50,7.25,PMID:19320489,https://www.ncbi.nlm.nih.gov/pubmed/19320489,19320489,,
5017,2011475,16043015,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D09MHS,3-demethoxy-3D-glucopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D09MHS,T08910,GABA(A) receptor gamma-2 (GABRG2),https://idrblab.net/ttd/data/target/details/T08910,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5018,2011476,16043015,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D09MHS,3-demethoxy-3D-glucopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D09MHS,T55285,Glycine receptor (GlyR),https://idrblab.net/ttd/data/target/details/T55285,P23415,Glycine receptor subunit alpha-1,2741.0,GLRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5019,2011477,16043015,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D09MHS,3-demethoxy-3D-glucopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D09MHS,T55285,Glycine receptor (GlyR),https://idrblab.net/ttd/data/target/details/T55285,P23416,Glycine receptor subunit alpha-2,2742.0,GLRA2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5020,2011478,16043015,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D09MHS,3-demethoxy-3D-glucopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D09MHS,T55285,Glycine receptor (GlyR),https://idrblab.net/ttd/data/target/details/T55285,O75311,Glycine receptor subunit alpha-3,8001.0,GLRA3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5021,2011479,16043015,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D09MHS,3-demethoxy-3D-glucopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D09MHS,T55285,Glycine receptor (GlyR),https://idrblab.net/ttd/data/target/details/T55285,P48167,Glycine receptor subunit beta,2743.0,GLRB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5022,2011480,16043015,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D09MHS,3-demethoxy-3D-glucopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D09MHS,T80387,GABA(A) receptor beta-2 (GABRB2),https://idrblab.net/ttd/data/target/details/T80387,P47870,Gamma-aminobutyric acid receptor subunit beta-2,2561.0,GABRB2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5023,2011481,16043015,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D09MHS,3-demethoxy-3D-glucopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D09MHS,T51487,GABA(A) receptor alpha-1 (GABRA1),https://idrblab.net/ttd/data/target/details/T51487,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5024,2011482,16043015,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D09MHS,3-demethoxy-3D-glucopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D09MHS,T50269,Strychnine-binding glycine receptor (GLRA1),https://idrblab.net/ttd/data/target/details/T50269,P23415,Glycine receptor subunit alpha-1,2741.0,GLRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5025,2011483,16043019,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(3S,4S,5R)-3,4,5-trihydroxyoxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D04RVA,3-demethoxy-3-D-lyxopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D04RVA,T50269,Strychnine-binding glycine receptor (GLRA1),https://idrblab.net/ttd/data/target/details/T50269,P23415,Glycine receptor subunit alpha-1,2741.0,GLRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5026,2011484,16049404,IUPHAR/BPS Guide to PHARMACOLOGY,Motolimod,9026,motolimod,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9026,1758,TLR8,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1758,Q9NR97,Toll-like receptor 8,51311.0,TLR8,9606.0,Homo sapiens (human),Agonist,pEC50,7,PMID:22128302,https://www.ncbi.nlm.nih.gov/pubmed/22128302,22128302,,
5027,2011485,16049404,Drug Gene Interaction database (DGIdb),Motolimod,,MOTOLIMOD,https://www.dgidb.org/drugs/ncit:C80521,,TLR8,https://www.dgidb.org/genes/hgnc:15632,,,51311.0,TLR8,9606.0,Homo sapiens (human),,,,,,,,
5028,2011486,16052011,Drug Gene Interaction database (DGIdb),Goserelin Acetate,,GOSERELIN ACETATE,https://www.dgidb.org/drugs/rxcui:203146,,GNRHR,https://www.dgidb.org/genes/hgnc:4421,,,2798.0,GNRHR,9606.0,Homo sapiens (human),Agonist,,,,,,,
5029,2011487,16058752,Drug Gene Interaction database (DGIdb),"3-Pyridazinamine, N-(1-((3,4-difluorophenyl)methyl)-4-piperidinyl)-6-(trifluoromethyl)-",,JNJ-37822681,https://www.dgidb.org/drugs/drugbank:DB12579,,DRD2,https://www.dgidb.org/genes/hgnc:3023,,,1813.0,DRD2,9606.0,Homo sapiens (human),,,,,,,,
5030,2011488,16059787,Therapeutic Target Database (TTD),annulin A,D0DB2N,ANNULIN A,https://idrblab.net/ttd/data/drug/details/D0DB2N,T89697,"Indoleamine 2,3-dioxygenase 1 (IDO1)",https://idrblab.net/ttd/data/target/details/T89697,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5031,2011489,16066809,Drug Gene Interaction database (DGIdb),Naltalimide,,NALTALIMIDE,https://www.dgidb.org/drugs/ncit:C174856,,OPRM1,https://www.dgidb.org/genes/hgnc:8156,,,4988.0,OPRM1,9606.0,Homo sapiens (human),Agonist,,,,,,,
5032,2011490,16072115,BindingDB,"Methyl isoplatydesmine, 4",86023,"Methyl isoplatydesmine, 4",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=86023,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787.0,Tetronarce californica (Pacific electric ray),,Ki (nM),3.00e+4,PMID:17252943|DOI:10.1080/14756360600889708,https://www.ncbi.nlm.nih.gov/pubmed/17252943|https://doi.org/10.1080/14756360600889708,17252943,10.1080/14756360600889708,
5033,2011491,16072115,BindingDB,"Methyl isoplatydesmine, 4",86023,"Methyl isoplatydesmine, 4",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=86023,254,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=254,,,,,,,,Ki (nM),1.90e+4,PMID:17252943|DOI:10.1080/14756360600889708,https://www.ncbi.nlm.nih.gov/pubmed/17252943|https://doi.org/10.1080/14756360600889708,17252943,10.1080/14756360600889708,
5034,2011492,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,340273,ABCB5,https://ctdbase.org/detail.go?type=gene&acc=340273,,,340273.0,ABCB5,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of ABCB5 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5035,2011493,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,11194,ABCB8,https://ctdbase.org/detail.go?type=gene&acc=11194,,,11194.0,ABCB8,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of ABCB8 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5036,2011494,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of ABCC1 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5037,2011495,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606.0,Homo sapiens (human),AC 93253 results in increased expression of ABCC2 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5038,2011496,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,215,ABCD1,https://ctdbase.org/detail.go?type=gene&acc=215,,,215.0,ABCD1,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of ABCD1 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5039,2011497,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of BCL2 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5040,2011498,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of BIRC5 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5041,2011499,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890.0,CCNA2,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of CCNA2 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5042,2011500,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,894,CCND2,https://ctdbase.org/detail.go?type=gene&acc=894,,,894.0,CCND2,9606.0,Homo sapiens (human),AC 93253 results in increased expression of CCND2 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5043,2011501,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of CCNE1 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5044,2011906,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,9134,CCNE2,https://ctdbase.org/detail.go?type=gene&acc=9134,,,9134.0,CCNE2,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of CCNE2 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5045,2011907,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of CDK2 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5046,2011908,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of CDK4 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5047,2011909,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of CDKN1B mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5048,2011910,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,4100,MAGEA1,https://ctdbase.org/detail.go?type=gene&acc=4100,,,4100.0,MAGEA1,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of MAGEA1 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5049,2011911,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,4286,MITF,https://ctdbase.org/detail.go?type=gene&acc=4286,,,4286.0,MITF,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of MITF mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5050,2011912,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of MKI67 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5051,2011913,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,4893,NRAS,https://ctdbase.org/detail.go?type=gene&acc=4893,,,4893.0,NRAS,9606.0,Homo sapiens (human),AC 93253 results in decreased expression of NRAS mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5052,2011914,16078948,Comparative Toxicogenomics Database (CTD),AC-93253 iodide,C542662,AC 93253,https://ctdbase.org/detail.go?type=chem&acc=C542662,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),AC 93253 affects the expression of TP53 mRNA,,,PMID:25912555,https://www.ncbi.nlm.nih.gov/pubmed/25912555,25912555,,
5053,2011915,16081752,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D0LP2K,3-demethoxy-3-D-mannopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D0LP2K,T51487,GABA(A) receptor alpha-1 (GABRA1),https://idrblab.net/ttd/data/target/details/T51487,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5054,2011916,16081752,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D0LP2K,3-demethoxy-3-D-mannopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D0LP2K,T50269,Strychnine-binding glycine receptor (GLRA1),https://idrblab.net/ttd/data/target/details/T50269,P23415,Glycine receptor subunit alpha-1,2741.0,GLRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5055,2011929,16081752,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D0LP2K,3-demethoxy-3-D-mannopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D0LP2K,T08910,GABA(A) receptor gamma-2 (GABRG2),https://idrblab.net/ttd/data/target/details/T08910,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5056,2011930,16081752,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D0LP2K,3-demethoxy-3-D-mannopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D0LP2K,T55285,Glycine receptor (GlyR),https://idrblab.net/ttd/data/target/details/T55285,P23415,Glycine receptor subunit alpha-1,2741.0,GLRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5057,2011931,16081752,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D0LP2K,3-demethoxy-3-D-mannopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D0LP2K,T55285,Glycine receptor (GlyR),https://idrblab.net/ttd/data/target/details/T55285,P23416,Glycine receptor subunit alpha-2,2742.0,GLRA2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5058,2011932,16081752,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D0LP2K,3-demethoxy-3-D-mannopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D0LP2K,T55285,Glycine receptor (GlyR),https://idrblab.net/ttd/data/target/details/T55285,O75311,Glycine receptor subunit alpha-3,8001.0,GLRA3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5059,2011933,16081752,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D0LP2K,3-demethoxy-3-D-mannopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D0LP2K,T55285,Glycine receptor (GlyR),https://idrblab.net/ttd/data/target/details/T55285,P48167,Glycine receptor subunit beta,2743.0,GLRB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5060,2011934,16081752,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D0LP2K,3-demethoxy-3-D-mannopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D0LP2K,T80387,GABA(A) receptor beta-2 (GABRB2),https://idrblab.net/ttd/data/target/details/T80387,P47870,Gamma-aminobutyric acid receptor subunit beta-2,2561.0,GABRB2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5061,2011935,16082784,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D08YLW,3-demethoxy-3-L-fucopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D08YLW,T51487,GABA(A) receptor alpha-1 (GABRA1),https://idrblab.net/ttd/data/target/details/T51487,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5062,2011936,16082784,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D08YLW,3-demethoxy-3-L-fucopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D08YLW,T50269,Strychnine-binding glycine receptor (GLRA1),https://idrblab.net/ttd/data/target/details/T50269,P23415,Glycine receptor subunit alpha-1,2741.0,GLRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5063,2011937,16082784,Therapeutic Target Database (TTD),"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]amino]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",D08YLW,3-demethoxy-3-L-fucopyranosylaminothiocolchicine,https://idrblab.net/ttd/data/drug/details/D08YLW,T08910,GABA(A) receptor gamma-2 (GABRG2),https://idrblab.net/ttd/data/target/details/T08910,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5064,2002068,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,6897,TARS1,https://ctdbase.org/detail.go?type=gene&acc=6897,,,6897.0,TARS1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of TARS1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
5065,2002069,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,80222,TARS2,https://ctdbase.org/detail.go?type=gene&acc=80222,,,80222.0,TARS2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of TARS2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
5066,2002070,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,6898,TAT,https://ctdbase.org/detail.go?type=gene&acc=6898,,,6898.0,TAT,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of TAT mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
5067,2002071,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,9797,TATDN2,https://ctdbase.org/detail.go?type=gene&acc=9797,,,9797.0,TATDN2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of TATDN2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
5068,2002072,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,23216,TBC1D1,https://ctdbase.org/detail.go?type=gene&acc=23216,,,23216.0,TBC1D1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of TBC1D1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
5069,2028011,16483569,IUPHAR/BPS Guide to PHARMACOLOGY,"1,4-Bis(4-chlorophenyl)-2-[(4-methylphenyl)sulfonyl]butane-1,4-dione",11559,compound II [PMID: 29351497],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11559,2801,regulator of G-protein signaling 17,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2801,Q9UGC6,Regulator of G-protein signaling 17,26575.0,RGS17,9606.0,Homo sapiens (human),Inhibition,pIC50,4.72,PMID:29351497,https://www.ncbi.nlm.nih.gov/pubmed/29351497,29351497,,
5070,2028012,16654980,Drug Gene Interaction database (DGIdb),Buparlisib,,BUPARLISIB,https://www.dgidb.org/drugs/ncit:C90565,,PIK3R3,https://www.dgidb.org/genes/hgnc:8981,,,8503.0,PIK3R3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5071,2028013,16654987,Therapeutic Target Database (TTD),"Benzonitrile, 3-(((5-(6-methyl-2-pyridinyl)-4-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)amino)-",D0H6ZP,IN-1166,https://idrblab.net/ttd/data/drug/details/D0H6ZP,T65864,Stress-activated protein kinase 2a (p38 alpha),https://idrblab.net/ttd/data/target/details/T65864,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5072,2028014,16654987,Therapeutic Target Database (TTD),"Benzonitrile, 3-(((5-(6-methyl-2-pyridinyl)-4-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)amino)-",D0H6ZP,IN-1166,https://idrblab.net/ttd/data/drug/details/D0H6ZP,T06037,JNK2 messenger RNA (JNK2 mRNA),https://idrblab.net/ttd/data/target/details/T06037,P45984,Mitogen-activated protein kinase 9,5601.0,MAPK9,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5073,2028015,16654987,Therapeutic Target Database (TTD),"Benzonitrile, 3-(((5-(6-methyl-2-pyridinyl)-4-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)amino)-",D0H6ZP,IN-1166,https://idrblab.net/ttd/data/drug/details/D0H6ZP,T53389,TGF-beta receptor type I (TGFBR1),https://idrblab.net/ttd/data/target/details/T53389,P36897,TGF-beta receptor type-1,7046.0,TGFBR1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5074,2028016,16658352,Therapeutic Target Database (TTD),1-Guanidino-7-sulphamoylisoquinoline,D0K4PK,1-guanidino-7-isoquinolinesulphonamide,https://idrblab.net/ttd/data/drug/details/D0K4PK,T17758,Urokinase-type plasminogen activator (PLAU),https://idrblab.net/ttd/data/target/details/T17758,P00749,Urokinase-type plasminogen activator,5328.0,PLAU,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5075,2028017,16658352,Therapeutic Target Database (TTD),1-Guanidino-7-sulphamoylisoquinoline,D0K4PK,1-guanidino-7-isoquinolinesulphonamide,https://idrblab.net/ttd/data/drug/details/D0K4PK,T89034,Plasminogen (PLG),https://idrblab.net/ttd/data/target/details/T89034,P00747,Plasminogen,5340.0,PLG,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5076,2028018,16658353,Therapeutic Target Database (TTD),1-Guanidino-4-chloro-7-sulfamoyl-isoquinoline,D06CJP,4-chloro-1-guanidino-7-isoquinolinesulphonamide,https://idrblab.net/ttd/data/drug/details/D06CJP,T17758,Urokinase-type plasminogen activator (PLAU),https://idrblab.net/ttd/data/target/details/T17758,P00749,Urokinase-type plasminogen activator,5328.0,PLAU,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5077,2028019,16658631,Therapeutic Target Database (TTD),1-Guanidino-7-phenylsulphamoylisoquinoline,D00PEJ,1-guanidino-N-phenyl-7-isoquinolinesulphonamide,https://idrblab.net/ttd/data/drug/details/D00PEJ,T89034,Plasminogen (PLG),https://idrblab.net/ttd/data/target/details/T89034,P00747,Plasminogen,5340.0,PLG,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5078,2028020,16658631,Therapeutic Target Database (TTD),1-Guanidino-7-phenylsulphamoylisoquinoline,D00PEJ,1-guanidino-N-phenyl-7-isoquinolinesulphonamide,https://idrblab.net/ttd/data/drug/details/D00PEJ,T45299,Tissue-type plasminogen activator (PLAT),https://idrblab.net/ttd/data/target/details/T45299,P00750,Tissue-type plasminogen activator,5327.0,PLAT,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5079,2028021,16658631,Therapeutic Target Database (TTD),1-Guanidino-7-phenylsulphamoylisoquinoline,D00PEJ,1-guanidino-N-phenyl-7-isoquinolinesulphonamide,https://idrblab.net/ttd/data/drug/details/D00PEJ,T17758,Urokinase-type plasminogen activator (PLAU),https://idrblab.net/ttd/data/target/details/T17758,P00749,Urokinase-type plasminogen activator,5328.0,PLAU,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5080,2028045,16659801,IUPHAR/BPS Guide to PHARMACOLOGY,PMID17929793C23e,6346,compound 23e [PMID: 17929793],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6346,289,mGlu1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289,P23385,Metabotropic glutamate receptor 1,24414.0,Grm1,10116.0,Rattus norvegicus (Norway rat),Negative,pKi,8.82,PMID:17929793,https://www.ncbi.nlm.nih.gov/pubmed/17929793,17929793,,
5081,2028046,16659801,IUPHAR/BPS Guide to PHARMACOLOGY,PMID17929793C23e,6346,compound 23e [PMID: 17929793],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6346,289,mGlu1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289,Q13255,Metabotropic glutamate receptor 1,2911.0,GRM1,9606.0,Homo sapiens (human),Negative,pIC50,8.54,PMID:17929793,https://www.ncbi.nlm.nih.gov/pubmed/17929793,17929793,,
5082,2028047,16659802,IUPHAR/BPS Guide to PHARMACOLOGY,PMID17929793C23i,6348,compound 23i [PMID: 17929793],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6348,289,mGlu1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289,Q13255,Metabotropic glutamate receptor 1,2911.0,GRM1,9606.0,Homo sapiens (human),Negative,pIC50,8.85,PMID:17929793,https://www.ncbi.nlm.nih.gov/pubmed/17929793,17929793,,
5083,2028048,16659803,IUPHAR/BPS Guide to PHARMACOLOGY,PMID17929793C23h,6338,compound 23h [PMID: 17929793],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6338,289,mGlu1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289,Q13255,Metabotropic glutamate receptor 1,2911.0,GRM1,9606.0,Homo sapiens (human),Negative,pIC50,8.66,PMID:17929793,https://www.ncbi.nlm.nih.gov/pubmed/17929793,17929793,,
5084,2028049,16659803,IUPHAR/BPS Guide to PHARMACOLOGY,PMID17929793C23h,6338,compound 23h [PMID: 17929793],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6338,289,mGlu1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289,P23385,Metabotropic glutamate receptor 1,24414.0,Grm1,10116.0,Rattus norvegicus (Norway rat),Negative,pKi,8.82,PMID:17929793,https://www.ncbi.nlm.nih.gov/pubmed/17929793,17929793,,
5085,2028050,16659967,IUPHAR/BPS Guide to PHARMACOLOGY,PMID17929793C23c,6345,compound 23c [PMID: 17929793],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6345,289,mGlu1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289,P23385,Metabotropic glutamate receptor 1,24414.0,Grm1,10116.0,Rattus norvegicus (Norway rat),Negative,pKi,9.4,PMID:17929793,https://www.ncbi.nlm.nih.gov/pubmed/17929793,17929793,,
5086,2028051,16659967,IUPHAR/BPS Guide to PHARMACOLOGY,PMID17929793C23c,6345,compound 23c [PMID: 17929793],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6345,289,mGlu1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289,Q13255,Metabotropic glutamate receptor 1,2911.0,GRM1,9606.0,Homo sapiens (human),Negative,pIC50,8.6,PMID:17929793,https://www.ncbi.nlm.nih.gov/pubmed/17929793,17929793,,
5087,2028052,16660135,IUPHAR/BPS Guide to PHARMACOLOGY,"4-fluoro-N-methyl-N-[4-[6-(propan-2-ylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]benzamide",8767,FITM,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8767,289,mGlu1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289,P23385,Metabotropic glutamate receptor 1,24414.0,Grm1,10116.0,Rattus norvegicus (Norway rat),Negative,pKi,8.27,PMID:22316010,https://www.ncbi.nlm.nih.gov/pubmed/22316010,22316010,,
5088,2028053,16662948,Drug Gene Interaction database (DGIdb),3-Fluoro-5-(5-((2-methylthiazol-4-yl)ethynyl)pyridin-2-yl)benzonitrile,,STX107,https://www.dgidb.org/drugs/chembl:CHEMBL3642985,,GRM5,https://www.dgidb.org/genes/hgnc:4597,,,2915.0,GRM5,9606.0,Homo sapiens (human),Negative modulator,,,,,,,
5089,2028054,16662948,Drug Gene Interaction database (DGIdb),3-Fluoro-5-(5-((2-methylthiazol-4-yl)ethynyl)pyridin-2-yl)benzonitrile,,STX107,https://www.dgidb.org/drugs/chembl:CHEMBL3642985,,GRM5,https://www.dgidb.org/genes/hgnc:4597,,,2915.0,GRM5,9606.0,Homo sapiens (human),,,,,,,,
5090,2028092,16682486,Drug Gene Interaction database (DGIdb),5-(2-Hydroxy-ethyl)-3-morpholin-4-yl-phenazin-5-ium,,CHEMBL:CHEMBL1493528,https://www.dgidb.org/drugs/chembl:CHEMBL1493528,,SENP8,https://www.dgidb.org/genes/hgnc:22992,,,123228.0,SENP8,9606.0,Homo sapiens (human),,,,,,,,
5091,2028093,16682486,Drug Gene Interaction database (DGIdb),5-(2-Hydroxy-ethyl)-3-morpholin-4-yl-phenazin-5-ium,,CHEMBL:CHEMBL1493528,https://www.dgidb.org/drugs/chembl:CHEMBL1493528,,CASP3,https://www.dgidb.org/genes/hgnc:1504,,,836.0,CASP3,9606.0,Homo sapiens (human),,,,,,,,
5092,2027875,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,143872,ARHGAP42,https://ctdbase.org/detail.go?type=gene&acc=143872,,,143872.0,ARHGAP42,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP42 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5093,2027876,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,143872,ARHGAP42,https://ctdbase.org/detail.go?type=gene&acc=143872,,,143872.0,ARHGAP42,9606.0,Homo sapiens (human),Phenylmercuric acetate results in increased expression of ARHGAP42 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5094,2027877,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,23526,ARHGAP45,https://ctdbase.org/detail.go?type=gene&acc=23526,,,23526.0,ARHGAP45,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGAP45 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5095,2027878,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,23526,ARHGAP45,https://ctdbase.org/detail.go?type=gene&acc=23526,,,23526.0,ARHGAP45,9606.0,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of ARHGAP45 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5096,2027879,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,84837,ARHGAP5-AS1,https://ctdbase.org/detail.go?type=gene&acc=84837,,,84837.0,ARHGAP5-AS1,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP5-AS1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5097,2027880,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,84837,ARHGAP5-AS1,https://ctdbase.org/detail.go?type=gene&acc=84837,,,84837.0,ARHGAP5-AS1,9606.0,Homo sapiens (human),Phenylmercuric acetate results in increased expression of ARHGAP5-AS1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5098,2027881,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5099,2027882,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,9606.0,Homo sapiens (human),Phenylmercuric acetate results in increased expression of ARHGDIB mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5100,2027883,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,115557,ARHGEF25,https://ctdbase.org/detail.go?type=gene&acc=115557,,,115557.0,ARHGEF25,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF25 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5101,2027884,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,115557,ARHGEF25,https://ctdbase.org/detail.go?type=gene&acc=115557,,,115557.0,ARHGEF25,9606.0,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of ARHGEF25 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5102,2027885,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,26084,ARHGEF26,https://ctdbase.org/detail.go?type=gene&acc=26084,,,26084.0,ARHGEF26,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF26 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5103,2027886,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,26084,ARHGEF26,https://ctdbase.org/detail.go?type=gene&acc=26084,,,26084.0,ARHGEF26,9606.0,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of ARHGEF26 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5104,2027887,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,55207,ARL8B,https://ctdbase.org/detail.go?type=gene&acc=55207,,,55207.0,ARL8B,9606.0,Homo sapiens (human),Phenylmercuric acetate results in increased expression of ARL8B mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5105,2027888,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,50650,ARHGEF3,https://ctdbase.org/detail.go?type=gene&acc=50650,,,50650.0,ARHGEF3,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGEF3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5106,2027889,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,50650,ARHGEF3,https://ctdbase.org/detail.go?type=gene&acc=50650,,,50650.0,ARHGEF3,9606.0,Homo sapiens (human),Phenylmercuric acetate results in increased expression of ARHGEF3 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5107,2027890,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,50649,ARHGEF4,https://ctdbase.org/detail.go?type=gene&acc=50649,,,50649.0,ARHGEF4,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5108,2027891,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,50649,ARHGEF4,https://ctdbase.org/detail.go?type=gene&acc=50649,,,50649.0,ARHGEF4,9606.0,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of ARHGEF4 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5109,2027892,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,23229,ARHGEF9,https://ctdbase.org/detail.go?type=gene&acc=23229,,,23229.0,ARHGEF9,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF9 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5110,2028094,16684434,Drug Gene Interaction database (DGIdb),Thimerosal,,THIMEROSAL,https://www.dgidb.org/drugs/rxcui:10472,,TP53,https://www.dgidb.org/genes/hgnc:11998,,,7157.0,TP53,9606.0,Homo sapiens (human),,,,,,,,
5111,2028095,16684434,Drug Gene Interaction database (DGIdb),Thimerosal,,THIMEROSAL,https://www.dgidb.org/drugs/rxcui:10472,,ALOX15,https://www.dgidb.org/genes/hgnc:433,,,246.0,ALOX15,9606.0,Homo sapiens (human),,,,,,,,
5112,2028096,16684434,Drug Gene Interaction database (DGIdb),Thimerosal,,THIMEROSAL,https://www.dgidb.org/drugs/rxcui:10472,,MAPK1,https://www.dgidb.org/genes/hgnc:6871,,,5594.0,MAPK1,9606.0,Homo sapiens (human),,,,,,,,
5113,2028097,16684434,Drug Gene Interaction database (DGIdb),Thimerosal,,THIMEROSAL,https://www.dgidb.org/drugs/rxcui:10472,,HTT,https://www.dgidb.org/genes/hgnc:4851,,,3064.0,HTT,9606.0,Homo sapiens (human),,,,,,,,
5114,2028098,16684434,Drug Gene Interaction database (DGIdb),Thimerosal,,THIMEROSAL,https://www.dgidb.org/drugs/rxcui:10472,,VDR,https://www.dgidb.org/genes/hgnc:12679,,,7421.0,VDR,9606.0,Homo sapiens (human),,,,,,,,
5115,2028099,16684434,Drug Gene Interaction database (DGIdb),Thimerosal,,THIMEROSAL,https://www.dgidb.org/drugs/rxcui:10472,,SMAD3,https://www.dgidb.org/genes/hgnc:6769,,,4088.0,SMAD3,9606.0,Homo sapiens (human),,,,,,,,
5116,2028100,16684434,Drug Gene Interaction database (DGIdb),Thimerosal,,THIMEROSAL,https://www.dgidb.org/drugs/rxcui:10472,,NTSR1,https://www.dgidb.org/genes/hgnc:8039,,,4923.0,NTSR1,9606.0,Homo sapiens (human),,,,,,,,
5117,2028101,16718576,BindingDB,Milciclib,31545,Milciclib,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31545,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),45,PMID:19603809|DOI:10.1021/jm9006559,https://www.ncbi.nlm.nih.gov/pubmed/19603809|https://doi.org/10.1021/jm9006559,19603809,10.1021/jm9006559,
5118,2028102,16718576,BindingDB,Milciclib,31545,Milciclib,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31545,108,Cyclin-dependent kinase 5 activator 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=108,Q15078,Cyclin-dependent kinase 5 activator 1,8851.0,CDK5R1,9606.0,Homo sapiens (human),,IC50 (nM),265,PMID:19603809|DOI:10.1021/jm9006559,https://www.ncbi.nlm.nih.gov/pubmed/19603809|https://doi.org/10.1021/jm9006559,19603809,10.1021/jm9006559,
5119,2028103,16718576,BindingDB,Milciclib,31545,Milciclib,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31545,93,Cyclin-dependent kinase 4/G1/S-specific cyclin-D1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=93,P11802,Cyclin-dependent kinase 4,1019.0,CDK4,9606.0,Homo sapiens (human),,IC50 (nM),160,PMID:19603809|DOI:10.1021/jm9006559,https://www.ncbi.nlm.nih.gov/pubmed/19603809|https://doi.org/10.1021/jm9006559,19603809,10.1021/jm9006559,
5120,2028104,16718576,BindingDB,Milciclib,31545,Milciclib,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31545,3688,High affinity nerve growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3688,P04629,High affinity nerve growth factor receptor,4914.0,NTRK1,9606.0,Homo sapiens (human),,IC50 (nM),53,PMID:19603809|DOI:10.1021/jm9006559,https://www.ncbi.nlm.nih.gov/pubmed/19603809|https://doi.org/10.1021/jm9006559,19603809,10.1021/jm9006559,
5121,2028105,16718576,BindingDB,Milciclib,31545,Milciclib,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31545,81,Cyclin-dependent kinase 2/G1/S-specific cyclin-E1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=81,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),363,PMID:19603809|DOI:10.1021/jm9006559,https://www.ncbi.nlm.nih.gov/pubmed/19603809|https://doi.org/10.1021/jm9006559,19603809,10.1021/jm9006559,
5122,2028120,16718576,BindingDB,Milciclib,31545,Milciclib,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31545,95,Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=95,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,IC50 (nM),398,PMID:19603809|DOI:10.1021/jm9006559,https://www.ncbi.nlm.nih.gov/pubmed/19603809|https://doi.org/10.1021/jm9006559,19603809,10.1021/jm9006559,
5123,2028121,16718576,BindingDB,Milciclib,31545,Milciclib,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31545,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),1051,PMID:19603809|DOI:10.1021/jm9006559,https://www.ncbi.nlm.nih.gov/pubmed/19603809|https://doi.org/10.1021/jm9006559,19603809,10.1021/jm9006559,
5124,2028122,16719221,Drug Gene Interaction database (DGIdb),3-[[2-[(methylaminosulfonyl)amino]-3-fluoropyridin-4-yl]methyl]-4-methyl-7-[(pyrimidin-2-yl)oxy]-2H-1-benzopyran-2-one,,AVUTOMETINIB,https://www.dgidb.org/drugs/ncit:C80060,,FGFR1,https://www.dgidb.org/genes/hgnc:3688,,,2260.0,FGFR1,9606.0,Homo sapiens (human),,,,,,,,
5125,2028123,16719221,Drug Gene Interaction database (DGIdb),3-[[2-[(methylaminosulfonyl)amino]-3-fluoropyridin-4-yl]methyl]-4-methyl-7-[(pyrimidin-2-yl)oxy]-2H-1-benzopyran-2-one,,AVUTOMETINIB,https://www.dgidb.org/drugs/ncit:C80060,,BRAF,https://www.dgidb.org/genes/hgnc:1097,,,673.0,BRAF,9606.0,Homo sapiens (human),,,,,,,,
5126,2028124,16725048,IUPHAR/BPS Guide to PHARMACOLOGY,PMID23084894C9n,6362,compound 9n [PMID: 23084894],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6362,289,mGlu1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289,Q13255,Metabotropic glutamate receptor 1,2911.0,GRM1,9606.0,Homo sapiens (human),Negative,pIC50,8.15,PMID:23084894,https://www.ncbi.nlm.nih.gov/pubmed/23084894,23084894,,
5127,2028623,16725338,BindingDB,"Aminopyridine N-oxide, 47",31621,"Aminopyridine N-oxide, 47",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31621,3881,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3881,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),,IC50 (nM),9,PMID:19678708|DOI:10.1021/jm9008604,https://www.ncbi.nlm.nih.gov/pubmed/19678708|https://doi.org/10.1021/jm9008604,19678708,10.1021/jm9008604,
5128,2028125,16725726,Drug Gene Interaction database (DGIdb),"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol",,GSK-690693,https://www.dgidb.org/drugs/drugbank:DB12745,,PRKCB,https://www.dgidb.org/genes/hgnc:9395,,,5579.0,PRKCB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5129,2028126,16725726,Drug Gene Interaction database (DGIdb),"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol",,GSK-690693,https://www.dgidb.org/drugs/drugbank:DB12745,,PRKCI,https://www.dgidb.org/genes/hgnc:9404,,,5584.0,PRKCI,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5130,2028127,16725726,Drug Gene Interaction database (DGIdb),"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol",,GSK-690693,https://www.dgidb.org/drugs/drugbank:DB12745,,PRKCA,https://www.dgidb.org/genes/hgnc:9393,,,5578.0,PRKCA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5131,2028128,16725726,Drug Gene Interaction database (DGIdb),"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol",,GSK-690693,https://www.dgidb.org/drugs/drugbank:DB12745,,AKT1,https://www.dgidb.org/genes/hgnc:391,,,207.0,AKT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5132,2028129,16725726,Drug Gene Interaction database (DGIdb),"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol",,GSK-690693,https://www.dgidb.org/drugs/drugbank:DB12745,,PRKCQ,https://www.dgidb.org/genes/hgnc:9410,,,5588.0,PRKCQ,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5133,2028130,16725726,Drug Gene Interaction database (DGIdb),"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol",,GSK-690693,https://www.dgidb.org/drugs/drugbank:DB12745,,AKT3,https://www.dgidb.org/genes/hgnc:393,,,10000.0,AKT3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5134,2028131,16728608,Therapeutic Target Database (TTD),3-isopr-sal-cyclosal-d4TMP,D0E4GM,3-isopr-sal-cyclosal-d4TMP,https://idrblab.net/ttd/data/drug/details/D0E4GM,T99799,Cholinesterase (BCHE),https://idrblab.net/ttd/data/target/details/T99799,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5135,2027949,16731496,BindingDB,5-{5-[(2S)-2-amino-3-(4-bromo-2-fluorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16554,(2S)-1-(4-bromo-2-fluorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16554,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),10.0,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5136,2027950,16731497,BindingDB,5-{5-[(2S)-2-amino-3-(4-bromo-3-fluorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16555,(2S)-1-(4-bromo-3-fluorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16555,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),1.3,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5137,2027951,16731498,BindingDB,"5-{5-[(2S)-2-amino-3-(2-bromo-4,6-difluorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16556,"(2S)-1-(2-bromo-4,6-difluorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16556,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),49,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5138,2027952,16731499,BindingDB,5-{5-[(2S)-2-amino-3-(5-fluoro-2-methylphenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16557,(2S)-1-(5-fluoro-2-methylphenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16557,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),3.9,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5139,2027953,16731500,BindingDB,5-{5-[(2S)-2-amino-3-(4-bromo-3-methylphenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16558,(2S)-1-(3-methyl-4-bromophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16558,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),2.5,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5140,2027954,16731501,BindingDB,5-{5-[(2S)-2-amino-3-(4-fluoro-3-methylphenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16559,(2S)-1-(3-methyl-4-fluorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16559,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),11,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5141,2027955,16731503,BindingDB,5-{5-[(2S)-2-amino-3-[2-(trifluoromethoxy)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16572,(2S)-1-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}-3-[2-(trifluoromethoxy)phenyl]propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16572,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),15.3,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5142,2028022,16731505,BindingDB,5-{5-[(2S)-2-amino-3-[4-(trifluoromethoxy)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16574,(2S)-1-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}-3-[4-(trifluoromethoxy)phenyl]propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16574,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),20.3,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5143,2028023,16731507,BindingDB,5-{5-[(2S)-2-amino-3-(3-phenylphenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16575,5-{5-[(2S)-2-amino-3-(3-phenylphenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16575,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),126,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5144,2028024,16731509,BindingDB,"5-{5-[(2S)-2-amino-3-(2,2-difluoro-2H-1,3-benzodioxol-4-yl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16577,"(2S)-1-(2,2-difluoro-1,3-benzodioxol-4-yl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16577,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),14,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5145,2028025,16731662,BindingDB,5-{5-[(2S)-2-amino-3-(4-fluoro-2-methylphenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16560,(2S)-1-(2-methyl-4-fluorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16560,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),6.0,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5146,2028026,16731663,BindingDB,5-{5-[(2S)-2-amino-3-[3-(piperidin-4-ylmethoxy)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16581,5-{5-[(2S)-2-amino-3-[3-(piperidin-4-ylmethoxy)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16581,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),6.8,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5147,2028027,16731664,BindingDB,5-{5-[(2S)-2-amino-3-{3-[(1-methylpiperidin-4-yl)methoxy]phenyl}propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16583,5-{5-[(2S)-2-amino-3-{3-[(1-methylpiperidin-4-yl)methoxy]phenyl}propoxy]pyridin-3-yl}-3-methyl-1H-indazole,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16583,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),78,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5148,2028028,16731671,BindingDB,4-(2-{3-[(2S)-2-amino-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propyl]phenoxy}ethyl)morpholine,16579,(2S)-1-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}-3-[3-(2-morpholin-4-ylethoxy)phenyl]propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16579,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),751,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5149,2028132,16731825,Therapeutic Target Database (TTD),3-chloro-N-{4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl}-4-[(methylamino)methyl]thiophene-2-carboxamide,D02PAU,ZK-814048,https://idrblab.net/ttd/data/drug/details/D02PAU,T84631,Coagulation factor Xa (F10),https://idrblab.net/ttd/data/target/details/T84631,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5150,2028133,16731825,Therapeutic Target Database (TTD),3-chloro-N-{4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl}-4-[(methylamino)methyl]thiophene-2-carboxamide,D02PAU,ZK-814048,https://idrblab.net/ttd/data/drug/details/D02PAU,T40332,Neutrophil elastase (NE),https://idrblab.net/ttd/data/target/details/T40332,P08246,Neutrophil elastase,1991.0,ELANE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5151,2028134,16731825,Therapeutic Target Database (TTD),3-chloro-N-{4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl}-4-[(methylamino)methyl]thiophene-2-carboxamide,D02PAU,ZK-814048,https://idrblab.net/ttd/data/drug/details/D02PAU,T82739,Plasma kallikrein (KLKB1),https://idrblab.net/ttd/data/target/details/T82739,P03952,Plasma kallikrein,3818.0,KLKB1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5152,2028029,16731834,BindingDB,5-{5-[(2S)-2-amino-3-[3-(2-aminoethoxy)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16584,5-{5-[(2S)-2-amino-3-[3-(2-aminoethoxy)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16584,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),47,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5153,2028030,16731836,BindingDB,"(3Z)-5-(5-{[(2S)-2-amino-3-phenylpropyl]oxy}pyridin-3-yl)-3-(1H-pyrrol-2-ylmethylidene)-1,3-dihydro-2H-indol-2-one",16534,"(3Z)-5-(5-{[(2S)-2-amino-3-phenylpropyl]oxy}pyridin-3-yl)-3-(1H-pyrrol-2-ylmethylidene)-1,3-dihydro-2H-indol-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16534,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),16,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5154,2028031,16731838,BindingDB,"3-[(2S)-2-amino-3-[3-(trifluoromethyl)phenyl]propoxy]-5-{1H-pyrazolo[3,4-c]pyridin-5-yl}pyridine",16585,"(2S)-1-{[5-(1H-pyrazolo[3,4-c]pyridin-5-yl)pyridin-3-yl]oxy}-3-[3-(trifluoromethyl)phenyl]propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16585,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),7.2,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5155,2028032,16731838,BindingDB,"3-[(2S)-2-amino-3-[3-(trifluoromethyl)phenyl]propoxy]-5-{1H-pyrazolo[3,4-c]pyridin-5-yl}pyridine",16585,"(2S)-1-{[5-(1H-pyrazolo[3,4-c]pyridin-5-yl)pyridin-3-yl]oxy}-3-[3-(trifluoromethyl)phenyl]propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16585,448,cAMP-dependent protein kinase catalytic subunit alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=448,P00517,cAMP-dependent protein kinase catalytic subunit alpha,282322.0,PRKACA,9913.0,Bos taurus (cattle),,IC50 (nM),78,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5156,2028033,16731841,BindingDB,"3-[(2S)-2-amino-3-(2,3-difluorophenyl)propoxy]-5-{3-methyl-1H-pyrazolo[3,4-c]pyridin-5-yl}pyridine",16588,"(2S)-1-(2,3-difluorophenyl)-3-{[5-(3-methyl-1H-pyrazolo[3,4-c]pyridin-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16588,448,cAMP-dependent protein kinase catalytic subunit alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=448,P00517,cAMP-dependent protein kinase catalytic subunit alpha,282322.0,PRKACA,9913.0,Bos taurus (cattle),,IC50 (nM),7,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5157,2028055,16731841,BindingDB,"3-[(2S)-2-amino-3-(2,3-difluorophenyl)propoxy]-5-{3-methyl-1H-pyrazolo[3,4-c]pyridin-5-yl}pyridine",16588,"(2S)-1-(2,3-difluorophenyl)-3-{[5-(3-methyl-1H-pyrazolo[3,4-c]pyridin-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16588,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),5,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5158,2028056,16731843,BindingDB,"5-{5-[(2S)-2-amino-3-phenylpropoxy]pyridin-3-yl}-2,3-dihydro-1H-indol-2-one",16533,"5-(5-{[(2S)-2-amino-3-phenylpropyl]oxy}pyridin-3-yl)-1,3-dihydro-2H-indol-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16533,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),2650,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5159,2028057,16731987,BindingDB,(S)-5-(5-(2-amino-3-phenylpropoxy)pyridin-3-yl)-3-(furan-2-ylmethylene)indolin-2-one,16535,"(3E)-5-{5-[(2S)-2-amino-3-phenylpropoxy]pyridin-3-yl}-3-(furan-2-ylmethylidene)-2,3-dihydro-1H-indol-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16535,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),1.4,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5160,2028058,16731988,BindingDB,5-{5-[(2S)-2-amino-3-(3-fluorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16536,(2S)-1-(3-fluorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16536,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),8.4,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5161,2028059,16731989,BindingDB,"5-{5-[(2S)-2-amino-3-(2,4-difluorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16538,"(2S)-1-(2,4-difluorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16538,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),21.0,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5162,2028060,16731990,BindingDB,"5-{5-[(2S)-2-amino-3-(2,4,6-trifluorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16541,"(2S)-1-(2,4,6-trifluorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16541,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),31,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5163,2028080,16731991,BindingDB,5-{5-[(2S)-2-amino-3-(3-chlorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16543,(2S)-1-(3-chlorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16543,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),5.9,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5164,2028081,16731992,BindingDB,5-{5-[(2S)-2-amino-3-(2-bromophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16545,(2S)-1-(2-bromophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16545,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),23,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5165,2028082,16732132,BindingDB,5-{5-[(2S)-2-amino-3-(4-chloro-3-fluorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16550,(2S)-1-(3-fluoro-4-chlorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16550,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),3.6,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5166,2028083,16732276,BindingDB,"3-[(2S)-2-amino-3-[3-(trifluoromethyl)phenyl]propoxy]-5-{3-chloro-1H-pyrazolo[3,4-c]pyridin-5-yl}pyridine",16586,"(2S)-1-{[5-(3-chloro-1H-pyrazolo[3,4-c]pyridin-5-yl)pyridin-3-yl]oxy}-3-[3-(trifluoromethyl)phenyl]propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16586,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),2.9,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5167,2028084,16732276,BindingDB,"3-[(2S)-2-amino-3-[3-(trifluoromethyl)phenyl]propoxy]-5-{3-chloro-1H-pyrazolo[3,4-c]pyridin-5-yl}pyridine",16586,"(2S)-1-{[5-(3-chloro-1H-pyrazolo[3,4-c]pyridin-5-yl)pyridin-3-yl]oxy}-3-[3-(trifluoromethyl)phenyl]propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16586,448,cAMP-dependent protein kinase catalytic subunit alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=448,P00517,cAMP-dependent protein kinase catalytic subunit alpha,282322.0,PRKACA,9913.0,Bos taurus (cattle),,IC50 (nM),15,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5168,2028085,16732278,BindingDB,"5-{5-[(2S)-2-amino-3-(2,4,6-trimethylphenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16562,"(2S)-1-(2,4,6-trimethylphenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16562,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),39,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5169,2028086,16732279,BindingDB,5-{5-[(2S)-2-amino-3-[3-(trifluoromethyl)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16564,(2S)-1-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}-3-[3-(trifluoromethyl)phenyl]propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16564,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),1.2,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5170,2028087,16732279,BindingDB,5-{5-[(2S)-2-amino-3-[3-(trifluoromethyl)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16564,(2S)-1-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}-3-[3-(trifluoromethyl)phenyl]propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16564,448,cAMP-dependent protein kinase catalytic subunit alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=448,P00517,cAMP-dependent protein kinase catalytic subunit alpha,282322.0,PRKACA,9913.0,Bos taurus (cattle),,IC50 (nM),5,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5171,2028088,16732414,BindingDB,5-{5-[(2S)-2-amino-3-[4-fluoro-3-(trifluoromethyl)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16567,(2S)-1-[4-fluoro-3-(trifluoromethyl)phenyl]-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16567,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),1.8,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5172,2028089,16732415,BindingDB,5-{5-[(2S)-2-amino-3-[2-fluoro-5-(trifluoromethyl)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16569,(2S)-1-[6-fluoro-3-(trifluoromethyl)phenyl]-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16569,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),1.2,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5173,2028090,16732416,BindingDB,5-{5-[(2S)-2-amino-3-[2-fluoro-4-(trifluoromethyl)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16571,(2S)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16571,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),12.1,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5174,2028091,16732417,BindingDB,5-{5-[(2S)-2-amino-3-[3-(trifluoromethoxy)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16573,(2S)-1-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}-3-[3-(trifluoromethoxy)phenyl]propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16573,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),3.3,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5175,2028106,16732418,BindingDB,"5-{5-[(2S)-2-amino-3-(2H-1,3-benzodioxol-5-yl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16576,"(2S)-1-(1,3-benzodioxol-5-yl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16576,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),42,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5176,2028107,16732419,BindingDB,"5-{5-[(2S)-2-amino-3-(2,2,3,3-tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-yl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16578,"(2S)-1-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}-3-(2,2,3,3-tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16578,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),13,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5177,2028108,16732420,BindingDB,5-{5-[(2S)-2-amino-3-{3-[2-(piperidin-4-yl)ethoxy]phenyl}propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16580,5-{5-[(2S)-2-amino-3-{3-[2-(piperidin-4-yl)ethoxy]phenyl}propoxy]pyridin-3-yl}-3-methyl-1H-indazole,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16580,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),290,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5178,2028109,16732881,BindingDB,"5-{5-[(2S)-2-amino-3-(2,3-difluorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16537,"(2S)-1-(2,3-difluorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16537,448,cAMP-dependent protein kinase catalytic subunit alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=448,P00517,cAMP-dependent protein kinase catalytic subunit alpha,282322.0,PRKACA,9913.0,Bos taurus (cattle),,IC50 (nM),9,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5179,2028110,16732881,BindingDB,"5-{5-[(2S)-2-amino-3-(2,3-difluorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16537,"(2S)-1-(2,3-difluorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16537,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),8.5,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5180,2028111,16732883,BindingDB,"5-{5-[(2S)-2-amino-3-(2,6-difluorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16539,"(2S)-1-(2,6-difluorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16539,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),65.5,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
5181,2028135,16735659,Therapeutic Target Database (TTD),"3-Biphenyl-4-ylethynyl-5-methyl-[1,2,4]triazine",D0L6PL,"3-biphenyl-4-ylethynyl-5-methyl-[1,2,4]triazine",https://idrblab.net/ttd/data/drug/details/D0L6PL,T99347,Metabotropic glutamate receptor 5 (mGluR5),https://idrblab.net/ttd/data/target/details/T99347,P41594,Metabotropic glutamate receptor 5,2915.0,GRM5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5182,2028136,16735840,Therapeutic Target Database (TTD),"3-(3-Methylphenylethynyl)-5-methyl[1,2,4]triazine",D03QRG,"3-(3-methylphenylethynyl)-5-methyl[1,2,4]triazine",https://idrblab.net/ttd/data/drug/details/D03QRG,T99347,Metabotropic glutamate receptor 5 (mGluR5),https://idrblab.net/ttd/data/target/details/T99347,P41594,Metabotropic glutamate receptor 5,2915.0,GRM5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5183,2028137,16735841,Therapeutic Target Database (TTD),"3-(3-Bromophenylethynyl)-5-methyl[1,2,4]triazine",D0R0JE,"3-(3-bromophenylethynyl)-5-methyl[1,2,4]triazine",https://idrblab.net/ttd/data/drug/details/D0R0JE,T99347,Metabotropic glutamate receptor 5 (mGluR5),https://idrblab.net/ttd/data/target/details/T99347,P41594,Metabotropic glutamate receptor 5,2915.0,GRM5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5184,2028138,16736030,Therapeutic Target Database (TTD),"1,2,4-Triazine, 5-methyl-3-(2-phenylethynyl)-",D0EK6F,"5-methyl-3-phenylethynyl[1,2,4]triazine",https://idrblab.net/ttd/data/drug/details/D0EK6F,T99347,Metabotropic glutamate receptor 5 (mGluR5),https://idrblab.net/ttd/data/target/details/T99347,P41594,Metabotropic glutamate receptor 5,2915.0,GRM5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5185,2028139,16736031,Therapeutic Target Database (TTD),"1,2,4-Triazine, 3-[2-(3-chlorophenyl)ethynyl]-5-methyl-",D0U2GG,"5-(3-chlorophenylethynyl)-5-methyl[1,2,4]triazine",https://idrblab.net/ttd/data/drug/details/D0U2GG,T99347,Metabotropic glutamate receptor 5 (mGluR5),https://idrblab.net/ttd/data/target/details/T99347,P41594,Metabotropic glutamate receptor 5,2915.0,GRM5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5186,2028140,16736529,IUPHAR/BPS Guide to PHARMACOLOGY,"6-chloro-9-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-9H-purin-2-amine",9258,BIIB021,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9258,2905,heat shock protein 90 alpha family class A member 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2905,P07900,Heat shock protein HSP 90-alpha,3320.0,HSP90AA1,9606.0,Homo sapiens (human),Inhibition,pIC50,8.7,PMID:24332488,https://www.ncbi.nlm.nih.gov/pubmed/24332488,24332488,,
5187,2028141,16737207,IUPHAR/BPS Guide to PHARMACOLOGY,"Benzonitrile, 3-fluoro-5-(2-(2-(fluoromethyl)-4-thiazolyl)ethynyl)-",6434,SP203,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6434,293,mGlu5 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=293,P31424,Metabotropic glutamate receptor 5,24418.0,Grm5,10116.0,Rattus norvegicus (Norway rat),Negative,pIC50,10.44,PMID:17571866,https://www.ncbi.nlm.nih.gov/pubmed/17571866,17571866,,
5188,2011421,16738084,BindingDB,5-(Benzyl(methyl)amino)-1-(5-(pyridin-2-yl)oxazol-2-yl)pentan-1-one,23111,"5-[benzyl(methyl)amino]-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]pentan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23111,2325,DNA ligase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2325,P18858,DNA ligase 1,3978.0,LIG1,9606.0,Homo sapiens (human),,Ki (nM),200,PMID:17559203|DOI:10.1021/jm061414r,https://www.ncbi.nlm.nih.gov/pubmed/17559203|https://doi.org/10.1021/jm061414r,17559203,10.1021/jm061414r,
5189,2028142,16739288,IUPHAR/BPS Guide to PHARMACOLOGY,"6-(benzyloxy)-7-methyl-3,4-dihydro-2H-pyrido[3,4-b]indol-1(9H)-one",6358,compound 22 [PMID: 17276684],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6358,289,mGlu1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289,Q13255,Metabotropic glutamate receptor 1,2911.0,GRM1,9606.0,Homo sapiens (human),Negative,pKi,8.44,PMID:17276684,https://www.ncbi.nlm.nih.gov/pubmed/17276684,17276684,,
5190,2028154,16739288,IUPHAR/BPS Guide to PHARMACOLOGY,"6-(benzyloxy)-7-methyl-3,4-dihydro-2H-pyrido[3,4-b]indol-1(9H)-one",6358,compound 22 [PMID: 17276684],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6358,289,mGlu1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289,P23385,Metabotropic glutamate receptor 1,24414.0,Grm1,10116.0,Rattus norvegicus (Norway rat),Negative,pIC50,6.78,PMID:17276684,https://www.ncbi.nlm.nih.gov/pubmed/17276684,17276684,,
5191,2028155,16741245,IUPHAR/BPS Guide to PHARMACOLOGY,"4-[(3-Chloro-4-{[(2r)-3,3,3-Trifluoro-2-Hydroxy-2-Methylpropanoyl]amino}phenyl)sulfonyl]-N,N-Dimethylbenzamide",9362,AZD7545,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9362,2915,pyruvate dehydrogenase kinase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2915,Q15118,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",5163.0,PDK1,9606.0,Homo sapiens (human),Inhibition,pIC50,7.43,PMID:14641019,https://www.ncbi.nlm.nih.gov/pubmed/14641019,14641019,,
5192,2028156,16745325,Therapeutic Target Database (TTD),2-(4-methoxyphenyl)-6-morpholino-4H-pyran-4-one,D00IRL,2-(4-methoxyphenyl)-6-morpholino-4H-pyran-4-one,https://idrblab.net/ttd/data/drug/details/D00IRL,T81735,DNA-dependent protein kinase catalytic (PRKDC),https://idrblab.net/ttd/data/target/details/T81735,P78527,DNA-dependent protein kinase catalytic subunit,5591.0,PRKDC,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5193,2028157,16748617,Therapeutic Target Database (TTD),3-(4-Hexylthiosemicarbazono)methyl-benzoic acid,D0Y9SI,3-(4-hexylthiosemicarbazono)methyl-benzoic acid,https://idrblab.net/ttd/data/drug/details/D0Y9SI,T33489,Steryl-sulfatase (STS),https://idrblab.net/ttd/data/target/details/T33489,P08842,Steryl-sulfatase,412.0,STS,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5194,2028158,16748635,Therapeutic Target Database (TTD),"N-benzyl-9-oxo-9,10-dihydroacridine-3-carboxamide",D0Z0YB,"N-benzyl-9-oxo-9,10-dihydroacridine-3-carboxamide",https://idrblab.net/ttd/data/drug/details/D0Z0YB,T89360,Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2),https://idrblab.net/ttd/data/target/details/T89360,P12268,Inosine-5'-monophosphate dehydrogenase 2,3615.0,IMPDH2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5195,2011422,16749269,BindingDB,2-[1-benzyl-2-oxo-5-[(2S)-2-(phenoxymethyl)pyrrolidin-1-yl]sulfonylindol-3-ylidene]propanedinitrile,29588,CHEMBL226779,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29588,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),27.8,PMID:19326941|DOI:10.1021/jm900135r,https://www.ncbi.nlm.nih.gov/pubmed/19326941|https://doi.org/10.1021/jm900135r,19326941,10.1021/jm900135r,
5196,2011423,16749269,BindingDB,2-[1-benzyl-2-oxo-5-[(2S)-2-(phenoxymethyl)pyrrolidin-1-yl]sulfonylindol-3-ylidene]propanedinitrile,29588,CHEMBL226779,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29588,120,Caspase-6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=120,P55212,Caspase-6,839.0,CASP6,9606.0,Homo sapiens (human),,IC50 (nM),918,PMID:19326941|DOI:10.1021/jm900135r,https://www.ncbi.nlm.nih.gov/pubmed/19326941|https://doi.org/10.1021/jm900135r,19326941,10.1021/jm900135r,
5197,2028159,16750123,Therapeutic Target Database (TTD),7-[(3-Chlorobenzyl)oxy]-2-Oxo-2h-Chromene-4-Carbaldehyde,D0C9WW,7-(3-chlorobenzyloxy)-4-carboxaldehyde-coumarin,https://idrblab.net/ttd/data/drug/details/D0C9WW,T83875,Monoamine oxidase type A (MAO-A),https://idrblab.net/ttd/data/target/details/T83875,P21397,Amine oxidase [flavin-containing] A,4128.0,MAOA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5198,2028160,16750123,Therapeutic Target Database (TTD),7-[(3-Chlorobenzyl)oxy]-2-Oxo-2h-Chromene-4-Carbaldehyde,D0C9WW,7-(3-chlorobenzyloxy)-4-carboxaldehyde-coumarin,https://idrblab.net/ttd/data/drug/details/D0C9WW,T83011,Monoamine oxidase type B (MAO-B),https://idrblab.net/ttd/data/target/details/T83011,P27338,Amine oxidase [flavin-containing] B,4129.0,MAOB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5199,2028161,16750271,Drug Gene Interaction database (DGIdb),Unii-4T71DC0G0A,,CT-1578,https://www.dgidb.org/drugs/chembl:CHEMBL2035185,,FLT3,https://www.dgidb.org/genes/hgnc:3765,,,2322.0,FLT3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5200,2028162,16750271,Drug Gene Interaction database (DGIdb),Unii-4T71DC0G0A,,CT-1578,https://www.dgidb.org/drugs/chembl:CHEMBL2035185,,CSF1R,https://www.dgidb.org/genes/hgnc:2433,,,1436.0,CSF1R,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5201,2028163,16755143,IUPHAR/BPS Guide to PHARMACOLOGY,"5-(5-(3-(Trifluoromethyl)-4-(((2S)-1,1,1-trifluoropropan-2-yl)oxy)phenyl)-1,2,4-oxadiazol-3-yl)-1H-benzimidazole",9569,ASP4058,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9569,279,S1P5 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=279,Q9H228,Sphingosine 1-phosphate receptor 5,53637.0,S1PR5,9606.0,Homo sapiens (human),Agonist,pEC50,8.12,PMID:25347187,https://www.ncbi.nlm.nih.gov/pubmed/25347187,25347187,,
5202,2028164,16755143,IUPHAR/BPS Guide to PHARMACOLOGY,"5-(5-(3-(Trifluoromethyl)-4-(((2S)-1,1,1-trifluoropropan-2-yl)oxy)phenyl)-1,2,4-oxadiazol-3-yl)-1H-benzimidazole",9569,ASP4058,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9569,277,S1P3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=277,Q99500,Sphingosine 1-phosphate receptor 3,1903.0,S1PR3,9606.0,Homo sapiens (human),Agonist,pEC50,6.04,PMID:25347187,https://www.ncbi.nlm.nih.gov/pubmed/25347187,25347187,,
5203,2028620,16755143,IUPHAR/BPS Guide to PHARMACOLOGY,"5-(5-(3-(Trifluoromethyl)-4-(((2S)-1,1,1-trifluoropropan-2-yl)oxy)phenyl)-1,2,4-oxadiazol-3-yl)-1H-benzimidazole",9569,ASP4058,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9569,278,S1P4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=278,O95977,Sphingosine 1-phosphate receptor 4,8698.0,S1PR4,9606.0,Homo sapiens (human),Agonist,pEC50,5.64,PMID:25347187,https://www.ncbi.nlm.nih.gov/pubmed/25347187,25347187,,
5204,2028621,16756389,Therapeutic Target Database (TTD),1-Adamantan-1-yl-3-[4-(4-fluorophenoxy)butyl]urea,D0A4VS,1-adamantan-1-yl-3-[4-(4-fluorophenoxy)butyl]urea,https://idrblab.net/ttd/data/drug/details/D0A4VS,T35734,Soluble epoxide hydrolase (EPHX2),https://idrblab.net/ttd/data/target/details/T35734,P34913,Bifunctional epoxide hydrolase 2,2053.0,EPHX2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5205,2028622,16756510,Therapeutic Target Database (TTD),1-Adamantan-1-yl-3-(4-hydroxybutyl)urea,D0F5XQ,1-adamantan-1-yl-3-(4-hydroxybutyl)urea,https://idrblab.net/ttd/data/drug/details/D0F5XQ,T35734,Soluble epoxide hydrolase (EPHX2),https://idrblab.net/ttd/data/target/details/T35734,P34913,Bifunctional epoxide hydrolase 2,2053.0,EPHX2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5206,2028629,16756626,Therapeutic Target Database (TTD),cis-1-Adamantan-1-yl-3-(4-methoxycyclohexyl)urea,D08RFH,Cis-1-adamantan-1-yl-3-(4-methoxycyclohexyl)urea,https://idrblab.net/ttd/data/drug/details/D08RFH,T35734,Soluble epoxide hydrolase (EPHX2),https://idrblab.net/ttd/data/target/details/T35734,P34913,Bifunctional epoxide hydrolase 2,2053.0,EPHX2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5207,2028624,16756754,Therapeutic Target Database (TTD),"N-(3-{1-[4-(3,4-Difluorophenoxy)benzyl]-4-piperidinyl}-4-methylphenyl)-2-methylpropanamide",D0C7SE,SNAP-94847,https://idrblab.net/ttd/data/drug/details/D0C7SE,T92609,Adrenergic receptor alpha-1A (ADRA1A),https://idrblab.net/ttd/data/target/details/T92609,P35348,Alpha-1A adrenergic receptor,148.0,ADRA1A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5208,2028625,16756754,Therapeutic Target Database (TTD),"N-(3-{1-[4-(3,4-Difluorophenoxy)benzyl]-4-piperidinyl}-4-methylphenyl)-2-methylpropanamide",D0C7SE,SNAP-94847,https://idrblab.net/ttd/data/drug/details/D0C7SE,T67162,Dopamine D2 receptor (D2R),https://idrblab.net/ttd/data/target/details/T67162,P14416,D(2) dopamine receptor,1813.0,DRD2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5209,2028626,16756780,Therapeutic Target Database (TTD),Endiandrin A,D09FQL,ENDIANDRIN A,https://idrblab.net/ttd/data/drug/details/D09FQL,T30687,Glucocorticoid receptor messenger RNA (GCR mRNA),https://idrblab.net/ttd/data/target/details/T30687,P04150,Glucocorticoid receptor,2908.0,NR3C1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5210,2028627,16756782,Therapeutic Target Database (TTD),di-O-methylendiandrin A,D0PR2T,DI-O-METHYLENDIANDRIN A,https://idrblab.net/ttd/data/drug/details/D0PR2T,T30687,Glucocorticoid receptor messenger RNA (GCR mRNA),https://idrblab.net/ttd/data/target/details/T30687,P04150,Glucocorticoid receptor,2908.0,NR3C1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5211,2011415,16757459,BindingDB,"Oxamic acid derivative, 1",23224,7-{[4-(formamidoformic acid)-3-methoxyphenyl]methoxy}-5-hydroxy-4-oxo-4H-chromene-2-carboxylic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23224,2344,"Malate dehydrogenase, mitochondrial",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2344,P00346,"Malate dehydrogenase, mitochondrial",,,9823.0,Sus scrofa (pig),,IC50 (nM),64000,PMID:17636950|DOI:10.1021/jm070336k,https://www.ncbi.nlm.nih.gov/pubmed/17636950|https://doi.org/10.1021/jm070336k,17636950,10.1021/jm070336k,
5212,2011416,16757459,BindingDB,"Oxamic acid derivative, 1",23224,7-{[4-(formamidoformic acid)-3-methoxyphenyl]methoxy}-5-hydroxy-4-oxo-4H-chromene-2-carboxylic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23224,2345,"Malate dehydrogenase, cytoplasmic",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2345,P11708,"Malate dehydrogenase, cytoplasmic",396894.0,MDH1,9823.0,Sus scrofa (pig),,IC50 (nM),>232000,PMID:17636950|DOI:10.1021/jm070336k,https://www.ncbi.nlm.nih.gov/pubmed/17636950|https://doi.org/10.1021/jm070336k,17636950,10.1021/jm070336k,
5213,2011417,16757459,BindingDB,"Oxamic acid derivative, 1",23224,7-{[4-(formamidoformic acid)-3-methoxyphenyl]methoxy}-5-hydroxy-4-oxo-4H-chromene-2-carboxylic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23224,2342,L-lactate dehydrogenase B chain,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2342,Q5E9B1,L-lactate dehydrogenase B chain,281275.0,LDHB,9913.0,Bos taurus (cattle),,IC50 (nM),>232000,PMID:17636950|DOI:10.1021/jm070336k,https://www.ncbi.nlm.nih.gov/pubmed/17636950|https://doi.org/10.1021/jm070336k,17636950,10.1021/jm070336k,
5214,2011418,16757459,BindingDB,"Oxamic acid derivative, 1",23224,7-{[4-(formamidoformic acid)-3-methoxyphenyl]methoxy}-5-hydroxy-4-oxo-4H-chromene-2-carboxylic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23224,2343,L-lactate dehydrogenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2343,,,,,,,,IC50 (nM),48300,PMID:17636950|DOI:10.1021/jm070336k,https://www.ncbi.nlm.nih.gov/pubmed/17636950|https://doi.org/10.1021/jm070336k,17636950,10.1021/jm070336k,
5215,2011419,16757459,BindingDB,"Oxamic acid derivative, 1",23224,7-{[4-(formamidoformic acid)-3-methoxyphenyl]methoxy}-5-hydroxy-4-oxo-4H-chromene-2-carboxylic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23224,2341,L-lactate dehydrogenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2341,Q27743,L-lactate dehydrogenase,,,5836.0,Plasmodium falciparum CDC/Honduras,,IC50 (nM),87300,PMID:17636950|DOI:10.1021/jm070336k,https://www.ncbi.nlm.nih.gov/pubmed/17636950|https://doi.org/10.1021/jm070336k,17636950,10.1021/jm070336k,
5216,2011420,16757572,Drug Gene Interaction database (DGIdb),Nilotinib hydrochloride monohydrate,,NILOTINIB HYDROCHLORIDE MONOHYDRATE,https://www.dgidb.org/drugs/ncit:C95229,,ABL1,https://www.dgidb.org/genes/hgnc:76,,,25.0,ABL1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5217,2011424,16757572,Drug Gene Interaction database (DGIdb),Nilotinib hydrochloride monohydrate,,NILOTINIB HYDROCHLORIDE MONOHYDRATE,https://www.dgidb.org/drugs/ncit:C95229,,BCR,https://www.dgidb.org/genes/hgnc:1014,,,613.0,BCR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5218,2028628,16759169,IUPHAR/BPS Guide to PHARMACOLOGY,3-amino-6-chloro-5-(dimethylamino)-N-(pyridin-3-yl)pyrazine-2-carboxamide,3388,ACDPP,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3388,293,mGlu5 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=293,P41594,Metabotropic glutamate receptor 5,2915.0,GRM5,9606.0,Homo sapiens (human),Antagonist,pIC50,6.9,PMID:15686941,https://www.ncbi.nlm.nih.gov/pubmed/15686941,15686941,,
5219,2011425,16759173,Drug Gene Interaction database (DGIdb),Pravastatin Sodium,,PRAVASTATIN SODIUM,https://www.dgidb.org/drugs/rxcui:203144,,TLR4,https://www.dgidb.org/genes/hgnc:11850,,,7099.0,TLR4,9606.0,Homo sapiens (human),,,,,,,,
5220,2011426,16759173,Drug Gene Interaction database (DGIdb),Pravastatin Sodium,,PRAVASTATIN SODIUM,https://www.dgidb.org/drugs/rxcui:203144,,SLC22A6,https://www.dgidb.org/genes/hgnc:10970,,,9356.0,SLC22A6,9606.0,Homo sapiens (human),,,,,,,,
5221,2011427,16759173,Drug Gene Interaction database (DGIdb),Pravastatin Sodium,,PRAVASTATIN SODIUM,https://www.dgidb.org/drugs/rxcui:203144,,APOE,https://www.dgidb.org/genes/hgnc:613,,,348.0,APOE,9606.0,Homo sapiens (human),,,,,,,,
5222,2011428,16759173,Drug Gene Interaction database (DGIdb),Pravastatin Sodium,,PRAVASTATIN SODIUM,https://www.dgidb.org/drugs/rxcui:203144,,RHOA,https://www.dgidb.org/genes/hgnc:667,,,387.0,RHOA,9606.0,Homo sapiens (human),,,,,,,,
5223,2011429,16759173,Drug Gene Interaction database (DGIdb),Pravastatin Sodium,,PRAVASTATIN SODIUM,https://www.dgidb.org/drugs/rxcui:203144,,ABCB11,https://www.dgidb.org/genes/hgnc:42,,,8647.0,ABCB11,9606.0,Homo sapiens (human),,,,,,,,
5224,2011430,16760358,BindingDB,Cathepsin Inhibitor III,36325,Cathepsin Inhibitor III,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36325,4360,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4360,P00787,Cathepsin B,,,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),1.2e+3,PMID:16407991|DOI:10.1038/nchembio707,https://www.ncbi.nlm.nih.gov/pubmed/16407991|https://doi.org/10.1038/nchembio707,16407991,10.1038/nchembio707,
5225,2011431,16760358,BindingDB,Cathepsin Inhibitor III,36325,Cathepsin Inhibitor III,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36325,4361,Cathepsin Z,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4361,Q9R1T3,Cathepsin Z,252929.0,Ctsz,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),1.5e+3,PMID:16407991|DOI:10.1038/nchembio707,https://www.ncbi.nlm.nih.gov/pubmed/16407991|https://doi.org/10.1038/nchembio707,16407991,10.1038/nchembio707,
5226,2011432,16760358,BindingDB,Cathepsin Inhibitor III,36325,Cathepsin Inhibitor III,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36325,4359,Pro-cathepsin H,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4359,P00786,Pro-cathepsin H,25425.0,Ctsh,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),6.6e+3,PMID:16407991|DOI:10.1038/nchembio707,https://www.ncbi.nlm.nih.gov/pubmed/16407991|https://doi.org/10.1038/nchembio707,16407991,10.1038/nchembio707,
5227,2011433,16760394,BindingDB,Z-Devd-fmk,228619,"US9345789, Z-DEVD-FMK",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228619,50004229,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50004229,P70677,Caspase-3 ,12367.0,Casp3,10090.0,Mus musculus (house mouse),,IC50 (nM),1.3e+2,PMID:20017516|DOI:10.1021/cb900232a,https://www.ncbi.nlm.nih.gov/pubmed/20017516|https://doi.org/10.1021/cb900232a,20017516,10.1021/cb900232a,
5228,2011434,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Emamectin inhibits the reaction [ABCB1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|abamectin inhibits the reaction [ABCB1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|abcb1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride|ivermectin inhibits the reaction [ABCB1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride],,,PMID:25865432,https://www.ncbi.nlm.nih.gov/pubmed/25865432,25865432,,
5229,2011435,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),[zosuquidar trihydrochloride results in decreased activity of ABCB1 protein] which results in decreased export of bisbenzimide ethoxide trihydrochloride,,,PMID:34896433,https://www.ncbi.nlm.nih.gov/pubmed/34896433,34896433,,
5230,2011436,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),9-((2-phosphonylmethoxy)ethyl)guanine analog inhibits the reaction [ABCB1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride],,,PMID:23856525,https://www.ncbi.nlm.nih.gov/pubmed/23856525,23856525,,
5231,2011437,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Dabrafenib inhibits the reaction [ABCB1 protein results in increased export of bisbenzimide ethoxide trihydrochloride]|abcb1 protein results in increased export of bisbenzimide ethoxide trihydrochloride,,,PMID:34780725,https://www.ncbi.nlm.nih.gov/pubmed/34780725,34780725,,
5232,2011438,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606.0,Homo sapiens (human),Bisbenzimide ethoxide trihydrochloride inhibits the reaction [ABCB11 protein results in increased transport of taurocholic acid]|bisbenzimide ethoxide trihydrochloride results in decreased activity of ABCB11 protein,,,PMID:24014644,https://www.ncbi.nlm.nih.gov/pubmed/24014644,24014644,,
5233,2011439,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10090.0,Mus musculus (house mouse),Ivermectin inhibits the reaction [ABCB1A protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|abcb1a protein results in increased transport of bisbenzimide ethoxide trihydrochloride|emamectin inhibits the reaction [ABCB1A protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|abamectin inhibits the reaction [ABCB1A protein results in increased transport of bisbenzimide ethoxide trihydrochloride],,,PMID:25865432,https://www.ncbi.nlm.nih.gov/pubmed/25865432,25865432,,
5234,2011440,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606.0,Homo sapiens (human),Emamectin inhibits the reaction [ABCC1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|abamectin inhibits the reaction [ABCC1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|ivermectin inhibits the reaction [ABCC1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|abcc1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride,,,PMID:25865432,https://www.ncbi.nlm.nih.gov/pubmed/25865432,25865432,,
5235,2011441,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9913.0,Bos taurus (cattle),"Prochloraz promotes the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|triclabendazole sulfoxide inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|salicylamide inhibits the reaction [prochloraz promotes the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [prochloraz promotes the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]]|tetrachlorodibenzodioxin promotes the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|monepantel sulfone inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [tetrachlorodibenzodioxin promotes the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]]|monepantel inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [tetrachlorodibenzodioxin promotes the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]]|salicylamide inhibits the reaction [tetrachlorodibenzodioxin promotes the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]]|3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [prochloraz promotes the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]]|albendazole sulfoxide inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|abcg2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride",,,PMID:24389113,https://www.ncbi.nlm.nih.gov/pubmed/24389113,24389113,,
5236,2011456,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),"Cimetidine inhibits the reaction [ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride]|3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride]|nitrofurantoin inhibits the reaction [ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride]|2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride]|abcg2 protein results in increased export of bisbenzimide ethoxide trihydrochloride|methotrexate inhibits the reaction [ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride]|danofloxacin inhibits the reaction [ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride]",,,PMID:26907376,https://www.ncbi.nlm.nih.gov/pubmed/26907376,26907376,,
5237,2011457,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),"[MLN 8237 affects the activity of ABCG2 protein] which affects the export of bisbenzimide ethoxide trihydrochloride|[3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester results in decreased activity of ABCG2 protein] which results in decreased export of bisbenzimide ethoxide trihydrochloride",,,PMID:34896433,https://www.ncbi.nlm.nih.gov/pubmed/34896433,34896433,,
5238,2011458,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),ABCG2 protein polymorphism results in decreased export of bisbenzimide ethoxide trihydrochloride|genistein promotes the reaction [ABCG2 protein polymorphism results in decreased export of bisbenzimide ethoxide trihydrochloride]|genistein inhibits the reaction [ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride],,,PMID:26850786,https://www.ncbi.nlm.nih.gov/pubmed/26850786,26850786,,
5239,2011459,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),ABCG2 protein results in decreased abundance of bisbenzimide ethoxide trihydrochloride|cyclosporine inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|verlukast inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|abcg2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride|reserpine inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride],,,PMID:12869632,https://www.ncbi.nlm.nih.gov/pubmed/12869632,12869632,,
5240,2011460,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride,,,PMID:26850786|PMID:26907376|PMID:27450509|PMID:34717915,https://www.ncbi.nlm.nih.gov/pubmed/26850786|https://www.ncbi.nlm.nih.gov/pubmed/26907376|https://www.ncbi.nlm.nih.gov/pubmed/27450509|https://www.ncbi.nlm.nih.gov/pubmed/34717915,26850786|26907376|27450509|34717915,,
5241,2011461,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),Bisbenzimide ethoxide trihydrochloride results in decreased activity of ABCG2 protein,,,PMID:27475308,https://www.ncbi.nlm.nih.gov/pubmed/27475308,27475308,,
5242,2011462,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),[MYC protein results in increased expression of ABCG2 protein] which results in increased export of bisbenzimide ethoxide trihydrochloride,,,PMID:19239227,https://www.ncbi.nlm.nih.gov/pubmed/19239227,19239227,,
5243,2011463,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),Porphyrins inhibits the reaction [ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride],,,PMID:34717915,https://www.ncbi.nlm.nih.gov/pubmed/34717915,34717915,,
5244,2011464,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),Tobacco smoke pollution inhibits the reaction [ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride]|tryptoquivaline inhibits the reaction [ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride],,,PMID:27450509,https://www.ncbi.nlm.nih.gov/pubmed/27450509,27450509,,
5245,2011465,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9986.0,Oryctolagus cuniculus (rabbit),ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride|azoxystrobin inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride]|methiocarb inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride]|diflufenican inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride]|carbendazim inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride]|dimethoate inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride]|dithianone inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride]|propamocarb inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride]|tryptoquivaline inhibits the reaction [chlorpyrifos inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride]]|chlorpyrifos inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride]|chlormequat inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride]|tolclofos-methyl inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride]|rimsulfuron inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride]|ioxynil inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride]|dimethomorph inhibits the reaction [ABCG2 protein results in increased secretion of bisbenzimide ethoxide trihydrochloride],,,PMID:27288731,https://www.ncbi.nlm.nih.gov/pubmed/27288731,27288731,,
5246,2011466,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),9-((2-phosphonylmethoxy)ethyl)guanine analog inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]|abcg2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride|zosuquidar trihydrochloride inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride],,,PMID:23856525,https://www.ncbi.nlm.nih.gov/pubmed/23856525,23856525,,
5247,2011467,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),Dabrafenib inhibits the reaction [ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride]|abcg2 protein results in increased export of bisbenzimide ethoxide trihydrochloride,,,PMID:34780725,https://www.ncbi.nlm.nih.gov/pubmed/34780725,34780725,,
5248,2011468,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,735312,ABCG2A,https://ctdbase.org/detail.go?type=gene&acc=735312,,,735312.0,abcg2a,8022.0,Oncorhynchus mykiss (rainbow trout),Bisbenzimide ethoxide trihydrochloride results in decreased activity of ABCG2A protein,,,PMID:27475308,https://www.ncbi.nlm.nih.gov/pubmed/27475308,27475308,,
5249,2011469,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,9606.0,Homo sapiens (human),KEAP1 protein results in decreased export of bisbenzimide ethoxide trihydrochloride,,,PMID:25841332,https://www.ncbi.nlm.nih.gov/pubmed/25841332,25841332,,
5250,2012183,16760503,Comparative Toxicogenomics Database (CTD),Bisbenzimide ethoxide trihydrochloride,C017807,bisbenzimide ethoxide trihydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C017807,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),[MYC protein results in increased expression of ABCG2 protein] which results in increased export of bisbenzimide ethoxide trihydrochloride,,,PMID:19239227,https://www.ncbi.nlm.nih.gov/pubmed/19239227,19239227,,
5251,2012184,16760658,Drug Gene Interaction database (DGIdb),Sodium Salicylate,,SODIUM SALICYLATE,https://www.dgidb.org/drugs/rxcui:9907,,NGB,https://www.dgidb.org/genes/hgnc:14077,,,58157.0,NGB,9606.0,Homo sapiens (human),,,,,,,,
5252,2012185,16760658,Drug Gene Interaction database (DGIdb),Sodium Salicylate,,SODIUM SALICYLATE,https://www.dgidb.org/drugs/rxcui:9907,,HSPA4,https://www.dgidb.org/genes/hgnc:5237,,,3308.0,HSPA4,9606.0,Homo sapiens (human),,,,,,,,
5253,2012186,16760658,Drug Gene Interaction database (DGIdb),Sodium Salicylate,,SODIUM SALICYLATE,https://www.dgidb.org/drugs/rxcui:9907,,CDKN1A,https://www.dgidb.org/genes/hgnc:1784,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),,,,,,,,
5254,2012187,16775011,Therapeutic Target Database (TTD),3-(4-Chloro-2-cyclohexylphenoxy)propanoic acid,D0J5OX,3-(4-chloro-2-cyclohexylphenoxy)propanoic acid,https://idrblab.net/ttd/data/drug/details/D0J5OX,T61722,Prostaglandin D2 receptor 2 (PTGDR2),https://idrblab.net/ttd/data/target/details/T61722,Q9Y5Y4,Prostaglandin D2 receptor 2,11251.0,PTGDR2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5255,2012188,16786802,Therapeutic Target Database (TTD),"6,7-dichloro-1H-indole-2,3-dione",D0Z8HX,"6,7-dichloro-1H-indole-2,3-dione",https://idrblab.net/ttd/data/drug/details/D0Z8HX,T76369,Liver carboxylesterase (CES1),https://idrblab.net/ttd/data/target/details/T76369,P23141,Liver carboxylesterase 1,1066.0,CES1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5256,2012189,16786802,BindingDB,"6,7-dichloro-1H-indole-2,3-dione",22834,"6,7-dichloro-2,3-dihydro-1H-indole-2,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22834,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:17378546|DOI:10.1021/jm061471k,https://www.ncbi.nlm.nih.gov/pubmed/17378546|https://doi.org/10.1021/jm061471k,17378546,10.1021/jm061471k,
5257,2012190,16786802,BindingDB,"6,7-dichloro-1H-indole-2,3-dione",22834,"6,7-dichloro-2,3-dihydro-1H-indole-2,3-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22834,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:17378546|DOI:10.1021/jm061471k,https://www.ncbi.nlm.nih.gov/pubmed/17378546|https://doi.org/10.1021/jm061471k,17378546,10.1021/jm061471k,
5258,2012191,17027464,IUPHAR/BPS Guide to PHARMACOLOGY,"2-(2-chlorophenyl)-4-methyl-5-(pyridin-2-ylmethyl)-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione",9935,GKT136901,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9935,3001,NADPH oxidase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3001,Q9Y5S8,NADPH oxidase 1,27035.0,NOX1,9606.0,Homo sapiens (human),Inhibition,pKi,6.8,PMID:20942471,https://www.ncbi.nlm.nih.gov/pubmed/20942471,20942471,,
5259,2012192,17027464,IUPHAR/BPS Guide to PHARMACOLOGY,"2-(2-chlorophenyl)-4-methyl-5-(pyridin-2-ylmethyl)-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione",9935,GKT136901,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9935,3002,cytochrome b-245 beta chain,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3002,P04839,Cytochrome b-245 heavy chain,1536.0,CYBB,9606.0,Homo sapiens (human),Inhibition,pKi,5.82,PMID:20942471,https://www.ncbi.nlm.nih.gov/pubmed/20942471,20942471,,
5260,2012193,17027464,IUPHAR/BPS Guide to PHARMACOLOGY,"2-(2-chlorophenyl)-4-methyl-5-(pyridin-2-ylmethyl)-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione",9935,GKT136901,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9935,3004,NADPH oxidase 4,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3004,Q9NPH5,NADPH oxidase 4,50507.0,NOX4,9606.0,Homo sapiens (human),Inhibition,pKi,6.78,PMID:20942471,https://www.ncbi.nlm.nih.gov/pubmed/20942471,20942471,,
5261,2012305,17379334,IUPHAR/BPS Guide to PHARMACOLOGY,"3,3,6,6-Tetramethyl-9-(4-((2-methylbenzyl)oxy)phenyl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione",9748,BMS-986187,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9748,319,μ receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=319,P33535,Mu-type opioid receptor,25601.0,Oprm1,10116.0,Rattus norvegicus (Norway rat),Positive,pKi,7.2,PMID:29233847,https://www.ncbi.nlm.nih.gov/pubmed/29233847,29233847,,
5262,2012306,17379334,IUPHAR/BPS Guide to PHARMACOLOGY,"3,3,6,6-Tetramethyl-9-(4-((2-methylbenzyl)oxy)phenyl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione",9748,BMS-986187,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9748,317,δ receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=317,P41143,Delta-type opioid receptor,4985.0,OPRD1,9606.0,Homo sapiens (human),Positive,pKi,8.15,,,,,
5263,2029034,17544146,BindingDB,"4-methyl-5-(4-methylbenzoyl)-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one",222416,"5-(4-methylbenzoyl)-4-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one (A4)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=222416,239,Gag-Pol polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=239,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706.0,HIV-1 M:B_HXB2R,,IC50 (nM),>1.00e+5,PMID:28371664|DOI:10.1016/j.bioorg.2017.03.013,https://www.ncbi.nlm.nih.gov/pubmed/28371664|https://doi.org/10.1016/j.bioorg.2017.03.013,28371664,10.1016/j.bioorg.2017.03.013,
5264,2028397,17738342,BindingDB,"3-Carboxamido coumarin, 23",29173,"3-carboxamido coumarin, 23",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29173,384,Amine oxidase [flavin-containing] A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=384,P21397,Amine oxidase [flavin-containing] A,4128.0,MAOA,9606.0,Homo sapiens (human),,,,PMID:19267475|DOI:10.1021/jm801496u,https://www.ncbi.nlm.nih.gov/pubmed/19267475|https://doi.org/10.1021/jm801496u,19267475,10.1021/jm801496u,
5265,2028398,17738342,BindingDB,"3-Carboxamido coumarin, 23",29173,"3-carboxamido coumarin, 23",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29173,385,Amine oxidase [flavin-containing] B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=385,P27338,Amine oxidase [flavin-containing] B,4129.0,MAOB,9606.0,Homo sapiens (human),,IC50 (nM),19070,PMID:19267475|DOI:10.1021/jm801496u,https://www.ncbi.nlm.nih.gov/pubmed/19267475|https://doi.org/10.1021/jm801496u,19267475,10.1021/jm801496u,
5266,2012307,17747460,Drug Gene Interaction database (DGIdb),"1(2H)-Phthalazinone, 4-((4-chlorophenyl)methyl)-2-(((2R)-1-(4-(4-(3-(hexahydro-1H-azepin-1-yl)propoxy)phenyl)butyl)-2-pyrrolidinyl)methyl)-",,GSK-1004723,https://www.dgidb.org/drugs/drugbank:DB12806,,HRH1,https://www.dgidb.org/genes/hgnc:5182,,,3269.0,HRH1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5267,2012308,17753774,DrugBank,"(1S)-2-methyl-6-methylidenecyclohexa-2,4-dien-1-amine",DB03842,2-Chloro-6-Methyl-Aniline,https://www.drugbank.ca/drugs/DB03842,BE0001248,Endolysin,https://www.drugbank.ca/bio_entities/BE0001248,P00720,Endolysin,1258585.0,e,10665.0,Escherichia virus T4,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5268,2012309,17753777,DrugBank,2-Phenylheme,DB03906,2-Phenylheme,https://www.drugbank.ca/drugs/DB03906,BE0000735,Heme oxygenase 1,https://www.drugbank.ca/bio_entities/BE0000735,P09601,Heme oxygenase 1,3162.0,HMOX1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5269,2012310,17753779,BindingDB,,14341,"(2R)-2-(3-{5-[amino(iminiumyl)methyl]-1H-1,3-benzodiazol-2-yl}-5-(2-methoxyphenyl)-4-oxidophenyl)butanedioate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14341,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),780,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
5270,2012311,17753779,BindingDB,,14341,"(2R)-2-(3-{5-[amino(iminiumyl)methyl]-1H-1,3-benzodiazol-2-yl}-5-(2-methoxyphenyl)-4-oxidophenyl)butanedioate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14341,1529,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1529,P07477,Trypsin-1,5644.0,PRSS1,9606.0,Homo sapiens (human),,Ki (nM),8000,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
5271,2012312,17753779,BindingDB,,14341,"(2R)-2-(3-{5-[amino(iminiumyl)methyl]-1H-1,3-benzodiazol-2-yl}-5-(2-methoxyphenyl)-4-oxidophenyl)butanedioate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14341,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),>75000,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
5272,2012313,17753779,BindingDB,,14341,"(2R)-2-(3-{5-[amino(iminiumyl)methyl]-1H-1,3-benzodiazol-2-yl}-5-(2-methoxyphenyl)-4-oxidophenyl)butanedioate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14341,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),3500,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
5273,2012321,17753779,BindingDB,,14341,"(2R)-2-(3-{5-[amino(iminiumyl)methyl]-1H-1,3-benzodiazol-2-yl}-5-(2-methoxyphenyl)-4-oxidophenyl)butanedioate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14341,5163,Urokinase-type plasminogen activator,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5163,P00749,Urokinase-type plasminogen activator,5328.0,PLAU,9606.0,Homo sapiens (human),,Ki (nM),750,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
5274,2012322,17753797,BindingDB,,14358,"4-(2-aminiumylethyl)-2-{5-[amino(iminiumyl)methyl]-1H-1,3-benzodiazol-2-yl}-6-phenylbenzen-1-olate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14358,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),1000,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
5275,2012323,17753797,BindingDB,,14358,"4-(2-aminiumylethyl)-2-{5-[amino(iminiumyl)methyl]-1H-1,3-benzodiazol-2-yl}-6-phenylbenzen-1-olate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14358,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),110,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
5276,2012324,17753797,DrugBank,,DB04246,CRA_23653,https://www.drugbank.ca/drugs/DB04246,BE0001739,Trypsin-1,https://www.drugbank.ca/bio_entities/BE0001739,P07477,Trypsin-1,5644.0,PRSS1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
5277,2012325,17753800,BindingDB,,14342,"(2R)-2-(3-{5-[amino(iminiumyl)methyl]-1H-1,3-benzodiazol-2-yl}-5-(2-fluorophenyl)-4-oxidophenyl)butanedioate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14342,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),70000,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
5278,2012326,17753800,BindingDB,,14342,"(2R)-2-(3-{5-[amino(iminiumyl)methyl]-1H-1,3-benzodiazol-2-yl}-5-(2-fluorophenyl)-4-oxidophenyl)butanedioate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14342,1529,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1529,P07477,Trypsin-1,5644.0,PRSS1,9606.0,Homo sapiens (human),,Ki (nM),2900,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
5279,2012327,17753800,BindingDB,,14342,"(2R)-2-(3-{5-[amino(iminiumyl)methyl]-1H-1,3-benzodiazol-2-yl}-5-(2-fluorophenyl)-4-oxidophenyl)butanedioate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14342,5163,Urokinase-type plasminogen activator,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5163,P00749,Urokinase-type plasminogen activator,5328.0,PLAU,9606.0,Homo sapiens (human),,Ki (nM),85,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
5280,2012328,17753800,BindingDB,,14342,"(2R)-2-(3-{5-[amino(iminiumyl)methyl]-1H-1,3-benzodiazol-2-yl}-5-(2-fluorophenyl)-4-oxidophenyl)butanedioate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14342,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),1200,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
5281,2012338,17753800,BindingDB,,14342,"(2R)-2-(3-{5-[amino(iminiumyl)methyl]-1H-1,3-benzodiazol-2-yl}-5-(2-fluorophenyl)-4-oxidophenyl)butanedioate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14342,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),170,PMID:12742021|DOI:10.1016/s0022-2836(03)00399-1,https://www.ncbi.nlm.nih.gov/pubmed/12742021|https://doi.org/10.1016/s0022-2836(03)00399-1,12742021,10.1016/s0022-2836(03)00399-1,
5282,2012339,17753826,DrugBank,"(3R,4S,5S,6R)-2-[[4-[(S)-hydroxy(methoxy)methyl]phenyl]methyl]-7-[[4-(hydroxymethyl)phenyl]methyl]-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepane-4,5-diol",DB04042,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",https://www.drugbank.ca/drugs/DB04042,BE0002050,Gag-Pol polyprotein,https://www.drugbank.ca/bio_entities/BE0002050,P03366,Gag-Pol polyprotein,,,11678.0,Human immunodeficiency virus type 1 BH10,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5283,2012340,17753879,DrugBank,Cystein-S-Yl Cacodylate,DB03676,Cystein-S-Yl Cacodylate,https://www.drugbank.ca/drugs/DB03676,BE0001210,Gag-Pol polyprotein,https://www.drugbank.ca/bio_entities/BE0001210,P12497,Gag-Pol polyprotein,,,11698.0,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5284,2012341,17753880,DrugBank,S-(Dimethylarsenic)Cysteine,DB03963,S-(Dimethylarsenic)Cysteine,https://www.drugbank.ca/drugs/DB03963,BE0001164,Toll-like receptor 2,https://www.drugbank.ca/bio_entities/BE0001164,O60603,Toll-like receptor 2,7097.0,TLR2,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5285,2012342,17753880,DrugBank,S-(Dimethylarsenic)Cysteine,DB03963,S-(Dimethylarsenic)Cysteine,https://www.drugbank.ca/drugs/DB03963,BE0001331,Capsid scaffolding protein,https://www.drugbank.ca/bio_entities/BE0001331,P16753,Capsid scaffolding protein,,,10360.0,Human herpesvirus 5 strain AD169,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5286,2012343,17753880,DrugBank,S-(Dimethylarsenic)Cysteine,DB03963,S-(Dimethylarsenic)Cysteine,https://www.drugbank.ca/drugs/DB03963,BE0001210,Gag-Pol polyprotein,https://www.drugbank.ca/bio_entities/BE0001210,P12497,Gag-Pol polyprotein,,,11698.0,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5287,2012344,17753880,DrugBank,S-(Dimethylarsenic)Cysteine,DB03963,S-(Dimethylarsenic)Cysteine,https://www.drugbank.ca/drugs/DB03963,BE0000263,"Nitric oxide synthase, endothelial",https://www.drugbank.ca/bio_entities/BE0000263,P29474,"Nitric oxide synthase, endothelial",4846.0,NOS3,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
5288,2012345,17753880,DrugBank,S-(Dimethylarsenic)Cysteine,DB03963,S-(Dimethylarsenic)Cysteine,https://www.drugbank.ca/drugs/DB03963,BE0001597,Coatomer subunit gamma-1,https://www.drugbank.ca/bio_entities/BE0001597,Q9Y678,Coatomer subunit gamma-1,22820.0,COPG1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5289,2012346,17753880,DrugBank,S-(Dimethylarsenic)Cysteine,DB03963,S-(Dimethylarsenic)Cysteine,https://www.drugbank.ca/drugs/DB03963,BE0001612,Genome polyprotein,https://www.drugbank.ca/bio_entities/BE0001612,P03300,Genome polyprotein,919920.0,PVgp1,12081.0,Human poliovirus 1 Mahoney,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5290,2012362,17753880,DrugBank,S-(Dimethylarsenic)Cysteine,DB03963,S-(Dimethylarsenic)Cysteine,https://www.drugbank.ca/drugs/DB03963,BE0001585,DNA repair protein XRCC4,https://www.drugbank.ca/bio_entities/BE0001585,Q13426,DNA repair protein XRCC4,7518.0,XRCC4,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5291,2012363,17753880,DrugBank,S-(Dimethylarsenic)Cysteine,DB03963,S-(Dimethylarsenic)Cysteine,https://www.drugbank.ca/drugs/DB03963,BE0001618,Peptide methionine sulfoxide reductase MsrA,https://www.drugbank.ca/bio_entities/BE0001618,P0A745,Peptide methionine sulfoxide reductase MsrA,75202459.0,,623.0,Shigella flexneri,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5292,2012364,17753915,DrugBank,"6-Chloropurine riboside, 5'-monophosphate",DB03948,"6-Chloropurine Riboside, 5'-Monophosphate",https://www.drugbank.ca/drugs/DB03948,BE0000761,Inosine-5'-monophosphate dehydrogenase 1,https://www.drugbank.ca/bio_entities/BE0000761,P20839,Inosine-5'-monophosphate dehydrogenase 1 ,3614.0,IMPDH1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5293,2012365,17753915,DrugBank,"6-Chloropurine riboside, 5'-monophosphate",DB03948,"6-Chloropurine Riboside, 5'-Monophosphate",https://www.drugbank.ca/drugs/DB03948,BE0000722,Inosine-5'-monophosphate dehydrogenase 2,https://www.drugbank.ca/bio_entities/BE0000722,P12268,Inosine-5'-monophosphate dehydrogenase 2,3615.0,IMPDH2,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5294,2012366,17753950,DrugBank,"3-Amino-4,5-dihydroxy-cyclohex-1-enecarboxylate",DB03746,"3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate",https://www.drugbank.ca/drugs/DB03746,BE0001819,3-dehydroquinate dehydratase,https://www.drugbank.ca/bio_entities/BE0001819,P24670,3-dehydroquinate dehydratase,,,90370.0,Salmonella enterica subsp. enterica serovar Typhi,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5295,2012367,17753973,DrugBank,1-Hydroxy-2-S-glutathionyl-3-para-nitrophenoxy-propane,DB03706,1-Hydroxy-2-S-glutathionyl-3-para-nitrophenoxy-propane,https://www.drugbank.ca/drugs/DB03706,BE0000812,Glutathione S-transferase Mu 4,https://www.drugbank.ca/bio_entities/BE0000812,Q03013,Glutathione S-transferase Mu 4,2948.0,GSTM4,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
5296,2012368,17753979,DrugBank,2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid,DB03821,2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid,https://www.drugbank.ca/drugs/DB03821,BE0003195,Arylsulfatase A,https://www.drugbank.ca/bio_entities/BE0003195,P15289,Arylsulfatase A,410.0,ARSA,9606.0,Homo sapiens (human),,,,,,,,
5297,2012369,17753992,DrugBank,L-gamma-glutamyl-S-[(S)-[(4-bromophenyl)(hydroxy)amino](hydroxy)methyl]-L-cysteinylglycine,DB03889,S-(N-hydroxy-N-bromophenylcarbamoyl)glutathione,https://www.drugbank.ca/drugs/DB03889,BE0001825,"Hydroxyacylglutathione hydrolase, mitochondrial",https://www.drugbank.ca/bio_entities/BE0001825,Q16775,"Hydroxyacylglutathione hydrolase, mitochondrial",3029.0,HAGH,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5298,2012370,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001274,Beta-lactamase OXA-10,https://www.drugbank.ca/bio_entities/BE0001274,P14489,Beta-lactamase OXA-10,84239014.0,,287.0,Pseudomonas aeruginosa,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5299,2012371,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001258,UDP-N-acetylmuramoylalanine--D-glutamate ligase,https://www.drugbank.ca/bio_entities/BE0001258,P14900,UDP-N-acetylmuramoylalanine--D-glutamate ligase,944818.0,murD,83333.0,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5300,2012372,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001344,Alanine racemase,https://www.drugbank.ca/bio_entities/BE0001344,P10724,Alanine racemase,,,1422.0,Geobacillus stearothermophilus,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5301,2012373,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001538,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase",https://www.drugbank.ca/bio_entities/BE0001538,P22188,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase",944791.0,murE,83333.0,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5302,2012374,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001535,Parathion hydrolase,https://www.drugbank.ca/bio_entities/BE0001535,P0A433,Parathion hydrolase,,,336203.0,Sphingobium fuliginis,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5303,2012375,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001492,Folylpolyglutamate synthase,https://www.drugbank.ca/bio_entities/BE0001492,P15925,Folylpolyglutamate synthase,,,1582.0,Lacticaseibacillus casei,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5304,2012376,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001452,Dihydroorotase,https://www.drugbank.ca/bio_entities/BE0001452,P05020,Dihydroorotase,945787.0,pyrC,83333.0,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5305,2012377,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001072,Cyclin-dependent kinase 2,https://www.drugbank.ca/bio_entities/BE0001072,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5306,2012378,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001725,D-hydantoinase,https://www.drugbank.ca/bio_entities/BE0001725,Q8VTT5,D-hydantoinase,,,329.0,Ralstonia pickettii,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5307,2012379,17754054,DrugBank,Lysine Nz-Carboxylic Acid,DB03801,Lysine Nz-Carboxylic Acid,https://www.drugbank.ca/drugs/DB03801,BE0001733,Beta-lactamase OXA-1,https://www.drugbank.ca/bio_entities/BE0001733,P13661,Beta-lactamase OXA-1,84239099.0,,562.0,Escherichia coli,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
5308,2028392,17754438,Drug Gene Interaction database (DGIdb),"2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol",,PF-04217903,https://www.dgidb.org/drugs/drugbank:DB12848,,MET,https://www.dgidb.org/genes/hgnc:7029,,,4233.0,MET,9606.0,Homo sapiens (human),,,,,,,,
5309,2028393,17755248,Drug Gene Interaction database (DGIdb),Eribulin Mesylate,,ERIBULIN MESYLATE,https://www.dgidb.org/drugs/rxcui:1045452,,TUBA3E,https://www.dgidb.org/genes/hgnc:20765,,,112714.0,TUBA3E,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5310,2028394,17755248,Drug Gene Interaction database (DGIdb),Eribulin Mesylate,,ERIBULIN MESYLATE,https://www.dgidb.org/drugs/rxcui:1045452,,ESR2,https://www.dgidb.org/genes/hgnc:3468,,,2100.0,ESR2,9606.0,Homo sapiens (human),,,,,,,,
5311,2028395,17755248,ChEMBL,Eribulin Mesylate,CHEMBL1683544,ERIBULIN MESYLATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1683544/,CHEMBL2095182,Tubulin,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2095182/,Q9H4B7,Tubulin beta-1 chain,81027.0,TUBB1,9606.0,Homo sapiens (human),Tubulin inhibitor,,,PMID:22619477,https://www.ncbi.nlm.nih.gov/pubmed/22619477,22619477,,
5312,2028396,18546352,Therapeutic Target Database (TTD),2-(2-(2-Fluorophenylamino)phenyl)acetic acid,D0I8YN,2-(2-(2-fluorophenylamino)phenyl)acetic acid,https://idrblab.net/ttd/data/drug/details/D0I8YN,T22658,Interleukin-8 (IL8),https://idrblab.net/ttd/data/target/details/T22658,P10145,Interleukin-8,3576.0,CXCL8,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5313,2028399,18574682,Drug Gene Interaction database (DGIdb),"N-[2-(1,3-benzodioxol-5-yl)-2-[4-(4-methoxyphenyl)piperazin-1-yl]ethyl]-3,3-dimethylbutanamide",,CHEMBL:CHEMBL590675,https://www.dgidb.org/drugs/chembl:CHEMBL590675,,RACGAP1,https://www.dgidb.org/genes/hgnc:9804,,,29127.0,RACGAP1,9606.0,Homo sapiens (human),,,,,,,,
5314,2028407,18708949,BindingDB,"Triazole, 7e",29305,"triazole, 7e",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29305,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),>50000,PMID:19271755|DOI:10.1021/jm801503n,https://www.ncbi.nlm.nih.gov/pubmed/19271755|https://doi.org/10.1021/jm801503n,19271755,10.1021/jm801503n,
5315,2028408,18708949,BindingDB,"Triazole, 7e",29305,"triazole, 7e",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29305,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),107,PMID:19271755|DOI:10.1021/jm801503n,https://www.ncbi.nlm.nih.gov/pubmed/19271755|https://doi.org/10.1021/jm801503n,19271755,10.1021/jm801503n,
5316,2028400,18782968,BindingDB,"Thienopyrrolizine derivative, 4k",85764,"Thienopyrrolizine derivative, 4k",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=85764,1003,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1003,P49841,Glycogen synthase kinase-3 beta,2932.0,GSK3B,9606.0,Homo sapiens (human),,IC50 (nM),>5.0e+4,PMID:15662962|DOI:10.1080/14756360400004565,https://www.ncbi.nlm.nih.gov/pubmed/15662962|https://doi.org/10.1080/14756360400004565,15662962,10.1080/14756360400004565,
5317,2028401,18782968,BindingDB,"Thienopyrrolizine derivative, 4k",85764,"Thienopyrrolizine derivative, 4k",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=85764,1003,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1003,P49841,Glycogen synthase kinase-3 beta,2932.0,GSK3B,9606.0,Homo sapiens (human),,IC50 (nM),>5.0e+4,PMID:15662962|DOI:10.1080/14756360400004565,https://www.ncbi.nlm.nih.gov/pubmed/15662962|https://doi.org/10.1080/14756360400004565,15662962,10.1080/14756360400004565,
5318,2028402,18782969,BindingDB,"Thienopyrrolizine derivative, 4i",85762,"Thienopyrrolizine derivative, 4i",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=85762,1003,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1003,P49841,Glycogen synthase kinase-3 beta,2932.0,GSK3B,9606.0,Homo sapiens (human),,IC50 (nM),>5.0e+4,PMID:15662962|DOI:10.1080/14756360400004565,https://www.ncbi.nlm.nih.gov/pubmed/15662962|https://doi.org/10.1080/14756360400004565,15662962,10.1080/14756360400004565,
5319,2028403,18782969,BindingDB,"Thienopyrrolizine derivative, 4i",85762,"Thienopyrrolizine derivative, 4i",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=85762,1003,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1003,P49841,Glycogen synthase kinase-3 beta,2932.0,GSK3B,9606.0,Homo sapiens (human),,IC50 (nM),>5.0e+4,PMID:15662962|DOI:10.1080/14756360400004565,https://www.ncbi.nlm.nih.gov/pubmed/15662962|https://doi.org/10.1080/14756360400004565,15662962,10.1080/14756360400004565,
5320,2028404,18782970,BindingDB,"Thienopyrrolizine derivative, 4h",85761,"Thienopyrrolizine derivative, 4h",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=85761,1003,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1003,P49841,Glycogen synthase kinase-3 beta,2932.0,GSK3B,9606.0,Homo sapiens (human),,IC50 (nM),>5.0e+4,PMID:15662962|DOI:10.1080/14756360400004565,https://www.ncbi.nlm.nih.gov/pubmed/15662962|https://doi.org/10.1080/14756360400004565,15662962,10.1080/14756360400004565,
5321,2028405,18782970,BindingDB,"Thienopyrrolizine derivative, 4h",85761,"Thienopyrrolizine derivative, 4h",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=85761,1003,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1003,P49841,Glycogen synthase kinase-3 beta,2932.0,GSK3B,9606.0,Homo sapiens (human),,IC50 (nM),>5.0e+4,PMID:15662962|DOI:10.1080/14756360400004565,https://www.ncbi.nlm.nih.gov/pubmed/15662962|https://doi.org/10.1080/14756360400004565,15662962,10.1080/14756360400004565,
5322,2028406,18784677,IUPHAR/BPS Guide to PHARMACOLOGY,3-Hydroxy-6-methoxy-2-phenyl-2-(2-phenylethynyl)chroman-4-one,394,MRS1062,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=394,18,A1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=18,P25099,Adenosine receptor A1,29290.0,Adora1,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,4.3,PMID:8691424,https://www.ncbi.nlm.nih.gov/pubmed/8691424,8691424,,
5323,2029035,18943987,BindingDB,"N-[1-(1,3-benzothiazol-2-yl)-5-carbamimidamido-1-oxopentan-2-yl]formamide",14082,2-ketobenzothiazole 22,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14082,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),1300,PMID:15771442|DOI:10.1021/jm0303857,https://www.ncbi.nlm.nih.gov/pubmed/15771442|https://doi.org/10.1021/jm0303857,15771442,10.1021/jm0303857,
5324,2029036,18943987,BindingDB,"N-[1-(1,3-benzothiazol-2-yl)-5-carbamimidamido-1-oxopentan-2-yl]formamide",14082,2-ketobenzothiazole 22,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14082,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,IC50 (nM),>50000,PMID:15771442|DOI:10.1021/jm0303857,https://www.ncbi.nlm.nih.gov/pubmed/15771442|https://doi.org/10.1021/jm0303857,15771442,10.1021/jm0303857,
5325,2028409,18968508,Drug Gene Interaction database (DGIdb),"N,N''-Bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine dihydrochloride",,ALEXIDINE HYDROCHLORIDE,https://www.dgidb.org/drugs/chembl:CHEMBL1487183,,HKDC1,https://www.dgidb.org/genes/hgnc:23302,,,80201.0,HKDC1,9606.0,Homo sapiens (human),,,,,,,,
5326,2028410,18968508,Drug Gene Interaction database (DGIdb),"N,N''-Bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine dihydrochloride",,ALEXIDINE HYDROCHLORIDE,https://www.dgidb.org/drugs/chembl:CHEMBL1487183,,USP1,https://www.dgidb.org/genes/hgnc:12607,,,7398.0,USP1,9606.0,Homo sapiens (human),,,,,,,,
5327,2028411,18968508,Drug Gene Interaction database (DGIdb),"N,N''-Bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine dihydrochloride",,ALEXIDINE HYDROCHLORIDE,https://www.dgidb.org/drugs/chembl:CHEMBL1487183,,IDH1,https://www.dgidb.org/genes/hgnc:5382,,,3417.0,IDH1,9606.0,Homo sapiens (human),,,,,,,,
5328,2028412,18968508,Drug Gene Interaction database (DGIdb),"N,N''-Bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine dihydrochloride",,ALEXIDINE HYDROCHLORIDE,https://www.dgidb.org/drugs/chembl:CHEMBL1487183,,ATXN2,https://www.dgidb.org/genes/hgnc:10555,,,6311.0,ATXN2,9606.0,Homo sapiens (human),,,,,,,,
5329,2029032,18968508,Drug Gene Interaction database (DGIdb),"N,N''-Bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine dihydrochloride",,ALEXIDINE HYDROCHLORIDE,https://www.dgidb.org/drugs/chembl:CHEMBL1487183,,UBE2N,https://www.dgidb.org/genes/hgnc:12492,,,7334.0,UBE2N,9606.0,Homo sapiens (human),,,,,,,,
5330,2029033,18968508,Drug Gene Interaction database (DGIdb),"N,N''-Bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine dihydrochloride",,ALEXIDINE HYDROCHLORIDE,https://www.dgidb.org/drugs/chembl:CHEMBL1487183,,TMPRSS15,https://www.dgidb.org/genes/hgnc:9490,,,5651.0,TMPRSS15,9606.0,Homo sapiens (human),,,,,,,,
5331,2029160,19700663,Therapeutic Target Database (TTD),"8-(3-Chlorophenyl)-6-(pyridin-4-ylmethyl)pyrido[2,3-d]pyridazin-5-one",D0O3BL,RS-14491,https://idrblab.net/ttd/data/drug/details/D0O3BL,T61744,Phosphodiesterase 4A (PDE4A),https://idrblab.net/ttd/data/target/details/T61744,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5332,2029161,19700663,Therapeutic Target Database (TTD),"8-(3-Chlorophenyl)-6-(pyridin-4-ylmethyl)pyrido[2,3-d]pyridazin-5-one",D0O3BL,RS-14491,https://idrblab.net/ttd/data/drug/details/D0O3BL,T10265,Phosphodiesterase 4B (PDE4B),https://idrblab.net/ttd/data/target/details/T10265,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",5142.0,PDE4B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5333,2029162,19896458,Comparative Toxicogenomics Database (CTD),2-Acetylamino-3-(ethylthio)propanoic acid,C110991,S-ethyl-N-acetyl-cysteine,https://ctdbase.org/detail.go?type=chem&acc=C110991,3875,KRT18,https://ctdbase.org/detail.go?type=gene&acc=3875,,,3875.0,KRT18,10090.0,Mus musculus (house mouse),S-ethyl-N-acetyl-cysteine inhibits the reaction [sodium arsenite results in increased expression of KRT18 mrna],,,PMID:17340120,https://www.ncbi.nlm.nih.gov/pubmed/17340120,17340120,,
5334,2029037,20054870,Drug Gene Interaction database (DGIdb),Cimetropium Bromide,,CIMETROPIUM BROMIDE,https://www.dgidb.org/drugs/ncit:C90696,,CHRM5,https://www.dgidb.org/genes/hgnc:1954,,,1133.0,CHRM5,9606.0,Homo sapiens (human),,,,,,,,
5335,2029038,20055804,Comparative Toxicogenomics Database (CTD),Carboxyatractyloside,C003853,carboxyatractyloside,https://ctdbase.org/detail.go?type=chem&acc=C003853,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606.0,Homo sapiens (human),Carboxyatractyloside inhibits the reaction [ABCB11 protein results in increased transport of taurodeoxycholic acid],,,PMID:35101544,https://www.ncbi.nlm.nih.gov/pubmed/35101544,35101544,,
5336,2029039,20055804,Comparative Toxicogenomics Database (CTD),Carboxyatractyloside,C003853,carboxyatractyloside,https://ctdbase.org/detail.go?type=chem&acc=C003853,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Carboxyatractyloside inhibits the reaction [N-caproylsphingosine results in increased expression of ICAM1 mrna],,,PMID:12952965,https://www.ncbi.nlm.nih.gov/pubmed/12952965,12952965,,
5337,2029040,20055804,Comparative Toxicogenomics Database (CTD),Carboxyatractyloside,C003853,carboxyatractyloside,https://ctdbase.org/detail.go?type=chem&acc=C003853,291,SLC25A4,https://ctdbase.org/detail.go?type=gene&acc=291,,,291.0,SLC25A4,10116.0,Rattus norvegicus (Norway rat),Carboxyatractyloside binds to SLC25A4 protein|carboxyatractyloside inhibits the reaction [oxophenylarsine binds to SLC25A4 protein],,,PMID:18667415,https://www.ncbi.nlm.nih.gov/pubmed/18667415,18667415,,
5338,2029041,20055804,Comparative Toxicogenomics Database (CTD),Carboxyatractyloside,C003853,carboxyatractyloside,https://ctdbase.org/detail.go?type=chem&acc=C003853,292,SLC25A5,https://ctdbase.org/detail.go?type=gene&acc=292,,,292.0,SLC25A5,9606.0,Homo sapiens (human),Carboxyatractyloside results in decreased activity of SLC25A5 protein,,,PMID:26746582,https://www.ncbi.nlm.nih.gov/pubmed/26746582,26746582,,
5339,2029051,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EDN1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5340,2029052,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1909,EDNRA,https://ctdbase.org/detail.go?type=gene&acc=1909,,,1909.0,EDNRA,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of EDNRA mrna|[fulvestrant co-treated with tamoxifen co-treated with ZD4054] results in decreased expression of EDNRA mrna|tamoxifen inhibits the reaction [estradiol results in increased expression of EDNRA mrna],,,PMID:19943105,https://www.ncbi.nlm.nih.gov/pubmed/19943105,19943105,,
5341,2029053,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1909,EDNRA,https://ctdbase.org/detail.go?type=gene&acc=1909,,,1909.0,EDNRA,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR1 protein] results in increased expression of EDNRA mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of EDNRA mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
5342,2029054,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1915,EEF1A1,https://ctdbase.org/detail.go?type=gene&acc=1915,,,1915.0,EEF1A1,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of EEF1A1 protein|[tretinoin co-treated with tamoxifen] results in increased expression of EEF1A1 protein,,,PMID:17098229,https://www.ncbi.nlm.nih.gov/pubmed/17098229,17098229,,
5343,2029055,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1937,EEF1G,https://ctdbase.org/detail.go?type=gene&acc=1937,,,1937.0,EEF1G,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EEF1G mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5344,2029056,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,29904,EEF2K,https://ctdbase.org/detail.go?type=gene&acc=29904,,,29904.0,EEF2K,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EEF2K mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5345,2029057,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,399665,EEIG1,https://ctdbase.org/detail.go?type=gene&acc=399665,,,399665.0,EEIG1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol results in increased expression of EEIG1 mrna],,,PMID:14605097,https://www.ncbi.nlm.nih.gov/pubmed/14605097,14605097,,
5346,2029058,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,80820,EEPD1,https://ctdbase.org/detail.go?type=gene&acc=80820,,,80820.0,EEPD1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EEPD1 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
5347,2029059,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2202,EFEMP1,https://ctdbase.org/detail.go?type=gene&acc=2202,,,2202.0,EFEMP1,9606.0,Homo sapiens (human),Tamoxifen affects the expression of EFEMP1 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
5348,2029086,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,30008,EFEMP2,https://ctdbase.org/detail.go?type=gene&acc=30008,,,30008.0,EFEMP2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EFEMP2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5349,2029087,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,80303,EFHD1,https://ctdbase.org/detail.go?type=gene&acc=80303,,,80303.0,EFHD1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EFHD1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5350,2029088,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1942,EFNA1,https://ctdbase.org/detail.go?type=gene&acc=1942,,,1942.0,EFNA1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EFNA1 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
5351,2029089,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1949,EFNB3,https://ctdbase.org/detail.go?type=gene&acc=1949,,,1949.0,EFNB3,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EFNB3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5352,2029090,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,22979,EFR3B,https://ctdbase.org/detail.go?type=gene&acc=22979,,,22979.0,EFR3B,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of EFR3B mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
5353,2029091,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9343,EFTUD2,https://ctdbase.org/detail.go?type=gene&acc=9343,,,9343.0,EFTUD2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EFTUD2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5354,2029092,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [[estradiol co-treated with EGF protein] results in increased expression of TGFA mrna]|tamoxifen inhibits the reaction [EGF protein results in increased expression of IL20 mrna]|tamoxifen inhibits the reaction [[estradiol co-treated with EGF protein] results in increased expression of CDC6 mrna]|tamoxifen inhibits the reaction [[estradiol co-treated with EGF protein] results in increased expression of CCND1 mrna]|tamoxifen inhibits the reaction [[estradiol co-treated with EGF protein] results in increased expression of GFRA2 mrna]|tamoxifen inhibits the reaction [EGF protein results in increased expression of HBEGF mrna]|tamoxifen inhibits the reaction [[estradiol co-treated with EGF protein] results in increased expression of CXCL12 mrna]|tamoxifen inhibits the reaction [[estradiol co-treated with EGF protein] results in increased expression of MERTK mrna]|tamoxifen inhibits the reaction [EGF protein results in increased expression of FCMR mrna]|tamoxifen inhibits the reaction [[estradiol co-treated with EGF protein] results in increased expression of SGK1 mrna]|[egf protein results in increased activity of EGFR protein] which results in decreased susceptibility to tamoxifen|tamoxifen inhibits the reaction [EGF protein results in increased expression of RELB mrna]|tamoxifen inhibits the reaction [EGF protein results in increased expression of GADD45A mrna]|tamoxifen inhibits the reaction [[estradiol co-treated with EGF protein] results in increased expression of ARTN mrna]|egfr mutant form inhibits the reaction [[EGF protein results in increased activity of EGFR protein] which results in decreased susceptibility to tamoxifen]|tamoxifen inhibits the reaction [[estradiol co-treated with EGF protein] results in increased expression of MCM7 mrna]|tamoxifen inhibits the reaction [[estradiol co-treated with EGF protein] results in increased expression of MCM4 mrna]|tamoxifen inhibits the reaction [[estradiol co-treated with EGF protein] results in increased expression of RET mrna],,,PMID:24758408,https://www.ncbi.nlm.nih.gov/pubmed/24758408,24758408,,
5355,2029093,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,9606.0,Homo sapiens (human),EGF protein results in increased susceptibility to tamoxifen,,,PMID:14649542,https://www.ncbi.nlm.nih.gov/pubmed/14649542,14649542,,
5356,2029094,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,9606.0,Homo sapiens (human),Tamoxifen affects the activity of EGF protein,,,PMID:19395996,https://www.ncbi.nlm.nih.gov/pubmed/19395996,19395996,,
5357,2029095,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),[EGF protein results in increased activity of EGFR protein] which results in decreased susceptibility to tamoxifen,,,PMID:24758408,https://www.ncbi.nlm.nih.gov/pubmed/24758408,24758408,,
5358,2029096,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),EGFR mutant form inhibits the reaction [[EGF protein results in increased activity of EGFR protein] which results in decreased susceptibility to tamoxifen],,,PMID:24758408,https://www.ncbi.nlm.nih.gov/pubmed/24758408,24758408|24758408,,
5359,2029097,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),EGFR protein results in decreased susceptibility to tamoxifen,,,PMID:15665275|PMID:16000581,https://www.ncbi.nlm.nih.gov/pubmed/15665275|https://www.ncbi.nlm.nih.gov/pubmed/16000581,15665275|16000581,,
5360,2029098,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in increased expression of EGFR mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of EGFR protein|[tamoxifen co-treated with ESR1 protein] results in decreased expression of EGFR mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of EGFR protein,,,PMID:19347870,https://www.ncbi.nlm.nih.gov/pubmed/19347870,19347870,,
5361,2029099,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of EGFR protein|tamoxifen results in increased expression of EGFR mRNA,,,PMID:20005069,https://www.ncbi.nlm.nih.gov/pubmed/20005069,20005069,,
5362,2029100,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EGFR mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5363,2029101,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in increased expression of EGR1 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
5364,2029158,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EGR1 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
5365,2029159,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,10116.0,Rattus norvegicus (Norway rat),[bexarotene co-treated with tamoxifen] results in decreased expression of EGR1 mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
5366,2029163,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,59729.0,Taeniopygia guttata (zebra finch),Tamoxifen results in decreased expression of EGR1 mRNA,,,PMID:19420261,https://www.ncbi.nlm.nih.gov/pubmed/19420261,19420261,,
5367,2029164,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,30845,EHD3,https://ctdbase.org/detail.go?type=gene&acc=30845,,,30845.0,EHD3,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EHD3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5368,2029165,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1962,EHHADH,https://ctdbase.org/detail.go?type=gene&acc=1962,,,1962.0,EHHADH,9606.0,Homo sapiens (human),Tamoxifen results in decreased expression of EHHADH mRNA,,,PMID:27089845,https://www.ncbi.nlm.nih.gov/pubmed/27089845,27089845,,
5369,2029166,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1962,EHHADH,https://ctdbase.org/detail.go?type=gene&acc=1962,,,1962.0,EHHADH,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EHHADH mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
5370,2029167,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1962,EHHADH,https://ctdbase.org/detail.go?type=gene&acc=1962,,,1962.0,EHHADH,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of EHHADH mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
5371,2029168,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1962,EHHADH,https://ctdbase.org/detail.go?type=gene&acc=1962,,,1962.0,EHHADH,10116.0,Rattus norvegicus (Norway rat),Tamoxifen results in increased expression of EHHADH mrna|[tamoxifen co-treated with bexarotene] results in increased expression of EHHADH mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
5372,2029169,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9538,EI24,https://ctdbase.org/detail.go?type=gene&acc=9538,,,9538.0,EI24,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EI24 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5373,2029170,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10209,EIF1,https://ctdbase.org/detail.go?type=gene&acc=10209,,,10209.0,EIF1,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR1 protein] results in increased expression of EIF1 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
5374,2029171,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10209,EIF1,https://ctdbase.org/detail.go?type=gene&acc=10209,,,10209.0,EIF1,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of EIF1 mRNA,,,PMID:19400957,https://www.ncbi.nlm.nih.gov/pubmed/19400957,19400957,,
5375,2029172,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,13664,EIF1A,https://ctdbase.org/detail.go?type=gene&acc=13664,,,13664.0,Eif1a,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF1A mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5376,2029173,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9086,EIF1AY,https://ctdbase.org/detail.go?type=gene&acc=9086,,,9086.0,EIF1AY,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF1AY mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5377,2029174,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10289,EIF1B,https://ctdbase.org/detail.go?type=gene&acc=10289,,,10289.0,EIF1B,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF1B mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5378,2029175,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,5610,EIF2AK2,https://ctdbase.org/detail.go?type=gene&acc=5610,,,5610.0,EIF2AK2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF2AK2 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
5379,2029176,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1965,EIF2S1,https://ctdbase.org/detail.go?type=gene&acc=1965,,,1965.0,EIF2S1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF2S1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5380,2029177,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8894,EIF2S2,https://ctdbase.org/detail.go?type=gene&acc=8894,,,8894.0,EIF2S2,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of EIF2S2 mRNA,,,PMID:19400957,https://www.ncbi.nlm.nih.gov/pubmed/19400957,19400957,,
5381,2029190,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8664,EIF3D,https://ctdbase.org/detail.go?type=gene&acc=8664,,,8664.0,EIF3D,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF3D mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5382,2029191,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8665,EIF3F,https://ctdbase.org/detail.go?type=gene&acc=8665,,,8665.0,EIF3F,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF3F mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5383,2029192,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8666,EIF3G,https://ctdbase.org/detail.go?type=gene&acc=8666,,,8666.0,EIF3G,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF3G mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5384,2029193,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8668,EIF3I,https://ctdbase.org/detail.go?type=gene&acc=8668,,,8668.0,EIF3I,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF3I mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5385,2029194,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,27335,EIF3K,https://ctdbase.org/detail.go?type=gene&acc=27335,,,27335.0,EIF3K,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF3K mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5386,2029195,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9775,EIF4A3,https://ctdbase.org/detail.go?type=gene&acc=9775,,,9775.0,EIF4A3,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF4A3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5387,2029196,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1977,EIF4E,https://ctdbase.org/detail.go?type=gene&acc=1977,,,1977.0,EIF4E,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF4E mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5388,2029197,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1983,EIF5,https://ctdbase.org/detail.go?type=gene&acc=1983,,,1983.0,EIF5,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of EIF5 mRNA,,,PMID:15604281,https://www.ncbi.nlm.nih.gov/pubmed/15604281,15604281,,
5389,2029198,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1983,EIF5,https://ctdbase.org/detail.go?type=gene&acc=1983,,,1983.0,EIF5,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF5 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5390,2029199,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,3692,EIF6,https://ctdbase.org/detail.go?type=gene&acc=3692,,,3692.0,EIF6,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EIF6 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5391,2029209,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1994,ELAVL1,https://ctdbase.org/detail.go?type=gene&acc=1994,,,1994.0,ELAVL1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of ELAVL1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5392,2029210,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1999,ELF3,https://ctdbase.org/detail.go?type=gene&acc=1999,,,1999.0,ELF3,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in decreased expression of ELF3 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
5393,2029211,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,79767,ELMO3,https://ctdbase.org/detail.go?type=gene&acc=79767,,,79767.0,ELMO3,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of ELMO3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5394,2029212,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,64834,ELOVL1,https://ctdbase.org/detail.go?type=gene&acc=64834,,,64834.0,ELOVL1,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of ELOVL1 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
5395,2029213,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,83401,ELOVL3,https://ctdbase.org/detail.go?type=gene&acc=83401,,,83401.0,ELOVL3,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of ELOVL3 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
5396,2029214,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,79071,ELOVL6,https://ctdbase.org/detail.go?type=gene&acc=79071,,,79071.0,ELOVL6,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of ELOVL6 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
5397,2029215,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,79071,ELOVL6,https://ctdbase.org/detail.go?type=gene&acc=79071,,,79071.0,ELOVL6,10116.0,Rattus norvegicus (Norway rat),[bexarotene co-treated with tamoxifen] results in increased expression of ELOVL6 mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
5398,2029216,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9694,EMC2,https://ctdbase.org/detail.go?type=gene&acc=9694,,,9694.0,EMC2,9606.0,Homo sapiens (human),Tamoxifen affects the expression of EMC2 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
5399,2029217,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,55831,EMC3,https://ctdbase.org/detail.go?type=gene&acc=55831,,,55831.0,EMC3,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EMC3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5400,2029218,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,83460,EMC6,https://ctdbase.org/detail.go?type=gene&acc=83460,,,83460.0,EMC6,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EMC6 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
5401,2028383,21044338,BindingDB,ImmA-Et,36494,CHEMBL554965,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36494,4410,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4410,,,,,,,,,,PMID:18030989|DOI:10.1021/cb700166z,https://www.ncbi.nlm.nih.gov/pubmed/18030989|https://doi.org/10.1021/cb700166z,18030989,10.1021/cb700166z,
5402,2028384,21044338,BindingDB,ImmA-Et,36494,CHEMBL554965,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36494,4412,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4412,B5Y1L0,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,,,507522.0,Klebsiella pneumoniae 342,,,,PMID:18030989|DOI:10.1021/cb700166z,https://www.ncbi.nlm.nih.gov/pubmed/18030989|https://doi.org/10.1021/cb700166z,18030989,10.1021/cb700166z,
5403,2028385,21044338,BindingDB,ImmA-Et,36494,CHEMBL554965,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36494,4414,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4414,Q5HFG2,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,,,93062.0,Staphylococcus aureus subsp. aureus COL,,,,PMID:18030989|DOI:10.1021/cb700166z,https://www.ncbi.nlm.nih.gov/pubmed/18030989|https://doi.org/10.1021/cb700166z,18030989,10.1021/cb700166z,
5404,2028386,21044338,BindingDB,ImmA-Et,36494,CHEMBL554965,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36494,2245,S-methyl-5'-thioadenosine phosphorylase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2245,Q13126,S-methyl-5'-thioadenosine phosphorylase,4507.0,MTAP,9606.0,Homo sapiens (human),,,,PMID:18030989|DOI:10.1021/cb700166z,https://www.ncbi.nlm.nih.gov/pubmed/18030989|https://doi.org/10.1021/cb700166z,18030989,10.1021/cb700166z,
5405,2028387,21044338,BindingDB,ImmA-Et,36494,CHEMBL554965,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36494,2246,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2246,P0AF12,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,66671551.0,mtnN,83333.0,Escherichia coli K-12,,,,PMID:18030989|DOI:10.1021/cb700166z,https://www.ncbi.nlm.nih.gov/pubmed/18030989|https://doi.org/10.1021/cb700166z,18030989,10.1021/cb700166z,
5406,2028388,21044338,BindingDB,ImmA-Et,36494,CHEMBL554965,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36494,4413,Adenosylhomocysteine nucleosidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4413,,,,,,,,,,PMID:18030989|DOI:10.1021/cb700166z,https://www.ncbi.nlm.nih.gov/pubmed/18030989|https://doi.org/10.1021/cb700166z,18030989,10.1021/cb700166z,
5407,2028389,21145345,BindingDB,1-[1-hydroxy-4-(naphthalen-1-yl)butan-2-yl]-1H-imidazole-4-carboxamide,22919,1-[1-hydroxy-4-(naphthalen-1-yl)butan-2-yl]-1H-imidazole-4-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22919,2318,Adenosine deaminase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2318,P00813,Adenosine deaminase,100.0,ADA,9606.0,Homo sapiens (human),,Ki (nM),680,PMID:14709046|DOI:10.1021/ja038606l,https://www.ncbi.nlm.nih.gov/pubmed/14709046|https://doi.org/10.1021/ja038606l,14709046,10.1021/ja038606l,
5408,2028390,21192457,Therapeutic Target Database (TTD),N-(5-Benzyloxy-isoquinolin-1-yl)-guanidine,D0C3QE,N-(5-Benzyloxy-isoquinolin-1-yl)-guanidine,https://idrblab.net/ttd/data/drug/details/D0C3QE,T45299,Tissue-type plasminogen activator (PLAT),https://idrblab.net/ttd/data/target/details/T45299,P00750,Tissue-type plasminogen activator,5327.0,PLAT,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5409,2028391,21192814,BindingDB,"5-Fluoro-2-thiophen-2-yl-1,2-dihydroquinazolin-4-amine",36395,"5-Fluoro-2-thiophen-2-yl-1,2-dihydroquinazolin-4-amine, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36395,3609,"Nitric oxide synthase, inducible",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3609,P35228,"Nitric oxide synthase, inducible",4843.0,NOS2,9606.0,Homo sapiens (human),,IC50 (nM),1e+1,PMID:18849972|DOI:10.1038/nchembio.115,https://www.ncbi.nlm.nih.gov/pubmed/18849972|https://doi.org/10.1038/nchembio.115,18849972,10.1038/nchembio.115,
5410,2012355,21963897,BindingDB,"[4-(4-Chloro-benzenesulfonyl)-4-(2,5-difluoro-phenyl)-cyclohexyl]-methanesulfonamide",28978,"cyclohexyl sulfone-based compound, 22",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28978,277,Gamma-secretase subunit APH-1A/Gamma-secretase subunit PEN-2/Nicastrin [34-709]/Presenilin-1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=277,P49768,Presenilin-1,5663.0,PSEN1,9606.0,Homo sapiens (human),,,,PMID:16275079|DOI:10.1016/j.bmcl.2005.10.009,https://www.ncbi.nlm.nih.gov/pubmed/16275079|https://doi.org/10.1016/j.bmcl.2005.10.009,16275079,10.1016/j.bmcl.2005.10.009,
5411,2012356,21963931,BindingDB,"2-{1-[(4-Chlorobenzene)sulfonyl]-4-[(cyclopropanesulfonyl)methyl]cyclohexyl}-1,4-difluorobenzene",28972,"2-{1-[(4-chlorobenzene)sulfonyl]-4-[(cyclopropanesulfonyl)methyl]cyclohexyl}-1,4-difluorobenzene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28972,277,Gamma-secretase subunit APH-1A/Gamma-secretase subunit PEN-2/Nicastrin [34-709]/Presenilin-1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=277,P49768,Presenilin-1,5663.0,PSEN1,9606.0,Homo sapiens (human),,,,PMID:16275079|DOI:10.1016/j.bmcl.2005.10.009,https://www.ncbi.nlm.nih.gov/pubmed/16275079|https://doi.org/10.1016/j.bmcl.2005.10.009,16275079,10.1016/j.bmcl.2005.10.009,
5412,2012357,22024419,BindingDB,3-Amino-4-bromo-6-chloropyridazine,625972,EN300-106927,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625972,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),1810,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
5413,2012354,22032643,BindingDB,3-{1-[3-Fluoro-4-(trifluoromethyl)phenyl]propyl}-1-isoquinolin-5-ylurea,20394,3-{1-[3-fluoro-4-(trifluoromethyl)phenyl]propyl}-1-isoquinolin-5-ylurea,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20394,6342,Transient receptor potential cation channel subfamily V member 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6342,Q8NER1,Transient receptor potential cation channel subfamily V member 1,7442.0,TRPV1,9606.0,Homo sapiens (human),,,,PMID:17507218|DOI:10.1016/j.bmcl.2007.04.105,https://www.ncbi.nlm.nih.gov/pubmed/17507218|https://doi.org/10.1016/j.bmcl.2007.04.105,17507218,10.1016/j.bmcl.2007.04.105,
5414,2012361,22333239,BindingDB,Methyl 1-methanesulfonyl-5-(N-methanesulfonylfuran-2-amido)-2-methyl-1H-indole-3-carboxylate,496268,CVD-0013094,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496268,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),935,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
5415,2012358,22431252,BindingDB,"5-methyl-N-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",28807,"5-methyl-N-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28807,3445,"Dihydroorotate dehydrogenase (quinone), mitochondrial [100-517]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3445,,,,,,,,IC50 (nM),>100000,PMID:19296651|DOI:10.1021/jm801343r,https://www.ncbi.nlm.nih.gov/pubmed/19296651|https://doi.org/10.1021/jm801343r,19296651,10.1021/jm801343r,
5416,2012359,22464120,Drug Gene Interaction database (DGIdb),4-[5-(2-Azanylpyrimidin-4-yl)-4-(4-fluorophenyl)imidazol-1-yl]cyclohexan-1-ol,,CHEMBL:CHEMBL1888586,https://www.dgidb.org/drugs/chembl:CHEMBL1888586,,YES1,https://www.dgidb.org/genes/hgnc:12841,,,7525.0,YES1,9606.0,Homo sapiens (human),,,,,,,,
5417,2012360,22485769,BindingDB,"4-((4-Chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexanamine",28981,"4-[(4-chlorobenzene)sulfonyl]-4-(2,5-difluorophenyl)cyclohexan-1-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28981,277,Gamma-secretase subunit APH-1A/Gamma-secretase subunit PEN-2/Nicastrin [34-709]/Presenilin-1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=277,P49768,Presenilin-1,5663.0,PSEN1,9606.0,Homo sapiens (human),,,,PMID:16275079|DOI:10.1016/j.bmcl.2005.10.009,https://www.ncbi.nlm.nih.gov/pubmed/16275079|https://doi.org/10.1016/j.bmcl.2005.10.009,16275079,10.1016/j.bmcl.2005.10.009,
5418,2011864,23396327,BindingDB,tert-butyl N-(4-{2-[2-chloro-5-({[1-(pyridin-4-yl)piperidin-4-yl]methyl}carbamoyl)phenoxy]ethyl}phenyl)carbamate,13627,3-Oxybenzamide 13,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13627,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),4531,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
5419,2011865,23396328,BindingDB,tert-butyl N-(4-{2-[2-fluoro-5-({[1-(pyridin-4-yl)piperidin-4-yl]methyl}carbamoyl)phenoxy]ethyl}phenyl)carbamate,13637,3-Oxybenzamide 23,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13637,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),10000,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
5420,2011866,23500144,BindingDB,"[[4-[(E,2R)-2-benzothiazol-2-yl-2-benzotriazol-1-yl-5-phenyl-pent-4-enyl]phenyl]-difluoro-methyl]phosphonic acid",13597,"({4-[(4E)-2-(1,3-benzothiazol-2-yl)-2-(1H-1,2,3-benzotriazol-1-yl)-5-phenylpent-4-en-1-yl]phenyl}difluoromethyl)phosphonic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13597,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),23,PMID:14516196|DOI:10.1021/bi035098j,https://www.ncbi.nlm.nih.gov/pubmed/14516196|https://doi.org/10.1021/bi035098j,14516196,10.1021/bi035098j,
5421,2011867,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5422,2011868,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0001067,ATP-binding cassette sub-family G member 2,https://www.drugbank.ca/bio_entities/BE0001067,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5423,2011869,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0003645,Solute carrier family 22 member 8,https://www.drugbank.ca/bio_entities/BE0003645,Q8TCC7,Solute carrier family 22 member 8,9376.0,SLC22A8,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,,,,,
5424,2011870,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0001066,Solute carrier family 22 member 6,https://www.drugbank.ca/bio_entities/BE0001066,Q4U2R8,Solute carrier family 22 member 6,9356.0,SLC22A6,9606.0,Homo sapiens (human),Substrate,,,,,,,
5425,2011871,23634441,DrugBank,Vadadustat,DB12255,Vadadustat,https://www.drugbank.ca/drugs/DB12255,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606.0,Homo sapiens (human),Binder,,,,,,,
5426,2011872,23642275,Therapeutic Target Database (TTD),"(2S)-(+)-5-(1,3,5-Trimethylpyrazol-4-YL)-2-(dimethylamino)tetralin",D0X9YS,AS-19,https://idrblab.net/ttd/data/drug/details/D0X9YS,T79062,5-HT 7 receptor (HTR7),https://idrblab.net/ttd/data/target/details/T79062,P34969,5-hydroxytryptamine receptor 7,3363.0,HTR7,9606.0,Homo sapiens (human),Agonist,,,,,,,
5427,2011873,23643664,IUPHAR/BPS Guide to PHARMACOLOGY,"6-(4-([1,1'-biphenyl]-2-yl)piperazin-1-yl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)hexanamide",8434,LP-12,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8434,1,5-HT1A receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1,P08908,5-hydroxytryptamine receptor 1A,3350.0,HTR1A,9606.0,Homo sapiens (human),Agonist,pKi,7.22,PMID:17649988,https://www.ncbi.nlm.nih.gov/pubmed/17649988,17649988,,
5428,2011881,23644674,BindingDB,,13738,"5-methyl-5-(propan-2-yl)-2-{[2-(trifluoromethyl)phenyl]amino}-4,5-dihydro-1,3-thiazol-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13738,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,Ki (nM),503,PMID:17266194|DOI:10.1021/jm061214f,https://www.ncbi.nlm.nih.gov/pubmed/17266194|https://doi.org/10.1021/jm061214f,17266194,10.1021/jm061214f,
5429,2011502,23645318,BindingDB,"3-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-inden-5-yl N-butyl-N-methylcarbamate",10765,"3-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-inden-5-yl N-butyl-N-methylcarbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10765,254,Carboxylic ester hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=254,,,,,,,,IC50 (nM),53700,PMID:12431053|DOI:10.1021/jm020120c,https://www.ncbi.nlm.nih.gov/pubmed/12431053|https://doi.org/10.1021/jm020120c,12431053,10.1021/jm020120c,
5430,2011503,23645321,BindingDB,"3-[methyl(prop-2-yn-1-yl)amino]-2,3-dihydro-1H-inden-5-ol hydrochloride",10803,"3-[methyl(prop-2-yn-1-yl)amino]-2,3-dihydro-1H-inden-5-ol hydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10803,1129,Amine oxidase [flavin-containing] A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1129,P21396,Amine oxidase [flavin-containing] A ,,,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),15,PMID:12431053|DOI:10.1021/jm020120c,https://www.ncbi.nlm.nih.gov/pubmed/12431053|https://doi.org/10.1021/jm020120c,12431053,10.1021/jm020120c,
5431,2011504,23645321,BindingDB,"3-[methyl(prop-2-yn-1-yl)amino]-2,3-dihydro-1H-inden-5-ol hydrochloride",10803,"3-[methyl(prop-2-yn-1-yl)amino]-2,3-dihydro-1H-inden-5-ol hydrochloride",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10803,1130,Amine oxidase [flavin-containing] B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1130,P19643,Amine oxidase [flavin-containing] B,25750.0,Maob,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),30,PMID:12431053|DOI:10.1021/jm020120c,https://www.ncbi.nlm.nih.gov/pubmed/12431053|https://doi.org/10.1021/jm020120c,12431053,10.1021/jm020120c,
5432,2011018,23646326,BindingDB,"{1-[(2R,3S,4R,5R)-3,4,5-trihydroxyoxan-2-yl]-1H-1,2,3-triazol-4-yl}methyl 4-sulfamoylbenzoate",12929,"4-({[4-(Aminosulfonyl)benzoyl]oxy}methyl-1-(beta-D-arabinopyranosyl)-1H-1,2,3-triazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12929,1233,Carbonic anhydrase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1233,Q16790,Carbonic anhydrase 9,768.0,CA9,9606.0,Homo sapiens (human),,Ki (nM),96,PMID:17064072|DOI:10.1021/jm060967z,https://www.ncbi.nlm.nih.gov/pubmed/17064072|https://doi.org/10.1021/jm060967z,17064072,10.1021/jm060967z,
5433,2011019,23646326,BindingDB,"{1-[(2R,3S,4R,5R)-3,4,5-trihydroxyoxan-2-yl]-1H-1,2,3-triazol-4-yl}methyl 4-sulfamoylbenzoate",12929,"4-({[4-(Aminosulfonyl)benzoyl]oxy}methyl-1-(beta-D-arabinopyranosyl)-1H-1,2,3-triazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12929,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),5.8,PMID:17064072|DOI:10.1021/jm060967z,https://www.ncbi.nlm.nih.gov/pubmed/17064072|https://doi.org/10.1021/jm060967z,17064072,10.1021/jm060967z,
5434,2011020,23646326,BindingDB,"{1-[(2R,3S,4R,5R)-3,4,5-trihydroxyoxan-2-yl]-1H-1,2,3-triazol-4-yl}methyl 4-sulfamoylbenzoate",12929,"4-({[4-(Aminosulfonyl)benzoyl]oxy}methyl-1-(beta-D-arabinopyranosyl)-1H-1,2,3-triazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12929,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),7.7,PMID:17064072|DOI:10.1021/jm060967z,https://www.ncbi.nlm.nih.gov/pubmed/17064072|https://doi.org/10.1021/jm060967z,17064072,10.1021/jm060967z,
5435,2011021,23646361,BindingDB,L-Alanyl-L-valyl-L-prolyl-L-isoleucinamide,13200,"(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13200,2972,E3 ubiquitin-protein ligase XIAP [241-356],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2972,P98170,E3 ubiquitin-protein ligase XIAP,331.0,XIAP,9606.0,Homo sapiens (human),,Ki (nM),580,PMID:18954041|DOI:10.1021/jm8006849,https://www.ncbi.nlm.nih.gov/pubmed/18954041|https://doi.org/10.1021/jm8006849,18954041,10.1021/jm8006849,
5436,2011022,23646362,BindingDB,"(3S,6S,8aS)-6-[(2S)-2-aminobutanamido]-N-(diphenylmethyl)-5-oxo-octahydroindolizine-3-carboxamide",13210,"(3S,6S,8aS)-6-[(2S)-2-aminobutanamido]-N-(diphenylmethyl)-5-oxo-octahydroindolizine-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13210,2972,E3 ubiquitin-protein ligase XIAP [241-356],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2972,P98170,E3 ubiquitin-protein ligase XIAP,331.0,XIAP,9606.0,Homo sapiens (human),,Ki (nM),350,PMID:18954041|DOI:10.1021/jm8006849,https://www.ncbi.nlm.nih.gov/pubmed/18954041|https://doi.org/10.1021/jm8006849,18954041,10.1021/jm8006849,
5437,2011882,23646374,BindingDB,[3-(2-cyclohexylethyl)-4-methyl-2-oxo-2H-chromen-7-yl] sulfamate,13423,CHEMBL167368,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13423,1068,Steryl-sulfatase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1068,P08842,Steryl-sulfatase,412.0,STS,9606.0,Homo sapiens (human),,IC50 (nM),46,PMID:12767917|DOI:10.1016/s0006-291x(03)00865-9,https://www.ncbi.nlm.nih.gov/pubmed/12767917|https://doi.org/10.1016/s0006-291x(03)00865-9,12767917,10.1016/s0006-291x(03)00865-9,
5438,2011883,23646375,BindingDB,"(15S)-14-hydroxy-4-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-5-yl sulfamate",13424,"(15S)-14-hydroxy-4-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-5-yl sulfamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13424,1068,Steryl-sulfatase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1068,P08842,Steryl-sulfatase,412.0,STS,9606.0,Homo sapiens (human),,IC50 (nM),34,PMID:12767917|DOI:10.1016/s0006-291x(03)00865-9,https://www.ncbi.nlm.nih.gov/pubmed/12767917|https://doi.org/10.1016/s0006-291x(03)00865-9,12767917,10.1016/s0006-291x(03)00865-9,
5439,2011884,23646376,BindingDB,"(15S)-5-hydroxy-4-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-yl sulfamate",13425,"(15S)-5-hydroxy-4-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-yl sulfamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13425,1068,Steryl-sulfatase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1068,P08842,Steryl-sulfatase,412.0,STS,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:12767917|DOI:10.1016/s0006-291x(03)00865-9,https://www.ncbi.nlm.nih.gov/pubmed/12767917|https://doi.org/10.1016/s0006-291x(03)00865-9,12767917,10.1016/s0006-291x(03)00865-9,
5440,2011885,23646377,BindingDB,"(15S)-4-methoxy-15-methyl-5-(sulfamoyloxy)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-yl sulfamate",13426,"(15S)-4-methoxy-15-methyl-5-(sulfamoyloxy)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-yl sulfamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13426,1068,Steryl-sulfatase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1068,P08842,Steryl-sulfatase,412.0,STS,9606.0,Homo sapiens (human),,IC50 (nM),39,PMID:12767917|DOI:10.1016/s0006-291x(03)00865-9,https://www.ncbi.nlm.nih.gov/pubmed/12767917|https://doi.org/10.1016/s0006-291x(03)00865-9,12767917,10.1016/s0006-291x(03)00865-9,
5441,2011886,23646378,BindingDB,"(15S)-4-ethyl-15-methyl-5-(sulfamoyloxy)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-yl sulfamate",13428,"(15S)-4-ethyl-15-methyl-5-(sulfamoyloxy)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-yl sulfamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13428,1068,Steryl-sulfatase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1068,P08842,Steryl-sulfatase,412.0,STS,9606.0,Homo sapiens (human),,IC50 (nM),1900,PMID:12767917|DOI:10.1016/s0006-291x(03)00865-9,https://www.ncbi.nlm.nih.gov/pubmed/12767917|https://doi.org/10.1016/s0006-291x(03)00865-9,12767917,10.1016/s0006-291x(03)00865-9,
5442,2011887,23646379,BindingDB,"(2R,5S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl sulfamate",13429,"(2R,5S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl sulfamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13429,1068,Steryl-sulfatase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1068,P08842,Steryl-sulfatase,412.0,STS,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:12767917|DOI:10.1016/s0006-291x(03)00865-9,https://www.ncbi.nlm.nih.gov/pubmed/12767917|https://doi.org/10.1016/s0006-291x(03)00865-9,12767917,10.1016/s0006-291x(03)00865-9,
5443,2011894,23646398,BindingDB,"N-[(3S)-2-[(tert-butoxy)carbonyl]-3-(hydroxymethyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",13447,"N-[(3S)-2-[(tert-butoxy)carbonyl]-3-(hydroxymethyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13447,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),>500000,PMID:16386905|DOI:10.1016/j.bmcl.2005.12.051,https://www.ncbi.nlm.nih.gov/pubmed/16386905|https://doi.org/10.1016/j.bmcl.2005.12.051,16386905,10.1016/j.bmcl.2005.12.051,
5444,2011895,23646399,BindingDB,"N-[(3S)-2-[(tert-butoxy)carbonyl]-3-(methoxycarbonyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",13450,"N-[(3S)-2-[(tert-butoxy)carbonyl]-3-(methoxycarbonyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13450,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),19000,PMID:16386905|DOI:10.1016/j.bmcl.2005.12.051,https://www.ncbi.nlm.nih.gov/pubmed/16386905|https://doi.org/10.1016/j.bmcl.2005.12.051,16386905,10.1016/j.bmcl.2005.12.051,
5445,2011896,23646400,BindingDB,"N-[(3S)-2-[(tert-butoxy)carbonyl]-3-[(2-methylpropoxy)carbonyl]-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",13451,"N-[(3S)-2-[(tert-butoxy)carbonyl]-3-[(2-methylpropoxy)carbonyl]-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13451,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),16700,PMID:16386905|DOI:10.1016/j.bmcl.2005.12.051,https://www.ncbi.nlm.nih.gov/pubmed/16386905|https://doi.org/10.1016/j.bmcl.2005.12.051,16386905,10.1016/j.bmcl.2005.12.051,
5446,2011897,23646401,BindingDB,"N-[(3S)-2-[(tert-butoxy)carbonyl]-3-(3-methyl-1,2,4-oxadiazol-5-yl)-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",13452,"N-[(3S)-2-[(tert-butoxy)carbonyl]-3-(3-methyl-1,2,4-oxadiazol-5-yl)-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13452,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),8230,PMID:16386905|DOI:10.1016/j.bmcl.2005.12.051,https://www.ncbi.nlm.nih.gov/pubmed/16386905|https://doi.org/10.1016/j.bmcl.2005.12.051,16386905,10.1016/j.bmcl.2005.12.051,
5447,2011898,23646402,BindingDB,"N-[(3S)-2-{3-[3-methanesulfonamido-5-(trifluoromethyl)phenyl]propanoyl}-3-(methylcarbamoyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",13456,"N-[(3S)-2-{3-[3-methanesulfonamido-5-(trifluoromethyl)phenyl]propanoyl}-3-(methylcarbamoyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13456,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),183700,PMID:16386905|DOI:10.1016/j.bmcl.2005.12.051,https://www.ncbi.nlm.nih.gov/pubmed/16386905|https://doi.org/10.1016/j.bmcl.2005.12.051,16386905,10.1016/j.bmcl.2005.12.051,
5448,2011899,23646403,BindingDB,"N-[(3S)-3-(methylcarbamoyl)-2-{3-[3-(trifluoromethyl)phenyl]propanoyl}-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",13457,"N-[(3S)-3-(methylcarbamoyl)-2-{3-[3-(trifluoromethyl)phenyl]propanoyl}-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13457,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),146000,PMID:16386905|DOI:10.1016/j.bmcl.2005.12.051,https://www.ncbi.nlm.nih.gov/pubmed/16386905|https://doi.org/10.1016/j.bmcl.2005.12.051,16386905,10.1016/j.bmcl.2005.12.051,
5449,2011900,23646404,BindingDB,"N-[(3S)-2-{2-[3-hydroxy-2-(methoxycarbonyl)phenoxy]acetyl}-3-(methylcarbamoyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",13459,"N-[(3S)-2-{2-[3-hydroxy-2-(methoxycarbonyl)phenoxy]acetyl}-3-(methylcarbamoyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]sulfamic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13459,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),93400,PMID:16386905|DOI:10.1016/j.bmcl.2005.12.051,https://www.ncbi.nlm.nih.gov/pubmed/16386905|https://doi.org/10.1016/j.bmcl.2005.12.051,16386905,10.1016/j.bmcl.2005.12.051,
5450,2011901,23646405,BindingDB,Difluoromethylphosphonic acid (DFMP) deriv. 7,13467,(2R)-2-{[(1S)-1-carbamoyl-2-{4-[difluoro(phosphono)methyl]phenyl}ethyl]carbamoyl}-2-(1-{4-[difluoro(phosphono)methyl]phenyl}acetamido)acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13467,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),0.4,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5451,2011902,23646406,BindingDB,Difluoromethylphosphonic acid (DFMP) deriv. 8,13468,(2R)-2-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}-2-(1-{4-[difluoro(phosphono)methyl]phenyl}acetamido)acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13468,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),33000,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5452,2011903,23646407,BindingDB,Difluoromethylphosphonic acid (DFMP) deriv. 9,13470,Difluoromethylphosphonic acid (DFMP) deriv. 9,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13470,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),46,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5453,2011904,23646408,BindingDB,Difluoromethylphosphonic acid (DFMP) deriv. 10,13471,({4-[(2S)-2-carbamoyl-2-[2-(1-{4-[difluoro(phosphono)methyl]phenyl}acetamido)acetamido]ethyl]phenyl}difluoromethyl)phosphonic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13471,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),42,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5454,2011905,23646409,BindingDB,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(4-methoxy-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1$l^{6},2-thiazolidine-1,1,3-trione",13476,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(4-methoxy-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1,2-thiazolidine-1,1,3-trione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13476,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),550,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5455,2011923,23646410,BindingDB,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-{[4-(trifluoromethyl)-1,3-benzothiazol-2-yl]amino}ethyl]phenyl}-1$l^{6},2-thiazolidine-1,1,3-trione",13477,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-{[4-(trifluoromethyl)-1,3-benzothiazol-2-yl]amino}ethyl]phenyl}-1,2-thiazolidine-1,1,3-trione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13477,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),740,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5456,2011924,23646411,BindingDB,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(4-bromo-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1$l^{6},2-thiazolidine-1,1,3-trione",13478,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(4-bromo-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1,2-thiazolidine-1,1,3-trione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13478,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),1100,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5457,2011925,23646412,BindingDB,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(6-chloro-4-fluoro-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1$l^{6},2-thiazolidine-1,1,3-trione",13479,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(6-chloro-4-fluoro-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1,2-thiazolidine-1,1,3-trione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13479,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),1800,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5458,2011926,23646413,BindingDB,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(5-fluoro-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1$l^{6},2-thiazolidine-1,1,3-trione",13480,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(5-fluoro-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1,2-thiazolidine-1,1,3-trione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13480,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),420,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5459,2011927,23646414,BindingDB,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(5-chloro-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1$l^{6},2-thiazolidine-1,1,3-trione",13481,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(5-chloro-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1,2-thiazolidine-1,1,3-trione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13481,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),970,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5460,2011928,23646415,BindingDB,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]amino}ethyl]phenyl}-1$l^{6},2-thiazolidine-1,1,3-trione",13482,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]amino}ethyl]phenyl}-1,2-thiazolidine-1,1,3-trione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13482,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),1300,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5461,2011944,23646416,BindingDB,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-{[6-(trifluoromethyl)-1,3-benzothiazol-2-yl]amino}ethyl]phenyl}-1$l^{6},2-thiazolidine-1,1,3-trione",13483,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-{[6-(trifluoromethyl)-1,3-benzothiazol-2-yl]amino}ethyl]phenyl}-1,2-thiazolidine-1,1,3-trione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13483,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),330,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5462,2011945,23646417,BindingDB,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(6-methoxy-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1$l^{6},2-thiazolidine-1,1,3-trione",13484,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(6-methoxy-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1,2-thiazolidine-1,1,3-trione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13484,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),350,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5463,2011946,23646418,BindingDB,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(6-bromo-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1$l^{6},2-thiazolidine-1,1,3-trione",13485,"(5S)-5-{4-[(2S)-2-(1H-1,3-benzodiazol-2-yl)-2-[(6-bromo-1,3-benzothiazol-2-yl)amino]ethyl]phenyl}-1,2-thiazolidine-1,1,3-trione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13485,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),500,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5464,2011967,23646422,BindingDB,"N-[(1S)-1-(1H-1,3-benzodiazol-2-yl)-2-[4-(1,1,3-trioxo-1$l^{6},2-thiazolidin-5-yl)phenyl]ethyl]-2,2-difluoropropanamide",13489,Isothiazolidinone (IZD) deriv. 25,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13489,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),300,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5465,2011968,23646423,BindingDB,"N-[(1S)-1-(1H-1,3-benzodiazol-2-yl)-2-[4-(1,1,3-trioxo-1$l^{6},2-thiazolidin-5-yl)phenyl]ethyl]-2,2-difluoro-2-phenylacetamide",13490,Isothiazolidinone (IZD) deriv. 26,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13490,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),200,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5466,2011969,23646424,BindingDB,"N-[(1S)-1-(1H-1,3-benzodiazol-2-yl)-2-[4-(1,1,3-trioxo-1$l^{6},2-thiazolidin-5-yl)phenyl]ethyl]-2-methylpropanamide",13491,Isothiazolidinone (IZD) deriv. 27,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13491,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),3200,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5467,2011970,23646425,BindingDB,"N-[(1S)-1-(1H-1,3-benzodiazol-2-yl)-2-[4-(1,1,3-trioxo-1$l^{6},2-thiazolidin-5-yl)phenyl]ethyl]-3-phenylpropanamide",13492,Isothiazolidinone (IZD) deriv. 28,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13492,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),600,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5468,2011971,23646426,BindingDB,Isothiazolidinone (IZD) deriv. 29,13493,Isothiazolidinone (IZD) deriv. 29,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13493,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),40,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5469,2011972,23646427,BindingDB,"N-[(1S)-1-(1H-1,3-benzodiazol-2-yl)-2-[4-(1,1,3-trioxo-1$l^{6},2-thiazolidin-5-yl)phenyl]ethyl]-3-fluorobenzene-1-sulfonamide",13495,Isothiazolidinone (IZD) deriv. 31,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13495,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),66,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5470,2011973,23646428,BindingDB,"N-[(1S)-1-(1H-1,3-benzodiazol-2-yl)-2-[4-(1,1,3-trioxo-1$l^{6},2-thiazolidin-5-yl)phenyl]ethyl]-3-methyl-4-phenylbenzene-1-sulfonamide",13497,Isothiazolidinone (IZD) deriv. 33,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13497,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),90,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5471,2011982,23646429,BindingDB,"N-[(1S)-1-(1H-1,3-benzodiazol-2-yl)-2-[4-(1,1,3-trioxo-1$l^{6},2-thiazolidin-5-yl)phenyl]ethyl]-4-(propan-2-yl)benzene-1-sulfonamide",13498,Isothiazolidinone (IZD) deriv. 34,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13498,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),100,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5472,2011983,23646430,BindingDB,"N-[(1S)-1-(1H-1,3-benzodiazol-2-yl)-2-[4-(1,1,3-trioxo-1$l^{6},2-thiazolidin-5-yl)phenyl]ethyl]-3-phenoxybenzene-1-sulfonamide",13499,Isothiazolidinone (IZD) deriv. 35,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13499,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),110,PMID:17028182|DOI:10.1074/jbc.M607913200,https://www.ncbi.nlm.nih.gov/pubmed/17028182|https://doi.org/10.1074/jbc.M607913200,17028182,10.1074/jbc.M607913200,
5473,2011994,23646441,BindingDB,"(3R)-3-amino-4-(2,5-difluorophenyl)-1-[(8R)-8-methyl-3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[3,4-a]pyrazin-7-yl]butan-1-one",13515,"(3R)-3-amino-4-(2,5-difluorophenyl)-1-[(8R)-8-methyl-3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[3,4-a]pyrazin-7-yl]butan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13515,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),7.2,PMID:17055272|DOI:10.1016/j.bmcl.2006.09.099,https://www.ncbi.nlm.nih.gov/pubmed/17055272|https://doi.org/10.1016/j.bmcl.2006.09.099,17055272,10.1016/j.bmcl.2006.09.099,
5474,2011995,23646442,BindingDB,"(5R)-1-[(3R)-3-amino-4-(2,5-difluorophenyl)butanoyl]-5-methylimidazolidin-4-one",13516,"(5R)-1-[(3R)-3-amino-4-(2,5-difluorophenyl)butanoyl]-5-methylimidazolidin-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13516,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),160,PMID:17055272|DOI:10.1016/j.bmcl.2006.09.099,https://www.ncbi.nlm.nih.gov/pubmed/17055272|https://doi.org/10.1016/j.bmcl.2006.09.099,17055272,10.1016/j.bmcl.2006.09.099,
5475,2011996,23646443,BindingDB,"(3R)-4-[(3R)-3-amino-4-(2,5-difluorophenyl)butanoyl]-3-methylpiperazin-2-one",13517,"(3R)-4-[(3R)-3-amino-4-(2,5-difluorophenyl)butanoyl]-3-methylpiperazin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13517,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),89,PMID:17055272|DOI:10.1016/j.bmcl.2006.09.099,https://www.ncbi.nlm.nih.gov/pubmed/17055272|https://doi.org/10.1016/j.bmcl.2006.09.099,17055272,10.1016/j.bmcl.2006.09.099,
5476,2011997,23646444,BindingDB,"(3R)-4-[(3R)-3-amino-4-(2,5-difluorophenyl)butanoyl]-3-methyl-1,4-diazepan-2-one",13518,"(3R)-4-[(3R)-3-amino-4-(2,5-difluorophenyl)butanoyl]-3-methyl-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13518,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),14,PMID:17055272|DOI:10.1016/j.bmcl.2006.09.099,https://www.ncbi.nlm.nih.gov/pubmed/17055272|https://doi.org/10.1016/j.bmcl.2006.09.099,17055272,10.1016/j.bmcl.2006.09.099,
5477,2011998,23646445,BindingDB,"(3S)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-methyl-1,4-diazepan-2-one",13520,"(3S)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-methyl-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13520,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),150,PMID:17055272|DOI:10.1016/j.bmcl.2006.09.099,https://www.ncbi.nlm.nih.gov/pubmed/17055272|https://doi.org/10.1016/j.bmcl.2006.09.099,17055272,10.1016/j.bmcl.2006.09.099,
5478,2011999,23646446,BindingDB,"(3S)-4-[(3S)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-methyl-1,4-diazepan-2-one",13521,"(3S)-4-[(3S)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-methyl-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13521,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),2300,PMID:17055272|DOI:10.1016/j.bmcl.2006.09.099,https://www.ncbi.nlm.nih.gov/pubmed/17055272|https://doi.org/10.1016/j.bmcl.2006.09.099,17055272,10.1016/j.bmcl.2006.09.099,
5479,2012000,23646447,BindingDB,"(3R)-4-[(3S)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-methyl-1,4-diazepan-2-one",13522,"(3R)-4-[(3S)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-methyl-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13522,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),67000,PMID:17055272|DOI:10.1016/j.bmcl.2006.09.099,https://www.ncbi.nlm.nih.gov/pubmed/17055272|https://doi.org/10.1016/j.bmcl.2006.09.099,17055272,10.1016/j.bmcl.2006.09.099,
5480,2012022,23646451,BindingDB,"(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(pyridin-2-ylmethyl)-1,4-diazepan-2-one",13527,"(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(pyridin-2-ylmethyl)-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13527,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),53000,PMID:17055272|DOI:10.1016/j.bmcl.2006.09.099,https://www.ncbi.nlm.nih.gov/pubmed/17055272|https://doi.org/10.1016/j.bmcl.2006.09.099,17055272,10.1016/j.bmcl.2006.09.099,
5481,2012023,23646451,BindingDB,"(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(pyridin-2-ylmethyl)-1,4-diazepan-2-one",13527,"(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(pyridin-2-ylmethyl)-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13527,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),0.49,PMID:17055272|DOI:10.1016/j.bmcl.2006.09.099,https://www.ncbi.nlm.nih.gov/pubmed/17055272|https://doi.org/10.1016/j.bmcl.2006.09.099,17055272,10.1016/j.bmcl.2006.09.099,
5482,2012024,23646451,BindingDB,"(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(pyridin-2-ylmethyl)-1,4-diazepan-2-one",13527,"(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(pyridin-2-ylmethyl)-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13527,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),89000,PMID:17055272|DOI:10.1016/j.bmcl.2006.09.099,https://www.ncbi.nlm.nih.gov/pubmed/17055272|https://doi.org/10.1016/j.bmcl.2006.09.099,17055272,10.1016/j.bmcl.2006.09.099,
5483,2012025,23646452,BindingDB,"(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(1H-pyrazol-1-ylmethyl)-1,4-diazepan-2-one",13528,"(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(1H-pyrazol-1-ylmethyl)-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13528,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),75000,PMID:17055272|DOI:10.1016/j.bmcl.2006.09.099,https://www.ncbi.nlm.nih.gov/pubmed/17055272|https://doi.org/10.1016/j.bmcl.2006.09.099,17055272,10.1016/j.bmcl.2006.09.099,
5484,2012026,23646452,BindingDB,"(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(1H-pyrazol-1-ylmethyl)-1,4-diazepan-2-one",13528,"(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(1H-pyrazol-1-ylmethyl)-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13528,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),0.29,PMID:17055272|DOI:10.1016/j.bmcl.2006.09.099,https://www.ncbi.nlm.nih.gov/pubmed/17055272|https://doi.org/10.1016/j.bmcl.2006.09.099,17055272,10.1016/j.bmcl.2006.09.099,
5485,2012027,23646452,BindingDB,"(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(1H-pyrazol-1-ylmethyl)-1,4-diazepan-2-one",13528,"(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(1H-pyrazol-1-ylmethyl)-1,4-diazepan-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13528,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),80000,PMID:17055272|DOI:10.1016/j.bmcl.2006.09.099,https://www.ncbi.nlm.nih.gov/pubmed/17055272|https://doi.org/10.1016/j.bmcl.2006.09.099,17055272,10.1016/j.bmcl.2006.09.099,
5486,2012028,23646453,BindingDB,"2-[(4-Carbamimidoylphenyl)amino]-2-(3,5-diethoxyphenyl)acetic acid",13558,"2-[(4-carbamimidoylphenyl)amino]-2-(3,5-diethoxyphenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13558,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),190,PMID:16213138|DOI:10.1016/j.bmcl.2005.04.079,https://www.ncbi.nlm.nih.gov/pubmed/16213138|https://doi.org/10.1016/j.bmcl.2005.04.079,16213138,10.1016/j.bmcl.2005.04.079,
5487,2012029,23646453,BindingDB,"2-[(4-Carbamimidoylphenyl)amino]-2-(3,5-diethoxyphenyl)acetic acid",13558,"2-[(4-carbamimidoylphenyl)amino]-2-(3,5-diethoxyphenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13558,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),16900,PMID:16213138|DOI:10.1016/j.bmcl.2005.04.079,https://www.ncbi.nlm.nih.gov/pubmed/16213138|https://doi.org/10.1016/j.bmcl.2005.04.079,16213138,10.1016/j.bmcl.2005.04.079,
5488,2012030,23646453,BindingDB,"2-[(4-Carbamimidoylphenyl)amino]-2-(3,5-diethoxyphenyl)acetic acid",13558,"2-[(4-carbamimidoylphenyl)amino]-2-(3,5-diethoxyphenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13558,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),5600,PMID:16213138|DOI:10.1016/j.bmcl.2005.04.079,https://www.ncbi.nlm.nih.gov/pubmed/16213138|https://doi.org/10.1016/j.bmcl.2005.04.079,16213138,10.1016/j.bmcl.2005.04.079,
5489,2012053,23646458,BindingDB,2-[(4-carbamimidoylphenyl)amino]-2-{3-ethynyl-5-[(3R)-oxolan-3-yloxy]phenyl}acetic acid,13569,2-[(4-carbamimidoylphenyl)amino]-2-{3-ethynyl-5-[(3R)-oxolan-3-yloxy]phenyl}acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13569,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),8800,PMID:16213138|DOI:10.1016/j.bmcl.2005.04.079,https://www.ncbi.nlm.nih.gov/pubmed/16213138|https://doi.org/10.1016/j.bmcl.2005.04.079,16213138,10.1016/j.bmcl.2005.04.079,
5490,2012054,23646458,BindingDB,2-[(4-carbamimidoylphenyl)amino]-2-{3-ethynyl-5-[(3R)-oxolan-3-yloxy]phenyl}acetic acid,13569,2-[(4-carbamimidoylphenyl)amino]-2-{3-ethynyl-5-[(3R)-oxolan-3-yloxy]phenyl}acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13569,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),6600,PMID:16213138|DOI:10.1016/j.bmcl.2005.04.079,https://www.ncbi.nlm.nih.gov/pubmed/16213138|https://doi.org/10.1016/j.bmcl.2005.04.079,16213138,10.1016/j.bmcl.2005.04.079,
5491,2012055,23646458,BindingDB,2-[(4-carbamimidoylphenyl)amino]-2-{3-ethynyl-5-[(3R)-oxolan-3-yloxy]phenyl}acetic acid,13569,2-[(4-carbamimidoylphenyl)amino]-2-{3-ethynyl-5-[(3R)-oxolan-3-yloxy]phenyl}acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13569,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),15300,PMID:16213138|DOI:10.1016/j.bmcl.2005.04.079,https://www.ncbi.nlm.nih.gov/pubmed/16213138|https://doi.org/10.1016/j.bmcl.2005.04.079,16213138,10.1016/j.bmcl.2005.04.079,
5492,2012056,23646459,BindingDB,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{3-ethoxy-5-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,13570,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{3-ethoxy-5-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13570,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),1500,PMID:16213138|DOI:10.1016/j.bmcl.2005.04.079,https://www.ncbi.nlm.nih.gov/pubmed/16213138|https://doi.org/10.1016/j.bmcl.2005.04.079,16213138,10.1016/j.bmcl.2005.04.079,
5493,2012057,23646459,BindingDB,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{3-ethoxy-5-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,13570,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{3-ethoxy-5-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13570,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),4500,PMID:16213138|DOI:10.1016/j.bmcl.2005.04.079,https://www.ncbi.nlm.nih.gov/pubmed/16213138|https://doi.org/10.1016/j.bmcl.2005.04.079,16213138,10.1016/j.bmcl.2005.04.079,
5494,2012058,23646459,BindingDB,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{3-ethoxy-5-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,13570,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{3-ethoxy-5-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13570,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),4600,PMID:16213138|DOI:10.1016/j.bmcl.2005.04.079,https://www.ncbi.nlm.nih.gov/pubmed/16213138|https://doi.org/10.1016/j.bmcl.2005.04.079,16213138,10.1016/j.bmcl.2005.04.079,
5495,2012059,23646459,BindingDB,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{3-ethoxy-5-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,13570,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{3-ethoxy-5-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13570,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),120,PMID:16213138|DOI:10.1016/j.bmcl.2005.04.079,https://www.ncbi.nlm.nih.gov/pubmed/16213138|https://doi.org/10.1016/j.bmcl.2005.04.079,16213138,10.1016/j.bmcl.2005.04.079,
5496,2012060,23646460,BindingDB,2-[(4-Carbamimidoylphenyl)amino]-2-[3-ethoxy-5-(pyridin-3-yl)phenyl]acetic acid,13572,2-[(4-carbamimidoylphenyl)amino]-2-[3-ethoxy-5-(pyridin-3-yl)phenyl]acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13572,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),510,PMID:16213138|DOI:10.1016/j.bmcl.2005.04.079,https://www.ncbi.nlm.nih.gov/pubmed/16213138|https://doi.org/10.1016/j.bmcl.2005.04.079,16213138,10.1016/j.bmcl.2005.04.079,
5497,2012061,23646460,BindingDB,2-[(4-Carbamimidoylphenyl)amino]-2-[3-ethoxy-5-(pyridin-3-yl)phenyl]acetic acid,13572,2-[(4-carbamimidoylphenyl)amino]-2-[3-ethoxy-5-(pyridin-3-yl)phenyl]acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13572,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),10200,PMID:16213138|DOI:10.1016/j.bmcl.2005.04.079,https://www.ncbi.nlm.nih.gov/pubmed/16213138|https://doi.org/10.1016/j.bmcl.2005.04.079,16213138,10.1016/j.bmcl.2005.04.079,
5498,2012074,23646463,BindingDB,2-[2-(benzenesulfonyl)-4-(benzyloxy)-5-methoxyphenyl]-N-benzyl-2-[(4-carbamimidoylphenyl)amino]acetamide,13582,2-[2-(benzenesulfonyl)-4-(benzyloxy)-5-methoxyphenyl]-N-benzyl-2-[(4-carbamimidoylphenyl)amino]acetamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13582,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),>74000,PMID:15664864|DOI:10.1016/j.bmcl.2004.10.092,https://www.ncbi.nlm.nih.gov/pubmed/15664864|https://doi.org/10.1016/j.bmcl.2004.10.092,15664864,10.1016/j.bmcl.2004.10.092,
5499,2012075,23646463,BindingDB,2-[2-(benzenesulfonyl)-4-(benzyloxy)-5-methoxyphenyl]-N-benzyl-2-[(4-carbamimidoylphenyl)amino]acetamide,13582,2-[2-(benzenesulfonyl)-4-(benzyloxy)-5-methoxyphenyl]-N-benzyl-2-[(4-carbamimidoylphenyl)amino]acetamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13582,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),420,PMID:15664864|DOI:10.1016/j.bmcl.2004.10.092,https://www.ncbi.nlm.nih.gov/pubmed/15664864|https://doi.org/10.1016/j.bmcl.2004.10.092,15664864,10.1016/j.bmcl.2004.10.092,
5500,2012076,23646464,BindingDB,2-[(4-Carbamimidoylphenyl)amino]-2-[3-ethoxy-5-(oxolan-3-yloxy)phenyl]acetic acid,13588,(4-Carbamimidoyl-phenylamino)-[3-ethoxy-5-(tetra-hydrofuran-3-yloxy)-phenyl]-acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13588,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),140,PMID:16621574|DOI:10.1016/j.bmc.2006.03.042,https://www.ncbi.nlm.nih.gov/pubmed/16621574|https://doi.org/10.1016/j.bmc.2006.03.042,16621574,10.1016/j.bmc.2006.03.042,
5501,2012077,23646464,BindingDB,2-[(4-Carbamimidoylphenyl)amino]-2-[3-ethoxy-5-(oxolan-3-yloxy)phenyl]acetic acid,13588,(4-Carbamimidoyl-phenylamino)-[3-ethoxy-5-(tetra-hydrofuran-3-yloxy)-phenyl]-acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13588,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),10700,PMID:16621574|DOI:10.1016/j.bmc.2006.03.042,https://www.ncbi.nlm.nih.gov/pubmed/16621574|https://doi.org/10.1016/j.bmc.2006.03.042,16621574,10.1016/j.bmc.2006.03.042,
5502,2012078,23646464,BindingDB,2-[(4-Carbamimidoylphenyl)amino]-2-[3-ethoxy-5-(oxolan-3-yloxy)phenyl]acetic acid,13588,(4-Carbamimidoyl-phenylamino)-[3-ethoxy-5-(tetra-hydrofuran-3-yloxy)-phenyl]-acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13588,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),>6800,PMID:16621574|DOI:10.1016/j.bmc.2006.03.042,https://www.ncbi.nlm.nih.gov/pubmed/16621574|https://doi.org/10.1016/j.bmc.2006.03.042,16621574,10.1016/j.bmc.2006.03.042,
5503,2012079,23646464,BindingDB,2-[(4-Carbamimidoylphenyl)amino]-2-[3-ethoxy-5-(oxolan-3-yloxy)phenyl]acetic acid,13588,(4-Carbamimidoyl-phenylamino)-[3-ethoxy-5-(tetra-hydrofuran-3-yloxy)-phenyl]-acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13588,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2900,PMID:16621574|DOI:10.1016/j.bmc.2006.03.042,https://www.ncbi.nlm.nih.gov/pubmed/16621574|https://doi.org/10.1016/j.bmc.2006.03.042,16621574,10.1016/j.bmc.2006.03.042,
5504,2012080,23646465,BindingDB,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{5-ethoxy-2-fluoro-3-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,13591,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{5-ethoxy-2-fluoro-3-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13591,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),3700,PMID:16621574|DOI:10.1016/j.bmc.2006.03.042,https://www.ncbi.nlm.nih.gov/pubmed/16621574|https://doi.org/10.1016/j.bmc.2006.03.042,16621574,10.1016/j.bmc.2006.03.042,
5505,2012081,23646465,BindingDB,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{5-ethoxy-2-fluoro-3-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,13591,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{5-ethoxy-2-fluoro-3-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13591,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),1500,PMID:16621574|DOI:10.1016/j.bmc.2006.03.042,https://www.ncbi.nlm.nih.gov/pubmed/16621574|https://doi.org/10.1016/j.bmc.2006.03.042,16621574,10.1016/j.bmc.2006.03.042,
5506,2012082,23646465,BindingDB,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{5-ethoxy-2-fluoro-3-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,13591,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{5-ethoxy-2-fluoro-3-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13591,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),410,PMID:16621574|DOI:10.1016/j.bmc.2006.03.042,https://www.ncbi.nlm.nih.gov/pubmed/16621574|https://doi.org/10.1016/j.bmc.2006.03.042,16621574,10.1016/j.bmc.2006.03.042,
5507,2012083,23646465,BindingDB,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{5-ethoxy-2-fluoro-3-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,13591,(2R)-2-[(4-carbamimidoylphenyl)amino]-2-{5-ethoxy-2-fluoro-3-[(3S)-oxolan-3-yloxy]phenyl}acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13591,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),35,PMID:16621574|DOI:10.1016/j.bmc.2006.03.042,https://www.ncbi.nlm.nih.gov/pubmed/16621574|https://doi.org/10.1016/j.bmc.2006.03.042,16621574,10.1016/j.bmc.2006.03.042,
5508,2012084,23646466,BindingDB,"({4-[(2R)-2-(1H-1,2,3-benzotriazol-1-yl)-2-phenylethyl]phenyl}difluoromethyl)phosphonic acid",13593,"({4-[(2R)-2-(1H-1,2,3-benzotriazol-1-yl)-2-phenylethyl]phenyl}difluoromethyl)phosphonic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13593,1384,Tyrosine-protein phosphatase non-receptor type 1 [1-298],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1384,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),8040,PMID:14516196|DOI:10.1021/bi035098j,https://www.ncbi.nlm.nih.gov/pubmed/14516196|https://doi.org/10.1021/bi035098j,14516196,10.1021/bi035098j,
5509,2012085,23646469,BindingDB,(3S)-3-{[(1S)-1-{[(1S)-1-carbamoylpentyl]carbamoyl}-2-[4-(sulfooxy)phenyl]ethyl]carbamoyl}-3-acetamidopropanoic acid,13606,(3S)-3-{[(1S)-1-{[(1S)-1-carbamoylpentyl]carbamoyl}-2-[4-(sulfooxy)phenyl]ethyl]carbamoyl}-3-acetamidopropanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13606,1405,Tyrosine-protein phosphatase non-receptor type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1405,P20417,Tyrosine-protein phosphatase non-receptor type 1,24697.0,Ptpn1,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),5000,PMID:11341829|DOI:10.1021/bi002865v,https://www.ncbi.nlm.nih.gov/pubmed/11341829|https://doi.org/10.1021/bi002865v,11341829,10.1021/bi002865v,
5510,2012096,23646470,BindingDB,2-(carboxymethoxy)-5-[(2S)-2-(3-formamidopropanoic acid)-2-(pentylcarbamoyl)ethyl]benzoic acid,13610,2-(carboxymethoxy)-5-[(2S)-2-(3-formamidopropanoic acid)-2-(pentylcarbamoyl)ethyl]benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13610,1405,Tyrosine-protein phosphatase non-receptor type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1405,P20417,Tyrosine-protein phosphatase non-receptor type 1,24697.0,Ptpn1,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),2800,PMID:11341829|DOI:10.1021/bi002865v,https://www.ncbi.nlm.nih.gov/pubmed/11341829|https://doi.org/10.1021/bi002865v,11341829,10.1021/bi002865v,
5511,2012097,23646471,BindingDB,"2-(carboxymethoxy)-5-[(2S)-2-(pentylcarbamoyl)-2-[(2S)-3-phenyl-2-[1-(5-sulfanyl-1H-1,2,3-triazol-1-yl)acetamido]propanamido]ethyl]benzoic acid",13614,"2-(carboxymethoxy)-5-[(2S)-2-(pentylcarbamoyl)-2-[(2S)-3-phenyl-2-[1-(5-sulfanyl-1H-1,2,3-triazol-1-yl)acetamido]propanamido]ethyl]benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13614,1405,Tyrosine-protein phosphatase non-receptor type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1405,P20417,Tyrosine-protein phosphatase non-receptor type 1,24697.0,Ptpn1,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),120,PMID:11341829|DOI:10.1021/bi002865v,https://www.ncbi.nlm.nih.gov/pubmed/11341829|https://doi.org/10.1021/bi002865v,11341829,10.1021/bi002865v,
5512,2012098,23646472,BindingDB,4-chloro-3-[2-(4-acetamidophenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13628,3-Oxybenzamide 14,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13628,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),10000,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
5513,2012099,23646473,BindingDB,3-[2-(4-acetamidophenyl)ethoxy]-4-fluoro-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide,13638,3-Oxybenzamide 24,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13638,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),10000,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
5514,2012100,23646474,BindingDB,"3-[2-(2,4-dichlorophenyl)ethoxy]-4-iodo-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide",13641,3-Oxybenzamide 27,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13641,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),156,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
5515,2012101,23646475,BindingDB,"3-bromo-5-[2-(2,4-dichlorophenyl)ethoxy]-4-methoxy-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide",13661,3-Oxybenzamide 47,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13661,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),1053,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
5516,2012102,23646476,BindingDB,"2-Bromo-3-[2-(2,4-dichlorophenyl)ethoxy]-5-({[1-(pyridin-4-yl)piperidin-4-yl]methyl}carbamoyl)phenyl acetate",13669,"2-bromo-3-[2-(2,4-dichlorophenyl)ethoxy]-5-({[1-(pyridin-4-yl)piperidin-4-yl]methyl}carbamoyl)phenyl acetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13669,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),285,PMID:15857135|DOI:10.1021/jm049187l,https://www.ncbi.nlm.nih.gov/pubmed/15857135|https://doi.org/10.1021/jm049187l,15857135,10.1021/jm049187l,
5517,2012103,23646477,BindingDB,Morpholinone-based inhibitor 35,13737,"(2S)-3-[(3S)-3-benzyl-5-oxo-1,9-dioxa-4-azaspiro[5.5]undecan-4-yl]-N-(cyclopentylmethyl)-2-hydroxy-N-(4-methoxyphenyl)propane-1-sulfonamido",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13737,125,"Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=125,P03367,Gag-Pol polyprotein,,,11686.0,Human immunodeficiency virus type 1 (BRU ISOLATE),,Ki (nM),23,PMID:16904316|DOI:10.1016/j.bmcl.2006.07.014,https://www.ncbi.nlm.nih.gov/pubmed/16904316|https://doi.org/10.1016/j.bmcl.2006.07.014,16904316,10.1016/j.bmcl.2006.07.014,
5518,2012104,23646478,BindingDB,,13746,2-((S)-1-(2-fluorophenyl)ethylamino)-5-isopropyl-5-methylthiazol-4(5H)-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13746,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,Ki (nM),3,PMID:17266194|DOI:10.1021/jm061214f,https://www.ncbi.nlm.nih.gov/pubmed/17266194|https://doi.org/10.1021/jm061214f,17266194,10.1021/jm061214f,
5519,2012105,23646479,BindingDB,Adamantane ether 5,13755,"(1R,3R,4S,7S)-4-(2-methyl-2-phenoxypropanamido)adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13755,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),1500,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5520,2012106,23646479,BindingDB,Adamantane ether 5,13755,"(1R,3R,4S,7S)-4-(2-methyl-2-phenoxypropanamido)adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13755,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),119,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5521,2012107,23646479,BindingDB,Adamantane ether 5,13755,"(1R,3R,4S,7S)-4-(2-methyl-2-phenoxypropanamido)adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13755,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),39,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5522,2012108,23646479,BindingDB,Adamantane ether 5,13755,"(1R,3R,4S,7S)-4-(2-methyl-2-phenoxypropanamido)adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13755,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),17000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5523,2012109,23646480,BindingDB,Adamantane ether 6,13756,"(1R,3R,4S,7S)-4-(2-methyl-2-phenoxypropanamido)adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13756,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),23000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5524,2012110,23646480,BindingDB,Adamantane ether 6,13756,"(1R,3R,4S,7S)-4-(2-methyl-2-phenoxypropanamido)adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13756,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),5,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5525,2012111,23646480,BindingDB,Adamantane ether 6,13756,"(1R,3R,4S,7S)-4-(2-methyl-2-phenoxypropanamido)adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13756,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),4,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5526,2012112,23646480,BindingDB,Adamantane ether 6,13756,"(1R,3R,4S,7S)-4-(2-methyl-2-phenoxypropanamido)adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13756,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),40000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5527,2012113,23646481,BindingDB,Adamantane ether 7,13757,"(1R,3R,4S,7S)-4-[2-(2-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13757,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),140,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5528,2012114,23646481,BindingDB,Adamantane ether 7,13757,"(1R,3R,4S,7S)-4-[2-(2-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13757,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),8,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5529,2012115,23646481,BindingDB,Adamantane ether 7,13757,"(1R,3R,4S,7S)-4-[2-(2-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13757,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),8,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5530,2012116,23646481,BindingDB,Adamantane ether 7,13757,"(1R,3R,4S,7S)-4-[2-(2-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13757,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),1800,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5531,2012117,23646482,BindingDB,Adamantane ether 8,13758,"(1R,3R,4S,7S)-4-[2-(3-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13758,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),3500,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5532,2012118,23646482,BindingDB,Adamantane ether 8,13758,"(1R,3R,4S,7S)-4-[2-(3-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13758,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),15,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5533,2012119,23646482,BindingDB,Adamantane ether 8,13758,"(1R,3R,4S,7S)-4-[2-(3-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13758,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),51,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5534,2012120,23646482,BindingDB,Adamantane ether 8,13758,"(1R,3R,4S,7S)-4-[2-(3-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13758,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),540,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5535,2012121,23646483,BindingDB,Adamantane ether 9,13759,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13759,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),1700,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5536,2012122,23646483,BindingDB,Adamantane ether 9,13759,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13759,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),70,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5537,2012123,23646483,BindingDB,Adamantane ether 9,13759,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13759,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),22,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5538,2012124,23646483,BindingDB,Adamantane ether 9,13759,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13759,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),30000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5539,2012125,23646484,BindingDB,Adamantane ether 10,13760,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13760,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),12000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5540,2012126,23646484,BindingDB,Adamantane ether 10,13760,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13760,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),6,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5541,2012127,23646484,BindingDB,Adamantane ether 10,13760,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13760,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),3,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5542,2012128,23646484,BindingDB,Adamantane ether 10,13760,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13760,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),40000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5543,2012129,23646485,BindingDB,Adamantane ether 15,13761,"(1R,3R,4S,7S)-4-[2-(4-methoxyphenoxy)-2-methylpropanamido]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13761,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),55000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5544,2012130,23646485,BindingDB,Adamantane ether 15,13761,"(1R,3R,4S,7S)-4-[2-(4-methoxyphenoxy)-2-methylpropanamido]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13761,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),4,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5545,2012131,23646485,BindingDB,Adamantane ether 15,13761,"(1R,3R,4S,7S)-4-[2-(4-methoxyphenoxy)-2-methylpropanamido]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13761,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),6,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5546,2012132,23646485,BindingDB,Adamantane ether 15,13761,"(1R,3R,4S,7S)-4-[2-(4-methoxyphenoxy)-2-methylpropanamido]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13761,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),18000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5547,2012133,23646486,BindingDB,Adamantane ether 16,13762,"4-({[(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantan-1-yl]formamido}methyl)benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13762,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),20000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5548,2012134,23646486,BindingDB,Adamantane ether 16,13762,"4-({[(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantan-1-yl]formamido}methyl)benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13762,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),15,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5549,2012135,23646486,BindingDB,Adamantane ether 16,13762,"4-({[(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantan-1-yl]formamido}methyl)benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13762,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),12,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5550,2012136,23646486,BindingDB,Adamantane ether 16,13762,"4-({[(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantan-1-yl]formamido}methyl)benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13762,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),5800,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5551,2012137,23646487,BindingDB,Adamantane ether 17,13763,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-{[4-(methanesulfonylcarbamoyl)phenyl]methyl}adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13763,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),10000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5552,2012149,23646487,BindingDB,Adamantane ether 17,13763,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-{[4-(methanesulfonylcarbamoyl)phenyl]methyl}adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13763,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),25,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5553,2012150,23646487,BindingDB,Adamantane ether 17,13763,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-{[4-(methanesulfonylcarbamoyl)phenyl]methyl}adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13763,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),25,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5554,2012151,23646487,BindingDB,Adamantane ether 17,13763,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-{[4-(methanesulfonylcarbamoyl)phenyl]methyl}adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13763,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),50000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5555,2012152,23646488,BindingDB,Adamantane ether 18,13764,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-{[4-(1H-1,2,3,4-tetrazol-5-yl)phenyl]methyl}adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13764,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),26000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5556,2012153,23646488,BindingDB,Adamantane ether 18,13764,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-{[4-(1H-1,2,3,4-tetrazol-5-yl)phenyl]methyl}adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13764,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),16,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5557,2012154,23646488,BindingDB,Adamantane ether 18,13764,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-{[4-(1H-1,2,3,4-tetrazol-5-yl)phenyl]methyl}adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13764,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),18,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5558,2012155,23646488,BindingDB,Adamantane ether 18,13764,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-{[4-(1H-1,2,3,4-tetrazol-5-yl)phenyl]methyl}adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13764,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),6200,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5559,2012166,23646489,BindingDB,Adamantane ether 19,13765,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-[(4-sulfamoylphenyl)methyl]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13765,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),16000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5560,2012167,23646489,BindingDB,Adamantane ether 19,13765,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-[(4-sulfamoylphenyl)methyl]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13765,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),24,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5561,2012168,23646489,BindingDB,Adamantane ether 19,13765,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-[(4-sulfamoylphenyl)methyl]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13765,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),51,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5562,2012169,23646489,BindingDB,Adamantane ether 19,13765,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-[(4-sulfamoylphenyl)methyl]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13765,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),>30000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5563,2012170,23646490,BindingDB,Adamantane ether 20,13766,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-(1,3-thiazol-5-ylmethyl)adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13766,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),13000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5564,2012171,23646490,BindingDB,Adamantane ether 20,13766,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-(1,3-thiazol-5-ylmethyl)adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13766,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),27,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5565,2012172,23646490,BindingDB,Adamantane ether 20,13766,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-(1,3-thiazol-5-ylmethyl)adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13766,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),11,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5566,2012194,23646490,BindingDB,Adamantane ether 20,13766,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-(1,3-thiazol-5-ylmethyl)adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13766,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),21000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5567,2012195,23646491,BindingDB,Adamantane ether 21,13767,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13767,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),19000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5568,2012196,23646491,BindingDB,Adamantane ether 21,13767,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13767,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),14,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5569,2012197,23646491,BindingDB,Adamantane ether 21,13767,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13767,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),25,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5570,2012198,23646491,BindingDB,Adamantane ether 21,13767,"(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13767,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),5300,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5571,2012199,23646492,BindingDB,Adamantane ether 22,13768,"N-[(1R,2S,5R,7S)-5-[(carbamoylmethyl)carbamoyl]adamantan-2-yl]-2-(4-chlorophenoxy)-2-methylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13768,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),20000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5572,2012200,23646492,BindingDB,Adamantane ether 22,13768,"N-[(1R,2S,5R,7S)-5-[(carbamoylmethyl)carbamoyl]adamantan-2-yl]-2-(4-chlorophenoxy)-2-methylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13768,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),12,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5573,2012218,23646492,BindingDB,Adamantane ether 22,13768,"N-[(1R,2S,5R,7S)-5-[(carbamoylmethyl)carbamoyl]adamantan-2-yl]-2-(4-chlorophenoxy)-2-methylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13768,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),4,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5574,2012219,23646492,BindingDB,Adamantane ether 22,13768,"N-[(1R,2S,5R,7S)-5-[(carbamoylmethyl)carbamoyl]adamantan-2-yl]-2-(4-chlorophenoxy)-2-methylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13768,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),90000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5575,2012220,23646493,BindingDB,Adamantane ether 23,13769,"2-(4-chlorophenoxy)-2-methyl-N-[(1R,2S,5R,7S)-5-{[(methylcarbamoyl)amino]carbonyl}adamantan-2-yl]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13769,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),8,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5576,2012221,23646493,BindingDB,Adamantane ether 23,13769,"2-(4-chlorophenoxy)-2-methyl-N-[(1R,2S,5R,7S)-5-{[(methylcarbamoyl)amino]carbonyl}adamantan-2-yl]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13769,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),16000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5577,2012222,23646493,BindingDB,Adamantane ether 23,13769,"2-(4-chlorophenoxy)-2-methyl-N-[(1R,2S,5R,7S)-5-{[(methylcarbamoyl)amino]carbonyl}adamantan-2-yl]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13769,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),13,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5578,2012223,23646493,BindingDB,Adamantane ether 23,13769,"2-(4-chlorophenoxy)-2-methyl-N-[(1R,2S,5R,7S)-5-{[(methylcarbamoyl)amino]carbonyl}adamantan-2-yl]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13769,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),12000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5579,2012224,23646494,BindingDB,Adamantane ether 24,13770,"2-(4-chlorophenoxy)-N-[(1R,2S,5R,7S)-5-(hydroxymethyl)adamantan-2-yl]-2-methylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13770,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),25000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5580,2012241,23646494,BindingDB,Adamantane ether 24,13770,"2-(4-chlorophenoxy)-N-[(1R,2S,5R,7S)-5-(hydroxymethyl)adamantan-2-yl]-2-methylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13770,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),9,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5581,2012242,23646494,BindingDB,Adamantane ether 24,13770,"2-(4-chlorophenoxy)-N-[(1R,2S,5R,7S)-5-(hydroxymethyl)adamantan-2-yl]-2-methylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13770,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),>100000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5582,2012243,23646494,BindingDB,Adamantane ether 24,13770,"2-(4-chlorophenoxy)-N-[(1R,2S,5R,7S)-5-(hydroxymethyl)adamantan-2-yl]-2-methylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13770,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),6,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5583,2012244,23646495,BindingDB,Adamantane ether 25,13771,"2-{[(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantan-1-yl]methoxy}acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13771,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),210,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5584,2012245,23646495,BindingDB,Adamantane ether 25,13771,"2-{[(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantan-1-yl]methoxy}acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13771,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),45000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5585,2012246,23646495,BindingDB,Adamantane ether 25,13771,"2-{[(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantan-1-yl]methoxy}acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13771,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),110,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5586,2012247,23646495,BindingDB,Adamantane ether 25,13771,"2-{[(1R,3R,4S,7S)-4-[2-(4-chlorophenoxy)-2-methylpropanamido]adamantan-1-yl]methoxy}acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13771,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5587,2012268,23646496,BindingDB,Adamantane ether 26,13772,"2-(2-chloro-4-fluorophenoxy)-2-methyl-N-[(1R,2S,5R,7S)-5-(1H-1,2,3,4-tetrazol-5-yl)adamantan-2-yl]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13772,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),550,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5588,2012269,23646496,BindingDB,Adamantane ether 26,13772,"2-(2-chloro-4-fluorophenoxy)-2-methyl-N-[(1R,2S,5R,7S)-5-(1H-1,2,3,4-tetrazol-5-yl)adamantan-2-yl]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13772,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),11,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5589,2012270,23646496,BindingDB,Adamantane ether 26,13772,"2-(2-chloro-4-fluorophenoxy)-2-methyl-N-[(1R,2S,5R,7S)-5-(1H-1,2,3,4-tetrazol-5-yl)adamantan-2-yl]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13772,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),1200,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5590,2012271,23646496,BindingDB,Adamantane ether 26,13772,"2-(2-chloro-4-fluorophenoxy)-2-methyl-N-[(1R,2S,5R,7S)-5-(1H-1,2,3,4-tetrazol-5-yl)adamantan-2-yl]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13772,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),10,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5591,2012272,23646497,BindingDB,Adamantane ether 27,13773,"(1R,3R,4S,7S)-4-[2-(2-chlorophenoxy)-2-methylpropanamido]-N-methanesulfonyladamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13773,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),28,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5592,2012273,23646497,BindingDB,Adamantane ether 27,13773,"(1R,3R,4S,7S)-4-[2-(2-chlorophenoxy)-2-methylpropanamido]-N-methanesulfonyladamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13773,1409,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1409,P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,15484.0,Hsd11b2,10090.0,Mus musculus (house mouse),,IC50 (nM),1200,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5593,2012274,23646497,BindingDB,Adamantane ether 27,13773,"(1R,3R,4S,7S)-4-[2-(2-chlorophenoxy)-2-methylpropanamido]-N-methanesulfonyladamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13773,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),96,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5594,2012290,23646497,BindingDB,Adamantane ether 27,13773,"(1R,3R,4S,7S)-4-[2-(2-chlorophenoxy)-2-methylpropanamido]-N-methanesulfonyladamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13773,1407,11-beta-hydroxysteroid dehydrogenase type 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1407,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606.0,Homo sapiens (human),,IC50 (nM),580,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5595,2012291,23646498,BindingDB,Adamantane ether 28,13774,"(1R,3R,4S,7S)-N-(benzenesulfonyl)-4-[2-(2-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13774,1406,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1406,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),500,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5596,2012292,23646498,BindingDB,Adamantane ether 28,13774,"(1R,3R,4S,7S)-N-(benzenesulfonyl)-4-[2-(2-chlorophenoxy)-2-methylpropanamido]adamantane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13774,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),1000,PMID:17110106|DOI:10.1016/j.bmcl.2006.10.074,https://www.ncbi.nlm.nih.gov/pubmed/17110106|https://doi.org/10.1016/j.bmcl.2006.10.074,17110106,10.1016/j.bmcl.2006.10.074,
5597,2012293,23646499,BindingDB,,13776,"2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(3-nitrophenyl)phenyl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13776,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),15,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5598,2012294,23646499,BindingDB,,13776,"2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(3-nitrophenyl)phenyl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13776,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),320,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5599,2012295,23646499,BindingDB,,13776,"2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(3-nitrophenyl)phenyl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13776,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),11000,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5600,2012296,23646499,BindingDB,,13776,"2-[3-(5-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(3-nitrophenyl)phenyl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13776,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),>150000,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5601,2012297,23646500,BindingDB,,13779,"2-[3-(1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(3-nitrophenyl)phenyl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13779,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),>150000,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5602,2012298,23646500,BindingDB,,13779,"2-[3-(1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(3-nitrophenyl)phenyl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13779,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),>150000,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5603,2012299,23646500,BindingDB,,13779,"2-[3-(1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(3-nitrophenyl)phenyl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13779,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),>150000,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5604,2012300,23646500,BindingDB,,13779,"2-[3-(1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(3-nitrophenyl)phenyl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13779,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),11000,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5605,2012301,23646501,BindingDB,,13780,"2-(3-{5-amino-1H-imidazo[4,5-b]pyridin-2-yl}-4-hydroxy-5-(3-nitrophenyl)phenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13780,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),39000,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5606,2012302,23646501,BindingDB,,13780,"2-(3-{5-amino-1H-imidazo[4,5-b]pyridin-2-yl}-4-hydroxy-5-(3-nitrophenyl)phenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13780,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),>150000,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5607,2012303,23646501,BindingDB,,13780,"2-(3-{5-amino-1H-imidazo[4,5-b]pyridin-2-yl}-4-hydroxy-5-(3-nitrophenyl)phenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13780,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),>150000,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5608,2012304,23646501,BindingDB,,13780,"2-(3-{5-amino-1H-imidazo[4,5-b]pyridin-2-yl}-4-hydroxy-5-(3-nitrophenyl)phenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13780,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),>150000,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5609,2012314,23646502,BindingDB,,13782,"2-(3-{5-amino-1H-pyrrolo[3,2-b]pyridin-2-yl}-4-hydroxy-5-phenylphenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13782,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),2400,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5610,2012315,23646503,BindingDB,,13783,"2-(3-{5-amino-1H-pyrrolo[3,2-b]pyridin-2-yl}-4-hydroxy-5-(3-methanesulfonylphenyl)phenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13783,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),7400,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5611,2012316,23646504,BindingDB,,13784,"2-(3-{5-amino-1H-pyrrolo[3,2-b]pyridin-2-yl}-4-hydroxy-5-(3-hydroxyphenyl)phenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13784,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),2500,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5612,2012317,23646505,BindingDB,,13785,"2-(3-{5-amino-1H-pyrrolo[3,2-b]pyridin-2-yl}-5-[3-(carbamoylamino)phenyl]-4-hydroxyphenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13785,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),12000,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5613,2012318,23646506,BindingDB,,13787,"2-(3-{5-amino-1H-pyrrolo[3,2-b]pyridin-2-yl}-4-hydroxy-5-(3-{[(pyridin-3-ylcarbamoyl)amino]methyl}phenyl)phenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13787,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),62,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5614,2012319,23646507,BindingDB,,13788,"2-(3-{5-amino-1H-pyrrolo[3,2-b]pyridin-2-yl}-5-{3-[({[2-(dimethylamino)ethyl]carbamoyl}amino)methyl]phenyl}-4-hydroxyphenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13788,1346,Coagulation factor VII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1346,P08709,Coagulation factor VII,2155.0,F7,9606.0,Homo sapiens (human),,Ki (nM),1400,PMID:16460932|DOI:10.1016/j.bmcl.2006.01.017,https://www.ncbi.nlm.nih.gov/pubmed/16460932|https://doi.org/10.1016/j.bmcl.2006.01.017,16460932,10.1016/j.bmcl.2006.01.017,
5615,2012320,23646508,BindingDB,"2-(3-aminopiperidin-1-yl)-1-[(2-chlorophenyl)methyl]-5-methyl-1H,4H,5H,6H-pyrrolo[3,4-d]imidazole-4,6-dione",13794,"2-(3-aminopiperidin-1-yl)-1-[(2-chlorophenyl)methyl]-5-methyl-1H,4H,5H,6H-pyrrolo[3,4-d]imidazole-4,6-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13794,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,Ki (nM),9,PMID:17010607|DOI:10.1016/j.bmcl.2006.09.024,https://www.ncbi.nlm.nih.gov/pubmed/17010607|https://doi.org/10.1016/j.bmcl.2006.09.024,17010607,10.1016/j.bmcl.2006.09.024,
5616,2012347,23646509,BindingDB,"2-(3-aminopiperidin-1-yl)-5-methyl-1-{[2-(trifluoromethyl)phenyl]methyl}-1H,4H,5H,6H-pyrrolo[3,4-d]imidazole-4,6-dione",13795,"2-(3-aminopiperidin-1-yl)-5-methyl-1-{[2-(trifluoromethyl)phenyl]methyl}-1H,4H,5H,6H-pyrrolo[3,4-d]imidazole-4,6-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13795,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,Ki (nM),10,PMID:17010607|DOI:10.1016/j.bmcl.2006.09.024,https://www.ncbi.nlm.nih.gov/pubmed/17010607|https://doi.org/10.1016/j.bmcl.2006.09.024,17010607,10.1016/j.bmcl.2006.09.024,
5617,2012348,23646510,BindingDB,"2-(3-aminopiperidin-1-yl)-5-methyl-1-{[2-(trifluoromethoxy)phenyl]methyl}-1H,4H,5H,6H-pyrrolo[3,4-d]imidazole-4,6-dione",13796,"2-(3-aminopiperidin-1-yl)-5-methyl-1-{[2-(trifluoromethoxy)phenyl]methyl}-1H,4H,5H,6H-pyrrolo[3,4-d]imidazole-4,6-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13796,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,Ki (nM),22,PMID:17010607|DOI:10.1016/j.bmcl.2006.09.024,https://www.ncbi.nlm.nih.gov/pubmed/17010607|https://doi.org/10.1016/j.bmcl.2006.09.024,17010607,10.1016/j.bmcl.2006.09.024,
5618,2012349,23646511,BindingDB,"3-{[2-(3-aminopiperidin-1-yl)-6-methyl-7-oxo-1H,6H,7H-imidazo[4,5-d]pyridazin-1-yl]methyl}benzonitrile",13797,"3-{[2-(3-aminopiperidin-1-yl)-6-methyl-7-oxo-1H,6H,7H-imidazo[4,5-d]pyridazin-1-yl]methyl}benzonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13797,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,Ki (nM),1200,PMID:17010607|DOI:10.1016/j.bmcl.2006.09.024,https://www.ncbi.nlm.nih.gov/pubmed/17010607|https://doi.org/10.1016/j.bmcl.2006.09.024,17010607,10.1016/j.bmcl.2006.09.024,
5619,2012350,23646512,BindingDB,"2-(3-{[2-(3-aminopiperidin-1-yl)-6-methyl-7-oxo-1H,6H,7H-imidazo[4,5-d]pyridazin-1-yl]methyl}phenyl)acetonitrile",13798,"2-(3-{[2-(3-aminopiperidin-1-yl)-6-methyl-7-oxo-1H,6H,7H-imidazo[4,5-d]pyridazin-1-yl]methyl}phenyl)acetonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13798,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,Ki (nM),11,PMID:17010607|DOI:10.1016/j.bmcl.2006.09.024,https://www.ncbi.nlm.nih.gov/pubmed/17010607|https://doi.org/10.1016/j.bmcl.2006.09.024,17010607,10.1016/j.bmcl.2006.09.024,
5620,2012351,23646512,BindingDB,"2-(3-{[2-(3-aminopiperidin-1-yl)-6-methyl-7-oxo-1H,6H,7H-imidazo[4,5-d]pyridazin-1-yl]methyl}phenyl)acetonitrile",13798,"2-(3-{[2-(3-aminopiperidin-1-yl)-6-methyl-7-oxo-1H,6H,7H-imidazo[4,5-d]pyridazin-1-yl]methyl}phenyl)acetonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13798,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,Ki (nM),>3000,PMID:17010607|DOI:10.1016/j.bmcl.2006.09.024,https://www.ncbi.nlm.nih.gov/pubmed/17010607|https://doi.org/10.1016/j.bmcl.2006.09.024,17010607,10.1016/j.bmcl.2006.09.024,
5621,2012352,23646513,BindingDB,"2-{[2-(3-aminopiperidin-1-yl)-5-benzyl-4,6-dioxo-1H,4H,5H,6H-pyrrolo[3,4-d]imidazol-1-yl]methyl}benzonitrile",13799,"2-{[2-(3-aminopiperidin-1-yl)-5-benzyl-4,6-dioxo-1H,4H,5H,6H-pyrrolo[3,4-d]imidazol-1-yl]methyl}benzonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13799,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,Ki (nM),29,PMID:17010607|DOI:10.1016/j.bmcl.2006.09.024,https://www.ncbi.nlm.nih.gov/pubmed/17010607|https://doi.org/10.1016/j.bmcl.2006.09.024,17010607,10.1016/j.bmcl.2006.09.024,
5622,2012353,23646514,BindingDB,"2-(3-aminopiperidin-1-yl)-1-{[2-(trifluoromethyl)phenyl]methyl}-1H,4H,9H-naphtho[2,3-d]imidazole-4,9-dione",13800,"2-(3-aminopiperidin-1-yl)-1-{[2-(trifluoromethyl)phenyl]methyl}-1H,4H,9H-naphtho[2,3-d]imidazole-4,9-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13800,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,Ki (nM),25,PMID:17010607|DOI:10.1016/j.bmcl.2006.09.024,https://www.ncbi.nlm.nih.gov/pubmed/17010607|https://doi.org/10.1016/j.bmcl.2006.09.024,17010607,10.1016/j.bmcl.2006.09.024,
5623,2011023,23647079,BindingDB,4-[(3R)-3-[(2-oxo-2-phenylethyl)amino]butyl]benzamide,15463,4-[(3R)-3-[(2-oxo-2- phenylethyl)amino]butyl]benzamide (20),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15463,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),280,PMID:24674599|DOI:10.1111/cbdd.12327,https://www.ncbi.nlm.nih.gov/pubmed/24674599|https://doi.org/10.1111/cbdd.12327,24674599,10.1111/cbdd.12327,
5624,2011505,23647506,BindingDB,"(3R)-3-(4-{[3-(2-methyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17176,"(3R)-3-(4-{[3-(2-methyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17176,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),2.51,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5625,2011506,23647507,BindingDB,"(3S)-3-(4-{[3-(3-chloro-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17177,"(3S)-3-(4-{[3-(3-chloro-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17177,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),2.00,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5626,2011507,23647508,BindingDB,"(3S)-3-(4-{[3-(4-{[(2-methylphenyl)carbamoyl]amino}-3-(trifluoromethoxy)phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17178,"(3S)-3-(4-{[3-(4-{[(2-methylphenyl)carbamoyl]amino}-3-(trifluoromethoxy)phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17178,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),19.95,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5627,2011508,23647509,BindingDB,"(3S)-3-(4-{[3-(3-ethoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17179,"(3S)-3-(4-{[3-(3-ethoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17179,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),5.01,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5628,2011509,23647510,BindingDB,"(3S)-3-(4-{[3-(3-ethyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17180,"(3S)-3-(4-{[3-(3-ethyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17180,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),50.1,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5629,2011510,23647511,BindingDB,"(3S)-3-(4-{[3-(3-methyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17181,"(3S)-3-(4-{[3-(3-methyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17181,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),2.51,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5630,2011511,23647512,BindingDB,"(3S)-3-(4-{[3-(2-chloro-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17182,"(3S)-3-(4-{[3-(2-chloro-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17182,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),25.12,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5631,2011512,23647513,BindingDB,"(3S)-3-(4-{[3-(2-methyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17183,"(3S)-3-(4-{[3-(2-methyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17183,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),19.9,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5632,2011513,23647514,BindingDB,3-(4-{[3-(4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-1H-pyrazol-1-yl]methyl}phenyl)propanoic acid,17184,3-(4-{[3-(4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-1H-pyrazol-1-yl]methyl}phenyl)propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17184,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),251.2,PMID:16455247|DOI:10.1016/j.bmcl.2006.01.025,https://www.ncbi.nlm.nih.gov/pubmed/16455247|https://doi.org/10.1016/j.bmcl.2006.01.025,16455247,10.1016/j.bmcl.2006.01.025,
5633,2011514,23647515,BindingDB,"3-(4-{[3-(4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-1H-1,2,4-triazol-1-yl]methyl}phenyl)propanoic acid",17185,"3-(4-{[3-(4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-1H-1,2,4-triazol-1-yl]methyl}phenyl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17185,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),501.2,PMID:16455247|DOI:10.1016/j.bmcl.2006.01.025,https://www.ncbi.nlm.nih.gov/pubmed/16455247|https://doi.org/10.1016/j.bmcl.2006.01.025,16455247,10.1016/j.bmcl.2006.01.025,
5634,2011515,23647516,BindingDB,3-(4-{[4-(4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-1H-imidazol-1-yl]methyl}phenyl)propanoic acid,17186,3-(4-{[4-(4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-1H-imidazol-1-yl]methyl}phenyl)propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17186,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16455247|DOI:10.1016/j.bmcl.2006.01.025,https://www.ncbi.nlm.nih.gov/pubmed/16455247|https://doi.org/10.1016/j.bmcl.2006.01.025,16455247,10.1016/j.bmcl.2006.01.025,
5635,2011516,23647517,BindingDB,3-(4-{[4-(4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-1H-pyrazol-1-yl]methyl}phenyl)propanoic acid,17187,3-(4-{[4-(4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-1H-pyrazol-1-yl]methyl}phenyl)propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17187,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),>1000,PMID:16455247|DOI:10.1016/j.bmcl.2006.01.025,https://www.ncbi.nlm.nih.gov/pubmed/16455247|https://doi.org/10.1016/j.bmcl.2006.01.025,16455247,10.1016/j.bmcl.2006.01.025,
5636,2011517,23647518,BindingDB,3-(4-{[3-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-1H-pyrazol-1-yl]methyl}phenyl)propanoic acid,17188,3-(4-{[3-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-1H-pyrazol-1-yl]methyl}phenyl)propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17188,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),25.12,PMID:16455247|DOI:10.1016/j.bmcl.2006.01.025,https://www.ncbi.nlm.nih.gov/pubmed/16455247|https://doi.org/10.1016/j.bmcl.2006.01.025,16455247,10.1016/j.bmcl.2006.01.025,
5637,2011518,23647519,BindingDB,"3-(4-{[5-(3-Methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-1,3,4-oxadiazol-2-yl]methyl}phenyl)propanoic acid",17189,"3-(4-{[5-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-1,3,4-oxadiazol-2-yl]methyl}phenyl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17189,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),>1000,PMID:16455247|DOI:10.1016/j.bmcl.2006.01.025,https://www.ncbi.nlm.nih.gov/pubmed/16455247|https://doi.org/10.1016/j.bmcl.2006.01.025,16455247,10.1016/j.bmcl.2006.01.025,
5638,2011519,23647520,BindingDB,"3-{4-[3-(4-{[(2-Methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]phenyl}propanoic acid",17190,"3-{4-[3-(4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]phenyl}propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17190,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),>1000,PMID:16455247|DOI:10.1016/j.bmcl.2006.01.025,https://www.ncbi.nlm.nih.gov/pubmed/16455247|https://doi.org/10.1016/j.bmcl.2006.01.025,16455247,10.1016/j.bmcl.2006.01.025,
5639,2011520,23647521,BindingDB,"3-(2-{[3-(4-{[(2-Methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",17192,"3-(2-{[3-(4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17192,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),398.10,PMID:16455247|DOI:10.1016/j.bmcl.2006.01.025,https://www.ncbi.nlm.nih.gov/pubmed/16455247|https://doi.org/10.1016/j.bmcl.2006.01.025,16455247,10.1016/j.bmcl.2006.01.025,
5640,2011521,23647522,BindingDB,"2-(4-{[3-(4-{[(2-Methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)acetic acid",17193,"2-(4-{[3-(4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17193,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),251.2,PMID:16455247|DOI:10.1016/j.bmcl.2006.01.025,https://www.ncbi.nlm.nih.gov/pubmed/16455247|https://doi.org/10.1016/j.bmcl.2006.01.025,16455247,10.1016/j.bmcl.2006.01.025,
5641,2011529,23647523,BindingDB,(3R)-3-{4-[2-(4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetamido]phenyl}butanoic acid,17195,(3R)-3-{4-[2-(4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetamido]phenyl}butanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17195,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),63.10,PMID:16455247|DOI:10.1016/j.bmcl.2006.01.025,https://www.ncbi.nlm.nih.gov/pubmed/16455247|https://doi.org/10.1016/j.bmcl.2006.01.025,16455247,10.1016/j.bmcl.2006.01.025,
5642,2011530,23647524,BindingDB,(3R)-3-{4-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetamido]phenyl}butanoic acid,17196,(3R)-3-{4-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetamido]phenyl}butanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17196,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),0.79,PMID:16455247|DOI:10.1016/j.bmcl.2006.01.025,https://www.ncbi.nlm.nih.gov/pubmed/16455247|https://doi.org/10.1016/j.bmcl.2006.01.025,16455247,10.1016/j.bmcl.2006.01.025,
5643,2011531,23647525,BindingDB,"2-[(2,6-Dichlorophenyl)formamido]-3-[2-(2,4-dichlorophenyl)quinolin-6-yl]propanoic acid",17199,"2,6-quinolinyl derivative, 21",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17199,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),748,PMID:17035017|DOI:10.1016/j.bmcl.2006.09.069,https://www.ncbi.nlm.nih.gov/pubmed/17035017|https://doi.org/10.1016/j.bmcl.2006.09.069,17035017,10.1016/j.bmcl.2006.09.069,
5644,2011532,23647526,BindingDB,"2-[(2,6-Dichlorophenyl)formamido]-3-[2-(2,6-difluorophenyl)quinolin-6-yl]propanoic acid",17200,"2,6-quinolinyl derivative, 22",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17200,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),371.5,PMID:17035017|DOI:10.1016/j.bmcl.2006.09.069,https://www.ncbi.nlm.nih.gov/pubmed/17035017|https://doi.org/10.1016/j.bmcl.2006.09.069,17035017,10.1016/j.bmcl.2006.09.069,
5645,2011533,23647527,BindingDB,"2-[(2,6-Dichlorophenyl)formamido]-3-[2-(2,6-dimethylphenyl)quinolin-6-yl]propanoic acid",17201,"2,6-quinolinyl derivative, 23",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17201,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),102,PMID:17035017|DOI:10.1016/j.bmcl.2006.09.069,https://www.ncbi.nlm.nih.gov/pubmed/17035017|https://doi.org/10.1016/j.bmcl.2006.09.069,17035017,10.1016/j.bmcl.2006.09.069,
5646,2011534,23647528,BindingDB,"3-[2-(2-Chloro-6-nitrophenyl)quinolin-6-yl]-2-[(2,6-dichlorophenyl)formamido]propanoic acid",17203,"2,6-quinolinyl derivative, 25",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17203,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),6.5,PMID:17035017|DOI:10.1016/j.bmcl.2006.09.069,https://www.ncbi.nlm.nih.gov/pubmed/17035017|https://doi.org/10.1016/j.bmcl.2006.09.069,17035017,10.1016/j.bmcl.2006.09.069,
5647,2011535,23647529,BindingDB,"2-[(2,6-Dichlorophenyl)formamido]-3-(2-phenylquinolin-6-yl)propanoic acid",17204,"2,6-quinolinyl derivative, 26",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17204,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,,,PMID:17035017|DOI:10.1016/j.bmcl.2006.09.069,https://www.ncbi.nlm.nih.gov/pubmed/17035017|https://doi.org/10.1016/j.bmcl.2006.09.069,17035017,10.1016/j.bmcl.2006.09.069,
5648,2011543,23647530,BindingDB,"3-[2-(2-Bromophenyl)quinolin-6-yl]-2-[(2,6-dichlorophenyl)formamido]propanoic acid",17205,"2,6-quinolinyl derivative, 27",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17205,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),153.5,PMID:17035017|DOI:10.1016/j.bmcl.2006.09.069,https://www.ncbi.nlm.nih.gov/pubmed/17035017|https://doi.org/10.1016/j.bmcl.2006.09.069,17035017,10.1016/j.bmcl.2006.09.069,
5649,2011544,23647531,BindingDB,"2,6-Quinolinyl derivative, 30",17208,"2,6-quinolinyl derivative, 30",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17208,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,,,PMID:17035017|DOI:10.1016/j.bmcl.2006.09.069,https://www.ncbi.nlm.nih.gov/pubmed/17035017|https://doi.org/10.1016/j.bmcl.2006.09.069,17035017,10.1016/j.bmcl.2006.09.069,
5650,2011545,23647532,BindingDB,"2-[(2,6-Dichlorophenyl)formamido]-3-[2-(2,6-dichloropyridin-4-yl)quinolin-6-yl]propanoic acid",17210,"2,6-quinolinyl derivative, 32",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17210,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),8.6,PMID:17035017|DOI:10.1016/j.bmcl.2006.09.069,https://www.ncbi.nlm.nih.gov/pubmed/17035017|https://doi.org/10.1016/j.bmcl.2006.09.069,17035017,10.1016/j.bmcl.2006.09.069,
5651,2011546,23647533,BindingDB,"2-[(2,6-Dichlorophenyl)formamido]-3-[2-(1,3-thiazol-2-yl)quinolin-6-yl]propanoic acid",17211,"2,6-quinolinyl derivative, 33",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17211,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,,,PMID:17035017|DOI:10.1016/j.bmcl.2006.09.069,https://www.ncbi.nlm.nih.gov/pubmed/17035017|https://doi.org/10.1016/j.bmcl.2006.09.069,17035017,10.1016/j.bmcl.2006.09.069,
5652,2011547,23647534,BindingDB,"3-{2-[2-Chloro-5-(trifluoromethyl)phenyl]quinolin-6-yl}-2-[(2,6-dichlorophenyl)formamido]propanoic acid",17212,"2,6-quinolinyl derivative, 34",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17212,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),208.5,PMID:17035017|DOI:10.1016/j.bmcl.2006.09.069,https://www.ncbi.nlm.nih.gov/pubmed/17035017|https://doi.org/10.1016/j.bmcl.2006.09.069,17035017,10.1016/j.bmcl.2006.09.069,
5653,2011548,23647535,BindingDB,"2-[(2,4-Dichloro-6-methylpyridin-3-yl)formamido]-3-[2-(2,6-dichlorophenyl)quinolin-6-yl]propanoic acid",17218,"2,6-quinolinyl derivative, 40",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17218,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),7.9,PMID:17035017|DOI:10.1016/j.bmcl.2006.09.069,https://www.ncbi.nlm.nih.gov/pubmed/17035017|https://doi.org/10.1016/j.bmcl.2006.09.069,17035017,10.1016/j.bmcl.2006.09.069,
5654,2011549,23647536,BindingDB,"3-[2-(2,6-Dichlorophenyl)quinolin-6-yl]-2-(phenylformamido)propanoic acid",17219,"2,6-quinolinyl derivative, 41",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17219,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),5640,PMID:17035017|DOI:10.1016/j.bmcl.2006.09.069,https://www.ncbi.nlm.nih.gov/pubmed/17035017|https://doi.org/10.1016/j.bmcl.2006.09.069,17035017,10.1016/j.bmcl.2006.09.069,
5655,2011550,23647537,BindingDB,"2-{[(2S)-1-benzyl-5-oxopyrrolidin-2-yl]formamido}-3-[2-(2,6-dichlorophenyl)quinolin-6-yl]propanoic acid",17221,"2,6-quinolinyl derivative, 43",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17221,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),15.3,PMID:17035017|DOI:10.1016/j.bmcl.2006.09.069,https://www.ncbi.nlm.nih.gov/pubmed/17035017|https://doi.org/10.1016/j.bmcl.2006.09.069,17035017,10.1016/j.bmcl.2006.09.069,
5656,2011579,23647538,BindingDB,"2-Azabicyclo[2.2.2]octane-based antagonist, 10",17222,(2S)-2-{[(3S)-2-(benzenesulfonyl)-2-azabicyclo[2.2.2]octan-3-yl]formamido}-3-[4-(pyridine-4-amido)phenyl]propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17222,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),36,PMID:16495061|DOI:10.1016/j.bmc.2006.01.067,https://www.ncbi.nlm.nih.gov/pubmed/16495061|https://doi.org/10.1016/j.bmc.2006.01.067,16495061,10.1016/j.bmc.2006.01.067,
5657,2011580,23647538,BindingDB,"2-Azabicyclo[2.2.2]octane-based antagonist, 10",17222,(2S)-2-{[(3S)-2-(benzenesulfonyl)-2-azabicyclo[2.2.2]octan-3-yl]formamido}-3-[4-(pyridine-4-amido)phenyl]propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17222,175,Integrin alpha-4/beta-7,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=175,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),120,PMID:16495061|DOI:10.1016/j.bmc.2006.01.067,https://www.ncbi.nlm.nih.gov/pubmed/16495061|https://doi.org/10.1016/j.bmc.2006.01.067,16495061,10.1016/j.bmc.2006.01.067,
5658,2011581,23647628,BindingDB,"1-(2,6-Dichlorophenyl)-5-(2,4-difluorophenyl)-7-[1-(propan-2-yl)piperidin-4-yl]-1,2,3,4-tetrahydroquinazolin-2-one",17061,"1-(2,6-dichlorophenyl)-5-(2,4-difluorophenyl)-7-[1-(propan-2-yl)piperidin-4-yl]-1,2,3,4-tetrahydroquinazolin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17061,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),0.2,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5659,2011582,23647629,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-(methylsulfanyl)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17062,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-(methylsulfanyl)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17062,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),10,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5660,2011583,23647630,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-methanesulfonyl-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17063,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-methanesulfonyl-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17063,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),4.2,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5661,2011584,23647631,BindingDB,"7-amino-5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17064,"7-amino-5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17064,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),5.3,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5662,2011585,23647632,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-(methylamino)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17065,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-(methylamino)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17065,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),2.0,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5663,2011592,23647633,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-(dimethylamino)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17066,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-(dimethylamino)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17066,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),3.0,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5664,2011593,23647634,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-(propan-2-ylamino)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17067,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-(propan-2-ylamino)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17067,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),1.1,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5665,2011594,23647635,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-[(2,2-dimethylpropyl)amino]-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17068,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-[(2,2-dimethylpropyl)amino]-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17068,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),0.8,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5666,2011595,23647636,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-{1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl}-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17069,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-{1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl}-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17069,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),1.9,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5667,2011596,23647637,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-hydroxy-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17070,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-hydroxy-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17070,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),4.0,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5668,2011597,23647638,BindingDB,"5-(2,4-dichlorophenyl)-1-(2,6-dichlorophenyl)-7-[(2-methoxyethyl)amino]-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17071,"5-(2,4-dichlorophenyl)-1-(2,6-dichlorophenyl)-7-[(2-methoxyethyl)amino]-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17071,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),2.0,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5669,2011605,23647639,BindingDB,"5-(2,4-dichlorophenyl)-1-(2,6-dichlorophenyl)-7-{[2-(dimethylamino)ethyl]amino}-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17072,"5-(2,4-dichlorophenyl)-1-(2,6-dichlorophenyl)-7-{[2-(dimethylamino)ethyl]amino}-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17072,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),5.6,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5670,2011606,23647640,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-[2-(dimethylamino)ethoxy]-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17073,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-[2-(dimethylamino)ethoxy]-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17073,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),4.2,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5671,2011607,23647641,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-{4-[2-(dimethylamino)ethyl]piperazin-1-yl}-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17074,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-{4-[2-(dimethylamino)ethyl]piperazin-1-yl}-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17074,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),0.5,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5672,2011608,23647642,BindingDB,"5-(2,4-dichlorophenyl)-1-(2,6-dichlorophenyl)-7-{4-[2-(dimethylamino)ethyl]piperazin-1-yl}-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17075,"5-(2,4-dichlorophenyl)-1-(2,6-dichlorophenyl)-7-{4-[2-(dimethylamino)ethyl]piperazin-1-yl}-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17075,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),1.0,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5673,2011609,23647643,BindingDB,"5-(2,4-dichlorophenyl)-1-(2,6-dichlorophenyl)-7-[4-(propan-2-yl)piperazin-1-yl]-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17076,"5-(2,4-dichlorophenyl)-1-(2,6-dichlorophenyl)-7-[4-(propan-2-yl)piperazin-1-yl]-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17076,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),20,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5674,2011610,23647644,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-(morpholin-4-ylamino)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17077,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-(morpholin-4-ylamino)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17077,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),4,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5675,2011617,23647645,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-(morpholin-4-yl)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17078,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-(morpholin-4-yl)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17078,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),2,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5676,2011618,23647646,BindingDB,"5-(2,4-dichlorophenyl)-1-(2,6-dichlorophenyl)-7-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17079,"5-(2,4-dichlorophenyl)-1-(2,6-dichlorophenyl)-7-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17079,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),2,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5677,2011619,23647647,BindingDB,"7-{1-azabicyclo[2.2.2]octan-3-ylamino}-5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17080,"7-{1-azabicyclo[2.2.2]octan-3-ylamino}-5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17080,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),1.2,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5678,2011620,23647648,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-({8-methyl-8-azabicyclo[3.2.1]octan-3-yl}amino)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17081,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-({8-methyl-8-azabicyclo[3.2.1]octan-3-yl}amino)-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17081,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),0.5,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5679,2011621,23647649,BindingDB,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",17083,"5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-7-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17083,1595,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1595,P47811,Mitogen-activated protein kinase 14 ,26416.0,Mapk14,10090.0,Mus musculus (house mouse),,IC50 (nM),0.7,PMID:16750629|DOI:10.1016/j.bmcl.2006.05.045,https://www.ncbi.nlm.nih.gov/pubmed/16750629|https://doi.org/10.1016/j.bmcl.2006.05.045,16750629,10.1016/j.bmcl.2006.05.045,
5680,2011622,23647650,BindingDB,3-chloro-N-{4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl}-4-{[2-(propan-2-ylamino)-1H-imidazol-1-yl]methyl}thiophene-2-carboxamide,17137,3-chloro-N-{4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl}-4-{[2-(propan-2-ylamino)-1H-imidazol-1-yl]methyl}thiophene-2-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17137,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),0.008,PMID:17536795|DOI:10.1021/jm070125f,https://www.ncbi.nlm.nih.gov/pubmed/17536795|https://doi.org/10.1021/jm070125f,17536795,10.1021/jm070125f,
5681,2011629,23647650,BindingDB,3-chloro-N-{4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl}-4-{[2-(propan-2-ylamino)-1H-imidazol-1-yl]methyl}thiophene-2-carboxamide,17137,3-chloro-N-{4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl}-4-{[2-(propan-2-ylamino)-1H-imidazol-1-yl]methyl}thiophene-2-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17137,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),1200,PMID:17536795|DOI:10.1021/jm070125f,https://www.ncbi.nlm.nih.gov/pubmed/17536795|https://doi.org/10.1021/jm070125f,17536795,10.1021/jm070125f,
5682,2011630,23647651,BindingDB,"(15R,18R)-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-3,5-dione",17140,"(15R,18R)-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-3,5-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17140,4500,Serine/threonine-protein kinase Chk1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4500,O14757,Serine/threonine-protein kinase Chk1,1111.0,CHEK1,9606.0,Homo sapiens (human),,Ki (nM),15,PMID:12244092|DOI:10.1074/jbc.M201233200,https://www.ncbi.nlm.nih.gov/pubmed/12244092|https://doi.org/10.1074/jbc.M201233200,12244092,10.1074/jbc.M201233200,
5683,2011631,23647651,BindingDB,"(15R,18R)-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-3,5-dione",17140,"(15R,18R)-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-3,5-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17140,177,Cyclin-A2/Cyclin-dependent kinase 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=177,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,Ki (nM),23,PMID:12244092|DOI:10.1074/jbc.M201233200,https://www.ncbi.nlm.nih.gov/pubmed/12244092|https://doi.org/10.1074/jbc.M201233200,12244092,10.1074/jbc.M201233200,
5684,2011632,23647651,BindingDB,"(15R,18R)-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-3,5-dione",17140,"(15R,18R)-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-3,5-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17140,93,Cyclin-dependent kinase 4/G1/S-specific cyclin-D1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=93,P11802,Cyclin-dependent kinase 4,1019.0,CDK4,9606.0,Homo sapiens (human),,Ki (nM),16,PMID:12244092|DOI:10.1074/jbc.M201233200,https://www.ncbi.nlm.nih.gov/pubmed/12244092|https://doi.org/10.1074/jbc.M201233200,12244092,10.1074/jbc.M201233200,
5685,2011633,23647651,BindingDB,"(15R,18R)-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-3,5-dione",17140,"(15R,18R)-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-3,5-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17140,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,Ki (nM),5.6,PMID:12244092|DOI:10.1074/jbc.M201233200,https://www.ncbi.nlm.nih.gov/pubmed/12244092|https://doi.org/10.1074/jbc.M201233200,12244092,10.1074/jbc.M201233200,
5686,2011634,23647652,BindingDB,"4-(5-{[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)-N-methylbenzene-1-sulfonamide",17144,"2-imino-thiazolidin-4-one analog, 6",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17144,947,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=947,P18266,Glycogen synthase kinase-3 beta,84027.0,Gsk3b,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),80,PMID:17570665|DOI:10.1016/j.bmcl.2007.04.110,https://www.ncbi.nlm.nih.gov/pubmed/17570665|https://doi.org/10.1016/j.bmcl.2007.04.110,17570665,10.1016/j.bmcl.2007.04.110,
5687,2011635,23647652,BindingDB,"4-(5-{[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)-N-methylbenzene-1-sulfonamide",17144,"2-imino-thiazolidin-4-one analog, 6",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17144,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),120,PMID:17570665|DOI:10.1016/j.bmcl.2007.04.110,https://www.ncbi.nlm.nih.gov/pubmed/17570665|https://doi.org/10.1016/j.bmcl.2007.04.110,17570665,10.1016/j.bmcl.2007.04.110,
5688,2011636,23647653,BindingDB,"N-[2-(dimethylamino)ethyl]-4-(5-{[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)benzene-1-sulfonamide",17145,"2-imino-thiazolidin-4-one analog, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17145,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),570,PMID:17570665|DOI:10.1016/j.bmcl.2007.04.110,https://www.ncbi.nlm.nih.gov/pubmed/17570665|https://doi.org/10.1016/j.bmcl.2007.04.110,17570665,10.1016/j.bmcl.2007.04.110,
5689,2011637,23647653,BindingDB,"N-[2-(dimethylamino)ethyl]-4-(5-{[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)benzene-1-sulfonamide",17145,"2-imino-thiazolidin-4-one analog, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17145,947,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=947,P18266,Glycogen synthase kinase-3 beta,84027.0,Gsk3b,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),510,PMID:17570665|DOI:10.1016/j.bmcl.2007.04.110,https://www.ncbi.nlm.nih.gov/pubmed/17570665|https://doi.org/10.1016/j.bmcl.2007.04.110,17570665,10.1016/j.bmcl.2007.04.110,
5690,2011638,23647654,BindingDB,"(5Z)-2-imino-5-({5-[4-(piperazine-1-sulfonyl)phenyl]furan-2-yl}methylidene)-1,3-thiazolidin-4-one",17146,"(5Z)-2-imino-5-({5-[4-(piperazine-1-sulfonyl)phenyl]furan-2-yl}methylidene)-1,3-thiazolidin-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17146,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),2900,PMID:17570665|DOI:10.1016/j.bmcl.2007.04.110,https://www.ncbi.nlm.nih.gov/pubmed/17570665|https://doi.org/10.1016/j.bmcl.2007.04.110,17570665,10.1016/j.bmcl.2007.04.110,
5691,2011639,23647655,BindingDB,"(5Z)-2-imino-5-({5-[4-(morpholine-4-sulfonyl)phenyl]furan-2-yl}methylidene)-1,3-thiazolidin-4-one",17147,"(5Z)-2-imino-5-({5-[4-(morpholine-4-sulfonyl)phenyl]furan-2-yl}methylidene)-1,3-thiazolidin-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17147,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),150000,PMID:17570665|DOI:10.1016/j.bmcl.2007.04.110,https://www.ncbi.nlm.nih.gov/pubmed/17570665|https://doi.org/10.1016/j.bmcl.2007.04.110,17570665,10.1016/j.bmcl.2007.04.110,
5692,2011640,23647656,BindingDB,"4-(5-{[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)benzamide",17148,"2-imino-thiazolidin-4-one analog, 10",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17148,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),9300,PMID:17570665|DOI:10.1016/j.bmcl.2007.04.110,https://www.ncbi.nlm.nih.gov/pubmed/17570665|https://doi.org/10.1016/j.bmcl.2007.04.110,17570665,10.1016/j.bmcl.2007.04.110,
5693,2011641,23647657,BindingDB,"4-(5-{[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)-2-(trifluoromethyl)benzene-1-sulfonamide",17149,"2-imino-thiazolidin-4-one analog, 11",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17149,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),610,PMID:17570665|DOI:10.1016/j.bmcl.2007.04.110,https://www.ncbi.nlm.nih.gov/pubmed/17570665|https://doi.org/10.1016/j.bmcl.2007.04.110,17570665,10.1016/j.bmcl.2007.04.110,
5694,2011642,23647657,BindingDB,"4-(5-{[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)-2-(trifluoromethyl)benzene-1-sulfonamide",17149,"2-imino-thiazolidin-4-one analog, 11",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17149,947,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=947,P18266,Glycogen synthase kinase-3 beta,84027.0,Gsk3b,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),2,PMID:17570665|DOI:10.1016/j.bmcl.2007.04.110,https://www.ncbi.nlm.nih.gov/pubmed/17570665|https://doi.org/10.1016/j.bmcl.2007.04.110,17570665,10.1016/j.bmcl.2007.04.110,
5695,2011643,23647658,BindingDB,"2-chloro-4-(5-{[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)benzene-1-sulfonamide",17150,"2-chloro-4-(5-{[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)benzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17150,947,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=947,P18266,Glycogen synthase kinase-3 beta,84027.0,Gsk3b,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),14,PMID:17570665|DOI:10.1016/j.bmcl.2007.04.110,https://www.ncbi.nlm.nih.gov/pubmed/17570665|https://doi.org/10.1016/j.bmcl.2007.04.110,17570665,10.1016/j.bmcl.2007.04.110,
5696,2011644,23647658,BindingDB,"2-chloro-4-(5-{[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)benzene-1-sulfonamide",17150,"2-chloro-4-(5-{[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)benzene-1-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17150,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),570,PMID:17570665|DOI:10.1016/j.bmcl.2007.04.110,https://www.ncbi.nlm.nih.gov/pubmed/17570665|https://doi.org/10.1016/j.bmcl.2007.04.110,17570665,10.1016/j.bmcl.2007.04.110,
5697,2011645,23647659,BindingDB,"4-(5-{1-[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]ethyl}furan-2-yl)benzene-1-sulfonamide",17151,"2-imino-thiazolidin-4-one analog, 13",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17151,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),30,PMID:17570665|DOI:10.1016/j.bmcl.2007.04.110,https://www.ncbi.nlm.nih.gov/pubmed/17570665|https://doi.org/10.1016/j.bmcl.2007.04.110,17570665,10.1016/j.bmcl.2007.04.110,
5698,2011646,23647659,BindingDB,"4-(5-{1-[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]ethyl}furan-2-yl)benzene-1-sulfonamide",17151,"2-imino-thiazolidin-4-one analog, 13",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17151,947,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=947,P18266,Glycogen synthase kinase-3 beta,84027.0,Gsk3b,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),430,PMID:17570665|DOI:10.1016/j.bmcl.2007.04.110,https://www.ncbi.nlm.nih.gov/pubmed/17570665|https://doi.org/10.1016/j.bmcl.2007.04.110,17570665,10.1016/j.bmcl.2007.04.110,
5699,2011647,23647660,BindingDB,"3-{4-[(3-{3-Methoxy-4-[(phenylcarbamoyl)amino]phenyl}-2-oxo-1,2-dihydropyridin-1-yl)methyl]phenyl}propanoic acid",17154,"3-{4-[(3-{3-methoxy-4-[(phenylcarbamoyl)amino]phenyl}-2-oxo-1,2-dihydropyridin-1-yl)methyl]phenyl}propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17154,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),1.58,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5700,2011648,23647661,BindingDB,"3-[4-({3-[3-Methoxy-4-({[2-(propan-2-yl)phenyl]carbamoyl}amino)phenyl]-2-oxo-1,2-dihydropyridin-1-yl}methyl)phenyl]propanoic acid",17157,"3-[4-({3-[3-methoxy-4-({[2-(propan-2-yl)phenyl]carbamoyl}amino)phenyl]-2-oxo-1,2-dihydropyridin-1-yl}methyl)phenyl]propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17157,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),316.2,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5701,2011655,23647662,BindingDB,"3-(4-{[3-(3-Methoxy-4-{[(2-methoxyphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",17158,"3-(4-{[3-(3-methoxy-4-{[(2-methoxyphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17158,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),6.31,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5702,2011656,23647663,BindingDB,"3-(4-{[3-(4-{[(2-Bromophenyl)carbamoyl]amino}-3-methoxyphenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",17159,"3-(4-{[3-(4-{[(2-bromophenyl)carbamoyl]amino}-3-methoxyphenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17159,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),5.01,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5703,2011657,23647664,BindingDB,"3-(4-{[3-(4-{[(2-Acetamidophenyl)carbamoyl]amino}-3-methoxyphenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",17160,"3-(4-{[3-(4-{[(2-acetamidophenyl)carbamoyl]amino}-3-methoxyphenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17160,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),6.31,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5704,2011658,23647665,BindingDB,"3-(4-{[3-(4-{[(2,3-Dimethylphenyl)carbamoyl]amino}-3-methoxyphenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",17161,"3-(4-{[3-(4-{[(2,3-dimethylphenyl)carbamoyl]amino}-3-methoxyphenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17161,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),25.12,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5705,2011659,23647666,BindingDB,"3-(4-{[3-(4-{[(2,4-Dimethylphenyl)carbamoyl]amino}-3-methoxyphenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",17162,"3-(4-{[3-(4-{[(2,4-dimethylphenyl)carbamoyl]amino}-3-methoxyphenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17162,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),25.12,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5706,2011660,23647667,BindingDB,"3-(4-{[3-(4-{[(2,5-Dimethylphenyl)carbamoyl]amino}-3-methoxyphenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",17163,"3-(4-{[3-(4-{[(2,5-dimethylphenyl)carbamoyl]amino}-3-methoxyphenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17163,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),7.94,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5707,2011661,23647668,BindingDB,"3-(4-{[3-(4-{[(2,6-Dimethylphenyl)carbamoyl]amino}-3-methoxyphenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",17164,"3-(4-{[3-(4-{[(2,6-dimethylphenyl)carbamoyl]amino}-3-methoxyphenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17164,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),2.00,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5708,2011662,23647669,BindingDB,"(3S)-3-(4-{[3-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17168,"(3S)-3-(4-{[3-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17168,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),1.0,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5709,2011663,23647670,BindingDB,"(3R)-3-(4-{[3-(3-chloro-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17170,"(3R)-3-(4-{[3-(3-chloro-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17170,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),1,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5710,2011664,23647671,BindingDB,"(3R)-3-(4-{[3-(4-{[(2-methylphenyl)carbamoyl]amino}-3-(trifluoromethoxy)phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17171,"(3R)-3-(4-{[3-(4-{[(2-methylphenyl)carbamoyl]amino}-3-(trifluoromethoxy)phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17171,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),3.98,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5711,2011665,23647672,BindingDB,"(3R)-3-(4-{[3-(3-ethoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17172,"(3R)-3-(4-{[3-(3-ethoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17172,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),2.00,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5712,2011666,23647673,BindingDB,"(3R)-3-(4-{[3-(3-ethyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17173,"(3R)-3-(4-{[3-(3-ethyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17173,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),6.31,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5713,2011673,23647674,BindingDB,"(3R)-3-(4-{[3-(3-methyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17174,"(3R)-3-(4-{[3-(3-methyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17174,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),1,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5714,2011674,23647675,BindingDB,"(3R)-3-(4-{[3-(2-chloro-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",17175,"(3R)-3-(4-{[3-(2-chloro-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)-2-oxo-1,2-dihydropyridin-1-yl]methyl}phenyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17175,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,Ki (nM),0.79,PMID:16931004|DOI:10.1016/j.bmcl.2006.08.044,https://www.ncbi.nlm.nih.gov/pubmed/16931004|https://doi.org/10.1016/j.bmcl.2006.08.044,16931004,10.1016/j.bmcl.2006.08.044,
5715,2011675,23647676,BindingDB,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-methyl-1-benzothiophene-2-carboxamide,17229,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-methyl-1-benzothiophene-2-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17229,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),>5000,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5716,2011676,23647676,BindingDB,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-methyl-1-benzothiophene-2-carboxamide,17229,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-methyl-1-benzothiophene-2-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17229,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),>5000,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5717,2011677,23647676,BindingDB,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-methyl-1-benzothiophene-2-carboxamide,17229,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-methyl-1-benzothiophene-2-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17229,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),>5000,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5718,2011678,23647677,BindingDB,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-5-methyl-1-benzothiophene-2-carboxamide,17230,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-5-methyl-1-benzothiophene-2-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17230,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),>5000,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5719,2011679,23647677,BindingDB,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-5-methyl-1-benzothiophene-2-carboxamide,17230,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-5-methyl-1-benzothiophene-2-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17230,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),54,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5720,2011686,23647678,BindingDB,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-5-propyl-4H,5H,6H-thieno[2,3-c]pyrrole-2-carboxamide",17247,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-5-propyl-4H,5H,6H-thieno[2,3-c]pyrrole-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17247,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),2.2,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5721,2011687,23647678,BindingDB,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-5-propyl-4H,5H,6H-thieno[2,3-c]pyrrole-2-carboxamide",17247,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-5-propyl-4H,5H,6H-thieno[2,3-c]pyrrole-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17247,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),3200,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5722,2011688,23647679,BindingDB,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-({[2-(2-hydroxyethoxy)ethyl]amino}methyl)thiophene-2-carboxamide,17254,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-({[2-(2-hydroxyethoxy)ethyl]amino}methyl)thiophene-2-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17254,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),3200,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5723,2011689,23647679,BindingDB,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-({[2-(2-hydroxyethoxy)ethyl]amino}methyl)thiophene-2-carboxamide,17254,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-({[2-(2-hydroxyethoxy)ethyl]amino}methyl)thiophene-2-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17254,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),3.4,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5724,2011690,23647680,BindingDB,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-({[2-(2-hydroxyethoxy)ethyl](methyl)amino}methyl)thiophene-2-carboxamide,17255,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-({[2-(2-hydroxyethoxy)ethyl](methyl)amino}methyl)thiophene-2-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17255,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),1.5,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5725,2011691,23647680,BindingDB,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-({[2-(2-hydroxyethoxy)ethyl](methyl)amino}methyl)thiophene-2-carboxamide,17255,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-({[2-(2-hydroxyethoxy)ethyl](methyl)amino}methyl)thiophene-2-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17255,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),1100,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5726,2011692,23647680,BindingDB,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-({[2-(2-hydroxyethoxy)ethyl](methyl)amino}methyl)thiophene-2-carboxamide,17255,3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-({[2-(2-hydroxyethoxy)ethyl](methyl)amino}methyl)thiophene-2-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17255,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),>5000,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5727,2011700,23647681,BindingDB,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-{[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]methyl}thiophene-2-carboxamide",17274,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-{[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]methyl}thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17274,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),>5000,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5728,2011701,23647681,BindingDB,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-{[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]methyl}thiophene-2-carboxamide",17274,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-{[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]methyl}thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17274,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),>5000,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5729,2011702,23647681,BindingDB,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-{[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]methyl}thiophene-2-carboxamide",17274,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-{[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]methyl}thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17274,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),20,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5730,2011703,23647682,BindingDB,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-[(2,3-dihydroxypropoxy)methyl]thiophene-2-carboxamide",17275,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-[(2,3-dihydroxypropoxy)methyl]thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17275,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),5.7,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5731,2011704,23647682,BindingDB,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-[(2,3-dihydroxypropoxy)methyl]thiophene-2-carboxamide",17275,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-[(2,3-dihydroxypropoxy)methyl]thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17275,177,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=177,P00760,Cationic trypsin,615026.0,LOC615026,9913.0,Bos taurus (cattle),,Ki (nM),>5000,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5732,2011705,23647682,BindingDB,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-[(2,3-dihydroxypropoxy)methyl]thiophene-2-carboxamide",17275,"3-chloro-N-{4-chloro-2-[(4-chlorophenyl)carbamoyl]phenyl}-4-[(2,3-dihydroxypropoxy)methyl]thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17275,334,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=334,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,Ki (nM),2400,PMID:17227710|DOI:10.1016/j.bmc.2006.12.019,https://www.ncbi.nlm.nih.gov/pubmed/17227710|https://doi.org/10.1016/j.bmc.2006.12.019,17227710,10.1016/j.bmc.2006.12.019,
5733,2011706,23647683,BindingDB,"amino (13S,17R)-3-(2-methoxyethoxy)-5',5',13-trimethyl-6'-oxospiro[7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17,2'-oxane]-2-carboxylate",17286,"(2R,15'S)-5'-(2-methoxyethoxy)-5,5,15'-trimethyl-6-oxospiro[oxane-2,14'-tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane]-2',4',6'-triene-4'-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17286,1799,Aldo-keto reductase family 1 member C3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1799,P42330,Aldo-keto reductase family 1 member C3,8644.0,AKR1C3,9606.0,Homo sapiens (human),,IC50 (nM),9.5,PMID:17166832|DOI:10.1074/jbc.M606784200,https://www.ncbi.nlm.nih.gov/pubmed/17166832|https://doi.org/10.1074/jbc.M606784200,17166832,10.1074/jbc.M606784200,
5734,2011714,23647683,Therapeutic Target Database (TTD),"amino (13S,17R)-3-(2-methoxyethoxy)-5',5',13-trimethyl-6'-oxospiro[7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17,2'-oxane]-2-carboxylate",D0ZR1V,EM-1424,https://idrblab.net/ttd/data/drug/details/D0ZR1V,T60857,Dihydrodiol dehydrogenase type I (AKR1C3),https://idrblab.net/ttd/data/target/details/T60857,P42330,Aldo-keto reductase family 1 member C3,8644.0,AKR1C3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5735,2011715,23647684,BindingDB,"[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 8-[(1S,10R,11S,14S,15S)-5,14-dihydroxy-15-methyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-2,4,6-trien-13-yl]octanoate",17288,"E2-adenosine hybrid compound, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17288,5642,17-beta-hydroxysteroid dehydrogenase type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5642,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),,IC50 (nM),93,PMID:12223444|DOI:10.1096/fj.02-0026fje,https://www.ncbi.nlm.nih.gov/pubmed/12223444|https://doi.org/10.1096/fj.02-0026fje,12223444,10.1096/fj.02-0026fje,
5736,2011716,23647685,BindingDB,"[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 9-[(8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]nonanoate",17290,"E2-adenosine hybrid compound, 8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17290,5642,17-beta-hydroxysteroid dehydrogenase type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5642,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),,IC50 (nM),52,PMID:12223444|DOI:10.1096/fj.02-0026fje,https://www.ncbi.nlm.nih.gov/pubmed/12223444|https://doi.org/10.1096/fj.02-0026fje,12223444,10.1096/fj.02-0026fje,
5737,2011717,23647685,BindingDB,"[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 9-[(8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]nonanoate",17290,"E2-adenosine hybrid compound, 8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17290,5642,17-beta-hydroxysteroid dehydrogenase type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5642,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),,Ki (nM),3.0,PMID:12223444|DOI:10.1096/fj.02-0026fje,https://www.ncbi.nlm.nih.gov/pubmed/12223444|https://doi.org/10.1096/fj.02-0026fje,12223444,10.1096/fj.02-0026fje,
5738,2011718,23647686,BindingDB,"[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 10-[(1S,10R,11S,14S,15S)-5,14-dihydroxy-15-methyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-2,4,6-trien-13-yl]decanoate",17291,"E2-adenosine hybrid compound, 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17291,5642,17-beta-hydroxysteroid dehydrogenase type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5642,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),,IC50 (nM),140,PMID:12223444|DOI:10.1096/fj.02-0026fje,https://www.ncbi.nlm.nih.gov/pubmed/12223444|https://doi.org/10.1096/fj.02-0026fje,12223444,10.1096/fj.02-0026fje,
5739,2011719,23647687,BindingDB,"[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl nonanoate",17293,Compound 10,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17293,5642,17-beta-hydroxysteroid dehydrogenase type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5642,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),,Ki (nM),250000,PMID:12223444|DOI:10.1096/fj.02-0026fje,https://www.ncbi.nlm.nih.gov/pubmed/12223444|https://doi.org/10.1096/fj.02-0026fje,12223444,10.1096/fj.02-0026fje,
5740,2011720,23647688,BindingDB,"(13S,14S,15S)-15-methyl-13-nonyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-2,4,6-triene-5,14-diol",17294,"(13S,14S,15S)-15-methyl-13-nonyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-triene-5,14-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17294,5642,17-beta-hydroxysteroid dehydrogenase type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5642,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),,,,PMID:12223444|DOI:10.1096/fj.02-0026fje,https://www.ncbi.nlm.nih.gov/pubmed/12223444|https://doi.org/10.1096/fj.02-0026fje,12223444,10.1096/fj.02-0026fje,
5741,2011728,23647689,BindingDB,"(2S,3S)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",17299,"(2S,3S)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17299,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),2180,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5742,2011729,23647689,BindingDB,"(2S,3S)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",17299,"(2S,3S)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17299,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),420,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5743,2011730,23647689,BindingDB,"(2S,3S)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",17299,"(2S,3S)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17299,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),14000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5744,2011731,23647689,BindingDB,"(2S,3S)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",17299,"(2S,3S)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17299,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),1600,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5745,2011732,23647690,BindingDB,"(2S,3R)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",17300,"(2S,3R)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17300,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),320,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5746,2011733,23647690,BindingDB,"(2S,3R)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",17300,"(2S,3R)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17300,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),18000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5747,2011734,23647690,BindingDB,"(2S,3R)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",17300,"(2S,3R)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17300,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),460,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5748,2011743,23647690,BindingDB,"(2S,3R)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",17300,"(2S,3R)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17300,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),220,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5749,2011744,23647691,BindingDB,"Phenylalanine derived inhibitor, 3",11140,"(1S,2S)-1-(dimethylcarbamoyl)-1-[4-(4-fluorophenyl)phenyl]-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11140,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5750,2011745,23647691,BindingDB,"Phenylalanine derived inhibitor, 3",11140,"(1S,2S)-1-(dimethylcarbamoyl)-1-[4-(4-fluorophenyl)phenyl]-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11140,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),12,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5751,2011746,23647691,BindingDB,"Phenylalanine derived inhibitor, 3",11140,"(1S,2S)-1-(dimethylcarbamoyl)-1-[4-(4-fluorophenyl)phenyl]-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11140,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),45000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5752,2011747,23647691,BindingDB,"Phenylalanine derived inhibitor, 3",11140,"(1S,2S)-1-(dimethylcarbamoyl)-1-[4-(4-fluorophenyl)phenyl]-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11140,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),69000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5753,2011748,23647692,BindingDB,"Phenylalanine derived inhibitor, 4",11189,"(2S,3S)-3-[4-(4-fluorophenyl)phenyl]-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11189,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),86000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5754,2011749,23647692,BindingDB,"Phenylalanine derived inhibitor, 4",11189,"(2S,3S)-3-[4-(4-fluorophenyl)phenyl]-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11189,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),64,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5755,2011758,23647692,BindingDB,"Phenylalanine derived inhibitor, 4",11189,"(2S,3S)-3-[4-(4-fluorophenyl)phenyl]-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11189,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),87000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5756,2011759,23647692,BindingDB,"Phenylalanine derived inhibitor, 4",11189,"(2S,3S)-3-[4-(4-fluorophenyl)phenyl]-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11189,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),2700,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5757,2011760,23647693,BindingDB,"Phenylalanine derived inhibitor, 5",11144,"(1S,2S)-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxo-1-(4-{[1,2,4]triazolo[1,5-a]pyridin-6-yl}phenyl)propan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11144,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5758,2011761,23647693,BindingDB,"Phenylalanine derived inhibitor, 5",11144,"(1S,2S)-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxo-1-(4-{[1,2,4]triazolo[1,5-a]pyridin-6-yl}phenyl)propan-2-aminium; 2,2,2-trifluoroacetate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11144,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5759,2011774,23647698,BindingDB,"Phenylalanine derived inhibitor, 9",17306,"(1S,2S)-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-{4-[methyl(4-methylbenzene)amido]phenyl}-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17306,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5760,2011775,23647698,BindingDB,"Phenylalanine derived inhibitor, 9",17306,"(1S,2S)-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-{4-[methyl(4-methylbenzene)amido]phenyl}-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17306,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5761,2011776,23647700,BindingDB,"Phenylalanine derived inhibitor, 10",17307,"(1S,2S)-1-(dimethylcarbamoyl)-1-{4-[(4-fluorobenzene)(methyl)amido]phenyl}-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17307,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5762,2011777,23647700,BindingDB,"Phenylalanine derived inhibitor, 10",17307,"(1S,2S)-1-(dimethylcarbamoyl)-1-{4-[(4-fluorobenzene)(methyl)amido]phenyl}-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17307,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5763,2011778,23647700,BindingDB,"Phenylalanine derived inhibitor, 10",17307,"(1S,2S)-1-(dimethylcarbamoyl)-1-{4-[(4-fluorobenzene)(methyl)amido]phenyl}-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17307,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),28,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5764,2011779,23647700,BindingDB,"Phenylalanine derived inhibitor, 10",17307,"(1S,2S)-1-(dimethylcarbamoyl)-1-{4-[(4-fluorobenzene)(methyl)amido]phenyl}-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17307,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5765,2011780,23647702,BindingDB,"Phenylalanine derived inhibitor, 11",17308,"(2S,3S)-3-{4-[(4-fluorobenzene)(methyl)amido]phenyl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17308,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5766,2011781,23647702,BindingDB,"Phenylalanine derived inhibitor, 11",17308,"(2S,3S)-3-{4-[(4-fluorobenzene)(methyl)amido]phenyl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17308,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),300,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5767,2011782,23647702,BindingDB,"Phenylalanine derived inhibitor, 11",17308,"(2S,3S)-3-{4-[(4-fluorobenzene)(methyl)amido]phenyl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17308,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5768,2011783,23647702,BindingDB,"Phenylalanine derived inhibitor, 11",17308,"(2S,3S)-3-{4-[(4-fluorobenzene)(methyl)amido]phenyl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17308,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),4700,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5769,2011784,23647704,BindingDB,"(1S,2S)-1-(dimethylcarbamoyl)-1-(4-acetamidophenyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium",17309,"(1S,2S)-1-(dimethylcarbamoyl)-1-(4-acetamidophenyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17309,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5770,2011785,23647704,BindingDB,"(1S,2S)-1-(dimethylcarbamoyl)-1-(4-acetamidophenyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium",17309,"(1S,2S)-1-(dimethylcarbamoyl)-1-(4-acetamidophenyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17309,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),60000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5771,2011808,23647706,BindingDB,"(2S,3S)-3-(4-acetamidophenyl)-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",17310,"(2S,3S)-3-(4-acetamidophenyl)-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17310,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),600,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5772,2011809,23647706,BindingDB,"(2S,3S)-3-(4-acetamidophenyl)-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",17310,"(2S,3S)-3-(4-acetamidophenyl)-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17310,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),82000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5773,2011810,23647706,BindingDB,"(2S,3S)-3-(4-acetamidophenyl)-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",17310,"(2S,3S)-3-(4-acetamidophenyl)-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17310,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),70000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5774,2011811,23647708,BindingDB,"(1S,2S)-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-[4-(N-methylacetamido)phenyl]-3-oxopropan-2-aminium",17311,"(1S,2S)-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-[4-(N-methylacetamido)phenyl]-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17311,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5775,2011835,23647712,BindingDB,"Cyclohexylglycine derived inhibitor, 6",17313,"(1S)-1-{4-[(2,4-difluorobenzene)sulfonamido]cyclohexyl}-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethan-1-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17313,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),990,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5776,2011836,23647712,BindingDB,"Cyclohexylglycine derived inhibitor, 6",17313,"(1S)-1-{4-[(2,4-difluorobenzene)sulfonamido]cyclohexyl}-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethan-1-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17313,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),48,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5777,2011837,23647712,BindingDB,"Cyclohexylglycine derived inhibitor, 6",17313,"(1S)-1-{4-[(2,4-difluorobenzene)sulfonamido]cyclohexyl}-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethan-1-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17313,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),2700,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5778,2011838,23647713,BindingDB,"Cyclohexylalanine derived inhibitor, 16",17314,"(1S,2S)-1-{4-[(2,4-difluorobenzene)sulfonamido]cyclohexyl}-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17314,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5779,2011839,23647713,BindingDB,"Cyclohexylalanine derived inhibitor, 16",17314,"(1S,2S)-1-{4-[(2,4-difluorobenzene)sulfonamido]cyclohexyl}-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17314,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),330,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5780,2011840,23647713,BindingDB,"Cyclohexylalanine derived inhibitor, 16",17314,"(1S,2S)-1-{4-[(2,4-difluorobenzene)sulfonamido]cyclohexyl}-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17314,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5781,2011841,23647715,BindingDB,"Cyclohexylalanine derived inhibitor, 17",17315,"(2S,3S)-3-{4-[(2,4-difluorobenzene)sulfonamido]cyclohexyl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17315,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),21000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5782,2011842,23647715,BindingDB,"Cyclohexylalanine derived inhibitor, 17",17315,"(2S,3S)-3-{4-[(2,4-difluorobenzene)sulfonamido]cyclohexyl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17315,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),460,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5783,2011843,23647715,BindingDB,"Cyclohexylalanine derived inhibitor, 17",17315,"(2S,3S)-3-{4-[(2,4-difluorobenzene)sulfonamido]cyclohexyl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17315,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),42000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5784,2011844,23647717,BindingDB,"Cyclohexylalanine derived inhibitor, 18",17316,"(1S,2S)-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxo-1-(4-{[4-(trifluoromethoxy)benzene]sulfonamido}cyclohexyl)propan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17316,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5785,2011845,23647717,BindingDB,"Cyclohexylalanine derived inhibitor, 18",17316,"(1S,2S)-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxo-1-(4-{[4-(trifluoromethoxy)benzene]sulfonamido}cyclohexyl)propan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17316,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),360,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5786,2011846,23647717,BindingDB,"Cyclohexylalanine derived inhibitor, 18",17316,"(1S,2S)-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxo-1-(4-{[4-(trifluoromethoxy)benzene]sulfonamido}cyclohexyl)propan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17316,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5787,2011847,23647719,BindingDB,"Cyclohexylalanine derived inhibitor, 19",17317,"(2S,3S)-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxo-3-(4-{[4-(trifluoromethoxy)benzene]sulfonamido}cyclohexyl)butan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17317,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),11000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5788,2011848,23647719,BindingDB,"Cyclohexylalanine derived inhibitor, 19",17317,"(2S,3S)-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxo-3-(4-{[4-(trifluoromethoxy)benzene]sulfonamido}cyclohexyl)butan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17317,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),440,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5789,2011849,23647719,BindingDB,"Cyclohexylalanine derived inhibitor, 19",17317,"(2S,3S)-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxo-3-(4-{[4-(trifluoromethoxy)benzene]sulfonamido}cyclohexyl)butan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17317,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),26000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5790,2011874,23647728,BindingDB,"(1S,2S)-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-[4-(N-methylacetamido)cyclohexyl]-3-oxopropan-2-aminium",17322,"(1S,2S)-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-[4-(N-methylacetamido)cyclohexyl]-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17322,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),29,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5791,2011875,23647728,BindingDB,"(1S,2S)-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-[4-(N-methylacetamido)cyclohexyl]-3-oxopropan-2-aminium",17322,"(1S,2S)-1-(dimethylcarbamoyl)-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-[4-(N-methylacetamido)cyclohexyl]-3-oxopropan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17322,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5792,2011876,23647729,BindingDB,"Cyclohexylalanine derived inhibitor, 26",17324,"(2S,3S)-3-{4-[cyclopropane(methyl)amido]cyclohexyl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17324,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),21,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5793,2011877,23647729,BindingDB,"Cyclohexylalanine derived inhibitor, 26",17324,"(2S,3S)-3-{4-[cyclopropane(methyl)amido]cyclohexyl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17324,1237,Dipeptidyl peptidase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1237,Q86TI2,Dipeptidyl peptidase 9,91039.0,DPP9,9606.0,Homo sapiens (human),,IC50 (nM),29000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5794,2011878,23647729,BindingDB,"Cyclohexylalanine derived inhibitor, 26",17324,"(2S,3S)-3-{4-[cyclopropane(methyl)amido]cyclohexyl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17324,1236,Dipeptidyl peptidase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1236,Q6V1X1,Dipeptidyl peptidase 8,54878.0,DPP8,9606.0,Homo sapiens (human),,IC50 (nM),12000,PMID:17350841|DOI:10.1016/j.bmcl.2007.02.066,https://www.ncbi.nlm.nih.gov/pubmed/17350841|https://doi.org/10.1016/j.bmcl.2007.02.066,17350841,10.1016/j.bmcl.2007.02.066,
5795,2011879,23647730,BindingDB,"(2S)-2-[(1-{2-[benzyl(1,3-thiazol-5-ylmethyl)amino]acetyl}-5-(2-methylphenyl)-1,2,3,6-tetrahydropyridin-4-yl)formamido]-4-(methylsulfanyl)butanoic acid",17326,"(2S)-2-[(1-{2-[benzyl(1,3-thiazol-5-ylmethyl)amino]acetyl}-5-(2-methylphenyl)-1,2,3,6-tetrahydropyridin-4-yl)formamido]-4-(methylsulfanyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17326,163,Protein farnesyltransferase subunit beta/geranylgeranyltransferase type-1 subunit alpha,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=163,P29702,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,281169.0,FNTA,9913.0,Bos taurus (cattle),,IC50 (nM),2.5,PMID:12657282|DOI:10.1016/S0960-894X(03)00095-7,https://www.ncbi.nlm.nih.gov/pubmed/12657282|https://doi.org/10.1016/S0960-894X(03)00095-7,12657282,10.1016/S0960-894X(03)00095-7,
5796,2011880,23647731,BindingDB,"(2S)-2-[(1-{[3-cyclohexyl-1-(1,3-thiazol-5-yl)propoxy]carbonyl}-5-(2-methylphenyl)-1,2,3,6-tetrahydropyridin-4-yl)formamido]-4-(methylsulfanyl)butanoic acid",17328,"(2S)-2-[(1-{[3-cyclohexyl-1-(1,3-thiazol-5-yl)propoxy]carbonyl}-5-(2-methylphenyl)-1,2,3,6-tetrahydropyridin-4-yl)formamido]-4-(methylsulfanyl)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17328,163,Protein farnesyltransferase subunit beta/geranylgeranyltransferase type-1 subunit alpha,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=163,P29702,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,281169.0,FNTA,9913.0,Bos taurus (cattle),,IC50 (nM),0.71,PMID:12657282|DOI:10.1016/S0960-894X(03)00095-7,https://www.ncbi.nlm.nih.gov/pubmed/12657282|https://doi.org/10.1016/S0960-894X(03)00095-7,12657282,10.1016/S0960-894X(03)00095-7,
5797,2011888,23647732,BindingDB,"1-(2-{[(4-cyanophenyl)methyl][(1-methyl-1H-imidazol-5-yl)methyl]amino}acetyl)-5-(naphthalen-1-yl)-1,2,3,6-tetrahydropyridine-4-carbonitrile",17329,"1-(2-{[(4-cyanophenyl)methyl][(1-methyl-1H-imidazol-5-yl)methyl]amino}acetyl)-5-(naphthalen-1-yl)-1,2,3,6-tetrahydropyridine-4-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17329,163,Protein farnesyltransferase subunit beta/geranylgeranyltransferase type-1 subunit alpha,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=163,P29702,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,281169.0,FNTA,9913.0,Bos taurus (cattle),,IC50 (nM),560,PMID:12657282|DOI:10.1016/S0960-894X(03)00095-7,https://www.ncbi.nlm.nih.gov/pubmed/12657282|https://doi.org/10.1016/S0960-894X(03)00095-7,12657282,10.1016/S0960-894X(03)00095-7,
5798,2011889,23647733,BindingDB,"1-(2-{benzyl[(1-methyl-1H-imidazol-5-yl)methyl]amino}acetyl)-5-(naphthalen-1-yl)-1,2,3,6-tetrahydropyridine-4-carbonitrile",17330,"1-(2-{benzyl[(1-methyl-1H-imidazol-5-yl)methyl]amino}acetyl)-5-(naphthalen-1-yl)-1,2,3,6-tetrahydropyridine-4-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17330,163,Protein farnesyltransferase subunit beta/geranylgeranyltransferase type-1 subunit alpha,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=163,P29702,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,281169.0,FNTA,9913.0,Bos taurus (cattle),,IC50 (nM),280,PMID:12657282|DOI:10.1016/S0960-894X(03)00095-7,https://www.ncbi.nlm.nih.gov/pubmed/12657282|https://doi.org/10.1016/S0960-894X(03)00095-7,12657282,10.1016/S0960-894X(03)00095-7,
5799,2011890,23647734,BindingDB,"1-[(2R)-3-(4-cyanophenyl)-2-{[(1-methyl-1H-imidazol-5-yl)methyl]amino}propanoyl]-5-(naphthalen-1-yl)-1,2,3,6-tetrahydropyridine-4-carbonitrile",17331,"1-[(2R)-3-(4-cyanophenyl)-2-{[(1-methyl-1H-imidazol-5-yl)methyl]amino}propanoyl]-5-(naphthalen-1-yl)-1,2,3,6-tetrahydropyridine-4-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17331,163,Protein farnesyltransferase subunit beta/geranylgeranyltransferase type-1 subunit alpha,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=163,P29702,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,281169.0,FNTA,9913.0,Bos taurus (cattle),,IC50 (nM),240,PMID:12657282|DOI:10.1016/S0960-894X(03)00095-7,https://www.ncbi.nlm.nih.gov/pubmed/12657282|https://doi.org/10.1016/S0960-894X(03)00095-7,12657282,10.1016/S0960-894X(03)00095-7,
5800,2011891,23647735,BindingDB,"1-[(2S)-3-(4-cyanophenyl)-2-{[(1-methyl-1H-imidazol-5-yl)methyl]amino}propanoyl]-5-(naphthalen-1-yl)-1,2,3,6-tetrahydropyridine-4-carbonitrile",17332,"1-[(2S)-3-(4-cyanophenyl)-2-{[(1-methyl-1H-imidazol-5-yl)methyl]amino}propanoyl]-5-(naphthalen-1-yl)-1,2,3,6-tetrahydropyridine-4-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17332,163,Protein farnesyltransferase subunit beta/geranylgeranyltransferase type-1 subunit alpha,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=163,P29702,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,281169.0,FNTA,9913.0,Bos taurus (cattle),,IC50 (nM),310,PMID:12657282|DOI:10.1016/S0960-894X(03)00095-7,https://www.ncbi.nlm.nih.gov/pubmed/12657282|https://doi.org/10.1016/S0960-894X(03)00095-7,12657282,10.1016/S0960-894X(03)00095-7,
5801,2011892,23647736,BindingDB,AoxSPF,17336,"(2S)-2-{[(2S)-1-({2-[(1S)-1-aminoethyl]-1,3-oxazol-4-yl}carbonyl)pyrrolidin-2-yl]formamido}-3-phenylpropanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17336,2972,E3 ubiquitin-protein ligase XIAP [241-356],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2972,P98170,E3 ubiquitin-protein ligase XIAP,331.0,XIAP,9606.0,Homo sapiens (human),,,,PMID:17336535|DOI:10.1016/j.bmc.2007.02.010,https://www.ncbi.nlm.nih.gov/pubmed/17336535|https://doi.org/10.1016/j.bmc.2007.02.010,17336535,10.1016/j.bmc.2007.02.010,
5802,2011893,23647737,BindingDB,AoxSPY,17339,"(2S)-2-{[(2S)-1-({2-[(1S)-1-aminoethyl]-1,3-oxazol-4-yl}carbonyl)pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17339,2972,E3 ubiquitin-protein ligase XIAP [241-356],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2972,P98170,E3 ubiquitin-protein ligase XIAP,331.0,XIAP,9606.0,Homo sapiens (human),,,,PMID:17336535|DOI:10.1016/j.bmc.2007.02.010,https://www.ncbi.nlm.nih.gov/pubmed/17336535|https://doi.org/10.1016/j.bmc.2007.02.010,17336535,10.1016/j.bmc.2007.02.010,
5803,2011917,23647738,BindingDB,"(2S,3R)-2-{[(2S)-1-({2-[(1S)-1-aminoethyl]-1,3-oxazol-4-yl}carbonyl)pyrrolidin-2-yl]formamido}-3-methylpentanoic acid",17340,"(2S,3R)-2-{[(2S)-1-({2-[(1S)-1-aminoethyl]-1,3-oxazol-4-yl}carbonyl)pyrrolidin-2-yl]formamido}-3-methylpentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17340,2972,E3 ubiquitin-protein ligase XIAP [241-356],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2972,P98170,E3 ubiquitin-protein ligase XIAP,331.0,XIAP,9606.0,Homo sapiens (human),,,,PMID:17336535|DOI:10.1016/j.bmc.2007.02.010,https://www.ncbi.nlm.nih.gov/pubmed/17336535|https://doi.org/10.1016/j.bmc.2007.02.010,17336535,10.1016/j.bmc.2007.02.010,
5804,2011918,23647739,BindingDB,"(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-{1-[(3S)-3-[(2S)-2-aminopropanamido]-2-oxoazepan-1-yl]acetamido}-3-methylpentanamido]propanamido]pentanediamido]hexanamido]-3-hydroxypropanamido]pentanedioic acid",17343,"(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-{1-[(3S)-3-[(2S)-2-aminopropanamido]-2-oxoazepan-1-yl]acetamido}-3-methylpentanamido]propanamido]pentanediamido]hexanamido]-3-hydroxypropanamido]pentanedioic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17343,2972,E3 ubiquitin-protein ligase XIAP [241-356],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2972,P98170,E3 ubiquitin-protein ligase XIAP,331.0,XIAP,9606.0,Homo sapiens (human),,Ki (nM),39800,PMID:17168540|DOI:10.1021/cb600276q,https://www.ncbi.nlm.nih.gov/pubmed/17168540|https://doi.org/10.1021/cb600276q,17168540,10.1021/cb600276q,
5805,2011919,23647739,BindingDB,"(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-{1-[(3S)-3-[(2S)-2-aminopropanamido]-2-oxoazepan-1-yl]acetamido}-3-methylpentanamido]propanamido]pentanediamido]hexanamido]-3-hydroxypropanamido]pentanedioic acid",17343,"(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-{1-[(3S)-3-[(2S)-2-aminopropanamido]-2-oxoazepan-1-yl]acetamido}-3-methylpentanamido]propanamido]pentanediamido]hexanamido]-3-hydroxypropanamido]pentanedioic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17343,1802,"Complex of Baculoviral IAP repeat-containing protein 7 [1-159,S150G] and E3 ubiquitin-protein ligase XIAP [336-348]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1802,Q96CA5 P98170,,,,,,,Ki (nM),15300,PMID:17168540|DOI:10.1021/cb600276q,https://www.ncbi.nlm.nih.gov/pubmed/17168540|https://doi.org/10.1021/cb600276q,17168540,10.1021/cb600276q,
5806,2011920,23647740,BindingDB,"(3R,6S,9aR)-2,2-dimethyl-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",17345,"(3R,6S,9aR)-2,2-dimethyl-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17345,1803,Baculoviral IAP repeat-containing protein 2 [266-354],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1803,Q13490,Baculoviral IAP repeat-containing protein 2,329.0,BIRC2,9606.0,Homo sapiens (human),,Ki (nM),50,PMID:17168540|DOI:10.1021/cb600276q,https://www.ncbi.nlm.nih.gov/pubmed/17168540|https://doi.org/10.1021/cb600276q,17168540,10.1021/cb600276q,
5807,2011921,23647740,BindingDB,"(3R,6S,9aR)-2,2-dimethyl-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",17345,"(3R,6S,9aR)-2,2-dimethyl-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17345,1804,Baculoviral IAP repeat-containing protein 3 [252-340],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1804,Q13489,Baculoviral IAP repeat-containing protein 3,330.0,BIRC3,9606.0,Homo sapiens (human),,Ki (nM),130,PMID:17168540|DOI:10.1021/cb600276q,https://www.ncbi.nlm.nih.gov/pubmed/17168540|https://doi.org/10.1021/cb600276q,17168540,10.1021/cb600276q,
5808,2011922,23647740,BindingDB,"(3R,6S,9aR)-2,2-dimethyl-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",17345,"(3R,6S,9aR)-2,2-dimethyl-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17345,1802,"Complex of Baculoviral IAP repeat-containing protein 7 [1-159,S150G] and E3 ubiquitin-protein ligase XIAP [336-348]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1802,Q96CA5 P98170,,,,,,,Ki (nM),50,PMID:17168540|DOI:10.1021/cb600276q,https://www.ncbi.nlm.nih.gov/pubmed/17168540|https://doi.org/10.1021/cb600276q,17168540,10.1021/cb600276q,
5809,2011938,23647740,BindingDB,"(3R,6S,9aR)-2,2-dimethyl-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",17345,"(3R,6S,9aR)-2,2-dimethyl-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17345,2972,E3 ubiquitin-protein ligase XIAP [241-356],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2972,P98170,E3 ubiquitin-protein ligase XIAP,331.0,XIAP,9606.0,Homo sapiens (human),,Ki (nM),770,PMID:17168540|DOI:10.1021/cb600276q,https://www.ncbi.nlm.nih.gov/pubmed/17168540|https://doi.org/10.1021/cb600276q,17168540,10.1021/cb600276q,
5810,2011939,23647741,BindingDB,"(3R,6S,9aS)-2,2-dimethyl-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",17346,"(3R,6S,9aS)-2,2-dimethyl-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17346,2972,E3 ubiquitin-protein ligase XIAP [241-356],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2972,P98170,E3 ubiquitin-protein ligase XIAP,331.0,XIAP,9606.0,Homo sapiens (human),,Ki (nM),2340,PMID:17168540|DOI:10.1021/cb600276q,https://www.ncbi.nlm.nih.gov/pubmed/17168540|https://doi.org/10.1021/cb600276q,17168540,10.1021/cb600276q,
5811,2011940,23647741,BindingDB,"(3R,6S,9aS)-2,2-dimethyl-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",17346,"(3R,6S,9aS)-2,2-dimethyl-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17346,1802,"Complex of Baculoviral IAP repeat-containing protein 7 [1-159,S150G] and E3 ubiquitin-protein ligase XIAP [336-348]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1802,Q96CA5 P98170,,,,,,,Ki (nM),190,PMID:17168540|DOI:10.1021/cb600276q,https://www.ncbi.nlm.nih.gov/pubmed/17168540|https://doi.org/10.1021/cb600276q,17168540,10.1021/cb600276q,
5812,2011941,23647742,BindingDB,"(3R,6S,9aR)-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",17347,"(3R,6S,9aR)-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17347,1802,"Complex of Baculoviral IAP repeat-containing protein 7 [1-159,S150G] and E3 ubiquitin-protein ligase XIAP [336-348]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1802,Q96CA5 P98170,,,,,,,Ki (nM),280,PMID:17168540|DOI:10.1021/cb600276q,https://www.ncbi.nlm.nih.gov/pubmed/17168540|https://doi.org/10.1021/cb600276q,17168540,10.1021/cb600276q,
5813,2011942,23647742,BindingDB,"(3R,6S,9aR)-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",17347,"(3R,6S,9aR)-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17347,2972,E3 ubiquitin-protein ligase XIAP [241-356],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2972,P98170,E3 ubiquitin-protein ligase XIAP,331.0,XIAP,9606.0,Homo sapiens (human),,Ki (nM),270,PMID:17168540|DOI:10.1021/cb600276q,https://www.ncbi.nlm.nih.gov/pubmed/17168540|https://doi.org/10.1021/cb600276q,17168540,10.1021/cb600276q,
5814,2011943,23647742,BindingDB,"(3R,6S,9aR)-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",17347,"(3R,6S,9aR)-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-6-[(2S)-2-(methylamino)propanamido]-5-oxo-octahydroazepino[2,1-b][1,3]thiazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17347,1804,Baculoviral IAP repeat-containing protein 3 [252-340],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1804,Q13489,Baculoviral IAP repeat-containing protein 3,330.0,BIRC3,9606.0,Homo sapiens (human),,Ki (nM),490,PMID:17168540|DOI:10.1021/cb600276q,https://www.ncbi.nlm.nih.gov/pubmed/17168540|https://doi.org/10.1021/cb600276q,17168540,10.1021/cb600276q,
5815,2011522,23647772,BindingDB,"5,6-Disubstituted anthranilic acid sulfonamide, 9l",17620,"5,6-disubstituted anthranilic acid sulfonamide, 9l",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17620,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),36000,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5816,2011523,23647773,BindingDB,"5,6-Disubstituted anthranilic acid sulfonamide, 9m",17621,"5,6-disubstituted anthranilic acid sulfonamide, 9m",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17621,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),280,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5817,2011524,23647774,BindingDB,"5,6-Disubstituted anthranilic acid sulfonamide, 9n",17622,2-chloro-3-ethyl-6-[(4-fluorobenzene)sulfonamido]benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17622,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),15,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5818,2011525,23647775,BindingDB,"5,6-Disubstituted anthranilic acid sulfonamide, 16a",17624,2-ethoxy-3-ethyl-6-[(4-fluorobenzene)sulfonamido]benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17624,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),38,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5819,2011526,23647776,BindingDB,2-(2-Aminoethoxy)-3-Ethyl-6-{[(4-Fluorophenyl)sulfonyl]amino}benzoic Acid,17625,2-(2-aminoethoxy)-3-ethyl-6-[(4-fluorobenzene)sulfonamido]benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17625,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),46,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5820,2011527,23647777,BindingDB,"5,6-Disubstituted anthranilic acid sulfonamide, 17b",17626,2-(carboxymethoxy)-3-ethyl-6-[(4-fluorobenzene)sulfonamido]benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17626,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),5800,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5821,2011528,23647778,BindingDB,"5,6-Disubstituted anthranilic acid sulfonamide, 19a",17627,2-(2-aminoethoxy)-3-ethyl-6-[(2-propylbenzene)sulfonamido]benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17627,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),16,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5822,2011536,23647779,BindingDB,3-Ethyl-2-methyl-6-(pyridine-2-sulfonamido)benzoic acid,17628,3-ethyl-2-methyl-6-(pyridine-2-sulfonamido)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17628,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),67,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5823,2011537,23647780,BindingDB,"5,6-Disubstituted anthranilic acid sulfonamide, 19c",17629,2-(2-aminoethoxy)-6-({2-[3-(diethylamino)propyl]-4-fluorobenzene}sulfonamido)-3-ethylbenzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17629,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),24,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5824,2011538,23647781,BindingDB,"5,6-Disubstituted anthranilic acid sulfonamide, 19d",17630,"5,6-disubstituted anthranilic acid sulfonamide, 19d",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17630,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),10,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5825,2011539,23647782,BindingDB,"5,6-Disubstituted anthranilic acid sulfonamide, 19e",17631,3-ethyl-2-methoxy-6-[(2-{[3-(2-methylpiperidin-1-yl)propyl]amino}benzene)sulfonamido]benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17631,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),18,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5826,2011540,23647783,BindingDB,"5,6-Disubstituted anthranilic acid sulfonamide, 19f",17632,3-ethyl-2-methoxy-6-[(2-{[2-(1-methylpyrrolidin-2-yl)ethyl]amino}benzene)sulfonamido]benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17632,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),15,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5827,2011541,23647784,BindingDB,"5,6-Disubstituted anthranilic acid sulfonamide, 19g",17633,"5,6-disubstituted anthranilic acid sulfonamide, 19g",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17633,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),26,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5828,2011542,23647785,BindingDB,"5,6-Disubstituted anthranilic acid sulfonamide, 19h",17634,"5,6-disubstituted anthranilic acid sulfonamide, 19h",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17634,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),17,PMID:17350258|DOI:10.1016/j.bmcl.2007.02.062,https://www.ncbi.nlm.nih.gov/pubmed/17350258|https://doi.org/10.1016/j.bmcl.2007.02.062,17350258,10.1016/j.bmcl.2007.02.062,
5829,2011551,23647786,BindingDB,"3-(3-phenylpropanamido)-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide",17850,"3-(3-phenylpropanamido)-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17850,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),>500000,PMID:17114291|DOI:10.1073/pnas.0608389103,https://www.ncbi.nlm.nih.gov/pubmed/17114291|https://doi.org/10.1073/pnas.0608389103,17114291,10.1073/pnas.0608389103,
5830,2011552,23647786,BindingDB,"3-(3-phenylpropanamido)-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide",17850,"3-(3-phenylpropanamido)-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17850,1808,Methionine aminopeptidase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1808,P53582,Methionine aminopeptidase 1,23173.0,METAP1,9606.0,Homo sapiens (human),,IC50 (nM),3500,PMID:17114291|DOI:10.1073/pnas.0608389103,https://www.ncbi.nlm.nih.gov/pubmed/17114291|https://doi.org/10.1073/pnas.0608389103,17114291,10.1073/pnas.0608389103,
5831,2011553,23647787,BindingDB,"3-[(E)-(2-methylpropylidene)amino]-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide",17851,"3-[(E)-(2-methylpropylidene)amino]-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17851,1808,Methionine aminopeptidase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1808,P53582,Methionine aminopeptidase 1,23173.0,METAP1,9606.0,Homo sapiens (human),,IC50 (nM),6400,PMID:17114291|DOI:10.1073/pnas.0608389103,https://www.ncbi.nlm.nih.gov/pubmed/17114291|https://doi.org/10.1073/pnas.0608389103,17114291,10.1073/pnas.0608389103,
5832,2011554,23647787,BindingDB,"3-[(E)-(2-methylpropylidene)amino]-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide",17851,"3-[(E)-(2-methylpropylidene)amino]-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17851,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),>1000000,PMID:17114291|DOI:10.1073/pnas.0608389103,https://www.ncbi.nlm.nih.gov/pubmed/17114291|https://doi.org/10.1073/pnas.0608389103,17114291,10.1073/pnas.0608389103,
5833,2011555,23647788,BindingDB,"3-(Octanoylamino)-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide",17852,"3-octanamido-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17852,1805,Methionine aminopeptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1805,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),,IC50 (nM),>500000,PMID:17114291|DOI:10.1073/pnas.0608389103,https://www.ncbi.nlm.nih.gov/pubmed/17114291|https://doi.org/10.1073/pnas.0608389103,17114291,10.1073/pnas.0608389103,
5834,2011556,23647788,BindingDB,"3-(Octanoylamino)-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide",17852,"3-octanamido-N-(1,3-thiazol-2-yl)pyridine-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17852,1808,Methionine aminopeptidase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1808,P53582,Methionine aminopeptidase 1,23173.0,METAP1,9606.0,Homo sapiens (human),,IC50 (nM),>500000,PMID:17114291|DOI:10.1073/pnas.0608389103,https://www.ncbi.nlm.nih.gov/pubmed/17114291|https://doi.org/10.1073/pnas.0608389103,17114291,10.1073/pnas.0608389103,
5835,2011557,23647789,BindingDB,"3,5-Pyrazolediamine Inhibitor, 5",17855,"3,5-Pyrazolediamine Inhibitor, 5",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17855,1865,Methionine aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1865,P0AE18,Methionine aminopeptidase,947882.0,map,83333.0,Escherichia coli K-12,,IC50 (nM),550,PMID:17120228|DOI:10.1002/prot.21207,https://www.ncbi.nlm.nih.gov/pubmed/17120228|https://doi.org/10.1002/prot.21207,17120228,10.1002/prot.21207,
5836,2011558,23647790,BindingDB,"3,5-Pyrazolediamine Inhibitor, 6",17856,"3,5-Pyrazolediamine Inhibitor, 6",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17856,1865,Methionine aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1865,P0AE18,Methionine aminopeptidase,947882.0,map,83333.0,Escherichia coli K-12,,IC50 (nM),550,PMID:17120228|DOI:10.1002/prot.21207,https://www.ncbi.nlm.nih.gov/pubmed/17120228|https://doi.org/10.1002/prot.21207,17120228,10.1002/prot.21207,
5837,2011559,23647791,BindingDB,"3,5-Pyrazolediamine Inhibitor, 8",17858,"3,5-Pyrazolediamine Inhibitor, 8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17858,1865,Methionine aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1865,P0AE18,Methionine aminopeptidase,947882.0,map,83333.0,Escherichia coli K-12,,IC50 (nM),1250,PMID:17120228|DOI:10.1002/prot.21207,https://www.ncbi.nlm.nih.gov/pubmed/17120228|https://doi.org/10.1002/prot.21207,17120228,10.1002/prot.21207,
5838,2011560,23647792,BindingDB,"3,5-Pyrazolediamine Inhibitor, 9",17859,"3,5-Pyrazolediamine Inhibitor, 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17859,1865,Methionine aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1865,P0AE18,Methionine aminopeptidase,947882.0,map,83333.0,Escherichia coli K-12,,IC50 (nM),1500,PMID:17120228|DOI:10.1002/prot.21207,https://www.ncbi.nlm.nih.gov/pubmed/17120228|https://doi.org/10.1002/prot.21207,17120228,10.1002/prot.21207,
5839,2011561,23647793,BindingDB,,17861,"3,5-Pyrazolediamine Inhibitor, 10",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17861,1865,Methionine aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1865,P0AE18,Methionine aminopeptidase,947882.0,map,83333.0,Escherichia coli K-12,,IC50 (nM),2000,PMID:17120228|DOI:10.1002/prot.21207,https://www.ncbi.nlm.nih.gov/pubmed/17120228|https://doi.org/10.1002/prot.21207,17120228,10.1002/prot.21207,
5840,2011562,23647794,BindingDB,"3,5-Pyrazolediamine Inhibitor, 11",17862,({4-[(E)-2-(5-amino-3-imino-3H-pyrazol-4-yl)diazen-1-yl]phenyl}hydrazinesulfonyl)methanimidamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17862,1865,Methionine aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1865,P0AE18,Methionine aminopeptidase,947882.0,map,83333.0,Escherichia coli K-12,,IC50 (nM),20000,PMID:17120228|DOI:10.1002/prot.21207,https://www.ncbi.nlm.nih.gov/pubmed/17120228|https://doi.org/10.1002/prot.21207,17120228,10.1002/prot.21207,
5841,2011563,23647795,BindingDB,"methyl (2S)-2-[(2S)-2-[(2S,3R)-3-amino-2-hydroxy-3-[4-(propan-2-yl)phenyl]propanamido]propanamido]-4-methylpentanoate",17864,"Amino-Alcohol Inhibitor, 13",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17864,1865,Methionine aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1865,P0AE18,Methionine aminopeptidase,947882.0,map,83333.0,Escherichia coli K-12,,IC50 (nM),3500,PMID:17120228|DOI:10.1002/prot.21207,https://www.ncbi.nlm.nih.gov/pubmed/17120228|https://doi.org/10.1002/prot.21207,17120228,10.1002/prot.21207,
5842,2011564,23647796,BindingDB,"methyl (2S)-2-[(2S)-2-[(2S,3R)-3-amino-2-hydroxy-3-(4-methylphenyl)propanamido]propanamido]-4-methylpentanoate",17866,"Amino-Alcohol Inhibitor, 15",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17866,1865,Methionine aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1865,P0AE18,Methionine aminopeptidase,947882.0,map,83333.0,Escherichia coli K-12,,IC50 (nM),25000,PMID:17120228|DOI:10.1002/prot.21207,https://www.ncbi.nlm.nih.gov/pubmed/17120228|https://doi.org/10.1002/prot.21207,17120228,10.1002/prot.21207,
5843,2011565,23647797,BindingDB,(2S)-2-amino-4-(methylsulfanyl)-1-(pyridin-2-yl)butan-1-one,17868,(2S)-2-amino-4-(methylsulfanyl)-1-(pyridin-2-yl)butan-1-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17868,1866,Methionine aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1866,P0A079,Methionine aminopeptidase,,,196620.0,Staphylococcus aureus subsp. aureus MW2,,IC50 (nM),16000,PMID:14998322|DOI:10.1021/jm034188j,https://www.ncbi.nlm.nih.gov/pubmed/14998322|https://doi.org/10.1021/jm034188j,14998322,10.1021/jm034188j,
5844,2011566,23647798,BindingDB,(3S)-3-amino-1-(cyclopropylamino)heptan-2-one,17869,"(3S)-3-amino-1-(cyclopropylamino)heptane-2,2-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17869,1866,Methionine aminopeptidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1866,P0A079,Methionine aminopeptidase,,,196620.0,Staphylococcus aureus subsp. aureus MW2,,IC50 (nM),7000,PMID:14998322|DOI:10.1021/jm034188j,https://www.ncbi.nlm.nih.gov/pubmed/14998322|https://doi.org/10.1021/jm034188j,14998322,10.1021/jm034188j,
5845,2011567,23647799,BindingDB,(2S)-2-(2-{3-[(2S)-4-methyl-2-[(4E)-7-methyl-2-(propan-2-yl)oct-4-enamido]pentanamido]-2-oxohexanamido}acetamido)-2-phenylacetic acid,17873,(2S)-2-(2-{3-[(2S)-4-methyl-2-[(4E)-7-methyl-2-(propan-2-yl)oct-4-enamido]pentanamido]-2-oxohexanamido}acetamido)-2-phenylacetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17873,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),4300,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5846,2011568,23647800,BindingDB,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-2-cyclohexylacetyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-2-oxohexanamide",17875,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-2-cyclohexylacetyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-2-oxohexanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17875,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),54,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5847,2011569,23647801,BindingDB,"tert-butyl N-{1-[(1R,5S)-2-[(1-carbamoyl-1-oxopentan-2-yl)carbamoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate",17876,"Ketoamide inhibitor, 5",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17876,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),220,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5848,2011570,23647802,BindingDB,"tert-butyl N-{1-[(1R,5S)-2-[(1-carbamoyl-1-oxohexan-2-yl)carbamoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate",17877,"Ketoamide inhibitor, 6",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17877,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),360,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5849,2011571,23647803,BindingDB,"tert-butyl N-{1-[(1R,5S)-2-[(1-carbamoyl-4-methyl-1-oxopentan-2-yl)carbamoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate",17878,"Ketoamide inhibitor, 8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17878,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),480,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5850,2011572,23647804,BindingDB,"tert-butyl N-{1-[(1R,5S)-2-[(1-carbamoyl-4,4-dimethyl-1-oxopentan-2-yl)carbamoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate",17879,"Ketoamide inhibitor, 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17879,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),>3300,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5851,2011573,23647805,BindingDB,"tert-butyl N-{1-[(1R,5S)-2-[(1-carbamoyl-3,3-dimethyl-1-oxobutan-2-yl)carbamoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate",17880,"Ketoamide inhibitor, 10",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17880,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),>69000,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5852,2011574,23647806,BindingDB,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-3-cyclopropyl-2-oxopropanamide",17881,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-3-cyclopropyl-2-oxopropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17881,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),1600,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5853,2011575,23647807,BindingDB,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-3-cyclobutyl-2-oxopropanamide",17882,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-3-cyclobutyl-2-oxopropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17882,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),100,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5854,2011576,23647808,BindingDB,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-3-cyclopentyl-2-oxopropanamide",17883,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-3-cyclopentyl-2-oxopropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17883,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),1800,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5855,2011577,23647809,BindingDB,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-(2,2-difluorocyclopropyl)-2-oxobutanamide",17884,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-(2,2-difluorocyclopropyl)-2-oxobutanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17884,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),50,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5856,2011578,23647810,BindingDB,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-(3,3-difluorocyclobutyl)-2-oxobutanamide",17885,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-(3,3-difluorocyclobutyl)-2-oxobutanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17885,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),115,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5857,2011586,23647811,BindingDB,"3-{[(1S,5R)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-dichloro-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-cyclobutyl-2-oxobutanamide",17886,"3-{[(1S,5R)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-dichloro-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-cyclobutyl-2-oxobutanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17886,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),19,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5858,2011587,23647812,BindingDB,"3-{[(1S,5R)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-difluoro-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-cyclobutyl-2-oxobutanamide",17887,"3-{[(1S,5R)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-difluoro-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-cyclobutyl-2-oxobutanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17887,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),140,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5859,2011588,23647813,BindingDB,"3-{[(3aR,6aR)-5-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-2,2-dimethyl-hexahydro-2H-furo[2,3-c]pyrrol-4-yl]formamido}-4-cyclobutyl-2-oxobutanamide",17888,"3-{[(3aR,6aR)-5-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-2,2-dimethyl-hexahydro-2H-furo[2,3-c]pyrrol-4-yl]formamido}-4-cyclobutyl-2-oxobutanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17888,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),500,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5860,2011589,23647814,BindingDB,"3-[(1-{2-[(Tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}pyrrolidin-2-yl)formamido]-4-cyclobutyl-2-oxobutanamide",17889,"3-[(1-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}pyrrolidin-2-yl)formamido]-4-cyclobutyl-2-oxobutanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17889,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),5000,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5861,2011590,23647815,BindingDB,"3-{[(1R,5R)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-7,7-dimethyl-6-oxa-3-azabicyclo[3.2.0]heptan-2-yl]formamido}-4-cyclobutyl-2-oxobutanamide",17890,"3-{[(1R,5R)-3-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-7,7-dimethyl-6-oxa-3-azabicyclo[3.2.0]heptan-2-yl]formamido}-4-cyclobutyl-2-oxobutanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17890,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),960,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5862,2011591,23647816,BindingDB,"2-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanamido}-N-(1-carbamoyl-3-cyclobutyl-1-oxopropan-2-yl)-4-methylpentanamide",17891,"2-{2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanamido}-N-(1-carbamoyl-3-cyclobutyl-1-oxopropan-2-yl)-4-methylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17891,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),1000,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5863,2011598,23647817,BindingDB,"tert-butyl N-[1-({1-[(1-carbamoyl-3-cyclobutyl-1-oxopropan-2-yl)carbamoyl]-3-methylbutyl}carbamoyl)-2,2-dimethylpropyl]carbamate",17892,"Ketoamide inhibitor, 28",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17892,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),15000,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5864,2011599,23647818,BindingDB,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-3-methylbutanoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-cyclopropyl-2-oxobutanamide",17893,"3-{[(1R,5S)-3-{2-[(tert-butylcarbamoyl)amino]-3-methylbutanoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-cyclopropyl-2-oxobutanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17893,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),100,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5865,2011600,23647819,BindingDB,"methyl N-{2-[(1R,5S)-2-[(1-carbamoyl-3-cyclopropyl-1-oxopropan-2-yl)carbamoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-1-cyclohexyl-2-oxoethyl}carbamate",17894,"Ketoamide inhibitor, 31",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17894,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),800,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5866,2011601,23647820,BindingDB,"ethyl N-{2-[(1R,5S)-2-[(1-carbamoyl-3-cyclopropyl-1-oxopropan-2-yl)carbamoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-1-cyclohexyl-2-oxoethyl}carbamate",17895,"Ketoamide inhibitor, 32",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17895,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),230,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5867,2011602,23647821,BindingDB,"propan-2-yl N-{2-[(1R,5S)-2-[(1-carbamoyl-3-cyclopropyl-1-oxopropan-2-yl)carbamoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-1-cyclohexyl-2-oxoethyl}carbamate",17896,"Ketoamide inhibitor, 33",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17896,1066,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1066,P27958,Genome polyprotein,,,63746.0,Hepatitis C virus (isolate H77),,Ki (nM),60,PMID:17444623|DOI:10.1021/jm060173k,https://www.ncbi.nlm.nih.gov/pubmed/17444623|https://doi.org/10.1021/jm060173k,17444623,10.1021/jm060173k,
5868,2011603,23647822,BindingDB,"4-{[(2S,4S)-4-fluoro-1-[2-(3-methoxy-4-{[(2-methoxyphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]methoxy}benzoic acid",17902,"4-{[(2S,4S)-4-fluoro-1-[2-(3-methoxy-4-{[(2-methoxyphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17902,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),9.2,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5869,2011604,23647823,BindingDB,"4-{[(2S,4S)-4-fluoro-1-{2-[3-methoxy-4-({[2-(trifluoromethyl)phenyl]carbamoyl}amino)phenyl]acetyl}pyrrolidin-2-yl]methoxy}benzoic acid",17903,"4-{[(2S,4S)-4-fluoro-1-{2-[3-methoxy-4-({[2-(trifluoromethyl)phenyl]carbamoyl}amino)phenyl]acetyl}pyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17903,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),106,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5870,2011611,23647824,BindingDB,"4-{[(2S,4S)-4-fluoro-1-{2-[3-methoxy-4-({[2-(propan-2-yl)phenyl]carbamoyl}amino)phenyl]acetyl}pyrrolidin-2-yl]methoxy}benzoic acid",17904,"4-{[(2S,4S)-4-fluoro-1-{2-[3-methoxy-4-({[2-(propan-2-yl)phenyl]carbamoyl}amino)phenyl]acetyl}pyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17904,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),769,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5871,2011612,23647825,BindingDB,"4-{[(2S,4S)-4-fluoro-1-[2-(3-methyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]methoxy}benzoic acid",17905,"4-{[(2S,4S)-4-fluoro-1-[2-(3-methyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17905,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),2.3,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5872,2011613,23647826,BindingDB,"4-{[(2S,4S)-1-[2-(3-ethyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",17906,"4-{[(2S,4S)-1-[2-(3-ethyl-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17906,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),15,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5873,2011614,23647827,BindingDB,"4-{[(2S,4S)-4-fluoro-1-[2-(4-{[(2-methylphenyl)carbamoyl]amino}-3-(propan-2-yl)phenyl)acetyl]pyrrolidin-2-yl]methoxy}benzoic acid",17907,"4-{[(2S,4S)-4-fluoro-1-[2-(4-{[(2-methylphenyl)carbamoyl]amino}-3-(propan-2-yl)phenyl)acetyl]pyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17907,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),216,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5874,2011615,23647828,BindingDB,"4-{[(2S,4S)-4-fluoro-1-[2-(4-{[(2-methylphenyl)carbamoyl]amino}-3-(trifluoromethyl)phenyl)acetyl]pyrrolidin-2-yl]methoxy}benzoic acid",17908,"4-{[(2S,4S)-4-fluoro-1-[2-(4-{[(2-methylphenyl)carbamoyl]amino}-3-(trifluoromethyl)phenyl)acetyl]pyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17908,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),15,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5875,2011616,23647829,BindingDB,"4-{[(2S,4S)-1-[2-(3-bromo-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",17910,"4-{[(2S,4S)-1-[2-(3-bromo-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17910,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),0.78,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5876,2011623,23647830,BindingDB,"4-{[(2S,4S)-1-[2-(4-{[(2-chlorophenyl)carbamoyl]amino}-3-methylphenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",17911,"4-{[(2S,4S)-1-[2-(4-{[(2-chlorophenyl)carbamoyl]amino}-3-methylphenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17911,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),13,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5877,2011624,23647831,BindingDB,"4-{[(2S,4S)-1-[2-(3-chloro-4-{[(2-chlorophenyl)carbamoyl]amino}phenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",17912,"4-{[(2S,4S)-1-[2-(3-chloro-4-{[(2-chlorophenyl)carbamoyl]amino}phenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17912,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.3,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5878,2011625,23647832,BindingDB,"4-{[(2S,4S)-1-[2-(3-bromo-4-{[(2-chlorophenyl)carbamoyl]amino}phenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",17913,"4-{[(2S,4S)-1-[2-(3-bromo-4-{[(2-chlorophenyl)carbamoyl]amino}phenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17913,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.3,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5879,2011626,23647833,BindingDB,"4-{[(2S,4S)-1-[2-(4-{[(2-bromophenyl)carbamoyl]amino}-3-methylphenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",17914,"4-{[(2S,4S)-1-[2-(4-{[(2-bromophenyl)carbamoyl]amino}-3-methylphenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17914,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),9.8,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5880,2011627,23647834,BindingDB,"4-{[(2S,4S)-1-[2-(4-{[(2-bromophenyl)carbamoyl]amino}-3-chlorophenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",17915,"4-{[(2S,4S)-1-[2-(4-{[(2-bromophenyl)carbamoyl]amino}-3-chlorophenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17915,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.7,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5881,2011628,23647835,BindingDB,"4-{[(2S,4S)-1-[2-(3-bromo-4-{[(2-bromophenyl)carbamoyl]amino}phenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",17916,"4-{[(2S,4S)-1-[2-(3-bromo-4-{[(2-bromophenyl)carbamoyl]amino}phenyl)acetyl]-4-fluoropyrrolidin-2-yl]methoxy}benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17916,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.4,PMID:17194595|DOI:10.1016/j.bmc.2006.12.006,https://www.ncbi.nlm.nih.gov/pubmed/17194595|https://doi.org/10.1016/j.bmc.2006.12.006,17194595,10.1016/j.bmc.2006.12.006,
5882,2011649,23647836,BindingDB,2-(4-{[(2S)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid,17918,2-(4-{[(2S)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17918,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.6,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5883,2011650,23647837,BindingDB,"2-(4-{[(2S,4R)-4-methoxy-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",17919,"2-(4-{[(2S,4R)-4-methoxy-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17919,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),2.0,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5884,2011726,23647838,BindingDB,"2-(1-{[(2S,4R)-4-methoxy-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperidin-4-yl)acetic acid",17920,"2-(1-{[(2S,4R)-4-methoxy-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperidin-4-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17920,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.1,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5885,2011725,23647839,BindingDB,"2-(1-{[(2S,4R)-4-(benzyloxy)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperidin-4-yl)acetic acid",17922,"2-(1-{[(2S,4R)-4-(benzyloxy)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperidin-4-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17922,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),0.94,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5886,2011724,23647840,BindingDB,"2-(4-{[(2S,4R)-4-hydroxy-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",17923,"2-(4-{[(2S,4R)-4-hydroxy-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17923,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),5.1,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5887,2011651,23647841,BindingDB,"2-(1-{[(2S,4R)-4-hydroxy-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperidin-4-yl)acetic acid",17924,"2-(1-{[(2S,4R)-4-hydroxy-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperidin-4-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17924,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.1,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5888,2011652,23647842,BindingDB,"2-(4-{[(3aR,4S,6aS)-5-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-2,2-dimethyl-hexahydro-[1,3]dioxolo[4,5-c]pyrrol-4-yl]carbonyl}piperazin-1-yl)acetic acid",17925,"2-(4-{[(3aR,4S,6aS)-5-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-2,2-dimethyl-hexahydro-[1,3]dioxolo[4,5-c]pyrrol-4-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17925,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.6,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5889,2011653,23647843,BindingDB,"2-(4-{[(2S,3R,4S)-3,4-dihydroxy-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",17926,"2-(4-{[(2S,3R,4S)-3,4-dihydroxy-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17926,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.4,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5890,2011654,23647844,BindingDB,"2-(4-{[(2S,4S)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-4-phenoxypyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",17927,"2-(4-{[(2S,4S)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-4-phenoxypyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17927,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.2,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5891,2011667,23647845,BindingDB,"2-(4-{[(2S,3S)-3-hydroxy-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",17930,"2-(4-{[(2S,3S)-3-hydroxy-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17930,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),0.96,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5892,2011668,23647846,BindingDB,"2-(4-{[(2S,4S)-4-fluoro-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",17931,"2-(4-{[(2S,4S)-4-fluoro-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17931,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.0,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5893,2011669,23647847,BindingDB,"2-(4-{[(2S,4R)-4-fluoro-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",17932,"2-(4-{[(2S,4R)-4-fluoro-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17932,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),2.2,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5894,2011670,23647848,BindingDB,"2-(4-{[(2S)-4,4-difluoro-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",17933,"2-(4-{[(2S)-4,4-difluoro-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17933,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.4,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5895,2011671,23647849,BindingDB,"2-(4-{[(2S,4S)-4-chloro-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",17934,"2-(4-{[(2S,4S)-4-chloro-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17934,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.1,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5896,2011672,23647850,BindingDB,"2-[4-({2-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-2,3-dihydro-1H-isoindol-1-yl}carbonyl)piperazin-1-yl]acetic acid",17935,"2-[4-({2-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-2,3-dihydro-1H-isoindol-1-yl}carbonyl)piperazin-1-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17935,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.5,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5897,2011680,23647851,BindingDB,"2-(4-{[(2S)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-2,3-dihydro-1H-indol-2-yl]carbonyl}piperazin-1-yl)acetic acid",17936,"2-(4-{[(2S)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-2,3-dihydro-1H-indol-2-yl]carbonyl}piperazin-1-yl)acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17936,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),2.6,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5898,2011681,23647852,BindingDB,2-(4-{[(2S)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-octahydro-1H-indol-2-yl]carbonyl}piperazin-1-yl)acetic acid,17937,2-(4-{[(2S)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]-octahydro-1H-indol-2-yl]carbonyl}piperazin-1-yl)acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17937,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1.0,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5899,2011682,23647853,BindingDB,2-(4-{[(2S)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)propanoic acid,17938,2-(4-{[(2S)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17938,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),66,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5900,2011683,23647854,BindingDB,"2-(4-{[(2S,4R)-4-(benzyloxy)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)-2-methylpropanoic acid",17940,"2-(4-{[(2S,4R)-4-(benzyloxy)-1-[2-(3-methoxy-4-{[(2-methylphenyl)carbamoyl]amino}phenyl)acetyl]pyrrolidin-2-yl]carbonyl}piperazin-1-yl)-2-methylpropanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17940,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),185,PMID:16377201|DOI:10.1016/j.bmc.2005.11.058,https://www.ncbi.nlm.nih.gov/pubmed/16377201|https://doi.org/10.1016/j.bmc.2005.11.058,16377201,10.1016/j.bmc.2005.11.058,
5901,2011684,23647855,BindingDB,"(2R,4S,5S)-5-amino-N-butyl-4-hydroxy-2,7,7-trimethyl-9-oxo-9-(1,2,3,4-tetrahydroquinolin-1-yl)nonanamide",17942,"(2R,4S,5S)-5-amino-N-butyl-4-hydroxy-2,7,7-trimethyl-9-oxo-9-(1,2,3,4-tetrahydroquinolin-1-yl)nonanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17942,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),52,PMID:10903938|DOI:10.1016/S1074-5521(00)00134-4,https://www.ncbi.nlm.nih.gov/pubmed/10903938|https://doi.org/10.1016/S1074-5521(00)00134-4,10903938,10.1016/S1074-5521(00)00134-4,
5902,2011685,23647855,BindingDB,"(2R,4S,5S)-5-amino-N-butyl-4-hydroxy-2,7,7-trimethyl-9-oxo-9-(1,2,3,4-tetrahydroquinolin-1-yl)nonanamide",17942,"(2R,4S,5S)-5-amino-N-butyl-4-hydroxy-2,7,7-trimethyl-9-oxo-9-(1,2,3,4-tetrahydroquinolin-1-yl)nonanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17942,1871,Pepsin A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1871,P00791,Pepsin A,,,9823.0,Sus scrofa (pig),,IC50 (nM),>100000,PMID:10903938|DOI:10.1016/S1074-5521(00)00134-4,https://www.ncbi.nlm.nih.gov/pubmed/10903938|https://doi.org/10.1016/S1074-5521(00)00134-4,10903938,10.1016/S1074-5521(00)00134-4,
5903,2011693,23647856,BindingDB,"methyl (3S)-1-[(5S,6S,8R)-5-amino-8-(butylcarbamoyl)-6-hydroxy-3,3,8-trimethyloctanoyl]-1,2,3,4-tetrahydroquinoline-3-carboxylate",17943,"Renin nonpeptide inhibitor, 3",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17943,1871,Pepsin A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1871,P00791,Pepsin A,,,9823.0,Sus scrofa (pig),,IC50 (nM),>100000,PMID:10903938|DOI:10.1016/S1074-5521(00)00134-4,https://www.ncbi.nlm.nih.gov/pubmed/10903938|https://doi.org/10.1016/S1074-5521(00)00134-4,10903938,10.1016/S1074-5521(00)00134-4,
5904,2011694,23647856,BindingDB,"methyl (3S)-1-[(5S,6S,8R)-5-amino-8-(butylcarbamoyl)-6-hydroxy-3,3,8-trimethyloctanoyl]-1,2,3,4-tetrahydroquinoline-3-carboxylate",17943,"Renin nonpeptide inhibitor, 3",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17943,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),0.8,PMID:10903938|DOI:10.1016/S1074-5521(00)00134-4,https://www.ncbi.nlm.nih.gov/pubmed/10903938|https://doi.org/10.1016/S1074-5521(00)00134-4,10903938,10.1016/S1074-5521(00)00134-4,
5905,2011695,23647857,BindingDB,"(3S,4R)-N-[(6-methoxynaphthalen-2-yl)methyl]-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)piperidin-3-amine",17952,"(3S,4R)-N-[(6-methoxynaphthalen-2-yl)methyl]-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)piperidin-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17952,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),73,PMID:15582452|DOI:10.1016/j.bmc.2004.09.056,https://www.ncbi.nlm.nih.gov/pubmed/15582452|https://doi.org/10.1016/j.bmc.2004.09.056,15582452,10.1016/j.bmc.2004.09.056,
5906,2011696,23647858,BindingDB,"(3S,4R)-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-N-(quinolin-7-ylmethyl)piperidin-3-amine",17953,"(3S,4R)-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-N-(quinolin-7-ylmethyl)piperidin-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17953,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),175,PMID:15582452|DOI:10.1016/j.bmc.2004.09.056,https://www.ncbi.nlm.nih.gov/pubmed/15582452|https://doi.org/10.1016/j.bmc.2004.09.056,15582452,10.1016/j.bmc.2004.09.056,
5907,2011697,23647859,BindingDB,"(3S,4R)-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-N-(1,2,3,4-tetrahydroquinolin-7-ylmethyl)piperidin-3-amine",17954,"(3S,4R)-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-N-(1,2,3,4-tetrahydroquinolin-7-ylmethyl)piperidin-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17954,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),255,PMID:15582452|DOI:10.1016/j.bmc.2004.09.056,https://www.ncbi.nlm.nih.gov/pubmed/15582452|https://doi.org/10.1016/j.bmc.2004.09.056,15582452,10.1016/j.bmc.2004.09.056,
5908,2011698,23647860,BindingDB,"methyl 6-({[(3S,4R)-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)piperidin-3-yl]amino}methyl)naphthalene-1-carboxylate",17955,"amino-aryl-piperidine-based compound, 20",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17955,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),282,PMID:15582452|DOI:10.1016/j.bmc.2004.09.056,https://www.ncbi.nlm.nih.gov/pubmed/15582452|https://doi.org/10.1016/j.bmc.2004.09.056,15582452,10.1016/j.bmc.2004.09.056,
5909,2011699,23647861,BindingDB,"(3S,4R)-N-(1-benzofuran-5-ylmethyl)-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)piperidin-3-amine",17956,"(3S,4R)-N-(1-benzofuran-5-ylmethyl)-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)piperidin-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17956,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),393,PMID:15582452|DOI:10.1016/j.bmc.2004.09.056,https://www.ncbi.nlm.nih.gov/pubmed/15582452|https://doi.org/10.1016/j.bmc.2004.09.056,15582452,10.1016/j.bmc.2004.09.056,
5910,2011707,23647862,BindingDB,"(3S,4R)-N-(1H-indol-5-ylmethyl)-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)piperidin-3-amine",17957,"(3S,4R)-N-(1H-indol-5-ylmethyl)-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)piperidin-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17957,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),2280,PMID:15582452|DOI:10.1016/j.bmc.2004.09.056,https://www.ncbi.nlm.nih.gov/pubmed/15582452|https://doi.org/10.1016/j.bmc.2004.09.056,15582452,10.1016/j.bmc.2004.09.056,
5911,2011708,23647863,BindingDB,"N-[(3S,4R)-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)piperidin-3-yl]naphthalene-2-carboxamide",17959,"N-[(3S,4R)-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)piperidin-3-yl]naphthalene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17959,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:15582452|DOI:10.1016/j.bmc.2004.09.056,https://www.ncbi.nlm.nih.gov/pubmed/15582452|https://doi.org/10.1016/j.bmc.2004.09.056,15582452,10.1016/j.bmc.2004.09.056,
5912,2011709,23647864,BindingDB,"(3S,4R)-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-N-[(4-phenylphenyl)methyl]piperidin-3-amine",17960,"(3S,4R)-4-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-N-[(4-phenylphenyl)methyl]piperidin-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17960,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:15582452|DOI:10.1016/j.bmc.2004.09.056,https://www.ncbi.nlm.nih.gov/pubmed/15582452|https://doi.org/10.1016/j.bmc.2004.09.056,15582452,10.1016/j.bmc.2004.09.056,
5913,2011710,23647865,BindingDB,(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-2-[(naphthalen-2-yloxy)methyl]piperazine,17961,(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-2-[(naphthalen-2-yloxy)methyl]piperazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17961,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),180,PMID:15755665|DOI:10.1016/j.bmc.2005.01.048,https://www.ncbi.nlm.nih.gov/pubmed/15755665|https://doi.org/10.1016/j.bmc.2005.01.048,15755665,10.1016/j.bmc.2005.01.048,
5914,2011711,23647866,BindingDB,(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-2-[(naphthalen-2-ylmethoxy)methyl]piperazine,17962,(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-2-[(naphthalen-2-ylmethoxy)methyl]piperazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17962,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),1700,PMID:15755665|DOI:10.1016/j.bmc.2005.01.048,https://www.ncbi.nlm.nih.gov/pubmed/15755665|https://doi.org/10.1016/j.bmc.2005.01.048,15755665,10.1016/j.bmc.2005.01.048,
5915,2011712,23647867,BindingDB,(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-2-{[(4-phenylphenyl)methoxy]methyl}piperazine,17963,(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-2-{[(4-phenylphenyl)methoxy]methyl}piperazine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17963,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),1020,PMID:15755665|DOI:10.1016/j.bmc.2005.01.048,https://www.ncbi.nlm.nih.gov/pubmed/15755665|https://doi.org/10.1016/j.bmc.2005.01.048,15755665,10.1016/j.bmc.2005.01.048,
5916,2011713,23647868,BindingDB,"(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-2-[(5,6,7,8-tetrahydronaphthalen-2-yloxy)methyl]piperazine",17964,"(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-2-[(5,6,7,8-tetrahydronaphthalen-2-yloxy)methyl]piperazine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17964,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),440,PMID:15755665|DOI:10.1016/j.bmc.2005.01.048,https://www.ncbi.nlm.nih.gov/pubmed/15755665|https://doi.org/10.1016/j.bmc.2005.01.048,15755665,10.1016/j.bmc.2005.01.048,
5917,2011721,23647869,BindingDB,"6-ethyl-5-[4-(3-methoxypropyl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]pyrimidine-2,4-diamine",17968,"1,4-benzoxazine, 5",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17968,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),2700,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5918,2011722,23647870,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-4-(3-methoxypropyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one",17969,"1,4-benzoxazin-3-one, 6",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17969,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),3900,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5919,2011723,23647871,BindingDB,"6-ethyl-5-[4-(3-methoxypropyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl]pyrimidine-2,4-diamine",17970,"1,4-benzoxazine, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17970,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),235,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5920,2011727,23647872,BindingDB,"6-ethyl-5-[(2R)-4-(3-methoxypropyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl]pyrimidine-2,4-diamine",17971,"1,4-benzoxazine, 8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17971,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),325,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5921,2011735,23647873,BindingDB,"6-ethyl-5-[(2S)-4-(3-methoxypropyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl]pyrimidine-2,4-diamine",17972,"1,4-benzoxazine, 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17972,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),310,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5922,2011736,23647874,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-4-(3-methoxypropyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",17973,"1,4-benzoxazin-3-one, 10",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17973,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),520,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5923,2011737,23647875,BindingDB,"(2R)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-4-(3-methoxypropyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",17974,"(2R)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-4-(3-methoxypropyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17974,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),125,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5924,2011738,23647875,BindingDB,"(2R)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-4-(3-methoxypropyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",17974,"(2R)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-4-(3-methoxypropyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17974,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),132,PMID:17113558|DOI:10.1016/j.ab.2006.10.017,https://www.ncbi.nlm.nih.gov/pubmed/17113558|https://doi.org/10.1016/j.ab.2006.10.017,17113558,10.1016/j.ab.2006.10.017,
5925,2011739,23647876,BindingDB,"(2S)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-4-(3-methoxypropyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",17975,"(2S)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-4-(3-methoxypropyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17975,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),1040,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5926,2011740,23647877,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-4-(3-methoxypropyl)-2-propyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",17976,"1,4-benzoxazin-3-one, 13",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17976,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),430,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5927,2011741,23647878,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-4-(3-methoxypropyl)-2-phenyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",17977,"1,4-benzoxazin-3-one, 14",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17977,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),220,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5928,2011742,23647879,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,4-difluorophenyl)-4-(3-methoxypropyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one",17978,"1,4-benzoxazin-3-one, 15",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17978,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),206,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5929,2011750,23647880,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(4-fluorophenyl)-4-(3-methoxypropyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one",17979,"1,4-benzoxazin-3-one, 16",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17979,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),325,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5930,2011751,23647881,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(2,3-difluorophenyl)-4-(3-methoxypropyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one",17981,"1,4-benzoxazin-3-one, 18",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17981,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),72,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5931,2011752,23647882,BindingDB,"N-{2-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-methyl-3-oxo-2-(trifluoromethyl)-3,4-dihydro-2H-1,4-benzoxazin-4-yl]ethyl}acetamide",17984,"1,4-benzoxazin-3-one, 21",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17984,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),17,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5932,2011753,23647883,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-ethyl-4-(3-methoxypropyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",17985,"1,4-benzoxazin-3-one, 22",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17985,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),52,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5933,2011754,23647884,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2,2-diethyl-4-(3-methoxypropyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one",17986,"1,4-benzoxazin-3-one, 23",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17986,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),245,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5934,2011755,23647885,BindingDB,"1,4-Benzoxazin-3-one, 24",17987,"1,4-benzoxazin-3-one, 24",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17987,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),100,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5935,2011756,23647886,BindingDB,"N-{2-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl]ethyl}acetamide",17989,"1,4-benzoxazin-3-one, 26",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17989,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),1,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5936,2011757,23647887,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-2-ethyl-4-(3-methoxypropyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one",17990,"1,4-benzoxazin-3-one, 27",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17990,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),175,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5937,2011812,23647896,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-4-(2-hydroxyethyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",17999,"1,4-benzoxazin-3-one, 36",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=17999,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),1080,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5938,2011813,23647897,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-4-(4-hydroxybutyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",18000,"1,4-benzoxazin-3-one, 37",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18000,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),43,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5939,2011814,23647898,BindingDB,"N-{2-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl]ethyl}-2-hydroxyacetamide",18001,"1,4-benzoxazin-3-one, 38",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18001,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),3,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5940,2011815,23647899,BindingDB,"3-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl]-N-methylpropanamide",18002,"1,4-benzoxazin-3-one, 39",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18002,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),6,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5941,2011816,23647900,BindingDB,"2-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl]-N-ethylacetamide",18003,"1,4-benzoxazin-3-one, 40",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18003,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),200,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5942,2011817,23647901,BindingDB,"N-{2-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl]ethyl}methanesulfonamide",18004,"1,4-benzoxazin-3-one, 41",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18004,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),630,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5943,2011818,23647902,BindingDB,"methyl N-{2-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl]ethyl}carbamate",18005,"1,4-benzoxazin-3-one, 42",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18005,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),2,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5944,2011828,23647905,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-4-(3-ethoxypropyl)-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",18008,"1,4-benzoxazin-3-one, 45",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18008,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),41,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5945,2011829,23647906,BindingDB,"6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-2-methyl-4-[2-(2,2,2-trifluoroethoxy)ethyl]-3,4-dihydro-2H-1,4-benzoxazin-3-one",18009,"1,4-benzoxazin-3-one, 46",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18009,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),188,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5946,2011830,23647907,BindingDB,"(2S)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-2-methyl-4-(4,4,4-trifluorobutyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one",18011,"(2S)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-2-methyl-4-(4,4,4-trifluorobutyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18011,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),48,PMID:17574423|DOI:10.1016/j.bmc.2007.05.069,https://www.ncbi.nlm.nih.gov/pubmed/17574423|https://doi.org/10.1016/j.bmc.2007.05.069,17574423,10.1016/j.bmc.2007.05.069,
5947,2011831,23647908,BindingDB,"Methyl 3-[7-(2,4-diamino-6-ethylpyrimidin-5-yl)-1,2,3,4-tetrahydroquinolin-1-yl]propanoate",18017,"6-ethyl-2,4-diaminopyrimidine-based compound, 12",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18017,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),198,PMID:17482464|DOI:10.1016/j.bmcl.2007.04.052,https://www.ncbi.nlm.nih.gov/pubmed/17482464|https://doi.org/10.1016/j.bmcl.2007.04.052,17482464,10.1016/j.bmcl.2007.04.052,
5948,2011832,23647909,BindingDB,"Methyl 4-[7-(2,4-diamino-6-ethylpyrimidin-5-yl)-1,2,3,4-tetrahydroquinolin-1-yl]butanoate",18018,"6-ethyl-2,4-diaminopyrimidine-based compound, 13",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18018,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),120,PMID:17482464|DOI:10.1016/j.bmcl.2007.04.052,https://www.ncbi.nlm.nih.gov/pubmed/17482464|https://doi.org/10.1016/j.bmcl.2007.04.052,17482464,10.1016/j.bmcl.2007.04.052,
5949,2011833,23647910,BindingDB,"Methyl 5-[7-(2,4-diamino-6-ethylpyrimidin-5-yl)-1,2,3,4-tetrahydroquinolin-1-yl]pentanoate",18019,"6-ethyl-2,4-diaminopyrimidine-based compound, 14",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18019,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),91,PMID:17482464|DOI:10.1016/j.bmcl.2007.04.052,https://www.ncbi.nlm.nih.gov/pubmed/17482464|https://doi.org/10.1016/j.bmcl.2007.04.052,17482464,10.1016/j.bmcl.2007.04.052,
5950,2011834,23647911,BindingDB,"(6R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-6-[({1-[2-(2-oxopyrrolidin-1-yl)ethyl]-1,2,3,4-tetrahydroquinolin-7-yl}oxy)methyl]piperazin-2-one",18023,"(6R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-6-[({1-[2-(2-oxopyrrolidin-1-yl)ethyl]-1,2,3,4-tetrahydroquinolin-7-yl}oxy)methyl]piperazin-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18023,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),606,PMID:16480874|DOI:10.1016/j.bmcl.2006.01.084,https://www.ncbi.nlm.nih.gov/pubmed/16480874|https://doi.org/10.1016/j.bmcl.2006.01.084,16480874,10.1016/j.bmcl.2006.01.084,
5951,2012329,23647912,BindingDB,"2-(7-{[(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-6-oxopiperazin-2-yl]methoxy}-1,2,3,4-tetrahydroquinolin-1-yl)ethyl 2-methylpropanoate",18027,"2-(7-{[(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-6-oxopiperazin-2-yl]methoxy}-1,2,3,4-tetrahydroquinolin-1-yl)ethyl 2-methylpropanoate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18027,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),550,PMID:16480874|DOI:10.1016/j.bmcl.2006.01.084,https://www.ncbi.nlm.nih.gov/pubmed/16480874|https://doi.org/10.1016/j.bmcl.2006.01.084,16480874,10.1016/j.bmcl.2006.01.084,
5952,2012330,23647913,BindingDB,"3-(7-{[(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-6-oxopiperazin-2-yl]methoxy}-1,2,3,4-tetrahydroquinolin-1-yl)propanoic acid",18030,"3-(7-{[(2R)-1-(4-{3-[(2-methoxyphenyl)methoxy]propoxy}phenyl)-6-oxopiperazin-2-yl]methoxy}-1,2,3,4-tetrahydroquinolin-1-yl)propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18030,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),450,PMID:16480874|DOI:10.1016/j.bmcl.2006.01.084,https://www.ncbi.nlm.nih.gov/pubmed/16480874|https://doi.org/10.1016/j.bmcl.2006.01.084,16480874,10.1016/j.bmcl.2006.01.084,
5953,2012331,23647914,BindingDB,"Ketopiperazine-based inhibitor, 15",18035,"Ketopiperazine-based inhibitor, 15",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18035,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),1200,PMID:16480874|DOI:10.1016/j.bmcl.2006.01.084,https://www.ncbi.nlm.nih.gov/pubmed/16480874|https://doi.org/10.1016/j.bmcl.2006.01.084,16480874,10.1016/j.bmcl.2006.01.084,
5954,2012332,23647915,BindingDB,"6-Ethyl-5-[1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",18038,"6-ethyl-5-[1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18038,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),58,PMID:17113558|DOI:10.1016/j.ab.2006.10.017,https://www.ncbi.nlm.nih.gov/pubmed/17113558|https://doi.org/10.1016/j.ab.2006.10.017,17113558,10.1016/j.ab.2006.10.017,
5955,2011024,23648260,BindingDB,pyridin-3-ylmethyl N-[(4-{[2-amino-5-(thiophen-2-yl)phenyl]carbamoyl}phenyl)methyl]carbamate,19412,CHEMBL235674,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19412,2482,Histone deacetylase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2482,Q92769,Histone deacetylase 2,3066.0,HDAC2,9606.0,Homo sapiens (human),,IC50 (nM),100,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5956,2011025,23648260,BindingDB,pyridin-3-ylmethyl N-[(4-{[2-amino-5-(thiophen-2-yl)phenyl]carbamoyl}phenyl)methyl]carbamate,19412,CHEMBL235674,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19412,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),20,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5957,2011026,23648261,BindingDB,"N-(2-amino-5-phenylphenyl)-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",19415,"N-(2-amino-5-phenylphenyl)-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19415,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),60,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5958,2011027,23648261,BindingDB,"N-(2-amino-5-phenylphenyl)-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",19415,"N-(2-amino-5-phenylphenyl)-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19415,2482,Histone deacetylase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2482,Q92769,Histone deacetylase 2,3066.0,HDAC2,9606.0,Homo sapiens (human),,IC50 (nM),100,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5959,2011028,23648262,BindingDB,"N-[2-amino-5-(thiophen-3-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",19416,"N-[2-amino-5-(thiophen-3-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19416,2482,Histone deacetylase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2482,Q92769,Histone deacetylase 2,3066.0,HDAC2,9606.0,Homo sapiens (human),,IC50 (nM),60,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5960,2011029,23648262,BindingDB,"N-[2-amino-5-(thiophen-3-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",19416,"N-[2-amino-5-(thiophen-3-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19416,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),50,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5961,2011030,23648263,BindingDB,"N-[2-amino-5-(furan-3-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",19417,"N-[2-amino-5-(furan-3-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19417,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),50,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5962,2011031,23648263,BindingDB,"N-[2-amino-5-(furan-3-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",19417,"N-[2-amino-5-(furan-3-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19417,2482,Histone deacetylase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2482,Q92769,Histone deacetylase 2,3066.0,HDAC2,9606.0,Homo sapiens (human),,IC50 (nM),70,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5963,2011032,23648264,BindingDB,"N-[2-amino-5-(1-benzothiophen-2-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",19418,"N-[2-amino-5-(1-benzothiophen-2-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19418,2482,Histone deacetylase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2482,Q92769,Histone deacetylase 2,3066.0,HDAC2,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5964,2011033,23648264,BindingDB,"N-[2-amino-5-(1-benzothiophen-2-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",19418,"N-[2-amino-5-(1-benzothiophen-2-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19418,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5965,2011034,23648265,BindingDB,"N-[2-amino-4-(thiophen-2-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",19419,"N-[2-amino-4-(thiophen-2-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19419,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5966,2011035,23648265,BindingDB,"N-[2-amino-4-(thiophen-2-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",19419,"N-[2-amino-4-(thiophen-2-yl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19419,2482,Histone deacetylase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2482,Q92769,Histone deacetylase 2,3066.0,HDAC2,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5967,2011036,23648266,BindingDB,"4-{[(3,4-dimethoxyphenyl)amino]methyl}-N-[2-hydroxy-5-(thiophen-2-yl)phenyl]benzamide",19421,"4-{[(3,4-dimethoxyphenyl)amino]methyl}-N-[2-hydroxy-5-(thiophen-2-yl)phenyl]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19421,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),40,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5968,2011037,23648266,BindingDB,"4-{[(3,4-dimethoxyphenyl)amino]methyl}-N-[2-hydroxy-5-(thiophen-2-yl)phenyl]benzamide",19421,"4-{[(3,4-dimethoxyphenyl)amino]methyl}-N-[2-hydroxy-5-(thiophen-2-yl)phenyl]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19421,2482,Histone deacetylase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2482,Q92769,Histone deacetylase 2,3066.0,HDAC2,9606.0,Homo sapiens (human),,IC50 (nM),60,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5969,2011038,23648267,BindingDB,N-(2-aminophenyl)quinoxaline-6-carboxamide,19424,N-(2-aminophenyl)quinoxaline-6-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19424,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),2000,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5970,2011039,23648267,BindingDB,N-(2-aminophenyl)quinoxaline-6-carboxamide,19424,N-(2-aminophenyl)quinoxaline-6-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19424,2482,Histone deacetylase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2482,Q92769,Histone deacetylase 2,3066.0,HDAC2,9606.0,Homo sapiens (human),,IC50 (nM),2000,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5971,2011040,23648267,BindingDB,N-(2-aminophenyl)quinoxaline-6-carboxamide,19424,N-(2-aminophenyl)quinoxaline-6-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19424,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,IC50 (nM),>20000,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5972,2011041,23648267,BindingDB,N-(2-aminophenyl)quinoxaline-6-carboxamide,19424,N-(2-aminophenyl)quinoxaline-6-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19424,1996,Histone deacetylase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1996,Q9BY41,Histone deacetylase 8,55869.0,HDAC8,9606.0,Homo sapiens (human),,IC50 (nM),>20000,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5973,2011042,23648268,BindingDB,N-[2-amino-5-(thiophen-2-yl)phenyl]-4-methoxybenzamide,19427,N-[2-amino-5-(thiophen-2-yl)phenyl]-4-methoxybenzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19427,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),50,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5974,2011043,23648268,BindingDB,N-[2-amino-5-(thiophen-2-yl)phenyl]-4-methoxybenzamide,19427,N-[2-amino-5-(thiophen-2-yl)phenyl]-4-methoxybenzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19427,2482,Histone deacetylase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2482,Q92769,Histone deacetylase 2,3066.0,HDAC2,9606.0,Homo sapiens (human),,IC50 (nM),200,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5975,2011044,23648268,BindingDB,N-[2-amino-5-(thiophen-2-yl)phenyl]-4-methoxybenzamide,19427,N-[2-amino-5-(thiophen-2-yl)phenyl]-4-methoxybenzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19427,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,IC50 (nM),>20000,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5976,2011045,23648268,BindingDB,N-[2-amino-5-(thiophen-2-yl)phenyl]-4-methoxybenzamide,19427,N-[2-amino-5-(thiophen-2-yl)phenyl]-4-methoxybenzamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19427,1996,Histone deacetylase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1996,Q9BY41,Histone deacetylase 8,55869.0,HDAC8,9606.0,Homo sapiens (human),,IC50 (nM),>20000,PMID:17941625|DOI:10.1021/jm701079h,https://www.ncbi.nlm.nih.gov/pubmed/17941625|https://doi.org/10.1021/jm701079h,17941625,10.1021/jm701079h,
5977,2011046,23648269,BindingDB,"4-[3-(4-chlorophenyl)-5-(3,5-dimethylpiperidin-1-yl)-1H-pyrazol-4-yl]pyridine",19431,"4-[3-(4-chlorophenyl)-5-(3,5-dimethylpiperidin-1-yl)-1H-pyrazol-4-yl]pyridine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19431,3881,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3881,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),,IC50 (nM),130,PMID:17948975|DOI:10.1021/jm0611915,https://www.ncbi.nlm.nih.gov/pubmed/17948975|https://doi.org/10.1021/jm0611915,17948975,10.1021/jm0611915,
5978,2011047,23648270,BindingDB,4-[3-(4-chlorophenyl)-5-(4-methylpiperidin-1-yl)-1H-pyrazol-4-yl]pyridine,19432,4-[3-(4-chlorophenyl)-5-(4-methylpiperidin-1-yl)-1H-pyrazol-4-yl]pyridine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19432,3881,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3881,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),,IC50 (nM),130,PMID:17948975|DOI:10.1021/jm0611915,https://www.ncbi.nlm.nih.gov/pubmed/17948975|https://doi.org/10.1021/jm0611915,17948975,10.1021/jm0611915,
5979,2011048,23648271,BindingDB,2-[3-(4-chlorophenyl)-4-(pyridin-4-yl)-1H-pyrazol-5-yl]-decahydroisoquinoline,19433,2-[3-(4-chlorophenyl)-4-(pyridin-4-yl)-1H-pyrazol-5-yl]-decahydroisoquinoline,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19433,3881,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3881,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),,IC50 (nM),260,PMID:17948975|DOI:10.1021/jm0611915,https://www.ncbi.nlm.nih.gov/pubmed/17948975|https://doi.org/10.1021/jm0611915,17948975,10.1021/jm0611915,
5980,2011049,23648272,BindingDB,1-[3-(4-chlorophenyl)-4-(pyridin-4-yl)-1H-pyrazol-5-yl]-decahydroquinoline,19435,1-[3-(4-chlorophenyl)-4-(pyridin-4-yl)-1H-pyrazol-5-yl]-decahydroquinoline,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19435,3881,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3881,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),,IC50 (nM),40,PMID:17948975|DOI:10.1021/jm0611915,https://www.ncbi.nlm.nih.gov/pubmed/17948975|https://doi.org/10.1021/jm0611915,17948975,10.1021/jm0611915,
5981,2011050,23648273,BindingDB,1-[3-(4-chlorophenyl)-4-(pyridin-4-yl)-1H-pyrazol-5-yl]piperidin-4-ol,19437,1-[3-(4-chlorophenyl)-4-(pyridin-4-yl)-1H-pyrazol-5-yl]piperidin-4-ol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19437,3881,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3881,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),,IC50 (nM),110,PMID:17948975|DOI:10.1021/jm0611915,https://www.ncbi.nlm.nih.gov/pubmed/17948975|https://doi.org/10.1021/jm0611915,17948975,10.1021/jm0611915,
5982,2011051,23648274,BindingDB,"Pyrazole-Based Inhibitor, 19",19438,"4-{5-[(8aS)-octahydropyrrolo[1,2-a]piperazin-2-yl]-3-(4-chlorophenyl)-1H-pyrazol-4-yl}pyridine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19438,3881,Mitogen-activated protein kinase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3881,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),,IC50 (nM),62,PMID:17948975|DOI:10.1021/jm0611915,https://www.ncbi.nlm.nih.gov/pubmed/17948975|https://doi.org/10.1021/jm0611915,17948975,10.1021/jm0611915,
5983,2011052,23648275,BindingDB,2-(4-Fluorophenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]phenoxy}-1-benzothiophen-6-ol,19444,2-(4-fluorophenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]phenoxy}-1-benzothiophen-6-ol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19444,369,Estrogen receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=369,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),,IC50 (nM),17.2,PMID:17489582|DOI:10.1021/jm070079j,https://www.ncbi.nlm.nih.gov/pubmed/17489582|https://doi.org/10.1021/jm070079j,17489582,10.1021/jm070079j,
5984,2011053,23648275,BindingDB,2-(4-Fluorophenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]phenoxy}-1-benzothiophen-6-ol,19444,2-(4-fluorophenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]phenoxy}-1-benzothiophen-6-ol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19444,370,Estrogen receptor beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=370,Q92731,Estrogen receptor beta,2100.0,ESR2,9606.0,Homo sapiens (human),,IC50 (nM),27.9,PMID:17489582|DOI:10.1021/jm070079j,https://www.ncbi.nlm.nih.gov/pubmed/17489582|https://doi.org/10.1021/jm070079j,17489582,10.1021/jm070079j,
5985,2011054,23648277,BindingDB,"Trifluoroethylamine inhibitor, 2",19492,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfonylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19492,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),282,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5986,2011055,23648277,BindingDB,"Trifluoroethylamine inhibitor, 2",19492,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfonylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19492,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),11,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5987,2011056,23648277,BindingDB,"Trifluoroethylamine inhibitor, 2",19492,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfonylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19492,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),31,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5988,2011057,23648277,BindingDB,"Trifluoroethylamine inhibitor, 2",19492,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfonylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19492,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),427,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5989,2011058,23648278,BindingDB,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-(methylsulfanyl)propanamide",19493,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-(methylsulfanyl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19493,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),456,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5990,2011059,23648278,BindingDB,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-(methylsulfanyl)propanamide",19493,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-(methylsulfanyl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19493,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),5.0,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5991,2011060,23648278,BindingDB,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-(methylsulfanyl)propanamide",19493,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-(methylsulfanyl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19493,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),80,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5992,2011061,23648278,BindingDB,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-(methylsulfanyl)propanamide",19493,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-(methylsulfanyl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19493,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),417,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5993,2011062,23648279,BindingDB,"Trifluoroethylamine inhibitor, 4",19494,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfinylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19494,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),8029,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5994,2011063,23648279,BindingDB,"Trifluoroethylamine inhibitor, 4",19494,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfinylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19494,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),2173,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5995,2011064,23648279,BindingDB,"Trifluoroethylamine inhibitor, 4",19494,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfinylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19494,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),639,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5996,2011065,23648279,BindingDB,"Trifluoroethylamine inhibitor, 4",19494,"(2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfinylpropanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19494,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5997,2011066,23648280,BindingDB,"Trifluoroethylamine inhibitor, 5",19495,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-fluorophenyl)phenyl]ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19495,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),5.3,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5998,2011067,23648280,BindingDB,"Trifluoroethylamine inhibitor, 5",19495,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-fluorophenyl)phenyl]ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19495,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
5999,2011068,23648280,BindingDB,"Trifluoroethylamine inhibitor, 5",19495,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-fluorophenyl)phenyl]ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19495,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),10,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6000,2011069,23648280,BindingDB,"Trifluoroethylamine inhibitor, 5",19495,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-fluorophenyl)phenyl]ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19495,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),170,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6001,2011070,23648281,BindingDB,"Trifluoroethylamine inhibitor, 7",19497,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfinyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19497,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),9724,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6002,2011071,23648281,BindingDB,"Trifluoroethylamine inhibitor, 7",19497,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfinyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19497,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),729,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6003,2011072,23648281,BindingDB,"Trifluoroethylamine inhibitor, 7",19497,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfinyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19497,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),1117,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6004,2011073,23648281,BindingDB,"Trifluoroethylamine inhibitor, 7",19497,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfinyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19497,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6005,2011074,23648282,BindingDB,"Trifluoroethylamine inhibitor, 8",19498,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(3-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19498,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),911,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6006,2011075,23648282,BindingDB,"Trifluoroethylamine inhibitor, 8",19498,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(3-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19498,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),314,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6007,2011076,23648282,BindingDB,"Trifluoroethylamine inhibitor, 8",19498,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(3-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19498,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),6.4,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6008,2011077,23648282,BindingDB,"Trifluoroethylamine inhibitor, 8",19498,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(3-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19498,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),3854,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6009,2011078,23648283,BindingDB,"Trifluoroethylamine inhibitor, 9",19499,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19499,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),1980,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6010,2011079,23648283,BindingDB,"Trifluoroethylamine inhibitor, 9",19499,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19499,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),2.5,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6011,2011080,23648283,BindingDB,"Trifluoroethylamine inhibitor, 9",19499,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19499,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),141,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6012,2011081,23648283,BindingDB,"Trifluoroethylamine inhibitor, 9",19499,"(2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19499,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),1035,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6013,2011082,23648284,BindingDB,"Trifluoroethylamine inhibitor, 13",19503,"(2R)-N-(1-cyanocyclopropyl)-3-{[(4-fluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19503,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),>10000,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6014,2011083,23648284,BindingDB,"Trifluoroethylamine inhibitor, 13",19503,"(2R)-N-(1-cyanocyclopropyl)-3-{[(4-fluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19503,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),86,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6015,2011084,23648284,BindingDB,"Trifluoroethylamine inhibitor, 13",19503,"(2R)-N-(1-cyanocyclopropyl)-3-{[(4-fluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19503,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),0.5,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6016,2011085,23648284,BindingDB,"Trifluoroethylamine inhibitor, 13",19503,"(2R)-N-(1-cyanocyclopropyl)-3-{[(4-fluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19503,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),2777,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6017,2011086,23648285,BindingDB,"Trifluoroethylamine inhibitor, 14",19504,"(2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19504,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),1844,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6018,2011087,23648285,BindingDB,"Trifluoroethylamine inhibitor, 14",19504,"(2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19504,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),0.3,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6019,2011088,23648285,BindingDB,"Trifluoroethylamine inhibitor, 14",19504,"(2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19504,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),105,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6020,2011089,23648285,BindingDB,"Trifluoroethylamine inhibitor, 14",19504,"(2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19504,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),>10000,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6021,2011090,23648286,BindingDB,"Trifluoroethylamine inhibitor, 15",19505,"(2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19505,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),>10000,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6022,2011091,23648286,BindingDB,"Trifluoroethylamine inhibitor, 15",19505,"(2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19505,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),121,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6023,2011092,23648286,BindingDB,"Trifluoroethylamine inhibitor, 15",19505,"(2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19505,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),0.3,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6024,2011093,23648286,BindingDB,"Trifluoroethylamine inhibitor, 15",19505,"(2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19505,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),1319,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6025,2011094,23648287,BindingDB,"Trifluoroethylamine inhibitor, 17",19507,"(2R)-N-(1-cyanocyclopropyl)-3-{[(2-phenylphenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19507,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),4041,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6026,2011095,23648287,BindingDB,"Trifluoroethylamine inhibitor, 17",19507,"(2R)-N-(1-cyanocyclopropyl)-3-{[(2-phenylphenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19507,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),1.8,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6027,2011096,23648287,BindingDB,"Trifluoroethylamine inhibitor, 17",19507,"(2R)-N-(1-cyanocyclopropyl)-3-{[(2-phenylphenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19507,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6028,2011097,23648287,BindingDB,"Trifluoroethylamine inhibitor, 17",19507,"(2R)-N-(1-cyanocyclopropyl)-3-{[(2-phenylphenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19507,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),>10000,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6029,2011098,23648288,BindingDB,"Trifluoroethylamine inhibitor, 18",19508,"(2R)-N-(1-cyanocyclopropyl)-3-{[2-(4-fluorophenyl)propane-2-]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19508,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),>10000,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6030,2011099,23648288,BindingDB,"Trifluoroethylamine inhibitor, 18",19508,"(2R)-N-(1-cyanocyclopropyl)-3-{[2-(4-fluorophenyl)propane-2-]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19508,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6031,2011100,23648288,BindingDB,"Trifluoroethylamine inhibitor, 18",19508,"(2R)-N-(1-cyanocyclopropyl)-3-{[2-(4-fluorophenyl)propane-2-]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19508,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),627,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6032,2011101,23648288,BindingDB,"Trifluoroethylamine inhibitor, 18",19508,"(2R)-N-(1-cyanocyclopropyl)-3-{[2-(4-fluorophenyl)propane-2-]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19508,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6033,2011102,23648289,BindingDB,"Trifluoroethylamine inhibitor, 19",19509,"(2R)-N-(1-cyanocyclopropyl)-3-[(4-fluorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19509,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),7280,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6034,2011103,23648289,BindingDB,"Trifluoroethylamine inhibitor, 19",19509,"(2R)-N-(1-cyanocyclopropyl)-3-[(4-fluorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19509,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),0.4,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6035,2011104,23648289,BindingDB,"Trifluoroethylamine inhibitor, 19",19509,"(2R)-N-(1-cyanocyclopropyl)-3-[(4-fluorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19509,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),22,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6036,2011105,23648289,BindingDB,"Trifluoroethylamine inhibitor, 19",19509,"(2R)-N-(1-cyanocyclopropyl)-3-[(4-fluorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19509,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),305,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6037,2011106,23648290,BindingDB,"Trifluoroethylamine inhibitor, 20",19510,"(2R)-3-[(4-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19510,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),290,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6038,2011107,23648290,BindingDB,"Trifluoroethylamine inhibitor, 20",19510,"(2R)-3-[(4-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19510,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),15,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6039,2011108,23648290,BindingDB,"Trifluoroethylamine inhibitor, 20",19510,"(2R)-3-[(4-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19510,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),0.3,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6040,2011109,23648290,BindingDB,"Trifluoroethylamine inhibitor, 20",19510,"(2R)-3-[(4-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19510,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),3453,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6041,2011110,23648291,BindingDB,"Trifluoroethylamine inhibitor, 21",19511,"(2R)-3-[(3-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19511,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),6629,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6042,2011111,23648291,BindingDB,"Trifluoroethylamine inhibitor, 21",19511,"(2R)-3-[(3-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19511,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),0.2,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6043,2011112,23648291,BindingDB,"Trifluoroethylamine inhibitor, 21",19511,"(2R)-3-[(3-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19511,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),23,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6044,2011113,23648291,BindingDB,"Trifluoroethylamine inhibitor, 21",19511,"(2R)-3-[(3-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19511,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),269,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6045,2011114,23648292,BindingDB,"Trifluoroethylamine inhibitor, 22",19512,"(2R)-N-(1-cyanocyclopropyl)-3-(1,3-thiazole-2-sulfonyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19512,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),376,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6046,2011115,23648292,BindingDB,"Trifluoroethylamine inhibitor, 22",19512,"(2R)-N-(1-cyanocyclopropyl)-3-(1,3-thiazole-2-sulfonyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19512,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),181,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6047,2011116,23648292,BindingDB,"Trifluoroethylamine inhibitor, 22",19512,"(2R)-N-(1-cyanocyclopropyl)-3-(1,3-thiazole-2-sulfonyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19512,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),5,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6048,2011117,23648292,BindingDB,"Trifluoroethylamine inhibitor, 22",19512,"(2R)-N-(1-cyanocyclopropyl)-3-(1,3-thiazole-2-sulfonyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19512,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),3612,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6049,2011118,23648293,BindingDB,"Trifluoroethylamine inhibitor, 23",19513,"(2R)-3-(1,3-benzothiazole-2-sulfonyl)-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19513,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),2971,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6050,2011119,23648293,BindingDB,"Trifluoroethylamine inhibitor, 23",19513,"(2R)-3-(1,3-benzothiazole-2-sulfonyl)-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19513,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),1.3,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6051,2011120,23648293,BindingDB,"Trifluoroethylamine inhibitor, 23",19513,"(2R)-3-(1,3-benzothiazole-2-sulfonyl)-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19513,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),114,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6052,2011121,23648293,BindingDB,"Trifluoroethylamine inhibitor, 23",19513,"(2R)-3-(1,3-benzothiazole-2-sulfonyl)-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19513,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),825,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6053,2011122,23648294,BindingDB,"Trifluoroethylamine inhibitor, 24",19514,"(2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19514,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),314,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6054,2011123,23648294,BindingDB,"Trifluoroethylamine inhibitor, 24",19514,"(2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19514,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),24,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6055,2011124,23648294,BindingDB,"Trifluoroethylamine inhibitor, 24",19514,"(2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19514,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),0.2,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6056,2011125,23648294,BindingDB,"Trifluoroethylamine inhibitor, 24",19514,"(2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19514,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),8507,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6057,2011126,23648295,BindingDB,"Trifluoroethylamine inhibitor, 25",19515,"(2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19515,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),4813,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6058,2011127,23648295,BindingDB,"Trifluoroethylamine inhibitor, 25",19515,"(2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19515,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),0.2,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6059,2011128,23648295,BindingDB,"Trifluoroethylamine inhibitor, 25",19515,"(2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19515,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),41,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6060,2011129,23648295,BindingDB,"Trifluoroethylamine inhibitor, 25",19515,"(2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19515,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),691,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6061,2011130,23648296,BindingDB,Morpholine-4-carboxylic acid (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide,19516,"(2S)-N-[(3S,5E)-6-(benzenesulfonyl)-4-oxo-1-phenylhex-5-en-3-yl]-4-methyl-2-(morpholin-4-ylcarbonylamino)pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19516,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),6.2,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6062,2011131,23648296,BindingDB,Morpholine-4-carboxylic acid (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide,19516,"(2S)-N-[(3S,5E)-6-(benzenesulfonyl)-4-oxo-1-phenylhex-5-en-3-yl]-4-methyl-2-(morpholin-4-ylcarbonylamino)pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19516,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),5.7,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6063,2011132,23648296,BindingDB,Morpholine-4-carboxylic acid (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide,19516,"(2S)-N-[(3S,5E)-6-(benzenesulfonyl)-4-oxo-1-phenylhex-5-en-3-yl]-4-methyl-2-(morpholin-4-ylcarbonylamino)pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19516,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),1.2,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6064,2011133,23648296,BindingDB,Morpholine-4-carboxylic acid (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide,19516,"(2S)-N-[(3S,5E)-6-(benzenesulfonyl)-4-oxo-1-phenylhex-5-en-3-yl]-4-methyl-2-(morpholin-4-ylcarbonylamino)pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19516,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),4504,PMID:17590332|DOI:10.1016/j.bmcl.2007.06.023,https://www.ncbi.nlm.nih.gov/pubmed/17590332|https://doi.org/10.1016/j.bmcl.2007.06.023,17590332,10.1016/j.bmcl.2007.06.023,
6065,2011134,23648297,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-[(2,2,2-trifluoroethyl)amino]pentanamide",19519,"(2S)-N-(cyanomethyl)-4-methyl-2-[(2,2,2-trifluoroethyl)amino]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19519,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),6183,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6066,2011135,23648297,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-[(2,2,2-trifluoroethyl)amino]pentanamide",19519,"(2S)-N-(cyanomethyl)-4-methyl-2-[(2,2,2-trifluoroethyl)amino]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19519,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6067,2011136,23648297,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-[(2,2,2-trifluoroethyl)amino]pentanamide",19519,"(2S)-N-(cyanomethyl)-4-methyl-2-[(2,2,2-trifluoroethyl)amino]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19519,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),4123,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6068,2011137,23648297,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-[(2,2,2-trifluoroethyl)amino]pentanamide",19519,"(2S)-N-(cyanomethyl)-4-methyl-2-[(2,2,2-trifluoroethyl)amino]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19519,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6069,2011138,23648298,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(2S)-1,1,1-trifluorohexan-2-yl]amino}pentanamide",19520,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(2S)-1,1,1-trifluorohexan-2-yl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19520,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6070,2011139,23648298,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(2S)-1,1,1-trifluorohexan-2-yl]amino}pentanamide",19520,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(2S)-1,1,1-trifluorohexan-2-yl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19520,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),391,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6071,2011140,23648298,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(2S)-1,1,1-trifluorohexan-2-yl]amino}pentanamide",19520,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(2S)-1,1,1-trifluorohexan-2-yl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19520,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),1950,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6072,2011141,23648298,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(2S)-1,1,1-trifluorohexan-2-yl]amino}pentanamide",19520,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(2S)-1,1,1-trifluorohexan-2-yl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19520,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),1308,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6073,2011142,23648299,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}pentanamide",19521,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19521,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),36,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6074,2011143,23648299,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}pentanamide",19521,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19521,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),34,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6075,2011144,23648299,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}pentanamide",19521,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19521,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),6.7,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6076,2011145,23648299,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}pentanamide",19521,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19521,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6077,2011146,23648300,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenylphenyl)ethyl]amino}pentanamide",19523,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenylphenyl)ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19523,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),1605,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6078,2011147,23648300,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenylphenyl)ethyl]amino}pentanamide",19523,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenylphenyl)ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19523,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),0.2,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6079,2011148,23648300,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenylphenyl)ethyl]amino}pentanamide",19523,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenylphenyl)ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19523,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),1473,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6080,2011149,23648300,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenylphenyl)ethyl]amino}pentanamide",19523,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenylphenyl)ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19523,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),303,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6081,2011150,23648301,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methylphenyl)phenyl]ethyl]amino}pentanamide",19529,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methylphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19529,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),282,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6082,2011151,23648301,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methylphenyl)phenyl]ethyl]amino}pentanamide",19529,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methylphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19529,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),0.3,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6083,2011152,23648301,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methylphenyl)phenyl]ethyl]amino}pentanamide",19529,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methylphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19529,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),1337,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6084,2011153,23648301,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methylphenyl)phenyl]ethyl]amino}pentanamide",19529,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methylphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19529,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),809,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6085,2011154,23648302,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methoxyphenyl)phenyl]ethyl]amino}pentanamide",19530,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methoxyphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19530,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),560,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6086,2011155,23648302,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methoxyphenyl)phenyl]ethyl]amino}pentanamide",19530,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methoxyphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19530,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),1660,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6087,2011156,23648302,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methoxyphenyl)phenyl]ethyl]amino}pentanamide",19530,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methoxyphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19530,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),0.1,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6088,2011157,23648302,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methoxyphenyl)phenyl]ethyl]amino}pentanamide",19530,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methoxyphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19530,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),196,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6089,2011158,23648303,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide",19534,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19534,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),265,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6090,2011159,23648303,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide",19534,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19534,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),0.3,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6091,2011160,23648303,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide",19534,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19534,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),6984,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6092,2011161,23648303,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide",19534,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19534,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),1480,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6093,2011162,23648304,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenoxyphenyl)ethyl]amino}pentanamide",19535,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenoxyphenyl)ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19535,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),771,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6094,2011163,23648304,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenoxyphenyl)ethyl]amino}pentanamide",19535,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenoxyphenyl)ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19535,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6095,2011164,23648304,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenoxyphenyl)ethyl]amino}pentanamide",19535,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenoxyphenyl)ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19535,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),2.3,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6096,2011165,23648304,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenoxyphenyl)ethyl]amino}pentanamide",19535,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-(4-phenoxyphenyl)ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19535,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),220,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6097,2011166,23648305,BindingDB,"(2S)-2-{[(1S)-1-(4-benzoylphenyl)-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",19536,"(2S)-2-{[(1S)-1-(4-benzoylphenyl)-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19536,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),254,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6098,2011167,23648305,BindingDB,"(2S)-2-{[(1S)-1-(4-benzoylphenyl)-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",19536,"(2S)-2-{[(1S)-1-(4-benzoylphenyl)-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19536,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),1.5,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6099,2011168,23648305,BindingDB,"(2S)-2-{[(1S)-1-(4-benzoylphenyl)-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",19536,"(2S)-2-{[(1S)-1-(4-benzoylphenyl)-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19536,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6100,2011169,23648305,BindingDB,"(2S)-2-{[(1S)-1-(4-benzoylphenyl)-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",19536,"(2S)-2-{[(1S)-1-(4-benzoylphenyl)-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19536,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),1915,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6101,2011170,23648306,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]ethyl]amino}pentanamide",19540,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19540,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),314,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6102,2011171,23648306,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]ethyl]amino}pentanamide",19540,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19540,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),436,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6103,2011172,23648306,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]ethyl]amino}pentanamide",19540,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19540,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),2.6,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6104,2011173,23648306,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]ethyl]amino}pentanamide",19540,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19540,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),4073,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6105,2011174,23648307,BindingDB,"(2S)-2-{[(1S)-1-[4-(1H-1,3-benzodiazol-4-yl)phenyl]-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",19542,"(2S)-2-{[(1S)-1-[4-(1H-1,3-benzodiazol-4-yl)phenyl]-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19542,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),0.4,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6106,2011175,23648307,BindingDB,"(2S)-2-{[(1S)-1-[4-(1H-1,3-benzodiazol-4-yl)phenyl]-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",19542,"(2S)-2-{[(1S)-1-[4-(1H-1,3-benzodiazol-4-yl)phenyl]-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19542,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),607,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6107,2011176,23648307,BindingDB,"(2S)-2-{[(1S)-1-[4-(1H-1,3-benzodiazol-4-yl)phenyl]-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",19542,"(2S)-2-{[(1S)-1-[4-(1H-1,3-benzodiazol-4-yl)phenyl]-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19542,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),4699,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6108,2011177,23648307,BindingDB,"(2S)-2-{[(1S)-1-[4-(1H-1,3-benzodiazol-4-yl)phenyl]-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",19542,"(2S)-2-{[(1S)-1-[4-(1H-1,3-benzodiazol-4-yl)phenyl]-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)-4-methylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19542,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),3047,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6109,2011178,23648308,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(4-methanesulfonylphenyl)phenyl]phenyl}ethyl]amino}pentanamide",19543,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(4-methanesulfonylphenyl)phenyl]phenyl}ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19543,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),2422,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6110,2011179,23648308,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(4-methanesulfonylphenyl)phenyl]phenyl}ethyl]amino}pentanamide",19543,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(4-methanesulfonylphenyl)phenyl]phenyl}ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19543,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),1873,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6111,2011180,23648308,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(4-methanesulfonylphenyl)phenyl]phenyl}ethyl]amino}pentanamide",19543,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(4-methanesulfonylphenyl)phenyl]phenyl}ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19543,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),653,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6112,2011181,23648308,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(4-methanesulfonylphenyl)phenyl]phenyl}ethyl]amino}pentanamide",19543,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(4-methanesulfonylphenyl)phenyl]phenyl}ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19543,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),1.2,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6113,2011182,23648309,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(pyridin-4-yl)phenyl]phenyl}ethyl]amino}pentanamide",19544,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(pyridin-4-yl)phenyl]phenyl}ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19544,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),<0.2,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6114,2011183,23648309,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(pyridin-4-yl)phenyl]phenyl}ethyl]amino}pentanamide",19544,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(pyridin-4-yl)phenyl]phenyl}ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19544,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),188,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6115,2011184,23648309,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(pyridin-4-yl)phenyl]phenyl}ethyl]amino}pentanamide",19544,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(pyridin-4-yl)phenyl]phenyl}ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19544,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606.0,Homo sapiens (human),,IC50 (nM),483,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6116,2011185,23648309,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(pyridin-4-yl)phenyl]phenyl}ethyl]amino}pentanamide",19544,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4-[4-(pyridin-4-yl)phenyl]phenyl}ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19544,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),342,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
6117,2011186,23648310,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19545,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19545,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),62,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6118,2011187,23648310,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19545,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19545,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),43,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6119,2011188,23648310,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19545,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19545,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),68,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6120,2011189,23648310,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19545,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19545,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),7.2,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6121,2011190,23648310,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19545,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19545,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),91,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6122,2011191,23648310,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19545,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19545,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),26,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6123,2011192,23648311,BindingDB,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4,4-dimethyl-2-[(3-methylphenyl)formamido]pentanamide",19547,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4,4-dimethyl-2-[(3-methylphenyl)formamido]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19547,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),216,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6124,2011193,23648311,BindingDB,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4,4-dimethyl-2-[(3-methylphenyl)formamido]pentanamide",19547,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4,4-dimethyl-2-[(3-methylphenyl)formamido]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19547,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),246,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6125,2011194,23648311,BindingDB,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4,4-dimethyl-2-[(3-methylphenyl)formamido]pentanamide",19547,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-4,4-dimethyl-2-[(3-methylphenyl)formamido]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19547,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),46,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6126,2011195,23648312,BindingDB,(2S)-2-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]acetamide,19548,(2S)-2-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]acetamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19548,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),23,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6127,2011196,23648312,BindingDB,(2S)-2-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]acetamide,19548,(2S)-2-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]acetamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19548,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),66,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6128,2011197,23648312,BindingDB,(2S)-2-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]acetamide,19548,(2S)-2-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]acetamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19548,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),22,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6129,2011198,23648313,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19549,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19549,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),4.6,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6130,2011199,23648313,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19549,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19549,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),205,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6131,2011200,23648313,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19549,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19549,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),9.7,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6132,2011201,23648314,BindingDB,(2S)-4-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]butanamide,19550,(2S)-4-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]butanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19550,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),38,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6133,2011202,23648314,BindingDB,(2S)-4-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]butanamide,19550,(2S)-4-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]butanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19550,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6134,2011203,23648314,BindingDB,(2S)-4-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]butanamide,19550,(2S)-4-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]butanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19550,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),326,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6135,2011204,23648315,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-2-phenylacetamide,19551,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-2-phenylacetamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19551,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),134,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6136,2011205,23648315,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-2-phenylacetamide,19551,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-2-phenylacetamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19551,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>30000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6137,2011206,23648315,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-2-phenylacetamide,19551,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-2-phenylacetamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19551,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),285,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6138,2011207,23648316,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-phenylpropanamide,19552,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-phenylpropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19552,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),29,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6139,2011208,23648316,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-phenylpropanamide,19552,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-phenylpropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19552,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),123,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6140,2011209,23648316,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-phenylpropanamide,19552,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-phenylpropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19552,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),3.7,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6141,2011210,23648317,BindingDB,(2S)-3-(4-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19553,(2S)-3-(4-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19553,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),1.4,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6142,2011211,23648317,BindingDB,(2S)-3-(4-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19553,(2S)-3-(4-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19553,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6143,2011212,23648317,BindingDB,(2S)-3-(4-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19553,(2S)-3-(4-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19553,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),16,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6144,2011213,23648318,BindingDB,(2S)-3-(3-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19554,(2S)-3-(3-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19554,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),33,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6145,2011214,23648318,BindingDB,(2S)-3-(3-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19554,(2S)-3-(3-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19554,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6146,2011215,23648318,BindingDB,(2S)-3-(3-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19554,(2S)-3-(3-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19554,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),1.5,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6147,2011216,23648319,BindingDB,(2S)-3-(2-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19555,(2S)-3-(2-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19555,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),5.0,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6148,2011217,23648319,BindingDB,(2S)-3-(2-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19555,(2S)-3-(2-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19555,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),595,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6149,2011218,23648319,BindingDB,(2S)-3-(2-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19555,(2S)-3-(2-chlorophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19555,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),35,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6150,2011219,23648320,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-3-(4-methylphenyl)-2-[(3-methylphenyl)formamido]propanamide,19556,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-3-(4-methylphenyl)-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19556,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),27,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6151,2011220,23648320,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-3-(4-methylphenyl)-2-[(3-methylphenyl)formamido]propanamide,19556,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-3-(4-methylphenyl)-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19556,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>65000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6152,2011221,23648320,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-3-(4-methylphenyl)-2-[(3-methylphenyl)formamido]propanamide,19556,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-3-(4-methylphenyl)-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19556,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),3.4,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6153,2011222,23648321,BindingDB,"Arylaminoethyl amide, 5k",19557,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-[4-(trifluoromethyl)phenyl]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19557,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),2.8,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6154,2011223,23648321,BindingDB,"Arylaminoethyl amide, 5k",19557,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-[4-(trifluoromethyl)phenyl]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19557,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6155,2011224,23648321,BindingDB,"Arylaminoethyl amide, 5k",19557,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-[4-(trifluoromethyl)phenyl]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19557,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),19,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6156,2011225,23648322,BindingDB,(2S)-3-(4-methoxyphenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19558,(2S)-3-(4-methoxyphenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19558,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),66,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6157,2011226,23648322,BindingDB,(2S)-3-(4-methoxyphenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19558,(2S)-3-(4-methoxyphenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19558,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6158,2011227,23648322,BindingDB,(2S)-3-(4-methoxyphenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19558,(2S)-3-(4-methoxyphenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19558,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),9.3,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6159,2011228,23648323,BindingDB,(2S)-3-(4-acetamidophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19559,(2S)-3-(4-acetamidophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19559,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),23,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6160,2011229,23648323,BindingDB,(2S)-3-(4-acetamidophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19559,(2S)-3-(4-acetamidophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19559,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6161,2011230,23648323,BindingDB,(2S)-3-(4-acetamidophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19559,(2S)-3-(4-acetamidophenyl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19559,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),123,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6162,2011231,23648324,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(pyridin-3-yl)propanamide,19560,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(pyridin-3-yl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19560,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),3707,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6163,2011232,23648324,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(pyridin-3-yl)propanamide,19560,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(pyridin-3-yl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19560,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6164,2011233,23648324,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(pyridin-3-yl)propanamide,19560,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(pyridin-3-yl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19560,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),673,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6165,2011234,23648325,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(pyridin-4-yl)propanamide,19561,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(pyridin-4-yl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19561,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),251,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6166,2011235,23648325,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(pyridin-4-yl)propanamide,19561,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(pyridin-4-yl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19561,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6167,2011236,23648325,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(pyridin-4-yl)propanamide,19561,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(pyridin-4-yl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19561,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),6769,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6168,2011237,23648326,BindingDB,(2S)-3-(furan-2-yl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19562,(2S)-3-(furan-2-yl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19562,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),>20000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6169,2011238,23648326,BindingDB,(2S)-3-(furan-2-yl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19562,(2S)-3-(furan-2-yl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19562,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>30000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6170,2011239,23648326,BindingDB,(2S)-3-(furan-2-yl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19562,(2S)-3-(furan-2-yl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19562,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),2991,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6171,2011240,23648327,BindingDB,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(1,3-thiazol-5-yl)propanamide",19563,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(1,3-thiazol-5-yl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19563,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),4214,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6172,2011241,23648327,BindingDB,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(1,3-thiazol-5-yl)propanamide",19563,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(1,3-thiazol-5-yl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19563,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6173,2011242,23648327,BindingDB,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(1,3-thiazol-5-yl)propanamide",19563,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(1,3-thiazol-5-yl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19563,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),>65000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6174,2011243,23648328,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(naphthalen-2-yl)propanamide,19564,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(naphthalen-2-yl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19564,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),16,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6175,2011244,23648328,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(naphthalen-2-yl)propanamide,19564,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(naphthalen-2-yl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19564,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6176,2011245,23648328,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(naphthalen-2-yl)propanamide,19564,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(naphthalen-2-yl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19564,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),1.1,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6177,2011246,23648329,BindingDB,(2S)-3-(1H-indol-2-yl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19565,(2S)-3-(1H-indol-2-yl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19565,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),7.2,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6178,2011247,23648329,BindingDB,(2S)-3-(1H-indol-2-yl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19565,(2S)-3-(1H-indol-2-yl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19565,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6179,2011248,23648329,BindingDB,(2S)-3-(1H-indol-2-yl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,19565,(2S)-3-(1H-indol-2-yl)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19565,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),29,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6180,2011249,23648330,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(4-phenylphenyl)propanamide,19566,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(4-phenylphenyl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19566,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),34,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6181,2011250,23648330,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(4-phenylphenyl)propanamide,19566,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(4-phenylphenyl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19566,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6182,2011251,23648330,BindingDB,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(4-phenylphenyl)propanamide,19566,(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(4-phenylphenyl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19566,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),1.2,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6183,2011252,23648331,BindingDB,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(2,3,4,5,6-pentafluorophenyl)propanamide",19567,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(2,3,4,5,6-pentafluorophenyl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19567,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),25,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6184,2011253,23648331,BindingDB,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(2,3,4,5,6-pentafluorophenyl)propanamide",19567,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(2,3,4,5,6-pentafluorophenyl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19567,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6185,2011254,23648331,BindingDB,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(2,3,4,5,6-pentafluorophenyl)propanamide",19567,"(2S)-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-methylphenyl)formamido]-3-(2,3,4,5,6-pentafluorophenyl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19567,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),>20000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6186,2011255,23648332,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-(naphthalen-2-ylformamido)propanamide,19568,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-(naphthalen-2-ylformamido)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19568,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),5.0,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6187,2011256,23648332,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-(naphthalen-2-ylformamido)propanamide,19568,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-(naphthalen-2-ylformamido)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19568,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),13,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6188,2011257,23648332,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-(naphthalen-2-ylformamido)propanamide,19568,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-(naphthalen-2-ylformamido)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19568,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),55,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6189,2011258,23648333,BindingDB,(2S)-2-[(5-chloro-1-benzofuran-2-yl)formamido]-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19569,(2S)-2-[(5-chloro-1-benzofuran-2-yl)formamido]-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19569,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),58,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6190,2011259,23648333,BindingDB,(2S)-2-[(5-chloro-1-benzofuran-2-yl)formamido]-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19569,(2S)-2-[(5-chloro-1-benzofuran-2-yl)formamido]-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19569,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),68,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6191,2011260,23648333,BindingDB,(2S)-2-[(5-chloro-1-benzofuran-2-yl)formamido]-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19569,(2S)-2-[(5-chloro-1-benzofuran-2-yl)formamido]-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19569,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),9.4,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6192,2011261,23648334,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-phenylphenyl)formamido]propanamide,19570,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-phenylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19570,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),2.9,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6193,2011262,23648334,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-phenylphenyl)formamido]propanamide,19570,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-phenylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19570,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),14,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6194,2011263,23648334,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-phenylphenyl)formamido]propanamide,19570,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-phenylphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19570,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>20000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6195,2011264,23648335,BindingDB,(2S)-2-{[4-(3-chlorophenyl)phenyl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19572,(2S)-2-{[4-(3-chlorophenyl)phenyl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19572,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),>79000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6196,2011265,23648335,BindingDB,(2S)-2-{[4-(3-chlorophenyl)phenyl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19572,(2S)-2-{[4-(3-chlorophenyl)phenyl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19572,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6197,2011266,23648335,BindingDB,(2S)-2-{[4-(3-chlorophenyl)phenyl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19572,(2S)-2-{[4-(3-chlorophenyl)phenyl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19572,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),7.4,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6198,2011267,23648336,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-phenoxyphenyl)formamido]propanamide,19573,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-phenoxyphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19573,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),8.0,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6199,2011268,23648336,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-phenoxyphenyl)formamido]propanamide,19573,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-phenoxyphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19573,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6200,2011269,23648336,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-phenoxyphenyl)formamido]propanamide,19573,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(3-phenoxyphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19573,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),106,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6201,2011270,23648337,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(4-phenoxyphenyl)formamido]propanamide,19574,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(4-phenoxyphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19574,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),>37000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6202,2011271,23648337,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(4-phenoxyphenyl)formamido]propanamide,19574,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(4-phenoxyphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19574,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>30000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6203,2011272,23648337,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(4-phenoxyphenyl)formamido]propanamide,19574,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(4-phenoxyphenyl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19574,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),17,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6204,2011273,23648338,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-{[4-(morpholin-4-yl)phenyl]formamido}propanamide,19575,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-{[4-(morpholin-4-yl)phenyl]formamido}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19575,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),4.0,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6205,2011274,23648338,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-{[4-(morpholin-4-yl)phenyl]formamido}propanamide,19575,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-{[4-(morpholin-4-yl)phenyl]formamido}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19575,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),341,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6206,2011275,23648338,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-{[4-(morpholin-4-yl)phenyl]formamido}propanamide,19575,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-{[4-(morpholin-4-yl)phenyl]formamido}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19575,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),148,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6207,2011276,23648339,BindingDB,"(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-{[4-(1H-1,2,4-triazol-1-yl)phenyl]formamido}propanamide",19576,"(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-{[4-(1H-1,2,4-triazol-1-yl)phenyl]formamido}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19576,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),303,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6208,2011277,23648339,BindingDB,"(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-{[4-(1H-1,2,4-triazol-1-yl)phenyl]formamido}propanamide",19576,"(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-{[4-(1H-1,2,4-triazol-1-yl)phenyl]formamido}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19576,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),718,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6209,2011287,23648339,BindingDB,"(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-{[4-(1H-1,2,4-triazol-1-yl)phenyl]formamido}propanamide",19576,"(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-{[4-(1H-1,2,4-triazol-1-yl)phenyl]formamido}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19576,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),26,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6210,2011288,23648340,BindingDB,"(2S)-3-cyclohexyl-2-({4-[(4,6-dimethylpyrimidin-2-yl)amino]phenyl}formamido)-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide",19577,"(2S)-3-cyclohexyl-2-({4-[(4,6-dimethylpyrimidin-2-yl)amino]phenyl}formamido)-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19577,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),2,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6211,2011289,23648340,BindingDB,"(2S)-3-cyclohexyl-2-({4-[(4,6-dimethylpyrimidin-2-yl)amino]phenyl}formamido)-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide",19577,"(2S)-3-cyclohexyl-2-({4-[(4,6-dimethylpyrimidin-2-yl)amino]phenyl}formamido)-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19577,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),438,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6212,2011290,23648340,BindingDB,"(2S)-3-cyclohexyl-2-({4-[(4,6-dimethylpyrimidin-2-yl)amino]phenyl}formamido)-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide",19577,"(2S)-3-cyclohexyl-2-({4-[(4,6-dimethylpyrimidin-2-yl)amino]phenyl}formamido)-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19577,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),176,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6213,2011291,23648341,BindingDB,(2S)-2-{[1-(5-bromopyrimidin-2-yl)piperidin-4-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19578,(2S)-2-{[1-(5-bromopyrimidin-2-yl)piperidin-4-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19578,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),7950,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6214,2011292,23648341,BindingDB,(2S)-2-{[1-(5-bromopyrimidin-2-yl)piperidin-4-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19578,(2S)-2-{[1-(5-bromopyrimidin-2-yl)piperidin-4-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19578,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6215,2011293,23648341,BindingDB,(2S)-2-{[1-(5-bromopyrimidin-2-yl)piperidin-4-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19578,(2S)-2-{[1-(5-bromopyrimidin-2-yl)piperidin-4-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19578,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),107,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6216,2011294,23648342,BindingDB,(2S)-2-{[1-(5-bromopyrimidin-2-yl)piperidin-3-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19579,(2S)-2-{[1-(5-bromopyrimidin-2-yl)piperidin-3-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19579,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),49,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6217,2011295,23648342,BindingDB,(2S)-2-{[1-(5-bromopyrimidin-2-yl)piperidin-3-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19579,(2S)-2-{[1-(5-bromopyrimidin-2-yl)piperidin-3-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19579,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6218,2011296,23648342,BindingDB,(2S)-2-{[1-(5-bromopyrimidin-2-yl)piperidin-3-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19579,(2S)-2-{[1-(5-bromopyrimidin-2-yl)piperidin-3-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19579,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),1296,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6219,2011297,23648343,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(5-methyl-1-phenyl-1H-pyrazol-4-yl)formamido]propanamide,19580,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(5-methyl-1-phenyl-1H-pyrazol-4-yl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19580,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),1581,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6220,2011298,23648343,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(5-methyl-1-phenyl-1H-pyrazol-4-yl)formamido]propanamide,19580,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(5-methyl-1-phenyl-1H-pyrazol-4-yl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19580,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),316,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6221,2011299,23648343,BindingDB,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(5-methyl-1-phenyl-1H-pyrazol-4-yl)formamido]propanamide,19580,(2S)-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-2-[(5-methyl-1-phenyl-1H-pyrazol-4-yl)formamido]propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19580,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),34,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6222,2011300,23648344,BindingDB,(2S)-2-{[5-(4-chlorophenyl)furan-2-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19581,(2S)-2-{[5-(4-chlorophenyl)furan-2-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19581,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),7.1,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6223,2011301,23648344,BindingDB,(2S)-2-{[5-(4-chlorophenyl)furan-2-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19581,(2S)-2-{[5-(4-chlorophenyl)furan-2-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19581,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),>6440,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6224,2011302,23648344,BindingDB,(2S)-2-{[5-(4-chlorophenyl)furan-2-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,19581,(2S)-2-{[5-(4-chlorophenyl)furan-2-yl]formamido}-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19581,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16183279|DOI:10.1016/j.bmcl.2005.08.017,https://www.ncbi.nlm.nih.gov/pubmed/16183279|https://doi.org/10.1016/j.bmcl.2005.08.017,16183279,10.1016/j.bmcl.2005.08.017,
6225,2011303,23648345,BindingDB,"(2S)-N-{2-[(4-methoxy-2,6-dimethylphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide",19586,"(2S)-N-{2-[(4-methoxy-2,6-dimethylphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19586,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),132,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6226,2011304,23648345,BindingDB,"(2S)-N-{2-[(4-methoxy-2,6-dimethylphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide",19586,"(2S)-N-{2-[(4-methoxy-2,6-dimethylphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19586,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),14,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6227,2011305,23648345,BindingDB,"(2S)-N-{2-[(4-methoxy-2,6-dimethylphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide",19586,"(2S)-N-{2-[(4-methoxy-2,6-dimethylphenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19586,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),131,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6228,2011306,23648346,BindingDB,(2S)-4-methyl-2-[(3-methylphenyl)formamido]-N-(2-{[4-(trifluoromethoxy)phenyl]amino}ethyl)pentanamide,19587,(2S)-4-methyl-2-[(3-methylphenyl)formamido]-N-(2-{[4-(trifluoromethoxy)phenyl]amino}ethyl)pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19587,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),125,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6229,2011307,23648346,BindingDB,(2S)-4-methyl-2-[(3-methylphenyl)formamido]-N-(2-{[4-(trifluoromethoxy)phenyl]amino}ethyl)pentanamide,19587,(2S)-4-methyl-2-[(3-methylphenyl)formamido]-N-(2-{[4-(trifluoromethoxy)phenyl]amino}ethyl)pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19587,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),120,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6230,2011308,23648346,BindingDB,(2S)-4-methyl-2-[(3-methylphenyl)formamido]-N-(2-{[4-(trifluoromethoxy)phenyl]amino}ethyl)pentanamide,19587,(2S)-4-methyl-2-[(3-methylphenyl)formamido]-N-(2-{[4-(trifluoromethoxy)phenyl]amino}ethyl)pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19587,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),104,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6231,2011309,23648347,BindingDB,(2S)-N-{2-[(4-chlorophenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19588,(2S)-N-{2-[(4-chlorophenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19588,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),458,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6232,2011310,23648347,BindingDB,(2S)-N-{2-[(4-chlorophenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19588,(2S)-N-{2-[(4-chlorophenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19588,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),92,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6233,2011311,23648347,BindingDB,(2S)-N-{2-[(4-chlorophenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19588,(2S)-N-{2-[(4-chlorophenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19588,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),408,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6234,2011312,23648348,BindingDB,(2S)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19589,(2S)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19589,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),478,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6235,2011313,23648348,BindingDB,(2S)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19589,(2S)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19589,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),62,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6236,2011314,23648348,BindingDB,(2S)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19589,(2S)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19589,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),563,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6237,2011315,23648349,BindingDB,"(2S)-N-[2-(2,3-dihydro-1H-indol-1-yl)ethyl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide",19590,"(2S)-N-[2-(2,3-dihydro-1H-indol-1-yl)ethyl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19590,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),230,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6238,2011316,23648349,BindingDB,"(2S)-N-[2-(2,3-dihydro-1H-indol-1-yl)ethyl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide",19590,"(2S)-N-[2-(2,3-dihydro-1H-indol-1-yl)ethyl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19590,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),88,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6239,2011317,23648349,BindingDB,"(2S)-N-[2-(2,3-dihydro-1H-indol-1-yl)ethyl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide",19590,"(2S)-N-[2-(2,3-dihydro-1H-indol-1-yl)ethyl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19590,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),310,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6240,2011318,23648350,BindingDB,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-phenylpropan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19597,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-phenylpropan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19597,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6241,2011319,23648350,BindingDB,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-phenylpropan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19597,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-phenylpropan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19597,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),9200,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6242,2011320,23648350,BindingDB,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-phenylpropan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19597,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-phenylpropan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19597,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),133,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6243,2011321,23648351,BindingDB,"(2S)-N-[(2R,3R)-3-(benzyloxy)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)butan-2-yl]-4-cyclohexyl-2-[(3-methoxyphenyl)formamido]butanamide",19600,"(2S)-N-[(2R,3R)-3-(benzyloxy)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)butan-2-yl]-4-cyclohexyl-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19600,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),15,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6244,2011322,23648351,BindingDB,"(2S)-N-[(2R,3R)-3-(benzyloxy)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)butan-2-yl]-4-cyclohexyl-2-[(3-methoxyphenyl)formamido]butanamide",19600,"(2S)-N-[(2R,3R)-3-(benzyloxy)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)butan-2-yl]-4-cyclohexyl-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19600,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),2,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6245,2011323,23648351,BindingDB,"(2S)-N-[(2R,3R)-3-(benzyloxy)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)butan-2-yl]-4-cyclohexyl-2-[(3-methoxyphenyl)formamido]butanamide",19600,"(2S)-N-[(2R,3R)-3-(benzyloxy)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)butan-2-yl]-4-cyclohexyl-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19600,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),4320,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6246,2011324,23648352,BindingDB,"(2S)-4-cyclohexyl-N-[(2R)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-hydroxypropan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19601,"(2S)-4-cyclohexyl-N-[(2R)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-hydroxypropan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19601,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6247,2011325,23648352,BindingDB,"(2S)-4-cyclohexyl-N-[(2R)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-hydroxypropan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19601,"(2S)-4-cyclohexyl-N-[(2R)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-hydroxypropan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19601,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),15530,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6248,2011326,23648352,BindingDB,"(2S)-4-cyclohexyl-N-[(2R)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-hydroxypropan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19601,"(2S)-4-cyclohexyl-N-[(2R)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-hydroxypropan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19601,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),50,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6249,2011327,23648353,BindingDB,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-4-hydroxybutan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19602,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-4-hydroxybutan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19602,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),208,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6250,2011328,23648353,BindingDB,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-4-hydroxybutan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19602,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-4-hydroxybutan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19602,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),1800,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6251,2011329,23648353,BindingDB,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-4-hydroxybutan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19602,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-4-hydroxybutan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19602,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6252,2011330,23648354,BindingDB,"(2S)-4-cyclohexyl-N-[(2R,3R)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-hydroxybutan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19603,"(2S)-4-cyclohexyl-N-[(2R,3R)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-hydroxybutan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19603,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),2750,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6253,2011331,23648354,BindingDB,"(2S)-4-cyclohexyl-N-[(2R,3R)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-hydroxybutan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19603,"(2S)-4-cyclohexyl-N-[(2R,3R)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-hydroxybutan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19603,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),20,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6254,2011332,23648354,BindingDB,"(2S)-4-cyclohexyl-N-[(2R,3R)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-hydroxybutan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19603,"(2S)-4-cyclohexyl-N-[(2R,3R)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-hydroxybutan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19603,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),8,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6255,2011333,23648355,BindingDB,"Arylaminoethyl amide, 8l",19604,"(2S)-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-4-methanesulfonylbutan-2-yl]-2-[(3-methoxyphenyl)formamido]-4,4-dimethylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19604,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),14,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6256,2011334,23648355,BindingDB,"Arylaminoethyl amide, 8l",19604,"(2S)-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-4-methanesulfonylbutan-2-yl]-2-[(3-methoxyphenyl)formamido]-4,4-dimethylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19604,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),19,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6257,2011335,23648355,BindingDB,"Arylaminoethyl amide, 8l",19604,"(2S)-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-4-methanesulfonylbutan-2-yl]-2-[(3-methoxyphenyl)formamido]-4,4-dimethylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19604,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),47,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6258,2011336,23648356,BindingDB,"(2S)-N-[(2S)-5-amino-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)pentan-2-yl]-4-cyclohexyl-2-[(3-methoxyphenyl)formamido]butanamide",19605,"(2S)-N-[(2S)-5-amino-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)pentan-2-yl]-4-cyclohexyl-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19605,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),10760,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6259,2011337,23648356,BindingDB,"(2S)-N-[(2S)-5-amino-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)pentan-2-yl]-4-cyclohexyl-2-[(3-methoxyphenyl)formamido]butanamide",19605,"(2S)-N-[(2S)-5-amino-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)pentan-2-yl]-4-cyclohexyl-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19605,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),42,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6260,2011338,23648356,BindingDB,"(2S)-N-[(2S)-5-amino-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)pentan-2-yl]-4-cyclohexyl-2-[(3-methoxyphenyl)formamido]butanamide",19605,"(2S)-N-[(2S)-5-amino-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)pentan-2-yl]-4-cyclohexyl-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19605,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),76,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6261,2011339,23648357,BindingDB,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-(4-hydroxyphenyl)propan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19607,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-(4-hydroxyphenyl)propan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19607,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),96,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6262,2011340,23648357,BindingDB,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-(4-hydroxyphenyl)propan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19607,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-(4-hydroxyphenyl)propan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19607,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),3410,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6263,2011341,23648357,BindingDB,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-(4-hydroxyphenyl)propan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",19607,"(2S)-4-cyclohexyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)-3-(4-hydroxyphenyl)propan-2-yl]-2-[(3-methoxyphenyl)formamido]butanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19607,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6264,2011342,23648358,BindingDB,(2S)-N-[(2S)-1-[(4-methoxyphenyl)amino]propan-2-yl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19610,(2S)-N-[(2S)-1-[(4-methoxyphenyl)amino]propan-2-yl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19610,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),55,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6265,2011343,23648358,BindingDB,(2S)-N-[(2S)-1-[(4-methoxyphenyl)amino]propan-2-yl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19610,(2S)-N-[(2S)-1-[(4-methoxyphenyl)amino]propan-2-yl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19610,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),1.6,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6266,2011344,23648358,BindingDB,(2S)-N-[(2S)-1-[(4-methoxyphenyl)amino]propan-2-yl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19610,(2S)-N-[(2S)-1-[(4-methoxyphenyl)amino]propan-2-yl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19610,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),15,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6267,2011345,23648359,BindingDB,(2S)-N-[(2R)-1-[(4-methoxyphenyl)amino]propan-2-yl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19611,(2S)-N-[(2R)-1-[(4-methoxyphenyl)amino]propan-2-yl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19611,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),212,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6268,2011346,23648359,BindingDB,(2S)-N-[(2R)-1-[(4-methoxyphenyl)amino]propan-2-yl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19611,(2S)-N-[(2R)-1-[(4-methoxyphenyl)amino]propan-2-yl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19611,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),75,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6269,2011347,23648359,BindingDB,(2S)-N-[(2R)-1-[(4-methoxyphenyl)amino]propan-2-yl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,19611,(2S)-N-[(2R)-1-[(4-methoxyphenyl)amino]propan-2-yl]-4-methyl-2-[(3-methylphenyl)formamido]pentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19611,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),337,PMID:16412634|DOI:10.1016/j.bmcl.2005.12.056,https://www.ncbi.nlm.nih.gov/pubmed/16412634|https://doi.org/10.1016/j.bmcl.2005.12.056,16412634,10.1016/j.bmcl.2005.12.056,
6270,2011348,23648360,BindingDB,"(2S)-2-[(7-chloro-1,3-benzoxazol-2-yl)amino]-3-cyclohexyl-N-[(2S)-1-(5-fluoro-2-oxo-2,3-dihydro-1H-indol-1-yl)propan-2-yl]propanamide",19628,"(2S)-2-[(7-chloro-1,3-benzoxazol-2-yl)amino]-3-cyclohexyl-N-[(2S)-1-(5-fluoro-2-oxo-2,3-dihydro-1H-indol-1-yl)propan-2-yl]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19628,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,Ki (nM),>30000,PMID:16446091|DOI:10.1016/j.bmcl.2005.12.095,https://www.ncbi.nlm.nih.gov/pubmed/16446091|https://doi.org/10.1016/j.bmcl.2005.12.095,16446091,10.1016/j.bmcl.2005.12.095,
6271,2011349,23648360,BindingDB,"(2S)-2-[(7-chloro-1,3-benzoxazol-2-yl)amino]-3-cyclohexyl-N-[(2S)-1-(5-fluoro-2-oxo-2,3-dihydro-1H-indol-1-yl)propan-2-yl]propanamide",19628,"(2S)-2-[(7-chloro-1,3-benzoxazol-2-yl)amino]-3-cyclohexyl-N-[(2S)-1-(5-fluoro-2-oxo-2,3-dihydro-1H-indol-1-yl)propan-2-yl]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19628,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:16446091|DOI:10.1016/j.bmcl.2005.12.095,https://www.ncbi.nlm.nih.gov/pubmed/16446091|https://doi.org/10.1016/j.bmcl.2005.12.095,16446091,10.1016/j.bmcl.2005.12.095,
6272,2011350,23648360,BindingDB,"(2S)-2-[(7-chloro-1,3-benzoxazol-2-yl)amino]-3-cyclohexyl-N-[(2S)-1-(5-fluoro-2-oxo-2,3-dihydro-1H-indol-1-yl)propan-2-yl]propanamide",19628,"(2S)-2-[(7-chloro-1,3-benzoxazol-2-yl)amino]-3-cyclohexyl-N-[(2S)-1-(5-fluoro-2-oxo-2,3-dihydro-1H-indol-1-yl)propan-2-yl]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19628,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),12300,PMID:16446091|DOI:10.1016/j.bmcl.2005.12.095,https://www.ncbi.nlm.nih.gov/pubmed/16446091|https://doi.org/10.1016/j.bmcl.2005.12.095,16446091,10.1016/j.bmcl.2005.12.095,
6273,2011351,23648361,BindingDB,(2S)-2-(cyclohexylmethyl)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-(morpholin-4-yl)-4-oxobutanamide,19639,(2S)-2-(cyclohexylmethyl)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-(morpholin-4-yl)-4-oxobutanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19639,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:17382545|DOI:10.1016/j.bmcl.2007.02.049,https://www.ncbi.nlm.nih.gov/pubmed/17382545|https://doi.org/10.1016/j.bmcl.2007.02.049,17382545,10.1016/j.bmcl.2007.02.049,
6274,2011352,23648361,BindingDB,(2S)-2-(cyclohexylmethyl)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-(morpholin-4-yl)-4-oxobutanamide,19639,(2S)-2-(cyclohexylmethyl)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-(morpholin-4-yl)-4-oxobutanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19639,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:17382545|DOI:10.1016/j.bmcl.2007.02.049,https://www.ncbi.nlm.nih.gov/pubmed/17382545|https://doi.org/10.1016/j.bmcl.2007.02.049,17382545,10.1016/j.bmcl.2007.02.049,
6275,2011353,23648362,BindingDB,(3S)-3-(cyclohexylmethyl)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-(morpholin-4-yl)-4-oxobutanamide,19641,(3S)-3-(cyclohexylmethyl)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-(morpholin-4-yl)-4-oxobutanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19641,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:17382545|DOI:10.1016/j.bmcl.2007.02.049,https://www.ncbi.nlm.nih.gov/pubmed/17382545|https://doi.org/10.1016/j.bmcl.2007.02.049,17382545,10.1016/j.bmcl.2007.02.049,
6276,2011354,23648362,BindingDB,(3S)-3-(cyclohexylmethyl)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-(morpholin-4-yl)-4-oxobutanamide,19641,(3S)-3-(cyclohexylmethyl)-N-{2-[(4-fluorophenyl)amino]ethyl}-4-(morpholin-4-yl)-4-oxobutanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19641,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:17382545|DOI:10.1016/j.bmcl.2007.02.049,https://www.ncbi.nlm.nih.gov/pubmed/17382545|https://doi.org/10.1016/j.bmcl.2007.02.049,17382545,10.1016/j.bmcl.2007.02.049,
6277,2011355,23648363,BindingDB,"Succinamide peptidomimetic, 23",19657,"(2R)-4,4-dimethyl-2-[2-(morpholin-4-yl)-2-oxoethyl]-N-[(2S)-1-{[4-(trifluoromethoxy)phenyl]amino}propan-2-yl]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19657,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),408,PMID:17382545|DOI:10.1016/j.bmcl.2007.02.049,https://www.ncbi.nlm.nih.gov/pubmed/17382545|https://doi.org/10.1016/j.bmcl.2007.02.049,17382545,10.1016/j.bmcl.2007.02.049,
6278,2011356,23648363,BindingDB,"Succinamide peptidomimetic, 23",19657,"(2R)-4,4-dimethyl-2-[2-(morpholin-4-yl)-2-oxoethyl]-N-[(2S)-1-{[4-(trifluoromethoxy)phenyl]amino}propan-2-yl]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19657,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),2331,PMID:17382545|DOI:10.1016/j.bmcl.2007.02.049,https://www.ncbi.nlm.nih.gov/pubmed/17382545|https://doi.org/10.1016/j.bmcl.2007.02.049,17382545,10.1016/j.bmcl.2007.02.049,
6279,2011357,23648364,BindingDB,"Succinamide peptidomimetic, 24",19658,"(2R)-5,5-dimethyl-2-[2-(morpholin-4-yl)-2-oxoethyl]-N-[(2S)-1-{[4-(trifluoromethoxy)phenyl]amino}propan-2-yl]hexanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19658,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:17382545|DOI:10.1016/j.bmcl.2007.02.049,https://www.ncbi.nlm.nih.gov/pubmed/17382545|https://doi.org/10.1016/j.bmcl.2007.02.049,17382545,10.1016/j.bmcl.2007.02.049,
6280,2011358,23648364,BindingDB,"Succinamide peptidomimetic, 24",19658,"(2R)-5,5-dimethyl-2-[2-(morpholin-4-yl)-2-oxoethyl]-N-[(2S)-1-{[4-(trifluoromethoxy)phenyl]amino}propan-2-yl]hexanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19658,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),70,PMID:17382545|DOI:10.1016/j.bmcl.2007.02.049,https://www.ncbi.nlm.nih.gov/pubmed/17382545|https://doi.org/10.1016/j.bmcl.2007.02.049,17382545,10.1016/j.bmcl.2007.02.049,
6281,2011359,23648365,BindingDB,"(2R)-2-benzyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)propan-2-yl]-4-(morpholin-4-yl)-4-oxobutanamide",19659,"(2R)-2-benzyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)propan-2-yl]-4-(morpholin-4-yl)-4-oxobutanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19659,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),>24000,PMID:17382545|DOI:10.1016/j.bmcl.2007.02.049,https://www.ncbi.nlm.nih.gov/pubmed/17382545|https://doi.org/10.1016/j.bmcl.2007.02.049,17382545,10.1016/j.bmcl.2007.02.049,
6282,2011360,23648365,BindingDB,"(2R)-2-benzyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)propan-2-yl]-4-(morpholin-4-yl)-4-oxobutanamide",19659,"(2R)-2-benzyl-N-[(2S)-1-(5-fluoro-2,3-dihydro-1H-indol-1-yl)propan-2-yl]-4-(morpholin-4-yl)-4-oxobutanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19659,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,Ki (nM),>30000,PMID:17382545|DOI:10.1016/j.bmcl.2007.02.049,https://www.ncbi.nlm.nih.gov/pubmed/17382545|https://doi.org/10.1016/j.bmcl.2007.02.049,17382545,10.1016/j.bmcl.2007.02.049,
6283,2011361,23648366,BindingDB,"Succinamide peptidomimetic, 28",19662,(2R)-N-[(2S)-3-methyl-1-{[4-(trifluoromethoxy)phenyl]amino}butan-2-yl]-2-[2-(morpholin-4-yl)-2-oxoethyl]-5-phenylpentanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19662,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,Ki (nM),14,PMID:17382545|DOI:10.1016/j.bmcl.2007.02.049,https://www.ncbi.nlm.nih.gov/pubmed/17382545|https://doi.org/10.1016/j.bmcl.2007.02.049,17382545,10.1016/j.bmcl.2007.02.049,
6284,2011373,23648455,BindingDB,"(1R,2R)-2-{1-benzyl-5-[4-(methylsulfanyl)phenyl]-1H-1,2,3-triazol-4-yl}-N-(cyanomethyl)-5,5-difluorocyclohexane-1-carboxamide",19907,"(1R,2R)-2-{1-benzyl-5-[4-(methylsulfanyl)phenyl]-1H-1,2,3-triazol-4-yl}-N-(cyanomethyl)-5,5-difluorocyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19907,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),2,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
6285,2011374,23648455,BindingDB,"(1R,2R)-2-{1-benzyl-5-[4-(methylsulfanyl)phenyl]-1H-1,2,3-triazol-4-yl}-N-(cyanomethyl)-5,5-difluorocyclohexane-1-carboxamide",19907,"(1R,2R)-2-{1-benzyl-5-[4-(methylsulfanyl)phenyl]-1H-1,2,3-triazol-4-yl}-N-(cyanomethyl)-5,5-difluorocyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19907,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),9,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
6286,2011375,23648456,BindingDB,"beta-Substituted cyclohexanecarboxamide, 10",19909,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{1-methyl-4-[4-(methylsulfanyl)phenyl]-1H-pyrazol-3-yl}cyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19909,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),0.4,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
6287,2011376,23648456,BindingDB,"beta-Substituted cyclohexanecarboxamide, 10",19909,"(1R,2R)-N-(cyanomethyl)-5,5-difluoro-2-{1-methyl-4-[4-(methylsulfanyl)phenyl]-1H-pyrazol-3-yl}cyclohexane-1-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19909,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),0.4,PMID:17408953|DOI:10.1016/j.bmcl.2007.03.028,https://www.ncbi.nlm.nih.gov/pubmed/17408953|https://doi.org/10.1016/j.bmcl.2007.03.028,17408953,10.1016/j.bmcl.2007.03.028,
6288,2011388,23648971,Drug Gene Interaction database (DGIdb),"5-Fluoro-N-(4-methyl-3-propionylaminosulfonylphenyl)-N'-(4-(prop-2-ynyloxy)phenyl)-2,4-pyrimidinediamine",,R-348,https://www.dgidb.org/drugs/drugbank:DB06321,,SYK,https://www.dgidb.org/genes/hgnc:11491,,,6850.0,SYK,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6289,2011391,23648971,Drug Gene Interaction database (DGIdb),"5-Fluoro-N-(4-methyl-3-propionylaminosulfonylphenyl)-N'-(4-(prop-2-ynyloxy)phenyl)-2,4-pyrimidinediamine",,R-348,https://www.dgidb.org/drugs/drugbank:DB06321,,JAK3,https://www.dgidb.org/genes/hgnc:6193,,,3718.0,JAK3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6290,2012333,23649002,Therapeutic Target Database (TTD),"(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide;N-(4-chloro-3-methyl-1,2-oxazol-5-yl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophene-3-sulfonamide",D04JPQ,PSN-101,https://idrblab.net/ttd/data/drug/details/D04JPQ,T87166,Glucokinase (GCK),https://idrblab.net/ttd/data/target/details/T87166,P35557,Hexokinase-4,2645.0,GCK,9606.0,Homo sapiens (human),Activator,,,,,,,
6291,2011377,23649245,ChEMBL,Pavinetant,CHEMBL3545233,PAVINETANT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545233/,CHEMBL4429,Neurokinin 3 receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL4429/,P29371,Neuromedin-K receptor,6870.0,TACR3,9606.0,Homo sapiens (human),Neurokinin 3 receptor antagonist,,,PMID:24525659,https://www.ncbi.nlm.nih.gov/pubmed/24525659,24525659,,
6292,2011381,23650961,ChEMBL,Toreforant,CHEMBL3301609,TOREFORANT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301609/,CHEMBL3759,Histamine H4 receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3759/,Q9H3N8,Histamine H4 receptor,59340.0,HRH4,9606.0,Homo sapiens (human),Histamine H4 receptor antagonist,,,PMID:16349977,https://www.ncbi.nlm.nih.gov/pubmed/16349977,16349977,,
6293,2011362,23652660,Chemical Probes Portal,"3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide",BI 605906,BI 605906,https://www.chemicalprobes.org/bi605906,,IKBKB,,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,3551.0,IKBKB,9606.0,Homo sapiens (human),Inhibitor,,"280 nM, 49 nM",PMID:21138416,https://www.ncbi.nlm.nih.gov/pubmed/21138416,21138416,,"http://www.biochemj.org/content/434/1/93, http://www.ncbi.nlm.nih.gov/pubmed/21138416"
6294,2011966,23652660,Comparative Toxicogenomics Database (CTD),"3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide",C556457,BI605906,https://ctdbase.org/detail.go?type=chem&acc=C556457,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,10090.0,Mus musculus (house mouse),BI605906 promotes the reaction [MRT67307 inhibits the reaction [IL1A protein results in increased phosphorylation of IKBKB protein]]|bi605906 inhibits the reaction [IL1A protein results in increased phosphorylation of IKBKB protein],,,PMID:21138416,https://www.ncbi.nlm.nih.gov/pubmed/21138416,21138416,,
6295,2011974,23652660,Comparative Toxicogenomics Database (CTD),"3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide",C556457,BI605906,https://ctdbase.org/detail.go?type=chem&acc=C556457,8517,IKBKG,https://ctdbase.org/detail.go?type=gene&acc=8517,,,8517.0,IKBKG,10090.0,Mus musculus (house mouse),[MRT67307 co-treated with BI605906] inhibits the reaction [IL1A protein results in increased phosphorylation of IKBKG protein],,,PMID:21138416,https://www.ncbi.nlm.nih.gov/pubmed/21138416,21138416,,
6296,2011975,23652660,Comparative Toxicogenomics Database (CTD),"3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide",C556457,BI605906,https://ctdbase.org/detail.go?type=chem&acc=C556457,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,10090.0,Mus musculus (house mouse),MRT67307 promotes the reaction [BI605906 inhibits the reaction [IL1A protein results in increased phosphorylation of TANK protein]]|[mrt67307 co-treated with BI605906] inhibits the reaction [IL1A protein results in increased phosphorylation of IKBKG protein]|bi605906 inhibits the reaction [IL1A protein results in increased phosphorylation of IKBKB protein]|bi605906 inhibits the reaction [IL1A protein results in increased phosphorylation of RELA protein]|bi605906 inhibits the reaction [IL1A protein results in increased phosphorylation of NFKB1 protein]|bi605906 promotes the reaction [MRT67307 inhibits the reaction [IL1A protein results in increased phosphorylation of IKBKB protein]]|bi605906 inhibits the reaction [IL1A protein results in increased phosphorylation of TANK protein],,,PMID:21138416,https://www.ncbi.nlm.nih.gov/pubmed/21138416,21138416,,
6297,2011976,23652660,Comparative Toxicogenomics Database (CTD),"3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide",C556457,BI605906,https://ctdbase.org/detail.go?type=chem&acc=C556457,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10090.0,Mus musculus (house mouse),BI605906 inhibits the reaction [TNF protein results in increased phosphorylation of NFKB1 protein]|bi605906 inhibits the reaction [MRT67307 promotes the reaction [TNF protein results in increased phosphorylation of NFKB1 protein]]|bi605906 inhibits the reaction [IL1A protein results in increased phosphorylation of NFKB1 protein],,,PMID:21138416,https://www.ncbi.nlm.nih.gov/pubmed/21138416,21138416,,
6298,2011977,23652660,Comparative Toxicogenomics Database (CTD),"3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide",C556457,BI605906,https://ctdbase.org/detail.go?type=chem&acc=C556457,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),BI605906 inhibits the reaction [IL1A protein results in increased phosphorylation of RELA protein],,,PMID:21138416,https://www.ncbi.nlm.nih.gov/pubmed/21138416,21138416,,
6299,2011978,23652660,Comparative Toxicogenomics Database (CTD),"3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide",C556457,BI605906,https://ctdbase.org/detail.go?type=chem&acc=C556457,10010,TANK,https://ctdbase.org/detail.go?type=gene&acc=10010,,,10010.0,TANK,10090.0,Mus musculus (house mouse),MRT67307 promotes the reaction [BI605906 inhibits the reaction [IL1A protein results in increased phosphorylation of TANK protein]]|bi605906 inhibits the reaction [IL1A protein results in increased phosphorylation of TANK protein],,,PMID:21138416,https://www.ncbi.nlm.nih.gov/pubmed/21138416,21138416,,
6300,2011979,23652660,Comparative Toxicogenomics Database (CTD),"3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide",C556457,BI605906,https://ctdbase.org/detail.go?type=chem&acc=C556457,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),BI605906 inhibits the reaction [TNF protein results in increased phosphorylation of NFKB1 protein]|bi605906 inhibits the reaction [MRT67307 promotes the reaction [TNF protein results in increased phosphorylation of NFKB1 protein]],,,PMID:21138416,https://www.ncbi.nlm.nih.gov/pubmed/21138416,21138416,,
6301,2011378,23652732,Comparative Toxicogenomics Database (CTD),Genz-123346 free base,C520404,"(2-(2',3'-dihydrobenzo(1,4)dioxin-6'-yl)-2-hydroxy-1-pyrrolidin-1-ylmethylethyl)nonanoic acid amide",https://ctdbase.org/detail.go?type=chem&acc=C520404,7357,UGCG,https://ctdbase.org/detail.go?type=gene&acc=7357,,,7357.0,UGCG,9606.0,Homo sapiens (human),"(2-(2',3'-dihydrobenzo(1,4)dioxin-6'-yl)-2-hydroxy-1-pyrrolidin-1-ylmethylethyl)nonanoic acid amide results in decreased activity of UGCG protein",,,PMID:33639165,https://www.ncbi.nlm.nih.gov/pubmed/33639165,33639165,,
6302,2012334,23653175,Therapeutic Target Database (TTD),Actb-1003,D0R6OM,ACTB-1003,https://idrblab.net/ttd/data/drug/details/D0R6OM,T91331,Fibroblast growth factor receptor 3 (FGFR3),https://idrblab.net/ttd/data/target/details/T91331,P22607,Fibroblast growth factor receptor 3,2261.0,FGFR3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6303,2012335,23653175,Therapeutic Target Database (TTD),Actb-1003,D0R6OM,ACTB-1003,https://idrblab.net/ttd/data/drug/details/D0R6OM,T58454,Fibroblast growth factor receptor 2 (FGFR2),https://idrblab.net/ttd/data/target/details/T58454,P21802,Fibroblast growth factor receptor 2,2263.0,FGFR2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6304,2012336,23653175,Therapeutic Target Database (TTD),Actb-1003,D0R6OM,ACTB-1003,https://idrblab.net/ttd/data/drug/details/D0R6OM,T94479,Ribosomal protein S6 kinase beta-1 (S6K1),https://idrblab.net/ttd/data/target/details/T94479,P23443,Ribosomal protein S6 kinase beta-1,6198.0,RPS6KB1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6305,2012337,23653175,Therapeutic Target Database (TTD),Actb-1003,D0R6OM,ACTB-1003,https://idrblab.net/ttd/data/drug/details/D0R6OM,T90989,Fibroblast growth factor receptor 4 (FGFR4),https://idrblab.net/ttd/data/target/details/T90989,P22455,Fibroblast growth factor receptor 4,2264.0,FGFR4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6306,2011980,23653492,Therapeutic Target Database (TTD),3-[1'-{4'-(Benzyloxy)-phenyl}]-quinuclidine-2-ene,D01UKV,3-[1'-{4'-(Benzyloxy)-phenyl}]-quinuclidine-2-ene,https://idrblab.net/ttd/data/drug/details/D01UKV,T81850,Squalene synthetase (FDFT1),https://idrblab.net/ttd/data/target/details/T81850,P37268,Squalene synthase,2222.0,FDFT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6307,2011379,23653584,Drug Gene Interaction database (DGIdb),PRX-07034 hydrochloride,,PRX-07034,https://www.dgidb.org/drugs/drugbank:DB05993,,HTR6,https://www.dgidb.org/genes/hgnc:5301,,,3362.0,HTR6,9606.0,Homo sapiens (human),,,,,,,,
6308,2011380,23653789,ChEMBL,Serlopitant,CHEMBL447955,SERLOPITANT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL447955/,CHEMBL249,Neurokinin 1 receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL249/,P25103,Substance-P receptor,6869.0,TACR1,9606.0,Homo sapiens (human),Neurokinin 1 receptor antagonist,,,PMID:20639026,https://www.ncbi.nlm.nih.gov/pubmed/20639026,20639026,,
6309,2012148,23656215,Comparative Toxicogenomics Database (CTD),"Benzeneacetamide, N-((1S)-2-(((5S)-4,5-dihydro-3-methyl-4-oxo-3H-2,3-benzodiazepin-5-yl)amino)-1-methyl-2-oxoethyl)-3,5-difluoro-alpha-hydroxy-, (alphaS)-",C522903,"2-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-(3-methyl-4-oxo-4,5-dihydro-3H-benzo(d)(1,2)diazepin-5-yl)propanamide",https://ctdbase.org/detail.go?type=chem&acc=C522903,81502,HM13,https://ctdbase.org/detail.go?type=gene&acc=81502,,,81502.0,HM13,9606.0,Homo sapiens (human),"2-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-(3-methyl-4-oxo-4,5-dihydro-3H-benzo(d)(1,2)diazepin-5-yl)propanamide binds to and results in decreased activity of HM13 protein|2-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-(3-methyl-4-oxo-4,5-dihydro-3H-benzo(d)(1,2)diazepin-5-yl)propanamide inhibits the reaction [L 685458 binds to HM13 protein]",,,PMID:17932033,https://www.ncbi.nlm.nih.gov/pubmed/17932033,17932033,,
6310,2011981,23657507,IUPHAR/BPS Guide to PHARMACOLOGY,3-[[4-(5-Hydroxy-2-methylanilino)pyrimidin-2-yl]amino]benzenesulfonamide,8146,compound 23 [PMID: 17600705],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8146,2268,TXK tyrosine kinase,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2268,P42681,Tyrosine-protein kinase TXK,7294.0,TXK,9606.0,Homo sapiens (human),Inhibition,pIC50,9.4,PMID:17600705,https://www.ncbi.nlm.nih.gov/pubmed/17600705,17600705,,
6311,2011007,23657800,DrugBank,1-(5-Chloro-2-Methoxyphenyl)-3-{6-[2-(Dimethylamino)-1-Methylethoxy]pyrazin-2-Yl}urea,DB07228,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,https://www.drugbank.ca/drugs/DB07228,BE0003382,Serine/threonine-protein kinase Chk1,https://www.drugbank.ca/bio_entities/BE0003382,O14757,Serine/threonine-protein kinase Chk1,1111.0,CHEK1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6312,2011382,23663537,ChEMBL,Theophylline Sodium Glycinate,CHEMBL1200578,THEOPHYLLINE SODIUM GLYCINATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200578/,CHEMBL2093863,Phosphodiesterase 4,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093863/,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",5142.0,PDE4B,9606.0,Homo sapiens (human),Phosphodiesterase 4 inhibitor,,,,,,,
6313,2011383,23663959,Drug Gene Interaction database (DGIdb),Meclofenamate Sodium,,MECLOFENAMATE SODIUM,https://www.dgidb.org/drugs/rxcui:6677,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,,,,,
6314,2011384,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,CYP1A2,https://www.dgidb.org/genes/hgnc:2596,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),,,,,,,,
6315,2011385,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,,,,,
6316,2011386,23663996,Drug Gene Interaction database (DGIdb),Montelukast Sodium,,MONTELUKAST SODIUM,https://www.dgidb.org/drugs/rxcui:115713,,POLH,https://www.dgidb.org/genes/hgnc:9181,,,5429.0,POLH,9606.0,Homo sapiens (human),,,,,,,,
6317,2011387,23665591,Therapeutic Target Database (TTD),Clavulanate Potassium,D05BCF,Clavulanate+Amoxicillin,https://idrblab.net/ttd/data/drug/details/D05BCF,T38179,Staphylococcus Beta-lactamase (Stap-coc blaZ),https://idrblab.net/ttd/data/target/details/T38179,P00807,Beta-lactamase,79052806.0,,1280.0,Staphylococcus aureus,Inhibitor,,,,,,,
6318,2012156,23666118,ChEMBL,Micafungin Sodium,CHEMBL1237070,MICAFUNGIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1237070/,CHEMBL2364673,"1,3-beta-glucan synthase",https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364673/,O13428,"1,3-beta-D-glucan-UDP glucosyltransferase ",,,5475.0,Candida,"1,3-beta-glucan synthase inhibitor",,,,,,,
6319,2011389,23667642,Drug Gene Interaction database (DGIdb),Diclofenac Potassium,,DICLOFENAC POTASSIUM,https://www.dgidb.org/drugs/rxcui:81997,,PTGS1,https://www.dgidb.org/genes/hgnc:9604,,,5742.0,PTGS1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6320,2011390,23668825,Drug Gene Interaction database (DGIdb),Ethacrynate Sodium,,ETHACRYNATE SODIUM,https://www.dgidb.org/drugs/rxcui:4108,,SLC12A1,https://www.dgidb.org/genes/hgnc:10910,,,6557.0,SLC12A1,9606.0,Homo sapiens (human),,,,,,,,
6321,2011005,23670447,Therapeutic Target Database (TTD),"sodium (Z)-2-(1,3-benzodioxol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-[(3,4,5-trimethoxyphenyl)methyl]but-2-enoate",D0L3AR,PD156707,https://idrblab.net/ttd/data/drug/details/D0L3AR,T23499,Endothelin A receptor (EDNRA),https://idrblab.net/ttd/data/target/details/T23499,P25101,Endothelin-1 receptor,1909.0,EDNRA,9606.0,Homo sapiens (human),Antagonist,,,,,,,
6322,2012147,23674541,Drug Gene Interaction database (DGIdb),Esomeprazole Sodium,,ESOMEPRAZOLE SODIUM,https://www.dgidb.org/drugs/rxcui:1294569,,ATP4A,https://www.dgidb.org/genes/hgnc:819,,,495.0,ATP4A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6323,2011392,23675318,Drug Gene Interaction database (DGIdb),Nalidixate sodium,,NALIDIXATE SODIUM,https://www.dgidb.org/drugs/ncit:C80641,,BAZ2B,https://www.dgidb.org/genes/hgnc:963,,,29994.0,BAZ2B,9606.0,Homo sapiens (human),,,,,,,,
6324,2011393,23681059,Drug Gene Interaction database (DGIdb),Naproxen Sodium,,NAPROXEN SODIUM,https://www.dgidb.org/drugs/rxcui:142442,,ABCB1,https://www.dgidb.org/genes/hgnc:40,,,5243.0,ABCB1,9606.0,Homo sapiens (human),,,,,,,,
6325,2011394,23681107,Drug Gene Interaction database (DGIdb),Alendronate Sodium,,ALENDRONATE SODIUM,https://www.dgidb.org/drugs/rxcui:203152,,PTPRC,https://www.dgidb.org/genes/hgnc:9666,,,5788.0,PTPRC,9606.0,Homo sapiens (human),,,,,,,,
6326,2011395,23690315,Drug Gene Interaction database (DGIdb),Ibuprofen sodium dihydrate,,"IBUPROFEN, SODIUM SALT",https://www.dgidb.org/drugs/rxcui:1429044,,FAAH,https://www.dgidb.org/genes/hgnc:3553,,,2166.0,FAAH,9606.0,Homo sapiens (human),,,,,,,,
6327,2011396,23725095,Drug Gene Interaction database (DGIdb),"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",,TEZAMPANEL,https://www.dgidb.org/drugs/ncit:C77316,,GRIA1,https://www.dgidb.org/genes/hgnc:4571,,,2890.0,GRIA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6328,2011397,23725095,Drug Gene Interaction database (DGIdb),"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",,TEZAMPANEL,https://www.dgidb.org/drugs/ncit:C77316,,GRIA2,https://www.dgidb.org/genes/hgnc:4572,,,2891.0,GRIA2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6329,2011398,23725095,Drug Gene Interaction database (DGIdb),"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",,TEZAMPANEL,https://www.dgidb.org/drugs/ncit:C77316,,GRIK5,https://www.dgidb.org/genes/hgnc:4583,,,2901.0,GRIK5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6330,2011399,23725095,Drug Gene Interaction database (DGIdb),"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",,TEZAMPANEL,https://www.dgidb.org/drugs/ncit:C77316,,GRIA4,https://www.dgidb.org/genes/hgnc:4574,,,2893.0,GRIA4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6331,2011400,23725095,Drug Gene Interaction database (DGIdb),"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",,TEZAMPANEL,https://www.dgidb.org/drugs/ncit:C77316,,GRIK2,https://www.dgidb.org/genes/hgnc:4580,,,2898.0,GRIK2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6332,2011401,23725095,Drug Gene Interaction database (DGIdb),"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",,TEZAMPANEL,https://www.dgidb.org/drugs/ncit:C77316,,GRIK1,https://www.dgidb.org/genes/hgnc:4579,,,2897.0,GRIK1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6333,2011402,23725095,Drug Gene Interaction database (DGIdb),"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",,TEZAMPANEL,https://www.dgidb.org/drugs/ncit:C77316,,GRIK4,https://www.dgidb.org/genes/hgnc:4582,,,2900.0,GRIK4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6334,2011403,23725095,ChEMBL,"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",CHEMBL3989703,TEZAMPANEL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989703/,CHEMBL2096670,Glutamate receptor ionotropic AMPA,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2096670/,P42261,Glutamate receptor 1,2890.0,GRIA1,9606.0,Homo sapiens (human),Glutamate receptor ionotropic AMPA antagonist,,,PMID:16470401|PMID:18793656|PMID:8609884|PMID:15033339,https://www.ncbi.nlm.nih.gov/pubmed/16470401|https://www.ncbi.nlm.nih.gov/pubmed/18793656|https://www.ncbi.nlm.nih.gov/pubmed/8609884|https://www.ncbi.nlm.nih.gov/pubmed/15033339,16470401|18793656|8609884|15033339,,
6335,2011404,23725095,ChEMBL,"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",CHEMBL3989703,TEZAMPANEL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989703/,CHEMBL2096670,Glutamate receptor ionotropic AMPA,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2096670/,P42262,Glutamate receptor 2,2891.0,GRIA2,9606.0,Homo sapiens (human),Glutamate receptor ionotropic AMPA antagonist,,,PMID:16470401|PMID:18793656|PMID:8609884|PMID:15033339,https://www.ncbi.nlm.nih.gov/pubmed/16470401|https://www.ncbi.nlm.nih.gov/pubmed/18793656|https://www.ncbi.nlm.nih.gov/pubmed/8609884|https://www.ncbi.nlm.nih.gov/pubmed/15033339,16470401|18793656|8609884|15033339,,
6336,2011405,23725095,ChEMBL,"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",CHEMBL3989703,TEZAMPANEL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989703/,CHEMBL2096670,Glutamate receptor ionotropic AMPA,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2096670/,P42263,Glutamate receptor 3,2892.0,GRIA3,9606.0,Homo sapiens (human),Glutamate receptor ionotropic AMPA antagonist,,,PMID:16470401|PMID:18793656|PMID:8609884|PMID:15033339,https://www.ncbi.nlm.nih.gov/pubmed/16470401|https://www.ncbi.nlm.nih.gov/pubmed/18793656|https://www.ncbi.nlm.nih.gov/pubmed/8609884|https://www.ncbi.nlm.nih.gov/pubmed/15033339,16470401|18793656|8609884|15033339,,
6337,2011406,23725095,ChEMBL,"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",CHEMBL3989703,TEZAMPANEL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989703/,CHEMBL2096670,Glutamate receptor ionotropic AMPA,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2096670/,P48058,Glutamate receptor 4,2893.0,GRIA4,9606.0,Homo sapiens (human),Glutamate receptor ionotropic AMPA antagonist,,,PMID:16470401|PMID:18793656|PMID:8609884|PMID:15033339,https://www.ncbi.nlm.nih.gov/pubmed/16470401|https://www.ncbi.nlm.nih.gov/pubmed/18793656|https://www.ncbi.nlm.nih.gov/pubmed/8609884|https://www.ncbi.nlm.nih.gov/pubmed/15033339,16470401|18793656|8609884|15033339,,
6338,2011407,23725095,ChEMBL,"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",CHEMBL3989703,TEZAMPANEL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989703/,CHEMBL2109241,Glutamate receptor ionotropic kainate,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2109241/,P39086,"Glutamate receptor ionotropic, kainate 1",2897.0,GRIK1,9606.0,Homo sapiens (human),Glutamate receptor ionotropic kainate antagonist,,,PMID:16470401|PMID:18793656|PMID:8609884|PMID:15033339,https://www.ncbi.nlm.nih.gov/pubmed/16470401|https://www.ncbi.nlm.nih.gov/pubmed/18793656|https://www.ncbi.nlm.nih.gov/pubmed/8609884|https://www.ncbi.nlm.nih.gov/pubmed/15033339,16470401|18793656|8609884|15033339,,
6339,2011408,23725095,ChEMBL,"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",CHEMBL3989703,TEZAMPANEL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989703/,CHEMBL2109241,Glutamate receptor ionotropic kainate,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2109241/,Q13002,"Glutamate receptor ionotropic, kainate 2",2898.0,GRIK2,9606.0,Homo sapiens (human),Glutamate receptor ionotropic kainate antagonist,,,PMID:16470401|PMID:18793656|PMID:8609884|PMID:15033339,https://www.ncbi.nlm.nih.gov/pubmed/16470401|https://www.ncbi.nlm.nih.gov/pubmed/18793656|https://www.ncbi.nlm.nih.gov/pubmed/8609884|https://www.ncbi.nlm.nih.gov/pubmed/15033339,16470401|18793656|8609884|15033339,,
6340,2011409,23725095,ChEMBL,"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",CHEMBL3989703,TEZAMPANEL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989703/,CHEMBL2109241,Glutamate receptor ionotropic kainate,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2109241/,Q13003,"Glutamate receptor ionotropic, kainate 3",2899.0,GRIK3,9606.0,Homo sapiens (human),Glutamate receptor ionotropic kainate antagonist,,,PMID:16470401|PMID:18793656|PMID:8609884|PMID:15033339,https://www.ncbi.nlm.nih.gov/pubmed/16470401|https://www.ncbi.nlm.nih.gov/pubmed/18793656|https://www.ncbi.nlm.nih.gov/pubmed/8609884|https://www.ncbi.nlm.nih.gov/pubmed/15033339,16470401|18793656|8609884|15033339,,
6341,2011410,23725095,ChEMBL,"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",CHEMBL3989703,TEZAMPANEL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989703/,CHEMBL2109241,Glutamate receptor ionotropic kainate,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2109241/,Q16099,"Glutamate receptor ionotropic, kainate 4",2900.0,GRIK4,9606.0,Homo sapiens (human),Glutamate receptor ionotropic kainate antagonist,,,PMID:16470401|PMID:18793656|PMID:8609884|PMID:15033339,https://www.ncbi.nlm.nih.gov/pubmed/16470401|https://www.ncbi.nlm.nih.gov/pubmed/18793656|https://www.ncbi.nlm.nih.gov/pubmed/8609884|https://www.ncbi.nlm.nih.gov/pubmed/15033339,16470401|18793656|8609884|15033339,,
6342,2011411,23725095,ChEMBL,"(3S,4aR,6R,8aR)-6-(2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid monohydrate",CHEMBL3989703,TEZAMPANEL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989703/,CHEMBL2109241,Glutamate receptor ionotropic kainate,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2109241/,Q16478,"Glutamate receptor ionotropic, kainate 5",2901.0,GRIK5,9606.0,Homo sapiens (human),Glutamate receptor ionotropic kainate antagonist,,,PMID:16470401|PMID:18793656|PMID:8609884|PMID:15033339,https://www.ncbi.nlm.nih.gov/pubmed/16470401|https://www.ncbi.nlm.nih.gov/pubmed/18793656|https://www.ncbi.nlm.nih.gov/pubmed/8609884|https://www.ncbi.nlm.nih.gov/pubmed/15033339,16470401|18793656|8609884|15033339,,
6343,2011003,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,RAD51C,https://www.dgidb.org/genes/hgnc:9820,,,5889.0,RAD51C,9606.0,Homo sapiens (human),,,,,,,,
6344,2011004,23725625,Drug Gene Interaction database (DGIdb),Olaparib,,OLAPARIB,https://www.dgidb.org/drugs/rxcui:1597582,,VHL,https://www.dgidb.org/genes/hgnc:12687,,,7428.0,VHL,9606.0,Homo sapiens (human),,,,,,,,
6345,2011412,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,9606.0,Homo sapiens (human),[olaparib co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein|ddit3 protein affects the reaction [[TNFSF10 protein co-treated with olaparib] results in increased expression of TNFRSF10B protein]|[olaparib co-treated with TNFSF10 protein] results in increased cleavage of CASP8 protein|[tnfsf10 protein co-treated with olaparib] results in increased expression of TNFRSF10B protein|casp8 protein affects the reaction [[olaparib co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein]|[olaparib co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein,,,PMID:25531448,https://www.ncbi.nlm.nih.gov/pubmed/25531448,25531448,,
6346,2011413,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),[fluorouracil co-treated with olaparib] results in increased expression of TP53 protein|tp53 gene mutant form affects the reaction [benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AX protein]],,,PMID:26544897,https://www.ncbi.nlm.nih.gov/pubmed/26544897,26544897,,
6347,2011414,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Olaparib results in increased phosphorylation of TP53 protein,,,PMID:25531448,https://www.ncbi.nlm.nih.gov/pubmed/25531448,25531448,,
6348,2012138,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,7515,XRCC1,https://ctdbase.org/detail.go?type=gene&acc=7515,,,7515.0,XRCC1,9606.0,Homo sapiens (human),Olaparib affects the reaction [[XRCC1 protein affects the susceptibility to camptothecin] which affects the abundance of NAD],,,PMID:35778544,https://www.ncbi.nlm.nih.gov/pubmed/35778544,35778544,,
6349,2012139,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,10090.0,Mus musculus (house mouse),[dietary fats co-treated with olaparib] results in decreased expression of ACACA mRNA,,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6350,2012140,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,32,ACACB,https://ctdbase.org/detail.go?type=gene&acc=32,,,32.0,ACACB,10090.0,Mus musculus (house mouse),[dietary fats co-treated with olaparib] results in decreased expression of ACACB mRNA,,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6351,2012141,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,51,ACOX1,https://ctdbase.org/detail.go?type=gene&acc=51,,,51.0,ACOX1,10090.0,Mus musculus (house mouse),[dietary fats co-treated with olaparib] results in decreased expression of ACOX1 mRNA,,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6352,2012142,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10090.0,Mus musculus (house mouse),Olaparib inhibits the reaction [[methionine deficiency co-treated with choline deficiency] results in increased expression of ACTA2 mrna],,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6353,2012143,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,2015,ADGRE1,https://ctdbase.org/detail.go?type=gene&acc=2015,,,2015.0,ADGRE1,10090.0,Mus musculus (house mouse),Olaparib inhibits the reaction [[methionine deficiency co-treated with choline deficiency] results in increased expression of ADGRE1 mrna],,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6354,2012144,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,9606.0,Homo sapiens (human),Olaparib inhibits the reaction [methylmercury compounds results in increased expression of AIFM1 protein],,,PMID:35396826,https://www.ncbi.nlm.nih.gov/pubmed/35396826,35396826,,
6355,2012145,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Olaparib promotes the reaction [nitroprusside results in increased phosphorylation of AKT1 protein]|olaparib promotes the reaction [hydrogen peroxide results in increased phosphorylation of AKT1 protein],,,PMID:30296409,https://www.ncbi.nlm.nih.gov/pubmed/30296409,30296409,,
6356,2012146,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,8314,BAP1,https://ctdbase.org/detail.go?type=gene&acc=8314,,,8314.0,BAP1,9606.0,Homo sapiens (human),BAP1 gene mutant form results in increased susceptibility to olaparib,,,PMID:22683710,https://www.ncbi.nlm.nih.gov/pubmed/22683710,22683710,,
6357,2012157,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),INCB054329 promotes the reaction [olaparib results in increased expression of BAX protein]|olaparib results in increased expression of BAX protein,,,PMID:29567272,https://www.ncbi.nlm.nih.gov/pubmed/29567272,29567272,,
6358,2012158,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Olaparib results in decreased expression of BCL2 protein,,,PMID:25531448,https://www.ncbi.nlm.nih.gov/pubmed/25531448,25531448,,
6359,2012159,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606.0,Homo sapiens (human),Olaparib results in decreased expression of BIRC5 protein,,,PMID:25531448,https://www.ncbi.nlm.nih.gov/pubmed/25531448,25531448,,
6360,2012160,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,672,BRCA1,https://ctdbase.org/detail.go?type=gene&acc=672,,,672.0,BRCA1,9606.0,Homo sapiens (human),BRCA1 affects the susceptibility to olaparib,,,PMID:21633166,https://www.ncbi.nlm.nih.gov/pubmed/21633166,21633166,,
6361,2012161,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,672,BRCA1,https://ctdbase.org/detail.go?type=gene&acc=672,,,672.0,BRCA1,9606.0,Homo sapiens (human),[olaparib co-treated with INCB054329] results in decreased expression of BRCA1 protein|olaparib promotes the reaction [INCB054329 results in decreased expression of BRCA1 protein]|[brd4 protein affects the susceptibility to olaparib] which affects the expression of BRCA1 protein,,,PMID:29567272,https://www.ncbi.nlm.nih.gov/pubmed/29567272,29567272,,
6362,2012162,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,675,BRCA2,https://ctdbase.org/detail.go?type=gene&acc=675,,,675.0,BRCA2,9606.0,Homo sapiens (human),BRCA2 affects the susceptibility to olaparib,,,PMID:21633166,https://www.ncbi.nlm.nih.gov/pubmed/21633166,21633166,,
6363,2012163,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,23476,BRD4,https://ctdbase.org/detail.go?type=gene&acc=23476,,,23476.0,BRD4,9606.0,Homo sapiens (human),[BRD4 protein affects the susceptibility to olaparib] which affects the cleavage of PARP1 protein|brd4 protein affects the susceptibility to olaparib|[brd4 protein affects the susceptibility to olaparib] which affects the expression of H2AX protein|[brd4 protein affects the susceptibility to olaparib] which affects the expression of BRCA1 protein,,,PMID:29567272,https://www.ncbi.nlm.nih.gov/pubmed/29567272,29567272,,
6364,2012164,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[fluorouracil co-treated with olaparib] results in increased cleavage of CASP3 protein]|[fluorouracil co-treated with olaparib] results in increased cleavage of CASP3 protein,,,PMID:26544897,https://www.ncbi.nlm.nih.gov/pubmed/26544897,26544897,,
6365,2012165,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),[olaparib co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein|casp8 protein affects the reaction [[olaparib co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein],,,PMID:25531448,https://www.ncbi.nlm.nih.gov/pubmed/25531448,25531448,,
6366,2012173,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Olaparib inhibits the reaction [methylmercury compounds results in increased cleavage of CASP3 protein],,,PMID:35396826,https://www.ncbi.nlm.nih.gov/pubmed/35396826,35396826,,
6367,2012174,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),Benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[fluorouracil co-treated with olaparib] results in increased cleavage of CASP8 protein]|[fluorouracil co-treated with olaparib] results in increased cleavage of CASP8 protein,,,PMID:26544897,https://www.ncbi.nlm.nih.gov/pubmed/26544897,26544897,,
6368,2012175,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),CASP8 protein affects the reaction [[olaparib co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein]|[olaparib co-treated with TNFSF10 protein] results in increased cleavage of CASP8 protein,,,PMID:25531448,https://www.ncbi.nlm.nih.gov/pubmed/25531448,25531448,,
6369,2012176,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),[olaparib co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein,,,PMID:25531448,https://www.ncbi.nlm.nih.gov/pubmed/25531448,25531448,,
6370,2012177,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Olaparib inhibits the reaction [methylmercury compounds results in increased expression of CASP9 protein],,,PMID:35396826,https://www.ncbi.nlm.nih.gov/pubmed/35396826,35396826,,
6371,2012178,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090.0,Mus musculus (house mouse),Olaparib inhibits the reaction [ethanol results in increased expression of CCL2 protein],,,PMID:29317476,https://www.ncbi.nlm.nih.gov/pubmed/29317476,29317476,,
6372,2012179,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,10090.0,Mus musculus (house mouse),Olaparib inhibits the reaction [[methionine deficiency co-treated with choline deficiency] results in increased expression of CCN2 mrna],,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6373,2012180,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),Olaparib promotes the reaction [INCB054329 results in decreased expression of CCNE1 protein]|[olaparib co-treated with INCB054329] results in decreased expression of CCNE1 protein,,,PMID:29567272,https://www.ncbi.nlm.nih.gov/pubmed/29567272,29567272,,
6374,2012181,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,729230,CCR2,https://ctdbase.org/detail.go?type=gene&acc=729230,,,729230.0,CCR2,10090.0,Mus musculus (house mouse),[ethanol co-treated with dietary fats co-treated with olaparib] results in decreased expression of CCR2 mRNA,,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6375,2012182,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),INCB054329 promotes the reaction [olaparib results in increased expression of CDKN1A protein]|olaparib results in increased expression of CDKN1A protein|olaparib promotes the reaction [INCB054329 results in increased expression of CDKN1A protein],,,PMID:29567272,https://www.ncbi.nlm.nih.gov/pubmed/29567272,29567272,,
6376,2012201,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,1111,CHEK1,https://ctdbase.org/detail.go?type=gene&acc=1111,,,1111.0,CHEK1,9606.0,Homo sapiens (human),Olaparib results in increased phosphorylation of CHEK1 protein,,,PMID:25531448,https://www.ncbi.nlm.nih.gov/pubmed/25531448,25531448,,
6377,2012202,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10090.0,Mus musculus (house mouse),Olaparib inhibits the reaction [[methionine deficiency co-treated with choline deficiency] results in increased expression of COL1A1 mrna],,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6378,2012203,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090.0,Mus musculus (house mouse),[ethanol co-treated with dietary fats co-treated with olaparib] results in decreased expression of CXCL2 mrna|olaparib inhibits the reaction [[methionine deficiency co-treated with choline deficiency] results in increased expression of CXCL2 mrna],,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6379,2012204,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606.0,Homo sapiens (human),Olaparib inhibits the reaction [methylmercury compounds results in increased expression of CYCS protein],,,PMID:35396826,https://www.ncbi.nlm.nih.gov/pubmed/35396826,35396826,,
6380,2012205,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,9606.0,Homo sapiens (human),DDIT3 protein affects the reaction [[TNFSF10 protein co-treated with olaparib] results in increased expression of TNFRSF10B protein]|olaparib results in increased expression of DDIT3 protein,,,PMID:25531448,https://www.ncbi.nlm.nih.gov/pubmed/25531448,25531448,,
6381,2012206,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,10090.0,Mus musculus (house mouse),[dietary fats co-treated with olaparib] results in decreased expression of FASN mRNA,,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6382,2012207,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,2271,FH,https://ctdbase.org/detail.go?type=gene&acc=2271,,,2271.0,FH,9606.0,Homo sapiens (human),FH mutant form results in increased susceptibility to olaparib,,,PMID:30013182,https://www.ncbi.nlm.nih.gov/pubmed/30013182,30013182,,
6383,2012208,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10090.0,Mus musculus (house mouse),[ethanol co-treated with dietary fats co-treated with olaparib] results in decreased expression of GPT protein|olaparib inhibits the reaction [[methionine deficiency co-treated with choline deficiency] results in increased expression of GPT protein],,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6384,2012209,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),TP53 gene mutant form affects the reaction [benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AX protein]]|benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AX protein]|[fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AX protein,,,PMID:26544897,https://www.ncbi.nlm.nih.gov/pubmed/26544897,26544897,,
6385,2012225,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),[BRD4 protein affects the susceptibility to olaparib] which affects the expression of H2AX protein|olaparib promotes the reaction [(+)-JQ1 compound results in increased expression of H2AX protein]|olaparib results in increased expression of H2AX protein|(+)-JQ1 compound promotes the reaction [olaparib results in increased expression of H2AX protein]|incb054329 promotes the reaction [olaparib results in increased expression of H2AX protein]|olaparib promotes the reaction [INCB054329 results in increased expression of H2AX protein],,,PMID:29567272,https://www.ncbi.nlm.nih.gov/pubmed/29567272,29567272,,
6386,2012226,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),Olaparib results in increased phosphorylation of H2AX protein,,,PMID:25531448,https://www.ncbi.nlm.nih.gov/pubmed/25531448,25531448,,
6387,2012227,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,3146,HMGB1,https://ctdbase.org/detail.go?type=gene&acc=3146,,,3146.0,HMGB1,10116.0,Rattus norvegicus (Norway rat),Olaparib inhibits the reaction [ethanol results in increased expression of HMGB1 protein],,,PMID:29339456,https://www.ncbi.nlm.nih.gov/pubmed/29339456,29339456,,
6388,2012228,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10090.0,Mus musculus (house mouse),[ethanol co-treated with dietary fats co-treated with olaparib] results in decreased expression of ICAM1 mRNA,,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6389,2012229,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),[ethanol co-treated with dietary fats co-treated with olaparib] results in decreased expression of IL1B mRNA,,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6390,2012230,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Olaparib inhibits the reaction [ethanol results in increased expression of IL6 protein],,,PMID:29317476,https://www.ncbi.nlm.nih.gov/pubmed/29317476,29317476,,
6391,2012231,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,546644,LY6G,https://ctdbase.org/detail.go?type=gene&acc=546644,,,546644.0,Ly6g,10090.0,Mus musculus (house mouse),Olaparib inhibits the reaction [[methionine deficiency co-treated with choline deficiency] results in increased expression of LY6G mrna]|[ethanol co-treated with dietary fats co-treated with olaparib] results in decreased expression of LY6G mRNA,,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6392,2012232,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,9606.0,Homo sapiens (human),Chloroquine promotes the reaction [olaparib promotes the reaction [[ferric ammonium citrate results in increased abundance of iron] which results in increased lipidation of MAP1LC3B protein]]|olaparib promotes the reaction [chloroquine results in increased lipidation of MAP1LC3B protein]|olaparib promotes the reaction [[ferric ammonium citrate results in increased abundance of iron] which results in increased lipidation of MAP1LC3B protein]|olaparib promotes the reaction [chloroquine promotes the reaction [[ferric ammonium citrate results in increased abundance of iron] which results in increased lipidation of MAP1LC3B protein]],,,PMID:34826546,https://www.ncbi.nlm.nih.gov/pubmed/34826546,34826546,,
6393,2012233,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,10116.0,Rattus norvegicus (Norway rat),Olaparib inhibits the reaction [hydrogen peroxide results in increased lipidation of MAP1LC3B protein]|bafilomycin A1 inhibits the reaction [olaparib inhibits the reaction [hydrogen peroxide results in increased lipidation of MAP1LC3B protein]],,,PMID:36639873,https://www.ncbi.nlm.nih.gov/pubmed/36639873,36639873,,
6394,2012248,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,9606.0,Homo sapiens (human),INCB054329 promotes the reaction [olaparib results in decreased expression of MKI67 protein]|olaparib promotes the reaction [INCB054329 results in decreased expression of MKI67 protein]|olaparib results in decreased expression of MKI67 protein,,,PMID:29567272,https://www.ncbi.nlm.nih.gov/pubmed/29567272,29567272,,
6395,2012249,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,4292,MLH1,https://ctdbase.org/detail.go?type=gene&acc=4292,,,4292.0,MLH1,9606.0,Homo sapiens (human),Olaparib inhibits the reaction [MLH1 protein results in decreased susceptibility to floxuridine],,,PMID:22194930,https://www.ncbi.nlm.nih.gov/pubmed/22194930,22194930,,
6396,2012250,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10090.0,Mus musculus (house mouse),[ethanol co-treated with dietary fats co-treated with olaparib] results in decreased expression of MPO protein,,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6397,2012251,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,4436,MSH2,https://ctdbase.org/detail.go?type=gene&acc=4436,,,4436.0,MSH2,9606.0,Homo sapiens (human),Olaparib inhibits the reaction [MSH2 protein results in decreased susceptibility to floxuridine],,,PMID:22194930,https://www.ncbi.nlm.nih.gov/pubmed/22194930,22194930,,
6398,2012252,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,4437,MSH3,https://ctdbase.org/detail.go?type=gene&acc=4437,,,4437.0,MSH3,9606.0,Homo sapiens (human),MSH3 protein results in decreased susceptibility to olaparib,,,PMID:21285347,https://www.ncbi.nlm.nih.gov/pubmed/21285347,21285347,,
6399,2012253,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),(+)-JQ1 compound promotes the reaction [olaparib results in increased cleavage of PARP1 protein]|olaparib results in increased cleavage of PARP1 protein|[brd4 protein affects the susceptibility to olaparib] which affects the cleavage of PARP1 protein|incb054329 promotes the reaction [olaparib results in increased cleavage of PARP1 protein]|olaparib promotes the reaction [INCB054329 results in increased cleavage of PARP1 protein],,,PMID:29567272,https://www.ncbi.nlm.nih.gov/pubmed/29567272,29567272,,
6400,2012254,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Olaparib inhibits the reaction [methylmercury compounds results in increased cleavage of PARP1 protein],,,PMID:35396826,https://www.ncbi.nlm.nih.gov/pubmed/35396826,35396826,,
6401,2012255,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Olaparib results in decreased activity of PARP1 protein,,,PMID:28001384,https://www.ncbi.nlm.nih.gov/pubmed/28001384,28001384,,
6402,2012256,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10090.0,Mus musculus (house mouse),Olaparib inhibits the reaction [hydrogen peroxide results in increased activity of PARP1 protein],,,PMID:24814482,https://www.ncbi.nlm.nih.gov/pubmed/24814482,24814482,,
6403,2012257,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Olaparib results in decreased activity of PARP1 protein,,,PMID:21417348,https://www.ncbi.nlm.nih.gov/pubmed/21417348,21417348,,
6404,2012258,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,10038,PARP2,https://ctdbase.org/detail.go?type=gene&acc=10038,,,10038.0,PARP2,9606.0,Homo sapiens (human),Olaparib binds to and results in decreased activity of PARP2 protein,,,PMID:28001384,https://www.ncbi.nlm.nih.gov/pubmed/28001384,28001384,,
6405,2012259,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,10038,PARP2,https://ctdbase.org/detail.go?type=gene&acc=10038,,,10038.0,PARP2,9606.0,Homo sapiens (human),Olaparib results in decreased activity of PARP2 protein,,,PMID:21417348,https://www.ncbi.nlm.nih.gov/pubmed/21417348,21417348,,
6406,2012260,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9606.0,Homo sapiens (human),INCB054329 promotes the reaction [olaparib results in decreased expression of PCNA protein]|olaparib results in decreased expression of PCNA protein,,,PMID:29567272,https://www.ncbi.nlm.nih.gov/pubmed/29567272,29567272,,
6407,2012261,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,5320,PLA2G2A,https://ctdbase.org/detail.go?type=gene&acc=5320,,,5320.0,PLA2G2A,10116.0,Rattus norvegicus (Norway rat),Olaparib inhibits the reaction [ethanol results in increased expression of PLA2G2A protein],,,PMID:29339456,https://www.ncbi.nlm.nih.gov/pubmed/29339456,29339456,,
6408,2012262,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,5321,PLA2G4A,https://ctdbase.org/detail.go?type=gene&acc=5321,,,5321.0,PLA2G4A,10116.0,Rattus norvegicus (Norway rat),Olaparib inhibits the reaction [ethanol results in increased expression of PLA2G4A protein],,,PMID:29339456,https://www.ncbi.nlm.nih.gov/pubmed/29339456,29339456,,
6409,2012263,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,10090.0,Mus musculus (house mouse),[dietary fats co-treated with olaparib] results in decreased expression of PPARA mRNA,,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6410,2012264,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,5888,RAD51,https://ctdbase.org/detail.go?type=gene&acc=5888,,,5888.0,RAD51,9606.0,Homo sapiens (human),[olaparib co-treated with INCB054329] results in decreased expression of RAD51 protein,,,PMID:29567272,https://www.ncbi.nlm.nih.gov/pubmed/29567272,29567272,,
6411,2012265,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,6390,SDHB,https://ctdbase.org/detail.go?type=gene&acc=6390,,,6390.0,SDHB,9606.0,Homo sapiens (human),SDHB mutant form results in increased susceptibility to olaparib,,,PMID:30013182,https://www.ncbi.nlm.nih.gov/pubmed/30013182,30013182,,
6412,2012266,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,9606.0,Homo sapiens (human),Olaparib promotes the reaction [[ferric ammonium citrate results in increased abundance of iron] which results in increased expression of SIRT1 protein]|olaparib results in increased expression of SIRT1 protein,,,PMID:34826546,https://www.ncbi.nlm.nih.gov/pubmed/34826546,34826546,,
6413,2012267,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,10116.0,Rattus norvegicus (Norway rat),Olaparib inhibits the reaction [hydrogen peroxide results in decreased expression of SQSTM1 protein],,,PMID:36639873,https://www.ncbi.nlm.nih.gov/pubmed/36639873,36639873,,
6414,2012282,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720.0,SREBF1,10090.0,Mus musculus (house mouse),[dietary fats co-treated with olaparib] results in decreased expression of SREBF1 mRNA,,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6415,2012283,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10090.0,Mus musculus (house mouse),Olaparib inhibits the reaction [[methionine deficiency co-treated with choline deficiency] results in increased expression of TGFB1 mrna],,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6416,2012284,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Olaparib inhibits the reaction [[methionine deficiency co-treated with choline deficiency] results in increased expression of TNF mrna]|[ethanol co-treated with dietary fats co-treated with olaparib] results in decreased expression of TNF mRNA,,,PMID:27984176,https://www.ncbi.nlm.nih.gov/pubmed/27984176,27984176,,
6417,2012285,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Olaparib inhibits the reaction [ethanol results in increased expression of TNF protein],,,PMID:29317476,https://www.ncbi.nlm.nih.gov/pubmed/29317476,29317476,,
6418,2012286,23725625,Comparative Toxicogenomics Database (CTD),Olaparib,C531550,olaparib,https://ctdbase.org/detail.go?type=chem&acc=C531550,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,9606.0,Homo sapiens (human),[TNFSF10 protein co-treated with olaparib] results in increased expression of TNFRSF10B protein|ddit3 protein affects the reaction [[TNFSF10 protein co-treated with olaparib] results in increased expression of TNFRSF10B protein]|olaparib results in increased expression of TNFRSF10B protein,,,PMID:25531448,https://www.ncbi.nlm.nih.gov/pubmed/25531448,25531448,,
6419,2011006,23728517,DrugBank,"(9beta,11alpha,13alpha,14beta,17alpha)-11-(Methoxymethyl)estra-1(10),2,4-Triene-3,17-Diol",DB07707,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",https://www.drugbank.ca/drugs/DB07707,BE0003740,Nuclear receptor coactivator 2,https://www.drugbank.ca/bio_entities/BE0003740,Q15596,Nuclear receptor coactivator 2,10499.0,NCOA2,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6420,2011008,23728517,DrugBank,"(9beta,11alpha,13alpha,14beta,17alpha)-11-(Methoxymethyl)estra-1(10),2,4-Triene-3,17-Diol",DB07707,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",https://www.drugbank.ca/drugs/DB07707,BE0000123,Estrogen receptor,https://www.drugbank.ca/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6421,2011010,23729147,DrugBank,"5-{[1-(2-Fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",DB07642,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",https://www.drugbank.ca/drugs/DB07642,BE0001215,m7GpppX diphosphatase,https://www.drugbank.ca/bio_entities/BE0001215,Q96C86,m7GpppX diphosphatase,28960.0,DCPS,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6422,2011009,23928102,IUPHAR/BPS Guide to PHARMACOLOGY,Forsythoside B,10303,forsythoside B,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10303,509,TRPV3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=509,Q8NET8,Transient receptor potential cation channel subfamily V member 3,162514.0,TRPV3,9606.0,Homo sapiens (human),Inhibition,pIC50,6.15,PMID:30377214,https://www.ncbi.nlm.nih.gov/pubmed/30377214,30377214,,
6423,2011011,24178109,DrugBank,N~2~-(Biphenyl-4-Ylsulfonyl)-N-Hydroxy-N~2~-(2-Hydroxyethyl)glycinamide,DB08029,N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide,https://www.drugbank.ca/drugs/DB08029,BE0001116,Stromelysin-1,https://www.drugbank.ca/bio_entities/BE0001116,P08254,Stromelysin-1,4314.0,MMP3,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6424,2011012,24178119,DrugBank,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DB07468,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",https://www.drugbank.ca/drugs/DB07468,BE0003893,Myosin-14,https://www.drugbank.ca/bio_entities/BE0003893,Q7Z406,Myosin-14,79784.0,MYH14,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6425,2011013,24178120,DrugBank,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DB07469,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",https://www.drugbank.ca/drugs/DB07469,BE0003893,Myosin-14,https://www.drugbank.ca/bio_entities/BE0003893,Q7Z406,Myosin-14,79784.0,MYH14,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6426,2011014,24178121,DrugBank,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",DB07470,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",https://www.drugbank.ca/drugs/DB07470,BE0003893,Myosin-14,https://www.drugbank.ca/bio_entities/BE0003893,Q7Z406,Myosin-14,79784.0,MYH14,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6427,2012287,24180536,BindingDB,"3-(2-(2-chlorobenzyl)-1H-benzo[d]imidazol-6-yl)-1-((trans)-4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",27963,"3-(2-(2-chlorobenzyl)-1H-benzo[d]imidazol-5-yl)-1-((1r,4r)-4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27963,188,Receptor tyrosine-protein kinase erbB-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=188,P04626,Receptor tyrosine-protein kinase erbB-2,2064.0,ERBB2,9606.0,Homo sapiens (human),,IC50 (nM),664,PMID:19217287|DOI:10.1016/j.bmcl.2009.01.086,https://www.ncbi.nlm.nih.gov/pubmed/19217287|https://doi.org/10.1016/j.bmcl.2009.01.086,19217287,10.1016/j.bmcl.2009.01.086,
6428,2012288,24180536,BindingDB,"3-(2-(2-chlorobenzyl)-1H-benzo[d]imidazol-6-yl)-1-((trans)-4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",27963,"3-(2-(2-chlorobenzyl)-1H-benzo[d]imidazol-5-yl)-1-((1r,4r)-4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27963,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),36,PMID:19217287|DOI:10.1016/j.bmcl.2009.01.086,https://www.ncbi.nlm.nih.gov/pubmed/19217287|https://doi.org/10.1016/j.bmcl.2009.01.086,19217287,10.1016/j.bmcl.2009.01.086,
6429,2012289,24180536,BindingDB,"3-(2-(2-chlorobenzyl)-1H-benzo[d]imidazol-6-yl)-1-((trans)-4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",27963,"3-(2-(2-chlorobenzyl)-1H-benzo[d]imidazol-5-yl)-1-((1r,4r)-4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27963,3392,"Epidermal growth factor receptor [671-1210,L858R]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3392,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),,IC50 (nM),65,PMID:19217287|DOI:10.1016/j.bmcl.2009.01.086,https://www.ncbi.nlm.nih.gov/pubmed/19217287|https://doi.org/10.1016/j.bmcl.2009.01.086,19217287,10.1016/j.bmcl.2009.01.086,
6430,2011015,24180718,DrugBank,"4-(6-{[(1r)-1-(Hydroxymethyl)propyl]amino}imidazo[1,2-B]pyridazin-3-Yl)benzoic Acid",DB07125,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",https://www.drugbank.ca/drugs/DB07125,BE0003788,Death-associated protein kinase 3,https://www.drugbank.ca/bio_entities/BE0003788,O43293,Death-associated protein kinase 3,1613.0,DAPK3,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6431,2011016,24180719,Drug Gene Interaction database (DGIdb),"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide",,PLX-4720,https://www.dgidb.org/drugs/drugbank:DB06999,,GNAQ,https://www.dgidb.org/genes/hgnc:4390,,,2776.0,GNAQ,9606.0,Homo sapiens (human),,,,,,,,
6432,2011017,24180721,DrugBank,"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",DB07524,"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",https://www.drugbank.ca/drugs/DB07524,BE0001277,Serine/threonine-protein kinase pim-1,https://www.drugbank.ca/bio_entities/BE0001277,P11309,Serine/threonine-protein kinase pim-1,5292.0,PIM1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6433,2028333,24204050,Comparative Toxicogenomics Database (CTD),Iqdma,C524250,"N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine",https://ctdbase.org/detail.go?type=chem&acc=C524250,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,9606.0,Homo sapiens (human),"N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine results in decreased phosphorylation of and results in decreased activity of SRC protein",,,PMID:18638462,https://www.ncbi.nlm.nih.gov/pubmed/18638462,18638462,,
6434,2028334,24204050,Comparative Toxicogenomics Database (CTD),Iqdma,C524250,"N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine",https://ctdbase.org/detail.go?type=chem&acc=C524250,6776,STAT5A,https://ctdbase.org/detail.go?type=gene&acc=6776,,,6776.0,STAT5A,9606.0,Homo sapiens (human),"N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine results in decreased phosphorylation of STAT5A protein|il6 protein inhibits the reaction [N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine results in decreased phosphorylation of STAT5A protein]",,,PMID:18638462,https://www.ncbi.nlm.nih.gov/pubmed/18638462,18638462,,
6435,2028335,24204050,Comparative Toxicogenomics Database (CTD),Iqdma,C524250,"N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine",https://ctdbase.org/detail.go?type=chem&acc=C524250,6777,STAT5B,https://ctdbase.org/detail.go?type=gene&acc=6777,,,6777.0,STAT5B,9606.0,Homo sapiens (human),"N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine results in decreased phosphorylation of STAT5B protein|il6 protein inhibits the reaction [N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine results in decreased phosphorylation of STAT5B protein]",,,PMID:18638462,https://www.ncbi.nlm.nih.gov/pubmed/18638462,18638462,,
6436,2028336,24204050,Comparative Toxicogenomics Database (CTD),Iqdma,C524250,"N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine",https://ctdbase.org/detail.go?type=chem&acc=C524250,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),"N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine results in decreased expression of VEGFA protein|il6 protein inhibits the reaction [N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine results in decreased expression of VEGFA protein]",,,PMID:18638462,https://www.ncbi.nlm.nih.gov/pubmed/18638462,18638462,,
6437,2028337,24285067,BindingDB,N-(2-Fluorophenyl)-2-hydroxybenzamide,234301,N-(2-fluorophenyl)-2-hydroxybenzamide (2),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=234301,10043,Epidermal growth factor receptor [645-1186],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10043,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),,IC50 (nM),24830,PMID:20583855|DOI:10.3109/14756361003671060,https://www.ncbi.nlm.nih.gov/pubmed/20583855|https://doi.org/10.3109/14756361003671060,20583855,10.3109/14756361003671060,
6438,2028355,24694277,BindingDB,N-(2-bromophenyl)-2-hydroxy-4-methylbenzamide,234312,N-(2-bromophenyl)-2-hydroxy-4-methylbenzamide (14),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=234312,10043,Epidermal growth factor receptor [645-1186],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10043,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),,IC50 (nM),22190,PMID:20583855|DOI:10.3109/14756361003671060,https://www.ncbi.nlm.nih.gov/pubmed/20583855|https://doi.org/10.3109/14756361003671060,20583855,10.3109/14756361003671060,
6439,2028338,24726843,BindingDB,Ethyl 5-trifluoroacetyl-2-thenoate,25153,"ethyl 5-(2,2,2-trifluoroacetyl)thiophene-2-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25153,6107,Histone deacetylase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6107,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),320,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
6440,2028339,24726843,BindingDB,Ethyl 5-trifluoroacetyl-2-thenoate,25153,"ethyl 5-(2,2,2-trifluoroacetyl)thiophene-2-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25153,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),350,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
6441,2028340,24726843,BindingDB,Ethyl 5-trifluoroacetyl-2-thenoate,25153,"ethyl 5-(2,2,2-trifluoroacetyl)thiophene-2-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25153,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,IC50 (nM),3500,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
6442,2028341,24726843,BindingDB,Ethyl 5-trifluoroacetyl-2-thenoate,25153,"ethyl 5-(2,2,2-trifluoroacetyl)thiophene-2-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25153,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),5700,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
6443,2028354,24726843,BindingDB,Ethyl 5-trifluoroacetyl-2-thenoate,25153,"ethyl 5-(2,2,2-trifluoroacetyl)thiophene-2-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25153,2556,Histone deacetylase 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2556,Q9UBN7,Histone deacetylase 6,10013.0,HDAC6,9606.0,Homo sapiens (human),,IC50 (nM),550,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
6444,2028342,24726844,BindingDB,Ethyl 5-trifluoroacetyl-2-furanoate,25154,"ethyl 5-(2,2,2-trifluoroacetyl)furan-2-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25154,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
6445,2028343,24726844,BindingDB,Ethyl 5-trifluoroacetyl-2-furanoate,25154,"ethyl 5-(2,2,2-trifluoroacetyl)furan-2-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25154,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
6446,2028344,24726844,BindingDB,Ethyl 5-trifluoroacetyl-2-furanoate,25154,"ethyl 5-(2,2,2-trifluoroacetyl)furan-2-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25154,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),3100,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
6447,2028345,24726844,BindingDB,Ethyl 5-trifluoroacetyl-2-furanoate,25154,"ethyl 5-(2,2,2-trifluoroacetyl)furan-2-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25154,6107,Histone deacetylase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6107,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),2500,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
6448,2028346,24726844,BindingDB,Ethyl 5-trifluoroacetyl-2-furanoate,25154,"ethyl 5-(2,2,2-trifluoroacetyl)furan-2-carboxylate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25154,2556,Histone deacetylase 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2556,Q9UBN7,Histone deacetylase 6,10013.0,HDAC6,9606.0,Homo sapiens (human),,IC50 (nM),550,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
6449,2028347,24739943,IUPHAR/BPS Guide to PHARMACOLOGY,Allitinib,9912,allitinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9912,2019,erb-b2 receptor tyrosine kinase 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2019,P04626,Receptor tyrosine-protein kinase erbB-2,2064.0,ERBB2,9606.0,Homo sapiens (human),Inhibition,pIC50,8.52,PMID:21789172,https://www.ncbi.nlm.nih.gov/pubmed/21789172,21789172,,
6450,2012086,24742034,BindingDB,,20676,"(2S)-2-{[4-({2-amino-6-methyl-4-oxo-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-5-yl}methyl)phenyl]formamido}pentanedioic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20676,9977,Bifunctional dihydrofolate reductase-thymidylate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9977,Q07422,Bifunctional dihydrofolate reductase-thymidylate synthase,,,5811.0,Toxoplasma gondii,,IC50 (nM),23,PMID:18072727|DOI:10.1021/jm701052u,https://www.ncbi.nlm.nih.gov/pubmed/18072727|https://doi.org/10.1021/jm701052u,18072727,10.1021/jm701052u,
6451,2012087,24742034,BindingDB,,20676,"(2S)-2-{[4-({2-amino-6-methyl-4-oxo-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-5-yl}methyl)phenyl]formamido}pentanedioic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20676,1876,Dihydrofolate reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1876,P0ABQ4,Dihydrofolate reductase,944790.0,folA,83333.0,Escherichia coli K-12,,IC50 (nM),>23000,PMID:18072727|DOI:10.1021/jm701052u,https://www.ncbi.nlm.nih.gov/pubmed/18072727|https://doi.org/10.1021/jm701052u,18072727,10.1021/jm701052u,
6452,2012088,24742034,BindingDB,,20676,"(2S)-2-{[4-({2-amino-6-methyl-4-oxo-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-5-yl}methyl)phenyl]formamido}pentanedioic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20676,1875,Dihydrofolate reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1875,P00374,Dihydrofolate reductase,1719.0,DHFR,9606.0,Homo sapiens (human),,IC50 (nM),120,PMID:18072727|DOI:10.1021/jm701052u,https://www.ncbi.nlm.nih.gov/pubmed/18072727|https://doi.org/10.1021/jm701052u,18072727,10.1021/jm701052u,
6453,2012089,24742034,BindingDB,,20676,"(2S)-2-{[4-({2-amino-6-methyl-4-oxo-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-5-yl}methyl)phenyl]formamido}pentanedioic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20676,9977,Bifunctional dihydrofolate reductase-thymidylate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9977,Q07422,Bifunctional dihydrofolate reductase-thymidylate synthase,,,5811.0,Toxoplasma gondii,,IC50 (nM),230,PMID:18072727|DOI:10.1021/jm701052u,https://www.ncbi.nlm.nih.gov/pubmed/18072727|https://doi.org/10.1021/jm701052u,18072727,10.1021/jm701052u,
6454,2028348,24743936,Drug Gene Interaction database (DGIdb),Encukalner,,ENCUKALNER,https://www.dgidb.org/drugs/chembl:CHEMBL5095264,,KCNQ3,https://www.dgidb.org/genes/hgnc:6297,,,3786.0,KCNQ3,9606.0,Homo sapiens (human),,,,,,,,
6455,2012090,24744027,Therapeutic Target Database (TTD),1-(4-(3-Cyclopropyl-5-(trifluoromethyl)phenylsulfonyl)piperazin-1-yl)-2-(4-(trifluoromethyl)phenyl)ethanone,D0O4RN,Sulfonylated piperazine derivative 5,https://idrblab.net/ttd/data/drug/details/D0O4RN,T76685,Cannabinoid receptor 1 (CB1),https://idrblab.net/ttd/data/target/details/T76685,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
6456,2028349,24747025,Drug Gene Interaction database (DGIdb),2-[3-(2-Hydroxy-ethyl)-3H-benzothiazol-2-ylidenemethyl]-1-methyl-pyridinium,,CHEMBL:CHEMBL589711,https://www.dgidb.org/drugs/chembl:CHEMBL589711,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),,,,,,,,
6457,2028350,24747025,Drug Gene Interaction database (DGIdb),2-[3-(2-Hydroxy-ethyl)-3H-benzothiazol-2-ylidenemethyl]-1-methyl-pyridinium,,CHEMBL:CHEMBL589711,https://www.dgidb.org/drugs/chembl:CHEMBL589711,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
6458,2012091,24747118,Drug Gene Interaction database (DGIdb),1-(2-Hydroxy-ethyl)-2-(3-methyl-3H-benzothiazol-2-ylidenemethyl)-pyridinium,,CHEMBL:CHEMBL592588,https://www.dgidb.org/drugs/chembl:CHEMBL592588,,PABPC1,https://www.dgidb.org/genes/hgnc:8554,,,26986.0,PABPC1,9606.0,Homo sapiens (human),,,,,,,,
6459,2012092,24747118,Drug Gene Interaction database (DGIdb),1-(2-Hydroxy-ethyl)-2-(3-methyl-3H-benzothiazol-2-ylidenemethyl)-pyridinium,,CHEMBL:CHEMBL592588,https://www.dgidb.org/drugs/chembl:CHEMBL592588,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
6460,2028351,24747998,Drug Gene Interaction database (DGIdb),"1-Morpholin-4-yl-2,3-diphenyloctan-3-ol",,CHEMBL:CHEMBL606460,https://www.dgidb.org/drugs/chembl:CHEMBL606460,,ATM,https://www.dgidb.org/genes/hgnc:795,,,472.0,ATM,9606.0,Homo sapiens (human),,,,,,,,
6461,2012093,24748204,Therapeutic Target Database (TTD),MK-5108,D0J6AB,MK-5108,https://idrblab.net/ttd/data/drug/details/D0J6AB,T46781,Aurora kinase B (AURKB),https://idrblab.net/ttd/data/target/details/T46781,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6462,2012094,24748204,Therapeutic Target Database (TTD),MK-5108,D0J6AB,MK-5108,https://idrblab.net/ttd/data/drug/details/D0J6AB,T87675,Aurora kinase A (AURKA),https://idrblab.net/ttd/data/target/details/T87675,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6463,2028352,24748204,Drug Gene Interaction database (DGIdb),MK-5108,,AURORA A KINASE INHIBITOR MK5108,https://www.dgidb.org/drugs/ncit:C90585,,AURKA,https://www.dgidb.org/genes/hgnc:11393,,,6790.0,AURKA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6464,2012095,24748573,Therapeutic Target Database (TTD),Silmitasertib,D09JEJ,CX-4945,https://idrblab.net/ttd/data/drug/details/D09JEJ,T51565,Casein kinase II alpha (CSNK2A1),https://idrblab.net/ttd/data/target/details/T51565,P68400,Casein kinase II subunit alpha,1457.0,CSNK2A1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6465,2028353,24748573,IUPHAR/BPS Guide to PHARMACOLOGY,Silmitasertib,8126,silmitasertib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8126,2035,homeodomain interacting protein kinase 3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2035,Q9H422,Homeodomain-interacting protein kinase 3,10114.0,HIPK3,9606.0,Homo sapiens (human),Inhibition,pIC50,7.35,PMID:21174434,https://www.ncbi.nlm.nih.gov/pubmed/21174434,21174434,,
6466,2028356,24756910,IUPHAR/BPS Guide to PHARMACOLOGY,Cudc-101,8894,CUDC-101,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8894,2019,erb-b2 receptor tyrosine kinase 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2019,P04626,Receptor tyrosine-protein kinase erbB-2,2064.0,ERBB2,9606.0,Homo sapiens (human),Inhibition,pIC50,7.8,PMID:20143778,https://www.ncbi.nlm.nih.gov/pubmed/20143778,20143778,,
6467,2028357,24759786,Therapeutic Target Database (TTD),"2-Benzoxazolamine, N-(4-ethylphenyl)-5-methyl-",D07XMM,N-(4-Ethylphenyl)-5-methylbenzo[d]oxazol-2-amine,https://idrblab.net/ttd/data/drug/details/D07XMM,T00140,Arachidonate 5-lipoxygenase (5-LOX),https://idrblab.net/ttd/data/target/details/T00140,P09917,Polyunsaturated fatty acid 5-lipoxygenase,240.0,ALOX5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6468,2028358,24761507,Drug Gene Interaction database (DGIdb),"2-[(Z)-(3,5-dimethyl-1,3-benzothiazol-2(3H)-ylidene)methyl]-1-(2-hydroxyethyl)pyridinium",,CHEMBL:CHEMBL590672,https://www.dgidb.org/drugs/chembl:CHEMBL590672,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
6469,2028359,24762154,Therapeutic Target Database (TTD),Isopropyl dodecylfluorophosphonate,D0HQ4M,Isopropyl dodecylfluorophosphonate,https://idrblab.net/ttd/data/drug/details/D0HQ4M,T76685,Cannabinoid receptor 1 (CB1),https://idrblab.net/ttd/data/target/details/T76685,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6470,2028360,24762154,Therapeutic Target Database (TTD),Isopropyl dodecylfluorophosphonate,D0HQ4M,Isopropyl dodecylfluorophosphonate,https://idrblab.net/ttd/data/drug/details/D0HQ4M,T30082,Acetylcholinesterase (AChE),https://idrblab.net/ttd/data/target/details/T30082,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6471,2028361,24765037,IUPHAR/BPS Guide to PHARMACOLOGY,Pexmetinib,9917,pexmetinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9917,2026,"FYN proto-oncogene, Src family tyrosine kinase",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2026,P06241,Tyrosine-protein kinase Fyn,2534.0,FYN,9606.0,Homo sapiens (human),Inhibition,pIC50,7.39,PMID:27287719,https://www.ncbi.nlm.nih.gov/pubmed/27287719,27287719,,
6472,2028362,24765037,IUPHAR/BPS Guide to PHARMACOLOGY,Pexmetinib,9917,pexmetinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9917,2032,"HCK proto-oncogene, Src family tyrosine kinase",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2032,P08631,Tyrosine-protein kinase HCK,3055.0,HCK,9606.0,Homo sapiens (human),Inhibition,pIC50,7.59,PMID:27287719,https://www.ncbi.nlm.nih.gov/pubmed/27287719,27287719,,
6473,2028363,24765037,IUPHAR/BPS Guide to PHARMACOLOGY,Pexmetinib,9917,pexmetinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9917,2060,"LYN proto-oncogene, Src family tyrosine kinase",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2060,P07948,Tyrosine-protein kinase Lyn,4067.0,LYN,9606.0,Homo sapiens (human),Inhibition,pIC50,7.6,PMID:27287719,https://www.ncbi.nlm.nih.gov/pubmed/27287719,27287719,,
6474,2028364,24765037,IUPHAR/BPS Guide to PHARMACOLOGY,Pexmetinib,9917,pexmetinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9917,2103,misshapen like kinase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2103,Q8N4C8,Misshapen-like kinase 1,50488.0,MINK1,9606.0,Homo sapiens (human),Inhibition,pIC50,7.59,PMID:27287719,https://www.ncbi.nlm.nih.gov/pubmed/27287719,27287719,,
6475,2028365,24770153,BindingDB,2-Allyl-1-ethoxy-4-methoxybenzene (4b),234358,2-Allyl-1-ethoxy-4-methoxybenzene (4b),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=234358,10054,Seed linoleate 9S-lipoxygenase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10054,P09186,Seed linoleate 9S-lipoxygenase-3,547869.0,LOX3,3847.0,Glycine max (soybean),,Ki (nM),27180,PMID:20939767|DOI:10.3109/14756366.2010.495717,https://www.ncbi.nlm.nih.gov/pubmed/20939767|https://doi.org/10.3109/14756366.2010.495717,20939767,10.3109/14756366.2010.495717,
6476,2028366,24770514,Drug Gene Interaction database (DGIdb),"6,8-Bis(benzylthio)octanoic acid",,DEVIMISTAT,https://www.dgidb.org/drugs/ncit:C80039,,PDHA2,https://www.dgidb.org/genes/hgnc:8807,,,5161.0,PDHA2,9606.0,Homo sapiens (human),,,,,,,,
6477,2028367,24770514,Drug Gene Interaction database (DGIdb),"6,8-Bis(benzylthio)octanoic acid",,DEVIMISTAT,https://www.dgidb.org/drugs/ncit:C80039,,PDHA1,https://www.dgidb.org/genes/hgnc:8806,,,5160.0,PDHA1,9606.0,Homo sapiens (human),,,,,,,,
6478,2028368,24770788,BindingDB,2-Allyl-4-methoxy-1-propoxybenzene (4c),234359,2-Allyl-4-methoxy-1-propoxybenzene (4c),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=234359,10054,Seed linoleate 9S-lipoxygenase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10054,P09186,Seed linoleate 9S-lipoxygenase-3,547869.0,LOX3,3847.0,Glycine max (soybean),,Ki (nM),3880,PMID:20939767|DOI:10.3109/14756366.2010.495717,https://www.ncbi.nlm.nih.gov/pubmed/20939767|https://doi.org/10.3109/14756366.2010.495717,20939767,10.3109/14756366.2010.495717,
6479,2028369,24770791,BindingDB,2-Allyl-1-butoxy-4-methoxybenzene (4e),234361,2-Allyl-1-butoxy-4-methoxybenzene (4e),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=234361,10054,Seed linoleate 9S-lipoxygenase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10054,P09186,Seed linoleate 9S-lipoxygenase-3,547869.0,LOX3,3847.0,Glycine max (soybean),,Ki (nM),17160,PMID:20939767|DOI:10.3109/14756366.2010.495717,https://www.ncbi.nlm.nih.gov/pubmed/20939767|https://doi.org/10.3109/14756366.2010.495717,20939767,10.3109/14756366.2010.495717,
6480,2028370,24771867,Drug Gene Interaction database (DGIdb),Alisertib,,ALISERTIB,https://www.dgidb.org/drugs/ncit:C71717,,AURKA,https://www.dgidb.org/genes/hgnc:11393,,,6790.0,AURKA,9606.0,Homo sapiens (human),,,,,,,,
6481,2028371,24771867,Drug Gene Interaction database (DGIdb),Alisertib,,ALISERTIB,https://www.dgidb.org/drugs/ncit:C71717,,TNK2,https://www.dgidb.org/genes/hgnc:19297,,,10188.0,TNK2,9606.0,Homo sapiens (human),,,,,,,,
6482,2028372,24771867,Drug Gene Interaction database (DGIdb),Alisertib,,ALISERTIB,https://www.dgidb.org/drugs/ncit:C71717,,FGFR3,https://www.dgidb.org/genes/hgnc:3690,,,2261.0,FGFR3,9606.0,Homo sapiens (human),,,,,,,,
6483,2028373,24771867,Drug Gene Interaction database (DGIdb),Alisertib,,ALISERTIB,https://www.dgidb.org/drugs/ncit:C71717,,AURKA,https://www.dgidb.org/genes/hgnc:11393,,,6790.0,AURKA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6484,2028374,24771867,Drug Gene Interaction database (DGIdb),Alisertib,,ALISERTIB,https://www.dgidb.org/drugs/ncit:C71717,,EGFR,https://www.dgidb.org/genes/hgnc:3236,,,1956.0,EGFR,9606.0,Homo sapiens (human),,,,,,,,
6485,2028375,24771867,Drug Gene Interaction database (DGIdb),Alisertib,,ALISERTIB,https://www.dgidb.org/drugs/ncit:C71717,,LRRK2,https://www.dgidb.org/genes/hgnc:18618,,,120892.0,LRRK2,9606.0,Homo sapiens (human),,,,,,,,
6486,2028376,24771867,Drug Gene Interaction database (DGIdb),Alisertib,,ALISERTIB,https://www.dgidb.org/drugs/ncit:C71717,,SRC,https://www.dgidb.org/genes/hgnc:11283,,,6714.0,SRC,9606.0,Homo sapiens (human),,,,,,,,
6487,2028377,24776358,BindingDB,"2-ethyl-1-[(3R)-1-[(5-methoxy-1H-1,3-benzodiazol-2-yl)carbonyl]pyrrolidin-3-yl]-1H-1,3-benzodiazole",21709,"2-ethyl-1-[(3R)-1-[(5-methoxy-1H-1,3-benzodiazol-2-yl)carbonyl]pyrrolidin-3-yl]-1H-1,3-benzodiazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21709,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),4200,PMID:18370373|DOI:10.1021/jm800079s,https://www.ncbi.nlm.nih.gov/pubmed/18370373|https://doi.org/10.1021/jm800079s,18370373,10.1021/jm800079s,
6488,2028378,24776358,BindingDB,"2-ethyl-1-[(3R)-1-[(5-methoxy-1H-1,3-benzodiazol-2-yl)carbonyl]pyrrolidin-3-yl]-1H-1,3-benzodiazole",21709,"2-ethyl-1-[(3R)-1-[(5-methoxy-1H-1,3-benzodiazol-2-yl)carbonyl]pyrrolidin-3-yl]-1H-1,3-benzodiazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21709,2556,Histone deacetylase 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2556,Q9UBN7,Histone deacetylase 6,10013.0,HDAC6,9606.0,Homo sapiens (human),,IC50 (nM),970,PMID:18370373|DOI:10.1021/jm800079s,https://www.ncbi.nlm.nih.gov/pubmed/18370373|https://doi.org/10.1021/jm800079s,18370373,10.1021/jm800079s,
6489,2028379,24776358,BindingDB,"2-ethyl-1-[(3R)-1-[(5-methoxy-1H-1,3-benzodiazol-2-yl)carbonyl]pyrrolidin-3-yl]-1H-1,3-benzodiazole",21709,"2-ethyl-1-[(3R)-1-[(5-methoxy-1H-1,3-benzodiazol-2-yl)carbonyl]pyrrolidin-3-yl]-1H-1,3-benzodiazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21709,6108,Histone deacetylase 5,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6108,Q9UQL6,Histone deacetylase 5,10014.0,HDAC5,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:18370373|DOI:10.1021/jm800079s,https://www.ncbi.nlm.nih.gov/pubmed/18370373|https://doi.org/10.1021/jm800079s,18370373,10.1021/jm800079s,
6490,2028380,24776358,BindingDB,"2-ethyl-1-[(3R)-1-[(5-methoxy-1H-1,3-benzodiazol-2-yl)carbonyl]pyrrolidin-3-yl]-1H-1,3-benzodiazole",21709,"2-ethyl-1-[(3R)-1-[(5-methoxy-1H-1,3-benzodiazol-2-yl)carbonyl]pyrrolidin-3-yl]-1H-1,3-benzodiazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21709,2645,Histone deacetylase 7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2645,Q8WUI4,Histone deacetylase 7,51564.0,HDAC7,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:18370373|DOI:10.1021/jm800079s,https://www.ncbi.nlm.nih.gov/pubmed/18370373|https://doi.org/10.1021/jm800079s,18370373,10.1021/jm800079s,
6491,2028381,24779745,Drug Gene Interaction database (DGIdb),Sotrastaurin acetate,,SOTRASTAURIN ACETATE,https://www.dgidb.org/drugs/ncit:C80631,,PRKCA,https://www.dgidb.org/genes/hgnc:9393,,,5578.0,PRKCA,9606.0,Homo sapiens (human),,,,,,,,
6492,2028382,24780383,IUPHAR/BPS Guide to PHARMACOLOGY,"N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)pyridin-2-yl]-N-methyl-6-(trifluoromethyl)pyridine-3-carboxamide",5616,ATL802,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5616,21,A3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=21,Q61618,Adenosine receptor A3,,,10090.0,Mus musculus (house mouse),Antagonist,pKi,5,PMID:10737749,https://www.ncbi.nlm.nih.gov/pubmed/10737749,10737749,,
6493,2012210,24795069,Drug Gene Interaction database (DGIdb),Valbenazine,,VALBENAZINE,https://www.dgidb.org/drugs/rxcui:1918219,,CYP2D6,https://www.dgidb.org/genes/hgnc:2625,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),,,,,,,,
6494,2012214,24798764,ChEMBL,Lomibuvir,CHEMBL3039503,LOMIBUVIR,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3039503/,CHEMBL5375,Hepatitis C virus NS5B RNA-dependent RNA polymerase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL5375/,Q8JXU8,RNA-directed RNA polymerase ,,,11103.0,Hepacivirus C,Hepatitis C virus NS5B RNA-dependent RNA polymerase negative allosteric modulator,,,PMID:28621755|PMID:24462692,https://www.ncbi.nlm.nih.gov/pubmed/28621755|https://www.ncbi.nlm.nih.gov/pubmed/24462692,28621755|24462692,,
6495,2012213,24801487,Therapeutic Target Database (TTD),Donepezil Fumarate,D0M7AU,N-methyl-Pip-F-homoF-vinyl sulfonyl phenyl (N-methyl-Pip-F-hF-VS phi),https://idrblab.net/ttd/data/drug/details/D0M7AU,T79062,5-HT 7 receptor (HTR7),https://idrblab.net/ttd/data/target/details/T79062,P34969,5-hydroxytryptamine receptor 7,3363.0,HTR7,9606.0,Homo sapiens (human),Antagonist,,,,,,,
6496,2012212,24811473,BindingDB,(2E)-3-(3-{6-[(4-hydroxycyclohexyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,28419,(2E)-3-(3-{6-[(4-hydroxycyclohexyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28419,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),265,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6497,2012211,24811474,BindingDB,Pim-IN-2,28416,(2E)-3-(3-{6-[(piperidin-4-ylmethyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28416,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),25,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6498,2012215,24811585,BindingDB,(2E)-3-(3-{6-[(4-aminobutyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,28395,(2E)-3-(3-{6-[(4-aminobutyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28395,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),22,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6499,2012217,24811585,BindingDB,(2E)-3-(3-{6-[(4-aminobutyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,28395,(2E)-3-(3-{6-[(4-aminobutyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28395,20,Serine/threonine-protein kinase pim-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=20,P11309,Serine/threonine-protein kinase pim-1,5292.0,PIM1,9606.0,Homo sapiens (human),,IC50 (nM),33,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6500,2012234,24811587,BindingDB,(2E)-3-[3-(6-{[3-(dimethylamino)propyl]amino}pyrazin-2-yl)phenyl]prop-2-enoic acid,28412,(2E)-3-[3-(6-{[3-(dimethylamino)propyl]amino}pyrazin-2-yl)phenyl]prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28412,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),94,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6501,2012237,24811590,BindingDB,(2E)-3-(3-{6-[(2-aminoethyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,28410,(2E)-3-(3-{6-[(2-aminoethyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28410,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),140,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6502,2012216,24811592,BindingDB,(2E)-3-(3-{6-[(3-aminopropyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,28411,(2E)-3-(3-{6-[(3-aminopropyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28411,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),27,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6503,2012238,24811687,BindingDB,(2E)-3-[3-(6-{[3-(dimethylamino)propyl](methyl)amino}pyrazin-2-yl)phenyl]prop-2-enoic acid,28413,(2E)-3-[3-(6-{[3-(dimethylamino)propyl](methyl)amino}pyrazin-2-yl)phenyl]prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28413,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),370,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6504,2012235,24811691,BindingDB,(2E)-3-(3-{6-[(3-methoxypropyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,28396,(2E)-3-(3-{6-[(3-methoxypropyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28396,20,Serine/threonine-protein kinase pim-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=20,P11309,Serine/threonine-protein kinase pim-1,5292.0,PIM1,9606.0,Homo sapiens (human),,IC50 (nM),370,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6505,2012239,24811691,BindingDB,(2E)-3-(3-{6-[(3-methoxypropyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,28396,(2E)-3-(3-{6-[(3-methoxypropyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28396,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),480,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6506,2012236,24811692,BindingDB,(2E)-3-(3-{6-[(3-hydroxypropyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,28415,(2E)-3-(3-{6-[(3-hydroxypropyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28415,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),310,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6507,2012278,24811792,BindingDB,(2E)-3-(3-{6-[(2-acetamidoethyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,28414,(2E)-3-(3-{6-[(2-acetamidoethyl)amino]pyrazin-2-yl}phenyl)prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28414,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),1020,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6508,2012279,24811793,BindingDB,(2E)-3-(3-{6-[4-(aminomethyl)piperidin-1-yl]pyrazin-2-yl}phenyl)prop-2-enoic acid,28417,(2E)-3-(3-{6-[4-(aminomethyl)piperidin-1-yl]pyrazin-2-yl}phenyl)prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28417,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),17,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6509,2012240,24811794,BindingDB,"(2e)-3-{3-[6-(4-Methyl-1,4-Diazepan-1-Yl)pyrazin-2-Yl]phenyl}prop-2-Enoic Acid",28394,"(2E)-3-{3-[6-(4-methyl-1,4-diazepan-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28394,20,Serine/threonine-protein kinase pim-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=20,P11309,Serine/threonine-protein kinase pim-1,5292.0,PIM1,9606.0,Homo sapiens (human),,IC50 (nM),57,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6510,2012277,24811794,BindingDB,"(2e)-3-{3-[6-(4-Methyl-1,4-Diazepan-1-Yl)pyrazin-2-Yl]phenyl}prop-2-Enoic Acid",28394,"(2E)-3-{3-[6-(4-methyl-1,4-diazepan-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28394,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),40,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6511,2012275,24811797,BindingDB,"(2E)-3-{3-[6-(1,4-diazepan-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid",28404,"(2E)-3-{3-[6-(1,4-diazepan-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28404,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),10,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6512,2012276,24811798,BindingDB,(2E)-3-{3-[6-(4-methylpiperazin-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid,28407,(2E)-3-{3-[6-(4-methylpiperazin-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28407,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),150,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6513,2012280,24811902,BindingDB,(2E)-3-{3-[6-(piperazin-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid,28408,(2E)-3-{3-[6-(piperazin-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28408,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),200,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6514,2012281,24811905,BindingDB,"(2E)-3-{3-[6-(4-acetyl-1,4-diazepan-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid",28406,"(2E)-3-{3-[6-(4-acetyl-1,4-diazepan-1-yl)pyrazin-2-yl]phenyl}prop-2-enoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28406,3422,Serine/threonine-protein kinase pim-2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3422,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),,IC50 (nM),880,PMID:19256503|DOI:10.1021/jm801242y,https://www.ncbi.nlm.nih.gov/pubmed/19256503|https://doi.org/10.1021/jm801242y,19256503,10.1021/jm801242y,
6515,2027973,24944097,ChEMBL,Avibactam sodium,CHEMBL2107817,AVIBACTAM SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107817/,CHEMBL2364670,Bacterial beta-lactamase TEM,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364670/,P62593,Beta-lactamase TEM,84568456.0,,2.0,Bacteria (eubacteria),Bacterial beta-lactamase TEM inhibitor,,,,,,,
6516,2027983,24949401,BindingDB,(2R)-2-({5-bromo-4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}amino)-2-phenylethan-1-ol,24704,(2R)-2-({5-bromo-4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}amino)-2-phenylethan-1-ol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24704,3688,High affinity nerve growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3688,P04629,High affinity nerve growth factor receptor,4914.0,NTRK1,9606.0,Homo sapiens (human),,IC50 (nM),120,PMID:18646745|DOI:10.1021/jm800343j,https://www.ncbi.nlm.nih.gov/pubmed/18646745|https://doi.org/10.1021/jm800343j,18646745,10.1021/jm800343j,
6517,2027984,24950016,BindingDB,[2-(Adamantan-1-yl)ethyl]({2-[(7-chloroquinolin-4-yl)amino]ethyl})amine,24727,"4-Aminoquinoline, 17",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24727,2349,Botulinum neurotoxin type A2 [1-425],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2349,Q45894,Botulinum neurotoxin type A2,,,536232.0,Clostridium botulinum A2 str. Kyoto,,IC50 (nM),11810,PMID:18637666|DOI:10.1021/jm800737y,https://www.ncbi.nlm.nih.gov/pubmed/18637666|https://doi.org/10.1021/jm800737y,18637666,10.1021/jm800737y,
6518,2027985,24950181,BindingDB,[2-(Adamantan-1-yl)ethyl]({3-[(7-chloroquinolin-4-yl)amino]propyl})amine,24726,"4-Aminoquinoline, 18",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24726,2349,Botulinum neurotoxin type A2 [1-425],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2349,Q45894,Botulinum neurotoxin type A2,,,536232.0,Clostridium botulinum A2 str. Kyoto,,IC50 (nM),50100,PMID:18637666|DOI:10.1021/jm800737y,https://www.ncbi.nlm.nih.gov/pubmed/18637666|https://doi.org/10.1021/jm800737y,18637666,10.1021/jm800737y,
6519,2027986,24950183,BindingDB,(Adamantan-1-ylmethyl)({2-[(7-chloroquinolin-4-yl)amino]ethyl})amine,24725,(adamantan-1-ylmethyl)({2-[(7-chloroquinolin-4-yl)amino]ethyl})amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24725,2349,Botulinum neurotoxin type A2 [1-425],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2349,Q45894,Botulinum neurotoxin type A2,,,536232.0,Clostridium botulinum A2 str. Kyoto,,IC50 (nM),18920,PMID:18637666|DOI:10.1021/jm800737y,https://www.ncbi.nlm.nih.gov/pubmed/18637666|https://doi.org/10.1021/jm800737y,18637666,10.1021/jm800737y,
6520,2027987,24950184,BindingDB,(Adamantan-1-ylmethyl)({3-[(7-chloroquinolin-4-yl)amino]propyl})amine,24724,(adamantan-1-ylmethyl)({3-[(7-chloroquinolin-4-yl)amino]propyl})amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24724,2349,Botulinum neurotoxin type A2 [1-425],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2349,Q45894,Botulinum neurotoxin type A2,,,536232.0,Clostridium botulinum A2 str. Kyoto,,IC50 (nM),31980,PMID:18637666|DOI:10.1021/jm800737y,https://www.ncbi.nlm.nih.gov/pubmed/18637666|https://doi.org/10.1021/jm800737y,18637666,10.1021/jm800737y,
6521,2027988,24950848,BindingDB,,24720,"5-methyl-3,4,17-triazatetracyclo[8.7.0.0^{2,6}.0^{11,16}]heptadeca-1(10),2,5,11,13,15-hexaene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24720,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),22,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
6522,2027989,24950848,BindingDB,,24720,"5-methyl-3,4,17-triazatetracyclo[8.7.0.0^{2,6}.0^{11,16}]heptadeca-1(10),2,5,11,13,15-hexaene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24720,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),42,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
6523,2027990,24950849,BindingDB,,24717,"3,4,16-triazatetracyclo[7.7.0.0^{2,6}.0^{10,15}]hexadeca-1(9),2,5,10,12,14-hexaen-5-ylmethanol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24717,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),340,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
6524,2028296,24950850,BindingDB,,24722,"7,7,16-trimethyl-5,11,14,15-tetraazapentacyclo[10.8.0.0^{2,10}.0^{4,8}.0^{13,17}]icosa-1(12),2,4(8),9,13,16-hexaen-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24722,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),<2,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
6525,2028297,24950850,BindingDB,,24722,"7,7,16-trimethyl-5,11,14,15-tetraazapentacyclo[10.8.0.0^{2,10}.0^{4,8}.0^{13,17}]icosa-1(12),2,4(8),9,13,16-hexaen-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24722,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),2,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
6526,2028298,24951007,BindingDB,,24723,"5,5,16-trimethyl-7,11,14,15-tetraazapentacyclo[10.8.0.0^{2,10}.0^{4,8}.0^{13,17}]icosa-1(12),2,4(8),9,13,16-hexaen-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24723,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),72,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
6527,2028299,24951007,BindingDB,,24723,"5,5,16-trimethyl-7,11,14,15-tetraazapentacyclo[10.8.0.0^{2,10}.0^{4,8}.0^{13,17}]icosa-1(12),2,4(8),9,13,16-hexaen-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24723,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),86,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
6528,2028300,24951008,BindingDB,,24718,2-(5-Methyl-1H-pyrazol-3-yl)-1H-indole,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24718,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),510,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
6529,2028301,24951008,BindingDB,,24718,2-(5-Methyl-1H-pyrazol-3-yl)-1H-indole,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24718,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),1100,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
6530,2028302,24951009,BindingDB,,24714,"5-methyl-3,4,16-triazatetracyclo[7.7.0.0^{2,6}.0^{10,15}]hexadeca-1(9),2,5,10,12,14-hexaene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24714,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),51,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
6531,2028303,24951009,BindingDB,,24714,"5-methyl-3,4,16-triazatetracyclo[7.7.0.0^{2,6}.0^{10,15}]hexadeca-1(9),2,5,10,12,14-hexaene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24714,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),220,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
6532,2028325,24951010,BindingDB,,24715,"5-cyclopropyl-3,4,16-triazatetracyclo[7.7.0.0^{2,6}.0^{10,15}]hexadeca-1(9),2,5,10,12,14-hexaene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24715,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),110,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
6533,2028165,24957011,Therapeutic Target Database (TTD),"L-Glutamic acid, N-((((1S)-1-carboxy-5-((((4-iodophenyl)amino)carbonyl)amino)pentyl)amino)carbonyl)-",DA03JS,MIP-1095,https://idrblab.net/ttd/data/drug/details/DA03JS,T97071,Glutamate carboxypeptidase II (GCPII),https://idrblab.net/ttd/data/target/details/T97071,Q04609,Glutamate carboxypeptidase 2,2346.0,FOLH1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6534,2028326,24958200,Drug Gene Interaction database (DGIdb),Niraparib,,NIRAPARIB,https://www.dgidb.org/drugs/rxcui:1918231,,PARP1,https://www.dgidb.org/genes/hgnc:270,,,142.0,PARP1,9606.0,Homo sapiens (human),,,,,,,,
6535,2028327,24958200,Drug Gene Interaction database (DGIdb),Niraparib,,NIRAPARIB,https://www.dgidb.org/drugs/rxcui:1918231,,FANCA,https://www.dgidb.org/genes/hgnc:3582,,,2175.0,FANCA,9606.0,Homo sapiens (human),,,,,,,,
6536,2028328,24961094,Therapeutic Target Database (TTD),"N-cyclohexyl-3-[2-(3,4-dichlorophenyl)ethylamino]-N-[2-[2-(5-hydroxy-3-oxo-4H-1,4-benzoxazin-8-yl)ethylamino]ethyl]propanamide",D06ONB,AZ505,https://idrblab.net/ttd/data/drug/details/D06ONB,T15797,SET and MYND domain-containing protein 2 (SMYD2),https://idrblab.net/ttd/data/target/details/T15797,Q9NRG4,N-lysine methyltransferase SMYD2,56950.0,SMYD2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6537,2028329,24964172,BindingDB,"3-(2-Hydroxyethyl)-20-(pyridin-2-ylmethoxy)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",24954,"3-(2-hydroxyethyl)-20-(pyridin-2-ylmethoxy)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24954,50001795,Mitogen-activated protein kinase kinase kinase 11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001795,Q16584,Mitogen-activated protein kinase kinase kinase 11,4296.0,MAP3K11,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
6538,2028330,24964172,BindingDB,"3-(2-Hydroxyethyl)-20-(pyridin-2-ylmethoxy)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",24954,"3-(2-hydroxyethyl)-20-(pyridin-2-ylmethoxy)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24954,6817,Mitogen-activated protein kinase kinase kinase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6817,P80192,Mitogen-activated protein kinase kinase kinase 9,4293.0,MAP3K9,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
6539,2028331,24964173,BindingDB,"3-(2-Hydroxyethyl)-20-(2-methoxyethoxy)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",24955,"3-(2-hydroxyethyl)-20-(2-methoxyethoxy)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24955,50001795,Mitogen-activated protein kinase kinase kinase 11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001795,Q16584,Mitogen-activated protein kinase kinase kinase 11,4296.0,MAP3K11,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
6540,2028332,24964173,BindingDB,"3-(2-Hydroxyethyl)-20-(2-methoxyethoxy)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",24955,"3-(2-hydroxyethyl)-20-(2-methoxyethoxy)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24955,6817,Mitogen-activated protein kinase kinase kinase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6817,P80192,Mitogen-activated protein kinase kinase kinase 9,4293.0,MAP3K9,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
6541,2028413,24964174,BindingDB,"4-{[3-(2-Hydroxyethyl)-14-oxo-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-20-yl]oxy}butanenitrile",24959,"4-{[3-(2-hydroxyethyl)-14-oxo-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-20-yl]oxy}butanenitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24959,6817,Mitogen-activated protein kinase kinase kinase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6817,P80192,Mitogen-activated protein kinase kinase kinase 9,4293.0,MAP3K9,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
6542,2028414,24964174,BindingDB,"4-{[3-(2-Hydroxyethyl)-14-oxo-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-20-yl]oxy}butanenitrile",24959,"4-{[3-(2-hydroxyethyl)-14-oxo-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-20-yl]oxy}butanenitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24959,50001795,Mitogen-activated protein kinase kinase kinase 11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001795,Q16584,Mitogen-activated protein kinase kinase kinase 11,4296.0,MAP3K11,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
6543,2028415,24964536,BindingDB,"2-{[3-(2-Hydroxyethyl)-14-oxo-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-20-yl]oxy}acetonitrile",24958,"2-{[3-(2-hydroxyethyl)-14-oxo-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-20-yl]oxy}acetonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24958,50001795,Mitogen-activated protein kinase kinase kinase 11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001795,Q16584,Mitogen-activated protein kinase kinase kinase 11,4296.0,MAP3K11,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
6544,2028416,24964536,BindingDB,"2-{[3-(2-Hydroxyethyl)-14-oxo-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-20-yl]oxy}acetonitrile",24958,"2-{[3-(2-hydroxyethyl)-14-oxo-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-20-yl]oxy}acetonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24958,6817,Mitogen-activated protein kinase kinase kinase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6817,P80192,Mitogen-activated protein kinase kinase kinase 9,4293.0,MAP3K9,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
6545,2028417,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,9606.0,Homo sapiens (human),[mangostin co-treated with MK 2206] results in decreased expression of ACTA2 protein|mk 2206 results in decreased expression of ACTA2 protein,,,PMID:30502394,https://www.ncbi.nlm.nih.gov/pubmed/30502394,30502394,,
6546,2028418,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [radon results in increased expression of ACTA2 protein],,,PMID:32949624,https://www.ncbi.nlm.nih.gov/pubmed/32949624,32949624,,
6547,2028419,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [AGT protein modified form results in increased secretion of IL6 protein]|mk 2206 inhibits the reaction [AGT protein modified form results in increased secretion of TNF protein],,,PMID:30354818,https://www.ncbi.nlm.nih.gov/pubmed/30354818,30354818,,
6548,2028420,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),[mangostin co-treated with MK 2206] results in decreased phosphorylation of AKT1 protein,,,PMID:30502394,https://www.ncbi.nlm.nih.gov/pubmed/30502394,30502394,,
6549,2028421,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),MK 2206 results in increased phosphorylation of AKT1 protein|romidepsin inhibits the reaction [[mirdametinib co-treated with MK 2206] results in increased phosphorylation of AKT1 protein]|[mirdametinib co-treated with MK 2206] results in increased phosphorylation of AKT1 protein,,,PMID:27634878,https://www.ncbi.nlm.nih.gov/pubmed/27634878,27634878,,
6550,2028422,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [benzo(a)pyrene results in increased phosphorylation of AKT1 protein],,,PMID:24685774,https://www.ncbi.nlm.nih.gov/pubmed/24685774,24685774,,
6551,2028423,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [PNPLA2 protein results in increased phosphorylation of AKT1 protein],,,PMID:31476254,https://www.ncbi.nlm.nih.gov/pubmed/31476254,31476254,,
6552,2028424,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [TMED3 protein results in increased phosphorylation of AKT1 protein],,,PMID:34758370,https://www.ncbi.nlm.nih.gov/pubmed/34758370,34758370,,
6553,2028425,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),MK 2206 results in decreased phosphorylation of AKT1 protein,,,PMID:22885370|PMID:30502394|PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/22885370|https://www.ncbi.nlm.nih.gov/pubmed/30502394|https://www.ncbi.nlm.nih.gov/pubmed/31445927,22885370|30502394|31445927,,
6554,2028426,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),MK 2206 results in decreased phosphorylation of and results in decreased activity of AKT1 protein,,,PMID:27897231,https://www.ncbi.nlm.nih.gov/pubmed/27897231,27897231,,
6555,2028427,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),Icariin inhibits the reaction [MK 2206 results in decreased phosphorylation of AKT1 protein],,,PMID:35259346,https://www.ncbi.nlm.nih.gov/pubmed/35259346,35259346,,
6556,2028428,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),LEPR affects the reaction [MK 2206 results in decreased phosphorylation of AKT1 protein],,,PMID:22949526,https://www.ncbi.nlm.nih.gov/pubmed/22949526,22949526,,
6557,2028429,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),MK 2206 results in decreased phosphorylation of AKT1 protein,,,PMID:22949526|PMID:30723155|PMID:35259346,https://www.ncbi.nlm.nih.gov/pubmed/22949526|https://www.ncbi.nlm.nih.gov/pubmed/30723155|https://www.ncbi.nlm.nih.gov/pubmed/35259346,22949526|30723155|35259346,,
6558,2028430,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),MK 2206 inhibits the reaction [diethylhexyl phthalate results in increased phosphorylation of and results in increased expression of AKT1 protein],,,PMID:29669060,https://www.ncbi.nlm.nih.gov/pubmed/29669060,29669060,,
6559,2028431,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),MK 2206 inhibits the reaction [IGF1 protein inhibits the reaction [isoflurane results in decreased phosphorylation of AKT1 protein]],,,PMID:25597859,https://www.ncbi.nlm.nih.gov/pubmed/25597859,25597859,,
6560,2028432,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,84335,AKT1S1,https://ctdbase.org/detail.go?type=gene&acc=84335,,,84335.0,AKT1S1,9606.0,Homo sapiens (human),MK 2206 results in decreased phosphorylation of AKT1S1 protein|[sto 609 co-treated with MK 2206] results in decreased phosphorylation of AKT1S1 protein,,,PMID:28634229,https://www.ncbi.nlm.nih.gov/pubmed/28634229,28634229,,
6561,2028433,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [cadmium chloride results in increased expression of ATF4],,,PMID:24057571,https://www.ncbi.nlm.nih.gov/pubmed/24057571,24057571,,
6562,2028434,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,572,BAD,https://ctdbase.org/detail.go?type=gene&acc=572,,,572.0,BAD,10090.0,Mus musculus (house mouse),MK 2206 inhibits the reaction [dexamethasone results in increased phosphorylation of BAD protein],,,PMID:30878453,https://www.ncbi.nlm.nih.gov/pubmed/30878453,30878453,,
6563,2028435,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,572,BAD,https://ctdbase.org/detail.go?type=gene&acc=572,,,572.0,BAD,10116.0,Rattus norvegicus (Norway rat),[MK 2206 inhibits the reaction [lipopolysaccharides co-treated with TNF protein]] which results in increased expression of BAD protein,,,PMID:36049518,https://www.ncbi.nlm.nih.gov/pubmed/36049518,36049518,,
6564,2028436,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606.0,Homo sapiens (human),[romidepsin co-treated with mirdametinib co-treated with MK 2206] results in increased expression of BAK1 protein|[mirdametinib co-treated with MK 2206] results in increased expression of BAK1 protein|[romidepsin co-treated with MK 2206] results in increased expression of BAK1 protein,,,PMID:27634878,https://www.ncbi.nlm.nih.gov/pubmed/27634878,27634878,,
6565,2028437,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [estradiol results in decreased expression of BAX protein]|esr1 protein alternative form promotes the reaction [MK 2206 inhibits the reaction [estradiol results in decreased expression of BAX protein]],,,PMID:34724321,https://www.ncbi.nlm.nih.gov/pubmed/34724321,34724321,,
6566,2028438,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [estradiol results in increased expression of BCL2 protein]|esr1 protein alternative form promotes the reaction [MK 2206 inhibits the reaction [estradiol results in increased expression of BCL2 protein]],,,PMID:34724321,https://www.ncbi.nlm.nih.gov/pubmed/34724321,34724321,,
6567,2028439,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,10018,BCL2L11,https://ctdbase.org/detail.go?type=gene&acc=10018,,,10018.0,BCL2L11,9606.0,Homo sapiens (human),[mirdametinib co-treated with MK 2206] results in increased expression of BCL2L11 protein|[romidepsin co-treated with MK 2206] results in increased expression of BCL2L11 protein|[romidepsin co-treated with mirdametinib co-treated with MK 2206] results in increased expression of BCL2L11 protein,,,PMID:27634878,https://www.ncbi.nlm.nih.gov/pubmed/27634878,27634878,,
6568,2028440,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,637,BID,https://ctdbase.org/detail.go?type=gene&acc=637,,,637.0,BID,10090.0,Mus musculus (house mouse),[mirdametinib co-treated with MK 2206] results in increased expression of BID protein modified form|[mirdametinib co-treated with MK 2206] results in increased expression of BID mRNA,,,PMID:28691888,https://www.ncbi.nlm.nih.gov/pubmed/28691888,28691888,,
6569,2028441,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606.0,Homo sapiens (human),[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with MK 2206] results in increased ubiquitination of BIRC5 protein,,,PMID:36807944,https://www.ncbi.nlm.nih.gov/pubmed/36807944,36807944,,
6570,2028442,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [epirubicin results in increased expression of BIRC5 protein],,,PMID:35872041,https://www.ncbi.nlm.nih.gov/pubmed/35872041,35872041,,
6571,2028443,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),ESR1 protein alternative form promotes the reaction [MK 2206 inhibits the reaction [estradiol results in decreased cleavage of CASP3 protein]]|mk 2206 inhibits the reaction [estradiol results in decreased cleavage of CASP3 protein],,,PMID:34724321,https://www.ncbi.nlm.nih.gov/pubmed/34724321,34724321,,
6572,2028444,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),[MK 2206 co-treated with platycodin D] results in increased activity of CASP3 protein,,,PMID:27897231,https://www.ncbi.nlm.nih.gov/pubmed/27897231,27897231,,
6573,2028445,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [soot analog results in increased expression of CASP3 protein],,,PMID:30240709,https://www.ncbi.nlm.nih.gov/pubmed/30240709,30240709,,
6574,2028446,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),MK 2206 results in increased cleavage of CASP3 protein,,,PMID:22885370,https://www.ncbi.nlm.nih.gov/pubmed/22885370,22885370,,
6575,2028447,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),MK 2206 inhibits the reaction [dexamethasone results in increased cleavage of CASP3 protein],,,PMID:30878453,https://www.ncbi.nlm.nih.gov/pubmed/30878453,30878453,,
6576,2028448,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840.0,CASP7,9606.0,Homo sapiens (human),[MK 2206 co-treated with platycodin D] results in increased activity of CASP7 protein,,,PMID:27897231,https://www.ncbi.nlm.nih.gov/pubmed/27897231,27897231,,
6577,2028449,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [soot analog results in increased expression of CASP9 protein],,,PMID:30240709,https://www.ncbi.nlm.nih.gov/pubmed/30240709,30240709,,
6578,2028450,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,10116.0,Rattus norvegicus (Norway rat),[MK 2206 inhibits the reaction [lipopolysaccharides co-treated with TNF protein]] which results in increased expression of CASP9 protein,,,PMID:36049518,https://www.ncbi.nlm.nih.gov/pubmed/36049518,36049518,,
6579,2028451,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [cyanoginosin LR results in increased expression of CCND1 protein],,,PMID:36115647,https://www.ncbi.nlm.nih.gov/pubmed/36115647,36115647,,
6580,2028452,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,941,CD80,https://ctdbase.org/detail.go?type=gene&acc=941,,,941.0,CD80,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [RARRES2 protein results in increased expression of CD80 protein]|mk 2206 results in decreased expression of CD80 protein,,,PMID:34398343,https://www.ncbi.nlm.nih.gov/pubmed/34398343,34398343,,
6581,2028453,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,942,CD86,https://ctdbase.org/detail.go?type=gene&acc=942,,,942.0,CD86,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [RARRES2 protein results in increased expression of CD86 protein]|mk 2206 results in decreased expression of CD86 protein,,,PMID:34398343,https://www.ncbi.nlm.nih.gov/pubmed/34398343,34398343,,
6582,2028454,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [particulate matter results in decreased expression of CDH1 protein],,,PMID:32687961,https://www.ncbi.nlm.nih.gov/pubmed/32687961,32687961,,
6583,2028455,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [radon results in decreased expression of CDH1 protein],,,PMID:32949624,https://www.ncbi.nlm.nih.gov/pubmed/32949624,32949624,,
6584,2028456,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,10090.0,Mus musculus (house mouse),[MK 2206 co-treated with U 0126] results in increased expression of CDH1 mrna|mk 2206 results in increased expression of CDH1 mRNA,,,PMID:30723155,https://www.ncbi.nlm.nih.gov/pubmed/30723155,30723155,,
6585,2028457,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [radon results in increased expression of CDH2 protein],,,PMID:32949624,https://www.ncbi.nlm.nih.gov/pubmed/32949624,32949624,,
6586,2028458,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [RARRES2 protein results in increased expression of CEBPA protein]|mk 2206 results in decreased expression of CEBPA protein,,,PMID:34398343,https://www.ncbi.nlm.nih.gov/pubmed/34398343,34398343,,
6587,2028459,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,1052,CEBPD,https://ctdbase.org/detail.go?type=gene&acc=1052,,,1052.0,CEBPD,10090.0,Mus musculus (house mouse),MK 2206 inhibits the reaction [endrin results in increased expression of CEBPD mrna],,,PMID:34801515,https://www.ncbi.nlm.nih.gov/pubmed/34801515,34801515,,
6588,2028460,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10090.0,Mus musculus (house mouse),Icariin inhibits the reaction [MK 2206 results in decreased phosphorylation of CREB1 protein]|mk 2206 results in decreased phosphorylation of CREB1 protein,,,PMID:35259346,https://www.ncbi.nlm.nih.gov/pubmed/35259346,35259346,,
6589,2028461,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [FAM83A protein results in increased expression of CTNNB1 protein],,,PMID:34931434,https://www.ncbi.nlm.nih.gov/pubmed/34931434,34931434,,
6590,2028462,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [TMED3 protein results in increased expression of CTNNB1 protein],,,PMID:34758370,https://www.ncbi.nlm.nih.gov/pubmed/34758370,34758370,,
6591,2028463,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [particulate matter results in increased expression of CXCL8 mrna],,,PMID:32687961,https://www.ncbi.nlm.nih.gov/pubmed/32687961,32687961,,
6592,2028464,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10090.0,Mus musculus (house mouse),[MK 2206 co-treated with icariin] results in increased expression of CYP11A1 mrna|icariin inhibits the reaction [MK 2206 results in decreased expression of CYP11A1 protein]|mk 2206 results in decreased expression of CYP11A1 protein,,,PMID:35259346,https://www.ncbi.nlm.nih.gov/pubmed/35259346,35259346,,
6593,2028478,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,2321,FLT1,https://ctdbase.org/detail.go?type=gene&acc=2321,,,2321.0,FLT1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [RARRES2 protein results in increased expression of FLT1 protein modified form]|mk 2206 results in decreased expression of FLT1 protein modified form,,,PMID:34398343,https://www.ncbi.nlm.nih.gov/pubmed/34398343,34398343,,
6594,2028479,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [radon results in increased expression of FN1 protein],,,PMID:32949624,https://www.ncbi.nlm.nih.gov/pubmed/32949624,32949624,,
6595,2028480,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,10090.0,Mus musculus (house mouse),[MK 2206 co-treated with U 0126] results in decreased expression of FN1 mRNA,,,PMID:30723155,https://www.ncbi.nlm.nih.gov/pubmed/30723155,30723155,,
6596,2028481,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,10116.0,Rattus norvegicus (Norway rat),MK 2206 inhibits the reaction [diethylhexyl phthalate results in increased expression of FN1 protein],,,PMID:29669060,https://www.ncbi.nlm.nih.gov/pubmed/29669060,29669060,,
6597,2028482,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [cyanoginosin LR results in increased expression of and results in increased phosphorylation of GSK3B protein],,,PMID:36115647,https://www.ncbi.nlm.nih.gov/pubmed/36115647,36115647,,
6598,2028483,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [FAM83A protein results in increased phosphorylation of GSK3B protein],,,PMID:34931434,https://www.ncbi.nlm.nih.gov/pubmed/34931434,34931434,,
6599,2028484,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [TMED3 protein results in increased phosphorylation of GSK3B protein],,,PMID:34758370,https://www.ncbi.nlm.nih.gov/pubmed/34758370,34758370,,
6600,2028485,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116.0,Rattus norvegicus (Norway rat),MK 2206 inhibits the reaction [diethylhexyl phthalate results in increased phosphorylation of GSK3B protein],,,PMID:29669060,https://www.ncbi.nlm.nih.gov/pubmed/29669060,29669060,,
6601,2028486,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116.0,Rattus norvegicus (Norway rat),MK 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[oxygen deficiency co-treated with oxygen] results in decreased phosphorylation of GSK3B protein]],,,PMID:34351043,https://www.ncbi.nlm.nih.gov/pubmed/34351043,34351043,,
6602,2028487,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,111785,HSD3B,https://ctdbase.org/detail.go?type=gene&acc=111785,,,111785.0,Hsd3b,10090.0,Mus musculus (house mouse),MK 2206 results in decreased expression of HSD3B protein|mk 2206 results in decreased expression of HSD3B mrna|icariin inhibits the reaction [MK 2206 results in decreased expression of HSD3B protein]|icariin inhibits the reaction [MK 2206 results in decreased expression of HSD3B mrna],,,PMID:35259346,https://www.ncbi.nlm.nih.gov/pubmed/35259346,35259346,,
6603,2028488,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,10116.0,Rattus norvegicus (Norway rat),MK 2206 inhibits the reaction [IGF1 protein inhibits the reaction [isoflurane results in decreased phosphorylation of AKT1 protein]],,,PMID:25597859,https://www.ncbi.nlm.nih.gov/pubmed/25597859,25597859,,
6604,2028489,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,9606.0,Homo sapiens (human),MK 2206 results in increased secretion of IL10 protein|mk 2206 inhibits the reaction [RARRES2 protein results in decreased secretion of IL10 protein],,,PMID:34398343,https://www.ncbi.nlm.nih.gov/pubmed/34398343,34398343,,
6605,2028490,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3592,IL12A,https://ctdbase.org/detail.go?type=gene&acc=3592,,,3592.0,IL12A,9606.0,Homo sapiens (human),MK 2206 results in decreased secretion of [IL12A protein binds to IL12B protein]|mk 2206 inhibits the reaction [RARRES2 protein results in increased secretion of [IL12A protein binds to IL12B protein]],,,PMID:34398343,https://www.ncbi.nlm.nih.gov/pubmed/34398343,34398343,,
6606,2028491,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3593,IL12B,https://ctdbase.org/detail.go?type=gene&acc=3593,,,3593.0,IL12B,9606.0,Homo sapiens (human),MK 2206 results in decreased secretion of [IL12A protein binds to IL12B protein]|mk 2206 inhibits the reaction [RARRES2 protein results in increased secretion of [IL12A protein binds to IL12B protein]],,,PMID:34398343,https://www.ncbi.nlm.nih.gov/pubmed/34398343,34398343,,
6607,2028492,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [particulate matter results in increased expression of IL1B mrna],,,PMID:31018152|PMID:32687961,https://www.ncbi.nlm.nih.gov/pubmed/31018152|https://www.ncbi.nlm.nih.gov/pubmed/32687961,31018152|32687961,,
6608,2028493,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [particulate matter results in increased secretion of IL1B protein],,,PMID:31018152,https://www.ncbi.nlm.nih.gov/pubmed/31018152,31018152,,
6609,2028494,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),MK 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[oxygen deficiency co-treated with oxygen] results in increased expression of IL1B protein]],,,PMID:34351043,https://www.ncbi.nlm.nih.gov/pubmed/34351043,34351043,,
6610,2028495,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [AGT protein modified form results in increased secretion of IL6 protein],,,PMID:30354818,https://www.ncbi.nlm.nih.gov/pubmed/30354818,30354818,,
6611,2028496,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [particulate matter results in increased expression of IL6 mrna],,,PMID:32687961,https://www.ncbi.nlm.nih.gov/pubmed/32687961,32687961,,
6612,2028497,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [RARRES2 protein results in increased secretion of IL6 protein]|mk 2206 results in decreased secretion of IL6 protein,,,PMID:34398343,https://www.ncbi.nlm.nih.gov/pubmed/34398343,34398343,,
6613,2028498,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),MK 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[oxygen deficiency co-treated with oxygen] results in increased expression of IL6 protein]],,,PMID:34351043,https://www.ncbi.nlm.nih.gov/pubmed/34351043,34351043,,
6614,2028499,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),MK 2206 inhibits the reaction [INS1 protein results in increased phosphorylation of SLC12A3 protein],,,PMID:22949526,https://www.ncbi.nlm.nih.gov/pubmed/22949526,22949526,,
6615,2028515,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3394,IRF8,https://ctdbase.org/detail.go?type=gene&acc=3394,,,3394.0,IRF8,9606.0,Homo sapiens (human),MK 2206 results in decreased expression of IRF8 protein|mk 2206 inhibits the reaction [RARRES2 protein results in increased expression of IRF8 protein],,,PMID:34398343,https://www.ncbi.nlm.nih.gov/pubmed/34398343,34398343,,
6616,2028516,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3791,KDR,https://ctdbase.org/detail.go?type=gene&acc=3791,,,3791.0,KDR,10116.0,Rattus norvegicus (Norway rat),[MK 2206 inhibits the reaction [lipopolysaccharides co-treated with TNF protein]] which results in increased expression of KDR protein,,,PMID:36049518,https://www.ncbi.nlm.nih.gov/pubmed/36049518,36049518,,
6617,2028517,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,10090.0,Mus musculus (house mouse),"MK 2206 inhibits the reaction [8-(4-chlorophenylthio)-2'-O-methyladenosine-3',5'-monophosphate acetoxymethyl ester analog results in increased secretion of LEP protein]",,,PMID:27381457,https://www.ncbi.nlm.nih.gov/pubmed/27381457,27381457,,
6618,2028518,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,3953,LEPR,https://ctdbase.org/detail.go?type=gene&acc=3953,,,3953.0,LEPR,10090.0,Mus musculus (house mouse),LEPR affects the reaction [MK 2206 results in decreased phosphorylation of AKT1 protein],,,PMID:22949526,https://www.ncbi.nlm.nih.gov/pubmed/22949526,22949526,,
6619,2028519,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,9606.0,Homo sapiens (human),MK 2206 promotes the reaction [butein results in increased lipidation of MAP1LC3B protein],,,PMID:35130734,https://www.ncbi.nlm.nih.gov/pubmed/35130734,35130734,,
6620,2028520,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,4217,MAP3K5,https://ctdbase.org/detail.go?type=gene&acc=4217,,,4217.0,MAP3K5,9606.0,Homo sapiens (human),MK 2206 promotes the reaction [cadmium chloride results in increased expression of MAP3K5 protein],,,PMID:29444456,https://www.ncbi.nlm.nih.gov/pubmed/29444456,29444456,,
6621,2028521,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),[MK 2206 co-treated with mirdametinib] results in decreased phosphorylation of MAPK1 protein,,,PMID:27634878,https://www.ncbi.nlm.nih.gov/pubmed/27634878,27634878,,
6622,2028522,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090.0,Mus musculus (house mouse),MK 2206 results in decreased phosphorylation of MAPK1 protein|u 0126 promotes the reaction [MK 2206 results in decreased phosphorylation of MAPK1 protein],,,PMID:30723155,https://www.ncbi.nlm.nih.gov/pubmed/30723155,30723155,,
6623,2028523,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),[MK 2206 co-treated with mirdametinib] results in decreased phosphorylation of MAPK3 protein,,,PMID:27634878,https://www.ncbi.nlm.nih.gov/pubmed/27634878,27634878,,
6624,2028524,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),MK 2206 results in decreased phosphorylation of MAPK3 protein|u 0126 promotes the reaction [MK 2206 results in decreased phosphorylation of MAPK3 protein],,,PMID:30723155,https://www.ncbi.nlm.nih.gov/pubmed/30723155,30723155,,
6625,2028525,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,4170,MCL1,https://ctdbase.org/detail.go?type=gene&acc=4170,,,4170.0,MCL1,9606.0,Homo sapiens (human),[mirdametinib co-treated with MK 2206] results in increased expression of MCL1 protein|[romidepsin co-treated with mirdametinib co-treated with MK 2206] results in increased expression of MCL1 protein|[romidepsin co-treated with MK 2206] results in increased expression of MCL1 protein,,,PMID:27634878,https://www.ncbi.nlm.nih.gov/pubmed/27634878,27634878,,
6626,2028526,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [radon results in increased expression of MTOR protein modified form],,,PMID:32949624,https://www.ncbi.nlm.nih.gov/pubmed/32949624,32949624,,
6627,2028527,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,10090.0,Mus musculus (house mouse),MTOR gene mutant form promotes the reaction [MK 2206 results in decreased expression of RPS6 protein modified form],,,PMID:29384525,https://www.ncbi.nlm.nih.gov/pubmed/29384525,29384525,,
6628,2028528,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),MK 2206 inhibits the reaction [PHLDA3 protein inhibits the reaction [[oxygen deficiency co-treated with oxygen] results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein]],,,PMID:34351043,https://www.ncbi.nlm.nih.gov/pubmed/34351043,34351043,,
6629,2028529,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116.0,Rattus norvegicus (Norway rat),[MK 2206 inhibits the reaction [lipopolysaccharides co-treated with TNF protein]] which results in increased expression of NOS3 protein,,,PMID:36049518,https://www.ncbi.nlm.nih.gov/pubmed/36049518,36049518,,
6630,2028530,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),[mirdametinib co-treated with MK 2206] results in increased cleavage of PARP1 protein|romidepsin promotes the reaction [[mirdametinib co-treated with MK 2206] results in increased cleavage of PARP1 protein]|[romidepsin co-treated with MK 2206] results in increased cleavage of PARP1 protein,,,PMID:27634878,https://www.ncbi.nlm.nih.gov/pubmed/27634878,27634878,,
6631,2028531,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),MK 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[oxygen deficiency co-treated with oxygen] results in increased expression of TNF protein]],,,PMID:34351043,https://www.ncbi.nlm.nih.gov/pubmed/34351043,34351043,,
6632,2028532,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059.0,Trp53,10090.0,Mus musculus (house mouse),[mirdametinib co-treated with MK 2206] results in increased expression of and results in increased phosphorylation of TRP53 protein,,,PMID:28691888,https://www.ncbi.nlm.nih.gov/pubmed/28691888,28691888,,
6633,2028533,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),MK 2206 results in increased expression of VEGFA protein|mk 2206 inhibits the reaction [RARRES2 protein results in decreased expression of VEGFA protein],,,PMID:34398343,https://www.ncbi.nlm.nih.gov/pubmed/34398343,34398343,,
6634,2028534,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,23612,PHLDA3,https://ctdbase.org/detail.go?type=gene&acc=23612,,,23612.0,PHLDA3,10116.0,Rattus norvegicus (Norway rat),MK 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[oxygen deficiency co-treated with oxygen] results in increased expression of TNF protein]]|mk 2206 inhibits the reaction [PHLDA3 protein inhibits the reaction [[oxygen deficiency co-treated with oxygen] results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein]]|mk 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[oxygen deficiency co-treated with oxygen] results in increased expression of IL6 protein]]|mk 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[oxygen deficiency co-treated with oxygen] results in increased expression of IL1B protein]]|mk 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[oxygen deficiency co-treated with oxygen] results in decreased phosphorylation of GSK3B protein]],,,PMID:34351043,https://www.ncbi.nlm.nih.gov/pubmed/34351043,34351043,,
6635,2028535,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,57104,PNPLA2,https://ctdbase.org/detail.go?type=gene&acc=57104,,,57104.0,PNPLA2,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [PNPLA2 protein results in increased phosphorylation of AKT1 protein],,,PMID:31476254,https://www.ncbi.nlm.nih.gov/pubmed/31476254,31476254,,
6636,2028536,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),MK 2206 inhibits the reaction [endrin results in increased expression of PPARG mrna],,,PMID:34801515,https://www.ncbi.nlm.nih.gov/pubmed/34801515,34801515,,
6637,2028537,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [taurocholic acid results in increased expression of PTGS2 protein]|mk 2206 inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 protein],,,PMID:26518876,https://www.ncbi.nlm.nih.gov/pubmed/26518876,26518876,,
6638,2028538,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,5919,RARRES2,https://ctdbase.org/detail.go?type=gene&acc=5919,,,5919.0,RARRES2,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [RARRES2 protein results in increased expression of EDN1 protein]|mk 2206 inhibits the reaction [RARRES2 protein results in increased expression of IRF8 protein]|mk 2206 inhibits the reaction [RARRES2 protein results in increased expression of CEBPA protein]|mk 2206 inhibits the reaction [RARRES2 protein results in increased secretion of IL6 protein]|mk 2206 inhibits the reaction [RARRES2 protein results in increased expression of FLT1 protein modified form]|mk 2206 inhibits the reaction [RARRES2 protein results in decreased secretion of IL10 protein]|mk 2206 inhibits the reaction [RARRES2 protein results in increased expression of CD80 protein]|mk 2206 inhibits the reaction [RARRES2 protein results in decreased expression of EDNRB protein modified form]|mk 2206 inhibits the reaction [RARRES2 protein results in increased secretion of TNF protein]|mk 2206 inhibits the reaction [RARRES2 protein results in decreased expression of VEGFA protein]|mk 2206 inhibits the reaction [RARRES2 protein results in increased expression of CD86 protein]|mk 2206 inhibits the reaction [RARRES2 protein results in increased secretion of [IL12A protein binds to IL12B protein]],,,PMID:34398343,https://www.ncbi.nlm.nih.gov/pubmed/34398343,34398343,,
6639,2028539,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [particulate matter results in increased phosphorylation of RELA protein],,,PMID:32687961,https://www.ncbi.nlm.nih.gov/pubmed/32687961,32687961,,
6640,2028540,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194.0,RPS6,9606.0,Homo sapiens (human),MK 2206 results in decreased phosphorylation of RPS6 protein,,,PMID:22885370,https://www.ncbi.nlm.nih.gov/pubmed/22885370,22885370,,
6641,2028541,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194.0,RPS6,10090.0,Mus musculus (house mouse),MTOR gene mutant form promotes the reaction [MK 2206 results in decreased expression of RPS6 protein modified form]|mk 2206 results in decreased expression of RPS6 protein modified form,,,PMID:29384525,https://www.ncbi.nlm.nih.gov/pubmed/29384525,29384525,,
6642,2028554,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198.0,RPS6KB1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [epirubicin results in increased phosphorylation of RPS6KB1 protein],,,PMID:35872041,https://www.ncbi.nlm.nih.gov/pubmed/35872041,35872041,,
6643,2028555,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,6559,SLC12A3,https://ctdbase.org/detail.go?type=gene&acc=6559,,,6559.0,SLC12A3,10090.0,Mus musculus (house mouse),MK 2206 inhibits the reaction [INS1 protein results in increased phosphorylation of SLC12A3 protein],,,PMID:22949526,https://www.ncbi.nlm.nih.gov/pubmed/22949526,22949526,,
6644,2028556,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,6615,SNAI1,https://ctdbase.org/detail.go?type=gene&acc=6615,,,6615.0,SNAI1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [radon results in increased expression of SNAI1 protein],,,PMID:32949624,https://www.ncbi.nlm.nih.gov/pubmed/32949624,32949624,,
6645,2028557,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,6615,SNAI1,https://ctdbase.org/detail.go?type=gene&acc=6615,,,6615.0,SNAI1,10090.0,Mus musculus (house mouse),[U 0126 co-treated with MK 2206] results in decreased expression of SNAI1 mrna|mk 2206 results in decreased expression of SNAI1 mRNA,,,PMID:30723155,https://www.ncbi.nlm.nih.gov/pubmed/30723155,30723155,,
6646,2028558,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,6591,SNAI2,https://ctdbase.org/detail.go?type=gene&acc=6591,,,6591.0,SNAI2,10090.0,Mus musculus (house mouse),[U 0126 co-treated with MK 2206] results in decreased expression of SNAI2 mRNA,,,PMID:30723155,https://www.ncbi.nlm.nih.gov/pubmed/30723155,30723155,,
6647,2028559,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7068,THRB,https://ctdbase.org/detail.go?type=gene&acc=7068,,,7068.0,THRB,9606.0,Homo sapiens (human),MK 2206 binds to and results in increased activity of THRB protein,,,PMID:25752796,https://www.ncbi.nlm.nih.gov/pubmed/25752796,25752796,,
6648,2028560,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7082,TJP1,https://ctdbase.org/detail.go?type=gene&acc=7082,,,7082.0,TJP1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [particulate matter results in decreased expression of TJP1 protein],,,PMID:32687961,https://www.ncbi.nlm.nih.gov/pubmed/32687961,32687961,,
6649,2028561,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,23423,TMED3,https://ctdbase.org/detail.go?type=gene&acc=23423,,,23423.0,TMED3,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [TMED3 protein results in increased phosphorylation of GSK3B protein]|mk 2206 inhibits the reaction [TMED3 protein results in increased expression of CTNNB1 protein]|mk 2206 inhibits the reaction [TMED3 protein results in increased phosphorylation of AKT1 protein],,,PMID:34758370,https://www.ncbi.nlm.nih.gov/pubmed/34758370,34758370,,
6650,2028562,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [1-nitropyrene results in increased expression of TNF mrna]|mk 2206 inhibits the reaction [3-nitrofluoranthene results in increased expression of TNF mrna],,,PMID:28633978,https://www.ncbi.nlm.nih.gov/pubmed/28633978,28633978,,
6651,2028563,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [AGT protein modified form results in increased secretion of TNF protein],,,PMID:30354818,https://www.ncbi.nlm.nih.gov/pubmed/30354818,30354818,,
6652,2028564,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [particulate matter results in increased expression of TNF mrna],,,PMID:32687961,https://www.ncbi.nlm.nih.gov/pubmed/32687961,32687961,,
6653,2028565,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),MK 2206 results in decreased secretion of TNF protein|mk 2206 inhibits the reaction [RARRES2 protein results in increased secretion of TNF protein],,,PMID:34398343,https://www.ncbi.nlm.nih.gov/pubmed/34398343,34398343,,
6654,2028566,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),MK 2206 results in increased susceptibility to TNF protein,,,PMID:31445927,https://www.ncbi.nlm.nih.gov/pubmed/31445927,31445927,,
6655,2028567,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),[MK 2206 inhibits the reaction [lipopolysaccharides co-treated with TNF protein]] which results in increased expression of VEGFA protein|[mk 2206 inhibits the reaction [lipopolysaccharides co-treated with TNF protein]] which results in increased expression of CASP9 protein|[mk 2206 inhibits the reaction [lipopolysaccharides co-treated with TNF protein]] which results in increased expression of KDR protein|[mk 2206 inhibits the reaction [lipopolysaccharides co-treated with TNF protein]] which results in increased expression of BAD protein|[mk 2206 inhibits the reaction [lipopolysaccharides co-treated with TNF protein]] which results in increased expression of NOS3 protein|[mk 2206 inhibits the reaction [lipopolysaccharides co-treated with TNF protein]] which results in increased expression of FGF2 protein,,,PMID:36049518,https://www.ncbi.nlm.nih.gov/pubmed/36049518,36049518,,
6656,2028568,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10116.0,Rattus norvegicus (Norway rat),[MK 2206 inhibits the reaction [lipopolysaccharides co-treated with TNF protein]] which results in increased expression of VEGFA protein,,,PMID:36049518,https://www.ncbi.nlm.nih.gov/pubmed/36049518,36049518,,
6657,2028569,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [radon results in increased expression of VIM protein],,,PMID:32949624,https://www.ncbi.nlm.nih.gov/pubmed/32949624,32949624,,
6658,2028570,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,10116.0,Rattus norvegicus (Norway rat),MK 2206 inhibits the reaction [diethylhexyl phthalate results in increased expression of VIM protein],,,PMID:29669060,https://www.ncbi.nlm.nih.gov/pubmed/29669060,29669060,,
6659,2028571,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,7494,XBP1,https://ctdbase.org/detail.go?type=gene&acc=7494,,,7494.0,XBP1,9606.0,Homo sapiens (human),MK 2206 promotes the reaction [cadmium chloride results in increased expression of XBP1 protein alternative form],,,PMID:29444456,https://www.ncbi.nlm.nih.gov/pubmed/29444456,29444456,,
6660,2028572,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,6935,ZEB1,https://ctdbase.org/detail.go?type=gene&acc=6935,,,6935.0,ZEB1,10090.0,Mus musculus (house mouse),[U 0126 co-treated with MK 2206] results in increased expression of ZEB1 mrna|mk 2206 results in increased expression of ZEB1 mRNA,,,PMID:30723155,https://www.ncbi.nlm.nih.gov/pubmed/30723155,30723155,,
6661,2028638,24964624,Comparative Toxicogenomics Database (CTD),MK-2206,C548887,MK 2206,https://ctdbase.org/detail.go?type=chem&acc=C548887,9839,ZEB2,https://ctdbase.org/detail.go?type=gene&acc=9839,,,9839.0,ZEB2,10090.0,Mus musculus (house mouse),MK 2206 results in decreased expression of ZEB2 mrna|[u 0126 co-treated with MK 2206] results in decreased expression of ZEB2 mRNA,,,PMID:30723155,https://www.ncbi.nlm.nih.gov/pubmed/30723155,30723155,,
6662,2028639,24964624,Drug Gene Interaction database (DGIdb),MK-2206,,AKT INHIBITOR MK2206,https://www.dgidb.org/drugs/ncit:C90581,,FGFR2,https://www.dgidb.org/genes/hgnc:3689,,,2263.0,FGFR2,9606.0,Homo sapiens (human),,,,,,,,
6663,2028640,24964624,Drug Gene Interaction database (DGIdb),MK-2206,,AKT INHIBITOR MK2206,https://www.dgidb.org/drugs/ncit:C90581,,BRAF,https://www.dgidb.org/genes/hgnc:1097,,,673.0,BRAF,9606.0,Homo sapiens (human),,,,,,,,
6664,2028641,24965599,BindingDB,"20-(2-Hydroxyethoxy)-3-(2-hydroxyethyl)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",24957,"20-(2-hydroxyethoxy)-3-(2-hydroxyethyl)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24957,6817,Mitogen-activated protein kinase kinase kinase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6817,P80192,Mitogen-activated protein kinase kinase kinase 9,4293.0,MAP3K9,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
6665,2028642,24965599,BindingDB,"20-(2-Hydroxyethoxy)-3-(2-hydroxyethyl)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",24957,"20-(2-hydroxyethoxy)-3-(2-hydroxyethyl)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24957,50001795,Mitogen-activated protein kinase kinase kinase 11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001795,Q16584,Mitogen-activated protein kinase kinase kinase 11,4296.0,MAP3K11,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
6666,2028643,24965602,BindingDB,"20-(Cyclopropylmethoxy)-3-(2-hydroxyethyl)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-14-one",24951,"20-(cyclopropylmethoxy)-3-(2-hydroxyethyl)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-14-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24951,50001795,Mitogen-activated protein kinase kinase kinase 11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001795,Q16584,Mitogen-activated protein kinase kinase kinase 11,4296.0,MAP3K11,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
6667,2028644,24965602,BindingDB,"20-(Cyclopropylmethoxy)-3-(2-hydroxyethyl)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-14-one",24951,"20-(cyclopropylmethoxy)-3-(2-hydroxyethyl)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-14-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24951,6817,Mitogen-activated protein kinase kinase kinase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6817,P80192,Mitogen-activated protein kinase kinase kinase 9,4293.0,MAP3K9,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
6668,2028645,24965990,Drug Gene Interaction database (DGIdb),Suvorexant,,SUVOREXANT,https://www.dgidb.org/drugs/rxcui:1547099,,HCRTR2,https://www.dgidb.org/genes/hgnc:4849,,,3062.0,HCRTR2,9606.0,Homo sapiens (human),,,,,,,,
6669,2027972,24968535,Therapeutic Target Database (TTD),[9-[[4-(dimethylamino)phenyl]methyl]-9-azabicyclo[3.3.1]nonan-3-yl] N-(2-methoxy-5-methylphenyl)carbamate,D0N6JH,N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl-phenylcarbamate analog 3,https://idrblab.net/ttd/data/drug/details/D0N6JH,T45674,Sigma intracellular receptor 2 (TMEM97),https://idrblab.net/ttd/data/target/details/T45674,Q5BJF2,Sigma intracellular receptor 2,27346.0,TMEM97,9606.0,Homo sapiens (human),Ligand,,,,,,,
6670,2027963,24978544,Comparative Toxicogenomics Database (CTD),bis[1-(hydroxy-kO)-5-{[2-(2-methoxyethoxy)ethoxy]methyl}-2-(sulfanyl-kS)pyridiniumato(2-)]zinc,C568608,PCI 5002,https://ctdbase.org/detail.go?type=chem&acc=C568608,10717,AP4B1,https://ctdbase.org/detail.go?type=gene&acc=10717,,,10717.0,AP4B1,9606.0,Homo sapiens (human),[PCI 5002 co-treated with zinc] results in increased expression of AP4B1 mRNA,,,PMID:18593933,https://www.ncbi.nlm.nih.gov/pubmed/18593933,18593933,,
6671,2027964,24978544,Comparative Toxicogenomics Database (CTD),bis[1-(hydroxy-kO)-5-{[2-(2-methoxyethoxy)ethoxy]methyl}-2-(sulfanyl-kS)pyridiniumato(2-)]zinc,C568608,PCI 5002,https://ctdbase.org/detail.go?type=chem&acc=C568608,116984,ARAP2,https://ctdbase.org/detail.go?type=gene&acc=116984,,,116984.0,ARAP2,9606.0,Homo sapiens (human),[PCI 5002 co-treated with zinc] results in increased expression of ARAP2 mRNA,,,PMID:18593933,https://www.ncbi.nlm.nih.gov/pubmed/18593933,18593933,,
6672,2027965,24978544,Comparative Toxicogenomics Database (CTD),bis[1-(hydroxy-kO)-5-{[2-(2-methoxyethoxy)ethoxy]methyl}-2-(sulfanyl-kS)pyridiniumato(2-)]zinc,C568608,PCI 5002,https://ctdbase.org/detail.go?type=chem&acc=C568608,9907,AP5Z1,https://ctdbase.org/detail.go?type=gene&acc=9907,,,9907.0,AP5Z1,9606.0,Homo sapiens (human),[PCI 5002 co-treated with zinc] results in increased expression of AP5Z1 mRNA,,,PMID:18593933,https://www.ncbi.nlm.nih.gov/pubmed/18593933,18593933,,
6673,2011278,24986635,ChEMBL,4-(3-(4-(1-methyl-1H-pyrazol-5-yl)phenylthio)phenyl)-tetrahydro-2H-pyran-4-carboxamide,CHEMBL4297416,PF-4191834,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297416/,CHEMBL215,Arachidonate 5-lipoxygenase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL215/,P09917,Polyunsaturated fatty acid 5-lipoxygenase,240.0,ALOX5,9606.0,Homo sapiens (human),Arachidonate 5-lipoxygenase inhibitor,,,PMID:20378715,https://www.ncbi.nlm.nih.gov/pubmed/20378715,20378715,,
6674,2011279,24986824,ChEMBL,Aslan003,CHEMBL2263632,ASLAN-003,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2263632/,CHEMBL1966,Dihydroorotate dehydrogenase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1966/,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",1723.0,DHODH,9606.0,Homo sapiens (human),Dihydroorotate dehydrogenase inhibitor,,,PMID:33054053,https://www.ncbi.nlm.nih.gov/pubmed/33054053,33054053,,
6675,2027966,24987688,Drug Gene Interaction database (DGIdb),Volixibat,,VOLIXIBAT,https://www.dgidb.org/drugs/ncit:C152907,,SLC10A2,https://www.dgidb.org/genes/hgnc:10906,,,6555.0,SLC10A2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6676,2011280,24993189,Drug Gene Interaction database (DGIdb),"1H-Pyrazolo[4,3-h]quinazoline-3-carboxamide, 4,5-dihydro-8-[[2-methoxy-5-(4-methyl-1-piperazinyl)phenyl]amino]-1-methyl-",,NMS-1286937,https://www.dgidb.org/drugs/chembl:CHEMBL1094408,,PLK1,https://www.dgidb.org/genes/hgnc:9077,,,5347.0,PLK1,9606.0,Homo sapiens (human),,,,,,,,
6677,2027967,24995524,ChEMBL,Sns-314,CHEMBL482767,SNS-314,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL482767/,CHEMBL3430911,Serine/threonine-protein kinase Aurora,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3430911/,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),Serine/threonine-protein kinase aurora inhibitor,,,PMID:19649632|PMID:26345296,https://www.ncbi.nlm.nih.gov/pubmed/19649632|https://www.ncbi.nlm.nih.gov/pubmed/26345296,19649632|26345296,,
6678,2027968,24995524,ChEMBL,Sns-314,CHEMBL482767,SNS-314,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL482767/,CHEMBL3430911,Serine/threonine-protein kinase Aurora,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3430911/,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),Serine/threonine-protein kinase aurora inhibitor,,,PMID:19649632|PMID:26345296,https://www.ncbi.nlm.nih.gov/pubmed/19649632|https://www.ncbi.nlm.nih.gov/pubmed/26345296,19649632|26345296,,
6679,2027969,24995524,ChEMBL,Sns-314,CHEMBL482767,SNS-314,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL482767/,CHEMBL3430911,Serine/threonine-protein kinase Aurora,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3430911/,Q9UQB9,Aurora kinase C,6795.0,AURKC,9606.0,Homo sapiens (human),Serine/threonine-protein kinase aurora inhibitor,,,PMID:19649632|PMID:26345296,https://www.ncbi.nlm.nih.gov/pubmed/19649632|https://www.ncbi.nlm.nih.gov/pubmed/26345296,19649632|26345296,,
6680,2011281,24996872,ChEMBL,"3-Isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole",CHEMBL3187503,GSK-1292263,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3187503/,CHEMBL5652,Glucose-dependent insulinotropic receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL5652/,Q8TDV5,Glucose-dependent insulinotropic receptor,139760.0,GPR119,9606.0,Homo sapiens (human),Glucose-dependent insulinotropic receptor agonist,,,PMID:24699248,https://www.ncbi.nlm.nih.gov/pubmed/24699248,24699248,,
6681,2027970,24996872,Drug Gene Interaction database (DGIdb),"3-Isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole",,GSK-1292263,https://www.dgidb.org/drugs/chembl:CHEMBL3187503,,GPR119,https://www.dgidb.org/genes/hgnc:19060,,,139760.0,GPR119,9606.0,Homo sapiens (human),,,,,,,,
6682,2027971,24996872,Drug Gene Interaction database (DGIdb),"3-Isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole",,GSK-1292263,https://www.dgidb.org/drugs/drugbank:DB12627,,GPR119,https://www.dgidb.org/genes/hgnc:19060,,,139760.0,GPR119,9606.0,Homo sapiens (human),Agonist,,,,,,,
6683,2028166,25012898,Comparative Toxicogenomics Database (CTD),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,C561240,N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C561240,47,ACLY,https://ctdbase.org/detail.go?type=gene&acc=47,,,47.0,ACLY,9606.0,Homo sapiens (human),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide results in decreased expression of ACLY mRNA,,,PMID:21561152,https://www.ncbi.nlm.nih.gov/pubmed/21561152,21561152,,
6684,2028167,25012898,Comparative Toxicogenomics Database (CTD),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,C561240,N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C561240,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide results in decreased expression of HMGCR mRNA,,,PMID:21561152,https://www.ncbi.nlm.nih.gov/pubmed/21561152,21561152,,
6685,2028168,25012898,Comparative Toxicogenomics Database (CTD),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,C561240,N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C561240,3157,HMGCS1,https://ctdbase.org/detail.go?type=gene&acc=3157,,,3157.0,HMGCS1,9606.0,Homo sapiens (human),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide results in decreased expression of HMGCS1 mRNA,,,PMID:21561152,https://www.ncbi.nlm.nih.gov/pubmed/21561152,21561152,,
6686,2028169,25012898,Comparative Toxicogenomics Database (CTD),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,C561240,N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C561240,3422,IDI1,https://ctdbase.org/detail.go?type=gene&acc=3422,,,3422.0,IDI1,9606.0,Homo sapiens (human),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide results in decreased expression of IDI1 mRNA,,,PMID:21561152,https://www.ncbi.nlm.nih.gov/pubmed/21561152,21561152,,
6687,2028170,25012898,Comparative Toxicogenomics Database (CTD),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,C561240,N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C561240,3638,INSIG1,https://ctdbase.org/detail.go?type=gene&acc=3638,,,3638.0,INSIG1,9606.0,Homo sapiens (human),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide results in decreased expression of INSIG1 mRNA,,,PMID:21561152,https://www.ncbi.nlm.nih.gov/pubmed/21561152,21561152,,
6688,2028171,25012898,Comparative Toxicogenomics Database (CTD),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,C561240,N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C561240,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,9606.0,Homo sapiens (human),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide results in decreased expression of LDLR mRNA,,,PMID:21561152,https://www.ncbi.nlm.nih.gov/pubmed/21561152,21561152,,
6689,2028172,25012898,Comparative Toxicogenomics Database (CTD),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,C561240,N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C561240,4597,MVD,https://ctdbase.org/detail.go?type=gene&acc=4597,,,4597.0,MVD,9606.0,Homo sapiens (human),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide results in decreased expression of MVD mRNA,,,PMID:21561152,https://www.ncbi.nlm.nih.gov/pubmed/21561152,21561152,,
6690,2028173,25012898,Comparative Toxicogenomics Database (CTD),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,C561240,N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C561240,4598,MVK,https://ctdbase.org/detail.go?type=gene&acc=4598,,,4598.0,MVK,9606.0,Homo sapiens (human),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide results in decreased expression of MVK mRNA,,,PMID:21561152,https://www.ncbi.nlm.nih.gov/pubmed/21561152,21561152,,
6691,2028174,25012898,Comparative Toxicogenomics Database (CTD),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,C561240,N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C561240,6319,SCD,https://ctdbase.org/detail.go?type=gene&acc=6319,,,6319.0,SCD,9606.0,Homo sapiens (human),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide results in decreased expression of SCD mRNA,,,PMID:21561152,https://www.ncbi.nlm.nih.gov/pubmed/21561152,21561152,,
6692,2028175,25012898,Comparative Toxicogenomics Database (CTD),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,C561240,N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C561240,6721,SREBF2,https://ctdbase.org/detail.go?type=gene&acc=6721,,,6721.0,SREBF2,10029.0,Cricetulus griseus (Chinese hamster),N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide results in decreased cleavage of SREBF2 protein,,,PMID:21561152,https://www.ncbi.nlm.nih.gov/pubmed/21561152,21561152,,
6693,2028176,25014973,Drug Gene Interaction database (DGIdb),Hymenoic acid,,HYMENOIC ACID,https://www.dgidb.org/drugs/chembl:CHEMBL494213,,POLD1,https://www.dgidb.org/genes/hgnc:9175,,,5424.0,POLD1,9606.0,Homo sapiens (human),,,,,,,,
6694,2028177,25015312,Therapeutic Target Database (TTD),Triazole derivative 1,D01CCT,Triazole derivative 1,https://idrblab.net/ttd/data/drug/details/D01CCT,T05387,Tissue transglutaminase (TG2),https://idrblab.net/ttd/data/target/details/T05387,P21980,Protein-glutamine gamma-glutamyltransferase 2,7052.0,TGM2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6695,2011282,25021165,IUPHAR/BPS Guide to PHARMACOLOGY,"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",5207,JZL184,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5207,1399,monoacylglycerol lipase,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1399,Q99685,Monoglyceride lipase,11343.0,MGLL,9606.0,Homo sapiens (human),Inhibition,pIC50,8.1,PMID:19029917,https://www.ncbi.nlm.nih.gov/pubmed/19029917,19029917,,
6696,2011283,25021165,IUPHAR/BPS Guide to PHARMACOLOGY,"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",5207,JZL184,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5207,1399,monoacylglycerol lipase,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1399,Q99685,Monoglyceride lipase,11343.0,MGLL,9606.0,Homo sapiens (human),Irreversible inhibition,pIC50,8.4,PMID:22542104,https://www.ncbi.nlm.nih.gov/pubmed/22542104,22542104,,
6697,2028178,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0000267,Carbonic anhydrase 1,http://www.t3db.ca/biodb/bio_entities/BE0000267,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),"Cobalt inhibits carbonic anhydrases.(a38, A98)",,,PMID:18237030|PMID:12164389,https://www.ncbi.nlm.nih.gov/pubmed/18237030|https://www.ncbi.nlm.nih.gov/pubmed/12164389,18237030|12164389,,
6698,2028179,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0000322,Carbonic anhydrase 2,http://www.t3db.ca/biodb/bio_entities/BE0000322,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),"Cobalt inhibits carbonic anhydrases.(a38, A98)",,,PMID:18237030|PMID:12164389,https://www.ncbi.nlm.nih.gov/pubmed/18237030|https://www.ncbi.nlm.nih.gov/pubmed/12164389,18237030|12164389,,
6699,2028180,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0000535,Carbonic anhydrase 4,http://www.t3db.ca/biodb/bio_entities/BE0000535,P22748,Carbonic anhydrase 4,762.0,CA4,9606.0,Homo sapiens (human),"Cobalt inhibits carbonic anhydrases.(a38, A98)",,,PMID:18237030|PMID:12164389,https://www.ncbi.nlm.nih.gov/pubmed/18237030|https://www.ncbi.nlm.nih.gov/pubmed/12164389,18237030|12164389,,
6700,2028181,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0000130,Hemoglobin subunit alpha,http://www.t3db.ca/biodb/bio_entities/BE0000130,P69905,Hemoglobin subunit alpha,3040.0,HBA2,9606.0,Homo sapiens (human),"Nitrite causes the autocatalytic oxidation of oxyhemoglobin to hydrogen peroxide and methemoglobin. this elevation of methemoglobin levels is a condition known as methemoglobinemia, and is characterized by tissue hypoxia, as methemoglobin cannot bind oxygen. (A2450, L1613)",,,PMID:18203719,https://www.ncbi.nlm.nih.gov/pubmed/18203719,18203719,,
6701,2028182,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0000629,Hemoglobin subunit beta,http://www.t3db.ca/biodb/bio_entities/BE0000629,P68871,Hemoglobin subunit beta,3043.0,HBB,9606.0,Homo sapiens (human),"Nitrite causes the autocatalytic oxidation of oxyhemoglobin to hydrogen peroxide and methemoglobin. this elevation of methemoglobin levels is a condition known as methemoglobinemia, and is characterized by tissue hypoxia, as methemoglobin cannot bind oxygen. (A2450, L1613)",,,PMID:18203719,https://www.ncbi.nlm.nih.gov/pubmed/18203719,18203719,,
6702,2028183,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0004987,Hemoglobin subunit delta,http://www.t3db.ca/biodb/bio_entities/BE0004987,P02042,Hemoglobin subunit delta,3045.0,HBD,9606.0,Homo sapiens (human),"Nitrite causes the autocatalytic oxidation of oxyhemoglobin to hydrogen peroxide and methemoglobin. this elevation of methemoglobin levels is a condition known as methemoglobinemia, and is characterized by tissue hypoxia, as methemoglobin cannot bind oxygen. (A2450, L1613)",,,PMID:18203719,https://www.ncbi.nlm.nih.gov/pubmed/18203719,18203719,,
6703,2028184,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0004975,Hemoglobin subunit epsilon,http://www.t3db.ca/biodb/bio_entities/BE0004975,P02100,Hemoglobin subunit epsilon,3046.0,HBE1,9606.0,Homo sapiens (human),"Nitrite causes the autocatalytic oxidation of oxyhemoglobin to hydrogen peroxide and methemoglobin. this elevation of methemoglobin levels is a condition known as methemoglobinemia, and is characterized by tissue hypoxia, as methemoglobin cannot bind oxygen. (A2450, L1613)",,,PMID:18203719,https://www.ncbi.nlm.nih.gov/pubmed/18203719,18203719,,
6704,2028185,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0004556,Hemoglobin subunit gamma-1,http://www.t3db.ca/biodb/bio_entities/BE0004556,P69891,Hemoglobin subunit gamma-1,3047.0,HBG1,9606.0,Homo sapiens (human),"Nitrite causes the autocatalytic oxidation of oxyhemoglobin to hydrogen peroxide and methemoglobin. this elevation of methemoglobin levels is a condition known as methemoglobinemia, and is characterized by tissue hypoxia, as methemoglobin cannot bind oxygen. (A2450, L1613)",,,PMID:18203719,https://www.ncbi.nlm.nih.gov/pubmed/18203719,18203719,,
6705,2028186,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0004998,Hemoglobin subunit gamma-2,http://www.t3db.ca/biodb/bio_entities/BE0004998,P69892,Hemoglobin subunit gamma-2,3048.0,HBG2,9606.0,Homo sapiens (human),"Nitrite causes the autocatalytic oxidation of oxyhemoglobin to hydrogen peroxide and methemoglobin. this elevation of methemoglobin levels is a condition known as methemoglobinemia, and is characterized by tissue hypoxia, as methemoglobin cannot bind oxygen. (A2450, L1613)",,,PMID:18203719,https://www.ncbi.nlm.nih.gov/pubmed/18203719,18203719,,
6706,2028187,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0004986,Hemoglobin subunit mu,http://www.t3db.ca/biodb/bio_entities/BE0004986,Q6B0K9,Hemoglobin subunit mu,3042.0,HBM,9606.0,Homo sapiens (human),"Nitrite causes the autocatalytic oxidation of oxyhemoglobin to hydrogen peroxide and methemoglobin. this elevation of methemoglobin levels is a condition known as methemoglobinemia, and is characterized by tissue hypoxia, as methemoglobin cannot bind oxygen. (A2450, L1613)",,,PMID:18203719,https://www.ncbi.nlm.nih.gov/pubmed/18203719,18203719,,
6707,2028188,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005028,Hemoglobin subunit theta-1,http://www.t3db.ca/biodb/bio_entities/BE0005028,P09105,Hemoglobin subunit theta-1,3049.0,HBQ1,9606.0,Homo sapiens (human),"Nitrite causes the autocatalytic oxidation of oxyhemoglobin to hydrogen peroxide and methemoglobin. this elevation of methemoglobin levels is a condition known as methemoglobinemia, and is characterized by tissue hypoxia, as methemoglobin cannot bind oxygen. (A2450, L1613)",,,PMID:18203719,https://www.ncbi.nlm.nih.gov/pubmed/18203719,18203719,,
6708,2028189,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005021,Hemoglobin subunit zeta,http://www.t3db.ca/biodb/bio_entities/BE0005021,P02008,Hemoglobin subunit zeta,3050.0,HBZ,9606.0,Homo sapiens (human),"Nitrite causes the autocatalytic oxidation of oxyhemoglobin to hydrogen peroxide and methemoglobin. this elevation of methemoglobin levels is a condition known as methemoglobinemia, and is characterized by tissue hypoxia, as methemoglobin cannot bind oxygen. (A2450, L1613)",,,PMID:18203719,https://www.ncbi.nlm.nih.gov/pubmed/18203719,18203719,,
6709,2028190,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0000898,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000898,P22557,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",212.0,ALAS2,9606.0,Homo sapiens (human),Cobalt inhibits heme synthesis by preventing synthesis of 5-aminolaevulinate via inhibition of 5-aminolaevulinate synthase. (L22),,,,,,,
6710,2028191,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0000409,"5-aminolevulinate synthase, nonspecific, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000409,P13196,"5-aminolevulinate synthase, nonspecific, mitochondrial",211.0,ALAS1,9606.0,Homo sapiens (human),Cobalt inhibits heme synthesis by preventing synthesis of 5-aminolaevulinate via inhibition of 5-aminolaevulinate synthase. (L22),,,,,,,
6711,2028192,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005051,DNA repair protein complementing XP-A cells,http://www.t3db.ca/biodb/bio_entities/BE0005051,P23025,DNA repair protein complementing XP-A cells,7507.0,XPA,9606.0,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,
6712,2028193,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005097,Ig alpha-1 chain C region,http://www.t3db.ca/biodb/bio_entities/BE0005097,P01876,Immunoglobulin heavy constant alpha 1,,,9606.0,Homo sapiens (human),"Cobalt interacts with specific iga antibodies, resulting in immunosensitization. (A102)",,,PMID:6663071,https://www.ncbi.nlm.nih.gov/pubmed/6663071,6663071,,
6713,2028194,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0004610,Ig alpha-2 chain C region,http://www.t3db.ca/biodb/bio_entities/BE0004610,P01877,Immunoglobulin heavy constant alpha 2,,,9606.0,Homo sapiens (human),"Cobalt interacts with specific iga antibodies, resulting in immunosensitization. (A102)",,,PMID:6663071,https://www.ncbi.nlm.nih.gov/pubmed/6663071,6663071,,
6714,2028195,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0002867,Ig epsilon chain C region,http://www.t3db.ca/biodb/bio_entities/BE0002867,P01854,Immunoglobulin heavy constant epsilon,,,9606.0,Homo sapiens (human),"Cobalt interacts with specific ige antibodies, resulting in immunosensitization. (A101)",,,PMID:3233723,https://www.ncbi.nlm.nih.gov/pubmed/3233723,3233723,,
6715,2028196,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142.0,PARP1,9606.0,Homo sapiens (human),Cobalt inhibits DNA repair by interacting with zinc finger DNA repair proteins. (A103),,,PMID:12426134,https://www.ncbi.nlm.nih.gov/pubmed/12426134,12426134,,
6716,2028197,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,http://www.t3db.ca/biodb/bio_entities/BE0000430,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,775.0,CACNA1C,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6717,2028198,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,http://www.t3db.ca/biodb/bio_entities/BE0002359,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D ,776.0,CACNA1D,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6718,2028199,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,http://www.t3db.ca/biodb/bio_entities/BE0002357,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,778.0,CACNA1F,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6719,2028200,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,http://www.t3db.ca/biodb/bio_entities/BE0002355,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,779.0,CACNA1S,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6720,2028201,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,http://www.t3db.ca/biodb/bio_entities/BE0000303,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,782.0,CACNB1,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6721,2028202,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,http://www.t3db.ca/biodb/bio_entities/BE0002354,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,783.0,CACNB2,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6722,2028203,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0002358,Voltage-dependent L-type calcium channel subunit beta-3,http://www.t3db.ca/biodb/bio_entities/BE0002358,P54284,Voltage-dependent L-type calcium channel subunit beta-3,784.0,CACNB3,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6723,2028204,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0002356,Voltage-dependent L-type calcium channel subunit beta-4,http://www.t3db.ca/biodb/bio_entities/BE0002356,O00305,Voltage-dependent L-type calcium channel subunit beta-4,785.0,CACNB4,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6724,2028205,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,http://www.t3db.ca/biodb/bio_entities/BE0002226,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,774.0,CACNA1B,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6725,2028206,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0000356,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,http://www.t3db.ca/biodb/bio_entities/BE0000356,O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,773.0,CACNA1A,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6726,2028207,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005099,Voltage-dependent R-type calcium channel subunit alpha-1E,http://www.t3db.ca/biodb/bio_entities/BE0005099,Q15878,Voltage-dependent R-type calcium channel subunit alpha-1E,777.0,CACNA1E,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6727,2028217,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0000679,Voltage-dependent calcium channel gamma-1 subunit,http://www.t3db.ca/biodb/bio_entities/BE0000679,Q06432,Voltage-dependent calcium channel gamma-1 subunit,786.0,CACNG1,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6728,2028218,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005108,Voltage-dependent calcium channel gamma-2 subunit,http://www.t3db.ca/biodb/bio_entities/BE0005108,Q9Y698,Voltage-dependent calcium channel gamma-2 subunit,10369.0,CACNG2,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6729,2028219,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005105,Voltage-dependent calcium channel gamma-3 subunit,http://www.t3db.ca/biodb/bio_entities/BE0005105,O60359,Voltage-dependent calcium channel gamma-3 subunit,10368.0,CACNG3,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6730,2028220,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005110,Voltage-dependent calcium channel gamma-4 subunit,http://www.t3db.ca/biodb/bio_entities/BE0005110,Q9UBN1,Voltage-dependent calcium channel gamma-4 subunit,27092.0,CACNG4,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6731,2028221,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005109,Voltage-dependent calcium channel gamma-5 subunit,http://www.t3db.ca/biodb/bio_entities/BE0005109,Q9UF02,Voltage-dependent calcium channel gamma-5 subunit,27091.0,CACNG5,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6732,2028222,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005106,Voltage-dependent calcium channel gamma-6 subunit,http://www.t3db.ca/biodb/bio_entities/BE0005106,Q9BXT2,Voltage-dependent calcium channel gamma-6 subunit,59285.0,CACNG6,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6733,2028223,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005101,Voltage-dependent calcium channel gamma-7 subunit,http://www.t3db.ca/biodb/bio_entities/BE0005101,P62955,Voltage-dependent calcium channel gamma-7 subunit,59284.0,CACNG7,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6734,2028224,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005104,Voltage-dependent calcium channel gamma-8 subunit,http://www.t3db.ca/biodb/bio_entities/BE0005104,Q8WXS5,Voltage-dependent calcium channel gamma-8 subunit,59283.0,CACNG8,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6735,2028241,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005113,Voltage-dependent calcium channel gamma-like subunit,http://www.t3db.ca/biodb/bio_entities/BE0005113,Q8WXS4,Voltage-dependent calcium channel gamma-like subunit,140738.0,TMEM37,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6736,2028242,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,http://www.t3db.ca/biodb/bio_entities/BE0000691,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,781.0,CACNA2D1,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6737,2028243,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0002396,Voltage-dependent calcium channel subunit alpha-2/delta-2,http://www.t3db.ca/biodb/bio_entities/BE0002396,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,9254.0,CACNA2D2,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6738,2028244,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0003563,Voltage-dependent calcium channel subunit alpha-2/delta-3,http://www.t3db.ca/biodb/bio_entities/BE0003563,Q8IZS8,Voltage-dependent calcium channel subunit alpha-2/delta-3,55799.0,CACNA2D3,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6739,2028245,25022080,Toxin and Toxin Target Database (T3DB),Cobaltic potassium nitrite,T3D1399,Potassium cobaltinitrite,http://www.t3db.ca/toxins/T3D1399,BE0005100,Voltage-dependent calcium channel subunit alpha-2/delta-4,http://www.t3db.ca/biodb/bio_entities/BE0005100,Q7Z3S7,Voltage-dependent calcium channel subunit alpha-2/delta-4,93589.0,CACNA2D4,9606.0,Homo sapiens (human),"Cobalt blocks high-voltage-activated calcium channels, possibly impairing neurotransmission. (A100)",,,PMID:14724759,https://www.ncbi.nlm.nih.gov/pubmed/14724759,14724759,,
6740,2011284,25022668,IUPHAR/BPS Guide to PHARMACOLOGY,"2-cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",8040,GSK650394,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8040,1534,serum/glucocorticoid regulated kinase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1534,O00141,Serine/threonine-protein kinase Sgk1,6446.0,SGK1,9606.0,Homo sapiens (human),Inhibition,pIC50,7.21,PMID:18794135,https://www.ncbi.nlm.nih.gov/pubmed/18794135,18794135,,
6741,2011285,25022668,IUPHAR/BPS Guide to PHARMACOLOGY,"2-cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",8040,GSK650394,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8040,1535,serum/glucocorticoid regulated kinase 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1535,Q9HBY8,Serine/threonine-protein kinase Sgk2,10110.0,SGK2,9606.0,Homo sapiens (human),Inhibition,pIC50,6.99,PMID:18794135,https://www.ncbi.nlm.nih.gov/pubmed/18794135,18794135,,
6742,2011286,25023738,IUPHAR/BPS Guide to PHARMACOLOGY,"2-((3,5-difluoro-4-hydroxyphenyl)amino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one",8038,BI-D1870,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8038,1530,ribosomal protein S6 kinase A6,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1530,Q9UK32,Ribosomal protein S6 kinase alpha-6,27330.0,RPS6KA6,9606.0,Homo sapiens (human),Inhibition,pIC50,7.82,PMID:17040210,https://www.ncbi.nlm.nih.gov/pubmed/17040210,17040210,,
6743,2028143,25023738,Comparative Toxicogenomics Database (CTD),"2-((3,5-difluoro-4-hydroxyphenyl)amino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one",C516541,BI D1870,https://ctdbase.org/detail.go?type=chem&acc=C516541,6794,STK11,https://ctdbase.org/detail.go?type=gene&acc=6794,,,6794.0,STK11,9606.0,Homo sapiens (human),BI D1870 results in decreased phosphorylation of STK11 protein,,,PMID:21488662,https://www.ncbi.nlm.nih.gov/pubmed/21488662,21488662,,
6744,2028144,25023870,BindingDB,[2-(4-Octylpyridin-1-ium-1-yl)-1-phosphonoethyl]phosphonic acid,153359,BPH-717,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=153359,7044,Decaprenyl diphosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7044,P9WFF6,Decaprenyl diphosphate synthase,,,83331.0,Mycobacterium tuberculosis CDC1551,,IC50 (nM),1.13e+5,PMID:25352216|DOI:10.1111/cbdd.12463,https://www.ncbi.nlm.nih.gov/pubmed/25352216|https://doi.org/10.1111/cbdd.12463,25352216,10.1111/cbdd.12463,
6745,2028145,25023889,BindingDB,[2-(3-Dodecoxypyridin-1-ium-1-yl)-1-phosphonoethyl]phosphonic acid,153357,BPH-716,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=153357,7044,Decaprenyl diphosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7044,P9WFF6,Decaprenyl diphosphate synthase,,,83331.0,Mycobacterium tuberculosis CDC1551,,IC50 (nM),7.7e+4,PMID:25352216|DOI:10.1111/cbdd.12463,https://www.ncbi.nlm.nih.gov/pubmed/25352216|https://doi.org/10.1111/cbdd.12463,25352216,10.1111/cbdd.12463,
6746,2028146,25025505,Drug Gene Interaction database (DGIdb),4-((4-(1H-tetrazol-1-yl)phenoxy)methyl)-2-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)thiazole,,MBX-2982,https://www.dgidb.org/drugs/drugbank:DB12345,,GPR119,https://www.dgidb.org/genes/hgnc:19060,,,139760.0,GPR119,9606.0,Homo sapiens (human),,,,,,,,
6747,2028147,25027092,Therapeutic Target Database (TTD),"{[(2R,3S,4R,5R)-5-(6-ethyl-5-fluoro-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid",D0P7AS,5-Fluoro-6-ethyluridine-5'-O-monophosphate,https://idrblab.net/ttd/data/drug/details/D0P7AS,T15851,Orotidine 5'-monophosphate decarboxylase (UMPS),https://idrblab.net/ttd/data/target/details/T15851,P11172,Uridine 5'-monophosphate synthase,7372.0,UMPS,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6748,2028246,25031016,Therapeutic Target Database (TTD),"US8569313, Inhibitor 18",D0CN2Q,"US8569313, Inhibitor 18",https://idrblab.net/ttd/data/drug/details/D0CN2Q,T31543,Suppressor of tumorigenicity 14 protein (ST14),https://idrblab.net/ttd/data/target/details/T31543,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,6768.0,ST14,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6749,2028247,25031103,Therapeutic Target Database (TTD),"US8569313, Inhibitor 19",D0RN9V,"US8569313, Inhibitor 19",https://idrblab.net/ttd/data/drug/details/D0RN9V,T31543,Suppressor of tumorigenicity 14 protein (ST14),https://idrblab.net/ttd/data/target/details/T31543,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,6768.0,ST14,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6750,2028248,25031140,Therapeutic Target Database (TTD),"US9617250, Example 1 Example 204 of D1",D04NEO,"US9617250, Example 1 Example 204 of D1",https://idrblab.net/ttd/data/drug/details/D04NEO,T11241,Sphingosine-1-phosphate receptor 3 (S1PR3),https://idrblab.net/ttd/data/target/details/T11241,Q99500,Sphingosine 1-phosphate receptor 3,1903.0,S1PR3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6751,2028148,25031915,Drug Gene Interaction database (DGIdb),Lucitanib,,LUCITANIB,https://www.dgidb.org/drugs/ncit:C95726,,FLT4,https://www.dgidb.org/genes/hgnc:3767,,,2324.0,FLT4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6752,2028149,25031915,IUPHAR/BPS Guide to PHARMACOLOGY,Lucitanib,7649,lucitanib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7649,2185,ret proto-oncogene,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2185,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),Inhibition,pIC50,6.7,PMID:22304225,https://www.ncbi.nlm.nih.gov/pubmed/22304225,22304225,,
6753,2028249,25031915,Drug Gene Interaction database (DGIdb),Lucitanib,,LUCITANIB,https://www.dgidb.org/drugs/ncit:C95726,,KDR,https://www.dgidb.org/genes/hgnc:6307,,,3791.0,KDR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6754,2028150,25032059,Therapeutic Target Database (TTD),N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide,D04DOL,N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide,https://idrblab.net/ttd/data/drug/details/D04DOL,T68547,Histone deacetylase 1 (HDAC1),https://idrblab.net/ttd/data/target/details/T68547,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6755,2028151,25032059,Therapeutic Target Database (TTD),N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide,D04DOL,N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide,https://idrblab.net/ttd/data/drug/details/D04DOL,T22274,Histone deacetylase 6 (HDAC6),https://idrblab.net/ttd/data/target/details/T22274,Q9UBN7,Histone deacetylase 6,10013.0,HDAC6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6756,2028250,25032613,BindingDB,"(2R)-2-[(4-chlorobenzene)(2,5-dichlorophenyl)sulfonamido]propyl N-ethyl-N-[3-(1H-imidazol-1-yl)propyl]carbamate",29011,"(2R)-2-[(4-chlorobenzene)(2,5-dichlorophenyl)sulfonamido]propyl N-ethyl-N-[3-(1H-imidazol-1-yl)propyl]carbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=29011,277,Gamma-secretase subunit APH-1A/Gamma-secretase subunit PEN-2/Nicastrin [34-709]/Presenilin-1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=277,P49768,Presenilin-1,5663.0,PSEN1,9606.0,Homo sapiens (human),,,,PMID:18178084|DOI:10.1016/j.bmcl.2007.11.102,https://www.ncbi.nlm.nih.gov/pubmed/18178084|https://doi.org/10.1016/j.bmcl.2007.11.102,18178084,10.1016/j.bmcl.2007.11.102,
6757,2028152,25034343,Therapeutic Target Database (TTD),6-(4-Methylpyridin-3-yl)-2-naphthonitrile,D0Q3CX,6-(4-Methylpyridin-3-yl)-2-naphthonitrile,https://idrblab.net/ttd/data/drug/details/D0Q3CX,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6758,2028153,25034344,Therapeutic Target Database (TTD),5-(6-Methoxynaphthalen-2-yl)pyridin-3-ol,D02JUJ,5-(6-Methoxynaphthalen-2-yl)pyridin-3-ol,https://idrblab.net/ttd/data/drug/details/D02JUJ,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6759,2028609,25034346,Therapeutic Target Database (TTD),3-Ethoxy-5-(6-methoxynaphthalen-2-yl)pyridine,D0Y3AV,3-Ethoxy-5-(6-methoxynaphthalen-2-yl)pyridine,https://idrblab.net/ttd/data/drug/details/D0Y3AV,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6760,2028610,25034426,Therapeutic Target Database (TTD),3-(6-Methoxynaphthalen-2-yl)-5-phenylpyridine,D0Q6BJ,3-(6-Methoxynaphthalen-2-yl)-5-phenylpyridine,https://idrblab.net/ttd/data/drug/details/D0Q6BJ,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6761,2028611,25034427,Therapeutic Target Database (TTD),4-(6-Methoxy-3-methylnaphthalen-2-yl)isoquinoline,D0S4KP,4-(6-Methoxy-3-methylnaphthalen-2-yl)isoquinoline,https://idrblab.net/ttd/data/drug/details/D0S4KP,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6762,2028612,25034430,Therapeutic Target Database (TTD),3-(6-Methoxynaphthalen-2-yl)-4-methylpyridine,D0B2UM,3-(6-Methoxynaphthalen-2-yl)-4-methylpyridine,https://idrblab.net/ttd/data/drug/details/D0B2UM,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6763,2028613,25034431,Therapeutic Target Database (TTD),3-(6-Methoxynaphthalen-2-yl)pyridin-4-amine,D02GFK,3-(6-Methoxynaphthalen-2-yl)pyridin-4-amine,https://idrblab.net/ttd/data/drug/details/D02GFK,T57392,Debrisoquine 4-hydroxylase (CYP2D6),https://idrblab.net/ttd/data/target/details/T57392,P10635,Cytochrome P450 2D6,1565.0,CYP2D6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6764,2028614,25034431,Therapeutic Target Database (TTD),3-(6-Methoxynaphthalen-2-yl)pyridin-4-amine,D02GFK,3-(6-Methoxynaphthalen-2-yl)pyridin-4-amine,https://idrblab.net/ttd/data/drug/details/D02GFK,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6765,2028615,25044690,Therapeutic Target Database (TTD),4-(Allylamino)-3-pyridinesulfonamide,D09TKG,4-(Allylamino)-3-pyridinesulfonamide,https://idrblab.net/ttd/data/drug/details/D09TKG,T13201,Carbonic anhydrase I (CA-I),https://idrblab.net/ttd/data/target/details/T13201,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6766,2028616,25044690,Therapeutic Target Database (TTD),4-(Allylamino)-3-pyridinesulfonamide,D09TKG,4-(Allylamino)-3-pyridinesulfonamide,https://idrblab.net/ttd/data/drug/details/D09TKG,T20401,Carbonic anhydrase II (CA-II),https://idrblab.net/ttd/data/target/details/T20401,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6767,2028617,25044690,Therapeutic Target Database (TTD),4-(Allylamino)-3-pyridinesulfonamide,D09TKG,4-(Allylamino)-3-pyridinesulfonamide,https://idrblab.net/ttd/data/drug/details/D09TKG,T16987,Carbonic anhydrase XII (CA-XII),https://idrblab.net/ttd/data/target/details/T16987,O43570,Carbonic anhydrase 12,771.0,CA12,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6768,2028618,25044690,Therapeutic Target Database (TTD),4-(Allylamino)-3-pyridinesulfonamide,D09TKG,4-(Allylamino)-3-pyridinesulfonamide,https://idrblab.net/ttd/data/drug/details/D09TKG,T64567,Carbonic anhydrase IX (CA-IX),https://idrblab.net/ttd/data/target/details/T64567,Q16790,Carbonic anhydrase 9,768.0,CA9,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6769,2028619,25044690,Therapeutic Target Database (TTD),4-(Allylamino)-3-pyridinesulfonamide,D09TKG,4-(Allylamino)-3-pyridinesulfonamide,https://idrblab.net/ttd/data/drug/details/D09TKG,T31992,Carbonic anhydrase XIV (CA-XIV),https://idrblab.net/ttd/data/target/details/T31992,Q9ULX7,Carbonic anhydrase 14,23632.0,CA14,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6770,2028630,25049753,Therapeutic Target Database (TTD),2-(biphenyl-4-ylsulfonamido)-N-hydroxyacetamide,D09ZOA,2-(biphenyl-4-ylsulfonamido)-N-hydroxyacetamide,https://idrblab.net/ttd/data/drug/details/D09ZOA,T65019,Matrix metalloproteinase-14 (MMP-14),https://idrblab.net/ttd/data/target/details/T65019,P50281,Matrix metalloproteinase-14,4323.0,MMP14,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6771,2028631,25049753,Therapeutic Target Database (TTD),2-(biphenyl-4-ylsulfonamido)-N-hydroxyacetamide,D09ZOA,2-(biphenyl-4-ylsulfonamido)-N-hydroxyacetamide,https://idrblab.net/ttd/data/drug/details/D09ZOA,T82393,TNF alpha converting enzyme (ADAM17),https://idrblab.net/ttd/data/target/details/T82393,P78536,Disintegrin and metalloproteinase domain-containing protein 17,6868.0,ADAM17,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6772,2028208,25053488,BindingDB,"(2R,3R)-2-amino-N,3-dimethyl-N-[(1R,2S,5S,6S,9R,12S,13R,16S)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0^{2,9}.0^{5,9}.0^{13,18}]icos-18-en-16-yl]pentanamide",27209,"(2R,3R)-2-amino-N,3-dimethyl-N-[(1R,2S,5S,6S,9R,12S,13R,16S)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0^{2,9}.0^{5,9}.0^{13,18}]icos-18-en-16-yl]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27209,2294,Histamine H3 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2294,Q9QYN8,Histamine H3 receptor,85268.0,Hrh3,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),2.88,PMID:18683917|DOI:10.1021/jm8003625,https://www.ncbi.nlm.nih.gov/pubmed/18683917|https://doi.org/10.1021/jm8003625,18683917,10.1021/jm8003625,
6773,2028209,25053489,BindingDB,"(2S)-2-acetamido-N,4-dimethyl-N-[(1R,2S,5S,6S,9R,12S,13R,16S)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0^{2,9}.0^{5,9}.0^{13,18}]icos-18-en-16-yl]pentanamide",27211,"(2S)-2-acetamido-N,4-dimethyl-N-[(1R,2S,5S,6S,9R,12S,13R,16S)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0^{2,9}.0^{5,9}.0^{13,18}]icos-18-en-16-yl]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27211,2288,Histamine H3 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2288,Q9Y5N1,Histamine H3 receptor,11255.0,HRH3,9606.0,Homo sapiens (human),,Ki (nM),1.62,PMID:18683917|DOI:10.1021/jm8003625,https://www.ncbi.nlm.nih.gov/pubmed/18683917|https://doi.org/10.1021/jm8003625,18683917,10.1021/jm8003625,
6774,2028210,25053489,BindingDB,"(2S)-2-acetamido-N,4-dimethyl-N-[(1R,2S,5S,6S,9R,12S,13R,16S)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0^{2,9}.0^{5,9}.0^{13,18}]icos-18-en-16-yl]pentanamide",27211,"(2S)-2-acetamido-N,4-dimethyl-N-[(1R,2S,5S,6S,9R,12S,13R,16S)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0^{2,9}.0^{5,9}.0^{13,18}]icos-18-en-16-yl]pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27211,2294,Histamine H3 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2294,Q9QYN8,Histamine H3 receptor,85268.0,Hrh3,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),6.76,PMID:18683917|DOI:10.1021/jm8003625,https://www.ncbi.nlm.nih.gov/pubmed/18683917|https://doi.org/10.1021/jm8003625,18683917,10.1021/jm8003625,
6775,2028632,25058047,Therapeutic Target Database (TTD),"3,7-Bis(2-hydroxyethyl)icaritin",D09WUP,"3,7-Bis(2-hydroxyethyl)icaritin",https://idrblab.net/ttd/data/drug/details/D09WUP,T07663,Phosphodiesterase 5A (PDE5A),https://idrblab.net/ttd/data/target/details/T07663,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",8654.0,PDE5A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6776,2028633,25058047,Comparative Toxicogenomics Database (CTD),"3,7-Bis(2-hydroxyethyl)icaritin",C532608,"3,7-bis(2-hydroxyethyl)icaritin",https://ctdbase.org/detail.go?type=chem&acc=C532608,8654,PDE5A,https://ctdbase.org/detail.go?type=gene&acc=8654,,,8654.0,PDE5A,9606.0,Homo sapiens (human),"3,7-bis(2-hydroxyethyl)icaritin results in decreased activity of PDE5A protein",,,PMID:18778098,https://www.ncbi.nlm.nih.gov/pubmed/18778098,18778098,,
6777,2028634,25058128,BindingDB,N-({6-[(4-Cyano-2-Fluorobenzyl)oxy]naphthalen-2-Yl}sulfonyl)-D-Glutamic Acid,26455,(2R)-2-({6-[(4-cyano-2-fluorophenyl)methoxy]naphthalene-2-}sulfonamido)pentanedioic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26455,3040,UDP-N-acetylmuramoylalanine--D-glutamate ligase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3040,P14900,UDP-N-acetylmuramoylalanine--D-glutamate ligase,944818.0,murD,83333.0,Escherichia coli K-12,,IC50 (nM),85000,PMID:19007109|DOI:10.1021/jm800762u,https://www.ncbi.nlm.nih.gov/pubmed/19007109|https://doi.org/10.1021/jm800762u,19007109,10.1021/jm800762u,
6778,2028635,25058129,BindingDB,N-({7-[(4-cyanobenzyl)oxy]naphthalen-2-yl}sulfonyl)-D-glutamic acid,26456,(2R)-2-({7-[(4-cyanophenyl)methoxy]naphthalene-2-}sulfonamido)pentanedioic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26456,3040,UDP-N-acetylmuramoylalanine--D-glutamate ligase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3040,P14900,UDP-N-acetylmuramoylalanine--D-glutamate ligase,944818.0,murD,83333.0,Escherichia coli K-12,,IC50 (nM),122000,PMID:19007109|DOI:10.1021/jm800762u,https://www.ncbi.nlm.nih.gov/pubmed/19007109|https://doi.org/10.1021/jm800762u,19007109,10.1021/jm800762u,
6779,2028636,25058133,BindingDB,"5-[3-(2,5-Dimethoxyphenyl)prop-1-Yn-1-Yl]-6-Ethylpyrimidine-2,4-Diamine",26519,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26519,1875,Dihydrofolate reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1875,P00374,Dihydrofolate reductase,1719.0,DHFR,9606.0,Homo sapiens (human),,IC50 (nM),1280,PMID:19007108|DOI:10.1021/jm800776a,https://www.ncbi.nlm.nih.gov/pubmed/19007108|https://doi.org/10.1021/jm800776a,19007108,10.1021/jm800776a,
6780,2028637,25058133,BindingDB,"5-[3-(2,5-Dimethoxyphenyl)prop-1-Yn-1-Yl]-6-Ethylpyrimidine-2,4-Diamine",26519,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26519,1877,Dihydrofolate reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1877,,,,,,,,IC50 (nM),890,PMID:19007108|DOI:10.1021/jm800776a,https://www.ncbi.nlm.nih.gov/pubmed/19007108|https://doi.org/10.1021/jm800776a,19007108,10.1021/jm800776a,
6781,2029147,25058173,Comparative Toxicogenomics Database (CTD),Bodipy,C095489,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",https://ctdbase.org/detail.go?type=chem&acc=C095489,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606.0,Homo sapiens (human),"ABCB11 protein affects the transport of 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",,,PMID:12739759,https://www.ncbi.nlm.nih.gov/pubmed/12739759,12739759,,
6782,2028646,25058310,BindingDB,4-[2-(4-Methoxyphenyl)-1-benzothiophen-3-yl]phenol,154527,2336 (17j),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=154527,4399,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337.0,PLD1,9606.0,Homo sapiens (human),,IC50 (nM),1.01e+4,PMID:25384256|DOI:10.1021/cb500828m,https://www.ncbi.nlm.nih.gov/pubmed/25384256|https://doi.org/10.1021/cb500828m,25384256,10.1021/cb500828m,
6783,2028647,25058310,BindingDB,4-[2-(4-Methoxyphenyl)-1-benzothiophen-3-yl]phenol,154527,2336 (17j),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=154527,7085,Phospholipase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7085,,,,,,,,IC50 (nM),>2.0e+4,PMID:25384256|DOI:10.1021/cb500828m,https://www.ncbi.nlm.nih.gov/pubmed/25384256|https://doi.org/10.1021/cb500828m,25384256,10.1021/cb500828m,
6784,2028648,25058310,BindingDB,4-[2-(4-Methoxyphenyl)-1-benzothiophen-3-yl]phenol,154527,2336 (17j),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=154527,6265,Phospholipase D2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6265,O14939,Phospholipase D2,5338.0,PLD2,9606.0,Homo sapiens (human),,IC50 (nM),3.2e+3,PMID:25384256|DOI:10.1021/cb500828m,https://www.ncbi.nlm.nih.gov/pubmed/25384256|https://doi.org/10.1021/cb500828m,25384256,10.1021/cb500828m,
6785,2028649,25058310,BindingDB,4-[2-(4-Methoxyphenyl)-1-benzothiophen-3-yl]phenol,154527,2336 (17j),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=154527,7085,Phospholipase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7085,,,,,,,,IC50 (nM),>3.0e+4,PMID:25384256|DOI:10.1021/cb500828m,https://www.ncbi.nlm.nih.gov/pubmed/25384256|https://doi.org/10.1021/cb500828m,25384256,10.1021/cb500828m,
6786,2028264,25058784,BindingDB,Chondramide C,65516,CHEBI:84382,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65516,286,Actin [R335K],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=286,P60010,Actin,850504.0,ACT1,559292.0,Saccharomyces cerevisiae S288C,,IC50 (nM),15100,PMID:28796488|DOI:10.1021/acschembio.7b00385,https://www.ncbi.nlm.nih.gov/pubmed/28796488|https://doi.org/10.1021/acschembio.7b00385,28796488,10.1021/acschembio.7b00385,
6787,2028265,25058784,BindingDB,Chondramide C,65516,CHEBI:84382,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65516,280,Actin [R183K],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=280,P60010,Actin,850504.0,ACT1,559292.0,Saccharomyces cerevisiae S288C,,IC50 (nM),11900,PMID:28796488|DOI:10.1021/acschembio.7b00385,https://www.ncbi.nlm.nih.gov/pubmed/28796488|https://doi.org/10.1021/acschembio.7b00385,28796488,10.1021/acschembio.7b00385,
6788,2029148,25059487,Therapeutic Target Database (TTD),"1-benzyl-N-(3,4-difluorobenzyl)-6-ethoxy-2-isopropyl-1H-indole-3-carboxamide",D0S0MC,"US8524917, 10",https://idrblab.net/ttd/data/drug/details/D0S0MC,T11241,Sphingosine-1-phosphate receptor 3 (S1PR3),https://idrblab.net/ttd/data/target/details/T11241,Q99500,Sphingosine 1-phosphate receptor 3,1903.0,S1PR3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6789,2029149,25059488,Therapeutic Target Database (TTD),"1-Benzyl-N-(3,4-difluorobenzyl)-2-isopropyl-6-propoxy-1H-indole-3-carboxamide",D0K8FK,"US8524917, 11",https://idrblab.net/ttd/data/drug/details/D0K8FK,T11241,Sphingosine-1-phosphate receptor 3 (S1PR3),https://idrblab.net/ttd/data/target/details/T11241,Q99500,Sphingosine 1-phosphate receptor 3,1903.0,S1PR3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6790,2029156,25059745,Therapeutic Target Database (TTD),"1-Benzyl-N-(3,4-difluorobenzyl)-6-isopropoxy-2-isopropyl-1H-indole-3-carboxamide",D0CV8R,"US8524917, 12",https://idrblab.net/ttd/data/drug/details/D0CV8R,T11241,Sphingosine-1-phosphate receptor 3 (S1PR3),https://idrblab.net/ttd/data/target/details/T11241,Q99500,Sphingosine 1-phosphate receptor 3,1903.0,S1PR3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6791,2028266,25062766,Therapeutic Target Database (TTD),Momelotinib,D0D5ZJ,Momelotinib,https://idrblab.net/ttd/data/drug/details/D0D5ZJ,T08391,Janus kinase 2 (JAK-2),https://idrblab.net/ttd/data/target/details/T08391,O60674,Tyrosine-protein kinase JAK2,3717.0,JAK2,9606.0,Homo sapiens (human),Modulator,,,,,,,
6792,2028267,25062766,Therapeutic Target Database (TTD),Momelotinib,D0D5ZJ,Momelotinib,https://idrblab.net/ttd/data/drug/details/D0D5ZJ,T62460,Janus kinase 1 (JAK-1),https://idrblab.net/ttd/data/target/details/T62460,P23458,Tyrosine-protein kinase JAK1,3716.0,JAK1,9606.0,Homo sapiens (human),Modulator,,,,,,,
6793,2028650,25062766,IUPHAR/BPS Guide to PHARMACOLOGY,Momelotinib,7791,momelotinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7791,2269,tyrosine kinase 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2269,P29597,Non-receptor tyrosine-protein kinase TYK2,7297.0,TYK2,9606.0,Homo sapiens (human),Inhibition,pIC50,7.7,PMID:28188131,https://www.ncbi.nlm.nih.gov/pubmed/28188131,28188131,,
6794,2028211,25066467,Drug Gene Interaction database (DGIdb),Rebastinib,,REBASTINIB,https://www.dgidb.org/drugs/ncit:C152162,,ABL1,https://www.dgidb.org/genes/hgnc:76,,,25.0,ABL1,9606.0,Homo sapiens (human),,,,,,,,
6795,2028268,25066467,IUPHAR/BPS Guide to PHARMACOLOGY,Rebastinib,9173,rebastinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9173,1923,"ABL proto-oncogene 1, non-receptor tyrosine kinase",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1923,P00519,Tyrosine-protein kinase ABL1,25.0,ABL1,9606.0,Homo sapiens (human),Inhibition,pIC50,9.1,PMID:21481795,https://www.ncbi.nlm.nih.gov/pubmed/21481795,21481795,,
6796,2028651,25066467,IUPHAR/BPS Guide to PHARMACOLOGY,Rebastinib,9173,rebastinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9173,2284,"YES proto-oncogene 1, Src family tyrosine kinase",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2284,P07947,Tyrosine-protein kinase Yes,7525.0,YES1,9606.0,Homo sapiens (human),Inhibition,pIC50,8.6 - 8.82,PMID:23787099,https://www.ncbi.nlm.nih.gov/pubmed/23787099,23787099,,
6797,2028652,25066467,Drug Gene Interaction database (DGIdb),Rebastinib,,REBASTINIB,https://www.dgidb.org/drugs/ncit:C152162,,ABL1,https://www.dgidb.org/genes/hgnc:76,,,25.0,ABL1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6798,2027956,25066566,BindingDB,"dibenzofuran (DBF) scaffold, (S)-22",28477,"(2S)-3-methyl-2-({12-[(4-methylphenoxycarbonyl)amino]-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaene-5-}sulfonamido)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28477,6145,Macrophage metalloelastase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6145,P39900,Macrophage metalloelastase,4321.0,MMP12,9606.0,Homo sapiens (human),,IC50 (nM),14.0,PMID:19278250|DOI:10.1021/jm900093d,https://www.ncbi.nlm.nih.gov/pubmed/19278250|https://doi.org/10.1021/jm900093d,19278250,10.1021/jm900093d,
6799,2027957,25066642,Drug Gene Interaction database (DGIdb),"1,3-Diethyl 2-pentadecylidenepropanedioate",,CHEMBL:CHEMBL404916,https://www.dgidb.org/drugs/chembl:CHEMBL404916,,KAT2B,https://www.dgidb.org/genes/hgnc:8638,,,8850.0,KAT2B,9606.0,Homo sapiens (human),,,,,,,,
6800,2027958,25066763,BindingDB,"dibenzofuran (DBF) scaffold, (S)-18",28473,"(2S)-2-[(12-{[(2-fluoroethoxy)carbonyl]amino}-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaene-5-)sulfonamido]-3-methylbutanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28473,6145,Macrophage metalloelastase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6145,P39900,Macrophage metalloelastase,4321.0,MMP12,9606.0,Homo sapiens (human),,IC50 (nM),2.1,PMID:19278250|DOI:10.1021/jm900093d,https://www.ncbi.nlm.nih.gov/pubmed/19278250|https://doi.org/10.1021/jm900093d,19278250,10.1021/jm900093d,
6801,2027959,25066763,BindingDB,"dibenzofuran (DBF) scaffold, (S)-18",28473,"(2S)-2-[(12-{[(2-fluoroethoxy)carbonyl]amino}-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaene-5-)sulfonamido]-3-methylbutanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28473,1260,Collagenase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1260,P45452,Collagenase 3,4322.0,MMP13,9606.0,Homo sapiens (human),,IC50 (nM),10,PMID:19278250|DOI:10.1021/jm900093d,https://www.ncbi.nlm.nih.gov/pubmed/19278250|https://doi.org/10.1021/jm900093d,19278250,10.1021/jm900093d,
6802,2027960,25066764,BindingDB,6JP4F7Kkx5,28469,"(2S)-2-({12-[(methoxycarbonyl)amino]-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaene-5-}sulfonamido)-3-methylbutanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28469,1260,Collagenase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1260,P45452,Collagenase 3,4322.0,MMP13,9606.0,Homo sapiens (human),,IC50 (nM),120,PMID:19278250|DOI:10.1021/jm900093d,https://www.ncbi.nlm.nih.gov/pubmed/19278250|https://doi.org/10.1021/jm900093d,19278250,10.1021/jm900093d,
6803,2027961,25066764,BindingDB,6JP4F7Kkx5,28469,"(2S)-2-({12-[(methoxycarbonyl)amino]-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaene-5-}sulfonamido)-3-methylbutanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28469,6145,Macrophage metalloelastase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6145,P39900,Macrophage metalloelastase,4321.0,MMP12,9606.0,Homo sapiens (human),,IC50 (nM),2,PMID:19278250|DOI:10.1021/jm900093d,https://www.ncbi.nlm.nih.gov/pubmed/19278250|https://doi.org/10.1021/jm900093d,19278250,10.1021/jm900093d,
6804,2027962,25066765,BindingDB,"dibenzofuran (DBF) scaffold, (S)-16",28471,"(2S)-3-methyl-2-({12-[(propoxycarbonyl)amino]-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaene-5-}sulfonamido)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28471,6145,Macrophage metalloelastase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6145,P39900,Macrophage metalloelastase,4321.0,MMP12,9606.0,Homo sapiens (human),,IC50 (nM),5.6,PMID:19278250|DOI:10.1021/jm900093d,https://www.ncbi.nlm.nih.gov/pubmed/19278250|https://doi.org/10.1021/jm900093d,19278250,10.1021/jm900093d,
6805,2027974,25066765,BindingDB,"dibenzofuran (DBF) scaffold, (S)-16",28471,"(2S)-3-methyl-2-({12-[(propoxycarbonyl)amino]-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaene-5-}sulfonamido)butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28471,1260,Collagenase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1260,P45452,Collagenase 3,4322.0,MMP13,9606.0,Homo sapiens (human),,IC50 (nM),10,PMID:19278250|DOI:10.1021/jm900093d,https://www.ncbi.nlm.nih.gov/pubmed/19278250|https://doi.org/10.1021/jm900093d,19278250,10.1021/jm900093d,
6806,2027975,25067176,BindingDB,"dibenzofuran (DBF) scaffold, (S)-23",28478,"(2S)-2-{[12-(carbamoylamino)-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaene-5-]sulfonamido}-3-methylbutanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28478,1260,Collagenase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1260,P45452,Collagenase 3,4322.0,MMP13,9606.0,Homo sapiens (human),,IC50 (nM),59,PMID:19278250|DOI:10.1021/jm900093d,https://www.ncbi.nlm.nih.gov/pubmed/19278250|https://doi.org/10.1021/jm900093d,19278250,10.1021/jm900093d,
6807,2027976,25067176,BindingDB,"dibenzofuran (DBF) scaffold, (S)-23",28478,"(2S)-2-{[12-(carbamoylamino)-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaene-5-]sulfonamido}-3-methylbutanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28478,6145,Macrophage metalloelastase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6145,P39900,Macrophage metalloelastase,4321.0,MMP12,9606.0,Homo sapiens (human),,IC50 (nM),7.6,PMID:19278250|DOI:10.1021/jm900093d,https://www.ncbi.nlm.nih.gov/pubmed/19278250|https://doi.org/10.1021/jm900093d,19278250,10.1021/jm900093d,
6808,2027977,25067178,BindingDB,"dibenzofuran (DBF) scaffold, (S)-26",28481,"(2S)-3-methyl-2-{[12-({[2-(thiophen-2-yl)ethyl]carbamoyl}amino)-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaene-5-]sulfonamido}butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28481,6145,Macrophage metalloelastase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6145,P39900,Macrophage metalloelastase,4321.0,MMP12,9606.0,Homo sapiens (human),,IC50 (nM),1.1,PMID:19278250|DOI:10.1021/jm900093d,https://www.ncbi.nlm.nih.gov/pubmed/19278250|https://doi.org/10.1021/jm900093d,19278250,10.1021/jm900093d,
6809,2027978,25067178,BindingDB,"dibenzofuran (DBF) scaffold, (S)-26",28481,"(2S)-3-methyl-2-{[12-({[2-(thiophen-2-yl)ethyl]carbamoyl}amino)-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaene-5-]sulfonamido}butanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28481,1260,Collagenase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1260,P45452,Collagenase 3,4322.0,MMP13,9606.0,Homo sapiens (human),,IC50 (nM),1.1,PMID:19278250|DOI:10.1021/jm900093d,https://www.ncbi.nlm.nih.gov/pubmed/19278250|https://doi.org/10.1021/jm900093d,19278250,10.1021/jm900093d,
6810,2028212,25067547,Drug Gene Interaction database (DGIdb),Oprozomib,,OPROZOMIB,https://www.dgidb.org/drugs/ncit:C91388,,PSMB5,https://www.dgidb.org/genes/hgnc:9542,,,5693.0,PSMB5,9606.0,Homo sapiens (human),,,,,,,,
6811,2028269,25067576,IUPHAR/BPS Guide to PHARMACOLOGY,[N-methyl-3H(3)]AZ-10419369,3219,[3H]N-methyl-AZ10419369,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3219,2,5-HT1B receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2,P28222,5-hydroxytryptamine receptor 1B,3351.0,HTR1B,9606.0,Homo sapiens (human),Partial agonist,pKd,9.4,PMID:19401496,https://www.ncbi.nlm.nih.gov/pubmed/19401496,19401496,,
6812,2028653,25069592,Therapeutic Target Database (TTD),(4-(6-morpholino-9H-purin-2-yl)phenyl)methanol,D00GQM,(4-(6-morpholino-9H-purin-2-yl)phenyl)methanol,https://idrblab.net/ttd/data/drug/details/D00GQM,T75243,Serine/threonine-protein kinase mTOR (mTOR),https://idrblab.net/ttd/data/target/details/T75243,P42345,Serine/threonine-protein kinase mTOR,2475.0,MTOR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6813,2028654,25069599,BindingDB,"N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-[4-(morpholin-4-yl)pyridin-2-yl]pyrimidin-4-yl]acetamide",26244,"N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-[4-(morpholin-4-yl)pyridin-2-yl]pyrimidin-4-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26244,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),4600,PMID:18947224|DOI:10.1021/jm800851u,https://www.ncbi.nlm.nih.gov/pubmed/18947224|https://doi.org/10.1021/jm800851u,18947224,10.1021/jm800851u,
6814,2028655,25069603,BindingDB,"N-[6-(6-aminopyridin-2-yl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl]acetamide",26248,"N-[6-(6-aminopyridin-2-yl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26248,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),440,PMID:18947224|DOI:10.1021/jm800851u,https://www.ncbi.nlm.nih.gov/pubmed/18947224|https://doi.org/10.1021/jm800851u,18947224,10.1021/jm800851u,
6815,2027979,25070031,Drug Gene Interaction database (DGIdb),Irdabisant,,IRDABISANT,https://www.dgidb.org/drugs/ncit:C170078,,HRH3,https://www.dgidb.org/genes/hgnc:5184,,,11255.0,HRH3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6816,2028270,25070031,Comparative Toxicogenomics Database (CTD),Irdabisant,C561238,6-(4-(3-(2-methylpyrrolidin-1-yl)propoxy)phenyl)-2H-pyridazin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C561238,11255,HRH3,https://ctdbase.org/detail.go?type=gene&acc=11255,,,11255.0,HRH3,9606.0,Homo sapiens (human),6-(4-(3-(2-methylpyrrolidin-1-yl)propoxy)phenyl)-2H-pyridazin-3-one binds to HRH3 protein|6-(4-(3-(2-methylpyrrolidin-1-yl)propoxy)phenyl)-2H-pyridazin-3-one inhibits the reaction [alpha-methylhistamine promotes the reaction [guanosine triphosphate binds to HRH3 protein]],,,PMID:21634396,https://www.ncbi.nlm.nih.gov/pubmed/21634396,21634396,,
6817,2029150,25070031,ChEMBL,Irdabisant,CHEMBL1829335,IRDABISANT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1829335/,CHEMBL264,Histamine H3 receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL264/,Q9Y5N1,Histamine H3 receptor,11255.0,HRH3,9606.0,Homo sapiens (human),Histamine H3 receptor antagonist,,,PMID:21634396|PMID:22001260,https://www.ncbi.nlm.nih.gov/pubmed/21634396|https://www.ncbi.nlm.nih.gov/pubmed/22001260,21634396|22001260,,
6818,2027980,25073775,Drug Gene Interaction database (DGIdb),"Benzamide, 2-[[2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyridinyl]amino]-N-methyl-",,VS-4718,https://www.dgidb.org/drugs/drugbank:DB15273,,PTK2,https://www.dgidb.org/genes/hgnc:9611,,,5747.0,PTK2,9606.0,Homo sapiens (human),,,,,,,,
6819,2027981,25073775,Drug Gene Interaction database (DGIdb),"Benzamide, 2-[[2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyridinyl]amino]-N-methyl-",,VS-4718,https://www.dgidb.org/drugs/drugbank:DB15273,,PTK2,https://www.dgidb.org/genes/hgnc:9611,,,5747.0,PTK2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6820,2029151,25073775,ChEMBL,"Benzamide, 2-[[2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyridinyl]amino]-N-methyl-",CHEMBL3040440,VS-4718,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3040440/,CHEMBL2695,Focal adhesion kinase 1,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2695/,Q05397,Focal adhesion kinase 1,5747.0,PTK2,9606.0,Homo sapiens (human),Focal adhesion kinase 1 inhibitor,,,PMID:20234191|PMID:20234193,https://www.ncbi.nlm.nih.gov/pubmed/20234191|https://www.ncbi.nlm.nih.gov/pubmed/20234193,20234191|20234193,,
6821,2029152,25074469,ChEMBL,Decapeptyl,CHEMBL1200554,TRIPTORELIN PAMOATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200554/,CHEMBL1855,Gonadotropin-releasing hormone receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1855/,P30968,Gonadotropin-releasing hormone receptor,2798.0,GNRHR,9606.0,Homo sapiens (human),Gonadotropin-releasing hormone receptor agonist,,,,,,,
6822,2027982,25074887,Drug Gene Interaction database (DGIdb),Cetrorelix,,CETRORELIX,https://www.dgidb.org/drugs/rxcui:68147,,SERPINE1,https://www.dgidb.org/genes/hgnc:8583,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),,,,,,,,
6823,2028213,25074887,DrugBank,Cetrorelix,DB00050,Cetrorelix,https://www.drugbank.ca/drugs/DB00050,BE0000203,Gonadotropin-releasing hormone receptor,https://www.drugbank.ca/bio_entities/BE0000203,P30968,Gonadotropin-releasing hormone receptor,2798.0,GNRHR,9606.0,Homo sapiens (human),Antagonist,,,PMID:11854630|PMID:12606421|PMID:14561652|PMID:14605254|PMID:16809153|PMID:11752352,https://www.ncbi.nlm.nih.gov/pubmed/11854630|https://www.ncbi.nlm.nih.gov/pubmed/12606421|https://www.ncbi.nlm.nih.gov/pubmed/14561652|https://www.ncbi.nlm.nih.gov/pubmed/14605254|https://www.ncbi.nlm.nih.gov/pubmed/16809153|https://www.ncbi.nlm.nih.gov/pubmed/11752352,11854630|12606421|14561652|14605254|16809153|11752352,,
6824,2028214,25074887,DrugBank,Cetrorelix,DB00050,Cetrorelix,https://www.drugbank.ca/drugs/DB00050,BE0000134,Lutropin-choriogonadotropic hormone receptor,https://www.drugbank.ca/bio_entities/BE0000134,P22888,Lutropin-choriogonadotropic hormone receptor,3973.0,LHCGR,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:11943741,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/11943741,17139284|17016423|11943741,,
6825,2029153,25074887,Drug Gene Interaction database (DGIdb),Cetrorelix,,CETRORELIX,https://www.dgidb.org/drugs/rxcui:68147,,GNRHR,https://www.dgidb.org/genes/hgnc:4421,,,2798.0,GNRHR,9606.0,Homo sapiens (human),,,,,,,,
6826,2028271,25077385,Therapeutic Target Database (TTD),N-alpha-Acetyl-nona-D-arginine amide acetate,D0Y2NU,ALX-40-4C,https://idrblab.net/ttd/data/drug/details/D0Y2NU,T93783,Human immunodeficiency virus Tat protein (HIV tat),https://idrblab.net/ttd/data/target/details/T93783,P04608,Protein Tat,155871.0,tat,11706.0,HIV-1 M:B_HXB2R,Modulator,,,,,,,
6827,2028215,25078060,Therapeutic Target Database (TTD),Apelin-13,D00QYH,apelin-13,https://idrblab.net/ttd/data/drug/details/D00QYH,T65783,Apelin receptor (APLNR),https://idrblab.net/ttd/data/target/details/T65783,P35414,Apelin receptor,187.0,APLNR,9606.0,Homo sapiens (human),Agonist,,,,,,,
6828,2029154,25078131,Comparative Toxicogenomics Database (CTD),Ovuplant,C066438,deslorelin,https://ctdbase.org/detail.go?type=chem&acc=C066438,2798,GNRHR,https://ctdbase.org/detail.go?type=gene&acc=2798,,,2798.0,GNRHR,9606.0,Homo sapiens (human),"Buserelin inhibits the reaction [GNRHR protein results in increased transport of deslorelin]|gnrhr protein results in increased transport of deslorelin|2,4-dinitrophenol inhibits the reaction [GNRHR protein results in increased transport of deslorelin]",,,PMID:15212170,https://www.ncbi.nlm.nih.gov/pubmed/15212170,15212170,,
6829,2028216,25079268,BindingDB,cyclo[Arg-Cys(1)-Thr-Arg-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro-Asp-Gly],21739,"2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-25,34-bis(3-carbamimidamidopropyl)-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecaazapentacyclo[29.20.4.0^{7,11}.0^{13,17}.0^{43,47}]pentapentacontan-40-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21739,8073,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8073,P00735,Prothrombin ,280685.0,F2,9913.0,Bos taurus (cattle),,Ki (nM),860,PMID:17985858|DOI:10.1021/jm0704898,https://www.ncbi.nlm.nih.gov/pubmed/17985858|https://doi.org/10.1021/jm0704898,17985858,10.1021/jm0704898,
6830,2028225,25079268,BindingDB,cyclo[Arg-Cys(1)-Thr-Arg-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro-Asp-Gly],21739,"2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-25,34-bis(3-carbamimidamidopropyl)-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecaazapentacyclo[29.20.4.0^{7,11}.0^{13,17}.0^{43,47}]pentapentacontan-40-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21739,2203,Suppressor of tumorigenicity 14 protein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2203,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,6768.0,ST14,9606.0,Homo sapiens (human),,Ki (nM),4750,PMID:17985858|DOI:10.1021/jm0704898,https://www.ncbi.nlm.nih.gov/pubmed/17985858|https://doi.org/10.1021/jm0704898,17985858,10.1021/jm0704898,
6831,2028226,25079269,BindingDB,cyclo[Asp-Gly-Phe(4-guanidino)-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro],21741,"2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-25-(4-aminobutyl)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-34-[(4-carbamimidamidophenyl)methyl]-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecaazapentacyclo[29.20.4.0^{7,11}.0^{13,17}.0^{43,47}]pentapentacontan-40-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21741,8073,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8073,P00735,Prothrombin ,280685.0,F2,9913.0,Bos taurus (cattle),,Ki (nM),163600,PMID:17985858|DOI:10.1021/jm0704898,https://www.ncbi.nlm.nih.gov/pubmed/17985858|https://doi.org/10.1021/jm0704898,17985858,10.1021/jm0704898,
6832,2028227,25079269,BindingDB,cyclo[Asp-Gly-Phe(4-guanidino)-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro],21741,"2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-25-(4-aminobutyl)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-34-[(4-carbamimidamidophenyl)methyl]-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecaazapentacyclo[29.20.4.0^{7,11}.0^{13,17}.0^{43,47}]pentapentacontan-40-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21741,2203,Suppressor of tumorigenicity 14 protein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2203,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,6768.0,ST14,9606.0,Homo sapiens (human),,Ki (nM),90000,PMID:17985858|DOI:10.1021/jm0704898,https://www.ncbi.nlm.nih.gov/pubmed/17985858|https://doi.org/10.1021/jm0704898,17985858,10.1021/jm0704898,
6833,2028228,25079270,BindingDB,cyclo[2Nal-Pro-Asp-Gly-Arg-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)],21746,"2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-25-(4-aminobutyl)-4,19-bis[(2S)-butan-2-yl]-34-(3-carbamimidamidopropyl)-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-49-(naphthalen-2-ylmethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecaazapentacyclo[29.20.4.0^{7,11}.0^{13,17}.0^{43,47}]pentapentacontan-40-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21746,2203,Suppressor of tumorigenicity 14 protein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2203,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,6768.0,ST14,9606.0,Homo sapiens (human),,Ki (nM),450,PMID:17985858|DOI:10.1021/jm0704898,https://www.ncbi.nlm.nih.gov/pubmed/17985858|https://doi.org/10.1021/jm0704898,17985858,10.1021/jm0704898,
6834,2028229,25079270,BindingDB,cyclo[2Nal-Pro-Asp-Gly-Arg-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)],21746,"2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-25-(4-aminobutyl)-4,19-bis[(2S)-butan-2-yl]-34-(3-carbamimidamidopropyl)-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-49-(naphthalen-2-ylmethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecaazapentacyclo[29.20.4.0^{7,11}.0^{13,17}.0^{43,47}]pentapentacontan-40-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21746,8073,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8073,P00735,Prothrombin ,280685.0,F2,9913.0,Bos taurus (cattle),,Ki (nM),16300,PMID:17985858|DOI:10.1021/jm0704898,https://www.ncbi.nlm.nih.gov/pubmed/17985858|https://doi.org/10.1021/jm0704898,17985858,10.1021/jm0704898,
6835,2028272,25080293,Therapeutic Target Database (TTD),Ozarelix,D0S9BH,Ozarelix,https://idrblab.net/ttd/data/drug/details/D0S9BH,T12475,Gonadotropin-releasing hormone receptor (GNRHR),https://idrblab.net/ttd/data/target/details/T12475,P30968,Gonadotropin-releasing hormone receptor,2798.0,GNRHR,9606.0,Homo sapiens (human),Modulator,,,,,,,
6836,2029155,25080293,Drug Gene Interaction database (DGIdb),Ozarelix,,OZARELIX,https://www.dgidb.org/drugs/ncit:C95214,,GNRHR2,https://www.dgidb.org/genes/hgnc:16341,,,114814.0,GNRHR2,9606.0,Homo sapiens (human),,,,,,,,
6837,2028273,25084501,Therapeutic Target Database (TTD),H-D-Ala-Lys-Pro-Val-Val-His-Leu-Phe-Ala-Asn-xiIle-Val-xiThr-Pro-Arg-xiThr-Pro-OH,D05QKO,NBI-5788,https://idrblab.net/ttd/data/drug/details/D05QKO,T54761,Myelin basic protein (MBP),https://idrblab.net/ttd/data/target/details/T54761,P02686,Myelin basic protein,4155.0,MBP,9606.0,Homo sapiens (human),Binder,,,,,,,
6838,2029112,25086585,Therapeutic Target Database (TTD),Ac-RYYRWKKKKKKK-NH2,D08FSD,SER-100,https://idrblab.net/ttd/data/drug/details/D08FSD,T52921,Nociceptin receptor (OPRL1),https://idrblab.net/ttd/data/target/details/T52921,P41146,Nociceptin receptor,4987.0,OPRL1,9606.0,Homo sapiens (human),Agonist,,,,,,,
6839,2029157,25096873,ChEMBL,Cariprazine hydrochloride,CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2024517/,CHEMBL234,Dopamine D3 receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL234/,P35462,D(3) dopamine receptor,1814.0,DRD3,9606.0,Homo sapiens (human),Dopamine D3 receptor modulator,,,PMID:20093397,https://www.ncbi.nlm.nih.gov/pubmed/20093397,20093397,,
6840,2028284,25101874,Therapeutic Target Database (TTD),Gepotidacin,D0R9US,GSK2140944,https://idrblab.net/ttd/data/drug/details/D0R9US,T96144,DNA topoisomerase II (TOP2),https://idrblab.net/ttd/data/target/details/T96144,P11388,DNA topoisomerase 2-alpha,7153.0,TOP2A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6841,2028285,25101874,Therapeutic Target Database (TTD),Gepotidacin,D0R9US,GSK2140944,https://idrblab.net/ttd/data/drug/details/D0R9US,T96144,DNA topoisomerase II (TOP2),https://idrblab.net/ttd/data/target/details/T96144,Q02880,DNA topoisomerase 2-beta,7155.0,TOP2B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6842,2027991,25102741,Drug Gene Interaction database (DGIdb),Imetitdihydrobromide,,IMETIT DIHYDROBROMIDE,https://www.dgidb.org/drugs/chembl:CHEMBL544911,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
6843,2028286,25102761,Drug Gene Interaction database (DGIdb),"5'-Guanidinonaltrindole di(trifluoroacetate) salt hydrate, hydrochloride",,CHEMBL:CHEMBL1255944,https://www.dgidb.org/drugs/chembl:CHEMBL1255944,,SMAD3,https://www.dgidb.org/genes/hgnc:6769,,,4088.0,SMAD3,9606.0,Homo sapiens (human),,,,,,,,
6844,2027992,25102845,DrugBank,"2-{3-[(2s)-4,4-Difluoro-2-(Pyrrolidin-1-Ylcarbonyl)pyrrolidin-1-Yl]-3-Oxopropyl}-Isoindole-1,3(2h)-Dione",DB08739,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",https://www.drugbank.ca/drugs/DB08739,BE0002148,Prolyl endopeptidase,https://www.drugbank.ca/bio_entities/BE0002148,P48147,Prolyl endopeptidase,5550.0,PREP,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6845,2028287,25102846,Drug Gene Interaction database (DGIdb),Cabozantinib s-malate,,CABOZANTINIB S-MALATE,https://www.dgidb.org/drugs/rxcui:1363267,,GNA11,https://www.dgidb.org/genes/hgnc:4379,,,2767.0,GNA11,9606.0,Homo sapiens (human),,,,,,,,
6846,2029178,25102846,Drug Gene Interaction database (DGIdb),Cabozantinib s-malate,,CABOZANTINIB S-MALATE,https://www.dgidb.org/drugs/rxcui:1363267,,HRAS,https://www.dgidb.org/genes/hgnc:5173,,,3265.0,HRAS,9606.0,Homo sapiens (human),,,,,,,,
6847,2029179,25102846,Drug Gene Interaction database (DGIdb),Cabozantinib s-malate,,CABOZANTINIB S-MALATE,https://www.dgidb.org/drugs/rxcui:1363267,,CFLAR,https://www.dgidb.org/genes/hgnc:1876,,,8837.0,CFLAR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6848,2027993,25102847,DrugBank,Cabozantinib,DB08875,Cabozantinib,https://www.drugbank.ca/drugs/DB08875,BE0000915,Hepatocyte growth factor receptor,https://www.drugbank.ca/bio_entities/BE0000915,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),Antagonist,,,PMID:21606412|PMID:21926191,https://www.ncbi.nlm.nih.gov/pubmed/21606412|https://www.ncbi.nlm.nih.gov/pubmed/21926191,21606412|21926191,,
6849,2027994,25102847,DrugBank,Cabozantinib,DB08875,Cabozantinib,https://www.drugbank.ca/drugs/DB08875,BE0000369,Vascular endothelial growth factor receptor 2,https://www.drugbank.ca/bio_entities/BE0000369,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),Antagonist,,,PMID:21606412|PMID:21926191,https://www.ncbi.nlm.nih.gov/pubmed/21606412|https://www.ncbi.nlm.nih.gov/pubmed/21926191,21606412|21926191,,
6850,2027995,25102847,DrugBank,Cabozantinib,DB08875,Cabozantinib,https://www.drugbank.ca/drugs/DB08875,BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,https://www.drugbank.ca/bio_entities/BE0002411,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),Antagonist,,,PMID:21606412,https://www.ncbi.nlm.nih.gov/pubmed/21606412,21606412,,
6851,2027996,25102847,DrugBank,Cabozantinib,DB08875,Cabozantinib,https://www.drugbank.ca/drugs/DB08875,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate,,,PMID:25854986|PMID:29089775,https://www.ncbi.nlm.nih.gov/pubmed/25854986|https://www.ncbi.nlm.nih.gov/pubmed/29089775,25854986|29089775,,
6852,2027997,25102847,DrugBank,Cabozantinib,DB08875,Cabozantinib,https://www.drugbank.ca/drugs/DB08875,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606.0,Homo sapiens (human),Substrate,,,,,,,
6853,2027998,25102847,DrugBank,Cabozantinib,DB08875,Cabozantinib,https://www.drugbank.ca/drugs/DB08875,BE0002887,Cytochrome P450 2C8,https://www.drugbank.ca/bio_entities/BE0002887,P10632,Cytochrome P450 2C8,1558.0,CYP2C8,9606.0,Homo sapiens (human),Inhibitor,,,PMID:27835047,https://www.ncbi.nlm.nih.gov/pubmed/27835047,27835047,,
6854,2028288,25105689,Drug Gene Interaction database (DGIdb),Evenamide,,EVENAMIDE,https://www.dgidb.org/drugs/chembl:CHEMBL3678076,,XK,https://www.dgidb.org/genes/hgnc:12811,,,7504.0,XK,9606.0,Homo sapiens (human),,,,,,,,
6855,2029180,25105689,ChEMBL,Evenamide,CHEMBL3678076,EVENAMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3678076/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,P35498,Sodium channel protein type 1 subunit alpha,6323.0,SCN1A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,,,,,
6856,2029181,25105689,ChEMBL,Evenamide,CHEMBL3678076,EVENAMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3678076/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,P35499,Sodium channel protein type 4 subunit alpha,6329.0,SCN4A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,,,,,
6857,2029182,25105689,ChEMBL,Evenamide,CHEMBL3678076,EVENAMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3678076/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q01118,Sodium channel protein type 7 subunit alpha,6332.0,SCN7A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,,,,,
6858,2029183,25105689,ChEMBL,Evenamide,CHEMBL3678076,EVENAMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3678076/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q14524,Sodium channel protein type 5 subunit alpha,6331.0,SCN5A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,,,,,
6859,2029184,25105689,ChEMBL,Evenamide,CHEMBL3678076,EVENAMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3678076/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q15858,Sodium channel protein type 9 subunit alpha,6335.0,SCN9A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,,,,,
6860,2029185,25105689,ChEMBL,Evenamide,CHEMBL3678076,EVENAMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3678076/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q99250,Sodium channel protein type 2 subunit alpha,6326.0,SCN2A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,,,,,
6861,2029186,25105689,ChEMBL,Evenamide,CHEMBL3678076,EVENAMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3678076/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q9NY46,Sodium channel protein type 3 subunit alpha,6328.0,SCN3A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,,,,,
6862,2029187,25105689,ChEMBL,Evenamide,CHEMBL3678076,EVENAMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3678076/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q9UI33,Sodium channel protein type 11 subunit alpha,11280.0,SCN11A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,,,,,
6863,2029188,25105689,ChEMBL,Evenamide,CHEMBL3678076,EVENAMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3678076/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q9UQD0,Sodium channel protein type 8 subunit alpha,6334.0,SCN8A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,,,,,
6864,2029189,25105689,ChEMBL,Evenamide,CHEMBL3678076,EVENAMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3678076/,CHEMBL2331043,Sodium channel alpha subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331043/,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,6336.0,SCN10A,9606.0,Homo sapiens (human),Sodium channel alpha subunit blocker,,,,,,,
6865,2029200,25105704,Therapeutic Target Database (TTD),"N-(2-(4-(2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)-2-naphthamide",D0CI4A,ML272,https://idrblab.net/ttd/data/drug/details/D0CI4A,T38996,Phospholipase D1 (PLD1),https://idrblab.net/ttd/data/target/details/T38996,Q13393,Phospholipase D1,5337.0,PLD1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6866,2027999,25108829,ChEMBL,"5-Thiazolecarboxamide, 4-methyl-N-[2-[3-(4-morpholinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-(3-pyridinyl)-",CHEMBL4297436,SRT-2104,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297436/,CHEMBL4506,NAD-dependent deacetylase sirtuin 1,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL4506/,Q96EB6,NAD-dependent protein deacetylase sirtuin-1,23411.0,SIRT1,9606.0,Homo sapiens (human),NAD-dependent deacetylase sirtuin 1 activator,,,PMID:27239324|PMID:23770971|PMID:26556603,https://www.ncbi.nlm.nih.gov/pubmed/27239324|https://www.ncbi.nlm.nih.gov/pubmed/23770971|https://www.ncbi.nlm.nih.gov/pubmed/26556603,27239324|23770971|26556603,,
6867,2028289,25108829,Therapeutic Target Database (TTD),"5-Thiazolecarboxamide, 4-methyl-N-[2-[3-(4-morpholinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-(3-pyridinyl)-",D04JNI,GSK2245840,https://idrblab.net/ttd/data/drug/details/D04JNI,T14731,NAD-dependent deacetylase sirtuin-1 (SIRT1),https://idrblab.net/ttd/data/target/details/T14731,Q96EB6,NAD-dependent protein deacetylase sirtuin-1,23411.0,SIRT1,9606.0,Homo sapiens (human),Modulator,,,,,,,
6868,2029201,25110406,Comparative Toxicogenomics Database (CTD),"2-({4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]-2,3-dihydro-1H-inden-1-yl}amino)ethan-1-ol",C532995,"2-(4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl amino)ethanol",https://ctdbase.org/detail.go?type=chem&acc=C532995,1901,S1PR1,https://ctdbase.org/detail.go?type=gene&acc=1901,,,1901.0,S1PR1,9606.0,Homo sapiens (human),"2-(4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl amino)ethanol affects the localization of and results in increased ubiquitination of S1PR1 protein",,,PMID:25880547,https://www.ncbi.nlm.nih.gov/pubmed/25880547,25880547,,
6869,2029202,25110701,BindingDB,(5-chloropyridin-3-yl) 1H-indole-4-carboxylate,429304,acs.jmedchem.1c00409_ST.426,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=429304,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),50,,,,,
6870,2029203,25110701,BindingDB,(5-chloropyridin-3-yl) 1H-indole-4-carboxylate,429304,CVD-0006354,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=429304,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),50,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
6871,2028000,25111933,DrugBank,(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid,DB08783,(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid,https://www.drugbank.ca/drugs/DB08783,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,https://www.drugbank.ca/bio_entities/BE0000623,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6872,2028001,25113120,DrugBank,"1-[(3S)-5-Phenyl-3-thiophen-2-YL-3H-1,4-benzodiazepin-2-YL]azetidin-3-OL",DB08698,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",https://www.drugbank.ca/drugs/DB08698,BE0004383,Glutamate racemase,https://www.drugbank.ca/bio_entities/BE0004383,Q9ZLT0,Glutamate racemase,,,85963.0,Helicobacter pylori J99,,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6873,2029204,25113156,BindingDB,(2R)-3-phenyl-2-(4-phenylphenoxy)propanoic acid,28760,(2R)-3-phenyl-2-(4-phenylphenoxy)propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28760,9947,Peroxisome proliferator-activated receptor alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9947,Q07869,Peroxisome proliferator-activated receptor alpha,5465.0,PPARA,9606.0,Homo sapiens (human),,,,PMID:19053776|DOI:10.1021/jm800733h,https://www.ncbi.nlm.nih.gov/pubmed/19053776|https://doi.org/10.1021/jm800733h,19053776,10.1021/jm800733h,
6874,2029205,25113156,BindingDB,(2R)-3-phenyl-2-(4-phenylphenoxy)propanoic acid,28760,(2R)-3-phenyl-2-(4-phenylphenoxy)propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28760,50001090,Peroxisome proliferator-activated receptor alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001090,P23204,Peroxisome proliferator-activated receptor alpha,19013.0,Ppara,10090.0,Mus musculus (house mouse),,,,PMID:19053776|DOI:10.1021/jm800733h,https://www.ncbi.nlm.nih.gov/pubmed/19053776|https://doi.org/10.1021/jm800733h,19053776,10.1021/jm800733h,
6875,2029206,25113156,BindingDB,(2R)-3-phenyl-2-(4-phenylphenoxy)propanoic acid,28760,(2R)-3-phenyl-2-(4-phenylphenoxy)propanoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28760,2209,Peroxisome proliferator-activated receptor gamma,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2209,P37231,Peroxisome proliferator-activated receptor gamma,5468.0,PPARG,9606.0,Homo sapiens (human),,,,PMID:19053776|DOI:10.1021/jm800733h,https://www.ncbi.nlm.nih.gov/pubmed/19053776|https://doi.org/10.1021/jm800733h,19053776,10.1021/jm800733h,
6876,2028274,25113157,DrugBank,Dcfbc,DB07754,DCFBC,https://www.drugbank.ca/drugs/DB07754,BE0000568,Glutamate carboxypeptidase 2,https://www.drugbank.ca/bio_entities/BE0000568,Q04609,Glutamate carboxypeptidase 2,2346.0,FOLH1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6877,2028275,25113171,DrugBank,"2-Fluoro-6-{[2-({2-Methoxy-4-[(Methylsulfonyl)methyl]phenyl}amino)-7h-Pyrrolo[2,3-D]pyrimidin-4-Yl]amino}benzamide",DB07845,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.drugbank.ca/drugs/DB07845,BE0003790,Mitogen-activated protein kinase 8,https://www.drugbank.ca/bio_entities/BE0003790,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6878,2028276,25113172,DrugBank,"2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide",DB07194,"2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide",https://www.drugbank.ca/drugs/DB07194,BE0001316,Tyrosine-protein kinase SYK,https://www.drugbank.ca/bio_entities/BE0001316,P43405,Tyrosine-protein kinase SYK,6850.0,SYK,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6879,2028277,25113181,DrugBank,3-[3-(4-Methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,DB07969,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,https://www.drugbank.ca/drugs/DB07969,BE0000915,Hepatocyte growth factor receptor,https://www.drugbank.ca/bio_entities/BE0000915,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6880,2028002,25113478,Toxin and Toxin Target Database (T3DB),,T3D1349,Mercuric oleate,http://www.t3db.ca/toxins/T3D1349,BE0003713,Tubulin gamma-1 chain,http://www.t3db.ca/biodb/bio_entities/BE0003713,P23258,Tubulin gamma-1 chain,7283.0,TUBG1,9606.0,Homo sapiens (human),"Organic mercury exerts developmental effects by binding to tubulin, preventing microtubule assembly and causing mitotic inhibition. (L7)",,,,,,,
6881,2028290,25113570,Toxin and Toxin Target Database (T3DB),CID 25113570,T3D1279,Tin(IV) sulfide,http://www.t3db.ca/toxins/T3D1279,BE0000227,Alcohol dehydrogenase 1A,http://www.t3db.ca/biodb/bio_entities/BE0000227,P07327,Alcohol dehydrogenase 1A,124.0,ADH1A,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
6882,2028291,25113570,Toxin and Toxin Target Database (T3DB),CID 25113570,T3D1279,Tin(IV) sulfide,http://www.t3db.ca/toxins/T3D1279,BE0000400,Alcohol dehydrogenase 1B,http://www.t3db.ca/biodb/bio_entities/BE0000400,P00325,All-trans-retinol dehydrogenase [NAD(+)] ADH1B,125.0,ADH1B,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
6883,2028292,25113570,Toxin and Toxin Target Database (T3DB),CID 25113570,T3D1279,Tin(IV) sulfide,http://www.t3db.ca/toxins/T3D1279,BE0000465,Alcohol dehydrogenase 1C,http://www.t3db.ca/biodb/bio_entities/BE0000465,P00326,Alcohol dehydrogenase 1C,126.0,ADH1C,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
6884,2028293,25113570,Toxin and Toxin Target Database (T3DB),CID 25113570,T3D1279,Tin(IV) sulfide,http://www.t3db.ca/toxins/T3D1279,BE0000360,Alcohol dehydrogenase 4,http://www.t3db.ca/biodb/bio_entities/BE0000360,P08319,All-trans-retinol dehydrogenase [NAD(+)] ADH4,127.0,ADH4,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
6885,2028294,25113570,Toxin and Toxin Target Database (T3DB),CID 25113570,T3D1279,Tin(IV) sulfide,http://www.t3db.ca/toxins/T3D1279,BE0003545,Alcohol dehydrogenase 6,http://www.t3db.ca/biodb/bio_entities/BE0003545,P28332,Alcohol dehydrogenase 6,130.0,ADH6,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
6886,2028295,25113570,Toxin and Toxin Target Database (T3DB),CID 25113570,T3D1279,Tin(IV) sulfide,http://www.t3db.ca/toxins/T3D1279,BE0000522,Alcohol dehydrogenase class 4 mu/sigma chain,http://www.t3db.ca/biodb/bio_entities/BE0000522,P40394,All-trans-retinol dehydrogenase [NAD,131.0,ADH7,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
6887,2029022,25113570,Toxin and Toxin Target Database (T3DB),CID 25113570,T3D1279,Tin(IV) sulfide,http://www.t3db.ca/toxins/T3D1279,BE0000009,Alcohol dehydrogenase class-3,http://www.t3db.ca/biodb/bio_entities/BE0000009,P11766,Alcohol dehydrogenase class-3,128.0,ADH5,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
6888,2029207,25116064,ChEMBL,Henatinib,CHEMBL1277072,HENATINIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1277072/,CHEMBL279,Vascular endothelial growth factor receptor 2,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL279/,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),Vascular endothelial growth factor receptor 2 inhibitor,,,,,,,
6889,2028278,25117272,Therapeutic Target Database (TTD),"2-(4-chlorophenyl)-6-(4-(2-hydroxy-2-methylpropoxy)-3-methoxyphenyl)thieno[2,3-d]pyridazin-7(6H)-one",D0N8CI,PMID25522065-Compound-15,https://idrblab.net/ttd/data/drug/details/D0N8CI,T09572,Melanin-concentrating hormone receptor 1 (MCHR1),https://idrblab.net/ttd/data/target/details/T09572,Q99705,Melanin-concentrating hormone receptor 1,2847.0,MCHR1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
6890,2029208,25118925,ChEMBL,"4-[4-[4-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine",CHEMBL3545076,LY-2584702,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545076/,CHEMBL4501,Ribosomal protein S6 kinase 1,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL4501/,P23443,Ribosomal protein S6 kinase beta-1,6198.0,RPS6KB1,9606.0,Homo sapiens (human),Ribosomal protein S6 kinase 1 inhibitor,,,PMID:24440085,https://www.ncbi.nlm.nih.gov/pubmed/24440085,24440085,,
6891,2028003,25121533,BindingDB,"Ethyl 3-(4-fluorobenzoyl)-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate",28529,"Azepino[4,5-b]indole, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28529,2179,Bile acid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2179,Q96RI1,Bile acid receptor,9971.0,NR1H4,9606.0,Homo sapiens (human),,,,PMID:19159286|DOI:10.1021/jm8014124,https://www.ncbi.nlm.nih.gov/pubmed/19159286|https://doi.org/10.1021/jm8014124,19159286,10.1021/jm8014124,
6892,2029023,25125014,IUPHAR/BPS Guide to PHARMACOLOGY,"(2S,3S)-3-[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]butane-1,2,4-triol",8176,BS-194,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8176,1981,cyclin dependent kinase 9,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1981,P50750,Cyclin-dependent kinase 9,1025.0,CDK9,9606.0,Homo sapiens (human),Inhibition,pIC50,7.05,PMID:21080703,https://www.ncbi.nlm.nih.gov/pubmed/21080703,21080703,,
6893,2029024,25125014,IUPHAR/BPS Guide to PHARMACOLOGY,"(2S,3S)-3-[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]butane-1,2,4-triol",8176,BS-194,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8176,1979,cyclin dependent kinase 7,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1979,P50613,Cyclin-dependent kinase 7,1022.0,CDK7,9606.0,Homo sapiens (human),Inhibition,pIC50,6.6,PMID:21080703,https://www.ncbi.nlm.nih.gov/pubmed/21080703,21080703,,
6894,2029025,25125014,IUPHAR/BPS Guide to PHARMACOLOGY,"(2S,3S)-3-[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]butane-1,2,4-triol",8176,BS-194,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8176,1977,cyclin dependent kinase 5,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1977,Q00535,Cyclin-dependent-like kinase 5 ,1020.0,CDK5,9606.0,Homo sapiens (human),Inhibition,pIC50,7.52,PMID:21080703,https://www.ncbi.nlm.nih.gov/pubmed/21080703,21080703,,
6895,2029029,25125014,IUPHAR/BPS Guide to PHARMACOLOGY,"(2S,3S)-3-[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]butane-1,2,4-triol",8176,BS-194,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8176,1961,cyclin dependent kinase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1961,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),Inhibition,pIC50,7.48,PMID:21080703,https://www.ncbi.nlm.nih.gov/pubmed/21080703,21080703,,
6896,2029030,25125014,IUPHAR/BPS Guide to PHARMACOLOGY,"(2S,3S)-3-[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]butane-1,2,4-triol",8176,BS-194,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8176,1973,cyclin dependent kinase 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1973,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),Inhibition,pIC50,8.52,PMID:21080703,https://www.ncbi.nlm.nih.gov/pubmed/21080703,21080703,,
6897,2029219,25125452,IUPHAR/BPS Guide to PHARMACOLOGY,2-[4-[4-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenyl]cyclohexyl]acetic acid,7661,A-935142,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7661,572,Kv11.1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=572,Q12809,Potassium voltage-gated channel subfamily H member 2,3757.0,KCNH2,9606.0,Homo sapiens (human),,,4.9 - 5,PMID:19426677,https://www.ncbi.nlm.nih.gov/pubmed/19426677,19426677,,
6898,2028004,25126798,DrugBank,Ruxolitinib,DB08877,Ruxolitinib,https://www.drugbank.ca/drugs/DB08877,BE0002408,Tyrosine-protein kinase JAK2,https://www.drugbank.ca/bio_entities/BE0002408,O60674,Tyrosine-protein kinase JAK2,3717.0,JAK2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:23514013|PMID:23061804|PMID:21919691,https://www.ncbi.nlm.nih.gov/pubmed/23514013|https://www.ncbi.nlm.nih.gov/pubmed/23061804|https://www.ncbi.nlm.nih.gov/pubmed/21919691,23514013|23061804|21919691,,
6899,2028005,25126798,DrugBank,Ruxolitinib,DB08877,Ruxolitinib,https://www.drugbank.ca/drugs/DB08877,BE0004145,Tyrosine-protein kinase JAK1,https://www.drugbank.ca/bio_entities/BE0004145,P23458,Tyrosine-protein kinase JAK1,3716.0,JAK1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:23514013|PMID:23061804|PMID:21919691,https://www.ncbi.nlm.nih.gov/pubmed/23514013|https://www.ncbi.nlm.nih.gov/pubmed/23061804|https://www.ncbi.nlm.nih.gov/pubmed/21919691,23514013|23061804|21919691,,
6900,2028006,25126798,DrugBank,Ruxolitinib,DB08877,Ruxolitinib,https://www.drugbank.ca/drugs/DB08877,BE0003493,Tyrosine-protein kinase JAK3,https://www.drugbank.ca/bio_entities/BE0003493,P52333,Tyrosine-protein kinase JAK3,3718.0,JAK3,9606.0,Homo sapiens (human),Inhibitor,,,PMID:23061804|PMID:21919691,https://www.ncbi.nlm.nih.gov/pubmed/23061804|https://www.ncbi.nlm.nih.gov/pubmed/21919691,23061804|21919691,,
6901,2028007,25126798,DrugBank,Ruxolitinib,DB08877,Ruxolitinib,https://www.drugbank.ca/drugs/DB08877,BE0004146,Non-receptor tyrosine-protein kinase TYK2,https://www.drugbank.ca/bio_entities/BE0004146,P29597,Non-receptor tyrosine-protein kinase TYK2,7297.0,TYK2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:21919691|PMID:23061804,https://www.ncbi.nlm.nih.gov/pubmed/21919691|https://www.ncbi.nlm.nih.gov/pubmed/23061804,21919691|23061804,,
6902,2028008,25126798,DrugBank,Ruxolitinib,DB08877,Ruxolitinib,https://www.drugbank.ca/drugs/DB08877,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate,,,PMID:23061804|PMID:24756798|PMID:30069628,https://www.ncbi.nlm.nih.gov/pubmed/23061804|https://www.ncbi.nlm.nih.gov/pubmed/24756798|https://www.ncbi.nlm.nih.gov/pubmed/30069628,23061804|24756798|30069628,,
6903,2028009,25126798,DrugBank,Ruxolitinib,DB08877,Ruxolitinib,https://www.drugbank.ca/drugs/DB08877,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606.0,Homo sapiens (human),Substrate,,,PMID:31145690,https://www.ncbi.nlm.nih.gov/pubmed/31145690,31145690,,
6904,2028010,25126798,DrugBank,Ruxolitinib,DB08877,Ruxolitinib,https://www.drugbank.ca/drugs/DB08877,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606.0,Homo sapiens (human),Binder,,,,,,,
6905,2028279,25126798,Therapeutic Target Database (TTD),Ruxolitinib,D04LKS,Ruxolitinib,https://idrblab.net/ttd/data/drug/details/D04LKS,T74363,Urokinase plasminogen activator surface receptor (PLAUR),https://idrblab.net/ttd/data/target/details/T74363,Q03405,Urokinase plasminogen activator surface receptor,5329.0,PLAUR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6906,2028500,25126798,Drug Gene Interaction database (DGIdb),Ruxolitinib,,RUXOLITINIB,https://www.dgidb.org/drugs/rxcui:1193326,,TP53,https://www.dgidb.org/genes/hgnc:11998,,,7157.0,TP53,9606.0,Homo sapiens (human),,,,,,,,
6907,2028501,25126798,Drug Gene Interaction database (DGIdb),Ruxolitinib,,RUXOLITINIB,https://www.dgidb.org/drugs/rxcui:1193326,,CSF3R,https://www.dgidb.org/genes/hgnc:2439,,,1441.0,CSF3R,9606.0,Homo sapiens (human),,,,,,,,
6908,2028502,25126798,Drug Gene Interaction database (DGIdb),Ruxolitinib,,RUXOLITINIB,https://www.dgidb.org/drugs/rxcui:1193326,,CSF3R,https://www.dgidb.org/genes/hgnc:2439,,,1441.0,CSF3R,9606.0,Homo sapiens (human),,,,,,,,
6909,2028503,25126798,Drug Gene Interaction database (DGIdb),Ruxolitinib,,RUXOLITINIB,https://www.dgidb.org/drugs/rxcui:1193326,,JAK2,https://www.dgidb.org/genes/hgnc:6192,,,3717.0,JAK2,9606.0,Homo sapiens (human),,,,,,,,
6910,2028504,25126798,Drug Gene Interaction database (DGIdb),Ruxolitinib,,RUXOLITINIB,https://www.dgidb.org/drugs/rxcui:1193326,,JAK2,https://www.dgidb.org/genes/hgnc:6192,,,3717.0,JAK2,9606.0,Homo sapiens (human),,,,,,,,
6911,2029026,25126798,Drug Gene Interaction database (DGIdb),Ruxolitinib,,RUXOLITINIB,https://www.dgidb.org/drugs/rxcui:1193326,,SH2B3,https://www.dgidb.org/genes/hgnc:29605,,,10019.0,SH2B3,9606.0,Homo sapiens (human),,,,,,,,
6912,2029220,25126798,Drug Gene Interaction database (DGIdb),Ruxolitinib,,RUXOLITINIB,https://www.dgidb.org/drugs/rxcui:1193326,,PLAUR,https://www.dgidb.org/genes/hgnc:9053,,,5329.0,PLAUR,9606.0,Homo sapiens (human),,,,,,,,
6913,2029221,25127112,Drug Gene Interaction database (DGIdb),Ruxolitinib Phosphate,,RUXOLITINIB PHOSPHATE,https://www.dgidb.org/drugs/rxcui:1193325,,JAK1,https://www.dgidb.org/genes/hgnc:6190,,,3716.0,JAK1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6914,2029222,25127112,Drug Gene Interaction database (DGIdb),Ruxolitinib Phosphate,,RUXOLITINIB PHOSPHATE,https://www.dgidb.org/drugs/rxcui:1193325,,JAK2,https://www.dgidb.org/genes/hgnc:6192,,,3717.0,JAK2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6915,2028280,25127713,Drug Gene Interaction database (DGIdb),Poziotinib,,POZIOTINIB,https://www.dgidb.org/drugs/ncit:C98838,,EGFR,https://www.dgidb.org/genes/hgnc:3236,,,1956.0,EGFR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6916,2029027,25127713,Therapeutic Target Database (TTD),Poziotinib,D00YER,HM-78136B,https://idrblab.net/ttd/data/drug/details/D00YER,T14597,Erbb2 tyrosine kinase receptor (HER2),https://idrblab.net/ttd/data/target/details/T14597,P04626,Receptor tyrosine-protein kinase erbB-2,2064.0,ERBB2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6917,2029028,25127713,Therapeutic Target Database (TTD),Poziotinib,D00YER,HM-78136B,https://idrblab.net/ttd/data/drug/details/D00YER,T59328,Epidermal growth factor receptor (EGFR),https://idrblab.net/ttd/data/target/details/T59328,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6918,2029223,25127713,Drug Gene Interaction database (DGIdb),Poziotinib,,POZIOTINIB,https://www.dgidb.org/drugs/ncit:C98838,,ERBB3,https://www.dgidb.org/genes/hgnc:3431,,,2065.0,ERBB3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6919,2028281,25128145,Drug Gene Interaction database (DGIdb),Filorexant,,FILOREXANT,https://www.dgidb.org/drugs/ncit:C169980,,HCRTR2,https://www.dgidb.org/genes/hgnc:4849,,,3062.0,HCRTR2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6920,2028505,25128145,Drug Gene Interaction database (DGIdb),Filorexant,,FILOREXANT,https://www.dgidb.org/drugs/ncit:C169980,,HCRTR1,https://www.dgidb.org/genes/hgnc:4848,,,3061.0,HCRTR1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6921,2028506,25129137,DrugBank,"2,6-dibromo-4-[(E)-2-phenylethenyl]phenol",DB08101,"2,6-dibromo-4-[(E)-2-phenylethenyl]phenol",https://www.drugbank.ca/drugs/DB08101,BE0000337,Transthyretin,https://www.drugbank.ca/bio_entities/BE0000337,P02766,Transthyretin,7276.0,TTR,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6922,2028282,25134245,DrugBank,cis-4-Methyl-N-[(1S)-3-(methylsulfanyl)-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,DB07569,CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE,https://www.drugbank.ca/drugs/DB07569,BE0001730,Lanosterol 14-alpha demethylase,https://www.drugbank.ca/bio_entities/BE0001730,P10614,Lanosterol 14-alpha demethylase,856398.0,ERG11,559292.0,Saccharomyces cerevisiae S288C,,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6923,2028283,25134246,DrugBank,N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,DB07560,N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,https://www.drugbank.ca/drugs/DB07560,BE0001730,Lanosterol 14-alpha demethylase,https://www.drugbank.ca/bio_entities/BE0001730,P10614,Lanosterol 14-alpha demethylase,856398.0,ERG11,559292.0,Saccharomyces cerevisiae S288C,,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6924,2028304,25134248,DrugBank,(S)-N-(4-Carbamimidoylbenzyl)-1-(3-Cyclohexylpropanoyl)pyrrolidine-2-Carboxamide,DB07131,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,https://www.drugbank.ca/drugs/DB07131,BE0001739,Trypsin-1,https://www.drugbank.ca/bio_entities/BE0001739,P07477,Trypsin-1,5644.0,PRSS1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6925,2028305,25134248,DrugBank,(S)-N-(4-Carbamimidoylbenzyl)-1-(3-Cyclohexylpropanoyl)pyrrolidine-2-Carboxamide,DB07131,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,https://www.drugbank.ca/drugs/DB07131,BE0000048,Prothrombin,https://www.drugbank.ca/bio_entities/BE0000048,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6926,2028306,25134249,DrugBank,N-(1-Benzylpiperidin-4-Yl)-4-Sulfanylbutanamide,DB07734,N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide,https://www.drugbank.ca/drugs/DB07734,BE0000988,Beta-secretase 1,https://www.drugbank.ca/bio_entities/BE0000988,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6927,2028307,25134250,DrugBank,"N-[1-(2,6-Dimethoxybenzyl)piperidin-4-Yl]-4-Sulfanylbutanamide",DB07735,"N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",https://www.drugbank.ca/drugs/DB07735,BE0000988,Beta-secretase 1,https://www.drugbank.ca/bio_entities/BE0000988,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6928,2028308,25134251,DrugBank,(2s)-4-(4-Fluorobenzyl)-N-(2-Sulfanylethyl)piperazine-2-Carboxamide,DB07736,(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide,https://www.drugbank.ca/drugs/DB07736,BE0000988,Beta-secretase 1,https://www.drugbank.ca/bio_entities/BE0000988,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6929,2028309,25134252,DrugBank,(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide,DB07737,(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide,https://www.drugbank.ca/drugs/DB07737,BE0000988,Beta-secretase 1,https://www.drugbank.ca/bio_entities/BE0000988,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6930,2028310,25134253,DrugBank,"N-[1-(5-Bromo-2,3-Dimethoxybenzyl)piperidin-4-Yl]-4-Sulfanylbutanamide",DB07738,"N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",https://www.drugbank.ca/drugs/DB07738,BE0000988,Beta-secretase 1,https://www.drugbank.ca/bio_entities/BE0000988,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6931,2028311,25134257,DrugBank,"2-(4-Hydroxybiphenyl-3-Yl)-4-Methyl-1h-Isoindole-1,3(2h)-Dione",DB07507,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",https://www.drugbank.ca/drugs/DB07507,BE0001501,Thymidylate synthase,https://www.drugbank.ca/bio_entities/BE0001501,P00469,Thymidylate synthase,,,1582.0,Lacticaseibacillus casei,,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6932,2028507,25134267,DrugBank,"N-[(2R)-2-{[(2S)-2-(1,3-Benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",DB08310,"N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",https://www.drugbank.ca/drugs/DB08310,BE0004268,Peptide deformylase,https://www.drugbank.ca/bio_entities/BE0004268,P9WIJ3,Peptide deformylase,45424390.0,MCAN_RS02220,83332.0,Mycobacterium tuberculosis H37Rv,,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6933,2028508,25134303,Drug Gene Interaction database (DGIdb),"4-Chloro-N-[5-methyl-2-[7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl]-3-pyridyl]-3-(trifluoromethyl)benzenesulfonamide",,ILACIRNON,https://www.dgidb.org/drugs/ncit:C175798,,CCR2,https://www.dgidb.org/genes/hgnc:1603,,,729230.0,CCR2,9606.0,Homo sapiens (human),,,,,,,,
6934,2029224,25134303,IUPHAR/BPS Guide to PHARMACOLOGY,"4-Chloro-N-[5-methyl-2-[7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl]-3-pyridyl]-3-(trifluoromethyl)benzenesulfonamide",11185,ilacirnon,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11185,59,CCR2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=59,P41597,C-C chemokine receptor type 2,,,9606.0,Homo sapiens (human),Antagonist,pIC50,8.3,,,,,
6935,2029225,25134303,IUPHAR/BPS Guide to PHARMACOLOGY,"4-Chloro-N-[5-methyl-2-[7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl]-3-pyridyl]-3-(trifluoromethyl)benzenesulfonamide",11185,ilacirnon,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11185,59,CCR2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=59,,,1231.0,CCR2,9606.0,Homo sapiens (human),Antagonist,pIC50,8.3,,,,,
6936,2028509,25134326,Drug Gene Interaction database (DGIdb),"N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine",,ALK INHIBITOR ASP3026,https://www.dgidb.org/drugs/ncit:C116727,,EML4,https://www.dgidb.org/genes/hgnc:1316,,,27436.0,EML4,9606.0,Homo sapiens (human),,,,,,,,
6937,2029226,25134326,ChEMBL,"N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine",CHEMBL3545360,ASP-3026,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545360/,CHEMBL4247,ALK tyrosine kinase receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL4247/,Q9UM73,ALK tyrosine kinase receptor,238.0,ALK,9606.0,Homo sapiens (human),ALK tyrosine kinase receptor inhibitor,,,PMID:24419060,https://www.ncbi.nlm.nih.gov/pubmed/24419060,24419060,,
6938,2028312,25138203,DrugBank,N-{2-Methyl-5-[(6-Phenylpyrimidin-4-Yl)amino]phenyl}methanesulfonamide,DB07175,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,https://www.drugbank.ca/drugs/DB07175,BE0000988,Beta-secretase 1,https://www.drugbank.ca/bio_entities/BE0000988,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6939,2028313,25138278,DrugBank,,DB08066,N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,https://www.drugbank.ca/drugs/DB08066,BE0000991,Aurora kinase A,https://www.drugbank.ca/bio_entities/BE0000991,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6940,2028314,25138278,DrugBank,,DB08066,N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,https://www.drugbank.ca/drugs/DB08066,BE0001072,Cyclin-dependent kinase 2,https://www.drugbank.ca/bio_entities/BE0001072,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6941,2028315,25138280,DrugBank,,DB08067,4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM,https://www.drugbank.ca/drugs/DB08067,BE0002408,Tyrosine-protein kinase JAK2,https://www.drugbank.ca/bio_entities/BE0002408,O60674,Tyrosine-protein kinase JAK2,3717.0,JAK2,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6942,2028316,25138289,DrugBank,(2s)-3-[(R)-[(1s)-1-Amino-3-Phenylpropyl](Hydroxy)phosphoryl]-2-Benzylpropanoic Acid,DB07448,(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid,https://www.drugbank.ca/drugs/DB07448,BE0003882,Cytosol aminopeptidase,https://www.drugbank.ca/bio_entities/BE0003882,P28838,Cytosol aminopeptidase,51056.0,LAP3,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6943,2028317,25138294,DrugBank,N-(5-(5-Fluoro-6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl)acetamide,DB07152,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,https://www.drugbank.ca/drugs/DB07152,BE0003782,TGF-beta receptor type-1,https://www.drugbank.ca/bio_entities/BE0003782,P36897,TGF-beta receptor type-1,7046.0,TGFBR1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6944,2028318,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,NTRK2,https://www.dgidb.org/genes/hgnc:8032,,,4915.0,NTRK2,9606.0,Homo sapiens (human),,,,,,,,
6945,2028510,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,NTRK2,https://www.dgidb.org/genes/hgnc:8032,,,4915.0,NTRK2,9606.0,Homo sapiens (human),,,,,,,,
6946,2028511,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,ALK,https://www.dgidb.org/genes/hgnc:427,,,238.0,ALK,9606.0,Homo sapiens (human),,,,,,,,
6947,2029031,25141092,Therapeutic Target Database (TTD),Entrectinib,D0O0LS,Entrectinib,https://idrblab.net/ttd/data/drug/details/D0O0LS,T69128,Proto-oncogene c-Ros (ROS1),https://idrblab.net/ttd/data/target/details/T69128,P08922,Proto-oncogene tyrosine-protein kinase ROS,6098.0,ROS1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6948,2029068,25141092,Therapeutic Target Database (TTD),Entrectinib,D0O0LS,Entrectinib,https://idrblab.net/ttd/data/drug/details/D0O0LS,T56418,ALK tyrosine kinase receptor (ALK),https://idrblab.net/ttd/data/target/details/T56418,Q9UM73,ALK tyrosine kinase receptor,238.0,ALK,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6949,2029069,25141092,Therapeutic Target Database (TTD),Entrectinib,D0O0LS,Entrectinib,https://idrblab.net/ttd/data/drug/details/D0O0LS,T84703,BDNF/NT-3 growth factors receptor (TrkB),https://idrblab.net/ttd/data/target/details/T84703,Q16620,BDNF/NT-3 growth factors receptor,4915.0,NTRK2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6950,2029070,25141092,Therapeutic Target Database (TTD),Entrectinib,D0O0LS,Entrectinib,https://idrblab.net/ttd/data/drug/details/D0O0LS,T51076,NT-3 growth factor receptor (TrkC),https://idrblab.net/ttd/data/target/details/T51076,Q16288,NT-3 growth factor receptor,4916.0,NTRK3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6951,2029071,25141092,Therapeutic Target Database (TTD),Entrectinib,D0O0LS,Entrectinib,https://idrblab.net/ttd/data/drug/details/D0O0LS,T07173,Tropomyosin-related kinase A (TrkA),https://idrblab.net/ttd/data/target/details/T07173,P04629,High affinity nerve growth factor receptor,4914.0,NTRK1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6952,2029072,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,FLT3,https://www.dgidb.org/genes/hgnc:3765,,,2322.0,FLT3,9606.0,Homo sapiens (human),,,,,,,,
6953,2029073,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,ROS1,https://www.dgidb.org/genes/hgnc:10261,,,6098.0,ROS1,9606.0,Homo sapiens (human),,,,,,,,
6954,2029074,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,EML4,https://www.dgidb.org/genes/hgnc:1316,,,27436.0,EML4,9606.0,Homo sapiens (human),,,,,,,,
6955,2029075,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,FER,https://www.dgidb.org/genes/hgnc:3655,,,2241.0,FER,9606.0,Homo sapiens (human),,,,,,,,
6956,2029076,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,PLK4,https://www.dgidb.org/genes/hgnc:11397,,,10733.0,PLK4,9606.0,Homo sapiens (human),,,,,,,,
6957,2029077,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,LCK,https://www.dgidb.org/genes/hgnc:6524,,,3932.0,LCK,9606.0,Homo sapiens (human),,,,,,,,
6958,2029078,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,RPS6KA3,https://www.dgidb.org/genes/hgnc:10432,,,6197.0,RPS6KA3,9606.0,Homo sapiens (human),,,,,,,,
6959,2029079,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,MST1R,https://www.dgidb.org/genes/hgnc:7381,,,4486.0,MST1R,9606.0,Homo sapiens (human),,,,,,,,
6960,2029080,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,CLK4,https://www.dgidb.org/genes/hgnc:13659,,,57396.0,CLK4,9606.0,Homo sapiens (human),,,,,,,,
6961,2029081,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,MET,https://www.dgidb.org/genes/hgnc:7029,,,4233.0,MET,9606.0,Homo sapiens (human),,,,,,,,
6962,2029082,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,SLK,https://www.dgidb.org/genes/hgnc:11088,,,9748.0,SLK,9606.0,Homo sapiens (human),,,,,,,,
6963,2029083,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,CLK2,https://www.dgidb.org/genes/hgnc:2069,,,1196.0,CLK2,9606.0,Homo sapiens (human),,,,,,,,
6964,2029084,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,KDR,https://www.dgidb.org/genes/hgnc:6307,,,3791.0,KDR,9606.0,Homo sapiens (human),,,,,,,,
6965,2029085,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,AXL,https://www.dgidb.org/genes/hgnc:905,,,558.0,AXL,9606.0,Homo sapiens (human),,,,,,,,
6966,2029102,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,BTK,https://www.dgidb.org/genes/hgnc:1133,,,695.0,BTK,9606.0,Homo sapiens (human),,,,,,,,
6967,2029103,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,IGF1R,https://www.dgidb.org/genes/hgnc:5465,,,3480.0,IGF1R,9606.0,Homo sapiens (human),,,,,,,,
6968,2029104,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,AURKA,https://www.dgidb.org/genes/hgnc:11393,,,6790.0,AURKA,9606.0,Homo sapiens (human),,,,,,,,
6969,2011786,25145656,Drug Gene Interaction database (DGIdb),Capmatinib,,CAPMATINIB,https://www.dgidb.org/drugs/rxcui:2362165,,MET,https://www.dgidb.org/genes/hgnc:7029,,,4233.0,MET,9606.0,Homo sapiens (human),,,,,,,,
6970,2029105,25145656,Therapeutic Target Database (TTD),Capmatinib,D07OJZ,Capmatinib,https://idrblab.net/ttd/data/drug/details/D07OJZ,T40474,Proto-oncogene c-Met (MET),https://idrblab.net/ttd/data/target/details/T40474,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),Modulator,,,,,,,
6971,2028112,25145683,BindingDB,"13-(carbamoylmethyl)-3-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-8-thia-4,6-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-triene-5-carboxamide",27878,"13-(carbamoylmethyl)-3-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-8-thia-4,6-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-triene-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27878,8198,Matrix metalloproteinase-14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8198,P50281,Matrix metalloproteinase-14,4323.0,MMP14,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:22689580|DOI:10.1074/jbc.M112.380782,https://www.ncbi.nlm.nih.gov/pubmed/22689580|https://doi.org/10.1074/jbc.M112.380782,22689580,10.1074/jbc.M112.380782,
6972,2028512,25147494,DrugBank,5'-Deoxy-5'-Piperidin-1-Ylthymidine,DB08596,5'-deoxy-5'-piperidin-1-ylthymidine,https://www.drugbank.ca/drugs/DB08596,BE0003317,Ribonuclease pancreatic,https://www.drugbank.ca/bio_entities/BE0003317,P07998,Ribonuclease pancreatic,6035.0,RNASE1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6973,2028513,25147495,DrugBank,"1-(2,5-Dideoxy-5-Pyrrolidin-1-Yl-Beta-L-Erythro-Pentofuranosyl)-5-Methylpyrimidine-2,4(1h,3h)-Dione",DB08661,"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",https://www.drugbank.ca/drugs/DB08661,BE0003317,Ribonuclease pancreatic,https://www.drugbank.ca/bio_entities/BE0003317,P07998,Ribonuclease pancreatic,6035.0,RNASE1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6974,2028072,25147562,BindingDB,2-(5-Bromopyridin-3-yl)-1-[5-(4-chlorophenyl)furan-2-yl]ethanone,429428,acs.jmedchem.1c00409_ST.543,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=429428,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,IC50 (nM),13000,PMID:34798775|DOI:10.1021/acs.jmedchem.1c00409,https://www.ncbi.nlm.nih.gov/pubmed/34798775|https://doi.org/10.1021/acs.jmedchem.1c00409,34798775,10.1021/acs.jmedchem.1c00409,
6975,2028073,25147563,BindingDB,2-(5-Bromopyridin-3-yl)-1-(5-(4-chlorophenyl)furan-2-yl)-2-fluoroethanone,429429,acs.jmedchem.1c00409_ST.652,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=429429,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009.0,Severe acute respiratory syndrome-related coronavirus,,IC50 (nM),28000,PMID:34798775|DOI:10.1021/acs.jmedchem.1c00409,https://www.ncbi.nlm.nih.gov/pubmed/34798775|https://doi.org/10.1021/acs.jmedchem.1c00409,34798775,10.1021/acs.jmedchem.1c00409,
6976,2028074,25147644,ChEMBL,Bradanicline,CHEMBL1258006,BRADANICLINE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1258006/,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2492/,P36544,Neuronal acetylcholine receptor subunit alpha-7,1139.0,CHRNA7,9606.0,Homo sapiens (human),Neuronal acetylcholine receptor protein alpha-7 subunit agonist,,,PMID:19482012|PMID:23126648,https://www.ncbi.nlm.nih.gov/pubmed/19482012|https://www.ncbi.nlm.nih.gov/pubmed/23126648,19482012|23126648,,
6977,2028319,25147644,IUPHAR/BPS Guide to PHARMACOLOGY,Bradanicline,3969,bradanicline,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3969,468,nicotinic acetylcholine receptor α7 subunit,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=468,P36544,Neuronal acetylcholine receptor subunit alpha-7,,,9606.0,Homo sapiens (human),Full agonist,,8.52,PMID:19482012,https://www.ncbi.nlm.nih.gov/pubmed/19482012,19482012,,
6978,2028320,25147644,IUPHAR/BPS Guide to PHARMACOLOGY,Bradanicline,3969,bradanicline,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3969,468,nicotinic acetylcholine receptor α7 subunit,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=468,,,1139.0,CHRNA7,9606.0,Homo sapiens (human),Full agonist,,8.52,PMID:19482012,https://www.ncbi.nlm.nih.gov/pubmed/19482012,19482012,,
6979,2028514,25147644,Drug Gene Interaction database (DGIdb),Bradanicline,,BRADANICLINE,https://www.dgidb.org/drugs/ncit:C169814,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,,,,,
6980,2028075,25147683,ChEMBL,Tarafenacin,CHEMBL1779046,TARAFENACIN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1779046/,CHEMBL245,Muscarinic acetylcholine receptor M3,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL245/,P20309,Muscarinic acetylcholine receptor M3,1131.0,CHRM3,9606.0,Homo sapiens (human),Muscarinic acetylcholine receptor M3 antagonist,,,PMID:19222482|PMID:25363415,https://www.ncbi.nlm.nih.gov/pubmed/19222482|https://www.ncbi.nlm.nih.gov/pubmed/25363415,19222482|25363415,,
6981,2028321,25147683,Drug Gene Interaction database (DGIdb),Tarafenacin,,TARAFENACIN,https://www.dgidb.org/drugs/ncit:C87644,,CHRM3,https://www.dgidb.org/genes/hgnc:1952,,,1131.0,CHRM3,9606.0,Homo sapiens (human),,,,,,,,
6982,2029106,25147683,Therapeutic Target Database (TTD),Tarafenacin,D04YEW,Tarafenacin,https://idrblab.net/ttd/data/drug/details/D04YEW,T67684,Muscarinic acetylcholine receptor M3 (CHRM3),https://idrblab.net/ttd/data/target/details/T67684,P20309,Muscarinic acetylcholine receptor M3,1131.0,CHRM3,9606.0,Homo sapiens (human),Antagonist,,,,,,,
6983,2028113,25147749,IUPHAR/BPS Guide to PHARMACOLOGY,"(6,6-Dimethyl-5,6-Dihydroimidazo[2,1-B][1,3]thiazol-3-Yl)methyl N,N'-Dicyclohexylimidothiocarbamate",2899,isothiourea-1t,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2899,71,CXCR4,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=71,P61073,C-X-C chemokine receptor type 4,7852.0,CXCR4,9606.0,Homo sapiens (human),Antagonist,pEC50,9,PMID:19053768,https://www.ncbi.nlm.nih.gov/pubmed/19053768,19053768,,
6984,2028114,25147749,IUPHAR/BPS Guide to PHARMACOLOGY,"(6,6-Dimethyl-5,6-Dihydroimidazo[2,1-B][1,3]thiazol-3-Yl)methyl N,N'-Dicyclohexylimidothiocarbamate",2899,isothiourea-1t,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2899,71,CXCR4,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=71,P61073,C-X-C chemokine receptor type 4,7852.0,CXCR4,9606.0,Homo sapiens (human),Antagonist,pIC50,8 - 8.1,PMID:19053768|PMID:30476826,https://www.ncbi.nlm.nih.gov/pubmed/19053768|https://www.ncbi.nlm.nih.gov/pubmed/30476826,19053768|30476826,,
6985,2028115,25147749,IUPHAR/BPS Guide to PHARMACOLOGY,"(6,6-Dimethyl-5,6-Dihydroimidazo[2,1-B][1,3]thiazol-3-Yl)methyl N,N'-Dicyclohexylimidothiocarbamate",2899,isothiourea-1t,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2899,71,CXCR4,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=71,O08565,C-X-C chemokine receptor type 4,60628.0,Cxcr4,10116.0,Rattus norvegicus (Norway rat),Antagonist,pIC50,7.96,PMID:19053768,https://www.ncbi.nlm.nih.gov/pubmed/19053768,19053768,,
6986,2028116,25147749,Therapeutic Target Database (TTD),"(6,6-Dimethyl-5,6-Dihydroimidazo[2,1-B][1,3]thiazol-3-Yl)methyl N,N'-Dicyclohexylimidothiocarbamate",D05VQJ,isothiourea-1t,https://idrblab.net/ttd/data/drug/details/D05VQJ,T96079,C-X-C chemokine receptor type 4 (CXCR4),https://idrblab.net/ttd/data/target/details/T96079,P61073,C-X-C chemokine receptor type 4,7852.0,CXCR4,9606.0,Homo sapiens (human),Antagonist,,,,,,,
6987,2028117,25147760,IUPHAR/BPS Guide to PHARMACOLOGY,"2-[4-(2-Bromo-5-thienyl)phenyl]-4-methyl-octahydro-1,4-benzoxazin-2-ol",3072,compound 9 [PMID: 18754614],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3072,645,squalene synthase ,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=645,Q02769,Squalene synthase,29580.0,Fdft1,10116.0,Rattus norvegicus (Norway rat),Inhibition,pIC50,6,PMID:18754614,https://www.ncbi.nlm.nih.gov/pubmed/18754614,18754614,,
6988,2028034,25147798,Comparative Toxicogenomics Database (CTD),Roflupram,C000627560,roflupram,https://ctdbase.org/detail.go?type=chem&acc=C000627560,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,10090.0,Mus musculus (house mouse),Roflupram inhibits the reaction [copper sulfate results in decreased expression of KEAP1 mrna],,,PMID:37353053,https://www.ncbi.nlm.nih.gov/pubmed/37353053,37353053,,
6989,2028035,25147798,Comparative Toxicogenomics Database (CTD),Roflupram,C000627560,roflupram,https://ctdbase.org/detail.go?type=chem&acc=C000627560,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090.0,Mus musculus (house mouse),Roflupram inhibits the reaction [copper sulfate results in increased expression of NFE2L2 mrna],,,PMID:37353053,https://www.ncbi.nlm.nih.gov/pubmed/37353053,37353053,,
6990,2028036,25147798,Comparative Toxicogenomics Database (CTD),Roflupram,C000627560,roflupram,https://ctdbase.org/detail.go?type=chem&acc=C000627560,114548,NLRP3,https://ctdbase.org/detail.go?type=gene&acc=114548,,,114548.0,NLRP3,10090.0,Mus musculus (house mouse),Roflupram inhibits the reaction [copper sulfate results in increased expression of NLRP3 protein],,,PMID:37353053,https://www.ncbi.nlm.nih.gov/pubmed/37353053,37353053,,
6991,2028037,25147798,Comparative Toxicogenomics Database (CTD),Roflupram,C000627560,roflupram,https://ctdbase.org/detail.go?type=chem&acc=C000627560,5142,PDE4B,https://ctdbase.org/detail.go?type=gene&acc=5142,,,5142.0,PDE4B,10090.0,Mus musculus (house mouse),Roflupram inhibits the reaction [copper sulfate results in increased expression of PDE4B protein],,,PMID:37353053,https://www.ncbi.nlm.nih.gov/pubmed/37353053,37353053,,
6992,2028038,25147798,Comparative Toxicogenomics Database (CTD),Roflupram,C000627560,roflupram,https://ctdbase.org/detail.go?type=chem&acc=C000627560,5566,PRKACA,https://ctdbase.org/detail.go?type=gene&acc=5566,,,5566.0,PRKACA,10090.0,Mus musculus (house mouse),Roflupram inhibits the reaction [copper sulfate results in decreased expression of PRKACA protein]|roflupram inhibits the reaction [copper sulfate results in decreased expression of PRKACA mrna],,,PMID:37353053,https://www.ncbi.nlm.nih.gov/pubmed/37353053,37353053,,
6993,2028039,25147798,Comparative Toxicogenomics Database (CTD),Roflupram,C000627560,roflupram,https://ctdbase.org/detail.go?type=chem&acc=C000627560,29108,PYCARD,https://ctdbase.org/detail.go?type=gene&acc=29108,,,29108.0,PYCARD,10090.0,Mus musculus (house mouse),Roflupram inhibits the reaction [copper sulfate results in increased expression of PYCARD mrna],,,PMID:37353053,https://www.ncbi.nlm.nih.gov/pubmed/37353053,37353053,,
6994,2028542,25148534,Comparative Toxicogenomics Database (CTD),chaetomugilin D,C539431,chaetomugilin D,https://ctdbase.org/detail.go?type=chem&acc=C539431,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Chaetomugilin D results in increased expression of and results in increased secretion of TNF protein,,,PMID:28535995,https://www.ncbi.nlm.nih.gov/pubmed/28535995,28535995,,
6995,2028543,25150849,Therapeutic Target Database (TTD),"(1R,3S)-5-[2-[(1R,3aS,7aS)-1-[(2R,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-4-yl]ethyl]-4-methylcyclohex-4-ene-1,3-diol",D0O0RY,JB-1,https://idrblab.net/ttd/data/drug/details/D0O0RY,T48069,Insulin-like growth factor I receptor (IGF1R),https://idrblab.net/ttd/data/target/details/T48069,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
6996,2028322,25150855,DrugBank,"Methyl N-[(2',4'-difluoro-4-hydroxy-5-iodobiphenyl-3-YL)carbonyl]-beta-alaninate",DB07962,"METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE",https://www.drugbank.ca/drugs/DB07962,BE0000337,Transthyretin,https://www.drugbank.ca/bio_entities/BE0000337,P02766,Transthyretin,7276.0,TTR,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6997,2028323,25150856,DrugBank,"N-[(2',4'-Difluoro-4-hydroxy-5-iodobiphenyl-3-YL)carbonyl]-beta-alanine",DB07963,"N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE",https://www.drugbank.ca/drugs/DB07963,BE0000337,Transthyretin,https://www.drugbank.ca/bio_entities/BE0000337,P02766,Transthyretin,7276.0,TTR,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
6998,2028040,25150857,Chemical Probes Portal,"N-(1-benzylpiperidin-4-yl)-6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine",BIX-01294,BIX-01294,https://www.chemicalprobes.org/bix-01294,,EHMT2,,Q96KQ7,Histone-lysine N-methyltransferase EHMT2,10919.0,EHMT2,9606.0,Homo sapiens (human),Uncompetitive SAM inhibitor,,2.7 uM,,,,,"http://www.cell.com/molecular-cell/abstract/S1097-2765(07)00040-8?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1097276507000408%3Fshowall%3Dtrue, http://www.ncbi.nlm.nih.gov/pubmed/?term=17289593"
6999,2028041,25151352,Chemical Probes Portal,Pexidartinib,PEXIDARTINIB,PEXIDARTINIB,https://www.chemicalprobes.org/pexidartinib,,CSF1R,,P07333,Macrophage colony-stimulating factor 1 receptor,1436.0,CSF1R,9606.0,Homo sapiens (human),Inhibitor,,13 nM,,,,,
7000,2028042,25151352,Drug Gene Interaction database (DGIdb),Pexidartinib,,PEXIDARTINIB,https://www.dgidb.org/drugs/rxcui:2183102,,CSF3R,https://www.dgidb.org/genes/hgnc:2439,,,1441.0,CSF3R,9606.0,Homo sapiens (human),,,,,,,,
7001,2028076,25151352,ChEMBL,Pexidartinib,CHEMBL3813873,PEXIDARTINIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3813873/,CHEMBL1844,Macrophage colony stimulating factor receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1844/,P07333,Macrophage colony-stimulating factor 1 receptor,1436.0,CSF1R,9606.0,Homo sapiens (human),Macrophage colony stimulating factor receptor inhibitor,,,PMID:22039576|PMID:25847190,https://www.ncbi.nlm.nih.gov/pubmed/22039576|https://www.ncbi.nlm.nih.gov/pubmed/25847190,22039576|25847190,,
7002,2028077,25151352,ChEMBL,Pexidartinib,CHEMBL3813873,PEXIDARTINIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3813873/,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1974/,P36888,Receptor-type tyrosine-protein kinase FLT3,2322.0,FLT3,9606.0,Homo sapiens (human),Tyrosine-protein kinase receptor FLT3 inhibitor,,,PMID:22039576|PMID:25847190,https://www.ncbi.nlm.nih.gov/pubmed/22039576|https://www.ncbi.nlm.nih.gov/pubmed/25847190,22039576|25847190,,
7003,2028078,25151352,ChEMBL,Pexidartinib,CHEMBL3813873,PEXIDARTINIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3813873/,CHEMBL1936,Stem cell growth factor receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1936/,P10721,Mast/stem cell growth factor receptor Kit,3815.0,KIT,9606.0,Homo sapiens (human),Stem cell growth factor receptor inhibitor,,,PMID:22039576|PMID:25847190,https://www.ncbi.nlm.nih.gov/pubmed/22039576|https://www.ncbi.nlm.nih.gov/pubmed/25847190,22039576|25847190,,
7004,2028544,25151352,Drug Gene Interaction database (DGIdb),Pexidartinib,,PEXIDARTINIB,https://www.dgidb.org/drugs/rxcui:2183102,,KIT,https://www.dgidb.org/genes/hgnc:6342,,,3815.0,KIT,9606.0,Homo sapiens (human),,,,,,,,
7005,2029107,25151352,Therapeutic Target Database (TTD),Pexidartinib,D09TAB,Pexidartinib,https://idrblab.net/ttd/data/drug/details/D09TAB,T20333,Macrophage colony-stimulating factor 1 receptor (CSF1R),https://idrblab.net/ttd/data/target/details/T20333,P07333,Macrophage colony-stimulating factor 1 receptor,1436.0,CSF1R,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7006,2029108,25151352,Therapeutic Target Database (TTD),Pexidartinib,D09TAB,Pexidartinib,https://idrblab.net/ttd/data/drug/details/D09TAB,T57700,Tyrosine-protein kinase Kit (KIT),https://idrblab.net/ttd/data/target/details/T57700,P10721,Mast/stem cell growth factor receptor Kit,3815.0,KIT,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7007,2029109,25151352,Therapeutic Target Database (TTD),Pexidartinib,D09TAB,Pexidartinib,https://idrblab.net/ttd/data/drug/details/D09TAB,T74312,Fms-like tyrosine kinase 3 (FLT-3),https://idrblab.net/ttd/data/target/details/T74312,P36888,Receptor-type tyrosine-protein kinase FLT3,2322.0,FLT3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7008,2029110,25151352,Drug Gene Interaction database (DGIdb),Pexidartinib,,PEXIDARTINIB,https://www.dgidb.org/drugs/rxcui:2183102,,CSF1,https://www.dgidb.org/genes/hgnc:2432,,,1435.0,CSF1,9606.0,Homo sapiens (human),,,,,,,,
7009,2029111,25151352,IUPHAR/BPS Guide to PHARMACOLOGY,Pexidartinib,8710,pexidartinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8710,1972,cyclin dependent kinase 19,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1972,Q9BWU1,Cyclin-dependent kinase 19,23097.0,CDK19,9606.0,Homo sapiens (human),Inhibition,pIC50,6.85,PMID:26222558,https://www.ncbi.nlm.nih.gov/pubmed/26222558,26222558,,
7010,2011363,25151504,Comparative Toxicogenomics Database (CTD),Cobicistat,D000069547,Cobicistat,https://ctdbase.org/detail.go?type=chem&acc=D000069547,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),[rifampin co-treated with cobicistat] results in increased expression of BAX mRNA,,,PMID:33629115,https://www.ncbi.nlm.nih.gov/pubmed/33629115,33629115,,
7011,2011364,25151504,Comparative Toxicogenomics Database (CTD),Cobicistat,D000069547,Cobicistat,https://ctdbase.org/detail.go?type=chem&acc=D000069547,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),[[rifampin results in increased activity of NR1I2 protein] which results in increased activity of CYP3A4 protein] which results in increased metabolism of and results in increased activity of and results in increased susceptibility to cobicistat,,,PMID:33629115,https://www.ncbi.nlm.nih.gov/pubmed/33629115,33629115,,
7012,2011365,25151504,Comparative Toxicogenomics Database (CTD),Cobicistat,D000069547,Cobicistat,https://ctdbase.org/detail.go?type=chem&acc=D000069547,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10090.0,Mus musculus (house mouse),"[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with cobicistat] results in increased expression of DDIT3 mrna|[rifampin co-treated with cobicistat] results in increased expression of DDIT3 mRNA",,,PMID:33629115,https://www.ncbi.nlm.nih.gov/pubmed/33629115,33629115,,
7013,2011366,25151504,Comparative Toxicogenomics Database (CTD),Cobicistat,D000069547,Cobicistat,https://ctdbase.org/detail.go?type=chem&acc=D000069547,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,10090.0,Mus musculus (house mouse),[rifampin co-treated with cobicistat] results in increased expression of GPX2 mRNA,,,PMID:33629115,https://www.ncbi.nlm.nih.gov/pubmed/33629115,33629115,,
7014,2011367,25151504,Comparative Toxicogenomics Database (CTD),Cobicistat,D000069547,Cobicistat,https://ctdbase.org/detail.go?type=chem&acc=D000069547,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,10090.0,Mus musculus (house mouse),"[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with cobicistat] results in increased expression of HSPA5 mrna|[rifampin co-treated with cobicistat] results in increased expression of HSPA5 mRNA",,,PMID:33629115,https://www.ncbi.nlm.nih.gov/pubmed/33629115,33629115,,
7015,2011368,25151504,Comparative Toxicogenomics Database (CTD),Cobicistat,D000069547,Cobicistat,https://ctdbase.org/detail.go?type=chem&acc=D000069547,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606.0,Homo sapiens (human),[[rifampin results in increased activity of NR1I2 protein] which results in increased activity of CYP3A4 protein] which results in increased metabolism of and results in increased activity of and results in increased susceptibility to cobicistat,,,PMID:33629115,https://www.ncbi.nlm.nih.gov/pubmed/33629115,33629115,,
7016,2011369,25151504,Comparative Toxicogenomics Database (CTD),Cobicistat,D000069547,Cobicistat,https://ctdbase.org/detail.go?type=chem&acc=D000069547,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,10090.0,Mus musculus (house mouse),"[1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased activity of NR1I3 protein] which results in increased susceptibility to cobicistat",,,PMID:33629115,https://www.ncbi.nlm.nih.gov/pubmed/33629115,33629115,,
7017,2011370,25151504,Comparative Toxicogenomics Database (CTD),Cobicistat,D000069547,Cobicistat,https://ctdbase.org/detail.go?type=chem&acc=D000069547,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,10090.0,Mus musculus (house mouse),[rifampin co-treated with cobicistat] results in increased expression of TNFRSF10B mRNA,,,PMID:33629115,https://www.ncbi.nlm.nih.gov/pubmed/33629115,33629115,,
7018,2011372,25151504,Comparative Toxicogenomics Database (CTD),Cobicistat,D000069547,Cobicistat,https://ctdbase.org/detail.go?type=chem&acc=D000069547,874,CBR3,https://ctdbase.org/detail.go?type=gene&acc=874,,,874.0,CBR3,10090.0,Mus musculus (house mouse),[rifampin co-treated with cobicistat] results in increased expression of CBR3 mRNA,,,PMID:33629115,https://www.ncbi.nlm.nih.gov/pubmed/33629115,33629115,,
7019,2011787,25151504,Comparative Toxicogenomics Database (CTD),Cobicistat,D000069547,Cobicistat,https://ctdbase.org/detail.go?type=chem&acc=D000069547,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,10090.0,Mus musculus (house mouse),[rifampin co-treated with cobicistat] results in increased expression of ATF3 mRNA,,,PMID:33629115,https://www.ncbi.nlm.nih.gov/pubmed/33629115,33629115,,
7020,2028043,25151504,Drug Gene Interaction database (DGIdb),Cobicistat,,COBICISTAT,https://www.dgidb.org/drugs/rxcui:1306284,,CYP3A5,https://www.dgidb.org/genes/hgnc:2638,,,1577.0,CYP3A5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7021,2028044,25151504,DrugBank,Cobicistat,DB09065,Cobicistat,https://www.drugbank.ca/drugs/DB09065,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20043009|PMID:28060009|PMID:26935921,https://www.ncbi.nlm.nih.gov/pubmed/20043009|https://www.ncbi.nlm.nih.gov/pubmed/28060009|https://www.ncbi.nlm.nih.gov/pubmed/26935921,20043009|28060009|26935921,,
7022,2028061,25151504,DrugBank,Cobicistat,DB09065,Cobicistat,https://www.drugbank.ca/drugs/DB09065,BE0002362,Cytochrome P450 3A5,https://www.drugbank.ca/bio_entities/BE0002362,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20043009|PMID:28627229,https://www.ncbi.nlm.nih.gov/pubmed/20043009|https://www.ncbi.nlm.nih.gov/pubmed/28627229,20043009|28627229,,
7023,2028062,25151504,DrugBank,Cobicistat,DB09065,Cobicistat,https://www.drugbank.ca/drugs/DB09065,BE0003612,Cytochrome P450 3A7,https://www.drugbank.ca/bio_entities/BE0003612,P24462,Cytochrome P450 3A7,100861540.0,CYP3A7-CYP3A51P,9606.0,Homo sapiens (human),Inhibitor,,,PMID:28627229|PMID:20043009,https://www.ncbi.nlm.nih.gov/pubmed/28627229|https://www.ncbi.nlm.nih.gov/pubmed/20043009,28627229|20043009,,
7024,2028063,25151504,DrugBank,Cobicistat,DB09065,Cobicistat,https://www.drugbank.ca/drugs/DB09065,BE0002362,Cytochrome P450 3A5,https://www.drugbank.ca/bio_entities/BE0002362,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606.0,Homo sapiens (human),Substrate,,,PMID:20043009,https://www.ncbi.nlm.nih.gov/pubmed/20043009,20043009,,
7025,2028064,25151504,DrugBank,Cobicistat,DB09065,Cobicistat,https://www.drugbank.ca/drugs/DB09065,BE0003612,Cytochrome P450 3A7,https://www.drugbank.ca/bio_entities/BE0003612,P24462,Cytochrome P450 3A7,100861540.0,CYP3A7-CYP3A51P,9606.0,Homo sapiens (human),Substrate,,,PMID:20043009,https://www.ncbi.nlm.nih.gov/pubmed/20043009,20043009,,
7026,2028065,25151504,DrugBank,Cobicistat,DB09065,Cobicistat,https://www.drugbank.ca/drugs/DB09065,BE0002363,Cytochrome P450 2D6,https://www.drugbank.ca/bio_entities/BE0002363,P10635,Cytochrome P450 2D6,1565.0,CYP2D6,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:20043009,https://www.ncbi.nlm.nih.gov/pubmed/20043009,20043009,,
7027,2028066,25151504,DrugBank,Cobicistat,DB09065,Cobicistat,https://www.drugbank.ca/drugs/DB09065,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate,,,PMID:28627229|PMID:20043009,https://www.ncbi.nlm.nih.gov/pubmed/28627229|https://www.ncbi.nlm.nih.gov/pubmed/20043009,28627229|20043009,,
7028,2028067,25151504,DrugBank,Cobicistat,DB09065,Cobicistat,https://www.drugbank.ca/drugs/DB09065,BE0001032,Multidrug resistance protein 1,https://www.drugbank.ca/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:22850510,https://www.ncbi.nlm.nih.gov/pubmed/22850510,22850510,,
7029,2028068,25151504,DrugBank,Cobicistat,DB09065,Cobicistat,https://www.drugbank.ca/drugs/DB09065,BE0001067,ATP-binding cassette sub-family G member 2,https://www.drugbank.ca/bio_entities/BE0001067,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:22850510,https://www.ncbi.nlm.nih.gov/pubmed/22850510,22850510,,
7030,2028069,25151504,DrugBank,Cobicistat,DB09065,Cobicistat,https://www.drugbank.ca/drugs/DB09065,BE0001004,Solute carrier organic anion transporter family member 1B1,https://www.drugbank.ca/bio_entities/BE0001004,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7031,2028070,25151504,DrugBank,Cobicistat,DB09065,Cobicistat,https://www.drugbank.ca/drugs/DB09065,BE0003659,Solute carrier organic anion transporter family member 1B3,https://www.drugbank.ca/bio_entities/BE0003659,Q9NPD5,Solute carrier organic anion transporter family member 1B3,28234.0,SLCO1B3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7032,2028071,25151504,ChEMBL,Cobicistat,CHEMBL2095208,COBICISTAT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2095208/,CHEMBL2364675,Cytochrome P450 3A,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364675/,P24462,Cytochrome P450 3A7,1551.0,CYP3A7,9606.0,Homo sapiens (human),Cytochrome P450 3A inhibitor,,,,,,,
7033,2028230,25151504,ChEMBL,Cobicistat,CHEMBL2095208,COBICISTAT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2095208/,CHEMBL2364675,Cytochrome P450 3A,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364675/,Q9HB55,Cytochrome P450 3A43 ,100861540.0,CYP3A7-CYP3A51P,9606.0,Homo sapiens (human),Cytochrome P450 3A inhibitor,,,,,,,
7034,2028231,25151504,ChEMBL,Cobicistat,CHEMBL2095208,COBICISTAT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2095208/,CHEMBL2364675,Cytochrome P450 3A,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364675/,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Cytochrome P450 3A inhibitor,,,,,,,
7035,2028232,25151504,ChEMBL,Cobicistat,CHEMBL2095208,COBICISTAT,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2095208/,CHEMBL2364675,Cytochrome P450 3A,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364675/,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606.0,Homo sapiens (human),Cytochrome P450 3A inhibitor,,,,,,,
7036,2028324,25151504,Drug Gene Interaction database (DGIdb),Cobicistat,,COBICISTAT,https://www.dgidb.org/drugs/rxcui:1306284,,CYP3A43,https://www.dgidb.org/genes/hgnc:17450,,,64816.0,CYP3A43,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7037,2028545,25151504,Drug Gene Interaction database (DGIdb),Cobicistat,,COBICISTAT,https://www.dgidb.org/drugs/rxcui:1306284,,CYP3A7,https://www.dgidb.org/genes/hgnc:2640,,,1551.0,CYP3A7,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7038,2028118,25151705,Therapeutic Target Database (TTD),"1-Ethyl-3-[3-(3,4,5-trimethoxyanilino)pyrido[2,3-b]pyrazin-6-yl]thiourea",D03FIE,AEZS-126,https://idrblab.net/ttd/data/drug/details/D03FIE,T95913,PI3-kinase gamma (PIK3CG),https://idrblab.net/ttd/data/target/details/T95913,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7039,2028784,25154628,BindingDB,"(2R,3R,4S,5R)-2-(6-amino-8-methyl-9H-purin-9-yl)-5-({[4-(aminooxy)butyl](methyl)amino}methyl)oxolane-3,4-diol",28428,"(2R,3R,4S,5R)-2-(6-amino-8-methyl-9H-purin-9-yl)-5-({[4-(aminooxy)butyl](methyl)amino}methyl)oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28428,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),5,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
7040,2028233,25154714,DrugBank,Daclatasvir,DB09102,Daclatasvir,https://www.drugbank.ca/drugs/DB09102,BE0002362,Cytochrome P450 3A5,https://www.drugbank.ca/bio_entities/BE0002362,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606.0,Homo sapiens (human),Substrate,,,PMID:26486762,https://www.ncbi.nlm.nih.gov/pubmed/26486762,26486762,,
7041,2028234,25154714,DrugBank,Daclatasvir,DB09102,Daclatasvir,https://www.drugbank.ca/drugs/DB09102,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate,,,PMID:26486762,https://www.ncbi.nlm.nih.gov/pubmed/26486762,26486762,,
7042,2028235,25154714,DrugBank,Daclatasvir,DB09102,Daclatasvir,https://www.drugbank.ca/drugs/DB09102,BE0003550,Cytochrome P450 3A43,https://www.drugbank.ca/bio_entities/BE0003550,Q9HB55,Cytochrome P450 3A43 ,64816.0,CYP3A43,9606.0,Homo sapiens (human),Substrate,,,PMID:26486762,https://www.ncbi.nlm.nih.gov/pubmed/26486762,26486762,,
7043,2028236,25154714,DrugBank,Daclatasvir,DB09102,Daclatasvir,https://www.drugbank.ca/drugs/DB09102,BE0003612,Cytochrome P450 3A7,https://www.drugbank.ca/bio_entities/BE0003612,P24462,Cytochrome P450 3A7,100861540.0,CYP3A7-CYP3A51P,9606.0,Homo sapiens (human),Substrate,,,PMID:26486762,https://www.ncbi.nlm.nih.gov/pubmed/26486762,26486762,,
7044,2028237,25154714,DrugBank,Daclatasvir,DB09102,Daclatasvir,https://www.drugbank.ca/drugs/DB09102,BE0001032,Multidrug resistance protein 1,https://www.drugbank.ca/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:26486762,https://www.ncbi.nlm.nih.gov/pubmed/26486762,26486762,,
7045,2028238,25154714,DrugBank,Daclatasvir,DB09102,Daclatasvir,https://www.drugbank.ca/drugs/DB09102,BE0001004,Solute carrier organic anion transporter family member 1B1,https://www.drugbank.ca/bio_entities/BE0001004,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:26486762,https://www.ncbi.nlm.nih.gov/pubmed/26486762,26486762,,
7046,2028239,25154714,DrugBank,Daclatasvir,DB09102,Daclatasvir,https://www.drugbank.ca/drugs/DB09102,BE0003659,Solute carrier organic anion transporter family member 1B3,https://www.drugbank.ca/bio_entities/BE0003659,Q9NPD5,Solute carrier organic anion transporter family member 1B3,28234.0,SLCO1B3,9606.0,Homo sapiens (human),Inhibitor,,,PMID:26486762,https://www.ncbi.nlm.nih.gov/pubmed/26486762,26486762,,
7047,2028240,25154714,DrugBank,Daclatasvir,DB09102,Daclatasvir,https://www.drugbank.ca/drugs/DB09102,BE0001067,ATP-binding cassette sub-family G member 2,https://www.drugbank.ca/bio_entities/BE0001067,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:26486762,https://www.ncbi.nlm.nih.gov/pubmed/26486762,26486762,,
7048,2011371,25154759,Therapeutic Target Database (TTD),"2-(4-Chlorophenylsulfonyl)naphthalene-1,4-diol",D0K1CU,"2-(4-chlorophenylsulfonyl)naphthalene-1,4-diol",https://idrblab.net/ttd/data/drug/details/D0K1CU,T72444,Bacterial Beta-ketoacyl-ACP synthase III (Bact fabH),https://idrblab.net/ttd/data/target/details/T72444,P0A6R0,3-oxoacyl-[acyl-carrier-protein] synthase 3,946003.0,fabH,83333.0,Escherichia coli K-12,Inhibitor,,,,,,,
7049,2028119,25154868,BindingDB,N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide,26740,N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26740,354,Fatty-acid amide hydrolase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=354,O00519,Fatty-acid amide hydrolase 1,2166.0,FAAH,9606.0,Homo sapiens (human),,IC50 (nM),16.2,PMID:17949010|DOI:10.1021/bi701378g,https://www.ncbi.nlm.nih.gov/pubmed/17949010|https://doi.org/10.1021/bi701378g,17949010,10.1021/bi701378g,
7050,2028546,25155578,DrugBank,1-{3-Oxo-3-[(2s)-2-(Pyrrolidin-1-Ylcarbonyl)pyrrolidin-1-Yl]propyl}-3-Phenylquinoxalin-2(1h)-One,DB08738,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,https://www.drugbank.ca/drugs/DB08738,BE0002148,Prolyl endopeptidase,https://www.drugbank.ca/bio_entities/BE0002148,P48147,Prolyl endopeptidase,5550.0,PREP,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
7051,2028251,25161177,Drug Gene Interaction database (DGIdb),(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide,,TOVORAFENIB,https://www.dgidb.org/drugs/ncit:C106254,,BRAF,https://www.dgidb.org/genes/hgnc:1097,,,673.0,BRAF,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7052,2028252,25161177,Drug Gene Interaction database (DGIdb),(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide,,TOVORAFENIB,https://www.dgidb.org/drugs/ncit:C106254,,BRAF,https://www.dgidb.org/genes/hgnc:1097,,,673.0,BRAF,9606.0,Homo sapiens (human),,,,,,,,
7053,2028547,25161177,Drug Gene Interaction database (DGIdb),(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide,,TOVORAFENIB,https://www.dgidb.org/drugs/ncit:C106254,,ARAF,https://www.dgidb.org/genes/hgnc:646,,,369.0,ARAF,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7054,2029113,25161177,IUPHAR/BPS Guide to PHARMACOLOGY,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide,9977,tovorafenib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9977,1943,"B-Raf proto-oncogene, serine/threonine kinase",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1943,P15056,Serine/threonine-protein kinase B-raf,673.0,BRAF,9606.0,Homo sapiens (human),Inhibition,pIC50,5.72,PMID:28082416,https://www.ncbi.nlm.nih.gov/pubmed/28082416,28082416,,
7055,2029114,25161177,Therapeutic Target Database (TTD),(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide,D07IEU,MLN2480,https://idrblab.net/ttd/data/drug/details/D07IEU,T51883,Serine/threonine-protein kinase Raf (RAF),https://idrblab.net/ttd/data/target/details/T51883,P10398,Serine/threonine-protein kinase A-Raf,369.0,ARAF,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7056,2029115,25161177,Therapeutic Target Database (TTD),(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide,D07IEU,MLN2480,https://idrblab.net/ttd/data/drug/details/D07IEU,T51883,Serine/threonine-protein kinase Raf (RAF),https://idrblab.net/ttd/data/target/details/T51883,P15056,Serine/threonine-protein kinase B-raf,673.0,BRAF,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7057,2029116,25161177,Therapeutic Target Database (TTD),(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide,D07IEU,MLN2480,https://idrblab.net/ttd/data/drug/details/D07IEU,T51883,Serine/threonine-protein kinase Raf (RAF),https://idrblab.net/ttd/data/target/details/T51883,P04049,RAF proto-oncogene serine/threonine-protein kinase,5894.0,RAF1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7058,2029117,25161177,Therapeutic Target Database (TTD),(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide,D07IEU,MLN2480,https://idrblab.net/ttd/data/drug/details/D07IEU,T90648,B-Raf messenger RNA (BRAF mRNA),https://idrblab.net/ttd/data/target/details/T90648,P15056,Serine/threonine-protein kinase B-raf,673.0,BRAF,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7059,2029118,25161177,Therapeutic Target Database (TTD),(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide,D07IEU,MLN2480,https://idrblab.net/ttd/data/drug/details/D07IEU,T52316,Raf messenger RNA (Raf mRNA),https://idrblab.net/ttd/data/target/details/T52316,P04049,RAF proto-oncogene serine/threonine-protein kinase,5894.0,RAF1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7060,2028079,25164607,IUPHAR/BPS Guide to PHARMACOLOGY,"(4S,4aS,10bS)-10b-(4-chlorophenyl)sulfonyl-7,10-difluoro-4-(2-methylsulfonylethyl)-2,4,4a,5-tetrahydro-1H-pyrano[3,4-c]chromene",8848,SCH-900229,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8848,2402,presenilin 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2402,P49768,Presenilin-1,5663.0,PSEN1,9606.0,Homo sapiens (human),Inhibition,pIC50,8.89 - 9,PMID:24900404,https://www.ncbi.nlm.nih.gov/pubmed/24900404,24900404,,
7061,2011788,25166397,Therapeutic Target Database (TTD),Methyl 2-(2-oxohexadecanamido)acetate,D07QSM,Methyl 2-(2-oxohexadecanamido)acetate,https://idrblab.net/ttd/data/drug/details/D07QSM,T14834,Cytosolic phospholipase A2 (GIVA cPLA2),https://idrblab.net/ttd/data/target/details/T14834,P47712,Cytosolic phospholipase A2,5321.0,PLA2G4A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7062,2028253,25166913,Therapeutic Target Database (TTD),Glasdegib,D0S5LO,PF-04449913,https://idrblab.net/ttd/data/drug/details/D0S5LO,T66505,Smoothened homolog (SMO),https://idrblab.net/ttd/data/target/details/T66505,Q99835,Smoothened homolog,6608.0,SMO,9606.0,Homo sapiens (human),Modulator,,,,,,,
7063,2028656,25166913,IUPHAR/BPS Guide to PHARMACOLOGY,Glasdegib,8201,glasdegib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8201,239,SMO,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=239,Q99835,Smoothened homolog,6608.0,SMO,9606.0,Homo sapiens (human),Antagonist,pIC50,8.3,PMID:24900436,https://www.ncbi.nlm.nih.gov/pubmed/24900436,24900436,,
7064,2028657,25166913,Drug Gene Interaction database (DGIdb),Glasdegib,,GLASDEGIB,https://www.dgidb.org/drugs/rxcui:2105845,,SMO,https://www.dgidb.org/genes/hgnc:11119,,,6608.0,SMO,9606.0,Homo sapiens (human),,,,,,,,
7065,2028658,25166913,ChEMBL,Glasdegib,CHEMBL2043437,GLASDEGIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2043437/,CHEMBL5971,Smoothened homolog,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL5971/,Q99835,Smoothened homolog,6608.0,SMO,9606.0,Homo sapiens (human),Smoothened homolog antagonist,,,,,,,
7066,2011790,25167017,ChEMBL,Litronesib,CHEMBL2105661,LITRONESIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105661/,CHEMBL4581,Kinesin-like protein 1,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL4581/,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),Kinesin-like protein 1 inhibitor,,,PMID:26304237|PMID:24752449,https://www.ncbi.nlm.nih.gov/pubmed/26304237|https://www.ncbi.nlm.nih.gov/pubmed/24752449,26304237|24752449,,
7067,2029119,25167017,Therapeutic Target Database (TTD),Litronesib,D0W9SL,LY2523355,https://idrblab.net/ttd/data/drug/details/D0W9SL,T28484,Kinesin-like protein KIF11 (KIF11),https://idrblab.net/ttd/data/target/details/T28484,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),Modulator,,,,,,,
7068,2028548,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,NRAS,https://www.dgidb.org/genes/hgnc:7989,,,4893.0,NRAS,9606.0,Homo sapiens (human),,,,,,,,
7069,2028549,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,PIK3CG,https://www.dgidb.org/genes/hgnc:8978,,,5294.0,PIK3CG,9606.0,Homo sapiens (human),,,,,,,,
7070,2028659,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,PIK3CA,https://www.dgidb.org/genes/hgnc:8975,,,5290.0,PIK3CA,9606.0,Homo sapiens (human),,,,,,,,
7071,2029120,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,MAP2K1,https://www.dgidb.org/genes/hgnc:6840,,,5604.0,MAP2K1,9606.0,Homo sapiens (human),,,,,,,,
7072,2029121,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,PIK3CA,https://www.dgidb.org/genes/hgnc:8975,,,5290.0,PIK3CA,9606.0,Homo sapiens (human),,,,,,,,
7073,2029122,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,RET,https://www.dgidb.org/genes/hgnc:9967,,,5979.0,RET,9606.0,Homo sapiens (human),,,,,,,,
7074,2011789,25170420,ChEMBL,Naproxen etemesil,CHEMBL2105683,NAPROXEN ETEMESIL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105683/,CHEMBL2094253,Cyclooxygenase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094253/,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606.0,Homo sapiens (human),Cyclooxygenase inhibitor,,,PMID:20804454,https://www.ncbi.nlm.nih.gov/pubmed/20804454,20804454,,
7075,2011791,25170420,ChEMBL,Naproxen etemesil,CHEMBL2105683,NAPROXEN ETEMESIL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105683/,CHEMBL2094253,Cyclooxygenase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094253/,P23219,Prostaglandin G/H synthase 1,5742.0,PTGS1,9606.0,Homo sapiens (human),Cyclooxygenase inhibitor,,,PMID:20804454,https://www.ncbi.nlm.nih.gov/pubmed/20804454,20804454,,
7076,2028550,25171648,Drug Gene Interaction database (DGIdb),Tepotinib,,TEPOTINIB,https://www.dgidb.org/drugs/rxcui:2477103,,MET,https://www.dgidb.org/genes/hgnc:7029,,,4233.0,MET,9606.0,Homo sapiens (human),,,,,,,,
7077,2028660,25171648,ChEMBL,Tepotinib,CHEMBL3402762,TEPOTINIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3402762/,CHEMBL3717,Hepatocyte growth factor receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3717/,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),Hepatocyte growth factor receptor inhibitor,,,PMID:23553846|PMID:25110867,https://www.ncbi.nlm.nih.gov/pubmed/23553846|https://www.ncbi.nlm.nih.gov/pubmed/25110867,23553846|25110867,,
7078,2029123,25171648,Therapeutic Target Database (TTD),Tepotinib,D0R8QG,Tepotinib,https://idrblab.net/ttd/data/drug/details/D0R8QG,T40474,Proto-oncogene c-Met (MET),https://idrblab.net/ttd/data/target/details/T40474,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),Modulator,,,,,,,
7079,2011792,25180103,Therapeutic Target Database (TTD),"7-Pyridin-3-yl-2H-1,4-benzothiazin-3(4H)-one",D0O7TC,"7-Pyridin-3-yl-2H-1,4-benzothiazin-3(4H)-one",https://idrblab.net/ttd/data/drug/details/D0O7TC,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7080,2011793,25180104,Therapeutic Target Database (TTD),"6-Pyridin-3-yl-1,2,3,4-tetrahydronaphthalen-2-ol",D02ZQM,"6-Pyridin-3-yl-1,2,3,4-tetrahydronaphthalen-2-ol",https://idrblab.net/ttd/data/drug/details/D02ZQM,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7081,2011794,25180108,Therapeutic Target Database (TTD),"6-Pyridin-3-yl-3,4-dihydronaphthalen-2(1H)-one",D07WLT,"6-Pyridin-3-yl-3,4-dihydronaphthalen-2(1H)-one",https://idrblab.net/ttd/data/drug/details/D07WLT,T84621,Steroid 11-beta-hydroxylase (CYP11B1),https://idrblab.net/ttd/data/target/details/T84621,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7082,2011795,25180108,Therapeutic Target Database (TTD),"6-Pyridin-3-yl-3,4-dihydronaphthalen-2(1H)-one",D07WLT,"6-Pyridin-3-yl-3,4-dihydronaphthalen-2(1H)-one",https://idrblab.net/ttd/data/drug/details/D07WLT,T37848,Albendazole monooxygenase (CYP3A4),https://idrblab.net/ttd/data/target/details/T37848,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7083,2028551,25181312,BindingDB,5'-[(3-Aminopropyl)(Methyl)amino]-5'-Deoxy-8-Methyladenosine,28448,"(2R,3R,4S,5R)-2-(6-amino-8-methyl-9H-purin-9-yl)-5-{[(3-aminopropyl)(methyl)amino]methyl}oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28448,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),70000,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
7084,2028552,25181313,BindingDB,"3-[{[(2r,3s,4r,5r)-5-(6-Amino-8-Methyl-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydrofuran-2-Yl]methyl}(Methyl)amino]propanamide",28432,"3-({[(2R,3S,4R,5R)-5-(6-amino-8-methyl-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)amino)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28432,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),400,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
7085,2028553,25181314,BindingDB,5'-{[2-(Aminooxy)ethyl](Methyl)amino}-5'-Deoxy-8-Methyladenosine,28421,"(2R,3R,4S,5R)-2-(6-amino-8-methyl-9H-purin-9-yl)-5-({[2-(aminooxy)ethyl](methyl)amino}methyl)oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28421,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),7,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
7086,2028573,25181315,DrugBank,5'-{[4-(Aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine,DB08163,5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine,https://www.drugbank.ca/drugs/DB08163,BE0000101,S-adenosylmethionine decarboxylase proenzyme,https://www.drugbank.ca/bio_entities/BE0000101,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
7087,2028574,25181316,BindingDB,"2-[{[(2r,3s,4r,5r)-5-(6-Amino-8-Methyl-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydrofuran-2-Yl]methyl}(Methyl)amino]acetamide",28434,"2-({[(2R,3S,4R,5R)-5-(6-amino-8-methyl-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)amino)acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28434,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,,,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
7088,2029124,25181317,BindingDB,N-benzyl-N-(2-{(4-cyanophenyl)[(1-methyl-1H-imidazol-5-yl)methyl]amino}ethyl)-2-methylbenzenesulfonamide,31425,"ethylenediamine scaffold, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31425,160,Protein farnesyltransferase subunit beta/geranylgeranyltransferase type-1 subunit alpha,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=160,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,2339.0,FNTA,9606.0,Homo sapiens (human),,IC50 (nM),160,PMID:19246009|DOI:10.1016/j.chembiol.2009.01.014,https://www.ncbi.nlm.nih.gov/pubmed/19246009|https://doi.org/10.1016/j.chembiol.2009.01.014,19246009,10.1016/j.chembiol.2009.01.014,
7089,2029125,25181317,BindingDB,N-benzyl-N-(2-{(4-cyanophenyl)[(1-methyl-1H-imidazol-5-yl)methyl]amino}ethyl)-2-methylbenzenesulfonamide,31425,"ethylenediamine scaffold, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31425,1376,ATP-dependent RNA helicase RhlE,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1376,,,,,,,,IC50 (nM),5.0,PMID:19246009|DOI:10.1016/j.chembiol.2009.01.014,https://www.ncbi.nlm.nih.gov/pubmed/19246009|https://doi.org/10.1016/j.chembiol.2009.01.014,19246009,10.1016/j.chembiol.2009.01.014,
7090,2028661,25181318,Therapeutic Target Database (TTD),3-{2'-[{[1-(tert-butoxycarbonyl)piperidin-4-yl]methyl}(2-{(4-cyanophenyl)[(1-methyl-1H-imidazol-5-yl)methyl]amino}ethyl)sulfamoyl]biphenyl-3-yl}propanoic acid,D0G1SN,ED1,https://idrblab.net/ttd/data/drug/details/D0G1SN,T40332,Neutrophil elastase (NE),https://idrblab.net/ttd/data/target/details/T40332,P08246,Neutrophil elastase,1991.0,ELANE,9606.0,Homo sapiens (human),,,,,,,,
7091,2029126,25181318,BindingDB,3-{2'-[{[1-(tert-butoxycarbonyl)piperidin-4-yl]methyl}(2-{(4-cyanophenyl)[(1-methyl-1H-imidazol-5-yl)methyl]amino}ethyl)sulfamoyl]biphenyl-3-yl}propanoic acid,31426,"ethylenediamine scaffold, 10",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31426,1376,ATP-dependent RNA helicase RhlE,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1376,,,,,,,,IC50 (nM),70.0,PMID:19246009|DOI:10.1016/j.chembiol.2009.01.014,https://www.ncbi.nlm.nih.gov/pubmed/19246009|https://doi.org/10.1016/j.chembiol.2009.01.014,19246009,10.1016/j.chembiol.2009.01.014,
7092,2029127,25181318,BindingDB,3-{2'-[{[1-(tert-butoxycarbonyl)piperidin-4-yl]methyl}(2-{(4-cyanophenyl)[(1-methyl-1H-imidazol-5-yl)methyl]amino}ethyl)sulfamoyl]biphenyl-3-yl}propanoic acid,31426,"ethylenediamine scaffold, 10",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31426,160,Protein farnesyltransferase subunit beta/geranylgeranyltransferase type-1 subunit alpha,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=160,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,2339.0,FNTA,9606.0,Homo sapiens (human),,IC50 (nM),800,PMID:19246009|DOI:10.1016/j.chembiol.2009.01.014,https://www.ncbi.nlm.nih.gov/pubmed/19246009|https://doi.org/10.1016/j.chembiol.2009.01.014,19246009,10.1016/j.chembiol.2009.01.014,
7093,2029128,25181319,BindingDB,Tert-Butyl 4-({(2-{(4-Cyanophenyl)[(1-Methyl-1h-Imidazol-5-Yl)methyl]amino}ethyl)[(2-Methylphenyl)sulfonyl]amino}methyl)piperidine-1-Carboxylate,31424,"ethylenediamine scaffold, 5",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31424,160,Protein farnesyltransferase subunit beta/geranylgeranyltransferase type-1 subunit alpha,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=160,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,2339.0,FNTA,9606.0,Homo sapiens (human),,IC50 (nM),4050,PMID:19246009|DOI:10.1016/j.chembiol.2009.01.014,https://www.ncbi.nlm.nih.gov/pubmed/19246009|https://doi.org/10.1016/j.chembiol.2009.01.014,19246009,10.1016/j.chembiol.2009.01.014,
7094,2029129,25181319,BindingDB,Tert-Butyl 4-({(2-{(4-Cyanophenyl)[(1-Methyl-1h-Imidazol-5-Yl)methyl]amino}ethyl)[(2-Methylphenyl)sulfonyl]amino}methyl)piperidine-1-Carboxylate,31424,"ethylenediamine scaffold, 5",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31424,1376,ATP-dependent RNA helicase RhlE,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1376,,,,,,,,IC50 (nM),3.0,PMID:19246009|DOI:10.1016/j.chembiol.2009.01.014,https://www.ncbi.nlm.nih.gov/pubmed/19246009|https://doi.org/10.1016/j.chembiol.2009.01.014,19246009,10.1016/j.chembiol.2009.01.014,
7095,2028575,25181472,Drug Gene Interaction database (DGIdb),Glesatinib,,GLESATINIB,https://www.dgidb.org/drugs/ncit:C77876,,FLT1,https://www.dgidb.org/genes/hgnc:3763,,,2321.0,FLT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7096,2028662,25181561,BindingDB,,50248106,CHEMBL461101,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50248106,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),21520,PMID:34798775|DOI:10.1021/acs.jmedchem.1c00409,https://www.ncbi.nlm.nih.gov/pubmed/34798775|https://doi.org/10.1021/acs.jmedchem.1c00409,34798775,10.1021/acs.jmedchem.1c00409,
7097,2028254,25181577,Therapeutic Target Database (TTD),Telotristat Ethyl,D0RE6T,Telotristat ethyl,https://idrblab.net/ttd/data/drug/details/D0RE6T,T51593,Tryptophan hydroxylase (TPH),https://idrblab.net/ttd/data/target/details/T51593,P17752,Tryptophan 5-hydroxylase 1,7166.0,TPH1,9606.0,Homo sapiens (human),Modulator,,,,,,,
7098,2028255,25181577,Therapeutic Target Database (TTD),Telotristat Ethyl,D0RE6T,Telotristat ethyl,https://idrblab.net/ttd/data/drug/details/D0RE6T,T51593,Tryptophan hydroxylase (TPH),https://idrblab.net/ttd/data/target/details/T51593,Q8IWU9,Tryptophan 5-hydroxylase 2,121278.0,TPH2,9606.0,Homo sapiens (human),Modulator,,,,,,,
7099,2028663,25182616,BindingDB,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide",27817,"2-{[2-({1-[2-(dimethylamino)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluoro-N-methylbenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27817,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),2,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
7100,2028664,25182616,BindingDB,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide",27817,"2-{[2-({1-[2-(dimethylamino)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluoro-N-methylbenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27817,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),5010,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
7101,2028665,25182616,BindingDB,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide",27817,"2-{[2-({1-[2-(dimethylamino)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluoro-N-methylbenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27817,1653,Mitogen-activated protein kinase 10,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1653,P53779,Mitogen-activated protein kinase 10,5602.0,MAPK10,9606.0,Homo sapiens (human),,IC50 (nM),2000,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
7102,2029130,25182616,IUPHAR/BPS Guide to PHARMACOLOGY,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide",5683,GSK-1838705A,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5683,1839,ALK receptor tyrosine kinase,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1839,Q9UM73,ALK tyrosine kinase receptor,238.0,ALK,9606.0,Homo sapiens (human),Inhibition,pIC50,9.3,PMID:19825801,https://www.ncbi.nlm.nih.gov/pubmed/19825801,19825801,,
7103,2029131,25182860,Therapeutic Target Database (TTD),"Urea, N-[6-[[6-(4-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]thio]-2-benzothiazolyl]-N'-[2-(4-morpholinyl)ethyl]-",D07ARN,SAR-125844,https://idrblab.net/ttd/data/drug/details/D07ARN,T40474,Proto-oncogene c-Met (MET),https://idrblab.net/ttd/data/target/details/T40474,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7104,2028783,25183016,BindingDB,"(2R,3R,4S,5R)-2-(6-amino-8-phenyl-9H-purin-9-yl)-5-({[2-(aminooxy)ethyl](methyl)amino}methyl)oxolane-3,4-diol",28424,"(2R,3R,4S,5R)-2-(6-amino-8-phenyl-9H-purin-9-yl)-5-({[2-(aminooxy)ethyl](methyl)amino}methyl)oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28424,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,,,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
7105,2028608,25183746,BindingDB,"2-({[(2R,3S,4R,5R)-5-(6-amino-8-methyl-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)amino)acetohydrazide",28438,"2-({[(2R,3S,4R,5R)-5-(6-amino-8-methyl-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)amino)acetohydrazide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28438,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),31000,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
7106,2028576,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,A5LHX3,Proteasome subunit beta type-11,122706.0,PSMB11,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7107,2028577,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,O00231,26S proteasome non-ATPase regulatory subunit 11,5717.0,PSMD11,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7108,2028578,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,O00232,26S proteasome non-ATPase regulatory subunit 12,5718.0,PSMD12,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7109,2028579,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,O00487,26S proteasome non-ATPase regulatory subunit 14,10213.0,PSMD14,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7110,2028580,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,O14818,Proteasome subunit alpha type-7,5688.0,PSMA7,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7111,2028581,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,O43242,26S proteasome non-ATPase regulatory subunit 3,5709.0,PSMD3,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7112,2028582,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P17980,26S proteasome regulatory subunit 6A,5702.0,PSMC3,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7113,2028583,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P20618,Proteasome subunit beta type-1,5689.0,PSMB1,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7114,2028584,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P25786,Proteasome subunit alpha type-1,5682.0,PSMA1,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7115,2028585,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P25787,Proteasome subunit alpha type-2,5683.0,PSMA2,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7116,2028586,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P25788,Proteasome subunit alpha type-3,5684.0,PSMA3,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7117,2028587,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P25789,Proteasome subunit alpha type-4,5685.0,PSMA4,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7118,2028588,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P28062,Proteasome subunit beta type-8,5696.0,PSMB8,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7119,2028589,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P28065,Proteasome subunit beta type-9,5698.0,PSMB9,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7120,2028590,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P28066,Proteasome subunit alpha type-5,5686.0,PSMA5,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7121,2028591,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P28070,Proteasome subunit beta type-4,5692.0,PSMB4,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7122,2028592,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P28072,Proteasome subunit beta type-6,5694.0,PSMB6,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7123,2028593,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P28074,Proteasome subunit beta type-5,5693.0,PSMB5,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7124,2028594,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P35998,26S proteasome regulatory subunit 7,5701.0,PSMC2,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7125,2028595,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P40306,Proteasome subunit beta type-10,5699.0,PSMB10,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7126,2028596,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P43686,26S proteasome regulatory subunit 6B,5704.0,PSMC4,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7127,2028597,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P48556,26S proteasome non-ATPase regulatory subunit 8,5714.0,PSMD8,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7128,2028598,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P49720,Proteasome subunit beta type-3,5691.0,PSMB3,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7129,2028599,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P49721,Proteasome subunit beta type-2,5690.0,PSMB2,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7130,2028600,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P51665,26S proteasome non-ATPase regulatory subunit 7,5713.0,PSMD7,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7131,2028601,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P55036,26S proteasome non-ATPase regulatory subunit 4,5710.0,PSMD4,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7132,2028602,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P60896,26S proteasome complex subunit SEM1,7979.0,SEM1,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7133,2028603,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P60900,Proteasome subunit alpha type-6,5687.0,PSMA6,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7134,2028604,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P62191,26S proteasome regulatory subunit 4,5700.0,PSMC1,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7135,2028605,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P62195,26S proteasome regulatory subunit 8,5705.0,PSMC5,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7136,2028606,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,P62333,26S proteasome regulatory subunit 10B,5706.0,PSMC6,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7137,2028607,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,Q13200,26S proteasome non-ATPase regulatory subunit 2,5708.0,PSMD2,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7138,2028666,25183872,IUPHAR/BPS Guide to PHARMACOLOGY,Ixazomib,8450,ixazomib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8450,2406,proteasome 20S subunit beta 5,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2406,P28074,Proteasome subunit beta type-5,5693.0,PSMB5,9606.0,Homo sapiens (human),Inhibition,pKi,9.03,PMID:20160034,https://www.ncbi.nlm.nih.gov/pubmed/20160034,20160034,,
7139,2028667,25183872,Drug Gene Interaction database (DGIdb),Ixazomib,,IXAZOMIB,https://www.dgidb.org/drugs/rxcui:1723735,,EML4,https://www.dgidb.org/genes/hgnc:1316,,,27436.0,EML4,9606.0,Homo sapiens (human),,,,,,,,
7140,2028785,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,Q15008,26S proteasome non-ATPase regulatory subunit 6,9861.0,PSMD6,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7141,2028786,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,Q16186,Proteasomal ubiquitin receptor ADRM1,11047.0,ADRM1,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7142,2028787,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,Q8TAA3,Proteasome subunit alpha-type 8,143471.0,PSMA8,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7143,2028788,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,Q99436,Proteasome subunit beta type-7,5695.0,PSMB7,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7144,2028789,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,Q99460,26S proteasome non-ATPase regulatory subunit 1,5707.0,PSMD1,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7145,2028790,25183872,ChEMBL,Ixazomib,CHEMBL2141296,IXAZOMIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296/,CHEMBL2364701,26S proteasome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2364701/,Q9UNM6,26S proteasome non-ATPase regulatory subunit 13,5719.0,PSMD13,9606.0,Homo sapiens (human),26S proteasome inhibitor,,,PMID:23995855|PMID:30867233,https://www.ncbi.nlm.nih.gov/pubmed/23995855|https://www.ncbi.nlm.nih.gov/pubmed/30867233,23995855|30867233,,
7146,2029132,25183872,Drug Gene Interaction database (DGIdb),Ixazomib,,IXAZOMIB,https://www.dgidb.org/drugs/rxcui:1723735,,PSMD6,https://www.dgidb.org/genes/hgnc:9564,,,9861.0,PSMD6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7147,2029133,25183872,Drug Gene Interaction database (DGIdb),Ixazomib,,IXAZOMIB,https://www.dgidb.org/drugs/rxcui:1723735,,SEM1,https://www.dgidb.org/genes/hgnc:10845,,,7979.0,SEM1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7148,2028791,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P02358,30S ribosomal protein S6,948723.0,rpsF,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7149,2028792,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P02359,30S ribosomal protein S7,947846.0,rpsG,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7150,2028793,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P02413,50S ribosomal protein L15,947798.0,rplO,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7151,2028794,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7J3,50S ribosomal protein L10,948490.0,rplJ,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7152,2028795,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7J7,50S ribosomal protein L11,83578992.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7153,2028796,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7K2,50S ribosomal protein L7/L12,948484.0,rplK,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7154,2028797,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7K6,50S ribosomal protein L19,83578990.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7155,2028798,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7L0,50S ribosomal protein L1,948489.0,rplL,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7156,2028799,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7L3,50S ribosomal protein L20,83578993.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7157,2028830,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7Q6,50S ribosomal protein L36,83578845.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7158,2028831,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7R5,30S ribosomal protein S10,947807.0,rpmC,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7159,2028849,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V0,30S ribosomal protein S2,8913847.0,rpmG,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7160,2028850,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V3,30S ribosomal protein S3,948216.0,rpmH,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7161,2028851,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7V8,30S ribosomal protein S4,84238873.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7162,2028852,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7W1,30S ribosomal protein S5,946349.0,rpmI,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7163,2028853,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7W7,30S ribosomal protein S8,84236820.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7164,2028854,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7X3,30S ribosomal protein S9,947805.0,rpmJ,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7165,2028855,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AA10,50S ribosomal protein L13,84234858.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7166,2028856,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0ADY3,50S ribosomal protein L14,947816.0,rpsJ,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7167,2028857,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0ADY7,50S ribosomal protein L16,83578291.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7168,2028869,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0ADZ0,50S ribosomal protein L23,947792.0,rpsK,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7169,2028870,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0ADZ4,30S ribosomal protein S15,84234860.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7170,2028871,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG44,50S ribosomal protein L17,947845.0,rpsL,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7171,2028872,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG48,50S ribosomal protein L21,84234829.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7172,2028873,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG51,50S ribosomal protein L30,947791.0,rpsM,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7173,2028874,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG55,50S ribosomal protein L6,83578268.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7174,2028875,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG59,30S ribosomal protein S14,947103.0,rpsP,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7175,2028876,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG63,30S ribosomal protein S17,83579843.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7176,2028877,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG67,30S ribosomal protein S1,948721.0,rpsR,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7177,2028889,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0C018,50S ribosomal protein L18,9735149.0,rpsR,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7178,2028890,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60422,50S ribosomal protein L2,947811.0,rpsS,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7179,2028891,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60438,50S ribosomal protein L3,84234841.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7180,2028892,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60624,50S ribosomal protein L24,944759.0,rpsT,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7181,2028893,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60723,50S ribosomal protein L4,83578037.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7182,2028894,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P61175,50S ribosomal protein L22,947874.0,rpsB,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7183,2028895,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P62399,50S ribosomal protein L5,83577893.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7184,2028896,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P68679,30S ribosomal protein S21,947814.0,rpsC,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7185,2028897,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P68919,50S ribosomal protein L25,84234843.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7186,2028920,25184541,ChEMBL,Contezolid,CHEMBL3287379,CONTEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3287379/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,Q2EEQ2,50S ribosomal protein L36 2,947793.0,rpsD,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:24694071|PMID:33913699,https://www.ncbi.nlm.nih.gov/pubmed/24694071|https://www.ncbi.nlm.nih.gov/pubmed/33913699,24694071|33913699,,
7187,2035515,25190584,BindingDB,"8-[Bis(2-chlorophenyl)methyl]-3-(2-methoxyethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one",26903,"8-[bis(2-chlorophenyl)methyl]-3-(2-methoxyethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26903,2100,Delta-type opioid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2100,P41143,Delta-type opioid receptor,4985.0,OPRD1,9606.0,Homo sapiens (human),,Ki (nM),28990,PMID:19147350|DOI:10.1016/j.bmcl.2008.12.092,https://www.ncbi.nlm.nih.gov/pubmed/19147350|https://doi.org/10.1016/j.bmcl.2008.12.092,19147350,10.1016/j.bmcl.2008.12.092,
7188,2035521,25190585,BindingDB,"3-(2-Aminoethyl)-8-[bis(2-chlorophenyl)methyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one",26904,"3-(2-aminoethyl)-8-[bis(2-chlorophenyl)methyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26904,2100,Delta-type opioid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2100,P41143,Delta-type opioid receptor,4985.0,OPRD1,9606.0,Homo sapiens (human),,Ki (nM),32,PMID:19147350|DOI:10.1016/j.bmcl.2008.12.092,https://www.ncbi.nlm.nih.gov/pubmed/19147350|https://doi.org/10.1016/j.bmcl.2008.12.092,19147350,10.1016/j.bmcl.2008.12.092,
7189,2035522,25190585,BindingDB,"3-(2-Aminoethyl)-8-[bis(2-chlorophenyl)methyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one",26904,"3-(2-aminoethyl)-8-[bis(2-chlorophenyl)methyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26904,2210,Nociceptin receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2210,P41146,Nociceptin receptor,4987.0,OPRL1,9606.0,Homo sapiens (human),,Ki (nM),47.8,PMID:19147350|DOI:10.1016/j.bmcl.2008.12.092,https://www.ncbi.nlm.nih.gov/pubmed/19147350|https://doi.org/10.1016/j.bmcl.2008.12.092,19147350,10.1016/j.bmcl.2008.12.092,
7190,2035523,25190586,BindingDB,"8-[Bis(2-chlorophenyl)methyl]-3-[2-(ethylamino)ethyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one",26906,"8-[bis(2-chlorophenyl)methyl]-3-[2-(ethylamino)ethyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26906,2210,Nociceptin receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2210,P41146,Nociceptin receptor,4987.0,OPRL1,9606.0,Homo sapiens (human),,Ki (nM),2.1,PMID:19147350|DOI:10.1016/j.bmcl.2008.12.092,https://www.ncbi.nlm.nih.gov/pubmed/19147350|https://doi.org/10.1016/j.bmcl.2008.12.092,19147350,10.1016/j.bmcl.2008.12.092,
7191,2028921,25190761,DrugBank,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",DB08285,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",https://www.drugbank.ca/drugs/DB08285,BE0001072,Cyclin-dependent kinase 2,https://www.drugbank.ca/bio_entities/BE0001072,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
7192,2028922,25190761,DrugBank,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",DB08285,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",https://www.drugbank.ca/drugs/DB08285,BE0003734,Cyclin-A2,https://www.drugbank.ca/bio_entities/BE0003734,P20248,Cyclin-A2,890.0,CCNA2,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
7193,2035516,25190790,BindingDB,"6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]hexanamide",27248,"6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]hexanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27248,1612,RAC-gamma serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1612,Q9Y243,RAC-gamma serine/threonine-protein kinase,10000.0,AKT3,9606.0,Homo sapiens (human),,IC50 (nM),36.9,PMID:19143565|DOI:10.1021/jm800797n,https://www.ncbi.nlm.nih.gov/pubmed/19143565|https://doi.org/10.1021/jm800797n,19143565,10.1021/jm800797n,
7194,2035517,25190791,BindingDB,"6-{[(1S,3R,4R)-3-(6-amino-9H-purin-9-yl)-4-hydroxycyclopentyl]formamido}-N-[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]hexanamide",27250,"6-{[(1S,3R,4R)-3-(6-amino-9H-purin-9-yl)-4-hydroxycyclopentyl]formamido}-N-[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]hexanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27250,1612,RAC-gamma serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1612,Q9Y243,RAC-gamma serine/threonine-protein kinase,10000.0,AKT3,9606.0,Homo sapiens (human),,IC50 (nM),43.1,PMID:19143565|DOI:10.1021/jm800797n,https://www.ncbi.nlm.nih.gov/pubmed/19143565|https://doi.org/10.1021/jm800797n,19143565,10.1021/jm800797n,
7195,2035518,25190791,BindingDB,"6-{[(1S,3R,4R)-3-(6-amino-9H-purin-9-yl)-4-hydroxycyclopentyl]formamido}-N-[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]hexanamide",27250,"6-{[(1S,3R,4R)-3-(6-amino-9H-purin-9-yl)-4-hydroxycyclopentyl]formamido}-N-[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]hexanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27250,1494,cAMP-dependent protein kinase catalytic subunit alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1494,P05132,cAMP-dependent protein kinase catalytic subunit alpha ,18747.0,Prkaca,10090.0,Mus musculus (house mouse),,IC50 (nM),2.41,PMID:19143565|DOI:10.1021/jm800797n,https://www.ncbi.nlm.nih.gov/pubmed/19143565|https://doi.org/10.1021/jm800797n,19143565,10.1021/jm800797n,
7196,2035519,25190792,BindingDB,"tert-butyl 2-(2-benzenesulfonamido-2,3-dihydro-1H-inden-5-yl)-1H-indole-1-carboxylate",27251,"indan derivative, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27251,878,Oxysterols receptor LXR-beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=878,P55055,Oxysterols receptor LXR-beta,7376.0,NR1H2,9606.0,Homo sapiens (human),,,,PMID:17587573|DOI:10.1016/j.bmcl.2007.06.017,https://www.ncbi.nlm.nih.gov/pubmed/17587573|https://doi.org/10.1016/j.bmcl.2007.06.017,17587573,10.1016/j.bmcl.2007.06.017,
7197,2035520,25190793,BindingDB,tert-butyl 2-[3-(2-benzenesulfonamidoethyl)phenyl]-1H-indole-1-carboxylate,27252,"Boc-indole derivative, 10",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27252,878,Oxysterols receptor LXR-beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=878,P55055,Oxysterols receptor LXR-beta,7376.0,NR1H2,9606.0,Homo sapiens (human),,,,PMID:17587573|DOI:10.1016/j.bmcl.2007.06.017,https://www.ncbi.nlm.nih.gov/pubmed/17587573|https://doi.org/10.1016/j.bmcl.2007.06.017,17587573,10.1016/j.bmcl.2007.06.017,
7198,2028668,25190911,BindingDB,5-(1H-benzimidazol-1-yl)-3-[(4-methylbenzyl)oxy]-2-thiophenecarboxamide,27443,"5-(1H-1,3-benzodiazol-1-yl)-3-[(4-methylphenyl)methoxy]thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27443,2700,Serine/threonine-protein kinase PLK1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2700,P53350,Serine/threonine-protein kinase PLK1,5347.0,PLK1,9606.0,Homo sapiens (human),,IC50 (nM),70,PMID:19097784|DOI:10.1016/j.bmcl.2008.11.041,https://www.ncbi.nlm.nih.gov/pubmed/19097784|https://doi.org/10.1016/j.bmcl.2008.11.041,19097784,10.1016/j.bmcl.2008.11.041,
7199,2028669,25190912,BindingDB,"5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide",27444,"5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)-3-[(4-methanesulfonylphenyl)methoxy]thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27444,2700,Serine/threonine-protein kinase PLK1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2700,P53350,Serine/threonine-protein kinase PLK1,5347.0,PLK1,9606.0,Homo sapiens (human),,IC50 (nM),75,PMID:19097784|DOI:10.1016/j.bmcl.2008.11.041,https://www.ncbi.nlm.nih.gov/pubmed/19097784|https://doi.org/10.1016/j.bmcl.2008.11.041,19097784,10.1016/j.bmcl.2008.11.041,
7200,2028670,25190915,BindingDB,"5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)benzyl]oxy}thiophene-2-carbonitrile",27448,"5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)-3-{[2-(trifluoromethyl)phenyl]methoxy}thiophene-2-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27448,2700,Serine/threonine-protein kinase PLK1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2700,P53350,Serine/threonine-protein kinase PLK1,5347.0,PLK1,9606.0,Homo sapiens (human),,IC50 (nM),700,PMID:19097784|DOI:10.1016/j.bmcl.2008.11.041,https://www.ncbi.nlm.nih.gov/pubmed/19097784|https://doi.org/10.1016/j.bmcl.2008.11.041,19097784,10.1016/j.bmcl.2008.11.041,
7201,2028923,25190926,Drug Gene Interaction database (DGIdb),5-(4-Chlorophenyl)-2-methoxy-3-(4-sulfamoylphenyl)benzamide,,GSK-711701A,https://www.dgidb.org/drugs/chembl:CHEMBL268885,,YES1,https://www.dgidb.org/genes/hgnc:12841,,,7525.0,YES1,9606.0,Homo sapiens (human),,,,,,,,
7202,2028924,25190929,Therapeutic Target Database (TTD),"13-Nitro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",D0E0QT,"8-Nitro-6H,11H-indeno[1,2-c]isoquinolin-5-one",https://idrblab.net/ttd/data/drug/details/D0E0QT,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142.0,PARP1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7203,2028925,25190931,Therapeutic Target Database (TTD),"13-Fluoro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",D0O0GA,"8-Fluoro-6H,11H-indeno[1,2-c]isoquinolin-5-one",https://idrblab.net/ttd/data/drug/details/D0O0GA,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142.0,PARP1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7204,2028926,25190932,Therapeutic Target Database (TTD),"14-Fluoro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-8-one",D07BBR,"9-Fluoro-6H,11H-indeno[1,2-c]isoquinolin-5-one",https://idrblab.net/ttd/data/drug/details/D07BBR,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142.0,PARP1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7205,2028671,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,360487,9530082P21RIKL,https://ctdbase.org/detail.go?type=gene&acc=360487,,,360487.0,9530082P21Rikl,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of 9530082P21RIKL mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7206,2028672,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,8714,ABCC3,https://ctdbase.org/detail.go?type=gene&acc=8714,,,8714.0,ABCC3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of ABCC3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7207,2028673,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,233799,ACSM2,https://ctdbase.org/detail.go?type=gene&acc=233799,,,233799.0,Acsm2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of ACSM2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7208,2028674,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,54988,ACSM5,https://ctdbase.org/detail.go?type=gene&acc=54988,,,54988.0,ACSM5,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of ACSM5 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7209,2028675,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,92,ACVR2A,https://ctdbase.org/detail.go?type=gene&acc=92,,,92.0,ACVR2A,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ACVR2A mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7210,2028676,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,102,ADAM10,https://ctdbase.org/detail.go?type=gene&acc=102,,,102.0,ADAM10,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ADAM10 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7211,2028677,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,11522,ADH1,https://ctdbase.org/detail.go?type=gene&acc=11522,,,11522.0,Adh1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of ADH1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7212,2028678,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,23394,ADNP,https://ctdbase.org/detail.go?type=gene&acc=23394,,,23394.0,ADNP,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ADNP mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7213,2028679,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,114896,AFG3L1,https://ctdbase.org/detail.go?type=gene&acc=114896,,,114896.0,Afg3l1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of AFG3L1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7214,2028680,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,55326,AGPAT5,https://ctdbase.org/detail.go?type=gene&acc=55326,,,55326.0,AGPAT5,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of AGPAT5 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7215,2028681,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,27245,AHDC1,https://ctdbase.org/detail.go?type=gene&acc=27245,,,27245.0,AHDC1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of AHDC1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7216,2028682,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,56672,AKIP1,https://ctdbase.org/detail.go?type=gene&acc=56672,,,56672.0,AKIP1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of AKIP1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7217,2028683,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,22977,AKR7A3,https://ctdbase.org/detail.go?type=gene&acc=22977,,,22977.0,AKR7A3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of AKR7A3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7218,2028684,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,216,ALDH1A1,https://ctdbase.org/detail.go?type=gene&acc=216,,,216.0,ALDH1A1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of ALDH1A1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7219,2028685,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,100020791,ALDH1A4,https://ctdbase.org/detail.go?type=gene&acc=100020791,,,100020791.0,,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of ALDH1A4 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7220,2028686,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of AOX1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7221,2028687,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,8905,AP1S2,https://ctdbase.org/detail.go?type=gene&acc=8905,,,8905.0,AP1S2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of AP1S2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7222,2028688,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1175,AP2S1,https://ctdbase.org/detail.go?type=gene&acc=1175,,,1175.0,AP2S1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of AP2S1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7223,2028689,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of APAF1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7224,2028690,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,327,APEH,https://ctdbase.org/detail.go?type=gene&acc=327,,,327.0,APEH,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of APEH mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7225,2028691,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of APP mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7226,2028692,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,57569,ARHGAP20,https://ctdbase.org/detail.go?type=gene&acc=57569,,,57569.0,ARHGAP20,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ARHGAP20 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7227,2028693,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,23365,ARHGEF12,https://ctdbase.org/detail.go?type=gene&acc=23365,,,23365.0,ARHGEF12,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ARHGEF12 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7228,2028694,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,140458,ASB5,https://ctdbase.org/detail.go?type=gene&acc=140458,,,140458.0,ASB5,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of ASB5 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7229,2028695,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,445,ASS1,https://ctdbase.org/detail.go?type=gene&acc=445,,,445.0,ASS1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ASS1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7230,2028696,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,22809,ATF5,https://ctdbase.org/detail.go?type=gene&acc=22809,,,22809.0,ATF5,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ATF5 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7231,2028697,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,11016,ATF7,https://ctdbase.org/detail.go?type=gene&acc=11016,,,11016.0,ATF7,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of ATF7 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7232,2028698,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,93974,ATP5IF1,https://ctdbase.org/detail.go?type=gene&acc=93974,,,93974.0,ATP5IF1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of ATP5IF1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7233,2028699,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,79370,BCL2L14,https://ctdbase.org/detail.go?type=gene&acc=79370,,,79370.0,BCL2L14,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of BCL2L14 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7234,2028700,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,66037,BOLL,https://ctdbase.org/detail.go?type=gene&acc=66037,,,66037.0,BOLL,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of BOLL mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7235,2028701,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,25966,C2CD2,https://ctdbase.org/detail.go?type=gene&acc=25966,,,25966.0,C2CD2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of C2CD2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7236,2028702,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,725,C4BPB,https://ctdbase.org/detail.go?type=gene&acc=725,,,725.0,C4BPB,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of C4BPB mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7237,2028703,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,728,C5AR1,https://ctdbase.org/detail.go?type=gene&acc=728,,,728.0,C5AR1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of C5AR1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7238,2028704,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,784,CACNB3,https://ctdbase.org/detail.go?type=gene&acc=784,,,784.0,CACNB3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CACNB3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7239,2028705,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,64921,CASD1,https://ctdbase.org/detail.go?type=gene&acc=64921,,,64921.0,CASD1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CASD1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7240,2028706,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,117155,CATSPER2,https://ctdbase.org/detail.go?type=gene&acc=117155,,,117155.0,CATSPER2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CATSPER2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7241,2028707,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,55749,CCAR1,https://ctdbase.org/detail.go?type=gene&acc=55749,,,55749.0,CCAR1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CCAR1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7242,2028708,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,90693,CCDC126,https://ctdbase.org/detail.go?type=gene&acc=90693,,,90693.0,CCDC126,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CCDC126 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7243,2028709,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,168455,CCDC71L,https://ctdbase.org/detail.go?type=gene&acc=168455,,,168455.0,CCDC71L,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of CCDC71L mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7244,2028710,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,79080,CCDC86,https://ctdbase.org/detail.go?type=gene&acc=79080,,,79080.0,CCDC86,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CCDC86 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7245,2028711,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,885,CCK,https://ctdbase.org/detail.go?type=gene&acc=885,,,885.0,CCK,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CCK mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7246,2028712,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,929,CD14,https://ctdbase.org/detail.go?type=gene&acc=929,,,929.0,CD14,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of CD14 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7247,2028713,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of CD36 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7248,2028714,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,921,CD5,https://ctdbase.org/detail.go?type=gene&acc=921,,,921.0,CD5,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CD5 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7249,2028715,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1045,CDX2,https://ctdbase.org/detail.go?type=gene&acc=1045,,,1045.0,CDX2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CDX2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7250,2028716,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,10659,CELF2,https://ctdbase.org/detail.go?type=gene&acc=10659,,,10659.0,CELF2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CELF2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7251,2028717,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,8824,CES2,https://ctdbase.org/detail.go?type=gene&acc=8824,,,8824.0,CES2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of CES2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7252,2028718,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,84952,CGNL1,https://ctdbase.org/detail.go?type=gene&acc=84952,,,84952.0,CGNL1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CGNL1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7253,2028719,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1107,CHD3,https://ctdbase.org/detail.go?type=gene&acc=1107,,,1107.0,CHD3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CHD3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7254,2028720,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,57019,CIAPIN1,https://ctdbase.org/detail.go?type=gene&acc=57019,,,57019.0,CIAPIN1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CIAPIN1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7255,2028721,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1149,CIDEA,https://ctdbase.org/detail.go?type=gene&acc=1149,,,1149.0,CIDEA,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of CIDEA mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7256,2028722,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,9076,CLDN1,https://ctdbase.org/detail.go?type=gene&acc=9076,,,9076.0,CLDN1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CLDN1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7257,2028723,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1365,CLDN3,https://ctdbase.org/detail.go?type=gene&acc=1365,,,1365.0,CLDN3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of CLDN3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7258,2028724,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,25999,CLIP3,https://ctdbase.org/detail.go?type=gene&acc=25999,,,25999.0,CLIP3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CLIP3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7259,2028725,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,57472,CNOT6,https://ctdbase.org/detail.go?type=gene&acc=57472,,,57472.0,CNOT6,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CNOT6 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7260,2028726,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1690,COCH,https://ctdbase.org/detail.go?type=gene&acc=1690,,,1690.0,COCH,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of COCH mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7261,2028727,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,9377,COX5A,https://ctdbase.org/detail.go?type=gene&acc=9377,,,9377.0,COX5A,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of COX5A mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7262,2028728,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,55313,CPPED1,https://ctdbase.org/detail.go?type=gene&acc=55313,,,55313.0,CPPED1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of CPPED1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7263,2028729,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,92359,CRB3,https://ctdbase.org/detail.go?type=gene&acc=92359,,,92359.0,CRB3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CRB3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7264,2028730,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,51084,CRYL1,https://ctdbase.org/detail.go?type=gene&acc=51084,,,51084.0,CRYL1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of CRYL1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7265,2028731,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1455,CSNK1G2,https://ctdbase.org/detail.go?type=gene&acc=1455,,,1455.0,CSNK1G2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CSNK1G2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7266,2028732,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,24300,CYP2B1,https://ctdbase.org/detail.go?type=gene&acc=24300,,,24300.0,Cyp2b1,10116.0,Rattus norvegicus (Norway rat),NR1I3 gene mutant form inhibits the reaction [momfluorothrin results in increased expression of CYP2B1 mrna]|nr1i3 mRNA promotes the reaction [momfluorothrin results in increased expression of CYP2B1 mrna]|momfluorothrin results in increased expression of CYP2B1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7267,2028733,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CYP2E1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7268,2028734,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,65210,CYP2J4,https://ctdbase.org/detail.go?type=gene&acc=65210,,,65210.0,Cyp2j4,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of CYP2J4 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7269,2028735,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,25642,CYP3A23-3A1,https://ctdbase.org/detail.go?type=gene&acc=25642,,,25642.0,Cyp3a23-3a1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of CYP3A23-3A1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7270,2028736,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,50549,CYP4A1,https://ctdbase.org/detail.go?type=gene&acc=50549,,,50549.0,Cyp4a1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of CYP4A1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7271,2028737,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1582,CYP8B1,https://ctdbase.org/detail.go?type=gene&acc=1582,,,1582.0,CYP8B1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of CYP8B1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7272,2028738,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,84418,CYSTM1,https://ctdbase.org/detail.go?type=gene&acc=84418,,,84418.0,CYSTM1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of CYSTM1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7273,2028739,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,23002,DAAM1,https://ctdbase.org/detail.go?type=gene&acc=23002,,,23002.0,DAAM1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of DAAM1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7274,2028740,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1611,DAP,https://ctdbase.org/detail.go?type=gene&acc=1611,,,1611.0,DAP,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of DAP mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7275,2028741,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,55861,DBNDD2,https://ctdbase.org/detail.go?type=gene&acc=55861,,,55861.0,DBNDD2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of DBNDD2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7276,2028742,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,8816,DCAF5,https://ctdbase.org/detail.go?type=gene&acc=8816,,,8816.0,DCAF5,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of DCAF5 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7277,2028743,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644.0,DDC,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of DDC mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7278,2028744,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,80821,DDHD1,https://ctdbase.org/detail.go?type=gene&acc=80821,,,80821.0,DDHD1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of DDHD1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7279,2028745,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,10059,DNM1L,https://ctdbase.org/detail.go?type=gene&acc=10059,,,10059.0,DNM1L,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of DNM1L mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7280,2028746,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1848,DUSP6,https://ctdbase.org/detail.go?type=gene&acc=1848,,,1848.0,DUSP6,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of DUSP6 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7281,2028747,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,9666,DZIP3,https://ctdbase.org/detail.go?type=gene&acc=9666,,,9666.0,DZIP3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of DZIP3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7282,2028748,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1946,EFNA5,https://ctdbase.org/detail.go?type=gene&acc=1946,,,1946.0,EFNA5,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of EFNA5 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7283,2028749,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,1982,EIF4G2,https://ctdbase.org/detail.go?type=gene&acc=1982,,,1982.0,EIF4G2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of EIF4G2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7284,2028750,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,22936,ELL2,https://ctdbase.org/detail.go?type=gene&acc=22936,,,22936.0,ELL2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ELL2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7285,2028751,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,4072,EPCAM,https://ctdbase.org/detail.go?type=gene&acc=4072,,,4072.0,EPCAM,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of EPCAM mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7286,2028752,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2048,EPHB2,https://ctdbase.org/detail.go?type=gene&acc=2048,,,2048.0,EPHB2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of EPHB2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7287,2028753,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2052,EPHX1,https://ctdbase.org/detail.go?type=gene&acc=2052,,,2052.0,EPHX1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of EPHX1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7288,2028754,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2069,EREG,https://ctdbase.org/detail.go?type=gene&acc=2069,,,2069.0,EREG,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of EREG mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7289,2028755,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2114,ETS2,https://ctdbase.org/detail.go?type=gene&acc=2114,,,2114.0,ETS2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ETS2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7290,2028756,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2131,EXT1,https://ctdbase.org/detail.go?type=gene&acc=2131,,,2131.0,EXT1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of EXT1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7291,2028757,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2157,F8,https://ctdbase.org/detail.go?type=gene&acc=2157,,,2157.0,F8,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of F8 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7292,2028758,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,23197,FAF2,https://ctdbase.org/detail.go?type=gene&acc=23197,,,23197.0,FAF2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of FAF2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7293,2028759,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,84498,FAM120B,https://ctdbase.org/detail.go?type=gene&acc=84498,,,84498.0,FAM120B,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of FAM120B mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7294,2028760,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,23014,FBXO21,https://ctdbase.org/detail.go?type=gene&acc=23014,,,23014.0,FBXO21,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of FBXO21 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7295,2028761,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,23767,FLRT3,https://ctdbase.org/detail.go?type=gene&acc=23767,,,23767.0,FLRT3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of FLRT3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7296,2028762,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,55640,FLVCR2,https://ctdbase.org/detail.go?type=gene&acc=55640,,,55640.0,FLVCR2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of FLVCR2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7297,2028763,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,752,FMNL1,https://ctdbase.org/detail.go?type=gene&acc=752,,,752.0,FMNL1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of FMNL1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7298,2028764,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2330,FMO5,https://ctdbase.org/detail.go?type=gene&acc=2330,,,2330.0,FMO5,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of FMO5 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7299,2028765,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,94234,FOXQ1,https://ctdbase.org/detail.go?type=gene&acc=94234,,,94234.0,FOXQ1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of FOXQ1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7300,2028766,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,8880,FUBP1,https://ctdbase.org/detail.go?type=gene&acc=8880,,,8880.0,FUBP1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of FUBP1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7301,2028767,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,8693,GALNT4,https://ctdbase.org/detail.go?type=gene&acc=8693,,,8693.0,GALNT4,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of GALNT4 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7302,2028768,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2676,GFRA3,https://ctdbase.org/detail.go?type=gene&acc=2676,,,2676.0,GFRA3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of GFRA3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7303,2028769,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2678,GGT1,https://ctdbase.org/detail.go?type=gene&acc=2678,,,2678.0,GGT1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of GGT1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7304,2028770,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,474344,GIMAP6,https://ctdbase.org/detail.go?type=gene&acc=474344,,,474344.0,GIMAP6,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of GIMAP6 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7305,2028771,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2731,GLDC,https://ctdbase.org/detail.go?type=gene&acc=2731,,,2731.0,GLDC,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of GLDC mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7306,2028772,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2886,GRB7,https://ctdbase.org/detail.go?type=gene&acc=2886,,,2886.0,GRB7,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of GRB7 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7307,2028773,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2894,GRID1,https://ctdbase.org/detail.go?type=gene&acc=2894,,,2894.0,GRID1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of GRID1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7308,2028774,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of GSTA2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7309,2028775,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of GSTM1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7310,2028776,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2952,GSTT1,https://ctdbase.org/detail.go?type=gene&acc=2952,,,2952.0,GSTT1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of GSTT1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7311,2028777,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,103140,GSTT3,https://ctdbase.org/detail.go?type=gene&acc=103140,,,103140.0,Gstt3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of GSTT3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7312,2028778,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,283464,GXYLT1,https://ctdbase.org/detail.go?type=gene&acc=283464,,,283464.0,GXYLT1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of GXYLT1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7313,2028779,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,10014,HDAC5,https://ctdbase.org/detail.go?type=gene&acc=10014,,,10014.0,HDAC5,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of HDAC5 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7314,2028780,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,3400,ID4,https://ctdbase.org/detail.go?type=gene&acc=3400,,,3400.0,ID4,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ID4 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7315,2028781,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,3454,IFNAR1,https://ctdbase.org/detail.go?type=gene&acc=3454,,,3454.0,IFNAR1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of IFNAR1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7316,2028782,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,3560,IL2RB,https://ctdbase.org/detail.go?type=gene&acc=3560,,,3560.0,IL2RB,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of IL2RB mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7317,2028800,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,55364,IMPACT,https://ctdbase.org/detail.go?type=gene&acc=55364,,,55364.0,IMPACT,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of IMPACT mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7318,2028801,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,51141,INSIG2,https://ctdbase.org/detail.go?type=gene&acc=51141,,,51141.0,INSIG2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of INSIG2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7319,2028802,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,26512,INTS6,https://ctdbase.org/detail.go?type=gene&acc=26512,,,26512.0,INTS6,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of INTS6 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7320,2028803,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,3717,JAK2,https://ctdbase.org/detail.go?type=gene&acc=3717,,,3717.0,JAK2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of JAK2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7321,2028804,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,57563,KLHL8,https://ctdbase.org/detail.go?type=gene&acc=57563,,,57563.0,KLHL8,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of KLHL8 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7322,2028805,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,4297,KMT2A,https://ctdbase.org/detail.go?type=gene&acc=4297,,,4297.0,KMT2A,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of KMT2A mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7323,2028806,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,197257,LDHD,https://ctdbase.org/detail.go?type=gene&acc=197257,,,197257.0,LDHD,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of LDHD mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7324,2028807,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,9227,LRAT,https://ctdbase.org/detail.go?type=gene&acc=9227,,,9227.0,LRAT,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of LRAT mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7325,2028808,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,4041,LRP5,https://ctdbase.org/detail.go?type=gene&acc=4041,,,4041.0,LRP5,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of LRP5 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7326,2028809,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,389816,LRRC26,https://ctdbase.org/detail.go?type=gene&acc=389816,,,389816.0,LRRC26,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of LRRC26 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7327,2028810,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,127495,LRRC39,https://ctdbase.org/detail.go?type=gene&acc=127495,,,127495.0,LRRC39,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of LRRC39 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7328,2028822,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,83742,MARVELD1,https://ctdbase.org/detail.go?type=gene&acc=83742,,,83742.0,MARVELD1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of MARVELD1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7329,2028823,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,53615,MBD3,https://ctdbase.org/detail.go?type=gene&acc=53615,,,53615.0,MBD3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of MBD3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7330,2028824,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,309809,MFSD4B2L1,https://ctdbase.org/detail.go?type=gene&acc=309809,,,309809.0,Mfsd4b2l1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of MFSD4B2L1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7331,2028825,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,57553,MICAL3,https://ctdbase.org/detail.go?type=gene&acc=57553,,,57553.0,MICAL3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of MICAL3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7332,2028826,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,4282,MIF,https://ctdbase.org/detail.go?type=gene&acc=4282,,,4282.0,MIF,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of MIF mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7333,2028827,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,55233,MOB1A,https://ctdbase.org/detail.go?type=gene&acc=55233,,,55233.0,MOB1A,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of MOB1A mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7334,2028828,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,79817,MOB3B,https://ctdbase.org/detail.go?type=gene&acc=79817,,,79817.0,MOB3B,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of MOB3B mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7335,2028829,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,4354,MPP1,https://ctdbase.org/detail.go?type=gene&acc=4354,,,4354.0,MPP1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of MPP1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7336,2028839,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,51642,MRPL48,https://ctdbase.org/detail.go?type=gene&acc=51642,,,51642.0,MRPL48,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of MRPL48 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7337,2028840,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,9,NAT1,https://ctdbase.org/detail.go?type=gene&acc=9,,,9.0,NAT1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of NAT1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7338,2028841,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,4537,ND3,https://ctdbase.org/detail.go?type=gene&acc=4537,,,4537.0,ND3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ND3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7339,2028842,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,5819,NECTIN2,https://ctdbase.org/detail.go?type=gene&acc=5819,,,5819.0,NECTIN2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of NECTIN2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7340,2028843,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,4763,NF1,https://ctdbase.org/detail.go?type=gene&acc=4763,,,4763.0,NF1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of NF1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7341,2028844,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,4784,NFIX,https://ctdbase.org/detail.go?type=gene&acc=4784,,,4784.0,NFIX,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of NFIX mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7342,2028845,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,79671,NLRX1,https://ctdbase.org/detail.go?type=gene&acc=79671,,,79671.0,NLRX1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of NLRX1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7343,2028846,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,4851,NOTCH1,https://ctdbase.org/detail.go?type=gene&acc=4851,,,4851.0,NOTCH1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of NOTCH1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7344,2028847,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,4862,NPAS2,https://ctdbase.org/detail.go?type=gene&acc=4862,,,4862.0,NPAS2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of NPAS2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7345,2028848,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,10116.0,Rattus norvegicus (Norway rat),NR1I3 gene mutant form inhibits the reaction [momfluorothrin results in increased expression of CYP2B1 mrna]|nr1i3 mRNA promotes the reaction [momfluorothrin results in increased expression of CYP2B1 mrna],,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7346,2028867,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,93183,PIGM,https://ctdbase.org/detail.go?type=gene&acc=93183,,,93183.0,PIGM,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of PIGM mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7347,2028868,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,5287,PIK3C2B,https://ctdbase.org/detail.go?type=gene&acc=5287,,,5287.0,PIK3C2B,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of PIK3C2B mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7348,2028888,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,5494,PPM1A,https://ctdbase.org/detail.go?type=gene&acc=5494,,,5494.0,PPM1A,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of PPM1A mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7349,2028898,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,24282,PRL3D4,https://ctdbase.org/detail.go?type=gene&acc=24282,,,24282.0,Prl3d4,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of PRL3D4 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7350,2028899,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,5618,PRLR,https://ctdbase.org/detail.go?type=gene&acc=5618,,,5618.0,PRLR,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of PRLR mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7351,2028900,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,5688,PSMA7,https://ctdbase.org/detail.go?type=gene&acc=5688,,,5688.0,PSMA7,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of PSMA7 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7352,2028901,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,9536,PTGES,https://ctdbase.org/detail.go?type=gene&acc=9536,,,9536.0,PTGES,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of PTGES mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7353,2028902,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,5793,PTPRG,https://ctdbase.org/detail.go?type=gene&acc=5793,,,5793.0,PTPRG,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of PTPRG mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7354,2028903,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,55278,QRSL1,https://ctdbase.org/detail.go?type=gene&acc=55278,,,55278.0,QRSL1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of QRSL1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7355,2028904,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,51552,RAB14,https://ctdbase.org/detail.go?type=gene&acc=51552,,,51552.0,RAB14,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of RAB14 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7356,2028905,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,84060,RBM48,https://ctdbase.org/detail.go?type=gene&acc=84060,,,84060.0,RBM48,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of RBM48 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7357,2028906,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,10231,RCAN2,https://ctdbase.org/detail.go?type=gene&acc=10231,,,10231.0,RCAN2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of RCAN2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7358,2028907,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,7905,REEP5,https://ctdbase.org/detail.go?type=gene&acc=7905,,,7905.0,REEP5,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of REEP5 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7359,2028908,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,92840,REEP6,https://ctdbase.org/detail.go?type=gene&acc=92840,,,92840.0,REEP6,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of REEP6 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7360,2028909,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,23504,RIMBP2,https://ctdbase.org/detail.go?type=gene&acc=23504,,,23504.0,RIMBP2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of RIMBP2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7361,2028910,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,6014,RIT2,https://ctdbase.org/detail.go?type=gene&acc=6014,,,6014.0,RIT2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of RIT2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7362,2028911,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,51444,RNF138,https://ctdbase.org/detail.go?type=gene&acc=51444,,,51444.0,RNF138,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of RNF138 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7363,2028912,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,285367,RPUSD3,https://ctdbase.org/detail.go?type=gene&acc=285367,,,285367.0,RPUSD3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of RPUSD3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7364,2028913,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,51773,RSF1,https://ctdbase.org/detail.go?type=gene&acc=51773,,,51773.0,RSF1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of RSF1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7365,2028914,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,6251,RSU1,https://ctdbase.org/detail.go?type=gene&acc=6251,,,6251.0,RSU1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of RSU1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7366,2028915,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,23168,RTF1,https://ctdbase.org/detail.go?type=gene&acc=23168,,,23168.0,RTF1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of RTF1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7367,2028916,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,10900,RUNDC3A,https://ctdbase.org/detail.go?type=gene&acc=10900,,,10900.0,RUNDC3A,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of RUNDC3A mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7368,2028917,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,6301,SARS1,https://ctdbase.org/detail.go?type=gene&acc=6301,,,6301.0,SARS1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SARS1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7369,2028918,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,23753,SDF2L1,https://ctdbase.org/detail.go?type=gene&acc=23753,,,23753.0,SDF2L1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SDF2L1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7370,2028919,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,23231,SEL1L3,https://ctdbase.org/detail.go?type=gene&acc=23231,,,23231.0,SEL1L3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SEL1L3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7371,2028930,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,223117,SEMA3D,https://ctdbase.org/detail.go?type=gene&acc=223117,,,223117.0,SEMA3D,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SEMA3D mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7372,2028931,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,5104,SERPINA5,https://ctdbase.org/detail.go?type=gene&acc=5104,,,5104.0,SERPINA5,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of SERPINA5 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7373,2028932,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,29950,SERTAD1,https://ctdbase.org/detail.go?type=gene&acc=29950,,,29950.0,SERTAD1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SERTAD1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7374,2028933,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,6555,SLC10A2,https://ctdbase.org/detail.go?type=gene&acc=6555,,,6555.0,SLC10A2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SLC10A2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7375,2028934,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SLC16A1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7376,2028935,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,10560,SLC19A2,https://ctdbase.org/detail.go?type=gene&acc=10560,,,10560.0,SLC19A2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SLC19A2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7377,2028936,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SLC29A1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7378,2028937,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,347734,SLC35B2,https://ctdbase.org/detail.go?type=gene&acc=347734,,,347734.0,SLC35B2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SLC35B2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7379,2028938,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,84912,SLC35B4,https://ctdbase.org/detail.go?type=gene&acc=84912,,,84912.0,SLC35B4,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SLC35B4 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7380,2028939,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,10991,SLC38A3,https://ctdbase.org/detail.go?type=gene&acc=10991,,,10991.0,SLC38A3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SLC38A3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7381,2028940,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,55630,SLC39A4,https://ctdbase.org/detail.go?type=gene&acc=55630,,,55630.0,SLC39A4,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of SLC39A4 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7382,2028941,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,80736,SLC44A4,https://ctdbase.org/detail.go?type=gene&acc=80736,,,80736.0,SLC44A4,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of SLC44A4 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7383,2028942,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,6521,SLC4A1,https://ctdbase.org/detail.go?type=gene&acc=6521,,,6521.0,SLC4A1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SLC4A1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7384,2028943,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,114798,SLITRK1,https://ctdbase.org/detail.go?type=gene&acc=114798,,,114798.0,SLITRK1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SLITRK1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7385,2028944,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,4091,SMAD6,https://ctdbase.org/detail.go?type=gene&acc=4091,,,4091.0,SMAD6,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SMAD6 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7386,2028945,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,388588,SMIM1,https://ctdbase.org/detail.go?type=gene&acc=388588,,,388588.0,SMIM1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of SMIM1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7387,2028946,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,27044,SND1,https://ctdbase.org/detail.go?type=gene&acc=27044,,,27044.0,SND1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SND1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7388,2028947,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,29887,SNX10,https://ctdbase.org/detail.go?type=gene&acc=29887,,,29887.0,SNX10,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of SNX10 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7389,2028948,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,399979,SNX19,https://ctdbase.org/detail.go?type=gene&acc=399979,,,399979.0,SNX19,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of SNX19 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7390,2028949,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,6667,SP1,https://ctdbase.org/detail.go?type=gene&acc=6667,,,6667.0,SP1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SP1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7391,2028950,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,3431,SP110,https://ctdbase.org/detail.go?type=gene&acc=3431,,,3431.0,SP110,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SP110 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7392,2028951,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,361099,SPETEX2G,https://ctdbase.org/detail.go?type=gene&acc=361099,,,361099.0,Spetex2g,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SPETEX2G mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7393,2028952,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720.0,SREBF1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of SREBF1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7394,2028953,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,10402,ST3GAL6,https://ctdbase.org/detail.go?type=gene&acc=10402,,,10402.0,ST3GAL6,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ST3GAL6 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7395,2028954,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,90627,STARD13,https://ctdbase.org/detail.go?type=gene&acc=90627,,,90627.0,STARD13,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of STARD13 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7396,2028955,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,6812,STXBP1,https://ctdbase.org/detail.go?type=gene&acc=6812,,,6812.0,STXBP1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of STXBP1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7397,2028956,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,25870,SUMF2,https://ctdbase.org/detail.go?type=gene&acc=25870,,,25870.0,SUMF2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of SUMF2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7398,2028957,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,342898,SYCN,https://ctdbase.org/detail.go?type=gene&acc=342898,,,342898.0,SYCN,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of SYCN mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7399,2028958,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,23232,TBC1D12,https://ctdbase.org/detail.go?type=gene&acc=23232,,,23232.0,TBC1D12,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TBC1D12 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7400,2028959,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,10312,TCIRG1,https://ctdbase.org/detail.go?type=gene&acc=10312,,,10312.0,TCIRG1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TCIRG1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7401,2028968,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,55258,THNSL2,https://ctdbase.org/detail.go?type=gene&acc=55258,,,55258.0,THNSL2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of THNSL2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7402,2028969,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,10440,TIMM17A,https://ctdbase.org/detail.go?type=gene&acc=10440,,,10440.0,TIMM17A,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TIMM17A mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7403,2028970,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,25976,TIPARP,https://ctdbase.org/detail.go?type=gene&acc=25976,,,25976.0,TIPARP,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TIPARP mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7404,2028971,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,83660,TLN2,https://ctdbase.org/detail.go?type=gene&acc=83660,,,83660.0,TLN2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TLN2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7405,2028972,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,9375,TM9SF2,https://ctdbase.org/detail.go?type=gene&acc=9375,,,9375.0,TM9SF2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TM9SF2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7406,2028973,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,56889,TM9SF3,https://ctdbase.org/detail.go?type=gene&acc=56889,,,56889.0,TM9SF3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TM9SF3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7407,2028974,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,64114,TMBIM1,https://ctdbase.org/detail.go?type=gene&acc=64114,,,64114.0,TMBIM1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of TMBIM1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7408,2028975,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,54929,TMEM161A,https://ctdbase.org/detail.go?type=gene&acc=54929,,,54929.0,TMEM161A,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TMEM161A mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7409,2028976,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,80775,TMEM177,https://ctdbase.org/detail.go?type=gene&acc=80775,,,80775.0,TMEM177,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of TMEM177 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7410,2028977,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,9540,TP53I3,https://ctdbase.org/detail.go?type=gene&acc=9540,,,9540.0,TP53I3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of TP53I3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7411,2028986,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,7168,TPM1,https://ctdbase.org/detail.go?type=gene&acc=7168,,,7168.0,TPM1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TPM1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7412,2028987,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,80128,TRIM46,https://ctdbase.org/detail.go?type=gene&acc=80128,,,80128.0,TRIM46,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TRIM46 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7413,2028988,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,68728,TRP53INP2,https://ctdbase.org/detail.go?type=gene&acc=68728,,,68728.0,Trp53inp2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TRP53INP2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7414,2028989,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,23093,TTLL5,https://ctdbase.org/detail.go?type=gene&acc=23093,,,23093.0,TTLL5,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TTLL5 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7415,2028990,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,10382,TUBB4A,https://ctdbase.org/detail.go?type=gene&acc=10382,,,10382.0,TUBB4A,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TUBB4A mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7416,2028991,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,51060,TXNDC12,https://ctdbase.org/detail.go?type=gene&acc=51060,,,51060.0,TXNDC12,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of TXNDC12 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7417,2028992,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,7326,UBE2G1,https://ctdbase.org/detail.go?type=gene&acc=7326,,,7326.0,UBE2G1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of UBE2G1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7418,2028993,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,71773,UGT2B1,https://ctdbase.org/detail.go?type=gene&acc=71773,,,71773.0,Ugt2b1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of UGT2B1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7419,2028994,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,9217,VAPB,https://ctdbase.org/detail.go?type=gene&acc=9217,,,9217.0,VAPB,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of VAPB mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7420,2028995,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,55339,WDR33,https://ctdbase.org/detail.go?type=gene&acc=55339,,,55339.0,WDR33,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of WDR33 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7421,2029005,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,26118,WSB1,https://ctdbase.org/detail.go?type=gene&acc=26118,,,26118.0,WSB1,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of WSB1 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7422,2029006,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,51741,WWOX,https://ctdbase.org/detail.go?type=gene&acc=51741,,,51741.0,WWOX,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of WWOX mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7423,2029007,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,388403,YPEL2,https://ctdbase.org/detail.go?type=gene&acc=388403,,,388403.0,YPEL2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of YPEL2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7424,2029008,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,84327,ZBED3,https://ctdbase.org/detail.go?type=gene&acc=84327,,,84327.0,ZBED3,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ZBED3 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7425,2029009,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,10472,ZBTB18,https://ctdbase.org/detail.go?type=gene&acc=10472,,,10472.0,ZBTB18,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ZBTB18 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7426,2029010,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,51201,ZDHHC2,https://ctdbase.org/detail.go?type=gene&acc=51201,,,51201.0,ZDHHC2,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of ZDHHC2 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7427,2029011,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,254887,ZDHHC23,https://ctdbase.org/detail.go?type=gene&acc=254887,,,254887.0,ZDHHC23,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ZDHHC23 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7428,2029012,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,79776,ZFHX4,https://ctdbase.org/detail.go?type=gene&acc=79776,,,79776.0,ZFHX4,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ZFHX4 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7429,2029013,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,22680,ZFP207,https://ctdbase.org/detail.go?type=gene&acc=22680,,,22680.0,Zfp207,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ZFP207 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7430,2029014,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,27081,ZFP275,https://ctdbase.org/detail.go?type=gene&acc=27081,,,27081.0,Zfp275,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in decreased expression of ZFP275 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7431,2029015,25193220,Comparative Toxicogenomics Database (CTD),Momfluorothrin,C000627226,momfluorothrin,https://ctdbase.org/detail.go?type=chem&acc=C000627226,243372,ZFP775,https://ctdbase.org/detail.go?type=gene&acc=243372,,,243372.0,Zfp775,10116.0,Rattus norvegicus (Norway rat),Momfluorothrin results in increased expression of ZFP775 mRNA,,,PMID:28520973,https://www.ncbi.nlm.nih.gov/pubmed/28520973,28520973,,
7432,2029134,25195216,Drug Gene Interaction database (DGIdb),"3-[5-[(Z)-[5-(anilinocarbamoyl)-2-oxo-1H-indol-3-ylidene]methyl]-2,4-dimethyl-1H-pyrrol-3-yl]propanoic acid",,CHEMBL:CHEMBL480356,https://www.dgidb.org/drugs/chembl:CHEMBL480356,,AKT1,https://www.dgidb.org/genes/hgnc:391,,,207.0,AKT1,9606.0,Homo sapiens (human),,,,,,,,
7433,2055116,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,5711,PSMD5,https://ctdbase.org/detail.go?type=gene&acc=5711,,,5711.0,PSMD5,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PSMD5 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
7434,2055117,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,10197,PSME3,https://ctdbase.org/detail.go?type=gene&acc=10197,,,10197.0,PSME3,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PSME3 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
7435,2055118,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,55269,PSPC1,https://ctdbase.org/detail.go?type=gene&acc=55269,,,55269.0,PSPC1,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PSPC1 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
7436,2055119,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,5723,PSPH,https://ctdbase.org/detail.go?type=gene&acc=5723,,,5723.0,PSPH,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PSPH protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
7437,2055120,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,5725,PTBP1,https://ctdbase.org/detail.go?type=gene&acc=5725,,,5725.0,PTBP1,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PTBP1 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
7438,2055121,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,58155,PTBP2,https://ctdbase.org/detail.go?type=gene&acc=58155,,,58155.0,PTBP2,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PTBP2 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
7439,2055122,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,55037,PTCD3,https://ctdbase.org/detail.go?type=gene&acc=55037,,,55037.0,PTCD3,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PTCD3 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
7440,2055123,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,5757,PTMA,https://ctdbase.org/detail.go?type=gene&acc=5757,,,5757.0,PTMA,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PTMA protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
7441,2055124,25195294,Comparative Toxicogenomics Database (CTD),"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",C554430,LDN 193189,https://ctdbase.org/detail.go?type=chem&acc=C554430,8073,PTP4A2,https://ctdbase.org/detail.go?type=gene&acc=8073,,,8073.0,PTP4A2,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PTP4A2 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
7442,2029016,25195344,BindingDB,"L-Alanyl-L-Valyl-N-(2,2-Diphenylethyl)-L-Prolinamide",27942,"(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanoyl]-N-(2,2-diphenylethyl)pyrrolidine-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27942,2972,E3 ubiquitin-protein ligase XIAP [241-356],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2972,P98170,E3 ubiquitin-protein ligase XIAP,331.0,XIAP,9606.0,Homo sapiens (human),,Ki (nM),345,PMID:19228017|DOI:10.1021/jm801450c,https://www.ncbi.nlm.nih.gov/pubmed/19228017|https://doi.org/10.1021/jm801450c,19228017,10.1021/jm801450c,
7443,2029017,25195344,BindingDB,"L-Alanyl-L-Valyl-N-(2,2-Diphenylethyl)-L-Prolinamide",27942,"(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanoyl]-N-(2,2-diphenylethyl)pyrrolidine-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27942,3381,"Complex of Baculoviral IAP repeat-containing protein 7 [63-159,S150G] and E3 ubiquitin-protein ligase XIAP [336-348]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3381,Q96CA5 P98170,,,,,,,Ki (nM),43,PMID:19228017|DOI:10.1021/jm801450c,https://www.ncbi.nlm.nih.gov/pubmed/19228017|https://doi.org/10.1021/jm801450c,19228017,10.1021/jm801450c,
7444,2029018,25195345,BindingDB,"N-[(3ar,6s,6as)-1-(N-Methyl-L-Alanyl-3-Methyl-L-Valyl)octahydrocyclopenta[b]pyrrol-6-Yl]-2,2-Diphenylacetamide",27918,"(2S)-N-[(2S)-1-[(3aR,6S,6aS)-6-(2,2-diphenylacetamido)-octahydrocyclopenta[b]pyrrol-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-(methylamino)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27918,2972,E3 ubiquitin-protein ligase XIAP [241-356],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2972,P98170,E3 ubiquitin-protein ligase XIAP,331.0,XIAP,9606.0,Homo sapiens (human),,Ki (nM),570,PMID:19228017|DOI:10.1021/jm801450c,https://www.ncbi.nlm.nih.gov/pubmed/19228017|https://doi.org/10.1021/jm801450c,19228017,10.1021/jm801450c,
7445,2029019,25195345,BindingDB,"N-[(3ar,6s,6as)-1-(N-Methyl-L-Alanyl-3-Methyl-L-Valyl)octahydrocyclopenta[b]pyrrol-6-Yl]-2,2-Diphenylacetamide",27918,"(2S)-N-[(2S)-1-[(3aR,6S,6aS)-6-(2,2-diphenylacetamido)-octahydrocyclopenta[b]pyrrol-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-(methylamino)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27918,1803,Baculoviral IAP repeat-containing protein 2 [266-354],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1803,Q13490,Baculoviral IAP repeat-containing protein 2,329.0,BIRC2,9606.0,Homo sapiens (human),,Ki (nM),129,PMID:19228017|DOI:10.1021/jm801450c,https://www.ncbi.nlm.nih.gov/pubmed/19228017|https://doi.org/10.1021/jm801450c,19228017,10.1021/jm801450c,
7446,2029020,25195345,BindingDB,"N-[(3ar,6s,6as)-1-(N-Methyl-L-Alanyl-3-Methyl-L-Valyl)octahydrocyclopenta[b]pyrrol-6-Yl]-2,2-Diphenylacetamide",27918,"(2S)-N-[(2S)-1-[(3aR,6S,6aS)-6-(2,2-diphenylacetamido)-octahydrocyclopenta[b]pyrrol-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-(methylamino)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27918,3381,"Complex of Baculoviral IAP repeat-containing protein 7 [63-159,S150G] and E3 ubiquitin-protein ligase XIAP [336-348]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3381,Q96CA5 P98170,,,,,,,Ki (nM),82,PMID:19228017|DOI:10.1021/jm801450c,https://www.ncbi.nlm.nih.gov/pubmed/19228017|https://doi.org/10.1021/jm801450c,19228017,10.1021/jm801450c,
7447,2029021,25195346,BindingDB,"N-[(3ar,6s,6as)-1-(N-Methyl-L-Alanyl-3-Methyl-L-Valyl)octahydrocyclopenta[b]pyrrol-6-Yl]naphthalene-1-Carboxamide",27919,"Azabicyclooctane scaffold, 14b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27919,3381,"Complex of Baculoviral IAP repeat-containing protein 7 [63-159,S150G] and E3 ubiquitin-protein ligase XIAP [336-348]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3381,Q96CA5 P98170,,,,,,,Ki (nM),46,PMID:19228017|DOI:10.1021/jm801450c,https://www.ncbi.nlm.nih.gov/pubmed/19228017|https://doi.org/10.1021/jm801450c,19228017,10.1021/jm801450c,
7448,2029042,25195346,BindingDB,"N-[(3ar,6s,6as)-1-(N-Methyl-L-Alanyl-3-Methyl-L-Valyl)octahydrocyclopenta[b]pyrrol-6-Yl]naphthalene-1-Carboxamide",27919,"Azabicyclooctane scaffold, 14b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27919,1803,Baculoviral IAP repeat-containing protein 2 [266-354],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1803,Q13490,Baculoviral IAP repeat-containing protein 2,329.0,BIRC2,9606.0,Homo sapiens (human),,Ki (nM),33,PMID:19228017|DOI:10.1021/jm801450c,https://www.ncbi.nlm.nih.gov/pubmed/19228017|https://doi.org/10.1021/jm801450c,19228017,10.1021/jm801450c,
7449,2029043,25195346,BindingDB,"N-[(3ar,6s,6as)-1-(N-Methyl-L-Alanyl-3-Methyl-L-Valyl)octahydrocyclopenta[b]pyrrol-6-Yl]naphthalene-1-Carboxamide",27919,"Azabicyclooctane scaffold, 14b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27919,2972,E3 ubiquitin-protein ligase XIAP [241-356],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2972,P98170,E3 ubiquitin-protein ligase XIAP,331.0,XIAP,9606.0,Homo sapiens (human),,Ki (nM),140,PMID:19228017|DOI:10.1021/jm801450c,https://www.ncbi.nlm.nih.gov/pubmed/19228017|https://doi.org/10.1021/jm801450c,19228017,10.1021/jm801450c,
7450,2028256,25195352,Chemical Probes Portal,"1-(4-(4-(2-(Isopropylsulfonyl)phenylamino)-1H-pyrrolo[2,3-b]pyridin-6-ylamino)-3-methoxyphenyl)piperidin-4-ol",MPS1-IN-1,MPS1-IN-1,https://www.chemicalprobes.org/mps1-in-1,,TTK,,P33981,Dual specificity protein kinase TTK,7272.0,TTK,9606.0,Homo sapiens (human),Inhibitor,,27 nM,PMID:20383151,https://www.ncbi.nlm.nih.gov/pubmed/20383151,20383151,,"http://www.nature.com/nchembio/journal/v6/n5/full/nchembio.345.html, http://www.ncbi.nlm.nih.gov/pubmed/20383151"
7451,2029044,25195354,ChEMBL,Pomaglumetad methionil,CHEMBL2110730,POMAGLUMETAD METHIONIL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110730/,CHEMBL5137,Metabotropic glutamate receptor 2,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL5137/,Q14416,Metabotropic glutamate receptor 2,2912.0,GRM2,9606.0,Homo sapiens (human),Metabotropic glutamate receptor 2 agonist,,,PMID:20571979|PMID:17204749,https://www.ncbi.nlm.nih.gov/pubmed/20571979|https://www.ncbi.nlm.nih.gov/pubmed/17204749,20571979|17204749,,
7452,2029045,25195354,ChEMBL,Pomaglumetad methionil,CHEMBL2110730,POMAGLUMETAD METHIONIL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110730/,CHEMBL2888,Metabotropic glutamate receptor 3,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2888/,Q14832,Metabotropic glutamate receptor 3,2913.0,GRM3,9606.0,Homo sapiens (human),Metabotropic glutamate receptor 3 agonist,,,PMID:20571979|PMID:17204749,https://www.ncbi.nlm.nih.gov/pubmed/20571979|https://www.ncbi.nlm.nih.gov/pubmed/17204749,20571979|17204749,,
7453,2028927,25195461,ChEMBL,"2(1H)-Pyridinone, 1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-",CHEMBL3337527,JNJ-40411813,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3337527/,CHEMBL5137,Metabotropic glutamate receptor 2,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL5137/,Q14416,Metabotropic glutamate receptor 2,2912.0,GRM2,9606.0,Homo sapiens (human),Metabotropic glutamate receptor 2 positive allosteric modulator,,,PMID:25692015|PMID:25692027|PMID:25032784,https://www.ncbi.nlm.nih.gov/pubmed/25692015|https://www.ncbi.nlm.nih.gov/pubmed/25692027|https://www.ncbi.nlm.nih.gov/pubmed/25032784,25692015|25692027|25032784,,
7454,2029046,25195495,ChEMBL,(S)-N-((1-(5-(4-Fluorophenyl)-2-methylthiazole-4-carbonyl)piperidin-2-yl)methyl)benzofuran-4-carboxamide,CHEMBL1272307,SB-649868,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1272307/,CHEMBL5113,Orexin receptor 1,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL5113/,O43613,Orexin receptor type 1,3061.0,HCRTR1,9606.0,Homo sapiens (human),Orexin receptor 1 antagonist,,,PMID:21045199,https://www.ncbi.nlm.nih.gov/pubmed/21045199,21045199,,
7455,2029047,25195495,ChEMBL,(S)-N-((1-(5-(4-Fluorophenyl)-2-methylthiazole-4-carbonyl)piperidin-2-yl)methyl)benzofuran-4-carboxamide,CHEMBL1272307,SB-649868,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1272307/,CHEMBL4792,Orexin receptor 2,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL4792/,O43614,Orexin receptor type 2,3062.0,HCRTR2,9606.0,Homo sapiens (human),Orexin receptor 2 antagonist,,,PMID:21045199,https://www.ncbi.nlm.nih.gov/pubmed/21045199,21045199,,
7456,2029048,25195511,ChEMBL,"2-{3-[4-(2,2-difluoro-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-ylamino)5-fluoro-pyrimidin-2-ylamino]phenoxy}N-methyl-acetamide 1-hydroxy-2-napthoic acid salt",CHEMBL3545340,R-343,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545340/,CHEMBL2599,Tyrosine-protein kinase SYK,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2599/,P43405,Tyrosine-protein kinase SYK,6850.0,SYK,9606.0,Homo sapiens (human),Tyrosine-protein kinase SYK inhibitor,,,,,,,
7457,2028928,25195624,IUPHAR/BPS Guide to PHARMACOLOGY,Bexagliflozin,12335,bexagliflozin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12335,916,Sodium/glucose cotransporter 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=916,P31639,Sodium/glucose cotransporter 2,6524.0,SLC5A2,9606.0,Homo sapiens (human),Inhibition,pIC50,8.64,PMID:21737266,https://www.ncbi.nlm.nih.gov/pubmed/21737266,21737266,,
7458,2028929,25195624,IUPHAR/BPS Guide to PHARMACOLOGY,Bexagliflozin,12335,bexagliflozin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12335,915,Sodium/glucose cotransporter 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=915,P13866,Sodium/glucose cotransporter 1,6523.0,SLC5A1,9606.0,Homo sapiens (human),Inhibition,pIC50,5.25,PMID:21737266,https://www.ncbi.nlm.nih.gov/pubmed/21737266,21737266,,
7459,2029049,25195624,Comparative Toxicogenomics Database (CTD),Bexagliflozin,C000705992,bexagliflozin,https://ctdbase.org/detail.go?type=chem&acc=C000705992,6524,SLC5A2,https://ctdbase.org/detail.go?type=gene&acc=6524,,,6524.0,SLC5A2,9606.0,Homo sapiens (human),Bexagliflozin results in decreased activity of SLC5A2 protein,,,PMID:21215314|PMID:36867399,https://www.ncbi.nlm.nih.gov/pubmed/21215314|https://www.ncbi.nlm.nih.gov/pubmed/36867399,21215314|36867399,,
7460,2029050,25195624,Comparative Toxicogenomics Database (CTD),Bexagliflozin,C000705992,bexagliflozin,https://ctdbase.org/detail.go?type=chem&acc=C000705992,6524,SLC5A2,https://ctdbase.org/detail.go?type=gene&acc=6524,,,6524.0,SLC5A2,9606.0,Homo sapiens (human),Bexagliflozin results in decreased activity of SLC5A2 protein,,,PMID:37148170|PMID:37651295,https://www.ncbi.nlm.nih.gov/pubmed/37148170|https://www.ncbi.nlm.nih.gov/pubmed/37651295,37148170|37651295,,
7461,2028960,25203945,DrugBank,"1-(3-Bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",DB08555,"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",https://www.drugbank.ca/drugs/DB08555,BE0001097,Mitogen-activated protein kinase 10,https://www.drugbank.ca/bio_entities/BE0001097,P53779,Mitogen-activated protein kinase 10,5602.0,MAPK10,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
7462,2028961,25203955,DrugBank,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",DB08703,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",https://www.drugbank.ca/drugs/DB08703,BE0004386,Mitogen-activated protein kinase kinase kinase 9,https://www.drugbank.ca/bio_entities/BE0004386,P80192,Mitogen-activated protein kinase kinase kinase 9,4293.0,MAP3K9,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
7463,2028962,25209862,Drug Gene Interaction database (DGIdb),Gallinamide A,,GALLINAMIDE A,https://www.dgidb.org/drugs/chembl:CHEMBL541700,,CTSL,https://www.dgidb.org/genes/hgnc:2537,,,1514.0,CTSL,9606.0,Homo sapiens (human),,,,,,,,
7464,2028963,25211876,BindingDB,"Benzoic acid, 2-((3-((5-methoxy-4-methyl-1H-indol-1-yl)sulfonyl)benzoyl)amino)-5-methyl-",28694,2-({3-[(5-methoxy-4-methyl-1H-indole-1-)sulfonyl]benzene}amido)-5-methylbenzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28694,9949,Peroxisome proliferator-activated receptor delta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9949,Q03181,Peroxisome proliferator-activated receptor delta,5467.0,PPARD,9606.0,Homo sapiens (human),,IC50 (nM),20,PMID:18722772|DOI:10.1016/j.bmcl.2008.08.011,https://www.ncbi.nlm.nih.gov/pubmed/18722772|https://doi.org/10.1016/j.bmcl.2008.08.011,18722772,10.1016/j.bmcl.2008.08.011,
7465,2028964,25211876,BindingDB,"Benzoic acid, 2-((3-((5-methoxy-4-methyl-1H-indol-1-yl)sulfonyl)benzoyl)amino)-5-methyl-",28694,2-({3-[(5-methoxy-4-methyl-1H-indole-1-)sulfonyl]benzene}amido)-5-methylbenzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28694,2209,Peroxisome proliferator-activated receptor gamma,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2209,P37231,Peroxisome proliferator-activated receptor gamma,5468.0,PPARG,9606.0,Homo sapiens (human),,IC50 (nM),3162,PMID:18722772|DOI:10.1016/j.bmcl.2008.08.011,https://www.ncbi.nlm.nih.gov/pubmed/18722772|https://doi.org/10.1016/j.bmcl.2008.08.011,18722772,10.1016/j.bmcl.2008.08.011,
7466,2028965,25211876,BindingDB,"Benzoic acid, 2-((3-((5-methoxy-4-methyl-1H-indol-1-yl)sulfonyl)benzoyl)amino)-5-methyl-",28694,2-({3-[(5-methoxy-4-methyl-1H-indole-1-)sulfonyl]benzene}amido)-5-methylbenzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28694,9947,Peroxisome proliferator-activated receptor alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9947,Q07869,Peroxisome proliferator-activated receptor alpha,5465.0,PPARA,9606.0,Homo sapiens (human),,IC50 (nM),3162,PMID:18722772|DOI:10.1016/j.bmcl.2008.08.011,https://www.ncbi.nlm.nih.gov/pubmed/18722772|https://doi.org/10.1016/j.bmcl.2008.08.011,18722772,10.1016/j.bmcl.2008.08.011,
7467,2028966,25211877,BindingDB,"Anthranilic acid deriv., 36",28698,5-chloro-2-({3-[(5-methoxy-4-methyl-1H-indole-1-)sulfonyl]benzene}amido)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28698,9947,Peroxisome proliferator-activated receptor alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9947,Q07869,Peroxisome proliferator-activated receptor alpha,5465.0,PPARA,9606.0,Homo sapiens (human),,IC50 (nM),3162,PMID:18722772|DOI:10.1016/j.bmcl.2008.08.011,https://www.ncbi.nlm.nih.gov/pubmed/18722772|https://doi.org/10.1016/j.bmcl.2008.08.011,18722772,10.1016/j.bmcl.2008.08.011,
7468,2028967,25211877,BindingDB,"Anthranilic acid deriv., 36",28698,5-chloro-2-({3-[(5-methoxy-4-methyl-1H-indole-1-)sulfonyl]benzene}amido)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28698,2209,Peroxisome proliferator-activated receptor gamma,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2209,P37231,Peroxisome proliferator-activated receptor gamma,5468.0,PPARG,9606.0,Homo sapiens (human),,IC50 (nM),3162,PMID:18722772|DOI:10.1016/j.bmcl.2008.08.011,https://www.ncbi.nlm.nih.gov/pubmed/18722772|https://doi.org/10.1016/j.bmcl.2008.08.011,18722772,10.1016/j.bmcl.2008.08.011,
7469,2028978,25211877,BindingDB,"Anthranilic acid deriv., 36",28698,5-chloro-2-({3-[(5-methoxy-4-methyl-1H-indole-1-)sulfonyl]benzene}amido)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28698,9949,Peroxisome proliferator-activated receptor delta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9949,Q03181,Peroxisome proliferator-activated receptor delta,5467.0,PPARD,9606.0,Homo sapiens (human),,IC50 (nM),16,PMID:18722772|DOI:10.1016/j.bmcl.2008.08.011,https://www.ncbi.nlm.nih.gov/pubmed/18722772|https://doi.org/10.1016/j.bmcl.2008.08.011,18722772,10.1016/j.bmcl.2008.08.011,
7470,2028257,25212148,Drug Gene Interaction database (DGIdb),Sitravatinib,,SITRAVATINIB,https://www.dgidb.org/drugs/ncit:C117734,,MET,https://www.dgidb.org/genes/hgnc:7029,,,4233.0,MET,9606.0,Homo sapiens (human),,,,,,,,
7471,2028258,25212148,Drug Gene Interaction database (DGIdb),Sitravatinib,,SITRAVATINIB,https://www.dgidb.org/drugs/ncit:C117734,,MAP3K20,https://www.dgidb.org/genes/hgnc:17797,,,51776.0,MAP3K20,9606.0,Homo sapiens (human),,,,,,,,
7472,2028979,25220903,DrugBank,"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate",DB08585,"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate",https://www.drugbank.ca/drugs/DB08585,BE0004343,Actinorhodin polyketide synthase acyl carrier protein,https://www.drugbank.ca/bio_entities/BE0004343,Q02054,Actinorhodin polyketide synthase acyl carrier protein,,,100226.0,Streptomyces coelicolor A3(2),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
7473,2028980,25220904,DrugBank,"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate",DB08586,"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate",https://www.drugbank.ca/drugs/DB08586,BE0004343,Actinorhodin polyketide synthase acyl carrier protein,https://www.drugbank.ca/bio_entities/BE0004343,Q02054,Actinorhodin polyketide synthase acyl carrier protein,,,100226.0,Streptomyces coelicolor A3(2),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
7474,2028981,25223264,BindingDB,"propan-2-yl 3-[(4-fluorophenyl)carbonyl]-1H,2H,3H,6H-azepino[4,5-b]indole-5-carboxylate",28530,"Azepino[4,5-b]indole, 6a",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28530,2179,Bile acid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2179,Q96RI1,Bile acid receptor,9971.0,NR1H4,9606.0,Homo sapiens (human),,,,PMID:19159286|DOI:10.1021/jm8014124,https://www.ncbi.nlm.nih.gov/pubmed/19159286|https://doi.org/10.1021/jm8014124,19159286,10.1021/jm8014124,
7475,2028982,25223265,BindingDB,"propyl 3-[(4-fluorophenyl)carbonyl]-1H,2H,3H,6H-azepino[4,5-b]indole-5-carboxylate",28531,"Azepino[4,5-b]indole, 6b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28531,2179,Bile acid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2179,Q96RI1,Bile acid receptor,9971.0,NR1H4,9606.0,Homo sapiens (human),,,,PMID:19159286|DOI:10.1021/jm8014124,https://www.ncbi.nlm.nih.gov/pubmed/19159286|https://doi.org/10.1021/jm8014124,19159286,10.1021/jm8014124,
7476,2028983,25223266,BindingDB,"butyl 3-[(4-fluorophenyl)carbonyl]-1H,2H,3H,6H-azepino[4,5-b]indole-5-carboxylate",28532,"Azepino[4,5-b]indole, 6c",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28532,2179,Bile acid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2179,Q96RI1,Bile acid receptor,9971.0,NR1H4,9606.0,Homo sapiens (human),,,,PMID:19159286|DOI:10.1021/jm8014124,https://www.ncbi.nlm.nih.gov/pubmed/19159286|https://doi.org/10.1021/jm8014124,19159286,10.1021/jm8014124,
7477,2028984,25223267,BindingDB,"propan-2-yl 3-[(4-fluorophenyl)carbonyl]-1,1-dimethyl-1H,2H,3H,6H-azepino[4,5-b]indole-5-carboxylate",28541,"Azepino[4,5-b]indole, 6l",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28541,2179,Bile acid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2179,Q96RI1,Bile acid receptor,9971.0,NR1H4,9606.0,Homo sapiens (human),,,,PMID:19159286|DOI:10.1021/jm8014124,https://www.ncbi.nlm.nih.gov/pubmed/19159286|https://doi.org/10.1021/jm8014124,19159286,10.1021/jm8014124,
7478,2028259,25223366,Comparative Toxicogenomics Database (CTD),"2-Amino-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)-7-(naphthalen-1-YL)-5-oxo-4H-chromene-3-carbonitrile",C553295,"2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile",https://ctdbase.org/detail.go?type=chem&acc=C553295,6507,SLC1A3,https://ctdbase.org/detail.go?type=gene&acc=6507,,,6507.0,SLC1A3,10116.0,Rattus norvegicus (Norway rat),"2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile results in decreased activity of SLC1A3 protein",,,PMID:22645130,https://www.ncbi.nlm.nih.gov/pubmed/22645130,22645130,,
7479,2028985,25223366,IUPHAR/BPS Guide to PHARMACOLOGY,"2-Amino-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)-7-(naphthalen-1-YL)-5-oxo-4H-chromene-3-carbonitrile",4609,UCPH-101,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4609,868,Excitatory amino acid transporter 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=868,P43003,Excitatory amino acid transporter 1,6507.0,SLC1A3,9606.0,Homo sapiens (human),Inhibition,pIC50,6.9,PMID:19161278,https://www.ncbi.nlm.nih.gov/pubmed/19161278,19161278,,
7480,2028260,25227436,Chemical Probes Portal,Capivasertib,CAPIVASERTIB,CAPIVASERTIB,https://www.chemicalprobes.org/capivasertib,,AKT1,,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),Inhibitor,,"3 nM, 8 nM",,,,,
7481,2028261,25227436,Chemical Probes Portal,Capivasertib,CAPIVASERTIB,CAPIVASERTIB,https://www.chemicalprobes.org/capivasertib,,AKT2,,P31751,RAC-beta serine/threonine-protein kinase,208.0,AKT2,9606.0,Homo sapiens (human),Inhibitor,,"3 nM, 8 nM",,,,,
7482,2028262,25227436,Chemical Probes Portal,Capivasertib,CAPIVASERTIB,CAPIVASERTIB,https://www.chemicalprobes.org/capivasertib,,AKT3,,Q9Y243,RAC-gamma serine/threonine-protein kinase,10000.0,AKT3,9606.0,Homo sapiens (human),Inhibitor,,"3 nM, 8 nM",,,,,
7483,2028996,25227436,Drug Gene Interaction database (DGIdb),Capivasertib,,CAPIVASERTIB,https://www.dgidb.org/drugs/ncit:C102564,,AKT2,https://www.dgidb.org/genes/hgnc:392,,,208.0,AKT2,9606.0,Homo sapiens (human),,,,,,,,
7484,2028997,25227436,Drug Gene Interaction database (DGIdb),Capivasertib,,CAPIVASERTIB,https://www.dgidb.org/drugs/ncit:C102564,,AKT1,https://www.dgidb.org/genes/hgnc:391,,,207.0,AKT1,9606.0,Homo sapiens (human),,,,,,,,
7485,2028998,25227436,Drug Gene Interaction database (DGIdb),Capivasertib,,CAPIVASERTIB,https://www.dgidb.org/drugs/ncit:C102564,,AKT2,https://www.dgidb.org/genes/hgnc:392,,,208.0,AKT2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7486,2028999,25227436,Drug Gene Interaction database (DGIdb),Capivasertib,,CAPIVASERTIB,https://www.dgidb.org/drugs/ncit:C102564,,PTEN,https://www.dgidb.org/genes/hgnc:9588,,,5728.0,PTEN,9606.0,Homo sapiens (human),,,,,,,,
7487,2029000,25227625,BindingDB,"4-benzoyl-1-(3-nitrophenyl)-5-phenyl-N-(sulfamoyl-1,3,4-thiadiazol-2-yl)-1h-pyrazole-3-carboxamide",238305,"N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]-4-benzoyl-1-(3-nitrophenyl)-5-phenyl-1H-pyrazole-3-carboxamide (1)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238305,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),3.0e+3,PMID:22957724|DOI:10.3109/14756366.2012.712516,https://www.ncbi.nlm.nih.gov/pubmed/22957724|https://doi.org/10.3109/14756366.2012.712516,22957724,10.3109/14756366.2012.712516,
7488,2029001,25227625,BindingDB,"4-benzoyl-1-(3-nitrophenyl)-5-phenyl-N-(sulfamoyl-1,3,4-thiadiazol-2-yl)-1h-pyrazole-3-carboxamide",238305,"N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]-4-benzoyl-1-(3-nitrophenyl)-5-phenyl-1H-pyrazole-3-carboxamide (1)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238305,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),1.40e+3,PMID:22957724|DOI:10.3109/14756366.2012.712516,https://www.ncbi.nlm.nih.gov/pubmed/22957724|https://doi.org/10.3109/14756366.2012.712516,22957724,10.3109/14756366.2012.712516,
7489,2029002,25227625,BindingDB,"4-benzoyl-1-(3-nitrophenyl)-5-phenyl-N-(sulfamoyl-1,3,4-thiadiazol-2-yl)-1h-pyrazole-3-carboxamide",238305,"N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]-4-benzoyl-1-(3-nitrophenyl)-5-phenyl-1H-pyrazole-3-carboxamide (1)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238305,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),3.0e+3,PMID:22957724|DOI:10.3109/14756366.2012.712516,https://www.ncbi.nlm.nih.gov/pubmed/22957724|https://doi.org/10.3109/14756366.2012.712516,22957724,10.3109/14756366.2012.712516,
7490,2029003,25227625,BindingDB,"4-benzoyl-1-(3-nitrophenyl)-5-phenyl-N-(sulfamoyl-1,3,4-thiadiazol-2-yl)-1h-pyrazole-3-carboxamide",238305,"N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]-4-benzoyl-1-(3-nitrophenyl)-5-phenyl-1H-pyrazole-3-carboxamide (1)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238305,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,IC50 (nM),1.4e+3,PMID:22957724|DOI:10.3109/14756366.2012.712516,https://www.ncbi.nlm.nih.gov/pubmed/22957724|https://doi.org/10.3109/14756366.2012.712516,22957724,10.3109/14756366.2012.712516,
7491,2029004,25227625,BindingDB,"4-benzoyl-1-(3-nitrophenyl)-5-phenyl-N-(sulfamoyl-1,3,4-thiadiazol-2-yl)-1h-pyrazole-3-carboxamide",238305,"N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]-4-benzoyl-1-(3-nitrophenyl)-5-phenyl-1H-pyrazole-3-carboxamide (1)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238305,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),4e+2,PMID:22957724|DOI:10.3109/14756366.2012.712516,https://www.ncbi.nlm.nih.gov/pubmed/22957724|https://doi.org/10.3109/14756366.2012.712516,22957724,10.3109/14756366.2012.712516,
7492,2029060,25227625,BindingDB,"4-benzoyl-1-(3-nitrophenyl)-5-phenyl-N-(sulfamoyl-1,3,4-thiadiazol-2-yl)-1h-pyrazole-3-carboxamide",238305,"N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]-4-benzoyl-1-(3-nitrophenyl)-5-phenyl-1H-pyrazole-3-carboxamide (1)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238305,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,IC50 (nM),1.2e+3,PMID:22957724|DOI:10.3109/14756366.2012.712516,https://www.ncbi.nlm.nih.gov/pubmed/22957724|https://doi.org/10.3109/14756366.2012.712516,22957724,10.3109/14756366.2012.712516,
7493,2029135,25227633,IUPHAR/BPS Guide to PHARMACOLOGY,"(3S)-N-hydroxy-4-{4-[(4-hydroxybut-2-yn-1-yl)oxy]benzenesulfonyl}-2,2-dimethylthiomorpholine-3-carboxamide",6486,XMT-1191,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6486,1573,Methionyl aminopeptidase 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1573,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),Inhibition,pIC50,8,,,,,
7494,2029136,25227633,Therapeutic Target Database (TTD),"(3S)-N-hydroxy-4-{4-[(4-hydroxybut-2-yn-1-yl)oxy]benzenesulfonyl}-2,2-dimethylthiomorpholine-3-carboxamide",D0MT5K,XMT-1191,https://idrblab.net/ttd/data/drug/details/D0MT5K,T75596,Methionine aminopeptidase 2 (METAP2),https://idrblab.net/ttd/data/target/details/T75596,P50579,Methionine aminopeptidase 2,10988.0,METAP2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7495,2029061,25229537,DrugBank,"1-[(2-Nitrophenyl)sulfonyl]-1H-pyrrolo[3,2-B]pyridine-6-carboxamide",DB08791,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",https://www.drugbank.ca/drugs/DB08791,BE0000915,Hepatocyte growth factor receptor,https://www.drugbank.ca/bio_entities/BE0000915,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
7496,2029062,25229546,DrugBank,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",DB08602,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",https://www.drugbank.ca/drugs/DB08602,BE0000706,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",https://www.drugbank.ca/bio_entities/BE0000706,Q13946,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",5150.0,PDE7A,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
7497,2029063,25229552,DrugBank,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",DB08118,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",https://www.drugbank.ca/drugs/DB08118,BE0001056,Glucokinase,https://www.drugbank.ca/bio_entities/BE0001056,P35557,Hexokinase-4,2645.0,GCK,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
7498,2028263,25229646,Chemical Probes Portal,1-((4-cyano-4-(pyridin-2-yl)piperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid,MSD-M1PAM,MSD-M1PAM,https://www.chemicalprobes.org/msd-m1pam,,CHRM1,,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606.0,Homo sapiens (human),Positive allosteric modulator,,,,,,,
7499,2029064,25231308,BindingDB,5'-Deoxy-5'-(dimethylamino)-8-methyladenosine,28452,"(2R,3R,4S,5R)-2-(6-amino-8-methyl-9H-purin-9-yl)-5-[(dimethylamino)methyl]oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28452,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),600,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
7500,2029065,25231309,BindingDB,5'-Deoxy-5'-(Dimethylamino)adenosine,28453,"(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-[(dimethylamino)methyl]oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28453,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),9000,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
7501,2029066,25231312,BindingDB,"{[(2S,3S,4R,5R)-5-(6-amino-8-methyl-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}dimethylsulfanium chloride",28454,"AdoMet substrate analogue, 25b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28454,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),3000,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
7502,2029067,25231487,BindingDB,"(2R,3R,4S,5R)-2-[6-amino-8-(methylamino)-9H-purin-9-yl]-5-({[2-(aminooxy)ethyl](methyl)amino}methyl)oxolane-3,4-diol",28423,"(2R,3R,4S,5R)-2-[6-amino-8-(methylamino)-9H-purin-9-yl]-5-({[2-(aminooxy)ethyl](methyl)amino}methyl)oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28423,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),86,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
7503,2029137,25235800,ChEMBL,MK-0941 mesylate,CHEMBL4297302,MK-0941,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297302/,CHEMBL3820,Hexokinase type IV,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3820/,P35557,Hexokinase-4,2645.0,GCK,9606.0,Homo sapiens (human),Hexokinase type IV activator,,,PMID:21994424,https://www.ncbi.nlm.nih.gov/pubmed/21994424,21994424,,
7504,2029138,25254071,Drug Gene Interaction database (DGIdb),Apitolisib,,APITOLISIB,https://www.dgidb.org/drugs/ncit:C91731,,PIK3CD,https://www.dgidb.org/genes/hgnc:8977,,,5293.0,PIK3CD,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7505,2029139,25254071,Drug Gene Interaction database (DGIdb),Apitolisib,,APITOLISIB,https://www.dgidb.org/drugs/ncit:C91731,,PIK3R3,https://www.dgidb.org/genes/hgnc:8981,,,8503.0,PIK3R3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7506,2029140,25254071,Drug Gene Interaction database (DGIdb),Apitolisib,,APITOLISIB,https://www.dgidb.org/drugs/ncit:C91731,,PIK3R1,https://www.dgidb.org/genes/hgnc:8979,,,5295.0,PIK3R1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
7507,2029141,25256198,Therapeutic Target Database (TTD),"5-(3-Chloro-4-fluorophenyl)-3-methyl-3-(pyrimidin-5-ylmethyl)-1-(1H-1,2,4-triazol-3-yl)indolin-2-one",D06NHS,TROX-1,https://idrblab.net/ttd/data/drug/details/D06NHS,T38338,Voltage-gated calcium channel alpha Cav2.2 (CACNA1B),https://idrblab.net/ttd/data/target/details/T38338,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,774.0,CACNA1B,9606.0,Homo sapiens (human),Inhibitor (gating inhibitor),,,,,,,
7508,2029142,25273635,Drug Gene Interaction database (DGIdb),"1H-Isoindol-1-one, 2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-, (+)-",,PAGOCLONE,https://www.dgidb.org/drugs/ncit:C74529,,GABRA2,https://www.dgidb.org/genes/hgnc:4076,,,2555.0,GABRA2,9606.0,Homo sapiens (human),,,,,,,,
7509,2029144,25741246,BindingDB,"NTSR-H4 inhibitor, 3",218813,"NTSR-H4 inhibitor, 3",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=218813,9197,"Neurotensin receptor type 1 [45-272,291-390,C386A,C388A]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9197,P30989,Neurotensin receptor type 1,4923.0,NTSR1,9606.0,Homo sapiens (human),,,,PMID:28032980|DOI:10.1021/acschembio.6b00646,https://www.ncbi.nlm.nih.gov/pubmed/28032980|https://doi.org/10.1021/acschembio.6b00646,28032980,10.1021/acschembio.6b00646,
7510,2029145,25741246,BindingDB,"NTSR-H4 inhibitor, 3",218813,"NTSR-H4 inhibitor, 3",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=218813,9197,"Neurotensin receptor type 1 [45-272,291-390,C386A,C388A]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9197,P30989,Neurotensin receptor type 1,4923.0,NTSR1,9606.0,Homo sapiens (human),,,,PMID:28032980|DOI:10.1021/acschembio.6b00646,https://www.ncbi.nlm.nih.gov/pubmed/28032980|https://doi.org/10.1021/acschembio.6b00646,28032980,10.1021/acschembio.6b00646,
7511,2029143,33008158,BindingDB,TAT-ENA-80bfd3e5-1,496502,TAT-ENA-80bfd3e5-1,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496502,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),975,,,,,
7512,2029146,35397514,Therapeutic Target Database (TTD),"4-Bromanyl-~{n}-(6-Methoxy-1,3-Dimethyl-2-Oxidanylidene-Benzimidazol-5-Yl)-2-Methyl-Benzenesulfonamide",D08RDI,OF-1,https://idrblab.net/ttd/data/drug/details/D08RDI,T41145,Bromodomain and PHD finger containing 1 (BRPF1),https://idrblab.net/ttd/data/target/details/T41145,P55201,Peregrin,7862.0,BRPF1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
